PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hsieh, AC; Liu, Y; Edlind, MP; Ingolia, NT; Janes, MR; Sher, A; Shi, EY; Stumpf, CR; Christensen, C; Bonham, MJ; Wang, SY; Ren, PD; Martin, M; Jessen, K; Feldman, ME; Weissman, JS; Shokat, KM; Rommel, C; Ruggero, D				Hsieh, Andrew C.; Liu, Yi; Edlind, Merritt P.; Ingolia, Nicholas T.; Janes, Matthew R.; Sher, Annie; Shi, Evan Y.; Stumpf, Craig R.; Christensen, Carly; Bonham, Michael J.; Wang, Shunyou; Ren, Pingda; Martin, Michael; Jessen, Katti; Feldman, Morris E.; Weissman, Jonathan S.; Shokat, Kevan M.; Rommel, Christian; Ruggero, Davide			The translational landscape of mTOR signalling steers cancer initiation and metastasis	NATURE			English	Article							TOP MESSENGER-RNAS; PROSTATE-CANCER; STEM-CELLS; IN-VIVO; PROTEIN-SYNTHESIS; PHOSPHORYLATION; RAPAMYCIN; PROMOTES; PATHWAY; COMPLEX	The mammalian target of rapamycin (mTOR) kinase is a master regulator of protein synthesis that couples nutrient sensing to cell growth and cancer. However, the downstream translationally regulated nodes of gene expression that may direct cancer development are poorly characterized. Using ribosome profiling, we uncover specialized translation of the prostate cancer genome by oncogenic mTOR signalling, revealing a remarkably specific repertoire of genes involved in cell proliferation, metabolism and invasion. We extend these findings by functionally characterizing a class of translationally controlled pro-invasion messenger RNAs that we show direct prostate cancer invasion and metastasis downstream of oncogenic mTOR signalling. Furthermore, we develop a clinically relevant ATP site inhibitor of mTOR, INK128, which reprograms this gene expression signature with therapeutic benefit for prostate cancer metastasis, for which there is presently no cure. Together, these findings extend our understanding of how the 'cancerous' translation machinery steers specific cancer cell behaviours, including metastasis, and may be therapeutically targeted.	[Hsieh, Andrew C.; Edlind, Merritt P.; Sher, Annie; Shi, Evan Y.; Stumpf, Craig R.; Christensen, Carly; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA; [Hsieh, Andrew C.; Edlind, Merritt P.; Sher, Annie; Shi, Evan Y.; Stumpf, Craig R.; Christensen, Carly; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Hsieh, Andrew C.] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Hsieh, Andrew C.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Liu, Yi; Janes, Matthew R.; Wang, Shunyou; Ren, Pingda; Martin, Michael; Jessen, Katti; Rommel, Christian] Intellikine Inc, La Jolla, CA 92037 USA; [Ingolia, Nicholas T.] Carnegie Inst Sci, Baltimore, MD 21218 USA; [Bonham, Michael J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Feldman, Morris E.; Weissman, Jonathan S.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Carnegie Institution for Science; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Ruggero, D (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA.	christian@intellikine.com; davide.ruggero@ucsf.edu	Stumpf, Craig/B-8703-2014	Stumpf, Craig/0000-0002-9946-8986; Weissman, Jonathan/0000-0003-2445-670X	American Cancer Society [119084-PF-10-233-01-TBE]; DOD; NIH [R01 CA154916, R01 CA140456]; Phi Beta Psi Sorority; NATIONAL CANCER INSTITUTE [R01CA154916, R01CA140456] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Phi Beta Psi Sorority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Barna for critical discussion and reading of this manuscript; T. Wilson for support and advice; T. Sanders and E. Llagostera-Martin for technical support with confocal microscopy; L. Li, E. Ulm, L. Kessler, J. Kucharski and L. Darjania for technical support for the discovery and development of INK128. J. Kurhanewicz and R. Bok of the Surbeck Institute for Advanced Imaging for technical support and MRI images; N. Sonenberg for providing the 4EBP1/2 double knockout mouse embryonic fibroblasts; J. M. Shen for support; and K. Tong for editing the manuscript. A. C. H. is supported in part by the American Cancer Society (119084-PF-10-233-01-TBE), and is a Prostate Cancer Foundation Young Investigator, and a recipient of the DOD Prostate Cancer Training Award. This work is supported by NIH R01 CA154916 (D. R.), NIH R01 CA140456 (D. R.) and the Phi Beta Psi Sorority (D. R.). D. R. is a Leukemia & Lymphoma Society Scholar.	Amato RJ, 2008, CLIN GENITOURIN CANC, V6, P97, DOI 10.3816/CGC.2008.n.015; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; George D. J, 2008, AM SOC CLIN ONC GEN; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Hofer MD, 2004, CANCER RES, V64, P825, DOI 10.1158/0008-5472.CAN-03-2755; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Nardella C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000189; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; PONTES JE, 1985, J UROLOGY, V134, P1137, DOI 10.1016/S0022-5347(17)47659-2; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Willett M, 2011, BIOCHEM J, V438, P217, DOI 10.1042/BJ20110435; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Zhou P, 2005, J CLIN ONCOL, V23, P6992, DOI 10.1200/JCO.2005.01.2906	41	858	883	2	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					55	U196		10.1038/nature10912	http://dx.doi.org/10.1038/nature10912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22367541	Green Accepted			2022-12-01	WOS:000303451900033
J	Chao, WCH; Kulkarni, K; Zhang, ZG; Kong, EH; Barford, D				Chao, William C. H.; Kulkarni, Kiran; Zhang, Ziguo; Kong, Eric H.; Barford, David			Structure of the mitotic checkpoint complex	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; SPINDLE-ASSEMBLY CHECKPOINT; KEN BOX; PSEUDOSUBSTRATE INHIBITION; MAD2 ACTIVATION; PROTEIN MAD2; CDC20; BINDING; BUBR1; APC/C	In mitosis, the spindle assembly checkpoint (SAC) ensures genome stability by delaying chromosome segregation until all sister chromatids have achieved bipolar attachment to the mitotic spindle. The SAC is imposed by the mitotic checkpoint complex (MCC), whose assembly is catalysed by unattached chromosomes and which binds and inhibits the anaphase-promoting complex/cyclosome (APC/C), the E3 ubiquitin ligase that initiates chromosome segregation. Here, using the crystal structure of Schizosaccharomyces pombe MCC(a complex of mitotic spindle assembly checkpoint proteins Mad2, Mad3 and APC/C co-activator protein Cdc20), we reveal the molecular basis of MCC-mediated APC/C inhibition and the regulation of MCC assembly. The MCC inhibits the APC/C by obstructing degron recognition sites on Cdc20 (the substrate recruitment subunit of the APC/C) and displacing Cdc20 to disrupt formation of a bipartite D-box receptor with the APC/C subunit Apc10. Mad2, in the closed conformation (C-Mad2), stabilizes the complex by optimally positioning the Mad3 KEN-box degron to bind Cdc20. Mad3 and p31(comet) (also known as MAD2L1-binding protein) compete for the same C-Mad2 interface, which explains how p31(comet) disrupts MCC assembly to antagonize the SAC. This study shows how APC/C inhibition is coupled to degron recognition by co-activators.	[Chao, William C. H.; Kulkarni, Kiran; Zhang, Ziguo; Kong, Eric H.; Barford, David] Inst Canc Res, Chester Beatty Labs, Div Struct Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Div Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk		Barford, David/0000-0001-8810-950X; Zhang, Ziguo/0000-0002-7268-9631	Cancer Research UK; ICR; Cancer Research UK [14109] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); ICR; Cancer Research UK(Cancer Research UK)	work was funded by a Cancer Research UK grant to D.B. and an ICR studentship to W.C.H.C. We thank J. Yang and J. He for advice, and staff at the Diamond Light Source beamline I02 for help with data collection.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Choi E, 2008, J BIOL CHEM, V283, P23701, DOI 10.1074/jbc.M803695200; D'Arcy S, 2010, J BIOL CHEM, V285, P14764, DOI 10.1074/jbc.M109.082016; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim S., 2011, SEMIN CELL DEV BIOL; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Ostapenko D, 2008, MOL CELL BIOL, V28, P4653, DOI 10.1128/MCB.00055-08; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Pfleger CM, 2000, GENE DEV, V14, P655; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Zhang YK, 2001, MOL CELL BIOL, V21, P5190, DOI 10.1128/MCB.21.15.5190-5199.2001	61	212	220	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					208	U89		10.1038/nature10896	http://dx.doi.org/10.1038/nature10896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22437499				2022-12-01	WOS:000303149900028
J	Etminan, M; Forooghian, F; Brophy, JM; Bird, ST; Maberley, D				Etminan, Mahyar; Forooghian, Farzin; Brophy, James M.; Bird, Steven T.; Maberley, David			Oral Fluoroquinolones and the Risk of Retinal Detachment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TENDON-RUPTURE; OLDER-ADULTS; CIPROFLOXACIN; TENDINOPATHY; GATIFLOXACIN; COLLAGEN; THERAPY	Context Fluoroquinolones are commonly prescribed classes of antibiotics. Despite numerous case reports of ocular toxicity, a pharmacoepidemiological study of their ocular safety, particularly retinal detachment, has not been performed. Objective To examine the association between use of oral fluoroquinolones and the risk of developing a retinal detachment. Design, Setting, and Patients Nested case-control study of a cohort of patients in British Columbia, Canada, who had visited an ophthalmologist between January 2000 and December 2007. Retinal detachment cases were defined as a procedure code for retinal repair surgery within 14 days of a physician service code. Ten controls were selected for each case using risk-set sampling, matching on age and the month and year of cohort entry. Main Outcome Measure The association between retinal detachment and current, recent, or past use of an oral fluoroquinolone. Results From a cohort of 989 591 patients, 4384 cases of retinal detachment and 43 840 controls were identified. Current use of fluoroquinolones was associated with a higher risk of developing a retinal detachment (3.3% of cases vs 0.6% of controls; adjusted rate ratio [ARR], 4.50 [95% CI, 3.56-5.70]). Neither recent use (0.3% of cases vs 0.2% of controls; ARR, 0.92 [95% CI, 0.45-1.87]) nor past use (6.6% of cases vs 6.1% of controls; ARR, 1.03 [95% CI, 0.89-1.19]) was associated with a retinal detachment. The absolute increase in the risk of a retinal detachment was 4 per 10 000 person-years (number needed to harm=2500 computed for any use of fluoroquinolones). There was no evidence of an association between development of a retinal detachment and beta-lactam antibiotics (ARR, 0.74 [95% CI, 0.35-1.57]) or short-acting beta-agonists (ARR, 0.95 [95% CI, 0.68-1.33]). Conclusion Patients taking oral fluoroquinolones were at a higher risk of developing a retinal detachment compared with nonusers, although the absolute risk for this condition was small. JAMA. 2012;307(13):1414-1419	[Etminan, Mahyar] Child & Family Res Inst British Columbia, Therapeut Evaluat Unit, Vancouver, BC, Canada; [Etminan, Mahyar] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Forooghian, Farzin; Maberley, David] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Brophy, James M.] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Brophy, James M.] McGill Univ, Dept Biostat, Montreal, PQ, Canada; [Brophy, James M.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Bird, Steven T.] US FDA, Ctr Drug Evaluat & Res Off Management, Silver Spring, MD USA; [Bird, Steven T.] Acad Collaborat Program, Silver Spring, MD USA	Child & Family Research Institute; University of British Columbia; University of British Columbia; McGill University; McGill University; McGill University; US Food & Drug Administration (FDA)	Etminan, M (corresponding author), 950 W 28th Ave,Room A4-195, Vancouver, BC V5Z 1L8, Canada.	metminan@popi.ubc.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875	Canadian National Institute for the Blind	Canadian National Institute for the Blind	The study was funded by the Canadian National Institute for the Blind.	Al-Amri AM, 2008, CORNEA, V27, P370, DOI 10.1097/ICO.0b013e31815dcfc4; British Columbia Ministry of Health, PHARMANET; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P374, DOI 10.1016/j.ijantimicag.2006.11.011; Harrell RM, 1999, SOUTHERN MED J, V92, P622, DOI 10.1097/00007611-199906000-00014; Health Canada, 1999, 126410 HLTH CAN; Huybrechts KF, 2011, CAN MED ASSOC J, V183, pE411, DOI 10.1503/cmaj.101406; KEREN G, 1991, INVEST OPHTH VIS SCI, V32, P2388; Khaliq Y, 2003, CLIN INFECT DIS, V36, P1404, DOI 10.1086/375078; Leone R, 2003, DRUG SAFETY, V26, P109, DOI 10.2165/00002018-200326020-00004; Ministry of Health, MED SERV PLAN BRIT C; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Ponsioen TL, 2008, INVEST OPHTH VIS SCI, V49, P4089, DOI 10.1167/iovs.07-1456; Population Data British Columbia, DISCH ABSTR DAT; Rampal S, 2008, HUM EXP TOXICOL, V27, P409, DOI 10.1177/0960327108092295; Reviglio Victor E, 2003, BMC Ophthalmol, V3, P10, DOI 10.1186/1471-2415-3-10; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Samarakoon N, 2007, CLIN EXP OPHTHALMOL, V35, P102, DOI 10.1111/j.1442-9071.2007.01427.x; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sharma T, 2002, RETINA-J RET VIT DIS, V22, P423, DOI 10.1097/00006982-200208000-00005; SIRBAT D, 1983, J FR OPHTALMOL, V6, P829; Sodhi A, 2008, SURV OPHTHALMOL, V53, P50, DOI 10.1016/j.survophthal.2007.10.007; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; SZARFMAN A, 1995, NEW ENGL J MED, V332, P193; Tsai WC, 2011, J ORTHOP RES, V29, P67, DOI 10.1002/jor.21196; US Department of Health and Human Services; US Food and Drug Administration, 21158S018 NDA US DEP; van der Linden PD, 2003, ARCH INTERN MED, V163, P1801, DOI 10.1001/archinte.163.15.1801; van der Linden PD, 2002, BRIT MED J, V324, P1306, DOI 10.1136/bmj.324.7349.1306; Williams JI, 1996, INVENTORY STUDIES AC; Williams RJ, 2000, AM J SPORT MED, V28, P364, DOI 10.1177/03635465000280031401	30	123	125	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1414	1419		10.1001/jama.2012.383	http://dx.doi.org/10.1001/jama.2012.383			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474205	Bronze			2022-12-01	WOS:000302294200028
J	McCloskey, A; Taniguchi, I; Shinmyozu, K; Ohno, M				McCloskey, Asako; Taniguchi, Ichiro; Shinmyozu, Kaori; Ohno, Mutsuhito			hnRNP C Tetramer Measures RNA Length to Classify RNA Polymerase II Transcripts for Export	SCIENCE			English	Article							NUCLEAR RIBONUCLEOPROTEIN-PARTICLES; CAP-BINDING COMPLEX; PRE-MESSENGER-RNA; PROTEINS	Specific RNA recognition is usually achieved by specific RNA sequences and/or structures. However, we show here a mechanism by which RNA polymerase II (Pol II) transcripts are classified according to their length. The heterotetramer of the heterogeneous nuclear ribonucleoprotein (hnRNP) C1/C2 measures the length of the transcripts like a molecular ruler, by selectively binding to the unstructured RNA regions longer than 200 to 300 nucleotides. Thus, the tetramer sorts the transcripts into two RNA categories, to be exported as either messenger RNA or uridine-rich small nuclear RNA (U snRNA), depending on whether or not they are longer than the threshold, respectively. Our findings reveal a new function of the C tetramer and highlight the biological importance of RNA recognition by the length.	[McCloskey, Asako; Taniguchi, Ichiro; Ohno, Mutsuhito] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Shinmyozu, Kaori] RIKEN Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	Kyoto University; RIKEN	Ohno, M (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	hitoohno@virus.kyoto-u.ac.jp		taniguchi, ichiro/0000-0002-9364-2680	Ministry of Education, Culture, Sports, Science and Technology of Japan [20112007]; Grants-in-Aid for Scientific Research [20112001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the members of our laboratory, especially M. Kitabatake and H. Kiriu, for useful suggestions and unpublished materials. We also thank M. Yoshida, H. Miyoshi, and T. Tani for providing us with spliceostatin A (SSA) and the p27 plasmid, the lentiviral transduction system, and pCDNA3.1GST-NES-NLS-GFP, respectively. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "RNA regulation" (20112007) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. A.M. and I.T. performed the experiments, except the mass spectrometric analyses, which were performed by K.S. I.T. initiated the in vitro system. M.O. obtained the funding, designed some experiments, and wrote the manuscript.	BARNETT SF, 1989, MOL CELL BIOL, V9, P492, DOI 10.1128/MCB.9.2.492; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Fuke H, 2008, NUCLEIC ACIDS RES, V36, P1037, DOI 10.1093/nar/gkm1120; HUANG M, 1994, MOL CELL BIOL, V14, P518, DOI 10.1128/MCB.14.1.518; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Masuyama K, 2004, GENE DEV, V18, P2074, DOI 10.1101/gad.1216204; McAfee JG, 1996, BIOCHEMISTRY-US, V35, P1212, DOI 10.1021/bi951974k; Nakielny S, 1996, J CELL BIOL, V134, P1365, DOI 10.1083/jcb.134.6.1365; Nojima T, 2007, J BIOL CHEM, V282, P15645, DOI 10.1074/jbc.M700629200; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Ohno M, 2002, MOL CELL, V9, P659, DOI 10.1016/S1097-2765(02)00454-9; Pawlicki JM, 2010, TRENDS CELL BIOL, V20, P52, DOI 10.1016/j.tcb.2009.10.004; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5	16	110	114	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1643	1646		10.1126/science.1218469	http://dx.doi.org/10.1126/science.1218469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461616				2022-12-01	WOS:000302062600050
J	Nakamura, K; Greenwood, A; Binder, L; Bigio, EH; Denial, S; Nicholson, L; Zhou, XZ; Lu, KP				Nakamura, Kazuhiro; Greenwood, Alex; Binder, Lester; Bigio, Eileen H.; Denial, Sarah; Nicholson, Linda; Zhou, Xiao Zhen; Lu, Kun Ping			Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease	CELL			English	Article							CIS-TRANS ISOMERIZATION; PHOSPHORYLATED-TAU; PROLYL ISOMERIZATION; REGULATORY MECHANISM; MOUSE MODEL; PIN1; PROTEIN; CANCER; MICE; NEURODEGENERATION	cis-trans isomerization of proteins phosphorylated by proline-directed kinases is proposed to control numerous signaling molecules and is implicated in the pathogenesis of Alzheimer's and other diseases. However, there is no direct evidence for the existence of cis-trans protein isomers in vivo or for their conformation-specific function or regulation. Here we develop peptide chemistries that allow the generation of cis- and trans-specific antibodies and use them to raise antibodies specific for isomers of phosphorylated tau. cis, but not trans, p-tau appears early in the brains of humans with mild cognitive impairment, accumulates exclusively in degenerated neurons, and localizes to dystrophic neurites during Alzheimer's progression. Unlike trans p-tau, the cis isomer cannot promote microtubule assembly, is more resistant to dephosphorylation and degradation, and is more prone to aggregation. Pin1 converts cis to trans p-tau to prevent Alzheimer's tau pathology. Isomer-specific antibodies and vaccines may therefore have value for the early diagnosis and treatment of Alzheimer's disease.	[Nakamura, Kazuhiro; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Greenwood, Alex; Denial, Sarah; Nicholson, Linda] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Binder, Lester] Northwestern Univ Feinberg, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Bigio, Eileen H.] Northwestern Univ Feinberg, Sch Med, Dept Pathol, Chicago, IL 60611 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Cornell University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Zhou, XZ (corresponding author), Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	xzhou@bidmc.harvard.edu; klu@bidmc.harvard.edu	Greenwood, Alex/GWU-8292-2022		NIH [P30 AG13854, R01CA122434, R01AG029385, R01AG039405, R01AG17870, R01CA167677]; NATIONAL CANCER INSTITUTE [R01CA122434, R01CA167677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013854, R01AG039405, R01AG029385, R01AG017870] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Lew Cantley and Tony Hunter for insightful advice, Peter Davies for some tau antibodies, Virginia Lee for tau transgenic mice, and the members of the Lu/Zhou laboratories for stimulating discussions. This study was supported by NIH grants P30 AG13854 to the Northwestern Alzheimer Disease Center, R01CA122434 to X.Z.Z., R01AG029385 to L.N. and K.P.L. and R01AG039405, R01AG17870, and R01CA167677 to K.P.L.	An SSA, 1999, J AM CHEM SOC, V121, P11558, DOI 10.1021/ja9930317; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Butterfield DA, 2006, J NEUROCHEM, V98, P1697, DOI 10.1111/j.1471-4159.2006.03995.x; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Davies P, 2000, METH MOLEC MED, V32, P361, DOI 10.1385/1-59259-195-7:361; Dawson HN, 2001, J CELL SCI, V114, P1179; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Ewers M, 2007, NEUROLOGY, V69, P2205, DOI 10.1212/01.wnl.0000286944.22262.ff; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Hamdane M, 2006, MOL CELL NEUROSCI, V32, P155, DOI 10.1016/j.mcn.2006.03.006; Hampel H, 2001, ANN NEUROL, V49, P545, DOI 10.1002/ana.111.abs; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Lee TH, 2011, MOL CELL, V42, P147, DOI 10.1016/j.molcel.2011.03.005; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Li YH, 2006, HUM MOL GENET, V15, P2560, DOI 10.1093/hmg/ddl178; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Ma SL, 2012, J BIOL CHEM, V287, P6969, DOI 10.1074/jbc.C111.298596; Ma SL, 2012, NEUROBIOL AGING, V33, P804, DOI 10.1016/j.neurobiolaging.2010.05.018; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Theuerkorn M, 2011, CURR OPIN PHARMACOL, V11, P281, DOI 10.1016/j.coph.2011.03.007; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008; Yukawa K, 2006, INT J MOL MED, V17, P869; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(05)00083-3; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026	53	182	198	0	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					232	244		10.1016/j.cell.2012.02.016	http://dx.doi.org/10.1016/j.cell.2012.02.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464332	Green Accepted, Bronze			2022-12-01	WOS:000302235400023
J	Onder, TT; Kara, N; Cherry, A; Sinha, AU; Zhu, N; Bernt, KM; Cahan, P; Mancarci, BO; Unternaehrer, J; Gupta, PB; Lander, ES; Armstrong, SA; Daley, GQ				Onder, Tamer T.; Kara, Nergis; Cherry, Anne; Sinha, Amit U.; Zhu, Nan; Bernt, Kathrin M.; Cahan, Patrick; Mancarci, B. Ogan; Unternaehrer, Juli; Gupta, Piyush B.; Lander, Eric S.; Armstrong, Scott A.; Daley, George Q.			Chromatin-modifying enzymes as modulators of reprogramming	NATURE			English	Article							HISTONE METHYLATION; PLURIPOTENT; CELLS; LEUKEMIA; PRC2	Generation of induced pluripotent stem cells (iPSCs) by somatic cell reprogramming involves global epigenetic remodelling(1). Whereas several proteins are known to regulate chromatin marks associated with the distinct epigenetic states of cells before and after reprogramming(2,3), the role of specific chromatin-modifying enzymes in reprogramming remains to be determined. To address how chromatin-modifying proteins influence reprogramming, we used short hairpin RNAs (shRNAs) to target genes in DNA and histone methylation pathways, and identified positive and negative modulators of iPSC generation. Whereas inhibition of the core components of the polycomb repressive complex 1 and 2, including the histone 3 lysine 27 methyltransferase EZH2, reduced reprogramming efficiency, suppression of SUV39H1, YY1 and DOT1L enhanced reprogramming. Specifically, inhibition of the H3K79 histone methyltransferase DOT1L by shRNA or a small molecule accelerated reprogramming, significantly increased the yield of iPSC colonies, and substituted for KLF4 and c-Myc (also known as MYC). Inhibition of DOT1L early in the reprogramming process is associated with a marked increase in two alternative factors, NANOG and LIN28, which play essential functional roles in the enhancement of reprogramming. Genome-wide analysis of H3K79me2 distribution revealed that fibroblast-specific genes associated with the epithelial to mesenchymal transition lose H3K79me2 in the initial phases of reprogramming. DOT1L inhibition facilitates the loss of this mark from genes that are fated to be repressed in the pluripotent state. These findings implicate specific chromatin-modifying enzymes as barriers to or facilitators of reprogramming, and demonstrate how modulation of chromatinmodifying enzymes can be exploited to more efficiently generate iPSCs with fewer exogenous transcription factors.	[Onder, Tamer T.; Cherry, Anne; Cahan, Patrick; Unternaehrer, Juli; Daley, George Q.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Onder, Tamer T.; Cherry, Anne; Cahan, Patrick; Unternaehrer, Juli; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Onder, Tamer T.; Cherry, Anne; Cahan, Patrick; Unternaehrer, Juli; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Onder, Tamer T.; Cherry, Anne; Zhu, Nan; Bernt, Kathrin M.; Cahan, Patrick; Unternaehrer, Juli; Armstrong, Scott A.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Onder, Tamer T.; Cherry, Anne; Cahan, Patrick; Unternaehrer, Juli; Daley, George Q.] Childrens Hosp Boston, Stem Cell Program, Boston, MA 02115 USA; [Kara, Nergis] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Sinha, Amit U.; Zhu, Nan; Bernt, Kathrin M.; Armstrong, Scott A.; Daley, George Q.] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Sinha, Amit U.; Zhu, Nan; Bernt, Kathrin M.; Armstrong, Scott A.] Harvard Univ, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; [Mancarci, B. Ogan] Bilkent Univ, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey; [Gupta, Piyush B.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Gupta, Piyush B.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lander, Eric S.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Ihsan Dogramaci Bilkent University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA.	George.Daley@childrens.harvard.edu	Cherry, Anne/E-7333-2011; Bernt, Kathrin/L-1826-2016; Onder, Tamer T/H-3330-2013; Onder, Tamer/O-3669-2019	Bernt, Kathrin/0000-0002-5400-0482; Onder, Tamer T/0000-0002-2372-9158; Onder, Tamer/0000-0002-2372-9158; Cahan, Patrick/0000-0003-3652-2540; Bernt, Kathrin/0000-0002-0691-356X; Mancarci, B. Ogan/0000-0002-1452-0889; Kara, Nergis/0000-0002-7891-0747; Unternaehrer-Hamm, Julia/0000-0001-5864-4704	US National Institutes of Health (NIH) [CA140575]; CHB Stem Cell Program; NATIONAL CANCER INSTITUTE [R01CA140575] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092760] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHB Stem Cell Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Hu and S. J. Elledge for providing the MSCV-PM vector, K. Ng and M. W. Lensch for teratoma injections and assessment and S. Loewer for discussions. We also thank E. Olhava and Epizyme Inc. for synthesizing and providing the DOT1L inhibitor, EPZ004777. G. Q. D. is an investigator of the Howard Hughes Medical Institute. Research was funded by grants from the US National Institutes of Health (NIH) to S. A. A. (CA140575) and G. Q. D., and the CHB Stem Cell Program.	Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schotta G, 2003, GENETICA, V117, P149, DOI 10.1023/A:1022923508198; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Stulemeijer IJE, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-2; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	30	470	495	1	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					598	U119		10.1038/nature10953	http://dx.doi.org/10.1038/nature10953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22388813	Green Accepted, Green Submitted, Green Published			2022-12-01	WOS:000302006100039
J	Raviglione, M; Zumla, A; Marais, B; Horton, R; Motsoaledi, A				Raviglione, Mario; Zumla, Alimuddin; Marais, Ben; Horton, Richard; Motsoaledi, Aaron			A sustainable agenda for tuberculosis control and research	LANCET			English	Editorial Material									[Raviglione, Mario] WHO, STOP TB Dept, CH-1211 Geneva, Switzerland; [Zumla, Alimuddin] UCL, Dept Infect, Div Infect & Immun, London, England; [Marais, Ben] Univ Sydney, Sydney Inst Emerging Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Marais, Ben] Univ Sydney, Childrens Hosp Westmead, Sydney, NSW 2006, Australia; [Horton, Richard] The Lancet, London NW1 7BY, England; [Motsoaledi, Aaron] Govt S Africa, Minist Hlth, Pretoria, South Africa	World Health Organization; University of London; University College London; University of Sydney; University of Sydney	Raviglione, M (corresponding author), WHO, STOP TB Dept, CH-1211 Geneva, Switzerland.	raviglionem@who.int	ZUMLA, Alimuddin/ABA-8208-2020; Marais, Ben/AAX-2626-2021	ZUMLA, Alimuddin/0000-0002-5111-5735; RAVIGLIONE, Mario/0000-0002-9331-2067				[Anonymous], 2012, LANCET, V379, P193, DOI 10.1016/S0140-6736(12)60081-6; [Anonymous], 2011, LANCET, V378, P1198, DOI 10.1016/S0140-6736(11)61526-2; [Anonymous], 2012, RIO 20 UN C SUST DEV; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P261; Dye C, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P289; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, POL STAT AUT REAL TI	9	16	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2012	379	9821					1077	1078		10.1016/S0140-6736(12)60373-0	http://dx.doi.org/10.1016/S0140-6736(12)60373-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916VR	22444391				2022-12-01	WOS:000302131800007
J	Pavia, AT				Pavia, Andrew T.			Laboratory Creation of a Highly Transmissible H5N1 Influenza Virus: Balancing Substantial Risks and Real Benefits	ANNALS OF INTERNAL MEDICINE			English	Article							RECEPTOR-BINDING; HUMAN INFECTION; HEMAGGLUTININ	Controversy erupted when influenza researchers announced that they had created an H5N1 influenza virus that was transmissible between ferrets. The controversy escalated when the National Science Advisory Board for Biosecurity (NSABB) recommended that the work be published but recommended significant voluntary redactions. The responses to the NSABB action and to the research itself have been polarized. A readily transmitted H5N1 virus could be extraordinarily lethal; therefore, the risk for accidental release is significant, and deliberate misuse of the data to create a biological weapon is possible. However, the knowledge gained by these and future experiments under appropriate safeguards is likely to allow critical understanding of influenza transmission and virulence. It would be irresponsible to adopt either extreme solution: to prevent and censor the research or to allow unlimited distribution without careful review by an independent group, such as the NSABB.	Univ Utah, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah	Pavia, AT (corresponding author), Univ Utah, 295 Chipeta Way, Salt Lake City, UT 84108 USA.	andy.pavia@hsc.utah.edu						Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], 2012, NY TIMES        0107; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Belser JA, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001705; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Enserink M, 2011, SCIENCE, V334, P1192, DOI 10.1126/science.334.6060.1192; Garcia-Sastre A, 2006, J INFECT DIS, V194, pS127, DOI 10.1086/507546; Grady D, 2011, NY TIMES        1220; Inglesby TV, 2011, BIOSECUR BIOTERROR; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; National Science Advisory Board for Biosecurity, 2007, PROP FRAM OVERS DUAL; National Science Advisory Board for Biosecurity, 2011, GUID ENH PERS REL ST; O'Toole T, 2009, BIOSECUR BIOTERROR, V7, P25, DOI 10.1089/bsp.2009.1001; Palese P, 2012, NATURE, V481, P115, DOI 10.1038/481115a; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tumpey TM, 2009, ANNU REV MICROBIOL, V63, P79, DOI 10.1146/annurev.micro.091208.073359; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Uyeki TM, 2009, CLIN INFECT DIS, V49, P279, DOI 10.1086/600035; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; WHO, 2012, CUM NUMB CONF HUM CA; Yen HL, 2009, P NATL ACAD SCI USA, V106, P286, DOI 10.1073/pnas.0811052106	27	3	3	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2012	156	6					463	U125		10.7326/0003-4819-156-6-201203200-00386	http://dx.doi.org/10.7326/0003-4819-156-6-201203200-00386			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PF	22282172				2022-12-01	WOS:000303150900019
J	McNally, EM				McNally, Elizabeth M.			GENETICS Broken giant linked to heart failure	NATURE			English	Editorial Material							DILATED CARDIOMYOPATHY; TITIN		[McNally, Elizabeth M.] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; [McNally, Elizabeth M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	McNally, EM (corresponding author), Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA.	emcnally@uchicago.edu	McNally, Elizabeth/W-4909-2019	McNally, Elizabeth/0000-0002-1221-719X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL061322] Funding Source: Medline; NIAMS NIH HHS [U54 AR052646] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; Gautel M, 2011, PFLUG ARCH EUR J PHY, V462, P119, DOI 10.1007/s00424-011-0946-1; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Miller MK, 2004, TRENDS CELL BIOL, V14, P119, DOI 10.1016/j.tcb.2004.01.003; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; van Rijsingen IAW, 2012, J AM COLL CARDIOL, V59, P493, DOI 10.1016/j.jacc.2011.08.078	8	10	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					281	282		10.1038/483281a	http://dx.doi.org/10.1038/483281a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22422258	Green Accepted			2022-12-01	WOS:000301481800035
J	Roh-Johnson, M; Shemer, G; Higgins, CD; McClellan, JH; Werts, AD; Tulu, US; Gao, L; Betzig, E; Kiehart, DP; Goldstein, B				Roh-Johnson, Minna; Shemer, Gidi; Higgins, Christopher D.; McClellan, Joseph H.; Werts, Adam D.; Tulu, U. Serdar; Gao, Liang; Betzig, Eric; Kiehart, Daniel P.; Goldstein, Bob			Triggering a Cell Shape Change by Exploiting Preexisting Actomyosin Contractions	SCIENCE			English	Article							C-ELEGANS GASTRULATION; TISSUE MORPHOGENESIS; APICAL CONSTRICTION; DORSAL CLOSURE; CORTICAL FLOWS; FORCES; DROSOPHILA; POLARITY; INVAGINATION; INTEGRATION	Apical constriction changes cell shapes, driving critical morphogenetic events, including gastrulation in diverse organisms and neural tube closure in vertebrates. Apical constriction is thought to be triggered by contraction of apical actomyosin networks. We found that apical actomyosin contractions began before cell shape changes in both Caenorhabitis elegans and Drosophila. In C. elegans, actomyosin networks were initially dynamic, contracting and generating cortical tension without substantial shrinking of apical surfaces. Apical cell-cell contact zones and actomyosin only later moved increasingly in concert, with no detectable change in actomyosin dynamics or cortical tension. Thus, apical constriction appears to be triggered not by a change in cortical tension, but by dynamic linking of apical cell-cell contact zones to an already contractile apical cortex.	[Roh-Johnson, Minna; Shemer, Gidi; Higgins, Christopher D.; McClellan, Joseph H.; Werts, Adam D.; Goldstein, Bob] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Tulu, U. Serdar; Kiehart, Daniel P.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Gao, Liang; Betzig, Eric] Howard Hughes Med Inst, Ashburn, VA 20147 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Howard Hughes Medical Institute	Goldstein, B (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	bobg@unc.edu		Werts, Adam/0000-0002-8977-5704; Goldstein, Bob/0000-0001-6961-675X	NIH [R01 GM083071, R01 GM33830]; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033830, R01GM083071] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Bloom, G. Edwards, J. Iwasa, J. Johnson, E. Munro, M. Peifer, D. Reiner, S. Rogers, and members of the Goldstein lab for comments on the manuscript; B. Eastwood and R. Taylor for help with particle image velocimetry; J. Fricks for help with statistical analysis; and A. Martin and E. Wieschaus for providing fly strains and sharing movies. This work was supported by NIH R01 GM083071 to B.G., NIH R01 GM33830 to D.P.K., and a Human Frontier Science Program postdoctoral fellowship to G.S. Data reported in this paper are presented in the main paper and in the supporting online material. U.S. patent application no. 13/160,492 concerning Bessel beam plane illumination microscopy has been filed by the Howard Hughes Medical Institute on behalf of E.B.	Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Grill SW, 2011, CURR OPIN GENET DEV, V21, P647, DOI 10.1016/j.gde.2011.09.005; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Kasza KE, 2011, CURR OPIN CELL BIOL, V23, P30, DOI 10.1016/j.ceb.2010.10.014; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Lee JY, 2006, CURR BIOL, V16, P1986, DOI 10.1016/j.cub.2006.08.090; Lee JY, 2010, CURR BIOL, V20, P253, DOI 10.1016/j.cub.2009.12.021; Lee JY, 2003, DEVELOPMENT, V130, P307, DOI 10.1242/dev.00211; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nance J, 2002, DEVELOPMENT, V129, P387; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103	29	172	177	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2012	335	6073					1232	1235		10.1126/science.1217869	http://dx.doi.org/10.1126/science.1217869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22323741	Green Accepted, Green Submitted			2022-12-01	WOS:000301225100047
J	Chisholm, D; Saxena, S				Chisholm, Dan; Saxena, Shekhar			Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study	BRITISH MEDICAL JOURNAL			English	Article							MIDDLE-INCOME COUNTRIES; POPULATION-LEVEL ANALYSIS; MENTAL-HEALTH; GLOBAL BURDEN; DEVELOPING-WORLD; DISORDERS; INTERVENTIONS	Objective To assess the comparative costs and effects of interventions to combat five neuropsychiatric conditions (schizophrenia, bipolar disorder, depression, epilepsy, and heavy alcohol use). Design Cost effectiveness analysis based on an epidemiological model. Setting Two epidemiologically defined World Health Organization sub-regions of the world: countries in sub-Saharan Africa with very high adult and high child mortality (AfrE); and countries in South East Asia with high adult and high child mortality (SearD). Data sources Published studies, costing databases. Main outcome measures Cost per capita and cost per disability adjusted life year (DALY) averted, expressed in international dollars ($Int) for the year 2005. Results Across 44 assessed intervention strategies for the five neuropsychiatric conditions, cost effectiveness values differed by as much as two orders of magnitude (from $Int100-250 to $Int10 000-25 000 for a year of healthy life gained). In both sub-regions, inpatient based treatment of schizophrenia with newer antipsychotic drugs was the most costly and least cost effective strategy. The most cost effective strategies in the African sub-region related to population based alcohol control, while in the South East Asian sub-region the most cost effective intervention was drug treatment of epilepsy in primary care. The cumulative cost per capita of the most cost effective set of interventions covering all five conditions was estimated at $Int4.90-5.70. This package comprises interventions for epilepsy (older first line antiepileptic drugs); depression (generically produced newer antidepressants and psychosocial treatment); bipolar disorder (mood stabiliser drug lithium); schizophrenia (neuroleptic antipsychotic drugs and psychosocial treatment); and heavy alcohol use (increased taxation and its enforcement, reduced access, and, in the African sub-region, advertising bans and brief advice to heavy drinkers in primary care). Conclusions Reallocation of resources to cost effective intervention strategies would increase health gain, save money and help implement much needed expansion of services for neuropsychiatric conditions in low resource settings.	[Chisholm, Dan] World Hlth Org, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland; [Saxena, Shekhar] World Hlth Org, Dept Mental Hlth & Substance Abuse, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization	Chisholm, D (corresponding author), World Hlth Org, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland.	chisholmd@who.int						Babor T., 2003, ALCOHOL NO ORDINARY; Chisholm D, 2005, BRIT J PSYCHIAT, V187, P559, DOI 10.1192/bjp.187.6.559; Chisholm D, 2005, EPILEPSIA, V46, P751, DOI 10.1111/j.1528-1167.2005.52704.x; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Chisholm D, 2004, BRIT J PSYCHIAT, V184, P393, DOI 10.1192/bjp.184.5.393; Chisholm D, 2008, B WORLD HEALTH ORGAN, V86, P542, DOI 10.2471/BLT.07.045377; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Engel J., 1997, EPILEPSY COMPREHENSI; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Ferri C, 2004, SOC PSYCH PSYCH EPID, V39, P218, DOI 10.1007/s00127-004-0729-5; Gureje O, 2007, WORLD PSYCHIATRY, V6, P42; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x; Nathan P. E., 2002, GUIDE TREATMENTS WOR; Rehm J., 2004, COMP QUANTIFICATION; Sabate E., 2003, ADHERENCE LONG TERM; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Tan-Torres ET, 2003, MAKING CHOICES HLTH, V1; World Health Organisation, 2010, GLOB STRAT RED HARMF; World health organization, 2006, DOLLARS DALYS DECISI; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization, 2020, GLOBAL REPORT EPIDEM; World Health Organization, 2008, MHGAP MENT HLTH GAP	28	65	65	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2012	344								e609	10.1136/bmj.e609	http://dx.doi.org/10.1136/bmj.e609			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XQ	22389339	Green Published, hybrid			2022-12-01	WOS:000301232600004
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING How can we treat multiple chronic conditions?	BRITISH MEDICAL JOURNAL			English	Editorial Material							MULTIMORBIDITY; PREVALENCE; CHALLENGES; CARE					dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Chen HY, 2011, PREV CHRONIC DIS, V8; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Institute of Medicine, 2012, BRIT MED J, DOI DOI 10.1136/BMJ.D4265; Institute of Medicine, 2012, LIV WELL CHRON ILLN; KAMEROW DB, 2011, BRIT MED J, V342, P1004; Soubhi H, 2010, ANN FAM MED, V8, P170, DOI 10.1370/afm.1056; Stange KC, 2012, JAMA-J AM MED ASSOC, V10, P2; Stange KC, 2012, ANN FAM MED, V10, P2, DOI 10.1370/afm.1354; Tinetti ME, 2011, NEW ENGL J MED, V364, P2478, DOI 10.1056/NEJMp1100535; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	12	15	15	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 29	2012	344								e1487	10.1136/bmj.e1487	http://dx.doi.org/10.1136/bmj.e1487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XE	22378931				2022-12-01	WOS:000301231400007
J	Schwartz, SD; Hubschman, JP; Heilwell, G; Franco-Cardenas, V; Pan, CK; Ostrick, RM; Mickunas, E; Gay, R; Klimanskaya, I; Lanza, R				Schwartz, Steven D.; Hubschman, Jean-Pierre; Heilwell, Gad; Franco-Cardenas, Valentina; Pan, Carolyn K.; Ostrick, Rosaleen M.; Mickunas, Edmund; Gay, Roger; Klimanskaya, Irina; Lanza, Robert			Embryonic stem cell trials for macular degeneration: a preliminary report	LANCET			English	Article							RETINAL-PIGMENT EPITHELIUM; TRANSPLANTATION; TRANSLOCATION; MORPHOLOGY; RPE	Background It has been 13 years since the discovery of human embryonic stem cells (hESCs). Our report provides the first description of hESC-derived cells transplanted into human patients. Methods We started two prospective clinical studies to establish the safety and tolerability of subretinal transplantation of hESC-derived retinal pigment epithelium (RPE) in patients with Stargardt's macular dystrophy and dry age-related macular degeneration-the leading cause of blindness in the developed world. Preoperative and postoperative ophthalmic examinations included visual acuity, fluorescein angiography, optical coherence tomography, and visual field testing. These studies are registered with ClinicalTrials.gov, numbers NCT01345006 and NCT01344993. Findings Controlled hESC differentiation resulted in greater than 99% pure RPE. The cells displayed typical RPE behaviour and integrated into the host RPE layer forming mature quiescent monolayers after trans plantation in animals. The stage of differentiation substantially affected attachment and survival of the cells in vitro after clinical formulation. Lightly pigmented cells attached and spread in a substantially greater proportion (>90%) than more darkly pigmented cells after culture. After surgery, structural evidence confirmed cells had attached and continued to persist during our study. We did not identify signs of hyperproliferation, abnormal growth, or immune mediated transplant rejection in either patient during the first 4 months. Although there is little agreement between investigators on visual endpoints in patients with low vision, it is encouraging that during the observation period neither patient lost vision. Best corrected visual acuity improved from hand motions to 20/800 (and improved from 0 to 5 letters on the Early Treatment Diabetic Retinopathy Study [ETDRS] visual acuity chart) in the study eye of the patient with Stargardt's macular dystrophy, and vision also seemed to improve in the patient with dry age-related macular degeneration (from 21 ETDRS letters to 28). Interpretation The hESC-derived RPE cells showed no signs of hyperproliferation, tumorigenicity, ectopic tissue formation, or apparent rejection after 4 months. The future therapeutic goal will be to treat patients earlier in the disease processes, potentially increasing the likelihood of photoreceptor and central visual rescue.	[Schwartz, Steven D.; Hubschman, Jean-Pierre; Heilwell, Gad; Franco-Cardenas, Valentina; Pan, Carolyn K.; Ostrick, Rosaleen M.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90095 USA; [Mickunas, Edmund; Gay, Roger; Klimanskaya, Irina; Lanza, Robert] Adv Cell Technol, Marlborough, MA 01752 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schwartz, SD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90095 USA.	schwartz@jsei.ucla.edu; rlanza@advancedcell.com		Pan, Carolyn/0000-0002-1031-7488; Hubschman, Jean-Pierre/0000-0002-8631-3467; Lanza, Robert/0000-0002-3047-3074	Advanced Cell Technology	Advanced Cell Technology	Advanced Cell Technology.	Aisenbrey S, 2006, ARCH OPHTHALMOL-CHIC, V124, P183, DOI 10.1001/archopht.124.2.183; ALGVERE PV, 1994, GRAEF ARCH CLIN EXP, V232, P707, DOI 10.1007/BF00184273; Binder S, 2004, INVEST OPHTH VIS SCI, V45, P4151, DOI 10.1167/iovs.04-0118; Binder S, 2002, AM J OPHTHALMOL, V133, P215, DOI 10.1016/S0002-9394(01)01373-3; Bull ND, 2011, STEM CELLS, V29, P1170, DOI 10.1002/stem.676; Chakravarthy U, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c981; Del Priore LV, 1998, ARCH OPHTHALMOL-CHIC, V116, P335, DOI 10.1001/archopht.116.3.335; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Fink DW, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, P619, DOI 10.1016/B978-0-12-374729-7.00068-8; Gamm DM, 2008, STEM CELLS, V26, P3182, DOI 10.1634/stemcells.2008-0300; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Kaplan H J, 1999, Chem Immunol, V73, P207; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Klimanskaya I, 2005, LANCET, V365, P1636, DOI 10.1016/S0140-6736(05)66473-2; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703; Lappas A, 2000, GRAEF ARCH CLIN EXP, V238, P631, DOI 10.1007/s004170000149; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Lu F, 2007, MOL VIS, V13, P2066; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; MacLaren RE, 2005, OPHTHALMOLOGY, V112, P2081, DOI 10.1016/j.ophtha.2005.06.029; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Okamura RM, 2007, J NEUROIMMUNOL, V192, P134, DOI 10.1016/j.jneuroim.2007.09.030; SONG MK, 1990, J CELL PHYSIOL, V143, P196, DOI 10.1002/jcp.1041430127; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tezel TH, 1998, EXP EYE RES, V66, P807, DOI 10.1006/exer.1998.0492; Tezel TH, 2007, AM J OPHTHALMOL, V143, P584, DOI 10.1016/j.ajo.2006.12.007; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thumann G, 2000, ARCH OPHTHALMOL-CHIC, V118, P1350	31	988	1073	12	318	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2012	379	9817					713	720		10.1016/S0140-6736(12)60028-2	http://dx.doi.org/10.1016/S0140-6736(12)60028-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	899CU	22281388				2022-12-01	WOS:000300792600027
J	Chung, HS; McHale, K; Louis, JM; Eaton, WA				Chung, Hoi Sung; McHale, Kevin; Louis, John M.; Eaton, William A.			Single-Molecule Fluorescence Experiments Determine Protein Folding Transition Path Times	SCIENCE			English	Article							BETA-HAIRPIN FORMATION; ENERGY LANDSCAPE; DYNAMICS; SIMULATIONS; INTERMEDIATE; COEFFICIENTS; MECHANISM; FUNNELS; DOMAIN; STATES	The transition path is the tiny fraction of an equilibrium molecular trajectory when a transition occurs as the free-energy barrier between two states is crossed. It is a single-molecule property that contains all the mechanistic information on how a process occurs. As a step toward observing transition paths in protein folding, we determined the average transition-path time for a fast- and a slow-folding protein from a photon-by-photon analysis of fluorescence trajectories in single-molecule Forster resonance energy transfer experiments. Whereas the folding rate coefficients differ by a factor of 10,000, the transition-path times differ by a factor of less than 5, which shows that a fast- and a slow-folding protein take almost the same time to fold when folding actually happens. A very simple model based on energy landscape theory can explain this result.	[Chung, Hoi Sung; McHale, Kevin; Louis, John M.; Eaton, William A.] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chung, HS (corresponding author), NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.	chunghoi@niddk.nih.gov; eaton@helix.nih.gov	Chung, Hoi Sung/C-2624-2009	Chung, Hoi Sung/0000-0001-6897-4969; Louis, John M/0000-0002-0052-1899	National Institute of Diabetes and Digestive and Kidney Diseases, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029055, ZIADK029053] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank I. Gopich, A. Szabo, and G. Hummer for numerous helpful discussions and A. Aniana for technical assistance in the expression and purification of proteins. This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH.	Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; Bowman GR, 2010, P NATL ACAD SCI USA, V107, P10890, DOI 10.1073/pnas.1003962107; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Cellmer T, 2008, P NATL ACAD SCI USA, V105, P18320, DOI 10.1073/pnas.0806154105; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; Gopich IV, 2009, J PHYS CHEM B, V113, P10965, DOI 10.1021/jp903671p; Hummer G, 2004, J CHEM PHYS, V120, P516, DOI 10.1063/1.1630572; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kubelka J, 2008, P NATL ACAD SCI USA, V105, P18655, DOI 10.1073/pnas.0808600105; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Liu F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3262489; McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971; Morrone A, 2011, BIOPHYS J, V101, P2053, DOI 10.1016/j.bpj.2011.09.013; Nguyen H, 2003, P NATL ACAD SCI USA, V100, P3948, DOI 10.1073/pnas.0538054100; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Park SH, 1999, NAT STRUCT BIOL, V6, P943, DOI 10.1038/13311; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Socci ND, 1996, J CHEM PHYS, V104, P5860, DOI 10.1063/1.471317; Wensley BG, 2010, NATURE, V463, P685, DOI 10.1038/nature08743; Yeh IC, 2004, J PHYS CHEM B, V108, P15873, DOI 10.1021/jp0477147	23	299	301	7	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					981	984		10.1126/science.1215768	http://dx.doi.org/10.1126/science.1215768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363011	Green Accepted			2022-12-01	WOS:000300931800050
J	Zauber, AG; Winawer, SJ; O'Brien, MJ; Lansdorp-Vogelaar, I; van Ballegooijen, M; Hankey, BF; Shi, WJ; Bond, JH; Schapiro, M; Panish, JF; Stewart, ET; Waye, JD				Zauber, Ann G.; Winawer, Sidney J.; O'Brien, Michael J.; Lansdorp-Vogelaar, Iris; van Ballegooijen, Marjolein; Hankey, Benjamin F.; Shi, Weiji; Bond, John H.; Schapiro, Melvin; Panish, Joel F.; Stewart, Edward T.; Waye, Jerome D.			Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FECAL-OCCULT-BLOOD; SOCIETY-TASK-FORCE; SCREENING COLONOSCOPY; NEGATIVE COLONOSCOPY; ADENOMATOUS POLYPS; QUALITY INDICATORS; NATIONAL POLYP; SOJOURN TIME; RISK; MORTALITY	BACKGROUND In the National Polyp Study (NPS), colorectal cancer was prevented by colonoscopic removal of adenomatous polyps. We evaluated the long-term effect of colonoscopic polypectomy in a study on mortality from colorectal cancer. METHODS We included in this analysis all patients prospectively referred for initial colonoscopy (between 1980 and 1990) at NPS clinical centers who had polyps (adenomas and nonadenomas). The National Death Index was used to identify deaths and to determine the cause of death; follow-up time was as long as 23 years. Mortality from colorectal cancer among patients with adenomas removed was compared with the expected incidence-based mortality from colorectal cancer in the general population, as estimated from the Surveillance Epidemiology and End Results (SEER) Program, and with the observed mortality from colorectal cancer among patients with nonadenomatous polyps (internal control group). RESULTS Among 2602 patients who had adenomas removed during participation in the study, after a median of 15.8 years, 1246 patients had died from any cause and 12 had died from colorectal cancer. Given an estimated 25.4 expected deaths from colorectal cancer in the general population, the standardized incidence-based mortality ratio was 0.47 (95% confidence interval [CI], 0.26 to 0.80) with colonoscopic polypectomy, suggesting a 53% reduction in mortality. Mortality from colorectal cancer was similar among patients with adenomas and those with nonadenomatous polyps during the first 10 years after polypectomy (relative risk, 1.2; 95% CI, 0.1 to 10.6). CONCLUSIONS These findings support the hypothesis that colonoscopic removal of adenomatous polyps prevents death from colorectal cancer. (Funded by the National Cancer Institute and others.)	[Zauber, Ann G.; Shi, Weiji] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Winawer, Sidney J.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Waye, Jerome D.] Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA; [O'Brien, Michael J.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Lansdorp-Vogelaar, Iris; van Ballegooijen, Marjolein] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Hankey, Benjamin F.] CANSTAT, Plano, TX USA; [Bond, John H.] Minneapolis Vet Affairs Med Ctr, Dept Med, Minneapolis, MN USA; [Schapiro, Melvin] Valley Presbyterian Hosp, Dept Med, Van Nuys, CA USA; [Panish, Joel F.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Stewart, Edward T.] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Boston University; Erasmus University Rotterdam; Erasmus MC; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Cedars Sinai Medical Center; Medical College of Wisconsin	Zauber, AG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 307 E 63rd St, New York, NY 10065 USA.	zaubera@mskcc.org	O'Brien, Michael J/R-7179-2019; Hug, Balthasar L./G-1568-2010	O'Brien, Michael J/0000-0003-1124-3537	National Cancer Institute [R01 CA026852, R01 CA046940, R01 CA079572, U01 CA097426, U01 CA115953, U01 CA152959]; Society of Memorial Sloan-Kettering Cancer Center; Tavel-Reznik Fund; Cantor Colon Cancer Fund; NATIONAL CANCER INSTITUTE [U01CA115953, P30CA008748, R01CA079572, U01CA152959, R01CA026852, U01CA097426, R01CA046940] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Society of Memorial Sloan-Kettering Cancer Center; Tavel-Reznik Fund; Cantor Colon Cancer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Cancer Institute (R01 CA026852 and R01 CA046940, to Drs. Zauber, Winawer, O'Brien, Bond, Schapiro, Panish, Stewart, and Waye; R01 CA079572, to Drs. Zauber, Winawer, O'Brien, and Bond; and U01 CA097426, U01 CA115953, and U01 CA152959, to Drs. Zauber, Winawer, O'Brien, Lansdorp-Vogelaar, and van Ballegooijen); and by funding from the Society of Memorial Sloan-Kettering Cancer Center (to Dr. Zauber), the Tavel-Reznik Fund (to Drs. Zauber and Winawer), and the Cantor Colon Cancer Fund (to Dr. Winawer).	Atkin W, 2004, GASTROENTEROLOGY, V126, P1247, DOI 10.1053/j.gastro.2004.01.023; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brenner H, 2010, GASTROENTEROLOGY, V138, P870, DOI 10.1053/j.gastro.2009.10.054; Breslow NE, 1987, STAT METHODS CANC RE; Bretthauer M, 2009, NEW ENGL J MED, V361, P300, DOI 10.1056/NEJMe0903924; Centers for Disease Control and Prevention, 2011, NAT DEATH IND; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; CHU KC, 1994, J CLIN EPIDEMIOL, V47, P1451, DOI 10.1016/0895-4356(94)90089-2; Ederer F, 1999, J CLIN EPIDEMIOL, V52, P447, DOI 10.1016/S0895-4356(99)00016-5; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Gyrd-Hansen D, 1997, INT J EPIDEMIOL, V26, P1172, DOI 10.1093/ije/26.6.1172; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Imperiale TF, 2009, NEW ENGL J MED, V361, P2004; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Jorgensen OD, 2007, ACTA ONCOL, V46, P355, DOI 10.1080/02841860600897918; Jouve JL, 2001, BRIT J CANCER, V84, P1477, DOI 10.1054/bjoc.2001.1752; Kahi CJ, 2009, CLIN GASTROENTEROL H, V7, P770, DOI 10.1016/j.cgh.2008.12.030; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Launoy G, 1997, INT J CANCER, V73, P220, DOI 10.1002/(SICI)1097-0215(19971009)73:2<220::AID-IJC10>3.0.CO;2-J; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman D, 2006, NEW ENGL J MED, V355, P2588, DOI 10.1056/NEJMe068254; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Neugut AI, 2010, JAMA-J AM MED ASSOC, V304, P461, DOI 10.1001/jama.2010.1001; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Olson SH, 2011, CANCER-AM CANCER SOC, V117, P2762, DOI 10.1002/cncr.25871; Prevost TC, 1998, AM J EPIDEMIOL, V148, P609; Rabeneck L, 2010, CLIN GASTROENTEROL H, V8, P275, DOI 10.1016/j.cgh.2009.10.022; Ransohoff DF, 2009, ANN INTERN MED, V150, P50, DOI 10.7326/0003-4819-150-1-200901060-00308; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2006, AM J GASTROENTEROL, V101, P873, DOI 10.1111/j.1572-0241.2006.00673.x; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Sandler RS, 2010, AM J GASTROENTEROL, V105, P1633, DOI 10.1038/ajg.2010.97; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Singh H, 2010, GASTROENTEROLOGY, V139, P1128, DOI 10.1053/j.gastro.2010.06.052; Torlakovic E, 2003, AM J SURG PATHOL, V27, P65, DOI 10.1097/00000478-200301000-00008; Vogelaar I, 2006, CANCER-AM CANCER SOC, V107, P1624, DOI 10.1002/cncr.22115; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Winawer S, 2009, COLONOSCOPY PRINCIPL, P401; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; WINAWER SJ, 1992, CANCER, V70, P1236, DOI 10.1002/1097-0142(19920901)70:3+<1236::AID-CNCR2820701508>3.0.CO;2-4; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 2006, GASTROENTEROLOGY, V130, P620, DOI 10.1053/j.gastro.2006.01.014	53	1919	2007	6	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					687	696		10.1056/NEJMoa1100370	http://dx.doi.org/10.1056/NEJMoa1100370			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	22356322	Green Accepted			2022-12-01	WOS:000300551500006
J	Raimundo, N; Song, L; Shutt, TE; McKay, SE; Cotney, J; Guan, MX; Gilliland, TC; Hohuan, D; Santos-Sacchi, J; Shadel, GS				Raimundo, Nuno; Song, Lei; Shutt, Timothy E.; McKay, Sharen E.; Cotney, Justin; Guan, Min-Xin; Gilliland, Thomas C.; Hohuan, David; Santos-Sacchi, Joseph; Shadel, Gerald S.			Mitochondrial Stress Engages E2F1 Apoptotic Signaling to Cause Deafness	CELL			English	Article							TRANSCRIPTION FACTOR B1; RIBOSOMAL-RNA MUTATION; NON-SYNDROMIC DEAFNESS; HEARING-LOSS; AMINOGLYCOSIDE OTOTOXICITY; GENE-EXPRESSION; A1555G MUTATION; DNA-POLYMERASE; HUMAN-DISEASE; MICE	Mitochondrial dysfunction causes poorly understood tissue-specific pathology stemming from primary defects in respiration, coupled with altered reactive oxygen species (ROS), metabolic signaling, and apoptosis. The A1555G mtDNA mutation that causes maternally inherited deafness disrupts mitochondrial ribosome function, in part, via increased methylation of the mitochondrial 12S rRNA by the methyltransferase mtTFB1. In patient-derived A1555G cells, we show that 12S rRNA hypermethylation causes ROS-dependent activation of AMP kinase and the proapoptotic nuclear transcription factor E2F1. This retrograde mitochondrial-stress relay is operative in vivo, as transgenic-mtTFB1 mice exhibit enhanced 12S rRNA methylation in multiple tissues, increased E2F1 and apoptosis in the stria vascularis and spiral ganglion neurons of the inner ear, and progressive E2F1-dependent hearing loss. This mouse mitochondrial disease model provides a robust platform for deciphering the complex tissue specificity of human mitochondrial- based disorders, as well as the precise pathogenic mechanism of maternally inherited deafness and its exacerbation by environmental factors.	[Raimundo, Nuno; Shutt, Timothy E.; McKay, Sharen E.; Gilliland, Thomas C.; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Song, Lei; Hohuan, David; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Surg Otolaryngol, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Song, Lei; Hohuan, David; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Cotney, Justin; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China	Yale University; Yale University; Yale University; Yale University; Zhejiang University	Shadel, GS (corresponding author), Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA.	gerald.shadel@yale.edu	Shutt, Tim/U-9047-2019; Cotney, Justin/C-9631-2012; Cotney, Justin L/ABE-8500-2021; Raimundo, Nuno/AAD-9498-2020	Shutt, Tim/0000-0001-5299-2943; Cotney, Justin/0000-0001-8230-2157; Cotney, Justin L/0000-0001-8230-2157; Raimundo, Nuno/0000-0002-5988-9129; Guan, Min-Xin/0000-0001-5067-6736	U.S. NIH [R01 HL-059655, R01 DC000273]; UMDF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000273] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMDF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grants R01 HL-059655 to G.S.S. and R01 DC000273 to J.S.-S. from the U.S. NIH and a UMDF fellowship to T.E.S. The authors thank Zimei Zhang for animal husbandry, Yale Animal Genomic Services for help in generating the Tg-mtTFB1 mice, and Dr. Susan Kaech for comments on the manuscript, helpful discussions and access to the SeaHorse instrument.	Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Bykhovskaya Y, 2004, MOL GENET METAB, V82, P27, DOI 10.1016/j.ymgme.2004.01.020; Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Cotney J, 2009, HUM MOL GENET, V18, P2670, DOI 10.1093/hmg/ddp208; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; DeGregori J, 2006, CURR MOL MED, V6, P739; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Goto Y, 2006, J CELL PHYSIOL, V209, P923, DOI 10.1002/jcp.20802; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105; Hou ST, 2000, J NEUROCHEM, V75, P91, DOI 10.1046/j.1471-4159.2000.0750091.x; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noguchi Y, 2004, LARYNGOSCOPE, V114, P344, DOI 10.1097/00005537-200402000-00031; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Pulicherla N, 2009, J MOL BIOL, V391, P884, DOI 10.1016/j.jmb.2009.06.015; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Raimundo N, 2009, ONCOGENE, V28, P1261, DOI 10.1038/onc.2008.472; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Shadel GS, 2008, AM J PATHOL, V172, P1445, DOI 10.2353/ajpath.2008.071163; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; Shadel GS, 2004, MOL GENET METAB, V82, P1, DOI 10.1016/j.ymgme.2004.02.003; Someya S, 2008, NEUROBIOL AGING, V29, P1080, DOI 10.1016/j.neurobiolaging.2007.01.014; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Warchol ME, 2010, CURR OPIN OTOLARYNGO, V18, P454, DOI 10.1097/MOO.0b013e32833e05ec	45	143	153	1	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					716	726		10.1016/j.cell.2011.12.027	http://dx.doi.org/10.1016/j.cell.2011.12.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341444	Green Accepted, Bronze			2022-12-01	WOS:000300622400013
J	Moynihan, R				Moynihan, Ray			REALITY CHECK Assaulting alternative medicine: worthwhile or witch hunt?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Clinical evidence, WHAT CONCL HAS CLIN; Elshaug A, 2011, TRANSF HLTH EC INT H; Furlan AD, 2010, AHRQ PUBLICATION; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Wulff KC, 2011, HEALTH AFFAIR, V30, P2269, DOI 10.1377/hlthaff.2011.0159	5	9	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2012	344								e1075	10.1136/bmj.e1075	http://dx.doi.org/10.1136/bmj.e1075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896IB	22337786	Green Submitted			2022-12-01	WOS:000300557800007
J	Orrell, M; Woods, B; Spector, A				Orrell, Martin; Woods, Bob; Spector, Aimee			UNCERTAINTIES PAGE Should we use individual cognitive stimulation therapy to improve cognitive function in people with dementia?	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ALZHEIMERS-DISEASE; EFFICACY		[Orrell, Martin] UCL, UCL Mental Hlth Sci Unit, London, England; [Orrell, Martin; Spector, Aimee] NE London Fdn Trust, Goodmayes Hosp, London, England; [Woods, Bob] Bangor Univ, Dementia Serv Dev Ctr, Bangor, Gwynedd, Wales; [Spector, Aimee] UCL, Dept Clin Educ & Hlth Psychol, London, England	University of London; University College London; Bangor University; University of London; University College London	Orrell, M (corresponding author), UCL, UCL Mental Hlth Sci Unit, London, England.	m.orrell@ucl.ac.uk	Woods, Bob/E-7140-2011	Woods, Bob/0000-0002-6781-651X; Orrell, Martin/0000-0002-1169-3530				Clare L, 2008, COCHRANE DB SYST REV, V4; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Knapp M, 2006, BRIT J PSYCHIAT, V188, P574, DOI 10.1192/bjp.bp.105.010561; Kurz AF, 2011, INT PSYCHOGERIATR, V23, P1364, DOI 10.1017/S1041610211001001; National Institute of Clinical Excellence, 2006, DEM SUPP PEOPL DEM T; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Onder G, 2005, BRIT J PSYCHIAT, V187, P450, DOI 10.1192/bjp.187.5.450; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Prince M, 2011, WORLD ALZHEIMER REPO; Spector A, 2003, BRIT J PSYCHIAT, V183, P248, DOI 10.1192/bjp.183.3.248; Woods B, 2012, COCHRANE DA IN PRESS	11	19	19	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2012	344								e633	10.1136/bmj.e633	http://dx.doi.org/10.1136/bmj.e633			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896IB	22337752				2022-12-01	WOS:000300557800002
J	Henry, M; Beguin, M; Requier, F; Rollin, O; Odoux, JF; Aupinel, P; Aptel, J; Tchamitchian, S; Decourtye, A				Henry, Mickael; Beguin, Maxime; Requier, Fabrice; Rollin, Orianne; Odoux, Jean-Francois; Aupinel, Pierrick; Aptel, Jean; Tchamitchian, Sylvie; Decourtye, Axel			A Common Pesticide Decreases Foraging Success and Survival in Honey Bees	SCIENCE			English	Article							APIS-MELLIFERA; SYSTEMIC INSECTICIDES; RECEPTORS; BEHAVIOR; MEMORY; DANCE	Nonlethal exposure of honey bees to thiamethoxam (neonicotinoid systemic pesticide) causes high mortality due to homing failure at levels that could put a colony at risk of collapse. Simulated exposure events on free-ranging foragers labeled with a radio-frequency identification tag suggest that homing is impaired by thiamethoxam intoxication. These experiments offer new insights into the consequences of common neonicotinoid pesticides used worldwide.	[Henry, Mickael; Aptel, Jean; Tchamitchian, Sylvie] INRA, Abeilles & Environm UR406, F-84914 Avignon, France; [Henry, Mickael; Beguin, Maxime; Rollin, Orianne; Aptel, Jean; Tchamitchian, Sylvie; Decourtye, Axel] UMT Protect Abeilles Environm, F-84914 Avignon, France; [Beguin, Maxime] Assoc Dev Apiculture Provencale, F-13626 Aix En Provence, France; [Requier, Fabrice] CNRS, Ctr Etud Biol Chize, USC INRA 1339, UPR1934, F-79360 Beauvoir Sur Niort, France; [Requier, Fabrice; Odoux, Jean-Francois; Aupinel, Pierrick] INRA, UE Entomol, UE1255, F-17700 Surgeres, France; [Rollin, Orianne; Decourtye, Axel] Assoc Coordinat Tech Agr, F-84914 Avignon, France	INRAE; Centre National de la Recherche Scientifique (CNRS); INRAE; INRAE	Henry, M (corresponding author), INRA, Abeilles & Environm UR406, F-84914 Avignon, France.	mickael.henry@avignon.inra.fr	Aupinel, Pierrick/Y-5436-2019; Rollin, Orianne/R-9705-2019; ODOUX, Jean-François/AAB-3596-2019	Rollin, Orianne/0000-0002-1455-9302; ODOUX, Jean-François/0000-0002-6264-4376; Tchamitchian, Marc/0000-0002-9251-2403; Requier, Fabrice/0000-0003-1638-3141	European Community [797/2004]; French Ministry of Agriculture [11-45R]	European Community(European Commission); French Ministry of Agriculture	This study was funded by the European Community program (797/2004) for French beekeeping coordinated by the French Ministry of Agriculture (convention FranceAgriMer 11-45R). Special thanks go to L. Belzunces, J. L. Brunet, B. Vaissie re, A. Maisonnasse, D. Fortini, Y. Le Conte, C. McDonnell, P. Jourdan, J. P. Vermandere, and V. Bretagnolle for valuable help and corrections, as well as three anonymous reviewers for useful comments on the manuscript. We are grateful to M. Grijolot for allowing experiments to take place in his fields. RFID devices were designed by Tag Tracing Solutions, Valence, France, and adapted to honey bees with the help of J. Fourrier, F. Brun, J. Devillers, M. Gauthier, and the ECOBEE monitoring facility. Data are in the supporting online material.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dukas R, 2008, INSECT SOC, V55, P252, DOI 10.1007/s00040-008-0995-4; Henry M, 2012, ECOL MODEL, V225, P103, DOI 10.1016/j.ecolmodel.2011.11.015; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Maienfisch P, 2001, PEST MANAG SCI, V57, P165, DOI 10.1002/1526-4998(200102)57:2<165::AID-PS289>3.0.CO;2-G; Menzel R, 2006, J COMP PHYSIOL A, V192, P889, DOI 10.1007/s00359-006-0136-3; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	27	885	947	38	1302	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					348	350		10.1126/science.1215039	http://dx.doi.org/10.1126/science.1215039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22461498	Green Submitted			2022-12-01	WOS:000302995400046
J	Wang, YC; Khan, Z; Kaschube, M; Wieschaus, EF				Wang, Yu-Chiun; Khan, Zia; Kaschube, Matthias; Wieschaus, Eric F.			Differential positioning of adherens junctions is associated with initiation of epithelial folding	NATURE			English	Article							APICAL CONSTRICTION; CELL-SHAPE; DROSOPHILA; BAZOOKA; POLARITY; PAR-1; ESTABLISHMENT; LOCALIZATION; ALGORITHM; STARDUST	During tissue morphogenesis, simple epithelial sheets undergo folding to form complex structures. The prevailing model underlying epithelial folding involves cell shape changes driven by myosin-dependent apical constriction(1). Here we describe an alternative mechanism that requires differential positioning of adherens junctions controlled by modulation of epithelial apical-basal polarity. Using live embryo imaging, we show that before the initiation of dorsal transverse folds during Drosophila gastrulation, adherens junctions shift basally in the initiating cells, but maintain their original subapical positioning in the neighbouring cells. Junctional positioning in the dorsal epithelium depends on the polarity proteins Bazooka and Par-1. In particular, the basal shift that occurs in the initiating cells is associated with a progressive decrease in Par-1 levels. We show that uniform reduction of the activity of Bazooka or Par-1 results in uniform apical or lateral positioning of junctions and in each case dorsal fold initiation is abolished. In addition, an increase in the Bazooka/Par-1 ratio causes formation of ectopic dorsal folds. The basal shift of junctions not only alters the apical shape of the initiating cells, but also forces the lateral membrane of the adjacent cells to bend towards the initiating cells, thereby facilitating tissue deformation. Our data thus establish a direct link between modification of epithelial polarity and initiation of epithelial folding.	[Wang, Yu-Chiun; Wieschaus, Eric F.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Wang, Yu-Chiun; Wieschaus, Eric F.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Khan, Zia] Princeton Univ, Dept Comp Sci, Princeton, NJ 08540 USA; [Khan, Zia; Kaschube, Matthias] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University; Princeton University	Wieschaus, EF (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	efw@princeton.edu	Wang, Yu-Chiun/N-6541-2015	Wang, Yu-Chiun/0000-0002-3797-4138; Khan, Zia/0000-0002-7859-3489	Helen Hay Whitney Foundation; National Institutes of Health/National Institute of General Medical Sciences [GM071508]; National Institute of Child Health and Human Development [5R37HD15587]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD015587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Martin, J. McDonald, D. St Johnston and J. Zallen for providing flies and antibodies; J. Goodhouse and S. Thiberge for assistance in microscopy; G. Deshpande, members of the Wieschaus and Schupbach laboratories for helpful comments on the manuscript and discussion. This work is supported by a postdoctoral fellowship from the Helen Hay Whitney Foundation to Y.-C.W., a National Institutes of Health/National Institute of General Medical Sciences P50 grant (GM071508) to Z.K. and M. K., and a National Institute of Child Health and Human Development grant (5R37HD15587) to E. F. W. E. F. W. is an investigator of the Howard Hughes Medical Institute.	Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Beucher S., 2018, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; Cavey M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002998; COHEN LD, 1993, IEEE T PATTERN ANAL, V15, P1131, DOI 10.1109/34.244675; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; Krahn MP, 2010, J CELL BIOL, V190, P751, DOI 10.1083/jcb.201006029; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lighthouse DV, 2008, DEV BIOL, V317, P59, DOI 10.1016/j.ydbio.2008.02.009; Lorensen WE., 1987, COMPUTER GRAPHICS P, V21, P163, DOI 10.1145/37401.37422; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Maurer CR, 2003, IEEE T PATTERN ANAL, V25, P265, DOI 10.1109/TPAMI.2003.1177156; McDonald JA, 2008, CURR BIOL, V18, P1659, DOI 10.1016/j.cub.2008.09.041; McGill MA, 2009, J CELL BIOL, V185, P787, DOI 10.1083/jcb.200812146; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Oda H, 2001, J CELL SCI, V114, P493; Palagyi K., 2001, Information Processing in Medical Imaging. 17th International Conference, IPMI 2001. Proceedings (Lecture Notes in Computer Science Vol.2082), P409; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; SWEETON D, 1991, DEVELOPMENT, V112, P775; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Walther RF, 2010, CURR BIOL, V20, P1065, DOI 10.1016/j.cub.2010.04.049	30	112	112	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					390	393		10.1038/nature10938	http://dx.doi.org/10.1038/nature10938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22456706	Green Accepted			2022-12-01	WOS:000302946500036
J	Hollenberg, AN				Hollenberg, Anthony N.			Metabolic Health and Nuclear-Receptor Sensitivity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INSULIN SENSITIVITY; IN-VIVO; NCOR		[Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Hollenberg, Anthony N.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hollenberg, AN (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.							Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Sutanto MM, 2010, J BIOL CHEM, V285, P18485, DOI 10.1074/jbc.M110.107680; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017	5	8	8	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1345	1347		10.1056/NEJMcibr1114529	http://dx.doi.org/10.1056/NEJMcibr1114529			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475600				2022-12-01	WOS:000302343000015
J	Smith, AJ; Dieppe, P; Porter, M; Blom, AW				Smith, Alison J.; Dieppe, Paul; Porter, Martyn; Blom, Ashley W.		Natl Joint Registry England & Wale	Risk of cancer in first seven years after metal-on-metal hip replacement compared with other bearings and general population: linkage study between the National Joint Registry of England and Wales and hospital episode statistics	BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; ARTHROPLASTY; METAANALYSIS; MORTALITY; IMPLANTS; COBALT; KNEE	Objective To determine whether use of metal-on-metal bearing surfaces is associated with an increased risk of a diagnosis of cancer in the early years after total hip replacement and specifically with an increase in malignant melanoma and haematological, prostate, and renal tract cancers. Design Linkage study with multivariable competing risks flexible parametric survival model to examine the incidence of new diagnoses of cancer in patients with metal-on-metal hip replacement compared with those with alternative bearings and to compare the observed incidence of diagnoses in patients undergoing hip replacement with that predicted by national incidence rates in the general population. Setting National Joint Registry of England and Wales (NJR) linked to NHS hospital episode statistics data. Participants 40 576 patients with hip replacement with metal-on-metal bearing surfaces and 248 995 with alternative bearings. Main outcome measures Incidence of all cancers and incidence of malignant melanoma and prostate, renal tract, and haematological cancers. Results The incidence of new diagnoses of cancer was low after hip replacement (1.25% at one year, 95% confidence interval 1.21% to 1.30%) and lower than that predicted from the age and sex matched normal population (1.65%, 1.60% to 1.70%). Compared with alternative bearings, there was no evidence that metal-on-metal bearing surfaces were associated with an increased risk of any cancer diagnosis in the seven years after surgery (mean follow-up of three years, 23% (n = 67 361) of patients observed for five years or more). Similarly, there was no increase in the risk of malignant melanoma or haematological, prostate, and renal tract cancers. The adjusted five year incidence of all cancers for men aged 60 was 4.8% (4.4% to 5.3%) with resurfacing, 6.2% (5.7% to 6.7%) with stemmed metal-on-metal, and 6.7% (6.5% to 7.0%) for other bearing surfaces. Equivalent rates for women aged 60 were lower: 3.1% (2.8% to 3.4%) with resurfacing, 4.0% (3.7% to 4.3%) with stemmed metal-on-metal, and 4.4% (4.2% to 4.5%) with other bearings. Conclusions These data are reassuring, but the findings are observational with short follow-up. The use of hospital episode statistics data might underestimate cancer diagnoses, and there is the possibility of confounding by indication. Furthermore, as some cancers have a long latency period it is important that we study the longer term outcomes and continue to investigate the effects of exposure to orthopaedic metals.	[Smith, Alison J.; Blom, Ashley W.] Univ Bristol, Musculosketal Res Unit, Sch Clin Sci, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England; [Dieppe, Paul] Univ Plymouth, Peninsula Med Sch, Exeter EX1 2LU, Devon, England; [Dieppe, Paul] Univ Exeter, Exeter EX1 2LU, Devon, England; [Porter, Martyn] Ctr Hip Surg, Wigan WN6 9EP, Lancs, England	University of Bristol; University of Exeter; University of Plymouth; University of Exeter	Smith, AJ (corresponding author), Univ Bristol, Musculosketal Res Unit, Sch Clin Sci, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England.	alison.smith@bristol.ac.uk		Blom, Ashley/0000-0002-9940-1095	National Joint Registry for England and Wales Steering Committee (NJRSC); DePuy	National Joint Registry for England and Wales Steering Committee (NJRSC); DePuy	This study was funded by the National Joint Registry for England and Wales Steering Committee (NJRSC) as one of several specialist topic areas included in its ongoing work programme. MP is a member of the NJRSC and is chair of the Editorial Board. Decisions over the design, data analysis, and data interpretation were made independently by the authors. The decision to submit for publication was made by AWB.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: MP receives royalties from the manufacturer DePuy for a cemented hip prosthesis.	AOANJRR, 2010, ANN REP AOANJRR; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P2357, DOI 10.1007/s11999-010-1262-3; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; Coviello E., 2009, STCOMPADJ STATA MODU; Doherty AT, 2001, J BONE JOINT SURG BR, V83B, P1075, DOI 10.1302/0301-620X.83B7.10102; Dowson D, 2004, J ARTHROPLASTY, V19, P124, DOI 10.1016/j.arth.2004.09.016; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Haddad FS, 2011, J BONE JOINT SURG BR, V93B, P572, DOI 10.1302/0301-620X.93B4.26429; Hart AJ, 2011, J BONE JOINT SURG BR, V93B, P1308, DOI 10.1302/0301-620X.93B10.26249; Jameson SS, 2011, J BONE JOINT SURG BR, V93B, P876, DOI 10.1302/0301-620X.93B7.26657; Judge A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4092; Keegan GM, 2007, J BONE JOINT SURG BR, V89B, P567, DOI 10.1302/0301-620X.89B5.18903; Keegan GM, 2008, CRIT REV TOXICOL, V38, P645, DOI 10.1080/10408440701845534 ; Lie SA, 2000, ACTA ORTHOP SCAND, V71, P19, DOI 10.1080/00016470052943838; LUMB GD, 1994, SCI TOTAL ENVIRON, V148, P185, DOI 10.1016/0048-9697(94)90395-6; National Joint Registry for England and Wales, 2011, 8 ANN REP NJR; Office for National Statistics, 2011, CANC STAT REG REG CA; Onega T, 2006, CANCER EPIDEM BIOMAR, V15, P1532, DOI 10.1158/1055-9965.EPI-06-0127; Parry MC, 2010, BIOMATERIALS, V31, P4477, DOI 10.1016/j.biomaterials.2010.02.038; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Smith AJ, 2012, LANCET          0312; Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J; Visuri T, 2003, ACTA ORTHOP SCAND, V74, P351, DOI 10.1080/00016470310014300; Visuri T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-78; Wagner P, 2011, EUR J CANCER, V47, P1061, DOI 10.1016/j.ejca.2010.11.023; World Health Organisation Global Health Observatory, 2012, CANC MORT MORB	26	96	98	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 3	2012	344								e2383	10.1136/bmj.e2383	http://dx.doi.org/10.1136/bmj.e2383			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GM	22490979	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000302607700002
J	Boucrot, E; Pick, A; Camdere, G; Liska, N; Evergren, E; McMahon, HT; Kozlov, MM				Boucrot, Emmanuel; Pick, Adi; Camdere, Gamze; Liska, Nicole; Evergren, Emma; McMahon, Harvey T.; Kozlov, Michael M.			Membrane Fission Is Promoted by Insertion of Amphipathic Helices and Is Restricted by Crescent BAR Domains	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; INFLUENZA-VIRUS; COATED PITS; EPSIN 1; CURVATURE; MECHANISMS; PROTEINS; SCISSION; VESICLE; DEFORMATION	Shallow hydrophobic insertions and crescent-shaped BAR scaffolds promote membrane curvature. Here, we investigate membrane fission by shallow hydrophobic insertions quantitatively and mechanistically. We provide evidence that membrane insertion of the ENTH domain of epsin leads to liposome vesiculation, and that epsin is required for clathrin-coated vesicle budding in cells. We also show that BAR-domain scaffolds from endophilin, amphiphysin, GRAF, and beta 2-centaurin limit membrane fission driven by hydrophobic insertions. A quantitative assay for vesiculation reveals an antagonistic relationship between amphipathic helices and scaffolds of N-BAR domains in fission. The extent of vesiculation by these proteins and vesicle size depend on the number and length of amphipathic helices per BAR domain, in accord with theoretical considerations. This fission mechanism gives a new framework for understanding membrane scission in the absence of mechanoenzymes such as dynamin and suggests how Arf and Sar proteins work in vesicle scission.	[Boucrot, Emmanuel; Camdere, Gamze; Liska, Nicole; Evergren, Emma; McMahon, Harvey T.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Pick, Adi; Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	MRC Laboratory Molecular Biology; Tel Aviv University; Sackler Faculty of Medicine	McMahon, HT (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	hmm@mrc-lmb.cam.ac.uk; michk@post.tau.ac.il	Evergren, Emma/X-3677-2019	Evergren, Emma/0000-0002-0775-2921; Boucrot, Emmanuel/0000-0001-7312-6462	Israel Science Foundation (ISF); Marie Curie Network "Virus Entry"; Medical Research Council UK [U105178795]; Cambridge Overseas Trust; Trinity College Cambridge; Austrian Academy; Medical Research Council [MC_U105178795] Funding Source: researchfish; MRC [MC_U105178795] Funding Source: UKRI	Israel Science Foundation (ISF)(Israel Science Foundation); Marie Curie Network "Virus Entry"; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Overseas Trust; Trinity College Cambridge; Austrian Academy; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Sew Yeu Peak-Chew for Mass Spectrometry, Tom Kirchhausen and David Drubin for the kind gift of sigma 2-EGFP BSC1 cells and SK-MEL-2 genome-edited cells, respectively, Rohit Mittal for helpful comments, and Felix Campeio for a supplemental computation. This work was supported by the Israel Science Foundation (ISF) and Marie Curie Network "Virus Entry" (M.M.K.), the Medical Research Council UK (grant number U105178795) (H.T.M., E.E., E.B.), Cambridge Overseas Trust and Trinity College Cambridge (G.C.), and Austrian Academy Science Fellowship (N.L.). E.B. designed, performed, and quantified live and fixed-cell imaging and ligand uptake, A.P. did theoretical modeling, G.C. and N.L. purified proteins and performed vesiculation assay and electron microscopy, E.E. performed and quantified electron microscopy of clathrin-coated pits, H.T.M. designed and performed vesiculation assay and supervised the project, M.M.K. suggested the mechanism and supervised the theoretical modeling. H.T.M., M.M.K., and E.B. wrote the paper with input from all the other authors.	Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Beck R, 2011, J CELL BIOL, V194, P765, DOI 10.1083/jcb.201011027; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Chen C, 2008, P NATL ACAD SCI USA, V105, P11790, DOI 10.1073/pnas.0803711105; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Coon Brian G, 2011, Commun Integr Biol, V4, P95, DOI 10.4161/cib.4.1.14129; Corda D, 2006, TRENDS CELL BIOL, V16, P167, DOI 10.1016/j.tcb.2006.01.007; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; GOORMAGHTIGH E, 1986, ANAL BIOCHEM, V159, P122, DOI 10.1016/0003-2697(86)90316-7; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hughes AC, 2004, MOL BRAIN RES, V128, P182, DOI 10.1016/j.molbrainres.2004.06.016; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; HUSE DA, 1991, PHYS REV LETT, V66, P437, DOI 10.1103/PhysRevLett.66.437; Jakobsson J, 2008, P NATL ACAD SCI USA, V105, P6445, DOI 10.1073/pnas.0710267105; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Kweon DH, 2006, MOL CELLS, V21, P428; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Schwarz US, 1999, PHYS REV E, V59, P5528, DOI 10.1103/PhysRevE.59.5528; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Wang J, 2011, P NATL ACAD SCI USA, V108, P12277, DOI 10.1073/pnas.1013101108; Williger BT, 1999, FEBS LETT, V454, P85, DOI 10.1016/S0014-5793(99)00771-1	40	266	267	1	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					124	136		10.1016/j.cell.2012.01.047	http://dx.doi.org/10.1016/j.cell.2012.01.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464325	Green Published, Green Submitted, hybrid			2022-12-01	WOS:000302235400015
J	Clare, DK; Vasishtan, D; Stagg, S; Quispe, J; Farr, GW; Topf, M; Horwich, AL; Saibil, HR				Clare, Daniel K.; Vasishtan, Daven; Stagg, Scott; Quispe, Joel; Farr, George W.; Topf, Maya; Horwich, Arthur L.; Saibil, Helen R.			ATP-Triggered Conformational Changes Delineate Substrate-Binding and -Folding Mechanics of the GroEL Chaperonin	CELL			English	Article							2.8 ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; ALLOSTERIC TRANSITIONS; ELECTRON-MICROSCOPY; KINETIC-ANALYSIS; FOLDED PROTEIN; CENTRAL CAVITY; UCSF CHIMERA; OPEN RING; POLYPEPTIDE	The chaperonin GroEL assists the folding of nascent or stress-denatured polypeptides by actions of binding and encapsulation. ATP binding initiates a series of conformational changes triggering the association of the cochaperonin GroES, followed by further large movements that eject the substrate polypeptide from hydrophobic binding sites into a GroES-capped, hydrophilic folding chamber. We used cryo-electron microscopy, statistical analysis, and flexible fitting to resolve a set of distinct GroEL-ATP conformations that can be ordered into a trajectory of domain rotation and elevation. The initial conformations are likely to be the ones that capture polypeptide substrate. Then the binding domains extend radially to separate from each other but maintain their binding surfaces facing the cavity, potentially exerting mechanical force upon kinetically trapped, misfolded substrates. The extended conformation also provides a potential docking site for GroES, to trigger the final, 100 degrees domain rotation constituting the "power stroke" that ejects substrate into the folding chamber.	[Clare, Daniel K.; Vasishtan, Daven; Topf, Maya; Saibil, Helen R.] Univ London Birkbeck Coll, Crystallog & Inst Struct & Mol Biol, London WC1E 7HX, England; [Stagg, Scott; Quispe, Joel] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Horwich, Arthur L.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Farr, George W.; Horwich, Arthur L.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Farr, George W.; Horwich, Arthur L.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	University of London; Birkbeck University London; Scripps Research Institute; Scripps Research Institute; Yale University; Howard Hughes Medical Institute; Yale University	Saibil, HR (corresponding author), Univ London Birkbeck Coll, Crystallog & Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England.	h.saibil@mail.cryst.bbk.ac.uk	Stagg, Scott/AAW-9294-2020	Topf, Maya/0000-0002-8185-1215; Clare, daniel/0000-0002-3372-8378	National Institutes of Health though the National Center for Research Resources at Crystallography, Department of Biological Sciences and ISMB, Birkbeck College [RR017573]; Wellcome Trust [070776, 089050]; BBSRC; MRC [G0600084]; Human Frontier Science Program [RGY0079/2009-C]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; Medical Research Council [G0600084] Funding Source: researchfish	National Institutes of Health though the National Center for Research Resources at Crystallography, Department of Biological Sciences and ISMB, Birkbeck College(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Richard Westlake, Dave Houldershaw, and Luchun Wang for computing and EM support; Wayne Fenton and Elena Orlova for discussion; and Helene Launay for help with the initial part of data analysis. We also thank Bridget Carragher, Clint Potter, Anchi Cheng, and the Leginon team for their help and access to the NRAMM facility at the Scripps Research Institute. This work was carried out at the National Resource for Automated Molecular Microscopy, supported by the National Institutes of Health though the National Center for Research Resources P41 program (RR017573) and at Crystallography, Department of Biological Sciences and ISMB, Birkbeck College, supported by Wellcome Trust programme grants (070776 and 089050) to H.R.S. D.V. was supported by a BBSRC PhD studentship. M.T. is supported by an MRC Career Development Award (G0600084) and the Human Frontier Science Program (RGY0079/2009-C).	BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Brocchieri L, 2000, PROTEIN SCI, V9, P476; Burston SG, 1996, NATURE, V383, P96, DOI 10.1038/383096a0; Chaudhry C, 2004, J MOL BIOL, V342, P229, DOI 10.1016/j.jmb.2004.07.015; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Danziger O, 2006, PROTEIN SCI, V15, P1270, DOI 10.1110/ps.062100606; Elad N, 2008, J STRUCT BIOL, V162, P108, DOI 10.1016/j.jsb.2007.11.007; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horovitz A, 2002, P NATL ACAD SCI USA, V99, P14095, DOI 10.1073/pnas.222303299; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Huo YW, 2010, STRUCTURE, V18, P1270, DOI 10.1016/j.str.2010.07.009; Kawata Y, 1999, BIOCHEMISTRY-US, V38, P15731, DOI 10.1021/bi9909750; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miyazaki T, 2002, J BIOL CHEM, V277, P50621, DOI 10.1074/jbc.M209183200; Motojima F, 2004, P NATL ACAD SCI USA, V101, P15005, DOI 10.1073/pnas.0406132101; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Nojima T, 2009, J BIOL CHEM, V284, P22834, DOI 10.1074/jbc.M109.020057; Orlova EV, 2010, METHOD ENZYMOL, V482, P321, DOI [10.1016/S0076-6879(10)82013-0, 10.1016/S0076-6879(10)82013_0]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Taniguchi M, 2004, J BIOL CHEM, V279, P16368, DOI 10.1074/jbc.M311806200; Tehver R, 2009, J MOL BIOL, V387, P390, DOI 10.1016/j.jmb.2008.12.032; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Tyagi NK, 2009, P NATL ACAD SCI USA, V106, P20264, DOI 10.1073/pnas.0911556106; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; White HE, 1997, NAT STRUCT BIOL, V4, P690, DOI 10.1038/nsb0997-690; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yang Z, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000360; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	60	122	124	0	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					113	123		10.1016/j.cell.2012.02.047	http://dx.doi.org/10.1016/j.cell.2012.02.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22445172	hybrid, Green Published			2022-12-01	WOS:000302235400014
J	Gasper, BJ; Minchella, DJ; Weaver, GC; Csonka, LN; Gardner, SM				Gasper, Brittany J.; Minchella, Dennis J.; Weaver, Gabriela C.; Csonka, Laszlo N.; Gardner, Stephanie M.			Adapting to Osmotic Stress and the Process of Science	SCIENCE			English	Editorial Material							INQUIRY		[Gasper, Brittany J.; Minchella, Dennis J.; Csonka, Laszlo N.; Gardner, Stephanie M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Weaver, Gabriela C.] Purdue Univ, Discovery Learning Res Ctr, W Lafayette, IN 47907 USA; [Weaver, Gabriela C.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Gardner, SM (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	sgardne@purdue.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Brewer, 2011, VISION CHANGE UNDERG; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Culham DE, 2008, BIOCHEMISTRY-US, V47, P13584, DOI 10.1021/bi801576x; DUNLAP VJ, 1985, J BACTERIOL, V163, P296, DOI 10.1128/JB.163.1.296-304.1985; Gardner SM, 2011, J UNDERGRAD NEUROSCI, V10, pA24; Gasper B. J., 2011, J MICROBIOL BIOL ED, V12; Gasper B. J., 2012, DNA CELL BIOL; Lindgren C. A., 2010, CHRONICLE HIGHE 0418; Luckie DB, 2004, ADV PHYSIOL EDUC, V28, P199, DOI 10.1152/advan.00025.2004; Weaver G., 2006, CHEM ED, V11, P125, DOI DOI 10.1333/S00897061008A; Weaver GC, 2008, NAT CHEM BIOL, V4, P577, DOI 10.1038/nchembio1008-577	11	7	7	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1590	1591		10.1126/science.1215582	http://dx.doi.org/10.1126/science.1215582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461603				2022-12-01	WOS:000302062600035
J	Yang, QH; Cogswell, ME; Flanders, WD; Hong, YL; Zhang, ZF; Loustalot, F; Gillespie, C; Merritt, R; Hu, FB				Yang, Quanhe; Cogswell, Mary E.; Flanders, W. Dana; Hong, Yuling; Zhang, Zefeng; Loustalot, Fleetwood; Gillespie, Cathleen; Merritt, Robert; Hu, Frank B.			Trends in Cardiovascular Health Metrics and Associations With All-Cause and CVD Mortality Among US Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; SCIENTIFIC STATEMENT; BLOOD-PRESSURE; RISK-FACTORS; PREVALENCE; POPULATION; DISEASE; NUTRITION	Context Recent recommendations from the American Heart Association aim to improve cardiovascular health by encouraging the general population to meet 7 cardiovascular health metrics: not smoking; being physically active; having normal blood pressure, blood glucose and total cholesterol levels, and weight; and eating a healthy diet. Objective To examine time trends in cardiovascular health metrics and to estimate joint associations and population-attributable fractions of these metrics in relation to all-cause and cardiovascular disease (CVD) mortality risk. Design, Setting, and Participants Study of a nationally representative sample of 44 959 US adults (>20 years), using data from the National Health and Nutrition Examination Survey (NHANES) 1988-1994, 1999-2004, and 2005-2010 and the NHANES III Linked Mortality File (through 2006). Main Outcome Measures All-cause, CVD, and ischemic heart disease (IHD) mortality. Results Few participants met all 7 cardiovascular health metrics (2.0% [95% CI, 1.5%-2.5%] in 1988-1994, 1.2% [95% CI, 0.8%-1.9%] in 2005-2010). Among NHANES III participants, 2673 all-cause, 1085 CVD, and 576 IHD deaths occurred (median follow-up, 14.5 years). Among participants who met 1 or fewer cardiovascular health metrics, age-and sex-standardized absolute risks were 14.8 (95% CI, 13.2-16.5) deaths per 1000 person-years for all-cause mortality, 6.5 (95% CI, 5.5-7.6) for CVD mortality, and 3.7 (95% CI, 2.8-4.5) for IHD mortality. Among those who met 6 or more metrics, corresponding risks were 5.4 (95% CI, 3.6-7.3) for all-cause mortality, 1.5 (95% CI, 0.5-2.5) for CVD mortality, and 1.1 (95% CI, 0.7-2.0) for IHD mortality. Adjusted hazard ratios were 0.49 (95% CI, 0.33-0.74) for all-cause mortality, 0.24 (95% CI, 0.13-0.47) for CVD mortality, and 0.30 (95% CI, 0.13-0.68) for IHD mortality, comparing participants who met 6 or more vs 1 or fewer cardiovascular health metrics. Adjusted population-attributable fractions were 59% (95% CI, 33%-76%) for all-cause mortality, 64% (95% CI, 28%-84%) for CVD mortality, and 63% (95% CI, 5%-89%) for IHD mortality. Conclusion Meeting a greater number of cardiovascular health metrics was associated with a lower risk of total and CVD mortality, but the prevalence of meeting all 7 cardiovascular health metrics was low in the study population. JAMA. 2012;307(12):1273-1283 Published online March 16, 2012. doi: 10.1001/jama.2012.339 www.jama.com	[Yang, Quanhe; Cogswell, Mary E.; Hong, Yuling; Zhang, Zefeng; Loustalot, Fleetwood; Gillespie, Cathleen; Merritt, Robert] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30341 USA; [Flanders, W. Dana] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Yang, QH (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, 4770 Buford Hwy NE,MS F-72, Atlanta, GA 30341 USA.	qay0@cdc.gov		Gillespie, Cathleen/0000-0003-1878-1055	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Bassuk SS, 2010, NUTR METAB CARDIOVAS, V20, P467, DOI 10.1016/j.numecd.2009.12.015; Bassuk SS, 2005, J APPL PHYSIOL, V99, P1193, DOI 10.1152/japplphysiol.00160.2005; Bazzano AT, 2009, AM J PREV MED, V37, pS201, DOI 10.1016/j.amepre.2009.08.005; Beddhu S, 2009, CLIN J AM SOC NEPHRO, V4, P1901, DOI 10.2215/CJN.01970309; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Buttar Harpal S, 2005, Exp Clin Cardiol, V10, P229; Centers for Disease Control and Prevention, 3 NAT HLTH NUTR EX S; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P764; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P1588, DOI 10.1001/jama.292.13.1588; Drescher K, 1997, BIOMETRICS, V53, P1170, DOI 10.2307/2533576; Dube S. R., 2010, Morbidity and Mortality Weekly Report, V59, P1135; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Farley TA, 2010, AM J PREV MED, V38, P600, DOI 10.1016/j.amepre.2010.02.016; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2011, AM J PUBLIC HEALTH, V101, P1922, DOI [10.2105/AJPH.2011.300167, 10.2105//AJPH.2011.300167]; Ford ES, 2009, CIRCULATION, V120, P1181, DOI 10.1161/CIRCULATIONAHA.108.835728; Ford ES, CIRCULATION, DOI [10.1161/CIRCULATIONAHA.111.049122, DOI 10.1161/CIRCULATIONAHA.111.04]; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Garrett Bridgette E., 2011, Morbidity and Mortality Weekly Report, V60, P109; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Ham S. A., 2004, Morbidity and Mortality Weekly Report, V53, P82; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hu F.B., 2008, OBESITY EPIDEMIOLOGY; Jackson L, 2009, DIABETES EDUCATOR, V35, P309, DOI 10.1177/0145721708330153; Kruger J., 2007, Morbidity and Mortality Weekly Report, V56, P1209; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; National Center for Health Statistics, 1988, 3 NAT HLTH NUTR EX S; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Sacks FM, 2010, NEW ENGL J MED, V362, P2102, DOI 10.1056/NEJMct0911013; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Shah VB, 2005, SUDAAN USERS MANUAL; Shay CM, 2012, CIRCULATION, V125, P45, DOI 10.1161/CIRCULATIONAHA.111.035733; Sherry B., 2010, Morbidity and Mortality Weekly Report, V59, P951; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Tomaselli GF, 2011, CIRCULATION, V124, P1795, DOI 10.1161/CIR.0b013e3182327084; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; Valderrama Amy L., 2011, Morbidity and Mortality Weekly Report, V60, P1248; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351	64	518	541	11	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2012	307	12					1273	1283		10.1001/jama.2012.339	http://dx.doi.org/10.1001/jama.2012.339			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914UP	22427615	Bronze, Green Accepted			2022-12-01	WOS:000301978400023
J	MacMahon, E				MacMahon, Eithne			PRACTICE POINTER Investigating the pregnant woman exposed to a child with a rash	BRITISH MEDICAL JOURNAL			English	Editorial Material							VARICELLA; RUBELLA; MEASLES; ZOSTER; WOMEN		[MacMahon, Eithne] Guys & St Thomas NHS Fdn Trust, Dept Infect Dis, St Thomas Hosp, Directorate Infect, London SE1 7EH, England; [MacMahon, Eithne] Kings Coll London, Dept Infect Dis, Sch Med, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	MacMahon, E (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Infect Dis, St Thomas Hosp, Directorate Infect, London SE1 7EH, England.	eithne.macmahon@gstt.nhs.uk						Asaria P, 2006, BRIT MED J, V333, P890, DOI 10.1136/bmj.38989.445845.7C; Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2; Boxall EH, 2011, EUR J CLIN MICROBIOL, V30, P1193, DOI 10.1007/s10096-011-1211-4; de Jong EP, 2011, PRENATAL DIAG, V31, P419, DOI 10.1002/pd.2714; Department of Health, 2011, IMM INF DIS GREEN BO; ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2; Health Protection Agency, 2011, GUID VIR RASH PREGN; MacMahon E, 2004, BRIT MED J, V329, P551, DOI 10.1136/bmj.38170.691956.AE; Manikkavasagan G, 2009, J OBSTET GYNAECOL, V29, P572, DOI 10.1080/01443610903104478; Maple PAC, 2009, J VIROL METHODS, V155, P143, DOI 10.1016/j.jviromet.2008.09.032; Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1; Miller E., 1993, Reviews in Medical Microbiology, V4, P222; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Zimmerman LA, 2011, J INFECT DIS, V204, pS381, DOI 10.1093/infdis/jir104	14	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 26	2012	344								e1790	10.1136/bmj.e1790	http://dx.doi.org/10.1136/bmj.e1790			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923DY	22451478				2022-12-01	WOS:000302600700009
J	Smith, MS				Smith, Mark Stafford			Change the approach to sustainable development	NATURE			English	Editorial Material									Commonwealth Sci & Ind Res Org Climate Adaptat Fl, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Smith, MS (corresponding author), Commonwealth Sci & Ind Res Org Climate Adaptat Fl, Canberra, ACT, Australia.	mark.staffordsmith@csiro.au	Smith, Mark Stafford/G-1680-2010	Smith, Mark Stafford/0000-0002-1333-3651					0	3	4	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2012	483	7390					375	375		10.1038/483375a	http://dx.doi.org/10.1038/483375a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	912CC	22437572	Bronze			2022-12-01	WOS:000301771200004
J	Pujadas, E; Feinberg, AP				Pujadas, Elisabet; Feinberg, Andrew P.			Regulated Noise in the Epigenetic Landscape of Development and Disease	CELL			English	Review							EPITHELIAL-MESENCHYMAL TRANSITIONS; GENE-EXPRESSION; DNA METHYLATION; ACTIVE CHROMATIN; CANCER; VARIABILITY; HSP90; STOCHASTICITY; ENVIRONMENT; PLASTICITY	In this Perspective, we synthesize past and present observations in the field of epigenetics to propose a model in which the epigenome can modulate cellular plasticity in development and disease by regulating the effects of noise. In this model, the epigenome facilitates phase transitions in development and reprogramming and mediates canalization, or the ability to produce a consistent phenotypic outcome despite being challenged by variable conditions, during cell fate commitment. After grounding our argument in a discussion of stochastic noise and nongenetic heterogeneity, we explore the hypothesis that distinct chromatin domains, which are known to be dysregulated in disease and remodeled during development, might underlie cellular plasticity more generally. We then present a modern portrayal of Waddington's epigenetic landscape through a mathematical formalism. We speculate that this new framework might impact how we approach disease mechanisms. In particular, it may help to explain the observation that the variability of DNA methylation and gene expression are increased in cancer, thus contributing to tumor cell heterogeneity.	[Pujadas, Elisabet; Feinberg, Andrew P.] Johns Hopkins Univ, Ctr Epigenet, Baltimore, MD 21205 USA	Johns Hopkins University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Ctr Epigenet, 570 Rangos,855 N Wolfe St, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Pujadas, Elisabet/AAC-2138-2021; Feinberg, Andrew/AAY-7666-2020	Pujadas, Elisabet/0000-0003-4795-7945; Feinberg, Andrew/0000-0002-8364-1991	NIH [DP1OD008324]; NIGMS [T32-GM007309]; NATIONAL CANCER INSTITUTE [R01CA054358] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008324] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Sean Taverna, Andre Levchenko, Winston Timp, Roger Reeves, Rolf Ohlsson, Tomas Ekstrom, Claes Wahlestedt, Brian Herb, Yun Liu, Michael Multhaup, Amy Unterman, Namyoung Jung, Onur Kilic, and Karen Reddy for reading and helpful comments during preparation of the manuscript. This work was supported by NIH Director's Pioneer Award DP1OD008324 to A.F. and NIGMS Medical Scientist Training Program Award T32-GM007309 to E.P.	Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Bao XM, 2007, GENETICA, V129, P339, DOI 10.1007/s10709-006-0012-7; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Delbruck M., 1940, J CHEM PHYS, V8, P5; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Elberg G, 2006, NEPHRON EXP NEPHROL, V102, pE113, DOI 10.1159/000090070; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fedoroff N, 2002, SCIENCE, V297, P1129, DOI 10.1126/science.1075988; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Girton JR, 2008, ADV GENET, V61, P1, DOI 10.1016/S0065-2660(07)00001-6; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; He LM, 1998, ONCOGENE, V16, P113, DOI 10.1038/sj.onc.1201501; Horsthemke W., 2006, NOISE INDUCED TRANSI; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Iwamoto K, 2011, GENOME RES, V21, P688, DOI 10.1101/gr.112755.110; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mar JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002207; McCullagh E, 2010, NAT CELL BIOL, V12, P954, DOI 10.1038/ncb2097; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Miller-Jensen K, 2011, TRENDS BIOTECHNOL, V29, P517, DOI 10.1016/j.tibtech.2011.05.004; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; OMHOLT SW, 2004, SCI AGING KNOWLEDGE, pE28; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Pirola L., 2010, CELL STEM CELL, V6, p[665, 5]; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Vaquero A, 2009, GENE DEV, V23, P1849, DOI 10.1101/gad.1807009; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Vogt G, 2008, J EXP BIOL, V211, P510, DOI 10.1242/jeb.008755; Waddington C.H., 1942, NATURE, V150, P3; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Waddington CH, 1957, STRATEGY GENES DISCU; Whitelaw NC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r111; Wittmann M, 2009, J NEUROSCI, V29, P14687, DOI 10.1523/JNEUROSCI.1160-09.2009; Yeyati PL, 2007, PLOS GENET, V3, P431, DOI 10.1371/journal.pgen.0030043	70	160	166	2	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 16	2012	148	6					1123	1131		10.1016/j.cell.2012.02.045	http://dx.doi.org/10.1016/j.cell.2012.02.045			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	913PI	22424224	Green Accepted, Bronze			2022-12-01	WOS:000301889500011
J	Ortegon, M; Lim, S; Chisholm, D; Mendis, S				Ortegon, Monica; Lim, Stephen; Chisholm, Dan; Mendis, Shanthi			Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MILLENNIUM DEVELOPMENT GOALS; MIDDLE-INCOME COUNTRIES; IMPROVING HEALTH; BLOOD-PRESSURE; INTERVENTIONS; CHOLESTEROL; GUIDELINES; MANAGEMENT; REDUCTION; SMOKING	Objective To determine the relative costs and health effects of interventions to combat cardiovascular disease, diabetes, and tobacco related disease in order to guide the allocation of resources in developing countries. Design Cost effectiveness analysis of 123 single or combined prevention and treatment strategies for cardiovascular disease, diabetes, and smoking by means of a lifetime population model. Setting Two World Health Organization sub-regions of the world: countries in sub-Saharan Africa with very high adult and high child mortality (AfrE) and countries in South East Asia with high adult and high child mortality (SearD). Data sources Demographic and epidemiological data were taken from the WHO databases of mortality and global burden of disease. Estimates of intervention coverage, effectiveness, and resource needs were drawn from clinical trials, observational studies, and treatment guidelines. Unit costs were taken from the WHO-CHOICE (Choosing Interventions that are Cost-Effective) price database. Main outcome measures Cost per disability adjusted life year (DALY) averted, expressed in international dollars ($Int) for the year 2005. Results Most of the interventions studied were considered highly cost effective, meaning they generate one healthy year of life at a cost of <$Int2000 (which is the gross domestic product per capita of the two regions considered here). Interventions that offer particularly good monetary value, and which could be considered for prioritised implementation or scale up, include demand reduction strategies of the Framework Convention for Tobacco Control (<$Int950 and <$Int200 per DALY averted in AfrE and SearD respectively); combination drug therapy for people with a >25% chance of experiencing a cardiovascular event over the next decade, either alone or together with specific multidrug regimens for the secondary prevention of post-acute ischaemic heart disease and stroke (<$Int150 and <$Int230 per DALY averted in AfrE and SearD respectively); and retinopathy screening and glycaemic control for patients with diabetes (<$Int2100 and <$Int950 per DALY averted in AfrE and SearD respectively). Conclusion This comparative economic assessment has identified a set of population-wide and individual strategies for prevention and control of cardiovascular disease that are inexpensive and cost effective in low resource settings.	[Ortegon, Monica] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Lim, Stephen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Chisholm, Dan] World Hlth Org, Dept Hlth Syst Financing, Geneva, Switzerland; [Mendis, Shanthi] World Hlth Org, Dept Chron Dis & Hlth Promot, Geneva, Switzerland	Universidad del Rosario; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; World Health Organization; World Health Organization	Ortegon, M (corresponding author), Carrera 24 63C-69, Bogota, Colombia.	monica.ortegon@urosario.edu.co	Mendis, Shanthi/GLT-0465-2022	mendis, shanthi/0000-0002-8959-5738				Abegunde D, 2006, ESSENTIAL MED NONCOM; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Baltussen R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e615; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Chisholm D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e609; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e612; Duc AH, 2011, HEALTH POLICY PLANN, V26, P210, DOI 10.1093/heapol/czq045; Evans, 2003, MAKING CHOICES HLTH; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Ezzati M., 2004, COMP QUANTIFICATION; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Grover SA, 2001, DIABETES CARE, V24, P45, DOI 10.2337/diacare.24.1.45; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P463, DOI 10.1053/j.ajkd.2009.11.017; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358; Jha P, 2006, DRUG ALCOHOL REV, V25, P597, DOI 10.1080/09595230600944511; Karthikeyan G, 2007, HEART, V93, P1334, DOI 10.1136/hrt.2007.131193; Lai T, 2007, HEALTH POLICY, V84, P75, DOI 10.1016/j.healthpol.2007.02.012; Lauer Jeremy A, 2003, Cost Eff Resour Alloc, V1, P6, DOI 10.1186/1478-7547-1-6; Manns B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5869; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Mihaylova B, 2005, LANCET, V365, P1779, DOI 10.1016/S0140-6736(05)63014-0; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Murray CJL, 2001, GLOBAL BURDEN DIS 20; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Organization WH Control RfIT, 2008, WHO REP GLOB TOB EP; Pezzella AT, 2011, GLOBAL EXPANSION CAR; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Rubinstein Adolfo, 2009, Cost Eff Resour Alloc, V7, P10, DOI 10.1186/1478-7547-7-10; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Shibuya K, 2003, BMJ-BRIT MED J, V327, P154, DOI 10.1136/bmj.327.7407.154; Stanciole AE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e608; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Steenland K, 1996, CIRCULATION, V94, P622, DOI 10.1161/01.CIR.94.4.622; United Nations General Assembly, 2011, A66L1 UN GEN ASS; Weatherly H, 2009, HEALTH POLICY, V93, P85, DOI 10.1016/j.healthpol.2009.07.012; World Health Organization, 2011, INF US MONT CARL LEA; World Health Organization, 2007, PREVENTION CARDIOVAS; World Health Organization, 2007, PACK ESS NONC PEN DI; World Health Organization, 2002, RED RISKS HLTH PROM; World Health Organization, 2005, PREVENTING CHRONIC D	48	59	59	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2012	344								e607	10.1136/bmj.e607	http://dx.doi.org/10.1136/bmj.e607			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XQ	22389337	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000301232600002
J	Smol, JP				Smol, John P.			CLIMATE CHANGE A planet in flux	NATURE			English	Editorial Material									Queens Univ Kingston, Canada Res Chair Environm Change, Kingston, ON, Canada	Queens University - Canada	Smol, JP (corresponding author), Queens Univ Kingston, Canada Res Chair Environm Change, Kingston, ON, Canada.	smolj@queensu.ca		Smol, John/0000-0002-2499-6696				DOUGLAS MSV, 1994, SCIENCE, V266, P416, DOI 10.1126/science.266.5184.416; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Smol JP, 2007, P NATL ACAD SCI USA, V104, P12395, DOI 10.1073/pnas.0702777104	4	77	78	4	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					S12	S15		10.1038/483S12a	http://dx.doi.org/10.1038/483S12a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22378120				2022-12-01	WOS:000300877900005
J	Spence, D				Spence, Des			FROM THE FRONTLINE Exploiting non-communicable disease	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2012	344								e1278	10.1136/bmj.e1278	http://dx.doi.org/10.1136/bmj.e1278			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900JQ	22362249				2022-12-01	WOS:000300883600009
J	Faden, RR; Karron, RA				Faden, Ruth R.; Karron, Ruth A.			The Obligation to Prevent the Next Dual-Use Controversy	SCIENCE			English	Editorial Material							FLU		[Faden, Ruth R.] Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA; [Karron, Ruth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Vaccine Initiat, Ctr Immunizat Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Faden, RR (corresponding author), Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA.	rfaden@jhu.edu						BERG P, 1974, SCIENCE, V185, P303, DOI 10.1126/science.185.4148.303; Butler D, 2012, NATURE, V481, P417, DOI 10.1038/481417a; Connor S., 2011, INDEPENDENT     1214; Editorial Board, 2012, NY TIMES        0108, pSR10; Enserink M, 2012, SCIENCE, V335, P20, DOI 10.1126/science.335.6064.20; Fouchier RAM, 2012, SCIENCE, V335, P662, DOI 10.1126/science.1218376; Fouchier RAM, 2012, SCIENCE, V335, P400, DOI [10.1126/science.1219412, 10.1126/science.335.6067.400]; Inglesby T., MILWAUKEE WISCONSIN; Jasanoff Sheila, 2005, DESIGNS NATURE SCI D; Kraemer JD, 2012, SCIENCE, V335, P1047, DOI 10.1126/science.1219215; Ledford H, 2012, NATURE, V481, P9, DOI 10.1038/481009a; National Research Council, 2004, BIOT RES AG TERR; Schneider E., 2011, COMMUNICATION   1214; Vogel D., 2004, YB EUROPEAN ENV LAW, V3, P43; WHO, 2012, GLOB INFL PROGR; Wohlers Anton E, 2010, Politics Life Sci, V29, P17, DOI 10.2990/29_2_17; [No title captured]	17	10	10	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					802	804		10.1126/science.1219668	http://dx.doi.org/10.1126/science.1219668			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	893LC	22323739				2022-12-01	WOS:000300356400027
J	Zbieg, JR; Yamaguchi, E; McInturff, EL; Krische, MJ				Zbieg, Jason R.; Yamaguchi, Eiji; McInturff, Emma L.; Krische, Michael J.			Enantioselective C-H Crotylation of Primary Alcohols via Hydrohydroxyalkylation of Butadiene	SCIENCE			English	Article							TRANSITION-METAL CATALYSIS; OXIDATION LEVEL; TRANSFER HYDROGENATION; CARBONYL CROTYLATION; BRONSTED ACID; ALDEHYDES; ALLYLATION; REAGENTS; KETONES; COMPLEXES	The direct, by-product-free conversion of basic feedstocks to products of medicinal and agricultural relevance is a broad goal of chemical research. Butadiene is a product of petroleum cracking and is produced on an enormous scale (about 12 x 10(6) metric tons annually). Here, with the use of a ruthenium catalyst modified by a chiral phosphate counterion, we report the direct redox-triggered carbon-carbon coupling of alcohols and butadiene to form products of carbonyl crotylation with high levels of anti-diastereoselectivity and enantioselectivity in the absence of stoichiometric by-products.	[Zbieg, Jason R.; Yamaguchi, Eiji; McInturff, Emma L.; Krische, Michael J.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Krische, MJ (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	mkrische@mail.utexas.edu	Yamaguchi, Eiji/ABI-2594-2020		Robert A. Welch Foundation [F-0038]; NIH's National Institute of General Medical Sciences [RO1-GM069445]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069445] Funding Source: NIH RePORTER	Robert A. Welch Foundation(The Welch Foundation); NIH's National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Robert A. Welch Foundation (grant F-0038) and the NIH's National Institute of General Medical Sciences (grant RO1-GM069445) are acknowledged for financial support.	ALPER H, 1990, J AM CHEM SOC, V112, P2803, DOI 10.1021/ja00163a053; Bower JF, 2011, TOP ORGANOMETAL CHEM, V34, P107, DOI 10.1007/978-3-642-15334-1_5; BROWN HC, 1986, J AM CHEM SOC, V108, P293, DOI 10.1021/ja00262a017; BROWN HC, 1986, J AM CHEM SOC, V108, P5919, DOI 10.1021/ja00279a042; Busacca CA, 2011, ADV SYNTH CATAL, V353, P1825, DOI 10.1002/adsc.201100488; Butters M, 2006, CHEM REV, V106, P3002, DOI 10.1021/cr050982w; Denmark SE, 2003, CHEM REV, V103, P2763, DOI 10.1021/cr020050h; DOBSON A, 1975, J CHEM SOC DALTON, P370, DOI 10.1039/dt9750000370; Gao X, 2011, J AM CHEM SOC, V133, P12795, DOI 10.1021/ja204570w; Gao X, 2011, J ORG CHEM, V76, P2350, DOI 10.1021/jo200068q; Hamilton GL, 2007, SCIENCE, V317, P496, DOI 10.1126/science.1145229; Hassan A, 2011, ORG PROCESS RES DEV, V15, P1236, DOI 10.1021/op200195m; Hiraki K., 1985, CHEM SOC DALTON T, P873; HOFFMANN RW, 1979, TETRAHEDRON LETT, P4653; Jiang GX, 2011, CHEM COMMUN, V47, P10022, DOI 10.1039/c1cc12499d; Kim H, 2011, J AM CHEM SOC, V133, P6517, DOI 10.1021/ja200712f; Kim IS, 2009, J AM CHEM SOC, V131, P2514, DOI 10.1021/ja808857w; Kohlpaintner C. W, 1996, APPL HOMOGENEOUS CAT, P29; Komanduri V, 2006, J AM CHEM SOC, V128, P16448, DOI 10.1021/ja0673027; Liao SH, 2010, ANGEW CHEM INT EDIT, V49, P628, DOI 10.1002/anie.200905332; Magano J, 2011, CHEM REV, V111, P2177, DOI 10.1021/cr100346g; Maytum HC, 2007, ORG LETT, V9, P4387, DOI 10.1021/ol702029n; Mukherjee S, 2007, J AM CHEM SOC, V129, P11336, DOI 10.1021/ja074678r; Rueping M, 2007, ANGEW CHEM INT EDIT, V46, P6903, DOI 10.1002/anie.200702439; Sheldon RA, 2007, GREEN CHEM, V9, P1273, DOI 10.1039/b713736m; Shibahara F, 2008, J AM CHEM SOC, V130, P6338, DOI 10.1021/ja801213x; van Leeuwen P. W. N. M., 2004, HOMOGENEOUS CATALYSI, P139; Xu B, 2011, ANGEW CHEM INT EDIT, V50, P11483, DOI 10.1002/anie.201105485; Xue P, 2004, ORGANOMETALLICS, V23, P4735, DOI 10.1021/om049646g; Yus M, 2011, CHEM REV, V111, P7774, DOI 10.1021/cr1004474; Zbieg JR, 2011, J AM CHEM SOC, V133, P10582, DOI 10.1021/ja2046028; Zbieg JR, 2011, J AM CHEM SOC, V133, P1141, DOI 10.1021/ja1104156; Zbieg JR, 2010, ADV SYNTH CATAL, V352, P2416, DOI 10.1002/adsc.201000599	33	259	260	2	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					324	327		10.1126/science.1219274	http://dx.doi.org/10.1126/science.1219274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22442385	Green Accepted			2022-12-01	WOS:000302995400039
J	Bazzini, AA; Lee, MT; Giraldez, AJ				Bazzini, Ariel A.; Lee, Miler T.; Giraldez, Antonio J.			Ribosome Profiling Shows That miR-430 Reduces Translation Before Causing mRNA Decay in Zebrafish	SCIENCE			English	Article							DEADENYLATION IN-VITRO; MEDIATED DEADENYLATION; LET-7 MICRORNA; REPRESSION; INITIATION; INHIBITION; GW182; CCR4-NOT; ELEGANS; TARGETS	MicroRNAs regulate gene expression through deadenylation, repression, and messenger RNA (mRNA) decay. However, the contribution of each mechanism in non-steady-state situations remains unclear. We monitored the impact of miR-430 on ribosome occupancy of endogenous mRNAs in wild-type and dicer mutant zebrafish embryos and found that miR-430 reduces the number of ribosomes on target mRNAs before causing mRNA decay. Translational repression occurs before complete deadenylation, and disrupting deadenylation with use of an internal polyadenylate tail did not block target repression. Lastly, we observed that ribosome density along the length of the message remains constant, suggesting that translational repression occurs by reducing the rate of initiation rather than affecting elongation or causing ribosomal drop-off. These results show that miR-430 regulates translation initiation before inducing mRNA decay during zebrafish development.	[Bazzini, Ariel A.; Lee, Miler T.; Giraldez, Antonio J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Giraldez, Antonio J.] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA	Yale University; Yale University	Giraldez, AJ (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	antonio.giraldez@yale.edu		Giraldez, Antonio/0000-0002-6823-137X	Pew Fellows Program in Biomedical Sciences; Pew Scholars Program in the Biomedical Sciences; Yale Scholar Program; NIH [R01GM081602-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD071697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081602, R01GM102251] Funding Source: NIH RePORTER	Pew Fellows Program in Biomedical Sciences; Pew Scholars Program in the Biomedical Sciences; Yale Scholar Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Wolin and the Wolin laboratory for vital intellectual and technical support and access to equipment and reagents; N. Ignolia, J. Weissman, D. Schoenberg, D. Patil, A. Staton, C. Takacs, and Y. Mishima for reagents and discussions; and S. Baserga, D. Cazalla, D. Cifuentes, and S. Moxon for discussions. Supported by the Pew Fellows Program in Biomedical Sciences (A. A. B.), the Pew Scholars Program in the Biomedical Sciences, the Yale Scholar Program, and NIH grants R01GM081602-05 (A. J. G).; Contributions: A. A. B. and A. J. G. designed the project. A. A. B. performed the experiments. A. A. B. and M. T. L. performed data analysis. A. A. B., M. T. L., and A.J.G. interpreted the data and wrote the manuscript. Sequencing data are deposited in the Gene Expression Omnibus (GEO) database with accession number GSE34743.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fabian MR, 2011, METHODS MOL BIOL, V725, P207, DOI 10.1007/978-1-61779-046-1_14; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fukaya T, 2011, EMBO J, V30, P4998, DOI 10.1038/emboj.2011.426; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mishima Y, 2012, P NATL ACAD SCI USA, V109, P1104, DOI 10.1073/pnas.1113350109; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Wu E, 2010, MOL CELL, V40, P558, DOI 10.1016/j.molcel.2010.11.003; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009	29	514	522	7	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					233	237		10.1126/science.1215704	http://dx.doi.org/10.1126/science.1215704			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22422859	Green Accepted			2022-12-01	WOS:000302703900051
J	Vash, P				Vash, Peter			Filling the Void	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Vash, P (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.	petervashmd@sbcglobal.net						FELITTI VJ, 1991, SOUTHERN MED J, V84, P328, DOI 10.1097/00007611-199103000-00008	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1381	1382		10.1001/jama.2012.403	http://dx.doi.org/10.1001/jama.2012.403			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474201				2022-12-01	WOS:000302294200024
J	Barretina, J; Caponigro, G; Stransky, N; Venkatesan, K; Margolin, AA; Kim, S; Wilson, CJ; Lehar, J; Kryukov, GV; Sonkin, D; Reddy, A; Liu, MW; Murray, L; Berger, MF; Monahan, JE; Morais, P; Meltzer, J; Korejwa, A; Jane-Valbuena, J; Mapa, FA; Thibault, J; Bric-Furlong, E; Raman, P; Shipway, A; Engels, IH; Cheng, J; Yu, GYK; Yu, JJ; Aspesi, P; de Silva, M; Jagtap, K; Jones, MD; Wang, L; Hatton, C; Palescandolo, E; Gupta, S; Mahan, S; Sougnez, C; Onofrio, RC; Liefeld, T; MacConaill, L; Winckler, W; Reich, M; Li, NX; Mesirov, JP; Gabriel, SB; Getz, G; Ardlie, K; Chan, V; Myer, VE; Weber, BL; Porter, J; Warmuth, M; Finan, P; Harris, JL; Meyerson, M; Golub, TR; Morrissey, MP; Sellers, WR; Schlegel, R; Garraway, LA				Barretina, Jordi; Caponigro, Giordano; Stransky, Nicolas; Venkatesan, Kavitha; Margolin, Adam A.; Kim, Sungjoon; Wilson, Christopher J.; Lehar, Joseph; Kryukov, Gregory V.; Sonkin, Dmitriy; Reddy, Anupama; Liu, Manway; Murray, Lauren; Berger, Michael F.; Monahan, John E.; Morais, Paula; Meltzer, Jodi; Korejwa, Adam; Jane-Valbuena, Judit; Mapa, Felipa A.; Thibault, Joseph; Bric-Furlong, Eva; Raman, Pichai; Shipway, Aaron; Engels, Ingo H.; Cheng, Jill; Yu, Guoying K.; Yu, Jianjun; Aspesi, Peter, Jr.; de Silva, Melanie; Jagtap, Kalpana; Jones, Michael D.; Wang, Li; Hatton, Charles; Palescandolo, Emanuele; Gupta, Supriya; Mahan, Scott; Sougnez, Carrie; Onofrio, Robert C.; Liefeld, Ted; MacConaill, Laura; Winckler, Wendy; Reich, Michael; Li, Nanxin; Mesirov, Jill P.; Gabriel, Stacey B.; Getz, Gad; Ardlie, Kristin; Chan, Vivien; Myer, Vic E.; Weber, Barbara L.; Porter, Jeff; Warmuth, Markus; Finan, Peter; Harris, Jennifer L.; Meyerson, Matthew; Golub, Todd R.; Morrissey, Michael P.; Sellers, William R.; Schlegel, Robert; Garraway, Levi A.			The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity	NATURE			English	Article							MALIGNANT-MELANOMA; INHIBITOR; KINASE; RECEPTOR; ANTAGONIST; EXPRESSION	The systematic translation of cancer genomic data into knowledge of tumour biology and therapeutic possibilities remains challenging. Such efforts should be greatly aided by robust preclinical model systems that reflect the genomic diversity of human cancers and for which detailed genetic and pharmacological annotation is available(1). Here we describe the Cancer Cell Line Encyclopedia (CCLE): a compilation of gene expression, chromosomal copy number and massively parallel sequencing data from947 human cancer cell lines. When coupled with pharmacological profiles for 24 anticancer drugs across 479 of the cell lines, this collection allowed identification of genetic, lineage, and gene-expression-based predictors of drug sensitivity. In addition to known predictors, we found that plasma cell lineage correlated with sensitivity to IGF1 receptor inhibitors; AHR expression was associated with MEK inhibitor efficacy in NRAS-mutant lines; and SLFN11 expression predicted sensitivity to topoisomerase inhibitors. Together, our results indicate that large, annotated cell-line collections may help to enable preclinical stratification schemata for anticancer agents. The generation of genetic predictions of drug response in the preclinical setting and their incorporation into cancer clinical trial design could speed the emergence of 'personalized' therapeutic regimens(2).	[Barretina, Jordi; Stransky, Nicolas; Margolin, Adam A.; Kryukov, Gregory V.; Murray, Lauren; Berger, Michael F.; Morais, Paula; Korejwa, Adam; Jane-Valbuena, Judit; Gupta, Supriya; Mahan, Scott; Sougnez, Carrie; Onofrio, Robert C.; Liefeld, Ted; Winckler, Wendy; Reich, Michael; Mesirov, Jill P.; Gabriel, Stacey B.; Getz, Gad; Ardlie, Kristin; Meyerson, Matthew; Golub, Todd R.; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Barretina, Jordi; Jane-Valbuena, Judit; Meyerson, Matthew; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Barretina, Jordi; Hatton, Charles; Palescandolo, Emanuele; MacConaill, Laura; Meyerson, Matthew; Golub, Todd R.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Caponigro, Giordano; Venkatesan, Kavitha; Wilson, Christopher J.; Lehar, Joseph; Sonkin, Dmitriy; Reddy, Anupama; Liu, Manway; Monahan, John E.; Meltzer, Jodi; Mapa, Felipa A.; Bric-Furlong, Eva; Raman, Pichai; Aspesi, Peter, Jr.; de Silva, Melanie; Jagtap, Kalpana; Jones, Michael D.; Wang, Li; Myer, Vic E.; Weber, Barbara L.; Porter, Jeff; Warmuth, Markus; Finan, Peter; Morrissey, Michael P.; Sellers, William R.; Schlegel, Robert] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Kim, Sungjoon; Thibault, Joseph; Shipway, Aaron; Engels, Ingo H.; Li, Nanxin; Harris, Jennifer L.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Cheng, Jill; Yu, Guoying K.; Yu, Jianjun; Chan, Vivien] Novartis Inst Biomed Res, Emeryville, CA 94608 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Novartis; Novartis; Novartis; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Garraway, LA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	robert.schlegel@novartis.com; Levi_Garraway@dfci.harvard.edu	Morrissey, Michael/C-6792-2013; Chan, Vivien W/N-7980-2019; Meyerson, Matthew L/E-7123-2012; Mesirov, Jill/AGF-7626-2022; Kryukov, Gregory V/A-9592-2008; Barretina, Jordi/A-7192-2013	Chan, Vivien W/0000-0001-7663-1130; Keskula, Paula/0000-0002-0458-9153; Meyerson, Matthew/0000-0002-9133-8108; Reich, Michael/0000-0003-4735-5514; Barretina, Jordi/0000-0002-3478-4080; Monahan, John/0000-0002-3125-8704; Kryukov, Gregory/0000-0002-6131-9483; Sonkin, Dmitriy/0000-0002-1649-0652; Hatton, Charlie/0000-0001-9903-4291; Wilson, Christopher/0000-0002-9146-522X; Jones, Michael/0000-0001-7541-7634	Novartis Institutes for Biomedical Research; National Cancer Institute; Starr Cancer Consortium; NIH; NATIONAL CANCER INSTITUTE [R33CA155554, R33CA126674] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	Novartis Institutes for Biomedical Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Starr Cancer Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the staff of the Biological Samples Platform, the Genetic Analysis Platform and the Sequencing Platform at the Broad Institute. We thank S. Banerji, J. Che, C. M. Johannessen, A. Su and N. Wagle for advice and discussion. We are grateful for the technical assistance and support of G. Bonamy, R. Brusch III, E. Gelfand, K. Gravelin, T. Huynh, S. Kehoe, K. Matthews, J. Nedzel, L. Niu, R. Pinchback, D. Roby, J. Slind, T. R. Smith, L. Tan, V. Trinh, C. Vickers, G. Yang, Y. Yao and X. Zhang. The Cancer Cell Line Encyclopedia project was enabled by a grant from the Novartis Institutes for Biomedical Research. Additional funding support was provided by the National Cancer Institute (M. M., L. A. G.), the Starr Cancer Consortium (M. F. B., L. A. G.), and the NIH Director's New Innovator Award (L.A.G.).	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Caponigro G, 2011, NAT REV DRUG DISCOV, V10, P179, DOI 10.1038/nrd3385; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; MacConaill LE, 2010, J CLIN ONCOL, V28, P5219, DOI 10.1200/JCO.2009.27.4944; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Moreau P, 2011, LEUKEMIA, V25, P872, DOI 10.1038/leu.2011.4; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishio M, 2011, J THORAC ONCOL, V6, P1889, DOI 10.1097/JTO.0b013e3182286d41; Reiners JJ, 1998, MOL PHARMACOL, V53, P438, DOI 10.1124/mol.53.3.438; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wagner LM, 2007, PEDIATR BLOOD CANCER, V48, P132, DOI 10.1002/pbc.20697; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	26	4577	4692	17	533	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					603	607		10.1038/nature11003	http://dx.doi.org/10.1038/nature11003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460905	Green Accepted			2022-12-01	WOS:000302006100040
J	Spaulding, AC; Thomas, DL				Spaulding, Anne C.; Thomas, David L.			Screening for HCV Infection in Jails	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							C VIRUS-INFECTION; HEPATITIS-C; PUBLIC-HEALTH		[Spaulding, Anne C.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30033 USA; [Thomas, David L.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Emory University; Rollins School Public Health; Johns Hopkins University	Spaulding, AC (corresponding author), Emory Univ, Rollins Sch Publ Hlth, 1518 Clifton Rd,Room 3033, Atlanta, GA 30033 USA.	aspauld@emory.edu			NIDA NIH HHS [R01 DA016078, DA R01 016078] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016078] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Colvin HM, HEPATITIS LIVER CANC; Flanigan TP, 2010, JAIDS-J ACQ IMM DEF, V55, pS78, DOI 10.1097/QAI.0b013e3181fbc94f; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Spaulding A, 1999, PREV MED, V28, P92, DOI 10.1006/pmed.1998.0418; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; US Department of Health and Human Services, COMB SIL EP VIR HEP	10	36	36	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2012	307	12					1259	1260		10.1001/jama.2012.374	http://dx.doi.org/10.1001/jama.2012.374			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914UP	22453565	Green Accepted			2022-12-01	WOS:000301978400019
J	Graff, J; Rei, D; Guan, JS; Wang, WY; Seo, J; Hennig, KM; Nieland, TJF; Fass, DM; Kao, PF; Kahn, M; Su, SC; Samiei, A; Joseph, N; Haggarty, SJ; Delalle, I; Tsai, LH				Graeff, Johannes; Rei, Damien; Guan, Ji-Song; Wang, Wen-Yuan; Seo, Jinsoo; Hennig, Krista M.; Nieland, Thomas J. F.; Fass, Daniel M.; Kao, Patricia F.; Kahn, Martin; Su, Susan C.; Samiei, Alireza; Joseph, Nadine; Haggarty, Stephen J.; Delalle, Ivana; Tsai, Li-Huei			An epigenetic blockade of cognitive functions in the neurodegenerating brain	NATURE			English	Article							LONG-TERM-MEMORY; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; CLINICAL-IMPLICATIONS; TRANSGENIC MICE; REMOTE MEMORIES; CDK5; PHOSPHORYLATION; EXPRESSION; CHROMATIN	Cognitive decline is a debilitating feature of most neurodegenerative diseases of the central nervous system, including Alzheimer's disease(1). The causes leading to such impairment are only poorly understood and effective treatments are slow to emerge(2). Here we show that cognitive capacities in the neurodegenerating brain are constrained by an epigenetic blockade of gene transcription that is potentially reversible. This blockade is mediated by histone deacetylase 2, which is increased by Alzheimer's-disease-related neurotoxic insults in vitro, in two mouse models of neurodegeneration and in patients with Alzheimer's disease. Histone deacetylase 2 associates with and reduces the histone acetylation of genes important for learning and memory, which show a concomitant decrease in expression. Importantly, reversing the build-up of histone deacetylase 2 by short-hairpin-RNA-mediated knockdown unlocks the repression of these genes, reinstates structural and synaptic plasticity, and abolishes neurodegeneration-associated memory impairments. These findings advocate for the development of selective inhibitors of histone deacetylase 2 and suggest that cognitive capacities following neurodegeneration are not entirely lost, but merely impaired by this epigenetic blockade.	[Graeff, Johannes; Rei, Damien; Guan, Ji-Song; Wang, Wen-Yuan; Seo, Jinsoo; Kahn, Martin; Su, Susan C.; Samiei, Alireza; Joseph, Nadine; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Graeff, Johannes; Rei, Damien; Guan, Ji-Song; Wang, Wen-Yuan; Seo, Jinsoo; Su, Susan C.; Joseph, Nadine; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Graeff, Johannes; Guan, Ji-Song; Wang, Wen-Yuan; Hennig, Krista M.; Nieland, Thomas J. F.; Fass, Daniel M.; Joseph, Nadine; Haggarty, Stephen J.; Tsai, Li-Huei] Broad Inst Harvard Univ & Massachusetts Inst Tech, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Hennig, Krista M.; Fass, Daniel M.; Haggarty, Stephen J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kao, Patricia F.; Delalle, Ivana] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Haggarty, Stephen J/M-9495-2016; Core, Vector/CAF-4832-2022; Seo, Jinsoo/AAD-4950-2019	Haggarty, Stephen J/0000-0002-7872-168X; Seo, Jinsoo/0000-0001-6432-6964; Kahn, Martin/0000-0002-4211-5020; Graff, Johannes/0000-0002-3219-3578; Guan, Ji-Song/0000-0001-5219-0289; Delalle, Ivana/0000-0002-1873-3064	Stanley Medical Research Institution; National Institutes of Health/National Institute on Drug Abuse [RO1DA028301]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [RO1NS078839]; Bard Richmond fellowship; Swiss National Science Foundation; Simons Foundation; Theodor und Ida Herzog-Egli foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028301] Funding Source: NIH RePORTER	Stanley Medical Research Institution; National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bard Richmond fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Simons Foundation; Theodor und Ida Herzog-Egli foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Mungenast, S. Jemielity, R. Madabushi, F. Calderon de Anda and M. Horn for reading the manuscript, A. M. for manuscript editing, M. Eichler for mouse colony maintenance, K. Fitch for sectioning the human brain samples and M. H. for quantification of Fig. 2a. This work was partly supported by the Stanley Medical Research Institution (to S.J.H. and L.-H.T.), National Institutes of Health/National Institute on Drug Abuse (RO1DA028301, to S.J.H.) and National Institutes of Health/National Institute of Neurological Disorders and Stroke (RO1NS078839, to L.-H.T.). J.G. was supported by a Bard Richmond fellowship and by the Swiss National Science Foundation, W.Y.W. by the Simons Foundation and M.K. by the Theodor und Ida Herzog-Egli foundation. L.-H.T. is an investigator of the Howard Hughes Medical Institute.	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Chrousos GP, 2009, ANN NY ACAD SCI, V1179, P153, DOI 10.1111/j.1749-6632.2009.04988.x; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; Guan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025735; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; Koshibu K, 2009, J NEUROSCI, V29, P13079, DOI 10.1523/JNEUROSCI.3610-09.2009; Lauterborn JC, 1996, J NEUROSCI, V16, P7428; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Qi YP, 1997, J NEUROSCI, V17, P1217; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sun JM, 2007, J BIOL CHEM, V282, P33227, DOI 10.1074/jbc.M703549200; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	38	555	589	7	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2012	483	7388					222	U123		10.1038/nature10849	http://dx.doi.org/10.1038/nature10849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22388814	Green Submitted, Green Accepted			2022-12-01	WOS:000301174900041
J	Dana, GV; Kuiken, T; Rejeski, D; Snow, AA				Dana, Genya V.; Kuiken, Todd; Rejeski, David; Snow, Allison A.			Four steps to avoid a synthetic-biology disaster	NATURE			English	Editorial Material									[Dana, Genya V.; Kuiken, Todd; Rejeski, David] Woodrow Wilson Int Ctr Scholars, Washington, DC 20004 USA; [Snow, Allison A.] Ohio State Univ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Dana, GV (corresponding author), Woodrow Wilson Int Ctr Scholars, Washington, DC 20004 USA.	gvdana@gmail.com	Kuiken, Todd/A-3784-2016; Kuiken, Todd/U-3476-2019	Kuiken, Todd/0000-0001-7851-6232; Kuiken, Todd/0000-0001-7851-6232				Bergin J, 2011, SYNTHETIC BIOL EMERG; Michael Davis J, 2010, COMPREHENSIVE ENV AS	2	61	63	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					29	29		10.1038/483029a	http://dx.doi.org/10.1038/483029a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900HP	22382962	Bronze			2022-12-01	WOS:000300877900025
J	Bouffard, C; Bouffard, M				Bouffard, Chantal; Bouffard, Mickael			The art of medicine Spectacular anatomy: plastination and salutary dread	LANCET			English	Editorial Material									[Bouffard, Chantal] Univ Sherbrooke, Div Genet, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada; [Bouffard, Mickael] Univ Montreal, Dept Art Hist, Fac Arts & Sci, Montreal, PQ, Canada	University of Sherbrooke; Universite de Montreal	Bouffard, C (corresponding author), Univ Sherbrooke, Div Genet, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada.	chantal.bouffard@usherbrooke.ca						Barnett R, 2008, LANCET, V372, P366, DOI 10.1016/S0140-6736(08)61145-9; Cuir R, 2006, ANTHROPOL TODAY, V22, P20, DOI 10.1111/j.1467-8322.2006.00473.x; Delpeux S, 2001, ART PRESS        MAY, P76; Hoffmann KA, 2010, EARLY POPULAR VISUAL, V4, P139; Le Floch-Prigent P., 2010, Morphologie, V94, P81, DOI 10.1016/j.morpho.2010.03.007; Lemire Michel, 1990, ARTISTES MORTELS; Morone JA, 1997, J HEALTH POLIT POLIC, V22, P993, DOI 10.1215/03616878-22-4-993; van Dijck J, 2001, CONFIGURATIONS, V9, P99, DOI 10.1353/con.2001.0008; von Hagens G, 2004, BODY WORLDS ANATOMIC	9	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2012	379	9817					704	705		10.1016/S0140-6736(12)60298-0	http://dx.doi.org/10.1016/S0140-6736(12)60298-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	899CU	22371965	Bronze			2022-12-01	WOS:000300792600014
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Would you like your telomeres tested?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Newswire PR, 2011, PR NEWSWIRE     1208	1	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2012	344								e681	10.1136/bmj.e681	http://dx.doi.org/10.1136/bmj.e681			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	892IE	22318437				2022-12-01	WOS:000300279100004
J	Xu, XH; Coats, JK; Yang, CF; Wang, A; Ahmed, OM; Alvarado, M; Izumi, T; Shah, NM				Xu, Xiaohong; Coats, Jennifer K.; Yang, Cindy F.; Wang, Amy; Ahmed, Osama M.; Alvarado, Maricruz; Izumi, Tetsuro; Shah, Nirao M.			Modular Genetic Control of Sexually Dimorphic Behaviors	CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; VENTROMEDIAL HYPOTHALAMIC NUCLEUS; POSTERODORSAL MEDIAL AMYGDALA; NON-GENOMIC ACTIONS; MICE LACKING; MESSENGER-RNA; LORDOSIS BEHAVIOR; SEX-DIFFERENCES; RAT-BRAIN; TARGETED DISRUPTION	Sex hormones such as estrogen and testosterone are essential for sexually dimorphic behaviors in vertebrates. However, the hormone-activated molecular mechanisms that control the development and function of the underlying neural circuits remain poorly defined. We have identified numerous sexually dimorphic gene expression patterns in the adult mouse hypothalamus and amygdala. We find that adult sex hormones regulate these expression patterns in a sex-specific, regionally restricted manner, suggesting that these genes regulate sex typical behaviors. Indeed, we find that mice with targeted disruptions of each of four of these genes (Brs3, Cckar, Irs4, Sytl4) exhibit extremely specific deficits in sex specific behaviors, with single genes controlling the pattern or extent of male sexual behavior, male aggression, maternal behavior, or female sexual behavior. Taken together, our findings demonstrate that various components of sexually dimorphic behaviors are governed by separable genetic programs.	[Coats, Jennifer K.; Yang, Cindy F.; Ahmed, Osama M.; Shah, Nirao M.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [Xu, Xiaohong; Wang, Amy; Alvarado, Maricruz; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Izumi, Tetsuro] Gunma Univ, Dept Mol Med, Maebashi, Gunma 3718512, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Gunma University	Shah, NM (corresponding author), Univ Calif San Francisco, Program Neurosci, MC 2722, San Francisco, CA 94158 USA.	nms@ucsf.edu		Ahmed, Osama/0000-0003-3539-3150; Yang, Cindy/0000-0001-6144-4658	NSF; Sandler postdoctoral fellowship; Genentech graduate fellowship; ARCS; Edward Mallinckrodt, Jr. Foundation; NARSAD; NIH [R01NS049488, DP1OD006425]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049488] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006425] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Sandler postdoctoral fellowship; Genentech graduate fellowship; ARCS; Edward Mallinckrodt, Jr. Foundation; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Axel, H. Baier, H. Bourne, and S. Lomvardas for comments on the manuscript; D. Anderson, C. Bargmann, D. Julius, H. Zoghbi, and Shahlab members for discussions; and A. Barczak, P. Nittler, and E. Tumer for help with microarrays. This work was supported by NSF graduate fellowship (O.M.A.); Sandler postdoctoral fellowship (X. X.); Genentech graduate fellowship (C.F.Y. and J.K.C.); ARCS award (J.K.C.); Edward Mallinckrodt, Jr. Foundation, NARSAD, and NIH (N.M.S.; R01NS049488, DP1OD006425).	AKESSON TR, 1987, NEUROENDOCRINOLOGY, V45, P257, DOI 10.1159/000124737; Allen E, 1923, J AMER MED ASSOC, V81, P819, DOI 10.1001/jama.1923.02650100027012; Arnold AP, 2003, ANN NY ACAD SCI, V1007, P176, DOI 10.1196/annals.1286.018; BABCOCK AM, 1988, PHYSIOL BEHAV, V43, P195, DOI 10.1016/0031-9384(88)90237-5; Balthazart J, 2010, EUR J NEUROSCI, V32, P2116, DOI 10.1111/j.1460-9568.2010.07518.x; Baum MJ, 2003, SCAND J PSYCHOL, V44, P213, DOI 10.1111/1467-9450.00338; BEEMAN EA, 1947, PHYSIOL ZOOL, V20, P373, DOI 10.1086/physzool.20.4.30151969; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Berna MJ, 2007, CURR OPIN PHARMACOL, V7, P583, DOI 10.1016/j.coph.2007.09.011; Blaustein JD, 2008, ANNU REV PSYCHOL, V59, P93, DOI 10.1146/annurev.psych.59.103006.093556; BLOCH GJ, 1987, PHYSIOL BEHAV, V39, P217, DOI 10.1016/0031-9384(87)90012-6; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Burks DJ, 2001, DIABETES, V50, pS140, DOI 10.2337/diabetes.50.2007.S140; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; Cooke BM, 2006, NEUROSCIENCE, V138, P997, DOI 10.1016/j.neuroscience.2005.06.018; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; DEVRIES GJ, 1990, J NEUROENDOCRINOL, V2, P1, DOI 10.1111/j.1365-2826.1990.tb00385.x; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; DORNAN WA, 1989, PHYSIOL BEHAV, V45, P969, DOI 10.1016/0031-9384(89)90223-0; Dugger BN, 2008, NEUROENDOCRINOLOGY, V88, P17, DOI 10.1159/000119740; Dugger BN, 2007, HORM BEHAV, V51, P195, DOI 10.1016/j.yhbeh.2006.10.001; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; EMERY DE, 1976, PHYSIOL BEHAV, V17, P803, DOI 10.1016/0031-9384(76)90044-5; Enoch MA, 2009, NEUROPSYCHOPHARMACOL, V34, P1245, DOI 10.1038/npp.2008.171; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Gagnidze K, 2010, PROG BRAIN RES, V186, P97, DOI 10.1016/B978-0-444-53630-3.00007-5; Gammie SC, 2001, BRAIN RES, V898, P232, DOI 10.1016/S0006-8993(01)02189-8; GANDELMAN R, 1972, HORM BEHAV, V3, P23, DOI 10.1016/0018-506X(72)90003-7; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; Ghosh MG, 2000, CANCER RES, V60, P6367; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; GUILLAMON A, 1988, DEV BRAIN RES, V44, P281, DOI 10.1016/0165-3806(88)90226-X; Henderson LP, 2007, NEUROPHARMACOLOGY, V52, P1439, DOI 10.1016/j.neuropharm.2007.01.022; Hilke S, 2007, BRAIN RES, V1144, P70, DOI 10.1016/j.brainres.2007.01.107; Holland KL, 1997, PHYSIOL BEHAV, V62, P537, DOI 10.1016/S0031-9384(97)80331-9; Holmes MM, 2009, NEUROSCIENCE, V158, P1251, DOI 10.1016/j.neuroscience.2008.11.020; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; Kellendonk C, 2009, TRENDS NEUROSCI, V32, P347, DOI 10.1016/j.tins.2009.02.003; KOCH M, 1989, BRAIN RES, V489, P101, DOI 10.1016/0006-8993(89)90012-7; KONISHI M, 1989, NEURON, V3, P541, DOI 10.1016/0896-6273(89)90264-X; Kopin AS, 1999, J CLIN INVEST, V103, P383, DOI 10.1172/JCI4901; Kudwa AE, 2003, J NEUROENDOCRINOL, V15, P978, DOI 10.1046/j.1365-2826.2003.01089.x; Kudwa AE, 2006, NEUROSCIENCE, V138, P921, DOI 10.1016/j.neuroscience.2005.10.018; Ladenheim EE, 2008, ENDOCRINOLOGY, V149, P971, DOI 10.1210/en.2007-1319; LAUBER AH, 1991, ENDOCRINOLOGY, V129, P3180, DOI 10.1210/endo-129-6-3180; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Liu Y, 2011, NATURE, V472, P95, DOI 10.1038/nature09822; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McDevitta MA, 2008, MOL CELL ENDOCRINOL, V290, P24, DOI 10.1016/j.mce.2008.04.003; MCGILL TE, 1964, SCIENCE, V145, P514, DOI 10.1126/science.145.3631.514; MENDELSON SD, 1984, PHARMACOL BIOCHEM BE, V21, P755, DOI 10.1016/S0091-3057(84)80015-5; Micevych P, 2009, FRONT NEUROENDOCRIN, V30, P315, DOI 10.1016/j.yfrne.2009.04.011; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Morris JA, 2008, BRAIN RES, V1190, P115, DOI 10.1016/j.brainres.2007.11.005; Morris JA, 2008, J COMP NEUROL, V506, P851, DOI 10.1002/cne.21536; Morrow EM, 2008, SCHIZOPHR RES, V106, P265, DOI 10.1016/j.schres.2008.08.021; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; Nett ST, 1999, J NEUROPHYSIOL, V81, P192, DOI 10.1152/jn.1999.81.1.192; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; ORO AE, 1988, NEUROENDOCRINOLOGY, V47, P225, DOI 10.1159/000124916; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Pirnik Z, 2010, PEPTIDES, V31, P139, DOI 10.1016/j.peptides.2009.09.035; Raskin K, 2009, J NEUROSCI, V29, P4461, DOI 10.1523/JNEUROSCI.0296-09.2009; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Ring JR, 1944, ENDOCRINOLOGY, V34, P269, DOI 10.1210/endo-34-4-269; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; ROSELLI C E, 1987, Steroids, V50, P495, DOI 10.1016/0039-128X(87)90034-1; SCHELLER RH, 1983, CELL, V32, P7, DOI 10.1016/0092-8674(83)90492-0; Scordalakes EM, 2003, BEHAV NEUROSCI, V117, P38, DOI 10.1037/0735-7044.117.1.38; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; SHUGHRUE PJ, 1992, ENDOCRINOLOGY, V131, P381, DOI 10.1210/en.131.1.381; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; van der Zanden LFM, 2011, NAT GENET, V43, P48, DOI 10.1038/ng.721; van Nas A, 2009, ENDOCRINOLOGY, V150, P1235, DOI 10.1210/en.2008-0563; Vasudevan N, 2008, FRONT NEUROENDOCRIN, V29, P238, DOI 10.1016/j.yfrne.2007.08.003; Verdugo RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-58; VONSCHILCHER F, 1976, BEHAV BIOL, V17, P187, DOI 10.1016/S0091-6773(76)90444-2; Wang J, 1999, J BIOL CHEM, V274, P28542, DOI 10.1074/jbc.274.40.28542; Wersinger SR, 1997, HORM BEHAV, V32, P176, DOI 10.1006/hbeh.1997.1419; Wersinger SR, 2002, MOL PSYCHIATR, V7, P975, DOI 10.1038/sj.mp.4001195; Whited KL, 2006, AM J PHYSIOL-GASTR L, V291, pG156, DOI 10.1152/ajpgi.00569.2005; Wiesner BP, 1930, Q J EXP PHYSIOL, V20, P273, DOI 10.1113/expphysiol.1930.sp000505; Winslow JT, 2002, NEUROPEPTIDES, V36, P221, DOI 10.1054/npep.2002.0909; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Wolfe CA, 2005, DEV BRAIN RES, V157, P34, DOI 10.1016/j.devbrainres.2005.03.001; Wu MV, 2011, CURR OPIN NEUROBIOL, V21, P116, DOI 10.1016/j.conb.2010.09.014; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yntema HG, 1999, GENOMICS, V62, P332, DOI 10.1006/geno.1999.6004; Zoghbi HY, 2010, NEURON, V68, P165, DOI 10.1016/j.neuron.2010.10.015	111	159	162	4	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2012	148	3					596	607		10.1016/j.cell.2011.12.018	http://dx.doi.org/10.1016/j.cell.2011.12.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304924	Green Accepted, Bronze			2022-12-01	WOS:000300225000025
J	Meyer, JR; Dobias, DT; Weitz, JS; Barrick, JE; Quick, RT; Lenski, RE				Meyer, Justin R.; Dobias, Devin T.; Weitz, Joshua S.; Barrick, Jeffrey E.; Quick, Ryan T.; Lenski, Richard E.			Repeatability and Contingency in the Evolution of a Key Innovation in Phage Lambda	SCIENCE			English	Article							BACTERIOPHAGE-LAMBDA; MEMBRANE-PROTEINS; RECEPTOR; ADAPTATION; MECHANISMS; MALTOPORIN; DYNAMICS; CONSISTS; BINDING; SURFACE	The processes responsible for the evolution of key innovations, whereby lineages acquire qualitatively new functions that expand their ecological opportunities, remain poorly understood. We examined how a virus, bacteriophage l, evolved to infect its host, Escherichia coli, through a novel pathway. Natural selection promoted the fixation of mutations in the virus's host-recognition protein, J, that improved fitness on the original receptor, LamB, and set the stage for other mutations that allowed infection through a new receptor, OmpF. These viral mutations arose after the host evolved reduced expression of LamB, whereas certain other host mutations prevented the phage from evolving the new function. This study shows the complex interplay between genomic processes and ecological conditions that favor the emergence of evolutionary innovations.	[Meyer, Justin R.; Lenski, Richard E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Meyer, Justin R.; Barrick, Jeffrey E.; Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Dobias, Devin T.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Quick, Ryan T.; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Washington University (WUSTL); University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Texas System; University of Texas Austin; Michigan State University	Meyer, JR (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	justin.raymond.meyer@gmail.com	Weitz, Joshua S/I-6696-2012; Barrick, Jeffrey/A-3046-2012	Weitz, Joshua S/0000-0002-3433-8312; Barrick, Jeffrey/0000-0003-0888-7358; Lenski, Richard/0000-0002-1064-8375	BEACON Center for the Study of Evolution in Action (NSF) [DBI-0939454]; Defense Advanced Research Projects Agency [HR0011-09-1-0055]; NIH [R00GM087550]; James S. McDonnell Foundation; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM087550] Funding Source: NIH RePORTER	BEACON Center for the Study of Evolution in Action (NSF); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the BEACON Center for the Study of Evolution in Action (NSF Cooperative Agreement DBI-0939454), the Defense Advanced Research Projects Agency (HR0011-09-1-0055 to R. E. L. and J.S.W.), and the NIH (R00GM087550 to J.E.B.). J.S.W. also acknowledges the support of the James S. McDonnell Foundation and the Burroughs Wellcome Fund. We thank N. Hajela and L. Zaman for help in the lab; D. Court for sharing phage cI26; the Michigan State University Research Technology Support Facility for help with genome sequencing; Z. Blount, T. Ferenci, C. Marx, L. Zaman, I. Wang, M. Kreitman, B. He, and J. Reinitz for discussions; and the anonymous reviewers for help revising. R. E. L. will make the evolved strains available to qualified recipients, subject to completion of a material transfer agreement that can be found at www.technologies.msu.edu/inventors/mta-cda/mta/mta-forms. The genome-sequence data for the phage and bacteria have been deposited in the National Center for Biotechnology Information, NIH, Sequence Read Archive (SRA043942). Other data and analysis scripts have been deposited at the Dryad Digital Repository (doi:10.5061/dryad.sh7rm2pt).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berkane E, 2006, BIOCHEMISTRY-US, V45, P2708, DOI 10.1021/bi051800v; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; BRAUNBRETON C, 1978, MOL GEN GENET, V159, P143, DOI 10.1007/BF00270887; Cairns J, 2007, PHAGE ORIGINS MOL BI; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Crozat E, 2011, J BACTERIOL, V193, P429, DOI 10.1128/JB.01341-10; Darwin C.R., 1877, DIFFERENT FORMS FLOW; Dennehy JJ, 2009, TRENDS MICROBIOL, V17, P450, DOI 10.1016/j.tim.2009.07.006; Dieckmann U., 2004, ADAPTIVE SPECIATION; Duffy S, 2007, EVOLUTION, V61, P2614, DOI 10.1111/j.1558-5646.2007.00226.x; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; ERNI B, 1987, J BIOL CHEM, V262, P5238; Esquinas-Rychen M, 2001, J MOL MICROB BIOTECH, V3, P361; Ferris MT, 2007, GENETICS, V176, P1013, DOI 10.1534/genetics.106.064634; Fisher R.A., 1930, GENETICAL THEORY NAT; Flores CO, 2011, P NATL ACAD SCI USA, V108, pE288, DOI 10.1073/pnas.1101595108; Friedman DI, 2001, CURR OPIN MICROBIOL, V4, P201, DOI 10.1016/S1369-5274(00)00189-2; Gallet R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-181; Gavrilets S., 2010, EXTENDED EVOLUTIONAR; Gould S.J., 1989, WONDERFUL LIFE; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; Gurnev PA, 2006, J MOL BIOL, V359, P1447, DOI 10.1016/j.jmb.2006.04.034; Hall AR, 2011, AM NAT, V177, P44, DOI 10.1086/657441; Hendrix R.W., 1983, LAMBDA, VII; HENDRIX RW, 1992, SCIENCE, V258, P1145, DOI 10.1126/science.1439823; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Katsura I., 1981, LAMBDA; Kefala G, 2010, PROTEIN SCI, V19, P1117, DOI 10.1002/pro.369; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Maynard ND, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001017; Mayr E, 1963, ANIMAL SPECIES EVOLU; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Pigliucci M, 2008, PHILOS SCI, V75, P887, DOI 10.1086/594532; SARIS PEJ, 1987, FEMS MICROBIOL LETT, V44, P371, DOI 10.1111/j.1574-6968.1987.tb02316.x; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schneider D, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-18; Thompson J.N., 2005, INTERSPEC INTERACT; Thompson J.N., 1994, COEVOLUTIONARY PROCE; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Wright S, 1931, GENETICS, V16, P0097	47	268	278	5	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2012	335	6067					428	432		10.1126/science.1214449	http://dx.doi.org/10.1126/science.1214449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22282803	Green Accepted			2022-12-01	WOS:000299466800039
J	Miller, AN; Long, SB				Miller, Alexandria N.; Long, Stephen B.			Crystal Structure of the Human Two-Pore Domain Potassium Channel K2P1	SCIENCE			English	Article							BACKGROUND K+ CHANNELS; SELECTIVITY FILTER; ION-BINDING; ALPHA-HELIX; FATTY-ACIDS; PORE; TREK-1; TWIK-1; LEAK; CONDUCTION	Two-pore domain potassium (K+) channels (K2P channels) control the negative resting potential of eukaryotic cells and regulate cell excitability by conducting K+ ions across the plasma membrane. Here, we present the 3.4 angstrom resolution crystal structure of a human K2P channel, K2P1 (TWIK-1). Unlike other K+ channel structures, K2P1 is dimeric. An extracellular cap domain located above the selectivity filter forms an ion pathway in which K+ ions flow through side portals. Openings within the transmembrane region expose the pore to the lipid bilayer and are filled with electron density attributable to alkyl chains. An interfacial helix appears structurally poised to affect gating. The structure lays a foundation to further investigate how K2P channels are regulated by diverse stimuli.	[Miller, Alexandria N.; Long, Stephen B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Miller, Alexandria N.] Mem Sloan Kettering Canc Ctr, Louis Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Long, SB (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	longs@mskcc.org		Long, Stephen/0000-0002-8144-1398; Miller, Alexandria N./0000-0003-3986-7923	Burroughs Wellcome Career Award in the Biomedical Sciences; Gerstner Young Investigator Award	Burroughs Wellcome Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); Gerstner Young Investigator Award	We thank the staff of beamlines X25 and X29 (National Synchrotron Light Source, Brookhaven National Laboratory) for assistance at the synchrotron; C. D. Lima, N. P. Pavletich, Z. Lu, and members of the Long laboratory for helpful discussions; and N. P. Pavletich, M. B. Long, and J. P. Greenfield for comments on the manuscript. This work was supported in part by a Burroughs Wellcome Career Award in the Biomedical Sciences and by a Gerstner Young Investigator Award to S. B. L. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB ID 3UKM).	AQVIST J, 1991, P NATL ACAD SCI USA, V88, P2026, DOI 10.1073/pnas.88.5.2026; Ashmole I, 2009, J PHYSIOL-LONDON, V587, P4769, DOI 10.1113/jphysiol.2009.175430; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chemin J, 2005, J BIOL CHEM, V280, P4415, DOI 10.1074/jbc.M408246200; Clarke CE, 2008, J BIOL CHEM, V283, P16985, DOI 10.1074/jbc.M801368200; Dedman A, 2009, EUR BIOPHYS J BIOPHY, V38, P293, DOI 10.1007/s00249-008-0318-8; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Feliciangeli S, 2007, CELL, V130, P563, DOI 10.1016/j.cell.2007.06.012; Feliciangeli S, 2010, J BIOL CHEM, V285, P4798, DOI 10.1074/jbc.M109.078535; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HODGKIN AL, 1947, J PHYSIOL-LONDON, V106, P341, DOI 10.1113/jphysiol.1947.sp004216; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P64, DOI 10.1007/s004240000496; Kjeldsen K, 2010, EXP CLIN CARDIOL, V15, pE96; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; LOCKHART DJ, 1992, SCIENCE, V257, P947, DOI 10.1126/science.1502559; LOCKHART DJ, 1993, SCIENCE, V260, P198, DOI 10.1126/science.8469972; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ma LQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001726; MacKinnon R, 2004, ANGEW CHEM INT EDIT, V43, P4265, DOI 10.1002/anie.200400662; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Plant LD, 2010, P NATL ACAD SCI USA, V107, P10743, DOI 10.1073/pnas.1004712107; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SALI D, 1988, NATURE, V335, P740, DOI 10.1038/335740a0; Sandoz G, 2011, P NATL ACAD SCI USA, V108, P2605, DOI 10.1073/pnas.1015788108; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009; Zhou Y, 2004, BIOCHEMISTRY-US, V43, P4978, DOI 10.1021/bi049876z; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	45	212	218	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2012	335	6067					432	436		10.1126/science.1213274	http://dx.doi.org/10.1126/science.1213274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22282804				2022-12-01	WOS:000299466800040
J	Ding, L; Saunders, TL; Enikolopov, G; Morrison, SJ				Ding, Lei; Saunders, Thomas L.; Enikolopov, Grigori; Morrison, Sean J.			Endothelial and perivascular cells maintain haematopoietic stem cells	NATURE			English	Article							PROGENITOR CELLS; SELF-RENEWAL; EXPRESSION; GENE; MICE; MAINTENANCE; DELETION; NICHES; TRANSPLANTATION; OSTEOBLASTS	Several cell types have been proposed to create niches for haematopoietic stem cells (HSCs). However, the expression patterns of HSC maintenance factors have not been systematically studied and no such factor has been conditionally deleted from any candidate niche cell. Thus, the cellular sources of these factors are undetermined. Stem cell factor (SCF; also known as KITL) is a key niche component that maintains HSCs. Here, using Scf(gfp) knock-in mice, we found that Scf was primarily expressed by perivascular cells throughout the bone marrow. HSC frequency and function were not affected when Scf was conditionally deleted from haematopoietic cells, osteoblasts, nestin-cre- or nestin-creER-expressing cells. However, HSCs were depleted from bone marrow when Scf was deleted from endothelial cells or leptin receptor (Lepr)-expressing perivascular stromal cells. Most HSCs were lost when Scf was deleted from both endothelial and Lepr-expressing perivascular cells. Thus, HSCs reside in a perivascular niche in which multiple cell types express factors that promote HSC maintenance.	[Ding, Lei; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Childrens Res Inst, Dept Pediat, Dallas, TX 75390 USA; [Saunders, Thomas L.] Univ Michigan, Ann Arbor, MI 48109 USA; [Enikolopov, Grigori] Cold Spring Harbor Lab, New York, NY 11724 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; Cold Spring Harbor Laboratory	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Childrens Res Inst, Dept Pediat, Dallas, TX 75390 USA.	Sean.Morrison@UTSouthwestern.edu	Morrison, Sean/ABD-5326-2021; Enikolopov, Grigori/P-5731-2019	Enikolopov, Grigori/0000-0001-8178-8917; Morrison, Sean/0000-0003-1587-8329; Saunders, Thom/0000-0003-2015-101X	Howard Hughes Medical Institute (HHMI); National Heart, Lung and Blood Institute [5R01HL097760]; Helen Hay Whitney Foundation; National Institute of Aging [R01AG040209]; NYSTEM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040209] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Helen Hay Whitney Foundation; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NYSTEM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Howard Hughes Medical Institute (HHMI) and the National Heart, Lung and Blood Institute (5R01HL097760). L. D. was supported by a Helen Hay Whitney Foundation Fellowship and by the HHMI. G. E. was supported by the National Institute of Aging (R01AG040209) and NYSTEM. We thank M. White and D. Adams for flow cytometry, E. Hughes at the UM transgenic core for helping to generate Scf<SUP>gfp</SUP> and Scf<SUP>fl</SUP> mice, M. Purkey for technical assistance, J. Peyer and M. Lim for discussion, and C. Mountford, S. Grove and R. Coolon for managing the mouse colony. This work was initiated in the Life Sciences Institute at the University of Michigan then completed at Children's Research Institute at UT Southwestern.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Barker JE, 1997, EXP HEMATOL, V25, P542; BARKER JE, 1994, EXP HEMATOL, V22, P174; Blair HC, 1999, BIOCHEM BIOPH RES CO, V255, P778, DOI 10.1006/bbrc.1999.0260; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; HEINRICH MC, 1993, BLOOD, V82, P771, DOI 10.1182/blood.V82.3.771.bloodjournal823771; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026918; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; WOLF NS, 1978, CELL TISSUE KINET, V11, P335, DOI 10.1111/j.1365-2184.1978.tb00806.x; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020	43	1221	1261	7	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2012	481	7382					457	U65		10.1038/nature10783	http://dx.doi.org/10.1038/nature10783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881GY	22281595	Green Accepted			2022-12-01	WOS:000299471800030
J	Plevka, P; Perera, R; Cardosa, J; Kuhn, RJ; Rossmann, MG				Plevka, Pavel; Perera, Rushika; Cardosa, Jane; Kuhn, Richard J.; Rossmann, Michael G.			Crystal Structure of Human Enterovirus 71	SCIENCE			English	Article							PICORNAVIRUS; RECEPTOR; DISEASE		[Plevka, Pavel; Perera, Rushika; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Cardosa, Jane] Sentinext Therapeut, George Town 10050, Malaysia	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	mr@purdue.edu	Perera, Rushika/E-7183-2017; Plevka, Pavel/H-8661-2014; Kuhn, Richard/AAR-2722-2021	Perera, Rushika/0000-0001-6798-2537; Plevka, Pavel/0000-0003-4215-3315; Kuhn, Richard/0000-0003-4148-1026	Department of Energy [DE-AC02-06CH11357]; NIH [AI11219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI011219, R01AI011219] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Advanced Photon Source (supported by the Department of Energy contract DE-AC02-06CH11357) staff, V. Srajer and R. Henning of the BioCARS beamline 14 (NIH National Center for Research Resources RR007707), R. Fischetti of GM/CA beamline 23, and S. Kelly and P. Chipman for their help. Supported by NIH grant AI11219 to M.G.R. Coordinates were deposited with the Protein Data Bank as entry 4AED.	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Miyamura K, 2011, J GEN VIROL, V92, P287, DOI 10.1099/vir.0.022418-0; ROSSMANN MG, 1994, PROTEIN SCI, V3, P1712, DOI 10.1002/pro.5560031010; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Rossmann MG, 2002, TRENDS MICROBIOL, V10, P324, DOI 10.1016/S0966-842X(02)02383-1; SHERRY B, 1986, J VIROL, V57, P246, DOI 10.1128/JVI.57.1.246-257.1986; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	8	151	168	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1274	1274		10.1126/science.1218713	http://dx.doi.org/10.1126/science.1218713			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22383808	Green Accepted			2022-12-01	WOS:000304905300037
J	Wu, HX; Wacker, D; Mileni, M; Katritch, V; Han, GW; Vardy, E; Liu, W; Thompson, AA; Huang, XP; Carroll, FI; Mascarella, SW; Westkaemper, RB; Mosier, PD; Roth, BL; Cherezov, V; Stevens, RC				Wu, Huixian; Wacker, Daniel; Mileni, Mauro; Katritch, Vsevolod; Han, Gye Won; Vardy, Eyal; Liu, Wei; Thompson, Aaron A.; Huang, Xi-Ping; Carroll, F. Ivy; Mascarella, S. Wayne; Westkaemper, Richard B.; Mosier, Philip D.; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.			Structure of the human kappa-opioid receptor in complex with JDTic	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEINS; OPIATE RECEPTOR; SALVINORIN-A; IN-VITRO; DOCKING; AGONIST; ANALOGS	Opioid receptors mediate the actions of endogenous and exogenous opioids on many physiological processes, including the regulation of pain, respiratory drive, mood, and-in the case of kappa-opioid receptor (kappa-OR)-dysphoria and psychotomimesis. Here we report the crystal structure of the human kappa-OR in complex with the selective antagonist JDTic, arranged in parallel dimers, at 2.9 angstrom resolution. The structure reveals important features of the ligand-binding pocket that contribute to the high affinity and subtype selectivity of JDTic for the human kappa-OR. Modelling of other important kappa-OR-selective ligands, including the morphinan-derived antagonists norbinaltorphimine and 5'-guanidinonaltrindole, and the diterpene agonist salvinorin A analogue RB-64, reveals both common and distinct features for binding these diverse chemotypes. Analysis of site-directed mutagenesis and ligand structure-activity relationships confirms the interactions observed in the crystal structure, thereby providing a molecular explanation for kappa-OR subtype selectivity, and essential insights for the design of compounds with new pharmacological properties targeting the human kappa-OR.	[Wu, Huixian; Wacker, Daniel; Mileni, Mauro; Katritch, Vsevolod; Han, Gye Won; Liu, Wei; Thompson, Aaron A.; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Vardy, Eyal; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Chapel Hill Med Sch, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Vardy, Eyal; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Chapel Hill Med Sch, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Carroll, F. Ivy; Mascarella, S. Wayne] Res Triangle Inst, Ctr Organ & Med Chem, Res Triangle Pk, NC 27709 USA; [Westkaemper, Richard B.; Mosier, Philip D.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; Virginia Commonwealth University	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Han, Gye Won/GLQ-8724-2022; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8673-2022; Stevens, Raymond/K-7272-2015; Roth, Bryan L/F-3928-2010; Cherezov, Vadim/L-9812-2013; Katritch, Vsevolod/Q-8357-2016; Katritch, Vsevolod/Y-2721-2019; Roth, Bryan/ABE-7032-2020; Wu, Huixian/N-6353-2014	Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; Katritch, Vsevolod/0000-0003-3883-4505; Roth, Bryan/0000-0002-0561-6520; Wu, Huixian/0000-0003-1357-9747; Huang, Xi-Ping/0000-0002-2585-653X; Thompson, Aaron/0000-0003-4314-4242; Mascarella, Wayne/0000-0003-0092-8178	PSI:Biology [U54 GM094618]; NIH [P50 GM073197, R01 DA017624, R01 DA027170, R01 DA009045]; NIMH; Michael Hooker Distinguished Chair of Pharmacology; Boehringer Ingelheim Fonds; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, P50GM073197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027170, R01DA017204, R01DA009045] Funding Source: NIH RePORTER	PSI:Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Distinguished Chair of Pharmacology; Boehringer Ingelheim Fonds(Boehringer Ingelheim); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by PSI:Biology grant U54 GM094618 (V. K., V. C., R. C. S.) for biological studies and structure production, NIH Roadmap grant P50 GM073197 (V. C., R. C. S.) for technology development and R01 DA017624 (B. L. R., E. V., R. B. M., P. D. M.), R01 DA027170 (B. L. R.), the NIMH Psychoactive Drug Screening Program Contract (B. L. R., X.-P. H.), the Michael Hooker Distinguished Chair of Pharmacology (B. L. R.), and the NIH grant R01 DA009045 (F. I. C.). D. W. is supported by a Boehringer Ingelheim Fonds PhD Fellowship. The JDTic X-ray structure was determined by C. George at the Laboratory for the Structure of Matter, Naval Research Laboratory. We thank J. Velasquez for help on molecular biology; T. Trinh, K. Allin and M. Chu for help on baculovirus expression; V. Setola for help with functional activity assays; J. Evans for help acquiring compounds; the National Institute of Drug Abuse Drug Supply Program for supplying JDTic and other opioid ligands used in these studies; K. Kadyshevskaya for assistance with figure preparation; E. Abola for assistance with manuscript preparation; A. Walker for assistance with manuscript preparation; J. Smith, R. Fischetti and N. Sanishvili for assistance in the development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Befort K, 1996, MOL PHARMACOL, V49, P216; Bricogne G, 2009, BUSTER V 2 8 0; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cai TB, 2008, J MED CHEM, V51, P1849, DOI 10.1021/jm701344b; Carlezon WA, 2009, PHARMACOL THERAPEUT, V123, P334, DOI 10.1016/j.pharmthera.2009.05.008; Carroll I, 2004, EUR J PHARMACOL, V501, P111, DOI 10.1016/j.ejphar.2004.08.028; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Chen SH, 2002, BIOCHEMISTRY-US, V41, P6045, DOI 10.1021/bi012189c; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Congreve M, 2011, J MED CHEM, V54, P4283, DOI 10.1021/jm200371q; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jackson KJ, 2010, PSYCHOPHARMACOLOGY, V210, P285, DOI 10.1007/s00213-010-1803-1; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metzger TG, 1996, NEUROCHEM RES, V21, P1287, DOI 10.1007/BF02532369; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Runyon SP, 2010, J MED CHEM, V53, P5290, DOI 10.1021/jm1004978; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Subramanian G, 1998, J MED CHEM, V41, P4777, DOI 10.1021/jm9803166; SURRATT CK, 1994, J BIOL CHEM, V269, P20548; Thomas JB, 2004, J MED CHEM, V47, P1070, DOI 10.1021/jm030467v; Thomas JB, 2001, J MED CHEM, V44, P2687, DOI 10.1021/jm015521r; Totrov M, 1997, PROTEINS, P215; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vortherms TA, 2007, J BIOL CHEM, V282, P3146, DOI 10.1074/jbc.M609264200; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Walsh SL, 2001, PSYCHOPHARMACOLOGY, V157, P151, DOI 10.1007/s002130100788; WANG JB, 1994, J BIOL CHEM, V269, P25966; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yan F, 2009, BIOCHEMISTRY-US, V48, P6898, DOI 10.1021/bi900605n; ZIMMERMAN DM, 1978, NATURE, V275, P332, DOI 10.1038/275332a0	50	667	682	1	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					327	U69		10.1038/nature10939	http://dx.doi.org/10.1038/nature10939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22437504	Green Accepted, Green Submitted			2022-12-01	WOS:000304099100033
J	Kolling, N; Behrens, TEJ; Mars, RB; Rushworth, MFS				Kolling, Nils; Behrens, Timothy E. J.; Mars, Rogier B.; Rushworth, Matthew F. S.			Neural Mechanisms of Foraging	SCIENCE			English	Article							ANTERIOR CINGULATE; VALUE COMPUTATIONS; DECISION-MAKING; REWARD SIGNALS; CORTEX; INFORMATION; VALUATION; STRIATUM	Behavioral economic studies involving limited numbers of choices have provided key insights into neural decision-making mechanisms. By contrast, animals' foraging choices arise in the context of sequences of encounters with prey or food. On each encounter, the animal chooses whether to engage or, if the environment is sufficiently rich, to search elsewhere. The cost of foraging is also critical. We demonstrate that humans can alternate between two modes of choice, comparative decision-making and foraging, depending on distinct neural mechanisms in ventromedial prefrontal cortex (vmPFC) and anterior cingulate cortex (ACC) using distinct reference frames; in ACC, choice variables are represented in invariant reference to foraging or searching for alternatives. Whereas vmPFC encodes values of specific well-defined options, ACC encodes the average value of the foraging environment and cost of foraging.	[Kolling, Nils; Behrens, Timothy E. J.; Mars, Rogier B.; Rushworth, Matthew F. S.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Behrens, Timothy E. J.; Mars, Rogier B.; Rushworth, Matthew F. S.] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Kolling, N (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	nils.kolling@psy.ox.ac.uk	Mars, Rogier/G-2312-2018; Mars, Rogier/GWZ-9665-2022	Mars, Rogier/0000-0001-6302-8631; Behrens, Timothy/0000-0003-0048-1177; Rushworth, Matthew/0000-0002-5578-9884; Kolling, Nils/0000-0002-0283-6966	U.K. Medical Research Council; Wellcome Trust; MRC [G0802146, G0600994, G0700399] Funding Source: UKRI; Medical Research Council [G0600994, G0700399, G0802146] Funding Source: researchfish	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by U.K. Medical Research Council and the Wellcome Trust.	Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Boorman ED, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001093; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Fellows LK, 2006, BRAIN, V129, P944, DOI 10.1093/brain/awl017; Freidin E, 2011, SCIENCE, V334, P1000, DOI 10.1126/science.1209626; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Lim SL, 2011, J NEUROSCI, V31, P13214, DOI 10.1523/JNEUROSCI.1246-11.2011; Magno E, 2006, J NEUROSCI, V26, P4769, DOI 10.1523/JNEUROSCI.0369-06.2006; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Noonan MP, 2011, J NEUROSCI, V31, P14399, DOI 10.1523/JNEUROSCI.6456-10.2011; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Stephens D.W., 1986, pi; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068	30	361	362	3	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					95	98		10.1126/science.1216930	http://dx.doi.org/10.1126/science.1216930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491854	Green Accepted			2022-12-01	WOS:000302405400059
J	Powell, AE; Wang, Y; Li, YN; Poulin, EJ; Means, AL; Washington, MK; Higginbotham, JN; Juchheim, A; Prasad, N; Levy, SE; Guo, Y; Shyr, Y; Aronow, BJ; Haigis, KM; Franklin, JL; Coffey, RJ				Powell, Anne E.; Wang, Yang; Li, Yina; Poulin, Emily J.; Means, Anna L.; Washington, Mary K.; Higginbotham, James N.; Juchheim, Alwin; Prasad, Nripesh; Levy, Shawn E.; Guo, Yan; Shyr, Yu; Aronow, Bruce J.; Haigis, Kevin M.; Franklin, Jeffrey L.; Coffey, Robert J.			The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor	CELL			English	Article							IMMUNOHISTOCHEMICAL ANALYSIS; OXIDATIVE STRESS; EXPRESSION MARKS; CANCER; RECEPTOR; GENE; PROLIFERATION; GROWTH; CRYPTS; POPULATION	Lineage mapping has identified both proliferative and quiescent intestinal stem cells, but the molecular circuitry controlling stem cell quiescence is incompletely understood. By lineage mapping, we show Lrig1, a pan-ErbB inhibitor, marks predominately noncycling, long-lived stem cells that are located at the crypt base and that, upon injury, proliferate and divide to replenish damaged crypts. Transcriptome profiling of Lrig1(+) colonic stem cells differs markedly from the profiling of highly proliferative, Lgr5(+) colonic stem cells; genes upregulated in the Lrig1(+) population include those involved in cell cycle repression and response to oxidative damage. Loss of Apc in Lrig1(+) cells leads to intestinal adenomas, and genetic ablation of Lrig1 results in heightened ErbB1-3 expression and duodenal adenomas. These results shed light on the relationship between proliferative and quiescent intestinal stem cells and support a model in which intestinal stem cell quiescence is maintained by calibrated ErbB signaling with loss of a negative regulator predisposing to neoplasia.	[Powell, Anne E.; Wang, Yang; Li, Yina; Poulin, Emily J.; Higginbotham, James N.; Franklin, Jeffrey L.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Powell, Anne E.; Wang, Yang; Li, Yina; Poulin, Emily J.; Higginbotham, James N.; Franklin, Jeffrey L.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Means, Anna L.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [Washington, Mary K.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Guo, Yan; Shyr, Yu] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Epithelial Biol Ctr, Nashville, TN 37232 USA; [Juchheim, Alwin; Haigis, Kevin M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Pathol Unit, Charlestown, MA 02129 USA; [Juchheim, Alwin; Haigis, Kevin M.] Harvard Univ, Sch Med, Dept Pathol, Charlestown, MA 02129 USA; [Prasad, Nripesh; Levy, Shawn E.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp, Med Ctr, Dept Biomed Informat, Cincinnati, OH 45229 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp, Med Ctr, Dept Dev Biol, Cincinnati, OH 45229 USA; [Coffey, Robert J.] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; HudsonAlpha Institute for Biotechnology; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Coffey, RJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA.	robert.coffey@vanderbilt.edu	Aronow, Bruce J/F-8438-2012; Wang, Yang/O-2300-2013	Wang, Yang/0000-0003-2801-8416; Levy, Shawn/0000-0002-1369-5740; Prasad, Nripesh/0000-0003-4074-2538; Zemper, Anne/0000-0001-8238-1406	National Cancer Institute [CA151566, CA46413]; MMHCC [U01CA084239]; Gastrointestinal Specialized Program of Research Excellence [P50CA095103, T32GM008554, T32CA119925]; Vanderbilt's Clinical and Translational Science Award; Transgenic Mouse/ES Cell, Cell Imaging, and Flow Cytometry Shared Resources; Coffey Memorial Gastrointestinal Cancer Fund; NATIONAL CANCER INSTITUTE [T32CA119925, P50CA095103, U01CA084239, R01CA151566, R01CA046413] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MMHCC; Gastrointestinal Specialized Program of Research Excellence; Vanderbilt's Clinical and Translational Science Award; Transgenic Mouse/ES Cell, Cell Imaging, and Flow Cytometry Shared Resources; Coffey Memorial Gastrointestinal Cancer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.E.P., Y.W., Y.L., K.M.H., J.L.F. and R.J.C. designed, executed and analyzed data. E.J.P., J.N.H., and A.J. provided technical assistance. S.E.L. conducted the RNA-Seq. A.L.M., M.K.W., N.P., Y.G., Y.S., and B.J.A. provided expert analysis. A.E.P. and R.J.C. assembled the manuscript. We thank Frank Revetta and Catherine Meador for technical assistance and Robert Whitehead for guidance. This work was supported by the National Cancer Institute CA151566 to R.J.C. and K.M.H., and CA46413, MMHCC U01CA084239, and Gastrointestinal Specialized Program of Research Excellence P50CA095103 to R.J.C., T32GM008554 to E.J.P. and T32CA119925 to A.E.P. The authors acknowledge the support of Vanderbilt's Clinical and Translational Science Award and Transgenic Mouse/ES Cell, Cell Imaging, and Flow Cytometry Shared Resources. We thank the Peter Powell and Mary Catherine Mundell Coffey Memorial Gastrointestinal Cancer Fund for its generous support.	AKASHI T, 1994, VIRCHOWS ARCH, V425, P399; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cai WB, 1997, INT J RADIAT BIOL, V71, P573, DOI 10.1080/095530097143905; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Escobar M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1260; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Graham SM, 2007, STEM CELLS, V25, P3111, DOI 10.1634/stemcells.2007-0250; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; HENDRY JH, 1992, RADIAT RES, V132, P115, DOI 10.2307/3578342; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Li YN, 2004, DEV BIOL, V270, P214, DOI 10.1016/j.ydbio.2004.03.009; Ljuslinder I, 2007, ACTA ONCOL, V46, P1118, DOI 10.1080/02841860701426823; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Thliveris AT, 2011, CANCER PREV RES, V4, P916, DOI 10.1158/1940-6207.CAPR-11-0022; Thomasson M, 2003, BRIT J CANCER, V89, P1285, DOI 10.1038/sj.bjc.6601208; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-75; WHITEHEAD RH, 1987, IN VITRO CELL DEV B, V23, P436; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Ye F, 2009, J NEURO-ONCOL, V94, P183, DOI 10.1007/s11060-009-9836-1; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	49	477	482	1	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					146	158		10.1016/j.cell.2012.02.042	http://dx.doi.org/10.1016/j.cell.2012.02.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464327	Green Accepted, Bronze			2022-12-01	WOS:000302235400017
J	Lay, T				Lay, Thorne			Why giant earthquakes keep catching us out	NATURE			English	Editorial Material									Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Lay, T (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	tlay@ucsc.edu	Lay, Thorne/ABE-6272-2021						0	9	9	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2012	483	7388					149	150		10.1038/483149a	http://dx.doi.org/10.1038/483149a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	904DT	22398538				2022-12-01	WOS:000301174900014
J	Zhang, LX; Wang, F; Wang, L; Wang, WK; Liu, BC; Liu, J; Chen, MH; He, Q; Liao, YH; Yu, XQ; Chen, N; Zhang, JE; Hu, Z; Liu, FY; Hong, DQ; Ma, LJ; Liu, H; Zhou, XL; Chen, JH; Pan, L; Chen, W; Wang, WM; Li, XM; Wang, HY				Zhang, Luxia; Wang, Fang; Wang, Li; Wang, Wenke; Liu, Bicheng; Liu, Jian; Chen, Menghua; He, Qiang; Liao, Yunhua; Yu, Xueqing; Chen, Nan; Zhang, Jian-e; Hu, Zhao; Liu, Fuyou; Hong, Daqing; Ma, Lijie; Liu, Hong; Zhou, Xiaoling; Chen, Jianghua; Pan, Ling; Chen, Wei; Wang, Weiming; Li, Xiaomei; Wang, Haiyan			Prevalence of chronic kidney disease in China: a cross-sectional survey	LANCET			English	Article							GLOMERULAR-FILTRATION-RATE; RISK-FACTORS; POPULATION; EPIDEMIOLOGY; HYPERTENSION; ALBUMINURIA; ASSOCIATION; BURDEN; WOMEN; CKD	Background The prevalence of chronic kidney disease is high in developing countries. However, no national survey of chronic kidney disease has been done incorporating both estimated glomerular filtration rate (eGFR) and albuminuria in a developing country with the economic diversity of China. We aimed to measure the prevalence of chronic kidney disease in China with such a survey. Methods We did a cross-sectional survey of a nationally representative sample of Chinese adults. Chronic kidney disease was defined as eGFR less than 60 mL/min per 1.73 m(2) or the presence of albuminuria. Participants completed a lifestyle and medical history questionnaire and had their blood pressure measured, and blood and urine samples taken. Serum creatinine was measured and used to estimate glomerular filtration rate. Urinary albumin and creatinine were tested to assess albuminuria. The crude and adjusted prevalence of indicators of kidney damage were calculated and factors associated with the presence of chronic kidney disease analysed by logistic regression. Findings 50 550 people were invited to participate, of whom 47 204 agreed. The adjusted prevalence of eGFR less than 60 mL/min per 1.73 m(2) was 1.7% (95% CI 1.5-1.9) and of albuminuria was 9.4% (8.9-10.0). The overall prevalence of chronic kidney disease was 10.8% (10.2-11.3); therefore the number of patients with chronic kidney disease in China is estimated to be about 119.5 million (112.9-125.0 million). In rural areas, economic development was independently associated with the presence of albuminuria. The prevalence of chronic kidney disease was high in north (16.9% [15.1-18.7]) and southwest (18.3% [16.4-20.4]) regions compared with other regions. Other factors independently associated with kidney damage were age, sex, hypertension, diabetes, history of cardiovascular disease, hyperuricaemia, area of residence, and economic status. Interpretation Chronic kidney disease has become an important public health problem in China. Special attention should be paid to residents in economically improving rural areas and specific geographical regions in China.	[Zhang, Luxia; Wang, Fang; Li, Xiaomei; Wang, Haiyan] Peking Univ, Hosp 1, Div Nephrol, Inst Nephrol, Beijing 100871, Peoples R China; [Wang, Li; Hong, Daqing] Sichuan Acad Med Sci, Div Nephrol, Chengdu, Peoples R China; [Wang, Li; Hong, Daqing] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Wang, Wenke; Ma, Lijie] Chifeng Second Hosp, Div Nephrol, Chifeng, Peoples R China; [Liu, Bicheng; Liu, Hong] Southwest Univ, Zhongda Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China; [Liu, Bicheng; Liu, Hong] Southwest Univ, Zhongda Hosp, Div Nephrol, Nanjing, Jiangsu, Peoples R China; [Liu, Jian] Xinjiang Med Univ, Hosp 1, Div Nephrol, Uramuqi, Peoples R China; [Chen, Menghua; Zhou, Xiaoling] Ningxia Univ Med, Affiliated Hosp, Div Nephrol, Yinchuan, Peoples R China; [He, Qiang; Chen, Jianghua] Zhejiang Univ, Affiliated Hosp 1, Div Nephrol, Hangzhou 310003, Zhejiang, Peoples R China; [Liao, Yunhua; Pan, Ling] Guangxi Univ Med, Affiliated Hosp 1, Div Nephrol, Nanning, Peoples R China; [Yu, Xueqing; Chen, Wei] Sun Yat Sen Univ, Affiliated Hosp 1, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Nan; Wang, Weiming] Shanghai Jiao Tong Univ, Ruijin Hosp, Div Nephrol, Shanghai 200030, Peoples R China; [Zhang, Jian-e] Hubei Univ Med, Taihe Hosp, Div Nephrol, Shiyan, Peoples R China; [Hu, Zhao] Shandong Univ, Qilu Hosp, Div Nephrol, Jinan 250100, Peoples R China; [Liu, Fuyou] Cent S Univ, Xiangya Hosp 2, Div Nephrol, Changsha, Peoples R China	Peking University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Southeast University - China; Southwest University - China; Southeast University - China; Southwest University - China; Xinjiang Medical University; Ningxia Medical University; Zhejiang University; Guangxi Medical University; Sun Yat Sen University; Shanghai Jiao Tong University; Hubei University of Medicine; Shandong University; Central South University	Wang, HY (corresponding author), Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China.	why@bjmu.edu.cn	zhou, xuan/GZA-8157-2022	Luxia, Zhang/0000-0003-2349-2936	Ministry of Science and Technology (China) [2007BAI04B10]; Science and Technology Commission of Shanghai [08dz1900502, 07JC14037]; Natural Science Funds of Ning Xia [NZ08102]; Science and Technology Department [30660069]; National Natural Science Foundation of China; Department of Health, Jiangsu Province [H200936]; Sichuan Science and Technology Department [05SG1635]; Ministry of Education (China) [BMU2009131]; International Society of Nephrology Research Committee; China Health and Medical Development Foundation	Ministry of Science and Technology (China)(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Funds of Ning Xia; Science and Technology Department(Science and Technology Development Fund (STDF)United States Agency for International Development (USAID)US-Egypt Science and Technology Joint Fund); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Health, Jiangsu Province; Sichuan Science and Technology Department; Ministry of Education (China)(Ministry of Education, China); International Society of Nephrology Research Committee; China Health and Medical Development Foundation	This study was supported by the National Key Technology R&D Program from the Ministry of Science and Technology (China; 2007BAI04B10); the Science and Technology Commission of Shanghai (08dz1900502 and 07JC14037); the Natural Science Funds of Ning Xia (NZ08102); the Science and Technology Department, the National Natural Science Funds (30660069); the National Natural Science Foundation of China; the Department of Health, Jiangsu Province (H200936); the Key Scientific and Technology Project from the Sichuan Science and Technology Department (05SG1635); the Program for New Century Excellent Talents in University from the Ministry of Education (China; BMU2009131); the International Society of Nephrology Research Committee; and the China Health and Medical Development Foundation. We thank Yong Jiang of the Chinese Center for Disease Control and Prevention for his contribution to the design of the study and statistical support, and William G Couser for constructive comments for the report.	Agarwal SK, 2005, NEPHROL DIAL TRANSPL, V20, P1638, DOI 10.1093/ndt/gfh855; [Anonymous], 1994, Vital Health Stat 1, P1; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bello AK, 2005, KIDNEY INT, V68, pS11, DOI 10.1111/j.1523-1755.2005.09802.x; Chen N, 2009, NEPHROL DIAL TRANSPL, V24, P2117, DOI 10.1093/ndt/gfn767; Chen W, 2011, NEPHROL DIAL TRANSPL, V26, P1592, DOI 10.1093/ndt/gfq608; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Greenland S, 1998, MODERN EPIDEMIOLOGY, P201; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Ito J, 2008, NEPHRON CLIN PRACT, V109, pC25, DOI 10.1159/000134379; Jin S, 2008, 10 REPORT CHINESE NA; Lin JL, 2011, AM J KIDNEY DIS, V57, P245, DOI 10.1053/j.ajkd.2010.09.027; Lin L, 2002, ZHONGHUA YU FANG YI, V36, P5; LIU LS, 1990, CLIN EXP HYPERTENS A, V12, P831; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; O'Donnell JK, 2011, NEPHROL DIAL TRANSPL, V26, P2798, DOI 10.1093/ndt/gfq385; Shi L, 2006, TISSUE ANTIGENS, V67, P38, DOI 10.1111/j.1399-0039.2005.00526.x; Varma PP, 2010, NEPHROL DIAL TRANSPL, V25, P3011, DOI 10.1093/ndt/gfq131; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhang LX, 2009, SEMIN NEPHROL, V29, P483, DOI 10.1016/j.semnephrol.2009.06.012	31	1288	1859	42	633	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2012	379	9818					815	822		10.1016/S0140-6736(12)60033-6	http://dx.doi.org/10.1016/S0140-6736(12)60033-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901RB	22386035				2022-12-01	WOS:000300983400031
J	Chipuk, JE; McStay, GP; Bharti, A; Kuwana, T; Clarke, CJ; Siskind, LJ; Obeid, LM; Green, DR				Chipuk, Jerry E.; McStay, Gavin P.; Bharti, Archana; Kuwana, Tomomi; Clarke, Christopher J.; Siskind, Leah J.; Obeid, Lina M.; Green, Douglas R.			Sphingolipid Metabolism Cooperates with BAK and BAX to Promote the Mitochondrial Pathway of Apoptosis	CELL			English	Article							RADIATION-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM; OUTER-MEMBRANE; CELL-DEATH; BH3 DOMAINS; CERAMIDE; SPHINGOMYELINASE; IDENTIFICATION; INHIBITION; SPHINGOSINE-1-PHOSPHATE	Mitochondria are functionally and physically associated with heterotypic membranes, yet little is known about how these interactions impact mitochondrial outer-membrane permeabilization (MOMP) and apoptosis. We observed that dissociation of heterotypic membranes from mitochondria inhibited BAK/BAX-dependent cytochrome c (cyto c) release. Biochemical purification of neutral sphingomyelinases that correlated with MOMP sensitization suggested that sphingolipid metabolism coordinates BAK/BAX activation. Using purified lipids and enzymes, sensitivity to MOMP was achieved by in vitro reconstitution of the sphingolipid metabolic pathway. Sphingolipid metabolism inhibitors blocked MOMP from heavy membrane preparations but failed to influence MOMP in the presence of sphingolipid-reconstituted, purified mitochondria. Furthermore, the sphingolipid products, sphingosine-1-PO4 and hexadecenal, cooperated specifically with BAK and BAX, respectively. Sphingolipid metabolism was also required for cellular responses to apoptosis. Our studies suggest that BAK/BAX activation and apoptosis are coordinated through BH3-only proteins and a specific lipid milieu that is maintained by heterotypic membrane-mitochondrial interactions.	[Chipuk, Jerry E.; Bharti, Archana] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [McStay, Gavin P.; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Kuwana, Tomomi] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52252 USA; [Clarke, Christopher J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Siskind, Leah J.; Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Siskind, Leah J.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Div Gen Med & Geriatr, Charleston, SC 29425 USA	Icahn School of Medicine at Mount Sinai; St Jude Children's Research Hospital; University of Iowa; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina	Chipuk, JE (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, 1 Gustave L Levy Pl, New York, NY 10029 USA.	jerry.chipuk@mssm.edu; douglas.green@stjude.org	Green, Douglas R/N-8083-2018; McStay, Gavin/K-9574-2013	Green, Douglas R/0000-0002-7332-1417; McStay, Gavin/0000-0003-1363-8719; obeid, lina/0000-0002-0734-0847; Siskind, Leah/0000-0001-5026-5187; Chipuk, Jerry Edward/0000-0002-1337-842X	NIH [CA157740, P20AA017067, AI52735, CA69381, AG024478]; NCI Cancer Center Core [P30CA21765]; VA Merit; VA [CDA-2]; VA REAP; ACS [IRG-97-219-11]; Cancer Center [P30 CA138313]; COBRE in Lipidomics and Pathobiology [NIH/NCRRP20 RR17677]; American Lebanese Syrian Associated Charities; March of Dimes Foundation [5-FY11-74]; NATIONAL CANCER INSTITUTE [R01CA157740, P30CA021765, P01CA069381, P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG024478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); VA Merit(US Department of Veterans Affairs); VA(US Department of Veterans Affairs); VA REAP; ACS(American Cancer Society); Cancer Center; COBRE in Lipidomics and Pathobiology; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); March of Dimes Foundation(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We would like to thank Dr. Ronald Gordon (MSSM) for TEM analysis; Dr. Richard Kolesnick (Memorial Sloan-Kettering) for the asm<SUP>-/-</SUP> liver; Dr. Joseph Opferman (SJCRH) for the MxCre bak<SUP>-/-</SUP> bax<SUP>-/f</SUP> animals; all members of the Obeid and Hannun laboratories (MUSC) for excellent discussion and training in sphingolipid biology, especially Drs. K. Alexa Orr Gandy, Stefka Spassieva, and Xingjun Wu; The Hartwell Center for Bioinformatics and Biotechnology; and members of the Kuwana Laboratory for technical assistance. This work was supported by: NIH CA157740 (to J.E.C.), pilot project from NIH P20AA017067 (to J.E.C.), NIH AI52735 (to D. R. G.), CA69381 (to D. R. G.), NIH AG024478 (to T. K.), an NCI Cancer Center Core Grant P30CA21765 (SJCRH), VA Merit (to L.M.O.), VA CDA-2 Award (to L.J.S), pilot project from the VA REAP (to L.J.S., and L.M.O.), the ACS IRG # IRG-97-219-11 (subaward to L.J.S.), Lipidomics Shared Resource of the Hollings Cancer Center supported by a Cancer Center Support Grant (P30 CA138313), pilot project (to L.J.S) from the NIH/NCRRP20 RR17677 COBRE in Lipidomics and Pathobiology, and the American Lebanese Syrian Associated Charities. This work was also supported in part by a Research Grant 5-FY11-74 from the March of Dimes Foundation (to J.E.C.).	Alphonse G, 2004, ONCOGENE, V23, P2703, DOI 10.1038/sj.onc.1207357; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Clarke CJ, 2011, BIOCHEM J, V435, P381, DOI 10.1042/BJ20101752; Colie S, 2009, CANCER RES, V69, P9346, DOI 10.1158/0008-5472.CAN-09-2198; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Demircan B, 2009, GENE CHROMOSOME CANC, V48, P83, DOI 10.1002/gcc.20620; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Kumar A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.3; Kumar A, 2011, CELL SIGNAL, V23, P1144, DOI 10.1016/j.cellsig.2011.02.009; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu YY, 2004, J LIPID RES, V45, P933, DOI 10.1194/jlr.M300486-JLR200; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Ott M, 2009, CELL DEATH DIFFER, V16, P1075, DOI 10.1038/cdd.2009.61; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pyne NJ, 2009, ADV ENZYME REGUL, V49, P214, DOI 10.1016/j.advenzreg.2009.01.011; Rodriguez-Lafrasse C, 2002, INT J CANCER, V101, P589, DOI 10.1002/ijc.10652; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; WAGNER T, 1977, EXP CELL RES, V107, P1, DOI 10.1016/0014-4827(77)90379-2; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Yabu T, 2009, J BIOL CHEM, V284, P20349, DOI 10.1074/jbc.M109.004580; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yang Z, 2006, FEMS YEAST RES, V6, P751, DOI 10.1111/j.1567-1364.2006.00052.x; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	62	296	309	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					988	1000		10.1016/j.cell.2012.01.038	http://dx.doi.org/10.1016/j.cell.2012.01.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385963	Green Accepted, Bronze			2022-12-01	WOS:000300985000018
J	Kolbe, JJ; Leal, M; Schoener, TW; Spiller, DA; Losos, JB				Kolbe, Jason J.; Leal, Manuel; Schoener, Thomas W.; Spiller, David A.; Losos, Jonathan B.			Founder Effects Persist Despite Adaptive Differentiation: A Field Experiment with Lizards	SCIENCE			English	Article							EVOLUTION; DYNAMICS; ROLES	The extent to which random processes such as founder events contribute to evolutionary divergence is a long-standing controversy in evolutionary biology. To determine the respective contributions of founder effects and natural selection, we conducted an experiment in which brown anole (Anolis sagrei) lizard populations were established on seven small islands in the Bahamas, from male-female pairs randomly drawn from the same large-island source. These founding events generated significant among-island genetic and morphological differences that persisted throughout the course of the experiment despite all populations adapting in the predicted direction-shorter hindlimbs-in response to the narrower vegetation on the small islands. Thus, using a replicated experiment in nature, we showed that both founder effects and natural selection jointly determine trait values in these populations.	[Kolbe, Jason J.; Losos, Jonathan B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Kolbe, Jason J.; Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Leal, Manuel] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Schoener, Thomas W.; Spiller, David A.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; [Schoener, Thomas W.; Spiller, David A.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	Harvard University; Harvard University; Duke University; University of California System; University of California Davis; University of California System; University of California Davis	Kolbe, JJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA.	jjkolbe@gmail.com	Leal, Manuel/A-7220-2010		National Geographic Society [8704-09]; NSF [DEB-0444763, DEB-0949415]; Duke University	National Geographic Society(National Geographic Society); NSF(National Science Foundation (NSF)); Duke University	We thank B. Pinder, J. Piovia-Scott, D. Steinberg, Y. Stuart, C. Thornber, and C. White for assistance; the National Geographic Society (grant 8704-09), NSF (grants DEB-0444763 and DEB-0949415), and Duke University for funding; and the Bahamas Ministry of Agriculture and the Bahamas Environment, Science & Technology Commission of the Ministry of the Environment for permission to conduct this research. This material was based on work supported by NSF while one of the authors (D.A.S.) was working at NSF. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of NSF.	Aguin-Pombo D., 2009, ENCY ISLANDS, P582; Barton N. H., 1998, P102; BARTON NH, 1984, ANNU REV ECOL SYST, V15, P133, DOI 10.1146/annurev.es.15.110184.001025; Berry R. J., 1998, P35; Carson H. L., 1971, STADLER S, V3, P51; CHAKRABORTY R, 1977, EVOLUTION, V31, P347, DOI 10.1111/j.1558-5646.1977.tb01017.x; Clegg SM, 2002, EVOLUTION, V56, P2090; Coyne JA, 1997, EVOLUTION, V51, P643, DOI 10.1111/j.1558-5646.1997.tb03650.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Grant P.R., 1998, EVOLUTION ISLANDS; Grant PR, 2002, P NATL ACAD SCI USA, V99, P7818, DOI 10.1073/pnas.132260299; Grant PR, 2001, GENETICA, V112, P359, DOI 10.1023/A:1013363032724; Kilpatrick C.W., 1981, P28; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos JB, 2000, EVOLUTION, V54, P301, DOI 10.1111/j.0014-3820.2000.tb00032.x; Mayr E., 1954, EVOLUTION PROCESS, P157; Mayr E, 1963, ANIMAL SPECIES EVOLU; NEI M, 1975, EVOLUTION, V29, P1, DOI [10.1111/j.1558-5646.1975.tb00807.x, 10.2307/2407137]; Price T.D., 2007, SPECIATION BIRDS; Reznick David, 2004, P101, DOI 10.1017/CBO9780511542022.009; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schoener TW, 2002, ECOL MONOGR, V72, P383, DOI 10.1890/0012-9615(2002)072[0383:POACAL]2.0.CO;2; Schoener TW, 2001, SCIENCE, V294, P1525, DOI 10.1126/science.1064396; Simoes P, 2008, EVOLUTION, V62, P1817, DOI 10.1111/j.1558-5646.2008.00423.x; Spiller DA, 2007, ECOLOGY, V88, P37, DOI 10.1890/0012-9658(2007)88[37:AOIFDF]2.0.CO;2; Tarr CL, 1998, MOL ECOL, V7, P719, DOI 10.1046/j.1365-294x.1998.00385.x; TEMPLETON AR, 1980, GENETICS, V94, P1011; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610	30	95	98	3	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1086	1089		10.1126/science.1209566	http://dx.doi.org/10.1126/science.1209566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22300849				2022-12-01	WOS:000300931100043
J	Kuchen, EE; Fox, S; de Reuille, PB; Kennaway, R; Bensmihen, S; Avondo, J; Calder, GM; Southam, P; Robinson, S; Bangham, A; Coen, E				Kuchen, Erika E.; Fox, Samantha; de Reuille, Pierre Barbier; Kennaway, Richard; Bensmihen, Sandra; Avondo, Jerome; Calder, Grant M.; Southam, Paul; Robinson, Sarah; Bangham, Andrew; Coen, Enrico			Generation of Leaf Shape Through Early Patterns of Growth and Tissue Polarity	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; SHOOT-MERISTEMLESS; LEAVES; MECHANISMS; COTYLEDON; GENES; CELL	A major challenge in biology is to understand how buds comprising a few cells can give rise to complex plant and animal appendages like leaves or limbs. We address this problem through a combination of time-lapse imaging, clonal analysis, and computational modeling. We arrive at a model that shows how leaf shape can arise through feedback between early patterns of oriented growth and tissue deformation. Experimental tests through partial leaf ablation support this model and allow reevaluation of previous experimental studies. Our model allows a range of observed leaf shapes to be generated and predicts observed clone patterns in different species. Thus, our experimentally validated model may underlie the development and evolution of diverse organ shapes.	[de Reuille, Pierre Barbier; Kennaway, Richard; Southam, Paul; Bangham, Andrew] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England; [Kuchen, Erika E.; Fox, Samantha; Bensmihen, Sandra; Avondo, Jerome; Calder, Grant M.; Robinson, Sarah; Coen, Enrico] John Innes Ctr, Norwich NR4 7UH, Norfolk, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bangham, A (corresponding author), Univ E Anglia, Sch Comp Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	a.bangham@uea.ac.uk; enrico.coen@jic.ac.uk	Kennaway, Richard/F-8190-2013; Barbier de Reuille, Pierre/J-5017-2012; Robinson, Sarah/AAX-6505-2020	Kennaway, Richard/0000-0001-9702-644X; Barbier de Reuille, Pierre/0000-0002-9970-765X; Fox, Samantha/0000-0003-1271-6412; bensmihen, sandra/0000-0003-1351-7220; Robinson, Sarah/0000-0001-7643-1059	U.K. Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/F005997/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005997/1, BBS/E/J/00000152] Funding Source: researchfish	U.K. Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the U.K. Biotechnology and Biological Sciences Research Council (BBSRC). We thank S. Sauret-Gueto, C. Hindle, and J. Chan for help in developing the tracking chamber; K. Lee for imaging cut leaves with OPT; and S. Grandison for mathematical support. The authors declare no competing financial interests. Further information and software can be downloaded at www.uea.ac.uk/cmp/research/cmpbio/Gftbox.	Aida M, 1999, DEVELOPMENT, V126, P1563; [Anonymous], 2011, PRINCIPLES DEV; Avery GS, 1933, AM J BOT, V20, P565, DOI 10.2307/2436259; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Boutte Y, 2007, CURR OPIN PLANT BIOL, V10, P616, DOI 10.1016/j.pbi.2007.07.008; Fleming AJ, 2003, PLANT BIOLOGY, V5, P341, DOI 10.1055/s-2003-42718; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Hasson A, 2011, PLANT CELL, V23, P54, DOI 10.1105/tpc.110.081448; HEJNOWICZ Z, 1984, J THEOR BIOL, V110, P93, DOI 10.1016/S0022-5193(84)80017-X; Held LI., 2002, IMAGINAL DISCS GENET; Kennaway R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002071; Kim GT, 2006, PHYSIOL PLANTARUM, V126, P494, DOI 10.1111/j.1399-3054.2005.00634.x; Rolland-Lagan AG, 2003, NATURE, V422, P161, DOI 10.1038/nature01443; Sarojam R, 2010, PLANT CELL, V22, P2113, DOI 10.1105/tpc.110.075853; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Schmundt D, 1998, PLANT J, V16, P505, DOI 10.1046/j.1365-313x.1998.00314.x; Sena G, 2009, NATURE, V457, P1150, DOI 10.1038/nature07597; Stopper GF, 2005, DEV BIOL, V288, P21, DOI 10.1016/j.ydbio.2005.09.010; Swink F., 1994, PLANTS CHICAGO REGIO; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; WOLF SD, 1986, AM J BOT, V73, P832, DOI 10.2307/2444294	21	157	160	6	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1092	1096		10.1126/science.1214678	http://dx.doi.org/10.1126/science.1214678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383846				2022-12-01	WOS:000300931100045
J	Xu, X; Hou, Y; Yin, XY; Bao, L; Tang, AF; Song, LT; Li, FQ; Tsang, S; Wu, K; Wu, HJ; He, WM; Zeng, L; Xing, MJ; Wu, RH; Jiang, H; Liu, X; Cao, DD; Guo, GW; Hu, XD; Gui, YT; Li, ZS; Xie, WY; Sun, XJ; Shi, M; Cai, ZM; Wang, B; Zhong, MM; Li, JX; Lu, ZH; Gu, N; Zhang, XQ; Goodman, L; Bolund, L; Wang, J; Yang, HM; Kristiansen, K; Dean, M; Li, YR; Wang, J				Xu, Xun; Hou, Yong; Yin, Xuyang; Bao, Li; Tang, Aifa; Song, Luting; Li, Fuqiang; Tsang, Shirley; Wu, Kui; Wu, Hanjie; He, Weiming; Zeng, Liang; Xing, Manjie; Wu, Renhua; Jiang, Hui; Liu, Xiao; Cao, Dandan; Guo, Guangwu; Hu, Xueda; Gui, Yaoting; Li, Zesong; Xie, Wenyue; Sun, Xiaojuan; Shi, Min; Cai, Zhiming; Wang, Bin; Zhong, Meiming; Li, Jingxiang; Lu, Zuhong; Gu, Ning; Zhang, Xiuqing; Goodman, Laurie; Bolund, Lars; Wang, Jian; Yang, Huanming; Kristiansen, Karsten; Dean, Michael; Li, Yingrui; Wang, Jun			Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor	CELL			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; LUNG-CANCER; SULT1A1 POLYMORPHISM; LYSINE ACETYLATION; RENAL-CARCINOMA; HIF PATHWAY; GENOME; GENE; EXPRESSION; PROTEIN	Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer and has very few mutations that are shared between different patients. To better understand the intratumoral genetics underlying mutations of ccRCC, we carried out single-cell exome sequencing on a ccRCC tumor and its adjacent kidney tissue. Our data indicate that this tumor was unlikely to have resulted from mutations in VHL and PBRM1. Quantitative population genetic analysis indicates that the tumor did not contain any significant clonal subpopulations and also showed that mutations that had different allele frequencies within the population also had different mutation spectrums. Analyses of these data allowed us to delineate a detailed intratumoral genetic landscape at a single-cell level. Our pilot study demonstrates that ccRCC may be more genetically complex than previously thought and provides information that can lead to new ways to investigate individual tumors, with the aim of developing more effective cellular targeted therapies.	[Xu, Xun; Hou, Yong; Yin, Xuyang; Bao, Li; Song, Luting; Li, Fuqiang; Wu, Kui; Wu, Hanjie; He, Weiming; Zeng, Liang; Xing, Manjie; Wu, Renhua; Jiang, Hui; Liu, Xiao; Cao, Dandan; Guo, Guangwu; Hu, Xueda; Wang, Bin; Zhong, Meiming; Li, Jingxiang; Zhang, Xiuqing; Goodman, Laurie; Bolund, Lars; Wang, Jian; Yang, Huanming; Kristiansen, Karsten; Dean, Michael; Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Xu, Xun] BGI Amer, Cambridge, MA 02142 USA; [Hou, Yong; Lu, Zuhong; Gu, Ning] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China; [Hou, Yong; Lu, Zuhong; Gu, Ning] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China; [Tang, Aifa; Li, Zesong; Sun, Xiaojuan; Cai, Zhiming] Shenzhen Second Peoples Hosp, Dept Urol, Shenzhen 518035, Peoples R China; [Tang, Aifa; Li, Zesong; Sun, Xiaojuan; Cai, Zhiming] Shenzhen Univ, Inst Urogenital Dis, Shenzhen 518060, Peoples R China; [Tsang, Shirley] BioMatrix LLC, Rockville, MD 20849 USA; [Wu, Hanjie] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou 510641, Guangdong, Peoples R China; [Xie, Wenyue; Shi, Min; Cai, Zhiming] Peking Univ, Shenzhen PKU HKUST Med Ctr, Inst Urol,Shenzhen Hosp, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen 518036, Peoples R China; [Bolund, Lars] Univ Aarhus, Inst Human Genet, DK-8100 Aarhus, Denmark; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-1165 Copenhagen, Denmark; [Dean, Michael] NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA	Beijing Genomics Institute (BGI); Southeast University - China; Southeast University - China; Second People's Hospital of Shenzhen; Shenzhen University; South China University of Technology; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Aarhus University; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangj@genomics.org.cn; deanm@mail.nih.gov; liyr@genomics.org.cn; wangj@genomics.org.cn	Wang, Jun/A-7261-2013; Kristiansen, Karsten/J-5148-2014; Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012; gui, yaoting/GLT-3684-2022; Liu, Xiao/P-2732-2015; Wu, Hanjie/AAY-2936-2020; Lu, Zuhong/A-5448-2013; Li, Yingrui/K-1064-2015; Xu, Xun/AAI-6763-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Kristiansen, Karsten/0000-0002-6024-0917; Dean, Michael C/0000-0003-2234-0631; Liu, Xiao/0000-0002-8073-0534; Wu, Hanjie/0000-0002-5451-4969; Xu, Xun/0000-0002-5338-5173; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874; Lu, Zuhong/0000-0003-3332-2615; CAO, Dandan/0000-0003-2899-8813; hou, yong/0000-0002-0420-0726; Goodman, Laurie/0000-0001-9724-5976	National Basic Research Program of China (973 program) [2011CB809202, 2011CB809203]; Chinese 863 program [2009AA022707, 2012AA02A201]; Shenzhen Municipal Government of China [ZYC201005250020A]; Key Laboratory Project, Shenzhen City [CX B200903 110066A, CXB201108250096A]; Shenzhen Key Laboratory of Gene Bank for National Life Science; Innovative Research Team of Guangdong; Guangdong Enterprise Key Laboratory of Human Disease Genomics; Shenzhen Key Laboratory, Shenzhen, China [CXB200903090055A, CXB201005250016A]; Danish Natural Science Research Council; Danish National Research Foundation; National Natural Science Foundation of China; Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; National Cancer Institute, National Institutes of Health, USA; NATIONAL CANCER INSTITUTE [ZIABC011300] Funding Source: NIH RePORTER	National Basic Research Program of China (973 program)(National Basic Research Program of China); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Key Laboratory Project, Shenzhen City; Shenzhen Key Laboratory of Gene Bank for National Life Science; Innovative Research Team of Guangdong; Guangdong Enterprise Key Laboratory of Human Disease Genomics; Shenzhen Key Laboratory, Shenzhen, China; Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; National Cancer Institute, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Basic Research Program of China (973 program numbers 2011CB809202 and 2011CB809203), the Chinese 863 program (numbers 2009AA022707 and 2012AA02A201), the Shenzhen Municipal Government of China (grant ZYC201005250020A), the Key Laboratory Project Supported by Shenzhen City (grants CX B200903 110066A and CXB201108250096A), and Shenzhen Key Laboratory of Gene Bank for National Life Science. This project was also supported by grants from the Innovative Research Team Project of Guangdong, the Guangdong Enterprise Key Laboratory of Human Disease Genomics, and the Promotion Program for Shenzhen Key Laboratory, Shenzhen, China (CXB200903090055A and CXB201005250016A). We also acknowledge the Ole Romer grant from the Danish Natural Science Research Council, the Danish National Research Foundation, the National Natural Science Foundation of China, and funds from the Shenzhen Municipal Government and the Local Government of Yantian District of Shenzhen. We also acknowledge support from the Intramural Research Program of the National Cancer Institute, National Institutes of Health, USA.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audenet F., 2012, BJU INT, V109, P1864, DOI [DOI 10.1111/j.1464-410X.2011.10661.x, 10.1111/j.1464-410X.2011.10661.x]; Baudot A, 2009, EMBO REP, V10, P359, DOI 10.1038/embor.2009.46; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bourachot B, 2003, EMBO J, V22, P6505, DOI 10.1093/emboj/cdg621; Caplin M, 2000, BRIT J SURG, V87, P1035, DOI 10.1046/j.1365-2168.2000.01488.x; Chen M, 2009, INT J CANCER, V125, P2342, DOI 10.1002/ijc.24642; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Geng H, 2011, J BIOL CHEM, V286, P38095, DOI 10.1074/jbc.M111.257055; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; HALL JL, 1983, MOL CELL BIOL, V3, P854, DOI 10.1128/MCB.3.5.854; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Liang G, 2004, CARCINOGENESIS, V25, P773, DOI 10.1093/carcin/bgh053; Ling JW, 2009, MOL HUM REPROD, V15, P739, DOI 10.1093/molehr/gap066; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ng CS, 2008, AM J ROENTGENOL, V191, P1220, DOI 10.2214/AJR.07.3568; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pei JM, 2010, GENE CHROMOSOME CANC, V49, P610, DOI 10.1002/gcc.20771; PISEGNA JR, 1992, BIOCHEM BIOPH RES CO, V189, P296, DOI 10.1016/0006-291X(92)91557-7; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Pugh TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn378; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salas S, 2009, INT J CANCER, V125, P851, DOI 10.1002/ijc.24457; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Takashima N, 2006, ONCOL REP, V15, P667; Tang DL, 2003, BREAST CANCER RES TR, V78, P217, DOI 10.1023/A:1022968303118; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Ye Y, 2010, ONCOGENE, V29, P3619, DOI 10.1038/onc.2010.116; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yu HG, 2006, INT J CANCER, V119, P2724, DOI 10.1002/ijc.22207; Zhang GQ, 2009, J BIOL CHEM, V284, P29050, DOI 10.1074/jbc.M109.010249; Zheng LZ, 2003, CANCER LETT, V202, P61, DOI 10.1016/j.canlet.2003.08.007	55	460	500	4	217	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					886	895		10.1016/j.cell.2012.02.025	http://dx.doi.org/10.1016/j.cell.2012.02.025			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385958	Bronze, Green Accepted			2022-12-01	WOS:000300985000010
J	Mulla, O; Prowse, S; Sanders, T; Nix, P				Mulla, Omar; Prowse, Simon; Sanders, Tim; Nix, Paul			10-MINUTE CONSULTATION Epistaxis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mulla, Omar; Prowse, Simon; Nix, Paul] Leeds Gen Infirm, Dept Ear Nose & Throat, Leeds LS1 3EX, W Yorkshire, England; [Sanders, Tim] Shap Med Practice, Penrith CA10 3LW, England	Leeds General Infirmary; University of Leeds	Mulla, O (corresponding author), Leeds Gen Infirm, Dept Ear Nose & Throat, Leeds LS1 3EX, W Yorkshire, England.	omarmulla@doctors.org.uk		Nix, Paul/0000-0002-7284-710X					0	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2012	344								e1097	10.1136/bmj.e1097	http://dx.doi.org/10.1136/bmj.e1097			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900JY	22362457				2022-12-01	WOS:000300884400001
J	Wu, X; Northcott, PA; Dubuc, A; Dupuy, AJ; Shih, DJH; Witt, H; Croul, S; Bouffet, E; Fults, DW; Eberhart, CG; Garzia, L; Van Meter, T; Zagzag, D; Jabado, N; Schwartzentruber, J; Majewski, J; Scheetz, TE; Pfister, SM; Korshunov, A; Li, XN; Scherer, SW; Cho, YJ; Akagi, K; MacDonald, TJ; Koster, J; McCabe, MG; Sarver, AL; Collins, VP; Weiss, WA; Largaespada, DA; Collier, LS; Taylor, MD				Wu, Xiaochong; Northcott, Paul A.; Dubuc, Adrian; Dupuy, Adam J.; Shih, David J. H.; Witt, Hendrik; Croul, Sidney; Bouffet, Eric; Fults, Daniel W.; Eberhart, Charles G.; Garzia, Livia; Van Meter, Timothy; Zagzag, David; Jabado, Nada; Schwartzentruber, Jeremy; Majewski, Jacek; Scheetz, Todd E.; Pfister, Stefan M.; Korshunov, Andrey; Li, Xiao-Nan; Scherer, Stephen W.; Cho, Yoon-Jae; Akagi, Keiko; MacDonald, Tobey J.; Koster, Jan; McCabe, Martin G.; Sarver, Aaron L.; Collins, V. Peter; Weiss, William A.; Largaespada, David A.; Collier, Lara S.; Taylor, Michael D.			Clonal selection drives genetic divergence of metastatic medulloblastoma	NATURE			English	Article							CANCER; ABERRATIONS; MUTAGENESIS; EXPRESSION; CELLS; MYCN	Medulloblastoma, the most common malignant paediatric brain tumour, arises in the cerebellum and disseminates through the cerebrospinal fluid in the leptomeningeal space to coat the brain and spinal cord(1). Dissemination, a marker of poor prognosis, is found in up to 40% of children at diagnosis and inmost children at the time of recurrence. Affected children therefore are treated with radiation to the entire developing brain and spinal cord, followed by high-dose chemotherapy, with the ensuing deleterious effects on the developing nervous system(2). The mechanisms of dissemination through the cerebrospinal fluid are poorly studied, and medulloblastoma metastases have been assumed to be biologically similar to the primary tumour(3,4). Here we show that in both mouse and human medulloblastoma, the metastases from an individual are extremely similar to each other but are divergent from the matched primary tumour. Clonal genetic events in the metastases can be demonstrated in a restricted subclone of the primary tumour, suggesting that only rare cells within the primary tumour have the ability to metastasize. Failure to account for the bicompartmental nature of metastatic medulloblastoma could be a major barrier to the development of effective targeted therapies.	[Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Wu, Xiaochong; Northcott, Paul A.; Dubuc, Adrian; Shih, David J. H.; Garzia, Livia] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Wu, Xiaochong; Northcott, Paul A.; Dubuc, Adrian; Shih, David J. H.; Garzia, Livia] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Dupuy, Adam J.; Scheetz, Todd E.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA; [Witt, Hendrik; Pfister, Stefan M.] Univ Heidelberg Hosp, German Canc Res Ctr DKFZ, D-69120 Heidelberg, Germany; [Witt, Hendrik; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Croul, Sidney] Univ Toronto, Dept Lab Med & Pathobiol, Arthur & Sonia Labatt Brain Tumour Res Ctr, Univ Hlth Network Pathol, Toronto, ON M5S 1A1, Canada; [Bouffet, Eric] Hosp Sick Children, Brain Tumour Program, Toronto, ON M5G 1X8, Canada; [Fults, Daniel W.] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT 84132 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Baltimore, MD 21210 USA; [Van Meter, Timothy] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Zagzag, David] NYU, Sch Med, Div Neuropathol, Dept Pathol & Neurosurg, New York, NY 10016 USA; [Jabado, Nada; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; [Jabado, Nada; Majewski, Jacek] McGill Univ, Dept Expt Med, Montreal, PQ H3Z 2Z3, Canada; [Schwartzentruber, Jeremy] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Korshunov, Andrey] Heidelberg Univ, German Canc Res Inst DKFZ, D-69120 Heidelberg, Germany; [Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Li, Xiao-Nan] Texas Childrens Canc Ctr, Brain Tumor Program, Houston, TX 77030 USA; [Li, Xiao-Nan] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5S 1A1, Canada; [Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5S 1A1, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5S 1A1, Canada; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Akagi, Keiko] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [MacDonald, Tobey J.] Emory Univ, Sch Med, Pediat Neurooncol Program, Atlanta, GA 30307 USA; [Koster, Jan] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1100 DE Amsterdam, Netherlands; [McCabe, Martin G.] Univ Manchester, Sch Canc & Enabling Sci, Manchester M20 4BX, Lancs, England; [Sarver, Aaron L.; Largaespada, David A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Collins, V. Peter] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Weiss, William A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Pediat & Neurol Surg, San Francisco, CA 94143 USA; [Collier, Lara S.] Univ Wisconsin, Sch Pharmacol, Madison, WI 53715 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Iowa; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Utah System of Higher Education; University of Utah; Johns Hopkins University; Virginia Commonwealth University; New York University; McGill University; McGill University; McGill University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Texas Children's Cancer Center; Baylor College of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Stanford University; Stanford University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Emory University; University of Amsterdam; Academic Medical Center Amsterdam; University of Manchester; University of Minnesota System; University of Minnesota Twin Cities; University of Cambridge; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison	Taylor, MD (corresponding author), Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada.	mdtaylor@sickkids.ca	Pfister, Stefan M/F-6860-2013; Shih, David J H/H-3186-2011; Koster, Jan/C-5934-2008; McCabe, Martin/P-5896-2015; Jabado, Nada/AAN-4026-2020; Northcott, Paul A/N-4022-2018; MacDonald, Tobey/D-4554-2013; Witt, Hendrik/L-7810-2015; Largaespada, David/C-9832-2014; Gotoh, Osamu/B-4704-2012; Bouffet, Eric/AAB-8999-2020; Shih, David J. H./AAE-8726-2019; Scherer, Stephen/B-3785-2013	Pfister, Stefan M/0000-0002-5447-5322; Shih, David J H/0000-0002-9802-4937; Koster, Jan/0000-0002-0890-7585; McCabe, Martin/0000-0002-5138-0707; Northcott, Paul A/0000-0002-1220-5252; Shih, David J. H./0000-0002-9802-4937; Scherer, Stephen/0000-0002-8326-1999; Croul, Sidney/0000-0002-2224-5485; Schwartzentruber, Jeremy/0000-0002-6183-2092; Taylor, Michael/0000-0001-7009-3466; Dupuy, Adam/0000-0002-8561-4911; Weiss, William/0000-0003-2230-9132; Scheetz, Todd/0000-0002-1965-5811; Korshunov, Andrey/0000-0002-5257-3623	National Institutes of Health [R01CA148699, NS055089]; Pediatric Brain Tumor Foundation; Canadian Cancer Society; Brainchild; American Brain Tumor Association; Canadian Institutes of Health Research; Kimmel Foundation;  [K01CA122183]; The Brain Tumour Charity [10/106] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K01CA122183, R01CA108622, R01CA148699, R01CA113636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; Canadian Cancer Society(Canadian Cancer Society (CCS)); Brainchild; American Brain Tumor Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kimmel Foundation; ; The Brain Tumour Charity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M.D.T. holds a Canadian Institutes of Health Research Clinician-Scientist Phase II Award, was a Sontag Foundation Distinguished Scholar, and is supported by grants from the National Institutes of Health (R01CA148699), the Pediatric Brain Tumor Foundation, the Canadian Cancer Society, and Brainchild. X. W. was supported by a fellowship from the American Brain Tumor Association in tribute to Tracy Greenwood. L. G. was supported by a fellowship from the Davis M. Ferguson Fund from the American Brain Tumor Association. A. D. was supported by a Vanier Doctoral Fellowship from the Canadian Institutes of Health Research. L. S. C. was supported by a grant (K01CA122183) and a Kimmel Scholar award from the Kimmel Foundation. C. E. was supported by a grant from the National Institutes of Health (NS055089). We thank S. Archer for technical writing assistance.	Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; GNEKOW AK, 1995, MED PEDIATR ONCOL, V24, P104, DOI 10.1002/mpo.2950240209; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Helms AW, 2000, DEVELOPMENT, V127, P1185; Korshunov A, 2008, ACTA NEUROPATHOL, V116, P383, DOI 10.1007/s00401-008-0422-y; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rao G, 2003, NEOPLASIA, V5, P198, DOI 10.1016/S1476-5586(03)80052-0; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Talmadge JE, 2007, CANCER RES, V67, P11471, DOI 10.1158/0008-5472.CAN-07-2496; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Wetmore C, 2001, CANCER RES, V61, P513	28	304	315	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					529	U254		10.1038/nature10825	http://dx.doi.org/10.1038/nature10825			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22343890	Green Submitted, Green Accepted			2022-12-01	WOS:000300770500051
J	Friedman, LJ; Gelles, J				Friedman, Larry J.; Gelles, Jeff			Mechanism of Transcription Initiation at an Activator-Dependent Promoter Defined by Single-Molecule Observation	CELL			English	Article							COLI RNA-POLYMERASE; OPEN COMPLEX-FORMATION; PROKARYOTIC ENHANCER; FACTOR SIGMA(54); DNA; PROTEIN; BINDING; ELONGATION; PATHWAY; ORGANIZATION	Understanding the pathway and kinetic mechanisms of transcription initiation is essential for quantitative understanding of gene regulation, but initiation is a multistep process, the features of which can be obscured in bulk analysis. We used a multiwavelength single-molecule fluorescence colocalization approach, CoSMoS, to define the initiation pathway at an activator-dependent bacterial sigma(54) promoter that recapitulates characteristic features of eukaryotic promoters activated by enhancer binding proteins. The experiments kinetically characterize all major steps of the initiation process, revealing heretofore unknown features, including reversible formation of two closed complexes with greatly differing stabilities, multiple attempts for each successful formation of an open complex, and efficient release of s 54 from the polymerase core at the start of transcript synthesis. Open complexes are committed to transcription, suggesting that regulation likely targets earlier steps in the mechanism. CoSMoS is a powerful, generally applicable method to elucidate the mechanisms of transcription and other multistep biochemical processes.	[Friedman, Larry J.; Gelles, Jeff] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University	Friedman, LJ (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	larryfj@brandeis.edu; gelles@brandeis.edu		Gelles, Jeff/0000-0001-7910-3421; Friedman, Larry/0000-0003-4946-8731	NIGMS [K25 GM00714, R01 GM43369, R01 GM81648]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081648, R01GM043369, K25GM000714, R37GM043369] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Rippe for plasmids and A. Hochschild, A. Hoskins, R. Landick, M. Marr, J. Mumm, and M. Osborne for helpful discussions. This work was supported by grants K25 GM00714 (to L.J.F.), R01 GM43369, and R01 GM81648 (to J.G.) from the NIGMS.	Amit R, 2011, CELL, V146, P105, DOI 10.1016/j.cell.2011.06.024; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Bernardo LMD, 2006, MOL MICROBIOL, V60, P749, DOI 10.1111/j.1365-2958.2006.05129.x; Bondarenko V, 2002, NUCLEIC ACIDS RES, V30, P636, DOI 10.1093/nar/30.3.636; Bose D, 2008, MOL CELL, V32, P337, DOI 10.1016/j.molcel.2008.09.015; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Burrows PC, 2008, J MOL BIOL, V375, P43, DOI 10.1016/j.jmb.2007.10.045; Burrows PC, 2009, J MOL BIOL, V387, P306, DOI 10.1016/j.jmb.2009.01.052; CANNON W, 1993, MOL MICROBIOL, V8, P287, DOI 10.1111/j.1365-2958.1993.tb01573.x; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Chen BY, 2007, STRUCTURE, V15, P429, DOI 10.1016/j.str.2007.02.007; Colquhoun David, 1995, P589; Crawford DJ, 2008, RNA, V14, P170, DOI 10.1261/rna.794808; Darst SA, 2004, TRENDS BIOCHEM SCI, V29, P159, DOI 10.1016/j.tibs.2004.02.005; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; Deighan P, 2011, GENE DEV, V25, P77, DOI 10.1101/gad.1991811; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Friedman LJ, 2006, BIOPHYS J, V91, P1023, DOI 10.1529/biophysj.106.084004; Grigorova IL, 2006, P NATL ACAD SCI USA, V103, P5332, DOI 10.1073/pnas.0600828103; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Ho MX, 2009, CURR OPIN STRUC BIOL, V19, P715, DOI 10.1016/j.sbi.2009.10.010; Hoskins AA, 2011, SCIENCE, V331, P1289, DOI 10.1126/science.1198830; Huo YX, 2006, MOL MICROBIOL, V59, P168, DOI 10.1111/j.1365-2958.2005.04943.x; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Joly N, 2012, BBA-MOL CELL RES, V1823, P108, DOI 10.1016/j.bbamcr.2011.08.012; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; Kontur WS, 2008, J MOL BIOL, V376, P1034, DOI 10.1016/j.jmb.2007.11.064; Lee CR, 2010, MOL MICROBIOL, V78, P1468, DOI 10.1111/j.1365-2958.2010.07419.x; Lin YC, 2005, NAT STRUCT MOL BIOL, V12, P603, DOI 10.1038/nsmb949; Magasanik B., 1996, ESCHERICHIA COLI SAL, P1344; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; MORRIS L, 1994, J BIOL CHEM, V269, P11563; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; NINFA AJ, 1987, CELL, V50, P1039, DOI 10.1016/0092-8674(87)90170-X; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; REITZER LJ, 1987, J BACTERIOL, V169, P4279, DOI 10.1128/jb.169.9.4279-4284.1987; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Rippe K, 1997, J MOL BIOL, V270, P125, DOI 10.1006/jmbi.1997.1079; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; SASSEDWIGHT S, 1990, CELL, V62, P945, DOI 10.1016/0092-8674(90)90269-K; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; Sclavi B, 2005, P NATL ACAD SCI USA, V102, P4706, DOI 10.1073/pnas.0408218102; Susa M, 2006, MOL MICROBIOL, V59, P1807, DOI 10.1111/j.1365-2958.2006.05058.x; Szalewska-Palasz A, 2007, J BIOL CHEM, V282, P18046, DOI 10.1074/jbc.M610181200; TINTUT Y, 1995, GENE DEV, V9, P2305, DOI 10.1101/gad.9.18.2305; Villain-Guillot P, 2007, DRUG DISCOV TODAY, V12, P200, DOI 10.1016/j.drudis.2007.01.005; WEDEL A, 1995, GENE DEV, V9, P2042, DOI 10.1101/gad.9.16.2042; Wigneshweraraj S, 2008, MOL MICROBIOL, V68, P538, DOI 10.1111/j.1365-2958.2008.06181.x	56	92	93	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					679	689		10.1016/j.cell.2012.01.018	http://dx.doi.org/10.1016/j.cell.2012.01.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341441	Bronze, Green Accepted			2022-12-01	WOS:000300622400010
J	Sridhar, D				Sridhar, Devi			Regulate alcohol for global health	NATURE			English	Editorial Material									[Sridhar, Devi] Univ Oxford Wolfson Coll, Dept Publ Hlth, Oxford OX2 6UD, England; [Sridhar, Devi] Univ Oxford Wolfson Coll, George Ctr Healthcare Innovat, Oxford OX2 6UD, England	University of Oxford; University of Oxford	Sridhar, D (corresponding author), Univ Oxford Wolfson Coll, Dept Publ Hlth, Oxford OX2 6UD, England.	devi.sridhar@dph.ox.ac.uk						Gostin LO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001031; L'hirondel A, 1998, World Health Stat Q, V51, P79; WHO, 2011, GLOB STAT REP ALC HL	3	22	22	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					302	302		10.1038/482302a	http://dx.doi.org/10.1038/482302a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	892LG	22337033	Bronze			2022-12-01	WOS:000300287100016
J	Inaba, M; Yamanaka, H; Kondo, S				Inaba, Masafumi; Yamanaka, Hiroaki; Kondo, Shigeru			Pigment Pattern Formation by Contact-Dependent Depolarization	SCIENCE			English	Article							ZEBRAFISH		[Inaba, Masafumi; Yamanaka, Hiroaki; Kondo, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University	Kondo, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	skondo@fbs.osaka-u.ac.jp		Inaba, Masafumi/0000-0001-6896-5819; Kondo, Shigeru/0000-0003-0192-5526	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Uehara Memorial Foundation; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [22370079] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Kawakami for providing the Tol2 vector and Y. Kurachi, K. Furutani, M. Okada, A. Ogura, and K. Ida for helpful discussions. This study was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [Grant-in-Aid for Scientific Research on Innovative Areas, Scientific Research on (B)] and grants from the Uehara Memorial Foundation and Mitsubishi Foundation.	Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; Maderspacher F, 2003, DEVELOPMENT, V130, P3447, DOI 10.1242/dev.00519; Meinhardt H., 1982, MODELS BIOL PATTERN; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Takahashi G, 2008, PIGM CELL MELANOMA R, V21, P677, DOI 10.1111/j.1755-148X.2008.00504.x; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757	9	127	133	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2012	335	6069					677	677		10.1126/science.1212821	http://dx.doi.org/10.1126/science.1212821			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323812				2022-12-01	WOS:000300047100042
J	Liu, X; Ramirez, S; Pang, PT; Puryear, CB; Govindarajan, A; Deisseroth, K; Tonegawa, S				Liu, Xu; Ramirez, Steve; Pang, Petti T.; Puryear, Corey B.; Govindarajan, Arvind; Deisseroth, Karl; Tonegawa, Susumu			Optogenetic stimulation of a hippocampal engram activates fear memory recall	NATURE			English	Article							DENTATE GYRUS; PATTERN SEPARATION; AMYGDALA; EXPRESSION; RETRIEVAL; PLASTICITY; STRATEGIES; ALLOCATION; CA3	A specific memory is thought to be encoded by a sparse population of neurons(1,2). These neurons can be tagged during learning for subsequent identification(3) and manipulation(4-6). Moreover, their ablation or inactivation results in reduced memory expression, suggesting their necessity in mnemonic processes. However, the question of sufficiency remains: it is unclear whether it is possible to elicit the behavioural output of a specific memory by directly activating a population of neurons that was active during learning. Here we show in mice that optogenetic reactivation of hippocampal neurons activated during fear conditioning is sufficient to induce freezing behaviour. We labelled a population of hippocampal dentate gyrus neurons activated during fear learning with channelrhodopsin-2 (ChR2)(7,8) and later optically reactivated these neurons in a different context. The mice showed increased freezing only upon light stimulation, indicating light-induced fear memory recall. This freezing was not detected in non-fear-conditioned mice expressing ChR2 in a similar proportion of cells, nor in fear-conditioned mice with cells labelled by enhanced yellow fluorescent protein instead of ChR2. Finally, activation of cells labelled in a context not associated with fear did not evoke freezing in mice that were previously fear-conditioned in a different context, suggesting that light-induced fear memory recall is context-specific. Together, our findings indicate that activating a sparse but specific ensemble of hippocampal neurons that contribute to a memory engram is sufficient for the recall of that memory. Moreover, our experimental approach offers a general method of mapping cellular populations bearing memory engrams.	[Liu, Xu; Ramirez, Steve; Pang, Petti T.; Puryear, Corey B.; Govindarajan, Arvind; Tonegawa, Susumu] MIT, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Dept Biol, Cambridge, MA 02139 USA; [Liu, Xu; Ramirez, Steve; Pang, Petti T.; Puryear, Corey B.; Govindarajan, Arvind; Tonegawa, Susumu] MIT, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Stanford University; Stanford University	Tonegawa, S (corresponding author), MIT, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu			Tonegawa laboratory; National Institutes of Health [R01-MH078821, P50-MH58880]; RIKEN Brain Science Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880, R01MH078821] Funding Source: NIH RePORTER	Tonegawa laboratory; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIKEN Brain Science Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Huang, G. Lin, M. Ragion and X. Zhou for help with the experiments, T. Ryan, A. Rivest, J. Young, R. Redondo and G. Dragoi for comments and discussions on the manuscript, and all the members of the Tonegawa laboratory for their support. This work is supported by National Institutes of Health grants R01-MH078821, P50-MH58880 to S. T. and RIKEN Brain Science Institute.	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Josselyn SA, 2010, J PSYCHIATR NEUROSCI, V35, P221, DOI 10.1503/jpn.100015; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Nakashiba T., 2012, CELL            0223, DOI [10.1016/j.cell.2012.01.046, DOI 10.1016/J.CELL.2012.01.046]; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rasband WS, 1997, IMAGE J; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Satvat E, 2011, J NEUROSCI, V31, P7163, DOI 10.1523/JNEUROSCI.0094-11.2011; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shockett PE, 1996, P NATL ACAD SCI USA, V93, P5173, DOI 10.1073/pnas.93.11.5173; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	30	861	885	9	416	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2012	484	7394					381	U415		10.1038/nature11028	http://dx.doi.org/10.1038/nature11028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22441246	Green Accepted, Green Submitted			2022-12-01	WOS:000302946500034
J	Hakim, O; Resch, W; Yamane, A; Klein, I; Kieffer-Kwon, KR; Jankovic, M; Oliveira, T; Bothmer, A; Voss, TC; Ansarah-Sobrinho, C; Mathe, E; Liang, GQ; Cobell, J; Nakahashi, H; Robbiani, DF; Nussenzweig, A; Hager, GL; Nussenzweig, MC; Casellas, R				Hakim, Ofir; Resch, Wolfgang; Yamane, Arito; Klein, Isaac; Kieffer-Kwon, Kyong-Rim; Jankovic, Mila; Oliveira, Thiago; Bothmer, Anne; Voss, Ty C.; Ansarah-Sobrinho, Camilo; Mathe, Ewy; Liang, Genqing; Cobell, Jesse; Nakahashi, Hirotaka; Robbiani, Davide F.; Nussenzweig, Andre; Hager, Gordon L.; Nussenzweig, Michel C.; Casellas, Rafael			DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes	NATURE			English	Article							CLASS-SWITCH RECOMBINATION; SEQUENCING REVEALS; HUMAN GENOME; BREAKS; CELLS; AID; IDENTIFICATION; REARRANGEMENTS; ORGANIZATION; MECHANISMS	Recurrent chromosomal translocations underlie both haematopoietic and solid tumours. Their origin has been ascribed to selection of random rearrangements, targeted DNA damage, or frequent nuclear interactions between translocation partners; however, the relative contribution of each of these elements has not been measured directly or on a large scale. Here we examine the role of nuclear architecture and frequency of DNA damage in the genesis of chromosomal translocations by measuring these parameters simultaneously in cultured mouse B lymphocytes. In the absence of recurrent DNA damage, translocations between Igh or Myc and all other genes are directly related to their contact frequency. Conversely, translocations associated with recurrent site-directed DNA damage are proportional to the rate of DNA break formation, as measured by replication protein A accumulation at the site of damage. Thus, non-targeted rearrangements reflect nuclear organization whereas DNA break formation governs the location and frequency of recurrent translocations, including those driving B-cell malignancies.	[Klein, Isaac; Jankovic, Mila; Oliveira, Thiago; Bothmer, Anne; Robbiani, Davide F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Hakim, Ofir; Voss, Ty C.; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Resch, Wolfgang; Yamane, Arito; Kieffer-Kwon, Kyong-Rim; Ansarah-Sobrinho, Camilo; Liang, Genqing; Cobell, Jesse; Nakahashi, Hirotaka; Casellas, Rafael] NCI, NIAMS, NIH, Bethesda, MD 20892 USA; [Oliveira, Thiago] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Genet, Natl Inst Sci & Technol Stem Cells & Cell Therapy, BR-14051140 Ribeirao Preto, SP, Brazil; [Oliveira, Thiago] Ctr Cell Based Therapy, BR-14051140 Ribeirao Preto, SP, Brazil; [Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu; casellar@mail.nih.gov	Oliveira, Thiago Y/ABF-5186-2020; Robbiani, Davide F./AAF-7662-2019; Mathe, Ewy/L-1616-2019; Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019; Yamane, Arito/A-2959-2013	Oliveira, Thiago Y/0000-0002-2654-0879; Robbiani, Davide F./0000-0001-7379-3484; Oliveira, Thiago Y/0000-0002-2654-0879; Mathe, Ewy/0000-0003-4491-8107; Hakim, Ofir/0000-0003-0063-2721; Resch, Wolfgang/0000-0001-7594-5963	Starr Foundation; NIH [AI037526]; NIAMS; NCI, NIH; NATIONAL CANCER INSTITUTE [ZIABC010283, ZIABC010027, ZIABC010959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037526, R01AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER	Starr Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank members of the Casellas and Nussenzweig laboratories for discussions; G. Gutierrez from NIAMS genomics facility for technical assistance. This work was supported in part by a grant from the Starr Foundation to M.C.N., by NIH grant number AI037526 to M.C.N. and the Intramural Research Program of NIAMS and NCI, NIH. M.C.N. is an HHMI investigator. This study made use of the high-performance computational capabilities of the Biowulf Linux cluster at the NIH (http://biowulf.nih.gov), and the resources of NCI's High-Throughput Imaging Facility.	Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chakalova L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000729; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Hakim O, 2011, GENOME RES, V21, P697, DOI 10.1101/gr.111153.110; Hakim O, 2010, CURR OPIN CELL BIOL, V22, P305, DOI 10.1016/j.ceb.2010.04.005; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9	28	158	164	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					69	+		10.1038/nature10909	http://dx.doi.org/10.1038/nature10909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22314321	Green Accepted			2022-12-01	WOS:000302343400035
J	Vervaeke, K; Lorincz, A; Nusser, Z; Silver, RA				Vervaeke, Koen; Loerincz, Andrea; Nusser, Zoltan; Silver, R. Angus			Gap Junctions Compensate for Sublinear Dendritic Integration in an Inhibitory Network	SCIENCE			English	Article							ELECTRICAL SYNAPSES; RAT; INTERNEURONS; POTENTIALS; MECHANISMS; LOCATION; EFFICACY; NEURONS; INPUTS; CELLS	Electrically coupled inhibitory interneurons dynamically control network excitability, yet little is known about how chemical and electrical synapses regulate their activity. Using two-photon glutamate uncaging and dendritic patch-clamp recordings, we found that the dendrites of cerebellar Golgi interneurons acted as passive cables. They conferred distance-dependent sublinear synaptic integration and weakened distal excitatory inputs. Gap junctions were present at a higher density on distal dendrites and contributed substantially to membrane conductance. Depolarization of one Golgi cell increased firing in its neighbors, and inclusion of dendritic gap junctions in interneuron network models enabled distal excitatory synapses to drive network activity more effectively. Our results suggest that dendritic gap junctions counteract sublinear dendritic integration by enabling excitatory synaptic charge to spread into the dendrites of neighboring inhibitory interneurons.	[Vervaeke, Koen; Silver, R. Angus] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Loerincz, Andrea; Nusser, Zoltan] Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, H-1083 Budapest, Hungary	University of London; University College London; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Silver, RA (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Mortimer St, London WC1E 6BT, England.	nusser.zoltan@koki.hu; a.silver@ucl.ac.uk	Nusser, Zoltan/K-8587-2014	Silver, Robin/0000-0002-5480-6638; Nusser, Zoltan/0000-0001-7004-4111	U.K. Biotechnology and Biological Sciences Research Council (BBSRC) [F005490]; Medical Research Council [G0400598]; Wellcome Trust [064413, 095667]; European Research Council (ERC); Janos Bolyai Scholarship; BBSRC [BB/F005490/1] Funding Source: UKRI; MRC [G0400598] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005490/1] Funding Source: researchfish	U.K. Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Research Council (ERC)(European Research Council (ERC)European Commission); Janos Bolyai Scholarship(Hungarian Academy of Sciences); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by U.K. Biotechnology and Biological Sciences Research Council (BBSRC) (F005490), Medical Research Council (G0400598), and Wellcome Trust (064413). R.A.S. holds a Wellcome Trust Principal Research Fellowship (095667) and a European Research Council (ERC) Advanced Grant, Z.N. a Wellcome Trust Project Grant and an ERC Advanced Grant, and A.L. a Janos Bolyai Scholarship. We thank D. Paul for the Cx36<SUP>-/-</SUP> mice; E. Chaigneau, T. Branco, and P. Gleeson for help; D. Attwell, M. Farrant, H. Hu, D. Kullmann, J. Rothman, and D. Ward for comments on the manuscript; and T. Fernandez-Alfonso, H. Hu, and D. Ruedt for discussions.	Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Dugue GP, 2009, NEURON, V61, P126, DOI 10.1016/j.neuron.2008.11.028; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gleeson P, 2007, NEURON, V54, P219, DOI 10.1016/j.neuron.2007.03.025; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kanichay RT, 2008, J NEUROSCI, V28, P8955, DOI 10.1523/JNEUROSCI.5469-07.2008; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Solinas S, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.002.2007; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Vervaeke K, 2010, NEURON, V67, P435, DOI 10.1016/j.neuron.2010.06.028; Vos BP, 1999, EUR J NEUROSCI, V11, P2621, DOI 10.1046/j.1460-9568.1999.00678.x; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041	29	80	82	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1624	1628		10.1126/science.1215101	http://dx.doi.org/10.1126/science.1215101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22403180	Green Accepted			2022-12-01	WOS:000302062600045
J	Wei, W; Ba, ZQ; Gao, M; Wu, Y; Ma, YT; Amiard, S; White, CI; Danielsen, JMR; Yang, YG; Qi, YJ				Wei, Wei; Ba, Zhaoqing; Gao, Min; Wu, Yang; Ma, Yanting; Amiard, Simon; White, Charles I.; Danielsen, Jannie Michaela Rendtlew; Yang, Yun-Gui; Qi, Yijun			A Role for Small RNAs in DNA Double-Strand Break Repair	CELL			English	Article							TRANS-ACTING SIRNAS; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; DIFFERENT PATHWAYS; STRUCTURAL BASIS; ATR; RECOGNITION; METHYLATION; GAMMA-H2AX; MECHANISMS	Eukaryotes have evolved complex mechanisms to repair DNA double-strand breaks (DSBs) through coordinated actions of protein sensors, transducers, and effectors. Here we show that similar to 21-nucleotide small RNAs are produced from the sequences in the vicinity of DSB sites in Arabidopsis and in human cells. We refer to these as diRNAs for DSB-induced small RNAs. In Arabidopsis, the biogenesis of diRNAs requires the PI3 kinase ATR, RNA polymerase IV (Pol IV), and Dicer-like proteins. Mutations in these proteins as well as in Pol V cause significant reduction in DSB repair efficiency. In Arabidopsis, diRNAs are recruited by Argonaute 2 (AGO2) to mediate DSB repair. Knock down of Dicer or Ago2 in human cells reduces DSB repair. Our findings reveal a conserved function for small RNAs in the DSB repair pathway. We propose that diRNAs may function as guide molecules directing chromatin modifications or the recruitment of protein complexes to DSB sites to facilitate repair.	[Wei, Wei; Ba, Zhaoqing; Wu, Yang; Ma, Yanting; Qi, Yijun] Nat Inst Biol Sci, Beijing 102206, Peoples R China; [Wei, Wei] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Wei, Wei] Peking Union Med Coll, Beijing 100730, Peoples R China; [Ba, Zhaoqing] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Gao, Min; Danielsen, Jannie Michaela Rendtlew; Yang, Yun-Gui] Chinese Acad Sci, Beijing Inst Genom, Dis Genom & Individualized Med Lab, Genome Struct & Stabil Grp, Beijing 100029, Peoples R China; [Amiard, Simon; White, Charles I.] Clermont Univ, Inst Natl Sante & Rech Med U931, Ctr Natl Rech Sci, Unite Mixte Rech 6247, F-63177 Aubiere, France; [Danielsen, Jannie Michaela Rendtlew] Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, Ubiquitin Signalling Grp, DK-2200 Copenhagen, Denmark; [Qi, Yijun] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Qi, Yijun] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Normal University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Tsinghua University; Tsinghua University	Qi, YJ (corresponding author), Nat Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	qiyijun@nibs.ac.cn	amiard, simon/J-6951-2015; Yang, Yungui/ABF-2507-2021; White, Charles I/F-1001-2011; Qi, Yijun/AAE-8797-2019	amiard, simon/0000-0002-0427-1647; White, Charles I/0000-0001-8152-5797; Ba, Zhaoqing/0000-0002-8431-5469; /0000-0002-5592-9349	National Basic Research Program of China (973 program) [2012CB910900, 2011CB100700, 2011CB812600, 2011CB510103]	National Basic Research Program of China (973 program)(National Basic Research Program of China)	We thank Drs. A. Britt, L. Du, M. Carmell, and B. Ding for critical reading of the manuscript and stimulating discussions. We are grateful to Dr. H. Puchta for DGU.US, DU.GUS and I-SceI trigger lines and Dr. M. Jasin for DR-GFP/U2OS cell line and PCBASce plasmid. This work was supported by National Basic Research Program of China (973 program 2012CB910900, 2011CB100700, and 2011CB812600 to Y.Q. and 2011CB510103 to Y.G.Y.).	Amiard S, 2010, PLANT CELL, V22, P3020, DOI 10.1105/tpc.110.078527; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; Culligan KM, 2008, PLANT J, V55, P629, DOI 10.1111/j.1365-313X.2008.03530.x; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee HC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000496; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mannuss A, 2010, PLANT CELL, V22, P3318, DOI 10.1105/tpc.110.078568; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Orel N, 2003, PLANT J, V35, P604, DOI 10.1046/j.1365-313X.2003.01832.x; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	56	417	438	4	149	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					101	112		10.1016/j.cell.2012.03.002	http://dx.doi.org/10.1016/j.cell.2012.03.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22445173	Bronze			2022-12-01	WOS:000302235400013
J	Messerschmidt, DM; de Vries, W; Ito, M; Solter, D; Ferguson-Smith, A; Knowles, BB				Messerschmidt, Daniel M.; de Vries, Wilhelmine; Ito, Mitsuteru; Solter, Davor; Ferguson-Smith, Anne; Knowles, Barbara B.			Trim28 Is Required for Epigenetic Stability During Mouse Oocyte to Embryo Transition	SCIENCE			English	Article							IMPRINTED EXPRESSION; H19 GENE; METHYLATION; IGF2; GENOME; TUMOR; 11P15	Phenotypic variability in genetic disease is usually attributed to genetic background variation or environmental influence. Here, we show that deletion of a single gene, Trim28 (Kap1 or Tif1 beta), from the maternal germ line alone, on an otherwise identical genetic background, results in severe phenotypic and epigenetic variability that leads to embryonic lethality. We identify early and minute epigenetic variations in blastomeres of the preimplantation embryo of these animals, suggesting that the embryonic lethality may result from the misregulation of genomic imprinting in mice lacking maternal Trim28. Our results reveal the long-range effects of a maternal gene deletion on epigenetic memory and illustrate the delicate equilibrium of maternal and zygotic factors during nuclear reprogramming.	[Messerschmidt, Daniel M.; Solter, Davor; Knowles, Barbara B.] Inst Med Biol, Mammalian Dev Grp, Singapore 138648, Singapore; [de Vries, Wilhelmine] Jackson Lab, Bar Harbor, ME 04609 USA; [Ito, Mitsuteru; Ferguson-Smith, Anne] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Solter, Davor] Duke NUS, Grad Sch Med, Singapore 169857, Singapore; [Ferguson-Smith, Anne] Singapore Inst Clin Sci, Singapore 117609, Singapore; [Knowles, Barbara B.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Jackson Laboratory; University of Cambridge; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Messerschmidt, DM (corresponding author), Inst Med Biol, Mammalian Dev Grp, Singapore 138648, Singapore.	daniel.m@imb.a-star.edu.sg	Messerschmidt, Daniel Martin/W-7193-2019; Solter, Davor/Q-5476-2019	Ferguson-Smith, Anne/0000-0002-7608-5894; Messerschmidt, Daniel Martin/0000-0003-2022-4696; Knowles, Barbara B./0000-0002-2597-5619	A*STAR, Singapore; Wellcome Trust; UK Technology Strategy Board; Medical Research Council [MR/J001597/1] Funding Source: researchfish; MRC [MR/J001597/1] Funding Source: UKRI	A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Wellcome Trust(Wellcome Trust); UK Technology Strategy Board; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was financed by A*STAR, Singapore and by grants from the Wellcome Trust and UK Technology Strategy Board. We thank H. Wollmann, S. Balu, D. Tham, and K. Yamazawa for their help. Microarray data and accession nos. can be found in the Supporting Online Material.	BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Cammas F, 2000, DEVELOPMENT, V127, P2955; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Feinberg AP, 1996, MED PEDIATR ONCOL, V27, P484; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Kaneda A, 2005, CANCER RES, V65, P11236, DOI 10.1158/0008-5472.CAN-05-2959; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; REIK W, 1994, HUM MOL GENET, V3, P1297, DOI 10.1093/hmg/3.8.1297; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Whitelaw NC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r111; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	26	240	254	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2012	335	6075					1499	1502		10.1126/science.1216154	http://dx.doi.org/10.1126/science.1216154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22442485				2022-12-01	WOS:000301837000050
J	Koch, C; Reid, RC				Koch, Christof; Reid, R. Clay			Observatories of the mind	NATURE			English	Editorial Material									[Koch, Christof] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Koch, Christof] CALTECH, Pasadena, CA 91125 USA; [Reid, R. Clay] Harvard Univ, Sch Med, Boston, MA 02115 USA	Allen Institute for Brain Science; California Institute of Technology; Harvard University; Harvard Medical School	Koch, C (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	christofk@alleninstitute.org		Koch, Christof/0000-0001-6482-8067				[Anonymous], 2011, NAT METHODS, V8, P1, DOI 10.1038/NMETH.F.321; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Waldrop MM, 2012, NATURE, V482, P456, DOI 10.1038/482456a; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286	5	61	64	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2012	483	7390					397	398		10.1038/483397a	http://dx.doi.org/10.1038/483397a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	912CC	22437592	Bronze			2022-12-01	WOS:000301771200014
J	Koivunen, P; Lee, S; Duncan, CG; Lopez, G; Lu, G; Ramkissoon, S; Losman, JA; Joensuu, P; Bergmann, U; Gross, S; Travins, J; Weiss, S; Looper, R; Ligon, KL; Verhaak, RGW; Yan, H; Kaelin, WG				Koivunen, Peppi; Lee, Sungwoo; Duncan, Christopher G.; Lopez, Giselle; Lu, Gang; Ramkissoon, Shakti; Losman, Julie A.; Joensuu, Paivi; Bergmann, Ulrich; Gross, Stefan; Travins, Jeremy; Weiss, Samuel; Looper, Ryan; Ligon, Keith L.; Verhaak, Roel G. W.; Yan, Hai; Kaelin, William G., Jr.			Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation	NATURE			English	Article							HYPOXIA-INDUCIBLE FACTOR; ONCOMETABOLITE 2-HYDROXYGLUTARATE; PROLYL 4-HYDROXYLASE; ACTIVE-SITE; MUTATIONS; TUMORS; IDH1; HYDROXYLASES; KNOCKOUTS; CELLS	The identification of succinate dehydrogenase (SDH), fumarate hydratase (FH) and isocitrate dehydrogenase (IDH) mutations in human cancers has rekindled the idea that altered cellular metabolism can transform cells. Inactivating SDH and FH mutations cause the accumulation of succinate and fumarate, respectively, which can inhibit 2-oxoglutarate (2-OG)-dependent enzymes, including the EGLN prolyl 4-hydroxylases that mark the hypoxia inducible factor (HIF) transcription factor for polyubiquitylation and proteasomal degradation(1). Inappropriate HIF activation is suspected of contributing to the pathogenesis of SDH-defective and FH-defective tumours but can suppress tumour growth in some other contexts. IDH1 and IDH2, which catalyse the interconversion of isocitrate and 2-OG, are frequently mutated in human brain tumours and leukaemias. The resulting mutants have the neomorphic ability to convert 2-OG to the (R)-enantiomer of 2-hydroxyglutarate ((R)-2HG)(2,3). Here we show that (R)-2HG, but not (S)-2HG, stimulates EGLN activity, leading to diminished HIF levels, which enhances the proliferation and soft agar growth of human astrocytes. These findings define an enantiomer-specific mechanism by which the (R)-2HG that accumulates in IDH mutant brain tumours promotes transformation and provide a justification for exploring EGLN inhibition as a potential treatment strategy.	[Lee, Sungwoo; Lu, Gang; Ramkissoon, Shakti; Losman, Julie A.; Ligon, Keith L.; Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lee, Sungwoo; Lu, Gang; Ramkissoon, Shakti; Losman, Julie A.; Ligon, Keith L.; Kaelin, William G., Jr.] Brigham & Womens Hosp, Boston, MA 02215 USA; [Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, Dept Med Biochem & Mol Biol, Bioctr Oulu, FIN-90014 Oulu, Finland; [Duncan, Christopher G.; Lopez, Giselle; Yan, Hai] Pediat Brain Tumor Fdn Inst, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC 27710 USA; [Duncan, Christopher G.; Lopez, Giselle; Yan, Hai] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Ramkissoon, Shakti; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ramkissoon, Shakti; Ligon, Keith L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Joensuu, Paivi] Univ Oulu, Dept Chem, FIN-90014 Oulu, Finland; [Bergmann, Ulrich] Univ Oulu, Dept Biochem, Mass Spectrometry Core Facil, Bioctr Oulu, FIN-90014 Oulu, Finland; [Gross, Stefan; Travins, Jeremy] Agios Pharmaceut, Cambridge, MA 02139 USA; [Weiss, Samuel] Univ Calgary, Fac Med, Dept Cell Biol, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Weiss, Samuel] Univ Calgary, Fac Med, Dept Anat, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Looper, Ryan] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Ligon, Keith L.] Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA; [Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of Oulu; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Agios Pharmaceuticals; University of Calgary; University of Calgary; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	william_kaelin@dfci.harvard.edu	Verhaak, Roel/ABE-7058-2020; Lopez, Giselle/M-2575-2019	Looper, Ryan/0000-0003-1626-1363; Duncan, Christopher/0000-0001-7205-2414; /0000-0001-5435-6668	National Institutes of Health; HHMI; Doris Duke Foundation; Academy of Finland [120156, 140765, 218129]; S. Juselius Foundation; NATIONAL CANCER INSTITUTE [R01CA140316, R01CA068490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Academy of Finland(Academy of Finland); S. Juselius Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. P. Hausinger and J. D. Rabinowitz for helpful suggestions and critical reading of the manuscript, C. Schofield and Y. Zhang for reagents, S. Chen and Y. Shi for JMJD2D assays, K. Koski for modelling and T. Aatsinki and E. Lehtimaki for technical assistance. W. G. K. is a Doris Duke Distinguished Clinical Scholar and a Howard Hughes Medical Institute (HHMI) Investigator. Supported by the National Institutes of Health (W. G. K.), HHMI (W. G. K.), Doris Duke Foundation (W. G. K.), Academy of Finland Grants 120156, 140765 and 218129 (P. K.) and S. Juselius Foundation (P.K.).	Acker T, 2005, CANCER CELL, V8, P131, DOI 10.1016/j.ccr.2005.07.003; Aghili M, 2009, J NEURO-ONCOL, V91, P233, DOI 10.1007/s11060-008-9706-2; Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; JUVA K, 1966, ANAL BIOCHEM, V15, P77, DOI 10.1016/0003-2697(66)90249-1; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Moroni I, 2004, NEUROLOGY, V62, P1882, DOI 10.1212/01.WNL.0000125335.21381.87; Nickols NG, 2007, ACS CHEM BIOL, V2, P561, DOI 10.1021/cb700110z; Ozisik PA, 2002, PEDIATR NEUROSURG, V37, P22, DOI 10.1159/000065097; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; PRITCHARD JB, 1995, J PHARMACOL EXP THER, V274, P1278; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Song LP, 2008, ONCOGENE, V27, P519, DOI 10.1038/sj.onc.1210670; Sonoda Y, 2001, CANCER RES, V61, P4956; Topaloglu O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni160; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang XV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017691; Williams SC, 2011, ACTA NEUROPATHOL, V121, P279, DOI 10.1007/s00401-010-0790-y; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	41	537	558	5	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2012	483	7390					485	U144		10.1038/nature10898	http://dx.doi.org/10.1038/nature10898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22343896	Green Accepted, Green Submitted			2022-12-01	WOS:000301771200047
J	Basler, M; Pilhofer, M; Henderson, GP; Jensen, GJ; Mekalanos, JJ				Basler, M.; Pilhofer, M.; Henderson, G. P.; Jensen, G. J.; Mekalanos, J. J.			Type VI secretion requires a dynamic contractile phage tail-like structure	NATURE			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; TARGET-CELLS; SYSTEM; TOMOGRAPHY; APPARATUS; ALIGNMENT; BACTERIA; ACTIN	Type VI secretion systems are bacterial virulence-associated nanomachines composed of proteins that are evolutionarily related to components of bacteriophage tails. Here we show that protein secretion by the type VI secretion system of Vibrio cholerae requires the action of a dynamic intracellular tubular structure that is structurally and functionally homologous to contractile phage tail sheath. Time-lapse fluorescence light microscopy reveals that sheaths of the type VI secretion system cycle between assembly, quick contraction, disassembly and re-assembly. Whole-cell electron cryotomography further shows that the sheaths appear as long tubular structures in either extended or contracted conformations that are connected to the inner membrane by a distinct basal structure. These data support a model in which the contraction of the type VI secretion system sheath provides the energy needed to translocate proteins out of effector cells and into adjacent target cells.	[Pilhofer, M.; Henderson, G. P.; Jensen, G. J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Basler, M.; Mekalanos, J. J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Pilhofer, M.; Jensen, G. J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Harvard University; Harvard Medical School; California Institute of Technology; Howard Hughes Medical Institute	Jensen, GJ (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	Jensen@caltech.edu; john_mekalanos@hms.harvard.edu	Basler, Marek/A-3559-2012	Basler, Marek/0000-0001-5414-2088	National Institute of Allergy and Infectious Diseases [AI-018045, AI-26289]; National Institute of General Medical Sciences [GM094800B]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI018045, R37AI018045, R01AI026289, R01AI018045] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. G. Bernhardt and N. T. Peters for assistance with fluorescence microscopy, discussions and for a gift of plasmids carrying sfGFP and mCherry2 genes. We thank the Nikon Imaging Center at Harvard Medical School for help with fluorescence microscopy, and Research Precision Instruments and Hamamatsu for lending an ORCA-Flash2.8 camera. We thank the Harvard Medical School Electron Microscopy Facility for help with and supervision of transmission electron microscopy. We thank M. K. Waldor for a V. cholerae 2740-80 strain and discussions. We thank D. Ewen Cameron for a knockout construct pWM91-flgG. We thank B. Wen and Z. Li for initial cryotomographic studies. This work was supported by National Institute of Allergy and Infectious Diseases grants AI-018045 and AI-26289 to J.J.M. and National Institute of General Medical Sciences grant GM094800B to G.J.J.	Amat F, 2008, J STRUCT BIOL, V161, P260, DOI 10.1016/j.jsb.2007.07.007; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2010, VIRULENCE, V1, P535, DOI 10.4161/viru.1.6.13732; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Bina JE, 2001, INFECT IMMUN, V69, P4681, DOI 10.1128/IAI.69.7.4681-4685.2001; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; GOLDBERG S, 1983, INFECT IMMUN, V42, P224, DOI 10.1128/IAI.42.1.224-230.1983; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Mastronarde DN, 2008, J MICROSC-OXFORD, V230, P212, DOI 10.1111/j.1365-2818.2008.01977.x; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pilhofer M, 2010, METHOD CELL BIOL, V96, P21, DOI 10.1016/S0091-679X(10)96002-0; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005	36	433	457	6	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2012	483	7388					182	U78		10.1038/nature10846	http://dx.doi.org/10.1038/nature10846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22367545	Green Accepted			2022-12-01	WOS:000301174900031
J	Baltussen, R; Smith, A				Baltussen, Rob; Smith, Andrew			Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study	BRITISH MEDICAL JOURNAL			English	Article							REFRACTIVE ERRORS; VISUAL IMPAIRMENT; SCHOOLCHILDREN; INTERVENTIONS; CHILDREN; HEALTH	Objective To determine the relative costs, effects, and cost effectiveness of selected interventions to control cataract, trachoma, refractive error, hearing loss, meningitis and chronic otitis media. Design Cost effectiveness analysis of or combined strategies for controlling vision and hearing loss by means of a lifetime population model. Setting Two World Health Organization sub-regions of the world where vision and hearing loss are major burdens: sub-Saharan Africa and South East Asia. Data sources Biological and behavioural parameters from clinical and observational studies and population based surveys. Intervention effects and resource inputs based on published reports, expert opinion, and the WHO-CHOICE database. Main outcome measures Cost per disability adjusted life year (DALY) averted, expressed in international dollars ($Int) for the year 2005. Results Treatment of chronic otitis media, extracapsular cataract surgery, trichiasis surgery, treatment for meningitis, and annual screening of schoolchildren for refractive error are among the most cost effective interventions to control hearing and vision impairment, with the cost per DALY averted <$Int285 in both regions. Screening of both schoolchildren (annually) and adults (every five years) for hearing loss costs around $Int1000 per DALY averted. These interventions can be considered highly cost effective. Mass treatment with azithromycin to control trachoma can be considered cost effective in the African but not the South East Asian sub-region. Conclusions Vision and hearing impairment control interventions are generally cost effective. To decide whether substantial investments in these interventions is warranted, this finding should be considered in relation to the economic attractiveness of other, existing or new, interventions in health.	[Baltussen, Rob] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Smith, Andrew] Univ London London Sch Hyg & Trop Med, Ctr Disabil & Dev, London WC1E 7HT, England	Radboud University Nijmegen; University of London; London School of Hygiene & Tropical Medicine	Baltussen, R (corresponding author), Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	R.Baltussen@elg.umcn.nl	Baltussen, R.M.P.M./L-4181-2015					Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; [Anonymous], 2011, INT DRUG PRICE INDIC; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Baltussen R, 2009, INT J AUDIOL, V48, P144, DOI 10.1080/14992020802538081; Baltussen RMRM, 2005, OPHTHAL EPIDEMIOL, V12, P91, DOI 10.1080/09286580590932761; Baltussen R, 2009, HEALTH POLICY, V89, P201, DOI 10.1016/j.healthpol.2008.06.003; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Congdon N, 2008, ARCH OPHTHALMOL-CHIC, V126, P1717, DOI 10.1001/archopht.126.12.1717; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; HOGEWEG M, 1992, ACTA OPHTHALMOL, V70, P407; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Hutubessy RCW, 2001, HEALTH ECON, V10, P473, DOI 10.1002/hec.614; Johns B, 2004, HEALTH ECON, V13, P1117, DOI 10.1002/hec.880; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Lauer Jeremy A, 2003, Cost Eff Resour Alloc, V1, P6, DOI 10.1186/1478-7547-1-6; Limburg H, 1999, ACTA OPHTHALMOL SCAN, V77, P310, DOI 10.1034/j.1600-0420.1999.770313.x; Limburg H, 1995, World Health Forum, V16, P173; Mackenzie I, 2009, ANN TROP MED PARASIT, V103, P565, DOI 10.1179/000349809X12459740922372; MATHERS C, 2002, GLOBAL BURDEN HEARIN; Mathers C., 2005, GLOBAL BURDEN ADULT; Murray CJ, 1996, GLOBAL BURDEN DIS, V1996, P201; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Smith A, 2006, INFECT HEARING IMPAI; Tan Torres T, 2003, WHO GUIDE COST EFFEC; Unicef, 2008, DAT SCH ENR; Vincent JE, 2010, OPTOMETRY VISION SCI, V87, P958, DOI 10.1097/OPX.0b013e3181fef3a9; Vision 2020, 2011, GLOB IN EL AV BLINDN; World Health Organisation World Wide Hearing, 2009, 7 WORKSH PROV HEAR A; World Health Organization, 2011, FACT SHEET MAGN CAUS; World Health Organization, 2011, FACT SHEET DEAFN HEA; World Health Organization, 2004, GLOB BURD DIS 2004 U	34	43	43	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2012	344								e615	10.1136/bmj.e615	http://dx.doi.org/10.1136/bmj.e615			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XQ	22389341	Green Accepted, Green Published, hybrid			2022-12-01	WOS:000301232600006
J	Wake, DB				Wake, David B.			Facing Extinction in Real Time	SCIENCE			English	Editorial Material							BATRACHOCHYTRIUM-DENDROBATIDIS; FUNGAL PATHOGEN; POPULATIONS; AMPHIBIANS; DECLINES; CHYTRIDIOMYCOSIS; DIVERSITY; DYNAMICS; AMERICA; CLIMATE		Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Wake, DB (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	wakelab@berkeley.edu	Wake, David/AAA-6766-2021	Wake, David/0000-0003-4835-2497				Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Early R, 2011, ECOL LETT, V14, P1125, DOI 10.1111/j.1461-0248.2011.01681.x; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Martinez-Solano I, 2007, MOL ECOL, V16, P4335, DOI 10.1111/j.1365-294X.2007.03527.x; Rovito SM, 2009, P NATL ACAD SCI USA, V106, P3231, DOI 10.1073/pnas.0813051106; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	16	62	65	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1052	1053		10.1126/science.1218364	http://dx.doi.org/10.1126/science.1218364			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383836				2022-12-01	WOS:000300931100031
J	Lee, JH; Silhavy, JL; Lee, JE; Al-Gazali, L; Thomas, S; Davis, EE; Bielas, SL; Hill, KJ; Iannicelli, M; Brancati, F; Gabriel, SB; Russ, C; Logan, CV; Sharif, SM; Bennett, CP; Abe, M; Hildebrandt, F; Diplas, BH; Attie-Bitach, T; Katsanis, N; Rajab, A; Koul, R; Sztriha, L; Waters, ER; Ferro-Novick, S; Woods, CG; Johnson, CA; Valente, EM; Zaki, MS; Gleeson, JG				Lee, Jeong Ho; Silhavy, Jennifer L.; Lee, Ji Eun; Al-Gazali, Lihadh; Thomas, Sophie; Davis, Erica E.; Bielas, Stephanie L.; Hill, Kiley J.; Iannicelli, Miriam; Brancati, Francesco; Gabriel, Stacey B.; Russ, Carsten; Logan, Clare V.; Sharif, Saghira Malik; Bennett, Christopher P.; Abe, Masumi; Hildebrandt, Friedhelm; Diplas, Bill H.; Attie-Bitach, Tania; Katsanis, Nicholas; Rajab, Anna; Koul, Roshan; Sztriha, Laszlo; Waters, Elizabeth R.; Ferro-Novick, Susan; Woods, C. Geoffrey; Johnson, Colin A.; Valente, Enza Maria; Zaki, Maha S.; Gleeson, Joseph G.			Evolutionarily Assembled cis-Regulatory Module at a Human Ciliopathy Locus	SCIENCE			English	Article							GENE; MUTATIONS; JOUBERT; TRANSPORT; MEMBRANE; DISEASE; CILIUM; CELLS; HEAD	Neighboring genes are often coordinately expressed within cis-regulatory modules, but evidence that nonparalogous genes share functions in mammals is lacking. Here, we report that mutation of either TMEM138 or TMEM216 causes a phenotypically indistinguishable human ciliopathy, Joubert syndrome. Despite a lack of sequence homology, the genes are aligned in a head-to-tail configuration and joined by chromosomal rearrangement at the amphibian-to-reptile evolutionary transition. Expression of the two genes is mediated by a conserved regulatory element in the noncoding intergenic region. Coordinated expression is important for their interdependent cellular role in vesicular transport to primary cilia. Hence, during vertebrate evolution of genes involved in ciliogenesis, nonparalogous genes were arranged to a functional gene cluster with shared regulatory elements.	[Lee, Jeong Ho; Silhavy, Jennifer L.; Lee, Ji Eun; Bielas, Stephanie L.; Hill, Kiley J.; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Neurogenet Lab, San Diego, CA 92103 USA; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; [Thomas, Sophie; Attie-Bitach, Tania] Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, INSERM,U781, Paris, France; [Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC USA; [Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol & Pediat, Durham, NC USA; [Iannicelli, Miriam; Brancati, Francesco; Valente, Enza Maria] Ist Ricovero & Cura Carattere Sci Casa Sollievo S, Mendel Lab, San Giovanni Rotondo, Italy; [Gabriel, Stacey B.; Russ, Carsten] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Abe, Masumi] Natl Inst Radiol Sci, Transcriptome Res Ctr, Chiba 260, Japan; [Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, HHMI, Ann Arbor, MI 48109 USA; [Diplas, Bill H.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Rajab, Anna] Minist Hlth, Directorate Gen Hlth Affairs, Genet Unit, Muscat, Oman; [Koul, Roshan] Sultan Qaboos Univ Hosp, Coll Med & Hlth Sci, Dept Child Hlth Neurol, Muscat, Oman; [Sztriha, Laszlo] Univ Szeged, Dept Pediat, Div B, Szeged, Hungary; [Waters, Elizabeth R.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Ferro-Novick, Susan] Univ Calif San Diego, HHMI, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Woods, C. Geoffrey] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Zaki, Maha S.] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Giza, Egypt	Howard Hughes Medical Institute; University of California System; University of California San Diego; United Arab Emirates University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Duke University; Duke University; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes for Quantum Science & Technology; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Johns Hopkins University; Sultan Qaboos University; Szeged University; California State University System; San Diego State University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Saint James's University Hospital; University of Leeds; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Neurogenet Lab, San Diego, CA 92103 USA.	jogleeson@ucsd.edu	THOMAS, Sophie/F-4492-2017; Katsanis, Nicholas/E-1837-2012; Zaki, Maha S/B-9361-2013; Lee, Jeong Ho/G-7361-2012; thomas, sophie/GVS-1279-2022; ATTIE-BITACH, Tania/K-1453-2017; Brancati, Francesco/AAC-3778-2022; Valente, Enza Maria/G-2942-2017	THOMAS, Sophie/0000-0002-8569-3277; ATTIE-BITACH, Tania/0000-0002-1155-3626; Brancati, Francesco/0000-0003-3624-2354; Valente, Enza Maria/0000-0002-0600-6820; Abe, Masumi/0000-0003-1550-2006; Johnson, Colin/0000-0002-2979-8234; Logan, Clare/0000-0003-4323-1602; Diplas, Bill/0000-0001-9248-7351; Davis, Erica/0000-0002-2412-8397; Bielas, Stephanie/0000-0003-0567-5632; Zaki, Maha/0000-0001-7840-0002; Katsanis, Nicholas/0000-0002-2480-0171	Broad Sequencing Plaform; UCSD Neuroscience Core [P30NS047101]; American Philosophical Society; Italian Ministry of Health [RC2010]; Telethon Foundation Italy [GGP08145]; Pierfranco and Luisa Mariani Foundation; l'Agence National pour la Recherche [ANR-2010-BLAN-1122 01-Foetocilpath]; American Heart Association [09POST2250641]; Newlife Foundation for Disabled Children; Medical Research Council [G0700073]; Sir Jules Thorn Charitable Trust [09/JTA]; European Community [241955]; SYSCILIA; NIH [NS052455, NS04843, DK068306, DK090917, U54 HG003067, EY021872, HD042601, DK075972, DK072301]; Simons Foundation Autism Research Initiative; HHMI; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021872] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301, R01DK068306, R01DK075972, RC4DK090917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS048453, R01NS052455] Funding Source: NIH RePORTER; MRC [G0700073] Funding Source: UKRI	Broad Sequencing Plaform; UCSD Neuroscience Core; American Philosophical Society; Italian Ministry of Health(Ministry of Health, Italy); Telethon Foundation Italy(Fondazione Telethon); Pierfranco and Luisa Mariani Foundation; l'Agence National pour la Recherche(French National Research Agency (ANR)); American Heart Association(American Heart Association); Newlife Foundation for Disabled Children; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sir Jules Thorn Charitable Trust; European Community(European Commission); SYSCILIA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; HHMI(Howard Hughes Medical Institute); The Sir Jules Thorn Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients and families for invaluable contributions; the Broad Sequencing Plaform, the UCSD Neuroscience Core (grant P30NS047101), and T. Meerloo at the UCSD ImmunoEM Core; M. G. Rosenfeld, B. Ren, P. Novick, K. Frazer, and S. Rifkin for discussion; and C. Janke (Centre de Recherche de Biochimie Macromoleculaire, Montpellier, France, GT335 antibody), T. Caspary (Emory Arl13b antibody), P. Aza-Blanc (Sanford-Burnham Institute, siRNAs), and D. Traver (UCSD) for ZF4 cells. This work was supported by the Daland Fellowship from the American Philosophical Society (J.H.L.), the Italian Ministry of Health (RC2010, Ricerca Finalizzata 2006), Telethon Foundation Italy (GGP08145, E.M.V.), the Pierfranco and Luisa Mariani Foundation (E.M.V.), l'Agence National pour la Recherche (grant ANR-2010-BLAN-1122 01-Foetocilpath, T.A.-B.), the American Heart Association (grant 09POST2250641, J.E.L.), Newlife Foundation for Disabled Children, the Medical Research Council (grant G0700073), the Sir Jules Thorn Charitable Trust (09/JTA, C.A.J.), European Community's Seventh Framework Programme FP7/2009 (241955), SYSCILIA (E.E.D., N.K., C.A.J.), Distinguished George W. Brumley Professorship (N.K.), the NIH (grants NS052455 and NS04843, J.G.G.; DK068306 and DK090917, F.H.; U54 HG003067, E.S. Lander; EY021872, E.E.D.; HD042601, DK075972, DK072301, N.K.), Simons Foundation Autism Research Initiative (J.G.G.), and HHMI (F.H., S.F.-N., J.G.G.).	Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Doherty D, 2009, SEMIN PEDIATR NEUROL, V16, P143, DOI 10.1016/j.spen.2009.06.002; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Jeziorska DM, 2009, SEMIN CELL DEV BIOL, V20, P856, DOI 10.1016/j.semcdb.2009.07.007; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kleymenova E, 2001, MOL CELL, V7, P823, DOI 10.1016/S1097-2765(01)00226-X; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; PAPERMASTER DS, 1985, INVEST OPHTH VIS SCI, V26, P1386; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Ruiz-Perez VL, 2003, AM J HUM GENET, V72, P728, DOI 10.1086/368063; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594	19	60	64	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					966	969		10.1126/science.1213506	http://dx.doi.org/10.1126/science.1213506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22282472	Green Accepted			2022-12-01	WOS:000300931800046
J	Murchison, EP; Schulz-Trieglaff, OB; Ning, ZM; Alexandrov, LB; Bauer, MJ; Fu, BY; Hims, M; Ding, ZH; Ivakhno, S; Stewart, C; Ng, BL; Wong, WD; Aken, B; White, S; Alsop, A; Becq, J; Bignell, GR; Cheetham, RK; Cheng, W; Connor, TR; Cox, AJ; Feng, ZP; Gu, Y; Grocock, RJ; Harris, SR; Khrebtukova, I; Kingsbury, Z; Kowarsky, M; Kreiss, A; Luo, SJ; Marshall, J; McBride, DJ; Murray, L; Pearse, AM; Raine, K; Rasolonjatovo, I; Shaw, R; Tedder, P; Tregidgo, C; Vilella, AJ; Wedge, DC; Woods, GM; Gormley, N; Humphray, S; Schroth, G; Smith, G; Hall, K; Searle, SMJ; Carter, NP; Papenfuss, AT; Futreal, PA; Campbell, PJ; Yang, FT; Bentley, DR; Evers, DJ; Stratton, MR				Murchison, Elizabeth P.; Schulz-Trieglaff, Ole B.; Ning, Zemin; Alexandrov, Ludmil B.; Bauer, Markus J.; Fu, Beiyuan; Hims, Matthew; Ding, Zhihao; Ivakhno, Sergii; Stewart, Caitlin; Ng, Bee Ling; Wong, Wendy; Aken, Bronwen; White, Simon; Alsop, Amber; Becq, Jennifer; Bignell, Graham R.; Cheetham, R. Keira; Cheng, William; Connor, Thomas R.; Cox, Anthony J.; Feng, Zhi-Ping; Gu, Yong; Grocock, Russell J.; Harris, Simon R.; Khrebtukova, Irina; Kingsbury, Zoya; Kowarsky, Mark; Kreiss, Alexandre; Luo, Shujun; Marshall, John; McBride, David J.; Murray, Lisa; Pearse, Anne-Maree; Raine, Keiran; Rasolonjatovo, Isabelle; Shaw, Richard; Tedder, Philip; Tregidgo, Carolyn; Vilella, Albert J.; Wedge, David C.; Woods, Gregory M.; Gormley, Niall; Humphray, Sean; Schroth, Gary; Smith, Geoffrey; Hall, Kevin; Searle, Stephen M. J.; Carter, Nigel P.; Papenfuss, Anthony T.; Futreal, P. Andrew; Campbell, Peter J.; Yang, Fengtang; Bentley, David R.; Evers, Dirk J.; Stratton, Michael R.			Genome Sequencing and Analysis of the Tasmanian Devil and Its Transmissible Cancer	CELL			English	Article							FACIAL-TUMOR DISEASE; EVOLUTION; DIVERSITY; PATTERNS; ORIGINS; DFTD	The Tasmanian devil (Sarcophilus harrisii), the largest marsupial carnivore, is endangered due to a transmissible facial cancer spread by direct transfer of living cancer cells through biting. Here we describe the sequencing, assembly, and annotation of the Tasmanian devil genome and whole-genome sequences for two geographically distant subclones of the cancer. Genomic analysis suggests that the cancer first arose from a female Tasmanian devil and that the clone has subsequently genetically diverged during its spread across Tasmania. The devil cancer genome contains more than 17,000 somatic base substitution mutations and bears the imprint of a distinct mutational process. Genotyping of somatic mutations in 104 geographically and temporally distributed Tasmanian devil tumors reveals the pattern of evolution and spread of this parasitic clonal lineage, with evidence of a selective sweep in one geographical area and persistence of parallel lineages in other populations.	[Murchison, Elizabeth P.; Ning, Zemin; Alexandrov, Ludmil B.; Fu, Beiyuan; Ding, Zhihao; Stewart, Caitlin; Ng, Bee Ling; Aken, Bronwen; White, Simon; Bignell, Graham R.; Cheng, William; Connor, Thomas R.; Gu, Yong; Harris, Simon R.; Marshall, John; McBride, David J.; Raine, Keiran; Wedge, David C.; Searle, Stephen M. J.; Carter, Nigel P.; Futreal, P. Andrew; Campbell, Peter J.; Yang, Fengtang; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Schulz-Trieglaff, Ole B.; Bauer, Markus J.; Hims, Matthew; Ivakhno, Sergii; Wong, Wendy; Becq, Jennifer; Cheetham, R. Keira; Cox, Anthony J.; Grocock, Russell J.; Kingsbury, Zoya; Murray, Lisa; Rasolonjatovo, Isabelle; Shaw, Richard; Tedder, Philip; Tregidgo, Carolyn; Gormley, Niall; Humphray, Sean; Smith, Geoffrey; Hall, Kevin; Bentley, David R.; Evers, Dirk J.] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Alsop, Amber] Australian Natl Univ, Res Sch Biol Sci, Comparat Genom Grp, Canberra, ACT 2601, Australia; [Feng, Zhi-Ping; Kowarsky, Mark; Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Feng, Zhi-Ping] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Khrebtukova, Irina; Luo, Shujun; Schroth, Gary] Illumina Hayward, Hayward, CA 94545 USA; [Kreiss, Alexandre; Woods, Gregory M.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7001, Australia; [Pearse, Anne-Maree] Dept Primary Ind Parks Water & Environm, Hlth Anim Lab, Kings Meadows, Tas 7249, Australia; [Vilella, Albert J.] European Bioinformat Inst, Hinxton CB10 1SA, England; [Papenfuss, Anthony T.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3010, Australia	Wellcome Trust Sanger Institute; Illumina; Australian National University; Walter & Eliza Hall Institute; University of Melbourne; Illumina; University of Tasmania; European Molecular Biology Laboratory (EMBL); University of Melbourne	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	elizabeth.murchison@sanger.ac.uk; mrs@sanger.ac.uk	Yang, Fan/GYU-4249-2022; Feng, Zhi-Ping/L-2083-2016; Alexandrov, Ludmil/B-6582-2014; Papenfuss, Anthony T/C-6297-2008; Harris, Simon R/K-1318-2013; Alexandrov, Ludmil/AAS-1454-2021; Connor, Thomas/ABD-6533-2021; Stewart, Caitlin Marie/AAA-9515-2022; Wedge, David/AAC-4977-2021; Connor, Thomas/ABE-5989-2020; Woods, Greg/J-7533-2014; Ning, Zemin/D-2411-2013	Alexandrov, Ludmil/0000-0003-3596-4515; Papenfuss, Anthony T/0000-0002-1102-8506; Harris, Simon R/0000-0003-1512-6194; Alexandrov, Ludmil/0000-0003-3596-4515; Stewart, Caitlin Marie/0000-0002-5070-4810; Connor, Thomas/0000-0003-2394-6504; Woods, Greg/0000-0001-8421-7917; Vilella, Albert/0000-0002-2005-2516; Ding, Zhihao/0000-0003-0961-2284; Cox, Anthony/0000-0002-6534-749X; Shaw, Richard/0000-0001-8145-1601; Ning, Zemin/0000-0003-4359-776X; Murchison, Elizabeth Proby/0000-0001-7462-8907; Aken, Bronwen/0000-0002-3032-4095; Kowarsky, Mark/0000-0001-5180-5683; Raine, Keiran/0000-0002-5634-1539; Wedge, David/0000-0002-7572-3196; White, Simon/0000-0001-6375-2363; Yang, Fengtang/0000-0002-3573-2354	NHMRC; King's College, Cambridge; Wellcome Trust [077012/Z/05/Z]; Dr Eric Guiler Tasmanian Devil Research Grant; L'Oreal UNESCO, UK and Ireland	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); King's College, Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission); Dr Eric Guiler Tasmanian Devil Research Grant; L'Oreal UNESCO, UK and Ireland(L'Oreal Group)	We are grateful to Sarah Peck, Colette Harmsen, Rodrigo Hamede, Kate Swift, Bobby Hua, Robyn Taylor, Stephen Pyecroft, and the Save the Tasmanian Devil Program for assistance with sample collection. We thank Erin Pleasance, Thierry Voet, Chris Greenman, David Obendorf, Janine Deakin, Stephen Rice, Sue Bumpstead, and Emma Werner for assistance and discussions. Thanks to Hannah Bender for permission to use DFTD image, to Willem Rens and Malcolm Ferguson-Smith (University of Cambridge) for providing the Tasmanian devil and opossum fibroblast cell lines, and to Matthew Breen (North Carolina State University) for providing images of opossum metaphases. E.P.M. was supported by an NHMRC Overseas Biomedical Fellowship, an EMBO Fellowship, and a Research Fellowship from King's College, Cambridge. This work was supported in part by a Wellcome Trust grant (077012/Z/05/Z), a Dr Eric Guiler Tasmanian Devil Research Grant, and a L'Oreal UNESCO For Women in Science Fellowship, UK and Ireland (E.P.M.). All authors at Illumina (see the affiliations) are employees of Illumina Inc., a public company that develops and markets systems for genetic analysis. All authors at Illumina receive stocks as part of their compensation.	Arnett HA, 2009, CYTOKINE, V46, P370, DOI 10.1016/j.cyto.2009.03.009; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Eldridge M.D.B., 2006, ATLAS MAMMALIAN CHRO, P30; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gandhi Manish J., 2007, Cell and Tissue Banking, V8, P267, DOI 10.1007/s10561-007-9036-1; Gartner HV, 1996, NEW ENGL J MED, V335, P1494, DOI 10.1056/NEJM199611143352004; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hamede RK, 2008, AUSTRAL ECOL, V33, P614, DOI 10.1111/j.1442-9993.2007.01827.x; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; Kreiss A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022402; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Lachish S, 2011, CONSERV GENET RESOUR, V3, P279, DOI 10.1007/s12686-010-9341-z; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loh R, 2006, VET PATHOL, V43, P896, DOI 10.1354/vp.43-6-896; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; MARTIN PG, 1967, CHROMOSOMA, V20, P290, DOI 10.1007/BF00326187; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Miller W., 2011, P NATL ACAD SCI US; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Murchison E P, 2008, Oncogene, V27 Suppl 2, pS19, DOI 10.1038/onc.2009.350; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Owen D, 2005, TASMANIAN DEVIL UNIQ; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Potter SC, 2004, GENOME RES, V14, P934, DOI 10.1101/gr.1859804; Rebbeck CA, 2011, SCIENCE, V331, P303, DOI 10.1126/science.1197696; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; SOUTHAM CM, 1957, SCIENCE, V125, P158, DOI 10.1126/science.125.3239.158; Stammers M, 2000, IMMUNOGENETICS, V51, P373, DOI 10.1007/s002510050633; Thomas R, 2009, CHROMOSOME RES, V17, P927, DOI 10.1007/s10577-009-9080-8; Tolar J, 2003, J PEDIAT HEMATOL ONC, V25, P430, DOI 10.1097/00043426-200306000-00002; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005	40	229	233	2	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					780	791		10.1016/j.cell.2011.11.065	http://dx.doi.org/10.1016/j.cell.2011.11.065			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341448	hybrid, Green Published, Green Submitted			2022-12-01	WOS:000300622400018
J	Price, DC; Chan, CX; Yoon, HS; Yang, EC; Qiu, H; Weber, APM; Schwacke, R; Gross, J; Blouin, NA; Lane, C; Reyes-Prieto, A; Durnford, DG; Neilson, JAD; Lang, BF; Burger, G; Steiner, JM; Loffelhardt, W; Meuser, JE; Posewitz, MC; Ball, S; Arias, MC; Henrissat, B; Coutinho, PM; Rensing, SA; Symeonidi, A; Doddapaneni, H; Green, BR; Rajah, VD; Boore, J; Bhattacharya, D				Price, Dana C.; Chan, Cheong Xin; Yoon, Hwan Su; Yang, Eun Chan; Qiu, Huan; Weber, Andreas P. M.; Schwacke, Rainer; Gross, Jeferson; Blouin, Nicolas A.; Lane, Chris; Reyes-Prieto, Adrian; Durnford, Dion G.; Neilson, Jonathan A. D.; Lang, B. Franz; Burger, Gertraud; Steiner, Juergen M.; Loeffelhardt, Wolfgang; Meuser, Jonathan E.; Posewitz, Matthew C.; Ball, Steven; Arias, Maria Cecilia; Henrissat, Bernard; Coutinho, Pedro M.; Rensing, Stefan A.; Symeonidi, Aikaterini; Doddapaneni, Harshavardhan; Green, Beverley R.; Rajah, Veeran D.; Boore, Jeffrey; Bhattacharya, Debashish			Cyanophora paradoxa Genome Elucidates Origin of Photosynthesis in Algae and Plants	SCIENCE			English	Article							PLASTID ENDOSYMBIOSIS; PROTEIN TRANSLOCATION; ANCIENT ORIGIN; COMMON ORIGIN; GREEN PLANTS; EVOLUTION; CYANELLES; NUCLEUS; SINGLE; ESTABLISHMENT	The primary endosymbiotic origin of the plastid in eukaryotes more than 1 billion years ago led to the evolution of algae and plants. We analyzed draft genome and transcriptome data from the basally diverging alga Cyanophora paradoxa and provide evidence for a single origin of the primary plastid in the eukaryote supergroup Plantae. C. paradoxa retains ancestral features of starch biosynthesis, fermentation, and plastid protein translocation common to plants and algae but lacks typical eukaryotic light-harvesting complex proteins. Traces of an ancient link to parasites such as Chlamydiae were found in the genomes of C. paradoxa and other Plantae. Apparently, Chlamydia-like bacteria donated genes that allow export of photosynthate from the plastid and its polymerization into storage polysaccharide in the cytosol.	[Price, Dana C.; Chan, Cheong Xin; Gross, Jeferson; Rajah, Veeran D.; Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Price, Dana C.; Chan, Cheong Xin; Gross, Jeferson; Rajah, Veeran D.; Bhattacharya, Debashish] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Yoon, Hwan Su; Yang, Eun Chan; Qiu, Huan] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA; [Yoon, Hwan Su] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Weber, Andreas P. M.] Univ Dusseldorf, Inst Plant Biochem, D-40225 Dusseldorf, Germany; [Schwacke, Rainer] Univ Cologne, Inst Bot, Bioctr Cologne, D-50674 Cologne, Germany; [Blouin, Nicolas A.; Lane, Chris] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Reyes-Prieto, Adrian] Univ New Brunswick, Canadian Inst Adv Res, Dept Biol, Fredericton, NB E3B 5A3, Canada; [Lang, B. Franz; Burger, Gertraud] Univ Montreal, Dept Biochim, Ctr Robert Cedergren, Montreal, PQ H3C 3J7, Canada; [Steiner, Juergen M.] Univ Halle Wittenberg, Dept Biol Plant Physiol, D-4010 Halle, Germany; [Loeffelhardt, Wolfgang] Univ Vienna, Dept Biochem & Cell Biol, Max F Perutz Labs, Vienna, Austria; [Meuser, Jonathan E.] Colorado Sch Mines, Dept Civil & Environm Engn, Golden, CO 80401 USA; [Posewitz, Matthew C.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Ball, Steven; Arias, Maria Cecilia] Univ Sci & Technol Lille, CNRS USTL, UMR 8576, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 1, F-13288 Marseille, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 2, F-13288 Marseille, France; [Rensing, Stefan A.; Symeonidi, Aikaterini] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Rensing, Stefan A.; Symeonidi, Aikaterini] Univ Freiburg, FRISYS Freiburg Initiat Syst Biol, D-79106 Freiburg, Germany; [Rensing, Stefan A.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Doddapaneni, Harshavardhan] Univ Iowa, Dept Biol, Roy J Carver Ctr Genom, Iowa City, IA 52242 USA; [Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Boore, Jeffrey] Genome Project Solut, Hercules, CA 94547 USA; [Boore, Jeffrey] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Bigelow Laboratory for Ocean Sciences; Sungkyunkwan University (SKKU); Heinrich Heine University Dusseldorf; University of Cologne; University of Rhode Island; Canadian Institute for Advanced Research (CIFAR); University of New Brunswick; Universite de Montreal; Martin Luther University Halle Wittenberg; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Colorado School of Mines; Colorado School of Mines; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Freiburg; University of Freiburg; University of Freiburg; University of Iowa; University of British Columbia; University of California System; University of California Berkeley	Bhattacharya, D (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.	bhattacharya@aesop.rutgers.edu	Weber, Andreas PM/A-6250-2011; Qiu, Huan/C-2671-2016; Henrissat, Bernard/J-2475-2012; Arias, Maria Cecilia/H-4886-2012; Chan, Cheong Xin/A-7005-2008; Yoon, Hwan Su/A-2974-2013; Weber, Andreas Paul Michael/O-3043-2019; Green, Beverley R./AAJ-5199-2021	Weber, Andreas PM/0000-0003-0970-4672; Henrissat, Bernard/0000-0002-3434-8588; Chan, Cheong Xin/0000-0002-3729-8176; Weber, Andreas Paul Michael/0000-0003-0970-4672; Green, Beverley R./0000-0002-4021-9387; Steiner, Jurgen/0000-0002-6572-7468; doddapaneni, harshavardhan/0000-0002-2433-633X; Yoon, Hwan Su/0000-0001-9507-0105; Yang, Eun Chan/0000-0001-8211-8130; Ball, Steven/0000-0003-1629-1650	National Science Foundation [MGSP 0625440, MCB 0946528, EF 0827023, DEB 0936884]; BioGreen 21 Rural Development Administration of South Korea [PJ008177]; Air Force Office of Scientific Research [FA9550-11-1-0211]; Deutsche Forschungsgemeinschaft CRC TR1; Austrian Science Foundation [P19683]; Canadian Institute for Health Research [MSP-14226]; German Federal Ministry of Education and Research; Natural Sciences and Engineering Research Council of Canada (NSERC); Office of Integrative Activities [1004057] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); BioGreen 21 Rural Development Administration of South Korea(Rural Development Administration (RDA), Republic of Korea); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Deutsche Forschungsgemeinschaft CRC TR1; Austrian Science Foundation(Austrian Science Fund (FWF)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was made possible by grants from the National Science Foundation (MGSP 0625440 and MCB 0946528) awarded to D. B. and J.B. Partial support came from NSF grants EF 0827023 and DEB 0936884 awarded to D. B. and H.S.Y. and by BioGreen 21 (PJ008177) Rural Development Administration of South Korea awarded to H.S.Y. Air Force Office of Scientific Research grant FA9550-11-1-0211 supported work by J.E.M. and M. C. P. A. P. M. W. appreciates support from Deutsche Forschungsgemeinschaft CRC TR1. W. L. acknowledges support from the Austrian Science Foundation (P19683). G. B. acknowledges funding from Canadian Institute for Health Research operating grant MSP-14226. S. R. and A. S. acknowledge funding from the German Federal Ministry of Education and Research. G. B. acknowledges the Natural Sciences and Engineering Research Council of Canada (NSERC) for general laboratory funding. We are grateful to B. Andersen and the staff at the Provasoli-Guillard National Center for Culture of Marine Phytoplankton (CCMP) for preparing the axenic culture of C. paradoxa. We thank I. Plante and L. Forget for technical assistance in mtDNA cloning and sequencing and N. Beck for development of the MFannot computer program. The sequence data used to assemble the draft C. paradoxa genome and the Illumina mRNA-seq reads from this alga are archived at the NCBI Sequence Read Archive (SRA) under accession number SRP00920. The assembled genome and cDNA contigs, gene models, gene annotations, supporting material that is not in the SOM, and the phylogenomic results are available at (22). The complete C. paradoxa and G. nostochinearum mitochondrial genomes are available at NCBI under accession numbers HQ849544 and NC_015117, respectively. The partial mitochondrial genome data from G. nostochinearum are available at the genome Web site as part of the aligned protein data set used to infer the plastid multigene tree. We are grateful for the helpful comments of two anonymous reviewers of this manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CAVALIERSMITH T, 1981, BIOSYSTEMS, V14, P461, DOI 10.1016/0303-2647(81)90050-2; Chan CX, 2011, CURR BIOL, V21, P328, DOI 10.1016/j.cub.2011.01.037; Colleoni C, 2010, MOL BIOL EVOL, V27, P2691, DOI 10.1093/molbev/msq158; Deschamps P, 2008, GENETICS, V178, P2373, DOI 10.1534/genetics.108.087205; Gross J, 2009, TRENDS PLANT SCI, V14, P13, DOI 10.1016/j.tplants.2008.10.003; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; Huang JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r99; Loffelhardt W., 1997, PLANT SYST EVOL S, V11, P149; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; McFadden GI, 2004, CURR BIOL, V14, pR514, DOI 10.1016/j.cub.2004.06.041; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meuser JE, 2009, J BIOTECHNOL, V142, P21, DOI 10.1016/j.jbiotec.2009.01.015; Moustafa A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002205; Moustafa A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-6; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Pfanzagl B, 1996, J BACTERIOL, V178, P332, DOI 10.1128/jb.178.2.332-339.1996; Plancke C, 2008, EUKARYOT CELL, V7, P247, DOI 10.1128/EC.00373-07; Posewitz M.C., 2009, CHLAMYDOMONAS SOURCE, P217; Reumann S, 2005, MOL MEMBR BIOL, V22, P73, DOI 10.1080/09687860500041916; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Reyes-Prieto A, 2010, MOL BIOL EVOL, V27, P1530, DOI 10.1093/molbev/msq032; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Sato Naoki, 2005, Genome Inform, V16, P56; Steiner JM, 2005, MOL MEMBR BIOL, V22, P123, DOI 10.1080/09687860500041411; Stiller JW, 2007, TRENDS PLANT SCI, V12, P391, DOI 10.1016/j.tplants.2007.08.002; Weber APM, 2006, EUKARYOT CELL, V5, P609, DOI 10.1128/EC.5.3.609-612.2006; WOLFE GR, 1994, NATURE, V367, P566, DOI 10.1038/367566a0; Wunder T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-236; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899; Yusa F, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-304	37	259	270	3	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					843	847		10.1126/science.1213561	http://dx.doi.org/10.1126/science.1213561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344442				2022-12-01	WOS:000300356400041
J	Singh, A; Sweeney, MF; Yu, M; Burger, A; Greninger, P; Benes, C; Haber, DA; Settleman, J				Singh, Anurag; Sweeney, Michael F.; Yu, Min; Burger, Alexa; Greninger, Patricia; Benes, Cyril; Haber, Daniel A.; Settleman, Jeff			TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers	CELL			English	Article							ONCOGENIC KRAS; BETA-CATENIN; RAS; PROTEIN; EXPRESSION; PROGRESSION; PATHWAYS; REVEALS; KINASE; GENES	Colon cancers frequently harbor KRAS mutations, yet only a subset of KRAS mutant colon cancer cell lines are dependent upon KRAS signaling for survival. In a screen for kinases that promote survival of KRAS-dependent colon cancer cells, we found that the TAK1 kinase (MAP3K7) is required for tumor cell viability. The induction of apoptosis by RNAi-mediated depletion or pharmacologic inhibition of TAK1 is linked to its suppression of hyperactivated Wnt signaling, evident in both endogenous and genetically reconstituted cells. In APC mutant/KRAS-dependent cells, KRAS stimulates BMP-7 secretion and BMP signaling, leading to TAK1 activation and enhancement of Wnt-dependent transcription. An in vitro-derived "TAK1 dependency signature'' is enriched in primary human colon cancers with mutations in both APC and KRAS, suggesting potential clinical utility in stratifying patient populations. Together, these findings identify TAK1 inhibition as a potential therapeutic strategy for a treatment-refractory subset of colon cancers exhibiting aberrant KRAS and Wnt pathway activation.	[Singh, Anurag; Sweeney, Michael F.; Yu, Min; Burger, Alexa; Greninger, Patricia; Benes, Cyril; Haber, Daniel A.; Settleman, Jeff] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Singh, Anurag; Sweeney, Michael F.; Yu, Min; Burger, Alexa; Greninger, Patricia; Benes, Cyril; Haber, Daniel A.; Settleman, Jeff] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu; settleman.jeffrey@gene.com	Singh, Anurag/C-7347-2014	Singh, Anurag/0000-0003-4705-8683; Yu, Min/0000-0002-3969-8720	NIH [K99 CA149169, R01 CA109447, R01 CA129933]; Lustgarten Foundation; NATIONAL CANCER INSTITUTE [K99CA149169, R01CA129933, R00CA149169, R01CA109447] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lustgarten Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH K99 CA149169 to A.S. as well as NIH R01 CA109447 and a Lustgarten Foundation grant to J.S. and NIH R01 CA129933 to D.A.H. We are grateful to Randall Peterson, David Ting, and Andre Bernards for critical evaluation and comments on the manuscript. We thank Laura Libby and Brian Brannigan for technical assistance with mouse xenograft experiments and KRAS/BRAF sequencing analyses, respectively. We thank Vijay Yajnik for providing TOP-FLASH reporter plasmids. Finally, we also thank Kevin Haigis, Moon Yee Hang, Miguel Rivera, Jianmin Zhang, Mingzhu Liu, and Matt Zubrowski for intellectual and technical advice.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gasch AP, 2002, GENOME BIOL, V3; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Lin ZH, 2008, J BIOL CHEM, V283, P33053, DOI 10.1074/jbc.M804039200; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Melisi D, 2011, JNCI-J NATL CANCER I, V103, P1190, DOI 10.1093/jnci/djr243; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nakamura K, 2005, GENE DEV, V19, P1749, DOI 10.1101/gad.1323705; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Rawlins P, 1999, INT J IMMUNOPHARMACO, V21, P799, DOI 10.1016/S0192-0561(99)00047-8; Reid JF, 2009, GENE CHROMOSOME CANC, V48, P953, DOI 10.1002/gcc.20697; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Starczynowski DT, 2011, J CLIN INVEST, V121, P4095, DOI 10.1172/JCI58818; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	36	199	211	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					639	650		10.1016/j.cell.2011.12.033	http://dx.doi.org/10.1016/j.cell.2011.12.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341439	Green Accepted, Bronze			2022-12-01	WOS:000300622400007
J	Majumdar, A; Cesario, WC; White-Grindley, E; Jiang, HQ; Ren, FZ; Khan, M; Li, LY; Choi, EML; Kannan, K; Guo, FL; Unruh, J; Slaughter, B; Si, K				Majumdar, Amitabha; Cesario, Wanda Colon; White-Grindley, Erica; Jiang, Huoqing; Ren, Fengzhen; Khan, Mohammed Repon''; Li, Liying; Choi, Edward Man-Lik; Kannan, Kasthuri; Guo, Fengli; Unruh, Jay; Slaughter, Brian; Si, Kausik			Critical Role of Amyloid-like Oligomers of Drosophila Orb2 in the Persistence of Memory	CELL			English	Article							CYTOPLASMIC POLYADENYLATION ELEMENT; LOCAL PROTEIN-SYNTHESIS; LONG-TERM-MEMORY; MESSENGER-RNA TRANSLATION; SYNAPTIC PLASTICITY; MUTANT DROSOPHILA; NEURONAL ISOFORM; APLYSIA CPEB; KINASE-II; FACILITATION	A long-standing question in the study of long-term memory is how a memory trace persists for years when the proteins that initiated the process turn over and disappear within days. Previously, we postulated that self-sustaining amyloidogenic oligomers of cytoplasmic polyadenylation elementbinding protein (CPEB) provide a mechanism for the maintenance of activity-dependent synaptic changes and, thus, the persistence of memory. Here, we found that the Drosophila CPEB Orb2 forms amyloid-like oligomers, and oligomers are enriched in the synaptic membrane fraction. Of the two protein isoforms of Orb2, the amyloid-like oligomer formation is dependent on the Orb2A form. A point mutation in the prion-like domain of Orb2A, which reduced amyloid-like oligomerization of Orb2, did not interfere with learning or memory persisting up to 24 hr. However the mutant flies failed to stabilize memory beyond 48 hr. These results support the idea that amyloid-like oligomers of neuronal CPEB are critical for the persistence of long-term memory.	[Majumdar, Amitabha; Cesario, Wanda Colon; White-Grindley, Erica; Jiang, Huoqing; Ren, Fengzhen; Khan, Mohammed Repon''; Li, Liying; Choi, Edward Man-Lik; Kannan, Kasthuri; Guo, Fengli; Unruh, Jay; Slaughter, Brian; Si, Kausik] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Khan, Mohammed Repon''; Li, Liying; Si, Kausik] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Kannan, Kasthuri] Penn State Univ, University Pk, PA 16802 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Si, K (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	ksi@stowers.org	Kannan, Kasthuri/A-5403-2013; Choi, Edward/AAQ-1502-2021	Choi, Edward/0000-0002-8148-120X; majumdar, amitabha/0000-0002-6594-0672; Kannan, Kasthuri/0000-0002-8479-0657; Unruh, Jay/0000-0003-3077-4990	NICHD; Searle Foundation; March of Dimes; Klingenstein Foundation; McKnight Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Searle Foundation; March of Dimes(March of Dimes); Klingenstein Foundation(Klingenstein Philanthropies); McKnight Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Gary Struhl, Paul Garrity, Gerry Rubin, Krystena Keleman, Douglas Armstrong, Greg Suh, Scott Wadell, Andre Fiala, and Troy Zars for the fly stocks and Patrick Verstreken for reagents for recombineering based tagging. We thank the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing transgenic RNAi fly stock. The monoclonal antibodies against CSP, Dlg, Synapsin, Syntaxin, and FasII were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA, USA. The antibodies against synaptotagmin, endophilin, and dPAK were kind gifts from Hugo Bellen and Nick Harden. We acknowledge Brian Sanderson, Eric Jessen, Kym Delventhal, and Kyle Weaver from the Stowers Institute Molecular Biology department for generating the mutant library. We thank Jenifer Krass in the Si lab for performing the blind analysis of the behavioral experiments. We are particularly thankful to Gunther Hollopeter and Dr. Rong Li of the Stowers Institute and Dr. Hiroshi Nishimune of KU Medical School for help in preparation of the manuscript. K.S. is supported by the Searle Foundation, the March of Dimes Basil O'Connor Starter Award, the Klingenstein Foundation, and the McKnight Foundation.	Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Atkins CM, 2004, J NEUROSCI, V24, P5193, DOI 10.1523/JNEUROSCI.0854-04.2004; Berry J, 2008, PROG BRAIN RES, V169, P293, DOI 10.1016/S0079-6123(07)00018-0; CHIN GJ, 1989, J NEUROSCI, V9, P38; Colomb J, 2009, GENES BRAIN BEHAV, V8, P407, DOI 10.1111/j.1601-183X.2009.00482.x; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Heinrich SU, 2011, P NATL ACAD SCI USA, V108, P2999, DOI 10.1073/pnas.1019368108; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Iconomidou VA, 2008, CURR PROTEIN PEPT SC, V9, P291, DOI 10.2174/138920308784534041; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kundel M, 2009, J NEUROSCI, V29, P13630, DOI 10.1523/JNEUROSCI.2910-08.2009; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mastushita-Sakai T, 2010, P NATL ACAD SCI USA, V107, P11987, DOI 10.1073/pnas.1004433107; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; MCGUIRE SE, 2004, SCI STKE, pPL6; Miniaci MC, 2008, NEURON, V59, P1024, DOI 10.1016/j.neuron.2008.07.036; Nisimura T, 2005, J NEUROSCI, V25, P7507, DOI 10.1523/JNEUROSCI.1862-05.2005; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saupe SJ, 2007, PRION, V1, P110, DOI 10.4161/pri.1.2.4666; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Venkatesh T.R., 1980, Basic Life Sciences, V16, P313; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; Wickner RB, 2008, BIOESSAYS, V30, P955, DOI 10.1002/bies.20821; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	53	195	204	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 3	2012	148	3					515	529		10.1016/j.cell.2012.01.004	http://dx.doi.org/10.1016/j.cell.2012.01.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22284910	Bronze			2022-12-01	WOS:000300225000019
J	Durkin, K; Coppieters, W; Drogemuller, C; Ahariz, N; Cambisano, N; Druet, T; Fasquelle, C; Haile, A; Horin, P; Huang, LS; Kamatani, Y; Karim, L; Lathrop, M; Moser, S; Oldenbroek, K; Rieder, S; Sartelet, A; Solkner, J; Stalhammar, H; Zelenika, D; Zhang, ZY; Leeb, T; Georges, M; Charlier, C				Durkin, Keith; Coppieters, Wouter; Droegemueller, Cord; Ahariz, Naima; Cambisano, Nadine; Druet, Tom; Fasquelle, Corinne; Haile, Aynalem; Horin, Petr; Huang, Lusheng; Kamatani, Yohichiro; Karim, Latifa; Lathrop, Mark; Moser, Simon; Oldenbroek, Kor; Rieder, Stefan; Sartelet, Arnaud; Soelkner, Johann; Stalhammar, Hans; Zelenika, Diana; Zhang, Zhiyan; Leeb, Tosso; Georges, Michel; Charlier, Carole			Serial translocation by means of circular intermediates underlies colour sidedness in cattle	NATURE			English	Article							GENE; PATTERN	Colour sidedness is a dominantly inherited phenotype of cattle characterized by the polarization of pigmented sectors on the flanks, snout and ear tips(1). It is also referred to as 'lineback' or 'witrik' (which means white back), as colour-sided animals typically display a white band along their spine. Colour sidedness is documented at least since the Middle Ages and is presently segregating in several cattle breeds around the globe, including in Belgian blue and brown Swiss(1,2). Here we report that colour sidedness is determined by a first allele on chromosome 29 (Cs-29), which results from the translocation of a 492-kilobase chromosome 6 segment encompassing KIT to chromosome 29, and a second allele on chromosome 6 (Cs-6), derived from the first by repatriation of fused 575-kilobase chromosome 6 and 29 sequences to the KIT locus. We provide evidence that both translocation events involved circular intermediates. This is the first example, to our knowledge, of a phenotype determined by homologous yet non-syntenic alleles that result from a novel copy-number-variant-generating mechanism.	[Durkin, Keith; Coppieters, Wouter; Ahariz, Naima; Cambisano, Nadine; Druet, Tom; Fasquelle, Corinne; Karim, Latifa; Sartelet, Arnaud; Zhang, Zhiyan; Georges, Michel; Charlier, Carole] Univ Liege B34, GIGA R, Unit Anim Genom, B-4000 Liege, Sart Tilman, Belgium; [Durkin, Keith; Coppieters, Wouter; Ahariz, Naima; Cambisano, Nadine; Druet, Tom; Fasquelle, Corinne; Karim, Latifa; Sartelet, Arnaud; Zhang, Zhiyan; Georges, Michel; Charlier, Carole] Univ Liege B34, Fac Vet Med, B-4000 Liege, Sart Tilman, Belgium; [Droegemueller, Cord; Leeb, Tosso] Univ Bern, Inst Genet, CH-3001 Bern, Switzerland; [Haile, Aynalem] ICARDA, Aleppo, Syria; [Horin, Petr] Univ Vet & Pharmaceut Sci Brno, Inst Genet, Brno 61242, Czech Republic; [Huang, Lusheng] Key Lab Anim Biotechnol Jiangxi Prov, Nanchang 330045, Jiangxi, Peoples R China; [Huang, Lusheng] Minist Agr China, Nanchang 330045, Jiangxi, Peoples R China; [Kamatani, Yohichiro; Lathrop, Mark; Zelenika, Diana] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75012 Paris, France; [Kamatani, Yohichiro; Lathrop, Mark; Zelenika, Diana] CEA IC Ctr Natl Genotypage, F-91057 Evry, France; [Moser, Simon; Rieder, Stefan] Bern Univ Appl Sci, Swiss Coll Agr, CH-3052 Zollikofen, Switzerland; [Oldenbroek, Kor] Ctr Genet Resources Netherlands CGN, NL-6701 BH Wageningen, Netherlands; [Soelkner, Johann] Univ Nat Resources & Appl Life Sci, Div Livestock Sci, A-1180 Vienna, Austria; [Stalhammar, Hans] Viking Genet, S-53221 Ornsro, Skara, Sweden	University of Liege; University of Liege; University of Bern; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA); University of Veterinary Sciences Brno; Ministry of Agriculture & Rural Affairs; Foundation Jean Dausset-CEPH; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Natural Resources & Life Sciences, Vienna	Georges, M (corresponding author), Univ Liege B34, GIGA R, Unit Anim Genom, 1 Ave Hop, B-4000 Liege, Sart Tilman, Belgium.	michel.georges@ulg.ac.be	Leeb, Tosso/G-3187-2014; Coppieters, Wouter/AAF-5030-2021; Oldenbroek, Kor/AAE-6063-2019; Kamatani, Yoichiro/N-5513-2015; Horin, Petr/E-3907-2012	Leeb, Tosso/0000-0003-0553-4880; Coppieters, Wouter/0000-0001-8109-7825; Charlier, Carole/0000-0002-9694-094X; Solkner, Johann/0000-0002-1517-5829; Druet, Tom/0000-0003-1637-1706; Georges, Michel/0000-0003-4124-2375; Drogemuller, Cord/0000-0001-9773-522X; Durkin, Keith/0000-0001-7475-6618	Walloon Direction General Operationnelle Agriculture, Resources Naturelles et Environnement [D31-1206, D31-1214]; Swiss National Science Foundation [31003A_133034]; GIGA-R	Walloon Direction General Operationnelle Agriculture, Resources Naturelles et Environnement; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GIGA-R	This work was funded by the Walloon Direction General Operationnelle Agriculture, Resources Naturelles et Environnement (grants D31-1206 and D31-1214) and the Swiss National Science Foundation (grant 31003A_133034 to T. L.). We are grateful for the support of the GIGA-R Genomics platform, to P. Melvin, to G. Mekuriaw and staff of the Andassa livestock research center, Viking Genetics, Swissgenetics and the Schweizer Braunviehzuchtverband for their assistance in sample collection, to J. Vermeesch and B. Nowakowska for their assistance with array CGH.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Brooks SA, 2007, CYTOGENET GENOME RES, V119, P225, DOI 10.1159/000112065; Charlier C, 1996, MAMM GENOME, V7, P138, DOI 10.1007/s003359900034; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Drogemuller C, 2009, ANIM GENET, V40, P225, DOI 10.1111/j.1365-2052.2008.01826.x; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Graux C, 2009, LEUKEMIA, V23, P125, DOI 10.1038/leu.2008.278; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu GE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-571; Marklund S, 1998, GENOME RES, V8, P826, DOI 10.1101/gr.8.8.826; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Olson T, 1999, GENETICS OF CATTLE, P33; Porter V, 2002, MASONS WORLD DICT LI; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Workman C, 2002, GENOME BIOL, V3; Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x	22	103	105	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2012	482	7383					81	U103		10.1038/nature10757	http://dx.doi.org/10.1038/nature10757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22297974	Green Published			2022-12-01	WOS:000299726000039
J	Varmus, H; Harlow, E				Varmus, Harold; Harlow, Ed			Provocative questions in cancer research	NATURE			English	Editorial Material							MORTALITY; OBESITY					harold.varmus@nih.gov	Devdariani, Alexander/G-5334-2010	Devdariani, Alexander/0000-0002-0605-6705				Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Annan Kofi A., 2000, WE PEOPLE ROLE UN 21; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Committee on a Framework for Developing a New Taxonomy of Disease National Research Council, 2011, PREC MED BUILD KNOWL; Guminski AD, 2002, LANCET ONCOL, V3, P312, DOI 10.1016/S1470-2045(02)00733-7; Hilbert D., 1902, GOTTINGER NACHRICHTE, V8, P437, DOI [10.1090/s0002-9904-1902-00923-3, DOI 10.1090/S0002-9904-1902-00923-3]; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Renehan AG, 2010, EUR J CANCER, V46, P2581, DOI 10.1016/j.ejca.2010.07.052; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769	9	23	23	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 26	2012	481	7382					436	437		10.1038/481436a	http://dx.doi.org/10.1038/481436a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	881GY	22281578				2022-12-01	WOS:000299471800014
J	Bazzocchi, A; Diano, D; Battista, G				Bazzocchi, Alberto; Diano, Danila; Battista, Giuseppe			How fat is fat?	LANCET			English	Editorial Material									[Bazzocchi, Alberto; Diano, Danila; Battista, Giuseppe] Univ Bologna, Imaging Div, Clin Dept Radiol & Histocytopathol Sci, StOrsola Malpighi Hosp, I-40138 Bologna, Italy; [Bazzocchi, Alberto] Rizzoli Orthopaed Inst, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Istituto Ortopedico Rizzoli	Bazzocchi, A (corresponding author), Univ Bologna, Imaging Div, Clin Dept Radiol & Histocytopathol Sci, StOrsola Malpighi Hosp, Via Massarenti 9, I-40138 Bologna, Italy.	abazzo@inwind.it	Bazzocchi, Alberto/O-8048-2016; Battista, Giuseppe/AAC-3362-2021	Bazzocchi, Alberto/0000-0002-2659-4535; Battista, Giuseppe/0000-0003-3639-3494					0	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 14	2012	380	9837					E1	E1		10.1016/S0140-6736(11)61925-9	http://dx.doi.org/10.1016/S0140-6736(11)61925-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	973KN	22484135				2022-12-01	WOS:000306359100001
J	Kung, Y; Ando, N; Doukov, TI; Blasiak, LC; Bender, G; Seravalli, J; Ragsdale, SW; Drennan, CL				Kung, Yan; Ando, Nozomi; Doukov, Tzanko I.; Blasiak, Leah C.; Bender, Guenes; Seravalli, Javier; Ragsdale, Stephen W.; Drennan, Catherine L.			Visualizing molecular juggling within a B-12-dependent methyltransferase complex	NATURE			English	Article							IRON-SULFUR PROTEIN; DEPENDENT METHIONINE SYNTHASE; WOOD-LJUNGDAHL PATHWAY; METHYL-GROUP TRANSFER; ACETYL COENZYME-A; CLOSTRIDIUM-THERMOACETICUM; REDUCTIVE ACTIVATION; CATALYSIS; SYSTEM; DOMAIN	Derivatives of vitamin B-12 are used in methyl group transfer in biological processes as diverse as methionine synthesis in humans and CO2 fixation in acetogenic bacteria(1-3). This seemingly straightforward reaction requires large, multimodular enzyme complexes that adopt multiple conformations to alternately activate, protect and perform catalysis on the reactive B-12 cofactor. Crystal structures determined thus far have provided structural information for only fragments of these complexes(4-12), inspiring speculation about the overall protein assembly and conformational movements inherent to activity. Here we present X-ray crystal structures of a complete 220 kDa complex that contains all enzymes responsible for B-12-dependent methyl transfer, namely the corrinoid iron-sulphur protein and its methyltransferase from the model acetogen Moorella thermoacetica. These structures provide the first three-dimensional depiction of all protein modules required for the activation, protection and catalytic steps of B-12-dependent methyl transfer. In addition, the structures capture B-12 at multiple locations between its 'resting' and catalytic positions, allowing visualization of the dramatic protein rearrangements that enable methyl transfer and identification of the trajectory for B-12 movement within the large enzyme scaffold. The structures are also presented alongside in crystallo spectroscopic data, which confirm enzymatic activity within crystals and demonstrate the largest known conformational movements of proteins in a crystalline state. Taken together, this work provides a model for the molecular juggling that accompanies turnover and helps explain why such an elaborate protein framework is required for such a simple, yet biologically essential reaction.	[Kung, Yan; Ando, Nozomi; Doukov, Tzanko I.; Blasiak, Leah C.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Ando, Nozomi; Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Bender, Guenes; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Seravalli, Javier] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln; Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	cdrennan@mit.edu		Ando, Nozomi/0000-0001-7062-1644; Doukov, Tzanko/0000-0001-8625-2572; Kung, Yan/0000-0002-6132-7969	National Institutes of Health [GM69857, GM39451]; MIT Energy Initiative; National Center for Research Resources at the National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039451, R01GM069857, R29GM039451, T32GM008334, R01GM039451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT Energy Initiative; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. E. Darty for his assistance with the purification of CFeSP. This work was supported by National Institutes of Health grants GM69857 (to C. L. D.) and GM39451 (to S. W. R.) and the MIT Energy Initiative (to C. L. D.). C. L. D. is a Howard Hughes Medical Institute Investigator. This work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bandarian V, 2002, NAT STRUCT BIOL, V9, P53; Bandarian V, 2003, P NATL ACAD SCI USA, V100, P8156, DOI 10.1073/pnas.1133218100; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BANERJEE RV, 1990, BIOCHEMISTRY-US, V29, P1129, DOI 10.1021/bi00457a005; BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; Barstow B, 2008, P NATL ACAD SCI USA, V105, P13362, DOI 10.1073/pnas.0802252105; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Datta S, 2008, P NATL ACAD SCI USA, V105, P4115, DOI 10.1073/pnas.0800329105; Dixon MM, 1996, STRUCTURE, V4, P1263, DOI 10.1016/S0969-2126(96)00135-9; Doukov T, 2000, STRUCTURE, V8, P817, DOI 10.1016/S0969-2126(00)00172-6; Doukov TI, 2007, J BIOL CHEM, V282, P6609, DOI 10.1074/jbc.M609828200; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; ELLIOTT JI, 1978, ARCH BIOCHEM BIOPHYS, V190, P351, DOI 10.1016/0003-9861(78)90285-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans JC, 2004, P NATL ACAD SCI USA, V101, P3729, DOI 10.1073/pnas.0308082100; HARDER SR, 1989, BIOCHEMISTRY-US, V28, P9080, DOI 10.1021/bi00449a019; Jarrett JT, 1996, BIOCHEMISTRY-US, V35, P2464, DOI 10.1021/bi952389m; Koutmos M, 2009, P NATL ACAD SCI USA, V106, P18527, DOI 10.1073/pnas.0906132106; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LJUNGDAH.LG, 1973, BIOCHEMISTRY-US, V12, P1802, DOI 10.1021/bi00733a022; LU WP, 1993, J BIOL CHEM, V268, P5605; Matthews RG, 2001, ACCOUNTS CHEM RES, V34, P681, DOI 10.1021/ar0000051; Matthews RG, 2008, CURR OPIN STRUC BIOL, V18, P658, DOI 10.1016/j.sbi.2008.11.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon S, 1998, BIOCHEMISTRY-US, V37, P5689, DOI 10.1021/bi9727996; Menon S, 1999, J BIOL CHEM, V274, P11513, DOI 10.1074/jbc.274.17.11513; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; Royant A, 2007, J APPL CRYSTALLOGR, V40, P1105, DOI 10.1107/S0021889807044196; SCHRAUZER GN, 1969, J AM CHEM SOC, V91, P3341, DOI 10.1021/ja01040a041; Seravalli J, 1999, BIOCHEMISTRY-US, V38, P5728, DOI 10.1021/bi982473c; Stich TA, 2006, J AM CHEM SOC, V128, P5010, DOI 10.1021/ja054690o; Svetlitchnaia T, 2006, P NATL ACAD SCI USA, V103, P14331, DOI 10.1073/pnas.0601420103; WIRT MD, 1995, BIOCHEMISTRY-US, V34, P5269, DOI 10.1021/bi00015a042; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008; ZHAO SY, 1995, BIOCHEMISTRY-US, V34, P15075, DOI 10.1021/bi00046a013; ZYDOWSKY TM, 1986, J AM CHEM SOC, V108, P3152, DOI 10.1021/ja00271a081	39	52	55	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					265	U159		10.1038/nature10916	http://dx.doi.org/10.1038/nature10916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22419154	Green Accepted, Green Submitted			2022-12-01	WOS:000303149900040
J	O'Grady, M; O'Hare, G				O'Grady, Michael; O'Hare, Gregory			How Smart Is Your City?	SCIENCE			English	Editorial Material									[O'Grady, Michael; O'Hare, Gregory] Univ Coll Dublin, Dublin 4, Ireland	University College Dublin	O'Grady, M (corresponding author), Univ Coll Dublin, Dublin 4, Ireland.	michael.j.ogrady@ucd.ie	O'Hare, Gregory M.P./AAA-7756-2022	O'Hare, Gregory M.P./0000-0002-5124-1686; O'Grady, Michael/0000-0002-3024-3666				Broring A, 2011, SENSORS-BASEL, V11, P7568, DOI 10.3390/s110807568; Cook DJ, 2012, SCIENCE, V335, P1579, DOI 10.1126/science.1217640; De Jong K. A., 2008, COMPUT INTELL MAG IE, V3, P12; Gershenfeld N, 2010, SCIENCE, V327, P1086, DOI 10.1126/science.1174082; Hildebrandt Mireille, 2008, REGULATING TECHNOLOG, p[175, 187]; Kabassi Katerina, 2010, Telematics and Informatics, V27, P51, DOI 10.1016/j.tele.2009.05.003; KASPER JD, 1994, J APPL GERONTOL, V13, P371, DOI 10.1177/073346489401300403; Landau R, 2010, QUAL HEALTH RES, V20, P409, DOI 10.1177/1049732309359171; Reggente M, 2010, CHEM ENGINEER TRANS, V23, P273, DOI 10.3303/CET1023046; Sheth A, 2008, IEEE INTERNET COMPUT, V12, P78, DOI 10.1109/MIC.2008.87; Streitz N., 2011, LECT NOTES COMPUT 3, P425; Vullers R. J. M., 2010, IEEE SOLID STATE CIR, V2, P29, DOI [10.1109/MSSC.2010.936667, DOI 10.1109/MSSC.2010.936667]	12	66	66	5	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1581	1582		10.1126/science.1217637	http://dx.doi.org/10.1126/science.1217637			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915YD	22461597	Green Submitted			2022-12-01	WOS:000302062600029
J	Rogulja, D; Young, MW				Rogulja, Dragana; Young, Michael W.			Control of Sleep by Cyclin A and Its Regulator	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; CIRCADIAN CLOCK; BEHAVIOR; CIRCUIT; REST	How and why the brain reversibly switches from a waking to a sleep state remain among the most intriguing questions in biology. We show that cyclin A (CycA) and regulator of cyclin A1, essential cell cycle factors, function in postmitotic neurons to promote sleep in Drosophila melanogaster. Reducing the abundance of CycA in neurons delayed the wake-sleep transition, caused multiple arousals from sleep, and reduced the homeostatic response to sleep deprivation. CycA is expressed in similar to 40 to 50 neurons in the adult brain, most of which are intermingled with circadian clock neurons, suggesting functional interactions among neurons controlling sleep and circadian behavior.	[Rogulja, Dragana; Young, Michael W.] Rockefeller Univ, Genet Lab, New York, NY 10065 USA	Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, 1230 York Ave, New York, NY 10065 USA.	young@mail.rockefeller.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020		NIH [NS053087, GM054339]; Jane Coffin Childs Memorial Fund for Medical Research; Merck fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054339, R37GM054339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053087] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; Merck fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Allada, B. Dickson, J. Hall, C. Lehner, A. Sehgal, F. Sprenger, and NIG-Fly Stock Center for reagents; N. Stavropoulos for custom MatLab software; and C. Bargmann, M. Crickmore, C. Desplan, A. Keene, S. Shaham, L. Vosshall, and members of the Young lab for helpful discussions and comments on the manuscript. This work was supported by NIH grants NS053087 and GM054339 (to M.W.Y.). D.R. was supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research and by a Merck fellowship.	Boothroyd CE, 2008, ANN NY ACAD SCI, V1129, P350, DOI 10.1196/annals.1417.006; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Lear BC, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000154; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Odajima J, 2011, DEV CELL, V21, P655, DOI 10.1016/j.devcel.2011.08.009; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Rothenfluh A, 2000, GENETICS, V156, P665; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Zielke N, 2006, EMBO REP, V7, P1266, DOI 10.1038/sj.embor.7400851	20	55	55	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1617	1621		10.1126/science.1212476	http://dx.doi.org/10.1126/science.1212476			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461610	Green Accepted			2022-12-01	WOS:000302062600043
J	Inglesby, TV				Inglesby, Thomas V.			Engineered H5N1: A Rare Time for Restraint in Science	ANNALS OF INTERNAL MEDICINE			English	Article								Two scientific teams have recently engineered the H5N1 virus to make it readily transmissible between ferrets. Given that ferrets are considered the most reliable animal surrogate for human influenza infection, the newly engineered H5N1 strain is probably transmissible between humans as well. The potential consequences of an engineered human-transmissible H5N1 strain are stunning. Although seasonal flu infects as much as 20% of the world's population-more than 1 billion persons-each year, only a small fraction of those with seasonal flu dies, most often the oldest, youngest, and sickest. If the newly engineered strain were to escape the laboratory (either by design or by accident) and spread as widely as seasonal flu with anywhere near the current confirmed H5N1 human case-fatality rate, it could endanger the lives of hundreds of millions of persons. The possible benefits of this work do not justify taking such risks. As clinicians, we have a stake in this issue with our responsibilities for the diagnosis and treatment of influenza. We embrace the principle of free and open exchange of scientific information, but we also believe in the principle of "first, do no harm." These 2 principles have come into a moment of rare conflict. It seems most reasonable and prudent to request that the involved scientific community and its institutions exercise restraint by restricting dissemination of the experimental results and discontinuing work on the engineered H5N1 strains. If a highly compelling case is made for continued work on this strain despite the risks, the work should be controlled and should merit the greatest scrutiny.	UPMC, Ctr Biosecur, Baltimore, MD 21202 USA		Inglesby, TV (corresponding author), UPMC, Ctr Biosecur, 621 E Pratt St,Suite 210, Baltimore, MD 21202 USA.	mjasen@upmc-biosecurity.org						[Anonymous], 2011, GUARDIAN        1231; MacKenzie D, 2011, NEW SCI         0926; WHO/GIP, 2003, CUM NUMB CONF HUM CA; World Health Organization, 2011, WHO CONC NEW H5N1 IN	4	5	6	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2012	156	6					460	U120		10.7326/0003-4819-156-6-201203200-00387	http://dx.doi.org/10.7326/0003-4819-156-6-201203200-00387			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PF	22282173				2022-12-01	WOS:000303150900018
J	Noblin, X; Rojas, NO; Westbrook, J; Llorens, C; Argentina, M; Dumais, J				Noblin, X.; Rojas, N. O.; Westbrook, J.; Llorens, C.; Argentina, M.; Dumais, J.			The Fern Sporangium: A Unique Catapult	SCIENCE			English	Article									[Noblin, X.] Univ Nice Sophia Antipolis UNS, Lab Phys Mat Condensee, CNRS UMR 7336, F-06108 Nice, France; [Rojas, N. O.; Llorens, C.; Argentina, M.] UNS, CNRS, Lab JA Dieudonne, UMR 7351, F-06108 Nice, France; [Westbrook, J.] Univ Florida, Dept Bot, Gainesville, FL 32611 USA; [Dumais, J.] Harvard Univ, Cambridge, MA 02138 USA	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Cote d'Azur; State University System of Florida; University of Florida; Harvard University	Noblin, X (corresponding author), Univ Nice Sophia Antipolis UNS, Lab Phys Mat Condensee, CNRS UMR 7336, Parc Valrose, F-06108 Nice, France.	xavier.noblin@unice.fr	Dumais, Jacques/H-7950-2013; Argentina, Mederic/I-8741-2014; Rojas, Nicolas O./AAV-3912-2021; Rojas, Nicolás O/C-8683-2019; Argentina, Mederic/AAR-8153-2021; Argentina, Mederic/AAQ-9236-2021	Dumais, Jacques/0000-0003-2344-4766; Argentina, Mederic/0000-0002-8926-7398; Rojas, Nicolas O./0000-0001-7562-2670; Argentina, Mederic/0000-0002-8926-7398	Materials Research Science and Engineering Center (Harvard University); CNRS (PIR); Agence Nationale de la Recherche; Commission nacional de Investigacion Cientifica y Tecnologica	Materials Research Science and Engineering Center (Harvard University); CNRS (PIR); Agence Nationale de la Recherche(French National Research Agency (ANR)); Commission nacional de Investigacion Cientifica y Tecnologica	This work was supported by the Materials Research Science and Engineering Center (Harvard University), the CNRS (PIR project "EVAPLANTE"), the Agence Nationale de la Recherche (project "CAVISOFT"), and the Commission nacional de Investigacion Cientifica y Tecnologica (N.R.).	CARPITA N, 1979, SCIENCE, V205, P1144, DOI 10.1126/science.205.4411.1144; HAIDER K, 1954, PLANTA, V44, P370, DOI 10.1007/BF01940087; Ingold C. T., 1965, SPORE LIBERATION; King AL, 1944, P NATL ACAD SCI USA, V30, P155, DOI 10.1073/pnas.30.7.155; Noblin X., 2009, P 6 PLANT BIOM C CAY; Noblin X, 2009, J EXP BIOL, V212, P2835, DOI 10.1242/jeb.029975; Renner O., 1915, JAHR WISS BOT, V56, P647; RITMAN KT, 1990, J EXP BOT, V41, P1157, DOI 10.1093/jxb/41.9.1157; Skotheim JM, 2004, P ROY SOC A-MATH PHY, V460, P1995, DOI 10.1098/rspa.2003.1270; Ursprung A., 1915, BER DEUT BOT GES, V33, P153	10	115	119	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2012	335	6074					1322	1322		10.1126/science.1215985	http://dx.doi.org/10.1126/science.1215985			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22422975	Green Submitted			2022-12-01	WOS:000301531600039
J	Hotta, K; Chen, X; Paton, RS; Minami, A; Li, H; Swaminathan, K; Mathews, II; Watanabe, K; Oikawa, H; Houk, KN; Kim, CY				Hotta, Kinya; Chen, Xi; Paton, Robert S.; Minami, Atsushi; Li, Hao; Swaminathan, Kunchithapadam; Mathews, Irimpan I.; Watanabe, Kenji; Oikawa, Hideaki; Houk, Kendall N.; Kim, Chu-Young			Enzymatic catalysis of anti-Baldwin ring closure in polyether biosynthesis	NATURE			English	Article							GENE-CLUSTER; EPOXIDE HYDROLASE; ANTIBIOTIC-STRUCTURE; ACTIVE-SITE; INSIGHTS; MODEL; CRYSTALLOGRAPHY; ISOMERASE; ENERGY; RULES	Polycyclic polyether natural products have fascinated chemists and biologists alike owing to their useful biological activity, highly complex structure and intriguing biosynthetic mechanisms. Following the original proposal for the polyepoxide origin of lasalocid and isolasalocid(1) and the experimental determination of the origins of the oxygen and carbon atoms of both lasalocid and monensin, a unified stereochemical model for the biosynthesis of polyether ionophore antibiotics was proposed(2). The model was based on a cascade of nucleophilic ring closures of postulated polyepoxide substrates generated by stereospecific oxidation of all-trans polyene polyketide intermediates(2). Shortly thereafter, a related model was proposed for the biogenesis of marine ladder toxins, involving a series of nominally disfavoured anti-Baldwin, endo-tet epoxide-ring-opening reactions(3-5). Recently, we identified Lsd19 from the Streptomyces lasaliensis gene cluster as the epoxide hydrolase responsible for the epoxide-opening cyclization of bisepoxyprelasalocid A(6) to form lasalocid A(7,8). Here we report the X-ray crystal structure of Lsd19 in complex with its substrate and product analogue(9) to provide the first atomic structure-to our knowledge-of a natural enzyme capable of catalysing the disfavoured epoxide-opening cyclic ether formation. On the basis of our structural and computational studies, we propose a general mechanism for the enzymatic catalysis of polyether natural product biosynthesis.	[Hotta, Kinya; Chen, Xi; Li, Hao; Swaminathan, Kunchithapadam; Kim, Chu-Young] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Paton, Robert S.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Minami, Atsushi; Oikawa, Hideaki] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan; [Mathews, Irimpan I.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 95124 USA; [Watanabe, Kenji] Univ Shizuoka, Grad Sch Pharmaceut Sci, Div Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan; [Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	National University of Singapore; University of Oxford; Hokkaido University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Shizuoka; University of California System; University of California Los Angeles	Kim, CY (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	chuyoung@nus.edu.sg	Minami, Atsushi/A-4314-2012; Paton, Robert/A-4564-2010; kikuchi, sachiko/G-5650-2012; Watanabe, Kenji/N-2012-2015; Kim, Chu-Young/D-8849-2012; Hotta, Kinya/A-2574-2009; Oikawa, Hideaki/F-9128-2012	Minami, Atsushi/0000-0002-4183-0268; Paton, Robert/0000-0002-0104-4166; Watanabe, Kenji/0000-0002-0463-4831; Kim, Chu-Young/0000-0003-3744-7802; Hotta, Kinya/0000-0002-9427-0081; Oikawa, Hideaki/0000-0002-6947-3397	Royal Commission; Fulbright-AstraZeneca; Japan Society for the Promotion of Science [LS103]; National Institutes of Health [GM075962]; MEXT [22108002]; National University of Singapore Life Sciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075962] Funding Source: NIH RePORTER	Royal Commission; Fulbright-AstraZeneca(AstraZeneca); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National University of Singapore Life Sciences Institute(National University of Singapore); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Royal Commission for the Exhibition of 1851 and Fulbright-AstraZeneca Research Fellowship (R.S.P.), the Japan Society for the Promotion of Science (No. LS103) (K.W.), the National Institutes of Health grant GM075962 (K.N.H.), the MEXT research grant on innovative area 22108002 (H.O.), and the National University of Singapore Life Sciences Institute Young Investigator Award (C.-Y.K.). Data collection was performed at the Stanford Synchrotron Radiation Lightsource. We thank D. W. Christianson, D. Hilvert and C. Khosla for critical reading and discussion of the manuscript.	BALDWIN JE, 1976, J CHEM SOC CHEM COMM, P734, DOI 10.1039/c39760000734; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CANE DE, 1983, J AM CHEM SOC, V105, P3594, DOI 10.1021/ja00349a040; Demydchuk Y, 2008, CHEMBIOCHEM, V9, P1136, DOI 10.1002/cbic.200700715; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frisch M. J., 2010, GAUSSIAN 09 REVISION; Gilmore K, 2011, CHEM REV, V111, P6513, DOI 10.1021/cr200164y; Grimme S, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2148954; Gruber K, 1999, BIOCHEMISTRY-US, V38, P7062, DOI 10.1021/bi990210s; Ha NC, 2000, J BIOL CHEM, V275, P41100, DOI 10.1074/jbc.M007561200; Ha NC, 2001, CURR OPIN STRUC BIOL, V11, P674, DOI 10.1016/S0959-440X(01)00268-8; Harvey BM, 2007, CHEM BIOL, V14, P703, DOI 10.1016/j.chembiol.2007.05.011; Hopmann KH, 2005, J AM CHEM SOC, V127, P14339, DOI 10.1021/ja050940p; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim DH, 2000, BIOCHEMISTRY-US, V39, P4581, DOI 10.1021/bi992119u; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leadlay PF, 2001, J IND MICROBIOL BIOT, V27, P360, DOI 10.1038/sj.jim.7000204; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Migita A, 2009, BIOSCI BIOTECH BIOCH, V73, P169, DOI 10.1271/bbb.80631; Minami A, 2011, ORG LETT, V13, P1638, DOI 10.1021/ol200100e; NA J, 1993, J AM CHEM SOC, V115, P8453, DOI 10.1021/ja00071a067; NAKANISHI K, 1985, TOXICON, V23, P473, DOI 10.1016/0041-0101(85)90031-5; Nakata T, 2005, CHEM REV, V105, P4314, DOI 10.1021/cr040627q; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Shichijo Y, 2008, J AM CHEM SOC, V130, P12230, DOI 10.1021/ja8040543; Smith L, 2008, CHEMBIOCHEM, V9, P2967, DOI 10.1002/cbic.200800585; Sun YH, 2003, CHEM BIOL, V10, P431, DOI 10.1016/S1074-5521(03)00092-9; TOUHARA K, 1993, J BIOL CHEM, V268, P19604; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van der Werf MJ, 1998, J BACTERIOL, V180, P5052, DOI 10.1128/JB.180.19.5052-5057.1998; WESTLEY JW, 1974, J ANTIBIOT, V27, P597, DOI 10.7164/antibiotics.27.597; WESTLEY JW, 1986, J NAT PROD, V49, P35, DOI 10.1021/np50043a003; Zhang X, 2008, J ORG CHEM, V73, P889, DOI 10.1021/jo701974n	37	78	79	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					355	U154		10.1038/nature10865	http://dx.doi.org/10.1038/nature10865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22388816	Green Accepted			2022-12-01	WOS:000301481800054
J	Teufel, R; Friedrich, T; Fuchs, G				Teufel, Robin; Friedrich, Thorsten; Fuchs, Georg			An oxygenase that forms and deoxygenates toxic epoxide	NATURE			English	Article							BURKHOLDERIA-CENOCEPACIA; CATABOLIC PATHWAY; ESCHERICHIA-COLI; DIAMOND CORE; ACID; COENZYME; MONOOXYGENASE; OXIDATION; CYCLE; METABOLISM	Catabolism may give rise to toxic intermediates that compromise cell vitality, such as epoxide formation in the recently elucidated and apparently universal bacterial coenzyme A (CoA)-dependent degradation of phenylacetic acid(1). This compound is central to the catabolism of a variety of aromatics, such as phenylalanine, lignin-related compounds or environmental contaminants(2,3). The key phenylacetyl-CoA monooxygenase (epoxidase) of the pathway, PaaABCE(1,4,5), is also connected to the production of various primary and secondary metabolites(6-9), as well as to the virulence of certain pathogens(1,10,11). However, the enzyme complex has so far not been investigated in detail. Here we characterize the bacterial multicomponent monooxygenase PaaABCE that, surprisingly, not only transforms phenylacetyl-CoA into its ring-1,2-epoxide, but also mediates the NADPH-dependent removal of the epoxide oxygen, regenerating phenylacetyl-CoA with formation of water. We provide evidence for a catalytic di-iron centre that is probably the key to the unprecedented deoxygenation of an organic compound by an oxygenase. Presumably, the bifunctionality is vital to avoid toxic intracellular epoxide levels if the subsequent catabolic steps are impeded. Our data suggest that detoxification is assisted by two thioesterases (PaaI and PaaY) forming non-reactive breakdown products. Hence, PaaABCE may harbour an intrinsic escape mechanism from its own toxic product and represents the archetype of a bifunctional oxygenase/deoxygenase. Analogous reactions may possibly be catalysed by other di-iron epoxidases.	[Teufel, Robin; Fuchs, Georg] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Friedrich, Thorsten] Univ Freiburg, Fak Chem, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Fuchs, G (corresponding author), Univ Freiburg, Fak Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	georg.fuchs@biologie.uni-freiburg.de		Teufel, Robin/0000-0001-5863-7248	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Deutsche Forschungsgemeinschaft for support; V. Mascaraque, G. Heijman and W. Ismail for their contributions in the initial stage of this work; M. Voss, M. Weiss, I. Sachelaru and T. Spatzal for technical assistance; M. Muller and V. Brecht for mass spectrometry analysis; and I. Berg and H. Heider for critical comments.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BEINERT H, 1983, ARCH BIOCHEM BIOPHYS, V222, P333, DOI 10.1016/0003-9861(83)90531-3; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Erb TJ, 2008, CURR MICROBIOL, V57, P27, DOI 10.1007/s00284-008-9147-3; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Fernandez C, 2006, APPL ENVIRON MICROB, V72, P7422, DOI 10.1128/AEM.01550-06; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Gallagher SC, 1997, EUR J BIOCHEM, V247, P635, DOI 10.1111/j.1432-1033.1997.00635.x; Geng HF, 2010, J BACTERIOL, V192, P4377, DOI 10.1128/JB.00410-10; Grishin AM, 2011, J BIOL CHEM, V286, P10735, DOI 10.1074/jbc.M110.194423; Hamlin JNR, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-222; Ismail W, 2003, EUR J BIOCHEM, V270, P3047, DOI 10.1046/j.1432-1033.2003.03683.x; Johansson AJ, 2009, DALTON T, P6741, DOI 10.1039/b907263b; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Law RJ, 2008, J BACTERIOL, V190, P7209, DOI 10.1128/JB.00481-08; Leahy JG, 2003, FEMS MICROBIOL REV, V27, P449, DOI 10.1016/S0168-6445(03)00023-8; LEE SK, 1993, J BIOL CHEM, V268, P21569; Luengo JM, 2001, MOL MICROBIOL, V39, P1434, DOI 10.1046/j.1365-2958.2001.02344.x; Moore BS, 1997, J ORG CHEM, V62, P2173, DOI 10.1021/jo962402o; Nordlund P, 1995, CURR OPIN STRUC BIOL, V5, P758, DOI 10.1016/0959-440X(95)80008-5; Park JB, 2006, BIOTECHNOL BIOENG, V95, P501, DOI 10.1002/bit.21037; PHILLIPS DH, 1994, CRIT REV TOXICOL, V24, pS35, DOI 10.3109/10408449409020139; Ramos-Vera WH, 2011, J BACTERIOL, V193, P1201, DOI 10.1128/JB.01156-10; Rather LJ, 2011, J BIOL CHEM, V286, P29241, DOI 10.1074/jbc.M111.236893; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; ROSENZWEIG AC, 1995, CHEM BIOL, V2, P409, DOI 10.1016/1074-5521(95)90222-8; Rowe GT, 2008, CHEM-EUR J, V14, P8303, DOI 10.1002/chem.200800283; Rowe GT, 2007, INORG CHEM, V46, P10594, DOI 10.1021/ic7011217; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Teufel R, 2011, J BIOL CHEM, V286, P11021, DOI 10.1074/jbc.M110.196667; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; Textor S, 1997, ARCH MICROBIOL, V168, P428, DOI 10.1007/s002030050518; Thiel V, 2010, ORG BIOMOL CHEM, V8, P234, DOI 10.1039/b909133e; Xue GQ, 2010, NAT CHEM, V2, P400, DOI [10.1038/NCHEM.586, 10.1038/nchem.586]	41	42	43	1	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					359	U161		10.1038/nature10862	http://dx.doi.org/10.1038/nature10862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22398448				2022-12-01	WOS:000301481800055
J	Kamel, H; Navi, BB; Fahimi, J				Kamel, Hooman; Navi, Babak B.; Fahimi, Jahan			National Trends in Ambulance Use by Patients With Stroke, 1997-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							OUTCOMES; REGISTRY; DELAY; TIME		[Kamel, Hooman; Navi, Babak B.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Fahimi, Jahan] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA	Cornell University; University of California System; University of California San Francisco	Kamel, H (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA.	hok9010@med.cornell.edu	Kamel, Hooman/AGG-9071-2022	Navi, Babak/0000-0001-8424-6128; Kamel, Hooman/0000-0002-5745-0307				Centers for Disease Control and Prevention, NAT AMB MED CAR SURV; Concannon TW, 2009, CIRC-CARDIOVASC QUAL, V2, P9, DOI 10.1161/CIRCOUTCOMES.108.813741; Deng YZ, 2006, NEUROLOGY, V66, P306, DOI 10.1212/01.wnl.0000196478.77152.fc; Lacy CR, 2001, STROKE, V32, P63, DOI 10.1161/01.STR.32.1.63; Ovbiagele B, 2010, STROKE, V41, P1748, DOI 10.1161/STROKEAHA.110.585455; Wojner-Alexandrov AW, 2005, STROKE, V36, P1512, DOI 10.1161/01.STR.0000170700.45340.39	6	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2012	307	10					1026	1028		10.1001/jama.2012.285	http://dx.doi.org/10.1001/jama.2012.285			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908GU	22416095	Bronze			2022-12-01	WOS:000301479700017
J	Myint, PK; Welch, AA				Myint, Phyo Kyaw; Welch, Ailsa A.			PRACTICE POINTER Healthier ageing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POPULATION; BEHAVIORS; MANAGEMENT; WOMEN; RISK; MEN		[Myint, Phyo Kyaw; Welch, Ailsa A.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Myint, Phyo Kyaw] Norfolk & Norwich Univ Hosp, Acad Dept Med Elderly, Norwich NR4 7UY, Norfolk, England	University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Myint, PK (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	Phyo.K.Myint@uea.ac.uk						Academy of Medical Sciences, 2011, REJ AG RES; Adams JM, 2004, EUR J PUBLIC HEALTH, V14, P331, DOI 10.1093/eurpub/14.3.331; [Anonymous], 2010, CONSENSUS VITAMIN D; [Anonymous], 2010, DIETARY GUIDELINES A; Bischoff-Ferrari H A, 2009, BMJ, V339, pb3692, DOI 10.1136/bmj.b3692; Boirie Y, 2009, J NUTR HEALTH AGING, V13, P717, DOI 10.1007/s12603-009-0203-x; Bond J., 1993, AGEING SOC INTRO SOC; Department of Health Social Services and Public Safety, 2011, START ACT STAY ACT R; Eriksson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005195; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Khaw KT, 1997, BMJ-BRIT MED J, V315, P1090, DOI 10.1136/bmj.315.7115.1090; Kirkwood TBL, 2011, PHILOS T R SOC B, V366, P64, DOI 10.1098/rstb.2010.0275; McMinn J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1732; Mead GE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub4; Morley JE, 2010, J AM MED DIR ASSOC, V11, P391, DOI 10.1016/j.jamda.2010.04.014; Myint PK, 2011, AGE AGEING, V40, P589, DOI 10.1093/ageing/afr058; Myint PK, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b349; Myint PK, 2010, HLTH AGEING DETERMIN; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Prescott-Clarke P, 1998, SERIES HS, V1; Van Pelt RE, 2001, AM J PHYSIOL-ENDOC M, V281, pE633, DOI 10.1152/ajpendo.2001.281.3.E633; Welch AA, 2010, AM J CLIN NUTR, V92, P1040, DOI 10.3945/ajcn.2010.29457	23	19	19	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2012	344								e1214	10.1136/bmj.e1214	http://dx.doi.org/10.1136/bmj.e1214			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	913BO	22411918				2022-12-01	WOS:000301846500002
J	Paige, JS; Nguyen-Duc, T; Song, WJ; Jaffrey, SR				Paige, Jeremy S.; Nguyen-Duc, Thinh; Song, Wenjiao; Jaffrey, Samie R.			Fluorescence Imaging of Cellular Metabolites with RNA	SCIENCE			English	Article							APTAMERS; SENSORS		[Paige, Jeremy S.; Nguyen-Duc, Thinh; Song, Wenjiao; Jaffrey, Samie R.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10065 USA	Cornell University	Jaffrey, SR (corresponding author), Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10065 USA.	srj2003@med.cornell.edu	song, wenjiao/E-4932-2012	song, wenjiao/0000-0002-6142-5390; Jaffrey, Samie/0000-0003-3615-6958	McKnight Foundation; NIH [EB010249, T32CA062948]; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010249] Funding Source: NIH RePORTER	McKnight Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank V. Schramm for inhibitors and M. Cohen, A. Deglincerti, W. Ping, and S. Blanchard for suggestions. Supported by the McKnight Foundation and NIH grants EB010249 and T32CA062948.	Cho EJ, 2009, ANNU REV ANAL CHEM, V2, P241, DOI 10.1146/annurev.anchem.1.031207.112851; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Lemke EA, 2011, NAT CHEM BIOL, V7, P480, DOI 10.1038/nchembio.620; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339	5	355	367	24	364	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2012	335	6073					1194	1194		10.1126/science.1218298	http://dx.doi.org/10.1126/science.1218298			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22403384	Green Accepted			2022-12-01	WOS:000301225100036
J	Kim, SE; Coste, B; Chadha, A; Cook, B; Patapoutian, A				Kim, Sung Eun; Coste, Bertrand; Chadha, Abhishek; Cook, Boaz; Patapoutian, Ardem			The role of Drosophila Piezo in mechanical nociception	NATURE			English	Article							MECHANOSENSORY TRANSDUCTION; SENSORY NEURONS; CHANNEL; MECHANOTRANSDUCTION; LOCOMOTION; SUBUNITS; HEARING	Transduction of mechanical stimuli by receptor cells is essential for senses such as hearing, touch and pain(1-4). Ion channels have a role in neuronal mechanotransduction in invertebrates(1); however, functional conservation of these ion channels in mammalian mechanotransduction is not observed. For example, no mechanoreceptor potential C (NOMPC), a member of transient receptor potential (TRP) ion channel family, acts as a mechanotransducer in Drosophila melanogaster(5) and Caenorhabditis elegans(6,7); however, it has no orthologues in mammals. Degenerin/epithelial sodium channel (DEG/ENaC) family members are mechanotransducers in C. elegans(8) and potentially in D. melanogaster(9); however, a direct role of its mammalian homologues in sensing mechanical force has not been shown. Recently, Piezo1 (also known as Fam38a) and Piezo2 (also known as Fam38b) were identified as components of mechanically activated channels in mammals(10). The Piezo family are evolutionarily conserved transmembrane proteins. It is unknown whether they function in mechanical sensing in vivo and, if they do, which mechanosensory modalities they mediate. Here we study the physiological role of the single Piezo member in D. melanogaster (Dmpiezo; also known as CG8486). Dmpiezo expression in human cells induces mechanically activated currents, similar to its mammalian counterparts(11). Behavioural responses to noxious mechanical stimuli were severely reduced in Dmpiezo knockout larvae, whereas responses to another noxious stimulus or touch were not affected. Knocking down Dmpiezo in sensory neurons that mediate nociception and express the DEG/ENaC ion channel pickpocket (ppk) was sufficient to impair responses to noxious mechanical stimuli. Furthermore, expression of Dmpiezo in these same neurons rescued the phenotype of the constitutive Dmpiezo knockout larvae. Accordingly, electrophysiological recordings from ppk-positive neurons revealed a Dmpiezo-dependent, mechanically activated current. Finally, we found that Dmpiezo and ppk function in parallel pathways in ppk-positive cells, and that mechanical nociception is abolished in the absence of both channels. These data demonstrate the physiological relevance of the Piezo family in mechanotransduction in vivo, supporting a role of Piezo proteins in mechanosensory nociception.	[Kim, Sung Eun; Coste, Bertrand; Chadha, Abhishek; Cook, Boaz; Patapoutian, Ardem] Scripps Res Inst TSRI, Dorris Neurosci Ctr, Dept Cell Biol, La Jolla, CA 92037 USA; [Patapoutian, Ardem] Novartis Res Fdn GNF, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Cook, B (corresponding author), Scripps Res Inst TSRI, Dorris Neurosci Ctr, Dept Cell Biol, La Jolla, CA 92037 USA.	bcook@scripps.edu; apatapou@gnf.org	KIM, SUNG EUN/E-4918-2011	Coste, Bertrand/0000-0002-0163-2494	National Institutes of Health; Novartis Research Foundation; Skaggs Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; Skaggs Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Y. N. Jan of the University of California San Francisco for providing ppk-EGFP5. Research was support by the National Institutes of Health and Novartis Research Foundation. S.E.K. and A.C. are supported by the Skaggs Institute.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Caldwell JC, 2003, P NATL ACAD SCI USA, V100, P16053, DOI 10.1073/pnas.2535546100; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	21	286	301	8	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2012	483	7388					209	212		10.1038/nature10801	http://dx.doi.org/10.1038/nature10801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22343891	Green Accepted			2022-12-01	WOS:000301174900038
J	Shevde, N				Shevde, Nirupama			STEM CELLS Flexible friends	NATURE			English	Editorial Material							PATIENT		Morgridge Inst Res Madison, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.	Shevde, N (corresponding author), Morgridge Inst Res Madison, Madison, WI USA.	rshevde@morgridgeinstitue.org						Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	4	12	20	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					S22	S26		10.1038/483S22a	http://dx.doi.org/10.1038/483S22a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	900HP	22378125	Bronze			2022-12-01	WOS:000300877900009
J	Spence, D				Spence, Des			Continuity is never out of fashion	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2012	344								e957	10.1136/bmj.e957	http://dx.doi.org/10.1136/bmj.e957			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	892IE	22318444				2022-12-01	WOS:000300279100013
J	Mack, JW; Cronin, A; Taback, N; Huskamp, HA; Keating, NL; Malin, JL; Earle, CC; Weeks, JC				Mack, Jennifer W.; Cronin, Angel; Taback, Nathan; Huskamp, Haiden A.; Keating, Nancy L.; Malin, Jennifer L.; Earle, Craig C.; Weeks, Jane C.			End-of-Life Care Discussions Among Patients With Advanced Cancer A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							METASTATIC COLORECTAL-CANCER; OUTCOMES RESEARCH; ILL PATIENTS; DEATH; SURVEILLANCE; SURVIVAL; PROGNOSTICATION; CHEMOTHERAPY; PREDICTORS; CARCINOMA	Background: National guidelines recommend that physicians discuss end-of-life (EOL) care planning with patients with cancer whose life expectancy is less than 1 year. Objective: To evaluate the incidence of EOL care discussions for patients with stage IV lung or colorectal cancer and where, when, and with whom these discussions take place. Design: Prospective cohort study of patients diagnosed with lung or colorectal cancer from 2003 to 2005. Setting: Participants lived in Northern California, Los Angeles County, North Carolina, Iowa, or Alabama or received care in 1 of 5 large HMOs or 1 of 15 Veterans Health Administration sites. Patients: 2155 patients with stage IV lung or colorectal cancer. Measurements: End-of-life care discussions reported in patient and surrogate interviews or documented in medical records through 15 months after diagnosis. Results: 73% of patients had EOL care discussions identified by at least 1 source. Among the 1470 patients who died during follow-up, 87% had EOL care discussions, compared with 41% of the 685 patients who were alive at the end of follow-up. Of the 1081 first EOL care discussions documented in records, 55% occurred in the hospital. Oncologists documented EOL care discussions with only 27% of their patients. Among 959 patients with documented EOL care discussions who died during follow-up, discussions took place a median of 33 days before death. Limitations: The depth and quality of EOL care discussions was not evaluated. Much of the information about discussions came from surrogates of patients who died before baseline interviews could be obtained. Conclusion: Although most patients with stage IV lung or colorectal cancer discuss EOL care planning with physicians before death, many discussions occur during acute hospital care, with providers other than oncologists, and late in the course of illness.	[Mack, Jennifer W.] Harvard Univ, Dana Farber Canc Inst, Childrens Hosp, Sch Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; Ontario Inst Canc Res, Toronto, ON, Canada	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Mack, JW (corresponding author), Harvard Univ, Dana Farber Canc Inst, Childrens Hosp, Sch Med, 450 Brookline Ave, Boston, MA 02215 USA.	jennifer_mack@dfci.harvard.edu	Keating, Nancy L/I-9968-2019	Keating, Nancy L/0000-0002-8274-4681; Taback, Nathan/0000-0001-9497-3951	National Cancer Institute (NCI) [U01 CA093344, U01 CA093332, U01 CA093324, U01 CA093348, U01 CA093329, U01 CA093339, U01 CA093326]; Department of Veterans Affairs [CRS 02-164]; American Cancer Society; National Palliative Care Research Center; NATIONAL CANCER INSTITUTE [U01CA093324, U01CA093329, U01CA093332, U01CA093339, K05CA166208, U01CA093344, U01CA093326] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); American Cancer Society(American Cancer Society); National Palliative Care Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work of the CanCORS Consortium was supported by grants from the National Cancer Institute (NCI) to the Statistical Coordinating Center (U01 CA093344) and the NCI-supported Primary Data Collection and Research Centers (grant U01 CA093332 to the Dana-Farber Cancer Institute/Cancer Research Network, grant U01 CA093324 to Harvard Medical School/Northern California Cancer Center, grant U01 CA093348 to RAND/University of California, Los Angeles, grant U01 CA093329 to the University of Alabama at Birmingham, grant U01 CA093339 to the University of Iowa, grant U01 CA093326 to University of North Carolina) and by grant CRS 02-164 from the Department of Veterans Affairs to the Durham Veterans Affairs Medical Center. Dr. Mack was funded by an American Cancer Society Mentored Research Scholar Grant and by the National Palliative Care Research Center.	American Association for Public Opinion Research, STAND DEF FIN DISP C; Ayanian JZ, 2004, J CLIN ONCOL, V22, P2992, DOI 10.1200/JCO.2004.06.020; Blackstock AW, 2002, JNCI-J NATL CANCER I, V94, P284, DOI 10.1093/jnci/94.4.284; Block SD, 2001, JAMA-J AM MED ASSOC, V285, P2898, DOI 10.1001/jama.285.22.2898; Catalano P, 2012, MED CARE IN PRESS; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Earle CC, 2000, CHEST, V117, P1239, DOI 10.1378/chest.117.5.1239; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Jenkins V, 2011, J CLIN ONCOL, V29, P61, DOI 10.1200/JCO.2010.30.0814; Kato I, 2001, CANCER, V92, P2211, DOI 10.1002/1097-0142(20011015)92:8<2211::AID-CNCR1565>3.0.CO;2-W; Keating NL, 2010, J CLIN ONCOL, V28, P4364, DOI 10.1200/JCO.2009.26.8870; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Lamont EB, 2003, JAMA-J AM MED ASSOC, V290, P98, DOI 10.1001/jama.290.1.98; Lehmann L, 2007, J CLIN ONCOL, V25; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Malin JL, 2006, SUPPORT CARE CANCER, V14, P837, DOI 10.1007/s00520-005-0902-8; MIYAJI NT, 1993, SOC SCI MED, V36, P249, DOI 10.1016/0277-9536(93)90008-R; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; National Comprehensive Cancer Network, PRACT GUID ONC PALL; National Consensus Project for Quality Palliative Care, CLIN PRACT GUID QUAL, V4th; Prigerson H G, 1991, Home Health Care Serv Q, V12, P81; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Ruddick W, 1999, BIOETHICS, V13, P343, DOI 10.1111/1467-8519.00162; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; WALLSTON KA, 1988, MED CARE, V26, P177, DOI 10.1097/00005650-198802000-00008; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863	32	273	275	2	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2012	156	3					204	U65		10.7326/0003-4819-156-3-201202070-00008	http://dx.doi.org/10.7326/0003-4819-156-3-201202070-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XD	22312140				2022-12-01	WOS:000299964200004
J	Junion, G; Spivakov, M; Girardot, C; Braun, M; Gustafson, EH; Birney, E; Furlong, EEM				Junion, Guillaume; Spivakov, Mikhail; Girardot, Charles; Braun, Martina; Gustafson, E. Hilary; Birney, Ewan; Furlong, Eileen E. M.			A Transcription Factor Collective Defines Cardiac Cell Fate and Reflects Lineage History	CELL			English	Article							HOLT-ORAM-SYNDROME; REGULATORY NETWORK; DROSOPHILA HEART; MUTUAL COFACTORS; FACTOR-BINDING; BOX GENES; MESODERM; ENHANCER; CARDIOGENESIS; TINMAN	Cell fate decisions are driven through the integration of inductive signals and tissue-specific transcription factors (TFs), although the details on how this information converges in cis remain unclear. Here, we demonstrate that the five genetic components essential for cardiac specification in Drosophila, including the effectors of Wg and Dpp signaling, act as a collective unit to cooperatively regulate heart enhancer activity, both in vivo and in vitro. Their combinatorial binding does not require any specific motif orientation or spacing, suggesting an alternative mode of enhancer function whereby cooperative activity occurs with extensive motif flexibility. A fraction of enhancers co-occupied by cardiogenic TFs had unexpected activity in the neighboring visceral mesoderm but could be rendered active in heart through single-site mutations. Given that cardiac and visceral cells are both derived from the dorsal mesoderm, this "dormant'' TF binding signature may represent a molecular footprint of these cells' developmental lineage.	[Junion, Guillaume; Spivakov, Mikhail; Girardot, Charles; Braun, Martina; Gustafson, E. Hilary; Furlong, Eileen E. M.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Spivakov, Mikhail; Birney, Ewan] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Furlong, EEM (corresponding author), European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany.	furlong@embl.de	Junion, guillaume/AAA-2034-2019; Junion, Guillaume/L-9129-2018; Girardot, Charles/AAF-2417-2020	Junion, guillaume/0000-0003-0458-6021; Girardot, Charles/0000-0003-4301-3920; Spivakov, Mikhail/0000-0002-0383-3943; Birney, Ewan/0000-0001-8314-8497; Gustafson, Eleanor Hilary/0000-0003-3978-8088; Furlong, Eileen/0000-0002-9544-8339	EMBL Genomics Core facility; Deutsche Forschungsgemeinschaft (DFG) [FU 750/1]; Human Frontier Science Program (HFSP); EMBO; EMBL EIPOD	EMBL Genomics Core facility; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); EMBL EIPOD	We are extremely grateful to M. Bienz, C.-H. Heldin, M. Frasch, and H. Jackle for antibodies. This work was technically supported by the EMBL Genomics Core facility, with specific thanks to Jos de Graaf for array hybridizations. We thank all members of the Furlong lab for discussions and comments on the manuscript, Stijn Van Dongen for help with assessing the robustness of clustering methods, and Thomas Sandmann for designing dsRNA probes. This work was supported by a Deutsche Forschungsgemeinschaft (DFG FU 750/1) grant and Human Frontier Science Program (HFSP) grant to E.E.M.F. and postdoctoral fellowships to G.J. from EMBO and to M.S. from the EMBL EIPOD program.	AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; CAMPOSORTEGA JA, 1997, EMBRYONIC DEV DROSPH; Cheeseman P., 1996, ADV KNOWLEDGE DISCOV; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Dai YS, 2001, J BIOL CHEM, V276, P37178, DOI 10.1074/jbc.M103731200; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Frasch M, 1999, SEMIN CELL DEV BIOL, V10, P61, DOI 10.1006/scdb.1998.0279; Gajewski K, 2001, DEV BIOL, V233, P425, DOI 10.1006/dbio.2001.0220; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jakobsen JS, 2007, GENE DEV, V21, P2448, DOI 10.1101/gad.437607; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; Kulkarni MM, 2003, DEVELOPMENT, V130, P6569, DOI 10.1242/dev.00890; Lee HH, 2005, DEVELOPMENT, V132, P1429, DOI 10.1242/dev.01687; Lee HH, 2000, DEVELOPMENT, V127, P5497; LEE HH, 2006, DEV LARVAL VISCERAL; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Lien CL, 1999, DEVELOPMENT, V126, P75; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Lockwood WK, 2002, MECH DEVELOP, V114, P13, DOI 10.1016/S0925-4773(02)00044-8; Molkentin JD, 2000, DEV BIOL, V217, P301, DOI 10.1006/dbio.1999.9544; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Perez-Pomares JM, 2009, INT J DEV BIOL, V53, P1427, DOI 10.1387/ijdb.072409jp; Reim I, 2005, DEVELOPMENT, V132, P4911, DOI 10.1242/dev.02077; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Sun GF, 2004, J CELL BIOCHEM, V92, P189, DOI 10.1002/jcb.20039; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Walter K, 2008, BLOOD, V112, P1673, DOI 10.1182/blood-2008-02-142786; Wilczynski B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.35; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354; Zaffran S, 2002, COLD SPRING HARB SYM, V67, P1, DOI 10.1101/sqb.2002.67.1; Zaffran S, 2002, CIRC RES, V91, P457, DOI 10.1161/01.RES.0000034152.74523.A8; Zaffran S, 2001, GENE DEV, V15, P2900; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	55	185	185	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 3	2012	148	3					473	486		10.1016/j.cell.2012.01.030	http://dx.doi.org/10.1016/j.cell.2012.01.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304916	Bronze			2022-12-01	WOS:000300225000016
J	Watson, J; Round, A; Hamilton, W				Watson, Jessica; Round, Alison; Hamilton, William			RATIONAL TESTING Raised inflammatory markers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ERYTHROCYTE SEDIMENTATION-RATE; C-REACTIVE PROTEIN; LOWER RESPIRATORY-TRACT; GENERAL-PRACTICE; DIAGNOSTIC-ACCURACY; PRIMARY-CARE; INFECTIONS; PNEUMONIA; CHILDREN; ADULTS		[Hamilton, William] Peninsula Coll Med & Dent, Exeter EX2 4SG, Devon, England; [Watson, Jessica] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Round, Alison] Castle Pl Practice, Tiverton EX16 6NP, Devon, England	University of Exeter; University of Plymouth; University of Bristol	Hamilton, W (corresponding author), Peninsula Coll Med & Dent, Exeter EX2 4SG, Devon, England.	willie.hamilton@pcmd.ac.uk	Hamilton, Willie/G-8612-2014	Watson, Jessica/0000-0002-8177-6438; Hamilton, William/0000-0003-1611-1373	National Institute for Health Research [ACF-2008-25-003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bundy DG, 2007, JAMA-J AM MED ASSOC, V298, P438, DOI 10.1001/jama.298.4.438; Butalia S, 2008, JAMA-J AM MED ASSOC, V299, P806, DOI 10.1001/jama.299.7.806; Cals JWL, 2010, FAM PRACT, V27, P212, DOI 10.1093/fampra/cmp088; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; DahlerEriksen BS, 1997, SCAND J PRIM HEALTH, V15, P35, DOI 10.3109/02813439709043427; DINANT GJ, 1991, BRIT J GEN PRACT, V41, P365; DINANT GJ, 1992, FAM PRACT, V9, P28, DOI 10.1093/fampra/9.1.28; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Falk G, 2009, FAM PRACT, V26, P10, DOI 10.1093/fampra/cmn095; FINCHER RME, 1986, ARCH INTERN MED, V146, P1581, DOI 10.1001/archinte.146.8.1581; Flood RG, 2008, PEDIATR INFECT DIS J, V27, P95, DOI 10.1097/INF.0b013e318157aced; FORD MJ, 1979, EUR J CLIN INVEST, V9, P191, DOI 10.1111/j.1365-2362.1979.tb00922.x; FROOM P, 1984, AM J CLIN PATHOL, V82, P198, DOI 10.1093/ajcp/82.2.198; GRONLIE M, 1991, Scandinavian Journal of Primary Health Care, V9, P97, DOI 10.3109/02813439109026591; Hassan Nada, 2011, BMJ, V342, pd3019, DOI 10.1136/bmj.d3019; Holm A, 2007, BRIT J GEN PRACT, V57, P555; Iversen OH, 1996, J INTERN MED, V240, P133, DOI 10.1046/j.1365-2796.1996.30195852000.x; Jakobsen KA, 2010, SCAND J PRIM HEALTH, V28, P229, DOI 10.3109/02813432.2010.506995; Johnson Heather L., 1999, Journal of Microbiology Immunology and Infection, V32, P73; Kesmarky G, 2008, CLIN HEMORHEOL MICRO, V39, P243, DOI 10.3233/CH-2008-1088; LluberasAcosta G, 1996, BRIT J CLIN PRACT, V50, P138; Monig H, 2002, FAM PRACT, V19, P436, DOI 10.1093/fampra/19.5.436; RAFNSSON V, 1979, ACTA MED SCAND, V206, P207; Sanders S, 2008, J PEDIATR, V153, P570, DOI 10.1016/j.jpeds.2008.04.023; Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008; THOMAS PD, 1987, CLIN RHEUMATOL, V6, P177, DOI 10.1007/BF02201020; THUE G, 1994, SCAND J CLIN LAB INV, V54, P291, DOI 10.3109/00365519409087525; Toriola AT, 2011, ANN ONCOL; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB; van Ravesteijn H, 2012, PATIENT EDUC COUNS, V86, P3, DOI 10.1016/j.pec.2011.02.003; Wiwanitkit Viroj, 2005, Infect Dis Obstet Gynecol, V13, P179, DOI 10.1080/10647440500068321; WYLER DJ, 1977, SOUTHERN MED J, V70, P1428, DOI 10.1097/00007611-197712000-00015	33	30	31	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2012	344								e454	10.1136/bmj.e454	http://dx.doi.org/10.1136/bmj.e454			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889QT	22306478	Green Submitted, Green Accepted			2022-12-01	WOS:000300089000001
J	Goldenberg, AJ; Sharp, RR				Goldenberg, Aaron J.; Sharp, Richard R.			The Ethical Hazards and Programmatic Challenges of Genomic Newborn Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sharp, Richard R.] Cleveland Clin, Dept Bioeth, Ctr Eth Humanities & Spiritual Care, Cleveland, OH 44195 USA; [Sharp, Richard R.] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Goldenberg, Aaron J.] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH USA; [Goldenberg, Aaron J.; Sharp, Richard R.] Case Western Reserve Univ, Sch Med, Ctr Genet Res Eth & Law, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Sharp, RR (corresponding author), Cleveland Clin, Dept Bioeth, Ctr Eth Humanities & Spiritual Care, 9500 Euclid Ave,JJ-60, Cleveland, OH 44195 USA.	sharpr3@ccf.org			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004500, P50HG003390] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01HG004500, P50HG003390, R01 HG004500, P50 HG003390] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2008, CHANG MOR FOC NEWB S; Botkin JR, 2006, PEDIATRICS, V117, P1793, DOI 10.1542/peds.2005-2547; Clayton EW, 2010, J LAW MED ETHICS, V38, P697, DOI 10.1111/j.1748-720X.2010.00522.x; Grosse SD, 2006, PEDIATRICS, V117, P923, DOI 10.1542/peds.2005-0553; Lewis MH, 2011, PEDIATRICS, V127, P703, DOI 10.1542/peds.2010-1468; Newborn screening in the genomic era: setting a research agenda, NEWB SCREEN GEN ER S; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Ross LF, 2010, KENNEDY INST ETHIC J, V20, P299; Sharp RR, 2011, GENET MED, V13, P191, DOI 10.1097/GIM.0b013e31820f603f; Tarini BA, 2006, PEDIATRICS, V118, P448, DOI 10.1542/peds.2005-2026	10	70	72	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2012	307	5					461	462		10.1001/jama.2012.68	http://dx.doi.org/10.1001/jama.2012.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884SH	22298675	Green Accepted			2022-12-01	WOS:000299728000024
J	Brohawn, SG; del Marmol, J; MacKinnon, R				Brohawn, Stephen G.; del Marmol, Josefina; MacKinnon, Roderick			Crystal Structure of the Human K2P TRAAK, a Lipid- and Mechano-Sensitive K+ Ion Channel	SCIENCE			English	Article							POLYUNSATURATED FATTY-ACIDS; DOMAIN POTASSIUM CHANNELS; ARACHIDONIC-ACID; TREK-1; PORE; RESOLUTION; TANDEM; LOCALIZATION; ACTIVATION; EXPRESSION	TRAAK channels, members of the two-pore domain K+ (potassium ion) channel family K2P, are expressed almost exclusively in the nervous system and control the resting membrane potential. Their gating is sensitive to polyunsaturated fatty acids, mechanical deformation of the membrane, and temperature changes. Physiologically, these channels appear to control the noxious input threshold for temperature and pressure sensitivity in dorsal root ganglia neurons. We present the crystal structure of human TRAAK at a resolution of 3.8 angstroms. The channel comprises two protomers, each containing two distinct pore domains, which create a two-fold symmetric K+ channel. The extracellular surface features a helical cap, 35 angstroms tall, that creates a bifurcated pore entryway and accounts for the insensitivity of two-pore domain K+ channels to inhibitory toxins. Two diagonally opposed gate-forming inner helices form membrane-interacting structures that may underlie this channel's sensitivity to chemical and mechanical properties of the cell membrane.	[MacKinnon, Roderick] Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@mail.rockefeller.edu		del Marmol, Josefina/0000-0003-2715-0482; Brohawn, Stephen/0000-0001-6768-3406	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chemin J, 2005, J BIOL CHEM, V280, P4415, DOI 10.1074/jbc.M408246200; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Cotten JF, 2006, ANESTH ANALG, V102, P779, DOI 10.1213/01.ane.0000194289.34345.63; Duprat F, 2000, MOL PHARMACOL, V57, P906; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Hille B., 2001, ION CHANNELS EXCITAB, V3; HODGKIN AL, 1947, J PHYSIOL-LONDON, V106, P341, DOI 10.1113/jphysiol.1947.sp004216; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; Kang D, 2005, J PHYSIOL-LONDON, V564, P103, DOI 10.1113/jphysiol.2004.081059; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P952, DOI 10.1007/s004240100626; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P64, DOI 10.1007/s004240000496; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lesage F, 2000, FEBS LETT, V471, P137, DOI 10.1016/S0014-5793(00)01388-0; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; Murbartian J, 2005, J BIOL CHEM, V280, P30175, DOI 10.1074/jbc.M503862200; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; OPSAHL LR, 1994, BIOPHYS J, V66, P75, DOI 10.1016/S0006-3495(94)80752-0; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	42	282	293	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2012	335	6067					436	441		10.1126/science.1213808	http://dx.doi.org/10.1126/science.1213808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22282805	Green Accepted			2022-12-01	WOS:000299466800041
J	Sarrazin, AF; Peel, AD; Averof, M				Sarrazin, Andres F.; Peel, Andrew D.; Averof, Michalis			A Segmentation Clock with Two-Segment Periodicity in Insects	SCIENCE			English	Article							VERTEBRATE SEGMENTATION; GRYLLUS-BIMACULATUS; ANNELID PLATYNEREIS; NOTCH; INVOLVEMENT; EVOLUTION; AXIS; GENERATION; NETWORKS; GENES	Vertebrate segmentation relies on a mechanism characterized by oscillating gene expression. Whether this mechanism is used by other segmented animals has been controversial. Rigorous proof of cyclic expression during arthropod segmentation has been lacking. We find that the segmentation gene odd-skipped (Tc-odd) oscillates with a two-segment periodicity in the beetle Tribolium castaneum. By bisecting embryos and culturing the two halves over different time intervals, we demonstrate that Tc-odd cycles with a period of about 95 minutes at 30 degrees C. Using live imaging and cell tracking in green fluorescent protein-expressing embryos, we can exclude that cell movements explain this dynamic expression. Our results show that molecular oscillators represent a common feature of segmentation in divergent animals and help reconcile the contrasting paradigms of insect and vertebrate segmentation.	[Sarrazin, Andres F.; Peel, Andrew D.; Averof, Michalis] Fdn Res & Technol Hellas FORTH, Inst Mol Biol & Biotechnol IMBB, GR-70013 Iraklion, Crete, Greece		Averof, M (corresponding author), Fdn Res & Technol Hellas FORTH, Inst Mol Biol & Biotechnol IMBB, Nikolaou Plastira 100, GR-70013 Iraklion, Crete, Greece.	averof@imbb.forth.gr	Sarrazin, Andres/A-1218-2013	Sarrazin, Andres/0000-0002-4307-1744; Averof, Michalis/0000-0002-6803-7251	CELLIMAGE and ZOONET (European Union)	CELLIMAGE and ZOONET (European Union)	We thank J. Schinko and G. Bucher for teaching us how to handle Tribolium and for help in generating the GFP-expressing transgenic line; J. P. Couso and S. Bishop for advice on embryo culture; D. Kosman, W. McGinnis, and C. Delidakis for advice on fluorescence in situ; and M. Strigini for critical comments on the manuscript. Our work was funded by the Marie Curie programs CELLIMAGE and ZOONET (FP6, European Union).	Brown S. J., 2009, COLD SPRING HARBOR P, P126; Chipman AD, 2004, CURR BIOL, V14, P1250, DOI 10.1016/j.cub.2004.07.026; Chipman AD, 2008, DEV BIOL, V319, P160, DOI 10.1016/j.ydbio.2008.02.038; Chipman AD, 2010, BIOESSAYS, V32, P60, DOI 10.1002/bies.200900130; Choe CP, 2006, P NATL ACAD SCI USA, V103, P6560, DOI 10.1073/pnas.0510440103; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; de Rosa R, 2005, EVOL DEV, V7, P574; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dray N, 2010, SCIENCE, V329, P339, DOI 10.1126/science.1188913; Kainz F, 2011, DEVELOPMENT, V138, P5015, DOI 10.1242/dev.073395; Krol AJ, 2011, DEVELOPMENT, V138, P2783, DOI 10.1242/dev.063834; Martin BL, 2009, CURR BIOL, V19, pR215, DOI 10.1016/j.cub.2009.01.052; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Mito T, 2011, DEVELOPMENT, V138, P3823, DOI 10.1242/dev.060681; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Oda H, 2007, DEVELOPMENT, V134, P2195, DOI 10.1242/dev.004598; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Peel A, 2003, CURR BIOL, V13, pR708, DOI 10.1016/j.cub.2003.08.045; Pueyo JI, 2008, P NATL ACAD SCI USA, V105, P16614, DOI 10.1073/pnas.0804093105; Schoppmeier M, 2005, DEV BIOL, V280, P211, DOI 10.1016/j.ydbio.2005.01.024; Stollewerk A, 2003, NATURE, V423, P863, DOI 10.1038/nature01682; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246	23	144	145	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					338	341		10.1126/science.1218256	http://dx.doi.org/10.1126/science.1218256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22403177				2022-12-01	WOS:000302995400043
J	Tang, W; Kannan, R; Blanchette, M; Baumann, P				Tang, Wen; Kannan, Ram; Blanchette, Marco; Baumann, Peter			Telomerase RNA biogenesis involves sequential binding by Sm and Lsm complexes	NATURE			English	Article							NUCLEAR RIBONUCLEOPROTEIN PARTICLE; SCHIZOSACCHAROMYCES-POMBE; IN-VITRO; YEAST TELOMERASE; U6 SNRNA; PROTEIN; HYPERMETHYLATION; IDENTIFICATION; ASSOCIATION; LENGTH	In most eukaryotes, the progressive loss of chromosome-terminal DNA sequences is counteracted by the enzyme telomerase, a reverse transcriptase that uses part of an RNA subunit as template to synthesize telomeric repeats. Many cancer cells express high telomerase activity, and mutations in telomerase subunits are associated with degenerative syndromes including dyskeratosis congenita and aplastic anaemia. The therapeutic value of altering telomerase activity thus provides ample impetus to study the biogenesis and regulation of this enzyme in human cells and model systems. We have previously identified a precursor of the fission yeast telomerase RNA subunit (TER1)(1) and demonstrated that the mature 3'-end is generated by the spliceosome in a single cleavage reaction akin to the first step of splicing(2). Directly upstream and partly overlapping with the spliceosomal cleavage site is a putative binding site for Sm proteins. Sm and like-Sm (LSm) proteins belong to an ancient family of RNA-binding proteins represented in all three domains of life(3). Members of this family form ring complexes on specific sets of target RNAs and have critical roles in their biogenesis, function and turnover. Here we demonstrate that the canonical Sm ring and the Lsm2-8 complex sequentially associate with fission yeast TER1. The Sm ring binds to the TER1 precursor, stimulates spliceosomal cleavage and promotes the hypermethylation of the 5'-cap by Tgs1. Sm proteins are then replaced by the Lsm2-8 complex, which promotes the association with the catalytic subunit and protects the mature 3'-end of TER1 from exonucleolytic degradation. Our findings define the sequence of events that occur during telomerase biogenesis and characterize roles for Sm and Lsm complexes as well as for the methylase Tgs1.	[Tang, Wen; Kannan, Ram; Baumann, Peter] Howard Hughes Med Inst, Kansas City, MO 64110 USA; [Tang, Wen; Kannan, Ram; Blanchette, Marco; Baumann, Peter] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Tang, Wen; Kannan, Ram; Baumann, Peter] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Blanchette, Marco] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Howard Hughes Medical Institute; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Baumann, P (corresponding author), Howard Hughes Med Inst, Kansas City, MO 64110 USA.	peb@stowers.org		Baumann, Peter/0000-0003-4892-1485	Stowers Institute for Medical Research; American Heart Association	Stowers Institute for Medical Research; American Heart Association(American Heart Association)	We thank S. Shuman for the tgs1 Delta strain, J. A. Box, J. T. Bunch, S. Hartnett and R. M. Helston for technical assistance, the Molecular Biology Core Facility for site-directed mutagenesis and sequencing, D. P. Baumann and R. M. Helston for proofreading the manuscript, and all members of the Baumann laboratory for discussions. This work was funded in part by the Stowers Institute for Medical Research. R. K. is supported by an award from the American Heart Association, and P. B. is an Early Career Scientist with the Howard Hughes Medical Institute.	Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Berman AJ, 2010, MOL CELL BIOL, V30, P4965, DOI 10.1128/MCB.00827-10; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; Bunch JT, 2005, MOL CELL BIOL, V25, P5567, DOI 10.1128/mcb.25.13.5567-5578.2005; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; Franke J, 2008, J CELL SCI, V121, P3553, DOI 10.1242/jcs.033308; Fu D, 2006, GENE DEV, V20, P531, DOI 10.1101/gad.1390306; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gunisova S, 2009, RNA, V15, P546, DOI 10.1261/rna.1194009; Haering CH, 2000, P NATL ACAD SCI USA, V97, P6367, DOI 10.1073/pnas.130187397; Harrington L, 2005, CHROMOSOME RES, V13, P493, DOI 10.1007/s10577-005-0994-5; Hausmann S, 2007, NUCLEIC ACIDS RES, V35, P1411, DOI 10.1093/nar/gkl1150; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Kufel J, 2003, J BIOL CHEM, V278, P2147, DOI 10.1074/jbc.M208856200; Kufel J, 2002, MOL CELL BIOL, V22, P5248, DOI 10.1128/MCB.22.14.5248-5256.2002; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; O'Connor CM, 2006, MOL CELL BIOL, V26, P2029, DOI 10.1128/MCB.26.6.2029-2036.2006; Patel SB, 2008, NUCLEIC ACIDS RES, V36, P6482, DOI 10.1093/nar/gkn658; PLESSEL G, 1994, MOL CELL BIOL, V14, P4160, DOI 10.1128/MCB.14.6.4160; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Terns MP, 2001, CURR BIOL, V11, pR862, DOI 10.1016/S0960-9822(01)00517-6; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; Yong J, 2010, MOL CELL, V38, P551, DOI 10.1016/j.molcel.2010.03.014	33	62	63	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					260	U152		10.1038/nature10924	http://dx.doi.org/10.1038/nature10924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22446625	Green Accepted			2022-12-01	WOS:000303149900039
J	Derecki, NC; Cronk, JC; Lu, ZJ; Xu, E; Abbott, SBG; Guyenet, PG; Kipnis, J				Derecki, Noel C.; Cronk, James C.; Lu, Zhenjie; Xu, Eric; Abbott, Stephen B. G.; Guyenet, Patrice G.; Kipnis, Jonathan			Wild-type microglia arrest pathology in a mouse model of Rett syndrome	NATURE			English	Article							CPG-BINDING PROTEIN-2; ALZHEIMERS-DISEASE; MUTANT MICE; MECP2; DEFICIENCY; MUTATIONS; SYMPTOMS; REVERSAL; DEATH; CELLS	Rett syndrome is an X-linked autism spectrum disorder. The disease is characterized inmost cases by mutation of the MECP2 gene, which encodes a methyl-CpG-binding protein(1-5). Although MECP2 is expressed in many tissues, the disease is generally attributed to a primary neuronal dysfunction(6). However, as shown recently, glia, specifically astrocytes, also contribute to Rett pathophysiology. Here we examine the role of another form of glia, microglia, in a murine model of Rett syndrome. Transplantation of wild-type bone marrow into irradiation-conditioned Mecp2-null hosts resulted in engraftment of brain parenchyma by bone-marrow-derived myeloid cells of microglial phenotype, and arrest of disease development. However, when cranial irradiation was blocked by lead shield, and microglial engraftment was prevented, disease was not arrested. Similarly, targeted expression of MECP2 in myeloid cells, driven by Lysm(cre) on an Mecp2-null background, markedly attenuated disease symptoms. Thus, through multiple approaches, wild-type Mecp2-expressing microglia within the context of an Mecp2-null male mouse arrested numerous facets of disease pathology: lifespan was increased, breathing patterns were normalized, apnoeas were reduced, body weight was increased to near that of wild type, and locomotor activity was improved. Mecp2(+/-) females also showed significant improvements as a result of wild-type microglial engraftment. These benefits mediated by wild-type microglia, however, were diminished when phagocytic activity was inhibited pharmacologically by using annexin V to block phosphatydilserine residues on apoptotic targets, thus preventing recognition and engulfment by tissue-resident phagocytes. These results suggest the importance of microglial phagocytic activity in Rett syndrome. Our data implicate microglia as major players in the pathophysiology of this devastating disorder, and suggest that bone marrow transplantation might offer a feasible therapeutic approach for it.	[Derecki, Noel C.; Cronk, James C.; Lu, Zhenjie; Xu, Eric; Kipnis, Jonathan] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; [Derecki, Noel C.; Cronk, James C.; Kipnis, Jonathan] Univ Virginia, Sch Med, Grad Program Neurosci, Charlottesville, VA 22908 USA; [Cronk, James C.; Kipnis, Jonathan] Univ Virginia, Sch Med, Med Scientist Training Program, Charlottesville, VA 22908 USA; [Xu, Eric] Univ Virginia, Undergrad Sch Arts & Sci, Charlottesville, VA 22908 USA; [Abbott, Stephen B. G.; Guyenet, Patrice G.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Kipnis, J (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA.	kipnis@virginia.edu		Abbott, Stephen BG/0000-0003-1244-3637	Hartwell Foundation; Rett Syndrome Research Trust;  [HD056293];  [AG034113]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034113] Funding Source: NIH RePORTER	Hartwell Foundation; Rett Syndrome Research Trust; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Smith for editing the manuscript. We thank the members of the Kipnis laboratory as well as the members of the University of Virginia Neuroscience Department for their comments during multiple discussions of this work. We also thank S. Feldman for injection of neonatal mice, I. Smirnov for tail vein injections, and B. Tomlin and J. Jones for their animal care. N.C.D. is a recipient of a Hartwell Foundation post-doctoral fellowship. This work was primarily supported by a grant from the Rett Syndrome Research Trust (to J.K.) and in part by HD056293 and AG034113 (to J.K).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; DRORBAUGH JE, 1955, PEDIATRICS, V16, P81; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HOOGERBRUGGE PM, 1988, SCIENCE, V239, P1035, DOI 10.1126/science.3278379; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lu ZJ, 2011, NAT CELL BIOL, V13, P1076, DOI 10.1038/ncb2299; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Nan XH, 2001, BRAIN DEV-JPN, V23, pS32, DOI 10.1016/S0387-7604(01)00333-3; Nijboer CH, 2010, BRAIN BEHAV IMMUN, V24, P420, DOI 10.1016/j.bbi.2009.11.009; OLDFORS A, 1990, PEDIATR NEUROL, V6, P310, DOI 10.1016/0887-8994(90)90022-S; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Van den Veyver IB, 2001, BRAIN DEV-JPN, V23, pS147, DOI 10.1016/S0387-7604(01)00376-X; Van den Veyver IB, 2002, MENT RETARD DEV D R, V8, P82, DOI 10.1002/mrdd.10025; Willemen HLDM, 2010, PAIN, V150, P550, DOI 10.1016/j.pain.2010.06.015; Zhang X, 2009, TOXICOL SCI, V111, P355, DOI 10.1093/toxsci/kfp167	30	426	439	3	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					105	+		10.1038/nature10907	http://dx.doi.org/10.1038/nature10907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22425995	Green Accepted			2022-12-01	WOS:000302343400043
J	Ayele, FT; Adeyemo, A; Finan, C; Hailu, E; Sinnott, P; Burlinson, ND; Aseffa, A; Rotimi, CN; Newport, MJ; Davey, G				Ayele, Fasil Tekola; Adeyemo, Adebowale; Finan, Chris; Hailu, Elena; Sinnott, Paul; Burlinson, Natalia Diaz; Aseffa, Abraham; Rotimi, Charles N.; Newport, Melanie J.; Davey, Gail			HLA Class II Locus and Susceptibility to Podoconiosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NON-FILARIAL ELEPHANTIASIS; ENDEMIC ELEPHANTIASIS; SOUTHERN ETHIOPIA; GENETIC-ANALYSIS; COMPLEX DISEASE; LOWER LEGS; ASSOCIATION; SILICOSIS; CONSENT; STIGMA	BACKGROUND Podoconiosis is a tropical lymphedema resulting from long-term barefoot exposure to red-clay soil derived from volcanic rock. The World Health Organization recently designated it as a neglected tropical disease. Podoconiosis develops in only a subgroup of exposed people, and studies have shown familial clustering with high heritability (63%). METHODS We conducted a genomewide association study of 194 case patients and 203 controls from southern Ethiopia. Findings were validated by means of family-based association testing in 202 family trios and HLA typing in 94 case patients and 94 controls. RESULTS We found a genomewide significant association of podoconiosis with the single-nucleotide polymorphism (SNP) rs17612858, located 5.8 kb from the HLA-DQA1 locus (in the allelic model: odds ratio, 2.44; 95% confidence interval [CI], 1.82 to 3.26; P = 1.42x10(-9); and in the additive model: odds ratio, 2.19; 95% CI, 1.66 to 2.90; P = 3.44x10(-8)), and suggestive associations (P<1.0x10(-5)) with seven other SNPs in or near HLA-DQB1, HLA-DQA1, and HLA-DRB1. We confirmed these associations using family-based association testing. HLA typing showed the alleles HLA-DRB1*0701 (odds ratio, 2.00), DQA1*0201 (odds ratio, 1.91), and DQB1*0202 (odds ratio, 1.79) and the HLA-DRB1*0701-DQB1*0202 haplotype (odds ratio, 1.92) were risk variants for podoconiosis. CONCLUSIONS Association between variants in HLA class II loci with podoconiosis (a noncommunicable disease) suggests that the condition may be a T-cell-mediated inflammatory disease and is a model for gene-environment interactions that may be relevant to other complex genetic disorders. (Funded by the Wellcome Trust and others.)	[Ayele, Fasil Tekola; Adeyemo, Adebowale; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Ayele, Fasil Tekola; Finan, Chris; Newport, Melanie J.; Davey, Gail] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Ayele, Fasil Tekola; Hailu, Elena; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Sinnott, Paul; Burlinson, Natalia Diaz] Royal London Hosp, Clin Transplantat Lab, London E1 1BB, England	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Brighton; University of Sussex; Barts Health NHS Trust; Royal London Hospital	Ayele, FT (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, NIH, Bldg 12A,Rm 4044,12 South Dr,MSC 5635, Bethesda, MD 20892 USA.	ayeleft@mail.nih.gov	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Adeyemo, Adebowale/0000-0002-3105-3231; Newport, Melanie/0000-0002-8946-7525; Davey, Gail/0000-0003-2796-7468; Tekola-Ayele, Fasil/0000-0003-4194-9370	Wellcome Trust [079791]; Association of Physicians of Great Britain and Ireland; Center for Research on Genomics and Global Health (CRGGH); National Human Genome Research Institute; National Institute of Diabetes and Digestive and Kidney Diseases; Center for Information Technology; Office of the Director at the National Institutes of Health [Z01HG200362]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362, Z01HG200362] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Association of Physicians of Great Britain and Ireland; Center for Research on Genomics and Global Health (CRGGH); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Information Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); Office of the Director at the National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funded by the Wellcome Trust and others.; Supported in part by grants from the Wellcome Trust (079791) and the Association of Physicians of Great Britain and Ireland's Links with Developing Country Scheme, as well as the Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH). The CRGGH is supported by a grant from the National Human Genome Research Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the Center for Information Technology, and the Office of the Director at the National Institutes of Health (Z01HG200362).	Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Caruso C, 2000, HUM IMMUNOL, V61, P942, DOI 10.1016/S0198-8859(00)00168-3; Cesbron-Gautier A, 2004, ANN BIOL CLIN-PARIS, V62, P93; Davey G, 2007, T ROY SOC TROP MED H, V101, P91, DOI 10.1016/j.trstmh.2006.05.002; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Destas K, 2003, TROP DOCT, V33, P217, DOI 10.1177/004947550303300410; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Lapolla W, 2011, NEW ENGL J MED, V364, pE23, DOI 10.1056/NEJMicm1008802; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; NEWMAN LS, 1993, SCIENCE, V262, P197, DOI 10.1126/science.8105535; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Price E W, 1972, Ethiop Med J, V10, P87; PRICE EW, 1981, ANN OCCUP HYG, V24, P1, DOI 10.1093/annhyg/24.1.1; PRICE EW, 1978, T ROY SOC TROP MED H, V72, P132, DOI 10.1016/0035-9203(78)90048-2; Price EW, 1990, PODOCONIOSIS NONFILA; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; Saltini C, 2001, EUR RESPIR J, V18, P677, DOI 10.1183/09031936.01.00106201; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Tekola F, 2006, TROP MED INT HEALTH, V11, P1136, DOI 10.1111/j.1365-3156.2006.01658.x; Tekola F, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-13; Tekola F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000482; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Ueki A, 2005, J OCCUP HEALTH, V47, P61, DOI 10.1539/joh.47.61; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; WOLDEGABRIEL G, 1990, GEOL SOC AM BULL, V102, P439, DOI 10.1130/0016-7606(1990)102<0439:GGARBD>2.3.CO;2; Yakob B, 2008, T ROY SOC TROP MED H, V102, P439, DOI 10.1016/j.trstmh.2008.01.023	28	100	101	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2012	366	13					1200	1208		10.1056/NEJMoa1108448	http://dx.doi.org/10.1056/NEJMoa1108448			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915DW	22455414	Bronze, Green Accepted			2022-12-01	WOS:000302005100008
J	Truepenny, P; Kaushik, V; Lempp, H				Truepenny, Paul; Kaushik, Viswanath; Lempp, Heidi			A PATIENT'S JOURNEY Polymyositis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kaushik, Viswanath] Lincoln Cty Hosp, Dept Rheumatol, Lincoln LN2 5QY, England; [Lempp, Heidi] Kings Coll London, Sch Med, Dept Acad Rheumatol, London WC2R 2LS, England	University of London; King's College London	Kaushik, V (corresponding author), Lincoln Cty Hosp, Dept Rheumatol, Lincoln LN2 5QY, England.	Viswanath.Kaushik@ulh.nhs.uk	Lempp, Heidi/T-2914-2017	Lempp, Heidi/0000-0003-2509-3656				ODDIS CV, 1990, J RHEUMATOL, V17, P1329	1	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 15	2012	344								e1181	10.1136/bmj.e1181	http://dx.doi.org/10.1136/bmj.e1181			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913CD	22422831	Bronze			2022-12-01	WOS:000301848100001
J	Detsky, AS				Detsky, Allan S.			Underestimating the Value of Reassurance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROSTATE-CANCER; MORTALITY		[Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto	Detsky, AS (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.	adetsky@mtsinai.on.ca						Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], CTV NEWS; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Chou R, 2011, JAMA-J AM MED ASSOC, V306, P2721, DOI 10.1001/jama.2011.1891; Detsky AS, 2001, NEW ENGL J MED, V345, P607, DOI 10.1056/NEJM200108233450809; Kim J, 2011, JAMA-J AM MED ASSOC, V306, P2717, DOI 10.1001/jama.2011.1881; KRAHN MD, 1994, JAMA-J AM MED ASSOC, V272, P773, DOI 10.1001/jama.272.10.773; Miller DC, 2011, JAMA-J AM MED ASSOC, V306, P2719, DOI 10.1001/jama.2011.1879; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Smith MR, 2011, NEW ENGL J MED, V364, P1770, DOI 10.1056/NEJMe1100787; Sullivan PW, 2011, MED DECIS MAKING, V31, P787, DOI 10.1177/0272989X11400755; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; *US PREV SERV TASK, SCREEN PROST CANC; Volk RJ, 2011, JAMA-J AM MED ASSOC, V306, P2715, DOI 10.1001/jama.2011.1893; Welch HG, 2011, JAMA-J AM MED ASSOC, V306, P2649, DOI 10.1001/jama.2011.1898	15	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2012	307	10					1035	1036		10.1001/jama.2012.235	http://dx.doi.org/10.1001/jama.2012.235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908GU	22416098				2022-12-01	WOS:000301479700023
J	Kmietowicz, Z				Kmietowicz, Zosia			BMJ GROUP IMPROVING HEALTH AWARDS Sports and exercise doctors: the unsung heroes of champions	BRITISH MEDICAL JOURNAL			English	Editorial Material												zkmietowicz@bmj.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 14	2012	344								e1787	10.1136/bmj.e1787	http://dx.doi.org/10.1136/bmj.e1787			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	913BY	22418414				2022-12-01	WOS:000301847600014
J	Gerlinger, M; Rowan, AJ; Horswell, S; Larkin, J; Endesfelder, D; Gronroos, E; Martinez, P; Matthews, N; Stewart, A; Tarpey, P; Varela, I; Phillimore, B; Begum, S; McDonald, NQ; Butler, A; Jones, D; Raine, K; Latimer, C; Santos, CR; Nohadani, M; Eklund, AC; Spencer-Dene, B; Clark, G; Pickering, L; Stamp, G; Gore, M; Szallasi, Z; Downward, J; Futreal, PA; Swanton, C				Gerlinger, Marco; Rowan, Andrew J.; Horswell, Stuart; Larkin, James; Endesfelder, David; Gronroos, Eva; Martinez, Pierre; Matthews, Nicholas; Stewart, Aengus; Tarpey, Patrick; Varela, Ignacio; Phillimore, Benjamin; Begum, Sharmin; McDonald, Neil Q.; Butler, Adam; Jones, David; Raine, Keiran; Latimer, Calli; Santos, Claudio R.; Nohadani, Mahrokh; Eklund, Aron C.; Spencer-Dene, Bradley; Clark, Graham; Pickering, Lisa; Stamp, Gordon; Gore, Martin; Szallasi, Zoltan; Downward, Julian; Futreal, P. Andrew; Swanton, Charles			Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; RENAL-CELL CARCINOMA; PANCREATIC-CANCER; GENOMIC ANALYSIS; LUNG-CANCER; MUTATIONS; NEPHRECTOMY; GENE; INSTABILITY; METASTASIS	BACKGROUND Intratumor heterogeneity may foster tumor evolution and adaptation and hinder personalized-medicine strategies that depend on results from single tumor-biopsy samples. METHODS To examine intratumor heterogeneity, we performed exome sequencing, chromosome aberration analysis, and ploidy profiling on multiple spatially separated samples obtained from primary renal carcinomas and associated metastatic sites. We characterized the consequences of intratumor heterogeneity using immunohistochemical analysis, mutation functional analysis, and profiling of messenger RNA expression. RESULTS Phylogenetic reconstruction revealed branched evolutionary tumor growth, with 63 to 69% of all somatic mutations not detectable across every tumor region. Intratumor heterogeneity was observed for a mutation within an autoinhibitory domain of the mammalian target of rapamycin (mTOR) kinase, correlating with S6 and 4EBP phosphorylation in vivo and constitutive activation of mTOR kinase activity in vitro. Mutational intratumor heterogeneity was seen for multiple tumor-suppressor genes converging on loss of function; SETD2, PTEN, and KDM5C underwent multiple distinct and spatially separated inactivating mutations within a single tumor, suggesting convergent phenotypic evolution. Gene-expression signatures of good and poor prognosis were detected in different regions of the same tumor. Allelic composition and ploidy profiling analysis revealed extensive intratumor heterogeneity, with 26 of 30 tumor samples from four tumors harboring divergent allelic-imbalance profiles and with ploidy heterogeneity in two of four tumors. CONCLUSIONS Intratumor heterogeneity can lead to underestimation of the tumor genomics landscape portrayed from single tumor-biopsy samples and may present major challenges to personalized-medicine and biomarker development. Intratumor heterogeneity, associated with heterogeneous protein function, may foster tumor adaptation and therapeutic failure through Darwinian selection. (Funded by the Medical Research Council and others.)	[Swanton, Charles] Canc Res UK London Res Inst, Translat Canc Therapeut Lab, London WC2A 3LY, England; [Larkin, James; Nohadani, Mahrokh; Pickering, Lisa; Stamp, Gordon; Gore, Martin] Royal Marsden Hosp, Dept Med, London SW3 6JJ, England; [Tarpey, Patrick; Varela, Ignacio; Butler, Adam; Jones, David; Raine, Keiran; Latimer, Calli; Futreal, P. Andrew] Wellcome Trust Sanger Inst, London, England; [Gerlinger, Marco] Barts & London Queen Marys Sch Med & Dent, Barts Canc Inst, London, England; [Swanton, Charles] UCL, Inst Canc, London, England; [Eklund, Aron C.; Szallasi, Zoltan] Tech Univ Denmark, DK-2800 Lyngby, Denmark; [Szallasi, Zoltan] Harvard Univ, Sch Med, Boston, MA USA	Cancer Research UK; Royal Marsden NHS Foundation Trust; Wellcome Trust Sanger Institute; University of London; Queen Mary University London; University of London; University College London; Technical University of Denmark; Harvard University; Harvard Medical School	Swanton, C (corresponding author), Canc Res UK London Res Inst, Translat Canc Therapeut Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	charles.swanton@cancer.org.uk	Jang, JaJune/F-6647-2011; Gronroos, Eva/P-6951-2015; Gronroos, Eva/E-9351-2013; Varela, Ignacio/G-1699-2016; Varela, Ignacio/AAA-7680-2021; wang, edwin/G-5372-2010	Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Gerlinger, Marco/0000-0003-2719-299X; Larkin, James/0000-0001-5569-9523; Horswell, Stuart/0000-0003-2787-1933; Downward, Julian/0000-0002-2331-4729; Swanton, Charles/0000-0002-4299-3018; Raine, Keiran/0000-0002-5634-1539; Santos, Claudio/0000-0002-8766-2247; Gronroos, Eva/0000-0001-8303-5409; Eklund, Aron Charles/0000-0003-0861-1001; Szallasi, Zoltan/0000-0001-5395-7509; Martinez, Pierre/0000-0001-7069-4413	Medical Research Council, Cancer Research UK; Royal Marsden Hospital; Novartis; EU; Wellcome Trust; Cancer Research UK [15680, 10747] Funding Source: researchfish; Medical Research Council [G0701935, G0902275] Funding Source: researchfish; MRC [G0902275, G0701935] Funding Source: UKRI	Medical Research Council, Cancer Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Cancer Research UK); Royal Marsden Hospital(Royal Society of New ZealandMarsden Fund (NZ)); Novartis(Novartis); EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the Medical Research Council, Cancer Research UK, the Royal Marsden Hospital Renal Research Fund, Novartis, EU Framework 7 Personalized RNA Interference to Enhance the Delivery of Individualized Cytotoxic and Targeted Therapeutics (PREDICT), and the Wellcome Trust (to Dr. Futreal).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brannon A Rose, 2010, Genes Cancer, V1, P152; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cho D, 2007, CLIN GENITOURIN CANC, V5, P379, DOI 10.3816/CGC.2007.n.020; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Flanigan RC, 2004, J UROLOGY, V171, P1071, DOI 10.1097/01.ju.0000110610.61545.ae; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	30	5347	5527	24	859	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2012	366	10					883	892		10.1056/NEJMoa1113205	http://dx.doi.org/10.1056/NEJMoa1113205			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904CY	22397650	Green Accepted			2022-12-01	WOS:000301172500005
J	Blinderman, CD; Krakauer, EL; Solomon, MZ				Blinderman, Craig D.; Krakauer, Eric L.; Solomon, Mildred Z.			Time to Revise the Approach to Determining Cardiopulmonary Resuscitation Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Blinderman, Craig D.] Columbia Univ, Med Ctr, Dept Anesthesiol, New York, NY 10032 USA; [Solomon, Mildred Z.] Harvard Univ, Sch Med, Div Med Eth, Boston, MA USA; [Krakauer, Eric L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Krakauer, Eric L.; Solomon, Mildred Z.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Krakauer, Eric L.] Massachusetts Gen Hosp, Palliat Care Serv, Boston, MA 02114 USA; [Krakauer, Eric L.] Massachusetts Gen Hosp, Optimum Care Comm, Boston, MA 02114 USA; [Solomon, Mildred Z.] Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA	Columbia University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital	Blinderman, CD (corresponding author), Columbia Univ, Med Ctr, Dept Anesthesiol, 622 W 168th St,PH5-530B, New York, NY 10032 USA.	cdb21@columbia.edu						Billings JA, 2011, ARCH INTERN MED, V171, P849, DOI 10.1001/archinternmed.2011.180; Brett AS, 2012, JAMA-J AM MED ASSOC, V307, P149, DOI 10.1001/jama.2011.1999; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Halpern SD, 2007, NEW ENGL J MED, V357, P1340, DOI 10.1056/NEJMsb071595; Kane RS, 1997, J AM GERIATR SOC, V45, P154, DOI 10.1111/j.1532-5415.1997.tb04500.x; Larkin GL, 2010, RESUSCITATION, V81, P302, DOI 10.1016/j.resuscitation.2009.11.021; [Standards for cardiopulmonary resuscitation (CPR) emergency cardiac care (ECC)], 1974, JAMA, V227, P837	7	51	51	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2012	307	9					917	918		10.1001/jama.2012.236	http://dx.doi.org/10.1001/jama.2012.236			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904CU	22396511				2022-12-01	WOS:000301172100017
J	Armstrong, AA; Mohideen, F; Lima, CD				Armstrong, Anthony A.; Mohideen, Firaz; Lima, Christopher D.			Recognition of SUMO-modified PCNA requires tandem receptor motifs in Srs2	NATURE			English	Article							UBIQUITIN-BINDING DOMAINS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNA; RECOMBINATION; CLAMP; PHOSPHORYLATION; POLYMERASES; RECRUITMENT	Ubiquitin (Ub) and ubiquitin-like (Ubl) modifiers such as SUMO (also known as Smt3 in Saccharomyces cerevisiae) mediate signal transduction through post-translational modification of substrate proteins in pathways that control differentiation, apoptosis and the cell cycle, and responses to stress such as the DNA damage response. In yeast, the proliferating cell nuclear antigen PCNA (also known as Pol30) is modified by ubiquitin in response to DNA damage and by SUMO during S phase. Whereas Ub-PCNA can signal for recruitment of translesion DNA polymerases, SUMO-PCNA signals for recruitment of the anti-recombinogenic DNA helicase Srs2. It remains unclear how receptors such as Srs2 specifically recognize substrates after conjugation to Ub and Ubls. Here we show, through structural, biochemical and functional studies, that the Srs2 carboxy-terminal domain harbours tandem receptor motifs that interact independently with PCNA and SUMO and that both motifs are required to recognize SUMO-PCNA specifically. The mechanism presented is pertinent to understanding how other receptors specifically recognize Ub- and Ubl-modified substrates to facilitate signal transduction.	[Armstrong, Anthony A.; Mohideen, Firaz; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA.	limac@mskcc.org		Lima, Christopher/0000-0002-9163-6092	NIH NCRR [RR-15301, P41RR012408]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NIH [R01 GM065872, F32 GM086066]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065872, F32GM086066] Funding Source: NIH RePORTER	NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kuriyan and B. Kelch for coordinates of the T4 clamp before publication. NE-CAT beamlines (Advanced Photon Source) supported by RR-15301 (NIH NCRR). APS supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Beamline X29 (National Synchrotron Light Source) supported by the US Department of Energy, the Office of Basic Energy Sciences and P41RR012408 (NIH NCRR). A.A.A., F.M. and C.D.L. are supported by NIH R01 GM065872 to C.D.L. and F32 GM086066 to A.A.A.	Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Baba D, 2006, J MOL BIOL, V359, P137, DOI 10.1016/j.jmb.2006.03.036; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Freudenthal BD, 2011, J MOL BIOL, V406, P9, DOI 10.1016/j.jmb.2010.12.015; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kazmirski SL, 2005, P NATL ACAD SCI USA, V102, P13801, DOI 10.1073/pnas.0506430102; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Scott MT, 2000, J BIOL CHEM, V275, P11529, DOI 10.1074/jbc.275.15.11529; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Ulrich HD, 2007, BIOCHEM SOC T, V35, P1385, DOI 10.1042/BST0351385; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Yunus Ali A., 2009, V497, P167, DOI 10.1007/978-1-59745-566-4_11	49	101	101	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2012	483	7387					59	U99		10.1038/nature10883	http://dx.doi.org/10.1038/nature10883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22382979	Green Accepted			2022-12-01	WOS:000300877900043
J	Boyle, EM; Poulsen, G; Field, DJ; Kurinczuk, JJ; Wolke, D; Alfirevic, Z; Quigley, MA				Boyle, Elaine M.; Poulsen, Gry; Field, David J.; Kurinczuk, Jennifer J.; Wolke, Dieter; Alfirevic, Zarko; Quigley, Maria A.			Effects of gestational age at birth on health outcomes at 3 and 5 years of age: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LATE-PRETERM BIRTH; INTERNATIONAL SURVEY; INFANTS BORN; TERM INFANTS; MORBIDITY; MORTALITY; CHILDREN; ADOLESCENTS; VALIDITY; RISK	Objective To investigate the burden of later disease associated with moderate/late preterm (32-36 weeks) and early term (37-38 weeks) birth. Design Secondary analysis of data from the Millennium Cohort Study (MCS). Setting Longitudinal study of infants born in the United Kingdom between 2000 and 2002. Participants 18 818 infants participated in the MCS. Effects of gestational age at birth on health outcomes at 3 (n=14 273) and 5 years (n=14 056) of age were analysed. Main outcome measures Growth, hospital admissions, longstanding illness/disability, wheezing/asthma, use of prescribed drugs, and parental rating of their children's health. Results Measures of general health, hospital admissions, and longstanding illness showed a gradient of increasing risk of poorer outcome with decreasing gestation, suggesting a "dose-response" effect of prematurity. The greatest contribution to disease burden at 3 and 5 years was in children born late/moderate preterm or early term. Population attributable fractions for having at least three hospital admissions between 9 months and 5 years were 5.7% (95% confidence interval 2.0% to 10.0%) for birth at 32-36 weeks and 7.2% (1.4% to 13.6%) for birth at 37-38 weeks, compared with 3.8% (1.3% to 6.5%) for children born very preterm (<32 weeks). Similarly, 2.7% (1.1% to 4.3%), 5.4% (2.4% to 8.6%), and 5.4% (0.7% to 10.5%) of limiting longstanding illness at 5 years were attributed to very preterm birth, moderate/late preterm birth, and early term birth. Conclusions These results suggest that health outcomes of moderate/late preterm and early term babies are worse than those of full term babies. Additional research should quantify how much of the effect is due to maternal/fetal complications rather than prematurity itself.	[Boyle, Elaine M.; Field, David J.] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Poulsen, Gry; Kurinczuk, Jennifer J.; Quigley, Maria A.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [Wolke, Dieter] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England; [Wolke, Dieter] Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England; [Alfirevic, Zarko] Univ Liverpool, Dept Womens & Childrens Hlth, Inst Translat Med, Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England	University of Leicester; University of Oxford; University of Warwick; University of Warwick; University of Liverpool	Boyle, EM (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England.	eb124@le.ac.uk	Boyle, Elaine M/I-6298-2018; Wolke, Dieter/C-5372-2008	Boyle, Elaine M/0000-0002-5038-3148; Wolke, Dieter/0000-0003-0304-268X; Quigley, Maria/0000-0002-8058-6181	BUPA Foundation; National Institute for Health Research [RP-PG-0407-10029] Funding Source: researchfish	BUPA Foundation; National Institute for Health Research(National Institute for Health Research (NIHR))	The BUPA Foundation funded the study but had no role in the study design, data analysis and interpretation, or writing of the report.	Abe K, 2010, J PEDIATR-US, V157, P74, DOI 10.1016/j.jpeds.2010.01.008; Baron IS, 2011, EARLY HUM DEV, V87, P115, DOI 10.1016/j.earlhumdev.2010.11.010; Bonellie Sandra, 2008, BMC Pregnancy Childbirth, V8, P5, DOI 10.1186/1471-2393-8-5; Centre for Longitudinal Studies, 2010, MILL COH STUD 1 2 3; Chyi LJ, 2008, J PEDIATR-US, V153, P25, DOI 10.1016/j.jpeds.2008.01.027; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; D'Souza-Vazirani D, 2005, ARCH PEDIAT ADOL MED, V159, P167, DOI 10.1001/archpedi.159.2.167; Escobar GJ, 2006, SEMIN PERINATOL, V30, P28, DOI 10.1053/j.semperi.2006.01.005; Escobar GJ, 2005, ARCH DIS CHILD, V90, P125, DOI 10.1136/adc.2003.039974; Ketende S, 2008, MILLENNIUM COHORT ST; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Lindstrom K, 2009, PEDIATRICS, V123, pE47, DOI 10.1542/peds.2008-1654; Mac Bird T, 2010, PEDIATRICS, V126, pE311, DOI 10.1542/peds.2009-2869; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; McIntire DD, 2008, OBSTET GYNECOL, V111, P35, DOI 10.1097/01.AOG.0000297311.33046.73; McLaurin KK, 2009, PEDIATRICS, V123, P653, DOI 10.1542/peds.2008-1439; Moser K, 2007, HLTH STAT Q, V13, P27; Natarajan S, 2007, STAT MED, V26, P3229, DOI 10.1002/sim.2779; Oddie SJ, 2005, ARCH DIS CHILD, V90, P119, DOI 10.1136/adc.2003.040766; Petrini JR, 2009, J PEDIATR-US, V154, P169, DOI 10.1016/j.jpeds.2008.08.020; Plewis I., 2007, INT J SOC RES METHOD, V10, P325, DOI DOI 10.1080/13645570701676955; Plewis I., 2007, MILLENNIUM COHORT ST; Poulsen G, 2011, J CLIN EPIDEMIOL, V64, P1444, DOI 10.1016/j.jclinepi.2011.03.007; Talge NM, 2010, PEDIATRICS, V126, P1124, DOI 10.1542/peds.2010-1536; Tomashek KM, 2007, J PEDIATR-US, V151, P450, DOI 10.1016/j.jpeds.2007.05.002; van Baar AL, 2009, PEDIATRICS, V124, P251, DOI 10.1542/peds.2008-2315; Vernacchio L, 2007, J AM BOARD FAM MED, V20, P160, DOI 10.3122/jabfm.2007.02.060125; Wang ML, 2004, PEDIATRICS, V114, P372, DOI 10.1542/peds.114.2.372; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	30	275	282	8	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2012	344								e896	10.1136/bmj.e896	http://dx.doi.org/10.1136/bmj.e896			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XJ	22381676	hybrid, Green Published, Green Submitted			2022-12-01	WOS:000301231900003
J	Prahallad, A; Sun, C; Huang, SD; Di Nicolantonio, F; Salazar, R; Zecchin, D; Beijersbergen, RL; Bardelli, A; Bernards, R				Prahallad, Anirudh; Sun, Chong; Huang, Sidong; Di Nicolantonio, Federica; Salazar, Ramon; Zecchin, Davide; Beijersbergen, Roderick L.; Bardelli, Alberto; Bernards, Rene			Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR	NATURE			English	Article							METASTATIC COLORECTAL-CANCER; PAPILLARY THYROID-CARCINOMA; BRAF MUTATIONS; PANITUMUMAB; CETUXIMAB; MELANOMA; TARGET; KRAS	Inhibition of the BRAF(V600E) oncoprotein by the small-molecule drug PLX4032 (vemurafenib) is highly effective in the treatment of melanoma(1). However, colon cancer patients harbouring the same BRAF (V600E) oncogenic lesion have poor prognosis and show only a very limited response to this drug(2-4). To investigate the cause of the limited therapeutic effect of PLX4032 in BRAF (V600E) mutant colon tumours, here we performed an RNA-interference-based genetic screen in human cells to search for kinases whose knockdown synergizes with BRAF(V600E) inhibition. We report that blockade of the epidermal growth factor receptor (EGFR) shows strong synergy with BRAF(V600E) inhibition. We find in multiple BRAF (V600E) mutant colon cancers that inhibition of EGFR by the antibody drug cetuximab or the small-molecule drugs gefitinib or erlotinib is strongly synergistic with BRAF(V600E) inhibition, both in vitro and in vivo. Mechanistically, we find that BRAF(V600E) inhibition causes a rapid feedback activation of EGFR, which supports continued proliferation in the presence of BRAF(V600E) inhibition. Melanoma cells express low levels of EGFR and are therefore not subject to this feedback activation. Consistent with this, we find that ectopic expression of EGFR in melanoma cells is sufficient to cause resistance to PLX4032. Our data suggest that BRAF(V600E) mutant colon cancers (approximately 8-10% of all colon cancers(2,3,5)), for which there are currently no targeted treatment options available, might benefit from combination therapy consisting of BRAF and EGFR inhibitors.	[Prahallad, Anirudh; Sun, Chong; Huang, Sidong; Beijersbergen, Roderick L.; Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Prahallad, Anirudh; Sun, Chong; Huang, Sidong; Beijersbergen, Roderick L.; Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands; [Di Nicolantonio, Federica; Zecchin, Davide; Bardelli, Alberto] Univ Turin, Lab Mol Genet, Inst Canc Res & Treatment, Sch Med, I-10060 Turin, Italy; [Di Nicolantonio, Federica; Bardelli, Alberto] FIRC IFOM Inst Mol Oncol, I-20100 Milan, Italy; [Salazar, Ramon] IDIBELL, Inst Catala Oncol LHospitalet de Llobregat, Lhospitalet Barcelona 08907, Spain	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Turin; IFOM - FIRC Institute of Molecular Oncology; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Sun, Chong/AAB-4859-2021; Toon, Christopher W/G-3610-2012; Di Nicolantonio, Federica/A-2503-2011; BARDELLI, Alberto/J-9721-2018	Sun, Chong/0000-0001-9008-2158; Di Nicolantonio, Federica/0000-0001-9618-2010; BARDELLI, Alberto/0000-0003-1647-5070; Huang, Sidong/0000-0002-2838-4726; Bernards, Rene/0000-0001-8677-3423; Beijersbergen, Roderick/0000-0003-0116-4130	EU [259015]; European Research Council; Netherlands Organisation for Scientific Research (NWO); Dutch Cancer Society; Netherlands Genomics Initiative (NGI); Associazione Italiana per la Ricerca sul Cancro (AIRC) [9970]; Italian Ministry of University and Research; Italian Ministry of Health, Regione Piemonte; Fondazione Piemontese per la Ricerca sul Cancro	EU(European Commission); European Research Council(European Research Council (ERC)European Commission); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Genomics Initiative (NGI); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health, Regione Piemonte; Fondazione Piemontese per la Ricerca sul Cancro	We thank P. Kumar, V. Gambino and W. Grernrum for assistance with experiments. We are grateful to C. Pochet for support. Major financial support for this work was provided by the EU Seventh Framework Programme, grant agreement 259015 (to A.B. and R.B.). Additional funding was provided by a European Research Council grant to R.B.; The Cancer Systems Biology Center grant by the Netherlands Organisation for Scientific Research (NWO); The Dutch Cancer Society; The Netherlands Genomics Initiative (NGI); The Associazione Italiana per la Ricerca sul Cancro (AIRC), 2010 Special Program Molecular Clinical Oncology 5x1000, project 9970; AIRC Investigator Grant (to A.B.); Italian Ministry of University and Research; Italian Ministry of Health, Regione Piemonte (to A.B. and F.D.N.); Intramural Grant, 5xmille 2008; and Fondazione Piemontese per la Ricerca sul Cancro (to A.B. and F.D.N.).	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Boone B, 2011, J CUTAN PATHOL, V38, P492, DOI 10.1111/j.1600-0560.2011.01673.x; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kimura ET, 2003, CANCER RES, V63, P1454; Kopetz S., 2010, J CLIN ONCOL, V28; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Simbulan-Rosenthal CM, 1998, J BIOL CHEM, V273, P13703, DOI 10.1074/jbc.273.22.13703; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Trovisco V, 2004, J PATHOL, V202, P247, DOI 10.1002/path.1511; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wang ZQ, 2002, J BIOL CHEM, V277, P19470, DOI 10.1074/jbc.M201097200	22	1362	1400	2	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					100	U146		10.1038/nature10868	http://dx.doi.org/10.1038/nature10868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22281684	Green Submitted			2022-12-01	WOS:000300877900053
J	Liu, S; Cipriano, LE; Holodniy, M; Owens, DK; Goldhaber-Fiebert, JD				Liu, Shan; Cipriano, Lauren E.; Holodniy, Mark; Owens, Douglas K.; Goldhaber-Fiebert, Jeremy D.			New Protease Inhibitors for the Treatment of Chronic Hepatitis C A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-STATE UTILITIES; QUALITY-OF-LIFE; VIRUS-INFECTION; PEGINTERFERON ALPHA-2B; VIROLOGICAL RESPONSE; GENETIC-VARIATION; ALL-CAUSE; RIBAVIRIN; IL28B; ASSOCIATION	Background: Chronic hepatitis C virus is difficult to treat and affects approximately 3 million Americans. Protease inhibitors increase the effectiveness of standard therapy, but they are costly. A genetic assay may identify patients most likely to benefit from this treatment advance. Objective: To assess the cost-effectiveness of new protease inhibitors and an interleukin (IL)-28B genotyping assay for treating chronic hepatitis C virus. Design: Decision-analytic Markov model. Data Sources: Published literature and expert opinion. Target Population: Treatment-naive patients with chronic, genotype 1 hepatitis C virus monoinfection. Time Horizon: Lifetime. Perspective: Societal. Intervention: Strategies are defined by the use of IL-28B genotyping and type of treatment (standard therapy [pegylated interferon with ribavirin]; triple therapy [standard therapy and a protease inhibitor]). Interleukin-28B-guided triple therapy stratifies patients with CC genotypes to standard therapy and those with non-CC types to triple therapy. Outcome Measures: Discounted costs (in 2010 U.S. dollars) and quality-adjusted life-years (QALYs); incremental cost-effectiveness ratios. Results of Base-Case Analysis: For patients with mild and advanced fibrosis, universal triple therapy reduced the lifetime risk for hepatocellular carcinoma by 38% and 28%, respectively, and increased quality-adjusted life expectancy by 3% and 8%, respectively, compared with standard therapy. Gains from IL-28B-guided triple therapy were smaller. If the protease inhibitor costs $1100 per week, universal triple therapy costs $102 600 per QALY (mild fibrosis) or $51 500 per QALY (advanced fibrosis) compared with IL-28B-guided triple therapy and $70 100 per QALY (mild fibrosis) and $36 300 per QALY (advanced fibrosis) compared with standard therapy. Results of Sensitivity Analysis: Results were sensitive to the cost of protease inhibitors and treatment adherence rates. Limitation: Data on the long-term comparative effectiveness of the new protease inhibitors are lacking. Conclusion: Both universal triple therapy and IL-28B-guided triple therapy are cost-effective when the least-expensive protease inhibitor are used for patients with advanced fibrosis.	[Goldhaber-Fiebert, Jeremy D.] Stanford Univ, CHP, PCOR, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Goldhaber-Fiebert, JD (corresponding author), Stanford Univ, CHP, PCOR, Ctr Primary Care & Outcomes Res, 117 Encina Commons, Stanford, CA 94305 USA.	shanliu@stanford.edu	Liu, Sheng/K-2815-2013; Cipriano, Lauren E/C-3521-2017	Cipriano, Lauren E/0000-0001-5568-4516; Holodniy, Mark/0000-0002-6655-7982; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	Stanford Graduate Fellowship; Social Sciences and Humanities Research Council of Canada; Institute for Operations Research and the Management Sciences; Department of Veterans Affairs; National Institutes of Health National Institute on Aging [K01 AG037593-01A1]; Stanford University;  [R01 DA15612-016]; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Institute for Operations Research and the Management Sciences; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Stanford University(Stanford University); ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Ms. Liu was supported by a Stanford Graduate Fellowship. Ms. Cipriano was supported by a doctoral scholarship from the Social Sciences and Humanities Research Council of Canada and by the Seth Bonder Scholarship for Applied Operations Research in Health Services from the Institute for Operations Research and the Management Sciences. Drs. Holodniy and Owens are supported by the Department of Veterans Affairs and supported in part by R01 DA15612-016. Dr. Goldhaber-Fiebert was supported in part by a National Institutes of Health National Institute on Aging Career Development Award (K01 AG037593-01A1; principal investigator, Dr. Goldhaber-Fiebert).; Stanford University.	[Anonymous], CANC STAT FACT SHEET; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Armstrong EP, 2004, CURR MED RES OPIN, V20, P671, DOI 10.1185/030079904125003485; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Bedossa P, 2009, J HEPATOL, V50, P1, DOI 10.1016/j.jhep.2008.10.014; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Birnkrant D, 2011, 201917 NDA US DEP HL; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Food and Drug Administration, 2011, BACKGR MAT BOC ADV C; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gold MR., 1996, COST EFFECTIVENESS H; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Gupta S, 2011, 18 C RETR OPP INF CR; Holtz-Eakin D, 2005, PRICES BRAND NAME DR; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jensen DM, 2009, ANN INTERN MED, V150, P528, DOI 10.7326/0003-4819-150-8-200904210-00007; Levin J., 2010, 61 ANN M AM ASS STUD; Liu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026783; McEvoy G., 2009, AHFS DRUG INFORM 200; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Merck & Co, 2011, FDA ANT DRUGS ADV CO; Mitra D, 2010, VALUE HEALTH, V13, P479, DOI 10.1111/j.1524-4733.2009.00691.x; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; Pollack A., 2011, NY TIMES, pB2; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poret AW, 2002, DIS MANAG, V5, P95; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Sherman KE, 2004, ARCH INTERN MED, V164, P2377, DOI 10.1001/archinte.164.21.2377; Siddiqui FA, 2008, HEPATOL INT, V2, P376, DOI 10.1007/s12072-008-9086-x; Stephens JM, 2010, 61 ANN M AM ASS STUD; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Thomson Corporation, 2009, RED BOOK 2009 PHARM; U.S. Department Of Labor Bureau of Labor Statistics, CONS PRIC IND; United States Department of Veterans Affairs, 2011, DRUG PHARM PRIC; van Heeswijk R, 2011, 18 C RETR OPP INF CR; Vertex Pharmaceuticals, 2011, 201917 NDA US FOOD D; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	57	155	157	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4					279	U68		10.7326/0003-4819-156-4-201202210-00005	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-00005			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896YO	22351713				2022-12-01	WOS:000300607600005
J	Xie, W; Barr, CL; Kim, A; Yue, F; Lee, AY; Eubanks, J; Dempster, EL; Ren, B				Xie, Wei; Barr, Cathy L.; Kim, Audrey; Yue, Feng; Lee, Ah Young; Eubanks, James; Dempster, Emma L.; Ren, Bing			Base-Resolution Analyses of Sequence and Parent-of-Origin Dependent DNA Methylation in the Mouse Genome	CELL			English	Article							DE-NOVO METHYLATION; NON-CPG METHYLATION; IMPRINTED GENES; STEM-CELLS; MAMMALIAN DEVELOPMENT; CHROMOSOME 2; IDENTIFICATION; DNMT3A; DOMAIN; BRAIN	Differential methylation of the two parental genomes in placental mammals is essential for genomic imprinting and embryogenesis. To systematically study this epigenetic process, we have generated a base-resolution, allele-specific DNA methylation (ASM) map in the mouse genome. We find parent-of-origin dependent (imprinted) ASM at 1,952 CG dinucleotides. These imprinted CGs form 55 discrete clusters including virtually all known germline differentially methylated regions (DMRs) and 23 previously unknown DMRs, with some occurring at microRNA genes. We also identify sequence-dependent ASM at 131,765 CGs. Interestingly, methylation at these sites exhibits a strong dependence on the immediate adjacent bases, allowing us to define a conserved sequence preference for the mammalian DNA methylation machinery. Finally, we report a surprising presence of non-CG methylation in the adult mouse brain, with some showing evidence of imprinting. Our results provide a resource for understanding the mechanisms of imprinting and allele-specific gene expression in mammalian cells.	[Barr, Cathy L.; Eubanks, James; Dempster, Emma L.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON M5G 2M9, Canada; [Xie, Wei; Kim, Audrey; Yue, Feng; Lee, Ah Young; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Barr, Cathy L.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Dempster, Emma L.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Ren, Bing] Univ Calif San Diego, Sch Med, Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Ludwig Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of London; King's College London; University of California System; University of California San Diego; University of California System; University of California San Diego	Barr, CL (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON M5G 2M9, Canada.	cbarr@uhnres.utoronto.ca; biren@ucsd.edu	Dempster, Emma L/C-8592-2014; Xie, Wei/J-1380-2017	Dempster, Emma L/0000-0003-1257-5314; Xie, Wei/0000-0003-2126-3849; Eubanks, James/0000-0001-8595-2024; Barr, Cathy/0000-0003-0361-0106	Krembil Seed Development Fund; Applied Biosystems (Life Technologies); Ludwig Institute for Cancer Research; NIH [U01ES017166]; National Human Genome Research Institute [R01 HG003991]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Krembil Seed Development Fund; Applied Biosystems (Life Technologies); Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs. Ryan Lister and Joseph Ecker for sharing the MethylC-Seq protocol and for valuable input on the experimental design. We are grateful to Dr. Paul Soloway for comments on the manuscript, Dr. Wei Wang for discussions, Ms. Lee Edsall and Samantha Kuan for technical support in deep sequencing, Richard Logan, Yu Feng, and Lissette Gomez for technical support in dissection of frontal cortex and extraction of DNA/RNA, Karen Wigg for initial RNA-Seq bioinformatics support, and members of the Ren laboratory for discussions. This study was funded in part by grants from the Krembil Seed Development Fund (C.L.B.), an Applied Biosystems (Life Technologies) 10K Genome Award (C.L.B.), and funding from the Ludwig Institute for Cancer Research (B.R.), the NIH Epigenomics Roadmap Project U01ES017166 (B.R.), and the National Human Genome Research Institute R01 HG003991 (B.R.).	Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen PY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r62; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Choufani S, 2011, GENOME RES, V21, P465, DOI 10.1101/gr.111922.110; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cooper WN, 2010, BRIEF FUNCT GENOMICS, V9, P315, DOI 10.1093/bfgp/elq018; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Dyachenko OV, 2010, EPIGENETICS-US, V5, P569, DOI 10.4161/epi.5.7.12702; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Haines TR, 2001, DEV BIOL, V240, P585, DOI 10.1006/dbio.2001.0504; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; Hellman A, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-11; Hiura H, 2010, NUCLEIC ACIDS RES, V38, P4929, DOI 10.1093/nar/gkq200; Imamura T, 2005, J BIOL CHEM, V280, P20171, DOI 10.1074/jbc.M501749200; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Royo H, 2008, BIOL CELL, V100, P149, DOI 10.1042/BC20070126; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Schulz R, 2008, EPIGENETICS-US, V3, P89, DOI 10.4161/epi.3.2.5900; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Singh P, 2011, MOL CELL BIOL, V31, P1757, DOI 10.1128/MCB.00961-10; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; SURANI MA, 1990, DEVELOPMENT, P89; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Tycko B, 2010, HUM MOL GENET, V19, pR210, DOI 10.1093/hmg/ddq376; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138; Zheng Y, 2010, NUCLEIC ACIDS RES, V38, P5527, DOI 10.1093/nar/gkq327; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	60	360	377	1	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					816	831		10.1016/j.cell.2011.12.035	http://dx.doi.org/10.1016/j.cell.2011.12.035			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341451	Green Accepted, Bronze			2022-12-01	WOS:000300622400021
J	Zhang, P; Smith-Nguyen, EV; Keshwani, MM; Deal, MS; Kornev, AP; Taylor, SS				Zhang, Ping; Smith-Nguyen, Eric V.; Keshwani, Malik M.; Deal, Michael S.; Kornev, Alexandr P.; Taylor, Susan S.			Structure and Allostery of the PKA RII beta Tetrameric Holoenzyme	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; SITE MUTATIONS DEFINE; REGULATORY SUBUNIT; CATALYTIC SUBUNIT; II-BETA; CRYSTAL-STRUCTURE; TERMINAL TAIL; ALPHA; BINDING; MECHANISM	In its physiological state, cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) is a tetramer that contains a regulatory (R) subunit dimer and two catalytic (C) subunits. We describe here the 2.3 angstrom structure of full-length tetrameric RII beta(2):C-2 holoenzyme. This structure showing a dimer of dimers provides a mechanistic understanding of allosteric activation by cAMP. The heterodimers are anchored together by an interface created by the beta(4)-beta(5) loop in the RII beta subunit, which docks onto the carboxyl-terminal tail of the adjacent C subunit, thereby forcing the C subunit into a fully closed conformation in the absence of nucleotide. Diffusion of magnesium adenosine triphosphate (ATP) into these crystals trapped not ATP, but the reaction products, adenosine diphosphate and the phosphorylated RII beta subunit. This complex has implications for the dissociation-reassociation cycling of PKA. The quaternary structure of the RII beta tetramer differs appreciably from our model of the RI alpha tetramer, confirming the small-angle x-ray scattering prediction that the structures of each PKA tetramer are different.	[Zhang, Ping; Keshwani, Malik M.; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Smith-Nguyen, Eric V.; Deal, Michael S.; Kornev, Alexandr P.; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Keshwani, Malik M.; Kornev, Alexandr P.; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	staylor@ucsd.edu	Kornev, Alexandr Petrovich/O-7826-2015; zhang, ping/G-7165-2015	Kornev, Alexandr Petrovich/0000-0002-1543-3795; Zhang, Ping/0000-0002-0340-281X	NIH [GM34921]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Taylor laboratory for helpful discussions and the Advanced Light Source (beam line 8.2.2) staff of Lawrence Berkeley National Laboratory for beam access and help with data collection. This work was supported by NIH grant GM34921 (S.S.T.). Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession numbers 3TNP and 3TNQ.	Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Boettcher AJ, 2011, STRUCTURE, V19, P265, DOI 10.1016/j.str.2010.12.005; Brown SHJ, 2009, J MOL BIOL, V393, P1070, DOI 10.1016/j.jmb.2009.09.014; CADD GG, 1990, J BIOL CHEM, V265, P19502; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; Cheng XD, 2001, J BIOL CHEM, V276, P4102, DOI 10.1074/jbc.M006447200; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Czyzyk TA, 2008, P NATL ACAD SCI USA, V105, P276, DOI 10.1073/pnas.0710607105; Diller TC, 2000, PROTEIN EXPRES PURIF, V20, P357, DOI 10.1006/prep.2000.1312; Diskar M, 2007, CELL SIGNAL, V19, P2024, DOI 10.1016/j.cellsig.2007.05.012; Gangal M, 1999, P NATL ACAD SCI USA, V96, P12394, DOI 10.1073/pnas.96.22.12394; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Heller WT, 2004, J BIOL CHEM, V279, P19084, DOI 10.1074/jbc.M313405200; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; HERBERG FW, 1993, BIOCHEMISTRY-US, V32, P14015, DOI 10.1021/bi00213a035; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manni S, 2008, J BIOL CHEM, V283, P24145, DOI 10.1074/jbc.M802278200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; RANGELALDAO R, 1976, J BIOL CHEM, V251, P3375; Schreyer SA, 2001, DIABETES, V50, P2555, DOI 10.2337/diabetes.50.11.2555; Vigil D, 2006, J MOL BIOL, V357, P880, DOI 10.1016/j.jmb.2006.01.006; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; Zawadzki KM, 2004, J BIOL CHEM, V279, P7029, DOI 10.1074/jbc.M310804200; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	38	116	120	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					712	716		10.1126/science.1213979	http://dx.doi.org/10.1126/science.1213979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323819	Green Accepted			2022-12-01	WOS:000300047100051
J	Cranford, SW; Tarakanova, A; Pugno, NM; Buehler, MJ				Cranford, Steven W.; Tarakanova, Anna; Pugno, Nicola M.; Buehler, Markus J.			Nonlinear material behaviour of spider silk yields robust webs	NATURE			English	Article							NATURALLY COMPLIANT STRUCTURES; MECHANICAL-PROPERTIES; DRAGLINE SILK; BIOMATERIAL; TOUGHNESS; STRENGTH; DESIGN; NANOSTRUCTURE; PERFORMANCE; ORIENTATION	Natural materials are renowned for exquisite designs that optimize function, as illustrated by the elasticity of blood vessels, the toughness of bone and the protection offered by nacre(1-5). Particularly intriguing are spider silks, with studies having explored properties ranging from their protein sequence(6) to the geometry of a web(7). This material system(8), highly adapted to meet a spider's many needs, has superior mechanical properties(9-15). In spite of much research into the molecular design underpinning the outstanding performance of silk fibres(1,6,10,13,16,17), and into the mechanical characteristics of web-like structures(18-21), it remains unknown how the mechanical characteristics of spider silk contribute to the integrity and performance of a spider web. Here we report web deformation experiments and simulations that identify the nonlinear response of silk threads to stress-involving softening at a yield point and substantial stiffening at large strain until failure-as being crucial to localize load-induced deformation and resulting in mechanically robust spider webs. Control simulations confirmed that a nonlinear stress response results in superior resistance to structural defects in the web compared to linear elastic or elastic-plastic (softening) material behaviour. We also show that under distributed loads, such as those exerted by wind, the stiff behaviour of silk under small deformation, before the yield point, is essential in maintaining the web's structural integrity. The superior performance of silk in webs is therefore not due merely to its exceptional ultimate strength and strain, but arises from the nonlinear response of silk threads to strain and their geometrical arrangement in a web.	[Cranford, Steven W.; Tarakanova, Anna; Buehler, Markus J.] MIT, Dept Civil & Environm Engn, LAMM, Cambridge, MA 02139 USA; [Cranford, Steven W.; Tarakanova, Anna; Buehler, Markus J.] MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA; [Tarakanova, Anna] Cornell Univ, Dept Appl & Engn Phys, Ithaca, NY 14853 USA; [Pugno, Nicola M.] Politecn Torino, Dept Struct Engn & Geotech, Lab Bioinspired Nanomech Giuseppe Maria Pugno, I-10129 Turin, Italy; [Buehler, Markus J.] MIT, Ctr Computat Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Cornell University; Polytechnic University of Turin; Massachusetts Institute of Technology (MIT)	Buehler, MJ (corresponding author), MIT, Dept Civil & Environm Engn, LAMM, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mbuehler@mit.edu	Buehler, Markus J./C-4580-2008; Cranford, Steve W./H-4260-2012; Pugno, Nicola/C-2289-2014	Buehler, Markus J./0000-0002-4173-9659; 	Office of Naval Research [N000141010562]; Army Research Office [W911NF-09-1-0541, W911NF-10-1-0127]; MIT-Italy (MITOR); Robert A. Brown Presidential Fellowship; METREGEN; European Research Council, under the European Union [279985]	Office of Naval Research(Office of Naval Research); Army Research Office; MIT-Italy (MITOR); Robert A. Brown Presidential Fellowship; METREGEN; European Research Council, under the European Union(European Research Council (ERC))	This work was supported primarily by the Office of Naval Research (N000141010562) with additional support from the National Science Foundation (MRSEC DMR-0819762, the NSF-REU programme, as well as CMMI-0642545) and the Army Research Office (W911NF-09-1-0541 and W911NF-10-1-0127). Support from the MIT-Italy programme (MITOR) and a Robert A. Brown Presidential Fellowship is gratefully acknowledged. N.M.P. is supported by the METREGEN grant (2009-2012) "Metrology on a cellular and macromolecular scale for regenerative medicine". An Ideas Starting Grant 2011 BIHSNAM on "Bio-inspired hierarchical super nanomaterials" was awarded to N.M.P. from the European Research Council, under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant (agreement number 279985). All simulations have been carried out at MIT's Laboratory for Atomistic and Molecular Mechanics (LAMM). We acknowledge assistance from S. and E. Buehler in taking photographs of the spider web.	Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Alam MS, 2007, MECH MATER, V39, P145, DOI 10.1016/j.mechmat.2006.04.005; Alam MS, 2005, INT J DAMAGE MECH, V14, P365, DOI 10.1177/1056789505054313; Aoyanagi Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.038102; Buehler MJ, 2006, NATURE, V439, P307, DOI 10.1038/nature04408; Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144; Foelix R., 2011, BIOL SPIDERS; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gosline JM, 1999, J EXP BIOL, V202, P3295; Kamat S, 2000, NATURE, V405, P1036, DOI 10.1038/35016535; Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149; Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]; Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099; Ko KK, 2002, MATER RES SOC SYMP P, V702, P17; Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Pugno NM, 2004, PHILOS MAG, V84, P2829, DOI 10.1080/14786430412331280382; Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105; Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a; Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420; Swanson BO, 2009, INTEGR COMP BIOL, V49, P21, DOI 10.1093/icb/icp013; TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2; VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70; Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023; VOLLRATH F, 1985, NATURWISSENSCHAFTEN, V72, P666, DOI 10.1007/BF00497445; Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221; Vollrath F, 2010, NATURE, V466, P319, DOI 10.1038/466319a	33	306	316	32	497	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 2	2012	482	7383					72	U91		10.1038/nature10739	http://dx.doi.org/10.1038/nature10739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22297972	Green Accepted, Green Submitted			2022-12-01	WOS:000299726000037
J	Thaunat, O; Granja, AG; Barral, P; Filby, A; Montaner, B; Collinson, L; Martinez-Martin, N; Harwood, NE; Bruckbauer, A; Batista, FD				Thaunat, Olivier; Granja, Aitor G.; Barral, Patricia; Filby, Andrew; Montaner, Beatriz; Collinson, Lucy; Martinez-Martin, Nuria; Harwood, Naomi E.; Bruckbauer, Andreas; Batista, Facundo D.			Asymmetric Segregation of Polarized Antigen on B Cell Division Shapes Presentation Capacity	SCIENCE			English	Article							LYMPH-NODE; CLASS-II; SUBCAPSULAR SINUS; GERMINAL-CENTERS; DENDRITIC CELLS; LYMPHOCYTES; ENDOSOMES; COMPLEXES; SELECTION; REVEALS	During the activation of humoral immune responses, B cells acquire antigen for subsequent presentation to cognate T cells. Here we show that after mouse B cells accumulate antigen, it is maintained in a polarized distribution for extended periods in vivo. Using high-throughput imaging flow cytometry, we observed that this polarization is preserved during B cell division, promoting asymmetric antigen segregation among progeny. Antigen inheritance correlates with the ability of progeny to activate T cells: Daughter cells receiving larger antigen stores exhibit a prolonged capacity to present antigen, which renders them more effective in competing for T cell help. The generation of progeny with differential capacities for antigen presentation may have implications for somatic hypermutation and class switching during affinity maturation and as B cells commit to effector cell fates.	[Thaunat, Olivier; Granja, Aitor G.; Barral, Patricia; Montaner, Beatriz; Martinez-Martin, Nuria; Harwood, Naomi E.; Bruckbauer, Andreas; Batista, Facundo D.] Canc Res UK, Lymphocyte Interact Lab, London Res Inst, London WC2A 3LY, England; [Filby, Andrew] Canc Res UK, Flow Cytometry Lab, London Res Inst, London WC2A 3LY, England; [Collinson, Lucy] Canc Res UK, Electron Microscopy Lab, London Res Inst, London WC2A 3LY, England	Cancer Research UK; Cancer Research UK; Cancer Research UK	Batista, FD (corresponding author), Canc Res UK, Lymphocyte Interact Lab, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	facundo.batista@cancer.org.uk	Martinez-Martin, Nuria/A-9160-2017; Bruckbauer, Andreas/A-9598-2008; Granja, Aitor/K-8102-2014; Thaunat, Olivier/M-2423-2014	Martinez-Martin, Nuria/0000-0003-2309-8920; Bruckbauer, Andreas/0000-0003-1419-9674; Barral, Patricia/0000-0003-4324-8973; Montaner, Beatriz/0000-0001-9877-7317; Collinson, Lucy/0000-0003-0260-613X; Thaunat, Olivier/0000-0002-3648-8963	Cancer Research UK; Royal Society; Societe Francaise de Transplantation; Societe Francaise de Nephrologie; Fondation pour la Recherche Medicale; Cancer Research UK [15691] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Royal Society(Royal Society of London); Societe Francaise de Transplantation; Societe Francaise de Nephrologie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Cancer Research UK(Cancer Research UK)	We thank D. Davies, Biomedical Research Council, Guy's and St Thomas' National Health Service Foundation Trust, and King's College London for assistance with flow cytometry and H. Armer for technical assistance with electron microscopy. We also thank the members of the Lymphocyte Interaction Laboratory for critical reading of the manuscript. This work was funded by Cancer Research UK. F. D. B. also receives support from the Royal Society Wolfson Merit Award, and O.T. receives financial support from Societe Francaise de Transplantation, Societe Francaise de Nephrologie, and Fondation pour la Recherche Medicale. The authors declare that they have no competing financial interests.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; ROCK KL, 1984, J EXP MED, V160, P1102, DOI 10.1084/jem.160.4.1102; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Siemasko K, 1998, J IMMUNOL, V160, P5203; Singhvi A, 2009, TRENDS CELL BIOL, V19, P1, DOI 10.1016/j.tcb.2008.10.004; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856	30	104	108	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2012	335	6067					475	479		10.1126/science.1214100	http://dx.doi.org/10.1126/science.1214100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22282815				2022-12-01	WOS:000299466800053
J	Gale, C; Santhakumaran, S; Nagarajan, S; Statnikov, Y; Modi, N				Gale, C.; Santhakumaran, S.; Nagarajan, S.; Statnikov, Y.; Modi, N.		Neonatal Data Anal Unit; Med Neonates Investigator Grp	Impact of managed clinical networks on NHS specialist neonatal services in England: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; PRETERM INFANTS; MORTALITY; CARE; LEVEL; TRANSPORT; RISK	Objective To assess the impact of reorganisation of neonatal specialist care services in England after a UK Department of Health report in 2003. Design A population-wide observational comparison of outcomes over two epochs, before and after the establishment of managed clinical neonatal networks. Setting Epoch one: 294 maternity and neonatal units in England, Wales, and Northern Ireland, 1 September 1998 to 31 August 2000, as reported by the Confidential Enquiry into Stillbirths and Sudden Deaths in Infancy Project 27/28. Epoch two: 146 neonatal units in England contributing data to the National Neonatal Research Database at the Neonatal Data Analysis Unit, 1 January 2009 to 31 December 2010. Participants Babies born at a gestational age of 27(+0)-28(+6) (weeks+days): 3522 live births in epoch one; 2919 babies admitted to a neonatal unit within 28 days of birth in epoch two. Intervention The national reorganisation of neonatal services into managed clinical networks. Main outcome measures The proportion of babies born at hospitals providing the highest volume of neonatal specialist care (>= 2000 neonatal intensive care days annually), having an acute transfer (within the first 24 hours after birth) and/or a late transfer (between 24 hours and 28 days after birth) to another hospital, assessed by change in distribution of transfer category ("none," "acute," "late"), and babies from multiple births separated by transfer. For acute transfers in epoch two, the level of specialist neonatal care provided at the destination hospital (British Association of Perinatal Medicine criteria). Results After reorganisation, there were increases in the proportions of babies born at 27-28 weeks' gestation in hospitals providing the highest volume of neonatal specialist care (18% (631/3495) v 49% (1325/2724); odds ratio 4.30, 95% confidence interval 3.83 to 4.82; P < 0.001) and in acute and late postnatal transfers (7% (235) v 12% (360) and 18% (579) v 22% (640), respectively; P < 0.001). There was no significant change in the proportion of babies from multiple births separated by transfer (33% (39) v 29% (38); 0.86, 0.50 to 1.46; P = 0.57). In epoch two, 32% of acute transfers were to a neonatal unit providing either an equivalent (n = 87) or lower (n = 26) level of specialist care. Conclusions There is evidence of some improvement in the delivery of neonatal specialist care after reorganisation. The increase in acute transfers in epoch two, in conjunction with the high proportion transferred to a neonatal unit providing an equivalent or lower level of specialist care, and the continued separation of babies from multiple births, are indicative of poor coordination between maternity and neonatal services to facilitate in utero transfer before delivery, and continuing inadequacies in capacity of intensive care cots. Historical data representing epoch one are available only in aggregate form, preventing examination of temporal trends or confounding factors. This limits the extent to which differences between epochs can be attributed to reorganisation and highlights the importance of routine, prospective data collection for evaluation of future health service reorganisations.	[Gale, C.; Santhakumaran, S.; Nagarajan, S.; Statnikov, Y.; Modi, N.; Neonatal Data Anal Unit; Med Neonates Investigator Grp] Univ London Imperial Coll Sci Technol & Med, Sect Neonatal Med, Dept Med, London SW10 9NH, England	Imperial College London	Modi, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Neonatal Med, Dept Med, Chelsea & Westminster Campus, London SW10 9NH, England.	n.modi@imperial.ac.uk	Gale, Chris/F-1833-2010	Gale, Chris/0000-0003-0707-876X; Greenough, Anne/0000-0002-8672-5349; Majeed, Azeem/0000-0002-2357-9858	National Institute of Health Research (NIHR) [RP-PG-0707-10010]; Department of Health; Danone; Abbott International; Royal College of Paediatrics and Child Health (RCPCH); Child Growth Foundation (CGF); Westminster Medical School Research Trust; Medical Research Council [G1000758, G1000758B] Funding Source: researchfish; National Institute for Health Research [RP-PG-0707-10010] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Department of Health; Danone(Danone Nutricia); Abbott International(Abbott Laboratories); Royal College of Paediatrics and Child Health (RCPCH); Child Growth Foundation (CGF); Westminster Medical School Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The Neonatal Data Analysis Unit is supported by a Programme Grant for Applied Research (RP-PG-0707-10010) from the National Institute of Health Research (NIHR) and unrestricted funding from the Department of Health, Danone, and Abbott International. The study funders had no role in study design, collection, analysis, and interpretation of data, writing of the report, or in the decision to submit the article for publication; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare financial support for the submitted work from the National Institute for Health Research (NIHR) through a Programme Grant for Applied Research (RP-PG-0707-10010). SN receives part funding from the Royal College of Paediatrics and Child Health (RCPCH) National Neonatal Audit Programme. CG receives part funding though an unrelated award to NM from the Child Growth Foundation (CGF) and support from the Westminster Medical School Research Trust. SS and YS are funded by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the RCPCH, CGF, Westminster Medical School Research Trust, NHS, NIHR, or Department of Health.	[Anonymous], 2007, PROVISION NEONATAL S; Binder S, 2011, PEDIATRICS, V127, P487, DOI 10.1542/peds.2010-1064; British Association of Perinatal Medicine (BAPM), 2001, STAND HOSP PROV NEON STAND HOSP PROV NEON, V2nd; Chien LY, 2001, OBSTET GYNECOL, V98, P247, DOI 10.1016/S0029-7844(01)01438-7; Chung JH, 2011, J PERINATOL, V31, P770, DOI 10.1038/jp.2011.29; COOKE RWI, 1992, ARCH DIS CHILD-FETAL, V67, P868; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Goodwin N, 2004, MANAGING DIVERSE NET; Greene A, 2009, QUAL SAF HEALTH CARE, V18, P456, DOI 10.1136/qshc.2007.023119; Guthrie BG, 2010, DELIVERING HLTH CARE; Honest H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13430; Kirrane H, 2010, CHANCE LIFETIME BLIS; KOLLEE LAA, 1992, OBSTET GYNECOL, V80, P635; Langhoff-Roos J, 2006, BMJ-BRIT MED J, V332, P937, DOI 10.1136/bmj.38751.524132.2F; Lasswell SM, 2010, JAMA-J AM MED ASSOC, V304, P992, DOI 10.1001/jama.2010.1226; Lui K, 2006, PEDIATRICS, V118, P2076, DOI 10.1542/peds.2006-1540; March of Dimes, 2012, PERISTATS; Marlow N, 2007, ARCH DIS CHILD-FETAL, V92, pF137, DOI 10.1136/adc.2005.086413; Mohamed MA, 2010, ARCH DIS CHILD-FETAL, V95, pF403, DOI 10.1136/adc.2010.183236; National Audit Office, 2007, CAR VULN BAB REORG N; National Institute for Health and Clinical Excellence, 2011, SPEC NEON CAR QUAL S; National Neonatal Audit Programme (NNAP), 2009, ANN REP NNAP; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Phibbs CS, 2007, NEW ENGL J MED, V356, P2165, DOI 10.1056/NEJMsa065029; Provan KG, 2007, J MANAGE, V33, P479, DOI 10.1177/0149206307302554; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Santhakumaran S, 2010, NEONATAL SPECIALIST; Scottish Executive, 1999, INTR MAN CLIN NETW N; Shlossman PA, 1997, AM J PERINAT, V14, P449, DOI 10.1055/s-2007-994178; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Thomas EL, 2011, PEDIATR RES, V70, P507, DOI 10.1203/PDR.0b013e31822d7860; Towers CV, 2000, OBSTET GYNECOL, V95, P291, DOI 10.1016/S0029-7844(99)00528-1; Zeitlin J, 2010, ARCH DIS CHILD-FETAL, V95, pF188, DOI 10.1136/adc.2008.156745	34	44	44	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e2105	10.1136/bmj.e2105	http://dx.doi.org/10.1136/bmj.e2105			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GM	22490978	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000302607700001
J	Kalager, M; Adami, HO; Bretthauer, M; Tamimi, RM				Kalager, Mette; Adami, Hans-Olov; Bretthauer, Michael; Tamimi, Rulla M.			Overdiagnosis of Invasive Breast Cancer Due to Mammography Screening: Results From the Norwegian Screening Program	ANNALS OF INTERNAL MEDICINE			English	Article							CARCINOMA IN-SITU; SOJOURN TIME; LEAD TIME; OVERDETECTION; OVERTREATMENT; COMPLETENESS; SENSITIVITY; PROGESTIN; ESTROGEN; REGISTRY	Background: Precise quantification of overdiagnosis of breast cancer (defined as the percentage of cases of cancer that would not have become clinically apparent in a woman's lifetime without screening) due to mammography screening has been hampered by lack of valid comparison groups that identify incidence trends attributable to screening versus those due to temporal trends in incidence. Objective: To estimate the percentage of overdiagnosis of breast cancer attributable to mammography screening. Design: Comparison of invasive breast cancer incidence with and without screening. Setting: A nationwide mammography screening program in Norway (inviting women aged 50 to 69 years), gradually implemented from 1996 to 2005. Participants: The Norwegian female population. Measurements: Concomitant incidence of invasive breast cancer from 1996 to 2005 in counties where the screening program was implemented compared with that in counties where the program was not yet implemented. To adjust for changes in temporal trends in breast cancer incidence, incidence rates during the preceding decade were also examined. The percentage of overdiagnosis was calculated by accounting for the expected decrease in incidence following cessation of screening after age 69 years (approach 1) and by comparing incidence in the current screening group with incidence among women 2 and 5 years older in the historical screening groups, accounting for average lead time (approach 2). Results: A total of 39 888 patients with invasive breast cancer were included, 7793 of whom were diagnosed after the screening program started. The estimated rate of overdiagnosis attributable to the program was 18% to 25% (P < 0.001) for approach 1 and 15% to 20% (P < 0.001) for approach 2. Thus, 15% to 25% of cases of cancer are overdiagnosed, translating to 6 to 10 women overdiagnosed for every 2500 women invited. Limitation: The study was registry-based. Conclusion: Mammography screening entails a substantial amount of overdiagnosis.	[Kalager, Mette] Brigham & Womens Hosp, Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Karolinska Inst, Stockholm, Sweden; Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Karolinska Institutet; University of Oslo; National Hospital Norway; Harvard University; Harvard Medical School	Kalager, M (corresponding author), Brigham & Womens Hosp, Harvard Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	mkalager@hsph.harvard.edu			Norwegian Research Council and Frontier Science	Norwegian Research Council and Frontier Science	Norwegian Research Council and Frontier Science.	Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Bakken L, 2004, INT J CANCER, V112, P130, DOI 10.1002/ijc.20389; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; BOER R, 1994, LANCET, V343, P979, DOI 10.1016/S0140-6736(94)90105-8; de Koning HJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1369; Duffy SW, 2008, BRIT J CANCER, V99, P1176, DOI 10.1038/sj.bjc.6604638; Duffy SW, 2005, BREAST CANCER RES, V7, P258, DOI 10.1186/bcr1354; Gotzsche PC, 2009, BRIT J CANCER, V100, P219, DOI 10.1038/sj.bjc.6604762; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Gotzsche PC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b86; Jatoi I, 2005, CURR PROB SURG, V42, P616, DOI 10.1067/j.cpsurg.2005.06.002; Jensen A, 2005, INT J CANCER, V113, P464, DOI 10.1002/ijc.20604; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kalager Mette, 2009, Tidsskr Nor Laegeforen, V129, P2595, DOI 10.4045/tidsskr.09.0024; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; MacMahon B., 1996, EPIDEMIOLOGY PRINCIP, V2nd; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; PERRY NM, 1996, EUROPEAN GUIDELINES; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rostgaard K, 2010, ACTA ONCOL, V49, P313, DOI 10.3109/02841861003602074; Shen Y, 2005, BIOSTATISTICS, V6, P604, DOI 10.1093/biostatistics/kxi030; Sorum R, 2010, BREAST, V19, P499, DOI 10.1016/j.breast.2010.05.014; Statistics Norway, STAT NORW; Tingulstad S, 2002, INT J CANCER, V98, P907, DOI 10.1002/ijc.10254; Vainio H., 2001, IARC HDB CANC PREVEN; Waaseth M, 2009, MATURITAS, V63, P220, DOI 10.1016/j.maturitas.2009.03.017; Weedon-Fekjaer H, 2008, J MED SCREEN, V15, P83, DOI 10.1258/jms.2008.007071; Weedon-Fekjaer H, 2009, ARCH INTERN MED, V169, P996, DOI 10.1001/archinternmed.2009.90; Welch HG, 2008, JNCI-J NATL CANCER I, V100, P228, DOI 10.1093/jnci/djn013; Welch HG, 2006, BRIT MED J, V332, P727, DOI 10.1136/bmj.332.7543.727; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Widmark A, 1995, 19955 STAT SAL, V5; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311; Zahl PH, 2008, LANCET ONCOL, V9, P199, DOI 10.1016/S1470-2045(08)70049-4; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	42	168	171	1	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					491	U61		10.7326/0003-4819-156-7-201204030-00005	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00005			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921GP	22473436				2022-12-01	WOS:000302466400003
J	Farago, AF; Snyder, EL; Jacks, T				Farago, Anna F.; Snyder, Eric L.; Jacks, Tyler			SnapShot: Lung Cancer Models	CELL			English	Editorial Material							RAPAMYCIN COMBINATION THERAPY; SOMATIC MUTATIONS; MOUSE; ADENOCARCINOMA; CELL		[Farago, Anna F.; Snyder, Eric L.; Jacks, Tyler] MIT, Cambridge, MA 02139 USA; [Farago, Anna F.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Farago, Anna F.] Dana Farber Partners Canc Care, Boston, MA 02215 USA; [Snyder, Eric L.] Brigham & Womens Hosp, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Farago, AF (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Chen Z, 2010, CANCER RES, V70, P9827, DOI 10.1158/0008-5472.CAN-10-1671; de Seranno S, 2010, EUR RESPIR J, V35, P426, DOI 10.1183/09031936.00124709; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595	10	28	30	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					246	+	246.e1	10.1016/j.cell.2012.03.015	http://dx.doi.org/10.1016/j.cell.2012.03.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464334	Bronze			2022-12-01	WOS:000302235400025
J	Chen, Z; Cheng, K; Walton, Z; Wang, YC; Ebi, H; Shimamura, T; Liu, Y; Tupper, T; Ouyang, J; Li, J; Gao, P; Woo, MS; Xu, CX; Yanagita, M; Altabef, A; Wang, SM; Lee, C; Nakada, Y; Pena, CG; Sun, YP; Franchetti, Y; Yao, C; Saur, A; Cameron, MD; Nishino, M; Hayes, DN; Wilkerson, MD; Roberts, PJ; Lee, CB; Bardeesy, N; Butaney, M; Chirieac, LR; Costa, DB; Jackman, D; Sharpless, NE; Castrillon, DH; Demetri, GD; Janne, PA; Pandolfi, PP; Cantley, LC; Kung, AL; Engelman, JA; Wong, KK				Chen, Zhao; Cheng, Katherine; Walton, Zandra; Wang, Yuchuan; Ebi, Hiromichi; Shimamura, Takeshi; Liu, Yan; Tupper, Tanya; Ouyang, Jing; Li, Jie; Gao, Peng; Woo, Michele S.; Xu, Chunxiao; Yanagita, Masahiko; Altabef, Abigail; Wang, Shumei; Lee, Charles; Nakada, Yuji; Pena, Christopher G.; Sun, Yanping; Franchetti, Yoko; Yao, Catherine; Saur, Amy; Cameron, Michael D.; Nishino, Mizuki; Hayes, D. Neil; Wilkerson, Matthew D.; Roberts, Patrick J.; Lee, Carrie B.; Bardeesy, Nabeel; Butaney, Mohit; Chirieac, Lucian R.; Costa, Daniel B.; Jackman, David; Sharpless, Norman E.; Castrillon, Diego H.; Demetri, George D.; Jaenne, Pasi A.; Pandolfi, Pier Paolo; Cantley, Lewis C.; Kung, Andrew L.; Engelman, Jeffrey A.; Wong, Kwok-Kin			A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response	NATURE			English	Article							STANDARDIZED UPTAKE VALUE; VOLUME MEASUREMENT; MOUSE MODELS; SURVIVAL; METAANALYSIS; GEFITINIB; DOCETAXEL; ADENOCARCINOMA; ARRY-142886; ACTIVATION	Targeted therapies have demonstrated efficacy against specific subsets of molecularly defined cancers(1-4). Although most patients with lung cancer are stratified according to a single oncogenic driver, cancers harbouring identical activating genetic mutations show large variations in their responses to the same targeted therapy(1,3). The biology underlying this heterogeneity is not well understood, and the impact of co-existing genetic mutations, especially the loss of tumour suppressors(5-) (9), has not been fully explored. Here we use genetically engineeredmousemodels to conduct a ` co-clinical' trial that mirrors an ongoing human clinical trial in patients with KRAS-mutant lung cancers. This trial aims to determine if the MEK inhibitor selumetinib (AZD6244)(10) increases the efficacy of docetaxel, a standard of care chemotherapy. Our studies demonstrate that concomitant loss of either p53 (also known as Tp53) or Lkb1 (also known as Stk11), two clinically relevant tumour suppressors(6,9,11,12), markedly impaired the response of Kras-mutant cancers to docetaxel monotherapy. We observed that the addition of selumetinib provided substantial benefit for mice with lung cancer caused by Kras and Kras and p53 mutations, but mice with Kras and Lkb1 mutations had primary resistance to this combination therapy. Pharmacodynamic studies, including positron-emission tomography (PET) and computed tomography (CT), identified biological markers in mice and patients that provide a rationale for the differential efficacy of these therapies in the different genotypes. These co-clinical results identify predictive genetic biomarkers that should be validated by interrogating samples from patients enrolled on the concurrent clinical trial. These studies also highlight the rationale for synchronous co-clinical trials, not only to anticipate the results of ongoing human clinical trials, but also to generate clinically relevant hypotheses that can inform the analysis and design of human studies.	[Chen, Zhao; Ebi, Hiromichi; Liu, Yan; Xu, Chunxiao; Jaenne, Pasi A.; Engelman, Jeffrey A.; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Chen, Zhao; Cheng, Katherine; Walton, Zandra; Liu, Yan; Ouyang, Jing; Gao, Peng; Woo, Michele S.; Xu, Chunxiao; Yanagita, Masahiko; Altabef, Abigail; Yao, Catherine; Butaney, Mohit; Jackman, David; Jaenne, Pasi A.; Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chen, Zhao; Cheng, Katherine; Walton, Zandra; Liu, Yan; Gao, Peng; Xu, Chunxiao; Demetri, George D.; Wong, Kwok-Kin] Dana Farber Canc Inst, Harvard Canc Ctr, Ludwig Ctr Dana Farber, Boston, MA 02115 USA; [Wang, Yuchuan; Tupper, Tanya; Sun, Yanping; Saur, Amy; Kung, Andrew L.] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Wang, Yuchuan; Sun, Yanping; Nishino, Mizuki] Dana Farber Canc Inst, Dept Imaging, Boston, MA 02115 USA; [Wang, Yuchuan; Nishino, Mizuki] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Ebi, Hiromichi; Bardeesy, Nabeel; Engelman, Jeffrey A.] Massachusetts Gen Hosp, Ctr Canc, Dept Med Oncol, Boston, MA 02114 USA; [Shimamura, Takeshi] Loyola Univ Chicago, Stritch Sch Med, Inst Oncol, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Li, Jie] Iowa State Univ, Dept Stat & Stat Lab, Ctr Survey Stat & Methodol, Ames, IA 50010 USA; [Wang, Shumei; Lee, Charles; Chirieac, Lucian R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Nakada, Yuji; Pena, Christopher G.; Castrillon, Diego H.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Nakada, Yuji; Pena, Christopher G.; Castrillon, Diego H.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Franchetti, Yoko] Harvard Univ, Sch Publ Hlth, Dept Biostat & Computat Biol, Dana Farber Canc Inst,Dept Biostat, Boston, MA 02115 USA; [Cameron, Michael D.] Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA; [Hayes, D. Neil; Wilkerson, Matthew D.; Roberts, Patrick J.; Lee, Carrie B.; Sharpless, Norman E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Costa, Daniel B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA; [Jaenne, Pasi A.; Wong, Kwok-Kin] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program,Dept Med & Pathol, Boston, MA 02115 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Kung, Andrew L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kung, Andrew L.] Childrens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Loyola University Chicago; Iowa State University; Harvard University; Brigham & Women's Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Scripps Research Institute; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Wong, KK (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	andrew_kung@dfci.harvard.edu; jengelman@partners.org; kwong1@partners.org	Cantley, Lewis C/D-1800-2014; Lee, Carrie/AAT-6939-2021; Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020; Butaney, Mohit/O-5511-2019; Ebi, Hiromichi/AAA-7358-2019; Chirieac, Lucian R./AAD-2030-2019	Cantley, Lewis C/0000-0002-1298-7653; Lee, Carrie/0000-0003-4786-3834; Kung, Andrew L/0000-0002-9091-488X; Butaney, Mohit/0000-0002-4760-4026; Ebi, Hiromichi/0000-0003-3155-7576; Walton, Zandra/0000-0002-0465-0153; Pandolfi, Pier Paolo/0000-0002-5352-5295; Cameron, Michael/0000-0003-3154-4775; Sharpless, Norman/0000-0001-7078-9455; wong, kwok kin/0000-0001-6323-235X; Costa, Daniel/0000-0002-0689-395X; Hayes, D. Neil/0000-0001-6203-7771; Wang, Yuchuan/0000-0001-5111-6562	National Institutes of Health [CA122794, CA140594, CA137181, CA137008, CA147940, CA137008-01, 1U01CA141576, Lung SPORE P50CA090578]; United against Lung Cancer Foundation; American Lung Association; Susan Spooner Research Fund; NATIONAL CANCER INSTITUTE [K23CA157631, R01CA140594, R01CA163896, R01CA137008, P30CA016086, U01CA141576, R01CA137181, RC2CA147940, P50CA090578, R01CA122794, P01CA120964, R01CA166480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United against Lung Cancer Foundation; American Lung Association; Susan Spooner Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Institutes of Health (CA122794, CA140594, CA137181, CA137008, CA147940, CA137008-01, 1U01CA141576, Lung SPORE P50CA090578), United against Lung Cancer Foundation, American Lung Association and Susan Spooner Research Fund.	Ahrendt SA, 2003, J NATL CANCER I, V95, P961, DOI 10.1093/jnci/95.13.961; Berghmans T, 2008, J THORAC ONCOL, V3, P6, DOI 10.1097/JTO.0b013e31815e6d6b; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; DYKES DJ, 1995, INVEST NEW DRUG, V13, P1, DOI 10.1007/BF02614214; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Erasmus Jeremy J, 2009, Proc Am Thorac Soc, V6, P171, DOI 10.1513/pats.200806-059LC; Gill RK, 2011, ONCOGENE, V30, P3784, DOI 10.1038/onc.2011.98; Hainsworth JD, 2010, J THORAC ONCOL, V5, P1630, DOI 10.1097/JTO.0b013e3181e8b3a3; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; LoRusso PM, 2008, J CLIN ONCOL, V26, P3051, DOI 10.1200/JCO.2007.14.9633; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nishino M, 2011, ACAD RADIOL, V18, P54, DOI 10.1016/j.acra.2010.08.021; Politi K, 2011, J CLIN ONCOL, V29, P2273, DOI 10.1200/JCO.2010.30.8304; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Tuveson D, 2011, NATURE, V471, P316, DOI 10.1038/471316a; Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201, DOI 10.1200/JCO.1999.17.10.3201; Verhoeven D, 2009, VIROLOGY, V390, P151, DOI 10.1016/j.virol.2009.05.004; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Zhao BS, 2010, CLIN CANCER RES, V16, P4647, DOI 10.1158/1078-0432.CCR-10-0125	30	351	362	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					613	617		10.1038/nature10937	http://dx.doi.org/10.1038/nature10937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22425996	Green Accepted, Green Published			2022-12-01	WOS:000302006100042
J	Ma, D; Lu, PL; Yan, CY; Fan, C; Yin, P; Wang, JW; Shi, YG				Ma, Dan; Lu, Peilong; Yan, Chuangye; Fan, Chao; Yin, Ping; Wang, Jiawei; Shi, Yigong			Structure and mechanism of a glutamate-GABA antiporter	NATURE			English	Article							AMINO-ACID ANTIPORTER; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; SUBSTRATE RECOGNITION; AGMATINE ANTIPORTER; BINDING-SITE; RESISTANCE; TRANSPORTER; ARGININE	Food-borne hemorrhagic Escherichia coli, exemplified by the strains O157:H7 and O104:H4 (refs 1, 2), require elaborate acid-resistance systems (ARs)(3) to survive the extremely acidic environment such as the stomach (pH approximate to 2). AR2 expels intracellular protons through the decarboxylation of L-glutamate (Glu) in the cytoplasm and exchange of the reaction product c-aminobutyric acid (GABA) with extracellular Glu. The latter process is mediated by the Glu-GABA antiporter GadC(4,5), a representative member of theamino-acid-polyamine-organocation superfamily of membrane transporters. The functional mechanism of GadC remains largely unknown. Here we show, with the use of anin vitro proteoliposome-based assay, that GadC transports GABA/Glu only under acidic conditions, with no detectable activity at pH values higher than 6.5. We determined the crystal structure of E. coli GadC at 3.1 angstrom resolution under basic conditions. GadC, comprising 12 transmembrane segments (TMs), exists in a closed state, with its carboxy-terminal domain serving as a plug to block an otherwise inward-open conformation. Structural and biochemical analyses reveal the essential transport residues, identify the transport path and suggest a conserved transport mechanism involving the rigid-body rotation of a helical bundle for GadC and other amino acid antiporters.	[Ma, Dan; Lu, Peilong; Fan, Chao; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Prot Sci Lab,Minist Educ, Beijing 100084, Peoples R China; [Ma, Dan; Lu, Peilong; Yan, Chuangye; Fan, Chao; Yin, Ping; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Yan, Chuangye; Yin, Ping; Wang, Jiawei] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Ma, Dan; Lu, Peilong; Yan, Chuangye; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Prot Sci Lab,Minist Educ, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021	Wang, Jiawei/0000-0001-9893-8539; Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X; Lu, Peilong/0000-0001-5894-9268	Ministry of Science and Technology [2009CB918801]; National Natural Science Foundation; Beijing Municipal Commissions of Education and Science and Technology	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology	We thank S. Huang and J. He (at SSRF beamline BL17U) and N. Shimizu, T. Kumasaka and S. Baba at the Spring-8 beamline BL41XU for on-site assistance, and N. Yan for discussion and comments on the manuscript. This work was supported by funds from the Ministry of Science and Technology (grant 2009CB918801), National Natural Science Foundation, and Beijing Municipal Commissions of Education and Science and Technology.	Abramson J, 2003, FEBS LETT, V555, P96, DOI 10.1016/S0014-5793(03)01087-1; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Robertson JL, 2010, NATURE, V468, P844, DOI 10.1038/nature09556; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Sasahara A, 2011, J BIOL CHEM, V286, P29044, DOI 10.1074/jbc.M111.260224; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Veenhoff LM, 1999, J BIOL CHEM, V274, P33244, DOI 10.1074/jbc.274.47.33244; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Waterman SR, 1996, MOL MICROBIOL, V21, P925, DOI 10.1046/j.1365-2958.1996.00058.x; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	35	137	146	3	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					632	U161		10.1038/nature10917	http://dx.doi.org/10.1038/nature10917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22407317				2022-12-01	WOS:000302006100046
J	Rule, S; Brook, BW; Haberle, SG; Turney, CSM; Kershaw, AP; Johnson, CN				Rule, Susan; Brook, Barry W.; Haberle, Simon G.; Turney, Chris S. M.; Kershaw, A. Peter; Johnson, Christopher N.			The Aftermath of Megafaunal Extinction: Ecosystem Transformation in Pleistocene Australia	SCIENCE			English	Article							LATE QUATERNARY EXTINCTIONS; NEW-GUINEA; SPORORMIELLA; COLLAPSE; SPORES	Giant vertebrates dominated many Pleistocene ecosystems. Many were herbivores, and their sudden extinction in prehistory could have had large ecological impacts. We used a high-resolution 130,000-year environmental record to help resolve the cause and reconstruct the ecological consequences of extinction of Australia's megafauna. Our results suggest that human arrival rather than climate caused megafaunal extinction, which then triggered replacement of mixed rainforest by sclerophyll vegetation through a combination of direct effects on vegetation of relaxed herbivore pressure and increased fire in the landscape. This ecosystem shift was as large as any effect of climate change over the last glacial cycle, and indicates the magnitude of changes that may have followed megafaunal extinction elsewhere in the world.	[Johnson, Christopher N.] Univ Tasmania, Sch Zool, Hobart, Tas 7001, Australia; [Rule, Susan; Haberle, Simon G.] Australian Natl Univ, Sch Culture Hist & Language, Canberra, ACT 0200, Australia; [Rule, Susan] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Brook, Barry W.] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Brook, Barry W.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Turney, Chris S. M.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Kershaw, A. Peter] Monash Univ, Sch Geog & Environm Sci, Clayton, Vic 3168, Australia	University of Tasmania; Australian National University; James Cook University; University of Adelaide; University of Adelaide; University of New South Wales Sydney; Monash University	Johnson, CN (corresponding author), Univ Tasmania, Sch Zool, Hobart, Tas 7001, Australia.	c.n.johnson@utas.edu.au	Turney, Chris S M/P-8701-2018; Brook, Barry W./G-2686-2011; Johnson, Christopher/J-7894-2014; Haberle, Simon/U-4118-2019; Johnson, Chris N/A-7275-2008	Turney, Chris S M/0000-0001-6733-0993; Brook, Barry W./0000-0002-2491-1517; Johnson, Christopher/0000-0002-9719-3771; Kershaw, Peter/0000-0002-9478-0567; Haberle, Simon/0000-0001-5802-6535	Australian Research Council; National Geographic Society; Monash Univ.; Royal Society; Australian Institute of Nuclear Science and Engineering; Natural Environment Research Council	Australian Research Council(Australian Research Council); National Geographic Society(National Geographic Society); Monash Univ.; Royal Society(Royal Society of London); Australian Institute of Nuclear Science and Engineering; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Australian Research Council, the National Geographic Society, Monash Univ., The Royal Society, Australian Institute of Nuclear Science and Engineering, and Natural Environment Research Council. We thank D. Bowman and E. Cameron for comments on the manuscript. The study was initiated by C.N.J. and B.W.B. and was designed by all authors. S.R. was responsible for data collection; B.W.B., C.N.J., S.R., and A.P.K. analyzed the data; C.S.M.T. developed the age model; C.N.J. led the writing; and all authors contributed to interpretation of results. The authors declare no competing interests. Original data will be provided by the corresponding author on request.	Brook B. W., 2006, ALCHERINGA, V1, P39; Burney DA, 2003, P NATL ACAD SCI USA, V100, P10800, DOI 10.1073/pnas.1534700100; Danell K., 2006, LARGE HERBIVORE ECOL; David B, 1997, ANTIQUITY, V71, P183, DOI 10.1017/S0003598X00084672; DAVIS OK, 1987, QUATERNARY RES, V28, P290, DOI 10.1016/0033-5894(87)90067-6; Davis OK, 2006, PALAEOGEOGR PALAEOCL, V237, P40, DOI 10.1016/j.palaeo.2005.11.028; Field J, 2008, EARTH-SCI REV, V89, P97, DOI 10.1016/j.earscirev.2008.04.006; Flannery T. F., 1994, FUTURE EATERS; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Gillespie R., 2006, ALCHERINGA, V1, P163, DOI DOI 10.1080/03115510608619580; Grun R, 2008, AUST J EARTH SCI, V55, P917, DOI 10.1080/08120090802097419; Hiscock P., 2008, ARCHAEOLOGY ANCIENT; Johnson C., 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2009, P ROY SOC B-BIOL SCI, V276, P2509, DOI 10.1098/rspb.2008.1921; KERSHAW AP, 1986, NATURE, V322, P47, DOI 10.1038/322047a0; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Leavesley MG., 2002, AUST ARCHAEOL, V54, P55, DOI [10.1080/03122417.2002.11682070, DOI 10.1080/03122417.2002.11682070]; Miller GH, 2005, SCIENCE, V309, P287, DOI 10.1126/science.1111288; Murphy BP, 2012, GLOBAL ECOL BIOGEOGR, V21, P142, DOI 10.1111/j.1466-8238.2011.00668.x; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Robinson GS, 2005, ECOL MONOGR, V75, P295, DOI 10.1890/03-4064; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Turney CSM, 2004, NATURE, V428, P306, DOI 10.1038/nature02386; Turney CSM, 2001, J QUATERNARY SCI, V16, P767, DOI 10.1002/jqs.643; Wood JR, 2011, QUATERNARY SCI REV, V30, P915, DOI 10.1016/j.quascirev.2011.01.007	25	216	220	9	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2012	335	6075					1483	1486		10.1126/science.1214261	http://dx.doi.org/10.1126/science.1214261			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22442481				2022-12-01	WOS:000301837000045
J	Lu, C; Ward, PS; Kapoor, GS; Rohle, D; Turcan, S; Abdel-Wahab, O; Edwards, CR; Khanin, R; Figueroa, ME; Melnick, A; Wellen, KE; O'Rourke, DM; Berger, SL; Chan, TA; Levine, RL; Mellinghoff, IK; Thompson, CB				Lu, Chao; Ward, Patrick S.; Kapoor, Gurpreet S.; Rohle, Dan; Turcan, Sevin; Abdel-Wahab, Omar; Edwards, Christopher R.; Khanin, Raya; Figueroa, Maria E.; Melnick, Ari; Wellen, Kathryn E.; O'Rourke, Donald M.; Berger, Shelley L.; Chan, Timothy A.; Levine, Ross L.; Mellinghoff, Ingo K.; Thompson, Craig B.			IDH mutation impairs histone demethylation and results in a block to cell differentiation	NATURE			English	Article							INTEGRATED GENOMIC ANALYSIS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; LEUKEMIA; GENE; DNA; TRANSCRIPTION; SETDB1; TUMORS; BRAIN	Recurrent mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 have been identified in gliomas, acute myeloid leukaemias (AML) and chondrosarcomas, and share a novel enzymatic property of producing 2-hydroxyglutarate (2HG) from alpha-ketoglutarate(1-6). Here we report that 2HG-producing IDH mutants can prevent the histone demethylation that is required for lineage-specific progenitor cells to differentiate into terminally differentiated cells. In tumour samples from glioma patients, IDH mutations were associated with a distinct gene expression profile enriched for genes expressed in neural progenitor cells, and this was associated with increased histone methylation. To test whether the ability of IDH mutants to promote histone methylation contributes to a block in cell differentiation in non-transformed cells, we tested the effect of neomorphic IDH mutants on adipocyte differentiation in vitro. Introduction of either mutant IDH or cell-permeable 2HG was associated with repression of the inducible expression of lineage-specific differentiation genes and a block to differentiation. This correlated with a significant increase in repressive histone methylation marks without observable changes in promoter DNA methylation. Gliomas were found to have elevated levels of similar histone repressive marks. Stable transfection of a 2HG-producing mutant IDH into immortalized astrocytes resulted in progressive accumulation of histone methylation. Of the marks examined, increased H3K9 methylation reproducibly preceded a rise in DNA methylation as cells were passaged in culture. Furthermore, we found that the 2HG-inhibitable H3K9 demethylase KDM4C was induced during adipocyte differentiation, and that RNA-interference suppression of KDM4C was sufficient to block differentiation. Together these data demonstrate that 2HG can inhibit histone demethylation and that inhibition of histone demethylation can be sufficient to block the differentiation of non-transformed cells.	[Lu, Chao; Ward, Patrick S.; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Lu, Chao; Ward, Patrick S.; Wellen, Kathryn E.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Kapoor, Gurpreet S.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Rohle, Dan; Turcan, Sevin; Abdel-Wahab, Omar; Chan, Timothy A.; Levine, Ross L.; Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Rohle, Dan; Mellinghoff, Ingo K.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10065 USA; [Edwards, Christopher R.; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Figueroa, Maria E.; Melnick, Ari] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY 10065 USA; [O'Rourke, Donald M.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Cornell University; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center	Thompson, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	thompsonc@mskcc.org	O'Rourke, Donald/AAC-3376-2021; Lu, Chao/E-8047-2012; levine, ross/AAE-7658-2019; Chan, Timothy A/ABD-5850-2021; Grieshaber-Bouyer, Ricardo/R-7512-2016; Turcan, Sevin/AAF-1095-2019; Melnick, Ari/AAA-5763-2020; Figueroa, Maria/AAE-8662-2019; Ward, Patrick/H-2361-2014	Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Turcan, Sevin/0000-0002-0885-5607; Ward, Patrick/0000-0001-6437-8174; Lu, Chao/0000-0003-0982-8122; O'Rourke, Donald/0000-0002-8479-7314; Mellinghoff, Ingo/0000-0002-4347-8149; Figueroa, Maria Eugenia/0000-0003-4887-4981; Berger, Shelley/0000-0001-5398-4400; Abdel-Wahab, Omar/0000-0002-3907-6171	National Cancer Institute; National Institutes of Health; Howard Hughes Medical Institute; MSKCC; Abramson Cancer Center at University of Pennsylvania; Doris Duke Charitable Foundation; American Society of Clinical Oncology;  [NCI-U54CA143798]; NATIONAL CANCER INSTITUTE [U54CA143798, R01CA105463, R01CA078831] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); MSKCC; Abramson Cancer Center at University of Pennsylvania; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Society of Clinical Oncology; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Thompson laboratory for technical help and critical reading of the manuscript. We thank T. A. Gocke and the genomic core of University of Pennsylvania for their assistance with the microarray study; the molecular cytology core facility of Memorial Sloan-Kettering Cancer Center (MSKCC) for technical help with the immunohistochemistry study; and O. Ouerfelli and M. K. Spassova at the organic synthesis core of MSKCC for the synthesis of octyl-2HG. This work was supported by grants from the National Cancer Institute and National Institutes of Health. R. L. L. is an Early Career Award recipient of the Howard Hughes Medical Institute and the Geoffrey Beene Junior Chair at MSKCC. D.M.O'R. is supported by the Betsy Cohen Fund of the Abramson Cancer Center at University of Pennsylvania. I. K. M. is supported by NCI-U54CA143798, the Doris Duke Charitable Foundation, and an Advanced Clinical Research Award in Glioma from the American Society of Clinical Oncology.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Habib M, 1999, EXP CELL RES, V249, P46, DOI 10.1006/excr.1999.4434; Hu ZB, 2001, ONCOGENE, V20, P6946, DOI 10.1038/sj.onc.1204850; Ingvarsdottir K, 2007, MOL CELL BIOL, V27, P7856, DOI 10.1128/MCB.00801-07; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Sonoda Y, 2001, CANCER RES, V61, P4956; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	30	1316	1364	7	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2012	483	7390					474	U130		10.1038/nature10860	http://dx.doi.org/10.1038/nature10860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22343901	Green Accepted			2022-12-01	WOS:000301771200045
J	Pani, AM; Mullarkey, EE; Aronowicz, J; Assimacopoulos, S; Grove, EA; Lowe, CJ				Pani, Ariel M.; Mullarkey, Erin E.; Aronowicz, Jochanan; Assimacopoulos, Stavroula; Grove, Elizabeth A.; Lowe, Christopher J.			Ancient deuterostome origins of vertebrate brain signalling centres	NATURE			English	Article							HEMICHORDATE SACCOGLOSSUS-KOWALEVSKII; NERVOUS-SYSTEM; FOREBRAIN DEVELOPMENT; TRANSCRIPTION FACTORS; CELL FATE; FGF8; AMPHIOXUS; HEDGEHOG; EVOLUTIONARY; EXPRESSION	Neuroectodermal signalling centres induce and pattern many novel vertebrate brain structures but are absent, or divergent, in invertebrate chordates. This has led to the idea that signalling-centre genetic programs were first assembled in stem vertebrates and potentially drove morphological innovations of the brain. However, this scenario presumes that extant cephalochordates accurately represent ancestral chordate characters, which has not been tested using close chordate outgroups. Here we report that genetic programs homologous to three vertebrate signalling centres-the anterior neural ridge, zona limitans intrathalamica and isthmic organizer-are present in the hemichordate Saccoglossus kowalevskii. Fgf8/17/18 (a single gene homologous to vertebrate Fgf8, Fgf17 and Fgf18), sfrp1/5, hh and wnt1 are expressed in vertebrate-like arrangements in hemichordate ectoderm, and homologous genetic mechanisms regulate ectodermal patterning in both animals. We propose that these genetic programs were components of an unexpectedly complex, ancient genetic regulatory scaffold for deuterostome body patterning that degenerated in amphioxus and ascidians, but was retained to pattern divergent structures in hemichordates and vertebrates.	[Pani, Ariel M.; Lowe, Christopher J.] Univ Chicago, Comm Evolut Biol, Chicago, IL 60637 USA; [Pani, Ariel M.; Lowe, Christopher J.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Mullarkey, Erin E.; Grove, Elizabeth A.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Aronowicz, Jochanan; Grove, Elizabeth A.; Lowe, Christopher J.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Assimacopoulos, Stavroula; Grove, Elizabeth A.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	University of Chicago; Stanford University; University of Chicago; University of Chicago; University of Chicago	Lowe, CJ (corresponding author), Univ Chicago, Comm Evolut Biol, 1025 E 57th St, Chicago, IL 60637 USA.	clowe@stanford.edu		Lowe, Christopher/0000-0002-7789-8643	Searle Kinship Foundation; Brain Research Foundation; National Science Foundation [1049106]; National Institutes of Health [R01 HD42330]; University of Chicago; Marine Biological Laboratory Frank R. Lillie Fellowship; National Institute of Child Health and Development [1T32HD055164-01A1]; National Institute of Neurological Disorders and Stroke [1F31NS074738-01A1]; National Science and Engineering Research Council of Canada; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055164, T32HD007009] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS074738] Funding Source: NIH RePORTER; Direct For Biological Sciences [1049106] Funding Source: National Science Foundation	Searle Kinship Foundation; Brain Research Foundation; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago(University of Chicago); Marine Biological Laboratory Frank R. Lillie Fellowship; National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Gerhart and M. Kirschner for assistance and support, R. Freeman for bioinformatics assistance, E. Farrelly, M. Terasaki and S. Darras for technical guidance, the members of the Lowe laboratory for discussions, and G. Wray and J. Gerhart for comments on drafts of the manuscript. We also thank the staff of the Marine Biological Laboratory, the Waquoit Bay National Estuarine Research Reserve, Carl ZeissandNikonfor assistance duringour field season. This work was funded by the Searle Kinship Foundation, Brain Research Foundation and National Science Foundation grant 1049106 (C. J. L.), National Institutes of Health grant R01 HD42330 (E. A. G.) and the University of Chicago Hinds Fund (A. M. P). A. M. P. was supported by a Marine Biological Laboratory Frank R. Lillie Fellowship, National Institute of Child Health and Development institutional training grant 1T32HD055164-01A1, and National Institute of Neurological Disorders and Stroke pre-doctoral fellowship 1F31NS074738-01A1. J. A. was supported by a National Science and Engineering Research Council of Canada pre-doctoral grant.	Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Campo-Paysaa F, 2008, GENESIS, V46, P640, DOI 10.1002/dvg.20444; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0; Darras S, 2011, DEVELOPMENT, V138, P959, DOI 10.1242/dev.059493; Echevarria D, 2003, BRAIN RES REV, V43, P179, DOI 10.1016/j.brainresrev.2003.08.002; Freeman RM, 2008, BIOL BULL-US, V214, P284, DOI 10.2307/25470670; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Gavino MA, 2011, CURR BIOL, V21, P294, DOI 10.1016/j.cub.2011.01.017; Gillis JA, 2012, P ROY SOC B-BIOL SCI, V279, P237, DOI 10.1098/rspb.2011.0599; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Holland L. Z., 2008, BRAIN BEHAV EVOL, V72; Holland LZ, 2009, NAT REV NEUROSCI, V10, P736, DOI 10.1038/nrn2703; Holland LZ, 2000, DEV GENES EVOL, V210, P522, DOI 10.1007/s004270000089; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Imai KS, 2009, DEVELOPMENT, V136, P285, DOI 10.1242/dev.026419; Irimia M, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-7; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Lacalli TC, 2006, INT J BIOL SCI, V2, P104; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; Meinertzhagen IA, 2004, ANNU REV NEUROSCI, V27, P453, DOI 10.1146/annurev.neuro.27.070203.144255; Meulemans D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000787; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nomaksteinsky M, 2009, CURR BIOL, V19, P1264, DOI 10.1016/j.cub.2009.05.063; Paek H, 2009, DEVELOPMENT, V136, P2457, DOI 10.1242/dev.032656; Reifers F, 1998, DEVELOPMENT, V125, P2381; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scholpp S, 2006, DEVELOPMENT, V133, P855, DOI 10.1242/dev.02248; Scholpp S, 2007, DEVELOPMENT, V134, P3167, DOI 10.1242/dev.001461; Scholpp S, 2010, TRENDS NEUROSCI, V33, P373, DOI 10.1016/j.tins.2010.05.003; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shimeld SM, 1999, DEV GENES EVOL, V209, P40, DOI 10.1007/s004270050225; Simon HH, 2004, CELL TISSUE RES, V318, P53, DOI 10.1007/s00441-004-0973-8; Takatori N, 2002, MECH DEVELOP, V116, P235, DOI 10.1016/S0925-4773(02)00150-8; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; Urbach R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-23; Walshe J, 2003, DEVELOPMENT, V130, P4337, DOI 10.1242/dev.00660; Wicht H, 2005, CAN J ZOOL, V83, P122, DOI 10.1139/Z04-163; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Zeltser LM, 2001, NAT NEUROSCI, V4, P683, DOI 10.1038/89455	50	162	165	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					289	U79		10.1038/nature10838	http://dx.doi.org/10.1038/nature10838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22422262	Green Accepted			2022-12-01	WOS:000301481800040
J	Schwab, M; Buchli, A				Schwab, Martin; Buchli, Anita			Plug the real brain drain	NATURE			English	Editorial Material									[Schwab, Martin; Buchli, Anita] Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; [Schwab, Martin; Buchli, Anita] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, CH-8057 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schwab, M (corresponding author), Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland.	schwab@hifo.uzh.ch						Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Baker M, 2011, NATURE, V479, P459, DOI 10.1038/479459a; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Kwon BK, 2010, J NEUROTRAUM, V27, P21, DOI 10.1089/neu.2009.1048; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Sobocki P, 2006, EUR J NEUROSCI, V24, P2691, DOI 10.1111/j.1460-9568.2006.05116.x; Zoerner B., 2010, ANN NY ACAD SCI, V1198, pE22	7	5	6	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					267	268		10.1038/483267a	http://dx.doi.org/10.1038/483267a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	908HP	22422244	Bronze			2022-12-01	WOS:000301481800022
J	Li, QG; Gao, KQ; Meng, QJ; Clarke, JA; Shawkey, MD; D'Alba, L; Pei, R; Ellison, M; Norell, MA; Vinther, J				Li, Quanguo; Gao, Ke-Qin; Meng, Qingjin; Clarke, Julia A.; Shawkey, Matthew D.; D'Alba, Liliana; Pei, Rui; Ellison, Mick; Norell, Mark A.; Vinther, Jakob			Reconstruction of Microraptor and the Evolution of Iridescent Plumage	SCIENCE			English	Article							COLOR; DINOSAURS; CHINA; ARCHAEOPTERYX; FLIGHT; MODEL; SIZE	Iridescent feather colors involved in displays of many extant birds are produced by nanoscale arrays of melanin-containing organelles (melanosomes). Data relevant to the evolution of these colors and the properties of melanosomes involved in their generation have been limited. A data set sampling variables of extant avian melanosomes reveals that those forming most iridescent arrays are distinctly narrow. Quantitative comparison of these data with melanosome imprints densely sampled from a previously unknown specimen of the Early Cretaceous feathered Microraptor predicts that its plumage was predominantly iridescent. The capacity for simple iridescent arrays is thus minimally inferred in paravian dinosaurs. This finding and estimation of Microraptor feathering consistent with an ornamental function for the tail suggest a centrality for signaling in early evolution of plumage and feather color.	[Shawkey, Matthew D.; D'Alba, Liliana] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Shawkey, Matthew D.; D'Alba, Liliana] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Li, Quanguo; Meng, Qingjin] Beijing Museum Nat Hist, Beijing 100050, Peoples R China; [Gao, Ke-Qin] Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China; [Clarke, Julia A.; Vinther, Jakob] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Pei, Rui; Ellison, Mick; Norell, Mark A.] Amer Museum Nat Hist, Dept Paleontol, New York, NY 10024 USA; [Vinther, Jakob] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron; Peking University; University of Texas System; University of Texas Austin; American Museum of Natural History (AMNH); Yale University	Shawkey, MD (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	shawkey@uakron.edu	D'Alba, Liliana/AAC-4969-2022; Vinther, Jakob/GZG-4679-2022; Li, Quanguo/ABE-9756-2021; Meng, Q./GSI-6185-2022	D'Alba, Liliana/0000-0002-2478-3455; Vinther, Jakob/0000-0002-3584-9616; Shawkey, Matthew/0000-0002-5131-8209	NSF EAR [0938199]; Air Force Office of Scientific Research [FA9550-09-1-0159]; National Natural Science Foundation of China [40532008]; Beijing Municipal Bureau of Human Resources; Beijing Academy of Science and Technology (BJAST); University of Texas at Austin; American Museum of Natural History	NSF EAR(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Bureau of Human Resources; Beijing Academy of Science and Technology (BJAST); University of Texas at Austin; American Museum of Natural History	The research was funded by NSF EAR 0938199, Air Force Office of Scientific Research FA9550-09-1-0159, National Natural Science Foundation of China 40532008, Beijing Municipal Bureau of Human Resources, Beijing Academy of Science and Technology (BJAST) Innovation Team Fund, University of Texas at Austin, and the American Museum of Natural History. The Copenhagen Museum of Natural History (J. Fjeldsaa) and the Yale University Peabody Museum (R. O. Prum and K. Zyskowski) provided extant feather samples. The fossil specimen is accessioned to the Beijing Museum of Natural History (BMNHC). Data are presented in the supporting online material.	Alexander DE, 2010, P NATL ACAD SCI USA, V107, P2972, DOI 10.1073/pnas.0911852107; Andersson Malte, 1994; Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Clarke JA, 2006, J ANAT, V208, P287, DOI 10.1111/j.1469-7580.2006.00534.x; Clarke JA, 2010, SCIENCE, V330, P954, DOI 10.1126/science.1193604; Del Hoyo J., 2019, HDB BIRDS WORLD ALIV; Doucet SM, 2002, CONDOR, V104, P30, DOI 10.1650/0010-5422(2002)104[0030:SPCMBS]2.0.CO;2; Doucet SM, 2009, J R SOC INTERFACE, V6, pS115, DOI 10.1098/rsif.2008.0395.focus; DURRER H, 1986, BIOL INTEGUMENT, V2, P239; Fisher R., 2005, TEACHING CHILDREN TH; Gatesy SM, 1996, EVOLUTION, V50, P2037, DOI 10.1111/j.1558-5646.1996.tb03590.x; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Maia R, 2012, J R SOC INTERFACE, V9, P734, DOI 10.1098/rsif.2011.0456; Maia R, 2011, P ROY SOC B-BIOL SCI, V278, P1973, DOI 10.1098/rspb.2010.1637; McGraw KJ, 2002, J EXP BIOL, V205, P3747; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Prum RO, 2010, EVOLUTION, V64, P3085, DOI 10.1111/j.1558-5646.2010.01054.x; Prum RO, 2006, BIRD COLORATION, V1, P295; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Scholes E, 2006, AUK, V123, P967, DOI 10.1642/0004-8038(2006)123[967:CEOCPP]2.0.CO;2; Shawkey MD, 2006, J R SOC INTERFACE, V3, P777, DOI 10.1098/rsif.2006.0131; Stoddard MC, 2011, BEHAV ECOL, V22, P1042, DOI 10.1093/beheco/arr088; Thomas ALR, 1997, BIOSCIENCE, V47, P215, DOI 10.2307/1313075; Toomey MB, 2010, BEHAV ECOL SOCIOBIOL, V64, P1047, DOI 10.1007/s00265-010-0926-z; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Vinther J, 2010, BIOL LETTERS, V6, P128, DOI 10.1098/rsbl.2009.0524; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740	32	128	130	4	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2012	335	6073					1215	1219		10.1126/science.1213780	http://dx.doi.org/10.1126/science.1213780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22403389				2022-12-01	WOS:000301225100042
J	Cook, DJ; Teves, L; Tymianski, M				Cook, Douglas J.; Teves, Lucy; Tymianski, Michael			Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain	NATURE			English	Article							ACUTE ISCHEMIC-STROKE; PROTEIN INTERACTIONS; NEUROPROTECTION; TRANSLATION; EVOLUTION; DIFFUSION; TRIALS; MODEL; RECOMMENDATIONS; PREDICTION	All attempts at treating strokes by pharmacologically reducing the human brain's vulnerability to ischaemia have failed, leaving stroke as a leading cause of death, disability and massive socioeconomic loss worldwide(1). Over decades, research has failed to translate over 1,000 experimental treatments from discovery in cells and rodents to use in humans(2-4), a scientific crisis that gave rise to the prevailing belief that pharmacological neuroprotection is not feasible or practicable in higher-order brains. To provide a strategy for advancing stroke therapy, we used higher-order gyrencephalic non-human primates, which bear genetic, anatomical and behavioural similarities to humans(5,6) and tested neuroprotection by PSD-95 inhibitors-promising compounds that uncouple postsynaptic density protein PSD-95 from neurotoxic signalling pathways(7-10). Here we show that stroke damage can be prevented in non-human primates in which a PSD-95 inhibitor is administered after stroke onset in clinically relevant situations. This treatment reduced infarct volumes as gauged by magnetic resonance imaging and histology, preserved the capacity of ischaemic cells to maintain gene transcription in genome-wide screens of ischaemic brain tissue, and significantly preserved neurological function in neuro-behavioural assays. The degree of tissue neuroprotection by magnetic resonance imaging corresponded strongly to the preservation of neurological function, supporting the intuitive but unproven dictum that integrity of brain tissue can reflect functional outcome. Our findings establish that tissue neuroprotection and improved functional outcome after stroke is unequivocally achievable in gyrencephalic non-human primates treated with PSD-95 inhibitors. Efforts must ensue to translate these findings to humans.	[Cook, Douglas J.; Teves, Lucy; Tymianski, Michael] Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada; [Tymianski, Michael] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Tymianski, Michael] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Tymianski, Michael] Univ Toronto, Dept Surg, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Tymianski, M (corresponding author), Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada.	mike.tymianski@uhn.ca		Tymianski, Mike/0000-0002-6311-9565	Canadian Stroke Network; Heart and Stroke Foundation of Ontario [NA 6988]; Canada Research Chair	Canadian Stroke Network; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants to M.T. from the Canadian Stroke Network and the Heart and Stroke Foundation of Ontario, grant NA 6988. D.J.C. is a recipient of a Canadian Stroke Network postdoctoral research fellowship. M.T. is a Canada Research Chair (Tier 1) in Translational Stroke Research. We thank M. Madden, B. Maloo, A. Goldstein, B. Madeira, W. Foltz and Z. Lu for assistance. We thank M. Salter and M. Hill for a review of the manuscript.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; [Anonymous], 2006, NATURE, V444, P532; Bardutzky J, 2007, STROKE, V38, P1336, DOI 10.1161/01.STR.0000259636.26950.3b; Bratane BT, 2011, STROKE, V42, P3265, DOI 10.1161/STROKEAHA.111.618801; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Enard D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000840; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; FINDLAY JM, 1991, J NEUROSURG, V75, P425, DOI 10.3171/jns.1991.75.3.0425; Fisher M, 2004, CEREBROVASC DIS, V17, P1, DOI 10.1159/000074790; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hand PJ, 2006, NEUROLOGY, V66, P1159, DOI 10.1212/01.wnl.0000202524.43850.81; Johnston KC, 2007, STROKE, V38, P1820, DOI 10.1161/STROKEAHA.106.479154; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kosior JC, 2007, J MAGN RESON IMAGING, V25, P653, DOI 10.1002/jmri.20843; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marshall JWB, 2003, ILAR J, V44, P153, DOI 10.1093/ilar.44.2.153; Marshall JWB, 1996, NEURODEGENERATION, V5, P275, DOI 10.1006/neur.1996.0036; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roitberg B, 2003, NEUROL RES, V25, P68, DOI 10.1179/016164103101200950; Sacchetti ML, 2008, STROKE, V39, P1659, DOI 10.1161/STROKEAHA.107.505024; Sanossian N, 2009, CEREBROVASC DIS, V28, P539, DOI 10.1159/000247596; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Savitz SI, 2007, EXP NEUROL, V205, P20, DOI 10.1016/j.expneurol.2007.03.003; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Stewart CB, 1998, CURR BIOL, V8, pR582, DOI 10.1016/S0960-9822(07)00367-3; Sun HS, 2008, STROKE, V39, P2544, DOI 10.1161/STROKEAHA.107.506048; YANAGIHARA T, 1978, BRAIN RES, V158, P435, DOI 10.1016/0006-8993(78)90686-8	37	290	312	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2012	483	7388					213	U112		10.1038/nature10841	http://dx.doi.org/10.1038/nature10841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22388811				2022-12-01	WOS:000301174900039
J	McGauran, A; Hawkes, N				McGauran, Ann; Hawkes, Nigel			PUBLIC HEALTH Is there a role for acute hospitals in tackling public health?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						[Anonymous], NAT HLTH PROM HOSP A; Cook G, 2010, MAKING EVERY HLTH CA	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 7	2012	344								e1325	10.1136/bmj.e1325	http://dx.doi.org/10.1136/bmj.e1325			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	908GV	22399702				2022-12-01	WOS:000301479800018
J	Hopkins, R; Rausher, MD				Hopkins, Robin; Rausher, Mark D.			Pollinator-Mediated Selection on Flower Color Allele Drives Reinforcement	SCIENCE			English	Article							REPRODUCTIVE CHARACTER DISPLACEMENT; PREMATING ISOLATION; PHLOX-DRUMMONDII; SEXUAL SELECTION; EVOLUTION; SPECIATION; HYBRIDIZATION; PREFERENCES; ADAPTATION; CONSTANCY	Reinforcement is the process by which reduced hybrid fitness generates selection favoring the evolution of stronger prezygotic reproductive barriers between emerging species. Using common-garden field experiments, we quantified the strength of reinforcing selection in nature by demonstrating strong selection favoring an allele conferring increased pigment intensity in the plant Phlox drummondii in areas of sympatry with the closely related species Phlox cuspidata. Incomplete hybrid sterility between the two species generates selection for traits that decrease interspecies hybridization. In contrast, selection on this locus is undetectable in the absence of P. cuspidata. We demonstrate that reinforcing selection is generated by nonrandom pollinator movement, in which pollinators move less frequently between intensely pigmented P. drummondii and P. cuspidata than between lightly pigmented P. drummondii and P. cuspidata.	[Hopkins, Robin; Rausher, Mark D.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Hopkins, R (corresponding author), Duke Univ, Dept Biol, Box 90338, Durham, NC 27708 USA.	robin.hopkins@duke.edu			University of Texas Stengl Research Station; NSF [0841521]	University of Texas Stengl Research Station; NSF(National Science Foundation (NSF))	We thank M. Kirkpatrick, S. Otto, M. Whitlock, D. Des Marais, and members of the Rausher and Kirkpatrick laboratory group for advice on this manuscript and S. Scarpino for statistical consultation. We thank the University of Texas Stengl Research Station for field experiment support. This work was supported by NSF grant 0841521 to M.D.R. and a NSF Doctoral Dissertation Improvement Grant to R.H. and M.D.R. R.H. was supported by the NSF Graduate Research Fellowship Program. All data presented here are available in the supporting material.	Albert AYK, 2004, EVOLUTION, V58, P1099; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; CAISSE M, 1978, HEREDITY, V40, P371, DOI 10.1038/hdy.1978.44; Campbell DR, 1997, AM NAT, V149, P295, DOI 10.1086/285991; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Dobzhansky T, 1937, GENETICS ORIGIN SPEC; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Hoballah ME, 2007, PLANT CELL, V19, P779, DOI 10.1105/tpc.106.048694; Hopkins R, 2012, EVOLUTION, V66, P469, DOI 10.1111/j.1558-5646.2011.01452.x; Hopkins R, 2011, NATURE, V469, P411, DOI 10.1038/nature09641; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Kirkpatrick M, 2000, P ROY SOC B-BIOL SCI, V267, P1649, DOI 10.1098/rspb.2000.1191; Kirkpatrick M, 1999, GENETICS, V151, P865; LEVIN DA, 1967, AM J BOT, V54, P1122, DOI 10.2307/2440537; LEVIN DA, 1985, EVOLUTION, V39, P1275, DOI 10.1111/j.1558-5646.1985.tb05693.x; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; Nosil P, 2003, P ROY SOC B-BIOL SCI, V270, P1911, DOI 10.1098/rspb.2003.2457; Ortiz-Barrientos D, 2009, ANN NY ACAD SCI, V1168, P156, DOI 10.1111/j.1749-6632.2009.04919.x; RAUSHER MD, 1978, SCIENCE, V200, P1071, DOI 10.1126/science.200.4345.1071; Ruane LG, 2008, EVOL ECOL, V22, P229, DOI 10.1007/s10682-007-9174-8; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Servedio MR, 2000, EVOLUTION, V54, P21, DOI 10.1111/j.0014-3820.2000.tb00003.x; Servedio MR, 2004, EVOLUTION, V58, P913, DOI 10.1111/j.0014-3820.2004.tb00425.x; Servedio MR, 2001, EVOLUTION, V55, P1909, DOI 10.1111/j.0014-3820.2001.tb01309.x; Wallace A.R., 1889, DARWINISM; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507	28	174	177	26	481	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1090	1092		10.1126/science.1215198	http://dx.doi.org/10.1126/science.1215198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22300852				2022-12-01	WOS:000300931100044
J	Kim, JY; Liu, CY; Zhang, FY; Duan, X; Wen, ZX; Song, J; Feighery, E; Lu, B; Rujescu, D; St Clair, D; Christian, K; Callicott, JH; Weinberger, DR; Song, HJ; Ming, GL				Kim, Ju Young; Liu, Cindy Y.; Zhang, Fengyu; Duan, Xin; Wen, Zhexing; Song, Juan; Feighery, Emer; Lu, Bai; Rujescu, Dan; St Clair, David; Christian, Kimberly; Callicott, Joseph H.; Weinberger, Daniel R.; Song, Hongjun; Ming, Guo-Li			Interplay between DISC1 and GABA Signaling Regulates Neurogenesis in Mice and Risk for Schizophrenia	CELL			English	Article							NEWLY GENERATED NEURONS; ADULT BRAIN; GENE-EXPRESSION; MOUSE HIPPOCAMPUS; DOWN-REGULATION; STRESS; INTEGRATION; MATURATION; KCC2; CELL	How extrinsic stimuli and intrinsic factors interact to regulate continuous neurogenesis in the postnatal mammalian brain is unknown. Here we show that regulation of dendritic development of newborn neurons by Disrupted-in-Schizophrenia 1 (DISC1) during adult hippocampal neurogenesis requires neurotransmitter GABA-induced, NKCC1-dependent depolarization through a convergence onto the AKT-mTOR pathway. In contrast, DISC1 fails to modulate early-postnatal hippocampal neurogenesis when conversion of GABA-induced depolarization to hyperpolarization is accelerated. Extending the period of GABA-induced depolarization or maternal deprivation stress restores DISC1-dependent dendritic regulation through mTOR pathway during early-postnatal hippocampal neurogenesis. Furthermore, DISC1 and NKCC1 interact epistatically to affect risk for schizophrenia in two independent case control studies. Our study uncovers an interplay between intrinsic DISC1 and extrinsic GABA signaling, two schizophrenia susceptibility pathways, in controlling neurogenesis and suggests critical roles of developmental tempo and experience in manifesting the impact of susceptibility genes on neuronal development and risk for mental disorders.	[Kim, Ju Young; Liu, Cindy Y.; Duan, Xin; Wen, Zhexing; Song, Juan; Christian, Kimberly; Song, Hongjun; Ming, Guo-Li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Kim, Ju Young; Liu, Cindy Y.; Wen, Zhexing; Song, Juan; Christian, Kimberly; Song, Hongjun; Ming, Guo-Li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Zhang, Fengyu; Duan, Xin; Song, Hongjun; Ming, Guo-Li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Feighery, Emer; Lu, Bai; Callicott, Joseph H.; Weinberger, Daniel R.] NIMH, Gene Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Rujescu, Dan] Univ Munich, Dept Psychiat, D-80336 Munich, Germany; [St Clair, David] Univ Aberdeen, Royal Cornhill Hosp, Aberdeen AB25 2ZD, Scotland; [Weinberger, Daniel R.; Song, Hongjun] Lieber Inst Brain Dev, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Munich; University of Aberdeen	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@jhmi.edu	Wen, Zhexing/B-9313-2014; St Clair, David/AAN-2412-2021; Rujescu, Dan/GRS-3875-2022; Zhang, Fengyu/M-1396-2019; Callicott, Joseph H/C-9102-2009; Callicott, Joseph H/AAE-7243-2022; Ming, Guo-li/J-7880-2013; Wen, Zhexing/L-1228-2018	Zhang, Fengyu/0000-0001-8504-0770; Callicott, Joseph H/0000-0003-1298-3334; Wen, Zhexing/0000-0002-1518-3845; Lu, Bai/0000-0001-5418-9759	NIH [NS048271, HD069184, NS047344, MH087874]; MSCRF; NARSAD; IMHRO; NIMH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002734, R21MH087874, R33MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS047344, R01NS048271, R01NS047344, R37NS047344] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSCRF; NARSAD(NARSAD); IMHRO; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of Ming and Song Laboratories for help and critical comments, L. Liu, Y. Cai, N. Powanpangkul, and Q. Hussaini for technical support, and A. Chiang and J. Wang for help with tissue processing. This work was supported by the NIH (NS048271 and HD069184), MSCRF, and NARSAD to G-l.M., by the NIH (NS047344 and MH087874) and IMHRO to H. S., by the NIMH intramural program to D. W., and by postdoctoral fellowships from MSCRF to J. Y. K., Z.W., J. S., and K.	Almasy L, 2008, AM J PSYCHIAT, V165, P1185, DOI 10.1176/appi.ajp.2008.07121869; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; Balu DT, 2011, NEUROSCI BIOBEHAV R, V35, P848, DOI 10.1016/j.neubiorev.2010.10.005; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Charych EI, 2009, NEUROPHARMACOLOGY, V57, P481, DOI 10.1016/j.neuropharm.2009.07.027; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Dean B, 2007, AUST NZ J PSYCHIAT, V41, P308, DOI 10.1080/00048670701213245; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Kang EC, 2011, NEURON, V72, P559, DOI 10.1016/j.neuron.2011.09.032; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Ming GL, 2009, CELL, V136, P990, DOI 10.1016/j.cell.2009.03.005; Nakata K, 2009, P NATL ACAD SCI USA, V106, P15873, DOI 10.1073/pnas.0903413106; Nicodemus KK, 2008, MOL PSYCHIATR, V13, P873, DOI 10.1038/sj.mp.4002153; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PERRY TL, 1979, LANCET, V1, P237; Platel JC, 2010, BRAIN RES REV, V63, P60, DOI 10.1016/j.brainresrev.2010.02.004; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Shim S, 2009, NEURON, V64, P471, DOI 10.1016/j.neuron.2009.09.025; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Tamura M, 2011, J NEUROSCI, V31, P11505, DOI 10.1523/JNEUROSCI.3447-10.2011; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsuang Ming T, 2004, World Psychiatry, V3, P73; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wu YM, 2003, J NEUROPHYSIOL, V89, P2021, DOI 10.1152/jn.00856.2002; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	51	154	163	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					1051	1064		10.1016/j.cell.2011.12.037	http://dx.doi.org/10.1016/j.cell.2011.12.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385968	Bronze, Green Accepted			2022-12-01	WOS:000300985000023
J	Palmer, LM; Schulz, JM; Murphy, SC; Ledergerber, D; Murayama, M; Larkum, ME				Palmer, Lucy M.; Schulz, Jan M.; Murphy, Sean C.; Ledergerber, Debora; Murayama, Masanori; Larkum, Matthew E.			The Cellular Basis of GABA(B)-Mediated Interhemispheric Inhibition	SCIENCE			English	Article							INTERNEURONS; NEURONS; ATTENTION; CORTEX; INPUT	Interhemispheric inhibition is thought to mediate cortical rivalry between the two hemispheres through callosal input. The long-lasting form of this inhibition is believed to operate via gamma-aminobutyric acid type B (GABA(B)) receptors, but the process is poorly understood at the cellular level. We found that the firing of layer 5 pyramidal neurons in rat somatosensory cortex due to contralateral sensory stimulation was inhibited for hundreds of milliseconds when paired with ipsilateral stimulation. The inhibition acted directly on apical dendrites via layer 1 interneurons but was silent in the absence of pyramidal cell firing, relying on metabotropic inhibition of active dendritic currents recruited during neuronal activity. The results not only reveal the microcircuitry underlying interhemispheric inhibition but also demonstrate the importance of active dendritic properties for cortical output.	[Palmer, Lucy M.; Schulz, Jan M.; Murphy, Sean C.; Ledergerber, Debora; Larkum, Matthew E.] Univ Bern, Inst Physiol, CH-3012 Bern, Switzerland; [Murayama, Masanori] RIKEN, Brain Sci Inst, Behav Neurophysiol Lab, Wako, Saitama 3510198, Japan; [Larkum, Matthew E.] Humboldt Univ, Dept Biol, D-10117 Berlin, Germany	University of Bern; RIKEN; Humboldt University of Berlin	Larkum, ME (corresponding author), Univ Bern, Inst Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	matthew.larkum@gmail.com	Murayama, Masanori/G-5457-2015; Murayama, Masanori/AHA-9840-2022	Murayama, Masanori/0000-0001-7623-010X; Schulz, Jan Michael/0000-0003-1557-5352; Larkum, Matthew/0000-0001-9799-2656; Palmer, Lucy/0000-0003-3676-657X	SystemsX.ch (NeuroChoice); Swiss National Science Foundation [PP00A-102721, 31003A_130694]	SystemsX.ch (NeuroChoice); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank B. Bettler, J. Seibt, E. Perez-Garci, T. Nyffeler, R. Muri and H. -R. Luscher for their helpful comments on the manuscript. We also thank B. Bettler and M. Gassman for kindly providing the knockout mice (GABA<INF>B1a</INF><SUP>-/-</SUP> and GABA<INF>B1b</INF><SUP>-/-</SUP>) and N. Nevian for technical assistance. This work was supported by SystemsX.ch (NeuroChoice) and the Swiss National Science Foundation (PP00A-102721 and 31003A_130694).	ASANUMA H, 1962, J NEUROPHYSIOL, V25, P198, DOI 10.1152/jn.1962.25.2.198; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Brecht M, 2002, J PHYSIOL-LONDON, V538, P495, DOI 10.1113/jphysiol.2001.012334; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Cazzoli D, 2009, EUR J NEUROSCI, V29, P1271, DOI 10.1111/j.1460-9568.2009.06665.x; Chu ZG, 2003, J NEUROSCI, V23, P96; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Forss N, 1999, BRAIN, V122, P1889, DOI 10.1093/brain/122.10.1889; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; GEFFEN GM, 1994, BEHAV BRAIN RES, V64, P131, DOI 10.1016/0166-4328(94)90125-2; Gerloff C, 2002, ACTA PSYCHOL, V110, P161, DOI 10.1016/S0001-6918(02)00032-X; HEILMAN KM, 1972, NEUROLOGY, V22, P660, DOI 10.1212/WNL.22.6.660; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Innocenti GM., 1986, GEN ORG CALLOSAL CON, P291, DOI [10.1007/978-1-4613-2149-1_9, DOI 10.1007/978-1-4613-2149-1_9]; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; Kobayashi M, 2004, NEUROLOGY, V62, P91, DOI 10.1212/WNL.62.1.91; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lopez-Bendito G, 2002, EUR J NEUROSCI, V15, P1766, DOI 10.1046/j.1460-9568.2002.02032.x; Murayama M, 2007, J NEUROPHYSIOL, V98, P1791, DOI 10.1152/jn.00082.2007; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; NEWBERRY NR, 1984, NATURE, V308, P450, DOI 10.1038/308450a0; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Schnitzler A, 1996, EXP BRAIN RES, V112, P381; SEYAL M, 1995, ANN NEUROL, V38, P264, DOI 10.1002/ana.410380221; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Williams S., 1999, J PHYSL, V521, P161; Wozny C, 2011, CEREB CORTEX, V21, P1818, DOI 10.1093/cercor/bhq257	34	201	205	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071					989	993		10.1126/science.1217276	http://dx.doi.org/10.1126/science.1217276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363012				2022-12-01	WOS:000300931800052
J	Kruse, AC; Hu, JX; Pan, AC; Arlow, DH; Rosenbaum, DM; Rosemond, E; Green, HF; Liu, T; Chae, PS; Dror, RO; Shaw, DE; Weis, WI; Wess, J; Kobilka, BK				Kruse, Andrew C.; Hu, Jianxin; Pan, Albert C.; Arlow, Daniel H.; Rosenbaum, Daniel M.; Rosemond, Erica; Green, Hillary F.; Liu, Tong; Chae, Pil Seok; Dror, Ron O.; Shaw, David E.; Weis, William I.; Wess, Juergen; Kobilka, Brian K.			Structure and dynamics of the M3 muscarinic acetylcholine receptor	NATURE			English	Article							CONFORMATIONAL-CHANGES; MOLECULAR-DYNAMICS; FORCE-FIELD; AMINO-ACID; BINDING; IDENTIFICATION; ACTIVATION; SITE; SELECTIVITY; VALIDATION	Acetylcholine, the first neurotransmitter to be identified(1), exerts many of its physiological actions via activation of a family of G-protein-coupled receptors (GPCRs) known as muscarinic acetylcholine receptors (mAChRs). Although the five mAChR subtypes (M1-M5) share a high degree of sequence homology, they show pronounced differences in G-protein coupling preference and the physiological responses they mediate(2-4). Unfortunately, despite decades of effort, no therapeutic agents endowed with clear mAChR subtype selectivity have been developed to exploit these differences(5,6). We describe here the structure of the G(q/11)-coupled M3 mAChR ('M3 receptor', from rat) bound to the bronchodilator drug tiotropium and identify the binding mode for this clinically important drug. This structure, together with that of the G(i/o)-coupled M2 receptor(7), offers possibilities for the design of mAChR subtype-selective ligands. Importantly, the M3 receptor structure allows a structural comparison between two members of a mammalian GPCR subfamily displaying different G-protein coupling selectivities. Furthermore, molecular dynamics simulations suggest that tiotropium binds transiently to an allosteric site en route to the binding pocket of both receptors. These simulations offer a structural view of an allosteric binding mode for an orthosteric GPCR ligand and provide additional opportunities for the design of ligands with different affinities or binding kinetics for different mAChR subtypes. Our findings not only offer insights into the structure and function of one of the most important GPCR families, but may also facilitate the design of improved therapeutics targeting these critical receptors.	[Kruse, Andrew C.; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Hu, Jianxin; Rosemond, Erica; Liu, Tong; Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, Bethesda, MD 20892 USA; [Pan, Albert C.; Arlow, Daniel H.; Green, Hillary F.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Rosenbaum, Daniel M.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chae, Pil Seok] Hanyang Univ, Dept Bionano Engn, Ansan 426791, South Korea; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); D. E. Shaw Research; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hanyang University; Stanford University	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	jwess@helix.nih.gov; kobilka@stanford.edu	Weis, William I/G-1437-2011; Pan, Albert/G-1475-2013	Weis, William I/0000-0002-5583-6150; Dror, Ron/0000-0002-6418-2793; Pan, Albert/0000-0001-5050-5603; Kobilka, Brian/0000-0001-5958-3990; Rosemond, Erica/0000-0002-9188-7713	National Institutes of Health [NS028471, GM56169]; Mathers Foundation; National Science Foundation; NIDDK, NIH, US Department of Health and Human Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; National Science Foundation(National Science Foundation (NSF)); NIDDK, NIH, US Department of Health and Human Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health grants NS028471 (B. K. K.) and GM56169 (W. I. W.), from the Mathers Foundation (B. K. K. and W. I. W.), and from the National Science Foundation (A. C. K.). This work was supported in part by the Intramural Research Program, NIDDK, NIH, US Department of Health and Human Services. We thank R. Grisshammer and S. Costanzi for advice and discussions during various stages of the project, Y. Zhou for carrying out radioligand binding assays with several M3 receptor-T4 fusion constructs, D. Scarpazza for developing software that enabled forced dissociation simulations, and A. Taube, K. Palmo and D. Borhani for advice related to simulations.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Barnes PJ, 2000, CHEST, V117, P63; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; BLIN N, 1995, J BIOL CHEM, V270, P17741, DOI 10.1074/jbc.270.30.17741; BLUML K, 1994, J BIOL CHEM, V269, P11537; BOLDEN C, 1992, J PHARMACOL EXP THER, V260, P576; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Casarosa P, 2010, J PHARMACOL EXP THER, V333, P201, DOI 10.1124/jpet.109.163188; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dowling MR, 2006, BRIT J PHARMACOL, V148, P927, DOI 10.1038/sj.bjp.0706819; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; DRUBBISCH V, 1992, PHARMACEUT RES, V9, P1644, DOI 10.1023/A:1015885029612; ELLIS J, 1991, BIOCHEM PHARMACOL, V42, P1927, DOI 10.1016/0006-2952(91)90591-R; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Gautam D, 2009, P NATL ACAD SCI USA, V106, P6398, DOI 10.1073/pnas.0900977106; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Han SJ, 2005, J BIOL CHEM, V280, P24870, DOI 10.1074/jbc.M500379200; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Izrailev S, 1997, BIOPHYS J, V72, P1568, DOI 10.1016/S0006-3495(97)78804-0; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Kukkonen JP, 1996, J PHARMACOL EXP THER, V279, P593; Lebon G, 2009, MOL PHARMACOL, V75, P331, DOI 10.1124/mol.108.050963; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; Loewi O, 1921, PFLUG ARCH GES PHYS, V189, P239, DOI 10.1007/BF01738910; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Poulin B, 2010, P NATL ACAD SCI USA, V107, P9440, DOI 10.1073/pnas.0914801107; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Redka DS, 2008, MOL PHARMACOL, V74, P834, DOI 10.1124/mol.108.048074; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shaw D. E., 2009, P C HIGH PERF COMP N; TU T, 2008, P 2008 ACM IEEE C SU; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; Werner H.-J., 2010, MOLPRO VERSION 2010; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604	58	595	607	6	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					552	556		10.1038/nature10867	http://dx.doi.org/10.1038/nature10867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358844	Green Accepted			2022-12-01	WOS:000300770500056
J	Tavares, L; Dimitrova, E; Oxley, D; Webster, J; Poot, R; Demmers, J; Bezstarosti, K; Taylor, S; Ura, H; Koide, H; Wutz, A; Vidal, M; Elderkin, S; Brockdorff, N				Tavares, Ligia; Dimitrova, Emilia; Oxley, David; Webster, Judith; Poot, Raymond; Demmers, Jeroen; Bezstarosti, Karel; Taylor, Stephen; Ura, Hiroki; Koide, Hiroshi; Wutz, Anton; Vidal, Miguel; Elderkin, Sarah; Brockdorff, Neil			RYBP-PRC1 Complexes Mediate H2A Ubiquitylation at Polycomb Target Sites Independently of PRC2 and H3K27me3	CELL			English	Article							EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; TRANSCRIPTION FACTOR YY1; GROUP PROTEINS RING1A/B; C-TERMINAL DOMAIN; HISTONE H2A; X-INACTIVATION; DEVELOPMENTAL REGULATORS; CHROMATIN-STRUCTURE; REPRESSIVE COMPLEX	Polycomb-repressive complex 1 (PRC1) has a central role in the regulation of heritable gene silencing during differentiation and development. PRC1 recruitment is generally attributed to interaction of the chromodomain of the core protein Polycomb with trimethyl histone H3K27 (H3K27me3), catalyzed by a second complex, PRC2. Unexpectedly we find that RING1B, the catalytic subunit of PRC1, and associated monoubiquitylation of histone H2A are targeted to closely overlapping sites in wild-type and PRC2-deficient mouse embryonic stem cells (mESCs), demonstrating an H3K27me3-independent pathway for recruitment of PRC1 activity. We show that this pathway is mediated by RYBP-PRC1, a complex comprising catalytic subunits of PRC1 and the protein RYBP. RYBP-PRC1 is recruited to target loci in mESCs and is also involved in Xist RNA-mediated silencing, the latter suggesting a wider role in Polycomb silencing. We discuss the implications of these findings for understanding recruitment and function of Polycomb repressors.	[Dimitrova, Emilia; Oxley, David; Webster, Judith; Elderkin, Sarah] Babraham Inst, Cambridge CB22 3AT, England; [Tavares, Ligia; Brockdorff, Neil] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Poot, Raymond] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Demmers, Jeroen; Bezstarosti, Karel] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [Taylor, Stephen] Univ Oxford, John Radcliffe Hosp, WIMM, Computat Biol Res Grp, Oxford OX3 9DS, England; [Ura, Hiroki; Koide, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan; [Wutz, Anton] Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Vidal, Miguel] CSIC, Ctr Invest Biol, Madrid 28040, Spain	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Oxford; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Kanazawa University; University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Elderkin, S (corresponding author), Babraham Inst, Babraham Res Campus, Cambridge CB22 3AT, England.	sarah.elderkin@babraham.ac.uk; neil.brockdorff@bioch.ox.ac.uk	Demmers, Jeroen AA/F-4046-2016; Ura, Hiroki/ABD-8427-2020; Vidal, Miguel/M-8861-2016	Demmers, Jeroen AA/0000-0002-8757-9611; Ura, Hiroki/0000-0002-7600-3481; Brockdorff, Neil/0000-0003-4838-2653; Koide, Hiroshi/0000-0001-5916-3179; Vidal, Miguel/0000-0003-4374-6761; Tavares, Ligia/0000-0001-9487-7978	Wellcome Trust [090532/Z/09/Z]; MRC [G0900747 91070]; Wellcome Trust, UK [WT081385, WT085102MA]; BBSRC; FCT, Portugal; Spanish Ministry of Science and Innovation [BFU2010-18146]; Fundacion Ramon Areces; BBSRC [BBS/E/B/0000L748, BBS/E/B/0000H234] Funding Source: UKRI; MRC [G0800784] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H234, BBS/E/B/0000L748] Funding Source: researchfish; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust, UK(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank members of the lab and Rob Klose and Len R. Stephens for discussion and advice. We thank Haruhiko Koseki for providing RING1B and MPH1 antibodies and for helpful discussions. We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z and MRC Hub grant G0900747 91070) for the generation of data. This work was funded by the Wellcome Trust, UK (N.B.; WT081385, S.E.; WT085102MA) and the BBSRC (E.D., D.O., and J.W.). L.T. received a PhD studentship from FCT, Portugal. M.V. is supported by grant BFU2010-18146 (Spanish Ministry of Science and Innovation) and Fundacion Ramon Areces.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Arrigoni R, 2006, FEBS LETT, V580, P6233, DOI 10.1016/j.febslet.2006.10.027; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Czypionka A, 2007, BIOCHEMISTRY-US, V46, P12764, DOI 10.1021/bi701343q; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Faust C, 1998, DEVELOPMENT, V125, P4495; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Herz HM, 2010, GENE DEV, V24, P857, DOI 10.1101/gad.1921610; Huen DS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-359; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kalenik JL, 1997, NUCLEIC ACIDS RES, V25, P843, DOI 10.1093/nar/25.4.843; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kyba M, 1998, MOL CELL BIOL, V18, P2712, DOI 10.1128/MCB.18.5.2712; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Nguyen CD, 2011, J MOL BIOL, V407, P273, DOI 10.1016/j.jmb.2010.12.041; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ren XJ, 2011, MOL CELL BIOL, V31, P2100, DOI 10.1128/MCB.05088-11; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Ura H, 2008, J BIOL CHEM, V283, P9713, DOI 10.1074/jbc.M707275200; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang RJ, 2010, STRUCTURE, V18, P966, DOI 10.1016/j.str.2010.04.013; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng LX, 2001, J BIOL CHEM, V276, P31945, DOI 10.1074/jbc.M102799200	76	414	430	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					664	678		10.1016/j.cell.2011.12.029	http://dx.doi.org/10.1016/j.cell.2011.12.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22325148	hybrid, Green Published			2022-12-01	WOS:000300622400009
J	Schmitt, J; Schneider, R; Elsig, J; Leuenberger, D; Lourantou, A; Chappellaz, J; Kohler, P; Joos, F; Stocker, TF; Leuenberger, M; Fischer, H				Schmitt, Jochen; Schneider, Robert; Elsig, Joachim; Leuenberger, Daiana; Lourantou, Anna; Chappellaz, Jerome; Koehler, Peter; Joos, Fortunat; Stocker, Thomas F.; Leuenberger, Markus; Fischer, Hubertus			Carbon Isotope Constraints on the Deglacial CO2 Rise from Ice Cores	SCIENCE			English	Article							ATMOSPHERIC CO2; SOUTHERN-OCEAN; LAST; AGE; VENTILATION; EXCHANGE; CYCLES; RECORD	The stable carbon isotope ratio of atmospheric CO2 (delta C-13(atm)) is a key parameter in deciphering past carbon cycle changes. Here we present delta C-13(atm) data for the past 24,000 years derived from three independent records from two Antarctic ice cores. We conclude that a pronounced 0.3 per mil decrease in delta C-13(atm) during the early deglaciation can be best explained by upwelling of old, carbon-enriched waters in the Southern Ocean. Later in the deglaciation, regrowth of the terrestrial biosphere, changes in sea surface temperature, and ocean circulation governed the delta C-13(atm) evolution. During the Last Glacial Maximum, delta C-13(atm) and atmospheric CO2 concentration were essentially constant, which suggests that the carbon cycle was in dynamic equilibrium and that the net transfer of carbon to the deep ocean had occurred before then.	[Schmitt, Jochen; Schneider, Robert; Elsig, Joachim; Leuenberger, Daiana; Joos, Fortunat; Stocker, Thomas F.; Leuenberger, Markus; Fischer, Hubertus] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Schmitt, Jochen; Schneider, Robert; Elsig, Joachim; Leuenberger, Daiana; Joos, Fortunat; Stocker, Thomas F.; Leuenberger, Markus; Fischer, Hubertus] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Schmitt, Jochen; Koehler, Peter; Fischer, Hubertus] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Lourantou, Anna; Chappellaz, Jerome] Univ Grenoble 1, CNRS, LGGE, UMR 5183, F-38041 Grenoble, France	University of Bern; University of Bern; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Schmitt, J (corresponding author), Univ Bern, Inst Phys, CH-3012 Bern, Switzerland.	schmitt@climate.unibe.ch	Fischer, Hubertus/A-1211-2014; Chappellaz, Jérôme A./A-4872-2011; Joos, Fortunat/B-4118-2018; Stocker, Thomas/B-1273-2013; Leuenberger, Markus C/K-9655-2016; Köhler, Peter/F-7293-2010; Schmitt, Jochen/B-7893-2009	Fischer, Hubertus/0000-0002-2787-4221; Joos, Fortunat/0000-0002-9483-6030; Leuenberger, Markus C/0000-0003-4299-6793; Köhler, Peter/0000-0003-0904-8484; Schmitt, Jochen/0000-0003-4695-3029	Deutsche Forschungsgemeinschaft; Helmholtz Gemeinschaft; Schweizerischer Nationalfonds; EC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Gemeinschaft(Helmholtz Association); Schweizerischer Nationalfonds(Swiss National Science Foundation (SNSF)); EC(European CommissionEuropean Commission Joint Research Centre)	We thank two anonymous reviewers for carefully reviewing the manuscript. Supported in part by Deutsche Forschungsgemeinschaft, Helmholtz Gemeinschaft, and Schweizerischer Nationalfonds. This work is a contribution to EPICA, a joint European Science Foundation/European Commission (EC) scientific program, funded by the EC under the Environment and Climate Program and by national contributions from Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Sweden, Switzerland, and the UK. The main logistic support at Dome C was provided by the Institut Polaire Francais-Paul Emile Victor (IPEV) and PNRA. Ice core material was also used from TALDICE, a joint European program led by Italy and funded by national contributions from Italy, France, Germany, Switzerland, and the UK. The main logistical support at Talos Dome was provided by PNRA. This is EPICA publication 284. The data are accessible online at http://doi.pangaea.de/10.1594/PANGAEA.772713.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Broecker W, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043969; Burke A, 2012, SCIENCE, V335, P557, DOI 10.1126/science.1208163; Ciais P, 2012, NAT GEOSCI, V5, P74, DOI [10.1038/NGEO1324, 10.1038/ngeo1324]; Elsig J, 2009, NATURE, V461, P507, DOI 10.1038/nature08393; Fischer H, 2010, QUATERNARY SCI REV, V29, P193, DOI 10.1016/j.quascirev.2009.06.007; Hodell DA, 2001, EARTH PLANET SC LETT, V192, P109, DOI 10.1016/S0012-821X(01)00430-7; Kohler P, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001703; Kohler P, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001228; Kohler P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002345; Laj C, 2004, GEOPHYS MONOGR SER, V145, P255, DOI 10.1029/145GM19; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; Lourantou A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003545; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lund DC, 2011, NAT GEOSCI, V4, P771, DOI [10.1038/NGEO1272, 10.1038/ngeo1272]; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Muscheler R, 2005, QUATERNARY SCI REV, V24, P1849, DOI 10.1016/j.quascirev.2005.01.012; Oliver KIC, 2010, CLIM PAST, V6, P645, DOI 10.5194/cp-6-645-2010; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Schmitt J, 2011, ATMOS MEAS TECH, V4, P1445, DOI 10.5194/amt-4-1445-2011; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291; Southon J, 2012, QUATERNARY SCI REV, V33, P32, DOI 10.1016/j.quascirev.2011.11.022; Stenni B, 2001, SCIENCE, V293, P2074, DOI 10.1126/science.1059702; Stott L, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001690; Tschumi T, 2011, CLIM PAST, V7, P771, DOI 10.5194/cp-7-771-2011; Yu JM, 2010, SCIENCE, V330, P1084, DOI 10.1126/science.1193221; Zech R, 2011, CLIM PAST, V7, P501, DOI 10.5194/cp-7-501-2011; Zeng N, 2007, CLIM PAST, V3, P135, DOI 10.5194/cp-3-135-2007; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/00167-0379(59)1550D-	35	266	269	2	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					711	714		10.1126/science.1217161	http://dx.doi.org/10.1126/science.1217161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22461496	Green Submitted			2022-12-01	WOS:000303872300047
J	Fiskerstrand, T; Arshad, N; Haukanes, BI; Tronstad, RR; Pham, KDC; Johansson, S; Havik, B; Tonder, SL; Levy, SE; Brackman, D; Boman, H; Biswas, KH; Apold, J; Hovdenak, N; Visweswariah, SS; Knappskog, PM				Fiskerstrand, Torunn; Arshad, Najla; Haukanes, Bjorn Ivar; Tronstad, Rune Rose; Pham, Khanh Do-Cong; Johansson, Stefan; Havik, Bjarte; Tonder, Siv L.; Levy, Shawn E.; Brackman, Damien; Boman, Helge; Biswas, Kabir Hassan; Apold, Jaran; Hovdenak, Nils; Visweswariah, Sandhya S.; Knappskog, Per M.			Familial Diarrhea Syndrome Caused by an Activating GUCY2C Mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; FUNCTIONAL ABDOMINAL-PAIN; IRRITABLE-BOWEL-SYNDROME; CROHNS-DISEASE; CLINICAL MANAGEMENT; NITRIC-OXIDE; CYCLASE-C; INFLAMMATION; DYSFUNCTION; MICE	BACKGROUND Familial diarrhea disorders are, in most cases, severe and caused by recessive mutations. We describe the cause of a novel dominant disease in 32 members of a Norwegian family. The affected members have chronic diarrhea that is of early onset, is relatively mild, and is associated with increased susceptibility to inflammatory bowel disease, small-bowel obstruction, and esophagitis. METHODS We used linkage analysis, based on arrays with single-nucleotide polymorphisms, to identify a candidate region on chromosome 12 and then sequenced GUCY2C, encoding guanylate cyclase C (GC-C), an intestinal receptor for bacterial heat-stable enterotoxins. We performed exome sequencing of the entire candidate region from three affected family members, to exclude the possibility that mutations in genes other than GUCY2C could cause or contribute to susceptibility to the disease. We carried out functional studies of mutant GC-C using HEK293T cells. RESULTS We identified a heterozygous missense mutation (c.2519G -> T) in GUCY2C in all affected family members and observed no other rare variants in the exons of genes in the candidate region. Exposure of the mutant receptor to its ligands resulted in markedly increased production of cyclic guanosine monophosphate (cGMP). This may cause hyperactivation of the cystic fibrosis transmembrane regulator (CFTR), leading to increased chloride and water secretion from the enterocytes, and may thus explain the chronic diarrhea in the affected family members. CONCLUSIONS Increased GC-C signaling disturbs normal bowel function and appears to have a proinflammatory effect, either through increased chloride secretion or additional effects of elevated cellular cGMP. Further investigation of the relevance of genetic variants affecting the GC-C-CFTR pathway to conditions such as Crohn's disease is warranted. (Funded by Helse Vest [Western Norway Regional Health Authority] and the Department of Science and Technology, Government of India.)	[Fiskerstrand, Torunn; Haukanes, Bjorn Ivar; Johansson, Stefan; Havik, Bjarte; Tonder, Siv L.; Boman, Helge; Apold, Jaran; Knappskog, Per M.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Pham, Khanh Do-Cong; Hovdenak, Nils] Haukeland Hosp, Dept Internal Med, N-5021 Bergen, Norway; [Tronstad, Rune Rose; Brackman, Damien] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Fiskerstrand, Torunn; Havik, Bjarte; Knappskog, Per M.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Johansson, Stefan] Univ Bergen, Dept Biomed, Bergen, Norway; [Arshad, Najla; Biswas, Kabir Hassan; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Levy, Shawn E.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Indian Institute of Science (IISC) - Bangalore; HudsonAlpha Institute for Biotechnology	Fiskerstrand, T (corresponding author), Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway.	torunn.fiskerstrand@helse-bergen.no; sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019; Johansson, Stefan/C-4394-2011; Arshad, Najla/H-9453-2019; Biswas, Kabir H/AAG-9156-2019	Visweswariah, Sandhya/0000-0003-2786-7344; Johansson, Stefan/0000-0002-2298-7008; Arshad, Najla/0000-0001-5553-311X; Biswas, Kabir H/0000-0001-9194-4127; Pham, Khanh Do-Cong/0000-0002-6476-1680; Levy, Shawn/0000-0002-1369-5740; Haukanes, Bjorn Ivar/0000-0003-1559-3366	Helse Vest (Western Norway Regional Health Authority) [911308]; Department of Science and Technology, Government of India; Indian Institute of Science; Council of Scientific and Industrial Research, Government of India	Helse Vest (Western Norway Regional Health Authority); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Indian Institute of Science; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	Supported by grants from Helse Vest (Western Norway Regional Health Authority) (911308, to Drs. Fiskerstrand, Haukanes, Johansson, Boman, and Knappskog) and the Department of Science and Technology, Government of India (to Dr. Visweswariah). Dr. Arshad was supported by a fellowship from the Indian Institute of Science, and Dr. Biswas was supported by a Senior Research Fellowship from the Council of Scientific and Industrial Research, Government of India.	Basu N, 2010, MOL CELL BIOCHEM, V334, P67, DOI 10.1007/s11010-009-0324-x; Biswas KH, 2009, J MOL EVOL, V68, P587, DOI 10.1007/s00239-009-9242-5; Canani RB, 2010, J PEDIATR GASTR NUTR, V50, P360, DOI 10.1097/MPG.0b013e3181d135ef; Caprilli R, 2008, J CROHNS COLITIS, V2, P352, DOI 10.1016/j.crohns.2008.06.001; COHEN MB, 1988, GASTROENTEROLOGY, V94, P367, DOI 10.1016/0016-5085(88)90423-4; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fries W, 2005, AM J GASTROENTEROL, V100, P2730, DOI 10.1111/j.1572-0241.2005.00325.x; Gong R, 2011, SCIENCE, V333, P1642, DOI 10.1126/science.1207675; Habre Jihad, 2008, Am J Surg, V196, pe48, DOI 10.1016/j.amjsurg.2007.11.029; Han XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016139; Kuhn Michaela, 2009, V191, P47, DOI 10.1007/978-3-540-68964-5_4; Kurjak M, 2001, J PHYSIOL-LONDON, V534, P827, DOI 10.1111/j.1469-7793.2001.00827.x; Laubitz D, 2008, AM J PHYSIOL-GASTR L, V295, pG63, DOI 10.1152/ajpgi.90207.2008; Lelievre V, 2007, PEPTIDES, V28, P1688, DOI 10.1016/j.peptides.2007.05.006; Lembo AJ, 2011, NEW ENGL J MED, V365, P527, DOI 10.1056/NEJMoa1010863; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mourad FH, 2000, GUT, V47, P382, DOI 10.1136/gut.47.3.382; Murek M, 2010, EXP PHYSIOL, V95, P471, DOI 10.1113/expphysiol.2009.049445; Navaneethan U, 2008, NAT CLIN PRACT GASTR, V5, P637, DOI 10.1038/ncpgasthep1264; Ochiai T, 1997, LIFE SCI, V61, P1479, DOI 10.1016/S0024-3205(97)00707-8; Ohman L, 2010, NAT REV GASTRO HEPAT, V7, P163, DOI 10.1038/nrgastro.2010.4; Qian X, 2008, ENDOCRINOLOGY, V149, P4499, DOI 10.1210/en.2007-1724; Saha S, 2009, J BIOL CHEM, V284, P27135, DOI 10.1074/jbc.M109.020032; Saito YA, 2011, GASTROENTEROL CLIN N, V40, P45, DOI 10.1016/j.gtc.2010.12.011; Saito YA, 2010, AM J GASTROENTEROL, V105, P833, DOI 10.1038/ajg.2010.116; Shen L, 2009, DIGEST DIS, V27, P443, DOI 10.1159/000233282; Shulman RJ, 2008, J PEDIATR-US, V153, P646, DOI 10.1016/j.jpeds.2008.04.062; Steinbrecher KA, 2011, J IMMUNOL, V186, P7205, DOI 10.4049/jimmunol.1002469; Steinbrecher KA, 2011, CURR OPIN GASTROEN, V27, P139, DOI 10.1097/MOG.0b013e328341ead5; Thompson WG, 1999, GUT, V45, P43; Valentino MA, 2011, J CLIN INVEST, V121, P3578, DOI 10.1172/JCI57925; Wedenoja S, 2010, ALIMENT PHARM THER, V31, P477, DOI 10.1111/j.1365-2036.2009.04197.x	35	132	138	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2012	366	17					1586	1595		10.1056/NEJMoa1110132	http://dx.doi.org/10.1056/NEJMoa1110132			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931FC	22436048				2022-12-01	WOS:000303200100007
J	Lin, SM; Tsai, JY; Hsiao, CD; Huang, YT; Chiu, CL; Liu, MH; Tung, JY; Liu, TH; Pan, RL; Sun, YJ				Lin, Shih-Ming; Tsai, Jia-Yin; Hsiao, Chwan-Deng; Huang, Yun-Tzu; Chiu, Chen-Liang; Liu, Mu-Hsuan; Tung, Jung-Yu; Liu, Tseng-Huang; Pan, Rong-Long; Sun, Yuh-Ju			Crystal structure of a membrane-embedded H+-translocating pyrophosphatase	NATURE			English	Article							SUBSTRATE-BINDING SUBUNIT; INORGANIC PYROPHOSPHATASE; MOLECULAR-CLONING; PURIFICATION; RESIDUES; ORGANIZATION; INHIBITION; STRATEGY; SEQUENCE; DOMAINS	H+-translocating pyrophosphatases (H+-PPases) are active proton transporters that establish a proton gradient across the endomembrane by means of pyrophosphate (PPi) hydrolysis(1,2). H+-PPases are found primarily as homodimers in the vacuolar membrane of plants and the plasma membrane of several protozoa and prokaryotes(2,3). The three-dimensional structure and detailed mechanisms underlying the enzymatic and proton translocation reactions of H+-PPases are unclear. Here we report the crystal structure of a Vigna radiata H+-PPase (VrH(+)-PPase) in complex with a non-hydrolysable substrate analogue, imidodiphosphate (IDP), at 2.35 angstrom resolution. Each VrH(+)-PPase subunit consists of an integral membrane domain formed by 16 transmembrane helices. IDP is bound in the cytosolic region of each subunit and trapped by numerous charged residues and five Mg2+ ions. A previously undescribed proton translocation pathway is formed by six core transmembrane helices. Proton pumping can be initialized by PPi hydrolysis, and H+ is then transported into the vacuolar lumen through a pathway consisting of Arg 242, Asp 294, Lys 742 and Glu 301. We propose a working model of the mechanism for the coupling between proton pumping and PPi hydrolysis by H+-PPases.	[Lin, Shih-Ming; Huang, Yun-Tzu; Chiu, Chen-Liang; Liu, Mu-Hsuan; Tung, Jung-Yu; Liu, Tseng-Huang; Pan, Rong-Long; Sun, Yuh-Ju] Natl Tsing Hua Univ, Dept Life Sci, Coll Life Sci, Hsinchu 30013, Taiwan; [Lin, Shih-Ming; Huang, Yun-Tzu; Chiu, Chen-Liang; Liu, Mu-Hsuan; Tung, Jung-Yu; Liu, Tseng-Huang; Pan, Rong-Long; Sun, Yuh-Ju] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Coll Life Sci, Hsinchu 30013, Taiwan; [Tsai, Jia-Yin; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	National Tsing Hua University; National Tsing Hua University; Academia Sinica - Taiwan	Sun, YJ (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Coll Life Sci, Hsinchu 30013, Taiwan.	rlpan@life.nthu.edu.tw; yjsun@life.nthu.edu.tw	Hsiao, Chwan-Deng/AAZ-8869-2021	Hsiao, Chwan-Deng/0000-0002-7012-1532	National Science Council of Taiwan [NSC 99-2311-B-007-007-MY3, NSC 100-2311-B-007-001-MY3, NSC 100-2627-M-007-012]; National Tsing Hua University, Taiwan [99N82416E1]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University, Taiwan	We thank M. F. Tam, P. C. Huang and H. J. Kung for their critical reading of the manuscript and for useful comments. The X-ray diffraction data were collected from the in-house X-ray facility at National Tsing Hua University and from beamlines BL13B1/BL13C1 at the National Synchrotron Radiation Research Center, Taiwan, and BL44XU/BL12B2 at SPring-8, Japan. This work was supported by grants from the National Science Council of Taiwan (NSC 99-2311-B-007-007-MY3 to Y.-J.S.; NSC 100-2311-B-007-001-MY3 and NSC 100-2627-M-007-012 to R.-L.P.) and National Tsing Hua University, Taiwan (99N82416E1 to Y.-J.S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALTSCHEFFSKY H, 1966, SCIENCE, V153, P1120, DOI 10.1126/science.153.3740.1120; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; BRITTEN CJ, 1989, FEBS LETT, V256, P200, DOI 10.1016/0014-5793(89)81748-X; Buch-Pedersen MJ, 2009, PFLUG ARCH EUR J PHY, V457, P573, DOI 10.1007/s00424-008-0503-8; CHANSON A, 1985, PLANT PHYSIOL, V79, P159, DOI 10.1104/pp.79.1.159; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferjani A, 2011, PLANT CELL, V23, P2895, DOI 10.1105/tpc.111.085415; GordonWeeks R, 1996, PLANT PHYSIOL, V111, P195, DOI 10.1104/pp.111.1.195; Guo SL, 2006, PLANT MOL BIOL, V60, P41, DOI 10.1007/s11103-005-2417-6; Hirono M, 2007, BBA-BIOENERGETICS, V1767, P930, DOI 10.1016/j.bbabio.2007.03.014; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hsu SH, 2009, BOT STUD, V50, P291; Huang YT, 2010, J BIOL CHEM, V285, P23655, DOI 10.1074/jbc.M110.134916; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee CH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.190215; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; Maeshima M, 2001, ANNU REV PLANT PHYS, V52, P469, DOI 10.1146/annurev.arplant.52.1.469; MCPHERSON A, 1990, EUR J BIOCHEM, V189, P1, DOI 10.1111/j.1432-1033.1990.tb15454.x; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan YJ, 2011, BBA-BIOENERGETICS, V1807, P59, DOI 10.1016/j.bbabio.2010.10.006; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; REA PA, 1992, TRENDS BIOCHEM SCI, V17, P348, DOI 10.1016/0968-0004(92)90313-X; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; REA PA, 1985, PLANT PHYSIOL, V77, P46, DOI 10.1104/pp.77.1.46; Samygina VR, 2007, J MOL BIOL, V366, P1305, DOI 10.1016/j.jmb.2006.11.082; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; Serrano A, 2004, J BIOENERG BIOMEMBR, V36, P127, DOI 10.1023/B:JOBB.0000019604.49875.b3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tzeng CM, 1996, BIOCHEM J, V316, P143, DOI 10.1042/bj3160143; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van RC, 2005, BBA-BIOENERGETICS, V1709, P84, DOI 10.1016/j.bbabio.2005.05.011; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340	43	112	122	4	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					399	403		10.1038/nature10963	http://dx.doi.org/10.1038/nature10963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22456709				2022-12-01	WOS:000302946500038
J	Cui, YJ; Wang, W; Dong, NZ; Lou, JL; Srinivasan, DK; Cheng, WW; Huang, XY; Liu, M; Fang, CD; Peng, JH; Chen, SH; Wu, SN; Liu, ZZ; Dong, L; Zhou, YQ; Wu, QY				Cui, Yujie; Wang, Wei; Dong, Ningzheng; Lou, Jinglei; Srinivasan, Dinesh Kumar; Cheng, Weiwei; Huang, Xiaoyi; Liu, Meng; Fang, Chaodong; Peng, Jianhao; Chen, Shenghan; Wu, Shannon; Liu, Zhenzhen; Dong, Liang; Zhou, Yiqing; Wu, Qingyu			Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy	NATURE			English	Article							PROATRIAL NATRIURETIC PEPTIDE; PLASMA SOLUBLE CORIN; SERINE-PROTEASE; PATHOGENESIS; PREECLAMPSIA; IMPLANTATION; HYPERTENSION	In pregnancy, trophoblast invasion and uterine spiral artery remodelling are important for lowering maternal vascular resistance and increasing uteroplacental blood flow. Impaired spiral artery remodelling has been implicated in pre-eclampsia, a major complication of pregnancy, for a long time but the underlying mechanisms remain unclear(1,2). Corin (also known as atrial natriuretic peptide-converting enzyme) is a cardiac protease that activates atrial natriuretic peptide (ANP), a cardiac hormone that is important in regulating blood pressure(3). Unexpectedly, corin expression was detected in the pregnant uterus(4). Here we identify a new function of corin and ANP in promoting trophoblast invasion and spiral artery remodelling. We show that pregnant corin-or ANP-deficient mice developed high blood pressure and proteinuria, characteristics of pre-eclampsia. In these mice, trophoblast invasion and uterine spiral artery remodelling were markedly impaired. Consistent with this, the ANP potently stimulated human trophoblasts in invading Matrigels. In patients with pre-eclampsia, uterine Corin messenger RNA and protein levels were significantly lower than that in normal pregnancies. Moreover, we have identified Corin gene mutations inpre-eclamptic patients, which decreased corin activity in processing pro-ANP. These results indicate that corin and ANP are essential for physiological changes at the maternal-fetal interface, suggesting that defects in corin and ANP function may contribute to pre-eclampsia.	[Cui, Yujie; Wang, Wei; Lou, Jinglei; Srinivasan, Dinesh Kumar; Peng, Jianhao; Chen, Shenghan; Wu, Shannon; Wu, Qingyu] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Dong, Ningzheng; Liu, Meng; Fang, Chaodong; Liu, Zhenzhen; Dong, Liang; Zhou, Yiqing; Wu, Qingyu] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China; [Dong, Ningzheng] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Key Lab Thrombosis & Hemostasis, Suzhou 215006, Peoples R China; [Cheng, Weiwei; Huang, Xiaoyi] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China	Cleveland Clinic Foundation; Soochow University - China; Soochow University - China; Shanghai Jiao Tong University	Wu, QY (corresponding author), Cleveland Clin, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wuq@ccf.org	Srinivasan, Dinesh Kumar/P-6528-2019; Srinivasan, Dinesh Kumar/E-6383-2017; Srinivasan, Dinesh Kumar/A-9872-2008	Srinivasan, Dinesh Kumar/0000-0001-6535-5441; Srinivasan, Dinesh Kumar/0000-0001-6535-5441; Wu, Qingyu/0000-0003-0561-9315	Ralph Wilson Medical Foundation; Bakken Heart-Brain Institute; National Institutes of Health [HL089298, HD064634]; National Natural Science Foundation of China [31070716, 81170247, 31161130356]; Priority Academic Program Development of Jiangsu Higher Education Institutions; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064634] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089298] Funding Source: NIH RePORTER	Ralph Wilson Medical Foundation; Bakken Heart-Brain Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Robbins for the alpha-myosin heavy chain promoter construct and L. Zhang for help with statistical analysis. This work was partly supported by grants from the Ralph Wilson Medical Foundation, the Bakken Heart-Brain Institute and the National Institutes of Health (HL089298, HD064634), and by grants from the National Natural Science Foundation of China (31070716, 81170247 and 31161130356) and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Chen SH, 2010, AM J PHYSIOL-HEART C, V299, pH1687, DOI 10.1152/ajpheart.00399.2010; Davisson RL, 2002, HYPERTENSION, V39, P337, DOI 10.1161/hy02t2.102904; Dong NZ, 2010, CLIN CHIM ACTA, V411, P1998, DOI 10.1016/j.cca.2010.08.021; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Irons DW, 1997, AM J PHYSIOL-RENAL, V273, pF483, DOI 10.1152/ajprenal.1997.273.3.F483; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Knappe S, 2004, J BIOL CHEM, V279, P34464, DOI 10.1074/jbc.M405041200; Kuhn M, 2009, J CLIN INVEST, V119, P2019, DOI 10.1172/JCI37430; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Pan JL, 2002, J BIOL CHEM, V277, P38390, DOI 10.1074/jbc.M205686200; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Tihtonen KM, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.033; Tokudome T, 2009, ARTERIOSCL THROM VAS, V29, P1516, DOI 10.1161/ATVBAHA.109.187526; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wang W, 2008, CIRC RES, V103, P502, DOI 10.1161/CIRCRESAHA.108.177352; Wu F, 2002, J BIOL CHEM, V277, P16900, DOI 10.1074/jbc.M201503200; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	33	209	228	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					246	U134		10.1038/nature10897	http://dx.doi.org/10.1038/nature10897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22437503	Green Accepted			2022-12-01	WOS:000303149900036
J	Laxminarayan, R; Heymann, DL				Laxminarayan, Ramanan; Heymann, David L.			Challenges of drug resistance in the developing world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIBIOTIC USE; IMPACT; ASSOCIATION; INFECTIONS; PREVALENCE; COUNTRIES; CHILDREN; VACCINE; EUROPE		[Heymann, David L.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA	University of London; London School of Hygiene & Tropical Medicine	Heymann, DL (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	david.heymann@hpa.org.uk	Laxminarayan, Ramanan/ABD-5050-2021					Apisarnthanarak A, 2008, INFECT CONT HOSP EP, V29, P572, DOI 10.1086/587496; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Dong HJ, 1999, HEALTH POLICY, V48, P29, DOI 10.1016/S0168-8510(99)00026-3; Dong HJ, 1999, INT J TECHNOL ASSESS, V15, P686, DOI 10.1017/S0266462399015482; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; Health Action International, 2010, BEING SICK NEED MED; Heymann DL, 2006, CELL, V124, P671, DOI 10.1016/j.cell.2006.02.009; IMS Health, 2011, MIDAS MARK SEGM DAT; Irungu P, 2011, ANAL EC INCENTIVES I; Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Larsson DGJ, 2009, REGUL TOXICOL PHARM, V53, P161, DOI 10.1016/j.yrtph.2009.01.008; Laxminarayan R., 2006, EC INFECT DIS, P49; Laxminarayan R, 2011, HEALTH AFFAIR, V30, P1096, DOI 10.1377/hlthaff.2011.0405; Lim V K, 1992, Malays J Pathol, V14, P41; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006512, 10.1371/journal.pone.0004308]; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Steinfeld H., 2006, Livestock Report 2006, P3; Sweidan M., 2005, P 2 NAT WORKSH RAT U, P1; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; World Health Organization, 2009, COMM BAS SURV ANT US	28	104	105	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e1567	10.1136/bmj.e1567	http://dx.doi.org/10.1136/bmj.e1567			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GM	22491075	Green Submitted			2022-12-01	WOS:000302607700010
J	Wood, AM; Pasupathy, D; Pell, JP; Fleming, M; Smith, GCS				Wood, Angela M.; Pasupathy, Dharmintra; Pell, Jill P.; Fleming, Michael; Smith, Gordon C. S.			Trends in socioeconomic inequalities in risk of sudden infant death syndrome, other causes of infant mortality, and stillbirth in Scotland: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SLEEPING POSITION; DEPRIVATION	Objectives To compare changes in inequalities in sudden infant death syndrome with other causes of infant mortality and stillbirth in Scotland, 1985-2008. Design Retrospective cohort study. Setting Scotland 1985-2008, analysed by four epochs of six years. Participants Singleton births of infants with birth weight >500 g born at 28-43 weeks' gestation. Main outcome measures Sudden infant death syndrome, other causes of postneonatal infant death, neonatal death, and stillbirth. Odds ratios expressed as the association across the range of seven categories of Carstairs deprivation score. Results The association between deprivation and the risk of all cause stillbirth and infant death varied between the four epochs (P=0.04). This was wholly explained by variation in the risk of sudden infant death syndrome (P<0.001 for interaction). Among women living in areas of low deprivation, there was a sharp decline in the rate of sudden infant death syndrome from 1990 to 1993. Among women living in areas of high deprivation, there was a slower decline in sudden infant death syndrome rates between 1992 and 2004. Consequently, the odds ratio for the association between socioeconomic deprivation and sudden infant death syndrome increased from 2.04 (95% confidence interval 1.53 to 2.72) in 1985-90, to 7.52 (4.62 to 12.25) in 1991-6, and 9.50 (5.46 to 16.53) in 1997-2002 but fell to 1.78 (0.87 to 3.65) in 2002-8. The interaction remained significant after adjustment for maternal characteristics. Conclusion The rate of sudden infant death syndrome declined throughout Scotland in the early 1990s. The decline had a later onset and was slower among women living in areas of high deprivation, probably because of slower uptake of recommended changes in infant sleeping position. The effect was to create a strong independent association between deprivation and sudden infant death syndrome where one did not exist before.	[Smith, Gordon C. S.] Univ Cambridge, Dept Obstet & Gynaecol, NIHR Biomed Res Ctr, Cambridge CB2 0SW, England; [Wood, Angela M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Pasupathy, Dharmintra] Kings Coll London, Womens Hlth Acad Ctr, London SE1 7EH, England; [Pell, Jill P.] Univ Glasgow, Publ Hlth Unit, Glasgow G12 8RZ, Lanark, Scotland; [Fleming, Michael] NHS Natl Serv Scotland, Infect Serv Div, Edinburgh EH12 9EB, Midlothian, Scotland	University of Cambridge; University of Cambridge; University of London; King's College London; University of Glasgow; NHS National Services Scotland	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, NIHR Biomed Res Ctr, Cambridge CB2 0SW, England.	gcss2@cam.ac.uk	Pasupathy, Dharmintra/N-9586-2019; Wood, Angela/GZA-5762-2022; Smith, Gordon/A-8070-2008	Pasupathy, Dharmintra/0000-0002-6722-1006; Wood, Angela/0000-0002-7937-304X; Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035; fleming, michael/0000-0002-2185-4502	NIHR Cambridge Comprehensive Biomedical Research Centre; MRC; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0600469] Funding Source: researchfish; MRC [G0600469] Funding Source: UKRI	NIHR Cambridge Comprehensive Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the NIHR Cambridge Comprehensive Biomedical Research Centre. DP was funded by an MRC clinical training fellowship. The funding bodies had no role in any aspect of the conduct, analysis, or presentation of this study.	BEAL S, 1988, LANCET, V2, P512; Blair PS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3666; Blair PS, 2006, LANCET, V367, P314, DOI 10.1016/S0140-6736(06)67968-3; Brooke H, 1997, BMJ-BRIT MED J, V314, P1516, DOI 10.1136/bmj.314.7093.1516; Carpenter RG, 2004, LANCET, V363, P185, DOI 10.1016/S0140-6736(03)15323-8; DEJONGE GA, 1989, BRIT MED J, V298, P722, DOI 10.1136/bmj.298.6675.722; FLEMING PJ, 1990, BRIT MED J, V301, P85, DOI 10.1136/bmj.301.6743.85; Guildea ZES, 2001, ARCH DIS CHILD, V84, P307, DOI 10.1136/adc.84.4.307; HEY EN, 1986, BRIT J OBSTET GYNAEC, V93, P1213, DOI 10.1111/j.1471-0528.1986.tb07854.x; Information Services Division NHS Scotland, 2008, SCOTT PER INF MORT R; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; LEE NNY, 1989, BRIT MED J, V298, P721, DOI 10.1136/bmj.298.6675.721; Little R, 2008, STAT ANAL MISSING DA; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Messer J, 2010, STAT B GESTATION SPE, P1; MITCHELL EA, 1991, NEW ZEAL MED J, V104, P71; Sadler DW, 1998, J CLIN PATHOL, V51, P689, DOI 10.1136/jcp.51.9.689; Shipton D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4347; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; World Health Organization, 2008, GLOB BURD DIS 2004 U	20	33	33	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2012	344								e1552	10.1136/bmj.e1552	http://dx.doi.org/10.1136/bmj.e1552			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913CE	22427307	Green Published, hybrid, Green Accepted			2022-12-01	WOS:000301848200002
J	Kretzschmar, T; Kohlen, W; Sasse, J; Borghi, L; Schlegel, M; Bachelier, JB; Reinhardt, D; Bours, R; Bouwmeester, HJ; Martinoia, E				Kretzschmar, Tobias; Kohlen, Wouter; Sasse, Joelle; Borghi, Lorenzo; Schlegel, Markus; Bachelier, Julien B.; Reinhardt, Didier; Bours, Ralph; Bouwmeester, Harro J.; Martinoia, Enrico			A petunia ABC protein controls strigolactone-dependent symbiotic signalling and branching	NATURE			English	Article							CASSETTE-TYPE TRANSPORTER; ARBUSCULAR MYCORRHIZA; MEDICAGO-TRUNCATULA; GENE FAMILY; PLANT; AUXIN; ARABIDOPSIS; ACID; PCR; GERMINATION	Strigolactones were originally identified as stimulators of the germination of root-parasitic weeds(1) that pose a serious threat to resource-limited agriculture(2). They are mostly exuded from roots and function as signalling compounds in the initiation of arbuscular mycorrhizae(3), which are plant-fungus symbionts with a global effect on carbon and phosphate cycling(4). Recently, strigolactones were established to be phytohormones that regulate plant shoot architecture by inhibiting the outgrowth of axillary buds(5,6). Despite their importance, it is not known how strigolactones are transported. ATP-binding cassette (ABC) transporters, however, are known to have functions in phytohormone translocation(7-9). Here we show that the Petunia hybrida ABC transporter PDR1 has a key role in regulating the development of arbuscular mycorrhizae and axillary branches, by functioning as a cellular strigolactone exporter. P. hybrida pdr1 mutants are defective in strigolactone exudation from their roots, resulting in reduced symbiotic interactions. Above ground, pdr1 mutants have an enhanced branching phenotype, which is indicative of impaired strigolactone allocation. Overexpression of Petunia axillaris PDR1 in Arabidopsis thaliana results in increased tolerance to high concentrations of a synthetic strigolactone, consistent with increased export of strigolactones from the roots. PDR1 is the first known component in strigolactone transport, providing new opportunities for investigating and manipulating strigolactone-dependent processes.	[Kretzschmar, Tobias; Sasse, Joelle; Borghi, Lorenzo; Schlegel, Markus; Bachelier, Julien B.; Martinoia, Enrico] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Kohlen, Wouter; Bours, Ralph; Bouwmeester, Harro J.] Wageningen Univ, Lab Plant Physiol, NL-6700 AR Wageningen, Netherlands; [Reinhardt, Didier] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Bouwmeester, Harro J.] Ctr Biosyst Genom, NL-6700 AB Wageningen, Netherlands	University of Zurich; Wageningen University & Research; University of Fribourg; Centre for BioSystems Genomics	Kretzschmar, T (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	t.kretzschmar@irri.org	kretzschmar, tobias/AAH-3739-2021; Borghi, Lorenzo/AAF-4631-2019; Reinhardt, Didier/M-8508-2014; Kretzschmar, Tobias/M-5930-2013; Martinoia, Enrico/AAH-8712-2021	Borghi, Lorenzo/0000-0002-9631-9694; Reinhardt, Didier/0000-0003-3495-6783; kretzschmar, tobias/0000-0002-8227-0746; Schlapfer, Joelle/0000-0001-5705-9888; Bouwmeester, Harro/0000-0003-0907-2732; Schlegel, Markus/0000-0003-3453-4783	Swiss National Foundation within the NCCR; Netherlands Organization for Scientific Research (NWO) [865.06.002, 834.08.001]; Centre for BioSystems Genomics (CBSG)	Swiss National Foundation within the NCCR; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Centre for BioSystems Genomics (CBSG)	We kindly thank the following: C. Gubeli for technical assistance; and T. Gerats, S. Hortensteiner, A. Osbourne, P. Schlapfer and C. Beveridge for comments. This study was funded by the Swiss National Foundation within the NCCR-Plant Survival (project 'ABC transporters involved in signaling') and by The Netherlands Organization for Scientific Research (NWO; VICI grant 865.06.002 and Equipment grant 834.08.001to H.J.B.). H.J.B. was co-financed by the Centre for BioSystems Genomics (CBSG).	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Badri DV, 2009, PLANT PHYSIOL, V151, P2006, DOI 10.1104/pp.109.147462; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Brewer PB, 2009, PLANT PHYSIOL, V150, P482, DOI 10.1104/pp.108.134783; Cervera M, 2005, METH MOL B, V286, P203; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Crawford S, 2010, DEVELOPMENT, V137, P2905, DOI 10.1242/dev.051987; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Feddermann N, 2010, PLANT J, V64, P470, DOI 10.1111/j.1365-313X.2010.04341.x; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hanlon MT, 2011, NEW PHYTOL, V189, P701, DOI 10.1111/j.1469-8137.2010.03567.x; Harrison SJ, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-19; Hayward A, 2009, PLANT PHYSIOL, V151, P400, DOI 10.1104/pp.109.137646; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Jasinski M, 2001, PLANT CELL, V13, P1095, DOI 10.1105/tpc.13.5.1095; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; KOES R, 1995, P NATL ACAD SCI USA, V92, P8149, DOI 10.1073/pnas.92.18.8149; Kohlen W, 2011, PLANT PHYSIOL, V155, P974, DOI 10.1104/pp.110.164640; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Liu W, 2011, PLANT CELL, V23, P3853, DOI 10.1105/tpc.111.089771; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutke W. Kevin, 2006, V344, P339; Mashiguchi K, 2009, BIOSCI BIOTECH BIOCH, V73, P2460, DOI 10.1271/bbb.90443; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Meyer A, 2006, J BIOL CHEM, V281, P7197, DOI 10.1074/jbc.M510766200; Moons A, 2008, PLANTA, V229, P53, DOI 10.1007/s00425-008-0810-5; Nagahashi G, 1999, BIOTECHNOL TECH, V13, P893, DOI 10.1023/A:1008938527757; Napoli C, 1996, PLANT PHYSIOL, V111, P27, DOI 10.1104/pp.111.1.27; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Sekhara RDMR, 2007, PLANT J, V51, P739, DOI 10.1111/j.1365-313X.2007.03175.x; Sharda JN, 2008, NEW PHYTOL, V180, P696, DOI 10.1111/j.1469-8137.2008.02600.x; Snowden KC, 2005, PLANT CELL, V17, P746, DOI 10.1105/tpc.104.027714; Snowden KC, 2003, FUNCT PLANT BIOL, V30, P987, DOI 10.1071/FP03081; Sugiyama A, 2008, PLANT SIGNAL BEHAV, V3, P38, DOI 10.4161/psb.3.1.4819; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Van den Broeck D, 1998, PLANT J, V13, P121, DOI 10.1046/j.1365-313X.1998.00004.x; Vandenbussche M, 2004, METH MOL B, V260, P115, DOI 10.1385/1-59259-755-6:115; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yoder JI, 2010, CURR OPIN PLANT BIOL, V13, P478, DOI 10.1016/j.pbi.2010.04.011; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang Q, 2010, PLANT CELL, V22, P1483, DOI 10.1105/tpc.110.074955; Zhang XW, 2008, HORTSCIENCE, V43, P300, DOI 10.21273/HORTSCI.43.2.300	49	364	384	11	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					341	U135		10.1038/nature10873	http://dx.doi.org/10.1038/nature10873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22398443	Green Accepted, Green Submitted			2022-12-01	WOS:000301481800051
J	Roberts, EK; Lu, A; Bergman, TJ; Beehner, JC				Roberts, Eila K.; Lu, Amy; Bergman, Thore J.; Beehner, Jacinta C.			A Bruce Effect in Wild Geladas	SCIENCE			English	Article							PREGNANCY BLOCK; REPRODUCTIVE CONDITION; MALE TAKEOVERS; SOCIAL-FACTORS; BABOONS; VOLE; MOUSE; INFANTICIDE; ADVANTAGES; MORTALITY	Female rodents are known to terminate pregnancies after exposure to unfamiliar males ("Bruce effect"). Although laboratory support abounds, direct evidence for a Bruce effect under natural conditions is lacking. Here, we report a strong Bruce effect in a wild primate, the gelada (Theropithecus gelada). Female geladas terminate 80% of pregnancies in the weeks after a dominant male is replaced. Further, data on interbirth intervals suggest that pregnancy termination offers fitness benefits for females whose offspring would otherwise be susceptible to infanticide. Taken together, data support the hypothesis that the Bruce effect can be an adaptive strategy for females.	[Roberts, Eila K.; Lu, Amy; Bergman, Thore J.; Beehner, Jacinta C.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Lu, Amy] New York Consortium Evolutionary Primatol, New York, NY 10016 USA; [Bergman, Thore J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Beehner, Jacinta C.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Beehner, JC (corresponding author), Univ Michigan, Dept Psychol, 580 Union Dr, Ann Arbor, MI 48109 USA.	jbeehner@umich.edu	Bergman, Thore J/B-8196-2008; Beehner, Jacinta/E-8467-2012	Bergman, Thore J/0000-0002-9615-5001; Beehner, Jacinta/0000-0001-6566-6872	Wildlife Conservation Society [67250]; National Geographic Society [8100-06]; Leakey Foundation; National Science Foundation [BCS-0715179, BCS-0824592]; University of Michigan; Ethiopian Wildlife Conservation Authority; Simien Mountains National Park	Wildlife Conservation Society; National Geographic Society(National Geographic Society); Leakey Foundation; National Science Foundation(National Science Foundation (NSF)); University of Michigan(University of Michigan System); Ethiopian Wildlife Conservation Authority; Simien Mountains National Park	Supported by the Wildlife Conservation Society (SSF grant 67250), the National Geographic Society (grant 8100-06), the Leakey Foundation, the National Science Foundation (grants BCS-0715179 and BCS-0824592), and the University of Michigan. Thanks to the Ethiopian Wildlife Conservation Authority, the wardens and staff of the Simien Mountains National Park, and the participants of the University of Michigan Gelada Research project, particularly A. Le Roux, N. Snyder-Mackler, D. Pappano, C. Wilton, J. Jarvey, S. Liberman, A. Spencer, V. Wilson, N. Sands, M. Zakalik, H. Gelaye, E. Jejaw, and A. Fanta for help in the field and T. Parr for help in the laboratory. All protocols were noninvasive and were approved in Ethiopia (Ethiopian Wildlife Conservation Authority) and the United States (University of Michigan University Committee on Use and Care of Animals, protocols 09554 and 0001011). The authors declare no competing financial interests. All authors contributed extensively to the work presented in this paper. Data available in the SOM.	Agoramoorthy G., 1988, HUM EVOL, V3, P279; Agoramoorthy G., 1988, HUM EVOL, V3, P297, DOI DOI 10.1007/BF02435859; Bartos L, 2011, BEHAV ECOL SOCIOBIOL, V65, P1567, DOI 10.1007/s00265-011-1166-6; Becker SD, 2008, CHEM SIGNAL, V11, P141, DOI 10.1007/978-0-387-73945-8_13; Becker SD, 2009, P ROY SOC B-BIOL SCI, V276, P1723, DOI 10.1098/rspb.2008.1780; Beehner JC, 2008, AM J PRIMATOL, V70, P1152, DOI 10.1002/ajp.20614; Beehner JC, 2006, BEHAV ECOL, V17, P741, DOI 10.1093/beheco/arl006; Beehner JC, 2006, HORM BEHAV, V49, P688, DOI 10.1016/j.yhbeh.2005.12.016; BERGER J, 1983, NATURE, V303, P59, DOI 10.1038/303059a0; Bergman TJ, 2011, AM J PHYS ANTHROPOL, V144, P88; BERTRAM BCR, 1975, J ZOOL, V177, P463; Bronson F. H., 1980, MODULATION REPROD PR, P243; BRUCE HM, 1960, J REPROD FERTIL, V1, P96, DOI 10.1530/jrf.0.0010096; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; COLMENARES F, 1988, FOLIA PRIMATOL, V50, P157, DOI 10.1159/000156343; Darwin C., 1871, DESCENT MAN SELECTIO; de la Maza HM, 1999, BEHAV ECOL SOCIOBIOL, V45, P107, DOI 10.1007/s002650050544; DOMINIC CJ, 1966, J REPROD FERTIL, V11, P415; Dunbar R., 1984, REPROD DECISIONS EC; HAMILTON WJ, 1990, BEHAV ECOL SOCIOBIOL, V26, P357; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; LABOV JB, 1981, AM NAT, V118, P361, DOI 10.1086/283828; Mahady SJ, 2002, BEHAV ECOL SOCIOBIOL, V52, P31, DOI 10.1007/s00265-002-0484-0; MALLORY FF, 1977, CAN J ZOOL, V55, P1, DOI 10.1139/z77-001; MILLIGAN SR, 1976, J REPROD FERTIL, V46, P97, DOI 10.1530/jrf.0.0460097; MORI U, 1985, Z TIERPSYCHOL, V67, P215; PARKES AS, 1961, SCIENCE, V134, P1049, DOI 10.1126/science.134.3485.1049; PEREIRA ME, 1983, AM J PRIMATOL, V4, P93, DOI 10.1002/ajp.1350040109; Pillay N, 2009, BEHAVIOUR, V146, P139, DOI 10.1163/156853908X390968; SCHWAGMEYER PL, 1979, AM NAT, V114, P932, DOI 10.1086/283541; WASSER SK, 1983, Q REV BIOL, V58, P513, DOI 10.1086/413545; Wolff JO, 2003, BIOSCIENCE, V53, P421, DOI 10.1641/0006-3568(2003)053[0421:LSWRFO]2.0.CO;2	33	93	94	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2012	335	6073					1222	1225		10.1126/science.1213600	http://dx.doi.org/10.1126/science.1213600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22362878				2022-12-01	WOS:000301225100044
J	Godley, LA; Le Beau, MM				Godley, Lucy A.; Le Beau, Michelle M.			The Histone Code and Treatments for Acute Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Godley, Lucy A.] Univ Chicago, Sect Hematol & Oncol, Chicago, IL 60637 USA; Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA	University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago	Godley, LA (corresponding author), Univ Chicago, Sect Hematol & Oncol, Chicago, IL 60637 USA.							Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	2	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2012	366	10					960	961		10.1056/NEJMcibr1113401	http://dx.doi.org/10.1056/NEJMcibr1113401			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904CY	22397660				2022-12-01	WOS:000301172500016
J	Hotz, M; Leisner, C; Chen, DC; Manatschal, C; Wegleiter, T; Ouellet, J; Lindstrom, D; Gottschling, DE; Vogel, J; Barral, Y				Hotz, Manuel; Leisner, Christian; Chen, Daici; Manatschal, Cristina; Wegleiter, Thomas; Ouellet, Jimmy; Lindstrom, Derek; Gottschling, Dan E.; Vogel, Jackie; Barral, Yves			Spindle Pole Bodies Exploit the Mitotic Exit Network in Metaphase to Drive Their Age-Dependent Segregation	CELL			English	Article							MICROTUBULE ORGANIZATION; BODY INHERITANCE; PROTEIN; ORIENTATION; CENTROSOME; ASYMMETRY; KINASE; YEAST; CHECKPOINT; HOMOLOG	Like many asymmetrically dividing cells, budding yeast segregates mitotic spindle poles nonrandomly between mother and daughter cells. During metaphase, the spindle positioning protein Kar9 accumulates asymmetrically, localizing specifically to astral microtubules emanating from the old spindle pole body (SPB) and driving its segregation to the bud. Here, we show that the SPB component Nud1/centriolin acts through the mitotic exit network (MEN) to specify asymmetric SPB inheritance. In the absence of MEN signaling, Kar9 asymmetry is unstable and its preference for the old SPB is disrupted. Consistent with this, phosphorylation of Kar9 by the MEN kinases Dbf2 and Dbf20 is not required to break Kar9 symmetry but is instead required to maintain stable association of Kar9 with the old SPB throughout metaphase. We propose that MEN signaling links Kar9 regulation to SPB identity through biasing and stabilizing the age-insensitive, cyclin-B-dependent mechanism of symmetry breaking.	[Hotz, Manuel; Leisner, Christian; Manatschal, Cristina; Wegleiter, Thomas; Ouellet, Jimmy; Barral, Yves] ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland; [Chen, Daici; Vogel, Jackie] McGill Univ, Dept Biol, Montreal, PQ H3G 0B1, Canada; [Lindstrom, Derek; Gottschling, Dan E.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; McGill University; Fred Hutchinson Cancer Center	Barral, Y (corresponding author), ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland.	yves.barral@bc.biol.ethz.ch	Chen, Daici/AAI-7285-2020	Chen, Daici/0000-0002-8872-0592; Barral, Yves/0000-0002-0989-3373; Ouellet, Jimmy/0000-0002-0215-7023	ERC; SNF; CIHR [MOP-64404]; NIH [AG023779]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023779, R01AG023779] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); SNF; CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Baldi, M. Bayer, A. Bolognesi, S. Buvelot-Frei, F. Caudron, L. Clay, A. Denoth, A. Farcas, M. Faty, P. Meraldi, M. Peter, J. Saarikangas, and C. Weirich for discussion and critical reading of the manuscript and N. Paget and R. Visintin for technical help. We also thank M. Charbonneau, S. Piatti, and F. Uhlmann for strains and reagents and the Light Microscopy Centre of the ETH Zurich for technical support. M. H. and Y.B. were supported by ETHZ and grants of ERC and SNF to Y.B. D. C. and J. V. were supported by CIHR grant MOP-64404 to J. V. D. L. and D. E. G. were supported by NIH grant AG023779 to D.E.G.	Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Barral Y, 2009, INT REV CEL MOL BIO, V278, P149, DOI 10.1016/S1937-6448(09)78004-9; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Bloom J, 2011, J BIOL CHEM, V286, P5434, DOI 10.1074/jbc.M110.205054; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Caydasi AK, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-28; Cepeda-Garcia C, 2010, MOL BIOL CELL, V21, P2685, DOI 10.1091/mbc.E10-03-0197; Conduit PT, 2010, CURR BIOL, V20, P2187, DOI 10.1016/j.cub.2010.11.055; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Gordon O, 2006, EMBO J, V25, P3856, DOI 10.1038/sj.emboj.7601254; Grava S, 2006, DEV CELL, V10, P425, DOI 10.1016/j.devcel.2006.02.018; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Gruneberg U, 2000, EMBO J, V19, P6475, DOI 10.1093/emboj/19.23.6475; Guthrie C, 1991, GUIDE YEAST GENETICS; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Hwang E, 2003, J CELL BIOL, V161, P483, DOI 10.1083/jcb.200302030; Januschke J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1245; Kaltschmidt JA, 2002, J CELL SCI, V115, P2257; Kammerer D, 2010, CURR BIOL, V20, P1233, DOI 10.1016/j.cub.2010.05.064; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Konig C, 2010, J CELL BIOL, V188, P351, DOI 10.1083/jcb.200911128; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Leisner C, 2008, CURR BIOL, V18, P1249, DOI 10.1016/j.cub.2008.07.091; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Meednu N, 2008, GENETICS, V180, P2033, DOI 10.1534/genetics.108.095042; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Monje-Casas F, 2009, DEV CELL, V16, P132, DOI 10.1016/j.devcel.2008.11.002; Moore JK, 2007, MOL BIOL CELL, V18, P1187, DOI 10.1091/mbc.E06-04-0360; Moore JK, 2006, MOL BIOL CELL, V17, P178, DOI 10.1091/mbc.e05-06-0565; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Queralt E, 2008, CURR OPIN CELL BIOL, V20, P661, DOI 10.1016/j.ceb.2008.09.003; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Verzijlbergen KF, 2010, P NATL ACAD SCI USA, V107, P64, DOI 10.1073/pnas.0911164107; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024; Yoder TJ, 2003, MOL BIOL CELL, V14, P3494, DOI 10.1091/mbc.E02-10-0655; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	52	50	51	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					958	972		10.1016/j.cell.2012.01.041	http://dx.doi.org/10.1016/j.cell.2012.01.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385961	Green Accepted, Bronze			2022-12-01	WOS:000300985000016
J	Olsen, SR; Bortone, DS; Adesnik, H; Scanziani, M				Olsen, Shawn R.; Bortone, Dante S.; Adesnik, Hillel; Scanziani, Massimo			Gain control by layer six in cortical circuits of vision	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; PRIMARY SOMATOSENSORY CORTEX; RESPONSE PROPERTIES; CORTICOTHALAMIC FEEDBACK; INTERLAMINAR CONNECTIONS; RECEPTIVE-FIELDS; END-INHIBITION; SYNAPTIC INPUT; NEURONS	After entering the cerebral cortex, sensory information spreads through six different horizontal neuronal layers that are interconnected by vertical axonal projections. It is believed that through these projections layers can influence each other's response to sensory stimuli, but the specific role that each layer has in cortical processing is still poorly understood. Here we show that layer six in the primary visual cortex of the mouse has a crucial role in controlling the gain of visually evoked activity in neurons of the upper layers without changing their tuning to orientation. This gain modulation results from the coordinated action of layer six intracortical projections to superficial layers and deep projections to the thalamus, with a substantial role of the intracortical circuit. This study establishes layer six as a major mediator of cortical gain modulation and suggests that it could be a node through which convergent inputs from several brain areas can regulate the earliest steps of cortical visual processing.	[Olsen, Shawn R.; Bortone, Dante S.; Adesnik, Hillel; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Olsen, Shawn R.; Bortone, Dante S.; Adesnik, Hillel; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA.	srolsen@ucsd.edu; massimo@biomail.ucsd.edu		Olsen, Shawn/0000-0002-9568-7057	Helen Hay Whitney Foundation; NINDS [5T32NS007220-28]; National Institutes of Health [RO1 NS069010]; Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007220, RC1NS069010] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to M. Carandini, J. Isaacson and the members of the Scanziani and Isaacson laboratories for helpful discussions of this project, to J. Isaacson, R. Malinow and T. Komiyama for providing feedback on the manuscript, to P. Abelkop for histological help and neonatal viral injections, to J. Evora for mouse colony support and genotyping, to B. Atallah for sharing the technique for silencing the cortex by photostimulation of parvalbumin neurons and for help with the in vivo recording setup and to W. Bruns for help coding analysis software. We thank the UCSD Neuroscience Microscopy Facility (P30 NS047101) for the use of their imaging equipment. S.R.O. and H.A. were supported by postdoctoral fellowships from the Helen Hay Whitney Foundation. D.S.B was supported by a UCSD Neurobiology Training Grant (NINDS: 5T32NS007220-28). M.S. is an investigator of the Howard Hughes Medical Institute. This work was also supported National Institutes of Health grant RO1 NS069010 and by the Gatsby Charitable Foundation.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Andolina IM, 2007, P NATL ACAD SCI USA, V104, P1685, DOI 10.1073/pnas.0609318104; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bagnall MW, 2011, NEURON, V71, P180, DOI 10.1016/j.neuron.2011.05.032; Binzegger T, 2007, J NEUROSCI, V27, P12242, DOI 10.1523/JNEUROSCI.3753-07.2007; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Briggs F, 2008, CURR OPIN NEUROBIOL, V18, P403, DOI 10.1016/j.conb.2008.09.002; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Casagrande V. A., 1994, AFFERENT IINTRINSIC; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cudeiro J, 2006, TRENDS NEUROSCI, V29, P298, DOI 10.1016/j.tins.2006.05.002; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; GRIEVE KL, 1991, EXP BRAIN RES, V87, P521; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jones E.G., 2007, THALAMUS; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lorente de No R, 1943, PHYSL NERVOUS SYSTEM, P274; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCCLURKIN JW, 1984, J PHYSIOL-LONDON, V348, P135, DOI 10.1113/jphysiol.1984.sp015103; Murphy BK, 2003, J NEUROSCI, V23, P10040; Murphy PC, 1999, SCIENCE, V286, P1552, DOI 10.1126/science.286.5444.1552; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; Ringach DL, 2002, J NEUROSCI, V22, P5639; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Thomson AM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00013; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Wang W, 2006, NAT NEUROSCI, V9, P1330, DOI 10.1038/nn1768; Worgotter F, 1998, J PHYSIOL-LONDON, V509, P797, DOI 10.1111/j.1469-7793.1998.797bm.x; Zhang ZW, 1997, J NEUROSCI, V17, P6365	50	329	332	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					47	U83		10.1038/nature10835	http://dx.doi.org/10.1038/nature10835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22367547	Green Accepted			2022-12-01	WOS:000300877900041
J	Gu, SY; Rumpel, S; Zhou, J; Strotmeier, J; Bigalke, H; Perry, K; Shoemaker, CB; Rummel, A; Jin, RS				Gu, Shenyan; Rumpel, Sophie; Zhou, Jie; Strotmeier, Jasmin; Bigalke, Hans; Perry, Kay; Shoemaker, Charles B.; Rummel, Andreas; Jin, Rongsheng			Botulinum Neurotoxin Is Shielded by NTNHA in an Interlocked Complex	SCIENCE			English	Article							CLOSTRIDIUM-BOTULINUM; RECEPTOR RECOGNITION; NONTOXIC COMPONENT; PROGENITOR TOXIN; SEROTYPE; BINDING; TRANSLOCATION; PURIFICATION; SEQUENCE; DOMAINS	Botulinum neurotoxins (BoNTs) are highly poisonous substances that are also effective medicines. Accidental BoNT poisoning often occurs through ingestion of Clostridium botulinum-contaminated food. Here, we present the crystal structure of a BoNT in complex with a clostridial nontoxic nonhemagglutinin (NTNHA) protein at 2.7 angstroms. Biochemical and functional studies show that NTNHA provides large and multivalent binding interfaces to protect BoNT from gastrointestinal degradation. Moreover, the structure highlights key residues in BoNT that regulate complex assembly in a pH-dependent manner. Collectively, our findings define the molecular mechanisms by which NTNHA shields BoNT in the hostile gastrointestinal environment and releases it upon entry into the circulation. These results will assist in the design of small molecules for inhibiting oral BoNT intoxication and of delivery vehicles for oral administration of biologics.	[Gu, Shenyan; Zhou, Jie; Jin, Rongsheng] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Rumpel, Sophie; Strotmeier, Jasmin; Bigalke, Hans; Rummel, Andreas] Hannover Med Sch, Inst Toxikol, D-30625 Hannover, Germany; [Perry, Kay] Cornell Univ, Argonne Natl Lab, NE CAT, Argonne, IL 60439 USA; [Perry, Kay] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Biomed Sci, Div Infect Dis, North Grafton, MA 01536 USA	Sanford Burnham Prebys Medical Discovery Institute; Hannover Medical School; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Jin, RS (corresponding author), Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rjin@sanfordburnham.org	Rummel, Andreas/I-7449-2013; Gu, Shenyan/F-5501-2011; Jin, Rongsheng/M-7797-2013	Jin, Rongsheng/0000-0003-0348-7363; Rummel, Andreas/0000-0002-0645-1641; Perry, Kay/0000-0002-4046-1704	Alfred P. Sloan Research Fellowship; Deutsche Forschungsgemeinschaft (DFG) [Exzellenzinitiative GSC 108]; Robert-Koch-Institut [1362/I-979]; National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health and Human Services (HHS) [U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R01AI091823] Funding Source: NIH RePORTER	Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Robert-Koch-Institut; National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health and Human Services (HHS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Brunger and T. Binz for critical reading of the manuscript; the staff of beamline 9-2 at the Stanford Synchrotron Radiation Lightsource (SSRL) and the NE-CAT staff of the Advanced Photon Source (APS), particularly K. Rajashankar, for assistance in data collection; G. Yao, N. Krez, A. M. Kruel, and J. Tremblay for excellent technical assistance; and R. Liddington and A. Bobkov for assistance with ITC and AUC. This work was partly supported by an Alfred P. Sloan Research Fellowship (R.J.), by the Deutsche Forschungsgemeinschaft (DFG Exzellenzinitiative GSC 108 to S.R.), by the Robert-Koch-Institut (1362/I-979 to A.R.), and by grants from the National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health and Human Services (HHS), under award number U54 AI057159 (C.B.S.). Atomic coordinates and structure factors for the VHH-bound M-PTC, M-PTC, and BoNT/Ai have been deposited with the Protein Data Bank under accession codes 3V0A, 3V0B, and 3V0C, respectively. Sanford-Burnham Medical Research Institute has a pending patent application, titled "Botulinum neurotoxin protective complex delivery compositions," that was filed in November of 2011. BoNT availability is subject to the restrictions that apply to HHS select agents and NIAID Category A pathogens.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2007, NAT STRUCT MOL BIOL, V14, P9, DOI 10.1038/nsmb0107-9; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Burkard F, 1997, J STRUCT BIOL, V120, P78, DOI 10.1006/jsbi.1997.3910; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen F, 1997, INFECT IMMUN, V65, P1626, DOI 10.1128/IAI.65.5.1626-1630.1997; Cheng LW, 2008, TOXICOLOGY, V249, P123, DOI 10.1016/j.tox.2008.04.018; Collins MD, 1998, J APPL MICROBIOL, V84, P5, DOI 10.1046/j.1365-2672.1997.00313.x; DEPAIVA A, 1993, J BIOL CHEM, V268, P20838; EAST AK, 1994, CURR MICROBIOL, V29, P69, DOI 10.1007/BF01575751; Eisele KH, 2011, TOXICON, V57, P555, DOI 10.1016/j.toxicon.2010.12.019; Eswaramoorthy S, 2004, BIOCHEMISTRY-US, V43, P2209, DOI 10.1021/bi035844k; FUJII N, 1993, J GEN MICROBIOL, V139, P79, DOI 10.1099/00221287-139-1-79; Hasegawa K, 2007, J BIOL CHEM, V282, P24777, DOI 10.1074/jbc.M703446200; Ito H, 2011, FEMS IMMUNOL MED MIC, V61, P323, DOI 10.1111/j.1574-695X.2011.00779.x; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Kouguchi H, 2002, J BIOL CHEM, V277, P2650, DOI 10.1074/jbc.M106762200; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin GY, 2010, APPL ENVIRON MICROB, V76, P40, DOI 10.1128/AEM.01882-09; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; OHISHI I, 1977, INFECT IMMUN, V16, P107, DOI 10.1128/IAI.16.1.107-109.1977; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Sagane Y, 2002, BIOCHEM BIOPH RES CO, V292, P434, DOI 10.1006/bbrc.2002.6689; SHONE CC, 1985, EUR J BIOCHEM, V151, P75, DOI 10.1111/j.1432-1033.1985.tb09070.x; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Wang JF, 2008, J BIOL CHEM, V283, P16993, DOI 10.1074/jbc.M710442200	32	148	160	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					977	981		10.1126/science.1214270	http://dx.doi.org/10.1126/science.1214270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363010	Green Accepted			2022-12-01	WOS:000300931800049
J	Douglas, SM; Bachelet, I; Church, GM				Douglas, Shawn M.; Bachelet, Ido; Church, George M.			A Logic-Gated Nanorobot for Targeted Transport of Molecular Payloads	SCIENCE			English	Article							DNA-ORIGAMI; NANOSCALE SHAPES; FOLDING DNA; CELLS; ENGAGEMENT; EXPRESSION; APTAMERS; LIGANDS	We describe an autonomous DNA nanorobot capable of transporting molecular payloads to cells, sensing cell surface inputs for conditional, triggered activation, and reconfiguring its structure for payload delivery. The device can be loaded with a variety of materials in a highly organized fashion and is controlled by an aptamer-encoded logic gate, enabling it to respond to a wide array of cues. We implemented several different logical AND gates and demonstrate their efficacy in selective regulation of nanorobot function. As a proof of principle, nanorobots loaded with combinations of antibody fragments were used in two different types of cell-signaling stimulation in tissue culture. Our prototype could inspire new designs with different selectivities and biologically active payloads for cell-targeting tasks.	[Church, George M.] Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Church, GM (corresponding author), Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.		Douglas, Shawn/GVU-2004-2022	Douglas, Shawn/0000-0001-5398-9041; church, george/0000-0001-6232-9969	Burroughs Wellcome Fund; Wyss Technology Development Fellowship; Life Sciences Research Foundation; Grants-in-Aid for Scientific Research [23770216] Funding Source: KAKEN	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Wyss Technology Development Fellowship; Life Sciences Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Ritz for providing NKL cells; C. Reynolds for technical assistance with NKL cells; C. Strong and G. McGill for assistance with 3D visualization using Molecular Maya; A. Marblestone for helpful discussions; and J. Markson for comments on the manuscript. S. M. D. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and a Wyss Technology Development Fellowship, and I. B. is supported by a fellowship from the Life Sciences Research Foundation. S. M. D. and I. B. designed and performed the experiments and analyzed the data; S. M. D., I. B., and G. M. C. wrote the manuscript.	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Ding B, 2006, SCIENCE, V314, P1583, DOI 10.1126/science.1131372; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; Hamaguchi N, 2001, ANAL BIOCHEM, V294, P126, DOI 10.1006/abio.2001.5169; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Kuzuya A, 2009, CHEMBIOCHEM, V10, P1811, DOI 10.1002/cbic.200900229; Nutiu R, 2003, J AM CHEM SOC, V125, P4771, DOI 10.1021/ja028962o; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Stephanopoulos N, 2010, NANO LETT, V10, P2714, DOI 10.1021/nl1018468; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; Vitale C, 2001, P NATL ACAD SCI USA, V98, P5764, DOI 10.1073/pnas.091097198; Voigt NV, 2010, NAT NANOTECHNOL, V5, P200, DOI [10.1038/nnano.2010.5, 10.1038/NNANO.2010.5]; Ye ZY, 2008, INFECT IMMUN, V76, P2541, DOI 10.1128/IAI.01310-07; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	24	1416	1460	48	1412	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					831	834		10.1126/science.1214081	http://dx.doi.org/10.1126/science.1214081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344439				2022-12-01	WOS:000300356400038
J	Moore, W				Moore, Wendy			PAST CARING Extreme measures: the history of breast cancer surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com						Austoker J, 1985, Soc Soc Hist Med Bull (Lond), V37, P100; HEISTER L, 1748, GEN SYSTEM SURG; Leopold E., 1999, DARKER RIBBON BREAST; OLSON JS, 2002, BATHSHEBAS BREAST WO	4	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2012	344								e834	10.1136/bmj.e834	http://dx.doi.org/10.1136/bmj.e834			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	892IE	22318439				2022-12-01	WOS:000300279100006
J	Lau, E; Kluger, H; Varsano, T; Lee, K; Scheffler, I; Rimm, DL; Ideker, T; Ronai, ZA				Lau, Eric; Kluger, Harriet; Varsano, Tal; Lee, KiYoung; Scheffler, Immo; Rimm, David L.; Ideker, Trey; Ronai, Ze'ev A.			PKC epsilon Promotes Oncogenic Functions of ATF2 in the Nucleus while Blocking Its Apoptotic Function at Mitochondria	CELL			English	Article							ACTIVATING TRANSCRIPTION FACTOR-2; DOUBLE-EDGED-SWORD; KINASE-C-EPSILON; GENE-EXPRESSION; SUBCELLULAR-LOCALIZATION; MELANOMA-CELLS; HEXOKINASE-II; CYTOCHROME-C; CANCER; SURVIVAL	The transcription factor ATF2 elicits oncogenic activities in melanoma and tumor suppressor activities in nonmalignant skin cancer. Here, we identify that ATF2 tumor suppressor function is determined by its ability to localize at the mitochondria, where it alters membrane permeability following genotoxic stress. The ability of ATF2 to reach the mitochondria is determined by PKC epsilon, which directs ATF2 nuclear localization. Genotoxic stress attenuates PKC epsilon effect on ATF2; enables ATF2 nuclear export and localization at the mitochondria, where it perturbs the HK1-VDAC1 complex; increases mitochondrial permeability; and promotes apoptosis. Significantly, high levels of PKC epsilon, as seen in melanoma cells, block ATF2 nuclear export and function at the mitochondria, thereby attenuating apoptosis following exposure to genotoxic stress. In melanoma tumor samples, high PKC epsilon levels associate with poor prognosis. Overall, our findings provide the framework for understanding how subcellular localization enables ATF2 oncogenic or tumor suppressor functions.	[Lau, Eric; Varsano, Tal; Ronai, Ze'ev A.] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA 92037 USA; [Kluger, Harriet; Rimm, David L.] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Lee, KiYoung; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lee, KiYoung; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Scheffler, Immo] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; [Lee, KiYoung] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon 443749, South Korea	Sanford Burnham Prebys Medical Discovery Institute; Yale University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ajou University	Ronai, ZA (corresponding author), Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA 92037 USA.	ronai@sbmri.org		Ideker, Trey/0000-0002-1708-8454; RONAI, ZEEV/0000-0002-3859-0400; Rimm, David/0000-0001-5820-4397	ACS; Illinois Division; NCI [117090-PF-09-112-01-GMC, 5-T32-CA121949, CA099961, CA051995]; NATIONAL CANCER INSTITUTE [R01CA099961, R29CA051995, R01CA051995, T32CA121949] Funding Source: NIH RePORTER	ACS(American Cancer Society); Illinois Division; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Meenhard Herlyn and John Clifford for melanoma and SCC cell lines, Jorge Moscat and Maria Diaz-Meco for PKC reagents, members of the Salvesen lab, Robbin Newlin and Yoav Altman for technical assistance, and Colin Goding for helpful comments on the manuscript. We also thank Ronai laboratory members, Meifan Chen, Hyungsoo Kim, Ersheng Kuang, Marzia Scortegagna, and Meera Shah for technical advice and assistance and Gustavo Gutierrez for bacterial ATF2 proteins. Support from ACS Postdoctoral Fellowship, Illinois Division and NCI T32 training grant (117090-PF-09-112-01-GMC and 5-T32-CA121949 to E.L.) and NCI grants (CA099961 and CA051995 to Z.A.R.) are gratefully acknowledged. D.L.R. is a consultant for and stockholder in HistoRx, the exclusive licensee of the Yale-owned AQUA technology used in this work.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Barrett LE, 2006, P NATL ACAD SCI USA, V103, P5155, DOI 10.1073/pnas.0510477103; Berger AJ, 2003, CANCER RES, V63, P8103; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Bhoumik A, 2002, J CLIN INVEST, V110, P643, DOI 10.1172/JCI200216081; Bhoumik A, 2004, P NATL ACAD SCI USA, V101, P4222, DOI 10.1073/pnas.0400195101; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Carvalho ACP, 2004, CELL DEATH DIFFER, V11, P1265, DOI 10.1038/sj.cdd.4401508; Deng XH, 2008, CANCER RES, V68, P9663, DOI 10.1158/0008-5472.CAN-08-2229; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Gillespie S, 2005, MOL CANCER THER, V4, P668, DOI 10.1158/1535-7163.MCT-04-0332; Gonelli A, 2009, MINI-REV MED CHEM, V9, P498, DOI 10.2174/138955709787847967; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; King MA, 2007, CYTOM PART A, V71A, P668, DOI 10.1002/cyto.a.20428; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Li Shuangwei, 2010, Genes Cancer, V1, P316; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Maekawa T, 2008, ONCOGENE, V27, P1045, DOI 10.1038/sj.onc.1210727; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Moin SM, 2007, J BIOL CHEM, V282, P21124, DOI 10.1074/jbc.M701696200; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Pass JM, 2001, AM J PHYSIOL-HEART C, V280, pH946, DOI 10.1152/ajpheart.2001.280.3.H946; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Sand JM, 2010, J INVEST DERMATOL, V130, P270, DOI 10.1038/jid.2009.212; Shah M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001258; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Shulga N, 2009, CELL CYCLE, V8, P3355, DOI 10.4161/cc.8.20.9853; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Yamasaki T, 2009, J BIOL CHEM, V284, P8567, DOI 10.1074/jbc.M808719200; Yu M, 2008, J INVEST DERMATOL, V128, P1797, DOI 10.1038/sj.jid.5701243; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356	39	58	64	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 3	2012	148	3					543	555		10.1016/j.cell.2012.01.016	http://dx.doi.org/10.1016/j.cell.2012.01.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304920	Green Accepted, Bronze			2022-12-01	WOS:000300225000021
J	Park, SJ; Ahmad, F; Philp, A; Baar, K; Williams, T; Luo, HB; Ke, HM; Rehmann, H; Taussig, R; Brown, AL; Kim, MK; Beaven, MA; Burgin, AB; Manganiello, V; Chung, JH				Park, Sung-Jun; Ahmad, Faiyaz; Philp, Andrew; Baar, Keith; Williams, Tishan; Luo, Haibin; Ke, Hengming; Rehmann, Holger; Taussig, Ronald; Brown, Alexandra L.; Kim, Myung K.; Beaven, Michael A.; Burgin, Alex B.; Manganiello, Vincent; Chung, Jay H.			Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases	CELL			English	Article							ACTIVATED PROTEIN-KINASE; SMALL-MOLECULE ACTIVATORS; LIFE-SPAN; PHOSPHOLIPASE-C; CYCLIC-AMP; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-FUNCTION; CALORIE RESTRICTION; SIGNALING PATHWAY; CARDIAC MYOCYTES	Resveratrol, a polyphenol in red wine, has been reported as a calorie restriction mimetic with potential antiaging and antidiabetogenic properties. It is widely consumed as a nutritional supplement, but its mechanism of action remains a mystery. Here, we report that the metabolic effects of resveratrol result from competitive inhibition of cAMP-degrading phosphodiesterases, leading to elevated cAMP levels. The resulting activation of Epac1, a cAMP effector protein, increases intracellular Ca2+ levels and activates the CamKK beta-AMPK pathway via phospholipase C and the ryanodine receptor Ca2+-release channel. As a consequence, resveratrol increases NAD(+) and the activity of Sirt1. Inhibiting PDE4 with rolipram reproduces all of the metabolic benefits of resveratrol, including prevention of diet-induced obesity and an increase in mitochondrial function, physical stamina, and glucose tolerance in mice. Therefore, administration of PDE4 inhibitors may also protect against and ameliorate the symptoms of metabolic diseases associated with aging.	[Park, Sung-Jun; Brown, Alexandra L.; Kim, Myung K.; Chung, Jay H.] NHLBI, Lab Obes & Aging Res, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Ahmad, Faiyaz; Manganiello, Vincent] NHLBI, Cardiovasc Pulm Branch, NIH, Bethesda, MD 20892 USA; [Beaven, Michael A.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Philp, Andrew; Baar, Keith] Univ Calif Davis, Funct Mol Biol Lab, Davis, CA 95616 USA; [Williams, Tishan; Ke, Hengming] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Luo, Haibin] Sun Yat Sen Univ, Sch Pharmaceut Sci, Struct Biol Lab, Guangzhou 510006, Guangdong, Peoples R China; [Rehmann, Holger] Univ Med Ctr, Dept Mol Canc Res, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; [Rehmann, Holger] Univ Med Ctr, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands; [Taussig, Ronald] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Burgin, Alex B.] Emerald BioStruct, Bainbridge Isl, WA 98110 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Davis; University of North Carolina; University of North Carolina Chapel Hill; Sun Yat Sen University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chung, JH (corresponding author), NHLBI, Lab Obes & Aging Res, Genet & Dev Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	chungj@nhlbi.nih.gov	Khan, Faiyaz Ahmad/AAW-7944-2021	Baar, Keith/0000-0001-9337-6186; Philp, Andrew/0000-0003-3860-4136	National Heart Lung and Blood Institute, National Institutes of Health; Netherlands Organization for Scientific Research (NWO); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006118, ZIAHL002540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059791] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program, National Heart Lung and Blood Institute, National Institutes of Health. We thank Andrew Marks for the Ryr2 phosphoantibody; Dr. Yan Tang for sharing data regarding inhibition of PDE3 by resveratrol; Marije Rensen-De Leeuw and Yan Tang for technical assistance; Shutong Yang and Dalton Saunders for animal management; and Alexandra Brown for manuscript review and comments. H.R. is supported by the Netherlands Organization for Scientific Research (NWO).	Ahmad F, 2009, BIOCHEM J, V424, P399, DOI 10.1042/BJ20090842; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Campos-Toimil M, 2007, EUR J PHARMACOL, V577, P91, DOI 10.1016/j.ejphar.2007.08.003; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; El-Mowafy AM, 2003, CARCINOGENESIS, V24, P869, DOI 10.1093/carcin/bgg015; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gevrey JC, 2002, J BIOL CHEM, V277, P22407, DOI 10.1074/jbc.M201624200; Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; MANGANIELLO V, 1973, J BIOL CHEM, V248, P7164; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pereira L, 2007, J PHYSIOL-LONDON, V583, P685, DOI 10.1113/jphysiol.2007.133066; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Pizon V, 1999, EXP CELL RES, V246, P56, DOI 10.1006/excr.1998.4284; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rondinone CM, 2000, J BIOL CHEM, V275, P10093, DOI 10.1074/jbc.275.14.10093; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; SELAWRY H, 1973, BIOCHEM BIOPH RES CO, V51, P198, DOI 10.1016/0006-291X(73)90528-7; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yang L, 2008, EXP NEUROL, V211, P311, DOI 10.1016/j.expneurol.2007.02.010	67	995	1052	25	341	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2012	148	3					421	433		10.1016/j.cell.2012.01.017	http://dx.doi.org/10.1016/j.cell.2012.01.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304913	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000300225000012
J	Ciesla, FJ; Sandford, SA				Ciesla, Fred J.; Sandford, Scott A.			Organic Synthesis via Irradiation and Warming of Ice Grains in the Solar Nebula	SCIENCE			English	Article							PROTOPLANETARY DISKS; CIRCUMSTELLAR DISKS; RESIDENCE TIMES; UV-IRRADIATION; INTERSTELLAR; EVOLUTION; MOLECULES; ANALOGS; PHOTOLYSIS; PARTICLES	Complex organic compounds, including many important to life on Earth, are commonly found in meteoritic and cometary samples, though their origins remain a mystery. We examined whether such molecules could be produced within the solar nebula by tracking the dynamical evolution of ice grains in the nebula and recording the environments to which they were exposed. We found that icy grains originating in the outer disk, where temperatures were less than 30 kelvin, experienced ultraviolet irradiation exposures and thermal warming similar to that which has been shown to produce complex organics in laboratory experiments. These results imply that organic compounds are natural by-products of protoplanetary disk evolution and should be important ingredients in the formation of all planetary systems, including our own.	[Ciesla, Fred J.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60430 USA; [Sandford, Scott A.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	University of Chicago; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Ciesla, FJ (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60430 USA.	fciesla@uchicago.edu			NASA; Astrobiology Institute	NASA(National Aeronautics & Space Administration (NASA)); Astrobiology Institute	F.J.C. and S. A. S. acknowledge funding from NASA's Origins of Solar Systems program. S. A. S. also thanks the Astrobiology Institute for funds.	Adams FC, 2006, ASTROPHYS J, V641, P504, DOI 10.1086/500393; Bernstein MP, 1999, SCIENCE, V283, P1135, DOI 10.1126/science.283.5405.1135; Bernstein MP, 2002, NATURE, V416, P401, DOI 10.1038/416401a; BERNSTEIN MP, 1995, ASTROPHYS J, V454, P327, DOI 10.1086/176485; Bethell TJ, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/78; Caro GMM, 2002, NATURE, V416, P403, DOI 10.1038/416403a; Carr JS, 2008, SCIENCE, V319, P1504, DOI 10.1126/science.1153807; Charnoz S, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/33; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Ciesla FJ, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/9; Ciesla FJ, 2010, ASTROPHYS J, V723, P514, DOI 10.1088/0004-637X/723/1/514; Ciesla FJ, 2006, ICARUS, V181, P178, DOI 10.1016/j.icarus.2005.11.009; HABING HJ, 1968, B ASTRON I NETH, V19, P421; HAGEN W, 1979, ASTROPHYS SPACE SCI, V65, P215, DOI 10.1007/BF00643502; Hartmann L, 1998, ASTROPHYS J, V495, P385, DOI 10.1086/305277; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Nakamura-Messenger K, 2006, SCIENCE, V314, P1439, DOI 10.1126/science.1132175; Nuevo M, 2011, ADV SPACE RES, V48, P1126, DOI 10.1016/j.asr.2011.05.020; Nuth JA, 2008, ASTROPHYS J LETT, V673, pL225, DOI 10.1086/528741; Oberg KI, 2009, ASTROPHYS J, V693, P1209, DOI 10.1088/0004-637X/693/2/1209; Peltzer E T, 1984, Adv Space Res, V4, P69, DOI 10.1016/0273-1177(84)90546-5; Sandford SA, 2001, METEORIT PLANET SCI, V36, P1117, DOI 10.1111/j.1945-5100.2001.tb01948.x; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Sano T, 2000, ASTROPHYS J, V543, P486, DOI 10.1086/317075; SCHUTTE WA, 1992, ADV SPACE RES-SERIES, V12, P47, DOI 10.1016/0273-1177(92)90152-N; Throop HB, 2011, ICARUS, V212, P885, DOI 10.1016/j.icarus.2011.01.002; WEIDENSCHILLING SJ, 1984, ICARUS, V60, P553, DOI 10.1016/0019-1035(84)90164-7; Willacy K, 2007, ASTROPHYS J, V660, P441, DOI 10.1086/512796; Woitke P, 2009, ASTRON ASTROPHYS, V501, P383, DOI 10.1051/0004-6361/200911821; Zhu ZH, 2009, ASTROPHYS J, V694, P1045, DOI 10.1088/0004-637X/694/2/1045	30	136	136	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					452	454		10.1126/science.1217291	http://dx.doi.org/10.1126/science.1217291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22461502	Green Submitted			2022-12-01	WOS:000303233400041
J	Sanada, T; Kim, M; Mimuro, H; Suzuki, M; Ogawa, M; Oyama, A; Ashida, H; Kobayashi, T; Koyama, T; Nagai, S; Shibata, Y; Gohda, J; Inoue, J; Mizushima, T; Sasakawa, C				Sanada, Takahito; Kim, Minsoo; Mimuro, Hitomi; Suzuki, Masato; Ogawa, Michinaga; Oyama, Akiho; Ashida, Hiroshi; Kobayashi, Taira; Koyama, Tomohiro; Nagai, Shinya; Shibata, Yuri; Gohda, Jin; Inoue, Jun-ichiro; Mizushima, Tsunehiro; Sasakawa, Chihiro			The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response	NATURE			English	Article							NF-KAPPA-B; CRYSTAL-STRUCTURES; PROTEIN; KINASE; ACTIVATION; HOST; TRAF6; INVASION; BACTERIA; DOMAIN	Many bacterial pathogens can enter various host cells and then survive intracellularly, transiently evade humoral immunity, and further disseminate to other cells and tissues. When bacteria enter host cells and replicate intracellularly, the host cells sense the invading bacteria as damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs) by way of various pattern recognition receptors. As a result, the host cells induce alarm signals that activate the innate immune system(1). Therefore, bacteria must modulate host inflammatory signalling and dampen these alarm signals(2-4.) How pathogens do this after invading epithelial cells remainsunclear, however. Herewe showthat OspI, a Shigella flexneri effector encoded by ORF169b on the large plasmid and delivered by the type III secretion system, dampens acute inflammatory responses during bacterial invasion by suppressing the tumour-necrosis factor (TNF)-receptor-associated factor 6 (TRAF6)-mediated signalling pathway. OspI is a glutamine deamidase that selectively deamidates the glutamine residue at position 100 in UBC13 to a glutamic acid residue. Consequently, the E2 ubiquitin-conjugating activity required for TRAF6 activation is inhibited, allowing S. flexneri OspI to modulate the diacylglycerolCBM (CARD-BCL10-MALT1) complex-TRAF6-nuclear-factorkB signalling pathway. We determined the 2.0 angstrom crystal structure of OspI, which contains a putative cysteine-histidine-aspartic acid catalytic triad. A mutational analysis showed this catalytic triad to be essential for the deamidation of UBC13. Our results suggest that S. flexneri inhibits acute inflammatory responses in the initial stage of infection by targeting the UBC13-TRAF6 complex.	[Sanada, Takahito; Kim, Minsoo; Sasakawa, Chihiro] Univ Tokyo, Dept Infect Dis Control, Int Res Ctr Infect Dis, Minato Ku, Tokyo 1088639, Japan; [Mimuro, Hitomi] Univ Tokyo, Int Res Ctr Infect Dis, Dept Infect Dis Control, Div Bacteriol,Minato Ku, Tokyo 1088639, Japan; [Suzuki, Masato; Ogawa, Michinaga; Oyama, Akiho; Ashida, Hiroshi; Kobayashi, Taira; Sasakawa, Chihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Bacterial Infect,Minato Ku, Tokyo 1088639, Japan; [Koyama, Tomohiro; Nagai, Shinya; Sasakawa, Chihiro] Nippon Inst Biol Sci, Tokyo 1980024, Japan; [Shibata, Yuri; Gohda, Jin; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Cellular & Mol Biol,Minato Ku, Tokyo 1088639, Japan; [Mizushima, Tsunehiro] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Picobiol Inst, Akoh, Hyogo 6781297, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Hyogo	Sasakawa, C (corresponding author), Univ Tokyo, Dept Infect Dis Control, Int Res Ctr Infect Dis, Minato Ku, Tokyo 1088639, Japan.	mizushi@sci.u-hyogo.ac.jp; sasakawa@ims.u-tokyo.ac.jp	Kobayashi, Taira/GQA-7087-2022; Kobayashi, Taira/AAH-5580-2020; Kobayashi, Taira/B-1149-2014; Suzuki, Masato/B-7568-2013	Kobayashi, Taira/0000-0001-7297-8524; Suzuki, Masato/0000-0001-8975-2193; Ashida, Hiroshi/0000-0003-1408-6864; Mizushima, Tsunehiro/0000-0002-6631-2889; Kim, Minsoo/0000-0001-8536-8653	Japan Initiative for Global Research Network on Infectious Diseases; Naito Foundation; Waksman Foundation of Japan; Yakult Bio-Science Foundation; Yakult Central Institute; Hayashi Memorial Foundation for Female Natural Scientists;  [23121525];  [23000012];  [23689027];  [23790471];  [23790472];  [22790403];  [23390102];  [23659220];  [18073003]; Grants-in-Aid for Scientific Research [22117002] Funding Source: KAKEN	Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Waksman Foundation of Japan(Waksman Foundation of Japan Inc.); Yakult Bio-Science Foundation; Yakult Central Institute; Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); ; ; ; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Fukuda for matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) analysis. We thank the members of the Sasakawa laboratory for their advice. We are grateful to R. Whittier for critical reading of the manuscript. Diffraction data were collected at the Osaka University beamline BL44XU at SPring-8. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (23121525 (T. M.)), a Grant-in-Aid for Specially Promoted Research (23000012 (C. S.)), a Grant-in Aid for Young Scientists (A) (23689027 (M. K.)), several Grants-in-Aid for Young Scientists (B) (23790471 (M.O.), 23790472 (H. A.) and 22790403 (T. S.)), a Grant-in-Aid for Scientific Research (B) (23390102 (H. M.)), a Grant-in-Aid for Challenging Exploratory Research (23659220 (H. M.)), a Grant-in-Aid for Scientific Research on Priority Areas (18073003 (C. S.)) and the Japan Initiative for Global Research Network on Infectious Diseases (C. S.). Part of this work was supported by grants from the Naito Foundation (M. K. and H. M.), the Waksman Foundation of Japan (M.O.), the Yakult Bio-Science Foundation (M.O.), the Yakult Central Institute (C. S.) and The Hayashi Memorial Foundation for Female Natural Scientists (M. K.).	Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buetow L, 2001, NAT STRUCT BIOL, V8, P584, DOI 10.1038/89610; Crow A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005582; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Hilbi H, 2009, CELL HOST MICROBE, V6, P102, DOI 10.1016/j.chom.2009.08.001; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kitadokoro K, 2007, P NATL ACAD SCI USA, V104, P5139, DOI 10.1073/pnas.0608197104; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Mattoo S, 2007, CURR OPIN IMMUNOL, V19, P392, DOI 10.1016/j.coi.2007.06.005; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Morikawa H, 2010, BIOCHEM BIOPH RES CO, V401, P268, DOI 10.1016/j.bbrc.2010.09.048; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; SASAKAWA C, 1986, INFECT IMMUN, V51, P470, DOI 10.1128/IAI.51.2.470-475.1986; SASAKAWA C, 1986, INFECT IMMUN, V54, P32, DOI 10.1128/IAI.54.1.32-36.1986; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YL, 2007, NUCLEIC ACIDS RES, V35, pD298, DOI 10.1093/nar/gkl952; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100	45	121	124	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					623	U149		10.1038/nature10894	http://dx.doi.org/10.1038/nature10894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22407319				2022-12-01	WOS:000302006100044
J	Moynihan, R				Moynihan, Ray			Times like these you need some "One Four Five"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Bradt J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006911.pub2, 10.1002/14651858.CD006911]; Gold C, 2009, CLIN PSYCHOL REV, V29, P193, DOI 10.1016/j.cpr.2009.01.001; Music In Hospitals, 2011, AB MUS HOSP; Procter S, 2011, NORD J MUSIC THER, V20, P242, DOI 10.1080/08098131.2010.489998	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2012	344								e2342	10.1136/bmj.e2342	http://dx.doi.org/10.1136/bmj.e2342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923FF	22457444				2022-12-01	WOS:000302604100006
J	Stouffer, DB; Sales-Pardo, M; Sirer, MI; Bascompte, J				Stouffer, Daniel B.; Sales-Pardo, Marta; Sirer, M. Irmak; Bascompte, Jordi			Evolutionary Conservation of Species' Roles in Food Webs	SCIENCE			English	Article							TROPHIC MODULES; NETWORKS; STABILITY; ARCHITECTURE; PERSISTENCE; COMPLEXITY; LIFE	Studies of ecological networks (the web of interactions between species in a community) demonstrate an intricate link between a community's structure and its long-term viability. It remains unclear, however, how much a community's persistence depends on the identities of the species present, or how much the role played by each species varies as a function of the community in which it is found. We measured species' roles by studying how species are embedded within the overall network and the subsequent dynamic implications. Using data from 32 empirical food webs, we find that species' roles and dynamic importance are inherent species attributes and can be extrapolated across communities on the basis of taxonomic classification alone. Our results illustrate the variability of roles across species and communities and the relative importance of distinct species groups when attempting to conserve ecological communities.	[Stouffer, Daniel B.; Bascompte, Jordi] EBD CSIC, Integrat Ecol Grp, Seville 41092, Spain; [Stouffer, Daniel B.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Sales-Pardo, Marta] Univ Rovira & Virgili, Dept Engn Quim, Tarragona 43007, Spain; [Sirer, M. Irmak] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Canterbury; Universitat Rovira i Virgili; Northwestern University	Stouffer, DB (corresponding author), EBD CSIC, Integrat Ecol Grp, Seville 41092, Spain.		Sales-Pardo, Marta/C-1725-2008; Sirer, Mehmet Irmak/E-1072-2013; Bascompte, Jordi/B-7596-2008; Sales-Pardo, Marta/O-9797-2019; Stouffer, Daniel/C-2223-2008	Sales-Pardo, Marta/0000-0002-8140-6525; Sirer, Mehmet Irmak/0000-0002-0300-5582; Bascompte, Jordi/0000-0002-0108-6411; Sales-Pardo, Marta/0000-0002-8140-6525; Stouffer, Daniel/0000-0001-9436-9674	Ministerio de Ciencia e Innovacion (MICINN), Spain [FIS2010-18639]; James S. McDonnell Foundation; European Union [PIRG-GA-2010-268342]; W. M. Keck Foundation; European Research Council under the European Community [FP7/2007-2013, 268543]	Ministerio de Ciencia e Innovacion (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); James S. McDonnell Foundation; European Union(European Commission); W. M. Keck Foundation(W.M. Keck Foundation); European Research Council under the European Community(European Research Council (ERC))	D.B.S. acknowledges the support of a Consejo Superior de Investigaciones Cientificas-Junta para la Ampliacion de Estudios Postdoctoral Fellowship and a Juan de la Cierva Fellowship from the Ministerio de Ciencia e Innovacion (MICINN), Spain. M. S. P. acknowledges the support of grant FIS2010-18639 from the MICINN, Spain; a Research Award from the James S. McDonnell Foundation; and grant PIRG-GA-2010-268342 from the European Union. M. I. S. acknowledges the support of a W. M. Keck Foundation grant. J.B. acknowledges the support of the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013) through an Advanced Grant (grant agreement 268543). A list of references from which the food web data can be obtained is found in table S1. All figures were generated with PyGrace (http://pygrace.sourceforge.net).	Allesina S, 2008, THEOR ECOL-NETH, V1, P55, DOI 10.1007/s12080-007-0007-8; Allesina S, 2009, ECOL LETT, V12, P652, DOI 10.1111/j.1461-0248.2009.01321.x; Bascompte J, 2005, ECOLOGY, V86, P2868, DOI 10.1890/05-0101; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Eklof A, 2012, P ROY SOC B-BIOL SCI, V279, P1588, DOI 10.1098/rspb.2011.2149; Garcia-Domingo JL, 2008, OIKOS, V117, P336, DOI 10.1111/j.2007.0030-1299.16261.x; Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Kondoh M, 2008, P NATL ACAD SCI USA, V105, P16631, DOI 10.1073/pnas.0805870105; Luczkovich JJ, 2003, J THEOR BIOL, V220, P303, DOI 10.1006/jtbi.2003.3147; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Pascual M., 2006, ECOLOGICAL NETWORKS; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Stouffer DB, 2007, P ROY SOC B-BIOL SCI, V274, P1931, DOI 10.1098/rspb.2007.0571; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Stouffer DB, 2010, ECOL LETT, V13, P154, DOI 10.1111/j.1461-0248.2009.01407.x; Stouffer DB, 2010, FUNCT ECOL, V24, P44, DOI 10.1111/j.1365-2435.2009.01644.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Townsend CR, 1998, ECOL LETT, V1, P200; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004	27	129	131	0	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2012	335	6075					1489	1492		10.1126/science.1216556	http://dx.doi.org/10.1126/science.1216556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22442483	Green Submitted			2022-12-01	WOS:000301837000047
J	Kuzyk, A; Schreiber, R; Fan, ZY; Pardatscher, G; Roller, EM; Hogele, A; Simmel, FC; Govorov, AO; Liedl, T				Kuzyk, Anton; Schreiber, Robert; Fan, Zhiyuan; Pardatscher, Guenther; Roller, Eva-Maria; Hoegele, Alexander; Simmel, Friedrich C.; Govorov, Alexander O.; Liedl, Tim			DNA-based self-assembly of chiral plasmonic nanostructures with tailored optical response	NATURE			English	Article							METAL NANOPARTICLE ASSEMBLIES; CIRCULAR-DICHROISM; SHAPES; SUPERSTRUCTURES; ORIGAMI	Matter structured on a length scale comparable to or smaller than the wavelength of light can exhibit unusual optical properties(1). Particularly promising components for such materials are metal nanostructures, where structural alterations provide a straightforward means of tailoring their surface plasmon resonances and hence their interaction with light(2,3). But the top-down fabrication of plasmonic materials with controlled optical responses in the visible spectral range remains challenging, because lithographic methods are limited in resolution and in their ability to generate genuinely three-dimensional architectures(4,5). Molecular self-assembly(6,7) provides an alternative bottom-up fabrication route not restricted by these limitations, and DNA-and peptide-directed assembly have proved to be viable methods for the controlled arrangement of metal nanoparticles in complex and also chiral geometries(8-14). Here we show that DNA origami(15,16) enables the high-yield production of plasmonic structures that contain nanoparticles arranged in nanometre-scale helices. We find, in agreement with theoretical predictions(17), that the structures in solution exhibit defined circular dichroism and optical rotatory dispersion effects at visible wavelengths that originate from the collective plasmon-plasmon interactions of the nanoparticles positioned with an accuracy better than two nanometres. Circular dichroism effects in the visible part of the spectrum have been achieved by exploiting the chiral morphology of organic molecules and the plasmonic properties of nanoparticles(18-20), or even without precise control over the spatial configuration of the nanoparticles(12,21,22). In contrast, the optical response of our nanoparticle assemblies is rationally designed and tunable in handedness, colour and intensity-in accordance with our theoretical model.	[Schreiber, Robert; Roller, Eva-Maria; Hoegele, Alexander; Liedl, Tim] Univ Munich, Fak Phys, D-80539 Munich, Germany; [Schreiber, Robert; Roller, Eva-Maria; Hoegele, Alexander; Liedl, Tim] Univ Munich, Ctr Nanosci, D-80539 Munich, Germany; [Kuzyk, Anton; Pardatscher, Guenther; Simmel, Friedrich C.] Tech Univ Munich, Phys Dept, D-85748 Garching, Germany; [Kuzyk, Anton; Pardatscher, Guenther; Simmel, Friedrich C.] Tech Univ Munich, ZNN WSI, D-85748 Garching, Germany; [Fan, Zhiyuan; Govorov, Alexander O.] Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA	University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; University System of Ohio; Ohio University	Liedl, T (corresponding author), Univ Munich, Fak Phys, Geschwister Scholl Pl 1, D-80539 Munich, Germany.	tim.liedl@lmu.de	Kuzyk, Anton/D-7317-2011; Fan, Zhiyuan/C-2504-2015; Simmel, Friedrich/G-3281-2010; Fan, Zhiyuan/AAY-1080-2021; Liedl, Tim/O-7539-2014; Hogele, Alexander/C-1080-2016	Kuzyk, Anton/0000-0001-8060-6122; Fan, Zhiyuan/0000-0002-9312-2271; Simmel, Friedrich/0000-0003-3829-3446; Fan, Zhiyuan/0000-0002-9312-2271; Liedl, Tim/0000-0002-0040-0173; Hogele, Alexander/0000-0002-0178-9117	Volkswagen Foundation; DFG Cluster of Excellence NIM (Nanosystems Initiative Munich); NSF (USA)	Volkswagen Foundation(Volkswagen); DFG Cluster of Excellence NIM (Nanosystems Initiative Munich); NSF (USA)(National Science Foundation (NSF))	We thank H. Dietz and G. Acuna for experimental advice and B. Yurke, E. Graugnard, J. O. Radler and J. P. Kotthaus for discussions. We acknowledge J. Buchner and M. Rief for giving us access to their CD spectrometers, E. Herold for help with the CD measurements, and T. Martin and S. Kempter for assistance. We also thank D. M. Smith for carefully reading the manuscript. This work was funded by the Volkswagen Foundation, the DFG Cluster of Excellence NIM (Nanosystems Initiative Munich) and the NSF (USA).	[Anonymous], 2016, NAT REV MATER, DOI DOI 10.1038/natrevmats.2016.21; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Chen CL, 2010, J AM CHEM SOC, V132, P6902, DOI 10.1021/ja102000g; Chen W, 2009, NANO LETT, V9, P2153, DOI 10.1021/nl900726s; Ding BQ, 2010, J AM CHEM SOC, V132, P3248, DOI 10.1021/ja9101198; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Fan JA, 2010, SCIENCE, V328, P1135, DOI 10.1126/science.1187949; Fan ZY, 2011, J PHYS CHEM C, V115, P13254, DOI 10.1021/jp204265x; Fan ZY, 2010, NANO LETT, V10, P2580, DOI 10.1021/nl101231b; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; George J, 2010, J AM CHEM SOC, V132, P2502, DOI 10.1021/ja908574j; Guerrero-Martinez A, 2011, NANO TODAY, V6, P381, DOI 10.1016/j.nantod.2011.06.003; Guerrero-Martinez A, 2011, ANGEW CHEM INT EDIT, V50, P5499, DOI 10.1002/anie.201007536; Halas NJ, 2011, CHEM REV, V111, P3913, DOI 10.1021/cr200061k; Jones MR, 2011, CHEM REV, V111, P3736, DOI 10.1021/cr1004452; Liu YM, 2011, CHEM SOC REV, V40, P2494, DOI 10.1039/c0cs00184h; Mastroianni AJ, 2009, J AM CHEM SOC, V131, P8455, DOI 10.1021/ja808570g; Pendry JB, 2004, SCIENCE, V306, P1353, DOI 10.1126/science.1104467; Pilo-Pais M, 2011, NANO LETT, V11, P3489, DOI 10.1021/nl202066c; Polman A, 2008, SCIENCE, V322, P868, DOI 10.1126/science.1163959; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schaaff TG, 2000, J PHYS CHEM B, V104, P2630, DOI 10.1021/jp993691y; Schreiber R, 2011, SMALL, V7, P1795, DOI 10.1002/smll.201100465; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Sharma J, 2009, SCIENCE, V323, P112, DOI 10.1126/science.1165831; Shemer G, 2006, J AM CHEM SOC, V128, P11006, DOI 10.1021/ja063702i; Soukoulis CM, 2011, NAT PHOTONICS, V5, P523, DOI [10.1038/nphoton.2011.154, 10.1038/NPHOTON.2011.154]; Tan SJ, 2011, NAT NANOTECHNOL, V6, P268, DOI [10.1038/nnano.2011.49, 10.1038/NNANO.2011.49]; Torring T, 2011, CHEM SOC REV, V40, P5636, DOI 10.1039/c1cs15057j; Urzhumov YA, 2007, OPT EXPRESS, V15, P14129, DOI 10.1364/OE.15.014129	30	1516	1544	76	1858	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					311	314		10.1038/nature10889	http://dx.doi.org/10.1038/nature10889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22422265	Green Submitted			2022-12-01	WOS:000301481800044
J	Marin-Burgin, A; Mongiat, LA; Pardi, MB; Schinder, AF				Marin-Burgin, Antonia; Mongiat, Lucas A.; Belen Pardi, M.; Schinder, Alejandro F.			Unique Processing During a Period of High Excitation/Inhibition Balance in Adult-Born Neurons	SCIENCE			English	Article							ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; DENTATE GYRUS; PATTERN SEPARATION; HIPPOCAMPAL NEUROGENESIS; INHIBITION; MEMORY; INTEGRATION; BRAIN; RAT	The adult dentate gyrus generates new granule cells (GCs) that develop over several weeks and integrate into the preexisting network. Although adult hippocampal neurogenesis has been implicated in learning and memory, the specific role of new GCs remains unclear. We examined whether immature adult-born neurons contribute to information encoding. By combining calcium imaging and electrophysiology in acute slices, we found that weak afferent activity recruits few mature GCs while activating a substantial proportion of the immature neurons. These different activation thresholds are dictated by an enhanced excitation/inhibition balance transiently expressed in immature GCs. Immature GCs exhibit low input specificity that switches with time toward a highly specific responsiveness. Therefore, activity patterns entering the dentate gyrus can undergo differential decoding by a heterogeneous population of GCs originated at different times.	[Marin-Burgin, Antonia; Mongiat, Lucas A.; Belen Pardi, M.; Schinder, Alejandro F.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Inst Leloir, Lab Plasticidad Neuronal, RA-1405 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Schinder, AF (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Inst Leloir, Lab Plasticidad Neuronal, Ave Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.	aschinder@leloir.org.ar	Marin-Burgin, Antonia/V-6602-2019; Mongiat, Lucas/GXG-5680-2022	Marin-Burgin, Antonia/0000-0003-0684-9796; Mongiat, Lucas/0000-0003-2643-8062; Schinder, Alejandro/0000-0003-4863-8348	CONICET; National Institutes of Health [FIRCA R03TW008607-01]; Howard Hughes Medical Institute [55005963]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2008, PICT2010]; FOGARTY INTERNATIONAL CENTER [R03TW008607] Funding Source: NIH RePORTER	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	We thank M. Veggetti for technical assistance, S. Ge for the channelrhodopsin-2 viral construct, and B. Aimone, Y. Li, F. Gage, and M. Scanziani for insightful discussions. A.M.B., L.A.M., and A.F.S. are investigators of the National Research Council (CONICET). M.B.P. was supported by a CONICET fellowship. This work was supported by the Guggenheim Fellowship and by grants from the National Institutes of Health (FIRCA R03TW008607-01), the Howard Hughes Medical Institute (grant 55005963), and the Agencia Nacional de Promocion Cientifica y Tecnologica PICT2008 to A.F.S. and PICT2010 to A.M.B. and A.F.S.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; BUZSAKI G, 1981, BRAIN RES, V230, P346, DOI 10.1016/0006-8993(81)90413-3; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ewell LA, 2010, J NEUROSCI, V30, P12597, DOI 10.1523/JNEUROSCI.1854-10.2010; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Lacefield CO, 2012, HIPPOCAMPUS, V22, P106, DOI 10.1002/hipo.20860; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Markwardt SJ, 2009, J NEUROSCI, V29, P15063, DOI 10.1523/JNEUROSCI.2727-09.2009; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A	32	249	254	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2012	335	6073					1238	1242		10.1126/science.1214956	http://dx.doi.org/10.1126/science.1214956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22282476	Green Accepted			2022-12-01	WOS:000301225100049
J	Allesina, S; Tang, S				Allesina, Stefano; Tang, Si			Stability criteria for complex ecosystems	NATURE			English	Article							FOOD WEBS; ECOLOGICAL COMMUNITIES; MUTUALISTIC NETWORKS; INTERACTION STRENGTH; BIODIVERSITY; ARCHITECTURE; DIVERSITY; MATRICES; MODELS	Forty years ago, May proved(1,2) that sufficiently large or complex ecological networks have a probability of persisting that is close to zero, contrary to previous expectations(3-5). May analysed large networks in which species interact at random(1,2,6). However, in natural systems pairs of species have well-defined interactions (for example predator-prey, mutualistic or competitive). Here we extend May's results to these relationships and find remarkable differences between predator-prey interactions, which are stabilizing, and mutualistic and competitive interactions, which are destabilizing. We provide analytic stability criteria for all cases. We use the criteria to prove that, counterintuitively, the probability of stability for predator-prey networks decreases when a realistic food web structure is imposed(7,8) or if there is a large preponderance of weak interactions(9,10). Similarly, stability is negatively affected by nestedness(11-14) in bipartite mutualistic networks. These results are found by separating the contribution of network structure and interaction strengths to stability. Stable predator-prey networks can be arbitrarily large and complex, provided that predator-prey pairs are tightly coupled. The stability criteria are widely applicable, because they hold for any system of differential equations.	[Allesina, Stefano; Tang, Si] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Allesina, Stefano] Univ Chicago, Computat Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Allesina, S (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	sallesina@uchicago.edu	Allesina, Stefano/A-2255-2009; Tang, Si/D-6633-2018	Tang, Si/0000-0002-1050-8604; Allesina, Stefano/0000-0003-0313-8374	National Science Foundation [EF0827493]; Direct For Biological Sciences [0827493] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Bergelson, L.-F. Bersier, A. M. de Roos, A. Eklof, C. A. Klausmeier, S. P. Lalley, R. M. May, K. S. McCann, M. Novak, P.P.A. Staniczenko and J. D. Yeakel for comments and discussion. This researchwas supported by National Science Foundation grant EF0827493.	Allesina S, 2008, THEOR ECOL-NETH, V1, P55, DOI 10.1007/s12080-007-0007-8; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Cohen J. E., 1990, COMMUNITY FOODWEBS D; DEANGELIS DL, 1987, ECOL MONOGR, V57, P1, DOI 10.2307/1942636; Elton C. S., 2001, ANIMAL ECOLOGY; Emmerson M, 2004, P ROY SOC B-BIOL SCI, V271, P397, DOI 10.1098/rspb.2003.2592; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Kokkoris GD, 2002, J ANIM ECOL, V71, P362, DOI 10.1046/j.1365-2656.2002.00604.x; LEVINS RICHARD, 1968; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; May RM, 2001, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MCNAUGHTON SJ, 1978, NATURE, V274, P251, DOI 10.1038/274251a0; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; SOMMERS HJ, 1988, PHYS REV LETT, V60, P1895, DOI 10.1103/PhysRevLett.60.1895; Tao T, 2010, ANN PROBAB, V38, P2023, DOI 10.1214/10-AOP534; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535; YODZIS P, 1981, NATURE, V289, P674, DOI 10.1038/289674a0	24	659	666	30	505	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2012	483	7388					205	208		10.1038/nature10832	http://dx.doi.org/10.1038/nature10832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22343894	Green Submitted			2022-12-01	WOS:000301174900037
J	Yu, TY; Chang, TC				Yu, Tse-Ya; Chang, Tien-Chun			Lingual Thyroid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yu, Tse-Ya; Chang, Tien-Chun] Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital	Yu, TY (corresponding author), Natl Taiwan Univ Hosp, Taipei, Taiwan.	tienchunchang@ntu.edu.tw		Chang, Tien-Chun/0000-0003-3385-2026					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2012	366	10					E15	E15		10.1056/NEJMicm1112306	http://dx.doi.org/10.1056/NEJMicm1112306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904CY	22397674				2022-12-01	WOS:000301172500012
J	Huybrechts, KF; Gerhard, T; Crystal, S; Olfson, M; Avorn, J; Levin, R; Lucas, JA; Schneeweiss, S				Huybrechts, K. F.; Gerhard, T.; Crystal, S.; Olfson, M.; Avorn, J.; Levin, R.; Lucas, J. A.; Schneeweiss, S.			Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							ATYPICAL ANTIPSYCHOTICS; BEHAVIORAL SYMPTOMS; ALZHEIMERS-DISEASE; MEDICATION USE; ELDERLY USERS; DEMENTIA; MORTALITY; ADULTS; ADJUSTMENT; EFFICACY	Objective To assess risks of mortality associated with use of individual antipsychotic drugs in elderly residents in nursing homes. Design Population based cohort study with linked data from Medicaid, Medicare, the Minimum Data Set, the National Death Index, and a national assessment of nursing home quality. Setting Nursing homes in the United States. Participants 75 445 new users of antipsychotic drugs (haloperidol, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone). All participants were aged >= 65, were eligible for Medicaid, and lived in a nursing home in 2001-5. Main outcome measures Cox proportional hazards models were used to compare 180 day risks of all cause and cause specific mortality by individual drug, with propensity score adjustment to control for potential confounders. Results Compared with risperidone, users of haloperidol had an increased risk of mortality (hazard ratio 2.07, 95% confidence interval 1.89 to 2.26) and users of quetiapine a decreased risk (0.81, 0.75 to 0.88). The effects were strongest shortly after the start of treatment, remained after adjustment for dose, and were seen for all causes of death examined. No clinically meaningful differences were observed for the other drugs. There was no evidence that the effect measure modification in those with dementia or behavioural disturbances. There was a dose-response relation for all drugs except quetiapine. Conclusions Though these findings cannot prove causality, and we cannot rule out the possibility of residual confounding, they provide more evidence of the risk of using these drugs in older patients, reinforcing the concept that they should not be used in the absence of clear need. The data suggest that the risk of mortality with these drugs is generally increased with higher doses and seems to be highest for haloperidol and least for quetiapine.	[Huybrechts, K. F.; Avorn, J.; Levin, R.; Schneeweiss, S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Huybrechts, K. F.; Avorn, J.; Levin, R.; Schneeweiss, S.] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Gerhard, T.; Crystal, S.] Rutgers State Univ, Ernest Mario Sch Pharm, New Brunswick, NJ 08901 USA; [Olfson, M.] Columbia Univ, New York, NY 10032 USA; [Lucas, J. A.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08901 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Columbia University; Rutgers State University New Brunswick	Huybrechts, KF (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA.	khuybrechts@partners.org	Schneeweiss, Sebastian/C-2125-2013; Olfson, Mark/AAA-8547-2021	Schneeweiss, Sebastian/0000-0003-2575-467X; Gerhard, Tobias/0000-0002-8598-5771	AHRQ/FDA [HS017918]; AHRQ [HS016097]; National Institute of Mental Health [R01-MH078708]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016097] Funding Source: NIH RePORTER	AHRQ/FDA; AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by AHRQ/FDA Award HS017918 and AHRQ Award HS016097. KFH and SS were partially funded by National Institute of Mental Health R01-MH078708. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Alexopoulos GS, 2004, J CLIN PSYCHIAT, V65, P5; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Atkins M, 1997, PSYCHIAT B, V21, P224, DOI [10.1192/pb.21.4.224, DOI 10.1192/PB.21.4.224]; Avorn J, 2005, CLIN GERIATRIC PSYCH, P23; Beck CK, 1998, AM J GERIAT PSYCHIAT, V6, pS41, DOI 10.1097/00019442-199821001-00006; BEERS M, 1988, JAMA-J AM MED ASSOC, V260, P3016, DOI 10.1001/jama.260.20.3016; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Briesacher BA, 2005, ARCH INTERN MED, V165, P1280, DOI 10.1001/archinte.165.11.1280; Bronskill SE, 2004, J AM GERIATR SOC, V52, P749, DOI 10.1111/j.1532-5415.2004.52212.x; Camp CJ, 2002, PSYCHIATR SERV, V53, P1397, DOI 10.1176/appi.ps.53.11.1397; Chan YC, 1999, PHARMACOTHERAPY, V19, P811, DOI 10.1592/phco.19.10.811.31560; Chen Y, 2010, ARCH INTERN MED, V170, P89, DOI 10.1001/archinternmed.2009.469; Cummings JL, 2005, CNS SPECTRUMS, V10, P22, DOI 10.1017/S1092852900014206; Department of Health and Human Services Office of the Inspector General, 2011, MED AT ANT DRUG CLAI; FDA, 2011, INF HEALTHC PROF ANT; *FDA PUBL HLTH ADV, 2010, DEATHS ANT ELD PAT B; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Huybrechts KF, 2011, AM J EPIDEMIOL, V174, P1089, DOI 10.1093/aje/kwr213; Huybrechts KF, 2011, CAN MED ASSOC J, V183, pE411, DOI 10.1503/cmaj.101406; Jeste DV, 2008, NEUROPSYCHOPHARMACOL, V33, P957, DOI 10.1038/sj.npp.1301492; Lawlor BA, 2004, J CLIN PSYCHIAT, V65, P5; Lehman AF, 1998, SCHIZOPHRENIA BULL, V24, P1; Liperoti R, 2003, J CLIN PSYCHIAT, V64, P1106, DOI 10.4088/JCP.v64n0918; Liperoti R, 2009, J CLIN PSYCHIAT, V70, P1340, DOI 10.4088/JCP.08m04597yel; Maher AR, 2011, JAMA-J AM MED ASSOC, V306, P1359, DOI 10.1001/jama.2011.1360; Maixner SM, 1999, J CLIN PSYCHIAT, V60, P29; Patorno E, 2010, JAMA-J AM MED ASSOC, V303, P1401, DOI 10.1001/jama.2010.410; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; RAY WA, 1980, AM J PUBLIC HEALTH, V70, P485, DOI 10.2105/AJPH.70.5.485; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rochon PA, 2007, ARCH INTERN MED, V167, P676, DOI 10.1001/archinte.167.7.676; Rossom RC, 2010, J AM GERIATR SOC, V58, P1027, DOI 10.1111/j.1532-5415.2010.02873.x; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneeweiss S, 2007, CAN MED ASSOC J, V176, P627, DOI 10.1503/cmaj.061250; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Schneeweiss S, 2009, EPIDEMIOLOGY, V20, P512, DOI 10.1097/EDE.0b013e3181a663cc; Sesso HD, 2006, CONTEMP CLIN TRIALS, V27, P333, DOI 10.1016/j.cct.2005.11.007; Setoguchi S, 2008, J AM GERIATR SOC, V56, P1644, DOI 10.1111/j.1532-5415.2008.01839.x; Snowden M, 2003, J AM GERIATR SOC, V51, P1305, DOI 10.1046/j.1532-5415.2003.51417.x; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Tariot PN, 1999, J CLIN PSYCHIAT, V60, P29; Wang PS, 2006, CURR NEUROL NEUROSCI, V6, P490, DOI 10.1007/s11910-006-0051-6; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607	45	169	174	0	28	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2012	344								e977	10.1136/bmj.e977	http://dx.doi.org/10.1136/bmj.e977			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900JY	22362541	Green Published, Green Submitted, hybrid			2022-12-01	WOS:000300884400010
J	Mousley, CJ; Yuan, PH; Gaur, NA; Trettin, KD; Nile, AH; Deminoff, SJ; Dewar, BJ; Wolpert, M; Macdonald, JM; Herman, PK; Hinnebusch, AG; Bankaitis, VA				Mousley, Carl J.; Yuan, Peihua; Gaur, Naseem A.; Trettin, Kyle D.; Nile, Aaron H.; Deminoff, Stephen J.; Dewar, Brian J.; Wolpert, Max; Macdonald, Jeffrey M.; Herman, Paul K.; Hinnebusch, Alan G.; Bankaitis, Vytas A.			A Sterol-Binding Protein Integrates Endosomal Lipid Metabolism with TOR Signaling and Nitrogen Sensing	CELL			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GOLGI-APPARATUS; COMPLEX; TRANSPORT; PATHWAY; GCN4; TRANSCRIPTION; TRAFFICKING; TRANSLATION; HOMEOSTASIS	Kes1, and other oxysterol-binding protein superfamily members, are involved in membrane and lipid trafficking through trans-Golgi network (TGN) and endosomal systems. We demonstrate that Kes1 represents a sterol-regulated antagonist of TGN/endosomal phosphatidylinositol-4-phosphate signaling. This regulation modulates TOR activation by amino acids and dampens gene expression driven by Gcn4, the primary transcriptional activator of the general amino acid control regulon. Kes1-mediated repression of Gcn4 transcription factor activity is characterized by nonproductive Gcn4 binding to its target sequences, involves TGN/endosome-derived sphingolipid signaling, and requires activity of the cyclin-dependent kinase 8 (CDK8) module of the enigmatic "large Mediator'' complex. These data describe a pathway by which Kes1 integrates lipid metabolism with TORC1 signaling and nitrogen sensing.	[Mousley, Carl J.; Yuan, Peihua; Trettin, Kyle D.; Nile, Aaron H.; Wolpert, Max; Bankaitis, Vytas A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Gaur, Naseem A.; Hinnebusch, Alan G.] Eugene Shriver Natl Inst Child Hlth & Human Dev, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Deminoff, Stephen J.; Herman, Paul K.] Ohio State Univ, Dept Mol Genet & Microbiol, Columbus, OH 43210 USA; [Dewar, Brian J.; Macdonald, Jeffrey M.] Univ N Carolina, Dept Biomed Engn, Sch Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Mousley, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	mousley@email.unc.edu; vytas@med.unc.edu	Yuan, Peihua/G-9088-2013	Yuan, Peihua/0000-0002-4633-0692; Mousley, Carl/0000-0002-0192-7030; Gaur, Naseem/0000-0002-1224-8789; Nile, Aaron/0000-0002-7370-8769	NIH [GM44530, GM65227]; NIEHS [T32EX007126, GM075941]; UNC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044530, R01GM065227, R21GM075941] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); UNC(Secretaria de Ciencia y Tecnologia (SECYT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This paper is dedicated to the memories of Christian Raetz and Eugene Kennedy. The work was supported by NIH grant GM44530 to V.A.B.; N.G. and A.G.H. were supported by the Intramural Research Program of the NIH; S.J.D. and P.K.H. by NIH grant GM65227 awarded to P.K.H.; and B.J.D. and J.M.M. by NIEHS T32EX007126 and GM075941. K.D.T. acknowledges support from the UNC William W. and Ida W. Taylor Honors Mentored Research Fellows Program. We thank Doug Cyr, Scott Moye Rowley, Chris Burd, and Dan Klionsky for strains and plasmids, Colin Stirling for CPY antibody, Chris Stefan, Scott Emr, and Maria Cardenas for discussions, and Lora Yanagisawa, Victoria Hewitt, and Robert Sons for comments on the manuscript. We acknowledge the UNC Lineberger Comprehensive Cancer Center Genome Analysis and Nucleic Acids Core facilities.	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Chen H, 2009, PROTEIN PEPTIDE LETT, V16, P450, DOI 10.2174/092986609787848036; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Dewar BJ, 2010, METABOLOMICS, V6, P439, DOI 10.1007/s11306-010-0204-0; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fang M, 1996, EMBO J, V15, P6447, DOI 10.1002/j.1460-2075.1996.tb01036.x; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Grundmann O, 2001, J BIOL CHEM, V276, P25661, DOI 10.1074/jbc.M101068200; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Mousley CJ, 2008, MOL BIOL CELL, V19, P4785, DOI 10.1091/mbc.E08-04-0426; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schulz T. A., 2009, BIOCHIM BIOPHYS ACTA, V1771, P769; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhang F, 2008, MOL CELL BIOL, V28, P6796, DOI 10.1128/MCB.00800-08	38	70	73	1	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					702	715		10.1016/j.cell.2011.12.026	http://dx.doi.org/10.1016/j.cell.2011.12.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341443	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000300622400012
J	Baker, M				Baker, Monya			THE CHANGES THAT COUNT	NATURE			English	Editorial Material							SELECTION											Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Lin MF, 2011, GENOME RES, V21, P1916, DOI 10.1101/gr.108753.110; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Rope AF, 2011, AM J HUM GENET, V89, P28, DOI 10.1016/j.ajhg.2011.05.017; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111	14	14	14	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2012	482	7384					257	262		10.1038/482257a	http://dx.doi.org/10.1038/482257a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	888HI	22318607				2022-12-01	WOS:000299994100046
J	Henao-Mejia, J; Elinav, E; Jin, CC; Hao, LM; Mehal, WZ; Strowig, T; Thaiss, CA; Kau, AL; Eisenbarth, SC; Jurczak, MJ; Camporez, JP; Shulman, GI; Gordon, JI; Hoffman, HM; Flavell, RA				Henao-Mejia, Jorge; Elinav, Eran; Jin, Chengcheng; Hao, Liming; Mehal, Wajahat Z.; Strowig, Till; Thaiss, Christoph A.; Kau, Andrew L.; Eisenbarth, Stephanie C.; Jurczak, Michael J.; Camporez, Joao-Paulo; Shulman, Gerald I.; Gordon, Jeffrey I.; Hoffman, Hal M.; Flavell, Richard A.			Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity	NATURE			English	Article							NONALCOHOLIC FATTY LIVER; NLRP3 INFLAMMASOME; ANIMAL-MODELS; STEATOHEPATITIS; ACTIVATION; MECHANISM; CIRRHOSIS	Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease in the Western world. Twenty per cent of NAFLD individuals develop chronic hepatic inflammation (non-alcoholic steatohepatitis, NASH) associated with cirrhosis, portal hypertension and hepatocellular carcinoma, yet the causes of progression from NAFLD to NASH remain obscure. Here, we show that the NLRP6 and NLRP3 inflammasomes and the effector protein IL-18 negatively regulate NAFLD/NASH progression, as well as multiple aspects of metabolic syndrome via modulation of the gut microbiota. Different mouse models reveal that inflammasome-deficiency-associated changes in the configuration of the gut microbiota are associated with exacerbated hepatic steatosis and inflammation through influx of TLR4 and TLR9 agonists into the portal circulation, leading to enhanced hepatic tumour-necrosis factor (TNF)-alpha expression that drives NASH progression. Furthermore, co-housing of inflammasome-deficient mice with wild-type mice results in exacerbation of hepatic steatosis and obesity. Thus, altered interactions between the gut microbiota and the host, produced by defective NLRP3 and NLRP6 inflammasome sensing, may govern the rate of progression of multiple metabolic syndrome-associated abnormalities, highlighting the central role of the microbiota in the pathogenesis of heretofore seemingly unrelated systemic auto-inflammatory and metabolic disorders.	[Henao-Mejia, Jorge; Elinav, Eran; Jin, Chengcheng; Strowig, Till; Thaiss, Christoph A.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Jin, Chengcheng] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Hao, Liming] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Mehal, Wajahat Z.; Jurczak, Michael J.; Camporez, Joao-Paulo; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Kau, Andrew L.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Kau, Andrew L.] Washington Univ, Sch Med, Dept Internal Med, Div Allergy & Immunol, St Louis, MO 63108 USA; [Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Shulman, Gerald I.; Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Hoffman, Hal M.] Univ Calif San Diego, Dept Pediat, Rady Childrens Hosp San Diego, La Jolla, CA 92093 USA	Yale University; Yale University; Yale University; Yale University; Washington University (WUSTL); Washington University (WUSTL); Yale University; Howard Hughes Medical Institute; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Elinav, Eran/ABE-8881-2020; Shulman, Gerald I./P-7176-2019; Kau, Andrew/AGX-9881-2022; Camporez, Joao Paulo G/B-9122-2015	Elinav, Eran/0000-0002-5775-2110; Shulman, Gerald I./0000-0003-1529-5668; Strowig, Till/0000-0003-0185-1459; Jurczak, Michael/0000-0002-6335-6915; Kau, Andrew/0000-0002-9386-3766; Jin, Chengcheng/0000-0001-9207-3191; Camporez, Joao Paulo/0000-0003-3486-4301; Eisenbarth, Stephanie/0000-0002-1244-208X	Cancer Research Institute; Israel-US educational foundation; American Physicians for Medicine in Israel Foundation; Leukemia and Lymphoma Society; VA Merit award; Howard Hughes Medical Institute; United States-Israel binational Foundation; Crohn's and Colitis Foundation of America;  [T32HL007974];  [K08A1085038];  [R01DK076674-01];  [R01 DK-40936];  [R24 DK-085638];  [P30 DK-45735];  [U24 DK-059635]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, R24DK085638, R01DK076674, U24DK059635, P30DK045735] Funding Source: NIH RePORTER	Cancer Research Institute; Israel-US educational foundation(US-Israel Binational Science Foundation); American Physicians for Medicine in Israel Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); VA Merit award(US Department of Veterans Affairs); Howard Hughes Medical Institute(Howard Hughes Medical Institute); United States-Israel binational Foundation(US-Israel Binational Science Foundation); Crohn's and Colitis Foundation of America; ; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Eynon, J. Alderman, A. Williams, F. Manzo and H. Elinav for technical assistance and discussions; M. Graham and C. Rahner for performing electron microscopy; D. R. Peaper for assistance in microbiological culture procedures; R. Sherwin for helpful advice; X. Fan for technical assistance; Yale Diabetes Endocrinology Research Center and Mouse Metabolic Phenotyping Center for assistance with the metabolic analysis. E. E. is supported by the Cancer Research Institute (2010-2012) and by a supplementary grant from the Israel-US educational foundation (2009) and is a recipient of the Claire and Emmanuel G. Rosenblatt award from the American Physicians for Medicine in Israel Foundation (2010-2011). J. H. M. and T. S. are supported by Leukemia and Lymphoma Society Postdoctoral Fellowships. S. C. E. is supported by T32HL007974 and K08A1085038. W.Z.M. is supported by R01DK076674-01 and the VA Merit award. This work was supported in part by the Howard Hughes Medical Institute (G. I. S., R. A. F.), the United States-Israel binational Foundation grant (E. E. and R. A. F.), the Crohn's and Colitis Foundation of America (A. K. and J. I. G.) and R01 DK-40936, R24 DK-085638, P30 DK-45735 and U24 DK-059635 The authors report no conflict of interest.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Almeida J, 2006, WORLD J GASTROENTERO, V12, P1493, DOI 10.3748/wjg.v12.i10.1493; Bajaj J. S., 2011, AJP GASTROINTESTINAL, V302, P168; BROOME U, 1990, GUT, V31, P468, DOI 10.1136/gut.31.4.468; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlton M, 2008, HEPATOLOGY, V47, P1431, DOI 10.1002/hep.22246; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Diehl AM, 2005, HEPATOL RES, V33, P138, DOI 10.1016/j.hepres.2005.09.022; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; Guo X, 2011, MUCOSAL IMMUNOL, V4, P294, DOI 10.1038/mi.2010.76; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hjelkrem M C, 2008, Minerva Med, V99, P583; Ikejima K, 2005, HEPATOL RES, V33, P151, DOI 10.1016/j.hepres.2005.09.024; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Makiura N, 2008, ORAL MICROBIOL IMMUN, V23, P348, DOI 10.1111/j.1399-302X.2007.00426.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; PROPST A, 1995, GASTROENTEROLOGY, V108, P1607, DOI 10.1016/0016-5085(95)90724-6; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Shimada M, 2002, J HEPATOL, V37, P154, DOI 10.1016/S0168-8278(02)00099-5; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Sutterwala FS, 2007, J LEUKOCYTE BIOL, V82, P259, DOI 10.1189/jlb.1206755; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Varela-Rey M, 2009, INT J BIOCHEM CELL B, V41, P969, DOI 10.1016/j.biocel.2008.10.027; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	41	1572	1683	23	689	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2012	482	7384					179	U67		10.1038/nature10809	http://dx.doi.org/10.1038/nature10809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888HI	22297845	Green Accepted			2022-12-01	WOS:000299994100030
J	Cease, AJ; Elser, JJ; Ford, CF; Hao, SG; Kang, L; Harrison, JF				Cease, Arianne J.; Elser, James J.; Ford, Colleen F.; Hao, Shuguang; Kang, Le; Harrison, Jon F.			Heavy Livestock Grazing Promotes Locust Outbreaks by Lowering Plant Nitrogen Content	SCIENCE			English	Article							INSECT HERBIVORE; GRASSLAND ECOSYSTEMS; FOOD SELECTION; LIFE-SPAN; CHINA; GEOMETRY; GRASSHOPPERS; REPRODUCTION; DEGRADATION; LIMITATION	Current paradigms generally assume that increased plant nitrogen (N) should enhance herbivore performance by relieving protein limitation, increasing herbivorous insect populations. We show, in contrast to this scenario, that host plant N enrichment and high-protein artificial diets decreased the size and viability of Oedaleus asiaticus, a dominant locust of north Asian grasslands. This locust preferred plants with low N content and artificial diets with low protein and high carbohydrate content. Plant N content was lowest and locust abundance highest in heavily livestock-grazed fields where soils were N-depleted, likely due to enhanced erosion. These results suggest that heavy livestock grazing and consequent steppe degradation in the Eurasian grassland promote outbreaks of this locust by reducing plant protein content.	[Cease, Arianne J.; Elser, James J.; Ford, Colleen F.; Harrison, Jon F.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Hao, Shuguang; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Pest Management, Beijing, Peoples R China	Arizona State University; Arizona State University-Tempe; Chinese Academy of Sciences; Institute of Zoology, CAS	Cease, AJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	arianne.cease@asu.edu; james.elser@asu.edu; lkang@ioz.ac.cn; jon.harrison@asu.edu	Elser, James/A-7082-2008; Kang, Le/ABD-1116-2022; Elser, James J/AAL-6199-2020; Cease, Arianne/F-9954-2014	Elser, James/0000-0002-1460-2155; Kang, Le/0000-0003-4262-2329; Elser, James J/0000-0002-1460-2155; Cease, Arianne/0000-0002-4778-0775	National Science Foundation (EAPSI, DDEP) [DEB-0925017, EAR-0746352]; Sigma Xi; Marley-Webb Foundation; Johnston Foundation; P.E.O.; Chinese Research Grants of Public Welfare Fund for Agriculture [200903021]; Foundation of Chinese Academy of Sciences [Kscx2-yw-z-1021]	National Science Foundation (EAPSI, DDEP); Sigma Xi; Marley-Webb Foundation; Johnston Foundation; P.E.O.; Chinese Research Grants of Public Welfare Fund for Agriculture; Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors thank F. Jin, D. Niren, D. Flynn, Y. Kong, Z. Fan, J. Esman, Q. Chen, and G. Zhang for field and laboratory assistance; M. Quinlan, D. Denardo, J. VandenBrooks, C. Klok, S. Behmer, and J. Sabo for helpful discussion of experimental design; J. Wu for funding and scientific support; and M. McCrackin, F. Clissold, and three anonymous reviewers for valuable comments on the manuscript. This work was supported by the National Science Foundation (EAPSI, DDEP to A. J. C., DEB-0925017 to J. J. E., and EAR-0746352 to J. F. H.), Sigma Xi, Achievement Rewards for College Scientists (Marley-Webb and Johnston Foundations), P.E.O. Scholar Award to A. J. C., the Chinese Research Grants of Public Welfare Fund for Agriculture (Project 200903021), and the Foundation of Chinese Academy of Sciences (Project Kscx2-yw-z-1021). A. J. C. designed and performed experiments, analyzed data, and wrote the paper. J. J. E. and J. F. H. designed experiments and wrote the paper. C. F. F. and S. H. designed and performed experiments. L. K. gave scientific support and guidance. Data used in the analyses are available in the Supporting Online Material.	Behmer ST, 2008, P NATL ACAD SCI USA, V105, P1977, DOI 10.1073/pnas.0711870105; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; BERNAYS EA, 1983, NITROGEN ECOLOGICAL, P321; Berner D, 2005, OIKOS, V111, P525, DOI 10.1111/j.1600-0706.2005.14144.x; Branson DH, 2006, BIOSCIENCE, V56, P743, DOI 10.1641/0006-3568(2006)56[743:SMOIHI]2.0.CO;2; Cease AJ, 2010, J INSECT PHYSIOL, V56, P926, DOI 10.1016/j.jinsphys.2010.05.020; Chen Z., 2000, TYPICAL STEPPE ECOSY; Clissold FJ, 2006, J ANIM ECOL, V75, P1000, DOI 10.1111/j.1365-2656.2006.01122.x; Clissold FJ, 2009, ECOLOGY, V90, P3393, DOI 10.1890/09-0130.1; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Flynn D. F. B., 2011, THESIS COLUMBIA U NE; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Han JG, 2008, RANGELAND J, V30, P233, DOI 10.1071/RJ08009; [IFA IFDC FAO], 2006, FERT US CROP; Joern A, 1997, OECOLOGIA, V112, P201, DOI 10.1007/s004420050301; Kang L., 1995, INSECT SCI, V2, P265; Kang L, 2007, PHILOS T R SOC B, V362, P997, DOI 10.1098/rstb.2007.2029; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; Raubenheimer D, 2003, J EXP BIOL, V206, P1669, DOI 10.1242/jeb.00336; Raubenheimer D, 1999, ENTOMOL EXP APPL, V91, P67, DOI 10.1023/A:1003682921131; RAUBENHEIMER D, 1993, ANIM BEHAV, V45, P953, DOI 10.1006/anbe.1993.1114; SIMPSON SJ, 1993, PHILOS T R SOC B, V342, P381, DOI 10.1098/rstb.1993.0166; Simpson SJ, 2009, AGING-US, V1, P875, DOI 10.18632/aging.100098; Song Huaiming, 2011, P IEEE INT C COMM KY, P1, DOI [DOI 10.1145/2063384.2063407, 10.1145/2063384.2063407]; Tong C, 2004, J ARID ENVIRON, V59, P133, DOI 10.1016/j.jaridenv.2004.01.004; White T.C., 1993, INADEQUATE ENV NITRO; Wu J., 2002, B ECOL SOC AM, V83, P189, DOI DOI 10.1890/0012-9623(2002)083; Wu L, 2008, J ENVIRON QUAL, V37, P663, DOI 10.2134/jeq2007.0196	30	146	182	12	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2012	335	6067					467	469		10.1126/science.1214433	http://dx.doi.org/10.1126/science.1214433			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22282812				2022-12-01	WOS:000299466800050
J	Levin, AM; Bates, DL; Ring, AM; Krieg, C; Lin, JT; Su, L; Moraga, I; Raeber, ME; Bowman, GR; Novick, P; Pande, VS; Fathman, CG; Boyman, O; Garcia, KC				Levin, Aron M.; Bates, Darren L.; Ring, Aaron M.; Krieg, Carsten; Lin, Jack T.; Su, Leon; Moraga, Ignacio; Raeber, Miro E.; Bowman, Gregory R.; Novick, Paul; Pande, Vijay S.; Fathman, C. Garrison; Boyman, Onur; Garcia, K. Christopher			Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'	NATURE			English	Article							SELECTIVE STIMULATION; MOLECULAR-CLONING; ALPHA-RECEPTOR; EXPRESSION; COMPLEXES; PROTEINS; DYNAMICS; KINETICS; CHAIN	The immunostimulatory cytokine interleukin-2 (IL-2) is a growth factor for a wide range of leukocytes, including T cells and natural killer (NK) cells(1-3). Considerable effort has been invested in using IL-2 as a therapeutic agent for a variety of immune disorders ranging from AIDS to cancer. However, adverse effects have limited its use in the clinic. On activated T cells, IL-2 signals through a quaternary 'high affinity' receptor complex consisting of IL-2, IL-2R alpha (termed CD25), IL-2R beta and IL-2R gamma(4-8). Naive T cells express only a low density of IL-2R beta and IL-2R gamma, and are therefore relatively insensitive to IL-2, but acquire sensitivity after CD25 expression, which captures the cytokine and presents it to IL-2R beta and IL-2R gamma. Here, using in vitro evolution, we eliminated the functional requirement of IL-2 for CD25 expression by engineering an IL-2 'superkine' (also called super-2) with increased binding affinity for IL-2R beta. Crystal structures of the IL-2 superkine in free and receptor-bound forms showed that the evolved mutations are principally in the core of the cytokine, and molecular dynamics simulations indicated that the evolved mutations stabilized IL-2, reducing the flexibility of a helix in the IL-2R beta binding site, into an optimized receptor-binding conformation resembling that when bound to CD25. The evolved mutations in the IL-2 superkine recapitulated the functional role of CD25 by eliciting potent phosphorylation of STAT5 and vigorous proliferation of T cells irrespective of CD25 expression. Compared to IL-2, the IL-2 superkine induced superior expansion of cytotoxic T cells, leading to improved antitumour responses in vivo, and elicited proportionally less expansion of T regulatory cells and reduced pulmonary oedema. Collectively, we show that in vitro evolution has mimicked the functional role of CD25 in enhancing IL-2 potency and regulating target cell specificity, which has implications for immunotherapy.	[Levin, Aron M.; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Bates, Darren L.; Ring, Aaron M.; Moraga, Ignacio; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Bates, Darren L.; Ring, Aaron M.; Moraga, Ignacio; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Krieg, Carsten; Raeber, Miro E.; Boyman, Onur] Univ Zurich, Lab Appl Immunobiol, CH-8006 Zurich, Switzerland; [Krieg, Carsten; Raeber, Miro E.; Boyman, Onur] Univ Zurich Hosp, Allergy Unit, Dept Dermatol, CH-8091 Zurich, Switzerland; [Lin, Jack T.; Su, Leon; Fathman, C. Garrison] Stanford Univ, Sch Med, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Bowman, Gregory R.; Novick, Paul; Pande, Vijay S.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of Zurich; University of Zurich; University Zurich Hospital; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	onur.boyman@uzh.ch; kcgarcia@stanford.edu	Raeber, Miro E/J-7626-2012; Pande, Vijay/ABE-8145-2020; Krieg, Carsten/ABA-6734-2020	Raeber, Miro E/0000-0003-2609-0246; Krieg, Carsten/0000-0002-5145-7591; Ring, Aaron/0000-0003-3699-2446; Su, Leon/0000-0001-7654-9997; Moraga, Ignacio/0000-0001-9909-0701; Boyman, Onur/0000-0001-8279-5545	Swiss National Science Foundation [NIH-RO1AI51321, PP00P3-128421]; Swiss Cancer League [KFS-02672-08-2010]; NIH [R01-GM062868, U01 DK078123, U19 AI 082719]; MRI-R2; American Recovery and Reinvestment Act [NIH-AR050942]; Stanford Medical Scientist Training Program [NIH-GM07365]; NATIONAL CANCER INSTITUTE [R01CA065237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082719, R01AI051321, R37AI051321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK078123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062868, T32GM007365] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRI-R2; American Recovery and Reinvestment Act; Stanford Medical Scientist Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge W. Leonard, R. Levy and R. Schwendener for reagents and discussion. This work was supported by NIH-RO1AI51321 (to K. C. G.), PP00P3-128421 from the Swiss National Science Foundation and KFS-02672-08-2010 from the Swiss Cancer League (both to O.B.), NIH R01-GM062868 (to V. S. P.), MRI-R2 (this award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5)) (to V.S.P.), NIH-AR050942 (to J.T.L.), NIH U01 DK078123 (to C. G. F.), and NIH U19 AI 082719 (to C. G. F.). A. M. R. was supported by the Stanford Medical Scientist Training Program (NIH-GM07365). K. C. G. is an Investigator of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; BAZAN JF, 1992, SCIENCE, V257, P410, DOI 10.1126/science.1631562; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bowman GR, 2010, CELL RES, V20, P622, DOI 10.1038/cr.2010.57; Bowman GR, 2009, METHODS, V49, P197, DOI 10.1016/j.ymeth.2009.04.013; Bowman GR, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216567; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Krieg C, 2010, P NATL ACAD SCI USA, V107, P11906, DOI 10.1073/pnas.1002569107; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOTT HR, 1995, J MOL BIOL, V247, P979, DOI 10.1006/jmbi.1994.0194; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; Noe F, 2008, CURR OPIN STRUC BIOL, V18, P154, DOI 10.1016/j.sbi.2008.01.008; Rao BM, 2004, MOL PHARMACOL, V66, P864, DOI 10.1124/mol.66.4.864; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; ROSENBERG SA, 1985, J EXP MED, V161, P1169, DOI 10.1084/jem.161.5.1169; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Thanos CD, 2006, P NATL ACAD SCI USA, V103, P15422, DOI 10.1073/pnas.0607058103; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpps.20, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]	39	315	356	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2012	484	7395					529	U159		10.1038/nature10975	http://dx.doi.org/10.1038/nature10975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22446627	Green Accepted			2022-12-01	WOS:000303200400054
J	Close, P; East, P; Dirac-Svejstrup, AB; Hartmann, H; Heron, M; Maslen, S; Chariot, A; Soding, J; Skehel, M; Svejstrup, JQ				Close, Pierre; East, Philip; Dirac-Svejstrup, A. Barbara; Hartmann, Holger; Heron, Mark; Maslen, Sarah; Chariot, Alain; Soeding, Johannes; Skehel, Mark; Svejstrup, Jesper Q.			DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation	NATURE			English	Article							PROTEOMIC ANALYSIS; BINDING-PROTEINS; IN-VIVO; CLEAVAGE; CELLS	Alternative messenger RNA splicing is the main reason that vast mammalian proteomic complexity can be achieved with a limited number of genes. Splicing is physically and functionally coupled to transcription, and is greatly affected by the rate of transcript elongation(1-3). As the nascent pre-mRNA emerges from transcribing RNA polymerase II (RNAPII), it is assembled into a messenger ribonucleoprotein (mRNP) particle; this is the functional form of the nascent pre-mRNA and determines the fate of the mature transcript(4). However, factors that connect the transcribing polymerase with the mRNP particle and help to integrate transcript elongation with mRNA splicing remain unclear. Here we characterize the human interactome of chromatin-associated mRNP particles. This led us to identify deleted in breast cancer 1 (DBC1) and ZNF326 (which we call ZNF-protein interacting with nuclear mRNPs and DBC1 (ZIRD)) as subunits of a novel protein complex-named DBIRD-that binds directly to RNAPII. DBIRD regulates alternative splicing of a large set of exons embedded in (A + T)-rich DNA, and is present at the affected exons. RNA-interference-mediated DBIRD depletion results in region-specific decreases in transcript elongation, particularly across areas encompassing affected exons. Together, these data indicate that the DBIRD complex acts at the interface between mRNP particles and RNAPII, integrating transcript elongation with the regulation of alternative splicing.	[Close, Pierre; Dirac-Svejstrup, A. Barbara; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Mech Transcript Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Close, Pierre; Chariot, Alain] Univ Liege, Unit Med Chem, GIGA Signal Transduct, GIGA R,CHU, B-4000 Liege, Belgium; [East, Philip] Canc Res UK London Res Inst, Bioinformat & Biostat Grp, London WC2A 3LY, England; [Hartmann, Holger; Heron, Mark; Soeding, Johannes] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Hartmann, Holger; Heron, Mark; Soeding, Johannes] Univ Munich, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Maslen, Sarah; Skehel, Mark] Canc Res UK London Res Inst, London Res Inst, Prot Anal & Prote Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK; University of Liege; Cancer Research UK; University of Munich; University of Munich; Cancer Research UK	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Mech Transcript Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk	Söding, Johannes/A-3341-2013	Söding, Johannes/0000-0001-9642-8244; Chariot, Alain/0000-0002-1691-4347; Svejstrup, Jesper/0000-0003-4964-6147; CLOSE, PIERRE/0000-0002-8844-9616; East, Philip/0000-0001-5801-5713	Cancer Research UK; European Research council (ERC); European Molecular Biology Organization (EMBO); Fonds Leon Fredericq foundation; Cancer Research UK [11567] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research council (ERC)(European Research Council (ERC)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Fonds Leon Fredericq foundation; Cancer Research UK(Cancer Research UK)	This work was supported by grants from Cancer Research UK and the European Research council (ERC) (to J.Q.S.), by an European Molecular Biology Organization (EMBO) long-term fellowship and by the Fonds Leon Fredericq foundation (to P. C.). We thank the Molecular Biology Core Facility at the Paterson Institute (Manchester) and Cell Services at London Research Insitute for analysis and help. We thank B. Chabot for CB3 cells, and members of the Svejstrup laboratory, P. Verrijjzer and T. H. Jensen for comments on the manuscript. P. C. is a senior research assistant at the Belgian National Foundation for Scientific Research (FNRS).	Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; BENDAVID Y, 1992, MOL CELL BIOL, V12, P4449, DOI 10.1128/MCB.12.10.4449; Chen YIG, 2007, NUCLEIC ACIDS RES, V35, P3928, DOI 10.1093/nar/gkm347; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; Fong N, 2009, NAT STRUCT MOL BIOL, V16, P916, DOI 10.1038/nsmb.1652; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert C, 2006, CURR PROTOC MOL BIOL, V75; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; Kiledjian Megerditch, 1994, P127; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim JE, 2009, CELL CYCLE, V8, P2932; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Lee JY, 2000, DNA CELL BIOL, V19, P227, DOI 10.1089/104454900314492; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Selth LA, 2011, METHODS MOL BIOL, V791, P253, DOI 10.1007/978-1-61779-316-5_19; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	24	86	90	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					386	389		10.1038/nature10925	http://dx.doi.org/10.1038/nature10925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22446626	Green Accepted			2022-12-01	WOS:000302946500035
J	Demeshkina, N; Jenner, L; Westhof, E; Yusupov, M; Yusupova, G				Demeshkina, Natalia; Jenner, Lasse; Westhof, Eric; Yusupov, Marat; Yusupova, Gulnara			A new understanding of the decoding principle on the ribosome	NATURE			English	Article							AMINOACYL-TRANSFER-RNA; EF-TU; MESSENGER-RNA; SELECTION; RECOGNITION; FIDELITY; ACTIVATION; MECHANISM	During protein synthesis, the ribosome accurately selects transfer RNAs (tRNAs) in accordance with the messenger RNA (mRNA) triplet in the decoding centre. tRNA selection is initiated by elongation factor Tu, which delivers tRNA to the aminoacyl tRNA-binding site (A site) and hydrolyses GTP upon establishing codon-anticodon interactions in the decoding centre(1-9). At the following proofreading step the ribosome re-examines the tRNA and rejects it if it does not match the A codon(2,3,10-14). It was suggested that universally conserved G530, A1492 and A1493 of 16S ribosomal RNA, critical for tRNA binding in the Asite(15-17), actively monitor cognate tRNA(18), and that recognition of the correct codon-anticodon duplex induces an overall ribosome conformational change (domain closure)(19). Here we propose an integrated mechanism for decoding based on six X-ray structures of the 70S ribosome determined at 3.1-3.4A resolution, modelling cognate or near-cognate states of the decoding centre at the proofreading step. We show that the 30S subunit undergoes an identical domain closure upon binding of either cognate or near-cognate tRNA. This conformational change of the 30S subunit forms a decoding centre that constrains the mRNA in such a way that the first two nucleotides of the A codon are limited to form Watson-Crick base pairs. When U center dot G and G center dot U mismatches, generally considered to form wobble base pairs, are at the first or second codon-anticodon position, the decoding centre forces this pair to adopt the geometry close to that of a canonical C center dot G pair. This by itself, or with distortions in the codon-anticodon mini-helix and the anticodon loop, causes the near-cognate tRNA to dissociate from the ribosome.	[Demeshkina, Natalia; Jenner, Lasse; Yusupov, Marat; Yusupova, Gulnara] Inst Genet & Biol Mol & Cellulaire, Dept Biol & Genom Struct, F-67400 Illkirch Graffenstaden, France; [Demeshkina, Natalia; Jenner, Lasse; Yusupov, Marat; Yusupova, Gulnara] CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; [Demeshkina, Natalia; Jenner, Lasse; Yusupov, Marat; Yusupova, Gulnara] INSERM, U964, F-67400 Illkirch Graffenstaden, France; [Demeshkina, Natalia; Jenner, Lasse; Yusupov, Marat; Yusupova, Gulnara] Univ Strasbourg, F-67000 Strasbourg, France; [Westhof, Eric] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, F-67084 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Yusupov, M (corresponding author), Inst Genet & Biol Mol & Cellulaire, Dept Biol & Genom Struct, F-67400 Illkirch Graffenstaden, France.	marat@igbmc.fr; gula@igbmc.fr	Yusupova, Gulnara/E-1877-2014; Yusupov, Marat/I-6126-2013; Jenner, Lasse/H-1584-2017	Yusupov, Marat/0000-0001-5544-0597; Jenner, Lasse/0000-0003-3917-8853	ANR [BLAN07-3_190451, ANR-07-PCVI-0015-01]; Fondation pour la Recherche Medicale en France; European Commission SPINE2	ANR(French National Research Agency (ANR)); Fondation pour la Recherche Medicale en France(Fondation pour la Recherche Medicale); European Commission SPINE2(European CommissionEuropean Commission Joint Research Centre)	We are grateful to C. Schulze-Briese and the staff at the Swiss Light Source (Switzerland) for help during synchrotron X-ray data collection. We thank S. Duclaud for ribosome preparation and the staff of the Structural Biology Department core facility at Institut de Genetique et de Biologie Moleculaire et Cellulaire, Universite de Strasbourg. This work was supported by ANR BLAN07-3_190451 (to M.Y.), ANR-07-PCVI-0015-01 (to G.Y.), Fondation pour la Recherche Medicale en France (to N.D.) and by the European Commission SPINE2.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2008, BPS DATABASE RNA BAS; Auffinger P, 2001, RNA, V7, P334, DOI 10.1017/S1355838201002382; Bebenek K, 2011, P NATL ACAD SCI USA, V108, P1862, DOI 10.1073/pnas.1012825108; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Dale T, 2005, TRENDS BIOCHEM SCI, V30, P659, DOI 10.1016/j.tibs.2005.10.006; EHRENBERG M, 1986, BIOCHIMIE, V68, P261, DOI 10.1016/S0300-9084(86)80023-2; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Lee TH, 2007, P NATL ACAD SCI USA, V104, P13661, DOI 10.1073/pnas.0705988104; Li W, 2008, EMBO J, V27, P3322, DOI 10.1038/emboj.2008.243; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; Mueller M, 2012, ACTA CRYSTALLOGR D, V68, P42, DOI 10.1107/S0907444911049833; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 2000, NAT STRUCT BIOL, V7, P104; POWERS T, 1994, J MOL BIOL, V235, P156, DOI 10.1016/S0022-2836(05)80023-3; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	31	232	237	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					256	U146		10.1038/nature10913	http://dx.doi.org/10.1038/nature10913			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22437501				2022-12-01	WOS:000303149900038
J	Kelly, DP				Kelly, Daniel P.			Irisin, Light My Fire	SCIENCE			English	Editorial Material							BROWN ADIPOSE-TISSUE; SKELETAL-MUSCLE; ADULT HUMANS; EXERCISE; PGC-1; FAT; DRIVES		Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA	Sanford Burnham Prebys Medical Discovery Institute	Kelly, DP (corresponding author), Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA.	dkelly@sanfordburnham.org	Kelly, Daniel/ABG-2056-2021		NIDDK NIH HHS [R01 DK045416] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045416] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	14	101	119	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					42	43		10.1126/science.1221688	http://dx.doi.org/10.1126/science.1221688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491843				2022-12-01	WOS:000302405400042
J	Shibata, Y; Kumar, P; Layer, R; Willcox, S; Gagan, JR; Griffith, JD; Dutta, A				Shibata, Yoshiyuki; Kumar, Pankaj; Layer, Ryan; Willcox, Smaranda; Gagan, Jeffrey R.; Griffith, Jack D.; Dutta, Anindya			Extrachromosomal MicroDNAs and Chromosomal Microdeletions in Normal Tissues	SCIENCE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; CIRCULAR DNA; HUMAN GENOME; CHROMATIN; VARIANTS; TRAITS	We have identified tens of thousands of short extrachromosomal circular DNAs (microDNA) in mouse tissues as well as mouse and human cell lines. These microDNAs are 200 to 400 base pairs long, are derived from unique nonrepetitive sequence, and are enriched in the 5'-untranslated regions of genes, exons, and CpG islands. Chromosomal loci that are enriched sources of microDNA in the adult brain are somatically mosaic for microdeletions that appear to arise from the excision of microDNAs. Germline microdeletions identified by the "Thousand Genomes" project may also arise from the excision of microDNAs in the germline lineage. We have thus identified a previously unknown DNA entity in mammalian cells and provide evidence that their generation leaves behind deletions in different genomic loci.	[Shibata, Yoshiyuki; Kumar, Pankaj; Layer, Ryan; Gagan, Jeffrey R.; Dutta, Anindya] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC USA	University of Virginia; University of North Carolina; University of North Carolina Chapel Hill	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073; Gagan, Jeffrey/0000-0003-4676-9969	 [R01 CA60499];  [GM84465];  [GM31819];  [ESO13773]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA060499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, R01GM031819, T32GM008136, R01GM084465] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 CA60499 and GM84465 (to A. D.), and GM31819 and ESO13773 (to J.D.G.). We thank all members of the Dutta Lab for helpful discussions and A. Prorock for assistance with DNA sequencing. Accession number for the sequence data submitted to Gene Expression Omnibus: GSE36088.	Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Changolkar LN, 2010, MOL CELL BIOL, V30, P5473, DOI 10.1128/MCB.00518-10; Cohen S, 2009, CYTOGENET GENOME RES, V124, P327, DOI 10.1159/000218136; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hideo Y., 1983, GENE, V26, P317; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; Lovmar L, 2006, HUM MUTAT, V27, P603, DOI 10.1002/humu.20341; Lupski JR, 2010, NAT GENET, V42, P1036, DOI 10.1038/ng1210-1036; Maeda T, 2004, BIOCHEM BIOPH RES CO, V319, P1117, DOI 10.1016/j.bbrc.2004.05.093; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Shibata Y, 2010, GENOME MED, V2, DOI 10.1186/gm191; SMITH CA, 1972, J MOL BIOL, V69, P163, DOI 10.1016/0022-2836(72)90222-7; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; THRESHER R, 1992, METHOD ENZYMOL, V211, P481	19	139	144	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					82	86		10.1126/science.1213307	http://dx.doi.org/10.1126/science.1213307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22403181	Green Accepted, Green Submitted			2022-12-01	WOS:000302405400056
J	Calderon, L; Boehm, T				Calderon, Lesly; Boehm, Thomas			Synergistic, Context-Dependent, and Hierarchical Functions of Epithelial Components in Thymic Microenvironments	CELL			English	Article							STEM-CELL-NICHE; DELTA-LIKE 4; T-CELL; BONE-MARROW; IMMATURE THYMOCYTES; LINEAGE COMMITMENT; BETA-SELECTION; SELF-RENEWAL; FETAL BLOOD; MAST-CELLS	Specialized niche environments specify and maintain stem and progenitor cells, but little is known about the identities and functional interactions of niche components in vivo. Here, we describe a modular system for the generation of artificial thymopoietic environments in the mouse embryo. Thymic epithelium that lacks hematopoietic function but is physiologically accessible for hematopoietic progenitor cells is functionalized by individual and combinatorial expression of four factors, the chemokines Ccl25 and Cxcl12, the cytokine Scf, and the Notch ligand DLL4. The distinct phenotypes and variable numbers of hematopoietic cells in the resulting epithelial environments reveal synergistic, context-dependent, and hierarchical interactions among effector molecules. The surprisingly simple rules determining hematopoietic properties enable the in vivo engineering of artificial environments conducive to the presence of distinct myeloid or T or B lymphoid lineage precursors; moreover, synthetic environments facilitate the procurement of physiological progenitor cell types for analytical purposes and future therapeutic applications.	[Calderon, Lesly; Boehm, Thomas] Max Planck Inst Immunbiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany	Max Planck Society	Boehm, T (corresponding author), Max Planck Inst Immunbiol & Epigenet, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de		Calderon, Lesly/0000-0001-5253-7369	Max-Planck Society; Deutsche Forschungsgemeinschaft	Max-Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank A. Haas-Assenbaum and B. Kanzler for help with the generation of transgenic mice, C. Happe, B. Hammerschmidt, and S. Birmelin for technical support, A. Wuerch and S. Hobitz for help with cell sorting, J.B. Swann, V. Taylor, and H.R. Rodewald for advice and helpful discussions, and R. Kemler and D. Vestweber for reagents. We also acknowledge the contributions of C. Hetzer-Egger during early stages of this project. Financial support for these studies was provided by the Max-Planck Society and the Deutsche Forschungsgemeinschaft. L.C. was a member of the International Max-Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), a joint international PhD programme of the Max Planck Institute of Immunobiology and Epigenetics (MPI-IB) and the University of Freiburg, Germany.	Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x; Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Bajoghli B, 2011, NATURE, V470, P90, DOI 10.1038/nature09655; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Benz C, 2004, EUR J IMMUNOL, V34, P3652, DOI 10.1002/eji.200425248; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Charbord P, 2002, EXP HEMATOL, V30, P1202, DOI 10.1016/S0301-472X(02)00895-0; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Corbeaux T, 2010, P NATL ACAD SCI USA, V107, P16613, DOI 10.1073/pnas.1004623107; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; JENKINSON EJ, 1981, J EXP MED, V153, P280, DOI 10.1084/jem.153.2.280; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Martinic MM, 2006, P NATL ACAD SCI USA, V103, P14435, DOI 10.1073/pnas.0606707103; Moritz DR, 1998, J IMMUNOL, V161, P4866; Nagasawa T, 2000, INT J HEMATOL, V72, P408; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; RODEWALD HR, 1995, CURR OPIN IMMUNOL, V7, P176, DOI 10.1016/0952-7915(95)80002-6; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schlenner SM, 2010, TRENDS IMMUNOL, V31, P303, DOI 10.1016/j.it.2010.06.002; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Soza-Ried C, 2008, J IMMUNOL, V181, P5272, DOI 10.4049/jimmunol.181.8.5272; Terszowski G, 2006, SCIENCE, V312, P284, DOI 10.1126/science.1123497; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Tsukamoto N, 2005, CELL IMMUNOL, V234, P77, DOI 10.1016/j.cellimm.2005.06.009; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; WORTIS HH, 1971, J EXP MED, V134, P681, DOI 10.1084/jem.134.3.681; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60	55	86	89	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					159	172		10.1016/j.cell.2012.01.049	http://dx.doi.org/10.1016/j.cell.2012.01.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464328	Bronze			2022-12-01	WOS:000302235400018
J	Yao, P; Potdar, AA; Arif, A; Ray, PS; Mukhopadhyay, R; Willard, B; Xu, YC; Yan, J; Saidel, GM; Fox, PL				Yao, Peng; Potdar, Alka A.; Arif, Abul; Ray, Partho Sarothi; Mukhopadhyay, Rupak; Willard, Belinda; Xu, Yichi; Yan, Jun; Saidel, Gerald M.; Fox, Paul L.			Coding Region Polyadenylation Generates a Truncated tRNA Synthetase that Counters Translation Repression	CELL			English	Article							SECONDARY STRUCTURE; NONCANONICAL FUNCTION; INITIATION-FACTOR; GAMMA-INTERFERON; TRANSCRIPT; TERMINATION; MECHANISMS; PHOSPHORYLATION; RECOGNITION; EXPRESSION	Posttranscriptional regulatory mechanisms superimpose "fine-tuning" control upon "on-off" switches characteristic of gene transcription. We have exploited computational modeling with experimental validation to resolve an anomalous relationship between mRNA expression and protein synthesis. The GAIT (gamma-interferon-activated inhibitor of translation) complex repressed VEGF-A synthesis to a low, constant rate independent of VEGF-A mRNA expression levels. Dynamic model simulations predicted an inhibitory GAIT-element-interacting factor to account for this relationship and led to the identification of a truncated form of glutamylprolyl tRNA synthetase (EPRS), a GAIT constituent that mediates binding to target transcripts. The truncated protein, EPRSN1, shields GAIT-element-bearing transcripts from the inhibitory GAIT complex, thereby dictating a "translational trickle" of GAIT target proteins. EPRSN1 mRNA is generated by poly-adenylation-directed conversion of a Tyr codon in the EPRS-coding sequence to a stop codon (PAY*). Genome-wide analysis revealed multiple candidate PAY* targets, including the authenticated target RRM1, suggesting a general mechanism for production of C terminus-truncated regulatory proteins.	[Yao, Peng; Potdar, Alka A.; Arif, Abul; Ray, Partho Sarothi; Mukhopadhyay, Rupak; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Willard, Belinda] Cleveland Clin, Lerner Res Inst, Mass Spectrometry Lab Prot Sequencing, Cleveland, OH 44195 USA; [Ray, Partho Sarothi] Indian Inst Sci Educ & Res, Dept Biol Sci, Kolkata 700064, W Bengal, India; [Mukhopadhyay, Rupak] Tezpur Univ, Dept Mol Biol & Biotechnol, Sonitpur 784028, Assam, India; [Xu, Yichi; Yan, Jun] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Potdar, Alka A.; Saidel, Gerald M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Saidel, Gerald M.] Case Western Reserve Univ, Ctr Modeling Integrated Metab Syst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Indian Institute of Science Education & Research (IISER) - Kolkata; Tezpur University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Case Western Reserve University; Case Western Reserve University	Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA.	foxp@ccf.org	Yao, Peng/Y-8047-2019; Yao, Peng/J-4492-2013; Ray, Partho Sarothi/H-3020-2019; Potdar, Alka/E-6882-2012; Yao, Peng/G-5218-2015; Mukhopadhyay, Rupak/Q-9168-2017	Yao, Peng/0000-0002-1145-3967; Yao, Peng/0000-0002-7029-8629; Ray, Partho Sarothi/0000-0002-8795-3060; Yao, Peng/0000-0003-1022-3948; Mukhopadhyay, Rupak/0000-0001-5211-1413; Saidel, Gerald/0000-0003-2159-2343; Yan, Jun/0000-0002-0405-0502; Xu, Yichi/0000-0002-8163-3920	National Institutes of Health [P01 HL029582, P01 HL076491, R01 GM086430, R01 DK083359]; American Heart Association, Great Rivers Affiliate; American Heart Association [10SDG3930003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Great Rivers Affiliate(American Heart Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Richard Padgett for helpful discussions and David Dignam for the gift of anti-PRS antibody. This work was supported in part by National Institutes of Health grants P01 HL029582, P01 HL076491, R01 GM086430, and R01 DK083359 to P.L.F. P.Y. was supported by a Postdoctoral Fellowship from the American Heart Association, Great Rivers Affiliate, and A.A. by National Center Scientist Development Grant 10SDG3930003 from the American Heart Association.	AHMED YF, 1991, CELL, V64, P727, DOI 10.1016/0092-8674(91)90502-P; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; BARSHIRA A, 1991, J VIROL, V65, P5165, DOI 10.1128/JVI.65.10.5165-5173.1991; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Hans H, 2000, MOL CELL BIOL, V20, P2926, DOI 10.1128/MCB.20.8.2926-2932.2000; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jordheim LP, 2011, LANCET ONCOL, V12, P693, DOI 10.1016/S1470-2045(10)70244-8; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kapasi P, 2007, MOL CELL, V25, P113, DOI 10.1016/j.molcel.2006.11.028; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Mazumder B, 2001, MOL CELL BIOL, V21, P6440, DOI 10.1128/MCB.21.19.6440-6449.2001; McMahon KW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-35; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Ray PS, 2011, MOL BIOL EVOL, V28, P437, DOI 10.1093/molbev/msq246; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wu CX, 2004, MOL CELL BIOL, V24, P2789, DOI 10.1128/MCB.24.7.2789-2796.2004	48	70	74	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					88	100		10.1016/j.cell.2012.02.018	http://dx.doi.org/10.1016/j.cell.2012.02.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22386318	Green Accepted, Bronze			2022-12-01	WOS:000302235400012
J	Gulland, A				Gulland, Anne			Joined-up working: introducing the best teams of the year	BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 27	2012	344								e2328	10.1136/bmj.e2328	http://dx.doi.org/10.1136/bmj.e2328			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923EV	22453186				2022-12-01	WOS:000302603100022
J	Kay, JN; Chu, MW; Sanes, JR				Kay, Jeremy N.; Chu, Monica W.; Sanes, Joshua R.			MEGF10 and MEGF11 mediate homotypic interactions required for mosaic spacing of retinal neurons	NATURE			English	Article							CHOLINERGIC AMACRINE CELLS; MOUSE RETINA; ENGULFMENT RECEPTOR; HORIZONTAL CELLS; RODENT RETINA; RESOURCE; MODELS; DSCAM	In many parts of the nervous system, neuronal somata display orderly spatial arrangements(1). In the retina, neurons of numerous individual subtypes form regular arrays called mosaics: they are less likely to be near neighbours of the same subtype than would occur by chance, resulting in 'exclusion zones' that separate them(1-4). Mosaic arrangements provide a mechanism to distribute each cell type evenly across the retina, ensuring that all parts of the visual field have access to a full set of processing elements(2). Remarkably, mosaics are independent of each other: although a neuron of one subtype is unlikely to be adjacent to another of the same subtype, there is no restriction on its spatial relationship to neighbouring neurons of other subtypes(5). This independence has led to the hypothesis that molecular cues expressed by specific subtypes pattern mosaics by mediating homotypic (within-subtype) short-range repulsive interactions(1,4-9). So far, however, no molecules have been identified that show such activity, so this hypothesis remains untested. Here we demonstrate in mouse that two related transmembrane proteins, MEGF10 and MEGF11, have critical roles in the formation of mosaics by two retinal interneuron subtypes, starburst amacrine cells and horizontal cells. MEGF10 and 11 and their invertebrate relatives Caenorhabditis elegans CED-1 and Drosophila Draper have hitherto been studied primarily as receptors necessary for engulfment of debris following apoptosis or axonal injury(10-14). Our results demonstrate that members of this gene family can also serve as subtype-specific ligands that pattern neuronal arrays.	[Kay, Jeremy N.; Chu, Monica W.; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Kay, Jeremy N.; Chu, Monica W.; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Sanes, JR (corresponding author), Harvard Univ, Ctr Brain Sci, 52 Oxford St, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu			National Institutes of Health [NS029169, EY022073]; Life Sciences Research Foundation; NATIONAL EYE INSTITUTE [R01EY022073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029169, R37NS029169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Tilton, P. Rogers, J. Couget, and the Harvard Genome Modification Facility for technical assistance; S. Sarin and M. Yamagata for critical discussions; the National Institutes of Health (NS029169 and EY022073 to J. R. S.) and Life Sciences Research Foundation (J.N.K.) for funding.	Budry L, 2011, P NATL ACAD SCI USA, V108, P12515, DOI 10.1073/pnas.1105929108; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cook JE, 2000, TRENDS NEUROSCI, V23, P26, DOI 10.1016/S0166-2236(99)01487-3; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Eglen SJ, 2006, MATH MED BIOL, V23, P79, DOI 10.1093/imammb/dql003; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Galli-Resta L, 2000, DEVELOPMENT, V127, P1509; GalliResta L, 1997, J NEUROSCI, V17, P7831; GRAY GE, 1992, DEVELOPMENT, V114, P271; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hong YK, 2011, J COMP NEUROL, V519, P1691, DOI 10.1002/cne.22595; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Huckfeldt RM, 2009, NAT NEUROSCI, V12, P35, DOI 10.1038/nn.2236; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Keeley PW, 2007, J COMP NEUROL, V505, P539, DOI 10.1002/cne.21518; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Poche RA, 2008, EUR J NEUROSCI, V27, P1607, DOI 10.1111/j.1460-9568.2008.06132.x; Raven MA, 2003, J COMP NEUROL, V461, P123, DOI 10.1002/cne.10693; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Reese BE, 2002, PROG RETIN EYE RES, V21, P153, DOI 10.1016/S1350-9462(01)00024-6; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Suzuki E, 2007, EXP CELL RES, V313, P3729, DOI 10.1016/j.yexcr.2007.06.015; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Whitney IE, 2008, J COMP NEUROL, V508, P1, DOI 10.1002/cne.21630; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446	35	119	121	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2012	483	7390					465	U117		10.1038/nature10877	http://dx.doi.org/10.1038/nature10877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22407321	Green Accepted			2022-12-01	WOS:000301771200043
J	Biermann, F; Abbott, K; Andresen, S; Backstrand, K; Bernstein, S; Betsill, MM; Bulkeley, H; Cashore, B; Clapp, J; Folke, C; Gupta, A; Gupta, J; Haas, PM; Jordan, A; Kanie, N; Kluvankova-Oravska, T; Lebel, L; Liverman, D; Meadowcroft, J; Mitchell, RB; Newell, P; Oberthur, S; Olsson, L; Pattberg, P; Sanchez-Rodriguez, R; Schroeder, H; Underdal, A; Vieira, SC; Vogel, C; Young, OR; Brock, A; Zondervan, R				Biermann, F.; Abbott, K.; Andresen, S.; Backstrand, K.; Bernstein, S.; Betsill, M. M.; Bulkeley, H.; Cashore, B.; Clapp, J.; Folke, C.; Gupta, A.; Gupta, J.; Haas, P. M.; Jordan, A.; Kanie, N.; Kluvankova-Oravska, T.; Lebel, L.; Liverman, D.; Meadowcroft, J.; Mitchell, R. B.; Newell, P.; Oberthur, S.; Olsson, L.; Pattberg, P.; Sanchez-Rodriguez, R.; Schroeder, H.; Underdal, A.; Camargo Vieira, S.; Vogel, C.; Young, O. R.; Brock, A.; Zondervan, R.			Navigating the Anthropocene: Improving Earth System Governance	SCIENCE			English	Editorial Material									[Biermann, F.; Gupta, J.; Pattberg, P.; Brock, A.] Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Biermann, F.; Backstrand, K.; Olsson, L.; Zondervan, R.] Lund Univ, S-22100 Lund, Sweden; [Abbott, K.] Arizona State Univ, Tempe, AZ 85287 USA; [Andresen, S.] Fridtjof Nansen Inst Polhogda, N-1326 Lysaker, Norway; [Bernstein, S.] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Betsill, M. M.] Colorado State Univ, Ft Collins, CO 80523 USA; [Bulkeley, H.] Univ Durham, Durham DH1 3LE, England; [Cashore, B.] Yale Univ, New Haven, CT 06511 USA; [Clapp, J.] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Folke, C.] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Folke, C.] Royal Swedish Acad Sci, Beijer Inst, S-10405 Stockholm, Sweden; [Gupta, A.] Univ Wageningen & Res Ctr, NL-6706 KN Wageningen, Netherlands; [Gupta, J.] UNESCO IHE Inst Water Educ, NL-2611 AX Delft, Netherlands; [Haas, P. M.] Univ Massachusetts, Amherst, MA 01003 USA; [Jordan, A.; Schroeder, H.] Univ E Anglia, Tyndall Ctr, Norwich NR4 7TJ, Norfolk, England; [Kanie, N.] Tokyo Inst Technol, Tokyo 1528552, Japan; [Kanie, N.] United Nations Univ, Inst Adv Studies, Yokohama, Kanagawa 2208502, Japan; [Kluvankova-Oravska, T.] Slovak Acad Sci, CETIP, Bratislava 81438, Slovakia; [Lebel, L.] Chiang Mai Univ, Chiang Mai 50200, Thailand; [Liverman, D.] Univ Arizona, Tucson, AZ 85721 USA; [Liverman, D.] Univ Oxford, Oxford OX1 2JD, England; [Meadowcroft, J.] Carleton Univ, Ottawa, ON K1S 5B6, Canada; [Mitchell, R. B.] Univ Oregon, Eugene, OR 97403 USA; [Newell, P.] Univ Sussex, Brighton BN1 9SN, E Sussex, England; [Oberthur, S.] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Sanchez-Rodriguez, R.] Colegio Frontera Norte, Tijuana 22560, Mexico; [Sanchez-Rodriguez, R.] Univ Calif Riverside, Riverside, CA 92521 USA; [Underdal, A.] Univ Oslo, N-0317 Oslo, Norway; [Camargo Vieira, S.] Univ Itauna, BR-35680054 Itauna, MG, Brazil; [Young, O. R.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	Vrije Universiteit Amsterdam; Lund University; Arizona State University; Arizona State University-Tempe; University of Toronto; Colorado State University; Durham University; Yale University; University of Waterloo; Stockholm University; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; Wageningen University & Research; IHE Delft Institute for Water Education; University of Massachusetts System; University of Massachusetts Amherst; University of East Anglia; Tokyo Institute of Technology; United Nations University; Slovak Academy of Sciences; Chiang Mai University; University of Arizona; University of Oxford; Carleton University; University of Oregon; University of Sussex; Vrije Universiteit Brussel; Colegio Frontera Norte; University of California System; University of California Riverside; University of Oslo; Universidade de Itauna; University of California System; University of California Santa Barbara	Biermann, F (corresponding author), Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands.	frank.biermann@vu.nl	Betsill, Michele/ABD-5548-2020; Clapp, Jennifer/GRO-3628-2022; Mitchell, Ronald/A-6997-2009; Folke, Carl/Z-1545-2019; Bulkeley, Harriet/Y-3348-2019; Biermann, Frank/D-4175-2013; Gupta, Joyeeta/L-8672-2013; Betsill, Michele/GQY-4502-2022; Lebel, Louis/D-4130-2014; Pattberg, Philipp/J-4141-2012	Betsill, Michele/0000-0001-7090-904X; Mitchell, Ronald/0000-0002-7281-1035; Biermann, Frank/0000-0002-0292-0703; Lebel, Louis/0000-0001-6187-6418; Gupta, Aarti/0000-0003-4908-7453; Folke, Carl/0000-0002-4050-3281; Gupta, Joyeeta/0000-0003-1424-2660; Schroeder, Heike/0000-0003-2342-2030; Oberthur, Sebastian/0000-0001-8626-5082; Brock, Andrea/0000-0001-5771-5603; Clapp, Jennifer/0000-0002-1871-8067; Abbott, Kenneth W./0000-0002-5540-1683; Olsson, Lennart/0000-0001-8353-1074; Pattberg, Philipp/0000-0003-1136-7791; Jordan, Andrew/0000-0001-7678-1024	ESRC [ES/F037163/1] Funding Source: UKRI; Economic and Social Research Council [ES/F037163/1] Funding Source: researchfish; Division Of Behavioral and Cognitive Sci [1134890] Funding Source: National Science Foundation	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Abbott K. W., 2006, ENVIRON LAW REP, V36, P10931; Abbott Kenneth W, 2006, RETHINKING DEV CARBO, V36, P10931; Bernstein S., 2005, J INT LAW INT RELATI, V1, P139, DOI DOI 10.1080/09692290903173087; Biermann F, 2000, ENVIRONMENT, V42, P22, DOI 10.1080/00139150009605762; Biermann F, 2007, GLOBAL ENVIRON CHANG, V17, P326, DOI 10.1016/j.gloenvcha.2006.11.010; Charnovitz S., 2002, GLOBAL ENV GOVERNANC, V27, P323; CHARNOVITZ S, 2002, COLUMBIA J ENV LAW, V27, P323; Earth System Governance Project, 2011, CHART MOM HAK VIS GO; Gupta A, 2010, GLOBAL ENVIRON POLIT, V10, P1, DOI 10.1162/GLEP_e_00011; Hovi J, 2006, GLOBAL ENVIRON POLIT, V6, P28, DOI 10.1162/glep.2006.6.3.28; Muller B, 2008, INT ADAPTATION FINAN; Newell P., 2009, MAINSTREAMING CLIMAT, P184; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Schellnhuber H. J., 2004, EARTH SYSTEM ANAL SU; Science and Implementation Plan of the Earth System Governance Project, 2009, SCI IMPL PLAN EARTH; Steffen W., 2004, GLOBAL CHANGE EARTH, DOI DOI 10.1029/2004EO350005; World Bank, 2009, WORLD DEV REP 2010 D; Young OR, 2008, INSTITUTIONS AND ENVIRONMENTAL CHANGE: PRINCIPAL FINDINGS, APPLICATIONS, AND RESEARCH FRONTIERS, P1	18	288	295	3	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2012	335	6074					1306	1307		10.1126/science.1217255	http://dx.doi.org/10.1126/science.1217255			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	908ZM	22422966				2022-12-01	WOS:000301531600030
J	Gagnon, MG; Seetharaman, SV; Bulkley, D; Steitz, TA				Gagnon, Matthieu G.; Seetharaman, Sai V.; Bulkley, David; Steitz, Thomas A.			Structural Basis for the Rescue of Stalled Ribosomes: Structure of YaeJ Bound to the Ribosome	SCIENCE			English	Article							PEPTIDYL-TRANSFER-RNA; TRANS-TRANSLATION; ESCHERICHIA-COLI; MESSENGER-RNA; CRYSTAL-STRUCTURE; GGQ MOTIF; TMRNA; SMPB; RELEASE; PROTEIN	In bacteria, the hybrid transfer-messenger RNA (tmRNA) rescues ribosomes stalled on defective messenger RNAs (mRNAs). However, certain gram-negative bacteria have evolved proteins that are capable of rescuing stalled ribosomes in a tmRNA-independent manner. Here, we report a 3.2 angstrom-resolution crystal structure of the rescue factor YaeJ bound to the Thermus thermophilus 70S ribosome in complex with the initiator tRNA(i)(fMet) and a short mRNA. The structure reveals that the C-terminal tail of YaeJ functions as a sensor to discriminate between stalled and actively translating ribosomes by binding in the mRNA entry channel downstream of the A site between the head and shoulder of the 30S subunit. This allows the N-terminal globular domain to sample different conformations, so that its conserved GGQ motif is optimally positioned to catalyze the hydrolysis of peptidyl-tRNA. This structure gives insights into the mechanism of YaeJ function and provides a basis for understanding how it rescues stalled ribosomes.	[Gagnon, Matthieu G.; Seetharaman, Sai V.; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Bulkley, David; Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Gagnon, Matthieu G.; Seetharaman, Sai V.; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu		Gagnon, Matthieu/0000-0003-4516-604X; Bulkley, David/0000-0002-2535-904X	NIH [GM022778]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to the members of the Steitz lab for useful suggestions and discussions. We thank R. Grodzicki for providing the tRNA<INF>i</INF><SUP>fMet</SUP> and the staffs of the Advanced Photon Source beamline 24-ID and the National Synchrotron Light Source beamline X29 for help during data collection and the Center for Structural Biology facility at Yale University for computational support. Special thanks to Y. Polikanov, J. Wang, and W. Meng for advice with crystallographic software. This work was supported by NIH grant GM022778 (to T. A. S.). Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 4DH9, 4DHA, 4DHB, and 4DHC. T. A. S. owns stock in and is on the advisory board of Rib-X Pharmaceuticals, which does structure-based design of drugs that target the ribosome.	Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Burakovsky DE, 2010, RNA, V16, P1848, DOI 10.1261/rna.2185710; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Felden B, 2011, RNA BIOL, V8, P440, DOI 10.4161/rna.8.3.15387; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Gutmann S, 2003, NATURE, V424, P699, DOI 10.1038/nature01831; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Handa Y, 2010, J MOL BIOL, V404, P260, DOI 10.1016/j.jmb.2010.09.033; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kurita D, 2007, NUCLEIC ACIDS RES, V35, P7248, DOI 10.1093/nar/gkm677; Kurita D, 2010, RNA, V16, P980, DOI 10.1261/rna.1916610; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Richter R, 2010, EMBO J, V29, P1116, DOI 10.1038/emboj.2010.14; Savelsbergh A, 2009, RNA, V15, P772, DOI 10.1261/rna.1592509; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Weis F, 2010, RNA, V16, P299, DOI 10.1261/rna.1757410; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Withey J, 1999, J BACTERIOL, V181, P2148, DOI 10.1128/JB.181.7.2148-2157.1999; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323	27	78	80	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2012	335	6074					1370	1372		10.1126/science.1217443	http://dx.doi.org/10.1126/science.1217443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22422986	Green Accepted			2022-12-01	WOS:000301531600053
J	Li, PL; Banjade, S; Cheng, HC; Kim, S; Chen, B; Guo, L; Llaguno, M; Hollingsworth, JV; King, DS; Banani, SF; Russo, PS; Jiang, QX; Nixon, BT; Rosen, MK				Li, Pilong; Banjade, Sudeep; Cheng, Hui-Chun; Kim, Soyeon; Chen, Baoyu; Guo, Liang; Llaguno, Marc; Hollingsworth, Javoris V.; King, David S.; Banani, Salman F.; Russo, Paul S.; Jiang, Qiu-Xing; Nixon, B. Tracy; Rosen, Michael K.			Phase transitions in the assembly of multivalent signalling proteins	NATURE			English	Article							NUCLEAR-BODIES; NCK; MECHANISMS; RNA; POLYMERIZATION; TRANSLATION; POLYMERS; GRANULES; DOMAINS; MOTIFS	Cells are organized on length scales ranging from angstrom to micrometres. However, the mechanisms by which angstrom-scale molecular properties are translated to micrometre-scale macroscopic properties are not well understood. Here we show that interactions between diverse synthetic, multivalent macromolecules (including multi-domain proteins and RNA) produce sharp liquid-liquid demixing phase separations, generating micrometre-sized liquid droplets in aqueous solution. This macroscopic transition corresponds to a molecular transition between small complexes and large, dynamic supramolecular polymers. The concentrations needed for phase transition are directly related to the valency of the interacting species. In the case of the actin-regulatory protein called neural Wiskott-Aldrich syndrome protein (N-WASP) interacting with its established biological partners NCK and phosphorylated nephrin(1), the phase transition corresponds to a sharp increase in activity towards an actin nucleation factor, the Arp2/3 complex. The transition is governed by the degree of phosphorylation of nephrin, explaining how this property of the system can be controlled to regulatory effect by kinases. The widespread occurrence of multivalent systems suggests that phase transitions may be used to spatially organize and biochemically regulate information throughout biology.	[Li, Pilong; Banjade, Sudeep; Cheng, Hui-Chun; Kim, Soyeon; Chen, Baoyu; Banani, Salman F.; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Li, Pilong; Banjade, Sudeep; Cheng, Hui-Chun; Kim, Soyeon; Chen, Baoyu; Banani, Salman F.; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Guo, Liang] Argonne Natl Lab, BioCAT IIT Adv Photon Source, Argonne, IL 60439 USA; [Llaguno, Marc; Jiang, Qiu-Xing] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Hollingsworth, Javoris V.; Russo, Paul S.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [Hollingsworth, Javoris V.; Russo, Paul S.] Louisiana State Univ, Macromol Studies Grp, Baton Rouge, LA 70803 USA; [King, David S.] Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA; [King, David S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Nixon, B. Tracy] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Argonne National Laboratory; University of Texas System; University of Texas Southwestern Medical Center Dallas; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Michael.Rosen@utsouthwestern.edu	Russo, Paul Stephen/ABC-6584-2020; Chen, Baoyu/A-7072-2011; Russo, Paul S/G-6473-2012; Jiang, Qiu-Xing/ABF-1143-2021; Jiang, Qiu-Xing/AAI-8579-2020	Russo, Paul Stephen/0000-0001-6009-2742; Chen, Baoyu/0000-0002-6366-159X; Llaguno, Marc/0000-0001-9568-9565	Howard Hughes Medical Institute; National Institutes of Health (NIH) [R01-GM56322, RR-08630]; Welch Foundation [I-1544]; Chilton Foundation; NIH EUREKA [R01-GM088745]; National Science Foundation [DMR-1005707]; Gates Millennium Fund; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; Direct For Mathematical & Physical Scien [1005707] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622, R01GM088745, R01GM056322] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Chilton Foundation; NIH EUREKA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Gates Millennium Fund; US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Onuchic and S. Padrick for discussion of the theoretical aspects of this study, L. Rice for sharing his fluorescence microscope, M. Socolich for a gift of purified eGFP, K. Luby-Phelps and A. Bugde for advice on FRAP experiments, S. Padrick and L. Doolittle for help in purifying actin and the Arp2/3 complex and for sharing reagents, N. Grishin and S. Shi for help withdatabase searches, K. Lynch for providing the PTB expression construct, D. Billadeau and T. Gomez for providing antibodies, A. Ramesh, W. Winkler and P.-L. Tsai for advice on RNA experiments, K. Roybal and C. Wulfing for sharing unpublished data, and J. Liu for help with cryo-electron tomography. This work was supported by the following: the Howard Hughes Medical Institute and grants from the National Institutes of Health (NIH) (R01-GM56322) and Welch Foundation (I-1544) to M. K. R., a Chilton Foundation Fellowship to H.-C. C., an NIH EUREKA award (R01-GM088745) to Q.-X. J., an NIH Cancer Biology T32 Training Grant to M. L., a National Science Foundation award (DMR-1005707) to P. S. R. and a Gates Millennium Fund award to J. V. H. Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-ENG-38. BioCAT is NIH-supported Research Center RR-08630.	Asherie N, 1998, BIOPHYS CHEM, V75, P213, DOI 10.1016/S0301-4622(98)00208-7; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chen BY, 2007, STRUCTURE, V15, P429, DOI 10.1016/j.str.2007.02.007; COHEN RJ, 1982, J PHYS CHEM-US, V86, P3696, DOI 10.1021/j100216a005; Dam TK, 2005, J BIOL CHEM, V280, P8640, DOI 10.1074/jbc.M412827200; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Flory PJ., 1953, PRINCIPLES POLYM CHE; GOLDBERG RJ, 1952, J AM CHEM SOC, V74, P5715, DOI 10.1021/ja01142a045; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Lehn JM, 2002, POLYM INT, V51, P825, DOI 10.1002/pi.852; Lettau M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-1; Li JF, 2010, POLYM J, V42, P609, DOI 10.1038/pj.2010.59; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Matera AG, 2006, CURR OPIN CELL BIOL, V18, P317, DOI 10.1016/j.ceb.2006.03.005; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Semenov A, 2007, RHEOL ACTA, V46, P541, DOI 10.1007/s00397-006-0149-4; Semenov AN, 1998, MACROMOLECULES, V31, P1373, DOI 10.1021/ma970616h; Sisu C, 2009, CHEMBIOCHEM, V10, P329, DOI 10.1002/cbic.200800550; STOCKMAYER WH, 1952, J POLYM SCI, V9, P69, DOI 10.1002/pol.1952.120090106; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanaka F., 2011, POLYM PHYS, DOI DOI 10.1017/CBO9780511975691	34	1196	1219	19	495	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					336	U129		10.1038/nature10879	http://dx.doi.org/10.1038/nature10879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22398450	Green Accepted			2022-12-01	WOS:000301481800050
J	Guo, WJ; Keckesova, Z; Donaher, JL; Shibue, T; Tischler, V; Reinhardt, F; Itzkovitz, S; Noske, A; Zurrer-Hardi, U; Bell, G; Tam, WL; Mani, SA; van Oudenaarden, A; Weinberg, RA				Guo, Wenjun; Keckesova, Zuzana; Donaher, Joana Liu; Shibue, Tsukasa; Tischler, Verena; Reinhardt, Ferenc; Itzkovitz, Shalev; Noske, Aurelia; Zuerrer-Haerdi, Ursina; Bell, George; Tam, Wai Leong; Mani, Sendurai A.; van Oudenaarden, Alexander; Weinberg, Robert A.			Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTIONAL NETWORK; CANCER; BREAST; GLAND; DIFFERENTIATION; MORPHOGENESIS; POPULATIONS; PROGENITORS; METASTASIS	Regulatory networks orchestrated by key transcription factors (TFs) have been proposed to play a central role in the determination of stem cell states. However, the master transcriptional regulators of adult stem cells are poorly understood. We have identified two TFs, Slug and Sox9, that act cooperatively to determine the mammary stem cell (MaSC) state. Inhibition of either Slug or Sox9 blocks MaSC activity in primary mammary epithelial cells. Conversely, transient coexpression of exogenous Slug and Sox9 suffices to convert differentiated luminal cells into MaSCs with long-term mammary gland-reconstituting ability. Slug and Sox9 induce MaSCs by activating distinct autoregulatory gene expression programs. We also show that coexpression of Slug and Sox9 promotes the tumorigenic and metastasis-seeding abilities of human breast cancer cells and is associated with poor patient survival, providing direct evidence that human breast cancer stem cells are controlled by key regulators similar to those operating in normal murine MaSCs.	[Guo, Wenjun; Keckesova, Zuzana; Donaher, Joana Liu; Shibue, Tsukasa; Reinhardt, Ferenc; Bell, George; Tam, Wai Leong; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tischler, Verena; Noske, Aurelia; Zuerrer-Haerdi, Ursina] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Itzkovitz, Shalev; van Oudenaarden, Alexander; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Itzkovitz, Shalev; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Mani, Sendurai A.] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77054 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Zurich; University Zurich Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Tischler, Verena/Q-7263-2017; van Oudenaarden, Alexander/AAA-1705-2019; Tam, Wai Leong/P-1497-2019; Mani, Sendurai A./A-7244-2009	Tischler, Verena/0000-0002-6673-8329; Tam, Wai Leong/0000-0003-2365-5264; Mani, Sendurai A./0000-0002-5918-4276	Breast Cancer Research Foundation; Alexander and Margaret Stewart Trust, National Cancer Institute [P01-CA080111]; National Institute of Health (NIH) [R01-CA078461]; National Cancer Institute [F32CA144404]; American Cancer Society and Ludwig Foundation; Department of Defense Breast Cancer; NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; NATIONAL CANCER INSTITUTE [U54CA143874, F32CA144404, P01CA080111, R01CA078461] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Alexander and Margaret Stewart Trust, National Cancer Institute; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society and Ludwig Foundation; Department of Defense Breast Cancer(United States Department of Defense); NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Scott Valastyan, Christina Scheel, Christine Chaffer, and Richard Goldsby for critical review of the manuscript. We thank Kong Jie Kah and Dr. Tal Kafri for providing tetracycline-inducible lentiviral vectors and Dr. Rudolf Jaenisch for providing Rosa26-M2rtTA mice. This research was supported by grants from the Breast Cancer Research Foundation, The Alexander and Margaret Stewart Trust, National Cancer Institute Program P01-CA080111, and National Institute of Health (NIH) R01-CA078461. R. A. W. is an American Cancer Society and Ludwig Foundation professor. W. G. was supported by a Susan G. Komen for the Cure postdoctoral fellowship and a fellowship from the National Cancer Institute (F32CA144404). Z.K. was supported by a Department of Defense Breast Cancer Postdoctoral Fellowship. S. I. and A.v.O. were supported by the NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874). W. G., Z.K., and R. A. W. are inventors on a patent application in part based on findings detailed in this publication.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; DEOME KB, 1959, CANCER RES, V19, P515; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2006, CELL CYCLE, V5, P1519, DOI 10.4161/cc.5.14.2983; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310	40	683	703	2	98	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					1015	1028		10.1016/j.cell.2012.02.008	http://dx.doi.org/10.1016/j.cell.2012.02.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385965	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000300985000020
J	Wang, JW; Sun, Q; Morita, Y; Jiang, H; Gross, A; Lechel, A; Hildner, K; Guachalla, LM; Gompf, A; Hartmann, D; Schambach, A; Wuestefeld, T; Dauch, D; Schrezenmeier, H; Hofmann, WK; Nakauchi, H; Ju, ZY; Kestler, HA; Zender, L; Rudolph, KL				Wang, Jianwei; Sun, Qian; Morita, Yohei; Jiang, Hong; Gross, Alexander; Lechel, Andre; Hildner, Kai; Guachalla, Luis Miguel; Gompf, Anne; Hartmann, Daniel; Schambach, Axel; Wuestefeld, Torsten; Dauch, Daniel; Schrezenmeier, Hubert; Hofmann, Wolf-Karsten; Nakauchi, Hiromitsu; Ju, Zhenyu; Kestler, Hans A.; Zender, Lars; Rudolph, K. Lenhard			A Differentiation Checkpoint Limits Hematopoietic Stem Cell Self-Renewal in Response to DNA Damage	CELL			English	Article							TRANSCRIPTION FACTOR; LIFE-SPAN; MULTIPOTENT PROGENITORS; TELOMERE DYSFUNCTION; MYELOID-LEUKEMIA; CANCER; MOUSE; SCREEN; MICE; AGE	Checkpoints that limit stem cell self-renewal in response to DNA damage can contribute to cancer protection but may also promote tissue aging. Molecular components that control stem cell responses to DNA damage remain to be delineated. Using in vivo RNAi screens, we identified basic leucine zipper transcription factor, ATF-like (BATF) as a major component limiting self-renewal of hematopoietic stem cells (HSCs) in response to telomere dysfunction and g-irradiation. DNA damage induces BATF in a G-CSF/ STAT3-dependent manner resulting in lymphoid differentiation of HSCs. BATF deletion improves HSC self-renewal and function in response to g-irradiation or telomere shortening but results in accumulation of DNA damage in HSCs. Analysis of bone marrow from patients with myelodysplastic syndrome supports the conclusion that DNA damage-dependent induction of BATF is conserved in human HSCs. Together, these results provide experimental evidence that a BATF-dependent differentiation checkpoint limits self-renewal of HSCs in response to DNA damage.	[Wang, Jianwei; Sun, Qian; Morita, Yohei; Jiang, Hong; Lechel, Andre; Guachalla, Luis Miguel; Gompf, Anne; Hartmann, Daniel; Rudolph, K. Lenhard] Univ Ulm, Inst Mol Med, D-89069 Ulm, Germany; [Wang, Jianwei; Sun, Qian; Morita, Yohei; Jiang, Hong; Lechel, Andre; Guachalla, Luis Miguel; Gompf, Anne; Hartmann, Daniel; Rudolph, K. Lenhard] Univ Ulm, Max Planck Res Dept Stem Cell Aging, D-89069 Ulm, Germany; [Gross, Alexander; Kestler, Hans A.] Univ Ulm, Res Grp Bioinformat & Syst Biol, Inst Neural Informat Proc, D-89069 Ulm, Germany; [Schrezenmeier, Hubert] Univ Ulm, Inst Clin Transfus Med & Immunogenet, D-89069 Ulm, Germany; [Ju, Zhenyu] Hangzhou Normal Univ Coll Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China; [Hildner, Kai] Univ Erlangen Nurnberg, Max Eder Res Grp, Dept Med 1, D-91054 Erlangen, Germany; [Schambach, Axel] Hannover Med Sch, Inst Expt Hematol, D-30625 Hannover, Germany; [Wuestefeld, Torsten; Dauch, Daniel; Zender, Lars] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Wuestefeld, Torsten; Dauch, Daniel; Zender, Lars] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Hofmann, Wolf-Karsten] Mannheim Univ Hosp, Dept Hematol & Oncol, D-68167 Mannheim, Germany; [Nakauchi, Hiromitsu] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci, Tokyo 1088639, Japan; [Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Tokyo 1088639, Japan; [Schrezenmeier, Hubert] German Red Cross Blood Transfus Serv Baden Wurtte, D-76530 Baden Baden, Germany	Ulm University; Max Planck Society; Ulm University; Ulm University; Ulm University; University of Erlangen Nuremberg; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Ruprecht Karls University Heidelberg; University of Tokyo; Japan Science & Technology Agency (JST)	Rudolph, KL (corresponding author), Univ Ulm, Inst Mol Med, D-89069 Ulm, Germany.	klrudolph@fli-leibniz.de	Lechel, André/AAQ-2041-2021; Kestler, Hans A./D-5799-2012; Schambach, Axel/C-5491-2011; Morita, Yohei/N-1260-2014	Lechel, André/0000-0003-0221-6959; Kestler, Hans A./0000-0002-4759-5254; Morita, Yohei/0000-0003-4163-5080; Rudolph, Karl Lenhard/0000-0002-4839-2862; Hartmann, Daniel/0000-0003-4366-8986; Guachalla, Luis Miguel/0000-0003-1152-9930	DFG [Ru745-11, Ru745-10, SFB497/C11, ZE545-2]; European Union (Telomarker); BMBF (SyStaR); International Graduate School in Molecular Medicine at Ulm University [GSC270]	DFG(German Research Foundation (DFG)); European Union (Telomarker)(European Commission); BMBF (SyStaR)(Federal Ministry of Education & Research (BMBF)); International Graduate School in Molecular Medicine at Ulm University	This work was supported by the DFG (Ru745-11 and -10, by the SFB497/C11, ZE545-2), the European Union (Telomarker), the BMBF (SyStaR), and by the International Graduate School in Molecular Medicine at Ulm University (GSC270). We thank Susan Schlenner and Hans-Reimer Rodewald for providing IL7R Cre reporter mice and Hans-Joerg Fehling for providing ROSA RFP mice.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Beausejour CM, 2006, NATURE, V443, P404, DOI 10.1038/nature05221; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dorsey MJ, 1995, ONCOGENE, V11, P2255; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; KASTAN MB, 1991, CANCER RES, V51, P4279; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liu Y, 2011, BLOOD, V117, P3257, DOI 10.1182/blood-2010-09-304402; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; OHYASHIKI JH, 1994, CANCER RES, V54, P3557; Pelicci PG, 2004, J CLIN INVEST, V113, P4, DOI 10.1172/JCI200420750; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Schambach A, 2006, EXP HEMATOL, V34, P588, DOI 10.1016/j.exphem.2006.02.005; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Senga T, 2002, ONCOGENE, V21, P8186, DOI 10.1038/sj.onc.1205918; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; SULLIVAN DM, 1987, CANCER RES, V47, P3973; TIAN SS, 1994, BLOOD, V84, P1760; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Wang JW, 2011, CURR OPIN IMMUNOL, V23, P532, DOI 10.1016/j.coi.2011.05.004; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; WRIGHT WE, 1992, TRENDS GENET, V8, P193, DOI 10.1016/0168-9525(92)90232-S; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	54	237	247	1	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					1001	1014		10.1016/j.cell.2012.01.040	http://dx.doi.org/10.1016/j.cell.2012.01.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385964	hybrid			2022-12-01	WOS:000300985000019
J	Meyer, R				Meyer, Ryan			Finding the true value of US climate science	NATURE			English	Editorial Material									Calif Ocean Sci Trust, Oakland, CA USA		Meyer, R (corresponding author), Calif Ocean Sci Trust, Oakland, CA USA.	ryan.meyer@calost.org		Meyer, Ryan/0000-0001-9696-7651					0	7	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 9	2012	482	7384					133	133		10.1038/482133a	http://dx.doi.org/10.1038/482133a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	888HI	22318567	Bronze			2022-12-01	WOS:000299994100004
J	Suthana, N; Haneef, Z; Stern, J; Mukamel, R; Behnke, E; Knowlton, B; Fried, I				Suthana, Nanthia; Haneef, Zulfi; Stern, John; Mukamel, Roy; Behnke, Eric; Knowlton, Barbara; Fried, Itzhak			Memory Enhancement and Deep-Brain Stimulation of the Entorhinal Area	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELECTRICAL-STIMULATION; HIPPOCAMPAL-THETA; GLOBUS-PALLIDUS; RECALL; NEUROGENESIS; RESET	BACKGROUND The medial temporal structures, including the hippocampus and the entorhinal cortex, are critical for the ability to transform daily experience into lasting memories. We tested the hypothesis that deep-brain stimulation of the hippocampus or entorhinal cortex alters memory performance. METHODS We implanted intracranial depth electrodes in seven subjects to identify seizure-onset zones for subsequent epilepsy surgery. The subjects completed a spatial learning task during which they learned destinations within virtual environments. During half the learning trials, focal electrical stimulation was given below the threshold that elicits an afterdischarge (i.e., a neuronal discharge that occurs after termination of the stimulus). RESULTS Entorhinal stimulation applied while the subjects learned locations of landmarks enhanced their subsequent memory of these locations: the subjects reached these landmarks more quickly and by shorter routes, as compared with locations learned without stimulation. Entorhinal stimulation also resulted in a resetting of the phase of the theta rhythm, as shown on the hippocampal electroencephalogram. Direct hippocampal stimulation was not effective. In this small series, no adverse events associated with the procedure were observed. CONCLUSIONS Stimulation of the entorhinal region enhanced memory of spatial information when applied during learning. (Funded by the National Institutes of Health and the Dana Foundation.)	[Suthana, Nanthia; Mukamel, Roy; Behnke, Eric; Fried, Itzhak] Univ Calif Los Angeles, Dept Neurosurg, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Suthana, Nanthia; Mukamel, Roy; Behnke, Eric; Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Haneef, Zulfi; Stern, John] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Knowlton, Barbara] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Fried, Itzhak] Tel Aviv Univ, Funct Neurosurg Unit, Tel Aviv Med Ctr, IL-69978 Tel Aviv, Israel; [Fried, Itzhak] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Fried, I (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, David Geffen Sch Med, 740 Westwood Plaza, Los Angeles, CA 90095 USA.	ifried@mednet.ucla.edu	Mukamel, Roy/AAV-2900-2021	Mukamel, Roy/0000-0001-9359-8950; Stern, John/0000-0002-3549-1642; Suthana, Nanthia/0000-0002-8796-3277	National Institutes of Health [5T32NS07449]; National Institute of Neurological Disorders and Stroke [NS033221]; Dana Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033221, T32NS007449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dana Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the National Institutes of Health (5T32NS07449), the National Institute of Neurological Disorders and Stroke (NS033221), and the Dana Foundation.	AGNEW WF, 1990, EPILEPSIA, V31, pS27, DOI 10.1111/j.1528-1157.1990.tb05845.x; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Boon P, 2007, EPILEPSIA, V48, P1551, DOI 10.1111/j.1528-1167.2007.01005.x; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Coleshill SG, 2004, J NEUROSCI, V24, P1612, DOI 10.1523/JNEUROSCI.4352-03.2004; Davis KD, 1997, NAT MED, V3, P671, DOI 10.1038/nm0697-671; Delis D.C., 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Ehret A, 2001, J NEUROCHEM, V76, P555, DOI 10.1046/j.1471-4159.2001.00030.x; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ekstrom AD, 2006, HIPPOCAMPUS, V16, P101; Engel JJ, 1993, SURG TREATMENT EPILE, P743; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Fried I, 1993, STEREOTACTIC SURG RA, P149; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P121, DOI 10.1016/0028-3932(90)90095-6; GORDON B, 1990, ELECTROEN CLIN NEURO, V75, P371, DOI 10.1016/0013-4694(90)90082-U; HALGREN E, 1985, BRAIN COGNITION, V4, P287, DOI 10.1016/0278-2626(85)90022-3; HALGREN E, 1985, ELECTROEN CLIN NEURO, V61, P375, DOI 10.1016/0013-4694(85)91028-4; Hamani C, 2008, ANN NEUROL, V63, P119, DOI 10.1002/ana.21295; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hua M., 2005, WECHSLER MEMORY SCAL, V3; Jobst B, 2010, EPILEPSY RES, V89, P154, DOI 10.1016/j.eplepsyres.2009.08.017; Lacruz ME, 2010, NEUROSCIENCE, V170, P623, DOI 10.1016/j.neuroscience.2010.06.042; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A, V3; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McCartney H, 2004, HIPPOCAMPUS, V14, P684, DOI 10.1002/hipo.20019; Meyers JE., 1995, REY COMPLEX FIGURE T; SMITH ML, 1989, NEUROPSYCHOLOGIA, V27, P71, DOI 10.1016/0028-3932(89)90091-2; Soriano-Mas C, 2005, BEHAV BRAIN RES, V160, P141, DOI 10.1016/j.bbr.2004.11.025; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Suthana NA, 2009, J NEUROSCI, V29, P10512, DOI 10.1523/JNEUROSCI.0621-09.2009; Toda H, 2008, J NEUROSURG, V108, P132, DOI 10.3171/JNS/2008/108/01/0132; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; Vinogradova O S, 1996, Neurosci Behav Physiol, V26, P113, DOI 10.1007/BF02359414; Wechsler D., 1997, WECHSLER ADULT INTEL; Williams JM, 2003, HIPPOCAMPUS, V13, P109, DOI 10.1002/hipo.10082	40	285	299	4	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2012	366	6					502	510		10.1056/NEJMoa1107212	http://dx.doi.org/10.1056/NEJMoa1107212			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888GH	22316444	Green Accepted			2022-12-01	WOS:000299991300006
J	Fee, C; Burstin, H; Maselli, JH; Hsia, RY				Fee, Christopher; Burstin, Helen; Maselli, Judith H.; Hsia, Renee Y.			Association of Emergency Department Length of Stay With Safety-Net Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPROVING QUALITY; TIME; ANTIBIOTICS; ANALGESIA; VISITS; REFORM; IMPACT; PAIN	Context Performance measures, particularly pay for performance, may have unintended consequences for safety-net institutions caring for disproportionate shares of Medicaid or uninsured patients. Objective To describe emergency department (ED) compliance with proposed length-of-stay measures for admissions (8 hours or 480 minutes) and discharges, transfers, and observations (4 hours or 240 minutes) by safety-net status. Design, Setting, and Participants The 2008 National Hospital Ambulatory Medical Care Survey (NHAMCS) ED data were stratified by safety-net status (Centers for Disease Control and Prevention definition) and disposition (admission, discharge, observation, transfer). The 2008 NHAMCS is a national probability sample of 396 hospitals (90.2% unweighted response rate) and 34 134 patient records. Visits were excluded for patients younger than 18 years, missing length-of-stay data or dispositions of missing, other, left against medical advice, or dead on arrival. Median and 90th percentile ED lengths of stay were calculated for each disposition and admission/discharge sub-categories (critical care, psychiatric, routine) stratified by safety-net status. Multivariable analyses determined associations with length-of-stay measure compliance. Main Outcome Measures Emergency Department length-of-stay measure compliance by disposition and safety-net status. Results Of the 72.1% ED visits (N=24 719) included in the analysis, 42.3% were to safety-net EDs and 57.7% were to non-safety-net EDs. The median length of stay for safety-net was 269 minutes (interquartile range [IQR], 178-397 minutes) for admission vs 281 minutes (IQR, 178-401 minutes) for non-safety-net EDs; 156 minutes (IQR, 95-239 minutes) for discharge vs 148 minutes (IQR, 88-238 minutes); 355 minutes (IQR, 221-675 minutes) for observations vs 298 minutes (IQR, 195-440 minutes); and 235 minutes (IQR, 155-378 minutes) for transfers vs 239 minutes (IQR, 142-368 minutes). Safety-net status was not independently associated with compliance with ED length-of-stay measures; the odds ratio was 0.83 for admissions (95% CI, 0.52-1.34); 1.03 for discharges (95% CI, 0.83-1.27); 1.05 for observations (95% CI, 0.57-1.95), 1.30 for transfers (95% CI, 0.70-2.45]); or subcategories except for psychiatric discharges (1.67, [95% CI, 1.02-2.74]). Conclusion Compliance with proposed ED length-of-stay measures for admissions, discharges, transfers, and observations did not differ significantly between safety-net and non-safety-net hospitals. JAMA. 2012;307(5):476-482	[Fee, Christopher; Hsia, Renee Y.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Maselli, Judith H.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Burstin, Helen] Natl Qual Forum, Washington, DC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fee, C (corresponding author), Univ Calif San Francisco, Dept Emergency Med, 505 Parnassus Ave,POB 0208, San Francisco, CA 94143 USA.	christopher.fee@ucsf.edu			Google; NIH/NCRR/OD UCSF-CTSI [KL2 RR024130]; Robert Wood Johnson Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	Google(Google Incorporated); NIH/NCRR/OD UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors have completed and submitted the ICMJE form for Disclosure of Potential Conflicts of Interest. Dr Fee has reported that he received consultancy fees from Google and honoraria from the University of California, San Francisco Office of Continuing Medical Education for organizing and speaking at an annual CME course. Dr Burstin is a paid employee of the National Quality Forum. No other disclosures were reported.; This work was supported by grant KL2 RR024130 (Dr Hsia) from the NIH/NCRR/OD UCSF-CTSI and by the Robert Wood Johnson Foundation Physician Faculty Scholars Program (Dr Hsia).	Accreditation Council for Graduate Medical Education, EM MED GUID; Agency for Healthcare Research and Quality U.S. Department of Health & Human Services, HEALTHC COST UT PROJ; [Anonymous], 2010, NAT HLTH HOSP NETW F; [Anonymous], 2009, NAT VOL CONS STAND E; Burt Catharine W, 2004, Vital Health Stat 13, P1; Carr BG, 2007, J TRAUMA, V63, P9, DOI 10.1097/TA.0b013e31805d8f6b; Centers for Disease Control and Prevention, NHAMCS EST PROC AMB; Centers for Disease Control and Prevention, 2010, NHAMCS SCOP SAMPL DE; Chang G, 2011, ANN EMERG MED, V58, P127, DOI 10.1016/j.annemergmed.2010.12.003; Fee C, 2007, ANN EMERG MED, V50, P501, DOI 10.1016/j.annemergmed.2007.08.003; Fee Christopher, 2007, Ann Emerg Med, V50, pe1, DOI 10.1016/j.annemergmed.2007.03.019; Graff L, 2002, ACAD EMERG MED, V9, P1091, DOI 10.1197/aemj.9.11.1091; Herring A, 2009, ACAD EMERG MED, V16, P609, DOI 10.1111/j.1553-2712.2009.00428.x; Kulstad EB, 2010, AM J EMERG MED, V28, P304, DOI 10.1016/j.ajem.2008.12.014; Mills AM, 2010, POSTGRAD MED, V122, P75, DOI 10.3810/pgm.2010.01.2101; Mills AM, 2009, ACAD EMERG MED, V16, P603, DOI 10.1111/j.1553-2712.2009.00441.x; Moskop JC, 2009, ANN EMERG MED, V53, P605, DOI 10.1016/j.annemergmed.2008.09.019; New Zealand Ministry of Health, EM DEP; Ontario Ministry of Health and Long-Term Care, ONT WAIT TIM EM ROOM; Pines JM, 2008, ACAD EMERG MED, V15, P825, DOI 10.1111/j.1553-2712.2008.00200.x; Pines JM, 2007, ANN EMERG MED, V50, P510, DOI 10.1016/j.annemergmed.2007.07.021; Pines JM, 2010, ACAD EMERG MED, V17, P834, DOI 10.1111/j.1553-2712.2010.00780.x; Pines JM, 2010, ACAD EMERG MED, V17, P276, DOI 10.1111/j.1553-2712.2009.00676.x; Pines JM, 2009, ACAD EMERG MED, V16, P617, DOI 10.1111/j.1553-2712.2009.00456.x; Pines JM, 2009, ACAD EMERG MED, V16, P403, DOI 10.1111/j.1553-2712.2009.00381.x; Sills MR, 2011, ANN EMERG MED, V57, P191, DOI 10.1016/j.annemergmed.2010.08.027; Smulowitz P, 2009, INTERN EMERG MED, V4, P501, DOI 10.1007/s11739-009-0313-9; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Wang CJ, 2009, NEW ENGL J MED, V361, P1821, DOI 10.1056/NEJMp0907656; Weber EJ, 2011, ANN EMERG MED, V57, P79, DOI 10.1016/j.annemergmed.2010.08.013	30	40	40	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2012	307	5					476	482		10.1001/jama.2012.41	http://dx.doi.org/10.1001/jama.2012.41			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884SH	22298679	Green Accepted, Bronze			2022-12-01	WOS:000299728000028
J	Metzger, T; Gache, V; Xu, M; Cadot, B; Folker, ES; Richardson, BE; Gomes, ER; Baylies, MK				Metzger, Thomas; Gache, Vincent; Xu, Mu; Cadot, Bruno; Folker, Eric S.; Richardson, Brian E.; Gomes, Edgar R.; Baylies, Mary K.			MAP and kinesin-dependent nuclear positioning is required for skeletal muscle function	NATURE			English	Article							DROSOPHILA-MELANOGASTER; NEUROMUSCULAR-JUNCTION; MYOBLAST FUSION; PROTEIN; IDENTIFICATION; CELLS; LOCALIZATION; MICROTUBULES; MICE; DIFFERENTIATION	The basic unit of skeletal muscle in all metazoans is the multinucleate myofibre, within which individual nuclei are regularly positioned(1). The molecular machinery responsible for myonuclear positioning is not known. Improperly positioned nuclei are a hallmark of numerous diseases of muscle(2), including centronuclear myopathies(3), but it is unclear whether correct nuclear positioning is necessary for muscle function. Here we identify the microtubule-associated protein ensconsin (Ens)/microtubule-associated protein 7 (MAP7) and kinesin heavy chain (Khc)/Kif5b as essential, evolutionarily conserved regulators of myonuclear positioning in Drosophila and cultured mammalian myotubes. We find that these proteins interact physically and that expression of the Kif5b motor domain fused to the MAP7 microtubule-binding domain rescues nuclear positioning defects in MAP7-depleted cells. This suggests that MAP7 links Kif5b to the microtubule cytoskeleton to promote nuclear positioning. Finally, we show that myonuclear positioning is physiologically important. Drosophila ens mutant larvae have decreased locomotion and incorrect myonuclear positioning, and these phenotypes are rescued by muscle-specific expression of Ens. We conclude that improper nuclear positioning contributes to muscle dysfunction in a cell-autonomous fashion.	[Gache, Vincent; Cadot, Bruno; Gomes, Edgar R.] Univ Paris 06, INSERM, UMR S 787, F-75634 Paris, France; [Metzger, Thomas; Xu, Mu; Folker, Eric S.; Richardson, Brian E.; Baylies, Mary K.] Sloan Kettering Inst, Program Dev Biol, New York, NY 10065 USA; [Metzger, Thomas; Baylies, Mary K.] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Gomes, Edgar R.] Grp Hosp Pitie Salpetriere, Inst Myol, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Memorial Sloan Kettering Cancer Center; Cornell University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gomes, ER (corresponding author), Univ Paris 06, INSERM, UMR S 787, F-75634 Paris, France.	edgar.gomes@upmc.fr; m-baylies@ski.mskcc.org	Gache, vincent/M-9556-2015; CADOT, bruno/E-1710-2013; GACHE, vincent/L-1990-2019; Gomes, Edgar/ABH-7441-2020; Gomes, Edgar r/D-9000-2015	Gache, vincent/0000-0002-2928-791X; CADOT, bruno/0000-0002-1888-3898; GACHE, vincent/0000-0002-2928-791X; Gomes, Edgar/0000-0002-6941-4872; Gomes, Edgar r/0000-0002-6941-4872; Folker, Eric/0000-0003-1619-7330	National Institutes of Health (NIH) [GM056989, GM0781318]; Muscular Dystrophy Association (MDA); NIH [T32 BM008539]; Fondation pour la Recherche Medicale (FRM); Region Ile-de-France; INSERM Avenir; Agence Nationale de la Recherche (ANR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056989, R01GM078318, T32GM008539] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Region Ile-de-France(Region Ile-de-France); INSERM Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Anderson, K. Hadjantonakis, A. Hall and D. Sassoon for comments on the manuscript. We thank the Baylies and Gomes Laboratories for discussions, and R. Fernandez-Gonzalez for his assistance in computational analysis. The initial screens in Drosophila were supported by National Institutes of Health (NIH) grants GM056989 and GM0781318 to M.B.; the Drosophila nuclear positioning analysis was supported by a Muscular Dystrophy Association (MDA) grant to M.B. T.M. was supported initially by NIH Training Grant T32 BM008539. B.C. was supported initially by a Fondation pour la Recherche Medicale (FRM) fellowship. V.G. was supported initially by a Region Ile-de-France fellowship. Mammalian work was supported by Muscular Dystrophy Association (MDA), INSERM Avenir programme and Agence Nationale de la Recherche (ANR) grants to E.R.G.	Bai J, 2007, DEV CELL, V13, P828, DOI 10.1016/j.devcel.2007.10.003; Beckett K, 2006, INT REV NEUROBIOL, V75, P55, DOI 10.1016/S0074-7742(06)75003-6; Brendza KM, 1999, J BIOL CHEM, V274, P31506, DOI 10.1074/jbc.274.44.31506; Brent J., 2009, J VIS EXP, V1108, DOI [DOI 10.3791/1108, 10.3791/1108]; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; Bruusgaard JC, 2003, J PHYSIOL-LONDON, V551, P467, DOI 10.1113/jphysiol.2003.045328; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.3.CO;2-K; De Palma C, 2010, CELL DEATH DIFFER, V17, P1684, DOI 10.1038/cdd.2010.48; FENG GP, 1995, GENETICS, V139, P1679; FISCHERVIZE JA, 1994, DEVELOPMENT, V120, P2609; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102; Guerin CM, 2009, DEVELOPMENT, V136, P1411, DOI 10.1242/dev.031823; Halfon MS, 2002, GENESIS, V34, P135, DOI 10.1002/gene.10136; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Lewis E., 1968, METHOD FEEDING ETHAN; Louis M., 2008, J VIS, pe638, DOI [10.3791/638, DOI 10.3791/638]; Louis M, 2008, NAT NEUROSCI, V11, P187, DOI 10.1038/nn2031; MASSON D, 1993, J CELL BIOL, V123, P357, DOI 10.1083/jcb.123.2.357; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Meyerzon M, 2009, DEVELOPMENT, V136, P2725, DOI 10.1242/dev.038596; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Parlakian A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009299; PAVLATH GK, 1989, NATURE, V337, P570, DOI 10.1038/337570a0; PENA P, 1993, BIOCHEM BIOPH RES CO, V195, P785, DOI 10.1006/bbrc.1993.2114; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Richardson BE, 2007, DEVELOPMENT, V134, P4357, DOI 10.1242/dev.010678; Richardson Brian E., 2008, V475, P263, DOI 10.1007/978-1-59745-250-2_15; Sung HH, 2008, DEV CELL, V15, P866, DOI 10.1016/j.devcel.2008.10.006; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	39	167	168	3	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					120	+		10.1038/nature10914	http://dx.doi.org/10.1038/nature10914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22425998	Green Accepted			2022-12-01	WOS:000302343400046
J	Garcia-Cao, I; Song, MS; Hobbs, RM; Laurent, G; Giorgi, C; de Boer, VCJ; Anastasiou, D; Ito, K; Sasaki, AT; Rameh, L; Carracedo, A; Vander Heiden, MG; Cantley, LC; Pinton, P; Haigis, MC; Pandolfi, PP				Garcia-Cao, Isabel; Song, Min Sup; Hobbs, Robin M.; Laurent, Gaelle; Giorgi, Carlotta; de Boer, Vincent C. J.; Anastasiou, Dimitrios; Ito, Keisuke; Sasaki, Atsuo T.; Rameh, Lucia; Carracedo, Arkaitz; Vander Heiden, Matthew G.; Cantley, Lewis C.; Pinton, Paolo; Haigis, Marcia C.; Pandolfi, Pier Paolo			Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic State	CELL			English	Article							DNA-DAMAGE RESPONSE; C-MYC; CELL-SIZE; SIGNALING PATHWAY; PYRUVATE-KINASE; PHOSPHOINOSITIDE 3-KINASE; CANCER SUSCEPTIBILITY; GROWTH; DROSOPHILA; EXPRESSION	Decremental loss of PTEN results in cancer susceptibility and tumor progression. PTEN elevation might therefore be an attractive option for cancer prevention and therapy. We have generated several transgenic mouse lines with PTEN expression elevated to varying levels by taking advantage of bacterial artificial chromosome (BAC)-mediated transgenesis. The "Super-PTEN" mutants are viable and show reduced body size due to decreased cell number, with no effect on cell size. Unexpectedly, PTEN elevation at the organism level results in healthy metabolism characterized by increased energy expenditure and reduced body fat accumulation. Cells derived from these mice show reduced glucose and glutamine uptake and increased mitochondrial oxidative phosphorylation and are resistant to oncogenic transformation. Mechanistically we find that PTEN elevation orchestrates this metabolic switch by regulating PI3K-dependent and -independent pathways and negatively impacting two of the most pronounced metabolic features of tumor cells: glutaminolysis and the Warburg effect.	[Garcia-Cao, Isabel; Song, Min Sup; Hobbs, Robin M.; Ito, Keisuke; Carracedo, Arkaitz; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Canc Genet Program, Beth Israel Deaconess Canc Ctr,Dept Med, Boston, MA 02215 USA; [Garcia-Cao, Isabel; Song, Min Sup; Hobbs, Robin M.; Ito, Keisuke; Carracedo, Arkaitz; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Med Ctr, Boston, MA 02215 USA; [Laurent, Gaelle; de Boer, Vincent C. J.; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Cell Biol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA; [Giorgi, Carlotta; Pinton, Paolo] Univ Ferrara, ICSI, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; [Giorgi, Carlotta; Pinton, Paolo] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy; [Anastasiou, Dimitrios; Sasaki, Atsuo T.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol,Beth Israel Deaconess Med Ctr, Dept Med,Div Signal Transduct, Boston, MA 02115 USA; [Rameh, Lucia] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; University of Ferrara; University of Ferrara; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston Biomedical Research Institute; Massachusetts Institute of Technology (MIT)	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Canc Genet Program, Beth Israel Deaconess Canc Ctr,Dept Med, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Carracedo, Arkaitz/F-7029-2011; de Boer, Vincent CJ/L-2196-2016; Pinton, Paolo/J-8025-2012; Cantley, Lewis C/D-1800-2014; Giorgi, Carlotta/K-4649-2016; de Boer, Vincent C.J./F-4879-2010; Hobbs, Robin/I-2577-2014	Carracedo, Arkaitz/0000-0001-5957-1260; de Boer, Vincent CJ/0000-0001-9928-1698; Pinton, Paolo/0000-0001-7108-6508; Cantley, Lewis C/0000-0002-1298-7653; de Boer, Vincent C.J./0000-0001-9928-1698; Anastasiou, Dimitrios/0000-0002-1269-843X; Giorgi, Carlotta/0000-0002-2494-7405; Hobbs, Robin/0000-0002-3853-2614; Pandolfi, Pier Paolo/0000-0002-5352-5295; Sasaki, Atsuo/0000-0003-2963-4501	Human Frontier Science Program (HFSP); Spanish Ministry of Education and Science (MEC); NIH [R01 CA-82328-09, P01-CA089021, R01-GM41890]; Italian Association for Cancer Research (AIRC); NATIONAL CANCER INSTITUTE [P01CA089021, R01CA082328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Spanish Ministry of Education and Science (MEC)(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Bhasin for help with microarray analysis, C. Clower for assistance with PKM splicing assays, W.J. Haveman for mouse genotyping, and Kaitlyn Webster for IHC analysis. I.G.-C. was supported by fellowships from the Human Frontier Science Program (HFSP) and the Spanish Ministry of Education and Science (MEC). This work was supported by NIH grants R01 CA-82328-09 to P.P.P., P01-CA089021 and R01-GM41890 to L.C.C., and Italian Association for Cancer Research (AIRC) grant to P.P.P.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Atsumi T, 2002, CANCER RES, V62, P5881; Banito A, 2010, EMBO REP, V11, P353, DOI 10.1038/embor.2010.47; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Colombo SL, 2010, P NATL ACAD SCI USA, V107, P18868, DOI 10.1073/pnas.1012362107; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang H, 1999, DEVELOPMENT, V126, P5365; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; King A, 2009, CURR OPIN CELL BIOL, V21, P885, DOI 10.1016/j.ceb.2009.09.009; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li M, 2008, NAT CELL BIOL, V10, P1083, DOI 10.1038/ncb1768; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Liu WB, 2010, BIOCHEM BIOPH RES CO, V402, P507, DOI 10.1016/j.bbrc.2010.10.061; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Najafov A, 2010, P NATL ACAD SCI USA, V107, P19135, DOI 10.1073/pnas.1014047107; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Ravitz MJ, 2007, CANCER RES, V67, P11209, DOI 10.1158/0008-5472.CAN-06-4351; Ruderman N, 2001, SCIENCE, V291, P2558, DOI 10.1126/science.1060277; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; WEXLER H, 1979, J NATL CANCER I, V63, P1393; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zundel W, 2000, GENE DEV, V14, P391	74	259	270	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					49	62		10.1016/j.cell.2012.02.030	http://dx.doi.org/10.1016/j.cell.2012.02.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22401813	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000302235400009
J	Lamming, DW; Ye, L; Katajisto, P; Goncalves, MD; Saitoh, M; Stevens, DM; Davis, JG; Salmon, AB; Richardson, A; Ahima, RS; Guertin, DA; Sabatini, DM; Baur, JA				Lamming, Dudley W.; Ye, Lan; Katajisto, Pekka; Goncalves, Marcus D.; Saitoh, Maki; Stevens, Deanna M.; Davis, James G.; Salmon, Adam B.; Richardson, Arlan; Ahima, Rexford S.; Guertin, David A.; Sabatini, David M.; Baur, Joseph A.			Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity	SCIENCE			English	Article							LIFE-SPAN EXTENSION; CALORIE RESTRICTION; GLUCOSE-METABOLISM; COMPLEX 2; KINASE; TOR; SENSITIVITY; DROSOPHILA; ABLATION; RECEPTOR	Rapamycin, an inhibitor of mechanistic target of rapamycin complex 1 (mTORC1), extends the life spans of yeast, flies, and mice. Calorie restriction, which increases life span and insulin sensitivity, is proposed to function by inhibition of mTORC1, yet paradoxically, chronic administration of rapamycin substantially impairs glucose tolerance and insulin action. We demonstrate that rapamycin disrupted a second mTOR complex, mTORC2, in vivo and that mTORC2 was required for the insulin-mediated suppression of hepatic gluconeogenesis. Further, decreased mTORC1 signaling was sufficient to extend life span independently from changes in glucose homeostasis, as female mice heterozygous for both mTOR and mLST8 exhibited decreased mTORC1 activity and extended life span but had normal glucose tolerance and insulin sensitivity. Thus, mTORC2 disruption is an important mediator of the effects of rapamycin in vivo.	[Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] Seven Cambridge Ctr, Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Ye, Lan; Davis, James G.; Baur, Joseph A.] Univ Penn, Perelman Sch Med, Dept Physiol, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Goncalves, Marcus D.; Ahima, Rexford S.] Univ Penn, Perelman Sch Med, Dept Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Salmon, Adam B.; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Health San Antonio	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu; baur@mail.med.upenn.edu	Goncalves, Marcus/L-6073-2019; Ahima, Rexford/W-1394-2019; Lamming, Dudley/O-7191-2015	Goncalves, Marcus/0000-0002-0784-9248; Lamming, Dudley/0000-0002-0079-4467; Katajisto, Pekka/0000-0002-3033-4189; Baur, Joseph/0000-0001-8262-6549; /0000-0002-1446-7256	American Federation for Aging Research (AFAR); Bingham Trust from Penn's Institute on Aging; NIH [CA129105]; AFAR; Starr Foundation; Koch Institute; Ellison Medical Foundation; Damon Runyon Fellowship; Ruth L. Kirschstein National Research Service [1F32AG032833-01A1]; American Heart Association [7600031]; Academy of Finland; Foundations' post-doc pool; NATIONAL CANCER INSTITUTE [R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG032833] Funding Source: NIH RePORTER	American Federation for Aging Research (AFAR); Bingham Trust from Penn's Institute on Aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFAR; Starr Foundation; Koch Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Damon Runyon Fellowship; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Academy of Finland(Academy of Finland); Foundations' post-doc pool; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all the members of the Baur and Sabatini laboratories, especially D. Frederick, A. Hutchins, P. Hsu, H. Keys, N. Kalaany, M. Laplante, M. Pacold, and Y. Sancak for help with protocols, reagents, and advice. We also thank D. Cohen and D. Harrison for valuable advice and consultation, C. Patterson for critical reading of the manuscript, and G. Bell of the Whitehead Institute Bioinformatics and Research Computing group for help with statistical analysis and R. The mtor-, Raptor-, and mlst8-deficient mice were generated in collaboration with Bristol-Meyers Squibb. Rictor conditional knockout mice were the kind gift of M. Magnuson. This project was supported by a research grant from the American Federation for Aging Research (AFAR) and a Bingham Trust Pilot Award from Penn's Institute on Aging to J.A.B.; a grant from NIH (CA129105) and awards from AFAR, the Starr Foundation, the Koch Institute Frontier Research Program, and the Ellison Medical Foundation to D.M.S.; and a Damon Runyon Fellowship to D.A.G. D.W.L. was supported by a Ruth L. Kirschstein National Research Service Award (1F32AG032833-01A1), L.Y. is supported by a postdoctoral fellowship from the American Heart Association (7600031), and P.K. is supported by the Academy of Finland and the Foundations' post-doc pool. Core services were provided by Penn's Diabetes and Endocrinology Research Center (P30DK19525). D.M.S. is an investigator of the Howard Hughes Medical Institute.	Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; OLSHANSKY SJ, 1985, AM J PUBLIC HEALTH, V75, P754, DOI 10.2105/AJPH.75.7.754; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Teutonico A, 2005, J AM SOC NEPHROL, V16, P3128, DOI 10.1681/ASN.2005050487; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Weindruch R., 1988, RETARDATION AGING DI; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181	30	809	847	3	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1638	1643		10.1126/science.1215135	http://dx.doi.org/10.1126/science.1215135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461615	Green Accepted, Green Submitted			2022-12-01	WOS:000302062600049
J	Turcan, S; Rohle, D; Goenka, A; Walsh, LA; Fang, F; Yilmaz, E; Campos, C; Fabius, AWM; Lu, C; Ward, PS; Thompson, CB; Kaufman, A; Guryanova, O; Levine, R; Heguy, A; Viale, A; Morris, LGT; Huse, JT; Mellinghoff, IK; Chan, TA				Turcan, Sevin; Rohle, Daniel; Goenka, Anuj; Walsh, Logan A.; Fang, Fang; Yilmaz, Emrullah; Campos, Carl; Fabius, Armida W. M.; Lu, Chao; Ward, Patrick S.; Thompson, Craig B.; Kaufman, Andrew; Guryanova, Olga; Levine, Ross; Heguy, Adriana; Viale, Agnes; Morris, Luc G. T.; Huse, Jason T.; Mellinghoff, Ingo K.; Chan, Timothy A.			IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype	NATURE			English	Article							ISLAND METHYLATOR PHENOTYPE; INTEGRATED GENOMIC ANALYSIS; DNA METHYLATION; GLIOBLASTOMA-MULTIFORME; ANAPLASTIC ASTROCYTOMA; COLORECTAL-CANCER; GENE; PATHWAYS; IDENTIFICATION; ABNORMALITIES	Both genome-wide genetic and epigenetic alterations are fundamentally important for the development of cancers, but the interdependence of these aberrations is poorly understood. Glioblastomas and other cancers with the CpG island methylator phenotype (CIMP) constitute a subset of tumours with extensive epigenomic aberrations and a distinct biology(1-3). Glioma CIMP (G-CIMP) is a powerful determinant of tumour pathogenicity, but the molecular basis of G-CIMP remains unresolved. Here we show that mutation of a single gene, isocitrate dehydrogenase 1 (IDH1), establishes G-CIMP by remodelling the methylome. This remodelling results in reorganization of the methylome and transcriptome. Examination of the epigenome of a large set of intermediate-grade gliomas demonstrates a distinct G-CIMP phenotype that is highly dependent on the presence of IDH mutation. Introduction of mutant IDH1 into primary human astrocytes alters specific histone marks, induces extensive DNA hypermethylation, and reshapes the methylome in a fashion that mirrors the changes observed in G-CIMP-positive lower-grade gliomas. Furthermore, the epigenomic alterations resulting from mutant IDH1 activate key gene expression programs, characterize G-CIMP-positive proneural glioblastomas but not other glioblastomas, and are predictive of improved survival. Our findings demonstrate that IDH mutation is the molecular basis of CIMP in gliomas, provide a framework for understanding oncogenesis in these gliomas, and highlight the interplay between genomic and epigenomic changes in human cancers.	[Turcan, Sevin; Rohle, Daniel; Goenka, Anuj; Walsh, Logan A.; Fang, Fang; Yilmaz, Emrullah; Campos, Carl; Fabius, Armida W. M.; Kaufman, Andrew; Guryanova, Olga; Levine, Ross; Heguy, Adriana; Morris, Luc G. T.; Huse, Jason T.; Mellinghoff, Ingo K.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Rohle, Daniel; Mellinghoff, Ingo K.; Chan, Timothy A.] Weill Cornell Coll Med, New York, NY 10065 USA; [Goenka, Anuj; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Lu, Chao; Ward, Patrick S.] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Morris, Luc G. T.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA; [Mellinghoff, Ingo K.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	mellingi@mskcc.org; chant@mskcc.org	Heguy, Adriana/GPP-3907-2022; Lu, Chao/E-8047-2012; Turcan, Sevin/AAF-1095-2019; Yilmaz, Emrullah/ABA-5486-2021; Yilmaz, Emrullah/AAR-6228-2021; Chan, Timothy A/ABD-5850-2021; levine, ross/AAE-7658-2019; Ward, Patrick/H-2361-2014	Turcan, Sevin/0000-0002-0885-5607; Yilmaz, Emrullah/0000-0003-2308-713X; Mellinghoff, Ingo/0000-0002-4347-8149; Ward, Patrick/0000-0001-6437-8174; Walsh, Logan/0000-0001-8771-2577; Guryanova, Olga/0000-0002-6514-8466; Lu, Chao/0000-0003-0982-8122; Campos, Carl/0000-0002-7616-8518	National Institutes of Health [R01CA154767-01]; National Cancer Institute [U54-CA143798]; American Society of Clinical Oncology; Doris Duke Charitable Fund; National Brain Tumor Society; MSKCC Brain Tumor Center; Louis Gerstner Foundation; STARR Cancer Consortium; Sontag Foundation; NATIONAL CANCER INSTITUTE [U54CA143798, P30CA008748, R01CA154767, T32CA009685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Clinical Oncology; Doris Duke Charitable Fund(Doris Duke Charitable Foundation (DDCF)); National Brain Tumor Society; MSKCC Brain Tumor Center; Louis Gerstner Foundation; STARR Cancer Consortium; Sontag Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Kayserian, K. Huberman, I. Dolgalev and S. Thomas for technical expertise. We thank C. Sawyers and E. Holland for helpful discussions. This grant was supported in part by the National Institutes of Health (R01CA154767-01) (T. A. C.), the National Cancer Institute (U54-CA143798) (I. K. M.), an Advanced Clinical Research Award in Glioma from the American Society of Clinical Oncology (I. K. M.), the Doris Duke Charitable Fund (I. K. M., T. A. C.), a National Brain Tumor Society Systems Biology Research Grant (I. K. M.), the MSKCC Brain Tumor Center (T. A. C.), the Louis Gerstner Foundation (T. A. C.), the STARR Cancer Consortium (T. A. C.) and the Sontag Foundation (T.A.C., I.K.M.).	Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; Cheng YW, 2008, CLIN CANCER RES, V14, P6005, DOI 10.1158/1078-0432.CCR-08-0216; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; Docherty SJ, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-3; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Major JE, 2007, BIOINFORMATICS, V23, P3091, DOI 10.1093/bioinformatics/btm339; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pieper RO, 2003, FRONT BIOSCI-LANDMRK, V8, pS19, DOI 10.2741/983; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2008, CANCER RES, V68, P2564, DOI 10.1158/0008-5472.CAN-07-6388; Sonoda Y, 2001, CANCER RES, V61, P4956; Sonoda Y, 2001, CANCER RES, V61, P6674; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Vlassenbroeck I, 2008, J MOL DIAGN, V10, P332, DOI 10.2353/jmoldx.2008.070169; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	42	1297	1337	2	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2012	483	7390					479	U137		10.1038/nature10866	http://dx.doi.org/10.1038/nature10866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22343889	Green Accepted			2022-12-01	WOS:000301771200046
J	Alder, A; Jamil, M; Marzorati, M; Bruno, M; Vermathen, M; Bigler, P; Ghisla, S; Bouwmeester, H; Beyer, P; Al-Babili, S				Alder, Adrian; Jamil, Muhammad; Marzorati, Mattia; Bruno, Mark; Vermathen, Martina; Bigler, Peter; Ghisla, Sandro; Bouwmeester, Harro; Beyer, Peter; Al-Babili, Salim			The Path from beta-Carotene to Carlactone, a Strigolactone-Like Plant Hormone	SCIENCE			English	Article							CLEAVAGE OXYGENASES; BIOSYNTHESIS; GERMINATION; STRIGA; INHIBITION; METABOLISM; OROBANCHE; CATALYZE; ENZYMES	Strigolactones, phytohormones with diverse signaling activities, have a common structure consisting of two lactones connected by an enol-ether bridge. Strigolactones derive from carotenoids via a pathway involving the carotenoid cleavage dioxygenases 7 and 8 (CCD7 and CCD8) and the iron-binding protein D27. We show that D27 is a beta-carotene isomerase that converts all-trans-beta-carotene into 9-cis-beta-carotene, which is cleaved by CCD7 into a 9-cis-configured aldehyde. CCD8 incorporates three oxygens into 9-cis-beta-apo-10'-carotenal and performs molecular rearrangement, linking carotenoids with strigolactones and producing carlactone, a compound with strigolactone-like biological activities. Knowledge of the structure of carlactone will be crucial for understanding the biology of strigolactones and may have applications in combating parasitic weeds.	[Alder, Adrian; Bruno, Mark; Beyer, Peter; Al-Babili, Salim] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Jamil, Muhammad; Bouwmeester, Harro] Wageningen Univ, Lab Plant Physiol, NL-6700 AR Wageningen, Netherlands; [Marzorati, Mattia; Vermathen, Martina; Bigler, Peter] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Ghisla, Sandro] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Bouwmeester, Harro] Ctr Biosyst Genom, NL-6700 AR Wageningen, Netherlands; [Beyer, Peter; Al-Babili, Salim] Ctr Biol Signalling Studies Bioss, D-79104 Freiburg, Germany	University of Freiburg; Wageningen University & Research; University of Bern; University of Konstanz; Centre for BioSystems Genomics	Al-Babili, S (corresponding author), Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.	salim.albabili@biologie.uni-freiburg.de	Jamil, Muhammad/D-8395-2014; Vermathen, Martina/ABA-1385-2020; Jamil, Muhammad/M-8923-2015	Jamil, Muhammad/0000-0001-5127-7454; Jamil, Muhammad/0000-0003-0221-518X; Bouwmeester, Harro/0000-0003-0907-2732; Al-Babili, Salim/0000-0003-4823-2882; Vermathen, Martina/0000-0002-0796-1643	Deutsche Forschungsgemeinschaft [AL892/1-4, Graduiertenkolleg 1305]; Higher Education Commission of Pakistan; Netherlands Organization for Scientific Research [865.06.002, 834.08.001]; Centre for BioSystems Genomics, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for BioSystems Genomics, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank S. Schurch and C. Buhr for technical help with ESI-MS analysis, E. Decker for valuable discussions, B. Zwanenburg for supplying GR24, W. Boland for beta-apo-13-carotenone, Y. Wang for seeds of rice d27, L. Zhu for seeds of htd-1, and J. Kyozuka for seeds of d3 and d10 mutants. Supported by the Deutsche Forschungsgemeinschaft (grant AL892/1-4 and the Graduiertenkolleg 1305 "Plant Signal Systems"), the Higher Education Commission of Pakistan, the Netherlands Organization for Scientific Research (VICI grant 865.06.002 and equipment grant 834.08.001), and the Centre for BioSystems Genomics, a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. Materials are available under an MTA agreement with the University of Freiburg. The University of Freiburg has filed European patent application (number 11 003 470.9) on carlactone and its applications.	*ADV CHEM DEV INC, 2008, ACD SHIFT PRED SOFTW; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Alder A, 2008, BIOCHEM J, V416, P289, DOI 10.1042/BJ20080568; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Bartley GE, 1999, EUR J BIOCHEM, V259, P396, DOI 10.1046/j.1432-1327.1999.00051.x; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Bouvier F, 2005, TRENDS PLANT SCI, V10, P187, DOI 10.1016/j.tplants.2005.02.007; Chojnacka K, 2011, ORG BIOMOL CHEM, V9, P5350, DOI 10.1039/c1ob05751k; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Englert G, 1995, CAROTENOIDS B, V1B; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Leyser O, 2008, DEV CELL, V15, P337, DOI 10.1016/j.devcel.2008.08.008; Leyser O, 2009, PLANT CELL ENVIRON, V32, P694, DOI 10.1111/j.1365-3040.2009.01930.x; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Medina HR, 2011, MOL MICROBIOL, V82, P199, DOI 10.1111/j.1365-2958.2011.07805.x; Moise AR, 2005, TRENDS PLANT SCI, V10, P178, DOI 10.1016/j.tplants.2005.02.006; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Schlicht M, 2008, PLANT J, V55, P709, DOI 10.1111/j.1365-313X.2008.03543.x; Schwartz SH, 2004, J BIOL CHEM, V279, P46940, DOI 10.1074/jbc.M409004200; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wang YH, 2011, CURR OPIN PLANT BIOL, V14, P94, DOI 10.1016/j.pbi.2010.11.002; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Yoneyama K, 2009, PEST MANAG SCI, V65, P467, DOI 10.1002/ps.1726; Yu QJ, 2011, J BIOL CHEM, V286, P8666, DOI 10.1074/jbc.M110.208017; Zechmeister L., 1962, CIS T ISOMERIC CAROT; Zwanenburg B, 2009, PEST MANAG SCI, V65, P478, DOI 10.1002/ps.1706	32	548	599	19	324	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2012	335	6074					1348	1351		10.1126/science.1218094	http://dx.doi.org/10.1126/science.1218094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22422982	Green Submitted			2022-12-01	WOS:000301531600047
J	Garcia, SM; Kolding, J; Rice, J; Rochet, MJ; Zhou, S; Arimoto, T; Beyer, JE; Borges, L; Bundy, A; Dunn, D; Fulton, EA; Hall, M; Heino, M; Law, R; Makino, M; Rijnsdorp, AD; Simard, F; Smith, ADM				Garcia, S. M.; Kolding, J.; Rice, J.; Rochet, M. -J.; Zhou, S.; Arimoto, T.; Beyer, J. E.; Borges, L.; Bundy, A.; Dunn, D.; Fulton, E. A.; Hall, M.; Heino, M.; Law, R.; Makino, M.; Rijnsdorp, A. D.; Simard, F.; Smith, A. D. M.			Reconsidering the Consequences of Selective Fisheries	SCIENCE			English	Editorial Material							BY-CATCH; MANAGING FISHERIES; MANAGEMENT; ECOSYSTEM; FISH; CONSERVATION; PHILOSOPHY; COMMUNITY; EVOLUTION; ATLANTIC		[Rochet, M. -J.] IFREMER, F-44300 Nantes, France; [Garcia, S. M.; Kolding, J.; Rice, J.; Makino, M.] Fisheries Expert Grp, Commiss Ecosyst Management, Int Union Conservat Nat IUCN CEM, B-1000 Brussels, Belgium; [Kolding, J.] Univ Bergen, Dept Biol, N-5020 Bergen, Norway; [Rice, J.] Fisheries & Oceans, Ottawa, ON K1A OE6, Canada; [Zhou, S.] CSIRO Marine & Atmospher Res, Brisbane, Qld 4001, Australia; [Arimoto, T.] Tokyo Univ Marine Sci & Technol, Tokyo 1088477, Japan; [Beyer, J. E.] Danish Natl Inst Aquat Resources DTU Aqua, DK-2920 Charlottenlund, Denmark; [Borges, L.] FishFix, Brussels, Belgium; [Bundy, A.] Bedford Inst Oceanog, Dartmouth, NS 83B 1A5, Canada; [Dunn, D.] Duke Univ, Marine Geospatial Ecol Lab, Beaufort, NC 28516 USA; [Fulton, E. A.; Smith, A. D. M.] CSIRO Marine & Atmospher Res, Hobart, Tas 7000, Australia; [Hall, M.] Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA; [Heino, M.] Inst Marine Res, N-5005 Bergen, Norway; [Heino, M.] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Law, R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Makino, M.] Fisheries Res Agcy, Yokohama, Kanagawa 2206115, Japan; [Simard, F.] IUCN, Global Marine Programme, CH-1196 Gland, Switzerland; [Rijnsdorp, A. D.] Inst Marine Resources & Ecosyst Studies IMARES, NL-1976 Ijmuiden, Netherlands	Ifremer; University of Bergen; Fisheries & Oceans Canada; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Tokyo University of Marine Science & Technology; Technical University of Denmark; Bedford Institute of Oceanography; Duke University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Institute of Marine Research - Norway; International Institute for Applied Systems Analysis (IIASA); University of York - UK; Fisheries Research Agency - Japan; Wageningen University & Research	Rochet, MJ (corresponding author), IFREMER, F-44300 Nantes, France.	Marie.Joelle.Rochet@ifremer.fr	Rijnsdorp, Adriaan/A-4217-2008; Bundy, Alida/H-2884-2015; GARCIA, Serge Michel/D-6758-2012; Fulton, Beth/AAJ-1398-2021; Zhou, Shijie/A-1886-2010; Fulton, Beth/A-2871-2008; Smith, Tony D/A-4017-2012; Heino, Mikko P/C-7241-2009	Rijnsdorp, Adriaan/0000-0003-0785-9662; Bundy, Alida/0000-0002-4282-0715; Fulton, Beth/0000-0002-5904-7917; Zhou, Shijie/0000-0002-9358-1013; Fulton, Beth/0000-0002-5904-7917; Heino, Mikko P/0000-0003-2928-3940; Dunn, Daniel/0000-0001-8932-0681; Beyer, Jan/0000-0002-4310-4112				Andersen KH, 2010, P ROY SOC B-BIOL SCI, V277, P795, DOI 10.1098/rspb.2009.1512; Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; [Anonymous], SAINSBURYS LAUNCHES; Beverton R.J.H., 1957, DYNAMICS EXPLOITED F, V1st; Birkeland C, 2005, TRENDS ECOL EVOL, V20, P356, DOI 10.1016/j.tree.2005.03.015; Bundy A, 2005, ICES J MAR SCI, V62, P503, DOI 10.1016/j.icesjms.2004.12.008; Clucas I., 1997, STUDY OPTIONS UTILIZ; Constable AJ, 2000, ICES J MAR SCI, V57, P778, DOI 10.1006/jmsc.2000.0725; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; Dunn DC, 2011, FISH FISH, V12, P110, DOI 10.1111/j.1467-2979.2010.00388.x; FAO, 2011, 957 FAO, P957; Garcia S. M., 2011, SCI WORKSH NAG JAP 1; Garcia SM, 2010, PHILOS T R SOC B, V365, P2869, DOI 10.1098/rstb.2010.0171; GOBERT B, 1994, FISH RES, V19, P87, DOI 10.1016/0165-7836(94)90016-7; Hall SJ, 2005, FISH FISH, V6, P134, DOI 10.1111/j.1467-2979.2005.00183.x; Halliday RG, 2002, FISH RES, V57, P211, DOI 10.1016/S0165-7836(02)00079-6; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Jul-Larsen E., 2003, 42612 FAO; Kennelly SJ, 2002, FISH FISH, V3, P340, DOI 10.1046/j.1467-2979.2002.00090.x; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Link JS, 2011, FISH FISH, V12, P152, DOI 10.1111/j.1467-2979.2011.00411.x; Maunder MN, 2002, FISH FISH, V3, P251, DOI 10.1046/j.1467-2979.2002.00089.x; Misund O.A., 2002, HDB FISH BIOL FISHER, VVol. II, P13, DOI DOI 10.1002/9780470693919.CH2; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; POPE JG, 1991, ICES MAR SC, V193, P22; Rochet MJ, 2012, P ROY SOC B-BIOL SCI, V279, P284, DOI 10.1098/rspb.2011.0893; Rochet MJ, 2011, CAN J FISH AQUAT SCI, V68, P469, DOI 10.1139/F10-159; SISSENWINE MP, 1987, CAN J FISH AQUAT SCI, V44, P913, DOI 10.1139/f87-110; UN, 2002, ACONF19920 UN; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zhou SJ, 2010, P NATL ACAD SCI USA, V107, P9485, DOI 10.1073/pnas.0912771107	33	320	326	0	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1045	1047		10.1126/science.1214594	http://dx.doi.org/10.1126/science.1214594			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383833	Green Published			2022-12-01	WOS:000300931100027
J	Wu, CY; Asokan, SB; Berginski, ME; Haynes, EM; Sharpless, NE; Griffith, JD; Gomez, SM; Bear, JE				Wu, Congying; Asokan, Sreeja B.; Berginski, Matthew E.; Haynes, Elizabeth M.; Sharpless, Norman E.; Griffith, Jack D.; Gomez, Shawn M.; Bear, James E.			Arp2/3 Is Critical for Lamellipodia and Response to Extracellular Matrix Cues but Is Dispensable for Chemotaxis	CELL			English	Article							EUKARYOTIC CHEMOTAXIS; ACTIN-FILAMENTS; CELL-MIGRATION; LEADING-EDGE; COMPLEX; MOTILITY; FIBROBLASTS; DICTYOSTELIUM; MECHANISMS; NETWORKS	Lamellipodia are sheet-like, leading edge protrusions in firmly adherent cells that contain Arp2/3-generated dendritic actin networks. Although lamellipodia are widely believed to be critical for directional cell motility, this notion has not been rigorously tested. Using fibroblasts derived from Ink4a/Arf-deficient mice, we generated a stable line depleted of Arp2/3 complex that lacks lamellipodia. This line shows defective random cell motility and relies on a filopodia-based protrusion system. Utilizing a microfluidic gradient generation system, we tested the role of Arp2/3 complex and lamellipodia in directional cell migration. Surprisingly, Arp2/3-depleted cells respond normally to shallow gradients of PDGF, indicating that lamellipodia are not required for fibroblast chemotaxis. Conversely, these cells cannot respond to a surface-bound gradient of extracellular matrix (haptotaxis). Consistent with this finding, cells depleted of Arp2/3 fail to globally align focal adhesions, suggesting that one principle function of lamellipodia is to organize cell-matrix adhesions in a spatially coherent manner.	[Wu, Congying; Asokan, Sreeja B.; Haynes, Elizabeth M.; Bear, James E.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Berginski, Matthew E.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Berginski, Matthew E.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Berginski, Matthew E.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Wu, Congying; Asokan, Sreeja B.; Haynes, Elizabeth M.; Sharpless, Norman E.; Griffith, Jack D.; Bear, James E.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Griffith, Jack D.] Univ N Carolina, Sch Med, Dept Biochem, Chapel Hill, NC 27599 USA; [Bear, James E.] Univ N Carolina, Sch Med, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bear, JE (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	jbear@email.unc.edu		Haynes, Elizabeth/0000-0002-5294-018X; Sharpless, Norman/0000-0001-7078-9455; Gomez, Shawn/0000-0002-8251-4552	HHMI, NIH [GM083035, UO1-CA141576, DK037871, GM31819, ES 13773]; LCCC Electron Microscopy Core [NIH CA16086]; UNC-Olympus Imaging Research Center, UNC Research Computing; Allbrittion lab; NATIONAL CANCER INSTITUTE [R01CA163896, P30CA016086, U01CA141576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083035, R01GM031819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379] Funding Source: NIH RePORTER	HHMI, NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LCCC Electron Microscopy Core; UNC-Olympus Imaging Research Center, UNC Research Computing; Allbrittion lab; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge support from HHMI, NIH grants to J.E.B. (GM083035), N.E.S. (UO1-CA141576), S. M. G. (DK037871), and J.D.G. (GM31819, ES 13773), the LCCC Electron Microscopy Core (supported by NIH CA16086) the UNC-Olympus Imaging Research Center, UNC Research Computing, the Allbrittion lab for use of facilities, members of the Bear lab for critical discussions, Zenon Rajfur for assistance with microinjection, and Klaus Hahn for the mCherry-FAK construct.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Di Nardo A, 2005, P NATL ACAD SCI USA, V102, P16263, DOI 10.1073/pnas.0508228102; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Melvin AT, 2011, BIOPHYS J, V100, P1893, DOI 10.1016/j.bpj.2011.02.047; Monypenny J, 2009, MOL CELL BIOL, V29, P2730, DOI 10.1128/MCB.01285-08; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nicholson-Dykstra SM, 2008, CELL MOTIL CYTOSKEL, V65, P904, DOI 10.1002/cm.20312; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ozgur S, 2011, J STRUCT BIOL, V174, P37, DOI 10.1016/j.jsb.2010.10.015; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; SCHWOB E, 1992, NATURE, V355, P179, DOI 10.1038/355179a0; Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; THIERY JP, 1984, CELL DIFFER DEV, V15, P1, DOI 10.1016/0045-6039(84)90024-1; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Vitriol EA, 2007, P NATL ACAD SCI USA, V104, P6702, DOI 10.1073/pnas.0701801104; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wickramarachchi DC, 2010, AUTOIMMUNITY, V43, P64, DOI 10.3109/08916930903374634; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yae K, 2006, MOL CELL BIOL, V26, P6185, DOI 10.1128/MCB.00018-06; Zaki M, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-28	38	320	325	3	69	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					973	987		10.1016/j.cell.2011.12.034	http://dx.doi.org/10.1016/j.cell.2011.12.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385962	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000300985000017
J	Savas, JN; Toyama, BH; Xu, T; Yates, JR; Hetzer, MW				Savas, Jeffrey N.; Toyama, Brandon H.; Xu, Tao; Yates, John R., III; Hetzer, Martin W.			Extremely Long-Lived Nuclear Pore Proteins in the Rat Brain	SCIENCE			English	Article							MOUSE-BRAIN; TURNOVER; CELLS; MYELIN		[Toyama, Brandon H.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Savas, Jeffrey N.; Xu, Tao; Yates, John R., III] Scripps Res Inst, Dept Biol Chem, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Toyama, Brandon/0000-0002-8355-9138	Hewitt Foundation; Ellison Medical foundation; Glenn foundation; National Institute of Aging [F32AG039127]; NIH [P41 RR011823, P01 AG031097, HHSN268201000035C, R01 MH067880, P30 CA014195]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039127, P01AG031097] Funding Source: NIH RePORTER	Hewitt Foundation; Ellison Medical foundation(Lawrence Ellison Foundation); Glenn foundation; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are supported by the Hewitt Foundation (B.H.T.); the Ellison Medical and Glenn foundations (M.W.H.); National Institute of Aging fellowship F32AG039127 (J.N.S.); and NIH grants P41 RR011823, P01 AG031097, HHSN268201000035C, and R01 MH067880 (J.R.Y. and J.N.S.) and P30 CA014195 (M.W.H.). The RAW files and parameter files are publicly available at http://fields.scripps.edu/published/ellnpp2011/.	Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Capelson M, 2010, COLD SH Q B, V75, P585, DOI 10.1101/sqb.2010.75.059; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; FISCHER CA, 1974, BRAIN RES, V74, P51, DOI 10.1016/0006-8993(74)90111-5; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; SHAPIRA R, 1981, J NEUROCHEM, V36, P1427, DOI 10.1111/j.1471-4159.1981.tb00582.x; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028	8	198	198	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					942	942		10.1126/science.1217421	http://dx.doi.org/10.1126/science.1217421			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22300851	Green Accepted			2022-12-01	WOS:000300931800038
J	Becker, T; Franckenberg, S; Wickles, S; Shoemaker, CJ; Anger, AM; Armache, JP; Sieber, H; Ungewickell, C; Berninghausen, O; Daberkow, I; Karcher, A; Thomm, M; Hopfner, KP; Green, R; Beckmann, R				Becker, Thomas; Franckenberg, Sibylle; Wickles, Stephan; Shoemaker, Christopher J.; Anger, Andreas M.; Armache, Jean-Paul; Sieber, Heidemarie; Ungewickell, Charlotte; Berninghausen, Otto; Daberkow, Ingo; Karcher, Annette; Thomm, Michael; Hopfner, Karl-Peter; Green, Rachel; Beckmann, Roland			Structural basis of highly conserved ribosome recycling in eukaryotes and archaea	NATURE			English	Article							MESSENGER-RNA DECAY; NO-GO DECAY; FREE PROTEIN-SYNTHESIS; X-RAY-STRUCTURE; ATP-BINDING; TRANSLATION TERMINATION; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; 80S RIBOSOME; THERMOCOCCUS-KODAKARAENSIS	Ribosome-driven protein biosynthesis is comprised of four phases: initiation, elongation, termination and recycling. In bacteria, ribosome recycling requires ribosome recycling factor and elongation factor G, and several structures of bacterial recycling complexes have been determined. In the eukaryotic and archaeal kingdoms, however, recycling involves the ABC-type ATPase ABCE1 and little is known about its structural basis. Here we present cryo-electron microscopy reconstructions of eukaryotic and archaeal ribosome recycling complexes containing ABCE1 and the termination factor paralogue Pelota. These structures reveal the overall binding mode of ABCE1 to be similar to canonical translation factors. Moreover, the iron-sulphur cluster domain of ABCE1 interacts with and stabilizes Pelota in a conformation that reaches towards the peptidyl transferase centre, thus explaining how ABCE1 may stimulate peptide-release activity of canonical termination factors. Using the mechanochemical properties of ABCE1, a conserved mechanism in archaea and eukaryotes is suggested that couples translation termination to recycling, and eventually to re-initiation.	[Becker, Thomas; Franckenberg, Sibylle; Wickles, Stephan; Anger, Andreas M.; Armache, Jean-Paul; Sieber, Heidemarie; Ungewickell, Charlotte; Berninghausen, Otto; Karcher, Annette; Hopfner, Karl-Peter; Beckmann, Roland] Univ Munich, Dept Biochem, Gene Ctr, D-81377 Munich, Germany; [Becker, Thomas; Franckenberg, Sibylle; Wickles, Stephan; Anger, Andreas M.; Armache, Jean-Paul; Sieber, Heidemarie; Ungewickell, Charlotte; Berninghausen, Otto; Karcher, Annette; Hopfner, Karl-Peter; Beckmann, Roland] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci Munich CiPSM, D-81377 Munich, Germany; [Shoemaker, Christopher J.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Karcher, Annette] Tietz Video & Image Proc Syst GmbH, D-82131 Gauting, Germany; [Thomm, Michael] Univ Icking, D-82057 Icking, Germany; [Thomm, Michael] Univ Regensburg, Dept Microbiol, NWF Biol & Preclin Med 3, D-93053 Regensburg, Germany	University of Munich; University of Munich; Howard Hughes Medical Institute; Johns Hopkins University; University of Regensburg	Beckmann, R (corresponding author), Univ Munich, Dept Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	becker@lmb.uni-muenchen.de; beckmann@lmb.uni-muenchen.de	Armache, Jean-Paul/U-3113-2019; Hopfner, Karl-Peter/B-6864-2014	Hopfner, Karl-Peter/0000-0002-4528-8357; Armache, Jean-Paul/0000-0001-9195-2282	Deutsche Forschungsgemeinschaft [SFB594, SFB646]; National Institutes of Health [U19 AI083025]; Fonds der chemischen Industrie; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Schele and A. Gilmozzi for technical assistance, and D. Wilson for critical discussions. This work was supported by grants from the Deutsche Forschungsgemeinschaft, SFB594 (to R. B.), SFB646 (to T. B., R. B. and K.-P. H.), National Institutes of Health U19 AI083025 (to K.-P. H.) and by the Fonds der chemischen Industrie (to S.F.).	Andersen DS, 2007, J BIOL CHEM, V282, P14752, DOI 10.1074/jbc.M701361200; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Atkinson GC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-290; Barthelme D, 2007, J BIOL CHEM, V282, P14598, DOI 10.1074/jbc.M700825200; Barthelme D, 2011, P NATL ACAD SCI USA, V108, P3228, DOI 10.1073/pnas.1015953108; Becker T, 2011, NAT STRUCT MOL BIOL, V18, P715, DOI 10.1038/nsmb.2057; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Chen LM, 2010, NAT STRUCT MOL BIOL, V17, P1233, DOI 10.1038/nsmb.1922; Coelho CMA, 2005, DEVELOPMENT, V132, P5411, DOI 10.1242/dev.02148; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endoh T, 2008, J BIOTECHNOL, V133, P177, DOI 10.1016/j.jbiotec.2007.08.036; Endoh T, 2007, APPL MICROBIOL BIOT, V74, P1153, DOI 10.1007/s00253-006-0753-3; Endoh T, 2006, J BIOTECHNOL, V126, P186, DOI 10.1016/j.jbiotec.2006.04.010; Estevez AM, 2004, MOL BIOCHEM PARASIT, V133, P137, DOI 10.1016/j.molbiopara.2003.09.009; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Karcher A, 2005, STRUCTURE, V13, P649, DOI 10.1016/j.str.2005.02.008; Karcher A, 2008, J BIOL CHEM, V283, P7962, DOI 10.1074/jbc.M707347200; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540	56	169	173	3	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					501	U221		10.1038/nature10829	http://dx.doi.org/10.1038/nature10829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358840	Green Accepted			2022-12-01	WOS:000300770500045
J	Berning, S; Willig, KI; Steffens, H; Dibaj, P; Hell, SW				Berning, Sebastian; Willig, Katrin I.; Steffens, Heinz; Dibaj, Payam; Hell, Stefan W.			Nanoscopy in a Living Mouse Brain	SCIENCE			English	Article							SPINES; GFP		[Berning, Sebastian; Willig, Katrin I.; Steffens, Heinz; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Dibaj, Payam] MPI Expt Med, D-37075 Gottingen, Germany	Max Planck Society	Willig, KI (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, Fassberg 11, D-37077 Gottingen, Germany.	kwillig@gwdg.de; shell@gwdg.de	Dibaj, Payam/GQH-9423-2022; Willig, Katrin/AAH-5418-2020; Dibaj, Payam/AAS-5479-2021	Dibaj, Payam/0000-0003-1585-6330; Willig, Katrin/0000-0002-1860-334X; 				Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Grotjohann T, 2011, NATURE, V478, P204, DOI 10.1038/nature10497; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027	7	260	275	5	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 3	2012	335	6068					551	551		10.1126/science.1215369	http://dx.doi.org/10.1126/science.1215369			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22301313	Green Submitted			2022-12-01	WOS:000299769200034
J	Yu, XC; Breitman, M; Goldberg, J				Yu, Xinchao; Breitman, Marianna; Goldberg, Jonathan			A Structure-Based Mechanism for Arf1-Dependent Recruitment of Coatomer to Membranes	CELL			English	Article							ADP-RIBOSYLATION FACTOR; GUANINE-NUCLEOTIDE EXCHANGE; COATED VESICLES; PROTEIN COMPLEX; ARF; BINDING; CARGO; COPII; ACTIVATION; TRANSPORT	Budding of COPI-coated vesicles from Golgi membranes requires an Arf family G protein and the coatomer complex recruited from cytosol. Arf is also required with coatomer-related clathrin adaptor complexes to bud vesicles from the trans-Golgi network and endosomal compartments. To understand the structural basis for Arf-dependent recruitment of a vesicular coat to the membrane, we determined the structure of Arf1 bound to the gamma zeta-COP subcomplex of coatomer. Structure-guided biochemical analysis reveals that a second Arf1-GTP molecule binds to beta delta-COP at a site common to the gamma-and beta-COP subunits. The Arf1-binding sites on coatomer are spatially related to PtdIns4,5P(2)-binding sites on the endocytic AP2 complex, providing evidence that the orientation of membrane binding is general for this class of vesicular coat proteins. A bivalent GTP-dependent binding mode has implications for the dynamics of coatomer interaction with the Golgi and for the selection of cargo molecules.	[Yu, Xinchao; Breitman, Marianna; Goldberg, Jonathan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Yu, Xinchao; Breitman, Marianna; Goldberg, Jonathan] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10065 USA.	jonathan@ximpact4.ski.mskcc.org			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Beraud-Dufour S, 1999, J BIOL CHEM, V274, P37629, DOI 10.1074/jbc.274.53.37629; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Boehm M, 2001, EMBO J, V20, P6265, DOI 10.1093/emboj/20.22.6265; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Ismail SA, 2010, CELL, V141, P812, DOI 10.1016/j.cell.2010.03.051; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Kliouchnikov L, 2009, MOL BIOL CELL, V20, P859, DOI 10.1091/mbc.E08-10-1010; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liu YZ, 2010, NAT STRUCT MOL BIOL, V17, P876, DOI 10.1038/nsmb.1853; Luo RB, 2008, J BIOL CHEM, V283, P21965, DOI 10.1074/jbc.M802268200; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Nickel W, 1998, J CELL SCI, V111, P3081; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Sun Z, 2007, TRAFFIC, V8, P582, DOI 10.1111/j.1600-0854.2007.00554.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0	36	76	79	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2012	148	3					530	542		10.1016/j.cell.2012.01.015	http://dx.doi.org/10.1016/j.cell.2012.01.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304919	Green Accepted, Bronze			2022-12-01	WOS:000300225000020
J	Meyer, K				Meyer, Kaspar			Another Remembered Present	SCIENCE			English	Editorial Material							RAT VISUAL-CORTEX; FEEDBACK CONNECTIONS; CONSCIOUSNESS; INFORMATION		Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA	University of Southern California	Meyer, K (corresponding author), Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA.	kaspar.meyer@usc.edu						Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Bullier J, 2001, TRENDS COGN SCI, V5, P369, DOI 10.1016/S1364-6613(00)01730-7; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; CHANGEUX JP, 1989, COGNITION, V33, P63, DOI 10.1016/0010-0277(89)90006-1; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Dehaene S, 2004, COGNITIVE NEUROSCIEN; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Edelman G, 2001, ANN NY ACAD SCI, V929, P111; Johnson RR, 1996, J COMP NEUROL, V368, P383, DOI 10.1002/(SICI)1096-9861(19960506)368:3<383::AID-CNE5>3.0.CO;2-1; Lamme V.A.F., 2000, BRAIN MIND, V1, P385, DOI [10.1023/A:1011569019782, DOI 10.1023/A:1011569019782]; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Meyer K, 2011, CEREB CORTEX, V21, P2113, DOI 10.1093/cercor/bhq289; Meyer K, 2010, NAT NEUROSCI, V13, P667, DOI 10.1038/nn.2533; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; Ro T, 2003, CURR BIOL, V13, P1038, DOI 10.1016/S0960-9822(03)00337-3; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Shao ZW, 1996, J NEUROSCI, V16, P7353; Smith FW, 2010, P NATL ACAD SCI USA, V107, P20099, DOI 10.1073/pnas.1000233107; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218	20	11	12	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2012	335	6067					415	416		10.1126/science.1214652	http://dx.doi.org/10.1126/science.1214652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	881FG	22282799				2022-12-01	WOS:000299466800034
J	Solt, LA; Wang, YJ; Banerjee, S; Hughes, T; Kojetin, DJ; Lundasen, T; Shin, Y; Liu, J; Cameron, MD; Noel, R; Yoo, SH; Takahashi, JS; Butler, AA; Kamenecka, TM; Burris, TP				Solt, Laura A.; Wang, Yongjun; Banerjee, Subhashis; Hughes, Travis; Kojetin, Douglas J.; Lundasen, Thomas; Shin, Youseung; Liu, Jin; Cameron, Michael D.; Noel, Romain; Yoo, Seung-Hee; Takahashi, Joseph S.; Butler, Andrew A.; Kamenecka, Theodore M.; Burris, Thomas P.			Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists	NATURE			English	Article							ORPHAN NUCLEAR RECEPTORS; ALPHA; CLOCK; HEME; COMPONENTS; LIGAND; BETA; IDENTIFICATION; TRANSCRIPTION; EXPRESSION	Synchronizing rhythms of behaviour and metabolic processes is important for cardiovascular health and preventing metabolic diseases. The nuclear receptors REV-ERB-alpha and REV-ERB-beta have an integral role in regulating the expression of core clock proteins driving rhythms in activity and metabolism. Here we describe the identification of potent synthetic REV-ERB agonists with in vivo activity. Administration of synthetic REV-ERB ligands alters circadian behaviour and the circadian pattern of core clock gene expression in the hypothalami of mice. The circadian pattern of expression of an array of metabolic genes in the liver, skeletal muscle and adipose tissue was also altered, resulting in increased energy expenditure. Treatment of diet-induced obese mice with a REV-ERB agonist decreased obesity by reducing fat mass and markedly improving dyslipidaemia and hyperglycaemia. These results indicate that synthetic REV-ERB ligands that pharmacologically target the circadian rhythm may be beneficial in the treatment of sleep disorders as well as metabolic diseases.	[Solt, Laura A.; Wang, Yongjun; Banerjee, Subhashis; Hughes, Travis; Kojetin, Douglas J.; Lundasen, Thomas; Liu, Jin; Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Shin, Youseung; Cameron, Michael D.; Noel, Romain; Kamenecka, Theodore M.] Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA; [Yoo, Seung-Hee; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yoo, Seung-Hee; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Butler, Andrew A.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Burris, Thomas P.] Scripps Res Inst, Ctr Diabet & Metab Dis, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Scripps Research Institute; Scripps Research Institute	Burris, TP (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	tburris@scripps.edu	NOEL, Romain/AAR-2564-2021; Takahashi, Joseph S./Y-2781-2019; Burris, Thomas P/B-3886-2016; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Burris, Thomas P/0000-0003-2922-4449; Takahashi, Joseph S/0000-0003-0384-8878; Hughes, Travis/0000-0002-5764-5884; Butler, Andrew/0000-0001-7196-0170; Cameron, Michael/0000-0003-3154-4775	National Institutes of Health [DK080201, MH092769, DK089984]; Howard Hughes Medical Institute; individual National Research Service Award [DK088499]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088499, R24DK089984, R01DK080201, R01DK073189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769, R01MH093429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); individual National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants (DK080201, MH092769 and DK089984) and the Howard Hughes Medical Institute. L. A. S. is the recipient of an individual National Research Service Award (DK088499).	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bray MS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.R110.214643; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Busby SA, 2011, ACS CHEM BIOL, V6, P618, DOI 10.1021/cb100396s; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Gimble JM, 2011, NAT REV ENDOCRINOL, V7, P98, DOI 10.1038/nrendo.2010.214; Grant D, 2010, ACS CHEM BIOL, V5, P925, DOI 10.1021/cb100141y; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin Lei, 2010, Nucl Recept Signal, V8, pe001, DOI 10.1621/nrs.08001; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	28	483	507	7	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					62	68		10.1038/nature11030	http://dx.doi.org/10.1038/nature11030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22460951	Green Accepted			2022-12-01	WOS:000303451900034
J	Whitehorn, PR; O'Connor, S; Wackers, FL; Goulson, D				Whitehorn, Penelope R.; O'Connor, Stephanie; Wackers, Felix L.; Goulson, Dave			Neonicotinoid Pesticide Reduces Bumble Bee Colony Growth and Queen Production	SCIENCE			English	Article							BOMBUS-TERRESTRIS HYMENOPTERA; APIS-MELLIFERA; LANDSCAPE-SCALE; NEST DENSITY; APIDAE; INSECTICIDES; POLLINATION; SUNFLOWER; HAZARDS; CROPS	Growing evidence for declines in bee populations has caused great concern because of the valuable ecosystem services they provide. Neonicotinoid insecticides have been implicated in these declines because they occur at trace levels in the nectar and pollen of crop plants. We exposed colonies of the bumble bee Bombus terrestris in the laboratory to field-realistic levels of the neonicotinoid imidacloprid, then allowed them to develop naturally under field conditions. Treated colonies had a significantly reduced growth rate and suffered an 85% reduction in production of new queens compared with control colonies. Given the scale of use of neonicotinoids, we suggest that they may be having a considerable negative impact on wild bumble bee populations across the developed world.	[Whitehorn, Penelope R.; O'Connor, Stephanie; Goulson, Dave] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Wackers, Felix L.] Univ Lancaster, Lancaster Environm Ctr LEC, Lancaster LA1 4YQ, England	University of Stirling; Lancaster University	Goulson, D (corresponding author), Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland.	dave.goulson@stir.ac.uk	Goulson, David/A-2462-2010; Serrano, Jose/A-2854-2009	Goulson, David/0000-0003-4421-2876; Serrano, Jose/0000-0002-1565-5216; Whitehorn, Penelope/0000-0001-9852-1012				Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; FELL RD, 1986, J KANSAS ENTOMOL SOC, V59, P72; Gels JA, 2002, J ECON ENTOMOL, V95, P722, DOI 10.1603/0022-0493-95.4.722; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Hayter KE, 2006, J APPL ECOL, V43, P1196, DOI 10.1111/j.1365-2664.2006.01219.x; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Morandin LA, 2003, ENVIRON ENTOMOL, V32, P555, DOI 10.1603/0046-225X-32.3.555; MULLER CB, 1992, ECOL ENTOMOL, V17, P343, DOI 10.1111/j.1365-2311.1992.tb01068.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Tasei JN, 2000, PEST MANAG SCI, V56, P784, DOI 10.1002/1526-4998(200009)56:9<784::AID-PS208>3.0.CO;2-T; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623	20	782	826	27	1136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					351	352		10.1126/science.1215025	http://dx.doi.org/10.1126/science.1215025			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22461500				2022-12-01	WOS:000302995400047
J	Smith, ZD; Chan, MM; Mikkelsen, TS; Gu, HC; Gnirke, A; Regev, A; Meissner, A				Smith, Zachary D.; Chan, Michelle M.; Mikkelsen, Tarjei S.; Gu, Hongcang; Gnirke, Andreas; Regev, Aviv; Meissner, Alexander			A unique regulatory phase of DNA methylation in the early mammalian embryo	NATURE			English	Article							NON-CPG METHYLATION; GENE-EXPRESSION; PATERNAL GENOME; MOUSE EMBRYO; WIDE; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; CELLS; PLURIPOTENT; PATTERNS	DNA methylation is highly dynamic during mammalian embryogenesis. It is broadly accepted that the paternal genome is actively depleted of 5-methylcytosine at fertilization, followed by passive loss that reaches a minimum at the blastocyst stage. However, this model is based on limited data, and so far no base-resolution maps exist to support and refine it. Here we generate genome-scale DNA methylation maps in mouse gametes and from the zygote through post-implantation. We find that the oocyte already exhibits global hypomethylation, particularly at specific families of long interspersed element 1 and long terminal repeat retroelements, which are disparately methylated between gametes and have lower methylation values in the zygote than in sperm. Surprisingly, the oocyte contributes a unique set of differentially methylated regions (DMRs)-including many CpG island promoters-that are maintained in the early embryo but are lost upon specification and absent from somatic cells. In contrast, sperm-contributed DMRs are largely intergenic and become hypermethylated after the blastocyst stage. Our data provide a genome-scale, base-resolution timeline of DNA methylation in the pre-specified embryo, when this epigenetic modification is most dynamic, before returning to the canonical somatic pattern.	[Smith, Zachary D.; Chan, Michelle M.; Mikkelsen, Tarjei S.; Gu, Hongcang; Gnirke, Andreas; Regev, Aviv; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Smith, Zachary D.; Mikkelsen, Tarjei S.; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Smith, Zachary D.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Chan, Michelle M.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu	Mikkelsen, Tarjei S/A-1306-2007	Mikkelsen, Tarjei S/0000-0002-8133-3135; Gu, Hongcang/0000-0002-1439-7606	NIH [5DP1OD003958, 5RC1AA019317, U01ES017155, P01GM099117]; HHMI; Harvard Stem Cell Institute; Massachusetts Life Science Center; Pew Charitable Trusts; Center for Excellence in Genome Science from the NHGRI [1P50HG006193-01]; Burroughs Wellcome Career Award at the Scientific Interface; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC1AA019317] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Harvard Stem Cell Institute; Massachusetts Life Science Center; Pew Charitable Trusts; Center for Excellence in Genome Science from the NHGRI; Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank all members of the Meissner and Regev laboratories. M. Garber, N. Yosef, J. Ye, R. Koche, C. Bock, R. Maehr and D. Egli for technical advice and discussion. We thank all members of the Broad Sequencing Platform, in particular F. Kelly and J. Meldrim, T. Fennel, K. Tibbetts and J. Fostel. We also thank S. Levine, M. Gravina and K. Thai from the MIT BioMicro Center. A.R. is an investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute. This work was supported by the NIH Pioneer Award (5DP1OD003958), the Burroughs Wellcome Career Award at the Scientific Interface and HHMI (to A.R.), the Harvard Stem Cell Institute (to T.S.M.) and the NIH (5RC1AA019317, U01ES017155 and P01GM099117), the Massachusetts Life Science Center and the Pew Charitable Trusts (to A.M.) and a Center for Excellence in Genome Science from the NHGRI (1P50HG006193-01, to A.R. and A.M.).	Behringer R., 2003, MANIPULATING MOUSE E; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Haines TR, 2001, DEV BIOL, V240, P585, DOI 10.1006/dbio.2001.0504; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Ichiyanagi K, 2011, GENOME RES, V21, P2058, DOI 10.1101/gr.123679.111; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lucifero D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-36; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; MONK M, 1987, DEVELOPMENT, V99, P371; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	55	690	716	5	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					339	U74		10.1038/nature10960	http://dx.doi.org/10.1038/nature10960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22456710	Green Submitted, Green Accepted			2022-12-01	WOS:000302946500025
J	Palty, R; Raveh, A; Kaminsky, I; Meller, R; Reuveny, E				Palty, Raz; Raveh, Adi; Kaminsky, Ido; Meller, Ruth; Reuveny, Eitan			SARAF Inactivates the Store Operated Calcium Entry Machinery to Prevent Excess Calcium Refilling	CELL			English	Article							FAST CA2+-DEPENDENT INACTIVATION; STROMAL INTERACTION MOLECULE-1; ACTIVATES CRAC CHANNELS; PLASMA-MEMBRANE; CA2+ ENTRY; ENDOPLASMIC-RETICULUM; ORAI CHANNELS; FRET MICROSCOPY; SENSOR STIM1; T-CELLS	Store operated calcium entry (SOCE) is a principal cellular process by which cells regulate basal calcium, refill intracellular Ca2+ stores, and execute a wide range of specialized activities. STIM and Orai proteins have been identified as the essential components enabling the reconstitution of Ca2+ release-activated Ca2+ (CRAC) channels that mediate SOCE. Here, we report the molecular identification of SARAF as a negative regulator of SOCE. Using heterologous expression, RNAi-mediated silencing and site directed mutagenesis combined with electrophysiological, biochemical and imaging techniques we show that SARAF is an endoplasmic reticulum membrane resident protein that associates with STIM to facilitate slow Ca2+-dependent inactivation of SOCE. SARAF plays a key role in shaping cytosolic Ca2+ signals and determining the content of the major intracellular Ca2+ stores, a role that is likely to be important in protecting cells from Ca2+ overfilling.	[Palty, Raz; Raveh, Adi; Kaminsky, Ido; Meller, Ruth; Reuveny, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reuveny, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.reuveny@weizmann.ac.il	Palty, Raz/HCH-3978-2022		Clore postdoctoral fellowship; Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF) [207/09]; Minerva Foundation (Munich)	Clore postdoctoral fellowship; Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF)(Israel Science Foundation); Minerva Foundation (Munich)	The authors would like to thank Elisha Shalgi for technical help and Dr. Dan Minor for his helpful comments and critical reading of the manuscript. The work was supported in part by the Clore postdoctoral fellowship (RP), the Josef Cohn Center for Biomembrane Research, The Israeli Science Foundation (ISF grant 207/09) and the Minerva Foundation (Munich) all to ER.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Berry PA, 2011, PROSTATE, V71, P1646, DOI 10.1002/pros.21384; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Camargo A, 2008, GENOMICS, V92, P404, DOI 10.1016/j.ygeno.2008.05.007; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Enyedi B, 2010, ANTIOXID REDOX SIGN, V13, P721, DOI 10.1089/ars.2009.2880; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Korzeniowski MK, 2009, J BIOL CHEM, V284, P21027, DOI 10.1074/jbc.M109.012252; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Litjens T, 2004, J PHYSIOL-LONDON, V558, P85, DOI 10.1113/jphysiol.2004.065870; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Louzao MC, 1996, J BIOL CHEM, V271, P14807, DOI 10.1074/jbc.271.25.14807; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Raveh A, 2010, CELL, V143, P750, DOI 10.1016/j.cell.2010.10.018; Rios E, 2010, J PHYSIOL SCI, V60, P81, DOI 10.1007/s12576-009-0069-z; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shen WW, 2011, J BIOL CHEM, V286, P36448, DOI 10.1074/jbc.M111.269415; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	61	199	205	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					425	438		10.1016/j.cell.2012.01.055	http://dx.doi.org/10.1016/j.cell.2012.01.055			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22464749	Bronze			2022-12-01	WOS:000302805600020
J	Lindenauer, PK; Lagu, T; Shieh, MS; Pekow, PS; Rothberg, MB				Lindenauer, Peter K.; Lagu, Tara; Shieh, Meng-Shiou; Pekow, Penelope S.; Rothberg, Michael B.			Association of Diagnostic Coding With Trends in Hospitalizations and Mortality of Patients With Pneumonia, 2003-2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEVERE SEPSIS; PERFORMANCE-MEASURES; UNITED-STATES; OUTCOMES; CARE; GUIDELINES; MANAGEMENT; OLDER	Context Recent reports suggest that the mortality rate of patients hospitalized with pneumonia has steadily declined. While this may be the result of advances in clinical care or improvements in quality, it may also represent an artifact of changes in diagnostic coding. Objective To compare estimates of trends in hospitalizations and inpatient mortality among patients with pneumonia using 2 approaches to case definition: one limited to patients with a principal diagnosis of pneumonia, and another that includes patients with a secondary diagnosis of pneumonia if the principal diagnosis is sepsis or respiratory failure. Design, Setting, and Participants Trends study using data from the 2003-2009 releases of the Nationwide Inpatient Sample. Main Outcome Measures Change in the annual hospitalization rate and change in inpatient mortality over time. Results From 2003 to 2009, the annual hospitalization rate for patients with a principal diagnosis of pneumonia declined 27.4%, from 5.5 to 4.0 per 1000, while the age-and sex-adjusted mortality decreased from 5.8% to 4.2% (absolute risk reduction [ARR], 1.6%; 95% CI, 1.4%-1.9%; relative risk reduction [RRR], 28.2%; 95% CI, 25.2%-31.2%). Over the same period, hospitalization rates of patients with a principal diagnosis of sepsis and a secondary diagnosis of pneumonia increased 177.6% from 0.4 to 1.1 per 1000, while inpatient mortality decreased from 25.1% to 22.2% (ARR, 3.0%; 95% CI, 1.6%-4.4%; RRR, 12%; 95% CI, 7.5%-16.1%); hospitalization rates for patients with a principal diagnosis of respiratory failure and a secondary diagnosis of pneumonia increased 9.3% from 0.44 to 0.48 per 1000 and mortality declined from 25.1% to 19.2% (ARR, 6.0%; 95% CI, 4.6%-7.3%; RRR, 23.7%; 95% CI, 19.7%-27.8%). However, when the 3 groups were combined, the hospitalization rate declined only 12.5%, from 6.3 to 5.6 per 1000, while the age-and sex-adjusted inpatient mortality rate increased from 8.3% to 8.8% (AR increase, 0.5%; 95% CI, 0.1%-0.9%; RR increase, 6.0%; 95% CI, 3.3%-8.8%). Over this same time frame, the age-, sex-, and comorbidity-adjusted mortality rate declined from 8.3% to 7.8% (ARR, 0.5%; 95% CI, 0.2%-0.9%; RRR, 6.3%; 95% CI, 3.8%-8.8%). Conclusions From 2003 to 2009, hospitalization and inpatient mortality rates for patients with a principal diagnosis of pneumonia decreased substantially, whereas hospitalizations with a principal diagnosis of sepsis or respiratory failure accompanied by a secondary diagnosis of pneumonia increased and mortality declined. However, when the 3 pneumonia diagnoses were combined, the decline in the hospitalization rate was attenuated and inpatient mortality was little changed, suggesting an association of these results with temporal trends in diagnostic coding. JAMA. 2012;307(13):1405-1413	[Lindenauer, Peter K.; Lagu, Tara; Shieh, Meng-Shiou; Pekow, Penelope S.; Rothberg, Michael B.] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; [Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.] Baystate Med Ctr, Div Gen Med & Geriatr, Springfield, MA 01199 USA; [Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Pekow, Penelope S.] Univ Massachusetts, Dept Publ Hlth, Div Biostat & Epidemiol, Amherst, MA 01003 USA	Baystate Medical Center; Baystate Medical Center; Tufts University; Massachusetts Department of Public Health; University of Massachusetts System; University of Massachusetts Amherst	Lindenauer, PK (corresponding author), Baystate Med Ctr, Ctr Qual Care Res, 280 Chestnut St,3rd Floor, Springfield, MA 01199 USA.	peter.lindenauer@bhs.org	Lagu, Tara/GPT-5173-2022	Lagu, Tara/0000-0001-6155-5796				[Anonymous], 2007, ICD 9 CM COD GUID PU; [Anonymous], 2007, ICD 9 CM COD GUID SE; [Anonymous], 2007, ICD 9 CM COD GUID PN; Baker DW, 2002, MED CARE, V40, P879, DOI 10.1097/00005650-200210000-00006; Bratzler DW, 2008, CLIN INFECT DIS, V47, pS193, DOI 10.1086/591404; Bratzler DW, 2007, CURR OPIN INFECT DIS, V20, P182, DOI 10.1097/QCO.0b013e3280495468; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Centers for Medicare and Medicaid Services, PREM HOSP QUAL INC D; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FastStats, FASTSTATS PNEUM; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Healthcare Cost and Utilization Project, OV NAT IMP SAMPL; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Meehan TP, 2001, AM J MED, V111, P203, DOI 10.1016/S0002-9343(01)00803-8; Metersky ML, 2000, ARCH INTERN MED, V160, P3385, DOI 10.1001/archinte.160.22.3385; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; Rothberg MB, 2010, HEALTH AFFAIR, V29, P1523, DOI 10.1377/hlthaff.2009.0287; Ruhnke GW, 2011, AM J MED, V124, P171, DOI 10.1016/j.amjmed.2010.08.019; The Joint Commission, IMPR AM HOSP JOINT C; The Joint Commission, FACTS ORYX HOSP NAT; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Whittle J, 1997, Am J Med Qual, V12, P187, DOI 10.1177/0885713X9701200404; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778; Yealy DM, 2005, ANN INTERN MED, V143, P881, DOI 10.7326/0003-4819-143-12-200512200-00006; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	35	228	230	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1405	1413		10.1001/jama.2012.384	http://dx.doi.org/10.1001/jama.2012.384			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474204	Bronze			2022-12-01	WOS:000302294200027
J	Zgierska, A; Miller, M; Rabago, D				Zgierska, Aleksandra; Miller, Michael; Rabago, David			Patient Satisfaction, Prescription Drug Abuse, and Potential Unintended Consequences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC NONCANCER PAIN		[Zgierska, Aleksandra; Rabago, David] Univ Wisconsin, Dept Family Med, Sch Med & Publ Hlth, Madison, WI 53715 USA; [Miller, Michael] Univ Wisconsin, Dept Psychiat, Sch Med & Publ Hlth, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zgierska, A (corresponding author), Univ Wisconsin, Dept Family Med, Sch Med & Publ Hlth, 1100 Delaplaine Ct, Madison, WI 53715 USA.	aleksandra.zgierska@fammed.wisc.edu			NIAAA NIH HHS [K23 AA017508] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA017508] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Brett AS, 2012, JAMA-J AM MED ASSOC, V307, P149, DOI 10.1001/jama.2011.1999; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Frantsve LME, 2007, PAIN MED, V8, P25, DOI 10.1111/j.1526-4637.2007.00250.x; Gugelmann HM, 2011, JAMA-J AM MED ASSOC, V306, P2258, DOI 10.1001/jama.2011.1712; Institute of Medicine, 2001, CROSSING QUALITY CHA; Matthias MS, 2010, PAIN MED, V11, P1688, DOI 10.1111/j.1526-4637.2010.00980.x; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Substance Abuse and Mental Health Services Administration (SAMHSA), 2010, RES 2009 NAT SURV DR, VI	10	136	137	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1377	1378		10.1001/jama.2012.419	http://dx.doi.org/10.1001/jama.2012.419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919AY	22474199	Green Accepted			2022-12-01	WOS:000302294200022
J	Patel, JP; Gonen, M; Figueroa, ME; Fernandez, H; Sun, ZX; Racevskis, J; Van Vlierberghe, P; Dolgalev, I; Thomas, S; Aminova, O; Huberman, K; Cheng, J; Viale, A; Socci, ND; Heguy, A; Cherry, A; Vance, G; Higgins, RR; Ketterling, RP; Gallagher, RE; Litzow, M; van den Brink, MRM; Lazarus, HM; Rowe, JM; Luger, S; Ferrando, A; Paietta, E; Tallman, MS; Melnick, A; Abdel-Wahab, O; Levine, RL				Patel, Jay P.; Goenen, Mithat; Figueroa, Maria E.; Fernandez, Hugo; Sun, Zhuoxin; Racevskis, Janis; Van Vlierberghe, Pieter; Dolgalev, Igor; Thomas, Sabrena; Aminova, Olga; Huberman, Kety; Cheng, Janice; Viale, Agnes; Socci, Nicholas D.; Heguy, Adriana; Cherry, Athena; Vance, Gail; Higgins, Rodney R.; Ketterling, Rhett P.; Gallagher, Robert E.; Litzow, Mark; van den Brink, Marcel R. M.; Lazarus, Hillard M.; Rowe, Jacob M.; Luger, Selina; Ferrando, Adolfo; Paietta, Elisabeth; Tallman, Martin S.; Melnick, Ari; Abdel-Wahab, Omar; Levine, Ross L.			Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NORMAL CYTOGENETICS; YOUNGER ADULTS; OLDER PATIENTS; MUTATIONS; TET2; IDENTIFY; DNMT3A; AML	BACKGROUND Acute myeloid leukemia (AML) is a heterogeneous disease with respect to presentation and clinical outcome. The prognostic value of recently identified somatic mutations has not been systematically evaluated in a phase 3 trial of treatment for AML. METHODS We performed a mutational analysis of 18 genes in 398 patients younger than 60 years of age who had AML and who were randomly assigned to receive induction therapy with high-dose or standard-dose daunorubicin. We validated our prognostic findings in an independent set of 104 patients. RESULTS We identified at least one somatic alteration in 97.3% of the patients. We found that internal tandem duplication in FLT3 (FLT3-ITD), partial tandem duplication in MLL (MLL-PTD), and mutations in ASXL1 and PHF6 were associated with reduced overall survival (P = 0.001 for FLT3-ITD, P = 0.009 for MLL-PTD, P = 0.05 for ASXL1, and P = 0.006 for PHF6); CEBPA and IDH2 mutations were associated with improved overall survival (P = 0.05 for CEBPA and P = 0.01 for IDH2). The favorable effect of NPM1 mutations was restricted to patients with co-occurring NPM1 and IDH1 or IDH2 mutations. We identified genetic predictors of outcome that improved risk stratification among patients with AML, independently of age, white-cell count, induction dose, and post-remission therapy, and validated the significance of these predictors in an independent cohort. High-dose daunorubicin, as compared with standarddose daunorubicin, improved the rate of survival among patients with DNMT3A or NPM1 mutations or MLL translocations (P = 0.001) but not among patients with wild-type DNMT3A, NPM1, and MLL (P = 0.67). CONCLUSIONS We found that DNMT3A and NPM1 mutations and MLL translocations predicted an improved outcome with high-dose induction chemotherapy in patients with AML. These findings suggest that mutational profiling could potentially be used for risk stratification and to inform prognostic and therapeutic decisions regarding patients with AML. (Funded by the National Cancer Institute and others.)	[Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Leukemia Serv, Dept Med, New York, NY 10065 USA; [Goenen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Cheng, Janice; Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10065 USA; [Figueroa, Maria E.; Melnick, Ari] Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY USA; [Racevskis, Janis; Gallagher, Robert E.; Paietta, Elisabeth] Montefiore Med Ctr, New York, NY USA; [Van Vlierberghe, Pieter; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, New York, NY USA; [Van Vlierberghe, Pieter; Ferrando, Adolfo] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Van Vlierberghe, Pieter; Ferrando, Adolfo] Columbia Univ, Dept Pathol, New York, NY USA; [van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Fernandez, Hugo] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Blood & Bone Marrow Transplantat, Tampa, FL 33682 USA; [Sun, Zhuoxin] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA; [Cherry, Athena] Stanford Hosp & Clin, Dept Pathol, Palo Alto, CA USA; [Vance, Gail] Indiana Univ Sch Med, Dept Med & Mol Genet, Bloomington, IN USA; [Higgins, Rodney R.] Abbott NW Hosp, Allina Cytogenet Lab, Minneapolis, MN 55407 USA; [Ketterling, Rhett P.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Litzow, Mark] Mayo Clin, Coll Med, Dept Hematol & Oncol, Rochester, MN USA; [Lazarus, Hillard M.] Case Western Reserve Univ, Sch Med, Div Hematol Oncol, Cleveland, OH 44106 USA; [Rowe, Jacob M.] Technion Israel Inst Technol, Jerusalem, Israel; [Rowe, Jacob M.] Shaare Zedek Med Ctr, Jerusalem, Israel; [Luger, Selina] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Montefiore Medical Center; Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Harvard University; Dana-Farber Cancer Institute; Stanford University; Indiana University System; Indiana University Bloomington; Mayo Clinic; Mayo Clinic; Case Western Reserve University; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Shaare Zedek Medical Center; University of Pennsylvania	Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Leukemia Serv, Dept Med, 1275 York Ave,Box 20, New York, NY 10065 USA.	leviner@mskcc.org	Dolgalev, Igor/AAY-6406-2020; Van Vlierberghe, Pieter/G-8894-2013; Figueroa, Maria/AAE-8662-2019; Heguy, Adriana/GPP-3907-2022; Melnick, Ari/AAA-5763-2020; Gonen, Mithat/E-4826-2012; levine, ross/AAE-7658-2019; Patel, Jay/HDM-6251-2022	Dolgalev, Igor/0000-0003-4451-126X; Van Vlierberghe, Pieter/0000-0001-9063-7205; Gonen, Mithat/0000-0001-8683-8477; Figueroa, Maria Eugenia/0000-0003-4887-4981; Abdel-Wahab, Omar/0000-0002-3907-6171; Ketterling, Rhett/0000-0001-6479-7897	National Cancer Institute (NCI) Physical Sciences Oncology Center [U54CA143798-01]; Gabrielle's Angel Fund; Starr Cancer Consortium; Memorial Sloan-Kettering Cancer Center; American Society; Leukemia and Lymphoma Society; Fund for Scientific Research (FWO) Flanders; Leukemia and Lymphoma Society Specialized Center; Sackler Center for Biomedical and Physical Sciences; Howard Hughes Medical Institute; NCI [CA21115, CA56771, CA114737]; NATIONAL CANCER INSTITUTE [U54CA143798, R01CA056771, R01CA155743, U24CA114737, U10CA023318, P30CA008748, U10CA021115] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Physical Sciences Oncology Center; Gabrielle's Angel Fund; Starr Cancer Consortium; Memorial Sloan-Kettering Cancer Center; American Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Fund for Scientific Research (FWO) Flanders(FWO); Leukemia and Lymphoma Society Specialized Center(Leukemia and Lymphoma Society); Sackler Center for Biomedical and Physical Sciences; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the National Cancer Institute (NCI) Physical Sciences Oncology Center (U54CA143798-01, to Dr. Levine), the Gabrielle's Angel Fund (to Dr. Levine), and the Starr Cancer Consortium (to Drs. Levine and Melnick) and funding from the Peter Solomon Fund at Memorial Sloan-Kettering Cancer Center. Mr. Patel is supported by an American Society of Hematology Trainee Research Award; Dr. Figueroa is funded by a Leukemia and Lymphoma Society Special Fellow Award; Drs. Van Vlierberghe and Abdel-Wahab are American Society of Hematology Basic Research Fellows; Dr. Van Vlierberghe is supported by the Fund for Scientific Research (FWO) Flanders; Dr. Melnick is funded by a Leukemia and Lymphoma Society Specialized Center of Research Award and Translational Research Program Award and is a Burroughs Wellcome Clinical Translational Scholar and a Scholar of the Leukemia and Lymphoma Society; Drs. Figueroa and Melnick are also supported by the Sackler Center for Biomedical and Physical Sciences; Dr. Levine is the recipient of an Early Career Award from the Howard Hughes Medical Institute; Dr. Paietta is supported by NCI grants CA21115 and CA114737; Dr. Gallagher is supported by NCI grant CA56771; and Dr. Ferrando is funded by a Leukemia and Lymphoma Society Scholar Award.	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Caligiuri MA, 1998, CANCER RES, V58, P55; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Frohling S, 2004, J CLIN ONCOL, V22, P624, DOI 10.1200/JCO.2004.06.060; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; Marcucci G., 2011, J CLIN ONCOL, V29, P1798; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Metzeler KH, 2011, BLOOD, V118, P6920, DOI 10.1182/blood-2011-08-368225; Metzeler KH, 2011, J CLIN ONCOL, V29, P1373, DOI 10.1200/JCO.2010.32.7742; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Westfall PH., 1993, RESAMPLING BASED MUL; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	24	1349	1407	12	146	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2012	366	12					1079	1089		10.1056/NEJMoa1112304	http://dx.doi.org/10.1056/NEJMoa1112304			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912BO	22417203	Green Accepted			2022-12-01	WOS:000301769700007
J	Weaver, P; Johnson, D				Weaver, Phil; Johnson, David			Think big for marine conservation	NATURE			English	Editorial Material									[Weaver, Phil] Global Ocean Biodivers Initiat, Southampton, Hants, England; [Weaver, Phil] Natl Oceanog Ctr, Southampton, Hants, England; [Johnson, David] Convent Protect Marine Environm NE Atlantic OSPAR, London, England	NERC National Oceanography Centre	Weaver, P (corresponding author), Global Ocean Biodivers Initiat, Southampton, Hants, England.	ppew@noc.ac.uk		Weaver, Philip/0000-0002-9541-3830	NERC [noc010011] Funding Source: UKRI; Natural Environment Research Council [noc010011] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))			0	24	25	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2012	483	7390					399	399		10.1038/483399a	http://dx.doi.org/10.1038/483399a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	912CC	22437593				2022-12-01	WOS:000301771200015
J	Neubauer, C; Gillet, R; Kelley, AC; Ramakrishnan, V				Neubauer, Cajetan; Gillet, Reynald; Kelley, Ann C.; Ramakrishnan, V.			Decoding in the Absence of a Codon by tmRNA and SmpB in the Ribosome	SCIENCE			English	Article							TRANSFER-MESSENGER-RNA; AMINOACYL-TRANSFER-RNA; SMALL PROTEIN-B; TRANS-TRANSLATION; STALLED RIBOSOMES; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TAGGING ACTIVITY; BINDING PROTEIN	In bacteria, ribosomes stalled at the end of truncated messages are rescued by transfer-messenger RNA (tmRNA), a bifunctional molecule that acts as both a transfer RNA (tRNA) and a messenger RNA (mRNA), and SmpB, a small protein that works in concert with tmRNA. Here, we present the crystal structure of a tmRNA fragment, SmpB and elongation factor Tu bound to the ribosome at 3.2 angstroms resolution. The structure shows how SmpB plays the role of both the anticodon loop of tRNA and portions of mRNA to facilitate decoding in the absence of an mRNA codon in the A site of the ribosome and explains why the tmRNA-SmpB system does not interfere with normal translation.	[Neubauer, Cajetan; Kelley, Ann C.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Gillet, Reynald] Univ Rennes 1, F-35042 Rennes, France; [Gillet, Reynald] CNRS, IGDR, UMR 6290, Translat & Folding Grp,Inst Univ France, F-35042 Rennes, France	MRC Laboratory Molecular Biology; Universite de Rennes 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Universitaire de France	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Neubauer, Cajetan/B-8935-2016	Neubauer, Cajetan/0000-0002-5348-5609; Ramakrishnan, V/0000-0002-4699-2194	MRC [U105184332]; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; Boehringer Ingelheim Fonds;  [ANR-08JCJC-0027-01];  [ANR-09-MIE]; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; Boehringer Ingelheim Fonds(Boehringer Ingelheim); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Tomizaki at Swiss Light Source and L. Ng and I. Sanchez for help with data collection. This work was supported by the MRC (grant U105184332), the Wellcome Trust, the Agouron Institute, and the Louis-Jeantet Foundation. C.N. was supported by a Boehringer Ingelheim Fonds scholarship and R. G. by grants ANR-08JCJC-0027-01 and ANR-09-MIE. Coordinates and structure factors have been deposited at the PDB with accession codes 4abr and 4abs. The strain Thermus thermophilus HB8-MRC-MSAW1 is available subject to a Material Transfer Agreement with the MRC.	Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; Cheng K, 2010, J STRUCT BIOL, V169, P342, DOI 10.1016/j.jsb.2009.10.015; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Dong G, 2002, EMBO J, V21, P1845, DOI 10.1093/emboj/21.7.1845; Fu J, 2010, EMBO J, V29, P3819, DOI 10.1038/emboj.2010.255; Gutmann S, 2003, NATURE, V424, P699, DOI 10.1038/nature01831; Hayes CS, 2010, FEBS LETT, V584, P413, DOI 10.1016/j.febslet.2009.11.023; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; Jacob Y, 2005, J BIOL CHEM, V280, P5503, DOI 10.1074/jbc.M409277200; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Kaur S, 2006, P NATL ACAD SCI USA, V103, P16484, DOI 10.1073/pnas.0607438103; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Kurita D, 2007, NUCLEIC ACIDS RES, V35, P7248, DOI 10.1093/nar/gkm677; Kurita D, 2010, RNA, V16, P980, DOI 10.1261/rna.1916610; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Miller MR, 2011, RNA, V17, P1727, DOI 10.1261/rna.2821711; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Nonin-Lecomte S, 2009, EMBO REP, V10, P160, DOI 10.1038/embor.2008.243; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Shimizu Y, 2006, J BIOL CHEM, V281, P15987, DOI 10.1074/jbc.M512165200; Someya T, 2003, FEBS LETT, V535, P94, DOI 10.1016/S0014-5793(02)03880-2; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Weis F, 2010, EMBO J, V29, P3810, DOI 10.1038/emboj.2010.252; Weis F, 2010, RNA, V16, P299, DOI 10.1261/rna.1757410; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281	36	81	84	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2012	335	6074					1366	1369		10.1126/science.1217039	http://dx.doi.org/10.1126/science.1217039			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22422985	Green Accepted			2022-12-01	WOS:000301531600052
J	Harjunmaa, E; Kallonen, A; Voutilainen, M; Hamalainen, K; Mikkola, ML; Jernvall, J				Harjunmaa, Enni; Kallonen, Aki; Voutilainen, Maria; Hamalainen, Keijo; Mikkola, Marja L.; Jernvall, Jukka			On the difficulty of increasing dental complexity	NATURE			English	Article							GENE-EXPRESSION; MAMMALIAN TEETH; TOOTH; EVOLUTION; INHIBITION; CYCLOPAMINE; DENTITION; PATTERNS; FEEDBACK; ACTIVIN	One of the fascinating aspects of the history of life is the apparent increase in morphological complexity through time(1), a well known example being mammalian cheek tooth evolution(2-4). In contrast, experimental studies of development more readily show a decrease in complexity, again well exemplified by mammalian teeth, in which tooth crown features called cusps are frequently lost in mutant and transgenic mice(5-7). Here we report that mouse tooth complexity can be increased substantially by adjusting multiple signalling pathways simultaneously. We cultured teeth in vitro and adjusted ectodysplasin (EDA), activin A and sonic hedgehog (SHH) pathways, all of which are individually required for normal tooth development. We quantified tooth complexity using the number of cusps and a topographic measure of surface complexity(8). The results show that whereas activation of EDA and activin A signalling, and inhibition of SHH signalling, individually cause subtle to moderate increases in complexity, cusp number is doubled when all three pathways are adjusted in unison. Furthermore, the increase in cusp number does not result from an increase in tooth size, but from an altered primary patterning phase of development. The combination of a lack of complex mutants(5-7), the paucity of natural variants with complex phenotypes(9), and our results of greatly increased dental complexity using multiple pathways, suggests that an increase may be inherently different from a decrease in phenotypic complexity.	[Harjunmaa, Enni; Voutilainen, Maria; Mikkola, Marja L.; Jernvall, Jukka] Univ Helsinki, Dev Biol Program, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Kallonen, Aki; Hamalainen, Keijo] Univ Helsinki, Dept Phys, Div Mat Phys, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Jernvall, J (corresponding author), Univ Helsinki, Dev Biol Program, Inst Biotechnol, POB 56, FIN-00014 Helsinki, Finland.	jernvall@fastmail.fm	Hamalainen, Keijo J/A-3986-2010	Hamalainen, Keijo J/0000-0002-9234-9810	Academy of Finland; Sigrid Juselius Foundation; Finnish Cultural Foundation; graduate school GSBM	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); graduate school GSBM	We thank I. Thesleff, P. Munne, A. R. Evans, I. Corfe, J. Moustakas, M. Murtoniemi, I. Salazar-Ciudad, S. Sova, J.-P. Suuronen and S. Zohdy for discussions or help; R. Santalahti, R. Savolainen and M. Makinen for technical assistance; M. Hyvonen for the activin A protein; P. Schneider for the Fc-EDA-A1-protein; and C. Tabin and A. Gritli-Linde for the ShhGFP mice. This study was funded by the Academy of Finland, the Sigrid Juselius Foundation, the Finnish Cultural Foundation, and the graduate school GSBM.	Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Bei M, 2009, CURR OPIN GENET DEV, V19, P504, DOI 10.1016/j.gde.2009.09.002; Cai JL, 2007, DEV BIOL, V304, P499, DOI 10.1016/j.ydbio.2007.01.002; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Charles C, 2009, P NATL ACAD SCI USA, V106, P22364, DOI 10.1073/pnas.0910086106; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cho SW, 2011, DEVELOPMENT, V138, P1807, DOI 10.1242/dev.056051; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Ferguson CA, 1998, GENE DEV, V12, P2636, DOI 10.1101/gad.12.16.2636; Gabris K, 2006, COMMUNITY DENT HLTH, V23, P80; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; GRUNEBERG H, 1965, J EMBRYOL EXP MORPH, V14, P137; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; HUNTER JP, 1995, P NATL ACAD SCI USA, V92, P10718, DOI 10.1073/pnas.92.23.10718; Ishida K, 2011, BIOCHEM BIOPH RES CO, V405, P455, DOI 10.1016/j.bbrc.2011.01.052; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KAY RF, 1994, AM J PHYS ANTHROPOL, V95, P333, DOI 10.1002/ajpa.1330950305; Kielan-Jaworowska Z., 2004, MAMMALS AGE DINOSAUR; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Mikkola ML, 2008, CYTOKINE GROWTH F R, V19, P219, DOI 10.1016/j.cytogfr.2008.04.008; Miles AEW., 2003, COLYERS VARIATIONS D; Narhi K, 2010, METHODS MOL BIOL, V666, P253, DOI 10.1007/978-1-60761-820-1_16; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Pispa J, 2004, DEV DYNAM, V231, P432, DOI 10.1002/dvdy.20138; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Skinner MM, 2010, AM J PHYS ANTHROPOL, V142, P157, DOI 10.1002/ajpa.21248; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Uhen MD, 2007, ANAT REC, V290, P514, DOI 10.1002/ar.20545	34	75	76	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					324	+		10.1038/nature10876	http://dx.doi.org/10.1038/nature10876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22398444				2022-12-01	WOS:000301481800047
J	Laganowsky, A; Liu, C; Sawaya, MR; Whitelegge, JP; Park, J; Zhao, ML; Pensalfini, A; Soriaga, AB; Landau, M; Teng, PK; Cascio, D; Glabe, C; Eisenberg, D				Laganowsky, Arthur; Liu, Cong; Sawaya, Michael R.; Whitelegge, Julian P.; Park, Jiyong; Zhao, Minglei; Pensalfini, Anna; Soriaga, Angela B.; Landau, Meytal; Teng, Poh K.; Cascio, Duilio; Glabe, Charles; Eisenberg, David			Atomic View of a Toxic Amyloid Small Oligomer	SCIENCE			English	Article							BETA-SHEET; GEOMETRICAL PROPERTIES; FIBRILLAR OLIGOMERS; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURES; PROTEINS; POLYPEPTIDE; MEMBRANE; FRAGMENT; PROVIDES	Amyloid diseases, including Alzheimer's, Parkinson's, and the prion conditions, are each associated with a particular protein in fibrillar form. These amyloid fibrils were long suspected to be the disease agents, but evidence suggests that smaller, often transient and polymorphic oligomers are the toxic entities. Here, we identify a segment of the amyloid-forming protein alpha B crystallin, which forms an oligomeric complex exhibiting properties of other amyloid oligomers: beta-sheet-rich structure, cytotoxicity, and recognition by an oligomer-specific antibody. The x-ray-derived atomic structure of the oligomer reveals a cylindrical barrel, formed from six antiparallel protein strands, that we term a cylindrin. The cylindrin structure is compatible with a sequence segment from the beta-amyloid protein of Alzheimer's disease. Cylindrins offer models for the hitherto elusive structures of amyloid oligomers.	[Laganowsky, Arthur; Liu, Cong; Sawaya, Michael R.; Park, Jiyong; Zhao, Minglei; Soriaga, Angela B.; Landau, Meytal; Teng, Poh K.; Cascio, Duilio; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, UCLA DOE Inst Genom & Prote, Dept Biol Chem, Los Angeles, CA 90095 USA; [Laganowsky, Arthur; Liu, Cong; Sawaya, Michael R.; Park, Jiyong; Zhao, Minglei; Soriaga, Angela B.; Landau, Meytal; Teng, Poh K.; Cascio, Duilio; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, UCLA DOE Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Neuropsychiat Inst NPI, Los Angeles, CA 90024 USA; [Pensalfini, Anna; Glabe, Charles] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Irvine	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, UCLA DOE Inst Genom & Prote, Dept Biol Chem, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Park, Jiyong/AAK-9684-2020; Landau, Meytal/J-3075-2012; Pensalfini, Anna/X-5563-2019; Landau, Meytal/AAF-3479-2021; liu, cong/H-1103-2011; Zhao, Minglei/J-4446-2015	Park, Jiyong/0000-0002-3225-4510; Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430; Zhao, Minglei/0000-0001-5832-6060; Laganowsky, Arthur/0000-0001-5012-5547	National Center for Research Resources of the NIH [RR-15301]; U.S. DOE [DE-AC02-06CH11357]; NIH [5T32GM008496, 1R01-AG029430]; UCLA; NSF [MCB-0445429]; Alzheimer's Disease Research at UCLA [NIH-016570]; HHMI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033069, P50AG016570, R01AG029430] Funding Source: NIH RePORTER	National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA(University of California System); NSF(National Science Foundation (NSF)); Alzheimer's Disease Research at UCLA; HHMI(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Goldschmidt for the 3D profile scan of ABC; J.-P. Colletier, D. Anderson, G. Fujii, J. Stroud, H. Chang, S. Sievers, J. Weissman, J. L. P. Benesch, G. Hochberg, and C. V. Robinson for useful discussion; J. Navarro at the UCLA Crystallization Facility; A. Berk and D. Guo for help with tissue culture experiments; and C. Ralston at the Advanced Light Source (ALS) 8.2.2 and K. Rajashankar and beamline staff at Argonne Photon Source (APS), Northeastern Collaborative Access Team beamlines 24-ID-E/C, for data collection. The last is supported by award RR-15301 from the National Center for Research Resources of the NIH. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract no. DE-AC02-06CH11357. We thank the NIH Chemistry Biology Interface Training program (award 5T32GM008496) sponsorship for A.L., UCLA Dissertation Year fellowships awarded to A.L. and M.Z., NSF award MCB-0445429, NIH award 1R01-AG029430, award NIH-016570 from Alzheimer's Disease Research at UCLA, and HHMI for support. Atomic coordinates and structure factors have been deposited in the PDB with the following accession codes: K11V (3SGO), K11V-Br2 (3SGM), K11V-Br8 (3SGN), K11V<SUP>V2L</SUP> (3SGP), K11V-TR (3SGR), and GDVIEV (3SGS). A11 is available under a uniform biological material transfer agreement with the University of California, Irvine. UCLA has filed a provisional patent on cylindrin as the possible generic etiologic agent of amyloid diseases.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Austen BM, 2008, BIOCHEMISTRY-US, V47, P1984, DOI 10.1021/bi701415b; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Conway J. D., 1986, THESIS UCLA; Dehle FC, 2010, CELL STRESS CHAPERON, V15, P1013, DOI 10.1007/s12192-010-0212-z; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Jang H, 2010, J MOL BIOL, V404, P917, DOI 10.1016/j.jmb.2010.10.025; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Kajava AV, 2010, FASEB J, V24, P1311, DOI 10.1096/fj.09-145979; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khemtemourian L, 2010, BBA-BIOMEMBRANES, V1798, P1805, DOI 10.1016/j.bbamem.2010.05.022; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Last NB, 2011, P NATL ACAD SCI USA, V108, P9460, DOI 10.1073/pnas.1102356108; Liu C, 2011, J AM CHEM SOC, V133, P6736, DOI 10.1021/ja200222n; Meehan S, 2007, J MOL BIOL, V372, P470, DOI 10.1016/j.jmb.2007.06.060; MURZIN AG, 1994, J MOL BIOL, V236, P1369, DOI 10.1016/0022-2836(94)90064-7; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Picone P, 2009, BIOPHYS J, V96, P4200, DOI 10.1016/j.bpj.2008.11.056; Pryciak P. M., 1986, PROTEIN STRUCTURE FO, V39, P243; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; SALEMME FR, 1981, J MOL BIOL, V146, P119, DOI 10.1016/0022-2836(81)90369-7; SALEMME FR, 1981, J MOL BIOL, V146, P101, DOI 10.1016/0022-2836(81)90368-5; Sarsoza F, 2009, ACTA NEUROPATHOL, V118, P505, DOI 10.1007/s00401-009-0530-3; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shafrir Y, 2010, PROTEINS, V78, P3473, DOI 10.1002/prot.22853; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yoshiike Y, 2007, NEUROMOL MED, V9, P270, DOI 10.1007/s12017-007-0003-6	50	438	444	6	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2012	335	6073					1228	1231		10.1126/science.1213151	http://dx.doi.org/10.1126/science.1213151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22403391	Green Accepted			2022-12-01	WOS:000301225100046
J	Kierzkowski, D; Nakayama, N; Routier-Kierzkowska, AL; Weber, A; Bayer, E; Schorderet, M; Reinhardt, D; Kuhlemeier, C; Smith, RS				Kierzkowski, Daniel; Nakayama, Naomi; Routier-Kierzkowska, Anne-Lise; Weber, Alain; Bayer, Emmanuelle; Schorderet, Martine; Reinhardt, Didier; Kuhlemeier, Cris; Smith, Richard S.			Elastic Domains Regulate Growth and Organogenesis in the Plant Shoot Apical Meristem	SCIENCE			English	Article							IN-VIVO ANALYSIS; CELL-WALL; MECHANICAL FORCES; AUXIN TRANSPORT; GENE-EXPRESSION; ARABIDOPSIS; APEX; MORPHOGENESIS; ELONGATION; INITIATION	Although genetic control of morphogenesis is well established, elaboration of complex shapes requires changes in the mechanical properties of cells. In plants, the first visible sign of leaf formation is a bulge on the flank of the shoot apical meristem. Bulging results from local relaxation of cell walls, which causes them to yield to internal hydrostatic pressure. By manipulation of tissue tension in combination with quantitative live imaging and finite-element modeling, we found that the slow-growing area at the shoot tip is substantially strain-stiffened compared with surrounding fast-growing tissue. We propose that strain stiffening limits growth, restricts organ bulging, and contributes to the meristem's functional zonation. Thus, mechanical signals are not just passive readouts of gene action but feed back on morphogenesis.	[Kierzkowski, Daniel; Nakayama, Naomi; Routier-Kierzkowska, Anne-Lise; Weber, Alain; Kuhlemeier, Cris; Smith, Richard S.] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [Bayer, Emmanuelle] CNRS, Lab Biogenese Membranaire, UMR5200, F-33076 Bordeaux, France; [Schorderet, Martine; Reinhardt, Didier] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland	University of Bern; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Fribourg	Smith, RS (corresponding author), Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland.	richard.smith@ips.unibe.ch	Reinhardt, Didier/M-8508-2014; Routier-Kierzkowska, Anne-Lise/AAO-9760-2020; bayer, emmanuelle/V-1329-2017	Reinhardt, Didier/0000-0003-3495-6783; Routier-Kierzkowska, Anne-Lise/0000-0003-0383-0811; bayer, emmanuelle/0000-0001-8642-5293	Swiss National Science Foundation; SystemsX.ch; European Union; European Molecular Biology Organization; Roche Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch; European Union(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Roche Research Foundation	We thank J. Dumais, A. Fleming, S. Robinson, D. Kwiatkowska, and P. Wojtaszek for reading the manuscript. This work was supported by the Swiss National Science Foundation, SystemsX.ch, and the European Union New and Emerging Science and Technology grant MechPlant. N.N. received European Molecular Biology Organization Long-Term and Roche Research Foundation fellowships.	Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dumais J, 2000, J PLANT GROWTH REGUL, V19, P7, DOI 10.1007/s003440000003; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Kutschera U, 2007, J PLANT PHYSIOL, V164, P1395, DOI 10.1016/j.jplph.2007.08.002; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; LOCKHART JA, 1965, J THEOR BIOL, V8, P264, DOI 10.1016/0022-5193(65)90077-9; Milani P, 2011, PLANT J, V67, P1116, DOI 10.1111/j.1365-313X.2011.04649.x; Mirabet V, 2011, ANNU REV PLANT BIOL, V62, P365, DOI 10.1146/annurev-arplant-042110-103852; Peaucelle A, 2008, CURR BIOL, V18, P1943, DOI 10.1016/j.cub.2008.10.065; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; RAYLE DL, 1992, PLANT PHYSIOL, V99, P1271, DOI 10.1104/pp.99.4.1271; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sablowski R, 2007, CURR OPIN PLANT BIOL, V10, P639, DOI 10.1016/j.pbi.2007.07.001; SELKER JML, 1992, DEV BIOL, V153, P29, DOI 10.1016/0012-1606(92)90089-Y; STEEVES T, 1988, PATTERNS PLANT DEV; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Vandiver R, 2009, PHILOS T R SOC A, V367, P3607, DOI 10.1098/rsta.2009.0114; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vernoux T, 2000, DEVELOPMENT, V127, P5157; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Vincent RR, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031909; Whitney SEC, 1999, PLANT PHYSIOL, V121, P657, DOI 10.1104/pp.121.2.657; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106	30	212	216	11	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1096	1099		10.1126/science.1213100	http://dx.doi.org/10.1126/science.1213100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383847	Green Submitted			2022-12-01	WOS:000300931100046
J	Stein, WE; Berry, CM; Hernick, LV; Mannolini, F				Stein, William E.; Berry, Christopher M.; Hernick, Linda VanAller; Mannolini, Frank			Surprisingly complex community discovered in the mid-Devonian fossil forest at Gilboa	NATURE			English	Article							NEW-YORK-STATE; EVOLUTION; PENNSYLVANIA; VENEZUELA; WETLANDS; USA	The origin of trees by the mid-Devonian epoch (398-385 million years ago) signals a major change in terrestrial ecosystems with potential long-term consequences including increased weathering, drop in atmospheric CO2, modified climate, changes in sedimentation patterns and mass extinction(1-3). However, little is known about the ecology of early forests or how changes in early terrestrial ecosystems influenced global processes. One of the most famous palaeontological records for this time is the 'oldest fossil forest' at Riverside Quarry, Gilboa, New York, USA, discovered in the 1920s(4,5). Hundreds of large Eospermatopteris sandstone casts, now thought to represent the bases of standing cladoxylopsid trees(6), were recovered from a horizon that was originally interpreted as a muddy swamp. After quarry operations ceased, relatively minor outcrops of similar fossils at nearby localities have provided limited opportunities to evaluate this pervasive view using modern methods(7,8). In 2010, removal of the quarry backfill enabled reappraisal of the palaeoecology of this important site. Here we describe a 1,200 m(2) map showing numerous Eospermatopteris root systems in life position within a mixed-age stand of trees. Unexpectedly, large woody rhizomes with adventitious roots and aerial branch systems identified as aneurophytalean progymnosperms run between, and probably climb into, Eospermatopteris trees. We describe the overall habit for these surprisingly large aneurophytaleans, the earliest fossil group having wood produced by a bifacial vascular cambium. The site also provides evidence for arborescence within lycopsids, extending the North American range for trees in this ecologically critical group. The rooting horizon is a dark grey sandy mudstone showing limited root penetration. Although clearly belonging to a wetland coastal plain environment(9), the forest was probably limited in duration and subject to periodic disturbance. These observations provide fundamental clarification of the palaeoecology of this mixed-group early forest, with important implications for interpreting coeval assemblage data worldwide.	[Stein, William E.] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; [Berry, Christopher M.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, S Glam, Wales; [Hernick, Linda VanAller; Mannolini, Frank] New York State Museum & Sci Serv, Albany, NY 12230 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Cardiff University	Stein, WE (corresponding author), SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA.	stein@binghamton.edu		Berry, Christopher/0000-0001-9521-5618	New York State Museum; UK Natural Environment Research Council (NERC) [NE/F010699/1]; NERC [NE/F010699/1] Funding Source: UKRI; Natural Environment Research Council [NE/F010699/1] Funding Source: researchfish	New York State Museum; UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial support was provided by the New York State Museum. C.M.B. acknowledges support from the UK Natural Environment Research Council (NERC) grant NE/F010699/1. Permission to work at the site by New York City Department of Environmental Protection (DEP) is acknowledged. On-site and other assistance was provided by E. Chase, P. Costa and G. Heath (DEP), as well as by P. Kollak and C. Tompkins of the Thalle Construction Company. We also thank P. Wright for advice and guidance on the major palaeosol horizon.	Algeo T. J, 2001, PLANTS INVADE LAND E, P213; Baird GC, 2008, B GEOSCI, V83, P357, DOI 10.3140/bull.geosci.2008.04.357; BANKS HP, 1985, GEOLOGICAL SOC AM SP, V201, P125; Beck C.B., 1988, ORIGIN EVOLUTION GYM, P1; BECK CB, 1976, REV PALAEOBOT PALYNO, V21, P5, DOI 10.1016/0034-6667(76)90020-8; Berry C.M., 2001, PLANTS INVADE LAND E, P120; Berry CM, 1997, REV PALAEOBOT PALYNO, V96, P47, DOI 10.1016/S0034-6667(96)00015-2; Berry CM, 2002, INT J PLANT SCI, V163, P699, DOI 10.1086/342037; BRIDGE JS, 1994, GEOL SOC AM BULL, V106, P1440, DOI 10.1130/0016-7606(1994)106<1440:MTARRI>2.3.CO;2; Bridge JS, 2000, GEOL SOC SPEC PUBL, V180, P85, DOI 10.1144/GSL.SP.2000.180.01.06; Dannenhoffer JM, 2007, INT J PLANT SCI, V168, P491, DOI 10.1086/512042; Davies NS, 2010, GEOLOGY, V38, P51, DOI 10.1130/G30443.1; Driese SG, 1997, PALAIOS, V12, P524, DOI 10.2307/3515409; Driese SG, 2001, PLANTS INVADE LAND E, P237; Gensel PG, 2001, AM FERN J, V91, P74, DOI 10.1640/0002-8444(2001)091[0074:ELE]2.0.CO;2; Goldring W., 1927, SCI MONTHLY, V24, P514; Goldring W., 1924, NEW YORK STATE MUSEU, V251, P50; Greb SF, 2006, GEOL SOC AM SPEC PAP, V399, P1, DOI 10.1130/2006.2399(01); GRIERSON J. D., 1963, PALAEONTOGRAPHICA AM, V4, P217; Hammond SE, 2005, BOT J LINN SOC, V148, P275, DOI 10.1111/j.1095-8339.2005.00418.x; Meyer-Berthaud B, 1999, NATURE, V398, P700, DOI 10.1038/19516; MILLER MF, 1991, DYNAMIC STRATIGRAPHY, P153; Mintz JS, 2010, PALAIOS, V25, P85, DOI 10.2110/palo.2009.p09-086r; PIGG KB, 1992, ANN MO BOT GARD, V79, P589, DOI 10.2307/2399754; Retallack GJ, 2011, PALAEOGEOGR PALAEOCL, V299, P110, DOI 10.1016/j.palaeo.2010.10.040; Stein WE, 2007, NATURE, V446, P904, DOI 10.1038/nature05705; White D., 1907, NY STATE MUS B, V107, P328; Wright VP, 2000, J SEDIMENT RES, V70, P619, DOI 10.1306/2DC4092C-0E47-11D7-8643000102C1865D	28	126	136	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					78	81		10.1038/nature10819	http://dx.doi.org/10.1038/nature10819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22382983				2022-12-01	WOS:000300877900048
J	Pocock, MJO; Evans, DM; Memmott, J				Pocock, Michael J. O.; Evans, Darren M.; Memmott, Jane			The Robustness and Restoration of a Network of Ecological Networks	SCIENCE			English	Article							POLLINATION NETWORKS; BIODIVERSITY; DIVERSITY; SERVICES	Understanding species' interactions and the robustness of interaction networks to species loss is essential to understand the effects of species' declines and extinctions. In most studies, different types of networks (such as food webs, parasitoid webs, seed dispersal networks, and pollination networks) have been studied separately. We sampled such multiple networks simultaneously in an agroecosystem. We show that the networks varied in their robustness; networks including pollinators appeared to be particularly fragile. We show that, overall, networks did not strongly covary in their robustness, which suggests that ecological restoration (for example, through agri-environment schemes) benefitting one functional group will not inevitably benefit others. Some individual plant species were disproportionately well linked to many other species. This type of information can be used in restoration management, because it identifies the plant taxa that can potentially lead to disproportionate gains in biodiversity.	[Pocock, Michael J. O.; Evans, Darren M.; Memmott, Jane] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol	Pocock, MJO (corresponding author), NERC Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England.	michael.pocock@ceh.ac.uk	Pocock, Michael/A-5632-2012; Evans, Darren Mark/J-9782-2012	Pocock, Michael/0000-0003-4375-0445; Evans, Darren/0000-0003-4061-6726	Biotechnology and Biological Sciences Research Council [BBD0156341]; Department for Environment, Food and Rural Affairs [BD2303]; BBSRC [BB/D015634/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D015634/1] Funding Source: researchfish; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J. Brooks helped throughout the project, and 14 field assistants helped with field and laboratory work; 15 taxonomists (listed in SOM text) assisted with species' identification; and Cate Le Grice-Mack (the landowner) gave full support throughout the project. The authors declare no competing interests. The interaction data are available from the Dryad Digital Repository, doi:10.5061/dryad.3s36r118. The project was supported by the Biotechnology and Biological Sciences Research Council (grant no. BBD0156341) and the Department for Environment, Food and Rural Affairs (grant no. BD2303).	[Anonymous], 2005, EC HUM WELL BEING BI; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; European Environment Agency, 2010, ASS BIOD EUR 2010 RE; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; HALL SJ, 1991, J ANIM ECOL, V60, P823, DOI 10.2307/5416; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; Melian CJ, 2009, OIKOS, V118, P122, DOI 10.1111/j.1600-0706.2008.16751.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Pocock MJO, 2010, AGR ECOSYST ENVIRON, V135, P279, DOI 10.1016/j.agee.2009.10.006; Sandhu HS, 2008, ECOL ECON, V64, P835, DOI 10.1016/j.ecolecon.2007.05.007; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; Wade MR, 2008, PHILOS T R SOC B, V363, P831, DOI 10.1098/rstb.2007.2186	30	370	381	21	563	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071					973	977		10.1126/science.1214915	http://dx.doi.org/10.1126/science.1214915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363009	Green Accepted			2022-12-01	WOS:000300931800048
J	Watts, G				Watts, Geoff			OBESITY The future of obesity treatment: what can drugs and surgery offer?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OVERWEIGHT; WEIGHT					geoff@scileg.freeserve.co.uk						Department of Health, HLTH LIV HLTH PEOPL; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; International Diabetes Federation, 2011, BAR SURG PROC INT TR; National Institutes of Health, 1991, GASTR SURG SEV OB CO; NICE, 2006, OB GUID PREV ID ASS; Wynne K, 2005, DIABETES, V54, P2390, DOI 10.2337/diabetes.54.8.2390; 2012, BRIT MED J, V344	8	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 14	2012	344								e1011	10.1136/bmj.e1011	http://dx.doi.org/10.1136/bmj.e1011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896HZ	22334541				2022-12-01	WOS:000300557600009
J	Sandhaus, RA				Sandhaus, Robert A.			Gene Therapy Meets Stem Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sandhaus, Robert A.] Natl Jewish Hlth, Denver, CO USA; [Sandhaus, Robert A.] AlphaNet, Miami, FL USA	National Jewish Health	Sandhaus, RA (corresponding author), Natl Jewish Hlth, Denver, CO USA.							Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	1	8	8	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2012	366	6					567	569		10.1056/NEJMcibr1113400	http://dx.doi.org/10.1056/NEJMcibr1113400			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888GH	22316453				2022-12-01	WOS:000299991300015
J	van de Water, W; Markopoulos, C; van de Velde, CJH; Seynaeve, C; Hasenburg, A; Rea, D; Putter, H; Nortier, JWR; de Craen, AJM; Hille, ETM; Bastiaannet, E; Hadji, P; Westendorp, RGJ; Liefers, GJ; Jones, SE				van de Water, Willemien; Markopoulos, Christos; van de Velde, Cornelis J. H.; Seynaeve, Caroline; Hasenburg, Annette; Rea, Daniel; Putter, Hein; Nortier, Johan W. R.; de Craen, Anton J. M.; Hille, Elysee T. M.; Bastiaannet, Esther; Hadji, Peyman; Westendorp, Rudi G. J.; Liefers, Gerrit-Jan; Jones, Stephen E.			Association Between Age at Diagnosis and Disease-Specific Mortality Among Postmenopausal Women With Hormone Receptor-Positive Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPETING CAUSES; INTERNATIONAL-SOCIETY; DEATH; STAGE; OLDER; RECOMMENDATIONS; GUIDELINES; SURVIVAL; THERAPY	Context In addition to classic tumor-related prognostic factors, patient characteristics may be associated with breast cancer outcome. Objective To assess the association between age at diagnosis and breast cancer outcome in postmenopausal women with hormone receptor-positive breast cancer. Design, Setting, and Patients Study analysis of 9766 patients enrolled in the TEAM (Tamoxifen Exemestane Adjuvant Multinational) randomized clinical trial between January 2001 and January 2006. Age at diagnosis was categorized as younger than 65 years (n=5349), 65 to 74 years (n=3060), and 75 years or older (n=1357). Main Outcome Measures Primary end point was disease-specific mortality; secondary end points were other-cause mortality and breast cancer relapse. Results During median follow-up of approximately 5.1 years, there were a total of 1043 deaths. Disease-specific mortality, as a proportion of all-cause mortality, decreased with categorical age group (78% [<65 years], 56% [65-74 years], and 36% [>= 75 years]; P<.001). In multivariable analyses, compared with patients younger than 65 years, disease-specific mortality increased with age for patients aged 65 to 74 years (hazard ratio [HR], 1.25; 95% CI, 1.01-1.54); and patients aged 75 years or older (HR, 1.63; 95% CI, 1.23-2.16) (P<.001). Similarly, breast cancer relapse increased with age for patients aged 65-74 years (HR, 1.07; 95% CI, 0.91-1.25 and patients aged 75 years or older (HR, 1.29; 95% CI, 1.05-1.60) (P=.06). Other-cause mortality increased with age in patients aged 65 to 74 years (HR, 2.66; 95% CI, 1.96-3.63) and patients aged 75 years or older (HR, 7.30; 95% CI, 5.29-10.07) (P<.001). Conclusion Among postmenopausal women with hormone receptor-positive breast cancer, increasing age was associated with a higher disease-specific mortality. JAMA. 2012;307(6):590-597	[van de Water, Willemien; van de Velde, Cornelis J. H.; Hille, Elysee T. M.; Bastiaannet, Esther; Liefers, Gerrit-Jan] Leiden Univ, Med Ctr, Dept Surg Oncol, NL-2300 RC Leiden, Netherlands; [van de Water, Willemien; de Craen, Anton J. M.; Bastiaannet, Esther; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, NL-2300 RC Leiden, Netherlands; [Putter, Hein] Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RC Leiden, Netherlands; [Nortier, Johan W. R.] Leiden Univ, Med Ctr, Dept Med Oncol, NL-2300 RC Leiden, Netherlands; [Markopoulos, Christos] Univ Athens, Sch Med, Dept Surg, Breast Unit, GR-11527 Athens, Greece; [Seynaeve, Caroline] Erasmus MC, Daniel Den Hoed Canc Ctr, Dept Med Oncol, Rotterdam, Netherlands; [Hasenburg, Annette] Univ Hosp Freiburg, Dept Obstet & Gynecol, Freiburg, Germany; [Rea, Daniel] Univ Birmingham, Dept Med Oncol, Birmingham, W Midlands, England; [Hadji, Peyman] Univ Marburg, Dept Gynecol, Marburg, Germany; [Jones, Stephen E.] US Oncol Res, Dept Med Oncol, The Woodlands, TX USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Athens Medical School; National & Kapodistrian University of Athens; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Freiburg; University of Birmingham; Philipps University Marburg; US Oncology Network	van de Velde, CJH (corresponding author), Leiden Univ, Med Ctr, Dept Surg Oncol, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.	c.j.h.van_de_velde@lumc.nl	Putter, Hein/C-2244-2018; Markopoulos, Christos/AAD-8501-2019; van de Velde, Cornelis/AAY-8360-2020	Putter, Hein/0000-0001-5395-1422; Markopoulos, Christos/0000-0002-5072-6390; 	Pfizer; AstraZeneca UK; Novartis; Dutch Cancer Society (KWF); USOncology Research	Pfizer(Pfizer); AstraZeneca UK(AstraZeneca); Novartis(Novartis); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); USOncology Research	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Markopoulos reported receipt of an institutional grant from Pfizer; honoraria for lectures from Pfizer, AstraZeneca UK, and Novartis; and has institutional grants pending from AstraZeneca UK and Novartis. Dr van de Velde reported receipt of an institutional grant from Pfizer and reported membership on the European Cancer Organization board. Dr Hasenburg reported receipt of an institutional consulting fee from Pfizer; support for travel to study meetings from Pfizer, GlaxoSmithKline, Sanofi Pasteur, AstraZeneca, Medconcept, Amgen, and Merck Sharp & Dohme; fees for participation in review activities from Pfizer; and payment for lectures from Pfizer, GlaxoSmithKline, Sanofi Pasteur, AstraZeneca, Medconcept, Amgen, and Merck Sharp & Dohme. Dr Rea reported receipt of an institutional grant from Pfizer and support for travel to study meetings from Pfizer. Dr de Craen reported receipt of an institutional grant from the Dutch Cancer Society (KWF). Dr Hille reported receipt of an institutional grant from Pfizer and has institutional grants pending from Pfizer and the Dutch Cancer Society (KWF). Dr Hadji reported receipt of an institutional research grant and a lecture fee and support for traveling to TEAM Steering Committee Meetings from Pfizer. Dr Jones reported receipt of an institutional research grant from USOncology Research, support to travel to meetings from Pfizer, and being an adviser and member Pfizer USA's speaker's bureau. The other authors reported no potential conflict of interest.	Allemani C, 2010, EUR J CANCER, V46, P1528, DOI 10.1016/j.ejca.2010.02.016; [Anonymous], 2009, INT SOC GER ONC ANN; Bastiaannet E, 2010, BREAST CANCER RES TR, V124, P801, DOI 10.1007/s10549-010-0898-8; Braithwaite D, 2010, JNCI-J NATL CANCER I, V102, P1468, DOI 10.1093/jnci/djq344; Chapman JAW, 2008, JNCI-J NATL CANCER I, V100, P252, DOI 10.1093/jnci/djn014; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Diab SG, 2000, J NATL CANCER I, V92, P550, DOI 10.1093/jnci/92.7.550; Du XL, 2008, AM J CLIN ONCOL-CANC, V31, P105, DOI 10.1097/COC.0b013e318142c865; Durbecq V, 2010, MANAGEMENT OF BREAST CANCER IN OLDER WOMEN, P21, DOI 10.1007/978-1-84800-265-4_2; Eisinger F, 2007, INT J CANCER, V120, P1136, DOI 10.1002/ijc.22444; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fish EB, 1998, ANN SURG ONCOL, V5, P368, DOI 10.1007/BF02303502; Gennari R, 2004, CANCER-AM CANCER SOC, V101, P1302, DOI 10.1002/cncr.20535; Giordano SH, 2005, J CLIN ONCOL, V23, P783, DOI 10.1200/JCO.2005.04.175; Hanrahan EO, 2007, J CLIN ONCOL, V25, P4952, DOI 10.1200/JCO.2006.08.0499; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Latouche A, 2007, STAT MED, V26, P5370, DOI 10.1002/sim.3114; Lewis JH, 2003, J CLIN ONCOL, V21, P1383, DOI 10.1200/JCO.2003.08.010; Lichtman SM, 2007, EUR J CANCER, V43, P14, DOI 10.1016/j.ejca.2006.11.004; Mell LK, 2010, CANCER-AM CANCER SOC, V116, P5365, DOI 10.1002/cncr.25370; National Cancer Institute, CANC STAT FACT SHEET; Pallis AG, 2010, EUR J CANCER, V46, P1502, DOI 10.1016/j.ejca.2010.02.022; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Schairer C, 2004, JNCI-J NATL CANCER I, V96, P1311, DOI 10.1093/jnci/djh253; van de Velde CJH, 2011, LANCET, V377, P321, DOI 10.1016/S0140-6736(10)62312-4; van de Water W, ONCOLOGIST, DOI [10.1634/theoncologist2011-0037, DOI 10.1634/THEONCOLOGIST2011-0037]; van Nes JGH, 2010, BRIT J SURG, V97, P671, DOI 10.1002/bjs.6962; White J, 2003, CANCER-AM CANCER SOC, V97, P893, DOI 10.1002/cncr.11141; Wildiers H, 2007, LANCET ONCOL, V8, P1101, DOI 10.1016/S1470-2045(07)70378-9; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936; Zulman DM, 2011, J GEN INTERN MED, V26, P783, DOI 10.1007/s11606-010-1629-x	32	145	147	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2012	307	6					590	597		10.1001/jama.2012.84	http://dx.doi.org/10.1001/jama.2012.84			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888GT	22318280	Bronze			2022-12-01	WOS:000299992500023
J	Vesper, HW; Kuiper, HC; Mirel, LB; Johnson, CL; Pirkle, JL				Vesper, Hubert W.; Kuiper, Heather C.; Mirel, Lisa B.; Johnson, Clifford L.; Pirkle, James L.			Levels of Plasma trans-Fatty Acids in Non-Hispanic White Adults in the United States in 2000 and 2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Vesper, Hubert W.; Kuiper, Heather C.; Pirkle, James L.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA; [Mirel, Lisa B.; Johnson, Clifford L.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Vesper, HW (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.	hvesper@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Centers for Disease Control and Prevention National Center for Health Statistics, NAT HLTH NUTR EX SUR; Gebauer SK, 2007, LIPIDS, V42, P787, DOI 10.1007/s11745-007-3095-8; Lagerstedt SA, 2001, MOL GENET METAB, V73, P38, DOI 10.1006/mgme.2001.3170; Mossoba MM, 2009, OFFICIAL METHODS DET, P20; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS5, DOI 10.1038/sj.ejcn.1602973; [No title captured]	6	68	69	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2012	307	6					562	563		10.1001/jama.2012.112	http://dx.doi.org/10.1001/jama.2012.112			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888GT	22318273	Green Accepted, Bronze			2022-12-01	WOS:000299992500014
J	Njau, J				Njau, Jackson			Reading Pliocene Bones	SCIENCE			English	Editorial Material							CARNIVORE TOOTH-MARKS; OLDUVAI GORGE; PERCUSSION MARKS; STONE TOOLS; FLK ZINJANTHROPUS; TANZANIA; HOMINID; ETHIOPIA; PLEISTOCENE; SURFACES		Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Njau, J (corresponding author), Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA.	jknjau@indiana.edu						BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Binford L.R., 1981, BONES ANCIENT MEN MO; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Blumenschine RJ, 2007, J HUM EVOL, V53, P420, DOI 10.1016/j.jhevol.2007.01.011; BUNN HT, 1981, NATURE, V291, P574, DOI 10.1038/291574a0; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; Dominguez-Rodrigo M, 2010, P NATL ACAD SCI USA, V107, P20929, DOI 10.1073/pnas.1013711107; Fernandez-Jalvo Y, 2011, J HUM EVOL, V60, P117, DOI 10.1016/j.jhevol.2010.08.003; ISAAC GL, 1978, J ANTHROPOL RES, V34, P311; Lartet M.E., 1860, Q J GEOL SOC LOND, V16, P471, DOI DOI 10.1144/GSL.JGS.1860.016.01-02.63; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; OLIVER JS, 1994, J HUM EVOL, V27, P267, DOI 10.1006/jhev.1994.1046; OLSEN SL, 1988, J ARCHAEOL SCI, V15, P535, DOI 10.1016/0305-4403(88)90081-7; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Turner C. G., 1983, CARNIVORES HUMAN SCA, P219	21	21	21	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					46	47		10.1126/science.1216221	http://dx.doi.org/10.1126/science.1216221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	920LG	22491846				2022-12-01	WOS:000302405400045
J	Begley, CG; Ellis, LM				Begley, C. Glenn; Ellis, Lee M.			Raise standards for preclinical cancer research	NATURE			English	Editorial Material									[Begley, C. Glenn] Amgen Inc, Thousand Oaks, CA 91359 USA; [Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Amgen; University of Texas System; UTMD Anderson Cancer Center	Begley, CG (corresponding author), Amgen Inc, Thousand Oaks, CA 91359 USA.	lellis@mdanderson.org	Coles, Simon/A-1795-2009	Coles, Simon/0000-0001-8414-9272				Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Francia G, 2010, NAT BIOTECHNOL, V28, P561, DOI 10.1038/nbt0610-561; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Rubin E. H., 2012, NATURE REV CLIN ONCO	5	1731	1769	2	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					531	533		10.1038/483531a	http://dx.doi.org/10.1038/483531a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915EF	22460880				2022-12-01	WOS:000302006100013
J	Guan, Y; Webby, R; Capua, I; Waldenstrom, J				Guan, Yi; Webby, Richard; Capua, Ilaria; Waldenstrom, Jonas			How to track a flu virus	NATURE			English	Editorial Material									[Guan, Yi] Shantou Univ, Coll Med, Joint Influenza Res Ctr, Shantou, Peoples R China; [Guan, Yi] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Webby, Richard] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Capua, Ilaria] Vet Publ Hlth Inst, Int Reference Lab Avian Influenza & Newcastle Dis, Legnaro, Italy; [Waldenstrom, Jonas] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden	Shantou University; University of Hong Kong; St Jude Children's Research Hospital; Linnaeus University	Guan, Y (corresponding author), Shantou Univ, Coll Med, Joint Influenza Res Ctr, Shantou, Peoples R China.		Webby, Richard J/N-5657-2018; Waldenström, Jonas/E-4460-2013	Waldenström, Jonas/0000-0002-1152-4235; Guan, Yi/0000-0001-6057-9243					0	8	8	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					535	536						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915EF	22460882	Bronze			2022-12-01	WOS:000302006100015
J	Melzer, S; Michael, M; Caputi, A; Eliava, M; Fuchs, EC; Whittington, MA; Monyer, H				Melzer, Sarah; Michael, Magdalena; Caputi, Antonio; Eliava, Marina; Fuchs, Elke C.; Whittington, Miles A.; Monyer, Hannah			Long-Range-Projecting GABAergic Neurons Modulate Inhibition in Hippocampus and Entorhinal Cortex	SCIENCE			English	Article							SPATIAL REPRESENTATION; THETA OSCILLATIONS; MEDIAL SEPTUM; INTERNEURONS; RAT; EXPRESSION; DIVERSITY; CA1	The hippocampus and entorhinal cortex play a pivotal role in spatial learning and memory. The two forebrain regions are highly interconnected via excitatory pathways. Using optogenetic tools, we identified and characterized long-range gamma-aminobutyric acid-releasing (GABAergic) neurons that provide a bidirectional hippocampal-entorhinal inhibitory connectivity and preferentially target GABAergic interneurons. Activation of long-range GABAergic axons enhances sub- and suprathreshold rhythmic theta activity of postsynaptic neurons in the target areas.	[Melzer, Sarah; Michael, Magdalena; Caputi, Antonio; Eliava, Marina; Fuchs, Elke C.; Monyer, Hannah] Heidelberg Univ, Fac Med, Dept Clin Neurobiol, D-69120 Heidelberg, Germany; [Melzer, Sarah; Michael, Magdalena; Caputi, Antonio; Eliava, Marina; Fuchs, Elke C.; Monyer, Hannah] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Whittington, Miles A.] Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Newcastle University - UK	Monyer, H (corresponding author), Heidelberg Univ, Fac Med, Dept Clin Neurobiol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	h.monyer@dkfz-heidelberg.de	Melzer, Sarah/AAJ-9475-2021	Melzer, Sarah/0000-0001-6028-9764; Monyer, Hannah/0000-0002-9332-5749; Whittington, Miles Adrian/0000-0002-0247-1362	European Research Council [250047]; German Ministry of Education and Research (BMBF) [01GQ1003A]	European Research Council(European Research Council (ERC)European Commission); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank K. Deisseroth for the AAVs, A. Vogt for help in generating mice, I. Preugschat-Gumprecht and R. Hinz for their technical assistance, and P. H. Seeburg for helpful discussions. This work was supported by a European Research Council grant (GABAcellsAndMemory grant 250047, to H. M.) and a German Ministry of Education and Research (BMBF) grant 01GQ1003A to H. M. and E.C.F.	Apergis-Schoute J, 2007, J NEUROSCI, V27, P4061, DOI 10.1523/JNEUROSCI.0068-07.2007; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; GERMROTH P, 1989, BRAIN RES, V494, P187, DOI 10.1016/0006-8993(89)90162-5; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Jinno S, 2002, BRAIN RES, V945, P219, DOI 10.1016/S0006-8993(02)02804-4; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Takacs VT, 2008, EUR J NEUROSCI, V28, P148, DOI 10.1111/j.1460-9568.2008.06319.x; Tamamaki N, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00202; Tolu S, 2010, FASEB J, V24, P723, DOI 10.1096/fj.09-139790; TOTH K, 1993, J NEUROSCI, V13, P3712; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; Zappone CA, 2001, J COMP NEUROL, V441, P324, DOI 10.1002/cne.1415	23	220	227	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2012	335	6075					1506	1510		10.1126/science.1217139	http://dx.doi.org/10.1126/science.1217139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22442486				2022-12-01	WOS:000301837000052
J	Copic, A; Latham, CF; Horlbeck, MA; D'Arcangelo, JG; Miller, EA				Copic, Alenka; Latham, Catherine F.; Horlbeck, Max A.; D'Arcangelo, Jennifer G.; Miller, Elizabeth A.			ER Cargo Properties Specify a Requirement for COPII Coat Rigidity Mediated by Sec13p	SCIENCE			English	Article							GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE ATPASE; ENDOPLASMIC-RETICULUM; EDGE ELEMENT; VESICLE COAT; EXIT SITES; COMPLEX; YEAST; CURVATURE; TRANSPORT	Eukaryotic secretory proteins exit the endoplasmic reticulum (ER) via transport vesicles generated by the essential coat protein complex II (COPII) proteins. The outer coat complex, Sec13-Sec31, forms a scaffold that is thought to enforce curvature. By exploiting yeast bypass-of-sec-thirteen (bst) mutants, where Sec13p is dispensable, we probed the relationship between a compromised COPII coat and the cellular context in which it could still function. Genetic and biochemical analyses suggested that Sec13p was required to generate vesicles from membranes that contained asymmetrically distributed cargoes that were likely to confer opposing curvature. Thus, Sec13p may rigidify the COPII cage and increase its membrane-bending capacity; this function could be bypassed when a bst mutation renders the membrane more deformable.	[Copic, Alenka; Latham, Catherine F.; Horlbeck, Max A.; D'Arcangelo, Jennifer G.; Miller, Elizabeth A.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Miller, EA (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	em2282@columbia.edu		Copic, Alenka/0000-0003-0166-7731; Miller, Elizabeth/0000-0002-1033-8369	Columbia Research Initiatives in Science and Engineering; NIH [GM085089, GM078186]; Columbia Frontiers of Science fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085089, R01GM078186] Funding Source: NIH RePORTER	Columbia Research Initiatives in Science and Engineering; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia Frontiers of Science fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Goldberg, C. Boone, E. Snapp, and M. Lee for strains and reagents; T. Swayne, E. Bauer, R. Rothstein, J. Dittmar, and members of the Rothstein laboratory for technical assistance; and B. Antonny, J. Derganc, M. Lee, and F. Pincet for valuable discussions. This work was supported by a Columbia Research Initiatives in Science and Engineering award and NIH grants GM085089 and GM078186 to E. A. M. and by a Columbia Frontiers of Science fellowship to A. C. M. A. H. was an I. I. Rabi Science Scholar of Columbia University. Additional data described in the manuscript are presented in the supporting online material.	BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Brohawn SG, 2009, NAT STRUCT MOL BIOL, V16, P1173, DOI 10.1038/nsmb.1713; Copic A, 2009, GENETICS, V182, P757, DOI 10.1534/genetics.109.101105; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; ElrodErickson MJ, 1996, MOL BIOL CELL, V7, P1043, DOI 10.1091/mbc.7.7.1043; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schneiter R, 2004, BIOCHEM J, V381, P941, DOI 10.1042/BJ20040320; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Whittle JRR, 2010, J CELL BIOL, V190, P347, DOI 10.1083/jcb.201003092; Wilbur JD, 2010, DEV CELL, V18, P841, DOI 10.1016/j.devcel.2010.04.007; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	30	93	93	4	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2012	335	6074					1359	1362		10.1126/science.1215909	http://dx.doi.org/10.1126/science.1215909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22300850	Green Accepted			2022-12-01	WOS:000301531600050
J	Shohat-Ophir, G; Kaun, KR; Azanchi, R; Heberlein, U				Shohat-Ophir, G.; Kaun, K. R.; Azanchi, R.; Heberlein, U.			Sexual Deprivation Increases Ethanol Intake in Drosophila	SCIENCE			English	Article							NEUROPEPTIDE Y-LIKE; SOCIAL-BEHAVIOR; NPY; MELANOGASTER; DEPRESSION; RATS; ADDICTION; RECEPTORS; SYSTEM; MEMORY	The brain's reward systems reinforce behaviors required for species survival, including sex, food consumption, and social interaction. Drugs of abuse co-opt these neural pathways, which can lead to addiction. Here, we used Drosophila melanogaster to investigate the relationship between natural and drug rewards. In males, mating increased, whereas sexual deprivation reduced, neuropeptide F (NPF) levels. Activation or inhibition of the NPF system in turn reduced or enhanced ethanol preference. These results thus link sexual experience, NPF system activity, and ethanol consumption. Artificial activation of NPF neurons was in itself rewarding and precluded the ability of ethanol to act as a reward. We propose that activity of the NPF-NPF receptor axis represents the state of the fly reward system and modifies behavior accordingly.	[Shohat-Ophir, G.; Kaun, K. R.; Azanchi, R.; Heberlein, U.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Shohat-Ophir, G (corresponding author), Janelia Farm Res Ctr, Howard Hughes Med Inst, Ashburn, VA 20147 USA.	shohatophirg@janelia.hhmi.org; ulrike.heberlein@ucsf.edu		Kaun, Karla/0000-0002-8756-9528	Sandler Research Fellowship; University of California, San Francisco; NIH-National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035] Funding Source: NIH RePORTER	Sandler Research Fellowship; University of California, San Francisco(University of California System); NIH-National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank F. Wolf, M. Schuldiner, O. Schuldiner, A. Devineni, K. McClure, R. Joseph, and N. Velazquez Ulloa for advice and comments on the manuscript; J. Levine for discussions; P. Shen for fly strains and antibodies; and the Bloomington Stock Center for fly strains. Funding was provided by the Sandler Research Fellowship (G.S.-O.), the Program for Breakthrough Biomedical Research at the University of California, San Francisco (U. H.), and NIH-National Institute on Alcohol Abuse and Alcoholism (U. H.). The authors declare that they have no competing interests. A detailed description of all materials and methods as well as supplementary figures are available as supporting online material.	Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; Dyzma M, 2010, SLEEP MED REV, V14, P161, DOI 10.1016/j.smrv.2009.09.001; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Horsell A, 1999, NEUROREPORT, V10, P3003, DOI 10.1097/00001756-199909290-00024; Hyman SE, 2007, AM J BIOETHICS, V7, P8, DOI 10.1080/15265160601063969; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jimenez-Vasquez PA, 2001, DEV BRAIN RES, V131, P149, DOI 10.1016/S0165-3806(01)00264-4; JOSSELYN SA, 1993, PHARMACOL BIOCHEM BE, V46, P543, DOI 10.1016/0091-3057(93)90542-2; KALRA SP, 1988, SYNAPSE, V2, P254, DOI 10.1002/syn.890020313; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; Kelley AE, 2002, J NEUROSCI, V22, P3306; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Krishnan V, 2011, CURR TOP BEHAV NEURO, V7, P121, DOI 10.1007/7854_2010_108; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Mehren JE, 2004, CURR OPIN NEUROBIOL, V14, P745, DOI 10.1016/j.conb.2004.10.012; Redrobe JP, 2002, LIFE SCI, V71, P2921, DOI 10.1016/S0024-3205(02)02159-8; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Sah R, 2009, BIOL PSYCHIAT, V66, P705, DOI 10.1016/j.biopsych.2009.04.037; Stogner KA, 2000, EUR J PHARMACOL, V387, pR9, DOI 10.1016/S0014-2999(99)00800-6; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; Thorsell A, 2002, NEUROSCI LETT, V332, P1, DOI 10.1016/S0304-3940(02)00904-7; Thorsell A, 2007, PEPTIDES, V28, P480, DOI 10.1016/j.peptides.2006.11.017; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Xu J, 2010, J NEUROSCI, V30, P2504, DOI 10.1523/JNEUROSCI.3262-09.2010	33	126	129	0	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2012	335	6074					1351	1355		10.1126/science.1215932	http://dx.doi.org/10.1126/science.1215932			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22422983	Green Accepted			2022-12-01	WOS:000301531600048
J	Heyward, AJ; Negri, AP				Heyward, A. J.; Negri, A. P.			Turbulence, Cleavage, and the Naked Embryo: A Case for Coral Clones	SCIENCE			English	Article									[Heyward, A. J.] Univ Western Australia, Australian Inst Marine Sci, Nedlands, WA 6009, Australia; [Negri, A. P.] AIMS, Townsville, Qld 4810, Australia	Australian Institute of Marine Science; University of Western Australia; Australian Institute of Marine Science	Heyward, AJ (corresponding author), Univ Western Australia, Australian Inst Marine Sci, 35 Stirling Highway, Nedlands, WA 6009, Australia.	a.heyward@aims.gov.au	Negri, Andrew P/G-9909-2017	Negri, Andrew P/0000-0003-1388-7395	AIMS, Monbusho (Japan); Sesoko Station; Palau International Coral Reef Center; Global Environmental Facility/World Bank	AIMS, Monbusho (Japan); Sesoko Station; Palau International Coral Reef Center; Global Environmental Facility/World Bank	We thank V. Beltran-Ramirez, A. Baird, R. Brinkman, J. Kerry, G. Jones, N. Webster, J. Gilmour, and M. van Oppen for assistance and AIMS, Monbusho (Japan), Sesoko Station, Palau International Coral Reef Center, and Global Environmental Facility/World Bank for funding and field support.	[Anonymous], 2011, BEAUF SCAL WIND SPEE; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Deane GB, 2002, NATURE, V418, P839, DOI 10.1038/nature00967; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; H÷rstadius S., 1973, EXPT EMBRYOLOGY ECHI	6	39	39	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1064	1064		10.1126/science.1216055	http://dx.doi.org/10.1126/science.1216055			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383841				2022-12-01	WOS:000300931100036
J	Hou, Y; Song, LT; Zhu, P; Zhang, B; Tao, Y; Xu, X; Li, FQ; Wu, K; Liang, J; Shao, D; Wu, HJ; Ye, XF; Ye, C; Wu, RH; Jian, M; Chen, Y; Xie, W; Zhang, RR; Chen, L; Liu, X; Yao, XT; Zheng, HC; Yu, C; Li, QB; Gong, ZL; Mao, M; Yang, X; Yang, L; Li, JX; Wang, W; Lu, ZH; Gu, N; Laurie, G; Bolund, L; Kristiansen, K; Wang, J; Yang, HM; Li, YR; Zhang, XQ; Wang, J				Hou, Yong; Song, Luting; Zhu, Ping; Zhang, Bo; Tao, Ye; Xu, Xun; Li, Fuqiang; Wu, Kui; Liang, Jie; Shao, Di; Wu, Hanjie; Ye, Xiaofei; Ye, Chen; Wu, Renhua; Jian, Min; Chen, Yan; Xie, Wei; Zhang, Ruren; Chen, Lei; Liu, Xin; Yao, Xiaotian; Zheng, Hancheng; Yu, Chang; Li, Qibin; Gong, Zhuolin; Mao, Mao; Yang, Xu; Yang, Lin; Li, Jingxiang; Wang, Wen; Lu, Zuhong; Gu, Ning; Laurie, Goodman; Bolund, Lars; Kristiansen, Karsten; Wang, Jian; Yang, Huanming; Li, Yingrui; Zhang, Xiuqing; Wang, Jun			Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm	CELL			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; ESSENTIAL THROMBOCYTHEMIA; CANCER; MUTATIONS; VARIANTS; ORIGIN; GENES	Tumor heterogeneity presents a challenge for inferring clonal evolution and driver gene identification. Here, we describe a method for analyzing the cancer genome at a single-cell nucleotide level. To perform our analyses, we first devised and validated a high-throughput whole-genome single-cell sequencing method using two lymphoblastoid cell line single cells. We then carried out whole-exome single-cell sequencing of 90 cells from a JAK2-negative myeloproliferative neoplasm patient. The sequencing data from 58 cells passed our quality control criteria, and these data indicated that this neoplasm represented a monoclonal evolution. We further identified essential thrombocythemia (ET)-related candidate mutations such as SESN2 and NTRK1, which may be involved in neoplasm progression. This pilot study allowed the initial characterization of the disease-related genetic architecture at the single-cell nucleotide level. Further, we established a single-cell sequencing method that opens the way for detailed analyses of a variety of tumor types, including those with high genetic complex between patients.	[Hou, Yong; Song, Luting; Zhang, Bo; Tao, Ye; Xu, Xun; Li, Fuqiang; Wu, Kui; Liang, Jie; Shao, Di; Wu, Hanjie; Ye, Xiaofei; Ye, Chen; Wu, Renhua; Jian, Min; Xie, Wei; Zhang, Ruren; Chen, Lei; Liu, Xin; Yao, Xiaotian; Zheng, Hancheng; Yu, Chang; Li, Qibin; Gong, Zhuolin; Yang, Xu; Yang, Lin; Li, Jingxiang; Laurie, Goodman; Bolund, Lars; Kristiansen, Karsten; Wang, Jian; Yang, Huanming; Li, Yingrui; Zhang, Xiuqing; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Hou, Yong; Lu, Zuhong; Gu, Ning] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China; [Hou, Yong; Xie, Wei; Zhang, Ruren; Lu, Zuhong; Gu, Ning] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China; [Song, Luting; Chen, Lei] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Song, Luting; Chen, Lei; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, CAS Max Planck Jr Res Grp, Kunming 650223, Yunnan, Peoples R China; [Song, Luting; Chen, Lei] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China; [Zhu, Ping] Peking Univ, Hosp 1, Dept Hematol, Beijing 100034, Peoples R China; [Mao, Mao] Pfizer Inc, San Diego, CA 92121 USA; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-1165 Copenhagen, Denmark	Beijing Genomics Institute (BGI); Southeast University - China; Southeast University - China; Wuhan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Pfizer; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Li, YR (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangj@genomics.org.cn; liyr@genomics.org.cn; zhangxq@genomics.org.cn; wangj@genomics.org.cn	Lu, Zuhong/A-5448-2013; Kristiansen, Karsten/J-5148-2014; Wang, Wen/AAP-9873-2020; Yu, Chang/AAE-8538-2019; Xu, Xun/AAI-6763-2020; Wu, Hanjie/AAY-2936-2020; Li, Yingrui/K-1064-2015; Wang, Jun/A-7261-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Kristiansen, Karsten/0000-0002-6024-0917; Xu, Xun/0000-0002-5338-5173; Wu, Hanjie/0000-0002-5451-4969; hou, yong/0000-0002-0420-0726; Shao, Di/0000-0002-1485-2074; Zhang, Bo/0000-0001-8890-8416; chen, lei/0000-0003-3989-9239; Wang, Jun/0000-0002-8540-8931; Liu, Xin/0000-0003-3256-2940; Wang, Jun/0000-0002-2113-5874; Lu, Zuhong/0000-0003-3332-2615; Yao, Xiaotian/0000-0002-3466-461X	National Basic Research Program of China (973 program) [2011CB809202, 2011CB809203]; Chinese 863 program [2009AA022707, 2012AA02A201]; Shenzhen Municipal Government of China [ZYC201005250020A]; Key Laboratory Project, Shenzhen City [CX B200903110066A, CXB201108250096A]; Shenzhen Key Laboratory of Gene Bank for National Life Science; Innovative Research Team of Guangdong; Guangdong Enterprise Key Laboratory of Human Disease Genomics; Danish Natural Science Research Council; Danish National Research Foundation; National Natural Science Foundation of China; Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen	National Basic Research Program of China (973 program)(National Basic Research Program of China); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Key Laboratory Project, Shenzhen City; Shenzhen Key Laboratory of Gene Bank for National Life Science; Innovative Research Team of Guangdong; Guangdong Enterprise Key Laboratory of Human Disease Genomics; Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen	This work was supported by a National Basic Research Program of China (973 program number 2011CB809202;2011CB809203), the Chinese 863 program (numbers 2009AA022707 and 2012AA02A201), the Shenzhen Municipal Government of China (grant ZYC201005250020A), the Key Laboratory Project Supported by Shenzhen City (grants CX B200903110066A and CXB201108250096A), and Shenzhen Key Laboratory of Gene Bank for National Life Science. This project was also supported by grants from the Innovative Research Team Project of Guangdong and the Guangdong Enterprise Key Laboratory of Human Disease Genomics. We also acknowledge the Ole Romer grant from the Danish Natural Science Research Council, the Danish National Research Foundation, the National Natural Science Foundation of China, and funds from the Shenzhen Municipal Government and the Local Government of Yantian District of Shenzhen.	Abramson N, 2000, AM FAM PHYSICIAN, V62, P2053; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Frank NY, 2009, LEUKEMIA RES, V33, P1303, DOI 10.1016/j.leukres.2009.04.035; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Haeno H, 2009, P NATL ACAD SCI USA, V106, P16616, DOI 10.1073/pnas.0908107106; Kawamata N, 2008, EXP HEMATOL, V36, P1471, DOI 10.1016/j.exphem.2008.06.006; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Mesa RA, 1999, AM J HEMATOL, V61, P10, DOI 10.1002/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Stegelmann F, 2010, HAEMATOL-HEMATOL J, V95, P666, DOI 10.3324/haematol.2009.013623; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Tefferi A, 2001, LEUKEMIA RES, V25, P369, DOI 10.1016/S0145-2126(00)00131-4; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630	32	396	430	6	174	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					873	885		10.1016/j.cell.2012.02.028	http://dx.doi.org/10.1016/j.cell.2012.02.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385957	Bronze			2022-12-01	WOS:000300985000009
J	Seo, MD; Velamakanni, S; Ishiyama, N; Stathopulos, PB; Rossi, AM; Khan, SA; Dale, P; Li, CM; Ames, JB; Ikura, M; Taylor, CW				Seo, Min-Duk; Velamakanni, Saroj; Ishiyama, Noboru; Stathopulos, Peter B.; Rossi, Ana M.; Khan, Samir A.; Dale, Philippa; Li, Congmin; Ames, James B.; Ikura, Mitsuhiko; Taylor, Colin W.			Structural and functional conservation of key domains in InsP(3) and ryanodine receptors	NATURE			English	Article							LIGAND-BINDING; CRYSTAL-STRUCTURES; CONFORMATIONAL-CHANGES; TRANSMEMBRANE DOMAINS; MOLECULAR-CLONING; INOSITOL; FORMS; PROBE	Inositol-1,4,5-trisphosphate receptors (InsP(3)Rs) and ryanodine receptors (RyRs) are tetrameric intracellular Ca2+ channels(1). In each of these receptor families, the pore, which is formed by carboxy-terminal transmembrane domains, is regulated by signals that are detected by large cytosolic structures. InsP(3)R gating is initiated by InsP(3) binding to the InsP(3)-binding core (IBC, residues 224-604 of InsP(3)R1)(2) and it requires the suppressor domain (SD, residues 1-223 of InsP(3)R1)(2-8). Here we present structures of the amino-terminal region (NT, residues 1-604) of rat InsP(3)R1 with (3.6 angstrom) and without (3.0 angstrom) InsP(3) bound. The arrangement of the three NT domains, SD, IBC-beta and IBC-alpha, identifies two discrete interfaces (alpha and beta) between the IBC and SD. Similar interfaces occur between equivalent domains (A, B and C) in RyR1 (ref. 9). The orientations of the three domains when docked into a tetrameric structure of InsP(3)R(10) and of the ABC domains docked into RyR(9) are remarkably similar. The importance of the alpha-interface for activation of InsP(3)R and RyR is confirmed by mutagenesis and, for RyR, by disease-causing mutations(9,11,12). Binding of InsP(3) causes partial closure of the clam-like IBC, disrupting the beta-interface and pulling the SD towards the IBC. This reorients an exposedSDloop ('hotspot' (HS) loop) that is essential for InsP(3)R activation(7). The loop is conserved in RyR and includes mutations that are associated with malignant hyperthermia and central core disease(9,11,12). The HS loop interacts with an adjacent NT, suggesting that activation re-arranges inter-subunit interactions. The A domain of RyR functionally replaced the SD in full-length InsP(3)R, and an InsP(3)R in which its C-terminal transmembrane region was replaced by that from RyR1 was gated by InsP(3) and blocked by ryanodine. Activation mechanisms are conserved between InsP(3)R and RyR. Allosteric modulation of two similar domain interfaces within an N-terminal subunit reorients the first domain (SD or A domain), allowing it, through interactions of the second domain of an adjacent subunit (IBC-beta or B domain), to gate the pore.	[Seo, Min-Duk; Ishiyama, Noboru; Stathopulos, Peter B.; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Seo, Min-Duk; Ishiyama, Noboru; Stathopulos, Peter B.; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Velamakanni, Saroj; Rossi, Ana M.; Khan, Samir A.; Dale, Philippa; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Li, Congmin; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Cambridge; University of California System; University of California Davis	Ikura, M (corresponding author), Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca; cwt1000@cam.ac.uk	Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044; Ikura, Mitsuhiko/0000-0002-9524-1303; Stathopulos, Peter/0000-0002-0536-6656; Rossi, Ana Maria/0000-0001-8743-1089; Ishiyama, Noboru/0000-0002-1426-6083	Heart and Stroke Foundation of Ontario [T-7181]; National Institutes of Health Research [EY012347, NS059969]; Wellcome Trust [085295]; Biotechnology and Biological Sciences Research Council [BB/H009736]; Medical Research Council [G0900049]; Canadian Institutes of Health Research; National Research Foundation of Korea [2009-352-E00006]; BBSRC [BB/H009736/1] Funding Source: UKRI; MRC [G0900049] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H009736/1] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059969] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Research Foundation of Korea(National Research Foundation of Korea); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Allen and D. MacLennan for gifts of plasmids encoding RyR2 and RyR1, respectively. C.W.T. thanks T. Rahman and V. Konieczny for discussions. M.I. acknowledges K. Mikoshiba and T. Michikawa for long-standing support and discussions. This work was supported by grants from the Heart and Stroke Foundation of Ontario (T-7181) to M.I., National Institutes of Health Research (EY012347 and NS059969) to J.B.A., the Wellcome Trust (085295), the Biotechnology and Biological Sciences Research Council (BB/H009736) and the Medical Research Council (G0900049) to C.W.T. M.-D.S. is supported by postdoctoral fellowships from the Canadian Institutes of Health Research and the National Research Foundation of Korea (2009-352-E00006). A.M.R. is a fellow of Queens' College, Cambridge. M.I. holds a Canadian Research Chair in Cancer Structural Biology.	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Anyatonwu G, 2009, J BIOL CHEM, V284, P8093, DOI 10.1074/jbc.M806932200; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; Chan J, 2010, J BIOL CHEM, V285, P36092, DOI 10.1074/jbc.M110.140160; CHU A, 1990, MOL PHARMACOL, V37, P735; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; George CH, 2004, MOL BIOL CELL, V15, P2627, DOI 10.1091/mbc.E03-09-0688; Hamada T, 2007, BIOCHEMISTRY-US, V46, P4272, DOI 10.1021/bi061557f; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; Kenakin T., 1997, PHARMACOLOGIC ANAL D, Vsecond edition, P137; LAI FA, 1989, J BIOENERG BIOMEMBR, V21, P227, DOI 10.1007/BF00812070; Lin CC, 2011, NAT STRUCT MOL BIOL, V18, P1172, DOI 10.1038/nsmb.2112; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Ludtke SJ, 2011, STRUCTURE, V19, P1192, DOI 10.1016/j.str.2011.05.003; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OTSU K, 1990, J BIOL CHEM, V265, P13472; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Rossi AM, 2009, NAT CHEM BIOL, V5, P631, DOI 10.1038/nchembio.195; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Serysheva II, 2010, CURR TOP MEMBR, V66, P171, DOI 10.1016/S1063-5823(10)66008-5; Sureshan KM, 2009, CHEM COMMUN, P1204, DOI 10.1039/b819328b; Tateishi H, 2009, CARDIOVASC RES, V81, P536, DOI 10.1093/cvr/cvn303; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	38	137	138	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2012	483	7387					108	U159		10.1038/nature10751	http://dx.doi.org/10.1038/nature10751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22286060	Green Accepted, Green Submitted			2022-12-01	WOS:000300877900055
J	Cohen, D				Cohen, Deborah			MEDICAL DEVICES How safe are metal-on-metal hip implants?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ION LEVELS; WEAR PARTICLES; JOHN CHARNLEY; ARTHROPLASTY; REPLACEMENT; COBALT; DEBRIS; TRIAL; JOINT; BLOOD					dcohen@bmj.com						Antoniou J, 2008, J BONE JOINT SURG AM, V90A, P142, DOI 10.2106/JBJS.H.00442; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P201, DOI 10.1081/CLT-100102420; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; Cobb AG, 2006, P I MECH ENG H, V220, P385, DOI 10.1243/09544119JEIM78; Cohen D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5977; Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905; Committee of Mutagencity of Chemicals in Food Consumer Products and the Environment, 2006, COM06S1 COMM MUT CHE; Daniel J, 2004, J BONE JOINT SURG BR, V86B, P177, DOI 10.1302/0301-620X.86B2.14600; Engh CA, 2009, CLIN ORTHOP RELAT R, V467, P101, DOI 10.1007/s11999-008-0540-9; FDA, 510K SUMM SAF EFF; FDA, MET ON MET IMPL FDAS; FREEMAN MAR, 1969, ANN RHEUM DIS, V28, P29; Fricka K, 2012, AM AC ORTH SURG ANN; Garbuz DS, 2010, CLIN ORTHOP RELAT R, V468, P318, DOI 10.1007/s11999-009-1029-x; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; Hart AJ, 2010, ACTA BIOMATER, V6, P4439, DOI 10.1016/j.actbio.2010.06.006; Heneghan C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1349; International Agency for Research on Cancer, 1990, IARC MON S; JONES DA, 1975, J BONE JOINT SURG BR, V57, P289, DOI 10.1302/0301-620X.57B3.289; Ladon D, 2004, J ARTHROPLASTY, V19, P78, DOI 10.1016/j.arth.2004.09.010; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; Langton DJ, 2011, ORTHOP CLIN N AM, V42, P169, DOI 10.1016/j.ocl.2011.01.006; Lavigne M, 2011, J BONE JOINT SURG AM, V93A, P128, DOI 10.2106/JBJS.J.01885; Learmonth ID, 2007, LANCET, V369, P542, DOI 10.1016/S0140-6736(07)60251-7; Malviya A, 2011, J BONE JOINT SURG BR, V93B, P1602, DOI 10.1302/0301-620X.93B12.27533; Medicines and Healthcare products Regulatory Agency (MHRA), 2010, MED DEV AL ALL MET O; MHRA, 2006, COMM SAF DEV EXP ADV; MHRA, 2007, COMM SAF DEV EXP ADV; MHRA, 2006, COMM SAF DEV M MARCH; MHRA, 2007, COMM SAF DEV M 5 JUL; National joint registry for England and Wales, 2011, 8 NAT JOINT REG ENGL; Schmalzried TP, 2000, CLIN ORTHOP RELAT R, P36; Takamua KM, 2012, AM AC ORTH SURG ANN; Treacy R, 2009, MODERN HIP RESURFACI; Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002	35	101	103	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 28	2012	344								e1410	10.1136/bmj.e1410	http://dx.doi.org/10.1136/bmj.e1410			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XA	22374741	Green Submitted, Bronze			2022-12-01	WOS:000301231000011
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Seeing through the alcohol statistics haze	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						2011, BRIT MED J, V343, pD5869, DOI DOI 10.1136/BMJ.D5869; 2011, BRIT MED J, V342, DOI DOI 10.1136/BMJ.D4166; 2010, BRIT MED J, V341, DOI DOI 10.1136/BMJ.C4790; 2010, BRIT MED J, V340, DOI DOI 10.1136/BMJ.C2153	4	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2012	344								e1273	10.1136/bmj.e1273	http://dx.doi.org/10.1136/bmj.e1273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900JQ	22362248				2022-12-01	WOS:000300883600010
J	Sun, YL; Christensen, J; Hviid, A; Li, J; Vedsted, P; Olsen, J; Vestergaard, M				Sun, Yuelian; Christensen, Jakob; Hviid, Anders; Li, Jiong; Vedsted, Peter; Olsen, Jorn; Vestergaard, Mogens			Risk of Febrile Seizures and Epilepsy After Vaccination With Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, and Haemophilus Influenzae Type b	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL-HOSPITAL-REGISTER; WHOLE-CELL PERTUSSIS; CASE-SERIES METHOD; CONTROLLED TRIAL; ADVERSE REACTIONS; DRAVET SYNDROME; TOXOID VACCINE; MEASLES; MUMPS; SAFETY	Context Vaccination with whole-cell pertussis vaccine carries an increased risk of febrile seizures, but whether this risk applies to the acellular pertussis vaccine is not known. In Denmark, acellular pertussis vaccine has been included in the combined diphtheriatetanus toxoids-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine since September 2002. Objective To estimate the risk of febrile seizures and epilepsy after DTaP-IPV-Hib vaccination given at 3, 5, and 12 months. Design, Setting, and Participants A population-based cohort study of 378 834 children who were born in Denmark between January 1, 2003, and December 31, 2008, and followed up through December 31, 2009; and a self-controlled case series (SCCS) study based on children with febrile seizures during follow-up of the cohort. Main Outcome Measures Hazard ratio (HR) of febrile seizures within 0 to 7 days (0, 1-3, and 4-7 days) after each vaccination and HR of epilepsy after first vaccination in the cohort study. Relative incidence of febrile seizures within 0 to 7 days (0, 1-3, and 4-7 days) after each vaccination in the SCCS study. Results A total of 7811 children were diagnosed with febrile seizures before 18 months, of whom 17 were diagnosed within 0 to 7 days after the first (incidence rate, 0.8 per 100 000 person-days), 32 children after the second (1.3 per 100 000 person-days), and 201 children after the third (8.5 per 100 000 person-days) vaccinations. Overall, children did not have higher risks of febrile seizures during the 0 to 7 days after the 3 vaccinations vs a reference cohort of children who were not within 0 to 7 days of vaccination. However, a higher risk of febrile seizures was found on the day of the first (HR, 6.02; 95% CI, 2.86-12.65) and on the day of the second (HR, 3.94; 95% CI, 2.18-7.10), but not on the day of the third vaccination (HR, 1.07; 95% CI, 0.73-1.57) vs the reference cohort. On the day of vaccination, 9 children were diagnosed with febrile seizures after the first (5.5 per 100 000 person-days), 12 children after the second (5.7 per 100 000 person-days), and 27 children after the third (13.1 per 100 000 person-days) vaccinations. The relative incidences from the SCCS study design were similar to the cohort study design. Within 7 years of follow-up, 131 unvaccinated children and 2117 vaccinated children were diagnosed with epilepsy, 813 diagnosed between 3 and 15 months (2.4 per 1000 person-years) and 1304 diagnosed later in life (1.3 per 1000 person-years). After vaccination, children had a lower risk of epilepsy between 3 and 15 months (HR, 0.63; 95% CI, 0.50-0.79) and a similar risk for epilepsy later in life (HR, 1.01; 95% CI, 0.66-1.56) vs unvaccinated children. Conclusions DTaP-IPV-Hib vaccination was associated with an increased risk of febrile seizures on the day of the first 2 vaccinations given at 3 and 5 months, although the absolute risk was small. Vaccination with DTaP-IPV-Hib was not associated with an increased risk of epilepsy. JAMA. 2012;307(8):823-831 www.jama.com	[Sun, Yuelian; Li, Jiong; Olsen, Jorn; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, DK-8000 Aarhus C, Denmark; [Vedsted, Peter; Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, DK-8000 Aarhus C, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus, Denmark; [Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Statens Serum Institut; University of California System; University of California Los Angeles	Sun, YL (corresponding author), Aarhus Univ, Dept Publ Hlth, Bartholins Alle 2, DK-8000 Aarhus C, Denmark.	ys@soci.au.dk	Olsen, Jørn/F-8801-2015; Vedsted, Peter/C-2583-2008; Vestergaard, Mogens/M-9333-2014; li, jiong/L-6534-2014; Hviid, Anders/AAH-4319-2020; Sun, Yuelian/AFF-2622-2022	Olsen, Jørn/0000-0001-7462-5140; Vedsted, Peter/0000-0003-2113-5599; Vestergaard, Mogens/0000-0001-8830-2174; li, jiong/0000-0002-1716-8067; Hviid, Anders/0000-0002-7509-9127; Sun, Yuelian/0000-0002-6905-0503; li, jiong/0000-0003-1125-026X; Christensen, Jakob/0000-0002-9385-6435	Lundbeck Foundation [195/04]; Lennart Grams Memorial Foundation; Danish Medical Research Council; NordForsk [070331]; European Research Council [206242]	Lundbeck Foundation(Lundbeckfonden); Lennart Grams Memorial Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk; European Research Council(European Research Council (ERC)European Commission)	This study was supported by a grant 195/04 from the Lundbeck Foundation. Dr Sun also received support from the Lennart Grams Memorial Foundation. The data recruitment was supported by grants 271-07-0437 and 09-072986 from the Danish Medical Research Council, grant 070331 from NordForsk, and Seventh Framework Programme (FP7) grant 206242 from the European Research Council.	Andersen TF, 1999, DAN MED BULL, V46, P263; Andrews N, 2010, VACCINE, V28, P7215, DOI 10.1016/j.vaccine.2010.08.062; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Berkovic SF, 2006, LANCET NEUROL, V5, P488, DOI 10.1016/S1474-4422(06)70446-X; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Commenges D, 1998, STAT MED, V17, P1973, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1973::AID-SIM892>3.0.CO;2-5; DECKER MD, 1995, PEDIATRICS, V96, P557; Edwards KM, 1996, NEW ENGL J MED, V334, P391, DOI 10.1056/NEJM199602083340609; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; Greco D, 1996, NEW ENGL J MED, V334, P341, DOI 10.1056/NEJM199602083340601; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Huang WT, 2010, PEDIATRICS, V126, pE263, DOI 10.1542/peds.2009-1496; Hviid A, 2004, VACCINE, V22, P3530, DOI 10.1016/j.vaccine.2004.03.046; Klein NP, 2010, PEDIATRICS, V126, pE1, DOI 10.1542/peds.2010-0665; Knudsen LB, 1998, DAN MED BULL, V45, P320; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Madsen T, 1933, J AMER MED ASSOC, V101, P187, DOI 10.1001/jama.1933.02740280007003; McIntosh AM, 2010, LANCET NEUROL, V9, P592, DOI 10.1016/S1474-4422(10)70107-1; MILLER DL, 1981, BRIT MED J, V282, P1595, DOI 10.1136/bmj.282.6276.1595; Pedersen CB, 2006, DAN MED BULL, V53, P441; Schmitt HJ, 2003, VACCINE, V21, P3653, DOI 10.1016/S0264-410X(03)00389-X; Tro-Baumann B, 2011, EPILEPSIA, V52, P175, DOI 10.1111/j.1528-1167.2010.02885.x; TROLLFORS B, 1995, NEW ENGL J MED, V333, P1045, DOI 10.1056/NEJM199510193331604; Vestergaard M, 2006, J CLIN EPIDEMIOL, V59, P61, DOI 10.1016/j.jclinepi.2005.05.008; Vestergaard M, 2004, JAMA-J AM MED ASSOC, V292, P351, DOI 10.1001/jama.292.3.351; Weldeselassie YG, 2011, EPIDEMIOL INFECT, V139, P1805, DOI 10.1017/S0950268811001531; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	28	58	64	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2012	307	8					823	831		10.1001/jama.2012.165	http://dx.doi.org/10.1001/jama.2012.165			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FQ	22357833				2022-12-01	WOS:000300551300025
J	Mackay, TFC; Richards, S; Stone, EA; Barbadilla, A; Ayroles, JF; Zhu, DH; Casillas, S; Han, Y; Magwire, MM; Cridland, JM; Richardson, MF; Anholt, RRH; Barron, M; Bess, C; Blankenburg, KP; Carbone, MA; Castellano, D; Chaboub, L; Duncan, L; Harris, Z; Javaid, M; Jayaseelan, JC; Jhangiani, SN; Jordan, KW; Lara, F; Lawrence, F; Lee, SL; Librado, P; Linheiro, RS; Lyman, RF; Mackey, AJ; Munidasa, M; Muzny, DM; Nazareth, L; Newsham, I; Perales, L; Pu, LL; Qu, C; Ramia, M; Reid, JG; Rollmann, SM; Rozas, J; Saada, N; Turlapati, L; Worley, KC; Wu, YQ; Yamamoto, A; Zhu, YM; Bergman, CM; Thornton, KR; Mittelman, D; Gibbs, RA				Mackay, Trudy F. C.; Richards, Stephen; Stone, Eric A.; Barbadilla, Antonio; Ayroles, Julien F.; Zhu, Dianhui; Casillas, Sonia; Han, Yi; Magwire, Michael M.; Cridland, Julie M.; Richardson, Mark F.; Anholt, Robert R. H.; Barron, Maite; Bess, Crystal; Blankenburg, Kerstin Petra; Carbone, Mary Anna; Castellano, David; Chaboub, Lesley; Duncan, Laura; Harris, Zeke; Javaid, Mehwish; Jayaseelan, Joy Christina; Jhangiani, Shalini N.; Jordan, Katherine W.; Lara, Fremiet; Lawrence, Faye; Lee, Sandra L.; Librado, Pablo; Linheiro, Raquel S.; Lyman, Richard F.; Mackey, Aaron J.; Munidasa, Mala; Muzny, Donna Marie; Nazareth, Lynne; Newsham, Irene; Perales, Lora; Pu, Ling-Ling; Qu, Carson; Ramia, Miquel; Reid, Jeffrey G.; Rollmann, Stephanie M.; Rozas, Julio; Saada, Nehad; Turlapati, Lavanya; Worley, Kim C.; Wu, Yuan-Qing; Yamamoto, Akihiko; Zhu, Yiming; Bergman, Casey M.; Thornton, Kevin R.; Mittelman, David; Gibbs, Richard A.			The Drosophila melanogaster Genetic Reference Panel	NATURE			English	Article							MCDONALD-KREITMAN TEST; SLIGHTLY DELETERIOUS MUTATIONS; ADAPTIVE PROTEIN EVOLUTION; QUANTITATIVE TRAITS; MOLECULAR EVOLUTION; DNA POLYMORPHISM; POPULATION-SIZE; RECOMBINATION; SELECTION; CHALLENGES	A major challenge of biology is understanding the relationship between molecular genetic variation and variation in quantitative traits, including fitness. This relationship determines our ability to predict phenotypes from genotypes and to understand how evolutionary forces shape variation within and between species. Previous efforts to dissect the genotype-phenotype map were based on incomplete genotypic information. Here, we describe the Drosophila melanogaster Genetic Reference Panel (DGRP), a community resource for analysis of population genomics and quantitative traits. The DGRP consists of fully sequenced inbred lines derived from a natural population. Population genomic analyses reveal reduced polymorphism in centromeric autosomal regions and the X chromosome, evidence for positive and negative selection, and rapid evolution of the X chromosome. Many variants in novel genes, most at low frequency, are associated with quantitative traits and explain a large fraction of the phenotypic variance. The DGRP facilitates genotype-phenotype mapping using the power of Drosophila genetics.	[Mackay, Trudy F. C.; Stone, Eric A.; Ayroles, Julien F.; Magwire, Michael M.; Carbone, Mary Anna; Duncan, Laura; Harris, Zeke; Jordan, Katherine W.; Lawrence, Faye; Lyman, Richard F.; Rollmann, Stephanie M.; Turlapati, Lavanya; Yamamoto, Akihiko] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Richards, Stephen; Zhu, Dianhui; Han, Yi; Bess, Crystal; Blankenburg, Kerstin Petra; Chaboub, Lesley; Javaid, Mehwish; Jayaseelan, Joy Christina; Jhangiani, Shalini N.; Lara, Fremiet; Lee, Sandra L.; Munidasa, Mala; Muzny, Donna Marie; Nazareth, Lynne; Newsham, Irene; Perales, Lora; Pu, Ling-Ling; Qu, Carson; Reid, Jeffrey G.; Saada, Nehad; Worley, Kim C.; Wu, Yuan-Qing; Zhu, Yiming; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Barbadilla, Antonio; Casillas, Sonia; Barron, Maite; Castellano, David; Ramia, Miquel] Univ Autonoma Barcelona, Genom Bioinformat & Evolut Grp, Inst Biotecnol & Biomed IBB, Dept Genet & Microbiol, Bellaterra 08193, Spain; [Ayroles, Julien F.; Thornton, Kevin R.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Richardson, Mark F.; Linheiro, Raquel S.; Bergman, Casey M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Anholt, Robert R. H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Librado, Pablo; Rozas, Julio] Univ Barcelona, Fac Biol, Mol Evolutionary Genet Grp, Dept Genet, E-08028 Barcelona, Spain; [Mackey, Aaron J.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Mittelman, David] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Mittelman, David] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	University of North Carolina; North Carolina State University; Baylor College of Medicine; Autonomous University of Barcelona; University of California System; University of California Irvine; University of Manchester; University of North Carolina; North Carolina State University; University of Barcelona; University of Virginia; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Mackay, TFC (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu	Rozas, Julio/A-1733-2009; Castellano, David/O-3582-2016; Barbadilla, Antonio/A-6915-2017; Bergman, Casey/F-7854-2010; Anholt, Robert/S-5977-2019; Stone, Eric/Q-7840-2016; Casillas, Sònia/I-5442-2014; JAYASEELAN, JOY CHRISTINA/F-9824-2015	Rozas, Julio/0000-0002-6839-9148; Castellano, David/0000-0001-8778-6007; Barbadilla, Antonio/0000-0002-0374-1475; Bergman, Casey/0000-0002-5462-9854; Casillas, Sònia/0000-0001-8191-0062; JAYASEELAN, JOY CHRISTINA/0000-0002-7759-0139; Librado, Pablo/0000-0001-5974-2189; Thornton, Kevin/0000-0003-0743-4445; Linheiro, Raquel/0000-0003-2659-0910; Barron Aduriz, Maite Garazi/0000-0001-6146-6259; Chaboub, Lesley/0000-0002-2773-8027; Worley, Kim/0000-0002-0282-1000; Stone, Eric/0000-0002-2725-4209; Richardson, Mark/0000-0002-1650-0064	National Institutes of Health [GM 45146, R01 GM 059469, MCI BFU 2009-09504, R01 GM 085183, NHGRI U54 HG003273]; NVIDIA Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085183, R01GM059469, R01GM045146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NVIDIA Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM 45146 to T. F. C. M., E. A. S. and R. R. H. A.; R01 GM 059469 to R. R. H. A., MCI BFU 2009-09504 to A. B., R01 GM 085183 to K. R. T., NHGRI U54 HG003273 to R. A. G.; and an award through the NVIDIA Foundation's "Compute the Cure" programme to D.M.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Andolfatto P, 2001, GENETICS, V158, P657; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Casillas S, 2007, MOL BIOL EVOL, V24, P2222, DOI 10.1093/molbev/msm150; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Charlesworth J, 2008, MOL BIOL EVOL, V25, P1007, DOI 10.1093/molbev/msn005; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Egea R, 2008, NUCLEIC ACIDS RES, V36, pW157, DOI 10.1093/nar/gkn337; Eyre-Walker A, 2002, GENETICS, V162, P2017; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Falconer DS, 1996, INTRO QUANTITATIVE G; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Harbison ST, 2004, GENETICS, V166, P1807, DOI 10.1534/genetics.166.4.1807; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; JENKINS DL, 1995, P ROY SOC B-BIOL SCI, V261, P203, DOI 10.1098/rspb.1995.0137; Jukes T.H., 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Lynch M., 1998, AM J HUM GENET; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sackton TB, 2009, GENOME BIOL EVOL, V1, P449, DOI 10.1093/gbe/evp048; SAWYER SA, 1992, GENETICS, V132, P1161; Sella G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000495; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; TAJIMA F, 1989, GENETICS, V123, P585; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Yamamoto A, 2008, P NATL ACAD SCI USA, V105, P12393, DOI 10.1073/pnas.0804889105	44	998	1013	9	275	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 9	2012	482	7384					173	178		10.1038/nature10811	http://dx.doi.org/10.1038/nature10811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888HI	22318601	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-01	WOS:000299994100029
J	Cooper, TF; O'Leary, RA; Lough, JM				Cooper, Timothy F.; O'Leary, Rebecca A.; Lough, Janice M.			Growth of Western Australian Corals in the Anthropocene	SCIENCE			English	Article							OCEAN ACIDIFICATION; CLIMATE-CHANGE; CARBON; CALCIFICATION; METABOLISM; PORITES; IMPACT; REEFS; CO2	Anthropogenic increases of atmospheric carbon dioxide lead to warmer sea surface temperatures and altered ocean chemistry. Experimental evidence suggests that coral calcification decreases as aragonite saturation drops but increases as temperatures rise toward thresholds optimal for coral growth. In situ studies have documented alarming recent declines in calcification rates on several tropical coral reef ecosystems. We show there is no widespread pattern of consistent decline in calcification rates of massive Porites during the 20th century on reefs spanning an 11 degrees latitudinal range in the southeast Indian Ocean off Western Australia. Increasing calcification rates on the high-latitude reefs contrast with the downward trajectory reported for corals on Australia's Great Barrier Reef and provide additional evidence that recent changes in coral calcification are responses to temperature rather than ocean acidification.	[Cooper, Timothy F.; O'Leary, Rebecca A.] Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Crawley 6009, Australia; [Lough, Janice M.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science; University of Western Australia; Australian Institute of Marine Science	Cooper, TF (corresponding author), Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Crawley 6009, Australia.	t.cooper@aims.gov.au	Lough, Janice M/L-1682-2013	Lough, Janice M/0000-0002-3789-1009	Australian Institute of Marine Science; BHP Billiton	Australian Institute of Marine Science; BHP Billiton	We thank N. Jeeves, K. Cook, T. Hyndes, P. Tinkler, G. Suosaari, M. Depczynski, and the crew of the RV Solander for support in collecting the cores; E. Matson for assistance in planning the sample collection, sample preparation, and undertaking the density measurements; and B. Radford for advice on the statistical analyses. An earlier version of the manuscript benefited from comments provided by A. Heyward and two anonymous reviewers. The coral calcification data used in this study has been archived in the AIMS Data Centre. This study was supported by the Australian Institute of Marine Science and BHP Billiton.	Buddemeier R.W., 1976, Oceanography and Marine Biology an Annual Review, V14, P183; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; CHALKER BE, 1990, CORAL REEFS, V9, P11, DOI 10.1007/BF00686717; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Eakin C. M., 2009, V205, P41; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Helmle KP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1222; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 1999, AM ZOOL, V39, P146; Lough JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034634; Lough JM, 2011, EARTH-SCI REV, V108, P170, DOI 10.1016/j.earscirev.2011.07.001; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pinheiro JC., 2000, MIXED EFFECTS MODELS, V43, P111; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SMITH SV, 1981, LIMNOL OCEANOGR, V26, P612, DOI 10.4319/lo.1981.26.4.0612; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Team RDCR, 2011, LANG ENV STAT COMP; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235	29	109	113	7	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2012	335	6068					593	596		10.1126/science.1214570	http://dx.doi.org/10.1126/science.1214570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22301320				2022-12-01	WOS:000299769200046
J	Mohd-Sarip, A; Lagarou, A; Doyen, CM; van der Knaap, JA; Aslan, U; Bezstarosti, K; Yassin, Y; Brock, HW; Demmers, JAA; Verrijzer, CP				Mohd-Sarip, Adone; Lagarou, Anna; Doyen, Cecile M.; van der Knaap, Jan A.; Aslan, Ulku; Bezstarosti, Karel; Yassin, Yasmin; Brock, Hugh W.; Demmers, Jeroen A. A.; Verrijzer, C. Peter			Transcription-Independent Function of Polycomb Group Protein PSC in Cell Cycle Control	SCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX; H2A UBIQUITYLATION; DROSOPHILA EMBRYOS; DYNAMIC REGULATION; DESTRUCTION; MITOSIS; APC11; UBIQUITINATION; MECHANISMS; MUTANTS	Polycomb group (PcG) proteins control development and cell proliferation through chromatin-mediated transcriptional repression. We describe a transcription-independent function for PcG protein Posterior sex combs (PSC) in regulating the destruction of cyclin B (CYC-B). A substantial portion of PSC was found outside canonical PcG complexes, instead associated with CYC-B and the anaphase-promoting complex (APC). Cell-based experiments and reconstituted reactions established that PSC and Lemming (LMG, also called APC11) associate and ubiquitylate CYC-B cooperatively, marking it for proteosomal degradation. Thus, PSC appears to mediate both developmental gene silencing and posttranslational control of mitosis. Direct regulation of cell cycle progression might be a crucial part of the PcG system's function in development and cancer.	[Mohd-Sarip, Adone; Lagarou, Anna; Doyen, Cecile M.; van der Knaap, Jan A.; Aslan, Ulku; Verrijzer, C. Peter] Erasmus Univ, Med Ctr, Dept Biochem, NL-3000 DR Rotterdam, Netherlands; [Mohd-Sarip, Adone; Lagarou, Anna; Doyen, Cecile M.; van der Knaap, Jan A.; Aslan, Ulku; Verrijzer, C. Peter] Erasmus Univ, Med Ctr, Ctr Biomed Genet, NL-3000 DR Rotterdam, Netherlands; [Bezstarosti, Karel; Demmers, Jeroen A. A.] Erasmus Univ, Med Ctr, Prote Ctr, NL-3000 DR Rotterdam, Netherlands; [Yassin, Yasmin; Brock, Hugh W.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of British Columbia	Verrijzer, CP (corresponding author), Erasmus Univ, Med Ctr, Dept Biochem, POB 1738, NL-3000 DR Rotterdam, Netherlands.	c.verrijzer@erasmusmc.nl	Mohd-Sarip, Adone/AAI-7912-2020; Demmers, Jeroen AA/F-4046-2016	Mohd-Sarip, Adone/0000-0003-2932-954X; Demmers, Jeroen AA/0000-0002-8757-9611	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [700.57.406]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission)	We thank S. Bray, J. Svejstrup, and Y. Moshkin for valuable discussions. This work was supported in part by Nederlandse Organisatie voor Wetenschappelijk Onderzoek Chemical Sciences Veni grant 700.57.406 (to A.M.-S.).	Beck SA, 2010, DEV BIOL, V339, P320, DOI 10.1016/j.ydbio.2009.12.031; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Martinez AM, 2006, GENE DEV, V20, P501, DOI 10.1101/gad.357106; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; O'Dor E, 2006, DEV BIOL, V290, P312, DOI 10.1016/j.ydbio.2005.11.015; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Parry DH, 2003, CURR BIOL, V13, P647, DOI 10.1016/S0960-9822(03)00242-2; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Voncken JW, 1999, J CELL SCI, V112, P4627; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985	29	26	26	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					744	747		10.1126/science.1215927	http://dx.doi.org/10.1126/science.1215927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22491092				2022-12-01	WOS:000303872300056
J	Jones, FC; Grabherr, MG; Chan, YF; Russell, P; Mauceli, E; Johnson, J; Swofford, R; Pirun, M; Zody, MC; White, S; Birney, E; Searle, S; Schmutz, J; Grimwood, J; Dickson, MC; Myers, RM; Miller, CT; Summers, BR; Knecht, AK; Brady, SD; Zhang, HL; Pollen, AA; Howes, T; Amemiya, C; Lander, ES; Di Palma, F; Lindblad-Toh, K; Kingsley, DM				Jones, Felicity C.; Grabherr, Manfred G.; Chan, Yingguang Frank; Russell, Pamela; Mauceli, Evan; Johnson, Jeremy; Swofford, Ross; Pirun, Mono; Zody, Michael C.; White, Simon; Birney, Ewan; Searle, Stephen; Schmutz, Jeremy; Grimwood, Jane; Dickson, Mark C.; Myers, Richard M.; Miller, Craig T.; Summers, Brian R.; Knecht, Anne K.; Brady, Shannon D.; Zhang, Haili; Pollen, Alex A.; Howes, Timothy; Amemiya, Chris; Lander, Eric S.; Di Palma, Federica; Lindblad-Toh, Kerstin; Kingsley, David M.		Broad Inst Genome Sequencing Platf; Whole Genome Assembly Team	The genomic basis of adaptive evolution in threespine sticklebacks	NATURE			English	Article							GENETIC ARCHITECTURE; PARALLEL EVOLUTION; REGULATORY CHANGES; SIGNALING PATHWAY; PELVIC REDUCTION; EVO-DEVO; VERTEBRATE; DUPLICATION; ADAPTATION; INVERSIONS	Marine stickleback fish have colonized and adapted to thousands of streams and lakes formed since the last ice age, providing an exceptional opportunity to characterize genomic mechanisms underlying repeated ecological adaptation in nature. Here we develop a high-quality reference genome assembly for threespine sticklebacks. By sequencing the genomes of twenty additional individuals from a global set of marine and freshwater populations, we identify a genome-wide set of loci that are consistently associated with marine-freshwater divergence. Our results indicate that reuse of globally shared standing genetic variation, including chromosomal inversions, has an important role in repeated evolution of distinct marine and freshwater sticklebacks, and in the maintenance of divergent ecotypes during early stages of reproductive isolation. Both coding and regulatory changes occur in the set of loci underlying marine-freshwater evolution, but regulatory changes appear to predominate in this well known example of repeated adaptive evolution in nature.	[Grabherr, Manfred G.; Russell, Pamela; Mauceli, Evan; Johnson, Jeremy; Swofford, Ross; Pirun, Mono; Zody, Michael C.; Lander, Eric S.; Di Palma, Federica; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Jones, Felicity C.; Chan, Yingguang Frank; Miller, Craig T.; Summers, Brian R.; Knecht, Anne K.; Brady, Shannon D.; Zhang, Haili; Pollen, Alex A.; Howes, Timothy; Kingsley, David M.] Stanford Univ, Sch Med, Dept Dev Biol, Beckman Ctr B300, Stanford, CA 94305 USA; [Grabherr, Manfred G.; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab Uppsala, S-75123 Uppsala, Sweden; [White, Simon; Searle, Stephen] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Birney, Ewan] European Bioinformat Inst, Cambridge CB10 1SA, England; [Schmutz, Jeremy; Grimwood, Jane; Dickson, Mark C.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Amemiya, Chris] Benaroya Res Inst Virginia Mason, Dept Mol Genet, Seattle, WA 98101 USA; [Kingsley, David M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Uppsala University; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); HudsonAlpha Institute for Biotechnology; Benaroya Research Institute; Virginia Mason Medical Center; Howard Hughes Medical Institute; Stanford University	Lindblad-Toh, K (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	kersli@broad.mit.edu; kingsley@stanford.edu	Schmutz, Jeremy/N-3173-2013; Chan, Yingguang Frank/ABG-9852-2020; Miller, Craig/GWQ-5012-2022; Jones, Felicity C/AAY-3523-2021; Grimwood, Jane/ABD-5737-2021	Schmutz, Jeremy/0000-0001-8062-9172; Chan, Yingguang Frank/0000-0001-6292-9681; Jones, Felicity C/0000-0002-5027-1031; Howes, Timothy/0000-0002-0370-0200; White, Simon/0000-0001-6375-2363; Swofford, Ross/0000-0003-3676-8479; Grabherr, Manfred/0000-0001-8792-6508; Russell, Pamela/0000-0003-2997-6392; Di-Palma, Federica/0000-0002-4394-0102; Nicol, Robert/0000-0003-1932-1392; Birney, Ewan/0000-0001-8314-8497	National Human Genome Research Institute (NHGRI); NHGRI CEGS [P50-HG002568]; Stanford Affymetrix Bio-X; Jane Coffins Childs Fund; NSF; NDSEG; ESF; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568, R01HG003474, U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI CEGS; Stanford Affymetrix Bio-X; Jane Coffins Childs Fund; NSF(National Science Foundation (NSF)); NDSEG; ESF(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Stickleback sequencing at Broad Institute was supported by grants from the National Human Genome Research Institute (NHGRI). R.M.M., J.S., J.G. and D.M.K. were supported by NHGRI CEGS Grant P50-HG002568; Y.F.C. by a Stanford Affymetrix Bio-X Graduate Fellowship; C.T.M. by the Jane Coffins Childs Fund; and B.R.S., T.R.H. and A.A.P. by graduate fellowships from NSF and NDSEG. D.M.K. is an investigator of the Howard Hughes Medical Institute. K.L.-T. is a EURYI award recipient funded by ESF. We thank W. Cresko for the BEPA individual used for reference genome sequencing; M. Bell, J. McKinnon, B. Jonsson, S. Mori, C. Peichel, D. Schluter, M. Kalbe, T. Reimchen, D.-P. Hojgaard, M. McLaughlin, B. Geyti and B. Blackman for discussions and assistance with specimens used in population surveys; and G. Bejerano for useful discussions and assistance with computational analysis.	Albert AYK, 2008, EVOLUTION, V62, P76, DOI 10.1111/j.1558-5646.2007.00259.x; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Barton NH, 1993, HYBRID ZONES EVOLUTI, P13, DOI DOI 10.1111/J.1558-5646.2009.00849.X; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Deagle BE, 2011, P R SOC B, V279, P1277, DOI DOI 10.1098/RSPB.2011.1552); Endler J.A., 1986, Monographs in Population Biology, pviii; Feder JL, 2003, GENETICS, V163, P939; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; HAGEN DW, 1967, J FISH RES BOARD CAN, V24, P1637, DOI 10.1139/f67-138; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jones FC, 2006, J EVOLUTION BIOL, V19, P1531, DOI 10.1111/j.1420-9101.2006.01122.x; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kawahara R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-209; Kimmel CB, 2005, P NATL ACAD SCI USA, V102, P5791, DOI 10.1073/pnas.0408533102; Kingsley David M., 2007, P41; Kingsley DM, 2004, BEHAVIOUR, V141, P1331, DOI 10.1163/1568539042948150; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kitano J, 2010, CURR BIOL, V20, P2124, DOI 10.1016/j.cub.2010.10.050; Knecht AK, 2007, EVOL DEV, V9, P141, DOI 10.1111/j.1525-142X.2007.00145.x; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Marshall William S., 2006, P177; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; McPhail J.D., 1994, P399; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Miyake A, 1999, J BIOL CHEM, V274, P25018, DOI 10.1074/jbc.274.35.25018; Miyake A, 2009, J NEUROSCI, V29, P14637, DOI 10.1523/JNEUROSCI.0901-09.2009; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; REIMCHEN TE, 1985, CAN J ZOOL, V63, P2944, DOI 10.1139/z85-441; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Vinogradov AE, 1998, CYTOMETRY, V31, P100, DOI 10.1002/(SICI)1097-0320(19980201)31:2<100::AID-CYTO5>3.0.CO;2-Q; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087	50	1158	1178	18	611	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					55	61		10.1038/nature10944	http://dx.doi.org/10.1038/nature10944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481358	Green Submitted, Green Accepted, hybrid			2022-12-01	WOS:000302343400033
J	Kuo, AJ; Song, JK; Cheung, P; Ishibe-Murakami, S; Yamazoe, S; Chen, JK; Patel, DJ; Gozani, O				Kuo, Alex J.; Song, Jikui; Cheung, Peggie; Ishibe-Murakami, Satoko; Yamazoe, Sayumi; Chen, James K.; Patel, Dinshaw J.; Gozani, Or			The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier-Gorlin syndrome	NATURE			English	Article							ORIGIN RECOGNITION COMPLEX; 20 METHYLTRANSFERASE PR-SET7; HBO1 HISTONE ACETYLASE; STRUCTURAL BASIS; CHROMATIN MODIFICATIONS; PRIMORDIAL DWARFISM; PHD FINGER; METHYLATION; MUTATIONS; H3	The recognition of distinctly modified histones by specialized 'effector' proteins constitutes a key mechanism for transducing molecular events at chromatin to biological outcomes(1). Effector proteins influence DNA-templated processes, including transcription, DNA recombination and DNA repair; however, no effector functions have yet been identified within the mammalian machinery that regulate DNA replication. Here we show that ORC1-a component of ORC (origin of replication complex), which mediates pre-DNA replication licensing(2)-contains a bromo adjacent homology (BAH) domain that specifically recognizes histone H4 dimethylated at lysine 20 (H4K20me2). Recognition of H4K20me2 is a property common to BAH domains present within diverse metazoan ORC1 proteins. Structural studies reveal that the specificity of the BAH domain for H4K20me2 is mediated by a dynamic aromatic dimethyl-lysine-binding cage and multiple intermolecular contacts involving the bound peptide. H4K20me2 is enriched at replication origins, and abrogating ORC1 recognition of H4K20me2 in cells impairs ORC1 occupancy at replication origins, ORC chromatin loading and cell-cycle progression. Mutation of the ORC1 BAH domain has been implicated in the aetiology of Meier-Gorlin syndrome (MGS)(3,4), a form of primordial dwarfism(5), and ORC1 depletion in zebrafish results in an MGS-like phenotype(4). We find that wild-type human ORC1, but not ORC1-H4K20me2-binding mutants, rescues the growth retardation of orc1 morphants. Moreover, zebrafish depleted of H4K20me2 have diminished body size, mirroring the phenotype of orc1 morphants. Together, our results identify the BAH domain as a novel methyl-lysine-binding module, thereby establishing the first direct link between histone methylation and the metazoan DNA replication machinery, and defining a pivotal aetiological role for the canonical H4K20me2 mark, via ORC1, in primordial dwarfism.	[Song, Jikui; Ishibe-Murakami, Satoko; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Kuo, Alex J.; Cheung, Peggie; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Yamazoe, Sayumi; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Memorial Sloan Kettering Cancer Center; Stanford University; Stanford University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; ogozani@stanford.edu	Chen, James/G-9972-2011; Kuo, Alex/AAL-2845-2020; Gozani, Or P/I-6157-2013	Chen, James/0000-0002-9220-8436; Gozani, Or/0000-0002-1365-4463	Abby Rockefeller Mauze Foundation; STARR Foundation; Maloris Foundation; Genentech Foundation; Ellison Senior Scholar in Aging Award;  [R01 GM079641];  [DP1 OD003792]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075622] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003792] Funding Source: NIH RePORTER	Abby Rockefeller Mauze Foundation; STARR Foundation; Maloris Foundation; Genentech Foundation(Roche HoldingGenentech); Ellison Senior Scholar in Aging Award; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Tennen for critical reading of the manuscript. This work was supported in part by grants to O.G. (R01 GM079641), D.J.P. (Abby Rockefeller Mauze, STARR and Maloris Foundations) and J.K.C. (DP1 OD003792), and a predoctoral fellowship to A.J.K. (Genentech Foundation). O.G. is a recipient of an Ellison Senior Scholar in Aging Award.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brustel J, 2011, TRENDS CELL BIOL, V21, P452, DOI 10.1016/j.tcb.2011.04.006; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; Costas C, 2011, NAT STRUCT MOL BIOL, V18, P395, DOI 10.1038/nsmb.1988; Dorn ES, 2011, EPIGENETICS-US, V6, P552, DOI 10.4161/epi.6.5.15082; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; Jacob Y, 2010, NATURE, V466, P987, DOI 10.1038/nature09290; KITSBERG D, 1993, NATURE, V366, P588, DOI 10.1038/366588a0; Klingseisen A, 2011, GENE DEV, V25, P2011, DOI 10.1101/gad.169037; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Sampath V, 2009, MOL CELL BIOL, V29, P2532, DOI 10.1128/MCB.01682-08; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Zhang ZG, 2002, EMBO J, V21, P4600, DOI 10.1093/emboj/cdf468	37	224	233	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					115	+		10.1038/nature10956	http://dx.doi.org/10.1038/nature10956			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22398447	Green Submitted, Green Accepted			2022-12-01	WOS:000302343400045
J	Hellinger, WC; Bacalis, LP; Kay, RS; Thompson, ND; Xia, GL; Lin, YL; Khudyakov, YE; Perz, JF				Hellinger, Walter C.; Bacalis, Laura P.; Kay, Robyn S.; Thompson, Nicola D.; Xia, Guo-Liang; Lin, Yulin; Khudyakov, Yury E.; Perz, Joseph F.			Health Care-Associated Hepatitis C Virus Infections Attributed to Narcotic Diversion	ANNALS OF INTERNAL MEDICINE			English	Article							OPERATING-ROOM; UNITED-STATES; TRANSMISSION; ANESTHESIOLOGIST; PERSONNEL; PATIENT; WORKERS; SYSTEM; ORGAN; TIME	Background: Three cases of genetically related hepatitis C virus (HCV) infection that were unattributable to infection control breaches were identified at a health care facility. Objective: To investigate HCV transmission from an HCV-infected health care worker to patients through drug diversion. Design: Cluster and look-back investigations. Setting: Acute care hospital and affiliated multispecialty clinic. Patients: Inpatients and outpatients during the period of HCV transmission. Measurements: Employee work and narcotic dispensing records, blood testing for HCV antibody and RNA, and sequencing of the NS5B gene and the hypervariable region 1 of the E2 gene. Results: 21 employees were recorded as being at work or as retrieving a narcotic from an automated dispensing cabinet in an area where a narcotic was administered to each of the 3 case patients; all employees provided blood samples for HCV testing. One employee was infected with HCV that had more than 95% NS5B sequence homology with the HCV strains of the 3 case patients. Quasi-species analysis showed close genetic relatedness with variants from each of the case patients and more than 97.9% nucleotide identity. The employee acknowledged parenteral opiate diversion. An investigation identified 6132 patients at risk for exposure to HCV because of the drug diversion. Of the 3929 living patients, 3444 (87.7%) were screened for infection. Two additional cases of genetically related HCV infection attributable to the employee were identified. Limitation: Of the living patients at risk for HCV exposure, 12.3% were not tested. Conclusion: Five cases of HCV infection occurring over 3 to 4 years were attributed to drug diversion by an HCV-infected health care worker. Studies of drug diversion and assessments of strategies to prevent narcotics tampering in all health care settings are needed.	[Hellinger, Walter C.] Mayo Clin, Div Infect Dis, Jacksonville, FL 32224 USA; Florida Dept Hlth, Tallahassee, FL USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Mayo Clinic; Florida Department of Health; Centers for Disease Control & Prevention - USA	Hellinger, WC (corresponding author), Mayo Clin, Div Infect Dis, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	helling@mayo.edu						Berge KH, 2008, ANESTHESIOLOGY, V109, P762, DOI 10.1097/ALN.0b013e31818a3814; Bosch X, 2000, LANCET, V355, P818, DOI 10.1016/S0140-6736(05)72446-6; Cody SH, 2002, ARCH INTERN MED, V162, P345, DOI 10.1001/archinte.162.3.345; Colorado Department of Public Health and Environment, 2009, FAQS COL HEP C INV; Domino KB, 2005, JAMA-J AM MED ASSOC, V293, P1453, DOI 10.1001/jama.293.12.1453; Dudzinski DM, 2010, NEW ENGL J MED, V363, P978, DOI 10.1056/NEJMhle1003134; Dunn D, 2005, AORN J, V82, P599; Dunn D, 2005, AORN J, V82, P592, DOI [DOI 10.1016/S0001-2092(06)60028-8, 10.1016/S0001-2092(06) 60028-8]; Dunn Debra, 2005, AORN J, V82, P573; Dunn S., 2005, AORN J, V82; Epstein RH, 2007, ANESTH ANALG, V105, P1053, DOI 10.1213/01.ane.0000281797.00935.08; Hadfield S, 2011, HEPATITIS C WOMAN LA; Henderson DK, 2010, INFECT CONT HOSP EP, V31, P203, DOI 10.1086/650298; Lee KC, 2005, 43 ANN M INF DIS SOC; MAKI DG, 1991, JAMA-J AM MED ASSOC, V265, P981, DOI 10.1001/jama.265.8.981; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; Ostrowsky BE, 2002, NEW ENGL J MED, V346, P1529, DOI 10.1056/NEJMoa012370; Perz Joseph F, 2010, Clin Liver Dis, V14, P137, DOI 10.1016/j.cld.2009.11.004; Ramachandran S, 2008, J VIROL METHODS, V151, P217, DOI 10.1016/j.jviromet.2008.05.005; Ross RS, 2000, NEW ENGL J MED, V343, P1851, DOI 10.1056/NEJM200012213432505; SCHMIDT KA, 1993, ANESTHESIOLOGY, V78, P184, DOI 10.1097/00000542-199301000-00025; SEHULSTER L, 1997, P INT C ANT AG CHEM, P293; Shemer-Avni Y, 2007, CLIN INFECT DIS, V45, pE32, DOI 10.1086/520014; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 1996, DHHS PUBL; Thompson ND, 2009, TRANSPL INFECT DIS, V11, P324, DOI 10.1111/j.1399-3062.2009.00406.x; Thompson ND, 2009, ANN INTERN MED, V150, P33, DOI 10.7326/0003-4819-150-1-200901060-00007; Tugwell BD, 2005, ANN INTERN MED, V143, P648, DOI 10.7326/0003-4819-143-9-200511010-00008; Williams IT, 2006, J CLIN VIROL, V36, pS43, DOI 10.1016/S1386-6532(06)80135-6; Williams IT, 2004, CLIN INFECT DIS, V38, P1592, DOI 10.1086/420935; Willock M, 1998, INT ANESTHESIOL CLIN, V36, P65, DOI 10.1097/00004311-199803610-00009	31	22	22	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					477	U34		10.7326/0003-4819-156-7-201204030-00002	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921GP	22473434				2022-12-01	WOS:000302466400001
J	Jacob, NP				Jacob, Nitya P.			Investigating Arabia Mountain: A Molecular Approach	SCIENCE			English	Editorial Material							COMMUNITIES		Emory Univ, Oxford Coll, Oxford, GA 30054 USA	Emory University	Jacob, NP (corresponding author), Emory Univ, Oxford Coll, Oxford, GA 30054 USA.	njacob@emory.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ash C, 2008, SCIENCE, V320, P1027, DOI 10.1126/science.320.5879.1027; BURBANCK MP, 1964, ECOLOGY, V45, P292, DOI 10.2307/1933842; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; HOULE G, 1989, VEGETATIO, V80, P25, DOI 10.1007/BF00049138; Jacob N., 2008, J COLL SCI TEACH, V38, P54; Jacob N., 2008, COUNCIL UNDERGRAD RE, V29, P24; Morgan J. G., 2011, INVESTIGATING BIOL; Zul D, 2007, APPL ENVIRON MICROB, V73, P6916, DOI 10.1128/AEM.01533-07	9	5	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1588	1589		10.1126/science.1213692	http://dx.doi.org/10.1126/science.1213692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461602				2022-12-01	WOS:000302062600034
J	Glickman, MS; Sawyers, CL				Glickman, Michael S.; Sawyers, Charles L.			Converting Cancer Therapies into Cures: Lessons from Infectious Diseases	CELL			English	Review							IMMUNODEFICIENCY-VIRUS-INFECTION; RESISTANT PROSTATE-CANCER; TYROSINE KINASE INHIBITOR; CATALASE-PEROXIDASE GENE; ESCHERICHIA-COLI K-12; CHRONIC-PHASE; LUNG-CANCER; ACQUIRED-RESISTANCE; CONTROLLED-TRIAL; DRUG-RESISTANCE	During the past decade, cancer drug development has shifted from a focus on cytotoxic chemotherapies to drugs that target specific molecular alterations in tumors. Although these drugs dramatically shrink tumors, the responses are temporary. Research is now focused on overcoming drug resistance, a frequent cause of treatment failure. Here we reflect on analogous challenges faced by researchers in infectious diseases. We compare and contrast the resistance mechanisms arising in cancer and infectious diseases and discuss how approaches for overcoming viral and bacterial infections, such as HIV and tuberculosis, are instructive for developing a more rational approach for cancer therapy. In particular, maximizing the effect of the initial treatment response, which often requires synergistic combination therapy, is foremost among these approaches. A remaining challenge in both fields is identifying drugs that eliminate drug-tolerant "persister'' cells (infectious disease) or tumor-initiating/stem cells (cancer) to prevent late relapse and shorten treatment duration.	[Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10065 USA; [Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Glickman, MS (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Dis Serv, 1275 York Ave, New York, NY 10065 USA.	glickmam@mskcc.org; sawyersc@mskcc.org	Sawyers, Charles/G-5327-2016	Glickman, Michael S/0000-0001-7918-5164	Howard Hughes Medical Institute; NCI; Stand Up to Cancer; Geoffrey Beene Cancer Research Center; Starr Cancer Consortium; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053417] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up to Cancer; Geoffrey Beene Cancer Research Center; Starr Cancer Consortium; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors apologize to those whose work could not be cited due to space limitations. Work in the Sawyers laboratory is supported by the Howard Hughes Medical Institute and grants from NCI and Stand Up to Cancer. Work in the Glickman laboratory is supported by the Geoffrey Beene Cancer Research Center, the Starr Cancer Consortium, and NIAID.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Allan EJ, 2009, ADV APPL MICROBIOL, V68, P1, DOI 10.1016/S0065-2164(09)01201-5; ALTAMIRANO M, 1994, J INFECT DIS, V169, P1162, DOI 10.1093/infdis/169.5.1162; [Anonymous], 1950, Br Med J, V2, P1073; [Anonymous], 1952, Br Med J, V2, P735; [Anonymous], 1947, Am Rev Tuberc, V56, P485; [Anonymous], 1948, Br Med J, V2, P769; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Borges S, 2006, CLIN PHARMACOL THER, V80, P61, DOI 10.1016/j.clpt.2006.03.013; Burgess MR, 2005, P NATL ACAD SCI USA, V102, P3395, DOI 10.1073/pnas.0409770102; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Casadevall A, 2009, EXPERT OPIN PHARMACO, V10, P1699, DOI 10.1517/14656560903066837; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Critical Path Institute, 2010, CRIT PATH TB DRUG RE; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Del Favero A, 2001, CLIN INFECT DIS, V33, P1295, DOI 10.1086/322646; DiPersio JF, 2009, J CLIN ONCOL, V27, P4767, DOI 10.1200/JCO.2008.20.7209; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; Food and Drug Administration [FDA], 2010, GUID IND COD 2 MOR U; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hughes TP, 2010, BLOOD, V116, P3758, DOI 10.1182/blood-2010-03-273979; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; LEHMANN J, 1946, LANCET, V250, P15; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Mackinnon S, 1997, BAILLIERE CLIN HAEM, V10, P357, DOI 10.1016/S0950-3536(97)80012-1; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; MASKELL R, 1978, J MED MICROBIOL, V11, P33, DOI 10.1099/00222615-11-1-33; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Schapiro JM, 1996, ANN INTERN MED, V124, P1039, DOI 10.7326/0003-4819-124-12-199606150-00003; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; SCHIMKE RT, 1978, SCIENCE, V202, P1051, DOI 10.1126/science.715457; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Skaggs BJ, 2006, P NATL ACAD SCI USA, V103, P19466, DOI 10.1073/pnas.0609239103; STEEN R, 1985, ANTIMICROB AGENTS CH, V27, P933, DOI 10.1128/AAC.27.6.933; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; WOLFSON JS, 1990, ANTIMICROB AGENTS CH, V34, P1938, DOI 10.1128/AAC.34.10.1938; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zolopa AR, 1999, ANN INTERN MED, V131, P813, DOI 10.7326/0003-4819-131-11-199912070-00003	84	131	134	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 16	2012	148	6					1089	1098		10.1016/j.cell.2012.02.015	http://dx.doi.org/10.1016/j.cell.2012.02.015			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	913PI	22424221	Bronze, Green Accepted			2022-12-01	WOS:000301889500008
J	Vaidyanathan, G				Vaidyanathan, Gayathri			Redefining Clinical Trials: The Age of Personalized Medicine	CELL			English	Editorial Material								The triumph of personalized cancer therapeutics in recent years is prompting some oncologists to rethink clinical trial design; other researchers have different priorities for trial reform.											0	20	21	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 16	2012	148	6					1079	1080		10.1016/j.cell.2012.02.041	http://dx.doi.org/10.1016/j.cell.2012.02.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	913PI	22424218	Bronze			2022-12-01	WOS:000301889500005
J	Koralek, AC; Jin, X; Ii, JDL; Costa, RM; Carmena, JM				Koralek, Aaron C.; Jin, Xin; Ii, John D. Long; Costa, Rui M.; Carmena, Jose M.			Corticostriatal plasticity is necessary for learning intentional neuroprosthetic skills	NATURE			English	Article							PREFRONTAL CORTEX; STRIATAL NEURONS; ACQUISITION; CONSOLIDATION; PERFORMANCE; CONTINGENCY; ACTIVATION; NETWORKS; CIRCUITS	The ability to learn new skills and perfect them with practice applies not only to physical skills but also to abstract skills(1), like motor planning or neuroprosthetic actions. Although plasticity in corticostriatal circuits has been implicated in learning physical skills(2-4), it remains unclear if similar circuits or processes are required for abstract skill learning. Here we use a novel behavioural task in rodents to investigate the role of corticostriatal plasticity in abstract skill learning. Rodents learned to control the pitch of an auditory cursor to reach one of two targets by modulating activity in primary motor cortex irrespective of physical movement. Degradation of the relation between action and outcome, as well as sensory-specific devaluation and omission tests, demonstrate that these learned neuroprosthetic actions are intentional and goal-directed, rather than habitual. Striatal neurons change their activity with learning, with more neurons modulating their activity in relation to target-reaching as learning progresses. Concomitantly, strong relations between the activity of neurons in motor cortex and the striatum emerge. Specific deletion of striatal NMDA receptors impairs the development of this corticostriatal plasticity, and disrupts the ability to learn neuroprosthetic skills. These results suggest that corticostriatal plasticity is necessary for abstract skill learning, and that neuroprosthetic movements capitalize on the neural circuitry involved in natural motor learning.	[Jin, Xin; Costa, Rui M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Koralek, Aaron C.; Ii, John D. Long; Carmena, Jose M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif Berkeley, Program Cognit Sci, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif Berkeley, UC Berkeley & UC San Francisco Joint Grad Grp Bio, Berkeley, CA 94720 USA; [Costa, Rui M.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Fundacao Champalimaud	Costa, RM (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, 5625 Fishers Lane, Bethesda, MD 20892 USA.	ruicosta@fchampalimaud.org; carmena@eecs.berkeley.edu		Koralek, Aaron/0000-0001-5205-0171; Costa, Rui M./0000-0003-0495-8374	National Science Foundation [0954243]; Multiscale Systems Research Center; Defense Advanced Research Projects Agency [N66001-10-C-2008]; Division of Intramural Clinical and Basic Research of the National Institute on Alcohol Abuse and Alcoholism [239527]; European Research Council [STG 243393]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Multiscale Systems Research Center; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Division of Intramural Clinical and Basic Research of the National Institute on Alcohol Abuse and Alcoholism; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Venkatraman for the three-axis accelerometer, Y. Li for the RGS9L-Cre mice, K. Nakazawa for the NMDAR1-loxP mice, G. Luo for genotyping, M. Davis for advice on staining and G. Martins for performing immunohistochemistry. This work was supported by National Science Foundation CAREER Award 0954243, the Multiscale Systems Research Center and the Defense Advanced Research Projects Agency contract N66001-10-C-2008 to J. M. C., and the Division of Intramural Clinical and Basic Research of the National Institute on Alcohol Abuse and Alcoholism, Marie Curie International Reintegration Grant 239527 and European Research Council STG 243393 to R.M.C.	Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Beauchamp MH, 2003, NEUROIMAGE, V20, P1649, DOI 10.1016/j.neuroimage.2003.07.003; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; Fincham JM, 2006, P NATL ACAD SCI USA, V103, P12941, DOI 10.1073/pnas.0605493103; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; GEORGOPOULOS AP, 1993, SCIENCE, V260, P47, DOI 10.1126/science.8465199; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07.006.2007, 10.3389/neuro.07/006.2007]; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kimchi EY, 2009, J NEUROSCI, V29, P3148, DOI 10.1523/JNEUROSCI.5206-08.2009; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; VanLehn K, 1996, ANNU REV PSYCHOL, V47, P513, DOI 10.1146/annurev.psych.47.1.513; Venkatraman S, 2010, J NEUROPHYSIOL, V104, P569, DOI 10.1152/jn.00121.2010; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012	30	238	242	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					331	335		10.1038/nature10845	http://dx.doi.org/10.1038/nature10845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22388818	Green Accepted			2022-12-01	WOS:000301481800049
J	Ananthakrishnan, AN; Higuchi, LM; Huang, ES; Khalili, H; Richter, JM; Fuchs, CS; Chan, AT				Ananthakrishnan, Ashwin N.; Higuchi, Leslie M.; Huang, Edward S.; Khalili, Hamed; Richter, James M.; Fuchs, Charles S.; Chan, Andrew T.			Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LONG-TERM USE; OLMSTED COUNTY; PREVALENCE; FREQUENCY; REPRODUCIBILITY; SUPPRESSION; MECHANISMS; MINNESOTA; VALIDITY	Background: Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) are anti-inflammatory but have been linked in some studies to Crohn disease (CD) and ulcerative colitis (UC). Objective: To assess the association between aspirin and NSAID use and incident CD and UC. Design: Prospective cohort study. Setting: Nurses' Health Study I. Patients: 76 795 U. S. women who provided biennially updated data about aspirin and NSAID use. Measurements: Incident CD and UC between 1990 and 2008 (outcome) and NSAID and aspirin use (exposure). Results: 123 incident cases of CD and 117 cases of UC occurred over 18 years and 1 295 317 person-years of follow-up. Compared with nonusers, women who used NSAIDs at least 15 days per month seemed to have increased risk for both CD (absolute difference in age-adjusted incidence, 6 cases per 100 000 person-years [95% CI, 0 to 13]; multivariate hazard ratio, 1.59 [CI, 0.99 to 2.56]) and UC (absolute difference, 7 cases per 100 000 person-years [CI, 1 to 12]; multivariate hazard ratio, 1.87 [CI, 1.16 to 2.99]). Less frequent NSAID use was not clearly associated with risk for CD or UC, and there was no clear association between aspirin use and disease. Limitations: Cohort participants were exclusively women, most of whom were white. Aspirin and NSAID use were self-reported. Conclusion: Frequent use of NSAIDs but not aspirin seemed to be associated with increased absolute incidence of CD and UC. The findings have more mechanistic than clinical implications, because the absolute incidence of CD or UC associated with NSAIDs was low and the increase in risk for CD or UC associated with NSAIDs is unlikely to alter the balance of more common and clinically significant risks and benefits associated with these agents.	[Chan, Andrew T.] Harvard Univ, Massachusetts Gen Hosp, Gastrointestinal Unit,Childrens Hosp Boston, Brigham & Womens Hosp,Sch Med, Boston, MA 02114 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute	Chan, AT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Gastrointestinal Unit,Childrens Hosp Boston, Brigham & Womens Hosp,Sch Med, 55 Fruit St,GRJ 722, Boston, MA 02114 USA.	achan@partners.org	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767	American Gastroenterological Association; IBD Working Group; Broad Medical Research Program; National Institutes of Health [R01 CA137178, P01 CA87969, P30 DK043351, K08 DK064256]; Broad Medical Research Foundation; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA137178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK064256, P30DK043351] Funding Source: NIH RePORTER	American Gastroenterological Association; IBD Working Group; Broad Medical Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	American Gastroenterological Association, IBD Working Group, Broad Medical Research Program, and National Institutes of Health.; By the American Gastroenterological Association (Dr. Ananthakrishnan), the Broad Medical Research Foundation ( Dr. Chan), the IBD Working Group ( Dr. Khalili), and the National Institutes of Health (R01 CA137178, P01 CA87969, P30 DK043351, and K08 DK064256).	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Bernstein CN, 2010, AM J GASTROENTEROL, V105, P1994, DOI 10.1038/ajg.2010.140; Bonner GF, 2000, AM J GASTROENTEROL, V95, P1946; Capone ML, 2004, CIRCULATION, V109, P1468, DOI 10.1161/01.CIR.0000124715.27937.78; Chan AT, 2007, ARCH INTERN MED, V167, P562, DOI 10.1001/archinte.167.6.562; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chan AT, 2006, CIRCULATION, V113, P1578, DOI 10.1161/CIRCULATIONAHA.105.595793; Chumanevich AA, 2010, CARCINOGENESIS, V31, P1787, DOI 10.1093/carcin/bgq158; Cornish JA, 2008, AM J GASTROENTEROL, V103, P2394, DOI 10.1111/j.1572-0241.2008.02064.x; Cosnes J, 2008, INFLAMM BOWEL DIS, V14, pS14, DOI 10.1002/ibd.20555; Danese S, 2006, WORLD J GASTROENTERO, V12, P4807; DUGGAN DE, 1975, BIOCHEM PHARMACOL, V24, P1749, DOI 10.1016/0006-2952(75)90450-5; Evans JMM, 1997, GUT, V40, P619, DOI 10.1136/gut.40.5.619; Felder JB, 2000, AM J GASTROENTEROL, V95, P1949; Fonager K, 1996, SCAND J GASTROENTERO, V31, P154, DOI 10.3109/00365529609031980; Gleeson MH, 2003, ALIMENT PHARM THER, V17, P817, DOI 10.1046/j.1365-2036.2003.01519.x; Hedin CR, 2011, GUT, V60, DOI 10.1136/gut.2011.239301.314; Huang ES, 2011, AM J MED, V124, P426, DOI 10.1016/j.amjmed.2010.12.022; JENKINS AP, 1991, GUT, V32, P66, DOI 10.1136/gut.32.1.66; Kefalakes H, 2009, EUR J CLIN PHARMACOL, V65, P963, DOI 10.1007/s00228-009-0719-3; Korzenik JR, 2006, CLIN GASTROENTEROL H, V4, P157, DOI 10.1016/j.cgh.2005.11.007; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Loftus EV, 2000, GUT, V46, P336, DOI 10.1136/gut.46.3.336; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; MOUM B, 1995, DIGESTION, V56, P377, DOI 10.1159/000201262; Musumba C, 2009, ALIMENT PHARM THER, V30, P517, DOI 10.1111/j.1365-2036.2009.04086.x; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rodriguez LAG, 2005, ALIMENT PHARM THER, V22, P309, DOI 10.1111/j.1365-2036.2005.02564.x; Singh S, 2009, AM J GASTROENTEROL, V104, P1298, DOI 10.1038/ajg.2009.15; Soderholm JD, 1999, GUT, V44, P96, DOI 10.1136/gut.44.1.96; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; STOWE SP, 1990, GASTROENTEROLOGY, V98, P104, DOI 10.1016/0016-5085(90)91297-J; Takeuchi K, 2006, CLIN GASTROENTEROL H, V4, P196, DOI 10.1016/S1542-3565(05)00980-8; TANNER AR, 1988, DIGESTION, V41, P116, DOI 10.1159/000199740; Thiebaut ACM, 2007, ANN INTERN MED, V146, P65, DOI 10.7326/0003-4819-146-1-200701020-00012; Ulrych T, 2011, J THROMB HAEMOST, V9, P790, DOI 10.1111/j.1538-7836.2011.04194.x; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	41	138	139	2	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2012	156	5					350	U170		10.7326/0003-4819-156-5-201203060-00007	http://dx.doi.org/10.7326/0003-4819-156-5-201203060-00007			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902OC	22393130	Green Accepted			2022-12-01	WOS:000301046800003
J	Ginsberg, GM; Lauer, JA; Zelle, S; Baeten, S; Baltussen, R				Ginsberg, Gary M.; Lauer, Jeremy A.; Zelle, Sten; Baeten, Steef; Baltussen, Rob			Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MILLENNIUM DEVELOPMENT GOALS; HUMAN-PAPILLOMAVIRUS TYPES; IMPROVING HEALTH; UTILITY ANALYSIS; CONSUMPTION; VACCINATION; PREVALENCE; WORLDWIDE; DISEASE; BURDEN	Objective To determine the costs and health effects of interventions to combat breast, cervical, and colorectal cancers in order to guide resource allocation decisions in developing countries. Setting Two World Health Organization sub-regions of the world: countries in sub-Saharan Africa with very high adult and high child mortality (AfrE); and countries in South East Asia with high adult and high child mortality (SearD). Design Cost effectiveness analysis of prevention and treatment strategies for breast, cervical, and colorectal cancer, using mathematical modelling based on a lifetime population model. Data sources Demographic and epidemiological data were taken from the WHO mortality and global burden of disease databases. Estimates of intervention coverage, effectiveness, and resource needs were based on clinical trials, treatment guidelines, and expert opinion. Unit costs were taken from the WHO-CHOICE price database. Main outcome measures Cost per disability adjusted life year (DALY) averted, expressed in international dollars ($Int) for the year 2005. Results In both regions certain interventions in cervical cancer control (screening through cervical smear tests or visual inspection with acetic acid in combination with treatment) and colorectal cancer control (increasing the coverage of treatment interventions) cost <$Int2000 per DALY averted and can be considered highly cost effective. In the sub-Saharan African region screening for colorectal cancer (by colonoscopy at age 50 in combination with treatment) costs $Int2000-6000 per DALY averted and can be considered cost effective. In both regions certain interventions in breast cancer control (treatment of all cancer stages in combination with mammography screening) cost $Int2000-6000 per DALY averted and can also be considered cost effective. Other interventions, such as campaigns to eat more fruit and vegetable or subsidies in colorectal cancer control, are not cost effective according to the criteria defined. Conclusion Highly cost effective interventions to combat cervical and colorectal cancer are available in the African and Asian sub-regions. In cervical cancer control, these include screening through smear tests or visual inspection in combination with treatment. In colorectal cancer, increasing treatment coverage is highly cost effective (screening through colonoscopy is cost effective in the African sub-region). In breast cancer control, mammography screening in combination with treatment of all stages is cost effective.	[Ginsberg, Gary M.] Minist Hlth, Dept Med Technol Assessment, Jerusalem, Israel; [Lauer, Jeremy A.] World Hlth Org, Dept Hlth Syst Financing, Geneva, Switzerland; [Baeten, Steef] Erasmus MC, Inst Hlth Policy & Management, Rotterdam, Netherlands; [Zelle, Sten; Baltussen, Rob] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, Nijmegen, Netherlands	World Health Organization; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	Ginsberg, GM (corresponding author), Minist Hlth, Dept Med Technol Assessment, Ben Tbai 2, Jerusalem, Israel.	gary.ginsberg@moh.health.gov.il	Baltussen, R.M.P.M./L-4181-2015	Ginsberg, Gary/0000-0003-1315-890X; Lauer, Jeremy A/0000-0003-0652-0691				Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Alam M, 2001, ARCH DERMATOL, V137, P337; Alliance for Cervical Cancer Prevention (ACCP), 2004, ISS DEPTH; [Anonymous], 2011, SOFTW PROGR UNC AN; Armstrong LR, 2000, CLIN INFECT DIS, V31, P107, DOI 10.1086/313914; Bland KI, 1998, CANCER-AM CANCER SOC, V83, P1262, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1262::AID-CNCR28>3.0.CO;2-2; Boer R, 2001, QUANTITATIVE METHODS, P13; Bornstein J, 2007, ISR MED ASSOC J, V9, P156; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BROWN ML, 1993, BREAST CANCER RES TR, V25, P113, DOI 10.1007/BF00662136; Brown RE, 2006, CURR MED RES OPIN, V22, P663, DOI 10.1185/030079906X99972; [Cervix Cancer Screening IARC Working Group on the Evaluation of Cancer Prevention Strategies], 2004, IARC HDB CANC PREV; Chisholm D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e609; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Coleman MA, 2011, VACCINE; de Velde NV, 2007, AM J EPIDEMIOL, V165, P762, DOI 10.1093/aje/kwk059; DEKONING HJ, 1991, INT J CANCER, V49, P531, DOI 10.1002/ijc.2910490410; Dixon H, 1998, PREV MED, V27, P572, DOI 10.1006/pmed.1998.0328; Evans, 2003, MAKING CHOICES HLTH; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Franceschi S, 2003, INT J CANCER, V107, P127, DOI 10.1002/ijc.11350; Ginsberg Gary M, 2010, Cost Eff Resour Alloc, V8, P2, DOI 10.1186/1478-7547-8-2; Ginsberg GM, 2007, VACCINE, V25, P6677, DOI 10.1016/j.vaccine.2007.07.018; Ginsberg GM, 2009, VACCINE, V27, P6060, DOI 10.1016/j.vaccine.2009.07.026; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Groot MT, 2006, BREAST J, V12, pS81, DOI 10.1111/j.1075-122X.2006.00206.x; Harford JB, 2011, BREAST, V20, pS20, DOI 10.1016/j.breast.2011.02.007; HERRINTON LJ, 1995, AM J EPIDEMIOL, V142, P961, DOI 10.1093/oxfordjournals.aje.a117744; Johns B, 2004, HEALTH ECON, V13, P1117, DOI 10.1002/hec.880; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Kim JJ, 2009, ANN INTERN MED, V151, P538, DOI 10.7326/0003-4819-151-8-200910200-00007; Kim JJ, 2005, JNCI-J NATL CANCER I, V97, P888, DOI 10.1093/jnci/dji162; Launois R, 1996, PHARMACOECONOMICS, V10, P504, DOI 10.2165/00019053-199610050-00008; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Management Sciences for Health, 2006, INT DRUG PRIC IND GU; MD Anderson Cancer Center, 2004, CLIN PRACT GUID MD A; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Murray CJL, 1996, GLOBAL BURDEN DIS, V1; *NAT COMPR CANC NE, 2004, CLIN PRACT GUID ONC; Newall AT, 2007, LANCET INFECT DIS, V7, P289, DOI 10.1016/S1473-3099(07)70083-X; Norum J, 1997, BREAST CANCER RES TR, V45, P7, DOI 10.1023/A:1005804101106; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Sankaranarayanan R, 1998, CANC SURVIVAL DEV CO, P173; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Shireman TI, 2001, INT J TECHNOL ASSESS, V17, P146, DOI 10.1017/S0266462301104137; US National Institute of Health, 2011, NAT CANC I REC; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; Wagner JL, 1995, OTABPH146; *WHO COMM MACROECO, 2001, MACR HLTH INV HLTH E; WHO Department of Essential Health Technologies, 2005, ESS HLTH CAR TECHN P; World Health Organization, 2020, GLOBAL REPORT EPIDEM	54	44	46	0	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2012	344								e614	10.1136/bmj.e614	http://dx.doi.org/10.1136/bmj.e614			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XQ	22389347	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-01	WOS:000301232600007
J	Lai, CSW; Franke, TF; Gan, WB				Lai, Cora Sau Wan; Franke, Thomas F.; Gan, Wen-Biao			Opposite effects of fear conditioning and extinction on dendritic spine remodelling	NATURE			English	Article							PREFRONTAL CORTEX; MEMORY; AMYGDALA; NEURONS; RAT; CONSOLIDATION; MECHANISMS; CIRCUITS; CONTEXT	It is generally believed that fear extinction is a form of new learning that inhibits rather than erases previously acquired fear memories(1-3). Although this view has gained much support from behavioural and electrophysiological studies(1-10), the hypothesis that extinction causes the partial erasure of fear memories remains viable. Using transcranial two-photon microscopy(11,12), we investigated how neural circuits are modified by fear learning and extinction by examining the formation and elimination of postsynaptic dendritic spines of layer-V pyramidal neurons in the mouse frontal association cortex. Here we show that fear conditioning by pairing an auditory cue with a footshock increases the rate of spine elimination. By contrast, fear extinction by repeated presentation of the same auditory cue without a footshock increases the rate of spine formation. The degrees of spine remodelling induced by fear conditioning and extinction strongly correlate with the expression and extinction of conditioned fear responses, respectively. Notably, spine elimination and formation induced by fear conditioning and extinction occur on the same dendritic branches in a cue-and location-specific manner: cue-specific extinction causes formation of dendritic spines within a distance of two micrometres from spines that were eliminated after fear conditioning. Furthermore, reconditioning preferentially induces elimination of dendritic spines that were formed after extinction. Thus, within vastly complex neuronal networks, fear conditioning, extinction and reconditioning lead to opposing changes at the level of individual synapses. These findings also suggest that fear memory traces are partially erased after extinction.	[Lai, Cora Sau Wan; Gan, Wen-Biao] NYU, Sch Med, Skirball Inst, Mol Neurobiol Program,Dept Physiol & Neurosci, New York, NY 10016 USA; [Franke, Thomas F.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Franke, Thomas F.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	New York University; New York University; New York University	Gan, WB (corresponding author), NYU, Sch Med, Skirball Inst, Mol Neurobiol Program,Dept Physiol & Neurosci, 540 1st Ave, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	, 0000-0002-5721-4259/K-3037-2019	, 0000-0002-5721-4259/0000-0002-5721-4259	National Institutes of Health [NS047325]; Alzheimer's Association; National Science Foundation [IOS-0757780]; NARSAD; G. Harold & Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); National Science Foundation(National Science Foundation (NSF)); NARSAD(NARSAD); G. Harold & Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. LeDoux as well as all the members in the Gan laboratory for comments on the manuscript. This work was supported by National Institutes of Health grant NS047325 and the Investigator-Initiated Research Grant from the Alzheimer's Association (W.-B.G.), and by the National Science Foundation (#IOS-0757780), a 2008 NARSAD Independent Investigator Award and the G. Harold & Leila Y. Mathers Foundation (T.F.F.).	Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BOUTON ME, 1983, J EXP PSYCHOL ANIM B, V9, P248, DOI 10.1037/0097-7403.9.3.248; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; CONDE F, 1995, J COMP NEUROL, V352, P567, DOI 10.1002/cne.903520407; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hong I, 2009, EUR J NEUROSCI, V30, P2089, DOI 10.1111/j.1460-9568.2009.07004.x; Kim JH, 2008, J NEUROSCI, V28, P1282, DOI 10.1523/JNEUROSCI.4736-07.2008; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lin CH, 2003, J NEUROSCI, V23, P8310; MCDONALD AJ, 1987, J COMP NEUROL, V262, P46, DOI 10.1002/cne.902620105; Merlo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003687; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rescorla RA, 1975, J EXPT PSYCHOL ANIMA, V1, P88, DOI DOI 10.1037/0097-7403.1.1.88; Sacchetti B, 2003, EXP BRAIN RES, V152, P323, DOI 10.1007/s00221-003-1534-1; THOMAS DR, 1986, J EXP ANAL BEHAV, V46, P305, DOI 10.1901/jeab.1986.46-305; Tronson NC, 2009, J NEUROSCI, V29, P3387, DOI 10.1523/JNEUROSCI.5619-08.2009; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	24	269	271	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					87	U130		10.1038/nature10792	http://dx.doi.org/10.1038/nature10792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22343895				2022-12-01	WOS:000300877900050
J	Zhang, BC; Kracker, S; Yasuda, T; Casola, S; Vanneman, M; Homig-Holzel, C; Wang, Z; Derudder, E; Li, S; Chakraborty, T; Cotter, SE; Koyama, S; Currie, T; Freeman, GJ; Kutok, JL; Rodig, SJ; Dranoff, G; Rajewsky, K				Zhang, Baochun; Kracker, Sven; Yasuda, Tomoharu; Casola, Stefano; Vanneman, Matthew; Homig-Holzel, Cornelia; Wang, Zhe; Derudder, Emmanuel; Li, Shuang; Chakraborty, Tirtha; Cotter, Shane E.; Koyama, Shohei; Currie, Treeve; Freeman, Gordon J.; Kutok, Jeffery L.; Rodig, Scott J.; Dranoff, Glenn; Rajewsky, Klaus			Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model	CELL			English	Article							NF-KAPPA-B; CYTOTOXIC T-LYMPHOCYTES; CELL-DEVELOPMENT; IFN-GAMMA; RESPONSES; EXPRESSION; ANTIBODIES; PEPTIDES; SURVIVAL; SIGNALS	B cells infected by Epstein-Barr virus (EBV), a transforming virus endemic in humans, are rapidly cleared by the immune system, but some cells harboring the virus persist for life. Under conditions of immunosuppression, EBV can spread from these cells and cause life-threatening pathologies. We have generated mice expressing the transforming EBV latent membrane protein 1 (LMP1), mimicking a constitutively active CD40 coreceptor, specifically in B cells. Like human EBV-infected cells, LMP1(+) B cells were efficiently eliminated by T cells, and breaking immune surveillance resulted in rapid, fatal lymphoproliferation and lymphomagenesis. The lymphoma cells expressed ligands for a natural killer (NK) cell receptor, NKG2D, andcould betargetedby anNKG2D-Fc fusion protein. These experiments indicate a central role for LMP1 in the surveillance and transformation of EBV-infected B cells in vivo, establish a preclinical model for B cell lymphomagenesis in immunosuppressed patients, and validate a new therapeutic approach.	[Zhang, Baochun; Kracker, Sven; Yasuda, Tomoharu; Casola, Stefano; Wang, Zhe; Derudder, Emmanuel; Li, Shuang; Chakraborty, Tirtha; Rajewsky, Klaus] Harvard Univ, Program Cellular & Mol Med, Childrens Hosp, Sch Med, Boston, MA 02115 USA; [Zhang, Baochun; Kracker, Sven; Yasuda, Tomoharu; Casola, Stefano; Wang, Zhe; Derudder, Emmanuel; Li, Shuang; Chakraborty, Tirtha; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Casola, Stefano; Homig-Holzel, Cornelia; Rajewsky, Klaus] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Vanneman, Matthew; Koyama, Shohei; Freeman, Gordon J.; Dranoff, Glenn] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Vanneman, Matthew; Koyama, Shohei; Freeman, Gordon J.; Dranoff, Glenn] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02215 USA; [Vanneman, Matthew; Koyama, Shohei; Freeman, Gordon J.; Dranoff, Glenn] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Cotter, Shane E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Cotter, Shane E.] Harvard Univ, Brigham & Womens Hosp, Dept Radiat Oncol, Sch Med, Boston, MA 02115 USA; [Currie, Treeve; Kutok, Jeffery L.; Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Cologne; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Rajewsky, K (corresponding author), Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.	klaus.rajewsky@mdc-berlin.de	Kracker, Sven/H-3681-2017; Freeman, Gordon/AAC-5380-2019; Casola, Stefano/AAN-8319-2021; Koyama, Shohei/AAU-4113-2021; Yasuda, Tomoharu/J-5102-2019; Vanneman, Matthew/AAM-6732-2021; Casola, Stefano/O-3922-2014; Rodig, Scott/Y-3889-2019	Kracker, Sven/0000-0003-4543-8236; Freeman, Gordon/0000-0002-7210-5616; Casola, Stefano/0000-0001-5580-0986; Koyama, Shohei/0000-0002-6897-9417; Vanneman, Matthew/0000-0003-3877-782X; Zhang, Baochun/0000-0003-1759-1161; Yasuda, Tomoharu/0000-0001-9997-6852; Rajewsky, Klaus/0000-0002-6633-6370; Derudder, Emmanuel/0000-0003-1421-4045	NIH [CA098285, CA078378, AI56299]; Leukemia and Lymphoma SCOR; Leukemia and Lymphoma Society; JSPS; Astellas Foundation for Research on Metabolic Disorders; NATIONAL CANCER INSTITUTE [P50CA100707, P01CA078378, R01CA050947, P01CA155258, R01CA098285, R01CA143083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma SCOR; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. S. Cobbold for the anti-CD4, -CD8, and -Thy1 hybridomas; Dr. L. Lanier for the CX5 hybridoma; Dr. R. Schreiber for anti-TNF alpha (TN3-19.12) and anti-IFN gamma (H22) antibodies; Drs. E. Cahir-McFarland and E. Kieff for MSCV-IRES-GFP- and MSCV-LMP1-IRES-GFP-expressing vectors; Dr. D. Raulet for NKG2D<SUP>-/-</SUP> mice; Mr. P. Sage and Dr. A. Sharpe for CIITA<SUP>-/-</SUP> mice; Drs. U. Basu, F. Meng, and F. Alt for the anti-AID antibody; and Dr. M. Schmidt-Supprian for the J<INF>H</INF> probe. We thank the NIH Tetramer Facility at Emory University for the PE-conjugated mCD1d-PBS57 tetramer. We are grateful to M. Bamberg, J. Xia, D. Ghitza, C. Grosse, X. Chen, A. Pellerin, J. Grundy, and J. Wang for technical assistance; M. Ottaviano for administrative assistance; S. Koralov for help with sequence analysis and intracellular cytokine staining; S. Peng for HPRT primers; K. Kochert for advice on statistics; and D. Calado, M. Janz, K. Wucherpfennig, and all Rajewsky lab members for critical comments and suggestions. This work was supported by NIH grants CA098285, CA078378, and AI56299 and a Leukemia and Lymphoma SCOR. B.Z. is supported by a postdoctoral fellowship of the Leukemia and Lymphoma Society. T.Y is supported by a JSPS Postdoctoral Fellowship for Research Abroad and by the Astellas Foundation for Research on Metabolic Disorders.	Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Blankenstein T, 2003, CURR OPIN IMMUNOL, V15, P148, DOI 10.1016/S0952-7915(03)00007-4; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Capello D, 2003, BLOOD, V102, P3775, DOI 10.1182/blood-2003-05-1683; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Craig FE, 2007, DIAGN MOL PATHOL, V16, P158, DOI 10.1097/PDM.0b013e31804f54a9; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Gottschalk S, 2005, ANNU REV MED, V56, P29, DOI 10.1146/annurev.med.56.082103.104727; Gourzi P, 2006, IMMUNITY, V24, P779, DOI 10.1016/j.immuni.2006.03.021; Harris N.L., 2001, TUMOURS HAEMATOPOIET, P267; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Homig-Holzel C, 2008, J EXP MED, V205, P1317, DOI 10.1084/jem.20080238; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jinushi M, 2008, P NATL ACAD SCI USA, V105, P1285, DOI 10.1073/pnas.0711293105; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Khanna R, 2000, ANNU REV MICROBIOL, V54, P19, DOI 10.1146/annurev.micro.54.1.19; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Le Clorennec C, 2006, BLOOD, V107, P2070, DOI 10.1182/blood-2005-05-2053; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Rastelli J, 2008, BLOOD, V111, P1448, DOI 10.1182/blood-2007-10-117655; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Savoldo B, 2006, BLOOD, V108, P2942, DOI 10.1182/blood-2006-05-021782; SCHULTZE JL, 1995, P NATL ACAD SCI USA, V92, P8200, DOI 10.1073/pnas.92.18.8200; Schultze JL, 1997, BLOOD, V89, P3806, DOI 10.1182/blood.V89.10.3806.3806_3806_3816; Soni V, 2007, ADV EXP MED BIOL, V597, P173; Souza TA, 2005, P NATL ACAD SCI USA, V102, P18093, DOI 10.1073/pnas.0509311102; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Vakiani E, 2008, HEMATOL ONCOL, V26, P199, DOI 10.1002/hon.859; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zhang L, 2005, J GENE MED, V7, P354, DOI 10.1002/jgm.677; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	50	104	112	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					739	751		10.1016/j.cell.2011.12.031	http://dx.doi.org/10.1016/j.cell.2011.12.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341446	Bronze, Green Accepted			2022-12-01	WOS:000300622400015
J	Herman, DS; Lam, L; Taylor, MRG; Wang, LB; Teekakirikul, P; Christodoulou, D; Conner, L; DePalma, SR; McDonough, B; Sparks, E; Teodorescu, DL; Cirino, AL; Banner, NR; Pennell, DJ; Graw, S; Merlo, M; Di Lenarda, A; Sinagra, G; Bos, JM; Ackerman, MJ; Mitchell, RN; Murry, CE; Lakdawala, NK; Ho, CY; Barton, PJR; Cook, SA; Mestroni, L; Seidman, JG; Seidman, CE				Herman, Daniel S.; Lam, Lien; Taylor, Matthew R. G.; Wang, Libin; Teekakirikul, Polakit; Christodoulou, Danos; Conner, Lauren; DePalma, Steven R.; McDonough, Barbara; Sparks, Elizabeth; Teodorescu, Debbie Lin; Cirino, Allison L.; Banner, Nicholas R.; Pennell, Dudley J.; Graw, Sharon; Merlo, Marco; Di Lenarda, Andrea; Sinagra, Gianfranco; Bos, J. Martijn; Ackerman, Michael J.; Mitchell, Richard N.; Murry, Charles E.; Lakdawala, Neal K.; Ho, Carolyn Y.; Barton, Paul J. R.; Cook, Stuart A.; Mestroni, Luisa; Seidman, J. G.; Seidman, Christine E.			Truncations of Titin Causing Dilated Cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TIBIAL MUSCULAR-DYSTROPHY; MUSCLE FILAMENT TITIN; C-TERMINAL TITIN; CARDIAC-HYPERTROPHY; GENE; MUTATIONS; EXPRESSION; TENSION; DOMAIN; TTN	BACKGROUND Dilated cardiomyopathy and hypertrophic cardiomyopathy arise from mutations in many genes. TTN, the gene encoding the sarcomere protein titin, has been insufficiently analyzed for cardiomyopathy mutations because of its enormous size. METHODS We analyzed TTN in 312 subjects with dilated cardiomyopathy, 231 subjects with hypertrophic cardiomyopathy, and 249 controls by using next-generation or dideoxy sequencing. We evaluated deleterious variants for cosegregation in families and assessed clinical characteristics. RESULTS We identified 72 unique mutations (25 nonsense, 23 frameshift, 23 splicing, and 1 large tandem insertion) that altered full-length titin. Among subjects studied by means of next-generation sequencing, the frequency of TTN mutations was significantly higher among subjects with dilated cardiomyopathy (54 of 203 [27%]) than among subjects with hypertrophic cardiomyopathy (3 of 231 [1%], P = 3x10(-16)) or controls (7 of 249 [3%], P = 9x10(-14)). TTN mutations cosegregated with dilated cardiomyopathy in families (combined lod score, 11.1) with high (>95%) observed penetrance after the age of 40 years. Mutations associated with dilated cardiomyopathy were overrepresented in the titin A-band but were absent from the Z-disk and M-band regions of titin (P <= 0.01 for all comparisons). Overall, the rates of cardiac outcomes were similar in subjects with and those without TTN mutations, but adverse events occurred earlier in male mutation carriers than in female carriers (P = 4x10(-5)). CONCLUSIONS TTN truncating mutations are a common cause of dilated cardiomyopathy, occurring in approximately 25% of familial cases of idiopathic dilated cardiomyopathy and in 18% of sporadic cases. Incorporation of sequencing approaches that detect TTN truncations into genetic testing for dilated cardiomyopathy should substantially increase test sensitivity, thereby allowing earlier diagnosis and therapeutic intervention for many patients with dilated cardiomyopathy. Defining the functional effects of TTN truncating mutations should improve our understanding of the pathophysiology of dilated cardiomyopathy. (Funded by the Howard Hughes Medical Institute and others.)	[Herman, Daniel S.; Lam, Lien; Wang, Libin; Teekakirikul, Polakit; Christodoulou, Danos; Conner, Lauren; DePalma, Steven R.; McDonough, Barbara; Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lam, Lien; Wang, Libin; DePalma, Steven R.; McDonough, Barbara; Sparks, Elizabeth; Seidman, Christine E.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Teekakirikul, Polakit; Teodorescu, Debbie Lin; Cirino, Allison L.; Lakdawala, Neal K.; Ho, Carolyn Y.; Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Mitchell, Richard N.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Taylor, Matthew R. G.; Mestroni, Luisa] Univ Colorado, Cardiovasc Inst, Denver, CO 80202 USA; [Graw, Sharon] Univ Colorado, Dept Psychiat, Denver, CO 80202 USA; [Banner, Nicholas R.; Pennell, Dudley J.; Barton, Paul J. R.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton & Harefield Natl Hlth Serv Fdn Tru, London SW7 2AZ, England; [Barton, Paul J. R.; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London SW7 2AZ, England; [Barton, Paul J. R.; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Merlo, Marco; Sinagra, Gianfranco] Osped Riuniti, Cardiovasc Dept, Trieste, Italy; [Merlo, Marco; Sinagra, Gianfranco] Univ Trieste, Trieste, Italy; [Di Lenarda, Andrea] Azienda Serv Sanit 1, Ctr Cardiovasc, Trieste, Italy; [Bos, J. Martijn; Ackerman, Michael J.] Mayo Clin, Dept Med, Rochester, MN USA; [Bos, J. Martijn; Ackerman, Michael J.] Mayo Clin, Dept Pediat, Rochester, MN USA; [Bos, J. Martijn; Ackerman, Michael J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Imperial College London; University of Trieste; University of Trieste; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, NRB 256,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	sinagra, gianfranco gs/P-7643-2014; Sinagra, Gianfranco/AAE-3943-2020; Teodorescu, Debbie/A-2689-2019; Di Lenarda, Andrea/AAC-2377-2022; Cook, Stuart/G-9567-2011	Teodorescu, Debbie/0000-0002-8981-227X; Di Lenarda, Andrea/0000-0001-8482-4872; SINAGRA, GIANFRANCO/0000-0003-2700-8478; Ho, Carolyn/0000-0002-7334-7924; Teekakirikul, Polakit/0000-0003-2407-7355; Barton, Paul/0000-0002-1165-7767; Mestroni, Luisa/0000-0003-1116-2286; DePalma, Steven/0000-0002-0381-5016; Pennell, Dudley/0000-0001-5523-1314; Cook, Stuart/0000-0001-6628-194X	Howard Hughes Medical Institute; National Institutes of Health; Leducq Foundation; American Heart Association; Muscular Dystrophy Association; U.K. National Institute for Health Research Cardiovascular Biomedical Research Unit (Royal Brompton and Harefield National Health Service Foundation Trust and Imperial College; British Heart Foundation; Medical Research Council U.K.; J. Ira and Nicki Harris Family Research Award; National Heart, Lung, and Blood Institute [N01-HV-48194]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052320, R01HL084553, U01HL066582, U01HL098166, R01HL080494, P01HL059139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; British Heart Foundation [SP/10/10/28431] Funding Source: researchfish; Medical Research Council [MC_U120085815] Funding Source: researchfish; MRC [MC_U120085815] Funding Source: UKRI	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); U.K. National Institute for Health Research Cardiovascular Biomedical Research Unit (Royal Brompton and Harefield National Health Service Foundation Trust and Imperial College; British Heart Foundation(British Heart Foundation); Medical Research Council U.K.(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); J. Ira and Nicki Harris Family Research Award; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the Howard Hughes Medical Institute (to Dr. C.E. Seidman); the National Institutes of Health (to Drs. Herman, Taylor, Graw, Ackerman, Mitchell, Murry, Ho, Mestroni, and J.G. Seidman); the Leducq Foundation (to Drs. Cook, J.G. Seidman, and C. E. Seidman); the American Heart Association and the Muscular Dystrophy Association (to Drs. Taylor and Mestroni); the U.K. National Institute for Health Research Cardiovascular Biomedical Research Unit (Royal Brompton and Harefield National Health Service Foundation Trust and Imperial College), the British Heart Foundation, and the Medical Research Council U.K. (to Drs. Banner, Pennell, Cook, and Barton); and the J. Ira and Nicki Harris Family Research Award (to Dr. Ho). Sequencing in subjects with dilated cardiomyopathy in group C was funded by a contract from the National Heart, Lung, and Blood Institute (N01-HV-48194).	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; [Anonymous], 2010, R LANG ENV STAT COMP; Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Carmignac V, 2007, ANN NEUROL, V61, P340, DOI 10.1002/ana.21089; Cazorla O, 2001, CIRC RES, V88, P1028, DOI 10.1161/hh1001.090876; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Gerull B, 2006, J MOL MED-JMM, V84, P478, DOI 10.1007/s00109-006-0060-6; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Gramlich M, 2009, J MOL CELL CARDIOL, V47, P352, DOI 10.1016/j.yjmcc.2009.04.014; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Grater F, 2005, BIOPHYS J, V88, P790, DOI 10.1529/biophysj.104.052423; Guo W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/753675; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Hackman P, 2008, NEUROMUSCULAR DISORD, V18, P922, DOI 10.1016/j.nmd.2008.07.010; Herman DS, 2009, NAT METHODS, V6, P507, DOI 10.1038/nmeth.1343; HOROWITS R, 1986, NATURE, V323, P160, DOI 10.1038/323160a0; Jones RC, 2004, J AM COLL CARDIOL, V44, P1025, DOI 10.1016/j.jacc.2004.05.077; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Liversage AD, 2001, J MOL BIOL, V305, P401, DOI 10.1006/jmbi.2000.4279; Maron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Muhle-Goll C, 2001, J MOL BIOL, V313, P431, DOI 10.1006/jmbi.2001.5017; Musa H, 2006, J CELL SCI, V119, P4322, DOI 10.1242/jcs.03198; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Peng J, 2007, CIRCULATION, V115, P743, DOI 10.1161/CIRCULATIONAHA.106.645499; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; TRINICK J, 1984, J MOL BIOL, V180, P331, DOI 10.1016/S0022-2836(84)80007-8; van der Ven PFM, 2000, J CELL SCI, V113, P1405; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Zimmerman RS, 2010, GENET MED, V12, P268, DOI 10.1097/GIM.0b013e3181d6f7c0	41	800	822	5	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					619	628		10.1056/NEJMoa1110186	http://dx.doi.org/10.1056/NEJMoa1110186			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892IL	22335739	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000300279800007
J	Vonlanthen, P; Bittner, D; Hudson, AG; Young, KA; Muller, R; Lundsgaard-Hansen, B; Roy, D; Di Piazza, S; Largiader, CR; Seehausen, O				Vonlanthen, P.; Bittner, D.; Hudson, A. G.; Young, K. A.; Mueller, R.; Lundsgaard-Hansen, B.; Roy, D.; Di Piazza, S.; Largiader, C. R.; Seehausen, O.			Eutrophication causes speciation reversal in whitefish adaptive radiations	NATURE			English	Article							ECOLOGICAL SPECIATION; LAKE; HYBRIDIZATION; FISH; REQUIREMENTS; CONSERVATION; BIODIVERSITY; GASTEROSTEUS; EVOLUTION; PATTERNS	Species diversity can be lost through two different but potentially interacting extinction processes: demographic decline and speciation reversal through introgressive hybridization. To investigate the relative contribution of these processes, we analysed historical and contemporary data of replicate whitefish radiations from 17 pre-alpine European lakes and reconstructed changes in genetic species differentiation through time using historical samples. Here we provide evidence that species diversity evolved in response to ecological opportunity, and that eutrophication, by diminishing this opportunity, has driven extinctions through speciation reversal and demographic decline. Across the radiations, the magnitude of eutrophication explains the pattern of species loss and levels of genetic and functional distinctiveness among remaining species. We argue that extinction by speciation reversal may be more widespread than currently appreciated. Preventing such extinctions will require that conservation efforts not only target existing species but identify and protect the ecological and evolutionary processes that generate and maintain species.	[Vonlanthen, P.; Hudson, A. G.; Lundsgaard-Hansen, B.; Di Piazza, S.; Seehausen, O.] Univ Bern, Inst Ecol & Evolut, Div Aquat Ecol & Evolut, CH-3012 Bern, Switzerland; [Vonlanthen, P.; Bittner, D.; Hudson, A. G.; Young, K. A.; Mueller, R.; Lundsgaard-Hansen, B.; Roy, D.; Di Piazza, S.; Seehausen, O.] EAWAG Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, CH-6047 Kastanienbaum, Switzerland; [Bittner, D.] Univ Bern, Inst Ecol & Evolut, Computat & Mol Populat Genet CMPG Lab, CH-3012 Bern, Switzerland; [Young, K. A.] Environm Agcy, Cardiff CF24 0TP, S Glam, Wales; [Roy, D.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada; [Largiader, C. R.] Univ Hosp Bern, Inselspital, Inst Clin Chem, CH-3010 Bern, Switzerland; [Largiader, C. R.] Univ Bern, Inselspital, CH-3010 Bern, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Bern; Dalhousie University; University of Bern; University Hospital of Bern; University of Bern	Seehausen, O (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Aquat Ecol & Evolut, Baltzerstr 6, CH-3012 Bern, Switzerland.	ole.seehausen@eawag.ch	Vonlanthen, Pascal/G-9224-2011; Hudson, Alan/J-9380-2014; Largiader, Carlo R/B-8798-2008; Seehausen, Ole/C-8272-2011	Hudson, Alan/0000-0001-6436-2025; Largiader, Carlo R/0000-0002-0889-8922; Seehausen, Ole/0000-0001-6598-1434	Eawag Action Field Grant 'AquaDiverse-understanding and predicting changes in aquatic biodiversity'	Eawag Action Field Grant 'AquaDiverse-understanding and predicting changes in aquatic biodiversity'	We thank all professional fishermen who provided fish specimens. We thank M. Kugler from the Amt fur Natur, Jagd und Fischerei, St. Gallen and the institute of Seenforschung and Fischereiwesen Langenargen for providing historical whitefish scales from Lake Constance. We acknowledge the Swiss Federal Institute for Aquatic Science and Technology (EAWAG), the Internationale Gewasserschutzkomission fur den Bodensee (IGKB) and the Federal Office for Environment (FOEN) for providing environmental data. We also thank G. Periat, S. Mwaiko, M. Barluenga, H. Araki, M. Maan, J. Brodersen, P. Nosil, K. Wagner and all members of the Fish Ecology and Evolution laboratory for assistance in the laboratory, and for comments and suggestions on the manuscript, B. Muller for help with the analysis of the oxygen profiles, and C. Melian for help with data analyses. We acknowledge financial support by the Eawag Action Field Grant 'AquaDiverse-understanding and predicting changes in aquatic biodiversity' (to O.S.).	Bernatchez L, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P175; Bittner D, 2010, MOL ECOL, V19, P2152, DOI 10.1111/j.1365-294X.2010.04623.x; Blumenshine SC, 1997, J N AM BENTHOL SOC, V16, P466, DOI 10.2307/1468138; Brede N, 2009, P NATL ACAD SCI USA, V106, P4758, DOI 10.1073/pnas.0807187106; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Coyne J.A., 2004, SPECIATION; Czerkies P, 2002, AQUACULTURE, V211, P375, DOI 10.1016/S0044-8486(02)00049-2; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; De Leon LF, 2011, EVOLUTION, V65, P2258, DOI 10.1111/j.1558-5646.2011.01297.x; Freyhof J, 2007, HDB EUROPEAN FRESHWA; Gilman RT, 2011, EVOLUTION, V65, P2592, DOI 10.1111/j.1558-5646.2011.01320.x; GOLDSCHMIDT T, 1993, CONSERV BIOL, V7, P686, DOI 10.1046/j.1523-1739.1993.07030686.x; Grant BR, 2008, PHILOS T R SOC B, V363, P2821, DOI 10.1098/rstb.2008.0051; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Harrod C, 2010, J ANIM ECOL, V79, P1057, DOI 10.1111/j.1365-2656.2010.01702.x; Heath D, 2010, EVOL APPL, V3, P77, DOI 10.1111/j.1752-4571.2009.00100.x; Hendry AP, 2006, P R SOC B, V273, P1887, DOI 10.1098/rspb.2006.3534; Hudson AG, 2011, P ROY SOC B-BIOL SCI, V278, P58, DOI 10.1098/rspb.2010.0925; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; LIECHTI P, 1994, SCHRIFTENREIHE UMWEL, V237; MCPHAIL JD, 1993, CAN J ZOOL, V71, P515, DOI 10.1139/z93-072; Muller R, 2004, FISHERIES MANAG ECOL, V11, P251, DOI 10.1111/j.1365-2400.2004.00393.x; MULLER R, 1992, HYDROBIOLOGIA, V243, P261, DOI 10.1007/BF00007041; Powers SP, 2005, MAR ECOL PROG SER, V302, P233, DOI 10.3354/meps302233; Pritchard JK, 2000, GENETICS, V155, P945; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rosenzweig ML, 2001, P NATL ACAD SCI USA, V98, P5404, DOI 10.1073/pnas.101092798; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Seehausen O, 2009, NATURE, V458, P1122, DOI 10.1038/4581122a; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; STEINMANN P, 1950, SCHWEIZERISCHE Z HYD, V12, P340, DOI DOI 10.1007/BF02489885; Straile D, 1998, ICES J MAR SCI, V55, P775, DOI 10.1006/jmsc.1998.0397; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Verschuren D, 2002, P ROY SOC B-BIOL SCI, V269, P289, DOI 10.1098/rspb.2001.1850; Vonlanthen P, 2009, J EVOLUTION BIOL, V22, P498, DOI 10.1111/j.1420-9101.2008.01670.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Wasko AP, 2003, HEREDITAS, V138, P161, DOI 10.1034/j.1601-5223.2003.01503.x; Woods PJ, 2009, J EVOLUTION BIOL, V22, P2305, DOI 10.1111/j.1420-9101.2009.01846.x	47	300	309	12	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					357	U1500		10.1038/nature10824	http://dx.doi.org/10.1038/nature10824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337055				2022-12-01	WOS:000300287100037
J	Kawaoka, Y				Kawaoka, Yoshihiro			Flu transmission work is urgent	NATURE			English	Editorial Material									[Kawaoka, Yoshihiro] Univ Tokyo, Tokyo 1138654, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin Madison, Madison, WI 53706 USA	University of Tokyo; University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Tokyo 1138654, Japan.	kawaokay@svm.vetmed.wisc.edu							0	44	44	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 9	2012	482	7384					155	155		10.1038/nature10884	http://dx.doi.org/10.1038/nature10884			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	888HI	22278057	Bronze			2022-12-01	WOS:000299994100013
J	Lustig, RH; Schmidt, LA; Brindis, CD				Lustig, Robert H.; Schmidt, Laura A.; Brindis, Claire D.			The toxic truth about sugar	NATURE			English	Editorial Material							FRUCTOSE		[Lustig, Robert H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Lustig, Robert H.] Univ Calif San Francisco, Ctr Obes Assessment Study & Treatment, San Francisco, CA 94143 USA; [Schmidt, Laura A.; Brindis, Claire D.] Univ Calif San Francisco, Clin & Translat Sci Inst, San Francisco, CA 94118 USA; [Schmidt, Laura A.; Brindis, Claire D.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94118 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lustig, RH (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	rlustig@peds.ucsf.edu	Lustig, Robert/O-9380-2019; Fernandez-Revelles, Andres B/A-4391-2012	Lustig, Robert/0000-0001-6983-2639; Fernandez-Revelles, Andres B/0000-0002-8089-650X; Brindis, Claire/0000-0002-2284-3936				Babor T., 2003, ALCOHOL NO ORDINARY; Engelhard C.L., 2009, REDUCING OBESITY POL; Finkelstein EA, 2003, HEALTH AFFAIR, V22, pW219; Garber Andrea K, 2011, Curr Drug Abuse Rev, V4, P146; Joint WHO/FAO Expert Consultation, 2003, WHO TECHN REP SER; Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008; Room R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2364; Sturm R, 2010, HEALTH AFFAIR, V29, P1052, DOI 10.1377/hlthaff.2009.0061; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Vio F., 2007, FOOD POLICY DEV COUN	10	486	500	3	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 2	2012	482	7383					27	29		10.1038/482027a	http://dx.doi.org/10.1038/482027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22297952	Bronze			2022-12-01	WOS:000299726000014
J	Charo, RA				Charo, R. Alta			Warning: Contraceptive Drugs May Cause Political Headaches	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Charo, R. Alta] Univ Wisconsin, Sch Law, Madison, WI 53706 USA; [Charo, R. Alta] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Sch Law, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				Abelson Reed, 2012, NY TIMES, p[A1, A3]; Bolstad E, 2012, MCCLATCHY NEWSP 0205; Charo R. Alta, 2007, HLTH CARE PROVIDER R; Equal Employment Opportunity Commission, DEC CONTR; Uttley LJ, 2002, NO STRINGS ATTACHED	5	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2012	366	15					1361	1364		10.1056/NEJMp1202701	http://dx.doi.org/10.1056/NEJMp1202701			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GV	22417204				2022-12-01	WOS:000302608600011
J	Kumar, SV; Lucyshyn, D; Jaeger, KE; Alos, E; Alvey, E; Harberd, NP; Wigge, PA				Kumar, S. Vinod; Lucyshyn, Doris; Jaeger, Katja E.; Alos, Enriqueta; Alvey, Elizabeth; Harberd, Nicholas P.; Wigge, Philip A.			Transcription factor PIF4 controls the thermosensory activation of flowering	NATURE			English	Article							ARABIDOPSIS-THALIANA; LOCUS-T; HIGH-TEMPERATURE; GIBBERELLIN; GROWTH; TIME; CONSTANS; LIGHT; EXPRESSION; PLANTS	Plant growth and development are strongly affected by small differences in temperature(1). Current climate change has already altered global plant phenology and distribution(2,3), and projected increases in temperature pose a significant challenge to agriculture(4). Despite the important role of temperature on plant development, the underlying pathways are unknown. It has previously been shown that thermal acceleration of flowering is dependent on the florigen, FLOWERING LOCUS T (FT)(5,6). How this occurs is, however, not understood, because the major pathway known to upregulate FT, the photoperiod pathway, is not required for thermal acceleration of flowering(6). Here we demonstrate a direct mechanism by which increasing temperature causes the bHLH transcription factor PHYTOCHROME INTERACTING FACTOR4 (PIF4) to activate FT. Our findings provide a new understanding of how plants control their timing of reproduction in response to temperature. Flowering time is an important trait in crops as well as affecting the life cycles of pollinator species. A molecular understanding of how temperature affects flowering will be important for mitigating the effects of climate change.	[Kumar, S. Vinod; Lucyshyn, Doris; Jaeger, Katja E.; Alos, Enriqueta; Alvey, Elizabeth; Harberd, Nicholas P.; Wigge, Philip A.] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Harberd, Nicholas P.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Oxford	Wigge, PA (corresponding author), Univ Cambridge, Sainsbury Lab, Bateman St, Cambridge CB2 1LR, England.	philip.wigge@slcu.cam.ac.uk	Wigge, Philip Anthony/ABD-5113-2021; Alos, Enriqueta/E-7674-2012	Wigge, Philip Anthony/0000-0003-4822-361X; Alos, Enriqueta/0000-0003-2878-2617; Lucyshyn, Doris/0000-0001-8558-1219; Kumar, S Vinod/0000-0001-9265-4906	King Abdullah University of Science and Technology [KUK-I1-002-03]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I019022/1, BB/D0100470/1]; Erwin Schroedinger Fellowship from the Austrian Science Fund FWF; John Innes Centre; European Research Council (ERC) [243140]; BBSRC [BBS/E/J/000CA402, BBS/E/J/000C0656, BBS/E/J/000CA346, BB/I019022/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [P19972, BBS/E/J/000CA346, BBS/E/J/000C0656, BB/I019022/1, BBS/E/J/000CA402, BBS/E/J/000C0636, BBS/E/J/00000610, BBS/E/J/00000583] Funding Source: researchfish	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Erwin Schroedinger Fellowship from the Austrian Science Fund FWF(Austrian Science Fund (FWF)); John Innes Centre; European Research Council (ERC)(European Research Council (ERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Prat, C. Fankhauser, K. Franklin, K. Goto, G. Coupland and D. Weigel for seeds. We are grateful to members of the Wigge laboratory for discussions. This work was supported in part by award No. KUK-I1-002-03 (to N.P.H.) made by King Abdullah University of Science and Technology and a Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/I019022/1 (to S.V.K.). D.L. was supported by an Erwin Schroedinger Fellowship from the Austrian Science Fund FWF. P.A.W. was supported by start-up funds from the John Innes Centre and BBSRC, a BBSRC grant (BB/D0100470/1) and a European Research Council Starting Grant (ERC 243140).	Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; BRIAN PW, 1958, NATURE, V181, P1122, DOI 10.1038/1811122a0; Brock MT, 2010, MOL ECOL, V19, P1187, DOI 10.1111/j.1365-294X.2010.04538.x; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Foreman J, 2011, PLANT J, V65, P441, DOI 10.1111/j.1365-313X.2010.04434.x; Franklin KA, 2011, P NATL ACAD SCI USA, V108, P20231, DOI 10.1073/pnas.1110682108; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Hisamatsu T, 2008, J EXP BOT, V59, P3821, DOI 10.1093/jxb/ern232; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Samach A, 2005, CURR OPIN PLANT BIOL, V8, P483, DOI 10.1016/j.pbi.2005.07.011; Stavang JA, 2009, PLANT J, V60, P589, DOI 10.1111/j.1365-313X.2009.03983.x; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105	26	444	490	18	358	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					242	U127		10.1038/nature10928	http://dx.doi.org/10.1038/nature10928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22437497	Green Accepted			2022-12-01	WOS:000303149900035
J	Filippakopoulos, P; Picaud, S; Mangos, M; Keates, T; Lambert, JP; Barsyte-Lovejoy, D; Felletar, I; Volkmer, R; Muller, S; Pawson, T; Gingras, AC; Arrowsmith, CH; Knapp, S				Filippakopoulos, Panagis; Picaud, Sarah; Mangos, Maria; Keates, Tracy; Lambert, Jean-Philippe; Barsyte-Lovejoy, Dalia; Felletar, Ildiko; Volkmer, Rudolf; Mueller, Susanne; Pawson, Tony; Gingras, Anne-Claude; Arrowsmith, Cheryl H.; Knapp, Stefan			Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; PEPTIDE ARRAYS; TRANSCRIPTION ELONGATION; BET BROMODOMAINS; PHD FINGER; PROTEIN; ACETYLATION; IDENTIFICATION	Bromodomains (BRDs) are protein interaction modules that specifically recognize epsilon-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks. The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity. Here, we present 29 high-resolution crystal structures, covering all BRD families. Comprehensive crossfamily structural analysis identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition. Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences. We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-containing peptides by BRD4. These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.	[Filippakopoulos, Panagis; Picaud, Sarah; Keates, Tracy; Felletar, Ildiko; Mueller, Susanne; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7LD, England; [Knapp, Stefan] Univ Oxford, Dept Oncol, Oxford OX3 7LD, England; [Mangos, Maria; Barsyte-Lovejoy, Dalia; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Lambert, Jean-Philippe; Pawson, Tony; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Volkmer, Rudolf] Charite Univ Med Berlin, Inst Med Immunol, D-10115 Berlin, Germany; [Pawson, Tony; Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Knapp, Stefan] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA	University of Oxford; University of Oxford; University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto; George Washington University	Filippakopoulos, P (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7LD, England.	panagis.filippakopoulos@sgc.ox.ac.uk; stefan.knapp@sgc.ox.ac.uk	Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020; Knapp, Stefan/AAG-2347-2019; Pawson, Tony J/E-4578-2013	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Knapp, Stefan/0000-0001-5995-6494; Lambert, Jean-Philippe/0000-0002-0833-1221; Filippakopoulos, Panagis/0000-0002-1515-1317; Volkmer, Rudolf/0000-0003-4710-1143; Muller-Knapp, Susanne/0000-0003-2402-4157; Arrowsmith, Cheryl/0000-0002-4971-3250	Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Pfizer; Eli Lilly; Novartis Research Foundation; Ontario Ministry of Research and Innovation; Wellcome Trust [095751/Z/11/Z]; Ontario Ministry of Health and Innovation; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Eli Lilly(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); Ontario Ministry of Health and Innovation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The SGC is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Pfizer, Eli Lilly, the Novartis Research Foundation, the Ontario Ministry of Research and Innovation, and the Wellcome Trust. P.F. is supported by a Wellcome Trust Career Development Fellowship (095751/Z/11/Z). T. P. and A.-C. G. are supported by a Global Leadership Round in Genomics and Life Sciences from the Ontario Ministry of Health and Innovation. J.-P.L. is supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada. A.-C. G. and C. H. A. hold Canada Research Chairs in Functional Proteomics and Structural Proteomics, respectively.	Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Beyer M, 2009, METHODS MOL BIOL, V570, P309, DOI 10.1007/978-1-60327-394-7_16; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Fairbridge NA, 2010, BIRTH DEFECTS RES A, V88, P619, DOI 10.1002/bdra.20695; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fossey SC, 2000, MAMM GENOME, V11, P919, DOI 10.1007/s003350010174; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; French CA, 2010, CANCER GENET CYTOGEN, V203, P16, DOI 10.1016/j.cancergencyto.2010.06.007; Goodwin GH, 2001, GENE, V268, P1, DOI 10.1016/S0378-1119(01)00428-0; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; Hewings DS, 2011, J MED CHEM, V54, P6761, DOI 10.1021/jm200640v; Huang H, 2003, DEV DYNAM, V227, P608, DOI 10.1002/dvdy.10344; Huang HD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-57; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li YY, 2011, J BIOL CHEM, V286, P13925, DOI 10.1074/jbc.M111.223198; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Podcheko A, 2007, MOL CELL BIOL, V27, P6484, DOI 10.1128/MCB.02409-06; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shen WQ, 2007, BIOCHEMISTRY-US, V46, P2100, DOI 10.1021/bi0611208; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Umehara T, 2010, J BIOL CHEM, V285, P7610, DOI 10.1074/jbc.M109.062422; Wang PJ, 2002, HUM MOL GENET, V11, P2341, DOI 10.1093/hmg/11.19.2341; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Wassarman DA, 2001, J CELL SCI, V114, P2895; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yordy JS, 2005, ONCOGENE, V24, P916, DOI 10.1038/sj.onc.1208245; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031; Zong RT, 2000, EMBO J, V19, P4123, DOI 10.1093/emboj/19.15.4123	84	1038	1119	13	194	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					214	231		10.1016/j.cell.2012.02.013	http://dx.doi.org/10.1016/j.cell.2012.02.013			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464331	Green Published, Green Accepted, hybrid			2022-12-01	WOS:000302235400022
J	Wu, Q; Clark, MS; Palmiter, RD				Wu, Qi; Clark, Michael S.; Palmiter, Richard D.			Deciphering a neuronal circuit that mediates appetite	NATURE			English	Article							FOOD-INTAKE; PARABRACHIAL NUCLEUS; ENERGY HOMEOSTASIS; SEROTONIN; BRAIN; RAT; ANOREXIA; TASTE; FOS; STARVATION	Hypothalamic neurons that co-express agouti-related protein (AgRP), neuropeptide Y and gamma-aminobutyric acid (GABA) are known to promote feeding and weight gain by integration of various nutritional, hormonal, and neuronal signals(1,2). Ablation of these neurons in mice leads to cessation of feeding that is accompanied by activation of Fos in most regions where they project(3-6). Previous experiments have indicated that the ensuing starvation is due to aberrant activation of the parabrachial nucleus (PBN) and it could be prevented by facilitating GABA(A) receptor signalling in the PBN within a critical adaptation period(5). We speculated that loss of GABA signalling from AgRP-expressing neurons (AgRP neurons) within the PBN results in unopposed excitation of the PBN, which in turn inhibits feeding. However, the source of the excitatory inputs to the PBN was unknown. Here we show that glutamatergic neurons in the nucleus tractus solitarius (NTS) and caudal serotonergic neurons control the excitability of PBN neurons and inhibit feeding. Blockade of serotonin (5-HT3) receptor signalling in the NTS by either the chronic administration of ondansetron or the genetic inactivation of Tph2 in caudal serotonergic neurons that project to the NTS protects against starvation when AgRP neurons are ablated. Likewise, genetic inactivation of glutamatergic signalling by the NTS onto N-methyl D-aspartate-type glutamate receptors in the PBN prevents starvation. We also show that suppressing glutamatergic output of the PBN reinstates normal appetite after AgRP neuron ablation, whereas it promotes weight gain without AgRP neuron ablation. Thus we identify the PBN as a hub that integrates signals from several brain regions to bidirectionally modulate feeding and body weight.	[Wu, Qi; Palmiter, Richard D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Wu, Qi; Palmiter, Richard D.] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA; [Clark, Michael S.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Palmiter, RD (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA.	palmiter@uw.edu			National Institutes of Health [DA024908]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Froelick, J. Wang and K. Battani for help with histology; A. Rainwater for help with mouse breeding; A. Quintana for propagating CAV2-Cre virus and preparing AAV1-CreGFP virus; and A. Guler and M. Carter for helpful comments on the manuscript. This work was supported in part by National Institutes of Health grant DA024908 to R.D.P.	Abizaid A, 2008, REGUL PEPTIDES, V149, P3, DOI 10.1016/j.regpep.2007.10.006; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; BERRIDGE KC, 1995, NEUROSCI BIOBEHAV R, V19, P121, DOI 10.1016/0149-7634(94)00026-W; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Fulwiler CE, 1984, BRAIN RES, V319, P229; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; HERBERT H, 1990, J COMP NEUROL, V293, P540, DOI 10.1002/cne.902930404; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; JHAMANDAS JH, 1992, AM J PHYSIOL, V263, pR324, DOI 10.1152/ajpregu.1992.263.2.R324; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Kaye W, 2008, PHYSIOL BEHAV, V94, P121, DOI 10.1016/j.physbeh.2007.11.037; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Rask-Andersen M, 2010, BRAIN RES REV, V62, P147, DOI 10.1016/j.brainresrev.2009.10.007; SWANK MW, 1994, BRAIN RES, V636, P202, DOI 10.1016/0006-8993(94)91018-9; Takase LF, 2008, BRAIN RES, V1200, P10, DOI 10.1016/j.brainres.2008.01.036; THOR KB, 1987, J COMP NEUROL, V265, P275, DOI 10.1002/cne.902650210; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Wu Q, 2008, J NEUROSCI, V28, P9218, DOI 10.1523/JNEUROSCI.2449-08.2008; Wu Q, 2008, P NATL ACAD SCI USA, V105, P2687, DOI 10.1073/pnas.0712062105; Wu Q, 2011, EUR J PHARMACOL, V660, P21, DOI 10.1016/j.ejphar.2010.10.110; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Xu Y, 2010, J NEUROSCI, V30, P14630, DOI 10.1523/JNEUROSCI.5412-09.2010; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243	30	230	240	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					594	U112		10.1038/nature10899	http://dx.doi.org/10.1038/nature10899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22419158	Green Accepted			2022-12-01	WOS:000302006100038
J	Czyzewski, BK; Wang, DN				Czyzewski, Bryan K.; Wang, Da-Neng			Identification and characterization of a bacterial hydrosulphide ion channel	NATURE			English	Article							ESCHERICHIA-COLI; SULFIDE ACQUISITION; CHLORIDE CHANNEL; MEMBRANE; TRANSPORTER; PURIFICATION; BIOCHEMISTRY; BINDING; PROTEIN; NIRC	The hydrosulphide ion (HS-) and its undissociated form, hydrogen sulphide (H2S), which are believed to have been critical to the origin of life on Earth(1), remain important in physiology and cellular signalling(2). As a major metabolite in anaerobic bacterial growth, hydrogen sulphide is a product of both assimilatory and dissimilatory sulphate reduction(2-4). These pathways can reduce various oxidized sulphur compounds including sulphate, sulphite and thiosulphate. The dissimilatory sulphate reduction pathway uses this molecule as the terminal electron acceptor for anaerobic respiration, in which process it produces excess amounts of H2S (ref. 4). The reduction of sulphite is a key intermediate step in all sulphate reduction pathways. In Clostridium and Salmonella, an inducible sulphite reductase is directly linked to the regeneration of NAD(+), which has been suggested to have a role in energy production and growth, as well as in the detoxification of sulphite(3). Above a certain concentration threshold, both H2S and HS- inhibit cell growth by binding the metal centres of enzymes and cytochrome oxidase(5), necessitating a release mechanism for the export of this toxic metabolite from the cell(5-9). Here we report the identification of a hydrosulphide ion channel in the pathogen Clostridium difficile through a combination of genetic, biochemical and functional approaches. The HS- channel is a member of the formate/nitrite transport family, in which about 50 hydrosulphide ion channels form a third subfamily alongside those for formate(10,11) (FocA) and for nitrite(12) (NirC). The hydrosulphide ion channel is permeable to formate and nitrite as well as to HS- ions. Such polyspecificity can be explained by the conserved ion selectivity filter observed in the channel's crystal structure. The channel has a low open probability and is tightly regulated, to avoid decoupling of the membrane proton gradient.	[Czyzewski, Bryan K.; Wang, Da-Neng] NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Czyzewski, Bryan K.] NYU, Sch Med, Mol Biophys Grad Program, New York, NY 10016 USA; [Wang, Da-Neng] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; New York University	Wang, DN (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, 540 1st Ave, New York, NY 10016 USA.	wang@saturn.med.nyu.edu		Wang, Da-Neng/0000-0002-6496-4699	NIH [R01-GM093825, R01-DK073973, R01-MH083840, U54-GM075026, R01-DK053973-08A1S1, F31-AI086072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI086072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073973, R01DK053973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093825, U54GM075026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083840] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful the staff at beamlines X25 and X29 of the National Synchrotron Light Source at Brookhaven National Laboratory and at beamline 23ID of the Advanced Photon Source at Argonne National Laboratory for assistance in X-ray diffraction experiments. We thank A. B. Waight for suggesting the project; J. J. Marden for assistance with cloning of mutants; T. Neubert and S. Blais for mass spectrometry measurements; the 2010 CCP4 Workshop for assistance in processing diffraction data; and A. David, H. Jackson, N. K. Karpowich, J. J. Marden, R. L. Mancusso, Y. Pan and M. Zhou for discussions. This work was financially supported by the NIH (R01-GM093825, R01-DK073973, R01-MH083840 and U54-GM075026). B. K. C. was partly supported by an NIH Supplement Grant to Promote Diversity in Health-Related Research (R01-DK053973-08A1S1) and an NIH pre-doctoral fellowship (F31-AI086072).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Auer M, 2001, BIOCHEMISTRY-US, V40, P6628, DOI 10.1021/bi010138+; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gks1195, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Cadene M, 2000, ANAL CHEM, V72, P5655, DOI 10.1021/ac000811l; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Crane BR, 1996, CURR OPIN STRUC BIOL, V6, P744, DOI 10.1016/S0959-440X(96)80003-0; Das P, 2009, MICROBIOL-SGM, V155, P2476, DOI 10.1099/mic.0.029611-0; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dhillon A, 2005, ASTROBIOLOGY, V5, P18, DOI 10.1089/ast.2005.5.18; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FETH S, 1993, J PHYS CHEM-US, V97, P11445, DOI 10.1021/j100146a017; Freytag JK, 2001, P NATL ACAD SCI USA, V98, P13408, DOI 10.1073/pnas.231589498; Goffredi SK, 1997, J EXP BIOL, V200, P2609; HALLENBECK PC, 1989, J BACTERIOL, V171, P3008, DOI 10.1128/jb.171.6.3008-3015.1989; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hille B, 1992, IONIC CHANNELS EXCIT, P362; Hirshfield Irvin N., 2003, Science Progress, V86, P245, DOI 10.3184/003685003783238626; Hughes MN, 2009, FREE RADICAL BIO MED, V47, P1346, DOI 10.1016/j.freeradbiomed.2009.09.018; Jacques AG, 1936, J GEN PHYSIOL, V19, P0397, DOI 10.1085/jgp.19.3.397; Jia WJ, 2009, BIOCHEM J, V417, P297, DOI 10.1042/BJ20080746; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Lee JK, 2005, P NATL ACAD SCI USA, V102, P18932, DOI 10.1073/pnas.0509469102; Li XD, 2001, FEBS LETT, V494, P165, DOI 10.1016/S0014-5793(01)02334-1; Lu W, 2011, SCIENCE, V332, P352, DOI 10.1126/science.1199098; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; MIDDLETON RE, 1994, BIOCHEMISTRY-US, V33, P13189, DOI 10.1021/bi00249a005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penel S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S3; Rabus R, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P659, DOI 10.1007/0-387-30742-7_22; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Safferling M, 2003, BIOCHEMISTRY-US, V42, P13969, DOI 10.1021/bi035173q; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; SIMONS J, 1987, CHEM REV, V87, P535, DOI 10.1021/cr00079a004; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; Tai CH, 2001, BIOCHEMISTRY-US, V40, P7446, DOI 10.1021/bi015511s; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; Wang DN, 2003, BBA-BIOMEMBRANES, V1610, P23, DOI 10.1016/S0005-2736(02)00709-5; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; WILSON W. JAMES, 1926, JOUR PATH BACT, V29, P310, DOI 10.1002/path.1700290312; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045	43	95	96	3	78	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 22	2012	483	7390					494	U155		10.1038/nature10881	http://dx.doi.org/10.1038/nature10881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22407320	Green Accepted			2022-12-01	WOS:000301771200049
J	Petitpierre, B; Kueffer, C; Broennimann, O; Randin, C; Daehler, C; Guisan, A				Petitpierre, Blaise; Kueffer, Christoph; Broennimann, Olivier; Randin, Christophe; Daehler, Curtis; Guisan, Antoine			Climatic Niche Shifts Are Rare Among Terrestrial Plant Invaders	SCIENCE			English	Article							NORTH-AMERICA; INVASIVE PLANTS; MULTIPLE INTRODUCTIONS; GLOBAL-SCALE; EVOLUTION; RANGE; CONSERVATISM; HOME; COMMUNITIES; PREDICTIONS	The assumption that climatic niche requirements of invasive species are conserved between their native and invaded ranges is key to predicting the risk of invasion. However, this assumption has been challenged recently by evidence of niche shifts in some species. Here, we report the first large-scale test of niche conservatism for 50 terrestrial plant invaders between Eurasia, North America, and Australia. We show that when analog climates are compared between regions, fewer than 15% of species have more than 10% of their invaded distribution outside their native climatic niche. These findings reveal that substantial niche shifts are rare in terrestrial plant invaders, providing support for an appropriate use of ecological niche models for the prediction of both biological invasions and responses to climate change.	[Petitpierre, Blaise; Broennimann, Olivier; Guisan, Antoine] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Kueffer, Christoph] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Kueffer, Christoph; Daehler, Curtis] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Randin, Christophe] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Hawaii System; University of Hawaii Manoa; University of Basel	Guisan, A (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Biophore Bldg, CH-1015 Lausanne, Switzerland.	antoine.guisan@unil.ch	Randin, Christophe F/K-6969-2016; Guisan, Antoine/A-1057-2011; Broennimann, Olivier/D-3495-2011; Kueffer, Christoph/H-6091-2013	Randin, Christophe F/0000-0002-4171-0178; Guisan, Antoine/0000-0002-3998-4815; Broennimann, Olivier/0000-0001-9913-3695; Kueffer, Christoph/0000-0001-6701-0703; Bronnimann, Olivier/0000-0001-5394-4564	National Center for Competence in Research (Plant Survival); USDA National Institute of Food and Agriculture [2006-35320-17360]	National Center for Competence in Research (Plant Survival); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	We thank R. Engler, E. Schumacher, and C. Angelo for contributing to the compilation of the data and J. Alexander, H. Possingham, L. Pellissier, and S. M. Gray for comments on the manuscript. A. G., O.B., and B. P. received main support from the National Center for Competence in Research (Plant Survival). C. D. and C. K. received support from the USDA National Institute of Food and Agriculture, Biology of Weedy and Invasive Species Program grant no. 2006-35320-17360. The climatic data used in this study are available online, and the species data used in this study were assembled from multiple sources with various release politics. All data sources are described in the SOM.	Alexander JM, 2010, OIKOS, V119, P1377, DOI 10.1111/j.1600-0706.2009.17977.x; Blair AC, 2010, EVOL APPL, V3, P40, DOI 10.1111/j.1752-4571.2009.00097.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Callaway RM, 2011, ECOLOGY, V92, P2208, DOI 10.1890/11-0518.1; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Crosby Alfred W., 1986, STUDIES ENV HIST; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Firn J, 2011, ECOL LETT, V14, P274, DOI 10.1111/j.1461-0248.2010.01584.x; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; FORNO IW, 1983, AQUAT BOT, V17, P71, DOI 10.1016/0304-3770(83)90019-0; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hierro JL, 2006, AM NAT, V168, P144, DOI 10.1086/505767; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Lauzeral C, 2011, GLOBAL ECOL BIOGEOGR, V20, P407, DOI 10.1111/j.1466-8238.2010.00611.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Mandle L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015297; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Novak SJ, 2001, BIOSCIENCE, V51, P114, DOI 10.1641/0006-3568(2001)051[0114:TPIASG]2.0.CO;2; Pairon M, 2010, ANN BOT-LONDON, V105, P881, DOI 10.1093/aob/mcq065; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Seastedt TR, 2011, ANNU REV ECOL EVOL S, V42, P133, DOI 10.1146/annurev-ecolsys-102710-145057; Seipel T, 2012, GLOBAL ECOL BIOGEOGR, V21, P236, DOI 10.1111/j.1466-8238.2011.00664.x; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Treier UA, 2009, ECOLOGY, V90, P1366, DOI 10.1890/08-0420.1; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Welk E, 2004, ECOL MODEL, V179, P551, DOI 10.1016/j.ecolmodel.2004.04.020; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Xu CY, 2010, ECOL LETT, V13, P32, DOI 10.1111/j.1461-0248.2009.01395.x	35	531	552	12	402	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2012	335	6074					1344	1348		10.1126/science.1215933	http://dx.doi.org/10.1126/science.1215933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22422981	Green Accepted, Green Submitted			2022-12-01	WOS:000301531600046
J	Jiang, XD; Clark, RA; Liu, LZ; Wagers, AJ; Fuhlbrigge, RC; Kupper, TS				Jiang, Xiaodong; Clark, Rachael A.; Liu, Luzheng; Wagers, Amy J.; Fuhlbrigge, Robert C.; Kupper, Thomas S.			Skin infection generates non-migratory memory CD8(+) T-RM cells providing global skin immunity	NATURE			English	Article							MIGRATION; TRAFFICKING; EFFECTOR; RESIDENT; HETEROGENEITY; ACTIVATION; SELECTIN; TISSUE	Protective T-cell memory has long been thought to reside in blood and lymph nodes, but recently the concept of immune memory in peripheral tissues mediated by resident memory T (T-RM) cells has been proposed(1-5). Here we show in mice that localized vaccinia virus (VACV) skin infection generates long-lived non-recirculating CD8(+) skin T-RM cells that reside within the entire skin. These skin T-RM cells are potent effector cells, and are superior to circulating central memory T (T-CM) cells at providing rapid long-term protection against cutaneous re-infection. We find that CD8(+) T cells are rapidly recruited to skin after acute VACV infection. CD8(+) T-cell recruitment to skin is independent of CD4(+) T cells and interferon-c, but requires the expression of E-and P-selectin ligands by CD8(+) T cells. Using parabiotic mice, we further show that circulating CD8(+) T-CM and CD8(+) skin T-RM cells are both generated after skin infection; however, CD8(+) T-CM cells recirculate between blood and lymph nodes whereas T-RM cells remain in the skin. Cutaneous CD8(+) T-RM cells produce effector cytokines and persist for at least 6 months after infection. Mice with CD8(+) skin T-RM cells rapidly cleared a subsequent re-infection with VACV whereas mice with circulating T-CM but no skin T-RM cells showed greatly impaired viral clearance, indicating that T-RM cells provide superior protection. Finally, we show that T-RM cells generated as a result of localized VACV skin infection reside not only in the site of infection, but also populate the entire skin surface and remain present for many months. Repeated re-infections lead to progressive accumulation of highly protective T-RM cells in non-involved skin. These findings have important implications for our understanding of protective immune memory at epithelial interfaces with the environment, and suggest novel strategies for vaccines that protect against tissue tropic organisms.	[Jiang, Xiaodong; Clark, Rachael A.; Liu, Luzheng; Fuhlbrigge, Robert C.; Kupper, Thomas S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Jiang, Xiaodong; Clark, Rachael A.; Liu, Luzheng; Fuhlbrigge, Robert C.; Kupper, Thomas S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst,Joslin Diabet Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	Kupper, TS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA.	tkupper@partners.org	Kupper, Thomas/O-4962-2019		National Institutes of Health (NIH) [R01AI041707, R37AI025082, TR01AI097128]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041707, R01AI025082, R37AI025082, R01AI097128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065807, R01AR056720] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank T. Tian, R. Purwar and Q. Zhan for technical assistance. We thank J. J. Campbell for discussion of the project. This work was supported by National Institutes of Health (NIH) grants R01AI041707, R37AI025082 and TR01AI097128 to T.S.K.	Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Chong BF, 2004, J IMMUNOL, V172, P1575, DOI 10.4049/jimmunol.172.3.1575; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Conrad C, 2007, NAT MED, V13, P836, DOI 10.1038/nm1605; Freyschmidt EJ, 2010, J IMMUNOL, V185, P1295, DOI 10.4049/jimmunol.0903144; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Jiang XD, 2010, P NATL ACAD SCI USA, V107, P7443, DOI 10.1073/pnas.0912943107; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lefrancois L, 2006, IMMUNOL REV, V211, P93, DOI 10.1111/j.0105-2896.2006.00393.x; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Roman E, 2002, J EXP MED, V196, P957, DOI 10.1084/jem.20021052; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Sanz P, 1999, P NATL ACAD SCI USA, V96, P2692, DOI 10.1073/pnas.96.6.2692; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4	30	600	613	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2012	483	7388					227	U129		10.1038/nature10851	http://dx.doi.org/10.1038/nature10851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22388819	Green Accepted			2022-12-01	WOS:000301174900042
J	Kanamori, H				Kanamori, Hiroo			Putting seismic research to most effective use	NATURE			English	Editorial Material									CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Kanamori, H (corresponding author), CALTECH, Pasadena, CA 91125 USA.	hiroo@gps.caltech.edu						Hayes GP, 2011, SEISMOL RES LETT, V82, P481, DOI 10.1785/gssrl.82.4.481; Heki K, 2011, SCIENCE, V332, P1390, DOI 10.1126/science.1206643	2	7	9	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2012	483	7388					147	148		10.1038/483147a	http://dx.doi.org/10.1038/483147a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	904DT	22398537	Bronze			2022-12-01	WOS:000301174900013
J	Ding, ZH; Wu, CJ; Jaskelioff, M; Ivanova, E; Kost-Alimova, M; Protopopov, A; Chu, GC; Wang, GC; Lu, X; Labrot, ES; Hu, J; Wang, W; Xiao, YH; Zhang, HL; Zhang, JH; Zhang, JF; Gan, BY; Perry, SR; Jiang, S; Li, LR; Horner, JW; Wang, YA; Chin, LD; DePinho, RA				Ding, Zhihu; Wu, Chang-Jiun; Jaskelioff, Mariela; Ivanova, Elena; Kost-Alimova, Maria; Protopopov, Alexei; Chu, Gerald C.; Wang, Guocan; Lu, Xin; Labrot, Emma S.; Hu, Jian; Wang, Wei; Xiao, Yonghong; Zhang, Hailei; Zhang, Jianhua; Zhang, Jingfang; Gan, Boyi; Perry, Samuel R.; Jiang, Shan; Li, Liren; Horner, James W.; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.			Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases	CELL			English	Article							GENE-EXPRESSION ANALYSIS; INTRAEPITHELIAL NEOPLASIA; GENOME INSTABILITY; CANCER; CARCINOMA; PROTEIN; BREAST; DAMAGE; PTEN; MICE	To determine the role of telomere dysfunction and telomerase reactivation in generating pro-oncogenic genomic events and in carcinoma progression, an inducible telomerase reverse transcriptase (mTert) allele was crossed onto a prostate cancer-prone mouse model null for Pten and p53 tumor suppressors. Constitutive telomerase deficiency and associated telomere dysfunction constrained cancer progression. In contrast, telomerase reactivation in the setting of telomere dysfunction alleviated intratumoral DNA-damage signaling and generated aggressive cancers with rearranged genomes and new tumor biological properties (bone metastases). Comparative oncogenomic analysis revealed numerous recurrent amplifications and deletions of relevance to human prostate cancer. Murine tumors show enrichment of the TGF-beta/SMAD4 network, and genetic validation studies confirmed the cooperative roles of Pten, p53, and Smad4 deficiencies in prostate cancer progression, including skeletal metastases. Thus, telomerase reactivation in tumor cells experiencing telomere dysfunction enables full malignant progression and provides a mechanism for acquisition of cancer-relevant genomic events endowing new tumor biological capabilities.	[Wu, Chang-Jiun; Kost-Alimova, Maria; Protopopov, Alexei; Zhang, Jianhua; Horner, James W.; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Ding, Zhihu; Wang, Guocan; Lu, Xin; Hu, Jian; Wang, Wei; Jiang, Shan; Wang, Y. Alan; DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Kost-Alimova, Maria; Protopopov, Alexei; Zhang, Jianhua; Horner, James W.; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Ding, Zhihu; Wu, Chang-Jiun; Jaskelioff, Mariela; Ivanova, Elena; Kost-Alimova, Maria; Protopopov, Alexei; Chu, Gerald C.; Wang, Guocan; Lu, Xin; Labrot, Emma S.; Hu, Jian; Wang, Wei; Xiao, Yonghong; Zhang, Hailei; Zhang, Jianhua; Zhang, Jingfang; Gan, Boyi; Perry, Samuel R.; Jiang, Shan; Li, Liren; Horner, James W.; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Ding, Zhihu; Jaskelioff, Mariela; Wang, Guocan; Lu, Xin; Hu, Jian; Wang, Wei; Gan, Boyi; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ding, Zhihu; Jaskelioff, Mariela; Wang, Guocan; Lu, Xin; Hu, Jian; Wang, Wei; Gan, Boyi; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Chu, Gerald C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Chin, LD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	lchin@mdanderson.org; rdepinho@mdanderson.org	Gan, Boyi/HDM-4206-2022	Ivanova, Elena/0000-0002-5069-4974; DePinho, Ronald/0000-0002-5625-577X	Damon Runyon Cancer Research Foundation; Multiple Myeloma Research Foundation; Prostate Cancer Foundation; DOD [W81XWH-07-PCRP-IDA]; Robert A. and Renee E. Belfer Foundation;  [NCI R01CA084628];  [U01CA141508]; NATIONAL CANCER INSTITUTE [U01CA141508, R01CA084628, K99CA194289] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Multiple Myeloma Research Foundation; Prostate Cancer Foundation; DOD(United States Department of Defense); Robert A. and Renee E. Belfer Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Zhou and J.P. Morin for excellent mouse husbandry and care, J. Paik, M. Kim, and H. Ying for helpful discussion. We thank W. Hahn for shRNA constructs. Z.D. was supported by the Damon Runyon Cancer Research Foundation. Y.A.W. was supported by the Multiple Myeloma Research Foundation. This work is supported by NCI R01CA084628 (R.A.D.), U01CA141508 (L.C. and R.A.D.), the Prostate Cancer Foundation (R.A.D. and Z.D.), and DOD W81XWH-07-PCRP-IDA (R.A.D. and Z.D.). R.A.D. was an American Cancer Society Research Professor and supported by the Robert A. and Renee E. Belfer Foundation. The gene signature and technology developed in this paper have been licensed by Metamark GENETICS (http://www.metamarkgenetics.com/). L.C. and R.A.D. are the founders of Metamark GENETICS. Z.D. and C.J.W. are consultants for Metamark GENETICS.	Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Acevedo VD, 2009, CELL CYCLE, V8, P580, DOI 10.4161/cc.8.4.7657; Aitchison AA, 2008, PROSTATE, V68, P661, DOI 10.1002/pros.20730; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chang YM, 2007, NEOPLASIA, V9, P90, DOI 10.1593/neo.06694; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Guo YP, 1997, CLIN CANCER RES, V3, P2269; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.20105]; Jenkins RB, 1997, CANCER RES, V57, P524; Johnson TR, 2008, MOL CANCER RES, V6, P1639, DOI 10.1158/1541-7786.MCR-08-0052; Kallakury BVS, 1997, DIAGN MOL PATHOL, V6, P192, DOI 10.1097/00019606-199708000-00003; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Koeneman KS, 1998, J UROLOGY, V160, P1533, DOI 10.1016/S0022-5347(01)62608-9; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin Y, 1997, J UROLOGY, V157, P1161, DOI 10.1016/S0022-5347(01)65160-7; Marino S, 2000, GENE DEV, V14, P994; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Meeker AK, 2002, CANCER RES, V62, P6405; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Rubin MA, 2008, MODERN PATHOL, V21, pS44, DOI 10.1038/modpathol.2008.11; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Sommerfeld HJ, 1996, CANCER RES, V56, P218; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Vukovic B, 2003, ONCOGENE, V22, P1978, DOI 10.1038/sj.onc.1206227; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang WB, 1998, CANCER RES, V58, P619; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	57	160	166	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					896	907		10.1016/j.cell.2012.01.039	http://dx.doi.org/10.1016/j.cell.2012.01.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22341455	Green Accepted, Bronze			2022-12-01	WOS:000300985000011
J	Reichmann, D; Xu, Y; Cremers, CM; Ilbert, M; Mittelman, R; Fitzgerald, MC; Jakob, U				Reichmann, Dana; Xu, Ying; Cremers, Claudia M.; Ilbert, Marianne; Mittelman, Roni; Fitzgerald, Michael C.; Jakob, Ursula			Order out of Disorder: Working Cycle of an Intrinsically Unfolded Chaperone	CELL			English	Article							REDOX-REGULATED CHAPERONE; THERMODYNAMIC ANALYSIS; SUBSTRATE-BINDING; HSP33; ACTIVATION; DNAK; PROTEINS; DOMAIN; SWITCH; SITE	The redox-regulated chaperone Hsp33 protects organisms against oxidative stress that leads to protein unfolding. Activation of Hsp33 is triggered by the oxidative unfolding of its own redox-sensor domain, making Hsp33 a member of a recently discovered class of chaperones that require partial unfolding for full chaperone activity. Here we address the long-standing question of how chaperones recognize client proteins. We show that Hsp33 uses its own intrinsically disordered regions to discriminate between unfolded and partially structured folding intermediates. Binding to secondary structure elements in client proteins stabilizes Hsp33's intrinsically disordered regions, and this stabilization appears to mediate Hsp33's high affinity for structured folding intermediates. Return to nonstress conditions reduces Hsp33's disulfide bonds, which then significantly destabilizes the bound client proteins and in doing so converts them into less-structured, folding-competent client proteins of ATP-dependent foldases. We propose a model in which energy-independent chaperones use internal order-to-disorder transitions to control substrate binding and release.	[Reichmann, Dana; Cremers, Claudia M.; Ilbert, Marianne; Jakob, Ursula] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Mittelman, Roni] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Xu, Ying; Fitzgerald, Michael C.] Duke Univ, Dept Chem, Durham, NC 27708 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	ujakob@umich.edu	Reichmann, Dana/J-4999-2019; Ilbert, marianne/ABG-5015-2021	Reichmann, Dana/0000-0003-0315-5334; ilbert, marianne/0000-0002-9070-2334	National Institutes of Health [GM065318, GM084174]; European Molecular Biology Organization; Human Frontiers postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084174, R01GM065318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontiers postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Rudiger for providing us with the raw data of the DnaK peptide array, Drs. Yosseff and Schreiber for the use of ProteOn and the analysis software, and Dr. Kay for purified Arc repressor protein. We thank Dr. Mayer for running the DnaK binding predictor on the CS sequence. We are grateful to Drs. Bardwell, Xu, and Walter for critically commenting on the manuscript. This project was supported by National Institutes of Health grants GM065318 to U.J. and GM084174 to M. C. F. and by the European Molecular Biology Organization and Human Frontiers postdoctoral fellowship to D. R.	BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; Chen ZJ, 2006, BIOCHEMISTRY-US, V45, P12325, DOI 10.1021/bi0612263; Cremers CM, 2010, J BIOL CHEM, V285, P11243, DOI 10.1074/jbc.M109.084350; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Gaspar AM, 2008, EUR BIOPHYS J BIOPHY, V37, P573, DOI 10.1007/s00249-008-0266-3; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Tang L, 2007, ANAL CHEM, V79, P5869, DOI 10.1021/ac0700777; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Voelz VA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000281; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1346, DOI 10.1021/bi902010t	25	100	103	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					947	957		10.1016/j.cell.2012.01.045	http://dx.doi.org/10.1016/j.cell.2012.01.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385960	Green Accepted, Bronze			2022-12-01	WOS:000300985000015
J	Sheron, N; Gilmore, I; Parsons, C; Hawkey, C; Rhodes, J				Sheron, Nick; Gilmore, Ian; Parsons, Camille; Hawkey, Chris; Rhodes, Jon			Projections of alcohol-related deaths in England and Wales-tragic toll or potential prize?	LANCET			English	Editorial Material									[Sheron, Nick; Parsons, Camille] Southampton Univ Hosp, NHS Fdn Trust, NIHR Biomed Res Unit Nutr Diet & Lifestyle, Southampton SO16 6YD, Hants, England; [Gilmore, Ian; Rhodes, Jon] Royal Liverpool Hosp, Liverpool L7 8XP, Merseyside, England; [Gilmore, Ian; Rhodes, Jon] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Hawkey, Chris] Univ Nottingham Hosp, Fac Med & Hlth Sci, Queens Med Ctr, Nottingham NG7 2UH, England	University of Southampton; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Nottingham	Sheron, N (corresponding author), Southampton Univ Hosp, NHS Fdn Trust, NIHR Biomed Res Unit Nutr Diet & Lifestyle, Southampton SO16 6YD, Hants, England.	nick.sheron@soton.ac.uk		Sheron, Nick/0000-0001-5232-8292; Sheron, Nick/0000-0002-6156-8367				Chisholm D, 2006, DRUG ALCOHOL REV, V25, P553, DOI 10.1080/09595230600944487; Department of Health, 2011, PUBL HLTH RESP DEAL; Jones L., 2008, ALCOHOL ATTRIBUTABLE; Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x; Northern Ireland Executive, 2012, NO IR HLTH MIN E POO; Office for National Statistics, 2006, DEF ALC REL DEATHS; Office for National Statistics, 2010, MORT STAT DEATHS DR; Office for National Statistics, 2012, ALC REL DEATHS UK 20; Sheron N, 2011, LANCET, V377, P1297, DOI 10.1016/S0140-6736(11)60022-6; The Scottish Government, 2009, CHANG SCOTL REL ALC; Verrill C, 2009, ADDICTION, V104, P768, DOI 10.1111/j.1360-0443.2009.02521.x; *WHO REG OFF EUR, 2008, EUR HLTH DAT HFA DB; Winnett R, 2011, DAILY TELEGRAPH 1227	13	21	21	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 25	2012	379	9817					687	688		10.1016/S0140-6736(12)60244-X	http://dx.doi.org/10.1016/S0140-6736(12)60244-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	899CU	22353260				2022-12-01	WOS:000300792600004
J	Fusar-Poli, P; Yung, AR				Fusar-Poli, Paolo; Yung, Alison R.			Should attenuated psychosis syndrome be included in DSM-5?	LANCET			English	Editorial Material							CRITERIA; RISK		[Fusar-Poli, Paolo] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London SE5 8AF, England; [Yung, Alison R.] Univ Melbourne, Orygen Youth Hlth Res Ctr, Ctr Youth Mental Hlth, Melbourne, Vic, Australia	University of London; King's College London; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne	Fusar-Poli, P (corresponding author), Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London SE5 8AF, England.	p.fusar@libero.it	Fusar-Poli, Paolo/D-8605-2011; Yung, Alison/N-6729-2019	Fusar-Poli, Paolo/0000-0003-3582-6788; Yung, Alison/0000-0002-0401-9791				Addington J, 2005, BRIT J PSYCHIAT, V187, pS120, DOI 10.1192/bjp.187.48.s120; Drake RJ, 2010, SCHIZOPHR RES, V120, P38, DOI 10.1016/j.schres.2010.03.013; Fusar-Poli P, 2010, J PSYCHIATR RES, V44, P294, DOI 10.1016/j.jpsychires.2009.08.016; Fusar-Poli P, ARCH GEN PS IN PRESS; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Jacobs E, 2011, SCHIZOPHR RES, V131, P24, DOI 10.1016/j.schres.2011.06.022; McGorry PD, 2009, J CLIN PSYCHIAT, V70, P1206, DOI 10.4088/JCP.08r04472; Schimmelmann BG, 2011, SCHIZOPHR RES, V125, P99, DOI 10.1016/j.schres.2010.09.018; Thompson A, 2011, SCHIZOPHR RES, V126, P51, DOI 10.1016/j.schres.2010.09.024; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Yung AR, 2008, SCHIZOPHR RES, V105, P10, DOI 10.1016/j.schres.2008.07.012	11	48	49	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2012	379	9816					591	592		10.1016/S0140-6736(11)61507-9	http://dx.doi.org/10.1016/S0140-6736(11)61507-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	897ES	22340290				2022-12-01	WOS:000300629000005
J	Yoon, BC; Jung, H; Dwivedy, A; O'Hare, CM; Zivraj, KH; Holt, CE				Yoon, Byung C.; Jung, Hosung; Dwivedy, Asha; O'Hare, Catherine M.; Zivraj, Krishna H.; Holt, Christine E.			Local Translation of Extranuclear Lamin B Promotes Axon Maintenance	CELL			English	Article							MESSENGER-RNA; PROTEIN-SYNTHESIS; NUCLEAR LAMIN; GROWTH CONES; MITOCHONDRIAL DYSFUNCTION; RETINAL AXONS; COMPLEX; CELLS; CNS; LOCALIZATION	Local protein synthesis plays a key role in regulating stimulus-induced responses in dendrites and axons. Recent genome-wide studies have revealed that thousands of different transcripts reside in these distal neuronal compartments, but identifying those with functionally significant roles presents a challenge. We performed an unbiased screen to look for stimulus-induced, protein synthesis-dependent changes in the proteome of Xenopus retinal ganglion cell (RGC) axons. The intermediate filament protein lamin B2 (LB2), normally associated with the nuclear membrane, was identified as an unexpected major target. Axonal ribosome immunoprecipitation confirmed translation of lb2 mRNA in vivo. Inhibition of lb2 mRNA translation in axons in vivo does not affect guidance but causes axonal degeneration. Axonal LB2 associates with mitochondria, and LB2-deficient axons exhibit mitochondrial dysfunction and defects in axonal transport. Our results thus suggest that axonally synthesized lamin B plays a crucial role in axon maintenance by promoting mitochondrial function.	[Yoon, Byung C.; Jung, Hosung; Dwivedy, Asha; O'Hare, Catherine M.; Zivraj, Krishna H.; Holt, Christine E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	ceh@mole.bio.cam.ac.uk	Jung, Hosung/A-4401-2012	Jung, Hosung/0000-0002-5059-8050; Holt, Christine Elizabeth/0000-0003-2829-121X; Yoon, Byung/0000-0003-2929-5677	Gates Cambridge Scholarship; Overseas Research Scholars Award; Wellcome Trust [085314/Z/08/Z]	Gates Cambridge Scholarship; Overseas Research Scholars Award; Wellcome Trust(Wellcome Trust)	We thank L. Strochlic and G.M.W. Cook for their groundwork in developing the proteomics technique; A. Kalous for assistance with retinal cultures; K. Lilley and members of her lab (R. Feret, M. Deery, and S. Hester) for technical assistance with DIGE experiments and MS analysis; A. Prochiantz for En-1; G. Krohne for LB2-GFP construct; N. Heintz for GFP-L10a construct; M. Coleman for Mito-GFP and RFP; and A. Sossick for OMX imaging. We are grateful to W. Harris and M. Agathocleous for many valuable discussions and M.-L. Baudet, J. Bixby, S. Bray, L. Leung, and A. Lin for critical reading of the manuscript. This work was supported by a Gates Cambridge Scholarship (B.C.Y.), Overseas Research Scholars Award (B.C.Y.), and Wellcome Trust Programme Grant (C.E.H..; grant 085314/Z/08/Z). B.C.Y. did experiments in Figures 1, 2, 3A, 3H, 3I, 4A-4C, 5, 6A-6H, 7D, 7E, S1, S2G, S2H, S3I, and S3J. H. J. did experiments in Figures 3D-3G, 4D-4F, 6I-6L, S3B-S3D, S3K, S4D, S4E, and S6B-S6H. A. D. did experiments in Figures 3J, 6L, 7A-7C, 7F-7I, S3L, S3M, S4A-S4C, S7A, an S7B. C.M.O. did experiments in Figure S7D and contributed to the writing. K.H.Z. did experiments in Figures 3B-3D and S3A. C.E.H. conceived and supervised the project. B.C.Y. designed proteomics experiments and identified LB2 and its LOF phenotypes. H.J. designed molecular biology, axon-TRAP, and LB2 Delta NLS experiments. H.J., B.C.Y., and C.E.H. wrote the manuscript.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Alvarez-Fischer D, 2011, NAT NEUROSCI, V14, P1260, DOI 10.1038/nn.2916; Andreassi C, 2010, NAT NEUROSCI, V13, P291, DOI 10.1038/nn.2486; Aschrafi A, 2010, MOL CELL NEUROSCI, V43, P422, DOI 10.1016/j.mcn.2010.01.009; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Busch A, 2009, EXP CELL RES, V315, P2373, DOI 10.1016/j.yexcr.2009.05.003; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Falk J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-107; Fountoulakis M, 2002, ELECTROPHORESIS, V23, P311, DOI 10.1002/1522-2683(200202)23:2<311::AID-ELPS311>3.0.CO;2-0; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gioio AE, 2001, J NEUROSCI RES, V64, P447, DOI 10.1002/jnr.1096; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; HARRIS WA, 1987, DEVELOPMENT, V101, P123; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; HOLT CE, 1984, J NEUROSCI, V4, P1130; HOLTZ D, 1989, CELL, V59, P969, DOI 10.1016/0092-8674(89)90753-8; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Ikegami K, 2003, NEUROSCIENCE, V122, P617, DOI 10.1016/j.neuroscience.2003.08.057; Jing XT, 2009, DEVELOPMENT, V136, P2955, DOI 10.1242/dev.037739; Kaasik A, 2007, J BIOL CHEM, V282, P32821, DOI 10.1074/jbc.M702295200; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Lilley KS, 2002, CURR OPIN CHEM BIOL, V6, P46, DOI 10.1016/S1367-5931(01)00275-7; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LOEWINGER L, 1988, EMBO J, V7, P2301, DOI 10.1002/j.1460-2075.1988.tb03073.x; Ma L, 2009, NAT CELL BIOL, V11, P246, DOI 10.1038/ncb1832; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pareyson D, 2009, LANCET NEUROL, V8, P654, DOI 10.1016/S1474-4422(09)70110-3; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Prufert K, 2004, J CELL SCI, V117, P6105, DOI 10.1242/jcs.01532; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; Simon DK, 1999, ANNU REV MED, V50, P111; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Su KG, 2009, CURR NEUROL NEUROSCI, V9, P411, DOI 10.1007/s11910-009-0060-3; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Taylor SW, 2002, J PROTEOME RES, V1, P451, DOI 10.1021/pr025533g; TOESCA A, 1992, CELL BIOL INT REP, V16, P165, DOI 10.1016/S0309-1651(06)80110-4; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wizenmann A, 2009, NEURON, V64, P355, DOI 10.1016/j.neuron.2009.09.018; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Zhang QG, 2009, TRAFFIC, V10, P1337, DOI 10.1111/j.1600-0854.2009.00945.x; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	66	188	190	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					752	764		10.1016/j.cell.2011.11.064	http://dx.doi.org/10.1016/j.cell.2011.11.064			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341447	hybrid, Green Published			2022-12-01	WOS:000300622400016
J	Josefowicz, SZ; Niec, RE; Kim, HY; Treuting, P; Chinen, T; Zheng, Y; Umetsu, DT; Rudensky, AY				Josefowicz, Steven Z.; Niec, Rachel E.; Kim, Hye Young; Treuting, Piper; Chinen, Takatoshi; Zheng, Ye; Umetsu, Dale T.; Rudensky, Alexander Y.			Extrathymically generated regulatory T cells control mucosal T(H)2 inflammation	NATURE			English	Article							TRANSCRIPTION FACTOR FOXP3; IN-VIVO; BOWEL-DISEASE; INDUCTION; RESPONSES; LINEAGE; FATE; GENE; MICE; HOMEOSTASIS	A balance between pro- and anti-inflammatory mechanisms at mucosal interfaces, which are sites of constitutive exposure to microbes and non-microbial foreign substances, allows for efficient protection against pathogens yet prevents adverse inflammatory responses associated with allergy, asthma and intestinal inflammation(1). Regulatory T (T-reg) cells prevent systemic and tissue-specific autoimmunity and inflammatory lesions at mucosal interfaces. These cells are generated in the thymus (tT(reg) cells) and in the periphery (induced (i)T-reg cells), and their dual origin implies a division of labour between tT(reg) and iT(reg) cells in immune homeostasis. Here we show that a highly selective blockage in differentiation of iT(reg) cells in mice did not lead to unprovoked multi-organ autoimmunity, exacerbation of induced tissue-specific autoimmune pathology, or increased pro-inflammatory responses of T helper 1 (T(H)1) and T(H)17 cells. However, mice deficient in iT(reg) cells spontaneously developed pronounced T(H)2-type pathologies at mucosal sites-in the gastrointestinal tract and lungs-with hallmarks of allergic inflammation and asthma. Furthermore, iT(reg)-cell deficiency altered gut microbial communities. These results suggest that whereas T-reg cells generated in the thymus appear sufficient for control of systemic and tissue-specific autoimmunity, extrathymic differentiation of T-reg cells affects commensal microbiota composition and serves a distinct, essential function in restraint of allergic-type inflammation at mucosal interfaces.	[Josefowicz, Steven Z.; Niec, Rachel E.; Chinen, Takatoshi; Rudensky, Alexander Y.] Howard Hughes Med Inst, New York, NY 10021 USA; [Josefowicz, Steven Z.; Niec, Rachel E.; Chinen, Takatoshi; Rudensky, Alexander Y.] Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA; [Josefowicz, Steven Z.] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Kim, Hye Young; Umetsu, Dale T.] Harvard Univ, Childrens Hosp, Sch Med, Div Immunol, Boston, MA 02115 USA; [Treuting, Piper] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA; [Chinen, Takatoshi] Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo 1608582, Japan; [Zheng, Ye] Salk Inst Biol Studies, Nomis Fdn Labs Immunobiol & Microbial Pathogenesi, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Rockefeller University; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; Keio University; Salk Institute	Rudensky, AY (corresponding author), Howard Hughes Med Inst, New York, NY 10021 USA.	rudenska@mskcc.org	Zheng, Ye/G-4866-2015; Treuting, Piper M./AAB-2721-2019; Kim, Hye Young/AAF-7609-2020	Zheng, Ye/0000-0001-5012-4309; Treuting, Piper M./0000-0002-1812-1519; Kim, Hye Young/0000-0001-5978-512X; Niec, Rachel/0000-0002-8525-3693; josefowicz, steven/0000-0001-7453-779X	NIH MSTP [GM07739]; NINDS [1F31NS073203-01]; Department of Microbiology and Immunology, Keio University School of Medicine; NIH [R37 AI034206]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS073203] Funding Source: NIH RePORTER	NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Microbiology and Immunology, Keio University School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Tedder for depleting CD20 antibody, R. Tudor for assistance interpreting lung pathology, P. DeRoos for assistance with Ig ELISA assays, B. Johnson for immunohistochemical expertise, Y. Chen for assistance with airway measurements, and E. Pamer, L. Lipuma, A. Gobourne and R. Khanin for help with analysis of intestinal microbiota. This work was supported by NIH MSTP grant GM07739 and NINDS grant 1F31NS073203-01 (R.E.N.), Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from Department of Microbiology and Immunology, Keio University School of Medicine (T. C.) and NIH grant R37 AI034206 (A. Y. R.). A. Y. R is an investigator with the Howard Hughes Medical Institute.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hori S, 2011, TRENDS IMMUNOL, V32, P295, DOI 10.1016/j.it.2011.04.004; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Magurran A.E., 2004, MEASURING BIOLOGICAL; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tian L, 2011, BLOOD, V118, P1845, DOI 10.1182/blood-2011-04-346056; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	39	586	608	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					395	U1510		10.1038/nature10772	http://dx.doi.org/10.1038/nature10772			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22318520	Green Accepted			2022-12-01	WOS:000300287100045
J	Kim, TW; Michniewicz, M; Bergmann, DC; Wang, ZY				Kim, Tae-Wuk; Michniewicz, Marta; Bergmann, Dominique C.; Wang, Zhi-Yong			Brassinosteroid regulates stomatal development by GSK3-mediated inhibition of a MAPK pathway	NATURE			English	Article							RECEPTOR KINASE BRI1; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; GSK3-LIKE KINASES; PLANT-GROWTH; ARABIDOPSIS; BZR1; DIFFERENTIATION; INTEGRATION; PERCEPTION	Plants must coordinate the regulation of biochemistry and anatomy to optimize photosynthesis and water-use efficiency. The formation of stomata, epidermal pores that facilitate gas exchange, is highly coordinated with other aspects of photosynthetic development. The signalling pathways controlling stomata development are not fully understood(1,2), although mitogen-activated protein kinase (MAPK) signalling is known to have key roles. Here we demonstrate in Arabidopsis that brassinosteroid regulates stomatal development by activating the MAPK kinase kinase (MAPKKK) YDA (also known as YODA). Genetic analyses indicate that receptor kinase-mediated brassinosteroid signalling inhibits stomatal development through the glycogen synthase kinase 3 (GSK3)-like kinase BIN2, and BIN2 acts upstream of YDA but downstream of the ERECTA family of receptor kinases. Complementary in vitro and in vivo assays show that BIN2 phosphorylates YDA to inhibit YDA phosphorylation of its substrate MKK4, and that activities of downstream MAPKs are reduced in brassinosteroid-deficient mutants but increased by treatment with either brassinosteroid or GSK3-kinase inhibitor. Our results indicate that brassinosteroid inhibits stomatal development by alleviating GSK3-mediated inhibition of this MAPK module, providing two key links; that of a plant MAPKKK to its upstream regulators and of brassinosteroid to a specific developmental output.	[Kim, Tae-Wuk; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Kim, Tae-Wuk] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Michniewicz, Marta; Bergmann, Dominique C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Carnegie Institution for Science; Hanyang University; Stanford University	Wang, ZY (corresponding author), Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA.	zywang24@stanford.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390; Bergmann, Dominique/0000-0003-0873-3543	National Institutes of Health [R01GM066258]; US Department of Energy [DE-FG02-08ER15973]; Herman Frasch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086632, R01GM066258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); Herman Frasch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Torii for providing seeds of the er erl1 erl2 triple mutant and scrm-D mutant, J.-M. Zhou for providing the HOPAI1 transgenic line and J. Li for providing the bin2-3 bil1 bil2 triple mutant. Research was primarily supported by a grant from the National Institutes of Health (R01GM066258), and partially supported by the US Department of Energy (DE-FG02-08ER15973) and the Herman Frasch Foundation. D. C. B. is an investigator of the Howard Hughes Medical Institute.	Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; Dong JA, 2010, CURR TOP DEV BIOL, V91, P267, DOI 10.1016/S0070-2153(10)91009-0; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kang CY, 2009, PLANT CELL, V21, P2624, DOI 10.1105/tpc.109.069765; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Luo XM, 2010, DEV CELL, V19, P872, DOI 10.1016/j.devcel.2010.10.023; Rowe MH, 2010, CURR OPIN PLANT BIOL, V13, P548, DOI 10.1016/j.pbi.2010.06.002; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; Saibo NJM, 2003, PLANT J, V33, P989, DOI 10.1046/j.1365-313X.2003.01684.x; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wrzaczek M, 2007, J BIOL CHEM, V282, P5249, DOI 10.1074/jbc.M610135200; Yan ZY, 2009, PLANT PHYSIOL, V150, P710, DOI 10.1104/pp.109.138099; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhang SQ, 1997, PLANT CELL, V9, P809, DOI 10.1105/tpc.9.5.809	33	346	379	18	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					419	U1526		10.1038/nature10794	http://dx.doi.org/10.1038/nature10794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22307275	Green Accepted			2022-12-01	WOS:000300287100050
J	Chen, GB; Bradford, WD; Seidel, CW; Li, R				Chen, Guangbo; Bradford, William D.; Seidel, Chris W.; Li, Rong			Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PHENOTYPIC VARIATION; BUDDING YEAST; KINETOCHORE; CHAPERONE	Aneuploidy-the state of having uneven numbers of chromosomes-is a hallmark of cancer(1) and a feature identified in yeast from diverse habitats(2-5). Recent studies have shown that aneuploidy is a form of large-effect mutation that is able to confer adaptive phenotypes under diverse stress conditions(2,6). Here we investigate whether pleiotropic stress could induce aneuploidy in budding yeast (Saccharomyces cerevisae). We show that whereas diverse stress conditions can induce an increase in chromosome instability, proteotoxic stress, caused by transient Hsp90 (also known as Hsp82 or Hsc82) inhibition or heat shock, markedly increased chromosome instability to produce a cell population with high karyotype diversity. The induced chromosome instability is linked to an evolutionarily conserved role for the Hsp90 chaperone complex in kinetochore assembly(7,8). Continued growth in the presence of an Hsp90 inhibitor resulted in the emergence of drug-resistant colonies with chromosome XV gain. This drug-resistance phenotype is a quantitative trait involving copy number increases of at least two genes located on chromosome XV. Shortterm exposure to Hsp90 stress potentiated fast adaptation to unrelated cytotoxic compounds by means of different aneuploid chromosome stoichiometries. These findings demonstrate that aneuploidy is a form of stress-inducible mutation in eukaryotes, capable of fuelling rapid phenotypic evolution and drug resistance, and reveal a new role for Hsp90 in regulating the emergence of adaptive traits under stress.	[Chen, Guangbo; Bradford, William D.; Seidel, Chris W.; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Chen, Guangbo; Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers.org			National Institutes of Health [RO1GM059964]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Pavelka, B. Rubinstein and H. Li for help with data analysis, J. Zhu, B. Fleharty and J. Haug for experimental assistance, S. Lindquist for helpful discussions, and T. Potapova and B. Slaughter for comments on the manuscript. Chromosome fragment strains and Chr XV disomy are gifts from F. Spencer and A. Amon, respectively. This work was supported by National Institutes of Health grant RO1GM059964 to R.L.	Bohen SP, 1998, MOL CELL BIOL, V18, P3330, DOI 10.1128/MCB.18.6.3330; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Davies AE, 2010, J CELL BIOL, V189, P261, DOI 10.1083/jcb.200910036; Gardner RD, 2001, GENETICS, V157, P1493; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Infante JJ, 2003, GENETICS, V165, P1745; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Niikura Y, 2006, ONCOGENE, V25, P4133, DOI 10.1038/sj.onc.1209461; Pavelka N, 2010, CURR OPIN CELL BIOL, V22, P809, DOI 10.1016/j.ceb.2010.06.003; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Selmecki A, 2010, EUKARYOT CELL, V9, P991, DOI 10.1128/EC.00060-10; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; SPENCER F, 1990, GENETICS, V124, P237; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210	21	171	173	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 9	2012	482	7384					246	250		10.1038/nature10795	http://dx.doi.org/10.1038/nature10795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888HI	22286062	Green Accepted			2022-12-01	WOS:000299994100044
J	Israel, MA; Yuan, SH; Bardy, C; Reyna, SM; Mu, YL; Herrera, C; Hefferan, MP; Van Gorp, S; Nazor, KL; Boscolo, FS; Carson, CT; Laurent, LC; Marsala, M; Gage, FH; Remes, AM; Koo, EH; Goldstein, LSB				Israel, Mason A.; Yuan, Shauna H.; Bardy, Cedric; Reyna, Sol M.; Mu, Yangling; Herrera, Cheryl; Hefferan, Michael P.; Van Gorp, Sebastiaan; Nazor, Kristopher L.; Boscolo, Francesca S.; Carson, Christian T.; Laurent, Louise C.; Marsala, Martin; Gage, Fred H.; Remes, Anne M.; Koo, Edward H.; Goldstein, Lawrence S. B.			Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells	NATURE			English	Article							AMYLOID BETA-PROTEIN; MICROTUBULE-BINDING; SENILE PLAQUES; DOWN-SYNDROME; MOUSE MODEL; TAU; APP; PHOSPHORYLATION; FIBROBLASTS; DYSFUNCTION	Our understanding of Alzheimer's disease pathogenesis is currently limited by difficulties in obtaining live neurons from patients and the inability to model the sporadic form of the disease. It may be possible to overcome these challenges by reprogramming primary cells from patients into induced pluripotent stem cells (iPSCs). Here we reprogrammed primary fibroblasts from two patients with familial Alzheimer's disease, both caused by a duplication of the amyloid-beta precursor protein gene(1) (APP; termed APP(Dp)), two with sporadic Alzheimer's disease (termed sAD1, sAD2) and two non-demented control individuals into iPSC lines. Neurons from differentiated cultures were purified with fluorescence-activated cell sorting and characterized. Purified cultures contained more than 90% neurons, clustered with fetal brain messenger RNA samples by microarray criteria, and could form functional synaptic contacts. Virtually all cells exhibited normal electrophysiological activity. Relative to controls, iPSC-derived, purified neurons from the two APP(Dp) patients and patient sAD2 exhibited significantly higher levels of the pathological markers amyloid-beta(1-40), phospho-tau(Thr 231) and active glycogen synthase kinase-3 beta (aGSK-3 beta). Neurons from APP(Dp) and sAD2 patients also accumulated large RAB5-positive early endosomes compared to controls. Treatment of purified neurons with beta-secretase inhibitors, but not gamma-secretase inhibitors, caused significant reductions in phospho-Tau(Thr 231) and aGSK-3 beta levels. These results suggest a direct relationship between APP proteolytic processing, but not amyloid-beta, in GSK-3 beta activation and tau phosphorylation in human neurons. Additionally, we observed that neurons with the genome of one sAD patient exhibited the phenotypes seen in familial Alzheimer's disease samples. More generally, we demonstrate that iPSC technology can be used to observe phenotypes relevant to Alzheimer's disease, even though it can take decades for overt disease to manifest in patients.	[Israel, Mason A.; Yuan, Shauna H.; Reyna, Sol M.; Herrera, Cheryl; Goldstein, Lawrence S. B.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Israel, Mason A.; Yuan, Shauna H.; Reyna, Sol M.; Herrera, Cheryl; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Israel, Mason A.; Reyna, Sol M.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Yuan, Shauna H.; Koo, Edward H.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Bardy, Cedric; Mu, Yangling; Gage, Fred H.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Hefferan, Michael P.; Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Van Gorp, Sebastiaan] Maastricht Univ, Med Ctr, Dept Anesthesiol, NL-6202 AZ Maastricht, Netherlands; [Nazor, Kristopher L.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Boscolo, Francesca S.; Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Carson, Christian T.] BD Biosci, La Jolla, CA 92037 USA; [Marsala, Martin] Slovak Acad Sci, Inst Neurobiol, SK-04001 Kosice, Slovakia; [Remes, Anne M.] Univ Oulu, Neurol & Clin Res Ctr, Dept Clin Med, FIN-90015 Oulu, Finland	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Maastricht University; Scripps Research Institute; University of California System; University of California San Diego; Slovak Academy of Sciences; University of Oulu	Goldstein, LSB (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu	Bardy, Cedric/F-1182-2019	Bardy, Cedric/0000-0001-8321-0852; Laurent, Louise/0000-0002-2095-7534; Yuan, Shauna/0000-0003-4058-4146; van Gorp, Sebastiaan/0000-0003-3820-7536; Israel, Mason/0000-0003-0867-0626	University of California, San Diego (UCSD) Alzheimer's Disease Research Center [AGO 5131]; UCSD [P30 NS047101]; California Institute of Regenerative Medicine (CIRM) [TR1-01250, CL1-00502, RM1-01717]; FP7 Marie Curie IOF; Weatherstone Foundation; National Institutes of Health [K12 HD001259]; Hartwell Foundation; Lookout Fund; McDonnell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, RC1NS068705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	University of California, San Diego (UCSD) Alzheimer's Disease Research Center; UCSD; California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); FP7 Marie Curie IOF; Weatherstone Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; Lookout Fund; McDonnell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Galasko, M. Sundsmo, J. Rivera, J. Fontaine, C. Gigliotti and B. Yu at the University of California, San Diego (UCSD) Alzheimer's Disease Research Center for patient samples and data (grant AGO 5131); S. Dowdy and N. Yoshioka for viral vectors; B. Balderas at BD Biosciences for antibodies; C. Santucci and S. Nguyen for teratoma assay assistance; the UCSD Neuroscience Microscopy Shared Facility (grant P30 NS047101); and Planned Parenthood of the Pacific Southwest for fetal brain specimens. Funding was from California Institute of Regenerative Medicine (CIRM) comprehensive grants (M. M., F. H. G., L. S. B. G.), CIRM predoctoral fellowship (M. A. I.), FP7 Marie Curie IOF (C. B.), Weatherstone Foundation fellowship (K. L. N.), National Institutes of Health K12 HD001259, the Hartwell Foundation (L. C. L., F. S. B.), the Lookout Fund and the McDonnell Foundation (F. H. G.). L. S. B. G. is an investigator with the Howard Hughes Medical Institute. Some experiments were conducted in J. F. Loring's laboratory (The Scripps Research Institute) with support from grants TR1-01250, CL1-00502, RM1-01717 (CIRM) and a gift from the Esther O'Keefe Foundation.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Buerger K, 2002, NEUROLOGY, V59, P627, DOI 10.1212/WNL.59.4.627; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Cataldo A, 2001, ANN NEUROL, V50, P661, DOI 10.1002/ana.1254.abs; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Emre N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012148; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gasparini L, 1998, FASEB J, V12, P17, DOI 10.1096/fasebj.12.1.17; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Qin S, 2004, ACTA NEUROPATHOL, V107, P209, DOI 10.1007/s00401-003-0800-4; Reddy BVVG, 2011, DEVELOPMENT, V138, P5201, DOI 10.1242/dev.069385; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rovelet-Lecrux A, 2007, J NEUROL NEUROSUR PS, V78, P1158, DOI 10.1136/jnnp.2006.113514; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takashima A., 2001, CURRENT PROTOCOLS CE, V12; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540	36	801	854	15	382	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2012	482	7384					216	U107		10.1038/nature10821	http://dx.doi.org/10.1038/nature10821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888HI	22278060	Green Submitted, Green Accepted			2022-12-01	WOS:000299994100038
J	MacFadden, DR; Crystal, E; Krahn, AD; Mangat, I; Healey, JS; Dorian, P; Birnie, D; Simpson, CS; Khaykin, Y; Pinter, A; Nanthakumar, K; Calzavara, AJ; Austin, PC; Tu, JV; Lee, DS				MacFadden, Derek R.; Crystal, Eugene; Krahn, Andrew D.; Mangat, Iqwal; Healey, Jeffrey S.; Dorian, Paul; Birnie, David; Simpson, Christopher S.; Khaykin, Yaariv; Pinter, Arnold; Nanthakumar, Kumaraswamy; Calzavara, Andrew J.; Austin, Peter C.; Tu, Jack V.; Lee, Douglas S.			Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database	ANNALS OF INTERNAL MEDICINE			English	Article							SUDDEN CARDIAC DEATH; PRIMARY PREVENTION; GENDER-DIFFERENCES; WOMEN; MORTALITY; SURVIVAL; REGISTRY; DISEASE; ARREST; IMPACT	Background: Sex differences in the use and outcomes of implantable cardioverter-defibrillators (ICDs) have not been fully studied. Objective: To examine potential sex differences in ICD implantation and device outcomes. Design: Health payer-mandated, prospective study of patients referred for ICD implantation, with comprehensive, longitudinal follow-up for complications, deaths, and device outcomes. Setting: 18 ICD implantation and follow-up centers in Ontario, Canada. Patients: 6021 patients (4733 men) referred for ICD implantation from February 2007 to July 2010. Measurements: Multivariate-adjusted ICD implantation rate, complications up to day 45, multivariate-adjusted complications, device outcomes (including appropriate shocks and therapies), and deaths occurring during 1-year follow-up. Results: Rates of ICD implantation were similar in men and women (relative risk, 0.99 [95% CI, 0.97 to 1.02]; P = 0.60). However, women were significantly more likely to experience major complications by 45 days (odds ratio, 1.78 [CI, 1.24 to 2.58]; P = 0.002) and 1 year (hazard ratio [HR], 1.91 [CI, 1.48 to 2.47]; P < 0.001) after implantation. Occurrence of any major or minor complication was also increased in women at both 45-day follow-up (odds ratio, 1.50 [CI, 1.12 to 2.00]; P = 0.006) and 1-year follow-up (HR, 1.55 [CI, 1.25 to 1.93]; P < 0.001). After implantation, women were less likely than men to receive appropriate ICD shock (HR, 0.69 [CI, 0.51 to 0.93]; P = 0.015) or appropriate therapy via shock or antitachycardia pacing (HR, 0.73 [CI, 0.59 to 0.90]; P = 0.003). Total mortality among defibrillator recipients did not differ between men and women (HR, 1.00 [CI, 0.64 to 1.55]; P = 0.99). Limitation: The differential effects of sex on prereferral events were not examined. Conclusion: Although ICD implantation rates were similar after referral to an electrophysiologist, women who underwent ICD implantation had greater risks for complications and were less likely to experience appropriate ICD-delivered therapies than men.	[Lee, Douglas S.] Inst Clin Evaluat Sci, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; Univ Toronto, Toronto, ON, Canada; Univ Western Ontario, London, ON, Canada; McMaster Univ, Hamilton, ON, Canada; Univ Ottawa, Ottawa, ON, Canada; Queens Univ, Kingston, ON, Canada; Southlake Reg Hlth Ctr, Newmarket, ON, Canada	University of Toronto; University of Toronto; Western University (University of Western Ontario); McMaster University; University of Ottawa; Queens University - Canada; Southlake Regional Health Centre	Lee, DS (corresponding author), Inst Clin Evaluat Sci, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dlee@ices.on.ca	, Nanthakumar/AAA-9943-2020	Lee, Douglas/0000-0001-7078-745X; Austin, Peter/0000-0003-3337-233X; Tu, Jack/0000-0003-0111-722X	Canadian Institutes of Health Research [MOP 111150]; Ontario Ministry of Health and Long-Term Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	Grant Support: By an operating grant from the Canadian Institutes of Health Research (MOP 111150) and the Ontario Ministry of Health and Long-Term Care.	Airaksinen KEJ, 1998, J AM COLL CARDIOL, V31, P301, DOI 10.1016/S0735-1097(97)00489-0; Albert CM, 2008, AM HEART J, V156, P367, DOI 10.1016/j.ahj.2008.02.026; Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; Albert CM, 1996, CIRCULATION, V93, P1170, DOI 10.1161/01.CIR.93.6.1170; Anderson KP, 2009, CIRCULATION, V119, P1069, DOI 10.1161/CIRCULATIONAHA.108.841452; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Birnie DH, 2007, CAN MED ASSOC J, V177, P41, DOI 10.1503/cmaj.060730; Chen HA, 2007, PACE, V30, P390, DOI 10.1111/j.1540-8159.2007.00680.x; Chugh SS, 2009, J AM COLL CARDIOL, V54, P2006, DOI 10.1016/j.jacc.2009.07.038; CUPPLES LA, 1992, CIRCULATION, V85, P11; Curtis LH, 2007, JAMA-J AM MED ASSOC, V298, P1517, DOI 10.1001/jama.298.13.1517; Daugherty SL, 2009, AM HEART J, V158, P224, DOI 10.1016/j.ahj.2009.05.018; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; El-Chami MF, 2007, HEART RHYTHM, V4, P1420, DOI 10.1016/j.hrthm.2007.07.024; Ghanbari H, 2009, ARCH INTERN MED, V169, P1500, DOI 10.1001/archinternmed.2009.255; Guru V, 2006, CIRCULATION, V113, P507, DOI 10.1161/CIRCULATIONAHA.105.576652; Henyan NN, 2006, J INTERN MED, V260, P467, DOI 10.1111/j.1365-2796.2006.01713.x; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Humphries KH, 2007, J AM COLL CARDIOL, V49, P1552, DOI 10.1016/j.jacc.2006.08.068; Jacobs AK, 2003, CIRCULATION, V107, P375, DOI 10.1161/01.CIR.0000048895.18974.6B; Jacobs AK, 2002, J AM COLL CARDIOL, V39, P1608, DOI 10.1016/S0735-1097(02)01835-1; Kannel WB, 1998, AM HEART J, V136, P205, DOI 10.1053/hj.1998.v136.90226; Lampert R, 2004, J AM COLL CARDIOL, V43, P2293, DOI 10.1016/j.jacc.2004.03.031; Larsen JA, 1998, J CARDIOVASC ELECTR, V9, P655, DOI 10.1111/j.1540-8167.1998.tb00950.x; Lee DS, 2008, HEART RHYTHM, V5, P1250, DOI 10.1016/j.hrthm.2008.05.015; Lee DS, 2007, J AM COLL CARDIOL, V49, P2408, DOI 10.1016/j.jacc.2007.02.058; Lee DS, 2010, J AM COLL CARDIOL, V55, P774, DOI 10.1016/j.jacc.2009.11.029; Lee DS, 2009, CIRC-HEART FAIL, V2, P616, DOI 10.1161/CIRCHEARTFAILURE.109.869743; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; MacFadden DR, 2009, HEART RHYTHM, V6, P1289, DOI 10.1016/j.hrthm.2009.05.017; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Peterson PN, 2009, CIRCULATION, V119, P1078, DOI 10.1161/CIRCULATIONAHA.108.793463; Rosner B., 1999, FUNDAMENTALS BIOSTAT; Russo AM, 2008, J CARDIOVASC ELECTR, V19, P720, DOI 10.1111/j.1540-8167.2008.01129.x; Russo AM, 2009, J CARDIOVASC ELECTR, V20, P973, DOI 10.1111/j.1540-8167.2009.01489.x; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Udell JA, 2007, INT J TECHNOL ASSESS, V23, P354, DOI 10.1017/S0266462307070389; Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4; Yancy CW, 2009, AM HEART J, V157, P754, DOI 10.1016/j.ahj.2008.12.016; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	41	94	94	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2012	156	3					195	+		10.7326/0003-4819-156-3-201202070-00007	http://dx.doi.org/10.7326/0003-4819-156-3-201202070-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XD	22312139				2022-12-01	WOS:000299964200003
J	Arima, Y; Harada, M; Kamimura, D; Park, JH; Kawano, F; Yull, FE; Kawamoto, T; Iwakura, Y; Betz, UAK; Marquez, G; Blackwell, TS; Ohira, Y; Hirano, T; Murakami, M				Arima, Yasunobu; Harada, Masaya; Kamimura, Daisuke; Park, Jin-Haeng; Kawano, Fuminori; Yull, Fiona E.; Kawamoto, Tadafumi; Iwakura, Yoichiro; Betz, Ulrich A. K.; Marquez, Gabriel; Blackwell, Timothy S.; Ohira, Yoshinobu; Hirano, Toshio; Murakami, Masaaki			Regional Neural Activation Defines a Gateway for Autoreactive T Cells to Cross the Blood-Brain Barrier	CELL			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE ENCEPHALOMYELITIS; ADOPTIVE TRANSFER; SPLEEN-CELLS; IN-VITRO; IMMUNE; PROLIFERATION; INTERLEUKIN-6; SYSTEM; MICE	Although it is believed that neural activation can affect immune responses, very little is known about the neuroimmune interactions involved, especially the regulators of immune traffic across the blood-brain barrier which occurs in neuroimmune diseases such as multiple sclerosis (MS). Using a mouse model of MS, experimental autoimmune encephalomyelitis, we show that autoreactive T cells access the central nervous system via the fifth lumbar spinal cord. This location is defined by IL-6 amplifier-dependent upregulation of the chemokine CCL20 in associated dorsal blood vessels, which in turn depends on gravity-induced activation of sensory neurons by the soleus muscle in the leg. Impairing soleus muscle contraction by tail suspension is sufficient to reduce localized chemokine expression and block entry of pathogenic T cells at the fifth lumbar cord, suggesting that regional neuroimmune interactions may offer therapeutic targets for a variety of neurological diseases.	[Arima, Yasunobu; Harada, Masaya; Kamimura, Daisuke; Park, Jin-Haeng; Hirano, Toshio; Murakami, Masaaki] Osaka Univ, Lab Dev Immunol, JST CREST, Grad Sch Frontier Biosci,Grad Sch Med, Suita, Osaka 5650871, Japan; [Arima, Yasunobu; Harada, Masaya; Kamimura, Daisuke; Park, Jin-Haeng; Hirano, Toshio; Murakami, Masaaki] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Kawano, Fuminori; Ohira, Yoshinobu] Osaka Univ, Dept Hlth & Sports Sci, Grad Sch Med, Osaka 5600043, Japan; [Yull, Fiona E.; Blackwell, Timothy S.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Kawamoto, Tadafumi] Tsurumi Univ, Dept Dent Med, Radioisotope Res Inst, Yokohama, Kanagawa 2308501, Japan; [Iwakura, Yoichiro] Univ Tokyo, Ctr Expt Med & Syst Biol, Inst Med Sci, Tokyo 1088639, Japan; [Betz, Ulrich A. K.] Portfolio Dev Merck Serono, Merck KGaA, D-64293 Darmstadt, Germany; [Marquez, Gabriel] Natl Ctr Biotechnol CNB CSIC, Madrid 28049, Spain; [Hirano, Toshio] RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Yokohama, Kanagawa 2300045, Japan	Osaka University; Osaka University; Osaka University; Vanderbilt University; Vanderbilt University; Tsurumi University; University of Tokyo; Merck KGaA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); RIKEN	Murakami, M (corresponding author), Osaka Univ, Lab Dev Immunol, JST CREST, Grad Sch Frontier Biosci,Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	murakami@molonc.med.osaka-u.ac.jp	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; , Masaaki/0000-0001-7159-7279; Kamimura, Daisuke/0000-0003-1022-4430; Harada, Masaya/0000-0002-1318-3542	KAKENHI; JST-CREST; Osaka Foundation for the Promotion of Clinical Immunology; Grants-in-Aid for Scientific Research [10J05573] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Osaka Foundation for the Promotion of Clinical Immunology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. M. Kopf (Max-Planck-Institute of Immunobiology, Germany) for the IL-6-deficient mice, Dr. G. Karsenty (Baylor College of Medicine, Houston, TX) for the type I collagen-Cre mice, and Dr. S. Akira (Osaka University, Osaka, Japan) for the STAT3<SUP>flox/flox</SUP> mice. We appreciate the excellent technical assistances provided by Dr. J-J. Jiang, Ms. A. Okuyama, and Ms. N. Kumai, and thank Ms. R. Masuda for her excellent secretarial work. We thank Dr. M. Yagi and Dr. P. Karagiannis (Osaka University) for carefully reading the manuscript. We are grateful to Dr. Fujio Murakami (Osaka University) for important discussions and advice for how to do the neural experiments and thank Dr. M. Miyasaka (Osaka University) for important discussions about blood vessels for lymphocyte migration. We are also grateful to Dr. Y. Nakatsuji and Dr. M. Kinoshita (Osaka University) for important discussions about MS patients and thank Dr. Y. Okuyama and Dr. H. Ogura (Osaka University) for important discussions and carefully reading this manuscript. We thank Dr. Y. Oke (Osaka University) for important discussions about the tail suspension experiment. We thank Jihye Lee for her help in preparing the Graphical Abstract. This work was supported by KAKENHI (Y.A., M.H., T.H., and M.M.), the JST-CREST program (T.H. and M.M.), and the Osaka Foundation for the Promotion of Clinical Immunology (M.M.).	Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; BROSNAN CF, 1985, P NATL ACAD SCI USA, V82, P5915, DOI 10.1073/pnas.82.17.5915; Canu MH, 2009, EXP NEUROL, V218, P98, DOI 10.1016/j.expneurol.2009.04.009; De-Doncker L, 2005, J EXP BIOL, V208, P4585, DOI 10.1242/jeb.01931; Dimitrijevic M, 2007, EUR J PHARMACOL, V577, P170, DOI 10.1016/j.ejphar.2007.08.021; Felten DL, 2000, PROG BRAIN RES, V122, P381; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Kaufman MP, 2002, CLIN AUTON RES, V12, P429, DOI 10.1007/s10286-002-0059-1; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kawano F, 2007, AM J PHYSIOL-CELL PH, V293, pC35, DOI 10.1152/ajpcell.00297.2006; Kawano F, 2002, NEUROSCIENCE, V114, P1133, DOI 10.1016/S0306-4522(02)00304-4; Longhurst JC, 2010, J ACUPUNCT MERIDIAN, V3, P67, DOI 10.1016/S2005-2901(10)60014-3; MATSUMOTO Y, 1988, AM J PATHOL, V133, P306; McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971; Murakami M, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00022; Murakami M, 2011, J EXP MED, V208, P103, DOI 10.1084/jem.20100900; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ohira M, 2002, JPN J PHYSIOL, V52, P235, DOI 10.2170/jjphysiol.52.235; Ohira Y., 2004, J GRAVIT PHYSL, V11, pP127; PANITCH HS, 1980, CELL IMMUNOL, V56, P163, DOI 10.1016/0008-8749(80)90091-X; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sadikot Ruxana T., 2008, V477, P383, DOI 10.1007/978-1-60327-517-0_29; Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Smith SA, 2006, EXP PHYSIOL, V91, P89, DOI 10.1113/expphysiol.2005.032367; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Takeda K, 1998, J IMMUNOL, V161, P4652; Thayer JF, 2010, BRAIN BEHAV IMMUN, V24, P1223, DOI 10.1016/j.bbi.2010.07.247; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Ueda N, 2006, INT IMMUNOL, V18, P1397, DOI 10.1093/intimm/dxl073; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Watkins LR, 1999, P NATL ACAD SCI USA, V96, P7710, DOI 10.1073/pnas.96.14.7710; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Xie WR, 2010, PAIN, V151, P447, DOI 10.1016/j.pain.2010.08.006	40	215	220	3	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2012	148	3					447	457		10.1016/j.cell.2012.01.022	http://dx.doi.org/10.1016/j.cell.2012.01.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304915	Bronze			2022-12-01	WOS:000300225000014
J	Swinnen, J; Squicciarini, P				Swinnen, Johan; Squicciarini, Pasquamaria			Mixed Messages on Prices and Food Security	SCIENCE			English	Editorial Material							COUNTRIES		[Swinnen, Johan; Squicciarini, Pasquamaria] Katholieke Univ Leuven, Ctr Inst & Econ Performance LICOS, Louvain, Belgium; [Swinnen, Johan; Squicciarini, Pasquamaria] Katholieke Univ Leuven, Dept Econ, Louvain, Belgium; [Swinnen, Johan] Stanford Univ, Ctr Food Secur & Environm, Palo Alto, CA 94304 USA	KU Leuven; KU Leuven; Stanford University	Squicciarini, P (corresponding author), Katholieke Univ Leuven, Ctr Inst & Econ Performance LICOS, Louvain, Belgium.	mara.squicciarini@econ.kuleuven.be	Swinnen, Johan/AAC-1736-2021	Swinnen, Johan/0000-0002-8650-1978				Anderson K., 2007, AGR TRADE REFORM DOH; Andreoni J, 2003, AM ECON REV, V93, P792, DOI 10.1257/000282803322157098; Banerjee A.V., 2011, PUBLIC AFFAIRS, DOI DOI 10.1111/J.1728-4457.2011.00462.X; Baumeister R.F., 2011, REV GEN PSYCHOL, V5, P323, DOI [10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bouet A., 2010, 00994 IFPRI; Bureau J. C., 2006, World Trade Review, V5, P225, DOI 10.1017/S147474560600276X; Christiaensen Luc., 2007, EARTH AGR POVERTY RE; Cline W.R., 2004, TRADE POLICY GLOBAL; FAO, 2008, FAOHLC08INF1; FAO, 2009, STAT FOOD INS WORLD; FAO, HIGH FOOD PRIC SUPP; Hawkins V., 2002, JOURNALISM STUD, P225, DOI [10.1080/14616700220129991, DOI 10.1080/14616700220129991]; Headey D., 2011, 01087 IFPRI; Hertel T. W., 2006, POVERTY WTO; Hertel TW, 2007, ECON POLICY, P289; Hertel Thomas W., 2005, J INT TRADE ECON DEV, V14, P377, DOI DOI 10.1080/09638190500372404; Ivanic M., 2008, WORKING PAPER SERIES; Jakobsen PV, 2000, J PEACE RES, V37, P131, DOI 10.1177/0022343300037002001; Marks L. A., 2003, Journal of Agribusiness, V21, P1; MARSHALL LL, 1981, SOC BEHAV PERSONAL, V9, P223, DOI 10.2224/sbp.1981.9.2.223; McCluskey J. J., 2004, American Journal of Agricultural Economics, V86, P1230, DOI 10.1111/j.0002-9092.2004.00670.x; McCluskey J. J., 2010, OXFORD HDB GOVT BUSI, P643; Naylor RL, 2010, POPUL DEV REV, V36, P693, DOI 10.1111/j.1728-4457.2010.00354.x; OXFAM International, AGR CAMP GLOB FOOD P; OXFAM International, 2005, INT CEL GET DUMP WSF; Panagariya A, 2005, WORLD ECON, V28, P1277, DOI 10.1111/j.1467-9701.2005.00734.x; ROSEACKERMAN S, 1982, Q J ECON, V97, P193, DOI 10.2307/1880754; Sarris A., 2010, FOOD SECURITY AFRICA; SWINNEN J., 2011, FOOD SECURITY TRANSI; Swinnen JFM, 2006, WORLD ECON, V29, P637, DOI 10.1111/j.1467-9701.2006.00804.x; Swinnen J, 2011, DEV POLICY REV, V29, P667, DOI 10.1111/j.1467-7679.2011.00552.x; Verpoorten M., 2012, 303 LICOS; World Bank, 2008, FOOD PRIC SURG COULD; World Bank, 2003, REACH RUR POOR; World Bank, 2009, IMPL AGR DEV WORLD B	35	93	95	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2012	335	6067					405	406		10.1126/science.1210806	http://dx.doi.org/10.1126/science.1210806			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	881FG	22282793				2022-12-01	WOS:000299466800028
J	Manglik, A; Kruse, AC; Kobilka, TS; Thian, FS; Mathiesen, JM; Sunahara, RK; Pardo, L; Weis, WI; Kobilka, BK; Granier, S				Manglik, Aashish; Kruse, Andrew C.; Kobilka, Tong Sun; Thian, Foon Sun; Mathiesen, Jesper M.; Sunahara, Roger K.; Pardo, Leonardo; Weis, William I.; Kobilka, Brian K.; Granier, Sebastien			Crystal structure of the mu-opioid receptor bound to a morphinan antagonist	NATURE			English	Article							BINDING; RESIDUES; OLIGOMERIZATION; DIPRENORPHINE; ETORPHINE; TOLERANCE; GPCR; LOOP	Opium is one of the world's oldest drugs, and its derivatives morphine and codeine are among the most used clinical drugs to relieve severe pain. These prototypical opioids produce analgesia as well as many undesirable side effects (sedation, apnoea and dependence) by binding to and activating the G-protein-coupled mu-opioid receptor (mu-OR) in the central nervous system. Here we describe the 2.8 angstrom crystal structure of the mouse mu-OR in complex with an irreversible morphinan antagonist. Compared to the buried binding pocket observed in most G-protein-coupled receptors published so far, the morphinan ligand binds deeply within a large solvent-exposed pocket. Of particular interest, the mu-OR crystallizes as a two-fold symmetrical dimer through a four-helix bundle motif formed by transmembrane segments 5 and 6. These high-resolution insights into opioid receptor structure will enable the application of structure-based approaches to develop better drugs for the management of pain and addiction.	[Manglik, Aashish; Kruse, Andrew C.; Kobilka, Tong Sun; Thian, Foon Sun; Mathiesen, Jesper M.; Weis, William I.; Kobilka, Brian K.; Granier, Sebastien] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Pardo, Leonardo] Univ Autonoma Barcelona, Unit Bioestat, Lab Med Computac, Barcelona 08193, Spain; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Granier, Sebastien] CNRS, INSERM, U661, UMR 5203, F-34094 Montpellier, France; [Granier, Sebastien] Univ Montpellier 1 & 2, Inst Genom Fonctionnelle, F-34094 Montpellier, France	Stanford University; University of Michigan System; University of Michigan; Autonomous University of Barcelona; Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier	Granier, S (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kobilka@stanford.edu; granier@stanford.edu	Weis, William I/G-1437-2011; Sunahara, Roger/AAJ-8667-2020; Granier, Sebastien/J-1089-2016	Weis, William I/0000-0002-5583-6150; Kobilka, Brian/0000-0001-5958-3990; Mathiesen, Jesper Mosolff/0000-0003-4251-4416; Pardo, Leonardo/0000-0003-1778-7420	INSERM; Stanford Medical Scientist Training Program; National Science Foundation; Lundbeck Foundation; National Institutes of Health [NS028471, DA031418]; Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031418] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Stanford Medical Scientist Training Program; National Science Foundation(National Science Foundation (NSF)); Lundbeck Foundation(Lundbeckfonden); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We acknowledge support from INSERM (S. G.), the Stanford Medical Scientist Training Program (A. M.), the National Science Foundation (A. C. K.), the Lundbeck Foundation (J.M.M.), the National Institutes of Health Grants NS028471 (B. K. K.) and DA031418 (B. K. K. and R. K. S.), and the Mathers Foundation (B. K. K. and W.I.W.).	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; ALFORD BT, 1974, J AM VET MED ASSOC, V164, P702; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Bonner G, 2000, EUR J PHARMACOL, V403, P37, DOI 10.1016/S0014-2999(00)00578-1; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cassel JA, 2005, EUR J PHARMACOL, V520, P29, DOI 10.1016/j.ejphar.2005.08.008; Chen CG, 1996, J BIOL CHEM, V271, P21422, DOI 10.1074/jbc.271.35.21422; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DISSE B, 1993, LIFE SCI, V52, P537, DOI 10.1016/0024-3205(93)90312-Q; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanelli F, 2011, CHEM REV, V111, pPR438, DOI 10.1021/cr100437t; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Golebiewska U, 2011, BIOCHEMISTRY-US, V50, P2829, DOI 10.1021/bi101701x; Gomes I, 2011, MOL PHARMACOL, V79, P1044, DOI 10.1124/mol.110.070847; Granier S, 2004, J BIOL CHEM, V279, P50904, DOI 10.1074/jbc.M405089200; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; He L, 2005, CURR BIOL, V15, P1028, DOI 10.1016/j.cub.2005.04.052; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hu JX, 2012, FASEB J, V26, P604, DOI 10.1096/fj.11-191510; Huang P, 2001, BIOCHEMISTRY-US, V40, P13501, DOI 10.1021/bi010917q; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Katzung BG, 2007, BASIC CLIN PHARM; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; KUROWSKI M, 1982, BRAIN RES, V249, P345, DOI 10.1016/0006-8993(82)90068-3; LORD JAH, 1977, NATURE, V267, P495, DOI 10.1038/267495a0; Mansour A, 1997, J NEUROCHEM, V68, P344, DOI 10.1046/j.1471-4159.1997.68010344.x; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molinari P, 2010, J BIOL CHEM, V285, P12522, DOI 10.1074/jbc.M109.059410; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PORTOGHESE PS, 1990, J MED CHEM, V33, P1714, DOI 10.1021/jm00168a028; RAFFA RB, 1994, EUR J PHARMACOL, V258, pR5, DOI 10.1016/0014-2999(94)90073-6; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rozenfeld R, 2011, RECEPT SER, P407, DOI 10.1007/978-1-60761-993-2_15; Schrodinger L., 2020, PYMOL; Seki T, 1998, EUR J PHARMACOL, V350, P301, DOI 10.1016/S0014-2999(98)00240-4; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Sporer KA, 1999, ANN INTERN MED, V130, P584, DOI 10.7326/0003-4819-130-7-199904060-00019; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	47	972	994	6	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					321	U170		10.1038/nature10954	http://dx.doi.org/10.1038/nature10954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22437502	Green Accepted			2022-12-01	WOS:000304099100032
J	Olszak, T; An, DD; Zeissig, S; Vera, MP; Richter, J; Franke, A; Glickman, JN; Siebert, R; Baron, RM; Kasper, DL; Blumberg, RS				Olszak, Torsten; An, Dingding; Zeissig, Sebastian; Vera, Miguel Pinilla; Richter, Julia; Franke, Andre; Glickman, Jonathan N.; Siebert, Reiner; Baron, Rebecca M.; Kasper, Dennis L.; Blumberg, Richard S.			Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function	SCIENCE			English	Article							NKT CELLS; AIRWAY INFLAMMATION; ULCERATIVE-COLITIS; HYGIENE HYPOTHESIS; CHEMOKINE CXCL16; RECOGNITION; METHYLATION; ACTIVATION; EXPRESSION; MODELS	Exposure to microbes during early childhood is associated with protection from immune-mediated diseases such as inflammatory bowel disease (IBD) and asthma. Here, we show that in germ-free (GF) mice, invariant natural killer T (iNKT) cells accumulate in the colonic lamina propria and lung, resulting in increased morbidity in models of IBD and allergic asthma as compared with that of specific pathogen-free mice. This was associated with increased intestinal and pulmonary expression of the chemokine ligand CXCL16, which was associated with increased mucosal iNKT cells. Colonization of neonatal-but not adult-GF mice with a conventional microbiota protected the animals from mucosal iNKT accumulation and related pathology. These results indicate that age-sensitive contact with commensal microbes is critical for establishing mucosal iNKT cell tolerance to later environmental exposures.	[An, Dingding; Kasper, Dennis L.] Harvard Univ, Brigham & Womens Hosp, Channing Lab, Sch Med, Boston, MA 02115 USA; [An, Dingding; Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Olszak, Torsten; Blumberg, Richard S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Zeissig, Sebastian] Univ Med Ctr Schleswig Holstein, Dept Internal Med 1, D-24105 Kiel, Germany; [Vera, Miguel Pinilla; Baron, Rebecca M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Richter, Julia; Siebert, Reiner] Univ Kiel, Inst Human Genet, D-24105 Kiel, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Glickman, Jonathan N.] GI Pathol, Caris Diagnost, Caris Life Sci, Newton, MA 02464 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Schleswig Holstein University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; University of Kiel	Kasper, DL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Channing Lab, Sch Med, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu; rblumberg@partners.org	Zeissig, Sebastian/B-6297-2012; Siebert, Reiner/A-8049-2010; Franke, Andre/B-2151-2010	Zeissig, Sebastian/0000-0001-5124-0897; Franke, Andre/0000-0003-1530-5811; Pinilla-Vera, Miguel/0000-0002-2773-1570	NIH [DK44319, DK51362, DK53056, DK88199, AI090102]; Crohn's Colitis Foundation of America; Harvard Digestive Diseases Center [DK034854]; Medizinausschuss Schleswig-Holstein, German Ministry of Education Research through the National Genome Research Network; Medical Faculty, Kiel; Deutsche Forschungsgemeinschaft (DFG) [OL 324/1-1, SZ 814/1-1, 814/4-1]; DFG Excellence Cluster "Inflammation at Interfaces"; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044319, R01DK088199, R37DK044319, R01DK051362, P30DK034854, R56DK053056, R01DK053056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's Colitis Foundation of America; Harvard Digestive Diseases Center; Medizinausschuss Schleswig-Holstein, German Ministry of Education Research through the National Genome Research Network; Medical Faculty, Kiel; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Excellence Cluster "Inflammation at Interfaces"(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Troy and S. Edwards for handling of the GF mice, J. Cusick for technical assistance, E. Nieuwenhuis and K. Schneeberger for assistance with epigenetics studies, A. Bellacosa and K. Baker for helpful discussions and manuscript preparation, and the KinderKrebsInitiative Buchholz/Holm-Seppensen for providing pyrosequencing infrastructure. The work was supported by NIH grants DK44319, DK51362, DK53056, and DK88199 (R. S. B.) and AI090102 (D. L. K.); Crohn's Colitis Foundation of America Senior Research Award (D. L. K.) and Crohn's and Colitis Foundation of America Postdoctoral Fellowship Award (D. A. and S.Z.); the Harvard Digestive Diseases Center (DK034854); the Medizinausschuss Schleswig-Holstein, German Ministry of Education Research through the National Genome Research Network (A. F.); The Medical Faculty, Kiel (R. S.) and the Deutsche Forschungsgemeinschaft (DFG) (OL 324/1-1, SZ 814/1-1, 814/4-1); as well as DFG Excellence Cluster "Inflammation at Interfaces" (A.F. and S.Z.). The data reported in this manuscript are tabulated in the main paper and in the supplementary materials.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Day C, 2009, EXP LUNG RES, V35, P272, DOI 10.1080/01902140802635517; Diegelmann J, 2010, INFLAMM BOWEL DIS, V16, P1871, DOI 10.1002/ibd.21306; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81; Goksor E, 2011, ACTA PAEDIATR, V100, P1561, DOI 10.1111/j.1651-2227.2011.02411.x; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Iwamura C, 2010, CURR OPIN IMMUNOL, V22, P807, DOI 10.1016/j.coi.2010.10.008; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lopez-Serrano P, 2010, SCAND J GASTROENTERO, V45, P1464, DOI 10.3109/00365521.2010.510575; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Meyer EH, 2008, ANNU REV MED, V59, P281, DOI 10.1146/annurev.med.59.061506.154139; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Pufulete M, 2005, GUT, V54, P648, DOI 10.1136/gut.2004.054718; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Roark JH, 1998, J IMMUNOL, V160, P3121; Schiechl G, 2011, J CLIN INVEST, V121, P1692, DOI 10.1172/JCI42540; Shaw SY, 2010, AM J GASTROENTEROL, V105, P2687, DOI 10.1038/ajg.2010.398; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sullivan BA, 2007, CURR TOP MICROBIOL, V314, P165; von Mutius E, 2007, IMMUNOBIOLOGY, V212, P433, DOI 10.1016/j.imbio.2007.03.002; Wei B, 2010, J IMMUNOL, V184, P1218, DOI 10.4049/jimmunol.0902620; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229; Yue SC, 2005, P NATL ACAD SCI USA, V102, P11811, DOI 10.1073/pnas.0503366102	33	1070	1130	9	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					489	493		10.1126/science.1219328	http://dx.doi.org/10.1126/science.1219328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22442383	Green Accepted			2022-12-01	WOS:000303233400051
J	Everitt, AR; Clare, S; Pertel, T; John, SP; Wash, RS; Smith, SE; Chin, CR; Feeley, EM; Sims, JS; Adams, DJ; Wise, HM; Kane, L; Goulding, D; Digard, P; Anttila, V; Baillie, JK; Walsh, TS; Hume, DA; Palotie, A; Xue, YL; Colonna, V; Tyler-Smith, C; Dunning, J; Gordon, SB; Smyth, RL; Openshaw, PJ; Dougan, G; Brass, AL; Kellam, P				Everitt, Aaron R.; Clare, Simon; Pertel, Thomas; John, Sinu P.; Wash, Rachael S.; Smith, Sarah E.; Chin, Christopher R.; Feeley, Eric M.; Sims, Jennifer S.; Adams, David J.; Wise, Helen M.; Kane, Leanne; Goulding, David; Digard, Paul; Anttila, Verneri; Baillie, J. Kenneth; Walsh, Tim S.; Hume, David A.; Palotie, Aarno; Xue, Yali; Colonna, Vincenza; Tyler-Smith, Chris; Dunning, Jake; Gordon, Stephen B.; Smyth, Rosalind L.; Openshaw, Peter J.; Dougan, Gordon; Brass, Abraham L.; Kellam, Paul		GenISIS Investigators; MOSAIC Investigators	IFITM3 restricts the morbidity and mortality associated with influenza	NATURE			English	Article							WEST NILE VIRUS; PROTEINS; PATHOGENESIS; INFECTION	The 2009 H1N1 influenza pandemic showed the speed with which a novel respiratory virus can spread and the ability of a generally mild infection to induce severe morbidity and mortality in a subset of the population. Recent in vitro studies show that the interferon-inducible transmembrane (IFITM) protein family members potently restrict the replication of multiple pathogenic viruses(1-7). Both the magnitude and breadth of the IFITM proteins' in vitro effects suggest that they are critical for intrinsic resistance to such viruses, including influenza viruses. Using a knockout mouse model(8), we now test this hypothesis directly and find that IFITM3 is essential for defending the host against influenza A virus in vivo. Mice lacking Ifitm3 display fulminant viral pneumonia when challenged with a normally low-pathogenicity influenza virus, mirroring the destruction inflicted by the highly pathogenic 1918 'Spanish' influenza(9,10). Similar increased viral replication is seen in vitro, with protection rescued by the re-introduction of Ifitm3. To test the role of IFITM3 in human influenza virus infection, we assessed the IFITM3 alleles of individuals hospitalized with seasonal or pandemic influenza H1N1/09 viruses. We find that a statistically significant number of hospitalized subjects show enrichment for a minor IFITM3 allele (SNP rs12252-C) that alters a splice acceptor site, and functional assays show the minor CC genotype IFITM3 has reduced influenza virus restriction in vitro. Together these data reveal that the action of a single intrinsic immune effector, IFITM3, profoundly alters the course of influenza virus infection in mouse and humans.	[Everitt, Aaron R.; Clare, Simon; Wash, Rachael S.; Smith, Sarah E.; Adams, David J.; Kane, Leanne; Goulding, David; Anttila, Verneri; Palotie, Aarno; Xue, Yali; Colonna, Vincenza; Tyler-Smith, Chris; Dougan, Gordon; Kellam, Paul] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Pertel, Thomas; John, Sinu P.; Chin, Christopher R.; Feeley, Eric M.; Sims, Jennifer S.; Brass, Abraham L.] MIT, Ragon Inst Massachusetts, Gen Hosp, Charlestown, MA 02129 USA; [Pertel, Thomas; John, Sinu P.; Chin, Christopher R.; Feeley, Eric M.; Sims, Jennifer S.; Brass, Abraham L.] Harvard Univ, Charlestown, MA 02129 USA; [Wise, Helen M.; Digard, Paul] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Baillie, J. Kenneth; Hume, David A.] Univ Edinburgh, Div Genet & Genom, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Baillie, J. Kenneth; Walsh, Tim S.] Univ Edinburgh, Dept Crit Care Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Colonna, Vincenza] Natl Res Council CNR, Inst Genet & Biophys A Buzzati Traverso, Naples, Italy; [Dunning, Jake; Openshaw, Peter J.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, Natl Heart & Lung Inst, London W2 1PG, England; [Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Smyth, Rosalind L.] Univ Liverpool, Inst Translat Med, Alder Hey Childrens Hosp, Liverpool L12 2AP, Merseyside, England; [Brass, Abraham L.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02117 USA; [Kellam, Paul] UCL, UCL MRC Ctr Med Mol Virol, Dept Infect, London W1T 4JF, England	Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Imperial College London; Liverpool School of Tropical Medicine; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; Harvard University; Massachusetts General Hospital; University of London; University College London	Kellam, P (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England.	abrass@partners.org; pk5@sanger.ac.uk	Semple, Malcolm Gracie/A-8790-2008; Hume, David A/C-7695-2013; Dunning, Jake/U-7181-2019; Baillie, John Kenneth/F-3124-2011; Haley, Chris S/F-3110-2013; Hayward, Andrew C/C-3268-2013; John, Sinu/AAS-2054-2020; Aylin, Paul/A-1073-2014; Johnston, Sebastian Lennox/I-2423-2012; Baillie, Kenneth/AEK-6650-2022; Openshaw, Peter/AAL-9442-2020; Digard, Paul/B-7717-2008; Nguyen-Van-Tam, Jonathan/I-2162-2019; Colonna, Vincenza/H-2021-2014; Hussell, Tracy/O-4630-2014	Semple, Malcolm Gracie/0000-0001-9700-0418; Dunning, Jake/0000-0002-4035-4562; Baillie, John Kenneth/0000-0001-5258-793X; Hayward, Andrew C/0000-0002-3549-6232; Johnston, Sebastian Lennox/0000-0003-3009-9200; Baillie, Kenneth/0000-0001-5258-793X; Openshaw, Peter/0000-0002-7220-2555; Digard, Paul/0000-0002-0872-9440; Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Adams, David/0000-0001-9490-0306; Smith, Sarah/0000-0001-8699-7670; Herberg, Jethro/0000-0001-6941-6491; Chin, Christopher/0000-0002-2140-3197; Ramsay, Pam/0000-0003-3545-4275; Aylin, Paul/0000-0003-4589-1743; Drumright, Lydia/0000-0002-3361-8080; Hume, David/0000-0002-2615-1478; Adamson, Walt/0000-0002-9786-2349; Murphy, Lee/0000-0001-6467-7449; Kellam, Paul/0000-0003-3166-4734; Ho, Ling Pei/0000-0001-8319-301X; Gordon, Stephen/0000-0001-6576-1116; Aston, Stephen/0000-0002-0701-8364; Feeley, Eric/0000-0003-0910-8758; Anttila, Verneri/0000-0002-0073-4675; Colonna, Vincenza/0000-0002-3966-0474; McCulloch, Corrienne/0000-0001-5773-5217; Barclay, Wendy/0000-0002-3948-0895; Pertel, Thomas/0000-0002-2286-6011; Hussell, Tracy/0000-0001-7186-6141; McNamara, Paul/0000-0002-7055-6034	Wellcome Trust [090382/Z/09/Z]; Imperial's Comprehensive Biomedical Research Centre (cBRC); Medical Research Council UK; Chief Scientist Office (Scotland); Charles H. Hood Foundation; Phillip T. and Susan M. Ragon Institute Foundation; Bill and Melinda Gates Foundation; National Institute of Allergy and Infectious Diseases [R01AI091786]; Wellcome Trust through the Edinburgh Clinical Academic Track (ECAT) [090385/Z/09/Z]; Comprehensive Local Research Networks (CLRNs); National Institute for Health Research (NIHR), UK; Biomedical Research Centre (BRC); Unit (BRU); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; BBSRC [BBS/E/D/20251969, BBS/E/D/20241864, BBS/E/D/20241866, BBS/E/D/20241863] Funding Source: UKRI; MRC [G0802752, G0901697, G0600371, G0800767, G0600511, MC_U122785833, MC_G1001212, G0800777] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864, BBS/E/D/20251969, BBS/E/D/20241863, BBS/E/D/20241866] Funding Source: researchfish; Cancer Research UK [13031] Funding Source: researchfish; Medical Research Council [975284, MC_G1001212, G0600371, G1000758, G0800777, G0600511, G1000758B, MC_U122785833, G0800767, G0802752, G0901697] Funding Source: researchfish; National Institute for Health Research [DHCS/04/G121/68, CL-2007-21-012, NF-SI-0508-10212] Funding Source: researchfish; Wellcome Trust [096964/Z/11/Z] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, S06/001] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Imperial's Comprehensive Biomedical Research Centre (cBRC); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office (Scotland); Charles H. Hood Foundation; Phillip T. and Susan M. Ragon Institute Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust through the Edinburgh Clinical Academic Track (ECAT); Comprehensive Local Research Networks (CLRNs); National Institute for Health Research (NIHR), UK(National Institute for Health Research (NIHR)); Biomedical Research Centre (BRC); Unit (BRU); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK	We would like to thank C. Brandt for maintaining mouse colony health and well-being and T. Hussell for provision of A/X-31 virus. We also thank D. Gurdasani and M. Sandhu for statistical analysis of genotype frequencies. We also thank M. Hu and I. Gallego Romero for calculating genome-wide selection statistics. This work was supported by the Wellcome Trust. The MOSAIC work was supported by Imperial's Comprehensive Biomedical Research Centre (cBRC), the Wellcome Trust (090382/Z/09/Z) and Medical Research Council UK. The GenISIS work was supported by the Chief Scientist Office (Scotland). A. L. B. is the recipient of a Charles H. Hood Foundation Child Health Research Award, and is supported by grants from the Phillip T. and Susan M. Ragon Institute Foundation, the Bill and Melinda Gates Foundation's Global Health Program and the National Institute of Allergy and Infectious Diseases (R01AI091786). J.K.B. is supported by a Wellcome Trust Clinical Lectureship (090385/Z/09/Z) through the Edinburgh Clinical Academic Track (ECAT). We acknowledge the assistance of K. Alshafi, E. Bailey, A. Bermingham, M. Berry, C. Bloom, E. Brannigan, S. Bremang, J. Clark, M. C. Cox, M. Cross, L. A. Cumming, S. Dyas, J. England-Smith, J. Enstone, D. Ferreira, N. Goddard, A. Godlee, S. Gormley, M. Guiver, M. O. Hassan-Ibrahim, H. Hill, P. Holloway, K. Hoschler, G. Houghton, F. Hughes, R. R. Israel, A. Jepson, K. D. Jones, W. P. Kelleher, M. Kidd, K. Knox, A. Lackenby, G. Lloyd, H. Longworth, M. Minns, S. Mookerjee, S. Mt-Isa, D. Muir, A. Paras, V. Pascual, L. Rae, S. Rodenhurst, F. Rozakeas, E. Scott, E. Sergi, N. Shah, V. Sutton, J. Vernazza, A. W. Walker, C. Wenden, T. Wotherspoon, A. D. Wright, F. Wurie and the clinical and laboratory staff of the Alder Hey Children's NHS Foundation Trust, Brighton & Sussex University Hospitals NHS Trust, Central Manchester University Hospitals NHS Foundation Trust, Chelsea and Westminster Hospital NHS Foundation Trust, Alder Hey Children's Hospital and Liverpool School of Tropical Medicine, Health Protection Agency Microbiology Services Colindale, Imperial College Healthcare NHS Trust, Liverpool Women's NHS Foundation Trust, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Royal Brompton and Harefield NHS Foundation Trust, The Roslin Institute, Edinburgh, University Hospitals Coventry and Warwickshire NHS Trust. The MOSAIC consortium was supported by several Comprehensive Local Research Networks (CLRNs), the National Institute for Health Research (NIHR), UK, and by the Biomedical Research Centre (BRC) and Unit (BRU) funds. Finally, we thank all patients and their relatives for their generous agreement to inclusion in this study.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Billharz R, 2009, J VIROL, V83, P10557, DOI 10.1128/JVI.00330-09; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; BRITTEN KM, 1993, BIOTECH HISTOCHEM, V68, P271, DOI 10.3109/10520299309105629; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Ellis J, 2011, EUROSURVEILLANCE, V16, P2; Fay JC, 2000, GENETICS, V155, P1405; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Hutchinson EC, 2008, J VIROL, V82, P11869, DOI 10.1128/JVI.01634-08; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; TAJIMA F, 1989, GENETICS, V123, P585; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/nchembio.405, 10.1038/NCHEMBIO.405]; Yum HK, 2001, J IMMUNOL, V167, P6601, DOI 10.4049/jimmunol.167.11.6601	33	526	557	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2012	484	7395					519	U146		10.1038/nature10921	http://dx.doi.org/10.1038/nature10921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22446628	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000303200400052
J	Carlton, JG; Caballe, A; Agromayor, M; Kloc, M; Martin-Serrano, J				Carlton, Jeremy G.; Caballe, Anna; Agromayor, Monica; Kloc, Magdalena; Martin-Serrano, Juan			ESCRT-III Governs the Aurora B-Mediated Abscission Checkpoint Through CHMP4C	SCIENCE			English	Article							CHROMOSOME SEGREGATION; CELL-DIVISION; CYTOKINESIS; MACHINERY; MIDBODY; PROTEIN; RECRUITMENT; CEP55; COMPLETION; DYNAMICS	The endosomal sorting complex required for transport (ESCRT) machinery plays an evolutionarily conserved role in cytokinetic abscission, the final step of cell division where daughter cells are physically separated. Here, we show that charged multivesicular body (MVB) protein 4C (CHMP4C), a human ESCRT-III subunit, is involved in abscission timing. This function correlated with its differential spatiotemporal distribution during late stages of cytokinesis. Accordingly, CHMP4C functioned in the Aurora B-dependent abscission checkpoint to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage. CHMP4C engaged the chromosomal passenger complex (CPC) via interaction with Borealin, which suggested a model whereby CHMP4C inhibits abscission upon phosphorylation by Aurora B. Thus, the ESCRT machinery may protect against genetic damage by coordinating midbody resolution with the abscission checkpoint.	[Carlton, Jeremy G.; Caballe, Anna; Agromayor, Monica; Kloc, Magdalena; Martin-Serrano, Juan] Kings Coll London, Sch Med, Dept Infect Dis, London SE1 9RT, England	University of London; King's College London	Martin-Serrano, J (corresponding author), Kings Coll London, Sch Med, Dept Infect Dis, London SE1 9RT, England.	juan.martin_serrano@kcl.ac.uk	Carlton, Jeremy/C-7702-2014; Carlton, Jeremy/X-2918-2019	Carlton, Jeremy/0000-0002-7255-1894; Caballe, Anna/0000-0002-3508-8474; Agromayor, Monica/0000-0001-6477-1750; Martin-Serrano, Juan/0000-0002-8183-3914	Medical Research Council [G0802777]; Lister Institute for Preventative Medicine; EMBO; Wellcome Trust [WT093056MA, 092429/Z/10/Z]; U.K. National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas's National Health Service Foundation Trust; King's College London; MRC [G0802777] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute for Preventative Medicine; EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome Trust); U.K. National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas's National Health Service Foundation Trust; King's College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Bieniasz for kind gifts of GFP-CHMP4-expressing cells. J.M.-S was funded by the Medical Research Council (G0802777), the Lister Institute for Preventative Medicine and the EMBO Young Investigators Program. J.M.-S and M. A. were funded by Wellcome Trust grant (WT093056MA). J.G.C. was funded by Wellcome Trust Value in People award (092429/Z/10/Z). We acknowledge the U.K. National Institute for Health Research Comprehensive Biomedical Research Centre at Guy's and St. Thomas's National Health Service Foundation Trust and King's College London for an equipment grant.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108; Caballe A, 2011, TRAFFIC, V12, P1318, DOI 10.1111/j.1600-0854.2011.01244.x; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Howard TL, 2001, J CELL SCI, V114, P2395; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Mackay DR, 2010, J CELL BIOL, V191, P923, DOI 10.1083/jcb.201007124; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Stauffer DR, 2001, J CELL SCI, V114, P2383; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512	28	186	192	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					220	225		10.1126/science.1217180	http://dx.doi.org/10.1126/science.1217180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22422861	Green Accepted			2022-12-01	WOS:000302703900048
J	Hong, WZ; Mosca, TJ; Luo, LQ				Hong, Weizhe; Mosca, Timothy J.; Luo, Liqun			Teneurins instruct synaptic partner matching in an olfactory map	NATURE			English	Article							RICH REPEAT PROTEINS; TRANSMEMBRANE PROTEINS; PAIR-RULE; RECEPTOR NEURONS; DROSOPHILA; GENE; EXPRESSION; SYSTEM; CHEMOAFFINITY; TRANSGENESIS	Neurons are interconnected with extraordinary precision to assemble a functional nervous system. Compared to axon guidance, far less is understood about how individual pre- and postsynaptic partners are matched. To ensure the proper relay of olfactory information in the fruitfly Drosophila, axons of similar to 50 classes of olfactory receptor neurons (ORNs) form one-to-one connections with dendrites of similar to 50 classes of projection neurons (PNs). Here, using genetic screens, we identified two evolutionarily conserved, epidermal growth factor (EGF)-repeat containing transmembrane Teneurin proteins, Ten-m and Ten-a, as synaptic-partner-matching molecules between PN dendrites and ORN axons. Ten-m and Ten-a are highly expressed in select PN-ORN matching pairs. Teneurin loss- and gain-of-function cause specific mismatching of select ORNs and PNs. Finally, Teneurins promote homophilic interactions in vitro, and Ten-m co-expression in non-partner PNs and ORNs promotes their ectopic connections in vivo. We propose that Teneurins instruct matching specificity between synaptic partners through homophilic attraction.	[Hong, Weizhe; Mosca, Timothy J.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	lluo@stanford.edu	Hong, Weizhe/E-3164-2010; Hong, Weizhe/AAD-7172-2020	Hong, Weizhe/0000-0003-1523-8575; Hong, Weizhe/0000-0003-1523-8575; Luo, Liqun/0000-0001-5467-9264; Mosca, Timothy/0000-0003-3485-0719	National Institutes of Health (NIH) [R01 DC-005982, 5T32 NS007280, HD007249]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank V. Favaloro for advice on biochemistry and D. Luginbuhl for technical assistance; K. Zinn for the EP collection; H. Zhu for the initial contribution; R. Wides and S. Baumgartner for teneurin reagents; B. Zhang, Bloomington, Kyoto, Harvard and Vienna Stock Centers for fly stocks; BestGene for injection service; and K. Shen, T. Clandinin, D. Berns, V. Favaloro, X. Gao, S. Hippenmeyer, C. Liu, K. Miyamichi and X. Yu for critiques. Supported by a National Institutes of Health (NIH) grant (R01 DC-005982 to L.L.), and Epilepsy, Neonatology and Developmental Biology Training Grants (NIH 5T32 NS007280 and HD007249 to T.J.M.). L.L. is an investigator of the Howard Hughes Medical Institute.	BAUMGARTNER S, 1993, MECH DEVELOP, V40, P165, DOI 10.1016/0925-4773(93)90074-8; BAUMGARTNER S, 1994, EMBO J, V13, P3728, DOI 10.1002/j.1460-2075.1994.tb06682.x; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bohm RA, 2010, P NATL ACAD SCI USA, V107, P16378, DOI 10.1073/pnas.1004669107; Brochtrup A, 2011, CURR OPIN NEUROBIOL, V21, P85, DOI 10.1016/j.conb.2010.11.001; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Chou YH, 2010, CELL, V142, P954, DOI 10.1016/j.cell.2010.08.015; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Endo K, 2007, NAT NEUROSCI, V10, P153, DOI 10.1038/nn1832; Fascetti N, 2002, MECH DEVELOP, V114, P197, DOI 10.1016/S0925-4773(02)00055-2; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kinel-Tahan Y, 2007, DEV DYNAM, V236, P2541, DOI 10.1002/dvdy.21284; Komiyama T, 2006, CURR OPIN NEUROBIOL, V16, P67, DOI 10.1016/j.conb.2005.12.002; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Lattemann M, 2007, NEURON, V53, P169, DOI 10.1016/j.neuron.2006.12.024; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; Liebl FLW, 2006, J NEUROBIOL, V66, P332, DOI 10.1002/neu.20229; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Rakovitsky N, 2007, MECH DEVELOP, V124, P911, DOI 10.1016/j.mod.2007.08.003; Rubin BP, 2002, DEVELOPMENT, V129, P4697; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tea JS, 2010, J NEUROSCI, V30, P9939, DOI 10.1523/JNEUROSCI.1643-10.2010; Toba G, 1999, GENETICS, V151, P725; Tucker RP, 2007, INT J BIOCHEM CELL B, V39, P292, DOI 10.1016/j.biocel.2006.09.012; Tucker RP, 2006, DEV BIOL, V290, P237, DOI 10.1016/j.ydbio.2005.11.038; van der Goes van Naters W, 2007, CURR BIOL, V17, P606, DOI DOI 10.1016/J.CUB.2007.02.043; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Young TR, 2009, INT J BIOCHEM CELL B, V41, P990, DOI 10.1016/j.biocel.2008.06.014; Zheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022956; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	63	151	155	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					201	+		10.1038/nature10926	http://dx.doi.org/10.1038/nature10926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22425994	Green Accepted			2022-12-01	WOS:000303149900027
J	Shapiro, BJ; Friedman, J; Cordero, OX; Preheim, SP; Timberlake, SC; Szabo, G; Polz, MF; Alm, EJ				Shapiro, B. Jesse; Friedman, Jonathan; Cordero, Otto X.; Preheim, Sarah P.; Timberlake, Sonia C.; Szabo, Gitta; Polz, Martin F.; Alm, Eric J.			Population Genomics of Early Events in the Ecological Differentiation of Bacteria	SCIENCE			English	Article							FUNDAMENTAL UNITS; RECOMBINATION; SELECTION	Genetic exchange is common among bacteria, but its effect on population diversity during ecological differentiation remains controversial. A fundamental question is whether advantageous mutations lead to selection of clonal genomes or, as in sexual eukaryotes, sweep through populations on their own. Here, we show that in two recently diverged populations of ocean bacteria, ecological differentiation has occurred akin to a sexual mechanism: A few genome regions have swept through subpopulations in a habitat-specific manner, accompanied by gradual separation of gene pools as evidenced by increased habitat specificity of the most recent recombinations. These findings reconcile previous, seemingly contradictory empirical observations of the genetic structure of bacterial populations and point to a more unified process of differentiation in bacteria and sexual eukaryotes than previously thought.	[Cordero, Otto X.; Preheim, Sarah P.; Szabo, Gitta; Polz, Martin F.; Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Shapiro, B. Jesse; Friedman, Jonathan; Alm, Eric J.] MIT, Program Computat & Syst Biol, Cambridge, MA 02139 USA; [Shapiro, B. Jesse; Alm, Eric J.] Broad Inst, Cambridge, MA 02142 USA; [Timberlake, Sonia C.; Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Polz, MF (corresponding author), MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.	mpolz@mit.edu; ejalm@mit.edu	Shapiro, B. Jesse/U-9337-2019; Friedman, Jonathan/I-6930-2019; Polz, Martin/ABE-7199-2020; Preheim, Sarah P/B-3432-2010	Shapiro, B. Jesse/0000-0001-6819-8699; Friedman, Jonathan/0000-0001-8476-8030; Preheim, Sarah P/0000-0001-7365-2382; Szabo, Gitta/0000-0002-0397-3022; /0000-0001-9296-3733; Polz, Martin/0000-0002-4975-2946	NSF [DEB-0918333, 0821391]; Gordon and Betty Moore Foundation; Department of Energy Genomes; Moore Foundation; Broad Institute; Natural Sciences and Engineering Research Council of Canada; Harvard MIDAS Center for Communicable Disease Dynamics; Merck-MIT; Netherlands Organisation for Scientific Research; Rosztoczy Foundation; Division Of Ocean Sciences [0911031] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Department of Energy Genomes(United States Department of Energy (DOE)); Moore Foundation(Gordon and Betty Moore Foundation); Broad Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Harvard MIDAS Center for Communicable Disease Dynamics; Merck-MIT(Merck & Company); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Rosztoczy Foundation; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. DeLong, S. W. Chisholm, J. Wakeley, P. Sabeti, W. Hanage, D. Neafsey, and M. Coleman for valuable suggestions and comments, and X. Didelot and P. Marttinen for help with software. Funding for this work was provided by NSF grant DEB-0918333 (to E.J.A. and M.F.P.), the NSF-supported Woods Hole Center for Oceans and Human Health (COOH), and grants from the Gordon and Betty Moore Foundation and the Department of Energy Genomes to Life program (M.F.P.). Funding for genome sequencing was provided by the Moore Foundation and the Broad Institute's SPARC program. Computational resources were provided by NSF grant 0821391. Support was provided by a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada and a postdoctoral fellowship from the Harvard MIDAS Center for Communicable Disease Dynamics (B.J.S.); a Merck-MIT fellowship (J.F.); the Netherlands Organisation for Scientific Research (O.X.C.); and the Rosztoczy Foundation (G.S.). Whole genomes sequences have been deposited at the DNA Data Bank of Japan, European Molecular Biology Laboratory, and GenBank under accessions AHTI00000000, AICZ00000000, and AIDA00000000-AIDS00000000 (table S6).	Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Denef VJ, 2010, ISME J, V4, P599, DOI 10.1038/ismej.2009.158; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; Eppley JM, 2007, GENETICS, V177, P407, DOI 10.1534/genetics.107.072892; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; GUTTMAN DS, 1994, GENETICS, V138, P993; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Majewski J, 2001, FEMS MICROBIOL LETT, V199, P161, DOI 10.1016/S0378-1097(01)00183-5; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Papke RT, 2007, P NATL ACAD SCI USA, V104, P14092, DOI 10.1073/pnas.0706358104; Preheim SP, 2011, APPL ENVIRON MICROB, V77, P7195, DOI 10.1128/AEM.00665-11; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Shapiro BJ, 2009, TRENDS MICROBIOL, V17, P196, DOI 10.1016/j.tim.2009.02.002; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Visick KL, 2009, MOL MICROBIOL, V74, P782, DOI 10.1111/j.1365-2958.2009.06899.x	25	335	337	4	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					48	51		10.1126/science.1218198	http://dx.doi.org/10.1126/science.1218198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491847	Green Accepted, Green Submitted			2022-12-01	WOS:000302405400046
J	Li, H; Opgenorth, PH; Wernick, DG; Rogers, S; Wu, TY; Higashide, W; Malati, P; Huo, YX; Cho, KM; Liao, JC				Li, Han; Opgenorth, Paul H.; Wernick, David G.; Rogers, Steve; Wu, Tung-Yun; Higashide, Wendy; Malati, Peter; Huo, Yi-Xin; Cho, Kwang Myung; Liao, James C.			Integrated Electromicrobial Conversion of CO2 to Higher Alcohols	SCIENCE			English	Article							ESCHERICHIA-COLI; CARBON-DIOXIDE; FORMIC-ACID; REDUCTION		[Li, Han; Wernick, David G.; Wu, Tung-Yun; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Li, Han; Liao, James C.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Opgenorth, Paul H.; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Rogers, Steve; Higashide, Wendy; Huo, Yi-Xin; Cho, Kwang Myung] Easel Biotechnol, Los Angeles, CA 90024 USA; [Malati, Peter] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Liao, James C.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.	liaoj@seas.ucla.edu		huo, yixin/0000-0003-4644-999X; Liao, James/0000-0002-4580-7276	Advanced Research Projects Agency-Energy (ARPA-E)	Advanced Research Projects Agency-Energy (ARPA-E)(United States Department of Energy (DOE))	This work is supported by the Electrofuel program of Advanced Research Projects Agency-Energy (ARPA-E).	Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2010, APPL MICROBIOL BIOT, V85, P651, DOI 10.1007/s00253-009-2085-6; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; IKEDA S, 1987, B CHEM SOC JPN, V60, P2517, DOI 10.1246/bcsj.60.2517; Mehdi H, 2008, TOP CATAL, V48, P49, DOI 10.1007/s11244-008-9047-6; Michan C, 1999, J BACTERIOL, V181, P2759; Pohlmann A, 2000, MOL MICROBIOL, V38, P626, DOI 10.1046/j.1365-2958.2000.02157.x; TOUATI D, 1988, J BACTERIOL, V170, P2511, DOI 10.1128/jb.170.6.2511-2520.1988; UDUPA KS, 1971, ELECTROCHIM ACTA, V16, P1593, DOI 10.1016/0013-4686(71)80028-2	9	444	475	26	662	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1596	1596		10.1126/science.1217643	http://dx.doi.org/10.1126/science.1217643			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461604				2022-12-01	WOS:000302062600036
J	Rankin, EB; Wu, C; Khatri, R; Wilson, TLS; Andersen, R; Araldi, E; Rankin, AL; Yuan, J; Kuo, CJ; Schipani, E; Giaccia, AJ				Rankin, Erinn B.; Wu, Colleen; Khatri, Richa; Wilson, Tremika L. S.; Andersen, Rebecca; Araldi, Elisa; Rankin, Andrew L.; Yuan, Jenny; Kuo, Calvin J.; Schipani, Emestina; Giaccia, Amato J.			The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPO	CELL			English	Article							HYPOXIA-INDUCIBLE-FACTOR; HEMATOPOIETIC STEM-CELLS; TUMOR-SUPPRESSOR; MICE; NICHE; HIF-1-ALPHA; ANEMIA; DIFFERENTIATION; PROGENITORS; DEFICIENCY	Osteoblasts are an important component of the hematopoietic microenvironment in bone. However, the mechanisms by which osteoblasts control hematopoiesis remain unknown. We show that augmented HIF signaling in osteoprogenitors results in HSC niche expansion associated with selective expansion of the erythroid lineage. Increased red blood cell production occurred in an EPO-dependent manner with increased EPO expression in bone and suppressed EPO expression in the kidney. In contrast, inactivation of HIF in osteoprogenitors reduced EPO expression in bone. Importantly, augmented HIF activity in osteoprogenitors protected mice from stress-induced anemia. Pharmacologic or genetic inhibition of prolyl hydroxylases1/2/3 in osteoprogenitors elevated EPO expression in bone and increased hematocrit. These data reveal an unexpected role for osteoblasts in the production of EPO and modulation of erythropoiesis. Furthermore, these studies demonstrate a molecular role for osteoblastic PHD/VHL/HIF signaling that can be targeted to elevate both HSCs and erythroid progenitors in the local hematopoietic microenvironment.	[Rankin, Erinn B.; Wu, Colleen; Andersen, Rebecca; Giaccia, Amato J.] Stanford Univ, Div Radiat & Canc Biol, Dept Radiat Oncol, Ctr Clin Sci Res, Stanford, CA 94303 USA; [Yuan, Jenny; Kuo, Calvin J.] Stanford Univ, Div Hematol, Stanford, CA 94303 USA; [Khatri, Richa; Wilson, Tremika L. S.; Araldi, Elisa; Schipani, Emestina] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA 02114 USA; [Rankin, Andrew L.] Pfizer, Inflammat & Immunol, Cambridge, MA 02140 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Pfizer	Giaccia, AJ (corresponding author), Stanford Univ, Div Radiat & Canc Biol, Dept Radiat Oncol, Ctr Clin Sci Res, Stanford, CA 94303 USA.	giaccia@stanford.edu	Araldi, Elisa/AAZ-5946-2021	Andersen, Rebecca/0000-0002-0702-3120; Kuo, Calvin/0000-0002-7427-5985; Araldi, Elisa/0000-0002-6596-6784; Rankin, Erinn/0000-0002-2045-2296	NIH [CA67166, CA088480, AR048191-06]; Sydney Frank Foundation; NIH National Research Service from the National Cancer Institute [T32 CA09151]; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [T32CA009151, R01CA088480, P01CA067166, R01CA116685, R37CA088480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085527] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sydney Frank Foundation; NIH National Research Service from the National Cancer Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants CA67166 and CA088480 and the Sydney Frank Foundation (A.J.G.) and NIH AR048191-06 (A.J.G. and E.S.). E.B.R. is supported by the NIH National Research Service Award T32 CA09151 from the National Cancer Institute. C.W. is supported by a Canadian Institutes of Health Research Fellowship. The authors would like to thank all of the investigators that generated and made the floxed/transgenic mice available for these studies: Dr. Volker Haase (Vhlh floxed), Dr. Randall Johnson (Hif-1 floxed), Drs. Brian Keith and Celeste Simon (Hif-2 floxed), Dr. Guo-Hua Fong (Phd1,2,3 floxed), and Dr. Andrew McMahon (Osterix-Cre).	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Akeno N, 2002, ENDOCRINOLOGY, V143, P420, DOI 10.1210/en.143.2.420; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Maes C, 2010, EMBO J, V29, P424, DOI 10.1038/emboj.2009.361; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Murray JK, 2010, J COMB CHEM, V12, P676, DOI 10.1021/cc100073a; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Ohishi M, 2009, AM J PATHOL, V174, P2160, DOI 10.2353/ajpath.2009.081026; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yan L, 2010, EXPERT OPIN THER PAT, V20, P1219, DOI 10.1517/13543776.2010.510836; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhan Yuxia, 2008, V430, P161, DOI 10.1007/978-1-59745-182-6_11; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	43	196	217	3	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					63	74		10.1016/j.cell.2012.01.051	http://dx.doi.org/10.1016/j.cell.2012.01.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464323	Green Accepted, Bronze			2022-12-01	WOS:000302235400010
J	Baker, MG; Barnard, LT; Kvalsvig, A; Verrall, A; Zhang, J; Keall, M; Wilson, N; Wall, T; Howden-Chapman, P				Baker, Michael G.; Barnard, Lucy Telfar; Kvalsvig, Amanda; Verrall, Ayesha; Zhang, Jane; Keall, Michael; Wilson, Nick; Wall, Teresa; Howden-Chapman, Philippa			Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study	LANCET			English	Article							ACUTE RHEUMATIC-FEVER; UNITED-STATES; DEVELOPED COUNTRY; TRENDS; HOSPITALIZATIONS; CAMPYLOBACTERIOSIS; DEPRIVATION; POPULATION; MORTALITY; CHILDREN	Background Although the burden of infectious diseases seems to be decreasing in developed countries, few national studies have measured the total incidence of these diseases. We aimed to develop and apply a robust systematic method for monitoring the epidemiology of serious infectious diseases. Methods We did a national epidemiological study with all hospital admissions for infectious and non-infectious diseases in New Zealand from 1989 to 2008, to investigate trends in incidence and distribution by ethnic group and socioeconomic status. We extended a recoding system based on the ninth revision of international classification of diseases (ICD-9) to the tenth revision (ICD-10), and applied this to data for hospital admissions from the New Zealand Ministry of Health, National Minimum Dataset. We filtered results to account for changes in health-care practices over time. Acute overnight admissions were the events of interest. Findings Infectious diseases made the largest contribution to hospital admissions of any cause. Their contribution increased from 20.5% of acute admissions in 1989-93, to 26.6% in 2004-08. We noted clear ethnic and social inequalities in infectious disease risk. In 2004-08, the age-standardised rate ratio was 2.15 (95% CI 2.14-2.16) for Maori (indigenous New Zealanders) and 2.35 (2.34-2.37) for Pacific peoples compared with the European and other group. The ratio was 2.81 (2.80-2.83) for the most socioeconomically deprived quintile compared with the least deprived quintile. These inequalities have increased substantially in the past 20 years, particularly for Maori and Pacific peoples in the most deprived quintile. Interpretation These findings support the need for stronger prevention efforts for infectious diseases, and reinforce the need to reduce ethnic and social inequalities and to address disparities in broad social determinants such as income levels, housing conditions, and access to health services. Our method could be adapted for infectious disease surveillance in other countries.	[Baker, Michael G.; Barnard, Lucy Telfar; Kvalsvig, Amanda; Verrall, Ayesha; Zhang, Jane; Keall, Michael; Wilson, Nick; Howden-Chapman, Philippa] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Wall, Teresa] Minist Hlth, Maori Hlth Directorate, Wellington, New Zealand	University of Otago	Baker, MG (corresponding author), Univ Otago, Dept Publ Hlth, POB 7343, Wellington 6242, New Zealand.	michael.baker@otago.ac.nz	Barnard-Brak, Lucy/K-2009-2019; Verrall, Ayesha/U-7223-2019; Barnard-Brak, Lucy/T-6856-2018	Verrall, Ayesha/0000-0001-9672-1352; Barnard-Brak, Lucy/0000-0001-7239-0720	New Zealand Ministry of Health; New Zealand Health Research Council	New Zealand Ministry of Health; New Zealand Health Research Council(Health Research Council of New Zealand)	New Zealand Ministry of Health, New Zealand Health Research Council.	[Anonymous], 2004, ETHN DAT PROT HLTH D; Armstrong GL, 1999, ARCH INTERN MED, V159, P2531, DOI 10.1001/archinte.159.21.2531; Baker M, 2000, PEDIATR INFECT DIS J, V19, P983, DOI 10.1097/00006454-200010000-00009; Baker M, 2008, J EPIDEMIOL COMMUN H, V62, P715, DOI 10.1136/jech.2007.063610; Baker M, 2012, DISTRIBUTION HOUSEHO; Baker MG, 2007, EPIDEMIOL INFECT, V135, P163, DOI 10.1017/S0950268806006583; Baker MG, 2009, EUROSURVEILLANCE, V14, P6; Baker MG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-332; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Christensen KLY, 2009, CLIN INFECT DIS, V49, P1025, DOI 10.1086/605562; Ford AC, 2006, COCHRANE DB SYST REV, V19; French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0; Grant CC, 1999, NEW ZEAL MED J, V112, P345; Harris R, 2007, HAUORA MAORI STANDAR, P249; Holman RC, 2001, AM J PUBLIC HEALTH, V91, P425, DOI 10.2105/AJPH.91.3.425; Jaine R, 2008, J PAEDIATR CHILD H, V44, P564, DOI 10.1111/j.1440-1754.2008.01384.x; Jaine R, 2011, PEDIATR INFECT DIS J, V30, P315, DOI 10.1097/INF.0b013e3181fbd85b; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Langley J, 2002, INJ PREV, V8, P332, DOI 10.1136/ip.8.4.332; Mills CF, 2002, NEW ZEAL MED J, V115, P254; *MIN HLTH, 2001, INT APPR INF DIS PRI; Ministry of Health, 2008, PRES ETHN COMP PRIOR; O'Hallahan J, 2009, NEW ZEAL MED J, V122, P48; O'Sullivan CE, 2010, EPIDEMIOL INFECT, V15, P1; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Perry B., 2010, HOUSEHOLD INCOMES NZ; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Rothman K. J., 2008, MODERN EPIDEMIOLOGY; Salmond C, 1998, AUST NZ J PUBL HEAL, V22, P835, DOI 10.1111/j.1467-842X.1998.tb01505.x; Sears A, 2011, EMERG INFECT DIS, V17, P1007, DOI [10.3201/eid1706.101272, 10.3201/eid/1706.101272]; Simonsen L, 1998, ARCH INTERN MED, V158, P1923, DOI 10.1001/archinte.158.17.1923; Statistics New Zealand, 2003, WHAT IS EXT CROWD NZ; Tobias M, 2008, AUST NZ J PUBL HEAL, V32, P431, DOI 10.1111/j.1753-6405.2008.00275.x	35	175	177	5	49	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 24	2012	379	9821					1112	1119		10.1016/S0140-6736(11)61780-7	http://dx.doi.org/10.1016/S0140-6736(11)61780-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916VR	22353263				2022-12-01	WOS:000302131800033
J	Hagihara, A; Hasegawa, M; Abe, T; Nagata, T; Wakata, Y; Miyazaki, S				Hagihara, Akihito; Hasegawa, Manabu; Abe, Takeru; Nagata, Takashi; Wakata, Yoshifumi; Miyazaki, Shogo			Prehospital Epinephrine Use and Survival Among Patients With Out-of-Hospital Cardiac Arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EUROPEAN-RESUSCITATION-COUNCIL; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; CARDIOPULMONARY-RESUSCITATION; STROKE-FOUNDATION; RECOMMENDED GUIDELINES; CHEST-COMPRESSION; UTSTEIN STYLE; LIFE-SUPPORT; TASK-FORCE	Context Epinephrine is widely used in cardiopulmonary resuscitation for out-of-hospital cardiac arrest (OHCA). However, the effectiveness of epinephrine use before hospital arrival has not been established. Objective To evaluate the association between epinephrine use before hospital arrival and short-and long-term mortality in patients with cardiac arrest. Design, Setting, and Participants Prospective, nonrandomized, observational propensity analysis of data from 417 188 OHCAs occurring in 2005-2008 in Japan in which patients aged 18 years or older had an OHCA before arrival of emergency medical service (EMS) personnel, were treated by EMS personnel, and were transported to the hospital. Main Outcome Measures Return of spontaneous circulation before hospital arrival, survival at 1 month after cardiac arrest, survival with good or moderate cerebral performance (Cerebral Performance Category [CPC] 1 or 2), and survival with no, mild, or moderate neurological disability (Overall Performance Category [OPC] 1 or 2). Results Return of spontaneous circulation before hospital arrival was observed in 2786 of 15 030 patients (18.5%) in the epinephrine group and 23 042 of 402 158 patients (5.7%) in the no-epinephrine group (P<.001); it was observed in 2446 (18.3%) and 1400 (10.5%) of 13 401 propensity-matched patients, respectively (P<.001). In the total sample, the numbers of patients with 1-month survival and survival with CPC 1 or 2 and OPC 1 or 2, respectively, were 805 (5.4%), 205 (1.4%), and 211 (1.4%) with epinephrine and 18 906 (4.7%), 8903 (2.2%), and 8831 (2.2%) without epinephrine (all P<.001). Corresponding numbers in propensity-matched patients were 687 (5.1%), 173 (1.3%), and 178 (1.3%) with epinephrine and 944 (7.0%), 413 (3.1%), and 410 (3.1%) without epinephrine (all P<.001). In all patients, a positive association was observed between prehospital epinephrine and return of spontaneous circulation before hospital arrival (adjusted odds ratio [OR], 2.36; 95% CI, 2.22-2.50; P<.001). In propensity-matched patients, a positive association was also observed (adjusted OR, 2.51; 95% CI, 2.24-2.80; P<.001). In contrast, among all patients, negative associations were observed between prehospital epinephrine and long-term outcome measures (adjusted ORs: 1-month survival, 0.46 [95% CI, 0.42-0.51]; CPC 1-2, 0.31 [95% CI, 0.26-0.36]; and OPC 1-2, 0.32 [95% CI, 0.27-0.38]; all P<.001). Similar negative associations were observed among propensity-matched patients (adjusted ORs: 1-month survival, 0.54 [95% CI, 0.43-0.68]; CPC 1-2, 0.21 [95% CI, 0.10-0.44]; and OPC 1-2, 0.23 [95% CI, 0.11-0.45]; all P<.001). Conclusion Among patients with OHCA in Japan, use of prehospital epinephrine was significantly associated with increased chance of return of spontaneous circulation before hospital arrival but decreased chance of survival and good functional outcomes 1 month after the event. JAMA. 2012;307(11):1161-1168	[Hagihara, Akihito] Kyushu Univ, Grad Sch Med, Dept Hlth Serv Management & Policy, Higashi Ku, Fukuoka 8128582, Japan; [Nagata, Takashi] Kyushu Univ Hosp, Dept Emergency, Fukuoka 812, Japan; [Nagata, Takashi] Kyushu Univ Hosp, Crit Care Ctr, Fukuoka 812, Japan; [Hasegawa, Manabu] Teikyo Heisei Univ, Minist Internal Affairs & Commun, Fire & Disaster Management Agcy, Ambulance Serv,Planning Div, Tokyo, Japan; [Miyazaki, Shogo] Teikyo Heisei Univ, Fac Hlth Care, Dept Acupuncture & Moxibust, Tokyo, Japan	Kyushu University; Kyushu University; Kyushu University	Hagihara, A (corresponding author), Kyushu Univ, Grad Sch Med, Dept Hlth Serv Management & Policy, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hagihara@hsmp.med.kyushu-u.ac.jp	Abe, Takeru/J-9512-2014	Abe, Takeru/0000-0003-3496-1953; Miyazaki, Shogo/0000-0001-7270-0725				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Angelos MG, 2008, RESUSCITATION, V77, P101, DOI 10.1016/j.resuscitation.2007.10.017; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; [Anonymous], 2007, JAP GUID EM CAR CARD; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Fire and Disaster Management Agency Guidelines for Resuscitation by Emergency Life-saving Technicians, 2006, FIRE DISASTER MANAGE; Grogaard HK, 2007, J AM COLL CARDIOL, V50, P1093, DOI 10.1016/j.jacc.2007.05.028; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Holmberg M, 2002, RESUSCITATION, V54, P37, DOI 10.1016/S0300-9572(02)00048-5; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Morrison LJ, 2010, CIRCULATION, V122, P8345, DOI 10.1161/CIRCULATIONAHA.110.971051; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Ogawa T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7106; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Ong MEH, 2007, ANN EMERG MED, V50, P635, DOI 10.1016/j.annemergmed.2007.03.028; OTTO CW, 1984, ANN EMERG MED, V13, P840, DOI 10.1016/S0196-0644(84)80455-2; Parsons LS, REDUCING BIAS PROPEN; PEARSON JW, 1963, AM HEART J, V66, P210, DOI 10.1016/0002-8703(63)90036-X; Ristagno G, 2007, CRIT CARE MED, V35, P2145, DOI 10.1097/01.CCM.0000280427.76175.D2; RIVERS EP, 1994, CHEST, V106, P1499, DOI 10.1378/chest.106.5.1499; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; TANG WC, 1995, CIRCULATION, V92, P3089, DOI 10.1161/01.CIR.92.10.3089; Virkkunen I, 2008, RESUSCITATION, V77, P207, DOI 10.1016/j.resuscitation.2007.12.006; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431	31	294	319	0	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2012	307	11					1161	1168		10.1001/jama.2012.294	http://dx.doi.org/10.1001/jama.2012.294			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911HN	22436956				2022-12-01	WOS:000301708000024
J	McDole, JR; Wheeler, LW; McDonald, KG; Wang, BM; Konjufca, V; Knoop, KA; Newberry, RD; Miller, MJ				McDole, Jeremiah R.; Wheeler, Leroy W.; McDonald, Keely G.; Wang, Baomei; Konjufca, Vjollca; Knoop, Kathryn A.; Newberry, Rodney D.; Miller, Mark J.			Goblet cells deliver luminal antigen to CD103(+) dendritic cells in the small intestine	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; BARRIER FUNCTION; CROHNS-DISEASE; MICE; TIGHT; COLITIS; LUMEN; MUC2	The intestinal immune system is exposed to a mixture of foreign antigens from diet, commensal flora and potential pathogens. Understanding how pathogen-specific immunity is elicited while avoiding inappropriate responses to the background of innocuous antigens is essential for understanding and treating intestinal infections and inflammatory diseases. The ingestion of protein antigen can induce oral tolerance, which is mediated in part by a subset of intestinal dendritic cells (DCs) that promote the development of regulatory T cells(1). The lamina propria (LP) underlies the expansive single-cell absorptive villous epithelium and contains a large population of DCs (CD11c(+) CD11b(+) MHCII+ cells) comprised of two predominant subsets: CD103(+) CX(3)CR1(-) DCs, which promote IgA production, imprint gut homing on lymphocytes and induce the development of regulatory T cells(2-9), and CD103(-) CX(3)CR1(+) DCs (with features of macrophages), which promote tumour necrosis factor-alpha (TNF-alpha) production, colitis, and the development of T(H)17 T cells(5-7,10). However, the mechanisms by which different intestinal LP-DC subsets capture luminal antigens in vivo remains largely unexplored. Using a minimally disruptive in vivo imaging approach we show that in the steady state, small intestine goblet cells (GCs) function as passages delivering low molecular weight soluble antigens from the intestinal lumen to underlying CD103(+) LP-DCs. The preferential delivery of antigens to DCs with tolerogenic properties implies a key role for this GC function in intestinal immune homeostasis.	[McDole, Jeremiah R.; Wang, Baomei; Miller, Mark J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Wheeler, Leroy W.; McDonald, Keely G.; Knoop, Kathryn A.; Newberry, Rodney D.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Konjufca, Vjollca] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Washington University (WUSTL); Washington University (WUSTL); Southern Illinois University System; Southern Illinois University	Miller, MJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	rnewberry@wustl.edu; miller@pathology.wustl.edu	Knoop, Kathryn/AAM-3570-2020	Knoop, Kathryn/0000-0003-2007-3066; Newberry, Rodney/0000-0002-4152-5191; Konjufca, Vjollca/0000-0002-7736-5097	NCI Cancer Center [P30 CA91842];  [DK064798];  [AI083538];  [AI095550];  [DK085941];  [AI077600];  [P30-DK52574]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095550, R01AI077600, R21AI083538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064798, P30DK052574, F32DK085941] Funding Source: NIH RePORTER	NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants DK064798 (R.D.N.), AI083538 (R.D.N.), AI095550 (R.D.N. and M.J.M.), DK085941 (L.W.W.) and AI077600 (M.J.M.). The authors thank W. Beatty for assistance with confocal microscopy, C. Eagon for assistance with human specimens, the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis for the use of the Siteman Flow Cytometry Core, which provided high-speed flow sorting and the Washington University Digestive Disease Research Core Center (DDRCC), which provided gnotobiotic mice. The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant number P30 CA91842. The Washington University DDRCC is supported by grant P30-DK52574.	Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; DVORAK AM, 1980, HUM PATHOL, V11, P561; Eri RD, 2011, MUCOSAL IMMUNOL, V4, P354, DOI 10.1038/mi.2010.74; Faust N, 2000, BLOOD, V96, P719; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hesse M, 2007, EXP CELL RES, V313, P3127, DOI 10.1016/j.yexcr.2007.05.019; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MADARA JL, 1982, J MEMBRANE BIOL, V66, P145, DOI 10.1007/BF01868490; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; McDonald KG, 2010, AM J PATHOL, V176, P2367, DOI 10.2353/ajpath.2010.090723; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; TRABUCCHI E, 1986, INT J TISSUE REACT, V8, P79; Tytgat KMAJ, 1996, BIOCHEM BIOPH RES CO, V224, P397, DOI 10.1006/bbrc.1996.1039; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Watson AJM, 2005, GASTROENTEROLOGY, V129, P902, DOI 10.1053/j.gastro.2005.06.015; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x	32	567	592	7	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					345	U141		10.1038/nature10863	http://dx.doi.org/10.1038/nature10863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22422267	Bronze, Green Accepted			2022-12-01	WOS:000301481800052
J	Peiris, JSM; Poon, LLM; Guan, Y				Peiris, J. S. M.; Poon, L. L. M.; Guan, Y.			Surveillance of Animal Influenza for Pandemic Preparedness	SCIENCE			English	Editorial Material							A VIRUS; H1N1 INFLUENZA; UNITED-STATES; HONG-KONG; RECEPTOR SPECIFICITY; SWINE; TRANSMISSIBILITY; REASSORTMENT; EMERGENCE; EVOLUTION		[Peiris, J. S. M.; Poon, L. L. M.; Guan, Y.] Li Ka Shing Fac Med, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Peiris, JSM (corresponding author), Li Ka Shing Fac Med, Sch Publ Hlth, Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	malik@hku.hk	Poon, Leo Lit Man/C-4382-2009; Poon, Leo/AAP-6887-2020	Poon, Leo Lit Man/0000-0002-9101-7953; Guan, Yi/0000-0001-6057-9243	PHS HHS [HHSN266200700005C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], PIP FRAMEWORK; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Capua I, 2010, EMERG INFECT DIS, V16, P719, DOI 10.3201/eid1604.091593; Chan RWY, 2011, J VIROL, V85, P11581, DOI 10.1128/JVI.05662-11; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Ducatez MF, 2011, EMERG INFECT DIS, V17, P1624, DOI 10.3201/eid1709.110338; Enserink M, 2012, SCIENCE, V335, P20, DOI 10.1126/science.335.6064.20; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; Lau EHY, 2007, EMERG INFECT DIS, V13, P1340, DOI 10.3201/eid1309.061549; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; National Center for Biotechnology Information (NIH), NAT CTR BIOT INF NIH; Nulluswami K., 2011, MMWR-MORBID MORTAL W, V60, P1; OECD, 2006, INN PHARM BIOT COMP; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; van Doremalen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025755; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Webby RJ, 2004, VIRUS RES, V103, P67, DOI 10.1016/j.virusres.2004.02.015; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; World Health Organization, 2011, ANT GEN CHAR INFL A; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108	28	34	34	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2012	335	6073					1173	1174		10.1126/science.1219936	http://dx.doi.org/10.1126/science.1219936			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22345402				2022-12-01	WOS:000301225100026
J	Huang, YWA; Ruiz, CR; Eyler, ECH; Lin, K; Meffert, MK				Huang, Yu-Wen A.; Ruiz, Claudia R.; Eyler, Elizabeth C. H.; Lin, Kathie; Meffert, Mollie K.			Dual Regulation of miRNA Biogenesis Generates Target Specificity in Neurotrophin-Induced Protein Synthesis	CELL			English	Article							MESSENGER-RNAS; TRANSLATION; EXPRESSION; MICRORNAS; INITIATION; LIN-28	Control of translation is a fundamental source of regulation in gene expression. The induction of protein synthesis by brain-derived neurotrophic factor (BDNF) critically contributes to enduring modifications of synaptic function, but how BDNF selectively affects only a minority of expressed mRNAs is poorly understood. We report that BDNF rapidly elevates Dicer, increasing mature miRNA levels and inducing RNA processing bodies in neurons. BDNF also rapidly induces Lin28, causing selective loss of Lin28-regulated miRNAs and a corresponding upregulation in translation of their target mRNAs. Binding sites for Lin28-regulated miRNAs are necessary and sufficient to confer BDNF responsiveness to a transcript. Lin28 deficiency, or expression of a Lin28-resistant Let-7 precursor miRNA, inhibits BDNF translation specificity and BDNF-dependent dendrite arborization. Our data establish that specificity in BDNF-regulated translation depends upon a two-part posttranscriptional control of miRNA biogenesis that generally enhances mRNA repression in association with GW182 while selectively derepressing and increasing translation of specific mRNAs.	[Huang, Yu-Wen A.; Ruiz, Claudia R.; Meffert, Mollie K.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Eyler, Elizabeth C. H.; Lin, Kathie; Meffert, Mollie K.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Meffert, MK (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	mkm@jhmi.edu			Braude Foundation, Johns Hopkins Brain Science Institute; Taiwan's National Science Council [TMS-094-2-A-030]; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080740] Funding Source: NIH RePORTER	Braude Foundation, Johns Hopkins Brain Science Institute; Taiwan's National Science Council; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Fritzler, J. Mendell, G. Hannon, and M. Caterina for generously sharing reagents and equipment. We thank J. Pomerantz and G. Seydoux for critical reading of the manuscript and scientific suggestions, and R. Green, D. Ginty, and A. Kolodkin for helpful discussions. This work was supported by the Braude Foundation, Johns Hopkins Brain Science Institute (to M. K. M.) and Research Grant TMS-094-2-A-030 from Taiwan's National Science Council (to Y.-W.A.H.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Narisawa-Saito M, 1999, NEUROSCIENCE, V88, P1009, DOI 10.1016/S0306-4522(98)00496-5; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Takei N, 2009, J BIOL CHEM, V284, P26340, DOI 10.1074/jbc.M109.023010; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	40	92	95	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					933	946		10.1016/j.cell.2012.01.036	http://dx.doi.org/10.1016/j.cell.2012.01.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385959	Green Accepted, Bronze			2022-12-01	WOS:000300985000014
J	Pfingsten, JS; Goodrich, KJ; Taabazuing, C; Ouenzar, F; Chartrand, P; Cech, TR				Pfingsten, Jennifer S.; Goodrich, Karen J.; Taabazuing, Cornelius; Ouenzar, Faissal; Chartrand, Pascal; Cech, Thomas R.			Mutually Exclusive Binding of Telomerase RNA and DNA by Ku Alters Telomerase Recruitment Model	CELL			English	Article							DOUBLE-STRAND BREAKS; DOMAIN PROTEIN MPS3; SACCHAROMYCES-CEREVISIAE; YEAST TELOMERASE; CATALYTIC SUBUNIT; REPAIR PATHWAY; BUDDING YEAST; IN-VITRO; END; HETERODIMER	In Saccharomyces cerevisiae, the Ku heterodimer contributes to telomere maintenance as acomponent of telomeric chromatin and as an accessory subunit of telomerase. How Ku binding to double-stranded DNA (dsDNA) and to telomerase RNA (TLC1) promotes Ku's telomeric functions is incompletely understood. We demonstrate that deletions designed to constrict the DNA-binding ring of Ku80 disrupt nonhomologous end-joining (NHEJ), telomeric gene silencing, and telomere length maintenance, suggesting that these functions require Ku's DNA end-binding activity. Contrary to the current model, a mutant Ku with low affinity for dsDNA also loses affinity for TLC1 both in vitro and in vivo. Competition experiments reveal that wild-type Ku binds dsDNA and TLC1 mutually exclusively. Cells expressing the mutant Ku are deficient in nuclear accumulation of TLC1, as expected from the RNA-binding defect. These findings force reconsideration of the mechanisms by which Ku assists in recruiting telomerase to natural telomeres and broken chromosome ends.	[Pfingsten, Jennifer S.; Goodrich, Karen J.; Taabazuing, Cornelius; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, Biofrontiers Inst, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Ouenzar, Faissal; Chartrand, Pascal] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Universite de Montreal	Cech, TR (corresponding author), Univ Colorado, Dept Chem & Biochem, Biofrontiers Inst, Howard Hughes Med Inst, Campus Box 215, Boulder, CO 80309 USA.	thomas.cech@colorado.edu	Ouenzar, Faissal/AAF-4332-2020	Chartrand, Pascal/0000-0002-3006-7279; Taabazuing, Cornelius/0000-0003-2361-5457	Canadian Institutes of Health Research [MOP89768]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank Alison Bertuch (Baylor College of Medicine) and Vicki Lundblad (Salk Institute) for generous gifts of yeast strains, Dan Gottschling (Fred Hutchinson Cancer Center) for providing plasmids and discussion, and Titia de Lange (Rockefeller University) for helpful ideas. We thank David B. McKay and Robert Batey (both University of Colorado-Boulder) for assisting in the computational analysis of the competition data and Jacob Schwartz for help with the analysis of real-time RT-PCR data. We also thank Robert Batey, Jeffrey Kieft, Jaya-krishnan Nandakumar, Jacob Schwartz, and Andrea Berman for comments on the manuscript. C. T. was an EXROP student of the Howard Hughes Medical Institute. This work was funded in part by Canadian Institutes of Health Research grant MOP89768 to P. C. J.S.P. and T. R. C. designed the experiments and wrote the paper with input from all authors. J.S.P. performed in vivo-based plating assays and northern blots, purified yeast Ku, and executed all in vitro-based assays. K.J.G. carried out Southern blots, northern Blots, westerns, plating assays, and quantitative RT-PCR. C. T. performed initial plating and Southern and northern experiments. F.O. and P. C. designed and performed cytolocalization of TLC1.	Antoniacci LM, 2007, CELL CYCLE, V6, P75, DOI 10.4161/cc.6.1.3647; Bertuch AA, 2003, MOL CELL BIOL, V23, P8202, DOI 10.1128/MCB.23.22.8202-8215.2003; Bianchi A, 1999, J BIOL CHEM, V274, P21223, DOI 10.1074/jbc.274.30.21223; BLIER PR, 1993, J BIOL CHEM, V268, P7594; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Bullock SL, 2010, NAT STRUCT MOL BIOL, V17, P703, DOI 10.1038/nsmb.1813; Bupp JM, 2007, J CELL BIOL, V179, P845, DOI 10.1083/jcb.200706040; Chan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000236; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen X, 2011, J BIOL CHEM, V286, P4931, DOI 10.1074/jbc.M110.195024; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Ferreira HC, 2011, NAT CELL BIOL, V13, P867, DOI 10.1038/ncb2263; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Gallardo F, 2008, EMBO J, V27, P748, DOI 10.1038/emboj.2008.21; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lopez CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002233; Ma YM, 2001, BIOCHEMISTRY-US, V40, P9638, DOI 10.1021/bi010932v; Milne GT, 1996, MOL CELL BIOL, V16, P4189; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Mozdy AD, 2008, MOL CELL BIOL, V28, P4152, DOI 10.1128/MCB.00512-08; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Pennaneach V, 2006, MOL MICROBIOL, V59, P1357, DOI 10.1111/j.1365-2958.2006.05026.x; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; Qi HY, 2000, GENE DEV, V14, P1777; Reiter NJ, 2008, NUCLEIC ACIDS RES, V36, P1227, DOI 10.1093/nar/gkm1141; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Riha K, 2006, ANNU REV GENET, V40, P237, DOI 10.1146/annurev.genet.39.110304.095755; Roberts SA, 2007, J BIOL CHEM, V282, P10605, DOI 10.1074/jbc.M611125200; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Teixeira MT, 2002, EMBO REP, V3, P652, DOI 10.1093/embo-reports/kvf133; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Yoo S, 1998, BIOCHEMISTRY-US, V37, P1336, DOI 10.1021/bi972100w; Zappulla DC, 2011, RNA, V17, P298, DOI 10.1261/rna.2483611; Zappulla DC, 2005, NAT STRUCT MOL BIOL, V12, P1072, DOI 10.1038/nsmb1019; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261	59	71	71	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					922	932		10.1016/j.cell.2012.01.033	http://dx.doi.org/10.1016/j.cell.2012.01.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22365814	Green Accepted, Bronze			2022-12-01	WOS:000300985000013
J	Simmons, EM; Hartwig, JF				Simmons, Eric M.; Hartwig, John F.			Catalytic functionalization of unactivated primary C-H bonds directed by an alcohol	NATURE			English	Article							METHYL-GROUPS; HYDROXYLATION; COMPLEXES; OXIDATION; TERPENES	New synthetic methods for the catalytic functionalization of C-H bonds have the potential to revolutionize the synthesis of complex molecules(1-4). However, the realization of this synthetic potential requires the ability to functionalize selectively one C-H bond in a compound containing many such bonds and an array of functional groups. The site-selective functionalization of aliphatic C-H bonds is one of the greatest challenges that must be met for C-H bond functionalization to be used widely in complex-molecule synthesis(1,3,5,6), and processes catalysed by transition-metals provide the opportunity to control selectivity(7,8). Current methods for catalytic, aliphatic C-H bond functionalization typically rely on the presence of one inherently reactive C-H bond(9,10), or on installation and subsequent removal of directing groups that are not components of the desired molecule(8). To overcome these limitations, we sought catalysts and reagents that would facilitate aliphatic C-H bond functionalization at a single site, with chemoselectivity derived from the properties of the catalyst and site-selectivity directed by common functional groups(11) contained in both the reactant and the desired product. Here we show that the combination of an iridium-phenanthroline catalyst and a dihydridosilane reagent leads to the site-selective gamma-functionalization of primary C-H bonds controlled by a hydroxyl group, the most common functional group in natural products(12). The scope of the reaction encompasses alcohols and ketones bearing many substitution patterns and auxiliary functional groups; this broad scope suggests that this methodology will be suitable for the site-selective and diastereoselective functionalization of complex natural products.	[Simmons, Eric M.; Hartwig, John F.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Hartwig, JF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 91820 USA.	jhartwig@berkeley.edu	Simmons, Eric/AAR-2677-2020	Simmons, Eric/0000-0002-3854-1561	US National Science Foundation [CHE-0910641]; US National Institutes of Health [GM087901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087901] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the US National Science Foundation (CHE-0910641 to J.F.H.) and the US National Institutes of Health (GM087901 to E.M.S.) for funding this work, and Johnson Matthey for a gift of [Ir(cod)OMe]<INF>2</INF>.	Boebel TA, 2008, J AM CHEM SOC, V130, P7534, DOI 10.1021/ja8015878; BOSWORTH N, 1972, J CHEM SOC PERK T 1, P943, DOI 10.1039/p19720000943; Chen K, 2008, J AM CHEM SOC, V130, P7247, DOI 10.1021/ja802491q; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; CORRIU RJP, 1973, J CHEM SOC CHEM COMM, P38, DOI 10.1039/c39730000038; Crotti C, 2007, DALTON T, P133, DOI 10.1039/b613837c; DENG JG, 1991, SYNTHESIS-STUTTGART, P963; Desai LV, 2004, J AM CHEM SOC, V126, P9542, DOI 10.1021/ja046831c; Feng YQ, 2010, ANGEW CHEM INT EDIT, V49, P958, DOI 10.1002/anie.200905134; Garcia-Granados A, 2007, J ORG CHEM, V72, P3500, DOI 10.1021/jo070116e; Giannis A, 2009, ANGEW CHEM INT EDIT, V48, P7911, DOI 10.1002/anie.200902520; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P7420, DOI 10.1002/anie.200502767; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Gutekunst WR, 2011, CHEM SOC REV, V40, P1976, DOI 10.1039/c0cs00182a; Henkel T, 1999, ANGEW CHEM INT EDIT, V38, P643, DOI 10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-G; Kasuya S, 2009, ORG LETT, V11, P3630, DOI 10.1021/ol901367m; KITAGAWA I, 1993, CHEM PHARM BULL, V41, P1337, DOI 10.1248/cpb.41.1337; Litvinas ND, 2009, ANGEW CHEM INT EDIT, V48, P4513, DOI 10.1002/anie.200901353; Lu Y, 2010, J AM CHEM SOC, V132, P5916, DOI 10.1021/ja101909t; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; MAJETICH G, 1995, TETRAHEDRON, V51, P7095, DOI 10.1016/0040-4020(95)00406-X; McMurray L, 2011, CHEM SOC REV, V40, P1885, DOI 10.1039/c1cs15013h; Miyazawa M, 2004, TETRAHEDRON, V60, P3091, DOI 10.1016/j.tet.2004.01.076; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; Ple K, 2004, EUR J ORG CHEM, V2004, P1588, DOI 10.1002/ejoc.200300723; Simmons EM, 2010, J AM CHEM SOC, V132, P17092, DOI 10.1021/ja1086547; Yu JQ, 2010, TOP CURR CHEM, V292, P1, DOI 10.1007/978-3-642-12356-6; Zalatan DN, 2010, TOP CURR CHEM, V292, P347, DOI 10.1007/128_2009_19	30	298	302	6	270	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2012	483	7387					70	73		10.1038/nature10785	http://dx.doi.org/10.1038/nature10785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22382981				2022-12-01	WOS:000300877900046
J	Cheung, TH; Quach, NL; Charville, GW; Liu, L; Park, L; Edalati, A; Yoo, B; Hoang, P; Rando, TA				Cheung, Tom H.; Quach, Navaline L.; Charville, Gregory W.; Liu, Ling; Park, Lidia; Edalati, Abdolhossein; Yoo, Bryan; Hoang, Phuong; Rando, Thomas A.			Maintenance of muscle stem-cell quiescence by microRNA-489	NATURE			English	Article							SATELLITE CELLS; SKELETAL-MUSCLE; SELF-RENEWAL; IN-VIVO; PROGRESSION; MECHANISM; MAMMALS; DEK	Among the key properties that distinguish adult mammalian stem cells from their more differentiated progeny is the ability of stem cells to remain in a quiescent state for prolonged periods of time(1,2). However, the molecular pathways for the maintenance of stem-cell quiescence remain elusive. Here we use adult mouse muscle stem cells (satellite cells) as a model system and show that the microRNA (miRNA) pathway is essential for the maintenance of the quiescent state. Satellite cells that lack a functional miRNA pathway spontaneously exit quiescence and enter the cell cycle. We identified quiescence-specific miRNAs in the satellite-cell lineage by microarray analysis. Among these, miRNA-489 (miR-489) is highly expressed in quiescent satellite cells and is quickly downregulated during satellite-cell activation. Further analysis revealed that miR-489 functions as a regulator of satellite-cell quiescence, as it post-transcriptionally suppresses the oncogene Dek, the protein product of which localizes to the more differentiated daughter cell during asymmetric division of satellite cells and promotes the transient proliferative expansion of myogenic progenitors. Our results provide evidence of the miRNA pathway in general, and of a specific miRNA, miR-489, in actively maintaining the quiescent state of an adult stem-cell population.	[Cheung, Tom H.; Quach, Navaline L.; Charville, Gregory W.; Liu, Ling; Park, Lidia; Edalati, Abdolhossein; Yoo, Bryan; Hoang, Phuong; Rando, Thomas A.] Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Cheung, Tom H.; Quach, Navaline L.; Charville, Gregory W.; Liu, Ling; Park, Lidia; Edalati, Abdolhossein; Yoo, Bryan; Hoang, Phuong; Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Charville, Gregory W.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev Ctr Excellence, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA.	rando@stanford.edu		Hoang, Phuong/0000-0002-1689-5043; Rando, Thomas/0000-0001-5843-8564	Glenn Foundation for Medical Research; National Institutes of Health (NIH) [P01 AG036695, R01 AG23806, R01 AR062185, DP1 OD000392]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056849, R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695, F30AG035521, R37AG023806, R01AG023806] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000392] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the Rando laboratory for comments and discussions. We thank B. Olwin for providing the syndecan 4 antibody. This work was supported by the Glenn Foundation for Medical Research and by grants from the National Institutes of Health (NIH) (P01 AG036695, R01 AG23806 (R37 MERIT Award), R01 AR062185 and DP1 OD000392 (an NIH Director's Pioneer Award)) and the Department of Veterans Affairs (Merit Review) to T.A.R.	Bertoni C, 2006, P NATL ACAD SCI USA, V103, P419, DOI 10.1073/pnas.0504505102; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tiscornia G, 2010, GENE DEV, V24, P2732, DOI 10.1101/gad.1982910; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	25	315	326	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					524	U247		10.1038/nature10834	http://dx.doi.org/10.1038/nature10834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358842	Green Accepted			2022-12-01	WOS:000300770500050
J	Haga, K; Kruse, AC; Asada, H; Yurugi-Kobayashi, T; Shiroishi, M; Zhang, C; Weis, WI; Okada, T; Kobilka, BK; Haga, T; Kobayashi, T				Haga, Kazuko; Kruse, Andrew C.; Asada, Hidetsugu; Yurugi-Kobayashi, Takami; Shiroishi, Mitsunori; Zhang, Cheng; Weis, William I.; Okada, Tetsuji; Kobilka, Brian K.; Haga, Tatsuya; Kobayashi, Takuya			Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist	NATURE			English	Article							BETA-ADRENERGIC-RECEPTOR; TRANSMEMBRANE DOMAIN; SCANNING MUTAGENESIS; CRYSTAL-STRUCTURE; BINDING-PROTEIN; EXPRESSION; INSIGHTS; ACTIVATION; RHODOPSIN; COMPLEX	The parasympathetic branch of the autonomic nervous system regulates the activity of multiple organ systems. Muscarinic receptors are G-protein-coupled receptors that mediate the response to acetylcholine released from parasympathetic nerves(1-5). Their role in the unconscious regulation of organ and central nervous system function makes them potential therapeutic targets for a broad spectrum of diseases. The M2 muscarinic acetylcholine receptor (M2 receptor) is essential for the physiological control of cardiovascular function through activation of G-protein-coupled inwardly rectifying potassium channels, and is of particular interest because of its extensive pharmacological characterization with both orthosteric and allosteric ligands. Here we report the structure of the antagonist-bound human M2 receptor, the first human acetylcholine receptor to be characterized structurally, to our knowledge. The antagonist 3-quinuclidinyl-benzilate binds in the middle of a long aqueous channel extending approximately two-thirds through the membrane. The orthosteric binding pocket is formed by amino acids that are identical in all five muscarinic receptor subtypes, and shares structural homology with other functionally unrelated acetylcholine binding proteins from different species. A layer of tyrosine residues forms an aromatic cap restricting dissociation of the bound ligand. A binding site for allosteric ligands has been mapped to residues at the entrance to the binding pocket near this aromatic cap. The structure of the M2 receptor provides insights into the challenges of developing subtype-selective ligands for muscarinic receptors and their propensity for allosteric regulation.	[Kruse, Andrew C.; Zhang, Cheng; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Haga, Kazuko; Okada, Tetsuji; Haga, Tatsuya] Gakushuin Univ, Dept Life Sci, Fac Sci, Tokyo 1718588, Japan; [Asada, Hidetsugu; Yurugi-Kobayashi, Takami; Kobayashi, Takuya] Kyoto Univ, Fac Med, Dept Med Chem & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Asada, Hidetsugu; Yurugi-Kobayashi, Takami; Shiroishi, Mitsunori; Kobayashi, Takuya] Japan Sci & Technol Agcy, ERATO, Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Shiroishi, Mitsunori] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Kobayashi, Takuya] Kyoto Univ, Fac Med, Japan Sci & Technol Agcy, Kyoto 6068501, Japan	Stanford University; Gakushuin University; Kyoto University; Japan Science & Technology Agency (JST); Kyushu University; Stanford University; Japan Science & Technology Agency (JST); Kyoto University	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	kobilka@stanford.edu; tatsuya.haga@gakushuin.ac.jp; t-coba@mfour.med.kyoto-u.ac.jp	Okada, Tetsuji/U-8732-2019; Weis, William I/G-1437-2011; Zhang, Cheng/O-4372-2015	Okada, Tetsuji/0000-0003-1913-428X; Weis, William I/0000-0002-5583-6150; Zhang, Cheng/0000-0001-9042-4007; Asada, Hidetsugu/0000-0001-6255-4728; Kobilka, Brian/0000-0001-5958-3990; Shiroishi, Mitsunori/0000-0002-3133-157X	Japan Society for the Promotion of Science; Japan Science and Technology Corporation (CREST); Ministry of Education, Culture, Sports, Science and Technology of Japan [15083201]; Japan Science and Technology Corporation (ERATO); Toray Science Foundation; Takeda Science Foundation; Ichiro Kanehara Foundation; Sumitomo Foundation; National Institutes of Health [NS028471, GM083118]; Mathers Foundation; National Science Foundation; Grants-in-Aid for Scientific Research [23370049] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Corporation (CREST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (ERATO)(Japan Science & Technology Agency (JST)); Toray Science Foundation(Toray Industries, Inc.); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ichiro Kanehara Foundation; Sumitomo Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; National Science Foundation(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Iwata at Kyoto University for supporting the production of M2 receptor, and we acknowledge support from the Japan Society for the Promotion of Science (Research for Future Program) (T. H.), from the Japan Science and Technology Corporation (CREST) (T. H.), from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid for Scientific Research on Priority Area 15083201 (T. H.), from the Japan Science and Technology Corporation (ERATO) (T. K.), from Toray Science Foundation (T. K.), from Takeda Science Foundation (T. K.), from Ichiro Kanehara Foundation (T. K.), from The Sumitomo Foundation (T. K.), from the National Institutes of Health Grants NS028471 and GM083118 (B. K. K.), from the Mathers Foundation (B. K. K. and W. I. W.), and from the National Science Foundation (A. C. K.). We thank T. S. Kobilka for organizing the GPCR Workshop 2010 that brought together the research groups, and for facilitating this collaboration	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Asada H, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-24; BLUML K, 1994, J BIOL CHEM, V269, P18870; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; Dale HH, 1914, J PHARMACOL EXP THER, V6, P147; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Furukawa H, 2002, MOL PHARMACOL, V62, P778, DOI 10.1124/mol.62.4.778; Goodwin JA, 2007, MOL PHARMACOL, V72, P1484, DOI 10.1124/mol.107.038265; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; HAGA K, 1985, NATURE, V316, P731, DOI 10.1038/316731a0; HAGA K, 1985, J BIOL CHEM, V260, P7927; HAGA K, 1983, J BIOL CHEM, V258, P3575; Haga T., 1990, RECEPTOR BIOCH PRACT, P51; Heitz F, 1999, EUR J PHARMACOL, V380, P183, DOI 10.1016/S0014-2999(99)00439-2; Hulme EC, 2003, RECEPTOR CHANNEL, V9, P215, DOI 10.1080/10606820308261; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Ichlyama S, 2006, FEBS LETT, V580, P23, DOI 10.1016/j.febslet.2005.11.042; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KAMEYAMA K, 1994, EUR J BIOCHEM, V226, P267, DOI 10.1111/j.1432-1033.1994.tb20050.x; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Oswald C, 2008, J BIOL CHEM, V283, P32848, DOI 10.1074/jbc.M806021200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVCHINNIKOV YA, 1982, FEBS LETT, V148, P179, DOI 10.1016/0014-5793(82)80805-3; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Ward SDC, 1999, MOL PHARMACOL, V56, P1031, DOI 10.1124/mol.56.5.1031; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weber W, 2002, CYTOTECHNOLOGY, V38, P77, DOI 10.1023/A:1021102015070; WESS J, 1993, LIFE SCI, V53, P1447, DOI 10.1016/0024-3205(93)90618-D; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8	39	597	611	4	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					547	U147		10.1038/nature10753	http://dx.doi.org/10.1038/nature10753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22278061	Green Published, Green Accepted			2022-12-01	WOS:000300770500055
J	Baldwin, LM; Trivers, KF; Matthews, B; Andrilla, CHA; Miller, JW; Berry, DL; Lishner, DM; Goff, BA				Baldwin, Laura-Mae; Trivers, Katrina F.; Matthews, Barbara; Andrilla, C. Holly A.; Miller, Jacqueline W.; Berry, Donna L.; Lishner, Denise M.; Goff, Barbara A.			Vignette-Based Study of Ovarian Cancer Screening: Do US Physicians Report Adhering to Evidence-Based Recommendations?	ANNALS OF INTERNAL MEDICINE			English	Article							RISK WOMEN; TRANSVAGINAL ULTRASOUND; CARE; SUSCEPTIBILITY; SERVICES; PROSTATE; EFFICACY; QUALITY; POPULATION; CA125	Background: No professional society or group recommends routine ovarian cancer screening, yet physicians' enthusiasm for several cancer screening tests before benefit has been proven suggests that some women may be exposed to potential harms. Objective: To provide nationally representative estimates of physicians' reported nonadherence to recommendations against ovarian cancer screening. Design: Cross-sectional survey of physicians offering women's primary care. The 12-page questionnaire contained a woman's annual examination vignette and questions about offers or orders for transvaginal ultrasonography (TVU) and cancer antigen 125 (CA-125). Setting: United States. Participants: 3200 physicians randomly sampled equally from the 2008 American Medical Association Physician Masterfile lists of family physicians, general internists, and obstetrician-gynecologists; 61.7% responded. After exclusions, 1088 respondents were included; their responses were weighted to represent the specialty distribution of practicing U. S. physicians nationally. Measurements: Reported nonadherence to screening recommendations (defined as sometimes or almost always ordering screening TVU or CA-125 or both). Results: Twenty-eight percent (95% CI, 24.5% to 32.9%) of physicians reported nonadherence to screening recommendations for women at low risk for ovarian cancer; 65.4% (CI, 61.1% to 69.4%) did so for women at medium risk for ovarian cancer. Six percent (CI, 4.4% to 8.9%) reported routinely ordering or offering ovarian cancer screening for low-risk women, as did 24.0% (CI, 20.5% to 28.0%) for medium-risk women (P <= 0.001). Thirty-three percent believed TVU or CA-125 was an effective screening test. In adjusted analysis, actual and physician-perceived patient risk, patient request for ovarian cancer screening, and physician belief that TVU or CA-125 was an effective screening test were the strongest predictors of physician-reported nonadherence to published recommendations. Limitation: The results are limited by their reliance on survey methods; there may be respondent-nonrespondent bias. Conclusion: One in 3 physicians believed that ovarian cancer screening was effective, despite evidence to the contrary. Substantial proportions of physicians reported routinely offering or ordering ovarian cancer screening, thereby exposing women to the documented risks of these tests.	[Baldwin, Laura-Mae] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Dana Farber Canc Inst, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; Harvard University; Dana-Farber Cancer Institute	Baldwin, LM (corresponding author), Univ Washington, Dept Family Med, Box 354982, Seattle, WA 98195 USA.	lmb@uw.edu	Andrilla, Holly/AAC-6264-2019	Goff, Barbara/0000-0003-0153-5544	Centers for Disease Control and Prevention through the University of Washington Health Promotion Research Centers [U48DP001911]; Centers for Disease Control and Prevention through the Alliance for Reducing Cancer, Northwest; Centers for Disease Control and Prevention [U48DP001911]; National Cancer Institute; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001911] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention through the University of Washington Health Promotion Research Centers; Centers for Disease Control and Prevention through the Alliance for Reducing Cancer, Northwest; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Grant Support: By the Centers for Disease Control and Prevention through the University of Washington Health Promotion Research Centers Cooperative Agreement U48DP001911 and through the Alliance for Reducing Cancer, Northwest, funded by both the Centers for Disease Control and Prevention (grant U48DP001911; V. Taylor, primary investigator) and the National Cancer Institute.	ACOG Committee on Gynecologic Practice, 2006, Obstet Gynecol, V108, P1611; Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; Ajzen I, 1975, BELIEF ATTITUDE INTE; Ajzen I., THEORY PLANNED BEHAV; American Cancer Society, OV CANC; American Cancer Society, 2010, OV CANC COMM QUEST S; American Cancer Society, 2011, AM CANC SOC GUID EAR; [Anonymous], 1994, Gynecol Oncol, V55, pS4; [Anonymous], 2009, Obstet Gynecol, V113, P957, DOI 10.1097/AOG.0b013e3181a106d4; [Anonymous], 2009, GYNECOL ONCOL, V113, P6, DOI 10.1016/j.ygyno.2009.02.017; Bell R, 1998, Health Technol Assess, V2, pi; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Buys SS, 2005, AM J OBSTET GYNECOL, V193, P1630, DOI 10.1016/j.ajog.2005.05.005; Centers for Disease Control and Prevention, NAT PROGR CANC REG N; Chan ECY, 2006, J GEN INTERN MED, V21, P257, DOI 10.1111/j.1525-1497.2006.00327.x; Dillman D.A., 2014, INTERNET MAIL MIXED; Dresselhaus TR, 2004, J GEN INTERN MED, V19, P1013, DOI 10.1007/s11606-004-0003-2; Economic Research Service, 2005, MEAS RUR RUR URB COM; Eichorn J., 2011, ONCLIVE         0518; Fishman DA, 2005, AM J OBSTET GYNECOL, V192, P1214, DOI 10.1016/j.ajog.2005.01.041; Fowler FJ, 1998, AM J MED, V104, P526, DOI 10.1016/S0002-9343(98)00124-7; Franks P, 2000, J GEN INTERN MED, V15, P163, DOI 10.1046/j.1525-1497.2000.04079.x; Gladstone CQ, 1994, CANADIAN TASK FORCE, P870; Goff BA, 2005, WOMENS HLTH PRIMARY, V8, P262; Goff BA, 2011, CANCER-AM CANCER SOC, V117, P4414, DOI 10.1002/cncr.26035; Green MJ, 2004, JAMA-J AM MED ASSOC, V292, P442, DOI 10.1001/jama.292.4.442; JACOBS I, 1993, BRIT MED J, V306, P1030, DOI 10.1136/bmj.306.6884.1030; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Katz DA, 2005, ANN EMERG MED, V46, P525, DOI 10.1016/j.annemergmed.2005.04.016; Keitz SA, 2007, ARCH INTERN MED, V167, P445, DOI 10.1001/archinte.167.5.445; Klein WMP, 2007, CA-CANCER J CLIN, V57, P147, DOI 10.3322/canjclin.57.3.147; Kravitz RL, 2003, ARCH INTERN MED, V163, P1673, DOI 10.1001/archinte.163.14.1673; Liede A, 2002, J CLIN ONCOL, V20, P1570, DOI 10.1200/JCO.20.6.1570; MacDonald Deborah J, 2006, Oncol Nurs Forum, V33, pE27, DOI 10.1188/06.ONF.E27-E35; Mehrotra A, 2007, ARCH INTERN MED, V167, P1876, DOI 10.1001/archinte.167.17.1876; Menon U, 2001, CURR OPIN OBSTET GYN, V13, P61, DOI 10.1097/00001703-200102000-00009; Morrill R, 1999, URBAN GEOGR, V20, P727, DOI 10.2747/0272-3638.20.8.727; Murray E, 2003, J AM BOARD FAM PRACT, V16, P513, DOI 10.3122/jabfm.16.6.513; Olivier RI, 2006, GYNECOL ONCOL, V100, P20, DOI 10.1016/j.ygyno.2005.08.038; Paley PJ, 2001, CURR OPIN ONCOL, V13, P399, DOI 10.1097/00001622-200109000-00015; Partridge E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0b013e31819cda77; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Schorge JO, 2010, GYNECOL ONCOL, V119, P7, DOI 10.1016/j.ygyno.2010.06.003; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Sifri R, 2003, CLIN GENET, V64, P355, DOI 10.1034/j.1399-0004.2003.00131.x; Skates SJ, 2004, J CLIN ONCOL, V22, P4059, DOI 10.1200/JCO.2004.03.091; Trivers KF, 2011, CANCER-AM CANCER SOC, V117, P5334, DOI 10.1002/cncr.26166; U.S. Census Bureau, 2012 STAT ABSTR POP; US Preventive Services Task Force Agency for Healthcare Research and Quality, 2004, SCREEN OV CANC TOP P; van der Velde NM, 2009, INT J CANCER, V124, P919, DOI 10.1002/ijc.24038; van Nagell JR, 2000, GYNECOL ONCOL, V77, P350, DOI 10.1006/gyno.2000.5816; White DB, 2008, CANCER EPIDEM BIOMAR, V17, P2980, DOI 10.1158/1055-9965.EPI-07-2879; Wideroff L, 2003, CANCER EPIDEM BIOMAR, V12, P295; Woodward ER, 2007, BJOG-INT J OBSTET GY, V114, P1500, DOI 10.1111/j.1471-0528.2007.01499.x	58	38	39	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2012	156	3					182	U46		10.7326/0003-4819-156-3-201202070-00006	http://dx.doi.org/10.7326/0003-4819-156-3-201202070-00006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XD	22312138				2022-12-01	WOS:000299964200002
J	Weedon-Fekjaer, H; Bakken, K; Vatten, LJ; Tretli, S				Weedon-Fekjaer, Harald; Bakken, Kjersti; Vatten, Lars J.; Tretli, Steinar			Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ESTROGEN PLUS PROGESTIN; MEAN SOJOURN TIME; REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; TEMPORAL VARIATION; NORDIC COUNTRIES; RATES; RISK; SENSITIVITY; OVERDIAGNOSIS	Objective To quantify the separate contributions of menopausal hormone treatment and mammography screening activities on trends in incidence of invasive breast cancer between 1987 and 2008. Design Population study using aggregated data analysed by an extended age-period-cohort model. Setting Norway. Population Norwegian women aged 30-90 between 1987 and 2008, including 50 102 newly diagnosed cases of invasive breast cancer. Main outcomes measures Attributable proportions of mammography screening and hormone treatment to recent incidence of invasive breast cancer, and the remaining variation in incidence after adjustment for mammography screening and hormone treatment. Results The incidence of invasive breast cancer in Norway increased steadily until 2002, levelled off, and then declined from 2006. All non-linear changes in incidence were explained by use of hormone treatment and mammography screening activities, with about similar contributions of each factor. In 2002, when the incidence among women aged 50-69 was highest, an estimated 23% of the cases in that age group could be attributed to mammography screening and 27% to use of hormone treatment. Conclusions Changes in incidence trends of invasive breast cancer since the early 1990s may be fully attributed to mammography screening and hormone treatment, with about similar contributions of each factor.	[Weedon-Fekjaer, Harald; Tretli, Steinar] Canc Registry Norway, Inst Populat Based Canc Res, Dept Etiol Res, N-0304 Oslo, Norway; [Bakken, Kjersti] Univ Tromso, Dept Community Med, N-9001 Tromso, Norway; [Bakken, Kjersti] Univ Bergen, N-5020 Bergen, Norway; [Vatten, Lars J.; Tretli, Steinar] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway	University of Oslo; UiT The Arctic University of Tromso; University of Bergen; Norwegian University of Science & Technology (NTNU)	Weedon-Fekjaer, H (corresponding author), Canc Registry Norway, Inst Populat Based Canc Res, Dept Etiol Res, POB 5313 Majorstuen, N-0304 Oslo, Norway.	harald.weedon-fekjaer@kreftregisteret.no	Vatten, Lars/AAF-9380-2022; Weedon-Fekjær, Harald/B-6900-2008; Vatten, Lars/AFK-2073-2022	Weedon-Fekjær, Harald/0000-0002-9109-0034; 	Norwegian Cancer Society [PK01-2008-0080]	Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by the Norwegian Cancer Society through a postdoctoral scholarship to HW-F (PK01-2008-0080).	Bakken K, 2011, INT J CANCER, V128, P144, DOI 10.1002/ijc.25314; Bakken L, 2004, INT J CANCER, V112, P130, DOI 10.1002/ijc.20389; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Calle EE, 2009, CANCER-AM CANCER SOC, V115, P936, DOI 10.1002/cncr.24101; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; CLEMMESEN J, 1948, BRIT J RADIOL, V21, P583, DOI 10.1259/0007-1285-21-252-583; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; Ernster V L, 1997, J Natl Cancer Inst Monogr, P151; Gapstur SM, 1999, JAMA-J AM MED ASSOC, V281, P2091, DOI 10.1001/jama.281.22.2091; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Hankinson S, 2002, TXB CANC EPIDEMIOLOG, P3001; Hemminki E, 2008, MATURITAS, V61, P299, DOI 10.1016/j.maturitas.2008.09.022; Hofvind S., 2005, NORWEGIAN BREAST CAN; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Hofvind S, 2006, INT J CANCER, V118, P3112, DOI 10.1002/ijc.21742; HOLFORD TR, 1983, BIOMETRICS, V39, P311, DOI 10.2307/2531004; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Katalinic A, 2008, BREAST CANCER RES TR, V107, P427, DOI 10.1007/s10549-007-9566-z; Kerlikowske K, 2007, JNCI-J NATL CANCER I, V99, P1335, DOI 10.1093/jnci/djm111; Lambe M, 2010, BREAST CANCER RES TR, V121, P679, DOI 10.1007/s10549-009-0615-7; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Moller B, 2005, EUR J CANCER PREV, V14, P117, DOI 10.1097/00008469-200504000-00007; Moller B, 2002, EUR J CANCER PREV, V11, pS1; NIELSEN M, 1984, CANCER-AM CANCER SOC, V54, P612, DOI 10.1002/1097-0142(1984)54:4<612::AID-CNCR2820540403>3.0.CO;2-B; NORDCAN, 2010, NORDCAN; PACI E, 1991, INT J EPIDEMIOL, V20, P852, DOI 10.1093/ije/20.4.852; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Statistics Norway, 2010, STAT NORW; Tretli S, 1996, CANCER CAUSE CONTROL, V7, P507, DOI 10.1007/BF00051882; Virnig Beth A., 2010, Journal of the National Cancer Institute Monographs, P113, DOI 10.1093/jncimonographs/lgq024; Weedon-Fekjaer H, 2005, J MED SCREEN, V12, P172, DOI 10.1258/096914105775220732; Weedon-Fekjaer H, 2008, J MED SCREEN, V15, P83, DOI 10.1258/jms.2008.007071; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	38	32	33	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2012	344								e299	10.1136/bmj.e299	http://dx.doi.org/10.1136/bmj.e299			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889QD	22290099	hybrid, Green Published, Green Submitted			2022-12-01	WOS:000300087400003
J	M'Gonigle, LK; Mazzucco, R; Otto, SP; Dieckmann, U				M'Gonigle, Leithen K.; Mazzucco, Rupert; Otto, Sarah P.; Dieckmann, Ulf			Sexual selection enables long-term coexistence despite ecological equivalence	NATURE			English	Article							SYMPATRIC SPECIATION; INCIPIENT SPECIATION; FEMALE CHOICE; HYBRID ZONES; EVOLUTION; PREFERENCE; DIVERSITY; MODELS; SPACE	Empirical data indicate that sexual preferences are critical for maintaining species boundaries(1-4), yet theoretical work has suggested that, on their own, they can have only a minimal role in maintaining biodiversity(5-9). This is because long-term coexistence within overlapping ranges is thought to be unlikely in the absence of ecological differentiation(9). Here we challenge this widely held view by generalizing a standard model of sexual selection to include two ubiquitous features of populations with sexual selection: spatial variation in local carrying capacity, and mate-search costs in females. We show that, when these two features are combined, sexual preferences can single-handedly maintain coexistence, even when spatial variation in local carrying capacity is so slight that it might go unnoticed empirically. This theoretical study demonstrates that sexual selection alone can promote the long-term coexistence of ecologically equivalent species with overlapping ranges, and it thus provides a novel explanation for the maintenance of species diversity.	[M'Gonigle, Leithen K.; Otto, Sarah P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Mazzucco, Rupert; Dieckmann, Ulf] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria	University of British Columbia; International Institute for Applied Systems Analysis (IIASA)	M'Gonigle, LK (corresponding author), Univ Calif Berkeley, Dept Environm Sci, 130 Mulford Hall, Berkeley, CA 94720 USA.	mgonigle@zoology.ubc.ca	Otto, Sarah Perin/K-5625-2012; Dieckmann, Ulf/E-1424-2011	Otto, Sarah Perin/0000-0003-3042-0818; Dieckmann, Ulf/0000-0001-7089-0393; Mazzucco, Rupert/0000-0002-7608-0196	Natural Sciences and Engineering Research Council (Canada); European Science Foundation; WWTF; European Commission; Austrian Science Fund; Austrian Ministry of Science and Research; Austrian Science Fund (FWF) [I 106] Funding Source: researchfish	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Science Foundation(European Science Foundation (ESF)European Commission); WWTF; European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry of Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank J. S. Brown, R. G. Fitz John, D. E. Irwin, J. Ohlberger, J. L. Payne, A. Pomiankowski and G. S. van Doorn for discussions. Funding was provided by a Natural Sciences and Engineering Research Council (Canada) grant to L. K. M. (CGS-D) and S.P.O. (Discovery Grant). L. K. M. received additional support from the European Science Foundation Research Networking Programme 'Frontiers of Speciation Research'. R. M. and U. D. gratefully acknowledge support by the Vienna Science and Technology Fund (WWTF). U. D. received additional financial support from the European Commission, the European Science Foundation, the Austrian Science Fund and the Austrian Ministry of Science and Research.	BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Dieckmann U., 2004, ADAPTIVE SPECIATION, P306; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Feulner PGD, 2008, J PHYSIOLOGY-PARIS, V102, P340, DOI 10.1016/j.jphysparis.2008.10.002; Fisher R.A., 1930, GENETICAL THEORY NAT; Gray DA, 2000, P NATL ACAD SCI USA, V97, P14449, DOI 10.1073/pnas.97.26.14449; Hollocher H, 1997, EVOLUTION, V51, P1175, DOI [10.1111/j.1558-5646.1997.tb03965.x, 10.2307/2411047]; Johansson J, 2006, AM NAT, V168, P572, DOI 10.1086/507996; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI [10.2307/2407961, 10.1111/j.1558-5646.1982.tb05003.x]; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LANDE R, 1982, EVOLUTION, V36, P213, DOI 10.1111/j.1558-5646.1982.tb05034.x; Mallet J, 2009, J EVOLUTION BIOL, V22, P2332, DOI 10.1111/j.1420-9101.2009.01816.x; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Payne RJH, 1997, EVOLUTION, V51, P1, DOI 10.1111/j.1558-5646.1997.tb02382.x; RYAN MJ, 1988, SCIENCE, V240, P1786, DOI 10.1126/science.240.4860.1786; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1999, ECOL LETT, V2, P262; SEGER J, 1985, EVOLUTION, V39, P1185, DOI [10.2307/2408776, 10.1111/j.1558-5646.1985.tb05685.x]; Tregenza T, 2000, EVOLUTION, V54, P1687, DOI 10.1111/j.0014-3820.2000.tb00713.x; TURNER GF, 1995, P ROY SOC B-BIOL SCI, V260, P287, DOI 10.1098/rspb.1995.0093; van Doorn GS, 2004, AM NAT, V163, P709, DOI 10.1086/383619; Weissing FJ, 2011, BEHAV ECOL SOCIOBIOL, V65, P461, DOI 10.1007/s00265-010-1125-7; Wilson AB, 2000, P ROY SOC B-BIOL SCI, V267, P2133, DOI 10.1098/rspb.2000.1260	26	61	61	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					506	509		10.1038/nature10971	http://dx.doi.org/10.1038/nature10971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22466286	Green Submitted			2022-12-01	WOS:000303200400049
J	Gehrig, SM; van der Poel, C; Sayer, TA; Schertzer, JD; Henstridge, DC; Church, JE; Lamon, S; Russell, AP; Davies, KE; Febbraio, MA; Lynch, GS				Gehrig, Stefan M.; van der Poel, Chris; Sayer, Timothy A.; Schertzer, Jonathan D.; Henstridge, Darren C.; Church, Jarrod E.; Lamon, Severine; Russell, Aaron P.; Davies, Kay E.; Febbraio, Mark A.; Lynch, Gordon S.			Hsp72 preserves muscle function and slows progression of severe muscular dystrophy	NATURE			English	Article							KAPPA-B; MDX; SKELETAL; PROTEIN; MICE; ACTIVATION; STRESS; OVEREXPRESSION; CONTRACTION; MYOPATHIES	Duchenne muscular dystrophy (DMD) is a severe and progressive muscle wasting disorder caused by mutations in the dystrophin gene that result in the absence of the membrane-stabilizing protein dystrophin(1-3). Dystrophin-deficient muscle fibres are fragile and susceptible to an influx of Ca2+, which activates inflammatory and muscle degenerative pathways(4-6). At present there is no cure for DMD, and existing therapies are ineffective. Here we show that increasing the expression of intramuscular heat shock protein 72 (Hsp72) preserves muscle strength and ameliorates the dystrophic pathology in two mouse models of muscular dystrophy. Treatment with BGP-15 (a pharmacological inducer of Hsp72 currently in clinical trials for diabetes) improved muscle architecture, strength and contractile function in severely affected diaphragm muscles in mdx dystrophic mice. In dko mice, a phenocopy of DMD that results in severe spinal curvature (kyphosis), muscle weakness and premature death(7,8), BGP-15 decreased kyphosis, improved the dystrophic pathophysiology in limb and diaphragm muscles and extended lifespan. We found that the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA, the main protein responsible for the removal of intracellular Ca2+) is dysfunctional in severely affected muscles of mdx and dko mice, and that Hsp72 interacts with SERCA to preserve its function under conditions of stress, ultimately contributing to the decreased muscle degeneration seen with Hsp72 upregulation. Treatment with BGP-15 similarly increased SERCA activity in dystrophic skeletal muscles. Our results provide evidence that increasing the expression of Hsp72 in muscle (through the administration of BGP-15) has significant therapeutic potential for DMD and related conditions, either as a self-contained therapy or as an adjuvant with other potential treatments, including gene, cell and pharmacological therapies.	[Gehrig, Stefan M.; van der Poel, Chris; Sayer, Timothy A.; Schertzer, Jonathan D.; Church, Jarrod E.; Lynch, Gordon S.] Univ Melbourne, Basic & Clin Myol Lab, Dept Physiol, Melbourne, Vic 3010, Australia; [Henstridge, Darren C.; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic 8008, Australia; [Lamon, Severine; Russell, Aaron P.] Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Burwood, Vic 3125, Australia; [Davies, Kay E.] Univ Oxford, MRC Funct Genom Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	University of Melbourne; Baker Heart and Diabetes Institute; Deakin University; University of Oxford	Lynch, GS (corresponding author), Univ Melbourne, Basic & Clin Myol Lab, Dept Physiol, Melbourne, Vic 3010, Australia.	gsl@unimelb.edu.au	Lynch, Gordon/G-9553-2015; Febbraio, Mark/AAE-9632-2019; Schertzer, Jonathan/P-3395-2017	Lynch, Gordon/0000-0001-9220-9810; Russell, Aaron/0000-0002-7323-9501; Febbraio, Mark/0000-0002-9296-4418; Schertzer, Jonathan/0000-0002-1547-5856; Church, Jarrod/0000-0001-8266-4043; Lamon, Severine/0000-0002-3271-6551	National Health and Medical Research Council (NHMRC) [1009114, 472650, 1004441]; Association Francaise contre les Myopathies (France); Muscular Dystrophy Association (USA); Swiss National Science Foundation; National Heart Foundation (Australia); National Heart Foundation; MRC [MC_U137761449] Funding Source: UKRI; Fondazione Telethon Funding Source: Custom; Medical Research Council [MC_U137761449] Funding Source: researchfish	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Association Francaise contre les Myopathies (France)(Association Francaise contre les Myopathies); Muscular Dystrophy Association (USA)(Muscular Dystrophy Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart Foundation (Australia)(National Heart Foundation of Australia); National Heart Foundation(National Heart Foundation of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondazione Telethon(Fondazione Telethon); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Koopman, J. G. Ryall and G. I. Lancaster for comments; J. Trieu, B. G. Gleeson, T. Naim and A. Chee for technical support; and C. Angelini and the Neuromuscular bank of tissues and DNA samples - Telethon Network of Genetic Biobanks for the provision of human muscle specimens. We thank N-Gene R&D Inc. USA for providing the BGP-15 compound. This study was supported in part by research grants from the National Health and Medical Research Council (NHMRC; project numbers 1009114 to G. S. L. and 472650 and 1004441 to M.A.F.), Association Francaise contre les Myopathies (France, to G. S. L.) and the Muscular Dystrophy Association (USA, to G. S. L.). M. A. F. is a Senior Principal Research Fellow of the NHMRC. A. P. R. was supported by a NHMRC Biomedical career Development Award. S. L. was supported by a postdoctoral fellowship from the Swiss National Science Foundation. S. M. G. was supported by a National Heart Foundation Postgraduate Scholarship (Australia). D. C. H. was supported by a National Heart Foundation Post-Doctoral Fellowship.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BORNMAN L, 1995, MUSCLE NERVE, V18, P23, DOI 10.1002/mus.880180105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Finsterer J, 2006, LUNG, V184, P205, DOI 10.1007/s00408-005-2584-x; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; Gehrig SM, 2010, AM J PATHOL, V176, P29, DOI 10.2353/ajpath.2010.090760; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; GREEN MARGARET C., 1952, OHIO JOUR SCI, V52, P31; Gregorevic P, 2002, AM J PATHOL, V161, P2263, DOI 10.1016/S0002-9440(10)64502-6; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kolodziejczyk SM, 2001, CURR BIOL, V11, P1278, DOI 10.1016/S0960-9822(01)00397-9; Literati-Nagy B, 2010, BRAIN RES BULL, V83, P340, DOI 10.1016/j.brainresbull.2010.09.005; Literati-Nagy B, 2009, HORM METAB RES, V41, P374, DOI 10.1055/s-0028-1128142; Lou JS, 2010, AM J HOSP PALLIAT ME, V27, P145, DOI 10.1177/1049909109358420; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morine KJ, 2010, HUM GENE THER, V21, P1735, DOI 10.1089/hum.2010.077; Murphy KT, 2010, FASEB J, V24, P4433, DOI 10.1096/fj.10-159608; Nicolas-Metral V, 2001, J MUSCLE RES CELL M, V22, P69, DOI 10.1023/A:1010384625954; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Plant DR, 2003, AM J PHYSIOL-CELL PH, V285, pC522, DOI 10.1152/ajpcell.00369.2002; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Saegusa T, 2003, J VET MED SCI, V65, P1365, DOI 10.1292/jvms.65.1365; Schertzer JD, 2005, AM J PHYSIOL-ENDOC M, V288, pE526, DOI 10.1152/ajpendo.00399.2004; Schertzer JD, 2007, AM J PATHOL, V171, P1180, DOI 10.2353/ajpath.2007.070292; Schertzer JD, 2006, AM J PHYSIOL-ENDOC M, V291, pE499, DOI 10.1152/ajpendo.00101.2006; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Taleb M, 2008, JARO-J ASSOC RES OTO, V9, P277, DOI 10.1007/s10162-008-0122-2; Tupling AR, 2004, J BIOL CHEM, V279, P52382, DOI 10.1074/jbc.M409336200; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Tutdibi O, 1999, J PHYSIOL-LONDON, V515, P859, DOI 10.1111/j.1469-7793.1999.859ab.x	43	193	201	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					394	398		10.1038/nature10980	http://dx.doi.org/10.1038/nature10980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22495301				2022-12-01	WOS:000302946500037
J	Herman, MA; Peroni, OD; Villoria, J; Schon, MR; Abumrad, NA; Bluher, M; Klein, S; Kahn, BB				Herman, Mark A.; Peroni, Odile D.; Villoria, Jorge; Schoen, Michael R.; Abumrad, Nada A.; Blueher, Matthias; Klein, Samuel; Kahn, Barbara B.			A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism	NATURE			English	Article							CARBOHYDRATE-RESPONSE ELEMENT; FATTY-ACID SYNTHESIS; BINDING-PROTEIN CHREBP; UCSC GENOME BROWSER; INSULIN-RESISTANCE; DIABETES-MELLITUS; TRANSGENIC MICE; LIVER; GENE; LIPOGENESIS	The prevalence of obesity and type 2 diabetes is increasing worldwide and threatens to shorten lifespan. Impaired insulin action in peripheral tissues is a major pathogenic factor. Insulin stimulates glucose uptake in adipose tissue through the GLUT4 (also known as SLC2A4) glucose transporter, and alterations in adipose tissue GLUT4 expression or function regulate systemic insulin sensitivity. Downregulation of human and mouse adipose tissue GLUT4 occurs early in diabetes development. Here we report that adipose tissue GLUT4 regulates the expression of carbohydrate-responsive-element-binding protein (ChREBP; also known as MLXIPL), a transcriptional regulator of lipogenic and glycolytic genes. Furthermore, adipose ChREBP is a major determinant of adipose tissue fatty acid synthesis and systemic insulin sensitivity. We find a new mechanism for glucose regulation of ChREBP: glucose-mediated activation of the canonical ChREBP isoform (ChREBP-alpha) induces expression of a novel, potent isoform (ChREBP-beta) that is transcribed from an alternative promoter. ChREBP-beta expression in human adipose tissue predicts insulin sensitivity, indicating that it may be an effective target for treating diabetes.	[Herman, Mark A.; Peroni, Odile D.; Villoria, Jorge; Kahn, Barbara B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Herman, Mark A.; Peroni, Odile D.; Villoria, Jorge; Kahn, Barbara B.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Schoen, Michael R.] Stadt Klinikum Karlsruhe, Clin Visceral Surg, D-76133 Karlsruhe, Germany; [Abumrad, Nada A.; Klein, Samuel] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Blueher, Matthias] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Municipal Hospital Karlsruhe; Washington University (WUSTL); Leipzig University	Kahn, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Herman, Mark/H-3232-2012	Schon, Michael/0000-0002-0698-4130; Herman, Mark/0000-0001-6979-103X	NIH [R37 DK43051, K08 DK076726]; BADERC [DK057521]; BNORC [DK046200]; Picower and JPB Foundations; Radcliffe Institute for Advanced Study; Nutrition and Obesity Research Unit [DK056341, DK037948]; Deutsche Forschungsgemeinschft DFG [KFO152, BL833/1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037948, R37DK043051, P30DK057521, K08DK076726, P30DK056341, R01DK098002, P30DK046200] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BADERC; BNORC; Picower and JPB Foundations; Radcliffe Institute for Advanced Study; Nutrition and Obesity Research Unit; Deutsche Forschungsgemeinschft DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Towle for providing reagents and discussion. We thank P. Pissios, I. Astapova, E. Rosen and the Rosen laboratory for discussions, K. Uyeda for providing ChREBP KO mice, and E. Shu for technical assistance. This work was supported by NIH R37 DK43051 (B.B.K.), K08 DK076726 (M.A.H.), BADERC DK057521 (B.B.K., M.A.H.), BNORC DK046200 (M.A.H.), the Picower and JPB Foundations (B.B.K.), a Fellowship from the Radcliffe Institute for Advanced Study (B.B.K.), DK056341 (Nutrition and Obesity Research Unit) (S.K.), DK037948 (S.K.), and the Deutsche Forschungsgemeinschft DFG, KFO152, BL833/1 (M.B.).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Caesar R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011525; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Denechaud PD, 2008, CURR OPIN LIPIDOL, V19, P301, DOI 10.1097/MOL.0b013e3282ffafaa; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI [10.1172/JCI23621, 10.1172/JCI200523621]; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Fukasawa M, 2010, BIOCHEM BIOPH RES CO, V391, P1166, DOI 10.1016/j.bbrc.2009.11.115; GNUDI L, 1995, ENDOCRINOLOGY, V136, P995, DOI 10.1210/en.136.3.995; HEMS DA, 1975, BIOCHEM J, V150, P167, DOI 10.1042/bj1500167; Hoffstedt J, 2007, J INTERN MED, V262, P131, DOI 10.1111/j.1365-2796.2007.01811.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2009, BIOCHEM BIOPH RES CO, V379, P499, DOI 10.1016/j.bbrc.2008.12.100; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Kursawe R, 2010, DIABETES, V59, P2288, DOI 10.2337/db10-0113; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Pashkov V, 2011, J BIOL CHEM, V286, P15116, DOI 10.1074/jbc.M110.216234; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sanchez J, 2009, ENDOCRINOLOGY, V150, P5341, DOI 10.1210/en.2009-0466; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029	46	395	416	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					333	U66		10.1038/nature10986	http://dx.doi.org/10.1038/nature10986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22466288	Green Submitted, Green Accepted			2022-12-01	WOS:000302946500024
J	Kon, T; Oyama, T; Shimo-Kon, R; Imamula, K; Shima, T; Sutoh, K; Kurisu, G				Kon, Takahide; Oyama, Takuji; Shimo-Kon, Rieko; Imamula, Kenji; Shima, Tomohiro; Sutoh, Kazuo; Kurisu, Genji			The 2.8 angstrom crystal structure of the dynein motor domain	NATURE			English	Article							MICROTUBULE-BINDING DOMAIN; CYTOPLASMIC DYNEIN; COILED-COIL; ATP HYDROLYSIS; AAA; MECHANISM; PROGRAM; CRYSTALLOGRAPHY; EXPRESSION; TRANSPORT	Dyneins are microtubule-based AAA(+) motor complexes that power ciliary beating, cell division, cell migration and intracellular transport. Here we report the most complete structure obtained so far, to our knowledge, of the 380-kDa motor domain of Dictyostelium discoideum cytoplasmic dynein at 2.8 angstrom resolution; the data are reliable enough to discuss the structure and mechanism at the level of individual amino acid residues. Features that can be clearly visualized at this resolution include the coordination of ADP in each of four distinct nucleotide-binding sites in the ring-shaped AAA(+) ATPase unit, a newly identified interaction interface between the ring and mechanical linker, and junctional structures between the ring and microtubule-binding stalk, all of which should be critical for the mechanism of dynein motility. We also identify a long-range allosteric communication pathway between the primary ATPase and the microtubule-binding sites. Our work provides a framework for understanding the mechanism of dynein-based motility.	[Kon, Takahide; Oyama, Takuji; Shimo-Kon, Rieko; Kurisu, Genji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kon, Takahide; Kurisu, Genji] Osaka Univ, Dept Macromol Sci, Sch Sci, Osaka 5600043, Japan; [Imamula, Kenji] Univ Tokyo, Dept Life Sci, Sch Arts & Sci, Tokyo 1538902, Japan; [Shima, Tomohiro] Univ Tokyo, Dept Phys, Grad Sch Sci, Bunkyou Ku, Tokyo 1130033, Japan; [Sutoh, Kazuo] Waseda Univ, Res Inst Sci & Engn, Toshima Ku, Tokyo 1710033, Japan	Osaka University; Osaka University; University of Tokyo; University of Tokyo; Waseda University	Kon, T (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takahide.kon@protein.osaka-u.ac.jp	KURISU, GENJI/AAD-7109-2022; KURISU, GENJI/ABA-5960-2020; Kon, Takahide/AAG-6975-2021	KURISU, GENJI/0000-0002-5354-0807; KURISU, GENJI/0000-0002-5354-0807; Oyama, Takuji/0000-0002-3411-7608; Kon, Takahide/0000-0002-1231-7609	Ministry of Education, Culture Sports, Science, and Technology of Japan [17770126, 20687011, 23370073, 16083205, 17107003, 17053006, 18054008, 20051006]; Human Frontier Science Program; Grants-in-Aid for Scientific Research [23370073] Funding Source: KAKEN	Ministry of Education, Culture Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank E. Yamashita, Y. Umena, M. Suzuki and A. Nakagawa of SPring-8 BL-44XU for their support during X-ray data collection; and T. Kikuchi and R. Ohkura for their technical support. We are grateful to C. Toyoshima for discussion of X-ray data collection; K. Kinosita Jr and T. Tsukihara for their support and encouragement. This work was supported by Grants-in-Aid for Scientific Research (17770126, 20687011 and 23370073 (T. K.), 16083205 and 17107003 (K. S.), 17053006, 18054008 and 20051006 (G. K.)) from the Ministry of Education, Culture Sports, Science, and Technology of Japan and a grant from the Human Frontier Science Program (T.K.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blaauw M, 2000, GENE, V252, P71, DOI 10.1016/S0378-1119(00)00227-4; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; DiBella LM, 2001, INT REV CYTOL, V210, P227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GIBBONS IR, 1981, J CELL BIOL, V91, pS107, DOI 10.1083/jcb.91.3.107s; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Kon T, 2009, METHOD CELL BIOL, V92, P65, DOI 10.1016/S0091-679X(08)92005-7; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Koonce MP, 1997, J BIOL CHEM, V272, P19714, DOI 10.1074/jbc.272.32.19714; Koonce MP, 1996, MOL BIOL CELL, V7, P935, DOI 10.1091/mbc.7.6.935; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mocz G, 1996, BIOCHEMISTRY-US, V35, P9204, DOI 10.1021/bi960662u; Neuwald AF, 1999, GENOME RES, V9, P27; Numata N, 2011, FEBS LETT, V585, P1185, DOI 10.1016/j.febslet.2011.03.036; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Schrodinger L., 2020, PYMOL; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h	50	166	167	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					345	U81		10.1038/nature10955	http://dx.doi.org/10.1038/nature10955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22398446				2022-12-01	WOS:000302946500026
J	Sparrow, DB; Chapman, G; Smith, AJ; Mattar, MZ; Major, JA; O'Reilly, VC; Saga, Y; Zackai, EH; Dormans, JP; Alman, BA; McGregor, L; Kageyama, R; Kusumi, K; Dunwoodie, SL				Sparrow, Duncan B.; Chapman, Gavin; Smith, Allanceson J.; Mattar, Muhammad Z.; Major, Joelene A.; O'Reilly, Victoria C.; Saga, Yumiko; Zackai, Elaine H.; Dormans, John P.; Alman, Benjamin A.; McGregor, Lesley; Kageyama, Ryoichiro; Kusumi, Kenro; Dunwoodie, Sally L.			A Mechanism for Gene-Environment Interaction in the Etiology of Congenital Scoliosis	CELL			English	Article							LUNATIC-FRINGE EXPRESSION; SOMITE SEGMENTATION CLOCK; PRESOMITIC MESODERM; SPONDYLOCOSTAL DYSOSTOSIS; VERTEBRAL SEGMENTATION; MOUSE SOMITOGENESIS; BOUNDARY FORMATION; DELTA-HOMOLOG; NOTCH; FGF8	Congenital scoliosis, a lateral curvature of the spine caused by vertebral defects, occurs in approximately 1 in 1,000 live births. Here we demonstrate that haploinsufficiency of Notch signaling pathway genes in humans can cause this congenital abnormality. We also show that in a mouse model, the combination of this genetic risk factor with an environmental condition (short-term gestational hypoxia) significantly increases the penetrance and severity of vertebral defects. We demonstrate that hypoxia disrupts FGF signaling, leading to a temporary failure of embryonic somitogenesis. Our results potentially provide a mechanism for the genesis of a host of common sporadic congenital abnormalities through gene-environment interaction.	[Sparrow, Duncan B.; Chapman, Gavin; Mattar, Muhammad Z.; Major, Joelene A.; O'Reilly, Victoria C.; Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Sydney, NSW 2010, Australia; [Sparrow, Duncan B.; Chapman, Gavin; Dunwoodie, Sally L.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Smith, Allanceson J.; Kusumi, Kenro] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Saga, Yumiko] Natl Inst Genet, Mammalian Dev Lab, Mishima, Shizuoka 4118540, Japan; [Zackai, Elaine H.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Dormans, John P.] Childrens Hosp Philadelphia, Div Orthopaed Surg, Philadelphia, PA 19104 USA; [Zackai, Elaine H.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Dormans, John P.] Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Alman, Benjamin A.] Univ Toronto, Inst Med Sci, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Alman, Benjamin A.] Univ Toronto, Div Orthopaed Surg, Toronto, ON M5G 1L5, Canada; [Alman, Benjamin A.] Univ Toronto, Dept Surg, Toronto, ON M5G 1L5, Canada; [Alman, Benjamin A.] Univ Toronto, Hosp Sick Children, Fac Med, Toronto, ON M5G 1X8, Canada; [McGregor, Lesley] Womens & Childrens Hosp, SA Pathol, S Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kageyama Lab, Kyoto 6068507, Japan	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Arizona State University; Arizona State University-Tempe; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); SA Pathology; Kyoto University	Sparrow, DB (corresponding author), Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Sydney, NSW 2010, Australia.	d.sparrow@victorchang.edu.au; s.dunwoodie@victorchang.edu.au	Sparrow, Duncan/B-3994-2008; Dunwoodie, Sally L/M-4019-2018; Kusumi, Kenro/J-2626-2012; Chapman, Gavin/A-9534-2012	Sparrow, Duncan/0000-0002-1141-6613; Dunwoodie, Sally L/0000-0002-2069-7349; Kusumi, Kenro/0000-0002-1458-4540; Chapman, Gavin/0000-0002-3513-723X	National Health and Medical Research Council [635500, 514900]; Westfield-Belconnen Fellowship; Hitchings-Elion Fellowship of the Burroughs Wellcome Fund; Cervical Spine Research Society; Ethel Brown Foerderer Fund for Excellence; Florence R.C. Murray Fund	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Westfield-Belconnen Fellowship; Hitchings-Elion Fellowship of the Burroughs Wellcome Fund; Cervical Spine Research Society; Ethel Brown Foerderer Fund for Excellence; Florence R.C. Murray Fund	We thank patients, their families, and clinicians for their contribution and cooperation; D. Chapman, S. Mansour, G. Martin, T. Vogt, and K. Willert for plasmids; K. Hozumi, R. Kopan, S. Piccolo, and P. Tam for mouse lines; E. Thompson and C. Barnett for assessment of family B; BioCORE staff, L. Tomlinson, S. Goettl, J.-S. Han, L. Lunny, and M. Maisenbacher for technical assistance; Herbert Smith for donating the confocal microscopes used in this study; and R. Harvey and K. Anderson for comments on the text. Work was supported by National Health and Medical Research Council Project grant 635500 (S. L. D. and D. B. S.); NHMRC Senior Research Fellowship 514900 (S. L. D.); a Westfield-Belconnen Fellowship (D. B. S.); and a Hitchings-Elion Fellowship of the Burroughs Wellcome Fund, Cervical Spine Research Society, Ethel Brown Foerderer Fund for Excellence and Florence R.C. Murray Fund (K. K.). D. B. S. dedicates this article to David Sparrow (December 11, 1927-March 22, 2012) an inspiring geneticist and loving father.	Alexander PG, 2010, BIRTH DEFECTS RES C, V90, P118, DOI 10.1002/bdrc.20179; [Anonymous], C SERIES DEV BIOL; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; BAGNALL KM, 1988, DEVELOPMENT, V103, P69; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; BURKE AC, 1995, DEVELOPMENT, V121, P333; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chapman G, 2011, HUM MOL GENET, V20, P905, DOI 10.1093/hmg/ddq529; Christ B, 2007, DEV DYNAM, V236, P2382, DOI 10.1002/dvdy.21189; Cordes R, 2004, DEVELOPMENT, V131, P1221, DOI 10.1242/dev.01030; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Frank DU, 2002, DEVELOPMENT, V129, P4591; Garg V, 2006, CURR OPIN CARDIOL, V21, P180, DOI 10.1097/01.hco.0000221578.18254.70; Geffers I, 2007, J CELL BIOL, V178, P465, DOI 10.1083/jcb.200702009; Geoffroy Saint-Hilaire Etienne, 1820, J COMPLEMENTAIRE SCI, V7, P271; Giampietro PF, 2009, ANN NY ACAD SCI, V1151, P38, DOI 10.1111/j.1749-6632.2008.03452.x; Gibb S, 2010, TRENDS CELL BIOL, V20, P593, DOI 10.1016/j.tcb.2010.07.001; Hedequist D, 2007, J PEDIATR ORTHOPED, V27, P106, DOI 10.1097/BPO.0b013e31802b4993; Huang R, 1996, ACTA ANAT, V155, P231; Huppert SS, 2005, DEV CELL, V8, P677, DOI 10.1016/j.devcel.2005.02.019; Hutter D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/401323; INGALLS TH, 1957, NEW ENGL J MED, V257, P1121, DOI 10.1056/NEJM195712052572306; INGALLS TH, 1952, NEW ENGL J MED, V247, P758, DOI 10.1056/NEJM195211132472004; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Maisenbacher MK, 2005, HUM GENET, V116, P416, DOI 10.1007/s00439-005-1253-8; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Nomura-Kitabayashi A, 2002, DEVELOPMENT, V129, P2473; Oginuma M, 2008, DEVELOPMENT, V135, P2555, DOI 10.1242/dev.019877; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shifley ET, 2008, DEVELOPMENT, V135, P899, DOI 10.1242/dev.006742; Solomon BD, 2010, HUM GENET, V127, P731, DOI 10.1007/s00439-010-0814-7; Sparrow DB, 2011, MAMM GENOME, V22, P362, DOI 10.1007/s00335-011-9335-5; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; TAM PPL, 1982, DIFFERENTIATION, V21, P109, DOI 10.1111/j.1432-0436.1982.tb01203.x; Turnpenny PD, 2012, EUR J HUM GENET, V20, P251, DOI 10.1038/ejhg.2011.181; Verras M, 2008, MOL CELL BIOL, V28, P7212, DOI 10.1128/MCB.00947-08; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; William DA, 2007, DEV BIOL, V305, P172, DOI 10.1016/j.ydbio.2007.02.007; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103	61	145	158	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					295	306		10.1016/j.cell.2012.02.054	http://dx.doi.org/10.1016/j.cell.2012.02.054			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22484060	Bronze			2022-12-01	WOS:000302805600010
J	Smith, R; Lunt, N; Hanefeld, J				Smith, Richard; Lunt, Neil; Hanefeld, Johanna			The implications of PIP are more than just cosmetic	LANCET			English	Editorial Material							TOURISM		[Smith, Richard] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England; [Lunt, Neil] Univ York, Dept Social Policy & Social Work, York YO10 5DD, N Yorkshire, England; [Hanefeld, Johanna] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh, Midlothian, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of York - UK; University of Edinburgh	Smith, R (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England.	richard.smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559				Cox S, 2012, BBC NEWS HLTH   0120; Department of Health, 2012, DEP HLTH STAT BREAST; Horton R, 2012, LANCET, V379, P204, DOI 10.1016/S0140-6736(12)60070-1; Lunt Neil, 2010, Open Med Inform J, V4, P1, DOI 10.2174/1874431101004010001; McKelvey A, 2009, BJOG-INT J OBSTET GY, V116, P1520, DOI 10.1111/j.1471-0528.2009.02294.x; Miyagi K, 2012, J PLAST RECONSTR AES, V65, P22, DOI 10.1016/j.bjps.2011.07.027; Office for National Statistics, 2011, INT PASS SURV 2011; Smith R, 2011, HEALTH POLICY, V103, P276, DOI 10.1016/j.healthpol.2011.06.009; Smith RD, 2009, LANCET, V373, P768, DOI 10.1016/S0140-6736(08)61780-8; UK National Health Service (NHS), 2012, PIP BREAST IMPL LAT; WHO, GLOB AL RESP SIL IMP	11	12	12	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1180	1181		10.1016/S0140-6736(12)60166-4	http://dx.doi.org/10.1016/S0140-6736(12)60166-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	22305764				2022-12-01	WOS:000302230400012
J	Molenaar, JJ; Koster, J; Zwijnenburg, DA; van Sluis, P; Valentijn, LJ; van der Ploeg, I; Hamdi, M; van Nes, J; Westerman, BA; van Arkel, J; Ebus, ME; Haneveld, F; Lakeman, A; Schild, L; Molenaar, P; Stroeken, P; van Noesel, MM; Ora, I; Santo, EE; Caron, HN; Westerhout, EM; Versteeg, R				Molenaar, Jan J.; Koster, Jan; Zwijnenburg, Danny A.; van Sluis, Peter; Valentijn, Linda J.; van der Ploeg, Ida; Hamdi, Mohamed; van Nes, Johan; Westerman, Bart A.; van Arkel, Jennemiek; Ebus, Marli E.; Haneveld, Franciska; Lakeman, Arjan; Schild, Linda; Molenaar, Piet; Stroeken, Peter; van Noesel, Max M.; Ora, Ingrid; Santo, Evan E.; Caron, Huib N.; Westerhout, Ellen M.; Versteeg, Rogier			Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes	NATURE			English	Article							ACTIVATING MUTATIONS; TUMOR-SUPPRESSOR; ALK KINASE; PATHWAY; ROLES; EXPRESSION; RECEPTOR; FAMILY; ACID	Neuroblastomais a childhood tumour of the peripheral sympathetic nervous system. The pathogenesis has for a long time been quite enigmatic, as only very few gene defects were identified in this often lethal tumour(1). Frequently detected gene alterations are limited to MYCN amplification (20%) and ALK activations (7%)(2-5). Here we present a whole-genome sequence analysis of 87 neuroblastoma of all stages. Few recurrent amino-acid-changing mutations were found. In contrast, analysis of structural defects identified a local shredding of chromosomes, known as chromothripsis, in 18% of high-stage neuroblastoma(6). These tumours are associated with a poor outcome. Structural alterations recurrently affected ODZ3, PTPRD and CSMD1, which are involved in neuronal growth cone stabilization(7-9). In addition, ATRX, TIAM1 and a series of regulators of the Rac/Rho pathway were mutated, further implicating defects in neuritogenesis in neuroblastoma. Most tumours with defects in these genes were aggressive high-stage neuroblastomas, but did not carry MYCN amplifications. The genomic landscape of neuroblastoma therefore reveals two novel molecular defects, chromothripsis and neuritogenesis gene alterations, which frequently occur in high-risk tumours.	[Molenaar, Jan J.; Koster, Jan; Zwijnenburg, Danny A.; van Sluis, Peter; Valentijn, Linda J.; van der Ploeg, Ida; Hamdi, Mohamed; van Nes, Johan; Westerman, Bart A.; van Arkel, Jennemiek; Ebus, Marli E.; Haneveld, Franciska; Lakeman, Arjan; Schild, Linda; Molenaar, Piet; Stroeken, Peter; Ora, Ingrid; Santo, Evan E.; Westerhout, Ellen M.; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogenom, NL-1105 AZ Amsterdam, Netherlands; [van Noesel, Max M.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Oncol Hematol, NL-3015 GJ Rotterdam, Netherlands; [Ora, Ingrid] Lund Univ, Skane Univ Hosp, Dept Pediat Oncol & Hematol, S-22185 Lund, Sweden; [Caron, Huib N.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Lund University; Skane University Hospital; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Versteeg, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncogenom, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.molenaar@amc.uva.nl; r.versteeg@amc.uva.nl	Versteeg, Rogier/AAQ-1765-2020; Øra, Ingrid/J-2596-2013; Westerman, Bart/ACM-8337-2022; Koster, Jan/C-5934-2008	Øra, Ingrid/0000-0002-3931-4125; Westerman, Bart/0000-0002-9898-9616; Koster, Jan/0000-0002-0890-7585; Versteeg, Rogier/0000-0001-7172-0388; van Nes, Johan/0000-0001-7691-1431	Villa Joep Foundation; KIKA; Tom Voute Fund; Netherlands Cancer Foundation	Villa Joep Foundation; KIKA; Tom Voute Fund; Netherlands Cancer Foundation	The research in this paper was supported by grants from the Villa Joep Foundation, KIKA, Tom Voute Fund, and the Netherlands Cancer Foundation. We thank R. Tearle and G. Tyrelle (Complete Genomics) for expert support and R. Volckmann, N. Hasselt, T. van Groningen, E. Dolman, K. Drabek and I. Dokter for their help.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arregui CO, 2000, NEUROCHEM RES, V25, P95, DOI 10.1023/A:1007595617447; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Chen QR, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-70; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matsuo N, 2003, MOL CELL NEUROSCI, V24, P69, DOI 10.1016/S1044-7431(03)00122-2; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Molenaar JJ, 2003, GENE CHROMOSOME CANC, V36, P242, DOI 10.1002/gcc.10166; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Rubin BP, 1999, DEV BIOL, V216, P195, DOI 10.1006/dbio.1999.9503; Santo E.E., 2011, ONCOGENE        0822, DOI [10.1038/onc.2011.344, DOI 10.1038/ONC.2011.344]; Shioda N, 2011, J NEUROSCI, V31, P346, DOI 10.1523/JNEUROSCI.4816-10.2011; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sun QL, 2000, MOL CELL NEUROSCI, V16, P686, DOI 10.1006/mcne.2000.0893; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; Valentijn LJ, 2005, CANCER RES, V65, P3136, DOI 10.1158/0008-5472.CAN-04-2469; Vandesompele J, 2001, MED PEDIATR ONCOL, V36, P5, DOI 10.1002/1096-911X(20010101)36:1<5::AID-MPO1003>3.0.CO;2-E; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Zheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022956	36	604	615	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					589	U107		10.1038/nature10910	http://dx.doi.org/10.1038/nature10910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22367537	Green Published, hybrid			2022-12-01	WOS:000302006100037
J	Emanuel, EJ; Fuchs, VR				Emanuel, Ezekiel J.; Fuchs, Victor R.			Shortening Medical Training by 30%	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EDUCATION		[Emanuel, Ezekiel J.] Univ Penn, Off Provost, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Fuchs, Victor R.] Stanford Univ, Dept Econ, Palo Alto, CA 94304 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Stanford University	Emanuel, EJ (corresponding author), Univ Penn, Off Provost, 1 Coll Hall,Room 122, Philadelphia, PA 19104 USA.	zemanuel@upenn.edu						Duke University School of Medicine Admissions website, YOUR ED YEAR ON BAS; Farrell D, ACCOUNTING COST US H; Flexner A, 1924, J AMER MED ASSOC, V82, P833, DOI 10.1001/jama.1924.02650370001001; Grochowski CO, 2007, ACAD MED, V82, P375, DOI 10.1097/ACM.0b013e3180333575; Harvard Medical School website, PROGR MED ED NEW PAT; Loftus LS, 1997, TEACH LEARN MED, V9, P248, DOI 10.1207/s15328015tlm0904_1; Sachdeva AK, 2007, ACAD MED, V82, P1200, DOI 10.1097/ACM.0b013e318159e052	7	104	105	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2012	307	11					1143	1144		10.1001/jama.2012.292	http://dx.doi.org/10.1001/jama.2012.292			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911HN	22436952				2022-12-01	WOS:000301708000019
J	Cobey, S; Lipsitch, M				Cobey, Sarah; Lipsitch, Marc			Niche and Neutral Effects of Acquired Immunity Permit Coexistence of Pneumococcal Serotypes	SCIENCE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CONJUGATE VACCINATION; DISEASE; EVOLUTION; INFANTS; COLONIZATION; CHILDREN; VACCINES; MODELS	Over 90 capsular serotypes of Streptococcus pneumoniae, a common nasopharyngeal colonizer and major cause of pneumonia, bacteremia, and meningitis, are known. It is unclear why some serotypes can persist at all: They are more easily cleared from carriage and compete poorly in vivo. Serotype-specific immune responses, which could promote diversity in principle, are weak enough to allow repeated colonizations by the same type. We show that weak serotype-specific immunity and an acquired response not specific to the capsule can together reproduce observed diversity. Serotype-specific immunity stabilizes competition, and acquired immunity to noncapsular antigens reduces fitness differences. Our model can be used to explain the effects of pneumococcal vaccination and indicates general factors that regulate the diversity of pathogens.	[Cobey, Sarah; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Cobey, Sarah; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Cobey, S (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, 677 Huntington Ave, Boston, MA 02115 USA.	scobey@hsph.harvard.edu		Lipsitch, Marc/0000-0003-1504-9213	National Institute of Allergy and Infectious Diseases (NIAID) [5R01AI048935]; National Institute of General Medical Sciences (NIGMS) [1F32GM097997, U54GM088558]; Pfizer; Novartis; AIR Worldwide; Avian/Pandemic Flu Registry (Outcome Sciences); Roche; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097997, U54GM088558] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pfizer(Pfizer); Novartis(Novartis); AIR Worldwide; Avian/Pandemic Flu Registry (Outcome Sciences); Roche(Roche Holding); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Abdullahi and A. Scott for sharing their data on the duration of carriage; E. Lee for help reviewing carriage studies; C. Laine for sharing an unpublished earlier review of such studies; and C. Buckee, W. Hanage, B. Levin, R. Malley, V. Pitzer, D. Weinberger, and J. Zelner for helpful comments. Computations were run on the Odyssey cluster supported by the FAS Science Division Research Computing Group at Harvard University. E-mail scobey@hsph.harvard.edu for the location of the code repository. The project was supported by awards 5R01AI048935 from the National Institute of Allergy and Infectious Diseases (NIAID) and 1F32GM097997 and U54GM088558 from the National Institute of General Medical Sciences (NIGMS). The content is solely the responsibility of the authors and does not necessarily represent the views of the NIGMS, NIAID, or the NIH. M. L. has received consulting fees or honoraria from Pfizer, Novartis, AIR Worldwide, and the Avian/Pandemic Flu Registry (Outcome Sciences), supported by Roche.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Buckee CO, 2010, P ROY SOC B-BIOL SCI, V277, P1635, DOI 10.1098/rspb.2009.2033; Buckee CO, 2009, P ROY SOC B-BIOL SCI, V276, P477, DOI 10.1098/rspb.2008.1122; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Hanage WP, 2010, EPIDEMICS-NETH, V2, P80, DOI 10.1016/j.epidem.2010.03.005; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Lipsitch M, 2012, EPIDEMIOLOGY, V23, P1, DOI [10.1097/EDE.0b013e31824f2f32, DOI 10.1097/EDE.0B013E31824F2F32]; Lipsitch M, 2009, EPIDEMICS-NETH, V1, P2, DOI 10.1016/j.epidem.2008.07.001; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; McLean AR, 1998, BRIT MED BULL, V54, P545; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Yu XH, 1999, J INFECT DIS, V180, P1569, DOI 10.1086/315096	32	114	115	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2012	335	6074					1376	1380		10.1126/science.1215947	http://dx.doi.org/10.1126/science.1215947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22383809	Green Accepted			2022-12-01	WOS:000301531600055
J	Stukel, TA; Fisher, ES; Alter, DA; Guttmann, A; Ko, DT; Fung, K; Wodchis, WP; Baxter, NN; Earle, CC; Lee, DS				Stukel, Therese A.; Fisher, Elliott S.; Alter, David A.; Guttmann, Astrid; Ko, Dennis T.; Fung, Kinwah; Wodchis, Walter P.; Baxter, Nancy N.; Earle, Craig C.; Lee, Douglas S.			Association of Hospital Spending Intensity With Mortality and Readmission Rates in Ontario Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CONGESTIVE-HEART-FAILURE; QUALITY-OF-CARE; SURGICAL OUTCOMES; 30-DAY MORTALITY; HIP FRACTURE; REGIONAL-VARIATIONS; CARDIAC MANAGEMENT; HEALTH OUTCOMES; UNITED-STATES	Context The extent to which better spending produces higher-quality care and better patient outcomes in a universal health care system with selective access to medical technology is unknown. Objective To assess whether acute care patients admitted to higher-spending hospitals have lower mortality and readmissions. Design, Setting, and Patients The study population comprised adults (>18 years) in Ontario, Canada, with a first admission for acute myocardial infarction (AMI) (n=179 139), congestive heart failure (CHF) (n=92 377), hip fracture (n=90 046), or colon cancer (n=26 195) during 1998-2008, with follow-up to 1 year. The exposure measure was the index hospital's end-of-life expenditure index for hospital, physician, and emergency department services. Main Outcome Measures The primary outcomes were 30-day and 1-year mortality and readmissions and major cardiac events (readmissions for AMI, angina, CHF, or death) for AMI and CHF. Results Patients' baseline health status was similar across hospital expenditure groups. Patients admitted to hospitals in the highest-vs lowest-spending intensity terciles had lower rates of all adverse outcomes. In the highest-vs lowest-spending hospitals, respectively, the age-and sex-adjusted 30-day mortality rate was 12.7% vs 12.8% for AMI, 10.2% vs 12.4% for CHF, 7.7% vs 9.7% for hip fracture, and 3.3% vs 3.9% for CHF; fully adjusted relative 30-day mortality rates were 0.93 (95% CI, 0.89-0.98) for AMI, 0.81 (95% CI, 0.76-0.86) for CHF, 0.74 (95% CI, 0.68-0.80) for hip fracture, and 0.78 (95% CI, 0.66-0.91) for colon cancer. Results for 1-year mortality, readmissions, and major cardiac events were similar. Higher-spending hospitals had higher nursing staff ratios, and their patients received more inpatient medical specialist visits, interventional (AMI cohort) and medical (AMI and CHF cohorts) cardiac therapies, preoperative specialty care (colon cancer cohort), and postdischarge collaborative care with a cardiologist and primary care physician (AMI and CHF cohorts). Conclusion Among Ontario hospitals, higher spending intensity was associated with lower mortality, readmissions, and cardiac event rates. JAMA. 2012;307(10):1037-1045 www.jama.com	[Stukel, Therese A.; Alter, David A.; Guttmann, Astrid; Ko, Dennis T.; Fung, Kinwah; Wodchis, Walter P.; Baxter, Nancy N.; Earle, Craig C.; Lee, Douglas S.] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Stukel, Therese A.; Alter, David A.; Guttmann, Astrid; Ko, Dennis T.; Wodchis, Walter P.; Baxter, Nancy N.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Stukel, Therese A.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON, Canada; [Guttmann, Astrid] Univ Toronto, Hosp Sick Children, Div Paediat Med, Toronto, ON M5G 1X8, Canada; [Ko, Dennis T.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON, Canada; [Stukel, Therese A.; Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Populat Hlth, Lebanon, NH USA; [Stukel, Therese A.; Fisher, Elliott S.] Dartmouth Med Sch, Lebanon, NH USA; [Alter, David A.; Baxter, Nancy N.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Alter, David A.; Wodchis, Walter P.] Toronto Rehabil Inst, Toronto, ON, Canada; [Lee, Douglas S.] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Dartmouth College; Dartmouth College; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Stukel, TA (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	stukel@ices.on.ca	Greiver, Michelle/N-8764-2015; Baxter, Nancy N/E-7020-2015	Greiver, Michelle/0000-0001-8957-0285; Baxter, Nancy N/0000-0003-4793-4620; Ko, Dennis/0000-0001-6840-8051; wodchis, walter/0000-0003-2494-7031; Lee, Douglas/0000-0001-7078-745X; Stukel, Therese/0000-0002-2951-1360	Canadian Institutes of Health Research [ETG92248]; US National Institute on Aging [1PO1-AG19783-01]; Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by an Emerging Team Grant (ETG92248) in Applied Health Services and Policy Research from the Canadian Institutes of Health Research, by a grant from the US National Institute on Aging (1PO1-AG19783-01), and by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care.	Alter DA, 2006, CIRCULATION, V113, P380, DOI 10.1161/CIRCULATIONAHA.105.560466; Austin PC, 2006, J ROY STAT SOC A STA, V169, P115, DOI 10.1111/j.1467-985X.2005.00380.x; Ayanian JZ, 2006, CIRCULATION, V113, P333, DOI 10.1161/CIRCULATIONAHA.105.598789; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Birkmeyer NJO, 2005, CANCER-AM CANCER SOC, V103, P435, DOI 10.1002/cncr.20785; Chen LM, 2010, ARCH INTERN MED, V170, P340, DOI 10.1001/archinternmed.2009.511; Fisher E, 2010, HLTH SERV RES 2, V45, P1908; Fisher E, 2010, HEALTH SERV RES, V45, P1893, DOI 10.1111/j.1475-6773.2010.01186.x; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Goodman DC, 2002, NEW ENGL J MED, V346, P1538, DOI 10.1056/NEJMoa011921; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Juurlink D., 2006, CANADIAN I HLTH INFO; Krumholz HM, 2008, CIRCULATION, V118, P2596, DOI 10.1161/CIRCULATIONAHA.108.191099; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Landrum MB, 2008, HEALTH AFFAIR, V27, P159, DOI 10.1377/hlthaff.27.1.159; Lee DS, 2010, CIRCULATION, V122, P1806, DOI 10.1161/CIRCULATIONAHA.110.940262; Lee DS, 2003, CAN J CARDIOL, V19, P357; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Martin S, 2008, J HEALTH ECON, V27, P826, DOI 10.1016/j.jhealeco.2007.12.002; Meyerhardt JA, 2003, ANN INTERN MED, V139, P649, DOI 10.7326/0003-4819-139-8-200310210-00008; Morrison RS, 1998, ANN INTERN MED, V128, P1010, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00010; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Neuman MD, 2009, J AM GERIATR SOC, V57, P2046, DOI 10.1111/j.1532-5415.2009.02492.x; OECD, 2011, OECD HLTH DAT 2011; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Richards J, 2012, DATA QUALITY STUDY C; Romley JA, 2011, ANN INTERN MED, V154, P160, DOI 10.7326/0003-4819-154-3-201102010-00005; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Rothberg MB, 2010, HEALTH AFFAIR, V29, P1523, DOI 10.1377/hlthaff.2009.0287; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Silber JH, 2010, HEALTH SERV RES, V45, P1872, DOI 10.1111/j.1475-6773.2010.01180.x; Skinner J., 2012, HDB HLTH EC, V2, P45; Skinner J, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp1000448; Skinner JS, 2006, HEALTH AFFAIR, V25, pW34, DOI 10.1377/hlthaff.25.w34; StataCorp, 2009, STAT STAT SOFTW SE R; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Stukel TA, 2010, MED CARE, V48, P157, DOI 10.1097/MLR.0b013e3181bd4da7; Tourangeau AE, 2007, J ADV NURS, V57, P32, DOI 10.1111/j.1365-2648.2006.04084.x; Tu JV, 2008, CAN MED ASSOC J, V179, P909, DOI 10.1503/cmaj.080749; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Tu JV, 2001, JAMA-J AM MED ASSOC, V285, P3116, DOI 10.1001/jama.285.24.3116; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104; Weller I, 2005, J BONE JOINT SURG BR, V87B, P361, DOI 10.1302/0301-620X.87B3.15300; World Health Organization, COUNTR; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566	52	104	105	0	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2012	307	10					1037	1045		10.1001/jama.2012.265	http://dx.doi.org/10.1001/jama.2012.265			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	908GU	22416099	Green Accepted			2022-12-01	WOS:000301479700024
J	Lalonde, K; Mucci, A; Ouellet, A; Gelinas, Y				Lalonde, Karine; Mucci, Alfonso; Ouellet, Alexandre; Gelinas, Yves			Preservation of organic matter in sediments promoted by iron	NATURE			English	Article							MARINE-SEDIMENTS; MINERAL SURFACES; SORPTION; METAL; SOIL	The biogeochemical cycles of iron and organic carbon are strongly interlinked. In oceanic waters, organic ligands have been shown to control the concentration of dissolved iron(1). In soils, solid iron phases shelter and preserve organic carbon(2), but the role of iron in the preservation of organic matter in sediments has not been clearly established. Here we use an iron reduction method previously applied to soils(3) to determine the amount of organic carbon associated with reactive iron phases in sediments of various mineralogies collected from a wide range of depositional environments. Our findings suggest that 21.5 +/- 8.6 per cent of the organic carbon in sediments is directly bound to reactive iron phases. We further estimate that a global mass of (19-45) x 10(15) grams of organic carbon is preserved in surface marine sediments as a result of its association with iron(4). We propose that these associations between organic carbon and iron, which are formed primarily through co-precipitation and/or direct chelation, promote the preservation of organic carbon in sediments. Because reactive iron phases are metastable over geological timescales, we suggest that they serve as an efficient 'rusty sink' for organic carbon, acting as a key factor in the long-term storage of organic carbon and thus contributing to the global cycles of carbon, oxygen and sulphur(5).	[Lalonde, Karine; Ouellet, Alexandre; Gelinas, Yves] Concordia Univ, GEOTOP, Montreal, PQ H4B 1R6, Canada; [Lalonde, Karine; Ouellet, Alexandre; Gelinas, Yves] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H4B 1R6, Canada; [Mucci, Alfonso] McGill Univ, GEOTOP, Montreal, PQ H3A 2A7, Canada	Concordia University - Canada; Concordia University - Canada; McGill University	Gelinas, Y (corresponding author), Concordia Univ, GEOTOP, 7141 Sherbrooke St W, Montreal, PQ H4B 1R6, Canada.	ygelinas@alcor.concordia.ca	Gélinas, Yves/K-4019-2013	Gélinas, Yves/0000-0001-5751-8378; Mucci, Alfonso/0000-0001-9155-6319	NSERC; CFI; FQRNT	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI(Canada Foundation for Innovation); FQRNT(FQRNT)	This work is dedicated to the memory of J.I. Hedges; in addition to being an inspiration to Y.G., he provided several sediment samples used in this work. We thank H. T. Yan for surface area measurements and the captains and crews of RV Coriolis II for their help during sampling missions on the St Lawrence estuary. L. N. Barazzuol is also acknowledged for her work during the first phase of the project. This work was supported by grants (Y.G. and A.M.) and scholarships (K.L.) from NSERC, CFI and FQRNT. This is GEOTOP contribution no. 2012-0001.	Arnarson TS, 2007, GEOCHIM COSMOCHIM AC, V71, P3545, DOI 10.1016/j.gca.2007.04.027; BAAS BECKING L. G. M., 1959, Journal of Sedimentary Petrology, V29, P454; BERNER RA, 1970, AM J SCI, V268, P1, DOI 10.2475/ajs.268.1.1; Berner RA, 2003, NATURE, V426, P323, DOI 10.1038/nature02131; BOUDOT JP, 1989, SOIL BIOL BIOCHEM, V21, P961, DOI 10.1016/0038-0717(89)90088-6; Burdige D. J., 2006, GEOCHEMISTRY MARINE, V107, P108; Canfield DE, 1997, GEOCHIM COSMOCHIM AC, V61, P3349, DOI 10.1016/S0016-7037(97)00172-5; Deflandre B, 2002, GEOCHIM COSMOCHIM AC, V66, P2547, DOI 10.1016/S0016-7037(02)00861-X; Guggenberger G, 2003, GEODERMA, V113, P293, DOI 10.1016/S0016-7061(02)00366-X; Haese RR, 1997, GEOCHIM COSMOCHIM AC, V61, P63, DOI 10.1016/S0016-7037(96)00312-2; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Jones DL, 1998, SOIL BIOL BIOCHEM, V30, P1895, DOI 10.1016/S0038-0717(98)00060-1; Kaiser K, 2000, ORG GEOCHEM, V31, P711, DOI 10.1016/S0146-6380(00)00046-2; Kraemer SM, 2004, AQUAT SCI, V66, P3, DOI 10.1007/s00027-003-0690-5; MACKEY DJ, 1994, ANAL CHIM ACTA, V284, P635, DOI 10.1016/0003-2670(94)85068-2; Mayer LM, 1999, GEOCHIM COSMOCHIM AC, V63, P207, DOI 10.1016/S0016-7037(99)00028-9; MAYER LM, 1994, GEOCHIM COSMOCHIM AC, V58, P1271, DOI 10.1016/0016-7037(94)90381-6; MAYER LM, 1995, MAR CHEM, V49, P123, DOI 10.1016/0304-4203(95)00011-F; MEHRA O. P., 1960, Proceedings 7th nat. Conf. Clays, V5, P317; Poulton SW, 2005, CHEM GEOL, V218, P203, DOI 10.1016/j.chemgeo.2005.01.007; Ransom B, 1997, MAR GEOL, V138, P1, DOI 10.1016/S0025-3227(97)00012-1; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; SCHWERTMANN U, 1966, NATURE, V212, P645, DOI 10.1038/212645b0; van der Zee C, 2003, GEOLOGY, V31, P993, DOI 10.1130/G19924.1; Wagai R, 2007, GEOCHIM COSMOCHIM AC, V71, P25, DOI 10.1016/j.gca.2006.08.047; Wang XC, 1998, GEOCHIM COSMOCHIM AC, V62, P1365, DOI 10.1016/S0016-7037(98)00074-X	28	626	666	137	1087	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 8	2012	483	7388					198	200		10.1038/nature10855	http://dx.doi.org/10.1038/nature10855			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22398559	Green Accepted			2022-12-01	WOS:000301174900035
J	Yun, MK; Wu, YN; Li, ZM; Zhao, Y; Waddell, MB; Ferreira, AM; Lee, RE; Bashford, D; White, SW				Yun, Mi-Kyung; Wu, Yinan; Li, Zhenmei; Zhao, Ying; Waddell, M. Brett; Ferreira, Antonio M.; Lee, Richard E.; Bashford, Donald; White, Stephen W.			Catalysis and Sulfa Drug Resistance in Dihydropteroate Synthase	SCIENCE			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE; CRYSTAL-STRUCTURE; FARNESYLPYROPHOSPHATE SYNTHETASE; STAPHYLOCOCCUS-AUREUS; MECHANISM; RECOGNITION; INHIBITORS	The sulfonamide antibiotics inhibit dihydropteroate synthase (DHPS), a key enzyme in the folate pathway of bacteria and primitive eukaryotes. However, resistance mutations have severely compromised the usefulness of these drugs. We report structural, computational, and mutagenesis studies on the catalytic and resistance mechanisms of DHPS. By performing the enzyme-catalyzed reaction in crystalline DHPS, we have structurally characterized key intermediates along the reaction pathway. Results support an S(N)1 reaction mechanism via formation of a novel cationic pterin intermediate. We also show that two conserved loops generate a substructure during catalysis that creates a specific binding pocket for p-aminobenzoic acid, one of the two DHPS substrates. This substructure, together with the pterin-binding pocket, explains the roles of the conserved active-site residues and reveals how sulfonamide resistance arises.	[Yun, Mi-Kyung; Wu, Yinan; Li, Zhenmei; Ferreira, Antonio M.; Bashford, Donald; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Wu, Yinan; Bashford, Donald; White, Stephen W.] Univ Tennessee, Integrated Program Biomed Sci, Hlth Sci Ctr, Memphis, TN 38163 USA; [Zhao, Ying; Lee, Richard E.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Waddell, M. Brett] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Ferreira, Antonio M.] St Jude Childrens Res Hosp, Dept Informat Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	White, SW (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	stephen.white@stjude.org	Lee, Richard/J-4997-2013; White, Stephen W/N-8164-2018; Bashford, Donald/F-5905-2011; Ferreira, Antonio/I-4423-2013; Lee, Richard/AAX-3996-2021	Lee, Richard/0000-0002-2397-0443; Bashford, Donald/0000-0001-5776-3744; Lee, Richard/0000-0002-2397-0443; Ferreira, Antonio/0000-0002-6581-6233	NIH [AI070721]; NIH Cancer Center (CORE) [CA21765]; ALSAC (the American Lebanese Syrian Associated Charities); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Center (CORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC (the American Lebanese Syrian Associated Charities)(American Lebanese Syrian Associated Charities (ALSAC)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. DuBois, C. Pemble, S. Gajewski, and D. Miller for assistance with the YpDHPS structure determination; J. Bollinger and E. Enemark for technical assistance; D. Hammoudeh and C. Rock for helpful discussions; and staff at SERCAT for assistance with synchrotron data collection. Supported by NIH grant AI070721 (S.W.W. and R.E.L.), NIH Cancer Center (CORE) support grant CA21765, and ALSAC (the American Lebanese Syrian Associated Charities). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID and 22-BM beamlines at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found at www.ser-cat.org/members.html. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38. Coordinates and structure factors for all the structures described have been deposited in the Protein Data Bank, and the PDB accession codes are listed in tables S1 and S2.	Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Anand N., 1996, BURGERS MED CHEM DRU, V2, P527; Babaoglu K, 2004, STRUCTURE, V12, P1705, DOI 10.1016/j.str.2004.07.011; Baca AM, 2000, J MOL BIOL, V302, P1193, DOI 10.1006/jmbi.2000.4094; BOCK L, 1974, J MED CHEM, V17, P23, DOI 10.1021/jm00247a006; Hampele IC, 1997, J MOL BIOL, V268, P21, DOI 10.1006/jmbi.1997.0944; Hevener KE, 2010, J MED CHEM, V53, P166, DOI 10.1021/jm900861d; Huovinen P, 2001, CLIN INFECT DIS, V32, P1608, DOI 10.1086/320532; Hyun DY, 2009, PEDIATR INFECT DIS J, V28, P57, DOI 10.1097/INF.0b013e3181826e5e; Levy C, 2008, BIOCHEM J, V412, P379, DOI 10.1042/BJ20071598; MASH EA, 1981, J AM CHEM SOC, V103, P3927, DOI 10.1021/ja00403a055; Masters PA, 2003, ARCH INTERN MED, V163, P402, DOI 10.1001/archinte.163.4.402; MERALI S, 1990, ANTIMICROB AGENTS CH, V34, P1075, DOI 10.1128/AAC.34.6.1075; Pappas G, 2009, J CHEMOTHERAPY, V21, P115, DOI 10.1179/joc.2009.21.2.115; Pemble CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014165; POULTER CD, 1981, J AM CHEM SOC, V103, P3926, DOI 10.1021/ja00403a054; Rebeille F, 1997, EMBO J, V16, P947, DOI 10.1093/emboj/16.5.947; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; Rice LB, 2009, CURR OPIN MICROBIOL, V12, P476, DOI 10.1016/j.mib.2009.08.001; ROLAND S, 1979, J BIOL CHEM, V254, P337; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Skold O, 2000, DRUG RESIST UPDATE, V3, P155, DOI 10.1054/drup.2000.0146	22	125	126	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1110	1114		10.1126/science.1214641	http://dx.doi.org/10.1126/science.1214641			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383850	Green Accepted			2022-12-01	WOS:000300931100050
J	Srivastava, R				Srivastava, Ranjana			What's the Alternative? The Worldwide Web of Integrative Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia	Monash University	Srivastava, R (corresponding author), Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia.								0	3	4	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2012	366	9					783	785		10.1056/NEJMp1110812	http://dx.doi.org/10.1056/NEJMp1110812			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	900GI	22375969				2022-12-01	WOS:000300874300004
J	MacKenzie, A				MacKenzie, Alex			Sense in Antisense Therapy for Spinal Muscular Atrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MOUSE MODEL; RESCUE; SMN		[MacKenzie, Alex] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [MacKenzie, Alex] Univ Ottawa, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa	MacKenzie, A (corresponding author), Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada.							Atweh G, 2010, HEMATOL ONCOL CLIN N, V24, P1131, DOI 10.1016/j.hoc.2010.08.001; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Porensky PN, 2011, HUM MOL GENET   1230	5	10	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 23	2012	366	8					761	763		10.1056/NEJMcibr1114629	http://dx.doi.org/10.1056/NEJMcibr1114629			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FS	22356331				2022-12-01	WOS:000300551500016
J	Kleinman, A				Kleinman, Arthur			The art of medicine Culture, bereavement, and psychiatry	LANCET			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Kleinman, A (corresponding author), Harvard Univ, William James Hall Room 330, Cambridge, MA 02138 USA.	kleinman@wjh.harvard.edu						American Psychiatric Association. (n.d.), DSM 5 DEV; Aries Philippe., 1981, HOUR OUR DEATH TRANS; Carey B, 2012, NY TIMES        0125; Kleinman Arthur, 1988, RETHINKING PSYCHIAT; Lock Margaret, 2010, ANTHR BIOMEDICINE, P83; Wakefield, 2007, LOSS SADNESS; Wakefield JC, 2012, WORLD PSYCHIATRY, V11, P3, DOI 10.1016/j.wpsyc.2012.01.002	7	55	56	2	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2012	379	9816					608	609		10.1016/S0140-6736(12)60258-X	http://dx.doi.org/10.1016/S0140-6736(12)60258-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	897ES	22355809				2022-12-01	WOS:000300629000018
J	Matsushita, H; Vesely, MD; Koboldt, DC; Rickert, CG; Uppaluri, R; Magrini, VJ; Arthur, CD; White, JM; Chen, YS; Shea, LK; Hundal, J; Wendl, MC; Demeter, R; Wylie, T; Allison, JP; Smyth, MJ; Old, LJ; Mardis, ER; Schreiber, RD				Matsushita, Hirokazu; Vesely, Matthew D.; Koboldt, Daniel C.; Rickert, Charles G.; Uppaluri, Ravindra; Magrini, Vincent J.; Arthur, Cora D.; White, J. Michael; Chen, Yee-Shiuan; Shea, Lauren K.; Hundal, Jasreet; Wendl, Michael C.; Demeter, Ryan; Wylie, Todd; Allison, James P.; Smyth, Mark J.; Old, Lloyd J.; Mardis, Elaine R.; Schreiber, Robert D.			Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting	NATURE			English	Article							ADAPTIVE IMMUNITY; TUMOR ESCAPE; IFN-GAMMA; GENOME; BREAST; GENE; RESOLUTION; MUTATIONS; RESPONSES; MELANOMA	Cancer immunoediting, the process by which the immune system controls tumour outgrowth and shapes tumour immunogenicity, is comprised of three phases: elimination, equilibrium and escape(1-5). Although many immune components that participate in this process are known, its underlying mechanisms remain poorly defined. A central tenet of cancer immunoediting is that T-cell recognition of tumour antigens drives the immunological destruction or sculpting of a developing cancer. However, our current understanding of tumour antigens comes largely from analyses of cancers that develop in immunocompetent hosts and thus may have already been edited. Little is known about the antigens expressed in nascent tumour cells, whether they are sufficient to induce protective antitumour immune responses or whether their expression is modulated by the immune system. Here, using massively parallel sequencing, we characterize expressed mutations in highly immunogenic methylcholanthrene-induced sarcomas derived from immunodeficient Rag2(-/-) mice that phenotypically resemble nascent primary tumour cells(1,3,5). Using class I prediction algorithms, we identify mutant spectrin-beta 2 as a potential rejection antigen of the d42m1 sarcoma and validate this prediction by conventional antigen expression cloning and detection. We also demonstrate that cancer immunoediting of d42m1 occurs via a T-cell-dependent immunoselection process that promotes outgrowth of pre-existing tumour cell clones lacking highly antigenic mutant spectrin-beta 2 and other potential strong antigens. These results demonstrate that the strong immunogenicity of an unedited tumour can be ascribed to expression of highly antigenic mutant proteins and show that outgrowth of tumour cells that lack these strong antigens via a T-cell-dependent immunoselection process represents one mechanism of cancer immunoediting.	[Matsushita, Hirokazu; Vesely, Matthew D.; Rickert, Charles G.; Arthur, Cora D.; White, J. Michael; Chen, Yee-Shiuan; Shea, Lauren K.; Schreiber, Robert D.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Koboldt, Daniel C.; Magrini, Vincent J.; Hundal, Jasreet; Wendl, Michael C.; Demeter, Ryan; Wylie, Todd; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Uppaluri, Ravindra] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA; [Magrini, Vincent J.; Wendl, Michael C.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Allison, James P.] Mem Sloan Kettering Canc Ctr, Dept Immunol, Ludwig Ctr Canc Immunotherapy, New York, NY 10021 USA; [Allison, James P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; [Smyth, Mark J.] Univ Melbourne, Dept Pathol, Parkville, Vic 2010, Australia; [Old, Lloyd J.] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Schreiber, RD (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	schreiber@immunology.wustl.edu	Mardis, Elaine/W-2202-2019; Schreiber, Robert D/A-1276-2013; Vesely, Matthew/AFM-2324-2022; uppaluri, ravi/AAU-2132-2020; Magrini, Vincent/AAT-5830-2020; Schreiber, Robert/Q-7550-2019; Vesely, Matthew/AAM-6813-2020; Smyth, Mark J/H-8709-2014; Wendl, Michael C/A-2741-2008	Schreiber, Robert D/0000-0001-6311-0432; Vesely, Matthew/0000-0001-9363-945X; Magrini, Vincent/0000-0002-2019-4872; Smyth, Mark J/0000-0001-7098-7240; White, James Michael/0000-0001-5110-6567; Schreiber, Robert/0000-0003-1590-2341; Allison, James/0000-0001-8980-5697	National Cancer Institute; Ludwig Institute for Cancer Research; Cancer Research Institute; WWWW Foundation; National Human Genome Research Institute; Howard Hughes Medical Institute; Ludwig Center for Cancer Immunotherapy; National Health and Medical Research Council of Australia (NHMRC); Association for International Cancer Research; NATIONAL CANCER INSTITUTE [R01CA043059, U01CA141541] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Institute for Cancer Research; Cancer Research Institute; WWWW Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ludwig Center for Cancer Immunotherapy; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Association for International Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to J. Archambault for expert technical assistance, T. H. Hansen (Washington University) for providing MHC class I antibodies, S. Horvath and P. M. Allen (Washington University) for synthesizing MHC class I peptides, the National Institutes of Health (NIH) Tetramer Core Facility for producing MHC class I tetramers, and T. S. Stappenbeck (Washington University) for technical help in recovering frozen tumour samples. We also thank E. Unanue, P. M. Allen and J. Bui for criticisms and comments, all members of the Schreiber laboratory for discussions, and the many members of The Genome Institute at Washington University School of Medicine, especially L. Ding for her insights into our analytical approaches. This work was supported by grants to R. D. S. from the National Cancer Institute, the Ludwig Institute for Cancer Research, the Cancer Research Institute, and the WWWW Foundation; and to E. R. M. from the National Human Genome Research Institute. M. D. V. is supported by a pre-doctoral fellowship from the Cancer Research Institute. J. P. A. is supported by the Howard Hughes Medical Institute and the Ludwig Center for Cancer Immunotherapy; M. J. S. by the National Health and Medical Research Council of Australia (NH&MRC) and from the Association for International Cancer Research; and L.J.O. by the Ludwig Institute for Cancer Research and the Cancer Research Institute.	Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; CHEN AC, 1989, P NATL ACAD SCI USA, V86, P1608, DOI 10.1073/pnas.86.5.1608; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; FELSENSTEIN, 1989, CLADISTICS, V5, P164; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; OLD LJ, 1964, ANNU REV MED, V15, P167, DOI 10.1146/annurev.me.15.020164.001123; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; PREHN RT, 1957, J NATL CANCER I, V18, P769; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Ranganath S, 1998, J IMMUNOL, V161, P3822; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005	36	826	875	4	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					400	U149		10.1038/nature10755	http://dx.doi.org/10.1038/nature10755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22318521	Green Accepted			2022-12-01	WOS:000300287100046
J	Song, JK; Teplova, M; Ishibe-Murakami, S; Patel, DJ				Song, Jikui; Teplova, Marianna; Ishibe-Murakami, Satoko; Patel, Dinshaw J.			Structure-Based Mechanistic Insights into DNMT1-Mediated Maintenance DNA Methylation	SCIENCE			English	Article							METHYLTRANSFERASE; REPLICATION; COMPLEX; DOMAIN; DNMT1; CYTOSINE; TARGET	DNMT1, the major maintenance DNA methyltransferase in animals, helps to regulate gene expression, genome imprinting, and X-chromosome inactivation. We report on the crystal structure of a productive covalent mouse DNMT1(731-1602)-DNA complex containing a central hemimethylated CpG site. The methyl group of methylcytosine is positioned within a shallow hydrophobic concave surface, whereas the cytosine on the target strand is looped out and covalently anchored within the catalytic pocket. The DNA is distorted at the hemimethylated CpG step, with side chains from catalytic and recognition loops inserting through both grooves to fill an intercalation-type cavity associated with a dual base flip-out on partner strands. Structural and biochemical data establish how a combination of active and autoinhibitory mechanisms ensures the high fidelity of DNMT1-mediated maintenance DNA methylation.	[Song, Jikui; Teplova, Marianna; Ishibe-Murakami, Satoko; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org			Abby Rockefeller Mauze Trust; STARR Foundation; Maloris Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Abby Rockefeller Mauze Trust; STARR Foundation; Maloris Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by funds from the Abby Rockefeller Mauze Trust and STARR and Maloris Foundations (D.J.P.). We thank T. Bestor and M. Goll for helpful discussions, and the staff of the NE-CAT beamlines at the Advanced Photon Source, Argonne National laboratory, for access and assistance with data collection. The structure of the complex has been deposited under accession no. 4DA4 in the Protein Data Bank.	Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; OSTERMAN DG, 1988, BIOCHEMISTRY-US, V27, P5204, DOI 10.1021/bi00414a039; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108	16	218	228	4	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2012	335	6069					709	712		10.1126/science.1214453	http://dx.doi.org/10.1126/science.1214453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323818	Green Accepted			2022-12-01	WOS:000300047100050
J	McNally, BA; Somasundaram, A; Yamashita, M; Prakriya, M				McNally, Beth A.; Somasundaram, Agila; Yamashita, Megumi; Prakriya, Murali			Gated regulation of CRAC channel ion selectivity by STIM1	NATURE			English	Article							CA2+-DEPENDENT INACTIVATION; ORAI1; PORE; PERMEATION; SUBUNIT	Two defining functional features of ion channels are ion selectivity and channel gating. Ion selectivity is generally considered an immutable property of the open channel structure, whereas gating involves transitions between open and closed channel states, typically without changes in ion selectivity(1). In store-operated Ca2+ release-activated Ca2+ (CRAC) channels, the molecular mechanism of channel gating by the CRAC channel activator, stromal interaction molecule 1 (STIM1), remains unknown. CRAC channels are distinguished by a very high Ca2+ selectivity and are instrumental in generating sustained intracellular calcium concentration elevations that are necessary for gene expression and effector function in many eukaryotic cells(2). Here we probe the central features of the STIM1 gating mechanism in the human CRAC channel protein, ORAI1, and identify V102, a residue located in the extracellular region of the pore, as a candidate for the channel gate. Mutations at V102 produce constitutively active CRAC channels that are open even in the absence of STIM1. Unexpectedly, although STIM1-free V102 mutant channels are not Ca2+-selective, their Ca2+ selectivity is dose-dependently boosted by interactions with STIM1. Similar enhancement of Ca2+ selectivity is also seen in wild-type ORAI1 channels by increasing the number of STIM1 activation domains that are directly tethered to ORAI1 channels, or by increasing the relative expression of full-length STIM1. Thus, exquisite Ca2+ selectivity is not an intrinsic property of CRAC channels but rather a tuneable feature that is bestowed on otherwise non-selective ORAI1 channels by STIM1. Our results demonstrate that STIM1-mediated gating of CRAC channels occurs through an unusual mechanism in which permeation and gating are closely coupled.	[McNally, Beth A.; Somasundaram, Agila; Yamashita, Megumi; Prakriya, Murali] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Sch Med, Chicago, IL 60611 USA	Northwestern University	Prakriya, M (corresponding author), Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Sch Med, 303 E Chicago Ave,Ward 8-296, Chicago, IL 60611 USA.	m-prakriya@northwestern.edu		Prakriya, Murali/0000-0003-0781-4480; Yamashita, Megumi/0000-0003-0196-0428	NIH [NS057499]; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057499, R56NS057499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Lingle, R. Lewis, K. Swartz, J. Sack, A. Gross, L. Tirado-Lee and T. Hornell for discussions and comments on the manuscript. This work was supported by NIH grant NS057499 to M. P. An American Heart Association predoctoral fellowship supported A.S.	Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Madl J, 2010, J BIOL CHEM, V285, P41135, DOI 10.1074/jbc.M110.177881; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Olcese R, 2007, J GEN PHYSIOL, V129, P457, DOI 10.1085/jgp.200709814; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P4538, DOI 10.1021/bi00412a047; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Scrimgeour N, 2009, J PHYSIOL-LONDON, V587, P2903, DOI 10.1113/jphysiol.2009.170662; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yamashita M, 2011, J BIOL CHEM, V286, P9429, DOI 10.1074/jbc.M110.189035; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	30	171	173	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2012	482	7384					241	U136		10.1038/nature10752	http://dx.doi.org/10.1038/nature10752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888HI	22278058	Green Accepted			2022-12-01	WOS:000299994100043
J	Ferner, R				Ferner, Robin			DRUG TALES AND OTHER STORIES Interactions	BRITISH MEDICAL JOURNAL			English	Editorial Material									Birmingham City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				2003, ARCH INTERN MED, V163, P2625; 2009, AM J MED, V122, P290, DOI DOI 10.1016/J.AMJMED.2008.09.038	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2012	344								e865	10.1136/bmj.e865	http://dx.doi.org/10.1136/bmj.e865			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892IE	22318440				2022-12-01	WOS:000300279100008
J	Li, GW; Oh, E; Weissman, JS				Li, Gene-Wei; Oh, Eugene; Weissman, Jonathan S.			The anti-Shine-Dalgarno sequence drives translational pausing and codon choice in bacteria	NATURE			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; RIBOSOMAL-RNA; IN-VIVO; ELONGATION; GENES; USAGE; TRANSCRIPTION; ABUNDANCE; REVEALS	Protein synthesis by ribosomes takes place on a linear substrate but at non-uniform speeds. Transient pausing of ribosomes can affect a variety of co-translational processes, including protein targeting and folding(1). These pauses are influenced by the sequence of the messenger RNA(2). Thus, redundancy in the genetic code allows the same protein to be translated at different rates. However, our knowledge of both the position and the mechanism of translational pausing in vivo is highly limited. Here we present a genome-wide analysis of translational pausing in bacteria by ribosome profiling-deep sequencing of ribosome-protected mRNA fragments(3-5). This approach enables the high-resolution measurement of ribosome density profiles along most transcripts at unperturbed, endogenous expression levels. Unexpectedly, we found that codons decoded by rare transfer RNAs do not lead to slow translation under nutrient-rich conditions. Instead, Shine-Dalgarno-(SD) 6-like features within coding sequences cause pervasive translational pausing. Using an orthogonal ribosome(7,8) possessing an altered anti-SD sequence, we show that pausing is due to hybridization between the mRNA and 16S ribosomal RNA of the translating ribosome. In protein-coding sequences, internal SD sequences are disfavoured, which leads to biased usage, avoiding codons and codon pairs that resemble canonical SD sites. Our results indicate that internal SD-like sequences are a major determinant of translation rates and a global driving force for the coding of bacterial genomes.	[Li, Gene-Wei; Oh, Eugene; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu		Oh, Eugene/0000-0003-1970-8423; Weissman, Jonathan/0000-0003-2445-670X; Li, Gene-Wei/0000-0001-7036-8511	Helen Hay Whitney Foundation; Howard Hughes Medical Institute	Helen Hay Whitney Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank E. Reuman, D. Burkhardt, C. Jan, C. Gross, J. Elf and members of the Weissman laboratory for discussions; J. Dunn for ribosome profiling data on S. cerevisiae; C. Chu for help with sequencing; and J. Chin for orthogonal ribosome reagents and advice. This research was supported by the Helen Hay Whitney Foundation (to G. W. L.) and by the Howard Hughes Medical Institute (to J.S.W.).	ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Baranov PV, 2002, EMBO REP, V3, P373, DOI 10.1093/embo-reports/kvf065; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Elf J, 2005, PLOS COMPUT BIOL, V1, P14, DOI 10.1371/journal.pcbi.0010002; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; KOLTER R, 1982, ANNU REV GENET, V16, P113, DOI 10.1146/annurev.ge.16.120182.000553; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; PEDERSEN S, 1984, EMBO J, V3, P2895, DOI 10.1002/j.1460-2075.1984.tb02227.x; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; PRUSS BM, 1994, J BACTERIOL, V176, P2143; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; WEISS RB, 1988, EMBO J, V7, P1503, DOI 10.1002/j.1460-2075.1988.tb02969.x; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	37	434	448	4	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					538	U172		10.1038/nature10965	http://dx.doi.org/10.1038/nature10965			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22456704	Green Submitted, Green Accepted			2022-12-01	WOS:000303200400056
J	Schrappe, M; Hunger, SP; Pui, CH; Saha, V; Gaynon, PS; Baruchel, A; Conter, V; Otten, J; Ohara, A; Versluys, AB; Escherich, G; Heyman, M; Silverman, LB; Horibe, K; Mann, G; Camitta, BM; Harbott, J; Riehm, H; Richards, S; Devidas, M; Zimmermann, M				Schrappe, Martin; Hunger, Stephen P.; Pui, Ching-Hon; Saha, Vaskar; Gaynon, Paul S.; Baruchel, Andre; Conter, Valentino; Otten, Jacques; Ohara, Akira; Versluys, Anne Birgitta; Escherich, Gabriele; Heyman, Mats; Silverman, Lewis B.; Horibe, Keizo; Mann, Georg; Camitta, Bruce M.; Harbott, Jochen; Riehm, Hansjoerg; Richards, Sue; Devidas, Meenakshi; Zimmermann, Martin			Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; STEM-CELL TRANSPLANTATION; PROGNOSTIC VALUE; COMPLETE REMISSION; SALVAGE THERAPY; AIEOP-BFM; T-CELL; CHILDREN; RISK; CHEMOTHERAPY	BACKGROUND Failure of remission-induction therapy is a rare but highly adverse event in children and adolescents with acute lymphoblastic leukemia (ALL). METHODS We identified induction failure, defined by the persistence of leukemic blasts in blood, bone marrow, or any extramedullary site after 4 to 6 weeks of remission-induction therapy, in 1041 of 44,017 patients (2.4%) 0 to 18 years of age with newly diagnosed ALL who were treated by a total of 14 cooperative study groups between 1985 and 2000. We analyzed the relationships among disease characteristics, treatments administered, and outcomes in these patients. RESULTS Patients with induction failure frequently presented with high-risk features, including older age, high leukocyte count, leukemia with a T-cell phenotype, the Philadelphia chromosome, and 11q23 rearrangement. With a median follow-up period of 8.3 years (range, 1.5 to 22.1), the 10-year survival rate (+/- SE) was estimated at only 32 +/- 1%. An age of 10 years or older, T-cell leukemia, the presence of an 11q23 rearrangement, and 25% or more blasts in the bone marrow at the end of induction therapy were associated with a particularly poor outcome. High hyperdiploidy (a modal chromosome number >50) and an age of 1 to 5 years were associated with a favorable outcome in patients with precursor B-cell leukemia. Allogeneic stem-cell transplantation from matched, related donors was associated with improved outcomes in T-cell leukemia. Children younger than 6 years of age with precursor B-cell leukemia and no adverse genetic features had a 10-year survival rate of 72 +/- 5% when treated with chemotherapy only. CONCLUSIONS Pediatric ALL with induction failure is highly heterogeneous. Patients who have T-cell leukemia appear to have a better outcome with allogeneic stem-cell transplantation than with chemotherapy, whereas patients who have precursor B-cell leukemia without other adverse features appear to have a better outcome with chemotherapy. (Funded by Deutsche Krebshilfe and others.)	[Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Pui, Ching-Hon] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Schrappe, Martin] Univ Kiel, Dept Pediat, Univ Med Ctr Schleswig Holstein, D-2300 Kiel, Germany; [Escherich, Gabriele] Univ Med Ctr Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Harbott, Jochen] Univ Giessen, Dept Pediat Hematol & Oncol, Oncogenet Lab, Giessen, Germany; [Riehm, Hansjoerg; Zimmermann, Martin] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-3000 Hannover, Germany; [Hunger, Stephen P.] Univ Colorado, Sch Med, Aurora, CO USA; [Hunger, Stephen P.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Hunger, Stephen P.] Childrens Hosp Colorado, Aurora, CO USA; [Saha, Vaskar] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Canc, Childrens Canc Grp, Manchester, Lancs, England; [Richards, Sue] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Gaynon, Paul S.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Baruchel, Andre] Hop Robert Debre, Dept Pediat Hematoimmunol, F-75019 Paris, France; [Baruchel, Andre] Univ Paris Diderot, Paris, France; [Conter, Valentino] Univ Milano Bicocca, Pediat Clin, Osped San Gerardo, Monza, Italy; [Conter, Valentino] Osped Riuniti Bergamo, Dept Pediat, I-24100 Bergamo, Italy; [Otten, Jacques] Univ Ziekenhuis Brussel, Dept Pediat, Hematooncol Unit, Brussels, Belgium; [Ohara, Akira] Toho Univ, Dept Pediat 1, Tokyo, Japan; [Versluys, Anne Birgitta] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Versluys, Anne Birgitta] Dutch Childhood Oncol Grp, The Hague, Netherlands; [Heyman, Mats] Karolinska Inst, Astrid Lindgren Childrens Hosp, Childhood Canc Res Unit, Stockholm, Sweden; [Silverman, Lewis B.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Silverman, Lewis B.] Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA 02115 USA; [Silverman, Lewis B.] Childrens Hosp Boston, Boston, MA USA; [Horibe, Keizo] Clin Res Ctr, Nagoya Med Ctr, Nagoya, Aichi, Japan; [Mann, Georg] Univ Med Sch, St Anna Childrens Hosp, Dept Pediat, Vienna, Austria; [Camitta, Bruce M.] Med Coll Wisconsin, Midwest Ctr Canc & Blood Disorders, Milwaukee, WI 53226 USA; [Camitta, Bruce M.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Camitta, Bruce M.] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Devidas, Meenakshi] Stat & Data Ctr, Childrens Oncol Grp, Gainesville, FL USA; [Devidas, Meenakshi] Univ Florida, Dept Biostat, Gainesville, FL USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Kiel; Schleswig Holstein University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Justus Liebig University Giessen; Hannover Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Manchester; University of Oxford; Children's Hospital Los Angeles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; San Gerardo Hospital; University of Milano-Bicocca; Ospedali Riuniti di Bergamo; University Hospital Brussels; Vrije Universiteit Brussel; Toho University; Utrecht University; Utrecht University Medical Center; Dutch Childhood Oncology Group; Karolinska Institutet; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Nagoya Medical Center; Saint Anna Children's Hospital; Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Children's Oncology Group (COG); State University System of Florida; University of Florida	Pui, CH (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	ching-hon.pui@stjude.org	Devidas, Meenakshi/H-1170-2019; Pui, Ching-Hon/N-8076-2018; Schrappe, Martin/ABA-6144-2020	Devidas, Meenakshi/0000-0002-1099-3478; Pui, Ching-Hon/0000-0003-0303-5658; Saha, Vaskar/0000-0002-2916-9649	Deutsche Krebshilfe; St. Anna Children's Cancer Research Institute, Austria; Deutsche Krebshilfe, Germany; Madeleine-Schickedanz-Kinderkrebsstiftung, Germany; Fordergemeinschaft Kinderkrebszentrum Hamburg, Germany; National Cancer Institute (NCI) [5PO1CA068484]; Assistance Publique-Hopitaux de Paris, INSERM, Institut Universitaire d'Hematologie and Centre de Recherche en Hematologie, Oncologie, et Pediatrie, France; American Lebanese Syrian Associated Charities; Medical Research Council, United Kingdom; Swedish Childhood Cancer Foundation; Danish Childhood Cancer Foundation; Norwegian Cancer Society; Fonds Cancer, Belgium; Ministry of Health, Labour, and Welfare, Japan; Children's Cancer Association of Japan;  [CA13539];  [CA98543];  [CA98413];  [CA30969];  [CA29139];  [CA21765]; MRC [MC_U137686856] Funding Source: UKRI; Cancer Research UK [14840] Funding Source: researchfish; Medical Research Council [MC_U137686856] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA068484, P30CA021765, U10CA030969, U10CA098543, U10CA013539, U10CA098413, U10CA029139] Funding Source: NIH RePORTER	Deutsche Krebshilfe(Deutsche Krebshilfe); St. Anna Children's Cancer Research Institute, Austria; Deutsche Krebshilfe, Germany(Deutsche Krebshilfe); Madeleine-Schickedanz-Kinderkrebsstiftung, Germany; Fordergemeinschaft Kinderkrebszentrum Hamburg, Germany; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Assistance Publique-Hopitaux de Paris, INSERM, Institut Universitaire d'Hematologie and Centre de Recherche en Hematologie, Oncologie, et Pediatrie, France; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Childhood Cancer Foundation(European Commission); Danish Childhood Cancer Foundation; Norwegian Cancer Society(Norwegian Cancer Society); Fonds Cancer, Belgium; Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Children's Cancer Association of Japan; ; ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Deutsche Krebshilfe and others.; Supported by St. Anna Children's Cancer Research Institute, Austria; Deutsche Krebshilfe, Germany; Madeleine-Schickedanz-Kinderkrebsstiftung, Germany; grants (CA13539, CA98543, and CA98413) to the Children's Cancer Group; Fordergemeinschaft Kinderkrebszentrum Hamburg, Germany; a grant (NCI 5PO1CA068484) from the National Cancer Institute to the Dana-Farber Cancer Institute; Assistance Publique-Hopitaux de Paris, INSERM, Institut Universitaire d'Hematologie and Centre de Recherche en Hematologie, Oncologie, et Pediatrie, France; grants (CA30969, CA29139, CA98543, and CA98413) to the Pediatric Oncology Group; a grant (CA21765) and funding from American Lebanese Syrian Associated Charities to St. Jude Children's Research Hospital; the Medical Research Council, United Kingdom; the Swedish Childhood Cancer Foundation; the Danish Childhood Cancer Foundation; the Norwegian Cancer Society; Fonds Cancer, Belgium; a Clinical Cancer Research grant from the Ministry of Health, Labour, and Welfare, Japan; and the Children's Cancer Association of Japan.	Arico M, 2000, NEW ENGL J MED, V342, P998, DOI 10.1056/NEJM200004063421402; Arico M, 2002, BLOOD, V100, P420, DOI 10.1182/blood.V100.2.420; Arico M, 2008, J CLIN ONCOL, V26, P283, DOI 10.1200/JCO.2007.12.3927; Bader P, 2009, J CLIN ONCOL, V27, P377, DOI 10.1200/JCO.2008.17.6065; Balduzzi A, 2005, LANCET, V366, P635, DOI 10.1016/S0140-6736(05)66998-X; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; CHESSELLS JM, 1995, LANCET, V345, P143, DOI 10.1016/S0140-6736(95)90164-7; Conter V, 2010, LEUKEMIA, V24, P255, DOI 10.1038/leu.2009.250; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; COX DR, 1972, J R STAT SOC B, V34, P187; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; Eckert C, 2001, LANCET, V358, P1239, DOI 10.1016/S0140-6736(01)06355-3; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Einsiedel HG, 2008, J CLIN ONCOL, V26, P2238; Gaynon PS, 2010, LEUKEMIA, V24, P285, DOI 10.1038/leu.2009.262; Gaynon PS, 2005, BRIT J HAEMATOL, V131, P579, DOI 10.1111/j.1365-2141.2005.05773.x; Heerema NA, 2000, J CLIN ONCOL, V18, P1876, DOI 10.1200/JCO.2000.18.9.1876; JANKASCHAUB GE, 1992, HAEMATOL BLOOD TRANS, V34, P233; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KASPERS GJL, 1995, BLOOD, V85, P751, DOI 10.1182/blood.V85.3.751.bloodjournal853751; Ko RH, 2010, J CLIN ONCOL, V28, P648, DOI 10.1200/JCO.2009.22.2950; Mann G, 2010, BLOOD, V116, P2644, DOI 10.1182/blood-2010-03-273532; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mitchell C, 2010, LEUKEMIA, V24, P406, DOI 10.1038/leu.2009.256; Moricke A, 2010, LEUKEMIA, V24, P265, DOI 10.1038/leu.2009.257; Moghrabi A, 2007, BLOOD, V109, P896, DOI 10.1182/blood-2006-06-027714; Moorman AV, 2010, LANCET ONCOL, V11, P429, DOI 10.1016/S1470-2045(10)70066-8; Moricke A, 2009, BLOOD, V113, P4478; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nachman JB, 2007, BLOOD, V110, P1112, DOI 10.1182/blood-2006-07-038299; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Ottmann OG, 2007, CANCER-AM CANCER SOC, V109, P2068, DOI 10.1002/cncr.22631; Oudot C, 2008, J CLIN ONCOL, V26, P1496, DOI 10.1200/JCO.2007.12.2820; PIETERS R, 1991, LANCET, V338, P399, DOI 10.1016/0140-6736(91)91029-T; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; RIEHM H, 1980, AM J PEDIAT HEMATOL, V2, P299; Salzer WL, 2010, LEUKEMIA, V24, P355, DOI 10.1038/leu.2009.261; Schmiegelow K, 2010, LEUKEMIA, V24, P345, DOI 10.1038/leu.2009.251; Schrappe M, 1998, BLOOD, V92, P2730; Schrappe M, 2000, BLOOD, V95, P3310; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Schrauder A, 2006, J CLIN ONCOL, V24, P5742, DOI 10.1200/JCO.2006.06.2679; Schultz KR, 2007, BLOOD, V109, P926, DOI 10.1182/blood-2006-01-024729; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Silverman LB, 2010, LEUKEMIA, V24, P320, DOI 10.1038/leu.2009.253; Silverman LB, 1999, CANCER-AM CANCER SOC, V85, P1395, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1395::AID-CNCR25>3.0.CO;2-2; Smith M, 1996, J CLIN ONCOL, V14, P680, DOI 10.1200/JCO.1996.14.2.680; SYNOLD TW, 1994, J CLIN INVEST, V94, P1996, DOI 10.1172/JCI117552; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Tsuchida M, 2010, LEUKEMIA, V24, P383, DOI 10.1038/leu.2009.260; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6; Vignetti M, 2007, BLOOD, V109, P3676, DOI 10.1182/blood-2006-10-052746; Yanada M, 2006, J CLIN ONCOL, V24, P460, DOI 10.1200/JCO.2005.03.2177	58	197	209	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2012	366	15					1371	1381		10.1056/NEJMoa1110169	http://dx.doi.org/10.1056/NEJMoa1110169			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GV	22494120	Green Accepted, Green Published			2022-12-01	WOS:000302608600001
J	Schulz, C; Perdiguero, EG; Chorro, L; Szabo-Rogers, H; Cagnard, N; Kierdorf, K; Prinz, M; Wu, BS; Jacobsen, SEW; Pollard, JW; Frampton, J; Liu, KJ; Geissmann, F				Schulz, Christian; Perdiguero, Elisa Gomez; Chorro, Laurent; Szabo-Rogers, Heather; Cagnard, Nicolas; Kierdorf, Katrin; Prinz, Marco; Wu, Bishan; Jacobsen, Sten Eirik W.; Pollard, Jeffrey W.; Frampton, Jon; Liu, Karen J.; Geissmann, Frederic			A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells	SCIENCE			English	Article							MONONUCLEAR PHAGOCYTE SYSTEM; IMMUNOHISTOCHEMICAL LOCALIZATION; SELF-RENEWAL; AORTIC ENDOTHELIUM; LANGERHANS CELLS; MICROGLIA DERIVE; FLT3 EXPRESSION; ANTIGEN F4/80; YOLK-SAC; MACROPHAGES	Macrophages and dendritic cells (DCs) are key components of cellular immunity and are thought to originate and renew from hematopoietic stem cells (HSCs). However, some macrophages develop in the embryo before the appearance of definitive HSCs. We thus reinvestigated macrophage development. We found that the transcription factor Myb was required for development of HSCs and all CD11b(high) monocytes and macrophages, but was dispensable for yolk sac (YS) macrophages and for the development of YS-derived F4/80(bright) macrophages in several tissues, such as liver Kupffer cells, epidermal Langerhans cells, and microglia-cell populations that all can persist in adult mice independently of HSCs. These results define a lineage of tissue macrophages that derive from the YS and are genetically distinct from HSC progeny.	[Schulz, Christian; Perdiguero, Elisa Gomez; Chorro, Laurent; Geissmann, Frederic] Kings Coll London, CMCBI, London SE1 1UL, England; [Schulz, Christian; Perdiguero, Elisa Gomez; Chorro, Laurent; Geissmann, Frederic] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 9RT, England; [Szabo-Rogers, Heather; Liu, Karen J.] Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England; [Cagnard, Nicolas] Univ Paris 05, Plateforme Bioinformat, INSERM IRNEM IFR94, F-75015 Paris, France; [Kierdorf, Katrin; Prinz, Marco] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany; [Kierdorf, Katrin; Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Wu, Bishan; Jacobsen, Sten Eirik W.] Univ Oxford, Haematopoiet Stem Cell Biol Lab, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England; [Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Ctr Study Reprod Biol & Womens Hlth, New York, NY 10461 USA; [Frampton, Jon] Univ Birmingham, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; University of Freiburg; University of Oxford; Yeshiva University; University of Birmingham	Geissmann, F (corresponding author), Kings Coll London, CMCBI, New Hunts House, London SE1 1UL, England.	frederic.geissmann@kcl.ac.uk	Perdiguero, Elisa Gomez/U-2120-2018; Schulz, Christian/J-8545-2012; Kierdorf, Katrin/AAO-6288-2021; Liu, Karen/F-2870-2010; Jacobsen, Sten Eirik W/D-3974-2018; Cagnard, Nicolas/K-2754-2014	Perdiguero, Elisa Gomez/0000-0002-7717-7897; Schulz, Christian/0000-0003-3878-7833; Liu, Karen/0000-0002-2483-2165; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Kierdorf, Katrin/0000-0002-9272-4780; Cagnard, Nicolas/0000-0002-9051-1896; geissmann, frederic/0000-0001-5029-2468	German National Academy of Sciences Leopoldina [LPDS 2009-31]; Wellcome Trust [WT081880AIA]; U.K. Biotechnology and Biological Sciences Research Council [BB/E013872]; U.K. Medical Research Council [MRC G0900867]; European Research Council [ERC-2010-StG-261299 MPS2010]; BBSRC [BB/I021922/1, BB/E013872/1] Funding Source: UKRI; MRC [G0501838, G0801073, G0900867, G1002033, MC_UU_12009/5] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I021922/1, BB/E013872/1] Funding Source: researchfish; Medical Research Council [G1002033, G0501838, MC_UU_12009/5, G0801073, G0900867] Funding Source: researchfish	German National Academy of Sciences Leopoldina; Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are indebted to S. McKercher, Sanford-Burnham Medical Research Institute La Jolla, California, USA, for providing Pu.1<SUP>+/-</SUP> mice and to T. Boehm and C. Bleul, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany, for providing Flt3-Cre mice. We also thank P. Saha for help with surgical procedures; C. Trouillet for help with flow cytometry and general organization of the lab; A. McGuigan and the staff of the Biological Service Unit at King's College London (KCL), Guy's Campus, for support with mouse husbandry; and S. Heck and the Flow facility of the Biomedical Research Centre (BRC) at King's Health Partners. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. MIAME data are available at www.ebi.ac.uk/ arrayexpress: GomezElisa_AgilentMouse, ArrayExpress accession: E-MEXP-3510. C. S. is supported by a fellowship program of the German National Academy of Sciences Leopoldina (LPDS 2009-31). K.J.L. is supported by the Wellcome Trust (WT081880AIA) and U.K. Biotechnology and Biological Sciences Research Council (BB/E013872). F. G. is the Arthritis Research U.K. Chair of Inflammation Biology, at KCL. This work was funded by grants MRC G0900867, from the U.K. Medical Research Council, and ERC-2010-StG-261299 MPS2010 from the European Research Council to F.G.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Buza-Vidas N, 2011, BLOOD, V118, P1544, DOI 10.1182/blood-2010-10-316232; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; HUME DA, 1983, J EXP MED, V157, P1704, DOI 10.1084/jem.157.5.1704; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; HUME DA, 1984, P NATL ACAD SCI-BIOL, V81, P4174, DOI 10.1073/pnas.81.13.4174; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Lichanska AM, 1999, BLOOD, V94, P127, DOI 10.1182/blood.V94.1.127.413k07_127_138; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; MORRIS L, 1991, DEVELOPMENT, V112, P517; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Mukouyama YS, 1999, CURR BIOL, V9, P833, DOI 10.1016/S0960-9822(99)80368-6; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; REAMS WM, 1973, DEV BIOL, V31, P114, DOI 10.1016/0012-1606(73)90323-0; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; VANFURTH R, 1984, J EXP MED, V160, P1273, DOI 10.1084/jem.160.5.1273	40	1622	1675	8	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					86	90		10.1126/science.1219179	http://dx.doi.org/10.1126/science.1219179			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22442384				2022-12-01	WOS:000302405400057
J	Fang, F; Fall, K; Mittleman, MA; Sparen, P; Ye, WM; Adami, HO; Valdimarsdottir, U				Fang, Fang; Fall, Katja; Mittleman, Murray A.; Sparen, Par; Ye, Weimin; Adami, Hans-Olov; Valdimarsdottir, Unnur			Suicide and Cardiovascular Death after a Cancer Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER; PSYCHOLOGICAL DISTRESS; PROSTATE-CANCER; CASE-CROSSOVER; RISK; PREVALENCE; DISORDERS; THERAPY; ILLNESS; DISEASE	BACKGROUND Receiving a diagnosis of cancer is a traumatic experience that may trigger immediate adverse health consequences beyond the effects of the disease or treatment. METHODS Using Poisson and negative binomial regression models, we conducted a historical cohort study involving 6,073,240 Swedes to examine the associations between a cancer diagnosis and the immediate risk of suicide or death from cardiovascular causes from 1991 through 2006. To adjust for unmeasured confounders, we also performed a nested, self-matched case-crossover analysis among all patients with cancer who died from suicide or cardiovascular diseases in the cohort. RESULTS As compared with cancer-free persons, the relative risk of suicide among patients receiving a cancer diagnosis was 12.6 (95% confidence interval [CI], 8.6 to 17.8) during the first week (29 patients; incidence rate, 2.50 per 1000 person-years) and 3.1 (95% CI, 2.7 to 3.5) during the first year (260 patients; incidence rate, 0.60 per 1000 personyears). The relative risk of cardiovascular death after diagnosis was 5.6 (95% CI, 5.2 to 5.9) during the first week (1318 patients; incidence rate, 116.80 per 1000 person-years) and 3.3 (95% CI, 3.1 to 3.4) during the first 4 weeks (2641 patients; incidence rate, 65.81 per 1000 person-years). The risk elevations decreased rapidly during the first year after diagnosis. Increased risk was particularly prominent for cancers with a poor prognosis. The case-crossover analysis largely confirmed results from the main analysis. CONCLUSIONS In this large cohort study, patients who had recently received a cancer diagnosis had increased risks of both suicide and death from cardiovascular causes, as compared with cancer-free persons. (Funded by the Swedish Council for Working Life and Social Research and others.)	[Fang, Fang; Sparen, Par; Ye, Weimin; Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Fall, Katja] Univ Orebro, Clin Epidemiol & Biostat Unit, Orebro, Sweden; [Fall, Katja] Orebro Univ Hosp, Orebro, Sweden; [Mittleman, Murray A.] Beth Israel Deaconess Med Ctr, Dept Med, Cardiovasc Epidemiol Res Unit, Boston, MA 02215 USA; [Mittleman, Murray A.] Harvard Univ, Sch Med, Boston, MA USA; [Fall, Katja; Mittleman, Murray A.; Adami, Hans-Olov; Valdimarsdottir, Unnur] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Fall, Katja; Valdimarsdottir, Unnur] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland	Karolinska Institutet; Orebro University; Orebro University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Iceland	Fang, F (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	fang.fang@ki.se	Papadopoulos, Fotios/H-1319-2019; Fall, Katja/AAE-1876-2021	Papadopoulos, Fotios/0000-0002-8692-3652; Fall, Katja/0000-0002-3649-2639; Valdimarsdottir, Unnur/0000-0001-5382-946X; Sparen, Par/0000-0002-5184-8971; Mittleman, Murray/0000-0001-9788-7274; Fang, Fang/0000-0002-3310-6456	Swedish Council for Working Life and Social Research [2008-1310, 2011-0473]; Swedish Research Council [SIMSAM 80748301]; Hjarnfonden and Svenska Sallskapet for Medicinsk Forskning	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Hjarnfonden and Svenska Sallskapet for Medicinsk Forskning	Supported by grants from the Swedish Council for Working Life and Social Research (2008-1310 and 2011-0473) and the Swedish Research Council (SIMSAM 80748301) and by postdoctoral fellowships (to Dr. Fang) from Hjarnfonden and Svenska Sallskapet for Medicinsk Forskning.	ALLEBECK P, 1989, J CLIN EPIDEMIOL, V42, P611, DOI 10.1016/0895-4356(89)90003-6; Annunziata MA, 2011, SUPPORT CARE CANCER, V19, P291, DOI 10.1007/s00520-010-0818-9; Carlson LE, 2010, J CLIN ONCOL, V28, P4884, DOI 10.1200/JCO.2009.27.3698; Collier A, 2011, AM J CLIN ONCOL 0203; Fall K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000197; Fang F, 2010, JNCI-J NATL CANCER I, V102, P307, DOI 10.1093/jnci/djp537; Hem E, 2004, J CLIN ONCOL, V22, P4209, DOI 10.1200/jco.2004.02.052; Ikeda RM, 2001, SUICIDE LIFE-THREAT, V32, P60, DOI 10.1521/suli.32.1.5.60.24207; Johnson TV, 2011, PSYCHOONCOLOGY  0124; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P763, DOI 10.1037/0022-006X.73.4.763; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Llorente MD, 2005, AM J GERIAT PSYCHIAT, V13, P195, DOI 10.1176/appi.ajgp.13.3.195; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Mehnert A, 2007, PSYCHO-ONCOLOGY, V16, P181, DOI 10.1002/pon.1057; Millar K, 2005, J PSYCHOSOM RES, V58, P335, DOI 10.1016/j.jpsychores.2004.10.005; Miller M, 2008, J CLIN ONCOL, V26, P4720, DOI 10.1200/JCO.2007.14.3990; Misono S, 2008, J CLIN ONCOL, V26, P4731, DOI 10.1200/JCO.2007.13.8941; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; Mouridsen H, 2007, J CLIN ONCOL, V25, P5715, DOI 10.1200/JCO.2007.12.1665; Norton TR, 2004, J CLIN ONCOL, V22, P919, DOI 10.1200/JCO.2004.07.028; Quan H, 2002, SOC PSYCH PSYCH EPID, V37, P190, DOI 10.1007/s001270200014; Schairer C, 2006, JNCI-J NATL CANCER I, V98, P1416, DOI 10.1093/jnci/djj377; Sellick SM, 2007, PSYCHO-ONCOL, V16, P534, DOI 10.1002/pon.1085; Senf B, 2010, SUPPORT CARE CANCER, V18, P957, DOI 10.1007/s00520-010-0850-9; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Turner J, 2005, PSYCHO-ONCOLOGY, V14, P396, DOI 10.1002/pon.856; Van Hemelrijck M, 2010, J CLIN ONCOL, V28, P3448, DOI 10.1200/JCO.2010.29.1567	27	275	281	4	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1310	1318		10.1056/NEJMoa1110307	http://dx.doi.org/10.1056/NEJMoa1110307			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475594				2022-12-01	WOS:000302343000008
J	Reinhardt, C; Bergentall, M; Greiner, TU; Schaffner, F; Ostergren-Lunden, G; Petersen, LC; Ruf, W; Backhed, F				Reinhardt, Christoph; Bergentall, Mattias; Greiner, Thomas U.; Schaffner, Florence; Ostergren-Lunden, Gunnel; Petersen, Lars C.; Ruf, Wolfram; Backhed, Fredrik			Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling	NATURE			English	Article							FACTOR CYTOPLASMIC DOMAIN; ENDOTHELIAL-CELLS; THROMBIN RECEPTOR; FACTOR EXPRESSION; ANGIOGENESIS; HEMOSTASIS; MICE	The gut microbiota is a complex ecosystem that has coevolved with host physiology. Colonization of germ-free (GF) mice with a microbiota promotes increased vessel density in the small intestine(1), but little is known about the mechanisms involved. Tissue factor (TF) is themembrane receptor that initiates the extrinsic coagulation pathway(2), and it promotes developmental and tumour angiogenesis(3,4). Here we show that the gut microbiota promotes TF glycosylation associated with localization of TF on the cell surface, the activation of coagulation proteases, and phosphorylation of theTFcytoplasmic domain in the small intestine. Anti-TF treatment of colonized GF mice decreased microbiota-induced vascular remodelling and expression of the proangiogenic factor angiopoietin-1 (Ang-1) in the small intestine. Mice with a genetic deletion of theTFcytoplasmic domain or with hypomorphic TF (F3) alleles had a decreased intestinal vessel density. Coagulation proteases downstream of TF activate protease-activated receptor (PAR) signalling implicated in angiogenesis(5). Vesseldensity and phosphorylation of the cytoplasmic domain of TF were decreased in small intestine fromPAR1-deficient (F2r(-/-)) but not PAR2-deficient (F2rl1(-/-)) mice, and inhibition of thrombin showed that thrombin-PAR1 signalling was upstream of TF phosphorylation. Thus, the microbiota-induced extravascular TF-PAR1 signalling loop is a novel pathway thatmay bemodulated to influence vascular remodelling in the small intestine.	[Reinhardt, Christoph; Bergentall, Mattias; Greiner, Thomas U.; Ostergren-Lunden, Gunnel; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, S-41345 Gothenburg, Sweden; [Reinhardt, Christoph; Bergentall, Mattias; Greiner, Thomas U.; Ostergren-Lunden, Gunnel; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, S-41345 Gothenburg, Sweden; [Reinhardt, Christoph] Univ Med Ctr Mainz, CTH, D-55131 Mainz, Germany; [Schaffner, Florence; Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Petersen, Lars C.] Novo Nordisk AS, Haemostasis Biol, DK-2760 Malov, Denmark; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	University of Gothenburg; University of Gothenburg; Johannes Gutenberg University of Mainz; Scripps Research Institute; Novo Nordisk; Novo Nordisk Foundation; University of Copenhagen	Backhed, F (corresponding author), Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, S-41345 Gothenburg, Sweden.	fredrik.backhed@wlab.gu.se	Backhed, Fredrik/ABE-6613-2020	Backhed, Fredrik/0000-0002-4871-8818	Swedish Foundation for Strategic Research; Swedish Research Council; Torsten and Ragnar Soderberg's foundation; Petrus and Augusta Hedlund's foundation; Swedish federal government under LUA/ALF; National Institutes of Health [HL-60742, HL-77753]; European Union; German Federal Ministry of Education and Research [BMBF 01EO1003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060742, R01HL077753] Funding Source: NIH RePORTER	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg's foundation; Petrus and Augusta Hedlund's foundation; Swedish federal government under LUA/ALF; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank R. Perkins for editing the manuscript; C. Arvidsson, A. Hallen, S. Wagoner, M. Karlsson, D. O'Donell, S. Islam, N. Hormann and A. Mohammadzadeh for technical assistance; A. Hallen for providing Supplementary Fig. 16; and P. Lindahl, J. Gordon, C. Betsholtz, M. Bergo, A. Wichmann, V. Tremaroli, M. Levin and S. Massberg for comments and suggestions. We are grateful to D. Kirchhofer for the gift of 1H1 monoclonal anti-mouse TF antibody, J. Nichols at Amgen for mL4-3, N. Mackman for the low-TF mice, M. Anderson for the human TF knock-in mice, and J. Gordon for providing CR2-tox176 mice. This study was supported by the Swedish Foundation for Strategic Research, the Swedish Research Council, Torsten and Ragnar Soderberg's foundation, Petrus and Augusta Hedlund's foundation, and the Swedish federal government under the LUA/ALF agreement to F. B., National Institutes of Health grants HL-60742 and HL-77753 to W. R., and a Marie Curie Fellowship, a Marie Curie Reintegration Grant from the European Union and the German Federal Ministry of Education and Research (BMBF 01EO1003) to C.R.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Belting M, 2004, NAT MED, V10, P502, DOI 10.1038/nm1037; Blackburn JS, 2008, AM J PATHOL, V173, P1736, DOI 10.2353/ajpath.2008.080512; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Camerer E, 1996, BLOOD, V88, P1339, DOI 10.1182/blood.V88.4.1339.bloodjournal8841339; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Dorfleutner A, 2004, MOL BIOL CELL, V15, P4416, DOI 10.1091/mbc.E03-09-0640; Dorfleutner A, 2003, BLOOD, V102, P3998, DOI 10.1182/blood-2003-04-1149; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Furlan-Freguia C, 2011, J CLIN INVEST, V121, P2932, DOI 10.1172/JCI46129; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; IWANAGA S, 1993, CURR OPIN IMMUNOL, V5, P74, DOI 10.1016/0952-7915(93)90084-6; Kirchhofer D, 2005, J THROMB HAEMOST, V3, P1098, DOI 10.1111/j.1538-7836.2005.01253.x; Krudysz-Amblo J, 2010, J BIOL CHEM, V285, P3371, DOI 10.1074/jbc.M109.055178; Luther T, 1996, AM J PATHOL, V149, P101; Melis E, 2001, BIOCHEM BIOPH RES CO, V286, P580, DOI 10.1006/bbrc.2001.5425; MORE L, 1993, J CLIN PATHOL, V46, P703, DOI 10.1136/jcp.46.8.703; MORRISSEY JH, 1987, CELL, V50, P129, DOI 10.1016/0092-8674(87)90669-6; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Perreault N, 1998, EXP CELL RES, V245, P34, DOI 10.1006/excr.1998.4221; Petersen LC, 2005, THROMB RES, V116, P75, DOI 10.1016/j.thromres.2004.11.003; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schaffner F, 2010, BLOOD, V116, P6106, DOI 10.1182/blood-2010-06-289314; Snyder LA, 2008, J THROMB HAEMOST, V6, P306, DOI 10.1111/j.1538-7836.2007.02833.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stappenbeck TS, 2002, METHOD ENZYMOL, V356, P167; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; van den Berg YW, 2009, P NATL ACAD SCI USA, V106, P19497, DOI 10.1073/pnas.0905325106; ZIONCHECK TF, 1992, J BIOL CHEM, V267, P3561	34	171	181	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					627	U155		10.1038/nature10893	http://dx.doi.org/10.1038/nature10893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22407318	Green Accepted			2022-12-01	WOS:000302006100045
J	Duprat, C; Protiere, S; Beebe, AY; Stone, HA				Duprat, C.; Protiere, S.; Beebe, A. Y.; Stone, H. A.			Wetting of flexible fibre arrays	NATURE			English	Article								Fibrous media are functional and versatile materials, as demonstrated by their ubiquity both in natural systems such as feathers(1-4) and adhesive pads(5) and in engineered systems from nanotextured surfaces(6) to textile products(7), where they offer benefits in filtration, insulation, wetting and colouring. The elasticity and high aspect ratios of the fibres allow deformation under capillary forces, which cause mechanical damage(8), matting(5,9) self-assembly(10,11) or colour changes(12), with many industrial and ecological consequences. Attempts to understand these systems have mostly focused on the wetting of rigid fibres(13-17) or on elastocapillary effects in planar geometries(18) and on a fibre brush withdrawn from an infinite bath(19). Here we consider the frequently encountered case of a liquid drop deposited on a flexible fibre array and show that flexibility, fibre geometry and drop volume are the crucial parameters that are necessary to understand the various observations referred to above. We identify the conditions required for a drop to remain compact with minimal spreading or to cause a pair of elastic fibres to coalesce. We find that there is a critical volume of liquid, and, hence, a critical drop size, above which this coalescence does not occur. We also identify a drop size that maximizes liquid capture. For both wetting and deformation of the substrates, we present rules that are deduced from the geometric and material properties of the fibres and the volume of the drop. These ideas are applicable to a wide range of fibrous materials, as we illustrate with examples for feathers, beetle tarsi, sprays and microfabricated systems.	[Duprat, C.; Beebe, A. Y.; Stone, H. A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Protiere, S.] CNRS, UMR 7190, Inst Jean le Rond dAlembert, F-75005 Paris, France; [Protiere, S.] Univ Paris 06, UMR 7190, Inst Jean le Rond dAlembert, F-75005 Paris, France	Princeton University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite	Stone, HA (corresponding author), Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA.	hastone@princeton.edu			Unilever; NFS; Emergence(s) Program of the City of Paris; CNRS; Div Of Chem, Bioeng, Env, & Transp Sys [1132835] Funding Source: National Science Foundation	Unilever(Unilever); NFS; Emergence(s) Program of the City of Paris; CNRS(Centre National de la Recherche Scientifique (CNRS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	C.D. and H.A.S. acknowledge Unilever and the NFS for financial support. S. P. acknowledges financial support from the Emergence(s) Program of the City of Paris and CNRS and thanks Princeton University for its hospitality. We thank A. Lips and P. Warren for comments.	Bedarkar A, 2010, APPL SURF SCI, V256, P7260, DOI 10.1016/j.apsusc.2010.05.061; Chandra D, 2010, ACCOUNTS CHEM RES, V43, P1080, DOI 10.1021/ar100001a; Chandra D, 2009, ACS APPL MATER INTER, V1, P1698, DOI 10.1021/am900253z; Dawson C, 1999, J THEOR BIOL, V199, P291, DOI 10.1006/jtbi.1999.0959; Eadie L, 2011, J R SOC INTERFACE, V8, P761, DOI 10.1098/rsif.2010.0487; Eisner T, 2000, P NATL ACAD SCI USA, V97, P6568, DOI 10.1073/pnas.97.12.6568; HARTUNG R, 1967, J WILDLIFE MANAGE, V31, P798, DOI 10.2307/3797987; Hubbe MA, 2006, BIORESOURCES, V1, P281; KAMO J, 1992, J MEMBRANE SCI, V70, P217, DOI 10.1016/0376-7388(92)80107-U; Keis K, 2004, NATO SCI SER II MATH, V169, P175; Kwon HM, 2008, J APPL PHYS, V103, DOI 10.1063/1.2913512; Liu KS, 2011, NANO TODAY, V6, P155, DOI 10.1016/j.nantod.2011.02.002; Minor FW, 1959, TEXT RES J, V29, P940; O'Hara PD, 2010, MAR POLLUT BULL, V60, P672, DOI 10.1016/j.marpolbul.2009.12.008; Pokroy B, 2009, SCIENCE, V323, P237, DOI 10.1126/science.1165607; Prakash M, 2008, SCIENCE, V320, P931, DOI 10.1126/science.1156023; PRINCEN HM, 1970, J COLLOID INTERF SCI, V34, P171, DOI 10.1016/0021-9797(70)90167-0; Py C, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/44005; RIJKE AM, 1968, J EXP BIOL, V48, P185; Rijke AM, 2010, WILSON J ORNITHOL, V122, P563, DOI 10.1676/09-172.1; Roman B, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/49/493101; Wu XF, 2010, J COLLOID INTERF SCI, V341, P326, DOI 10.1016/j.jcis.2009.09.019; Zi J, 2003, P NATL ACAD SCI USA, V100, P12576, DOI 10.1073/pnas.2133313100	23	198	199	11	344	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					510	513		10.1038/nature10779	http://dx.doi.org/10.1038/nature10779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358841				2022-12-01	WOS:000300770500047
J	Kadowaki, T; Kubota, N; Ueki, K; Yamauchi, T				Kadowaki, Takashi; Kubota, Naoto; Ueki, Kohjiro; Yamauchi, Toshimasa			SnapShot: Physiology of Insulin Signaling	CELL			English	Editorial Material							NUTRIENT HOMEOSTASIS; RECEPTOR; RESISTANCE; TISSUE; MICE		[Kadowaki, Takashi; Kubota, Naoto; Ueki, Kohjiro; Yamauchi, Toshimasa] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo	Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan.		Kubota, Naoto/N-7892-2015					Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; KADOWAKI T, 1988, SCIENCE, V240, P787, DOI 10.1126/science.2834824; Kadowaki T, 2012, CELL, V148, P624, DOI 10.1016/j.cell.2012.01.034; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179	10	7	9	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					834	U226	834.e1	10.1016/j.cell.2012.02.004	http://dx.doi.org/10.1016/j.cell.2012.02.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341452	Bronze			2022-12-01	WOS:000300622400024
J	Luo, WY; Sehgal, A				Luo, Wenyu; Sehgal, Amita			Regulation of Circadian Behavioral Output via a MicroRNA-JAK/STAT Circuit	CELL			English	Article							DROSOPHILA-MELANOGASTER; MOLECULAR OSCILLATIONS; SYNAPTIC TRANSMISSION; TARGET PREDICTIONS; CLOCK; EXPRESSION; KINASE; GENE; RECEPTOR; RHYTHMS	Although molecular components of the circadian clock are known, mechanisms that transmit signals from the clock and produce rhythmic behavior are poorly understood. We find that the microRNA miR-279 regulates the JAK/STAT pathway to drive rest: activity rhythms in Drosophila. Overexpression of microRNA miR-279 or miR-279 deletion attenuates rest: activity rhythms. Oscillations of the clock protein PERIOD are normal in pacemaker neurons lacking miR-279, suggesting that miR-279 acts downstream of the clock. We identify the JAK/STAT ligand, Upd, as a target of miR-279 and show that knockdown of Upd rescues the behavioral phenotype of miR-279 mutants. Manipulations of the JAK/STAT pathway also disrupt circadian rhythms. In addition, central clock neurons project in the vicinity of Upd-expressing neurons, providing a possible physical connection by which the central clock could regulate JAK/STAT signaling to control rest: activity rhythms.	[Luo, Wenyu; Sehgal, Amita] Univ Penn, Sch Med, Cell & Mol Biol Program, Philadelphia, PA 19104 USA; [Sehgal, Amita] Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Sch Med, Cell & Mol Biol Program, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu			NIH [1-R560NS-048471, 2R01NS04847]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048471, R56NS048471, R01NS035703, R37NS048471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are very grateful to Zhaohai Yang and Zhifeng Yue for generating the NE95-11-24 fly line. We thank L. Zipursky, B. Edgar, D. Bilder, S. Hou, G. Baeg, T. Cline, W. Odenwald, I. Rebay, J. Blau, and M. Rosbash for providing miR-279, JAK/STAT, and other fly stocks; S. Hou, D. Harrison, P. Taghert, and P. Hardin for STAT92E, UPD, HOP, PDFR, and CLK antibodies; E. Izaurralde and K. Basler for pAc5.1-F. Luc and pUASTattB vectors; X. Zheng and D. Chen for developing PER antibodies; W. Joiner, A. Crocker, and S. Kumar for outcrossing some mutants and GAL4 lines; and other members of the laboratory for useful discussions. The work was supported by NIH grants 1-R560NS-048471 and 2R01NS04847. A.S. is an Investigator in the HHMI.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Banerjee S, 2010, CANCER RES, V70, P1356, DOI 10.1158/0008-5472.CAN-09-2178; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; ESKIN A, 1979, FED PROC, V38, P2570; Ghiglione C, 2002, DEVELOPMENT, V129, P5437, DOI 10.1242/dev.00116; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kaneko M, 1997, J NEUROSCI, V17, P6745; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; Kojima S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011264; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Luo H, 1999, DEV BIOL, V213, P432, DOI 10.1006/dbio.1999.9390; McGuire S. E., 2004, SCI STKE, V2004, pp16, DOI DOI 10.1125/STKE.2202004P16; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; PERRIMON N, 1986, DEV BIOL, V118, P28, DOI 10.1016/0012-1606(86)90070-9; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; Shi LH, 2009, J BIOL CHEM, V284, P25791, DOI 10.1074/jbc.M109.033993; Vitalini MW, 2006, J BIOL RHYTHM, V21, P432, DOI 10.1177/0748730406294396; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yoon WH, 2011, NAT CELL BIOL, V13, P1062, DOI 10.1038/ncb2316; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658; Zheng X, 2007, P NATL ACAD SCI USA, V104, P15899, DOI 10.1073/pnas.0701599104	45	101	109	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					765	779		10.1016/j.cell.2011.12.024	http://dx.doi.org/10.1016/j.cell.2011.12.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22305007	Bronze, Green Accepted			2022-12-01	WOS:000300622400017
J	Wachter, RM; Bell, D				Wachter, Robert M.; Bell, Derek			Renaissance of hospital generalists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE MEDICAL UNITS; OLDER PATIENTS; CARE; ENGLAND; WORKING		[Wachter, Robert M.] Univ Calif San Francisco, Div Hosp Med, San Francisco, CA 94143 USA; [Bell, Derek] Univ London Imperial Coll Sci Technol & Med, London, England	University of California System; University of California San Francisco; Imperial College London	Wachter, RM (corresponding author), Univ Calif San Francisco, Div Hosp Med, San Francisco, CA 94143 USA.	bobw@medicine.ucsf.edu		Bell, Derek/0000-0002-9944-1097				*AC MED TASKF, 2007, AC MED CAR RIGHT PER; Auerbach AD, 2010, ARCH INTERN MED, V170, P2004, DOI 10.1001/archinternmed.2010.432; Bell D, 2008, BRIT J HOSP MED, V69, pM107, DOI 10.12968/hmed.2008.69.Sup7.30432; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Byrne D, 2011, EUR J INTERN MED, V22, P344, DOI 10.1016/j.ejim.2011.05.016; Goddard AF, 2010, CLIN MED, V10, P330; Goulding L, 2011, BMJ QUAL SAF    1118; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; Joint Royal Colleges of Physicians Training Board, AC INT MED AIM SUBSP; Jones MC, 2009, BRIT J HOSP MED, V70, pS8; Kuo YF, 2011, ANN INTERN MED, V155, P152, DOI 10.7326/0003-4819-155-3-201108020-00005; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; McKean SCW, 2006, J HOSP MED, V1, P57, DOI 10.1002/jhm.7; Peterson MC, 2009, MAYO CLIN PROC, V84, P248, DOI 10.1016/S0025-6196(11)61142-7; *ROYAL COLL PHYS, 2004, AC MED MAK WORK PAT; Scott I, 2009, INT J QUAL HEALTH C, V21, P397, DOI 10.1093/intqhc/mzp045; Seiler A, 2011, J HOSP MED      1031; Subbe CP, 2011, EUR J INTERN MED, V22, P339, DOI 10.1016/j.ejim.2011.05.015; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; Wachter RM, 2011, J HOSP MED, V6, pE1, DOI 10.1002/jhm.913; Ward D, 2009, CLIN MED, V9, P553, DOI 10.7861/clinmedicine.9-6-553; Weber EJ, 2011, ANN EMERG MED, V57, P79, DOI 10.1016/j.annemergmed.2010.08.013; Weingarten SR, 2002, ARCH INTERN MED, V162, P527, DOI 10.1001/archinte.162.5.527	25	28	28	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2012	344								e652	10.1136/bmj.e652	http://dx.doi.org/10.1136/bmj.e652			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896HW	22331278				2022-12-01	WOS:000300557300003
J	Kadowaki, T; Ueki, K; Yamauchi, T; Kubota, N				Kadowaki, Takashi; Ueki, Kohjiro; Yamauchi, Toshimasa; Kubota, Naoto			SnapShot: Insulin Signaling Pathways	CELL			English	Editorial Material							INSIGHTS; KINASE		[Kadowaki, Takashi; Ueki, Kohjiro; Yamauchi, Toshimasa; Kubota, Naoto] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo	Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan.		Kubota, Naoto/N-7892-2015					Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705	10	32	32	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 3	2012	148	3					624	U258	624.e1	10.1016/j.cell.2012.01.034	http://dx.doi.org/10.1016/j.cell.2012.01.034			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304926	Bronze			2022-12-01	WOS:000300225000028
J	Laan, L; Pavin, N; Husson, J; Romet-Lemonne, G; van Duijn, M; Lopez, MP; Vale, RD; Julicher, F; Reck-Peterson, SL; Dogterom, M				Laan, Liedewij; Pavin, Nenad; Husson, Julien; Romet-Lemonne, Guillaume; van Duijn, Martijn; Lopez, Magdalena Preciado; Vale, Ronald D.; Juelicher, Frank; Reck-Peterson, Samara L.; Dogterom, Marileen			Cortical Dynein Controls Microtubule Dynamics to Generate Pulling Forces that Position Microtubule Asters	CELL			English	Article							CELL CORTEX; CAENORHABDITIS-ELEGANS; FISSION YEAST; CYTOPLASMIC DYNEIN; MICROFABRICATED CHAMBERS; C-ELEGANS; SPINDLE; MOTOR; DEPOLYMERIZATION; PROCESSIVITY	Dynein at the cortex contributes to microtubule-based positioning processes such as spindle positioning during embryonic cell division and centrosome positioning during fibroblast migration. To investigate how cortical dynein interacts with microtubule ends to generate force and how this functional association impacts positioning, we have reconstituted the 'cortical' interaction between dynein and dynamic microtubule ends in an in vitro system using microfabricated barriers. We show that barrier-attached dynein captures microtubule ends, inhibits growth, and triggers microtubule catastrophes, thereby controlling microtubule length. The subsequent interaction with shrinking microtubule ends generates pulling forces up to several pN. By combining experiments in microchambers with a theoretical description of aster mechanics, we show that dynein-mediated pulling forces lead to the reliable centering of microtubule asters in simple confining geometries. Our results demonstrate the intrinsic ability of cortical microtubule-dynein interactions to regulate microtubule dynamics and drive positioning processes in living cells.	[Laan, Liedewij; Husson, Julien; Romet-Lemonne, Guillaume; van Duijn, Martijn; Lopez, Magdalena Preciado; Dogterom, Marileen] FOM Inst AMOLF, NL-1098 XG Amsterdam, Netherlands; [Pavin, Nenad; Juelicher, Frank] Max Planck Inst Phys Complex Syst MPI PKS, Dresden, Germany; [Pavin, Nenad] Univ Zagreb, Fac Sci, Dept Phys, Zagreb 10002, Croatia; [Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Reck-Peterson, Samara L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Laan, Liedewij; Vale, Ronald D.; Reck-Peterson, Samara L.; Dogterom, Marileen] Marine Biol Lab, Physiol Course, Woods Hole, MA 02543 USA	AMOLF; Max Planck Society; University of Zagreb; University of Zagreb, School of Dental Medicine; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Marine Biological Laboratory - Woods Hole	Dogterom, M (corresponding author), FOM Inst AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	dogterom@amolf.nl	Husson, Julien/B-8466-2018; Julicher, Frank/B-1828-2009; Pavin, Nenad/N-6376-2013	Husson, Julien/0000-0002-8230-1469; Julicher, Frank/0000-0003-4731-9185; Pavin, Nenad/0000-0002-4313-1081; van Duijn, Martijn/0000-0002-6654-994X; Reck-Peterson, Samara/0000-0002-1553-465X; Romet-Lemonne, Guillaume/0000-0002-4938-1065; Laan, Liedewij/0000-0002-7138-9004; Preciado Lopez, Magdalena/0000-0003-4929-3310	European network Active BIOMICS; HFSP; Stichting voor Fundamenteel Onderzoek der Materie (FOM); Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO); Volkswagen Stiftung; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM085967] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004268] Funding Source: NIH RePORTER	European network Active BIOMICS; HFSP(Human Frontier Science Program); Stichting voor Fundamenteel Onderzoek der Materie (FOM)(FOM (The Netherlands)); Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Volkswagen Stiftung(Volkswagen); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This collaborative project benefited greatly from interactions during the Physiology Course at the MBL, Woods Hole. All experiments were performed by L.L., together with J.H. (optical trap) and M.P.L. (supplemental gliding assays), based on chamber functionalization technology developed by G.R.L. and M.v.D., under supervision of M.D.R.V. and S.R.P. provided materials and expertise on dynein. Theory was developed by N.P. and L.L., under supervision of F.J. We thank M. Footer for providing us with axonemes; C. Celati for help with the centrosome purifications; E.L. Munteanu and J.W.J. Kerssemakers for developing the optical trap set-up, C. Retif, H. Bar, and M. Seynen for technical support, and S. Kryazhimskiy for help with statistical analysis. We thank S. Tans, I. Tolic-Norrelykke, and H. Bakker for critical reading of previous versions of the manuscript. N.P. acknowledges support by the Volkswagen Stiftung. M.D. greatfully acknowledges financial support from the European network Active BIOMICS, and from HFSP. This work is part of the research program of the "Stichting voor Fundamenteel Onderzoek der Materie (FOM),'' which is financially supported by the "Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO).''	Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Chang F, 1996, CELL, V84, P191, DOI 10.1016/S0092-8674(00)80973-3; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dogterom M, 1998, PHYS REV LETT, V81, P485, DOI 10.1103/PhysRevLett.81.485; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Faivre-Moskalenko C, 2002, P NATL ACAD SCI USA, V99, P16788, DOI 10.1073/pnas.252407099; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Grissom PM, 2009, MOL BIOL CELL, V20, P963, DOI 10.1091/mbc.E08-09-0979; Gusnowski EM, 2011, J CELL BIOL, V194, P377, DOI 10.1083/jcb.201103128; HAMAGUCHI MS, 1986, DEV GROWTH DIFFER, V28, P143, DOI 10.1111/j.1440-169x.1986.00143.x; Holy TE, 1997, P NATL ACAD SCI USA, V94, P6228, DOI 10.1073/pnas.94.12.6228; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kimura K, 2011, P NATL ACAD SCI USA, V108, P137, DOI 10.1073/pnas.1013275108; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Koonce MP, 1999, EMBO J, V18, P6786, DOI 10.1093/emboj/18.23.6786; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Laan L, 2008, P NATL ACAD SCI USA, V105, P8920, DOI 10.1073/pnas.0710311105; Laan L, 2010, METHOD CELL BIOL, V95, P617, DOI 10.1016/S0091-679X(10)95031-0; Labbe JC, 2003, CURR BIOL, V13, P707, DOI 10.1016/S0960-9822(03)00251-3; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; McIntosh JR, 2010, J CELL SCI, V123, P3425, DOI 10.1242/jcs.067611; Minc N, 2009, CURR BIOL, V19, P83, DOI 10.1016/j.cub.2008.12.008; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; O'Rourke SM, 2010, NAT CELL BIOL, V12, P1235, DOI 10.1038/ncb2128; Oguchi Y, 2011, NAT CELL BIOL, V13, P846, DOI 10.1038/ncb2256; Picone R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000542; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Romet-Lemonne G, 2005, NANO LETT, V5, P2350, DOI 10.1021/nl0507111; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Savoian MS, 2000, NAT CELL BIOL, V2, P948, DOI 10.1038/35046605; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Vallee RB, 2006, CELL CYCLE, V5, P2447, DOI 10.4161/cc.5.21.3395; Varma D, 2008, J CELL BIOL, V182, P1045, DOI 10.1083/jcb.200710106; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Wuhr M, 2009, CELL CYCLE, V8, P1115; Yamamoto A, 2001, MOL BIOL CELL, V12, P3933, DOI 10.1091/mbc.12.12.3933; Zhu J, 2010, MOL BIOL CELL, V21, P4418, DOI 10.1091/mbc.E10-07-0627	53	263	264	0	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 3	2012	148	3					502	514		10.1016/j.cell.2012.01.007	http://dx.doi.org/10.1016/j.cell.2012.01.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304918	Bronze, Green Submitted, Green Accepted			2022-12-01	WOS:000300225000018
J	Katz, SJ; Morrow, M				Katz, Steven J.; Morrow, Monica			The Challenge of Individualizing Treatments for Patients With Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WOMEN		[Katz, Steven J.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Katz, Steven J.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Morrow, Monica] Mem Sloan Kettering Canc Ctr, Dept Clin Oncol, New York, NY 10021 USA; [Morrow, Monica] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Cornell University	Katz, SJ (corresponding author), Univ Michigan, Dept Med, 300 N Ingalls,Room 7E10, Ann Arbor, MI 48109 USA.	skatz@umich.edu	KATZ, STEVEN/ABH-8886-2020					Anderson WF, 2007, J CLIN ONCOL, V25, P3923, DOI 10.1200/JCO.2007.11.6079; Gilovich T., 2002, HEURISTICS BIASES PS, V16th edn, DOI DOI 10.1017/CBO9780511808098; Haidt Jonathan, 2006, HAPPINESS HYPOTHESIS; HEWITT M, 1999, ENSURING QUALITY CAN, P97; Lantz PM, 2005, HEALTH SERV RES, V40, P745, DOI 10.1111/j.1475-6773.2005.00383.x; Morrow M, 2011, LANCET, V378, P1804, DOI 10.1016/S0140-6736(11)61350-0; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Patlak M., 2010, POLICY ISSUES DEV PE; Schwartz B., 2004, PARADOX CHOICE	9	27	27	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1379	1380		10.1001/jama.2012.409	http://dx.doi.org/10.1001/jama.2012.409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474200				2022-12-01	WOS:000302294200023
J	Jensen, M; Hoerndli, FJ; Brockie, PJ; Wang, R; Johnson, E; Maxfield, D; Francis, MM; Madsen, DM; Maricq, AV				Jensen, Michael; Hoerndli, Frederic J.; Brockie, Penelope J.; Wang, Rui; Johnson, Erica; Maxfield, Dane; Francis, Michael M.; Madsen, David M.; Maricq, Andres V.			Wnt Signaling Regulates Acetylcholine Receptor Translocation and Synaptic Plasticity in the Adult Nervous System	CELL			English	Article							TYROSINE KINASE; NICOTINIC RECEPTOR; PROTEIN; TRANSMISSION; MECHANISMS; CAM-1	The adult nervous system is plastic, allowing us to learn, remember, and forget. Experience-dependent plasticity occurs at synapses-the specialized points of contact between neurons where signaling occurs. However, the mechanisms that regulate the strength of synaptic signaling are not well understood. Here, we define a Wnt-signaling pathway that modifies synaptic strength in the adult nervous system by regulating the translocation of one class of acetylcholine receptors (AChRs) to synapses. In Caenorhabditis elegans, we show that mutations in CWN-2 (Wnt ligand), LIN-17 (Frizzled), CAM-1 (Ror receptor tyrosine kinase), or the downstream effector DSH-1 (disheveled) result in similar sub-synaptic accumulations of ACR-16/alpha 7 AChRs, a consequent reduction in synaptic current, and predictable behavioral defects. Photoconversion experiments revealed defective translocation of ACR-16/alpha 7 to synapses in Wnt-signaling mutants. Using optogenetic nerve stimulation, we demonstrate activity-dependent synaptic plasticity and its dependence on ACR-16/alpha 7 translocation mediated by Wnt signaling via LIN-17/CAM-1 heteromeric receptors.	[Jensen, Michael; Hoerndli, Frederic J.; Brockie, Penelope J.; Wang, Rui; Johnson, Erica; Maxfield, Dane; Francis, Michael M.; Madsen, David M.; Maricq, Andres V.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Maricq, AV (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	maricq@biology.utah.edu	Wang, Rui/C-8424-2011	jensen, michael/0000-0002-4517-822X; francis, michael/0000-0002-8076-6668; Hoerndli, Frederic/0000-0001-6838-0386	National Institutes of Health [NIH] [R01 NS070280]; American Heart Association [09PRE2060730]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070280, R01NS064263] Funding Source: NIH RePORTER	National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Maricq laboratory for comments on the manuscript, Kang Shen and Erik Jorgensen for plasmids and transgenic strains, and the Caenorhabditis Genetics Center (funded by the National Institutes of Health [NIH]) for providing worm strains. This research was made possible by support from NIH Grant R01 NS070280 and American Heart Association Predoctoral Grant 09PRE2060730 (M.J.).	Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Fang-Yen C, 2009, WORM BREED GAZ, V18, P32; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Farias GG, 2010, DEV DYNAM, V239, P94, DOI 10.1002/dvdy.22065; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Gleason JE, 2006, DEV BIOL, V298, P442, DOI 10.1016/j.ydbio.2006.06.050; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Green JL, 2007, DEVELOPMENT, V134, P4053, DOI 10.1242/dev.005363; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Henriquez JP, 2008, P NATL ACAD SCI USA, V105, P18812, DOI 10.1073/pnas.0806300105; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032; Kennerdell JR, 2009, DEVELOPMENT, V136, P3801, DOI 10.1242/dev.038109; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim C, 2003, DEV BIOL, V264, P376, DOI 10.1016/j.ydbio.2003.09.007; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681; Kourtis N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004547; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Shyu YJ, 2008, NAT PROTOC, V3, P588, DOI 10.1038/nprot.2008.16; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290	44	71	85	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					173	187		10.1016/j.cell.2011.12.038	http://dx.doi.org/10.1016/j.cell.2011.12.038			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464329	Bronze, Green Accepted			2022-12-01	WOS:000302235400019
J	Garner, AR; Rowland, DC; Hwang, SY; Baumgaertel, K; Roth, BL; Kentros, C; Mayford, M				Garner, Aleena R.; Rowland, David C.; Hwang, Sang Youl; Baumgaertel, Karsten; Roth, Bryan L.; Kentros, Cliff; Mayford, Mark			Generation of a Synthetic Memory Trace	SCIENCE			English	Article							MICROSTIMULATION; DISCRIMINATION; STIMULATION; HIPPOCAMPUS; RECEPTORS; DYNAMICS; NEURONS; MICE	We investigated the effect of activating a competing, artificially generated, neural representation on encoding of contextual fear memory in mice. We used a c-fos-based transgenic approach to introduce the hM(3)D(q) DREADD receptor (designer receptor exclusively activated by designer drug) into neurons naturally activated by sensory experience. Neural activity could then be specifically and inducibly increased in the hM(3)D(q)-expressing neurons by an exogenous ligand. When an ensemble of neurons for one context (ctxA) was artificially activated during conditioning in a distinct second context (ctxB), mice formed a hybrid memory representation. Reactivation of the artificially stimulated network within the conditioning context was required for retrieval of the memory, and the memory was specific for the spatial pattern of neurons artificially activated during learning. Similar stimulation impaired recall when not part of the initial conditioning.	[Garner, Aleena R.; Hwang, Sang Youl; Baumgaertel, Karsten; Mayford, Mark] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Garner, Aleena R.; Hwang, Sang Youl; Baumgaertel, Karsten; Mayford, Mark] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Garner, Aleena R.; Mayford, Mark] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92037 USA; [Rowland, David C.; Kentros, Cliff] Univ Oregon, Inst Neurosci, Dept Psychol, Eugene, OR 97403 USA; [Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Dept Biol Chem, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Dept Med Chem, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Program Neurosci, Chapel Hill, NC 27599 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; University of Oregon; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mayford, M (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mmayford@scripps.edu	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520; Kentros, Clifford/0000-0003-3850-3829; Garner, Aleena/0000-0002-3488-2959; Mayford, Mark/0000-0002-9001-5024	National Institute of Mental Health (NIMH) [R01MH057368, U19MH82441]; National Institute on Drug Abuse [R01DA028300]; Michael Hooker Distinguished Chair in Pharmacology; California Institute for Regenerative Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, R01MH057368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028300] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Michael Hooker Distinguished Chair in Pharmacology; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Cowansage for helpful discussions. Supported by National Institute of Mental Health (NIMH) grant R01MH057368 and National Institute on Drug Abuse grant R01DA028300 (M. M.), NIMH grant U19MH82441 and the Michael Hooker Distinguished Chair in Pharmacology (B. L. R.), and a graduate fellowship from the California Institute for Regenerative Medicine (A.R.G.).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Doty R W, 1969, Annu Rev Psychol, V20, P289, DOI 10.1146/annurev.ps.20.020169.001445; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jasper H., 1954, EPILEPSY FUNCTIONAL; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Shinkman PG, 1996, BEHAV NEUROSCI, V110, P914, DOI 10.1037/0735-7044.110.5.914; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	22	254	263	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2012	335	6075					1513	1516		10.1126/science.1214985	http://dx.doi.org/10.1126/science.1214985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22442487	Green Accepted, Green Submitted			2022-12-01	WOS:000301837000054
J	Walter, MJ; Shen, D; Ding, L; Shao, J; Koboldt, DC; Chen, K; Larson, DE; McLellan, MD; Dooling, D; Abbott, R; Fulton, R; Magrini, V; Schmidt, H; Kalicki-Veizer, J; O'Laughlin, M; Fan, X; Grillot, M; Witowski, S; Heath, S; Frater, JL; Eades, W; Tomasson, M; Westervelt, P; DiPersio, JF; Link, DC; Mardis, ER; Ley, TJ; Wilson, RK; Graubert, TA				Walter, Matthew J.; Shen, Dong; Ding, Li; Shao, Jin; Koboldt, Daniel C.; Chen, Ken; Larson, David E.; McLellan, Michael D.; Dooling, David; Abbott, Rachel; Fulton, Robert; Magrini, Vincent; Schmidt, Heather; Kalicki-Veizer, Joelle; O'Laughlin, Michelle; Fan, Xian; Grillot, Marcus; Witowski, Sarah; Heath, Sharon; Frater, John L.; Eades, William; Tomasson, Michael; Westervelt, Peter; DiPersio, John F.; Link, Daniel C.; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.; Graubert, Timothy A.			Clonal Architecture of Secondary Acute Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYELODYSPLASTIC SYNDROMES; POINT MUTATIONS; CANCER; PROGRESSION; EVOLUTION; NUMBER; MODEL; DELETION; RUNX1	BACKGROUND The myelodysplastic syndromes are a group of hematologic disorders that often evolve into secondary acute myeloid leukemia (AML). The genetic changes that underlie progression from the myelodysplastic syndromes to secondary AML are not well understood. METHODS We performed whole-genome sequencing of seven paired samples of skin and bone marrow in seven subjects with secondary AML to identify somatic mutations specific to secondary AML. We then genotyped a bone marrow sample obtained during the antecedent myelodysplastic-syndrome stage from each subject to determine the presence or absence of the specific somatic mutations. We identified recurrent mutations in coding genes and defined the clonal architecture of each pair of samples from the myelodysplastic-syndrome stage and the secondary-AML stage, using the allele burden of hundreds of mutations. RESULTS Approximately 85% of bone marrow cells were clonal in the myelodysplastic-syndrome and secondary-AML samples, regardless of the myeloblast count. The secondary-AML samples contained mutations in 11 recurrently mutated genes, including 4 genes that have not been previously implicated in the myelodysplastic syndromes or AML. In every case, progression to acute leukemia was defined by the persistence of an antecedent founding clone containing 182 to 660 somatic mutations and the outgrowth or emergence of at least one subclone, harboring dozens to hundreds of new mutations. All founding clones and subclones contained at least one mutation in a coding gene. CONCLUSIONS Nearly all the bone marrow cells in patients with myelodysplastic syndromes and secondary AML are clonally derived. Genetic evolution of secondary AML is a dynamic process shaped by multiple cycles of mutation acquisition and clonal selection. Recurrent gene mutations are found in both founding clones and daughter subclones. (Funded by the National Institutes of Health and others.)	[Graubert, Timothy A.] Washington Univ, Sch Med, Div Oncol, Stem Cell Biol Sect,Dept Internal Med, St Louis, MO 63110 USA; [Walter, Matthew J.; Ding, Li; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Frater, John L.; Graubert, Timothy A.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Walter, Matthew J.; Eades, William; Tomasson, Michael; Westervelt, Peter; DiPersio, John F.; Link, Daniel C.; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.; Graubert, Timothy A.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Shen, Dong; Ding, Li; Koboldt, Daniel C.; Chen, Ken; Larson, David E.; McLellan, Michael D.; Dooling, David; Abbott, Rachel; Fulton, Robert; Magrini, Vincent; Schmidt, Heather; Kalicki-Veizer, Joelle; O'Laughlin, Michelle; Fan, Xian; Mardis, Elaine R.; Ley, Timothy J.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Graubert, TA (corresponding author), Washington Univ, Sch Med, Div Oncol, Stem Cell Biol Sect,Dept Internal Med, Campus Box 8007,660 S Euclid Ave, St Louis, MO 63110 USA.	graubert@wustl.edu	Wilson, Richard K./AAF-4139-2019; Magrini, Vincent/AAT-5830-2020; Chen, Ken/AAU-1432-2021; Mardis, Elaine/W-2202-2019; Walter, Matthew J/S-7758-2018	Wilson, Richard K./0000-0002-1992-1358; Magrini, Vincent/0000-0002-2019-4872; Chen, Ken/0000-0003-4013-5279; Mallory, Xian/0000-0003-0365-0909; Graubert, Timothy/0000-0002-7710-1171; Larson, David/0000-0001-7934-5906; MCLELLAN, MICHAEL/0000-0002-2703-8784; Tomasson, Michael/0000-0003-4518-7123	National Institutes of Health [R01HL082973, RC2HL102927, U54HG003079, P01CA101937]; Howard Hughes Medical Institute; National Center for Research Resources [UL1RR024992]; NATIONAL CANCER INSTITUTE [P01CA101937] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082973, RC2HL102927] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the National Institutes of Health (R01HL082973 and RC2HL102927, to Dr. Graubert; U54HG003079, to Dr. Wilson; and P01CA101937, to Dr. Ley); a Howard Hughes Medical Institute Physician-Scientist Early Career Award (to Dr. Walter); and a grant from the National Center for Research Resources (UL1RR024992).	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bacher U, 2007, HAEMATOLOGICA, V92, P744, DOI 10.3324/haematol.10869; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bello C, 2011, CANCER-AM CANCER SOC, V117, P1463, DOI 10.1002/cncr.25598; Califano J, 1996, CANCER RES, V56, P2488; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen CY, 2007, BRIT J HAEMATOL, V139, P405, DOI 10.1111/j.1365-2141.2007.06811.x; Cogle CR, 2011, BLOOD, V117, P7121, DOI 10.1182/blood-2011-02-337964; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Schiavi E, 2005, EUR J NEUROSCI, V21, P3291, DOI 10.1111/j.1460-9568.2005.04164.x; Dicker F, 2010, LEUKEMIA, V24, P1528, DOI 10.1038/leu.2010.124; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Graubert TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004583; Greenberg, 1998, BLOOD, V91, P1100; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinrichs S, 2009, LEUKEMIA, V23, P1605, DOI 10.1038/leu.2009.82; HORIIKE S, 1994, LEUKEMIA, V8, P1331; Jasek M, 2010, LEUKEMIA, V24, P216, DOI 10.1038/leu.2009.189; LAI JL, 1995, LEUKEMIA, V9, P370; Larson RA, 2007, BEST PRACT RES CL HA, V20, P29, DOI 10.1016/j.beha.2006.10.006; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Notta F, 2011, NATURE, V471, DOI 10.1038/nature09877; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Schnittger S, 2011, LEUKEMIA, V25, P615, DOI 10.1038/leu.2010.299; Shih LY, 2004, LEUKEMIA, V18, P466, DOI 10.1038/sj.leu.2403274; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Steensma DP, 2006, LEUKEMIA RES, V30, P1227, DOI 10.1016/j.leukres.2005.12.001; VANKAMP H, 1992, BLOOD, V79, P1266, DOI 10.1182/blood.V79.5.1266.bloodjournal7951266; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106	39	563	582	3	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2012	366	12					1090	1098		10.1056/NEJMoa1106968	http://dx.doi.org/10.1056/NEJMoa1106968			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912BO	22417201	Green Accepted, Green Published			2022-12-01	WOS:000301769700008
J	Yuan, J; Nguyen, CK; Liu, XH; Kanellopoulou, C; Muljo, SA				Yuan, Joan; Nguyen, Cuong K.; Liu, Xiuhuai; Kanellopoulou, Chrysi; Muljo, Stefan A.			Lin28b Reprograms Adult Bone Marrow Hematopoietic Progenitors to Mediate Fetal-Like Lymphopoiesis	SCIENCE			English	Article							CD8(+) T-CELLS; STEM-CELLS; DEVELOPMENTAL SWITCH; MICRORNA BIOGENESIS; B-LYMPHOPOIESIS; NKT CELLS; EXPRESSION; LEVEL; MOUSE; MICE	The immune system develops in waves during ontogeny; it is initially populated by cells generated from fetal hematopoietic stem cells (HSCs) and later by cells derived from adult HSCs. Remarkably, the genetic programs that control these two distinct stem cell fates remain poorly understood. We report that Lin28b is specifically expressed in mouse and human fetal liver and thymus, but not in adult bone marrow or thymus. We demonstrate that ectopic expression of Lin28 reprograms hematopoietic stem/progenitor cells (HSPCs) from adult bone marrow, which endows them with the ability to mediate multilineage reconstitution that resembles fetal lymphopoiesis, including increased development of B-1a, marginal zone B, gamma/delta (gamma delta) T cells, and natural killer T (NKT) cells.	[Yuan, Joan; Nguyen, Cuong K.; Liu, Xiuhuai; Kanellopoulou, Chrysi; Muljo, Stefan A.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Muljo, SA (corresponding author), NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA.	stefan.muljo@nih.gov	Nguyen, Cuong/GYU-8270-2022; Muljo, Stefan A/F-5671-2015; yuan, joan/A-8185-2013; Nguyen, Cuong/D-7567-2013; Nguyen, Cuong Kieu/Q-8306-2019	Muljo, Stefan A/0000-0003-1013-446X; yuan, joan/0000-0001-9129-8356; Nguyen, Cuong/0000-0002-1741-669X; 	NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001131, ZIAAI001185] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. E. Paul for his generous support and advice throughout; T. Bender, J. Daniel, B. J. Fowlkes, R. Germain, M. Lenardo, W. E. Paul, and M. Schlissel for critical reading of this manuscript and constructive suggestions; K. Laky and B. J. Fowlkes for valuable advice and antibodies; NIH Tetramer Core Facility for reagents; M. Holt for NKT cell discussions; P. Burr for sequencing; J. Edwards and C. Eigsti for cell sorting; M. Foster for animal care; R. Zahr for technical support; and N. Bartonicek (EMBL-EBI, Hinxton, UK) for providing the RefSeq 3'UTR library for Sylamer analysis. We gratefully acknowledge the high-performance computational capabilities of the Biowulf Linux cluster at the NIH (http://biowulf.nih.gov) and NIAID Office of Cyber Infrastructure and Computational Biology High-Performance Computing cluster required for massively parallel sequencing analyses. The data reported in this paper are tabulated in the main text and in the Supporting Online Material. The RNA-Seq and NanoString data are available in the Gene Expression Omnibus (GEO) database (www.ncbi.nlm.nih.gov/geo) under the accession nos. GSE34854, GSE35081, and GSE35107. The materials and reagents used in the paper are available under a Materials Transfer Agreement. We apologize that we could not cite all the relevant references because of space limitations. The Integrative Immunobiology Unit is supported by the Intramural Research Program of the NIAID, NIH. The authors declare no competing financial interests.	Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Barber CL, 2011, P NATL ACAD SCI USA, V108, P13700, DOI 10.1073/pnas.1107172108; Belles C, 1996, J IMMUNOL, V156, P4280; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Brown JA, 2008, CLIN IMMUNOL, V127, P286, DOI 10.1016/j.clim.2008.02.008; Carey JB, 2008, J EXP MED, V205, P2043, DOI 10.1084/jem.20080559; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Grigoriadou K, 2003, J IMMUNOL, V171, P2413, DOI 10.4049/jimmunol.171.5.2413; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.iy.11.040193.003225; HARDY RR, 1991, P NATL ACAD SCI USA, V88, P11550, DOI 10.1073/pnas.88.24.11550; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; Ikeda K, 2011, BLOOD, V117, P5860, DOI 10.1182/blood-2011-02-334425; IKUTA K, 1991, J EXP MED, V174, P1279, DOI 10.1084/jem.174.5.1279; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Ito T, 2000, EXP HEMATOL, V28, P1269, DOI 10.1016/S0301-472X(00)00535-X; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Kiel MJ, 2005, DEV BIOL, V283, P29, DOI 10.1016/j.ydbio.2005.03.037; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lacombe J, 2010, BLOOD, V115, P792, DOI 10.1182/blood-2009-01-201384; Lai DZ, 2011, J EXP MED, V208, P1093, DOI 10.1084/jem.20101527; Lee YJ, 2010, J EXP MED, V207, P237, DOI 10.1084/jem.20091519; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Ranganath S, 1998, J IMMUNOL, V161, P3822; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Rebel VI, 1996, EXP HEMATOL, V24, P638; Tajima F, 2001, BLOOD, V97, P2618, DOI 10.1182/blood.V97.9.2618; Verykokakis M, 2010, IMMUNITY, V33, P203, DOI 10.1016/j.immuni.2010.07.013; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108	52	222	228	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2012	335	6073					1195	1200		10.1126/science.1216557	http://dx.doi.org/10.1126/science.1216557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22345399	Green Accepted			2022-12-01	WOS:000301225100037
J	Kanfi, Y; Naiman, S; Amir, G; Peshti, V; Zinman, G; Nahum, L; Bar-Joseph, Z; Cohen, HY				Kanfi, Yariv; Naiman, Shoshana; Amir, Gail; Peshti, Victoria; Zinman, Guy; Nahum, Liat; Bar-Joseph, Ziv; Cohen, Haim Y.			The sirtuin SIRT6 regulates lifespan in male mice	NATURE			English	Article							GENE-EXPRESSION; CALORIC RESTRICTION; METABOLIC SYNDROME; PROTECTS; RECEPTOR; ELEGANS; ABSENCE; TISSUE; MOUSE; IGF1	The significant increase in human lifespan during the past century confronts us with great medical challenges. To meet these challenges, the mechanisms that determine healthy ageing must be understood and controlled. Sirtuins are highly conserved deacetylases that have been shown to regulate lifespan in yeast, nematodes and fruitflies(1). However, the role of sirtuins in regulating worm and fly lifespan has recently become controversial(2). Moreover, the role of the seven mammalian sirtuins, SIRT1 to SIRT7 (homologues of the yeast sirtuin Sir2), in regulating lifespan is unclear(3). Here we show that male, but not female, transgenic mice overexpressing Sirt6 (ref. 4) have a significantly longer lifespan than wild-type mice. Gene expression analysis revealed significant differences between male Sirt6-transgenic mice and male wild-type mice: transgenic males displayed lower serum levels of insulin-like growth factor 1 (IGF1), higher levels of IGF-binding protein 1 and altered phosphorylation levels of major components of IGF1 signalling, a key pathway in the regulation of lifespan(5). This study shows the regulation of mammalian lifespan by a sirtuin family member and has important therapeutic implications for age-related diseases.	[Kanfi, Yariv; Naiman, Shoshana; Peshti, Victoria; Nahum, Liat; Cohen, Haim Y.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Amir, Gail] Hadassah Med Ctr, Dept Pathol, IL-91120 Jerusalem, Israel; [Amir, Gail] Hebrew Univ Jerusalem, IL-91120 Jerusalem, Israel; [Zinman, Guy; Bar-Joseph, Ziv] Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15217 USA	Bar Ilan University; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Carnegie Mellon University	Cohen, HY (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	Haim.Cohen@biu.ac.il	Bar-Joseph, Ziv/GWN-2754-2022; Kornweitz, Haya/L-6469-2018	Kornweitz, Haya/0000-0002-3562-0141; Bar-Joseph, Ziv/0000-0003-3430-6051; Cohen, Haim Y./0000-0002-6613-8710	National Institutes of Health [1RO1 GM085022]; Israeli Academy of Sciences; United States - Israel Binational Science Foundation; Israel Cancer Association; Koret Foundation; Israel Cancer Research Fund; Israel Health Ministry [41/1]; Israel Science Foundation; European Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli Academy of Sciences; United States - Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Association; Koret Foundation; Israel Cancer Research Fund; Israel Health Ministry; Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. S. Levy-Drummer, C. Wachtel, S. Schwarzbaum and members of the Cohen laboratory for their comments on the manuscript. This study was supported by National Institutes of Health grant 1RO1 GM085022 to Z.B.-J. and by grants from the Israeli Academy of Sciences, the United States - Israel Binational Science Foundation, the Israel Cancer Association, the Koret Foundation, the Israel Cancer Research Fund, the Israel Health Ministry, I-CORE program (41/1), the Israel Science Foundation and the European Research Council to H.Y.C.	Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Baur JA, 2010, SCIENCE, V329, P1012, DOI 10.1126/science.329.5995.1012; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Estep PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005242; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI 10.1016/j.febslet.2008.06.005; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lee PDK, 1997, P SOC EXP BIOL MED, V216, P319; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]; Rizki G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002235; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yeap BB, 2010, EUR J ENDOCRINOL, V162, P249, DOI 10.1530/EJE-09-0852; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x	26	696	726	2	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2012	483	7388					218	221		10.1038/nature10815	http://dx.doi.org/10.1038/nature10815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22367546				2022-12-01	WOS:000301174900040
J	Seal, KH; Shi, Y; Cohen, G; Cohen, BE; Maguen, S; Krebs, EE; Neylan, TC				Seal, Karen H.; Shi, Ying; Cohen, Gregory; Cohen, Beth E.; Maguen, Shira; Krebs, Erin E.; Neylan, Thomas C.			Association of Mental Health Disorders With Prescription Opioids and High-Risk Opioid Use in US Veterans of Iraq and Afghanistan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; OPERATIONS ENDURING FREEDOM; VIETNAM COMBAT VETERANS; CHRONIC NONCANCER PAIN; PRIMARY-CARE PATIENTS; MEDICATION USE; WAR; PREVALENCE; SYMPTOMS; PTSD	Context Record numbers of Iraq and Afghanistan veterans survive their war injuries and yet continue to experience pain and mental health problems, particularly post-traumatic stress disorder (PTSD). Little is known about the association of mental health disorders and prescription opioid use. Objective To investigate the effect of mental health disorders, particularly PTSD, on risks and adverse clinical outcomes associated with prescription opioid use. Design Retrospective cohort study involving 141 029 Iraq and Afghanistan veterans who received at least 1 non-cancer-related pain diagnosis within 1 year of entering the Department of Veterans Affairs (VA) health care system from October 1, 2005, through December 31, 2010. Main Outcome Measures Independent association of mental health disorders and the prescription of opioids, higher risk opioid use, and adverse clinical outcomes (eg, accidents and overdose) within 1 year of receiving a pain-related diagnosis. Results A total of 15 676 veterans were prescribed opioids within 1 year of their initial pain diagnosis. Compared with 6.5% of veterans without mental health disorders, 17.8% (adjusted relative risk [RR], 2.58; 95% CI, 2.49-2.67) of veterans with PTSD and 11.7% (adjusted RR, 1.74; 95% CI, 1.67-1.82) with other mental health diagnoses but without PTSD were significantly more likely to receive opioids for pain diagnoses. Of those who were prescribed pain medication, veterans with PTSD were more likely than those without mental health disorders to receive higher-dose opioids (22.7% vs 15.9%, adjusted RR, 1.42; 95% CI, 1.31-1.54), receive 2 or more opioids concurrently (19.8% vs 10.7%, adjusted RR, 1.87; 95% CI, 1.70-2.06), receive sedative hypnotics concurrently (40.7% vs 7.6%, adjusted RR, 5.46; 95% CI, 4.91-6.07), or obtain early opioid refills (33.8% vs 20.4%; adjusted RR, 1.64; 95% CI, 1.531.75). Receiving prescription opioids (vs not) was associated with an increased risk of adverse clinical outcomes for all veterans (9.5% vs 4.1%; RR, 2.33; 95% CI, 2.20-2.46), which was most pronounced in veterans with PTSD. Conclusion Among US veterans of Iraq and Afghanistan, mental health diagnoses, especially PTSD, were associated with an increased risk of receiving opioids for pain, high-risk opioid use, and adverse clinical outcomes. JAMA. 2012;307(9):940-947 www.jama.com	[Seal, Karen H.] Univ Calif San Francisco, San Francisco VA Med Ctr, Dept Med, San Francisco, CA 94121 USA; [Krebs, Erin E.] Indiana Univ Sch Med, Roudebush Vet Affairs Med Ctr, Indianapolis, IN USA; [Krebs, Erin E.] Regenstrief Inst Inc, Indianapolis, IN USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Seal, KH (corresponding author), Univ Calif San Francisco, San Francisco VA Med Ctr, Dept Med, 4150 Clement St,POB 111A-1, San Francisco, CA 94121 USA.	karen.seal@ucsf.edu		Krebs, Erin/0000-0003-0843-7410	Department of Veterans Affairs (VA), Health Services Research and Development (HSRD) at the San Francisco VA Medical Center; VA HSRD [RCD 06-042, CD2 07-215]; National Institutes of Health, National Heart, Lung, and Blood Institute [K23 HL 094765-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL094765] Funding Source: NIH RePORTER	Department of Veterans Affairs (VA), Health Services Research and Development (HSRD) at the San Francisco VA Medical Center(US Department of Veterans Affairs); VA HSRD; National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was financially supported by the Department of Veterans Affairs (VA), Health Services Research and Development (HSRD) Research Enhancement Award Program at the San Francisco VA Medical Center (Dr Seal), by VA HSRD Career Development Awards RCD 06-042 (Dr Maguen), and CD2 07-215 (Dr Krebs), and grant K23 HL 094765-01 from the National Institutes of Health, National Heart, Lung, and Blood Institute (Dr Cohen).	American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Andersen J, 2010, PSYCHOSOM MED, V72, P498, DOI 10.1097/PSY.0b013e3181d969a1; Becker WC, 2007, DRUG ALCOHOL DEPEN, V90, P280, DOI 10.1016/j.drugalcdep.2007.04.009; Beckham JC, 1998, AM J PSYCHIAT, V155, P1565, DOI 10.1176/ajp.155.11.1565; Braden JB, 2010, ARCH INTERN MED, V170, P1425, DOI 10.1001/archinternmed.2010.273; BRAUN P, 1990, J CLIN PSYCHIAT, V51, P236; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Dao J, 2011, NY TIMES        0212; Department of Veterans Affairs; Department of Defense, 2003, VA DOD CLIN PRACT GU; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Friedman MJ, 2000, J CLIN PSYCHIAT, V61, P44; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Harris KM, 2005, HEALTH SERV RES, V40, P117, DOI 10.1111/j.1475-6773.2005.00345.x; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2011, JAMA-J AM MED ASSOC, V306, P549, DOI 10.1001/jama.2011.1096; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kroenke K, 2009, JAMA-J AM MED ASSOC, V301, P2099, DOI 10.1001/jama.2009.723; Levinson L, 2011, HUFFINGTON POST 0221; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mills KL, 2005, PSYCHIAT SERV, V56, P940, DOI 10.1176/appi.ps.56.8.940; Morasco BJ, 2008, GEN HOSP PSYCHIAT, V30, P93, DOI 10.1016/j.genhosppsych.2007.12.004; Morasco BJ, 2010, PAIN, V151, P625, DOI 10.1016/j.pain.2010.08.002; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Phifer J, 2011, PAIN, V152, P2233, DOI 10.1016/j.pain.2011.04.019; Sansone RA, 2004, GEN HOSP PSYCHIAT, V26, P415, DOI 10.1016/j.genhosppsych.2004.07.003; Sayer NA, 2009, PSYCHIATRY, V72, P238, DOI 10.1521/psyc.2009.72.3.238; Schwartz AC, 2006, PSYCHOSOMATICS, V47, P136, DOI 10.1176/appi.psy.47.2.136; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Skurtveit S, 2010, PAIN MED, V11, P805, DOI 10.1111/j.1526-4637.2010.00870.x; Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659; Stecker T, 2010, PSYCHOSOMATICS, V51, P503, DOI 10.1176/appi.psy.51.6.503; Sullivan MD, 2006, ARCH INTERN MED, V166, P2087, DOI 10.1001/archinte.166.19.2087; Sullivan MD, 2010, PAIN, V151, P567, DOI 10.1016/j.pain.2010.08.036; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Warner Margaret, 2009, NCHS Data Brief, P1; Wu Phipson C, 2010, J Opioid Manag, V6, P133	52	359	360	3	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2012	307	9					940	947		10.1001/jama.2012.234	http://dx.doi.org/10.1001/jama.2012.234			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904CU	22396516				2022-12-01	WOS:000301172100022
J	Parducci, L; Jorgensen, T; Tollefsrud, MM; Elverland, E; Alm, T; Fontana, SL; Bennett, KD; Haile, J; Matetovici, I; Suyama, Y; Edwards, ME; Andersen, K; Rasmussen, M; Boessenkool, S; Coissac, E; Brochmann, C; Taberlet, P; Houmark-Nielsen, M; Larsen, NK; Orlando, L; Gilbert, MTP; Kjaer, KH; Alsos, IG; Willerslev, E				Parducci, Laura; Jorgensen, Tina; Tollefsrud, Mari Mette; Elverland, Ellen; Alm, Torbjorn; Fontana, Sonia L.; Bennett, K. D.; Haile, James; Matetovici, Irina; Suyama, Yoshihisa; Edwards, Mary E.; Andersen, Kenneth; Rasmussen, Morten; Boessenkool, Sanne; Coissac, Eric; Brochmann, Christian; Taberlet, Pierre; Houmark-Nielsen, Michael; Larsen, Nicolaj Krog; Orlando, Ludovic; Gilbert, M. Thomas P.; Kjaer, Kurt H.; Alsos, Inger Greve; Willerslev, Eske			Glacial Survival of Boreal Trees in Northern Scandinavia	SCIENCE			English	Article							ANCIENT DNA; PICEA-ABIES; POTENTIAL RANGE; HOLOCENE; MITOCHONDRIAL; NORWAY; POLLEN; SPRUCE; ANDOYA; PLANT	It is commonly believed that trees were absent in Scandinavia during the last glaciation and first recolonized the Scandinavian Peninsula with the retreat of its ice sheet some 9000 years ago. Here, we show the presence of a rare mitochondrial DNA haplotype of spruce that appears unique to Scandinavia and with its highest frequency to the west-an area believed to sustain ice-free refugia during most of the last ice age. We further show the survival of DNA from this haplotype in lake sediments and pollen of Trondelag in central Norway dating back similar to 10,300 years and chloroplast DNA of pine and spruce in lake sediments adjacent to the ice-free Andoya refugium in northwestern Norway as early as similar to 22,000 and 17,700 years ago, respectively. Our findings imply that conifer trees survived in ice-free refugia of Scandinavia during the last glaciation, challenging current views on survival and spread of trees as a response to climate changes.	[Parducci, Laura; Jorgensen, Tina; Haile, James; Andersen, Kenneth; Rasmussen, Morten; Houmark-Nielsen, Michael; Orlando, Ludovic; Gilbert, M. Thomas P.; Kjaer, Kurt H.; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Parducci, Laura; Fontana, Sonia L.; Matetovici, Irina] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Tollefsrud, Mari Mette] Norwegian Forest & Landscape Inst, N-1430 As, Norway; [Elverland, Ellen; Alm, Torbjorn; Alsos, Inger Greve] Tromso Univ Museum, NO-9037 Tromso, Norway; [Fontana, Sonia L.] Univ Gottingen, Dept Palynol & Climate Dynam, D-37073 Gottingen, Germany; [Fontana, Sonia L.] Univ Helsinki, Dept Geol, FI-00014 Helsinki, Finland; [Bennett, K. D.] Uppsala Univ, Dept Earth Sci, S-75236 Uppsala, Sweden; [Bennett, K. D.] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast BT7 1NN, Antrim, North Ireland; [Haile, James] Murdoch Univ, Ancient DNA Res Lab, Perth, WA 6150, Australia; [Matetovici, Irina] Univ Babes Bolyai, Mol Biol Ctr, Interdisciplinary Res Inst Bionanosci, RO-400271 Cluj Napoca, Romania; [Suyama, Yoshihisa] Tohoku Univ, Grad Sch Agr Sci, Osaki, Miyagi 9896711, Japan; [Edwards, Mary E.] Univ Southampton, Southampton SO17 1BJ, Hants, England; [Coissac, Eric] Danish Natl High Throughput DNA Sequencing Facil, DK-1353 Copenhagen, Denmark; [Boessenkool, Sanne; Brochmann, Christian] Univ Oslo, Natl Ctr Biosystemat, Nat Hist Museum, NO-0318 Oslo, Norway; [Coissac, Eric; Taberlet, Pierre] Univ Grenoble, Lab Ecol Alpine, CNRS, UMR 5553, F-38041 Grenoble 9, France; [Larsen, Nicolaj Krog] Aarhus Univ, Dept Geosci, DK-8000 Aarhus C, Denmark	University of Copenhagen; Uppsala University; The Norwegian Forest & Landscape Institute; UiT The Arctic University of Tromso; University of Gottingen; University of Helsinki; Uppsala University; Queens University Belfast; Murdoch University; Babes Bolyai University from Cluj; Tohoku University; University of Southampton; University of Oslo; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Aarhus University	Willerslev, E (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark.	ewillerslev@snm.ku.dk	Houmark-Nielsen, Michael/A-9121-2013; Alsos, Inger G/A-9507-2016; Suyama, Yoshihisa/H-6115-2017; Taberlet, Pierre/D-1178-2010; Gilbert, Marcus TP/A-8936-2013; Kjaer, Kurt/A-4199-2013; Boessenkool, Sanne/K-4274-2017; Coissac, Éric/AAE-8735-2019; Larsen, Nicolaj K./A-3509-2012; Alsos, Inger Greve/O-8154-2019; Willerslev, Eske/A-9619-2011; Bennett, Keith D/C-8619-2009; Willerslev, Eske/AAA-5686-2019; Parducci, Laura/B-8918-2012; Orlando, Ludovic/A-8932-2013; Parducci, Laura/H-9355-2019; Brochmann, Christian/A-4105-2009	Alsos, Inger G/0000-0002-8610-1085; Suyama, Yoshihisa/0000-0002-3136-5489; Taberlet, Pierre/0000-0002-3554-5954; Gilbert, Marcus TP/0000-0002-5805-7195; Kjaer, Kurt/0000-0002-8871-5179; Boessenkool, Sanne/0000-0001-8033-1165; Coissac, Éric/0000-0001-7507-6729; Larsen, Nicolaj K./0000-0002-0117-1106; Alsos, Inger Greve/0000-0002-8610-1085; Willerslev, Eske/0000-0002-7081-6748; Bennett, Keith D/0000-0002-3423-1531; Parducci, Laura/0000-0003-1956-4757; Orlando, Ludovic/0000-0003-3936-1850; Parducci, Laura/0000-0003-1956-4757; Fontana, Sonia/0000-0001-8238-4172	Swedish Research Council [2007-4490]; Carl Trygger's Foundation [08:303]; KAKENHI [22658046]; Royal Society; Danish National Research Foundation; Norwegian Forest and Landscape Institute, University of Tromso; Tromso University Museum; Roald Amundsen Centre for Arctic Research; European Commission [FP6-036866]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger's Foundation; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Royal Society(Royal Society of London); Danish National Research Foundation(Danmarks Grundforskningsfond); Norwegian Forest and Landscape Institute, University of Tromso; Tromso University Museum; Roald Amundsen Centre for Arctic Research; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank T. Giesecke and M. Lascoux for helpful comments; J. Chen, T. Geburek, and C. Sperisen for providing modern samples; and L. Yuan for initial spruce genotyping. We also thank T. Vorren and K.-D. Vorren for providing Andoya core samples with lithostratigraphy and radiocarbon dates. This study was supported by the Swedish Research Council (grant 2007-4490 to L.P.) and the Carl Trygger's Foundation (grant 08:303 to L.P.); KAKENHI (22658046); a Royal Society-Wolfson Merit Award to K.D.B.; the Danish National Research Foundation; the Norwegian Forest and Landscape Institute, University of Tromso; and the Tromso University Museum, the Roald Amundsen Centre for Arctic Research, and the European Commission under the Sixth Framework 378 Programme (EcoChange project, contract no. FP6-036866). L.P., T.J., M.M.T., and E.E. should be considered joint first authors. I.G.A. and E.W. should be considered joint senior authors. The authors declare no competing financial interests. P.T. is coinventor of patents related to the g/h primers and the use of the P6 loop of the chloroplast trnL (UAA) intron for plant identification using degraded template DNA. These patents only restrict commercial applications and have no impact on the use of this locus by academic researchers. The trnL DNA sequences can be found at the European Nucleotide Archive with the study accession no. ERP001153. The mtDNA sequences can be found at the European Molecular Biology Laboratory database with the accession no. HE652882-HE653002.	ALM T, 1993, BOREAS, V22, P171, DOI 10.1111/j.1502-3885.1993.tb00178.x; ALM T, 1991, NORD J BOT, V11, P465, DOI 10.1111/j.1756-1051.1991.tb01249.x; Andersen K., 2011, MOL ECOL, DOI [10.1111/j.1365-.2011.05261.x, DOI 10.1111/J.1365-.2011.05261.X]; Anderson LL, 2006, P NATL ACAD SCI USA, V103, P12447, DOI 10.1073/pnas.0605310103; Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Birks HH, 2005, J BIOGEOGR, V32, P1461, DOI 10.1111/j.1365-2699.2005.01287.x; Giesecke T, 2004, J BIOGEOGR, V31, P1523, DOI 10.1111/j.1365-2699.2004.01095.x; Grivet D, 1999, THEOR APPL GENET, V99, P346, DOI 10.1007/s001220051243; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Heikkila M, 2009, J QUATERNARY SCI, V24, P802, DOI 10.1002/jqs.1254; Hicks S, 2006, VEG HIST ARCHAEOBOT, V15, P253, DOI 10.1007/s00334-006-0063-9; Huntley B, 1983, ATLAS PRESENT POLLEN; Jorgensen T., 2011, MOL ECOL, DOI [10.1111/j.1365-.2011.05287.x, DOI 10.1111/J.1365-.2011.05287.X]; Kullman L, 2006, J BIOGEOGR, V33, P377, DOI 10.1111/j.1365-2699.2005.01451.x; KULLMAN L, 1995, ECOLOGY, V76, P2490, DOI 10.2307/2265823; Kullman L, 2002, J BIOGEOGR, V29, P1117, DOI 10.1046/j.1365-2699.2002.00743.x; Magyari EK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-66; Mangerud J, 2004, DEV QUA SCI, V2, P271; Parducci L, 2005, MOL ECOL, V14, P2873, DOI 10.1111/j.1365-294X.2005.02644.x; Paus A, 2011, QUATERNARY SCI REV, V30, P1780, DOI 10.1016/j.quascirev.2011.04.010; Preuten T, 2010, PLANT J, V64, P948, DOI 10.1111/j.1365-313X.2010.04389.x; Rauwolf U, 2010, MOL GENET GENOMICS, V283, P35, DOI 10.1007/s00438-009-0491-1; Segerstrom U, 2003, HOLOCENE, V13, P897, DOI 10.1191/0959683603hl672rp; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tarasov P., 2009, PAGES (Past Global Changes) News, V17, P122; Tollefsrud MM, 2009, HEREDITY, V102, P549, DOI 10.1038/hdy.2009.16; Tollefsrud MM, 2008, MOL ECOL, V17, P4134, DOI 10.1111/j.1365-294X.2008.03893.x; VORREN KD, 1978, BOREAS, V7, P19, DOI 10.1111/j.1502-3885.1978.tb00047.x; VORREN TO, 1988, BOREAS, V17, P41; Vorren TO, 2002, BOREAS, V31, P97, DOI 10.1080/030094802320129926; Welk E, 2006, J BIOGEOGR, V33, P2013, DOI 10.1111/j.1365-2699.2006.01558.x; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zazula GD, 2006, ARCTIC, V59, P391	38	231	248	4	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1083	1086		10.1126/science.1216043	http://dx.doi.org/10.1126/science.1216043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383845				2022-12-01	WOS:000300931100042
J	Noinaj, N; Easley, NC; Oke, M; Mizuno, N; Gumbart, J; Boura, E; Steere, AN; Zak, O; Aisen, P; Tajkhorshid, E; Evans, RW; Gorringe, AR; Mason, AB; Steven, AC; Buchanan, SK				Noinaj, Nicholas; Easley, Nicole C.; Oke, Muse; Mizuno, Naoko; Gumbart, James; Boura, Evzen; Steere, Ashley N.; Zak, Olga; Aisen, Philip; Tajkhorshid, Emad; Evans, Robert W.; Gorringe, Andrew R.; Mason, Anne B.; Steven, Alasdair C.; Buchanan, Susan K.			Structural basis for iron piracy by pathogenic Neisseria	NATURE			English	Article							BINDING PROTEIN-B; HUMAN SERUM TRANSFERRIN; X-RAY; MOLECULAR-DYNAMICS; C-LOBE; MENINGITIDIS; RECEPTOR; IDENTIFICATION; ANTIBODIES; SCATTERING	Neisseria are obligate human pathogens causing bacterial meningitis, septicaemia and gonorrhoea. Neisseria require iron for survival and can extract it directly from human transferrin for transport across the outer membrane. The transport system consists of TbpA, an integral outer membrane protein, and TbpB, a co-receptor attached to the cell surface; both proteins are potentially important vaccine and therapeutic targets. Two key questions driving Neisseria research are how human transferrin is specifically targeted, and how the bacteria liberate iron from transferrin at neutral pH. To address these questions, we solved crystal structures of the TbpA-transferrin complex and of the corresponding co-receptor TbpB. We characterized the TbpB-transferrin complex by small-angle X-ray scattering and the TbpA-TbpB-transferrin complex by electron microscopy. Our studies provide a rational basis for the specificity of TbpA for human transferrin, show how TbpA promotes iron release from transferrin, and elucidate how TbpB facilitates this process.	[Noinaj, Nicholas; Easley, Nicole C.; Oke, Muse; Boura, Evzen; Buchanan, Susan K.] NIDDK, Mol Biol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Mizuno, Naoko; Steven, Alasdair C.] NIAMSD, Struct Biol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Gumbart, James] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Steere, Ashley N.; Mason, Anne B.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [Zak, Olga; Aisen, Philip] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Tajkhorshid, Emad] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Tajkhorshid, Emad] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Evans, Robert W.] Brunel Univ, Sch Hlth Sci & Social Care, Div Biosci, Metalloprot Res Grp, Uxbridge UB8 3PH, Middx, England; [Gorringe, Andrew R.] Hlth Protect Agcy, Salisbury SP2 8NY, Wilts, England	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); United States Department of Energy (DOE); Argonne National Laboratory; University of Vermont; Yeshiva University; Albert Einstein College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Brunel University; Health Protection Agency	Buchanan, SK (corresponding author), NIDDK, Mol Biol Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA.	skbuchan@helix.nih.gov	Mizuno, Naoko/AAY-1926-2021; Gorringe, Andrew R/L-6022-2017; Boura, Evzen/I-2626-2012; Tajkhorshid, Emad/AAN-8323-2021; Mason, Anne B/A-6754-2008; Boura, Evzen/G-5275-2014	Mizuno, Naoko/0000-0002-1594-2821; Gorringe, Andrew R/0000-0003-2193-7954; Boura, Evzen/0000-0002-9652-4065; Tajkhorshid, Emad/0000-0001-8434-1010; Steere, Allen/0000-0002-5268-9853; Oke, Muse/0000-0002-0169-752X	NIH, National Institute of Diabetes and Digestive and Kidney Diseases; EPSRC Research Committee; NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases; USPHS [R01-DK21739]; AHA [10PRE4200010]; NIH [R01-GM086749, U54-GM087519, P41-RR05969]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021739, ZIADK036143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086749, U54GM087519] Funding Source: NIH RePORTER	NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EPSRC Research Committee(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.N., N.C.E., M.O., E.B. and S.K.B. are supported by the Intramural Research Program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases. M.O. was initially funded by an EPSRC Research Committee Studentship awarded to S.K.B. and R.W.E. N.M. and A.C.S. are supported by the Intramural Research Program of the NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases. A.B.M. was supported in part by USPHS grant R01-DK21739. A.N.S. is funded by an AHA Predoctoral Fellowship (10PRE4200010). E.T. acknowledges NIH support by R01-GM086749, U54-GM087519 and P41-RR05969. All the simulations were performed using TeraGrid resources (MCA06N060). We thank the respective staffs at the Southeast Regional Collaborative Access Team (SER-CAT) and General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT) beamlines at the Advanced Photon Source, Argonne National Laboratory for their assistance during data collection. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38 (SER-CAT), and by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract No. DE-AC02-06CH11357 (GM/CA-CAT). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSON JE, 1994, J BACTERIOL, V176, P3162, DOI 10.1128/jb.176.11.3162-3170.1994; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boulton IC, 1998, BIOCHEM J, V334, P269, DOI 10.1042/bj3340269; Calmettes C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206102; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P873; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Cornelissen CN, 1997, INFECT IMMUN, V65, P822, DOI 10.1128/IAI.65.2.822-828.1997; CORNELISSEN CN, 1993, J BACTERIOL, V175, P2448, DOI 10.1128/JB.175.8.2448-2450.1993; Deasy A, 2011, EXPERT REV VACCINES, V10, P335, DOI [10.1586/erv.11.3, 10.1586/ERV.11.3]; Eckenroth BE, 2011, P NATL ACAD SCI USA, V108, P13089, DOI 10.1073/pnas.1105786108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Gumbart J, 2007, BIOPHYS J, V93, P496, DOI 10.1529/biophysj.107.104158; Gumbart J, 2009, J MOL BIOL, V393, P1129, DOI 10.1016/j.jmb.2009.09.004; Halbrooks PJ, 2003, BIOCHEMISTRY-US, V42, P3701, DOI 10.1021/bi027071q; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hobbs MM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IRWIN SW, 1993, MOL MICROBIOL, V8, P1125, DOI 10.1111/j.1365-2958.1993.tb01657.x; Krell T, 2003, J BIOL CHEM, V278, P14712, DOI 10.1074/jbc.M204461200; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Mason AB, 2004, PROTEIN EXPRES PURIF, V36, P318, DOI 10.1016/j.pep.2004.04.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Noto JM, 2008, INFECT IMMUN, V76, P1960, DOI 10.1128/IAI.00020-08; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Price GA, 2007, VACCINE, V25, P7247, DOI 10.1016/j.vaccine.2007.07.038; Rokbi B, 1997, INFECT IMMUN, V65, P55, DOI 10.1128/IAI.65.1.55-63.1997; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; SCHRYVERS AB, 1989, INFECT IMMUN, V57, P2425, DOI 10.1128/IAI.57.8.2425-2429.1989; SCHRYVERS AB, 1988, MOL MICROBIOL, V2, P281, DOI 10.1111/j.1365-2958.1988.tb00029.x; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Silva LP, 2011, J BIOL CHEM, V286, P21353, DOI 10.1074/jbc.M111.226449; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Steere A. N., 2011, BIOCH BIOPHYS ACTA; Steere AN, 2010, PROTEIN EXPRES PURIF, V72, P32, DOI 10.1016/j.pep.2010.01.008; Stokes RH, 2005, INFECT IMMUN, V73, P944, DOI 10.1128/IAI.73.2.944-952.2005; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; SVERGUN OY, 1991, ZH VYSSH NERV DEYAT+, V41, P700; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wally J, 2006, J BIOL CHEM, V281, P24934, DOI 10.1074/jbc.M604592200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weynants VE, 2007, INFECT IMMUN, V75, P5434, DOI 10.1128/IAI.00411-07; Yost-Daljev MK, 2004, INFECT IMMUN, V72, P1775, DOI 10.1128/IAI.72.3.1775-1785.2004; Zak O, 2002, BIOCHEMISTRY-US, V41, P1647, DOI 10.1021/bi015868w	52	190	193	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2012	483	7387					53	U92		10.1038/nature10823	http://dx.doi.org/10.1038/nature10823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22327295	Green Accepted			2022-12-01	WOS:000300877900042
J	Su, D; Hu, Q; Li, Q; Thompson, JR; Cui, GF; Fazly, A; Davies, BA; Botuyan, MV; Zhang, ZG; Mer, G				Su, Dan; Hu, Qi; Li, Qing; Thompson, James R.; Cui, Gaofeng; Fazly, Ahmed; Davies, Brian A.; Botuyan, Maria Victoria; Zhang, Zhiguo; Mer, Georges			Structural basis for recognition of H3K56-acetylated histone H3-H4 by the chaperone Rtt106	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; MACROMOLECULAR STRUCTURES; LYSINE 56; ACETYLATION; DNA; CHROMATIN; H3; MODEL; SPECTROSCOPY; REFINEMENT	Dynamic variations in the structure of chromatin influence virtually all DNA-related processes in eukaryotes and are controlled in part by post-translational modifications of histones(1-3). One such modification, the acetylation of lysine 56 (H3K56ac) in the amino-terminal alpha-helix (alpha N) of histone H3, has been implicated in the regulation of nucleosome assembly during DNA replication and repair, and nucleosome disassembly during gene transcription(4-10). In Saccharomyces cerevisiae, the histone chaperone Rtt106 contributes to the deposition of newly synthesized H3K56ac-carrying H3-H4 complex on replicating DNA(5), but it is unclear how Rtt106 binds H3-H4 and specifically recognizes H3K56ac as there is no apparent acetylated lysine reader domain in Rtt106. Here, we show that two domains of Rtt106 are involved in a combinatorial recognition of H3-H4. An N-terminal domain homodimerizes and interacts with H3-H4 independently of acetylation while a double pleckstrin-homology (PH) domain binds the K56-containing region of H3. Affinity is markedly enhanced upon acetylation of K56, an effect that is probably due to increased conformational entropy of the aN helix of H3. Our data support a mode of interaction where the N-terminal homodimeric domain of Rtt106 intercalates between the two H3-H4 components of the (H3-H4)(2) tetramer while two double PH domains in the Rtt106 dimer interact with each of the two H3K56ac sites in (H3-H4)(2). We show that the Rtt106-(H3-H4)(2) interaction is important for gene silencing and the DNA damage response.	[Su, Dan; Hu, Qi; Li, Qing; Cui, Gaofeng; Fazly, Ahmed; Davies, Brian A.; Botuyan, Maria Victoria; Zhang, Zhiguo; Mer, Georges] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Zhang, ZG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu; mer.georges@mayo.edu	Cui, Gaofeng/A-1107-2013; hu, qi/K-1462-2014; su, dan/GYJ-1940-2022; Mer, Georges/AAT-4946-2021	Cui, Gaofeng/0000-0001-5267-9033; Mer, Georges/0000-0002-1900-1578; /0000-0003-3279-0425	US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA132878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072719] Funding Source: NIH RePORTER	US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to N. Juranic, S. Macura and T. Burghardt for experimental advice, Y. Kim for assistance with X-ray data collection, Z. Zhang for suggestions on chemical synthesis, and K. Luger and A. Hieb for advice on the preparation of histones. We acknowledge the use of synchrotron beamlines 19BM and 19ID of the Structural Biology Center at Argonne National Laboratory's APS, supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-ENG-38. This work was funded in part by National Institutes of Health grants to Z.Z. and G.M.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Bowman A, 2010, NUCLEIC ACIDS RES, V38, P695, DOI 10.1093/nar/gkp1003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Huang R, 2010, J AM CHEM SOC, V132, P9986, DOI 10.1021/ja103954u; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Liu YW, 2010, J BIOL CHEM, V285, P4251, DOI 10.1074/jbc.M109.055996; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1999, METHOD ENZYMOL, V304, P3; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	38	82	84	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					104	U152		10.1038/nature10861	http://dx.doi.org/10.1038/nature10861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22307274	Green Accepted			2022-12-01	WOS:000300877900054
J	Orchard, RC; Kittisopikul, M; Altschuler, SJ; Wu, LF; Suel, GM; Alto, NM				Orchard, Robert C.; Kittisopikul, Mark; Altschuler, Steven J.; Wu, Lani F.; Sueel, Guerol M.; Alto, Neal M.			Identification of F-actin as the Dynamic Hub in a Microbial-Induced GTPase Polarity Circuit	CELL			English	Article							SPONTANEOUS CELL POLARIZATION; N-WASP; PROTEIN; BINDING; CDC42; ACTIVATION; FAMILY; EZRIN; MECHANISM; NETWORK	Polarity in mammalian cells emerges from the assembly of signaling molecules into extensive biochemical interaction networks. Despite their complexity, bacterial pathogens have evolved parsimonious mechanisms to hijack these systems. Here, we develop a tractable experimental and theoretical model to uncover fundamental operating principles, in both mammalian cell polarity and bacterial pathogenesis. Using synthetic derivatives of the enteropathogenic Escherichia coli guanine-nucleotide exchange factor (GEF) Map, we discover that Cdc42 GTPase signal transduction is controlled by the interaction between Map and F-actin. Mathematical modeling reveals how actin dynamics coupled to a Map-dependent positive feedback loop spontaneously polarizes Cdc42 on the plasma membrane. By rewiring the pathogenic signaling circuit to operate through beta-integrin stimulation, we further show how Cdc42 is polarized in response to an extracellular spatial cue. Thus, a molecular pathway of polarity is proposed, centered on the interaction between GEFs and F-actin, which is likely to function in diverse biological systems.	[Orchard, Robert C.; Alto, Neal M.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Kittisopikul, Mark; Altschuler, Steven J.; Wu, Lani F.; Sueel, Guerol M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Kittisopikul, Mark; Altschuler, Steven J.; Wu, Lani F.; Sueel, Guerol M.] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Alto, NM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	neal.alto@utsouthwestern.edu	Kittisopikul, Mark/V-7680-2019	Kittisopikul, Mark/0000-0002-9558-6248	National Institutes of Health [AI083359, AI007520, GM T32008297, T32 08014, GM081549, GM071794, GM088428]; Welch Foundation [I-1704, I-1644, I-1619, I-1674]; James S. McDonnell Foundation [220020141]; NCI Cancer Center [1P30 CA142543-01]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071794, R01GM081549, R01GM088428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); James S. McDonnell Foundation; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank our colleagues, specifically K. Orth, M. Rosen, and members of the Alto lab, for helpful discussions in preparation of this manuscript. This work was supported National Institutes of Health grants (AI083359 to N.M.A, AI007520 to R.C.O, GM T32008297 to M.K., T32 08014 to M.K, GM081549 to L.F.W., GM071794 to S.J.A., GM088428 to G.M.S); the Welch Foundation (I-1704 to N.M.A, I-1644 to L.F.W., I-1619 to S.J.A., I-1674 to G.M.S); and the James S. McDonnell Foundation (220020141 to G.M.S). We are also grateful for the assistance of the UT Southwestern Live Cell Imaging Facility, a shared resource of the Harold C. Simmons Cancer Center, supported in part by an NCI Cancer Center Support Grant (1P30 CA142543-01).	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Banerjee J, 2009, BIOCHEMISTRY-US, V48, P8032, DOI 10.1021/bi9010013; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Berger CN, 2009, CELL MICROBIOL, V11, P309, DOI 10.1111/j.1462-5822.2008.01254.x; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Hou P, 2003, HUM MOL GENET, V12, P1981, DOI 10.1093/hmg/ddg209; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kenny B, 2002, MOL MICROBIOL, V44, P1095, DOI 10.1046/j.1365-2958.2002.02952.x; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Park KC, 2004, EMBO J, V23, P4177, DOI 10.1038/sj.emboj.7600368; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Saleh HS, 2009, J MOL BIOL, V385, P1015, DOI 10.1016/j.jmb.2008.11.051; Simpson N, 2006, MOL MICROBIOL, V60, P349, DOI 10.1111/j.1365-2958.2006.05109.x; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Upadhyay A, 2008, BIOCHEM J, V411, P485, DOI 10.1042/BJ20071546; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2003, NAT CELL BIOL, V5, P267, DOI 10.1038/ncb0403-267; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033	36	24	24	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					803	815		10.1016/j.cell.2011.11.063	http://dx.doi.org/10.1016/j.cell.2011.11.063			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341450	Bronze, Green Accepted			2022-12-01	WOS:000300622400020
J	Liao, J; Li, H; Zeng, WZ; Sauer, DB; Belmares, R; Jiang, YX				Liao, Jun; Li, Hua; Zeng, Weizhong; Sauer, David B.; Belmares, Ricardo; Jiang, Youxing			Structural Insight into the Ion-Exchange Mechanism of the Sodium/Calcium Exchanger	SCIENCE			English	Article							SODIUM-CALCIUM EXCHANGE; SARCOLEMMAL NA+-CA2+ EXCHANGER; CARDIAC NA+/CA2+ EXCHANGER; NA-CA EXCHANGE; CRYSTAL-STRUCTURE; NEUROTRANSMITTER TRANSPORTERS; FUNCTIONAL EXPRESSION; BACTERIAL HOMOLOG; CELLS; PROTEINS	Sodium/calcium (Na+/Ca2+) exchangers (NCX) are membrane transporters that play an essential role in maintaining the homeostasis of cytosolic Ca2+ for cell signaling. We demonstrated the Na+/Ca2+-exchange function of an NCX from Methanococcus jannaschii (NCX_Mj) and report its 1.9 angstrom crystal structure in an outward-facing conformation. Containing 10 transmembrane helices, the two halves of NCX_Mj share a similar structure with opposite orientation. Four ion-binding sites cluster at the center of the protein: one specific for Ca2+ and three that likely bind Na+. Two passageways allow for Na+ and Ca2+ access to the central ion-binding sites from the extracellular side. Based on the symmetry of NCX_Mj and its ability to catalyze bidirectional ion-exchange reactions, we propose a structure model for the inward-facing NCX_Mj.	[Liao, Jun; Li, Hua; Zeng, Weizhong; Sauer, David B.; Belmares, Ricardo; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Li, Hua; Zeng, Weizhong; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jiang, YX (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	youxing.jiang@utsouthwestern.edu	Li, Hua/ABH-1613-2021	Sauer, David/0000-0001-9291-4640; Liao, Jun/0000-0001-7487-5545; Li, Hua/0000-0003-1903-836X	U.S. DOE [DE-AC02-06CH11357]; Howard Hughes Medical Institute; David and Lucile Packard Foundation; Welch Foundation [I-1578]	U.S. DOE(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Welch Foundation(The Welch Foundation)	We thank D. Rosenbaum for technical support with LCP crystallization, D. Hilgemann for discussion, and N. Nguyen for critical review of the manuscript. Structures shown in this report are derived from work performed at the Advanced Photon Source (19-ID and 23-ID beamlines), Argonne National Laboratory. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U. S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract no. DE-AC02-06CH11357. We thank the beamline staff for assistance in data collection. This work was supported in part by the Howard Hughes Medical Institute and by grants from the David and Lucile Packard Foundation and the Welch Foundation (grant I-1578 to Y.J.). The atomic coordinates and structural factors have been deposited in the Protein Data Bank with the accession numbers 3V5U for the LCP crystal and 3V5S for the low-resolution crystal in detergent. The authors declare no competing financial interests.	Altimimi HF, 2007, CHANNELS, V1, P62, DOI 10.4161/chan.4366; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BLAUSTEIN MP, 1975, J MEMBRANE BIOL, V22, P285, DOI 10.1007/BF01868176; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hilgemann DW, 1996, BIOPHYS J, V71, P759, DOI 10.1016/S0006-3495(96)79275-5; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; KHANANSHVILI D, 1990, BIOCHEMISTRY-US, V29, P2437, DOI 10.1021/bi00462a001; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; MILANICK MA, 1991, ANN NY ACAD SCI, V639, P604, DOI 10.1111/j.1749-6632.1991.tb17358.x; Nicoll DA, 2002, ANN NY ACAD SCI, V976, P11; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Noble D, 2002, SCIENCE, V295, P1678, DOI 10.1126/science.1069881; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Pidcock E, 2001, J BIOL INORG CHEM, V6, P479, DOI 10.1007/s007750100214; REEVES JP, 1984, J BIOL CHEM, V259, P7733; REILANDER H, 1992, EMBO J, V11, P1689, DOI 10.1002/j.1460-2075.1992.tb05219.x; Ren XY, 2010, BIOCHEMISTRY-US, V49, P8585, DOI 10.1021/bi101173c; Saaf A, 2001, J BIOL CHEM, V276, P18905, DOI 10.1074/jbc.M101716200; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; TROSPER TL, 1983, BIOCHIM BIOPHYS ACTA, V731, P63, DOI 10.1016/0005-2736(83)90398-X; Watanabe Y, 2006, J PHARMACOL SCI, V102, P7, DOI 10.1254/jphs.FMJ06002X2; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	37	182	185	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2012	335	6069					686	690		10.1126/science.1215759	http://dx.doi.org/10.1126/science.1215759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323814				2022-12-01	WOS:000300047100044
J	Zhang, J; Coulston, RJ; Jones, ST; Geng, J; Scherman, OA; Abell, C				Zhang, Jing; Coulston, Roger J.; Jones, Samuel T.; Geng, Jin; Scherman, Oren A.; Abell, Chris			One-Step Fabrication of Supramolecular Microcapsules from Microfluidic Droplets	SCIENCE			English	Article							CONTROLLED MORPHOLOGY; POLYMER CAPSULES; ENCAPSULATION; CHEMISTRY; RELEASE; DEVICE; CARGO	Although many techniques exist for preparing microcapsules, it is still challenging to fabricate them in an efficient and scalable process without compromising functionality and encapsulation efficiency. We demonstrated a simple one-step approach that exploits a versatile host-guest system and uses microfluidic droplets to generate porous microcapsules with easily customizable functionality. The capsules comprise a polymer-gold nanoparticle composite held together by cucurbit[8]uril ternary complexes. The dynamic yet highly stable micrometer-sized structures can be loaded in one step during capsule formation and are amenable to on-demand encapsulant release. The internal chemical environment can be probed with surface enhanced Raman spectroscopy.	[Coulston, Roger J.; Jones, Samuel T.; Geng, Jin; Scherman, Oren A.; Abell, Chris] Univ Cambridge, Dept Chem, Melville Lab Polymer Synth, Cambridge CB2 1EW, England	University of Cambridge	Scherman, OA (corresponding author), Univ Cambridge, Dept Chem, Melville Lab Polymer Synth, Lensfield Rd, Cambridge CB2 1EW, England.	oas23@cam.ac.uk; ca26@cam.ac.uk	Geng, Jin/J-7106-2018	Geng, Jin/0000-0003-2181-0718; Jones, Samuel/0000-0002-3907-0810	Engineering and Physical Sciences Research Council [EP/H046593/1]; European Research Council [(ASPiRe) ERC-2009-StG-240629]; European Union [EP/H007024/1]; Engineering and Physical Sciences Research Council [EP/F035535/1] Funding Source: researchfish; EPSRC [EP/F035535/1, EP/H046593/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council Basic Technology Translational grant EP/H046593/1, a European Research Council Starting Investigator Grant (ASPiRe) ERC-2009-StG-240629, and a European Union NanoSci-E+ (CUBiHOLE) grant EP/H007024/1. SERS experiments were performed with the assistance of S. Mahajan. The DH5 alpha Escherichia coli strain was a kind gift from M. Welch and S. Bowden from the Department of Biochemistry, University of Cambridge. The naphthol-containing polymer was a kind gift from E. Appel from the Department of Chemistry, University of Cambridge. The authors thank X. Liu, C. A. Smith, S. Mahajan, J. J. Baumberg, and W. T. S. Huck for the helpful discussions. J.Z., R.J.C., O.A.S., and C. A. have filed a provisional application for a GB patent on the fabrication process.	Abalde-Cela S, 2011, SOFT MATTER, V7, P1321, DOI 10.1039/c0sm00601g; Abraham S, 2008, ADV MATER, V20, P2177, DOI 10.1002/adma.200700456; Anema JR, 2011, ANNU REV ANAL CHEM, V4, P129, DOI 10.1146/annurev.anchem.111808.073632; Arumugam P, 2007, POLYM INT, V56, P461, DOI 10.1002/pi.2210; Augustin MA, 2009, CHEM SOC REV, V38, P902, DOI 10.1039/b801739p; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Comiskey B, 1998, NATURE, V394, P253, DOI 10.1038/28349; Coulston RJ, 2011, CHEM COMMUN, V47, P164, DOI 10.1039/c0cc03250f; Cui JW, 2010, ADV FUNCT MATER, V20, P1625, DOI 10.1002/adfm.201000209; De Cock LJ, 2010, ANGEW CHEM INT EDIT, V49, P6954, DOI 10.1002/anie.200906266; Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E; Dong WF, 2003, PHYS CHEM CHEM PHYS, V5, P3003, DOI 10.1039/b301591b; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Esser-Kahn AP, 2011, MACROMOLECULES, V44, P5539, DOI 10.1021/ma201014n; Hwang H, 2011, LAB CHIP, V11, P87, DOI [10.1039/c0lc00125b, 10.1039/c01c00125b]; Jeon WS, 2002, CHEM COMMUN, P1828, DOI 10.1039/b202082c; Johnston APR, 2010, ANGEW CHEM INT EDIT, V49, P2664, DOI 10.1002/anie.200906840; Ke H. T., 2011, ANGEW CHEM, V123, P3073; Kim J, 2000, J AM CHEM SOC, V122, P540, DOI 10.1021/ja993376p; Leonard A, 2011, CHEM SOC REV, V40, P860, DOI 10.1039/c0cs00024h; Mahajan S, 2010, PHYS CHEM CHEM PHYS, V12, P10429, DOI 10.1039/c0cp00071j; Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104; Patra D, 2010, CHEM-ASIAN J, V5, P2442, DOI 10.1002/asia.201000301; Patra D, 2009, LANGMUIR, V25, P13852, DOI 10.1021/la9015756; Peyratout CS, 2004, ANGEW CHEM INT EDIT, V43, P3762, DOI 10.1002/anie.200300568; Rauwald U, 2008, ANGEW CHEM INT EDIT, V47, P3950, DOI 10.1002/anie.200705591; Theberge AB, 2010, ANGEW CHEM INT EDIT, V49, P5846, DOI 10.1002/anie.200906653; Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163; Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164; van Dongen SFM, 2009, CHEM REV, V109, P6212, DOI 10.1021/cr900072y; Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358; Yow HN, 2006, SOFT MATTER, V2, P940, DOI 10.1039/b606965g; Zhang H, 2006, J AM CHEM SOC, V128, P12205, DOI 10.1021/ja0635682	34	355	406	26	752	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					690	694		10.1126/science.1215416	http://dx.doi.org/10.1126/science.1215416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323815				2022-12-01	WOS:000300047100045
J	Mishra, GD; Kuh, D				Mishra, Gita D.; Kuh, Diana			Health symptoms during midlife in relation to menopausal transition: British prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							LATENT CLASS ANALYSIS; WOMENS HEALTH; VASOMOTOR SYMPTOMS; LIFE	Objective To characterise symptoms experienced by women during the transition into natural menopause, to classify women into distinct symptom profiles or trajectories, and to relate these profiles to sociodemographic factors and health behaviours. Design Nationally representative cohort study. Setting England, Scotland, and Wales. Participants 695 women followed-up since birth in 1946 and annually from age 47 to 54 who experienced natural menopause and reported on 20 common health symptoms. Main outcome measure Longitudinal profiles for reported bothersome symptoms. Results Of 20 individual symptoms, 18 formed into four stable symptom groups: psychological, somatic, vasomotor, and sexual discomfort. Using latent class analyses, all except the somatic group of symptoms showed a clear relation with the timing of menopause for some women. A small proportion of women (10%, n=63) had a severe psychological symptom profile that peaked at or in the year after menopause. For vasomotor symptoms, 14% of women (n=83) had the early severe profile that also peaked around early postmenopause and then declined noticeably; 11% (n=67) had the late severe profile of bothersome symptoms that increased rapidly in perimenopause and remained high for four years or more after menopause. Women were less likely to have a profile for severe vasomotor symptoms if they were from a non-manual social class (odds ratio 0.79, 95% confidence interval 0.57 to 1.01) or had degree level qualifications (0.37, 0.18 to 0.77). The 14% of women (n=85) who had the late severe profile for sexual discomfort showed a similar increase in symptoms until menopause, with symptoms persisting after menopause. Married women were more likely to have the late severe or late moderate profile than women of other marital status (2.40, 1.30 to 4.41). Four profiles each were identified for somatic symptoms (mild, moderate, severe, and very severe), although these did not vary by chronological age or age at menopause. Conclusion Profiles for psychological, vasomotor, and sexual discomfort symptoms relative to age at menopause could help health professionals to tailor their advice for women with natural menopause.	[Mishra, Gita D.; Kuh, Diana] Royal Free & Univ Coll Med Sch, MRC Unit Lifelong Hlth & Ageing, London WC1E 6BT, England; [Mishra, Gita D.] Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia	University of London; University College London; University of Queensland	Mishra, GD (corresponding author), Royal Free & Univ Coll Med Sch, MRC Unit Lifelong Hlth & Ageing, London WC1E 6BT, England.	g.mishra@sph.uq.edu.au	Kuh, Diana/L-6019-2014	Kuh, Diana/0000-0001-7386-2857	Medical Research Council; Australian National Health and Medical Research Council; Medical Research Council [MC_U123092725, MC_U123092720] Funding Source: researchfish; MRC [MC_U123092720, MC_U123092725] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Medical Research Council provided funding for the National Survey of Health and Development and financial support for DK and GDM. GDM also received funding from the Australian National Health and Medical Research Council.	Berecki-Gisolf J, 2009, MENOPAUSE, V16, P1021, DOI 10.1097/gme.0b013e3181a8c49f; Col NF, 2009, MENOPAUSE, V16, P453, DOI 10.1097/gme.0b013e31818d414e; Cray L, 2010, MENOPAUSE, V17, P972, DOI 10.1097/gme.0b013e3181dd1f95; Croudace TJ, 2003, AM J EPIDEMIOL, V157, P834, DOI 10.1093/aje/kwg049; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Freeman EW, 2007, CLIMACTERIC, V10, P197, DOI 10.1080/13697130601181486; Gold EB, 2006, AM J PUBLIC HEALTH, V96, P1226, DOI 10.2105/AJPH.2005.066936; Greene JG, 1998, MATURITAS, V29, P25, DOI 10.1016/S0378-5122(98)00025-5; Hardy R, 2002, SOC SCI MED, V55, P1975, DOI 10.1016/S0277-9536(01)00326-4; HUNTER M, 1986, MATURITAS, V8, P217, DOI 10.1016/0378-5122(86)90029-0; Kuh Diana, 2003, J Br Menopause Soc, V9, P55, DOI 10.1258/136218003100322206; Kuh DL, 1997, BRIT J OBSTET GYNAEC, V104, P923, DOI 10.1111/j.1471-0528.1997.tb14352.x; Mishra G, 2006, MENOPAUSE, V13, P880, DOI 10.1097/01.gme.0000228090.21196.bf; Muthen B.O., 2002, BEHAVIORMETRIKA, V29, P81, DOI [DOI 10.2333/BHMK.29.81, 10.2333/bhmk.29.81]; Muthen LK, 2010, MPLUS STAT SOFTWARE; National Institutes of Health, 2005, NIH STAT OF THE SCI; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; SIMPSON ER, 1983, J STEROID BIOCHEM, V19, P707, DOI 10.1016/0022-4731(83)90239-X; Soules M R, 2001, Menopause, V8, P402, DOI 10.1097/00042192-200111000-00004; Thurston RC, 2009, AM J EPIDEMIOL, V170, P766, DOI 10.1093/aje/kwp203; Wadsworth MEJ, 2003, SOC SCI MED, V57, P2193, DOI 10.1016/S0277-9536(03)00083-2	21	84	86	1	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2012	344								e402	10.1136/bmj.e402	http://dx.doi.org/10.1136/bmj.e402			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	892IE	22318435	Green Published, hybrid			2022-12-01	WOS:000300279100002
J	Shui, IM; Baggs, J; Patel, M; Parashar, UD; Rett, M; Belongia, EA; Hambidge, SJ; Glanz, JM; Klein, NP; Weintraub, E				Shui, Irene M.; Baggs, James; Patel, Manish; Parashar, Umesh D.; Rett, Melisa; Belongia, Edward A.; Hambidge, Simon J.; Glanz, Jason M.; Klein, Nicola P.; Weintraub, Eric			Risk of Intussusception Following Administration of a Pentavalent Rotavirus Vaccine in US Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNIZATION PRACTICES ACIP; UNITED-STATES; ADVISORY-COMMITTEE; ADVERSE EVENTS; SAFETY; GASTROENTERITIS; CHILDREN; RECOMMENDATIONS; SURVEILLANCE; PREVENTION	Context Current rotavirus vaccines were not associated with intussusception in large prelicensure trials. However, recent postlicensure data from international settings suggest the possibility of a low-level elevated risk, primarily in the first week after the first vaccine dose. Objective To examine the risk of intussusception following pentavalent rotavirus vaccine (RV5) in US infants. Design, Setting, and Patients This cohort study included infants 4 to 34 weeks of age, enrolled in the Vaccine Safety Datalink (VSD) who received RV5 from May 2006-February 2010. We calculated standardized incidence ratios (SIRs), relative risks (RRs), and 95% confidence intervals for the association between intussusception and RV5 by comparing the rates of intussusception in infants who had received RV5 with the rates of intussusception in infants who received other recommended vaccines without concomitant RV5 during the concurrent period and with the expected number of intussusception visits based on background rates assessed prior to US licensure of the RV5 (2001-2005). Main Outcome Measure Intussusception occurring in the 1- to 7-day and 1- to 30-day risk windows following RV5 vaccination. Results During the study period, 786 725 total RV5 doses, which included 309 844 first doses, were administered. We did not observe a statistically significant increased risk of intussusception with RV5 for either comparison group following any dose in either the 1- to 7-day or 1- to 30-day risk window. For the 1- to 30-day window following all RV5 doses, we observed 21 cases of intussusception compared with 20.9 expected cases (SIR, 1.01; 95% CI, 0.62-1.54); following dose 1, we observed 7 cases compared with 5.7 expected cases (SIR, 1.23; 95% CI, 0.5-2.54). For the 1- to 7-day window following all RV5 doses, we observed 4 cases compared with 4.3 expected cases (SIR, 0.92; 95% CI, 0.25-2.36); for dose 1, we observed 1 case compared with 0.8 expected case (SIR, 1.21; 95% CI, 0.03-6.75). The upper 95% CI limit of the SIR (6.75) from the historical comparison translates to an upper limit for the attributable risk of 1 intussusception case per 65 287 RV5 dose-1 recipients. Conclusion Among US infants aged 4 to 34 weeks who received RV5, the risk of intussusception was not increased compared with infants who did not receive the rotavirus vaccine. JAMA. 2012;307(6):598-604	[Shui, Irene M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Shui, Irene M.; Rett, Melisa] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Shui, Irene M.; Rett, Melisa] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Baggs, James; Patel, Manish; Parashar, Umesh D.; Weintraub, Eric] Ctr Dis Control & Prevent, Atlanta, GA USA; [Belongia, Edward A.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Hambidge, Simon J.; Glanz, Jason M.] Kaiser Permanente Colorado, Inst Hlth Res, Colorado Springs, CO USA; [Hambidge, Simon J.] Denver Hlth, Community Hlth Serv, Denver, CO USA; [Hambidge, Simon J.; Glanz, Jason M.] Univ Colorado, Sch Publ Hlth, Dept Epidemiol, Denver, CO 80202 USA; [Klein, Nicola P.] No Calif Kaiser Permanente, Vaccine Study Ctr, Oakland, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Centers for Disease Control & Prevention - USA; Kaiser Permanente; Denver Health Medical Center; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; Kaiser Permanente	Shui, IM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	ishui@hsph.harvard.edu		Baggs, James/0000-0003-0757-4683; Belongia, Edward/0000-0001-7478-0415	Centers for Disease Control and Prevention (CDC); AHIP; MedImmune; Kaiser Colorado Institute for Health Research; Merck; GlaxoSmithKline; Pfizer; Sanofi Pasteur; Novartis; Vaccine Safety Datalink [200-2002-00732]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); AHIP; MedImmune(AstraZenecaMedimmune); Kaiser Colorado Institute for Health Research; Merck(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Sanofi Pasteur; Novartis(Novartis); Vaccine Safety Datalink	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Shui reports receiving institutional support from America's Health Insurance Plan (AHIP) for writing or reviewing a manuscript and for travel support. Dr Rett reports receiving institutional support for writing or reviewing a manuscript and travel support from AHIP. Dr Belongia reports receiving institutional grant support from the Centers for Disease Control and Prevention (CDC) and AHIP and pending research support from MedImmune. Dr Hambidge reports receiving institutional grant and travel support from Kaiser Colorado Institute for Health Research-funding for Vaccine Safety Datalink work from the CDC through a cooperative agreement with AHIP and pending institutional support from the CDC for several vaccine safety investigations under the umbrella of the Vaccine Safety Datalink. Dr Glanz reports receiving institutional grant support from the CDC. Dr Klein reports receiving institutional grant support from the CDC and research support for other projects from Merck, GlaxoSmithKline, Pfizer, Sanofi Pasteur, and Novartis. No other financial conflicts were reported.; This study was supported in part by the Vaccine Safety Datalink contract (200-2002-00732) with AHIP, funded by the CDC.	Baggs J, 2011, PEDIATRICS, V127, pS45, DOI 10.1542/peds.2010-1722H; Bartlett D. L., 2010, Morbidity and Mortality Weekly Report, V59, P521; Belongia EA, 2010, PEDIATR INFECT DIS J, V29, P1, DOI 10.1097/INF.0b013e3181af8605; Bines JE, 2004, VACCINE, V22, P569, DOI 10.1016/j.vaccine.2003.09.016; Bines JE, 2009, J INFECT DIS, V200, pS282, DOI 10.1086/605051; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Chang EJ, 2002, PEDIATR INFECT DIS J, V21, P97, DOI 10.1097/00006454-200202000-00003; Cortese M, 2010, ADV COMM IMM PRACT M; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Curns AT, 2010, J INFECT DIS, V201, P1617, DOI 10.1086/652403; Greenberg HB, 2011, NEW ENGL J MED, V364, P2354, DOI 10.1056/NEJMe1105302; Johnson B, 2010, J PEDIATR GASTR NUTR, V51, P458, DOI 10.1097/MPG.0b013e3181d3273f; Justice F, 2005, J PAEDIATR CHILD H, V41, P475, DOI 10.1111/j.1440-1754.2005.00686.x; Kramarz P, 2001, PEDIATR INFECT DIS J, V20, P410, DOI 10.1097/00006454-200104000-00008; Lieu TA, 2007, MED CARE, V45, pS89, DOI 10.1097/MLR.0b013e3180616c0a; Macias M, 45 ICAAC ANN M DEC 1; Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea; Mullooly J, 1999, AM J EPIDEMIOL, V149, P186; Mullooly JP, 2008, METHOD INFORM MED, V47, P328, DOI 10.3414/ME0500; Murphy TV, 2003, J INFECT DIS, V187, P1309, DOI 10.1086/374420; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Parashar Umesh D., 2006, Morbidity and Mortality Weekly Report, V55, P1; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Shui IM, 2009, VACCINE, V27, P5307, DOI 10.1016/j.vaccine.2009.06.092; Simonsen L, 2001, LANCET, V358, P1224, DOI 10.1016/S0140-6736(01)06346-2; Steele AD, 2010, VACCINE, V28, P6542, DOI 10.1016/j.vaccine.2008.08.034; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS56, DOI 10.1097/INF.0b013e3181fefdc0; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664	32	96	103	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2012	307	6					598	604		10.1001/jama.2012.97	http://dx.doi.org/10.1001/jama.2012.97			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	888GT	22318281	Bronze			2022-12-01	WOS:000299992500024
J	McCahill, LE; Single, RM; Bowles, EJA; Feigelson, HS; James, TA; Barney, T; Engel, JM; Onitilo, AA				McCahill, Laurence E.; Single, Richard M.; Bowles, Erin J. Aiello; Feigelson, Heather S.; James, Ted A.; Barney, Tom; Engel, Jessica M.; Onitilo, Adedayo A.			Variability in Reexcision Following Breast Conservation Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARCINOMA IN-SITU; CONSERVING SURGERY; CANCER SURGERY; MARGIN STATUS; RE-EXCISION; POSITIVE MARGINS; SURGICAL MARGINS; THERAPY; QUALITY; WOMEN	Context Health care reform calls for increasing physician accountability and transparency of outcomes. Partial mastectomy is the most commonly performed procedure for invasive breast cancer and often requires reexcision. Variability in reexcision might be reflective of the quality of care. Objective To assess hospital and surgeon-specific variation in reexcision rates following partial mastectomy. Design, Setting, and Patients An observational study of breast surgery performed between 2003 and 2008 intended to evaluate variability in breast cancer surgical care outcomes and evaluate potential quality measures of breast cancer surgery. Women with invasive breast cancer undergoing partial mastectomy from 4 institutions were studied (1 university hospital [University of Vermont] and 3 large health plans [Kaiser Permanente Colorado, Group Health, and Marshfield Clinic]). Data were obtained from electronic medical records and chart abstraction of surgical, pathology, radiology, and outpatient records, including detailed surgical margin status. Logistic regression including surgeon-level random effects was used to identify predictors of reexcision. Main Outcome Measure Incidence of reexcision. Results A total of 2206 women with 2220 invasive breast cancers underwent partial mastectomy and 509 patients (22.9%; 95% CI, 21.2%-24.7%) underwent reexcision (454 patients [89.2%; 95% CI, 86.5%-91.9%] had 1 reexcision, 48 [9.4%; 95% CI, 6.9%-12.0%] had 2 reexcisions, and 7 [1.4%; 95% CI, 0.4%-2.4%] had 3 reexcisions). Among all patients undergoing initial partial mastectomy, total mastectomy was performed in 190 patients (8.5%; 95% CI, 7.2%-9.5%). Reexcision rates for margin status following initial surgery were 85.9% (95% CI, 82.0%-89.8%) for initial positive margins, 47.9% (95% CI, 42.0%-53.9%) for less than 1.0 mm margins, 20.2% (95% CI, 15.3%-25.0%) for 1.0 to 1.9 mm margins, and 6.3% (95% CI, 3.2%-9.3%) for 2.0 to 2.9 mm margins. For patients with negative margins, reexcision rates varied widely among surgeons (range, 0%-70%; P=.003) and institutions (range, 1.7%-20.9%; P<.001). Reexcision rates were not associated with surgeon procedure volume after adjusting for case mix (P=.92). Conclusion Substantial surgeon and institutional variation were observed in reexcision following partial mastectomy in women with invasive breast cancer. JAMA. 2012;307(5):467-475	[McCahill, Laurence E.] Michigan State Univ, Van Andel Res Inst, Richard J Lacks Canc Ctr, Grand Rapids, MI USA; [McCahill, Laurence E.] Michigan State Univ, Dept Surg, Grand Rapids, MI USA; [Single, Richard M.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [James, Ted A.] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Bowles, Erin J. Aiello] Grp Hlth Res Inst, Seattle, WA USA; [Feigelson, Heather S.] Kaiser Permanente Colorado, Denver, CO USA; [Engel, Jessica M.] St Michaels Stevens Point & Marshfield Clin Res F, Marshfield Clin Canc Care, Marshfield, WI USA; [Onitilo, Adedayo A.] Weston Ctr, Marshfield Clin, Hematol Oncol Dept, Weston, ACT, Australia; [Onitilo, Adedayo A.] Marshfield Clin Res Fdn, Marshfield, WI USA	Michigan State University; Van Andel Institute; Michigan State University; University of Vermont; University of Vermont; Kaiser Permanente	McCahill, LE (corresponding author), St Marys Hlth Care, Richard J Lacks Canc Ctr, 250 Cherry St SE, Grand Rapids, MI 49503 USA.	mccahill@trinity-health.org			National Institutes of Health [1RC1CA145402-01]; NATIONAL CANCER INSTITUTE [RC1CA145402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grant 1RC1CA145402-01 from the American Recovery and Reinvestment Act of 2009 by the National Institutes of Health.	Azu M, 2010, ANN SURG ONCOL, V17, P558, DOI 10.1245/s10434-009-0765-1; Birkmeyer JD, 2004, J AM COLL SURGEONS, V198, P626, DOI 10.1016/j.jamcollsurg.2003.11.017; Blair SL, 2009, J AM COLL SURGEONS, V209, P608, DOI 10.1016/j.jamcollsurg.2009.07.026; Bowles EA, 2011, CLIN MED RES, V9, P144, DOI [10.3121/cmr.2011. 1020. ps2-03, DOI 10.3121/CMR.2011.1020.PS2-03]; Cellini C, 2004, ANN SURG ONCOL, V11, P915, DOI 10.1245/ASO.2004.12.037; Chan KC, 2001, CANCER, V91, P9, DOI 10.1002/1097-0142(20010101)91:1<9::AID-CNCR2>3.0.CO;2-E; Dick Andrew W, 2011, J Natl Cancer Inst, V103, P92, DOI 10.1093/jnci/djq499; Dillon MF, 2007, ANN SURG ONCOL, V14, P1618, DOI 10.1245/s10434-006-9246-y; El-Tamer MB, 2007, ANN SURG, V245, P665, DOI 10.1097/01.sla.0000245833.48399.9a; Hornbrook Mark C, 2005, J Natl Cancer Inst Monogr, P12; Houssami N, 2010, EUR J CANCER, V46, P3219, DOI 10.1016/j.ejca.2010.07.043; Katipamula R, 2009, J CLIN ONCOL, V27, P4082, DOI 10.1200/JCO.2008.19.4225; Kotwall C, 2007, AM SURGEON, V73, P337; Kunos C, 2006, BREAST J, V12, P28, DOI 10.1111/j.1075-122X.2006.00181.x; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Lovrics PJ, 2010, CAN J SURG, V53, P305; McCahill LE, 2009, ARCH SURG-CHICAGO, V144, P455, DOI 10.1001/archsurg.2009.56; Menes TS, 2005, ANN SURG ONCOL, V12, P881, DOI 10.1245/ASO.2005.03.021; Morrow M, 2009, JAMA-J AM MED ASSOC, V302, P1551, DOI 10.1001/jama.2009.1450; Olsen MK, 2008, STAT MED, V27, P6055, DOI 10.1002/sim.3446; Papa MZ, 1999, J SURG ONCOL, V70, P167, DOI 10.1002/(SICI)1096-9098(199903)70:3<167::AID-JSO4>3.0.CO;2-7; Persing S, 2011, ANN SURG ONCOL, V18, P3061, DOI 10.1245/s10434-011-1916-8; Singletary SE, 2002, AM J SURG, V184, P383, DOI 10.1016/S0002-9610(02)01012-7; Spiegelhalter DJ, 2007, BAYESIAN APPROACHES; Taghian A, 2005, ANN SURG, V241, P629, DOI 10.1097/01.sla.0000157272.04803.1b; Waljee JF, 2008, ANN SURG ONCOL, V15, P1297, DOI 10.1245/s10434-007-9777-x; Weissman JS, 2011, NEW ENGL J MED, V364, P2276, DOI 10.1056/NEJMp1103069; Young OE, 2007, ANN ROY COLL SURG, V89, P118, DOI 10.1308/003588407X155473	28	360	367	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2012	307	5					467	475		10.1001/jama.2012.43	http://dx.doi.org/10.1001/jama.2012.43			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	884SH	22298678	Bronze			2022-12-01	WOS:000299728000027
J	Ricklefs, RE; Renner, SS				Ricklefs, Robert E.; Renner, Susanne S.			Global Correlations in Tropical Tree Species Richness and Abundance Reject Neutrality	SCIENCE			English	Article							DIVERSITY; SPECIATION; DIVERSIFICATION; COEVOLUTION; EXTINCTION	Patterns of species richness and relative abundance at some scales cannot be distinguished from predictions of null models, including zero-sum neutral models of population change and random speciation-extinction models of evolutionary diversification. Both models predict that species richness or population abundance produced by independent iterations of the same processes in different regions should be uncorrelated. We find instead that the number of species and individuals in families of trees in forest plots are strongly correlated across Southeast Asia, Africa, and tropical America. These correlations imply that deterministic processes influenced by evolutionarily conservative family-level traits constrain the number of confamilial tree species and individuals that can be supported in regional species pools and local assemblages in humid tropical forests.	[Ricklefs, Robert E.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Renner, Susanne S.] Univ Munich, Dept Biol, D-80638 Munich, Germany	University of Missouri System; University of Missouri Saint Louis; University of Munich	Ricklefs, RE (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	ricklefs@umsl.edu			Alexander von Humboldt Foundation; Curators of the University of Missouri	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Curators of the University of Missouri	We are grateful to the principal investigators of the CTFS forest plots used in this analysis for the assembly and sharing of unique data on the structure and dynamics of tropical forests: R. Condit, S. Hubbell, R. Foster (Barro Colorado Island, Panama); S. Bunyavejchewin (Huai Kha Khaeng, Thailand); D. Thomas, D. Kenfack, G. Chuyong (Korup, Cameroon); M. Alvarez (La Planada, Colombia); S. Tan, L. H. Seng, S. Davies, T. Yamakura (Lambir, Malaysia); S. Noor, R. Kassim (Pasoh, Malaysia); and R. Valencia (Yasuni, Ecuador). The manuscript benefitted from the insightful and constructive comments of two reviewers. R. E. R. thanks the Alexander von Humboldt Foundation and the Curators of the University of Missouri for financial support. Original data are available at www.ctfs.si.edu.	Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; CONDIT R, 1995, TRENDS ECOL EVOL, V10, P18, DOI 10.1016/S0169-5347(00)88955-7; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Gaston KJ, 1998, PHILOS T R SOC B, V353, P219, DOI 10.1098/rstb.1998.0204; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Givnish TJ, 2010, TAXON, V59, P1326, DOI 10.1002/tax.595003; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; HEY J, 1992, EVOLUTION, V46, P627, DOI [10.1111/j.1558-5646.1992.tb02071.x, 10.2307/2409633]; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; LEIGH EG, 1981, J THEOR BIOL, V90, P213; Liu XB, 2012, ECOL LETT, V15, P111, DOI 10.1111/j.1461-0248.2011.01715.x; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; RICKLEFS RE, 1994, EVOLUTION, V48, P1619, DOI 10.1111/j.1558-5646.1994.tb02200.x; Ricklefs RE, 2006, ECOLOGY, V87, P1424, DOI 10.1890/0012-9658(2006)87[1424:TUNTOB]2.0.CO;2; Ricklefs RE, 2010, PHILOS T R SOC B, V365, P1139, DOI 10.1098/rstb.2009.0279; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P1265, DOI 10.1073/pnas.0913626107; Ricklefs Robert E., 2009, P257; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Terborgh J, 1996, ECOLOGY, V77, P561, DOI 10.2307/2265630; Wing SL, 2009, P NATL ACAD SCI USA, V106, P18627, DOI 10.1073/pnas.0905130106	31	79	80	1	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 27	2012	335	6067					464	467		10.1126/science.1215182	http://dx.doi.org/10.1126/science.1215182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22282811				2022-12-01	WOS:000299466800049
J	Wahbi, K; Meune, C; Porcher, R; Becane, HM; Lazarus, A; Laforet, P; Stojkovic, T; Behin, A; Radvanyi-Hoffmann, H; Eymard, B; Duboc, D				Wahbi, Karim; Meune, Christophe; Porcher, Raphael; Becane, Henri Marc; Lazarus, Arnaud; Laforet, Pascal; Stojkovic, Tanya; Behin, Anthony; Radvanyi-Hoffmann, Helene; Eymard, Bruno; Duboc, Denis			Electrophysiological Study With Prophylactic Pacing and Survival in Adults With Myotonic Dystrophy and Conduction System Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROPENSITY-SCORE; MONTE-CARLO; MUTATION; DEATH; MULTIVARIATE; IMPUTATION; REPEAT; TYPE-1; MODEL; GENE	Context Up to one-third of patients with myotonic dystrophy type 1 die suddenly. Thus far, no intervention has effectively prevented sudden death. Objective To determine whether an invasive strategy based on systematic electrophysiological studies and prophylactic permanent pacing is associated with longer survival in patients presenting with myotonic dystrophy type 1 and major infranodal conduction delays than a noninvasive strategy. Design, Setting, and Patients A retrospective study, the DM1 Heart Registry included 914 consecutive patients older than 18 years with genetically confirmed myotonic dystrophy type 1 who were admitted to the Neurological Unit of the Myology Institute of Pitie-Salpetriere Hospital, a teaching medical center in Paris, France, between January 2000 and December 2009. Interventions Among 486 patients whose electrocardiogram showed a PR interval greater than 200 milliseconds, a QRS duration greater than 100 milliseconds, or both, the outcome of 341 (70.2%) who underwent an invasive strategy was compared with 145 (29.8%) who underwent a noninvasive strategy. A propensity score risk adjustment and propensity-based matching analysis was used to account for selection biases. Main Outcome Measures Rates of overall survival (main outcome measure) and sudden death, respiratory death, and other deaths (secondary outcome measures). Results Over a median follow-up of 7.4 years (range, 0-9.9 years), 50 patients died in the invasive strategy group and 30 died in the noninvasive strategy group (hazard ratio [HR], 0.74 [95 CI, 0.47-1.16]; P=. 19), corresponding to an overall 9-year survival of 74.4% (95% CI, 69.2%-79.9%). Regardless of the technique used to adjust for between-group differences in baseline characteristics, the invasive strategy was associated with a longer survival, with adjusted HRs ranging from 0.47 (95% CI, 0.26-0.84; P=. 01) for a covariate-adjusted analysis of propensitymatched data to 0.61 (95% CI, 0.38-0.99; P=. 047) for an analysis adjusted for propensity score quintiles. The survival difference was largely attributable to a lower incidence of sudden death, which occurred in 10 patients in the invasive strategy group and in 16 patients in the noninvasive strategy group, with HRs ranging from 0.24 (95% CI, 0.10-0.56; P=. 001) for an analysis adjusted for propensity score quintiles and covariates to 0.28 (95% CI, 0.13-0.61; P=. 001) for an unadjusted analysis of propensity-matched data. Conclusion Among patients with myotonic dystrophy type 1, an invasive strategy was associated with a higher rate of 9-year survival than a noninvasive strategy.	[Wahbi, Karim; Meune, Christophe; Lazarus, Arnaud; Duboc, Denis] Cochin Hosp, AP HP, Dept Cardiol, F-75679 Paris 14, France; [Wahbi, Karim; Laforet, Pascal; Eymard, Bruno] Univ Paris 06, Myol Inst, Pitie Salpetriere Hosp, F-75013 Paris, France; [Wahbi, Karim; Becane, Henri Marc; Laforet, Pascal; Stojkovic, Tanya; Behin, Anthony; Eymard, Bruno; Duboc, Denis] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Paris, France; [Meune, Christophe; Duboc, Denis] Sorbonne Paris Cite Univ, F-75006 Paris, France; [Porcher, Raphael] St Louis Hosp, AP HP, Biostat & Med Informat Technol Dept, Paris, France; [Porcher, Raphael] Univ Paris 07, Paris, France; [Lazarus, Arnaud] InParys Clin Res Grp, St Cloud, France; [Radvanyi-Hoffmann, Helene] Ambroise Pare Hosp, AP HP, Dept Mol Genet, Boulogne, France; [Duboc, Denis] Univ Paris 06, INSERM, UMRS 974, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Wahbi, K (corresponding author), Cochin Hosp, AP HP, Dept Cardiol, 27 Rue Faubourg St Jacques, F-75679 Paris 14, France.	karim.wahbi@cch.aphp.fr	STOJKOVIC, Tanya/AAA-3967-2021	Porcher, Raphael/0000-0002-5277-4679; wahbi, karim/0000-0001-7682-7387; Behin, Anthony/0000-0001-7179-5152	Association Francaise Contre les Myopathies (French Alliance Against Myopathies)	Association Francaise Contre les Myopathies (French Alliance Against Myopathies)	This study was funded by grants from the Association Francaise Contre les Myopathies (French Alliance Against Myopathies).	Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; ASHIZAWA T, 1991, LANCET, V338, P642, DOI 10.1016/0140-6736(91)90659-D; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2007, STAT MED, V26, P754, DOI 10.1002/sim.2618; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Die-Smulders CEM, 1998, BRAIN, V121, P1557, DOI 10.1093/brain/121.8.1557; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; European Heart Rhythm Association, 2006, J Am Coll Cardiol, V48, pe247, DOI 10.1016/j.jacc.2006.07.010; Gagnon C, 2010, NEUROMUSCULAR DISORD, V20, P847, DOI 10.1016/j.nmd.2010.08.006; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Groh WJ, 2008, NEW ENGL J MED, V358, P2688, DOI 10.1056/NEJMoa062800; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lazarus A, 1999, CIRCULATION, V99, P1041, DOI 10.1161/01.CIR.99.8.1041; Lazarus A, 2002, J AM COLL CARDIOL, V40, P1645, DOI 10.1016/S0735-1097(02)02339-2; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mathieu J, 1999, NEUROLOGY, V52, P1658, DOI 10.1212/WNL.52.8.1658; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; R:A language and enviroment for statistical computing, R LANG ENV STAT COMP; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Sekhon JS, 2011, J STAT SOFTW, V42, P1; van Buuren S, 2011, J STAT SOFTW, V45, P1; Walton J, 1994, DISORDERS VOLUNTARY, P1771; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618	31	94	97	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2012	307	12					1292	1301		10.1001/jama.2012.346	http://dx.doi.org/10.1001/jama.2012.346			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914UP	22453570	Bronze			2022-12-01	WOS:000301978400025
J	Su, YQ; Sugiura, K; Sun, FY; Pendola, JK; Cox, GA; Handel, MA; Schimenti, JC; Eppig, JJ				Su, You-Qiang; Sugiura, Koji; Sun, Fengyun; Pendola, Janice K.; Cox, Gregory A.; Handel, Mary Ann; Schimenti, John C.; Eppig, John J.			MARF1 Regulates Essential Oogenic Processes in Mice	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS; DNA-DAMAGE; OOCYTES	Development of fertilization-competent oocytes depends on integrated processes controlling meiosis, cytoplasmic development, and maintenance of genomic integrity. We show that meiosis arrest female 1 (MARF1) is required for these processes in mammalian oocytes. Mutations of Marf1 cause female infertility characterized by up-regulation of a cohort of transcripts, increased retrotransposon expression, defective cytoplasmic maturation, and meiotic arrest. Up-regulation of protein phosphatase 2 catalytic subunit (PPP2CB) is key to the meiotic arrest phenotype. Moreover, Iap and Line1 retrotransposon messenger RNAs are also up-regulated, and, concomitantly, DNA double-strand breaks are elevated in mutant oocytes. Therefore MARF1, by suppressing levels of specific transcripts, is an essential regulator of important oogenic processes leading to female fertility and the development of healthy offspring.	[Su, You-Qiang; Sugiura, Koji; Sun, Fengyun; Pendola, Janice K.; Cox, Gregory A.; Handel, Mary Ann; Eppig, John J.] Jackson Lab, Bar Harbor, ME 04609 USA; [Schimenti, John C.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA	Jackson Laboratory; Cornell University	Eppig, JJ (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	John.Eppig@jax.org	Su, You-Qiang/C-6160-2019; Sugiura, Koji/AAE-2966-2019	Su, You-Qiang/0000-0003-3537-6246; Sugiura, Koji/0000-0001-8945-3353	NIH [HD42137]; National Cancer Institute [CA34196]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD042137] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Conti for providing the Cdc25b plasmid and Gpr3<SUP>-/-</SUP> mice and K. Wigglesworth and M. O'Brien for technical assistance. Supported by NIH grant HD42137 (Y.-Q.S., K.S., F.S., J.K.P., M.A.H., J.C.S., and J.J.E.) and Scientific Services by grant CA34196 from the National Cancer Institute. Microarray data are deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo, data set GSE 31985).	Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-13; Callebaut I, 2010, BIOINFORMATICS, V26, P1140, DOI 10.1093/bioinformatics/btq122; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Swain JE, 2008, HUM REPROD UPDATE, V14, P431, DOI 10.1093/humupd/dmn025; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tatone C, 2011, HUM REPROD, V26, P1843, DOI 10.1093/humrep/der140; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Yan Y, 2010, ONCOGENE, V29, P4317, DOI 10.1038/onc.2010.187; Zamudio N, 2010, HEREDITY, V105, P92, DOI 10.1038/hdy.2010.53	14	73	78	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2012	335	6075					1496	1499		10.1126/science.1214680	http://dx.doi.org/10.1126/science.1214680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22442484	Green Accepted			2022-12-01	WOS:000301837000049
J	Kavousi, M; Elias-Smale, S; Rutten, JHW; Leening, MJG; Vliegenthart, R; Verwoert, GC; Krestin, GP; Oudkerk, M; de Maat, MPM; Leebeek, FWG; Mattace-Raso, FUS; Lindemans, J; Hofman, A; Steyerberg, EW; van der Lugt, A; van den Meiracker, AH; Witteman, JCM				Kavousi, Maryam; Elias-Smale, Suzette; Rutten, Joost H. W.; Leening, Maarten J. G.; Vliegenthart, Rozemarijn; Verwoert, Germaine C.; Krestin, Gabriel P.; Oudkerk, Matthijs; de Maat, Moniek P. M.; Leebeek, Frank W. G.; Mattace-Raso, Francesco U. S.; Lindemans, Jan; Hofman, Albert; Steyerberg, Ewout W.; van der Lugt, Aad; van den Meiracker, Anton H.; Witteman, Jacqueline C. M.			Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; CARDIOVASCULAR EVENTS; ATHEROSCLEROSIS RISK; MULTIPLE BIOMARKERS; ARTERIAL STIFFNESS; CALCIUM SCORE; PREDICTION; RECLASSIFICATION; STROKE	Background: Whether newer risk markers for coronary heart disease (CHD) improve CHD risk prediction remains unclear. Objective: To assess whether newer risk markers for CHD risk prediction and stratification improve Framingham risk score (FRS) predictions. Design: Prospective population-based study. Setting: The Rotterdam Study, Rotterdam, the Netherlands. Participants: 5933 asymptomatic, community-dwelling participants (mean age, 69.1 years [SD, 8.5]). Measurements: Traditional CHD risk factors used in the FRS (age, sex, systolic blood pressure, treatment of hypertension, total and high-density lipoprotein cholesterol levels, smoking, and diabetes) and newer CHD risk factors (N-terminal fragment of prohormone B-type natriuretic peptide levels, von Willebrand factor antigen levels, fibrinogen levels, chronic kidney disease, leukocyte count, C-reactive protein levels, homocysteine levels, uric acid levels, coronary artery calcium [CAC] scores, carotid intima-media thickness, peripheral arterial disease, and pulse wave velocity). Results: Adding CAC scores to the FRS improved the accuracy of risk predictions (c-statistic increase, 0.05 [95% CI, 0.02 to 0.06]; net reclassification index, 19.3% overall [39.3% in those at intermediate risk, by FRS]). Levels of N-terminal fragment of prohormone B-type natriuretic peptide also improved risk predictions but to a lesser extent (c-statistic increase, 0.02 [CI, 0.01 to 0.04]; net reclassification index, 7.6% overall [33.0% in those at intermediate risk, by FRS]). Improvements in predictions with other newer markers were marginal. Limitation: The findings may not be generalizable to younger or nonwhite populations. Conclusion: Among 12 CHD risk markers, improvements in FRS predictions were most statistically and clinically significant with the addition of CAC scores. Further investigation is needed to assess whether risk refinements using CAC scores lead to a meaningful change in clinical outcome. Whether to use CAC score screening as a more routine test for risk prediction requires full consideration of the financial and clinical costs of performing versus not performing the test for both persons and health systems.	[Witteman, Jacqueline C. M.] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen	Witteman, JCM (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	j.witteman@erasmusmc.nl	Elias-Smale, Suzette/F-2410-2014; Raso, Francesco Mattace-/L-2541-2015; Rutten, Joost/L-4618-2015; Kavousi, Maryam/F-1174-2018; Steyerberg, Ewout/C-1509-2018	Rutten, Joost/0000-0002-5259-9794; Kavousi, Maryam/0000-0001-5976-6519; Oudkerk, Matthijs/0000-0003-2800-4110; Steyerberg, Ewout/0000-0002-7787-0122; Mattace-Raso, Francesco/0000-0002-1688-6497; Leening, Maarten J. G./0000-0002-4143-4839	Erasmus University Medical Center; Erasmus University, Rotterdam, the Netherlands; Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Netherlands Heart Foundation [2003B179, 2007B159]; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMw) [918.76.619]; Netherlands Consortium for Healthy Ageing; Vereniging Trustfonds Erasmus Universiteit Rotterdam	Erasmus University Medical Center; Erasmus University, Rotterdam, the Netherlands(Netherlands Government); Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Consortium for Healthy Ageing; Vereniging Trustfonds Erasmus Universiteit Rotterdam	The Rotterdam Study is funded by Erasmus University Medical Center and Erasmus University, Rotterdam, the Netherlands; the Research Institute for Diseases in the Elderly; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. This study was supported by grants from the Netherlands Heart Foundation (2003B179 [Dr. Witteman], 2007B159 [Dr. Leebeek]), the Netherlands Organization for Scientific Research (NWO), the Netherlands Organization for Health Research and Development (ZonMw) (Vici grant 918.76.619), and the Netherlands Consortium for Healthy Ageing. The authors received additional funding from Vereniging Trustfonds Erasmus Universiteit Rotterdam.	Elias-Smale SE, 2010, J AM COLL CARDIOL, V56, P1407, DOI 10.1016/j.jacc.2010.06.029; Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; Pearte CA, 2006, CIRCULATION, V113, P2177, DOI 10.1161/CIRCULATIONAHA.105.610352; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Rana JS, 2009, HEART, V95, P1682, DOI 10.1136/hrt.2009.170134; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Rutten JHW, 2010, HYPERTENSION, V55, P785, DOI 10.1161/HYPERTENSIONAHA.109.143313; Steyerberg EW, 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, 10.1007/978-0-387-77244-8]; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodward M, 2007, J THROMB HAEMOST, V5, P1795, DOI 10.1111/j.1538-7836.2007.02677.x; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	33	279	281	2	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2012	156	6					438	U88		10.7326/0003-4819-156-6-201203200-00006	http://dx.doi.org/10.7326/0003-4819-156-6-201203200-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PF	22431676				2022-12-01	WOS:000303150900016
J	Tinetti, ME				Tinetti, Mary E.			The Retreat From Advanced Care Planning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							END; MEDICARE		Yale Univ, Sch Med, Dept Internal Med, Sch Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sch Epidemiol & Publ Hlth, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	mary.tinetti@yale.edu						Conway PH, 2011, JAMA-J AM MED ASSOC, V306, P2256, DOI 10.1001/jama.2011.1611; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Nicholas LH, 2011, JAMA-J AM MED ASSOC, V306, P1447, DOI 10.1001/jama.2011.1410; Pear Robert, 2010, N Y TIMES; RUTENBERG J, 2009, NY TIMES        0501, pA1; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	8	28	28	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2012	307	9					915	916		10.1001/jama.2012.229	http://dx.doi.org/10.1001/jama.2012.229			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904CU	22396510				2022-12-01	WOS:000301172100016
J	van Ginneken, E; Groenewegen, PP; McKee, M				van Ginneken, Ewout; Groenewegen, Peter P.; McKee, Martin			Personal healthcare budgets: what can England learn from the Netherlands?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[McKee, Martin] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Groenewegen, Peter P.] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands	University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Netherlands Institute for Health Services Research	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	martin.mckee@lshtm.ac.uk	Groenewegen, Peter/I-1574-2013; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Groenewegen, Peter/0000-0003-2127-8442				Boer L, 2010, ACHTERGRONDEN MOTIEV; Chevreul K., 2010, HLTH SYST TRANSIT, V12, P1, DOI DOI 10.1038/KI.2015.25; Dixon J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6608; Health Foundation, 2010, PERS HLTH BUDG RES S; Irvine A., 2011, PERSONAL HLTH BUDGET; Johnstone R, 2011, PUBLIC FINANCE  1005; Lansley A, 2011, COMMUNICATION   1004; McKee M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e399; Ministry of Health, 2011, DLZKZU3067294 MIN HL; Ministry of Health, 2011, DLZU3070332 MIN HLTH; NHS Confederation, 2011, PERS HLTH BUDG COUNT; Ramakers C, 2010, WEG NAAR SOLIDE PGB; Ramakers C., 2007, EVALUATIE PERSOONGEB; Sadiraj K., 2011, OPMARS PGB ONTWIKKEL; Social Care Institute for Excellence, 2009, SCIE RES BRIEF 20 IM; The Health Foundation, 2011, PERS TOUCH DUTCH EXP	16	22	22	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 6	2012	344								e1383	10.1136/bmj.e1383	http://dx.doi.org/10.1136/bmj.e1383			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	908GM	22396156	Green Submitted			2022-12-01	WOS:000301478900014
J	Shah, N				Shah, Nisha			A PATIENT'S JOURNEY Mood disorder in the perinatal period	BRITISH MEDICAL JOURNAL			English	Editorial Material									Camden & Islington NHS Fdn Trust, Highgate Mental Hlth Ctr, London N19 5NX, England		Shah, N (corresponding author), Camden & Islington NHS Fdn Trust, Highgate Mental Hlth Ctr, London N19 5NX, England.	Nisha.Shah@candi.nhs.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2012	344								e1209	10.1136/bmj.e1209	http://dx.doi.org/10.1136/bmj.e1209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904XJ	22381523	Bronze			2022-12-01	WOS:000301231900008
J	Secord, R; Bloch, JI; Chester, SGB; Boyer, DM; Wood, AR; Wing, SL; Kraus, MJ; McInerney, FA; Krigbaum, J				Secord, Ross; Bloch, Jonathan I.; Chester, Stephen G. B.; Boyer, Doug M.; Wood, Aaron R.; Wing, Scott L.; Kraus, Mary J.; McInerney, Francesca A.; Krigbaum, John			Evolution of the Earliest Horses Driven by Climate Change in the Paleocene-Eocene Thermal Maximum	SCIENCE			English	Article							ISOTOPE FRACTIONATION; STABLE-ISOTOPES; BERGMANNS RULE; BIGHORN BASIN; BODY-SIZE; CARBON; MAMMALS; ENVIRONMENT; BOUNDARY; FUTURE	Body size plays a critical role in mammalian ecology and physiology. Previous research has shown that many mammals became smaller during the Paleocene-Eocene Thermal Maximum (PETM), but the timing and magnitude of that change relative to climate change have been unclear. A high-resolution record of continental climate and equid body size change shows a directional size decrease of similar to 30% over the first similar to 130,000 years of the PETM, followed by a similar to 76% increase in the recovery phase of the PETM. These size changes are negatively correlated with temperature inferred from oxygen isotopes in mammal teeth and were probably driven by shifts in temperature and possibly high atmospheric CO2 concentrations. These findings could be important for understanding mammalian evolutionary responses to future global warming.	[Secord, Ross] Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE 68588 USA; [Secord, Ross; Bloch, Jonathan I.; Wood, Aaron R.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Chester, Stephen G. B.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Boyer, Doug M.] CUNY Brooklyn Coll, Dept Anthropol & Archaeol, Brooklyn, NY 11210 USA; [Wood, Aaron R.] S Dakota Sch Mines & Technol, Dept Geol & Geol Engn, Rapid City, SD 57701 USA; [Wing, Scott L.] Smithsonian Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Kraus, Mary J.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [McInerney, Francesca A.] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA; [Krigbaum, John] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA	University of Nebraska System; University of Nebraska Lincoln; State University System of Florida; University of Florida; Yale University; City University of New York (CUNY) System; Brooklyn College (CUNY); South Dakota School Mines & Technology; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Colorado System; University of Colorado Boulder; Northwestern University; State University System of Florida; University of Florida	Secord, R (corresponding author), Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE 68588 USA.	rsecord2@unl.edu	McInerney, Francesca A/ABE-3639-2020; Kraus, Mary J/C-3323-2008; McInerney, Francesca/B-7894-2009	McInerney, Francesca A/0000-0002-2020-6650; Kraus, Mary J/0000-0002-1721-2566; McInerney, Francesca/0000-0002-2020-6650; Bloch, Jonathan/0000-0003-1484-6931; Wing, Scott/0000-0002-2954-8905; Boyer, Douglas/0000-0002-8697-2999	NSF [EAR-0640076, EAR-0719941, EAR-0717892, EAR-0718740, EAR-0720268]	NSF(National Science Foundation (NSF))	We thank T. Bown, P. Gingerich, B. MacFadden, K. Rose, E. Sargis, and S. Strait for helpful discussions and advice; J. Curtis, B. Tucker, and A. Baczynski for help with isotope lab work; J. Bourque and A. Hastings for specimen preparation; and P. Koch and two anonymous reviewers for helpful comments. Supported by NSF grants EAR-0640076 (J.I.B., J.K., R.S.), EAR-0719941 (J.I.B.), EAR-0717892 (S.L.W.), EAR-0718740 (M.J.K.), and EAR-0720268 (F.A.M.). Data used in this paper are available in the SOM.	Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Bowen GJ, 2004, NATURE, V432, P495, DOI 10.1038/nature03115; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Chester SGB, 2010, J MAMM EVOL, V17, P227, DOI 10.1007/s10914-010-9141-y; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; Clyde WC, 1998, GEOLOGY, V26, P1011, DOI 10.1130/0091-7613(1998)026<1011:MCRTTL>2.3.CO;2; Cui Y, 2011, NAT GEOSCI, V4, P481, DOI [10.1038/NGEO1179, 10.1038/ngeo1179]; DANSGAARD W, 1964, TELLUS, V16, P436; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gingerich P.D., 1989, U MICH PAP PALEONT, V28, P1; Gingerich PD, 2001, GENETICA, V112, P127, DOI 10.1023/A:1013311015886; Gingerich PD, 2006, TRENDS ECOL EVOL, V21, P246, DOI 10.1016/j.tree.2006.03.006; IPCC, 2022, CLIMATE CHANGE 2022; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; Kraus MJ, 2007, PALAEOGEOGR PALAEOCL, V245, P444, DOI 10.1016/j.palaeo.2006.09.011; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Mayr E, 1963, ANIMAL SPECIES EVOLU; McInerney FA, 2011, ANNU REV EARTH PL SC, V39, P489, DOI 10.1146/annurev-earth-040610-133431; McNab BK, 2010, OECOLOGIA, V164, P13, DOI 10.1007/s00442-010-1621-5; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Owensby Clenton E., 1996, P363, DOI 10.1016/B978-012420870-4/50056-6; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Rodriguez MA, 2008, GLOBAL ECOL BIOGEOGR, V17, P274, DOI 10.1111/j.1466-8238.2007.00363.x; Secord R, 2008, PALEOBIOLOGY, V34, P282, DOI 10.1666/0094-8373(2008)034[0282:SIIEEM]2.0.CO;2; Secord R, 2010, NATURE, V467, P955, DOI 10.1038/nature09441; Smith FA, 2009, GLOBAL PLANET CHANGE, V65, P122, DOI 10.1016/j.gloplacha.2008.10.015; Smith FA, 2007, EARTH PLANET SC LETT, V262, P50, DOI 10.1016/j.epsl.2007.07.021; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913	30	107	112	0	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					959	962		10.1126/science.1213859	http://dx.doi.org/10.1126/science.1213859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363006	Green Published			2022-12-01	WOS:000300931800044
J	Hu, J; Hwang, SS; Liesa, M; Gan, BY; Sahin, E; Jaskelioff, M; Ding, ZH; Ying, HQ; Boutin, AT; Zhang, HL; Johnson, S; Ivanova, E; Kost-Alimova, M; Protopopov, A; Wang, YA; Shirihai, OS; Chin, L; DePinho, RA				Hu, Jian; Hwang, Soyoon Sarah; Liesa, Marc; Gan, Boyi; Sahin, Ergun; Jaskelioff, Mariela; Ding, Zhihu; Ying, Haoqiang; Boutin, Adam T.; Zhang, Hailei; Johnson, Shawn; Ivanova, Elena; Kost-Alimova, Maria; Protopopov, Alexei; Wang, Yaoqi Alan; Shirihai, Orian S.; Chin, Lynda; DePinho, Ronald A.			Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer	CELL			English	Article							TELOMERE DYSFUNCTION; DNA-DAMAGE; DEPENDENT APOPTOSIS; STEM-CELLS; DEFICIENCY; SUPPRESSION; GLUTAMINE; P53; MAINTENANCE; DISRUPTION	To assess telomerase as a cancer therapeutic target and determine adaptive mechanisms to telomerase inhibition, we modeled telomerase reactivation and subsequent extinction in T cell lymphomas arising in Atm(-/)-mice engineered with an inducible telomerase reverse transcriptase allele. Telomerase reactivation in the setting of telomere dysfunction enabled full malignant progression with alleviation of telomere dysfunction-induced checkpoints. These cancers possessed copy number alterations targeting key loci in human T cell lymphomagenesis. Upon telomerase extinction, tumor growth eventually slowed with reinstatement of telomere dysfunction-induced checkpoints, yet growth subsequently resumed as tumors acquired alternative lengthening of telomeres (ALT) and aberrant transcriptional networks centering on mitochondrial biology and oxidative defense. ALT+ tumors acquired amplification/overexpression of PGC-1 beta, a master regulator of mitochondrial biogenesis and function, and they showed marked sensitivity to PGC-1 beta or SOD2 knockdown. Genetic modeling of telomerase extinction reveals vulnerabilities that motivate coincidental inhibition of mitochondrial maintenance and oxidative defense mechanisms to enhance antitelomerase cancer therapy.	[Hu, Jian; Hwang, Soyoon Sarah; Ying, Haoqiang; Boutin, Adam T.; Kost-Alimova, Maria; Protopopov, Alexei; Wang, Yaoqi Alan; DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Gan, Boyi] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Hu, Jian; Hwang, Soyoon Sarah; Gan, Boyi; Sahin, Ergun; Jaskelioff, Mariela; Ding, Zhihu; Ying, Haoqiang; Boutin, Adam T.; Zhang, Hailei; Ivanova, Elena; Kost-Alimova, Maria; Protopopov, Alexei; Wang, Yaoqi Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Hu, Jian; Hwang, Soyoon Sarah; Gan, Boyi; Sahin, Ergun; Jaskelioff, Mariela; Ding, Zhihu; Ying, Haoqiang; Boutin, Adam T.; Zhang, Hailei; Johnson, Shawn; Ivanova, Elena; Kost-Alimova, Maria; Protopopov, Alexei; Wang, Yaoqi Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hu, Jian; Gan, Boyi; Sahin, Ergun; Jaskelioff, Mariela; Ding, Zhihu; Ying, Haoqiang; Boutin, Adam T.; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Liesa, Marc; Shirihai, Orian S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University	DePinho, RA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	rdepinho@mdanderson.org	Liesa, Marc/K-8590-2019; Gan, Boyi/HDM-4206-2022; Ying, Haoqiang/AAK-4325-2020	Liesa, Marc/0000-0002-5909-8570; Shirihai, Orian/0000-0002-9502-2661; Ivanova, Elena/0000-0002-5069-4974; DePinho, Ronald/0000-0002-5625-577X	leukemia and lymphoma society; Helen Hay Whitney fellowship; Fundacion Ramon Areces; NIH [R01-DK074778, R01-DK56690, R01CA84628, U01CA141508]; NATIONAL CANCER INSTITUTE [R01CA084628, U01CA141508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074778, R01DK035914, R01DK056690] Funding Source: NIH RePORTER	leukemia and lymphoma society(Leukemia and Lymphoma Society); Helen Hay Whitney fellowship; Fundacion Ramon Areces; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Jiang, R. Narurkar, and E. Fletcher-Sananikone for excellent mouse husbandry and care, and all members of DePinho and Chin labs for helpful discussion. We also thank Yingchui Liu for the Cox model analysis. J.H. and B.G. were supported by the leukemia and lymphoma society fellowship. A.T.B. is supported by the Helen Hay Whitney fellowship. M. L. is supported by the Fundacion Ramon Areces fellowship. O.S.S. is supported by R01 (R01-DK074778 and R01-DK56690) grants from NIH. L.C. and R.A.D. are supported by R01 (R01CA84628) and U01 (U01CA141508) grants from NIH. R.A.D. is an Ellison Foundation for Medical Research Senior Scholar and an American Cancer Society Research Professor.	Agrawal A, 2012, RECENT PAT ANTI-CANC, V7, P102, DOI 10.2174/157489212798357958; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Begus-Nahrmann Y, 2009, NAT GENET, V41, P1138, DOI 10.1038/ng.426; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Cesare AJ, 2009, NAT STRUCT MOL BIOL, V16, P1244, DOI 10.1038/nsmb.1725; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [DOI 10.1038/NATURE02118, 10.1038/nature02118]; Fan Q, 2009, NUCLEIC ACIDS RES, V37, P1740, DOI 10.1093/nar/gkn995; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Hall DB, 1996, NATURE, V382, P731, DOI 10.1038/382731a0; Harley CB, 1997, CANCER SURV, V29, P263; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lafferty-Whyte K, 2009, ONCOGENE, V28, P3765, DOI 10.1038/onc.2009.238; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Oexle K, 1997, HUM MOL GENET, V6, P905, DOI 10.1093/hmg/6.6.905; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Qi L, 2003, CANCER RES, V63, P8188; RETEL J, 1993, MUTAT RES, V299, P165, DOI 10.1016/0165-1218(93)90094-T; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Saharia A, 2009, ONCOGENE, V28, P1162, DOI 10.1038/onc.2008.458; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zeng SC, 2009, NAT CELL BIOL, V11, P616, DOI 10.1038/ncb1867; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200	50	199	205	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					651	663		10.1016/j.cell.2011.12.028	http://dx.doi.org/10.1016/j.cell.2011.12.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341440	Green Accepted, Bronze			2022-12-01	WOS:000300622400008
J	Ramani, AK; Chuluunbaatar, T; Verster, AJ; Na, H; Vu, V; Pelte, N; Wannissorn, N; Jiao, A; Fraser, AG				Ramani, Arun K.; Chuluunbaatar, Tungalag; Verster, Adrian J.; Na, Hong; Vu, Victoria; Pelte, Nadege; Wannissorn, Nattha; Jiao, Alan; Fraser, Andrew G.			The Majority of Animal Genes Are Required for Wild-Type Fitness	CELL			English	Article							FUNCTIONAL GENOMIC ANALYSIS; RNA INTERFERENCE; ELEGANS GENOME; YEAST; PHENOTYPE; DISPENSABILITY; EVOLUTION; GENOTYPE; ORTHOLOG	Almost all eukaryotic genes are conserved, suggesting that they have essential functions. However, only a minority of genes have detectable loss-of-function phenotypes in experimental assays, and multiple theories have been proposed to explain this discrepancy. Here, we use RNA-mediated interference in C. elegans to examine how knockdown of any gene affects the overall fitness of worm populations. Whereas previous studies typically assess phenotypes that are detectable by eye after a single generation, we monitored growth quantitatively over several generations. In contrast to previous estimates, we find that, in these multigeneration population assays, the majority of genes affect fitness, and this suggests that genetic networks are not robust to mutation. Our results demonstrate that, in a single environmental condition, most animal genes play essential roles. This is a higher proportion than for yeast genes, and we suggest that the source of negative selection is different in animals and in unicellular eukaryotes.	[Ramani, Arun K.; Chuluunbaatar, Tungalag; Verster, Adrian J.; Na, Hong; Vu, Victoria; Pelte, Nadege; Wannissorn, Nattha; Jiao, Alan; Fraser, Andrew G.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Ramani, Arun K.; Chuluunbaatar, Tungalag; Verster, Adrian J.; Na, Hong; Vu, Victoria; Pelte, Nadege; Wannissorn, Nattha; Jiao, Alan; Fraser, Andrew G.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Fraser, AG (corresponding author), Univ Toronto, Donnelly Ctr, 160 Coll St, Toronto, ON M5S 3E1, Canada.	andyfraser.utoronto@gmail.com		Fraser, Andrew/0000-0001-9939-6014	CIHR [488367]; NSERC [487143]; IOF [488530]; CFI [486071]; NSERC	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); IOF; CFI(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors would like to thank Corey Nislow, Charlie Boone, Michael Costanzo, John Calarco, Arneet Saltzman, and Don Moerman for helpful comments on the manuscript. The authors thank Brent Derry for the generous donation of a worm sorter, Union Biometrica for technical support, and CGC for providing us with worm strains. This research was supported, in part, by grants from CIHR (488367), NSERC (487143), IOF (488530), and CFI (486071) to A.G.F. and a NSERC grant (CGS-D) to A.J.V.	Ahringer J., 2006, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.47.1; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cutter AD, 2003, GENOME RES, V13, P2651, DOI 10.1101/gr.1659203; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Elvin M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-510; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hodgkin J, 1997, GENETICS, V146, P149; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; JOHNSEN RC, 1991, GENETICS, V129, P735; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kemphues Kenneth, 2005, WormBook, P1; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Krebs J.C., 2011, LEWINS GENES; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Poulin G, 2005, EMBO J, V24, P2613, DOI 10.1038/sj.emboj.7600726; Ramani AK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r101; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Schmitz C, 2007, P NATL ACAD SCI USA, V104, P834, DOI 10.1073/pnas.0510527104; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Stiernagle Theresa, 2006, WormBook, P1; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tischler J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r69; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wang Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000329; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	56	33	33	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					792	802		10.1016/j.cell.2012.01.019	http://dx.doi.org/10.1016/j.cell.2012.01.019			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341449	Bronze			2022-12-01	WOS:000300622400019
J	Whyte, WA; Bilodeau, S; Orlando, DA; Hoke, HA; Frampton, GM; Foster, CT; Cowley, SM; Young, RA				Whyte, Warren A.; Bilodeau, Steve; Orlando, David A.; Hoke, Heather A.; Frampton, Garrett M.; Foster, Charles T.; Cowley, Shaun M.; Young, Richard A.			Enhancer decommissioning by LSD1 during embryonic stem cell differentiation	NATURE			English	Article							HISTONE DEMETHYLASE; INTERACTION NETWORK; GENE; TRANSCRIPTION; CHROMATIN; EXPRESSION; COMPLEXES; PROGRAMS; OCT-3/4; SOX2	Transcription factors and chromatin modifiers are important in the programming and reprogramming of cellular states during development(1,2). Transcription factors bind to enhancer elements and recruit coactivators and chromatin-modifying enzymes to facilitate transcription initiation(3,4). During differentiation a subset of these enhancers must be silenced, but the mechanisms underlying enhancer silencing are poorly understood. Here we show that the histone demethylase lysine-specific demethylase 1 (LSD1; ref. 5), which demethylates histone H3 on Lys 4 or Lys 9 (H3K4/K9), is essential in decommissioning enhancers during the differentiation of mouse embryonic stem cells (ESCs). LSD1 occupies enhancers of active genes that are critical for control of the state of ESCs. However, LSD1 is not essential for the maintenance of ESC identity. Instead, ESCs lacking LSD1 activity fail to differentiate fully, and ESC-specific enhancers fail to undergo the histone demethylation events associated with differentiation. At active enhancers, LSD1 is a component of the NuRD (nucleosome remodelling and histone deacetylase) complex, which contains additional subunits that are necessary for ESC differentiation. We propose that the LSD1-NuRD complex decommissions enhancers of the pluripotency program during differentiation, which is essential for the complete shutdown of the ESC gene expression program and the transition to new cell states.	[Whyte, Warren A.; Bilodeau, Steve; Orlando, David A.; Hoke, Heather A.; Frampton, Garrett M.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Whyte, Warren A.; Hoke, Heather A.; Frampton, Garrett M.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Foster, Charles T.] Univ Munich, Adolf Butenandt Inst, Dept Mol Biol, D-80336 Munich, Germany; [Foster, Charles T.; Cowley, Shaun M.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Munich; University of Leicester	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Bilodeau, Steve/0000-0002-9799-3832; Cowley, Shaun/0000-0002-2510-1305; Frampton, Garrett/0000-0002-2361-2750	Canadian Institutes of Health Research; Medical Research Council; National Institutes of Health [HG002668, NS055923]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923] Funding Source: NIH RePORTER; MRC [MR/J009202/1, G0600135] Funding Source: UKRI; Medical Research Council [G0600135, MR/J009202/1] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Loven, M. H. Kagey, J. Dowen, A. C. Mullen, A. Sigova, P. B. Rahl, T. Lee and members of Y. Shi's laboratory for experimental assistance, reagents and helpful discussions; and J.-A. Kwon, V. Dhanapal, J. Love, S. Gupta, T. Volkert, W. Salmon and N. Watson for assistance with ChIP-Seq, expression arrays and immunofluorescence imaging acquisition. This work was supported by a Canadian Institutes of Health Research Fellowship (S. B.), a Career Development Award from the Medical Research Council (S. M. C.), and by National Institutes of Health grants HG002668 and NS055923 (R.Y.).	Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Choi J, 2010, BIOCHEM BIOPH RES CO, V401, P327, DOI 10.1016/j.bbrc.2010.09.014; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Musri MM, 2010, J BIOL CHEM, V285, P30034, DOI 10.1074/jbc.M110.151209; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Scimone ML, 2010, DEVELOPMENT, V137, P1231, DOI 10.1242/dev.042051; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Yeom YI, 1996, DEVELOPMENT, V122, P881; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	30	411	431	4	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 9	2012	482	7384					221	225		10.1038/nature10805	http://dx.doi.org/10.1038/nature10805			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888HI	22297846	Green Accepted			2022-12-01	WOS:000299994100039
J	Nunes, VD; Sawyer, L; Neilson, J; Sarri, G; Cross, JH				Nunes, Vanessa Delgado; Sawyer, Laura; Neilson, Julie; Sarri, Grammati; Cross, J. Helen			Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nunes, Vanessa Delgado; Sawyer, Laura; Neilson, Julie; Sarri, Grammati] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Cross, J. Helen] Great Ormond St Hosp Sick Children, UCL Inst Child Hlth, London, England; [Cross, J. Helen] Young Epilepsy, Lingfield RH7 6PW, England	Royal College of Physicians; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Nunes, VD (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	vanessa.nunes@rcplondon.ac.uk	Cross, J. Helen/ACK-3032-2022	Cross, J. Helen/0000-0001-7345-4829				[Anonymous], NAT HLTH SERV DRUG T; Chowdhury FA, 2008, EUR J NEUROL, V15, P1034, DOI 10.1111/j.1468-1331.2008.02260.x; Clinical Standards Advisory Group (CSAG), 2000, SERV PAT EP; Medicines and Healthcare Products Regulatory Agency, 2011, ANT; National Institute for Health and Clinical Excellence: Guidance, 2012, EP DIAGN MAN EP AD C	5	71	79	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2012	344								e281	10.1136/bmj.e281	http://dx.doi.org/10.1136/bmj.e281			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	885LE	22282528	Green Submitted			2022-12-01	WOS:000299779700003
J	Cho, H; Zhao, X; Hatori, M; Yu, RT; Barish, GD; Lam, MT; Chong, LW; DiTacchio, L; Atkins, AR; Glass, CK; Liddle, C; Auwerx, J; Downes, M; Panda, S; Evans, RM				Cho, Han; Zhao, Xuan; Hatori, Megumi; Yu, Ruth T.; Barish, Grant D.; Lam, Michael T.; Chong, Ling-Wa; DiTacchio, Luciano; Atkins, Annette R.; Glass, Christopher K.; Liddle, Christopher; Auwerx, Johan; Downes, Michael; Panda, Satchidananda; Evans, Ronald M.			Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta	NATURE			English	Article							CLOCK; RECEPTOR; TRANSCRIPTION; RHYTHMS; GENES; ROLES; OSCILLATOR; MOUSE; LIVER; MICE	The circadian clock acts at the genomic level to coordinate internal behavioural and physiological rhythms via the CLOCK-BMAL1 transcriptional heterodimer. Although the nuclear receptors REV-ERB-alpha and REV-ERB-beta have been proposed to form an accessory feedback loop that contributes to clock function(1,2), their precise roles and importance remain unresolved. To establish their regulatory potential, we determined the genome-wide cis-acting targets (cistromes) of both REV-ERB isoforms in murine liver, which revealed shared recognition at over 50% of their total DNA binding sites and extensive overlap with the master circadian regulator BMAL1. Although REV-ERB-alpha has been shown to regulate Bmal1 expression directly(1,2), our cistromic analysis reveals a more profound connection between BMAL1 and the REV-ERB-alpha and REV-ERB-beta genomic regulatory circuits than was previously suspected. Genes within the intersection of the BMAL1, REV-ERB-alpha and REV-ERB-beta cistromes are highly enriched for both clock and metabolic functions. As predicted by the cistromic analysis, dual depletion of Rev-erb-alpha and Rev-erb-beta function by creating double-knockout mice profoundly disrupted circadian expression of core circadian clock and lipid homeostatic gene networks. As a result, double-knockout mice show markedly altered circadian wheel-running behaviour and deregulated lipid metabolism. These data now unite REV-ERB-alpha and REV-ERB-beta with PER, CRY and other components of the principal feedback loop that drives circadian expression and indicate a more integral mechanism for the coordination of circadian rhythm and metabolism.	[Cho, Han; Zhao, Xuan; Yu, Ruth T.; Barish, Grant D.; Chong, Ling-Wa; Atkins, Annette R.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Hatori, Megumi; DiTacchio, Luciano; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Lam, Michael T.; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Liddle, Christopher] Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Auwerx, Johan] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu	DiTacchio, Luciano/D-6341-2011; Hatori, Megumi/GTY-3770-2022; Auwerx, Johan/ABE-9307-2021; Panda, Satchidananda/J-6891-2012; Evans, Ronald/AAF-4001-2019; Glass, Christopher/AAI-3933-2021	DiTacchio, Luciano/0000-0001-9570-7348; Evans, Ronald/0000-0002-9986-5965; Glass, Christopher/0000-0003-4344-3592; Hatori, Megumi/0000-0001-7888-158X; Yu, Ruth/0000-0002-9527-9627; Chong, Ling Wa/0000-0002-8571-5413; Auwerx, Johan/0000-0002-5065-5393	National Research Service Award [T32-HL007770]; National Institutes of Health [DK062434, DK057978, DK090962, DK091618, HL105278]; National Health and Medical Research Council of Australia [NHMRC 512354, 632886]; Helmsley Charitable Trust; Glenn Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007770, R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, R01DK091618, R24DK090962, R37DK057978] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Helmsley Charitable Trust; Glenn Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Kaufman, J. Alvarez, E. Banayo, H. Juguilon, S. Jacinto and H. Le for technical assistance; and L. Ong and S. Ganley for administrative assistance. We also thank L. Pei for discussion. R. M. E is an Investigator of the Howard Hughes Medical Institute at The Salk Institute for Biological Studies and March of Dimes Chair in Molecular and Developmental Biology. H. C. is a recipient of National Research Service Award (T32-HL007770). This work was supported by National Institutes of Health Grants (DK062434, DK057978, DK090962, DK091618 and HL105278), National Health and Medical Research Council of Australia Project Grants (NHMRC 512354 and 632886), the Helmsley Charitable Trust, the Glenn Foundation and the Howard Hughes Medical Institute.	Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chomez P, 2000, DEVELOPMENT, V127, P1489; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	29	658	687	10	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					123	127		10.1038/nature11048	http://dx.doi.org/10.1038/nature11048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22460952	Green Accepted			2022-12-01	WOS:000303451900047
J	Dudakov, JA; Hanash, AM; Jenq, RR; Young, LF; Ghosh, A; Singer, NV; West, ML; Smith, OM; Holland, AM; Tsai, JJ; Boyd, RL; van den Brink, MRM				Dudakov, Jarrod A.; Hanash, Alan M.; Jenq, Robert R.; Young, Lauren F.; Ghosh, Arnab; Singer, Natalie V.; West, Mallory L.; Smith, Odette M.; Holland, Amanda M.; Tsai, Jennifer J.; Boyd, Richard L.; van den Brink, Marcel R. M.			Interleukin-22 Drives Endogenous Thymic Regeneration in Mice	SCIENCE			English	Article							INNATE LYMPHOID-CELLS; ROR-GAMMA-T; EPITHELIAL-CELLS; INDUCER CELLS; IL-22; SIGNALS; DIFFERENTIATION; RECONSTITUTION; INFLAMMATION; HOMEOSTASIS	Endogenous thymic regeneration is a crucial function that allows for renewal of immune competence after stress, infection, or immunodepletion. However, the mechanisms governing this regeneration remain poorly understood. We detail such a mechanism, centered on interleukin-22 (IL-22) and triggered by the depletion of CD4(+)CD8(+) double-positive thymocytes. Intrathymic levels of IL-22 were increased after thymic insult, and thymic recovery was impaired in IL-22-deficient mice. IL-22, which signaled through thymic epithelial cells and promoted their proliferation and survival, was up-regulated by radio-resistant ROR gamma(t)(+)CCR6(+)NKp46(-) lymphoid tissue inducer cells after thymic injury in an IL-23-dependent manner. Administration of IL-22 enhanced thymic recovery after total body irradiation. These studies reveal mechanisms of endogenous thymic repair and offer innovative regenerative strategies for improving immune competence.	[Dudakov, Jarrod A.; Young, Lauren F.; Ghosh, Arnab; Singer, Natalie V.; West, Mallory L.; Smith, Odette M.; Holland, Amanda M.; Tsai, Jennifer J.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Dudakov, Jarrod A.; Boyd, Richard L.] Monash Univ, Monash Immunol & Stem Cell Labs, Melbourne, Vic 3800, Australia; [Hanash, Alan M.; Jenq, Robert R.; van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Jenq, Robert R.; van den Brink, Marcel R. M.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Holland, Amanda M.; Tsai, Jennifer J.; van den Brink, Marcel R. M.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Monash University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Dudakov, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	dudakovj@mskcc.org; vandenbm@mskcc.org		Ghosh, Arnab/0000-0003-3355-5427; Dudakov, Jarrod/0000-0001-6220-5632	NIH [HL069929, CA107096, AI080455, HL095075]; U.S. Department of Defense USAMRAA [W81XWH-09-1-0294]; Radiation Effects Research Foundation of the National Institute of Allergy and Infectious Diseases; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Lymphoma Foundation; Alex's Lemonade Stand; Peter Solomon Fund; Australian National Health and Medical Research Council [1012401]; Leukemia and Lymphoma Society [5534-11]; American Society of Hematology; American Society for Blood and Marrow Transplant; American Association of Cancer Research; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA107096, T32CA009207] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095075, K08HL115355, R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080455] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense USAMRAA(United States Department of Defense); Radiation Effects Research Foundation of the National Institute of Allergy and Infectious Diseases; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Lymphoma Foundation; Alex's Lemonade Stand; Peter Solomon Fund; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Society of Hematology; American Society for Blood and Marrow Transplant; American Association of Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Farr for the gift of the TE-71 TEC cell line; D. Littman, W. Ouyang, A. Beaulieu, J. Sun, and S. Prockop for the gift of mice; R. Essner and D. Schwartz for technical assistance; E. Velardi and Y. Shono for helpful discussion; and L. Reilly, B. Morcerf, and B. Rojas for administrative assistance. M.R.M.v.d.B. also thanks his former mentor J. J. van Rood. Supported by NIH R01 awards HL069929, CA107096, AI080455, and HL095075, U.S. Department of Defense USAMRAA award W81XWH-09-1-0294, the Radiation Effects Research Foundation of the National Institute of Allergy and Infectious Diseases, the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center (funded by W. H. Goodwin and A. Goodwin), the Lymphoma Foundation, Alex's Lemonade Stand, and the Peter Solomon Fund. J. A. D. was supported by fellowships from the Australian National Health and Medical Research Council (CJ Martin Biomedical Research Fellowship, 1012401) and the Leukemia and Lymphoma Society (5534-11). A. M. Ha. was supported by a Research Training Award for Fellows from the American Society of Hematology and a New Investigator Award from the American Society for Blood and Marrow Transplant. A. G. was supported by supported by a Judah Folkman Fellowship from the American Association of Cancer Research. A provisional patent application has been filed on the use of IL-22 as a thymopoietic growth factor (U.S. 61/487,517) with J. A. D, A. M. Ha., and M.R.M.v.d.B. listed as inventors.	Alpdogan O, 2006, BLOOD, V107, P2453, DOI 10.1182/blood-2005-07-2831; Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Kanai M, 2003, ONCOGENE, V22, P548, DOI 10.1038/sj.onc.1206109; Kim MY, 2005, J IMMUNOL, V174, P6686, DOI 10.4049/jimmunol.174.11.6686; Mak TW, 2001, NAT REV IMMUNOL, V1, P11, DOI 10.1038/35095551; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Purton JF, 2004, J IMMUNOL, V173, P3816, DOI 10.4049/jimmunol.173.6.3816; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; STOREK J, 1995, BONE MARROW TRANSPL, V16, P413; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; van den Brink MRM, 2004, NAT REV IMMUNOL, V4, P856, DOI 10.1038/nri1484; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	29	254	271	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					91	95		10.1126/science.1218004	http://dx.doi.org/10.1126/science.1218004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22383805	Green Accepted			2022-12-01	WOS:000302405400058
J	Benedito, R; Rocha, SF; Woeste, M; Zamykal, M; Radtke, F; Casanovas, O; Duarte, A; Pytowski, B; Adams, RH				Benedito, Rui; Rocha, Susana F.; Woeste, Marina; Zamykal, Martin; Radtke, Freddy; Casanovas, Oriol; Duarte, Antonio; Pytowski, Bronislaw; Adams, Ralf H.			Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling	NATURE			English	Article							TIP CELL-FORMATION; DLL4; ACTIVATION; GROWTH; BEVACIZUMAB; PATHWAYS; INHIBIT; LIGAND; MOUSE; D114	Developing tissues and growing tumours produce vascular endothelial growth factors (VEGFs), leading to the activation of the corresponding receptors in endothelial cells. The resultant angiogenic expansion of the local vasculature can promote physiological and pathological growth processes(1). Previous work has uncovered that the VEGF and Notch pathways are tightly linked. Signalling triggered by VEGF-A (also known as VEGF) has been shown to induce expression of the Notch ligand DLL4 in angiogenic vessels and, most prominently, in the tip of endothelial sprouts(2,3). DLL4 activates Notch in adjacent cells, which suppresses the expression of VEGF receptors and thereby restrains endothelial sprouting and proliferation(2,4-6). Here we show, by using inducible loss-of-function genetics in combination with inhibitors in vivo, that DLL4 protein expression in retinal tip cells is only weakly modulated by VEGFR2 signalling. Surprisingly, Notch inhibition also had no significant impact on VEGFR2 expression and induced deregulated endothelial sprouting and proliferation even in the absence of VEGFR2, which is the most important VEGF-A receptor and is considered to be indispensable for these processes. By contrast, VEGFR3, the main receptor for VEGF-C, was strongly modulated by Notch. VEGFR3 kinase-activity inhibitors but not ligand-blocking antibodies suppressed the sprouting of endothelial cells that had low Notch signalling activity. Our results establish that VEGFR2 and VEGFR3 are regulated in a highly differential manner by Notch. We propose that successful anti-angiogenic targeting of these receptors and their ligands will strongly depend on the status of endothelial Notch signalling.	[Benedito, Rui; Rocha, Susana F.; Woeste, Marina; Zamykal, Martin; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Benedito, Rui; Rocha, Susana F.; Woeste, Marina; Zamykal, Martin; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Radtke, Freddy] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland; [Casanovas, Oriol] IDIBELL, Catalan Inst Oncol, Translat Res Lab, Lhospitalet De Llobregat 08907, Spain; [Duarte, Antonio] Univ Tecn Lisboa, Fac Vet Med, Interdisciplinary Ctr Res Anim Hlth CIISA, P-1300474 Lisbon, Portugal; [Pytowski, Bronislaw] ImClone Syst, New York, NY 10014 USA	Max Planck Society; University of Munster; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universidade de Lisboa; Eli Lilly	Adams, RH (corresponding author), Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany.	rui.benedito@mpi-muenster.mpg.de; ralf.adams@mpi-muenster.mpg.de	Radtke, Freddy/Q-3198-2017; Benedito, Rui/AAQ-8096-2020; Duarte, Antonio/V-1178-2018; Adams, Ralf H/AAE-9274-2019; Benedito, Rui/G-8295-2012; Casanovas, Oriol/L-5210-2014	Radtke, Freddy/0000-0003-4315-4045; Benedito, Rui/0000-0003-2458-3055; Duarte, Antonio/0000-0002-9255-3635; Benedito, Rui/0000-0003-2458-3055; Casanovas, Oriol/0000-0002-4298-3995	Max Planck Society; University of Munster; German Research Foundation [SFB 629, SPP 1190]	Max Planck Society(Max Planck Society); University of Munster; German Research Foundation(German Research Foundation (DFG))	We thank M. Schiller, M. Ehling, M. Pitulescu and M. Nakayama for the help with experiments and discussions, and G. Breier and T. Honjo for floxed Vegfr2 and Rbpj mutant mice, respectively. Funding was provided by the Max Planck Society, the University of Munster and the German Research Foundation (programmes SFB 629 and SPP 1190).	Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Estrach S, 2011, CIRC RES, V109, P172, DOI 10.1161/CIRCRESAHA.111.240622; Galvagni F, 2010, CIRC RES, V106, P1839, DOI 10.1161/CIRCRESAHA.109.206326; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990; Jubb AM, 2010, LANCET ONCOL, V11, P1172, DOI 10.1016/S1470-2045(10)70232-1; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.0014-2956.2001.02476.x; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Lux A, 2007, BRIT J OPHTHALMOL, V91, P1318, DOI 10.1136/bjo.2006.113902; Manley PW, 2002, J MED CHEM, V45, P5687, DOI 10.1021/jm020899q; Manley PW, 2004, BBA-PROTEINS PROTEOM, V1697, P17, DOI 10.1016/j.bbapap.2003.11.010; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Prewett M, 1999, CANCER RES, V59, P5209; Pytowski B, 2005, JNCI-J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Siekmann AF, 2008, BIOESSAYS, V30, P303, DOI 10.1002/bies.20736; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stenzel D, 2011, EMBO REP, V12, P1135, DOI 10.1038/embor.2011.194; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Zhang LQ, 2010, CELL RES, V20, P1319, DOI 10.1038/cr.2010.116	36	257	275	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					110	+		10.1038/nature10908	http://dx.doi.org/10.1038/nature10908			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22426001				2022-12-01	WOS:000302343400044
J	Harvey, CD; Coen, P; Tank, DW				Harvey, Christopher D.; Coen, Philip; Tank, David W.			Choice-specific sequences in parietal cortex during a virtual-navigation decision task	NATURE			English	Article							HIPPOCAMPAL PLACE CELLS; PREFRONTAL CORTEX; WORKING-MEMORY; CELLULAR RESOLUTION; PERCEPTUAL DECISIONS; SPATIAL INFORMATION; ACTIVITY PATTERNS; NEURAL ACTIVITY; VISUAL-CORTEX; DYNAMICS	The posterior parietal cortex (PPC) has an important role in many cognitive behaviours; however, the neural circuit dynamics underlying PPC function are not well understood. Here we optically imaged the spatial and temporal activity patterns of neuronal populations in mice performing a PPC-dependent task that combined a perceptual decision and memory-guided navigation in a virtual environment. Individual neurons had transient activation staggered relative to one another in time, forming a sequence of neuronal activation spanning the entire length of a task trial. Distinct sequences of neurons were triggered on trials with opposite behavioural choices and defined divergent, choice-specific trajectories through a state space of neuronal population activity. Cells participating in the different sequences and at distinct time points in the task were anatomically intermixed over microcircuit length scales (<100 micrometres). During working memory decision tasks, the PPC may therefore perform computations through sequence-based circuit dynamics, rather than long-lived stable states, implemented using anatomically intermingled microcircuits.	[Harvey, Christopher D.; Coen, Philip; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Tank, David W.] Princeton Univ, Bezos Ctr Neural Circuit Dynam, Princeton, NJ 08544 USA; [Harvey, Christopher D.; Tank, David W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Harvey, Christopher D.; Coen, Philip; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; Princeton University	Harvey, CD (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	christopher_harvey@hms.harvard.edu; dwtank@princeton.edu	Fernandez-Revelles, Andres B/A-4391-2012	Fernandez-Revelles, Andres B/0000-0002-8089-650X; COEN, PHILIP/0000-0003-1495-1061	NIH [R01-MH083686, RC1-NS068148]; Helen Hay Whitney Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Dombeck for assistance with imaging methods and analysis; C. Domnisoru, M. de Bettencourt, C. Brody and A. Miri for discussions; and M. Goldman, J. Hopfield, D. Aronov, B. Scott and T. Hanks for comments on the manuscript. This work was supported by the NIH (R01-MH083686; RC1-NS068148), a fellowship from the Helen Hay Whitney Foundation (C.D.H.), and a Burroughs Wellcome Fund Career Award at the Scientific Interface (C.D.H.)	Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; BATUEV AS, 1994, ACTA NEUROBIOL EXP, V54, P335; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Braitenberg V, 1991, ANATOMY CORTEX STAT; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Burke SN, 2005, NEURON, V45, P667, DOI 10.1016/j.neuron.2005.01.042; Calton JL, 2009, NEUROBIOL LEARN MEM, V91, P186, DOI 10.1016/j.nlm.2008.09.015; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Corwin JV, 1998, PSYCHOBIOLOGY, V26, P87; Crowe DA, 2010, J NEUROSCI, V30, P11640, DOI 10.1523/JNEUROSCI.0954-10.2010; Curtis CE, 2010, TRENDS COGN SCI, V14, P216, DOI 10.1016/j.tics.2010.03.006; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Jun JK, 2010, J NEUROSCI, V30, P916, DOI 10.1523/JNEUROSCI.2062-09.2010; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Maass W, 2007, PLOS COMPUT BIOL, V3, P15, DOI 10.1371/journal.pcbi.0020165; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Seidemann E, 1996, J NEUROSCI, V16, P752; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Singh R, 2006, J NEUROSCI, V26, P3667, DOI 10.1523/JNEUROSCI.4864-05.2006; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	50	529	533	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					62	68		10.1038/nature10918	http://dx.doi.org/10.1038/nature10918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22419153	Green Accepted			2022-12-01	WOS:000302343400034
J	Cook, DJ				Cook, Diane J.			How Smart Is Your Home?	SCIENCE			English	Editorial Material									Washington State Univ, Pullman, WA 99164 USA	Washington State University	Cook, DJ (corresponding author), Washington State Univ, Pullman, WA 99164 USA.	cook@eecs.wsu.edu			NIBIB NIH HHS [R01 EB009675, R01 EB015853] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009675, R01EB015853] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alon J, 2009, IEEE T PATTERN ANAL, V31, P1685, DOI 10.1109/TPAMI.2008.203; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Das B, 2011, LECT NOTES COMPUT SC, V6719, P9, DOI 10.1007/978-3-642-21535-3_2; Dey AK, 2011, IEEE PERVAS COMPUT, V10, P4, DOI 10.1109/MPRV.2011.29; Kim E, 2010, IEEE PERVAS COMPUT, V9, P48, DOI 10.1109/MPRV.2010.7; O'Grady M, 2012, SCIENCE, V335, P1581, DOI 10.1126/science.1217637; Paradiso J, 2011, IEEE PERVAS COMPUT, V10, P11, DOI 10.1109/MPRV.2011.4; Pentland A, 2010, AM SCI, V98, P204, DOI 10.1511/2010.84.203; Song EY, 2008, IEEE INSTRU MEAS MAG, V11, P11, DOI 10.1109/MIM.2008.4483728; WEISER M, 1991, SCI AM, V265, P94, DOI 10.1038/scientificamerican0991-94; Youngblood GM, 2007, IEEE T SYST MAN CY C, V37, P561, DOI 10.1109/TSMCC.2007.897341	11	85	90	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1579	1581		10.1126/science.1217640	http://dx.doi.org/10.1126/science.1217640			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915YD	22461596	Green Accepted			2022-12-01	WOS:000302062600028
J	Mehari, A; Gladwin, MT; Tian, X; Machado, RF; Kato, GJ				Mehari, Alem; Gladwin, Mark T.; Tian, Xin; Machado, Roberto F.; Kato, Gregory J.			Mortality in Adults With Sickle Cell Disease and Pulmonary Hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Mehari, Alem] Howard Univ, Coll Med, Washington, DC 20059 USA; [Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Tian, Xin; Kato, Gregory J.] NHLBI, Bethesda, MD 20892 USA; [Machado, Roberto F.] Univ Illinois, Sect Pulm Crit Care Med Sleep & Allergy, Chicago, IL USA	Howard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehari, A (corresponding author), Howard Univ, Coll Med, Washington, DC 20059 USA.	gkato@mail.nih.gov	Kato, Gregory J/I-7615-2014	Kato, Gregory J/0000-0003-4465-3217; Machado, Roberto/0000-0002-3722-5954	Intramural NIH HHS [ZIA HL006011-04, ZIA HL006012-02, ZIA HL006015, ZIA HL006011, ZIA HL006015-04, ZIA HL006012] Funding Source: Medline; NHLBI NIH HHS [K23 HL098454, P01 HL103455, K23HL098454, R01HL096973, P01HL103455, R01 HL096973, R01 HL098032, R01HL098032] Funding Source: Medline; NIDDK NIH HHS [RC1DK085852, RC1 DK085852] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006015, K23HL098454, ZIAHL006012, R01HL098032, ZIAHL006014, ZIAHL006011, R01HL096973, P01HL103455, ZIAHL005116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK085852] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; Fonseca GHH, 2012, EUR RESPIR J, V39, P112, DOI 10.1183/09031936.00134410; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565	5	142	146	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2012	307	12					1254	1256		10.1001/jama.2012.358	http://dx.doi.org/10.1001/jama.2012.358			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	914UP	22453563	Bronze, Green Accepted			2022-12-01	WOS:000301978400017
J	Kaouane, N; Porte, Y; Vallee, M; Brayda-Bruno, L; Mons, N; Calandreau, L; Marighetto, A; Piazza, PV; Desmedt, A				Kaouane, Nadia; Porte, Yves; Vallee, Monique; Brayda-Bruno, Laurent; Mons, Nicole; Calandreau, Ludovic; Marighetto, Aline; Piazza, Pier Vincenzo; Desmedt, Aline			Glucocorticoids Can Induce PTSD-Like Memory Impairments in Mice	SCIENCE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SCRIPT-DRIVEN IMAGERY; AMYGDALA; FEAR; HIPPOCAMPUS; BRAIN; ACTIVATION; PATHWAY; TRAUMA	Posttraumatic stress disorder (PTSD) is characterized by a hypermnesia of the trauma and by a memory impairment that decreases the ability to restrict fear to the appropriate context. Infusion of glucocorticoids in the hippocampus after fear conditioning induces PTSD-like memory impairments and an altered pattern of neural activation in the hippocampal-amygdalar circuit. Mice become unable to identify the context as the correct predictor of the threat and show fear responses to a discrete cue not predicting the threat in normal conditions. These data demonstrate PTSD-like memory impairments in rodents and identify a potential pathophysiological mechanism of this condition.	[Kaouane, Nadia; Porte, Yves; Vallee, Monique; Brayda-Bruno, Laurent; Mons, Nicole; Marighetto, Aline; Piazza, Pier Vincenzo; Desmedt, Aline] Univ Bordeaux, Dept Life Sci, F-33077 Bordeaux, France; [Kaouane, Nadia; Porte, Yves; Brayda-Bruno, Laurent; Mons, Nicole; Marighetto, Aline; Desmedt, Aline] Ctr Neurosci Integrat & Cognit, CNRS, UMR 5228, F-33405 Talence, France; [Kaouane, Nadia; Vallee, Monique; Brayda-Bruno, Laurent; Marighetto, Aline; Piazza, Pier Vincenzo; Desmedt, Aline] INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France; [Calandreau, Ludovic] Univ Tours Haras Nationaux, INRA, Ctr Tours Nouzilly Physiol Reprod & Comportements, CNRS,UMR 6175,UMR 85, F-37380 Nouzilly, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE	Piazza, PV (corresponding author), Univ Bordeaux, Dept Life Sci, F-33077 Bordeaux, France.	pier-vincenzo.piazza@inserm.fr; aline.desmedt@inserm.fr	Mons, Nicole/AAD-5541-2019	Marighetto, Aline/0000-0002-8893-278X; VALLEE, Monique/0000-0002-3642-4257; Kaouane, Nadia/0000-0001-7359-0898; Desmedt, aline/0000-0002-1179-7161	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Fondation pour la Recherche sur le Cerveau; Conseil Regional d'Aquitaine; Ministere de l'Enseignement superieur et de la Recherche; University of Bordeaux	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche sur le Cerveau; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Ministere de l'Enseignement superieur et de la Recherche; University of Bordeaux	We thank F. Naneix for helpful discussions and C. Dupuy, A. Faugere, A. Grel, and F. Rouge-Pont for technical help. N.K., A. D., and P. V. P. conceived and designed the experiments. N.K., M. V., N.M., Y.P., L. B. B., L. C., and A. D. performed the experiments. N.K., M. V., and A. D. analyzed the data. N.K., A. M., A. D., and P. V. P. wrote the manuscript. This work was supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Fondation pour la Recherche sur le Cerveau, Conseil Regional d'Aquitaine, Ministere de l'Enseignement superieur et de la Recherche, and University of Bordeaux.	[Anonymous], 2000, DIAGN STAT MAN MENT; BREMNER JD, 1995, J TRAUMA STRESS, V8, P527, DOI 10.1007/BF02102888; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Calandreau L, 2006, J NEUROSCI, V26, P13556, DOI 10.1523/JNEUROSCI.3713-06.2006; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Desmedt A, 1998, J NEUROSCI, V18, P480; Elzinga BM, 2002, J AFFECT DISORDERS, V70, P1, DOI 10.1016/S0165-0327(01)00351-2; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Hunsaker MR, 2008, NEUROBIOL LEARN MEM, V89, P61, DOI 10.1016/j.nlm.2007.08.016; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Layton B, 2002, J NEUROPSYCH CLIN N, V14, P254, DOI 10.1176/appi.neuropsych.14.3.254; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Piazza PV, 1997, BRAIN RES REV, V25, P359, DOI 10.1016/S0165-0173(97)00025-8; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Revest JM, 2010, MOL PSYCHIATR, V15, P1140, DOI 10.1038/mp.2010.40; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Scicli AP, 2004, BEHAV NEUROSCI, V118, P5, DOI 10.1037/0735-7044.118.1.5; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Smith SD, 2008, J ABNORM PSYCHOL, V117, P479, DOI 10.1037/0021-843X.117.2.479; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Trifilieff P, 2007, NEUROBIOL LEARN MEM, V88, P424, DOI 10.1016/j.nlm.2007.05.004; Tronel S, 2007, BIOL PSYCHIAT, V62, P33, DOI 10.1016/j.biopsych.2006.09.009; van Zuiden M, 2012, BIOL PSYCHIAT, V71, P309, DOI 10.1016/j.biopsych.2011.10.026; Yehuda R, 2001, J CLIN PSYCHIAT, V62, P41	28	158	166	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2012	335	6075					1510	1513		10.1126/science.1207615	http://dx.doi.org/10.1126/science.1207615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22362879				2022-12-01	WOS:000301837000053
J	Miyanari, Y; Torres-Padilla, ME				Miyanari, Yusuke; Torres-Padilla, Maria-Elena			Control of ground-state pluripotency by allelic regulation of Nanog	NATURE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; REPLICATION; MAINTENANCE; EXPRESSION	Pluripotency is established through genome-wide reprogramming during mammalian pre-implantation development, resulting in the formation of the naive epiblast. Reprogramming involves both the resetting of epigenetic marks and the activation of pluripotent-cell-specific genes such as Nanog and Oct4 (also known as Pou5f1)(1-4). The tight regulation of these genes is crucial for reprogramming, but the mechanisms that regulate their expression in vivo have not been uncovered. Here we show that Nanog-but not Oct4-is monoallelically expressed in early pre-implantation embryos. Nanog then undergoes a progressive switch to biallelic expression during the transition towards ground-state pluripotency in the naive epiblast of the late blastocyst. Embryonic stem (ES) cells grown in leukaemia inhibitory factor (LIF) and serum express Nanog mainly monoallelically and show asynchronous replication of the Nanog locus, a feature of monoallelically expressed genes(5), but ES cells activate both alleles when cultured under 2i conditions, which mimic the pluripotent ground state in vitro. Live-cell imaging with reporter ES cells confirmed the allelic expression of Nanog and revealed allelic switching. The allelic expression of Nanog is regulated through the fibroblast growth factor-extracellular signal-regulated kinase signalling pathway, and it is accompanied by chromatin changes at the proximal promoter but occurs independently of DNA methylation. Nanog-heterozygous blastocysts have fewer inner-cell-mass derivatives and delayed primitive endoderm formation, indicating a role for the biallelic expression of Nanog in the timely maturation of the inner cell mass into a fully reprogrammed pluripotent epiblast. We suggest that the tight regulation of Nanog dose at the chromosome level is necessary for the acquisition of ground-state pluripotency during development. Our data highlight an unexpected role for allelic expression in controlling the dose of pluripotency factors in vivo, adding an extra level to the regulation of reprogramming.	[Miyanari, Yusuke; Torres-Padilla, Maria-Elena] Univ Strasbourg, Cite Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire,INSERM,U964, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Torres-Padilla, ME (corresponding author), Univ Strasbourg, Cite Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire,INSERM,U964, F-67404 Illkirch Graffenstaden, France.	metp@igbmc.fr			AVENIR/INSERM; Epigenesys NoE; FRM Alsace; EMBO [ALTF864-2008]; JSPS;  [ANR-09-Blanc-0114]	AVENIR/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Epigenesys NoE; FRM Alsace; EMBO(European Molecular Biology Organization (EMBO)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	We thank M. Okano for providing the triple DNA methyltransferase knockout cells, P. Avner and P. Clerc for hybrid ES cells, H. Scholer for the Oct4 probe (GOF6.1), J. Jaubert for M. musculus castaneus mice, R. Kemler and S. Rudloff for the Nanog<SUP>Gt1</SUP> mice, G. Charvin for advice on time-lapse analysis. We also thank M. Koch, A. Dierich, M.-C. Birling, E. Heard and I. Okamoto for advice, and A. Burton, E. Heard and O. Pourquie for critical reading of the manuscript. M.-E.T.-P. acknowledges funding from AVENIR/INSERM, ANR-09-Blanc-0114, Epigenesys NoE and FRM Alsace. Y.M. is a recipient of an EMBO long-term fellowship (ALTF864-2008, 2009) and a JSPS postdoctoral fellowship (2010-2011).	Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Jorgensen HF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r169; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Messerschmidt DM, 2010, DEV BIOL, V344, P129, DOI 10.1016/j.ydbio.2010.04.020; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sage D, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-17; Shufaro Y, 2010, STEM CELLS, V28, P443, DOI 10.1002/stem.303; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Weaver JR, 2009, MAMM GENOME, V20, P532, DOI 10.1007/s00335-009-9225-2; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	27	177	179	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2012	483	7390					470	U123		10.1038/nature10807	http://dx.doi.org/10.1038/nature10807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22327294				2022-12-01	WOS:000301771200044
J	Kraft, R; Herndon, DN; Al-Mousawi, AM; Williams, FN; Finnerty, CC; Jeschke, MG				Kraft, Robert; Herndon, David N.; Al-Mousawi, Ahmed M.; Williams, Felicia N.; Finnerty, Celeste C.; Jeschke, Marc G.			Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study	LANCET			English	Article							MORTALITY; CHILDREN; SEPSIS; AGE	Background Patient survival after severe burn injury is largely determined by burn size. Modern developments in burn care have greatly improved survival and outcomes. However, no large analysis of outcomes in paediatric burn patients with present treatment regimens exists. This study was designed to identify the burn size associated with significant increases in morbidity and mortality in paediatric patients. Methods We undertook a single-centre prospective observational cohort study using clinical data for paediatric patients with burns of at least 30% of their total body surface area (TBSA). Patients were stratified by burn size in 10% increments, ranging from 30% to 100% TBSA, with a secondary assignment made according to the outcome of a receiver operating characteristic (ROC) analysis. Statistical analysis was done with Student's t test, chi(2) test, logistic regression, and ROC analysis, as appropriate, with significance set at p<0.05. Findings 952 severely burned paediatric patients were admitted to the centre between 1998 and 2008. All groups were comparable in age (mean 7.3 [SD 5.3] years, ranging from 6.1 [5.1] years in the 30-39% TBSA group to 9.6 [5.4] years in the 90-100% TBSA group) and sex distribution (628 [66%] boys, ranging from 59% [73/123] in the 60-69% TBSA group to 82% [42/51] in the 90-100% TBSA group). 123 (13%) patients died (increasing from 3% [five of 180] in the 30-39% TBSA group to 55% [28/51] in the 90-100% TBSA group; p<0.0001), 154 (16%) developed multiorgan failure (increasing from 6% [ten] in the 30-39% TBSA group to 45% [23] in the 90-100% TBSA group; p<0.0001), and 89 (9%) had sepsis (increasing from 2% [three] in the 30-39% TBSA group to 26% [13] in the 90-100% TBSA group; p<0.0001). Burn size of 62% TBSA was a crucial threshold for mortality (odds ratio 10.07, 95% CI 5.56-18.22, p<0.0001). Interpretation We established that, in a modern paediatric burn care setting, a burn size of roughly 60% TBSA is a crucial threshold for postburn morbidity and mortality. On the basis of these findings, we recommend that paediatric patients with greater than 60% TBSA burns be immediately transferred to a specialised burn centre. Furthermore, at the burn centre, patients should be treated with increased vigilance and improved therapies, in view of the increased risk of poor outcome associated with this burn size.	[Jeschke, Marc G.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Dept Surg,Div Plast Surg,Ross Tilley Burn Ctr, Toronto, ON M4N 3M5, Canada; [Kraft, Robert; Herndon, David N.; Al-Mousawi, Ahmed M.; Williams, Felicia N.; Finnerty, Celeste C.; Jeschke, Marc G.] Univ Texas Med Branch, Shriners Hosp Children, Galveston, TX 77550 USA; [Finnerty, Celeste C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77550 USA; [Finnerty, Celeste C.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77550 USA; [Herndon, David N.; Al-Mousawi, Ahmed M.; Williams, Felicia N.; Finnerty, Celeste C.; Jeschke, Marc G.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77550 USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Jeschke, MG (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Dept Surg,Div Plast Surg,Ross Tilley Burn Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dherndon@utmb.edu; marc.jeschke@sunnybrook.ca	Herndon, David/AAC-3354-2020		Shriners Hospitals for Children [8660, 8740, 84080, 8760, 9145]; US National Institutes of Health [R01-GM56687, R01-GM087285-01, KL2RR029875, UL1RR029876, T32-GM008256, P50-GM60338]; US National Institute on Disability and Rehabilitation Research [H133A020102, H133A070026]; Institute for Translational Sciences; CFI [25407]; Physicians' Services Incorporated Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR029875, UL1RR029876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008256, P50GM060338, R01GM087285, R01GM056687] Funding Source: NIH RePORTER	Shriners Hospitals for Children; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Disability and Rehabilitation Research; Institute for Translational Sciences; CFI(Canada Foundation for Innovation); Physicians' Services Incorporated Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all the individuals who participated in this study; all the research staff; Eileen Figueroa and Steven Schuenke from the Department of Surgery, University of Texas Medical Branch, and Alisha Goldberg from the Institute for Translational Sciences, University of Texas Medical Branch, for their assistance in manuscript preparation; and Ronald P Mlcak, Deb Benjamin, Wesley Benjamin, Kathryn Epperson, Joanna Huddleston, Mary Kelly, Xuyang Liang, Maria Magno, Liz Montemayor, Marc Nicolai, Sylvia Ojeda, Maricela Pantoja, Cathy Reed, Lisa Magliolo Richardson, Lucille Robles, Siara Tinney, Judith A Underbrink, Pam Stevens, Mario M Celis, Holly Goode, Erick M Henry, and Maria E Cantu for their assistance in obtaining the study measurements. This work is supported by grants from Shriners Hospitals for Children (8660, 8740, 84080, 8760, and 9145), US National Institutes of Health (R01-GM56687, R01-GM087285-01, KL2RR029875, UL1RR029876, T32-GM008256, and P50-GM60338), US National Institute on Disability and Rehabilitation Research (H133A020102, H133A070026), Institute for Translational Sciences, CFI Leaders Opportunity Fund (project number 25407), and Physicians' Services Incorporated Foundation.	BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; BULL JP, 1949, ANN SURG, V130, P160, DOI 10.1097/00000658-194908000-00002; Cairns BA, 2008, J TRAUMA, V64, P1069, DOI 10.1097/TA.0b013e318166b7d9; Cox RA, 2007, PULM PHARMACOL THER, V20, P172, DOI 10.1016/j.pupt.2006.03.013; Cree MG, 2008, J BURN CARE RES, V29, P585, DOI 10.1097/BCR.0b013e31817db88f; Cree MG, 2009, BURNS, V35, P63, DOI 10.1016/j.burns.2008.04.010; Desai M H, 1988, J Burn Care Rehabil, V9, P637, DOI 10.1097/00004630-198811000-00014; DONG YL, 1993, J TRAUMA, V35, P340, DOI 10.1097/00005373-199309000-00002; DONG YL, 1993, J SURG RES, V54, P480, DOI 10.1006/jsre.1993.1074; Gibran NS, 2006, J BURN CARE RES, V27, P437, DOI 10.1097/01.BCR.0000226084.26680.56; Hart DW, 2001, ANN SURG, V233, P827, DOI 10.1097/00000658-200106000-00013; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jeschke MG, 2008, PEDIATRICS, V121, P497, DOI 10.1542/peds.2007-1363; Jeschke MG, 2007, SHOCK, V28, P172, DOI 10.1097/shk.0b013e318047b9e2; Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407; KLEIN GL, 1995, BONE, V17, P455, DOI 10.1016/8756-3282(95)00279-1; KNAUS WA, 1991, SCIENCE, V254, P389, DOI 10.1126/science.1925596; Leffler M, 2007, J SURG RES, V143, P398, DOI 10.1016/j.jss.2007.01.030; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; McEntire S J, 2006, Pediatr Rehabil, V9, P57, DOI 10.1080/13638490500074576; Mlcak RP, 2006, ANN SURG, V244, P121, DOI 10.1097/01.sla.0000217678.78472.d3; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Schinkel S, 2005, EUR J MED RES, V10, P76; Spies M, 2002, AM J PHYSIOL-GASTR L, V283, pG703, DOI 10.1152/ajpgi.00149.2001; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Wolf SE, 1997, ANN SURG, V225, P554, DOI 10.1097/00000658-199705000-00012; XIA ZF, 1992, J TRAUMA, V32, P245; ZAWACKI BE, 1979, ANN SURG, V189, P1, DOI 10.1097/00000658-197901000-00001	28	117	122	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2012	379	9820					1013	1021		10.1016/S0140-6736(11)61345-7	http://dx.doi.org/10.1016/S0140-6736(11)61345-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	911JE	22296810	Green Accepted			2022-12-01	WOS:000301712300029
J	Shi, L; Shen, QT; Kiel, A; Wang, J; Wang, HW; Melia, TJ; Rothman, JE; Pincet, F				Shi, Lei; Shen, Qing-Tao; Kiel, Alexander; Wang, Jing; Wang, Hong-Wei; Melia, Thomas J.; Rothman, James E.; Pincet, Frederic			SNARE Proteins: One to Fuse and Three to Keep the Nascent Fusion Pore Open	SCIENCE			English	Article							MEDIATED MEMBRANE-FUSION; DOPAMINE NEURONS; VESICLE FUSION; SPEED LIMIT; COMPLEX; EXOCYTOSIS; CELLS; TRANSMITTER; NANODISCS; SYNAPSES	Neurotransmitters are released through nascent fusion pores, which ordinarily dilate after bilayer fusion, preventing consistent biochemical studies. We used lipid bilayer nanodiscs as fusion partners; their rigid protein framework prevents dilation and reveals properties of the fusion pore induced by SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor). We found that although only one SNARE per nanodisc is required for maximum rates of bilayer fusion, efficient release of content on the physiologically relevant time scale of synaptic transmission apparently requires three or more SNARE complexes (SNAREpins) and the native transmembrane domain of vesicle-associated membrane protein 2 (VAMP2). We suggest that several SNAREpins simultaneously zippering their SNARE transmembrane helices within the freshly fused bilayers provide a radial force that prevents the nascent pore from resealing during synchronous neurotransmitter release.	[Shi, Lei; Kiel, Alexander; Wang, Jing; Melia, Thomas J.; Rothman, James E.; Pincet, Frederic] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Shen, Qing-Tao; Wang, Hong-Wei] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pincet, Frederic] Univ Paris 06, UMR CNRS 8550, Lab Phys Stat, F-75005 Paris, France; [Pincet, Frederic] Univ Paris 07, Ecole Normale Super, F-75005 Paris, France	Yale University; Yale University; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Rothman, JE (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	james.rothman@yale.edu; pincet@lps.ens.fr	Shi, Lei/AAX-9455-2021	PINCET, FREDERIC/0000-0002-4243-2157	Agence Nationale de la Recherche [09-Blanc-0129]; NIH; Partner University; Yale Normale Superieure laboratory; Ecole Normale Superieure laboratory; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027044, R37DK027044] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Partner University; Yale Normale Superieure laboratory; Ecole Normale Superieure laboratory; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by Agence Nationale de la Recherche grant 09-Blanc-0129 (F. P.), NIH grants (J.E.R.), and a Partner University Funds exchange grant between the Yale and Ecole Normale Superieure laboratories. We thank J. Shen (University of Colorado, Boulder) for providing the PDGFR-VAMP2 expressing vector; R. Beck, E. Rhoades, E. Karatekin, and A. Nath for many helpful discussions; and W. Xu and J. Coleman for their kind help.	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Brewer KD, 2011, P NATL ACAD SCI USA, V108, P12723, DOI 10.1073/pnas.1105128108; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Fang QH, 2008, P NATL ACAD SCI USA, V105, P15388, DOI 10.1073/pnas.0805377105; Fdez E, 2010, J CELL SCI, V123, P2473, DOI 10.1242/jcs.061325; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hu YM, 2008, SYNAPSE, V62, P953, DOI 10.1002/syn.20567; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Karatekin E, 2003, POLYM INT, V52, P486, DOI 10.1002/pi.1007; Katayama H, 2010, P NATL ACAD SCI USA, V107, P3453, DOI 10.1073/pnas.1000100107; KHANIN R, 1994, BIOPHYS J, V67, P966, DOI 10.1016/S0006-3495(94)80562-4; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Montecucco C, 2005, TRENDS BIOCHEM SCI, V30, P367, DOI 10.1016/j.tibs.2005.05.002; Pothos EN, 1998, J NEUROSCI, V18, P4106; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Smith EA, 2011, BIOPHYS J, V100, P2141, DOI 10.1016/j.bpj.2011.03.015; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609	34	185	189	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2012	335	6074					1355	1359		10.1126/science.1214984	http://dx.doi.org/10.1126/science.1214984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22422984	Green Accepted			2022-12-01	WOS:000301531600049
J	Buescher, JM; Liebermeister, W; Jules, M; Uhr, M; Muntel, J; Botella, E; Hessling, B; Kleijn, RJ; Le Chat, L; Lecointe, F; Mader, U; Nicolas, P; Piersma, S; Rugheimer, F; Becher, D; Bessieres, P; Bidnenko, E; Denham, EL; Dervyn, E; Devine, KM; Doherty, G; Drulhe, S; Felicori, L; Fogg, MJ; Goelzer, A; Hansen, A; Harwood, CR; Hecker, M; Hubner, S; Hultschig, C; Jarmer, H; Klipp, E; Leduc, A; Lewis, P; Molina, F; Noirot, P; Peres, S; Pigeonneau, N; Pohl, S; Rasmussen, S; Rinn, B; Schaffer, M; Schnidder, J; Schwikowski, B; Van Dijl, JM; Veiga, P; Walsh, S; Wilkinson, AJ; Stelling, J; Aymerich, S; Sauer, U				Buescher, Joerg Martin; Liebermeister, Wolfram; Jules, Matthieu; Uhr, Markus; Muntel, Jan; Botella, Eric; Hessling, Bernd; Kleijn, Roelco Jacobus; Le Chat, Ludovic; Lecointe, Francois; Maeder, Ulrike; Nicolas, Pierre; Piersma, Sjouke; Ruegheimer, Frank; Becher, Doerte; Bessieres, Philippe; Bidnenko, Elena; Denham, Emma L.; Dervyn, Etienne; Devine, Kevin M.; Doherty, Geoff; Drulhe, Samuel; Felicori, Liza; Fogg, Mark J.; Goelzer, Anne; Hansen, Annette; Harwood, Colin R.; Hecker, Michael; Hubner, Sebastian; Hultschig, Claus; Jarmer, Hanne; Klipp, Edda; Leduc, Aurelie; Lewis, Peter; Molina, Frank; Noirot, Philippe; Peres, Sabine; Pigeonneau, Nathalie; Pohl, Susanne; Rasmussen, Simon; Rinn, Bernd; Schaffer, Marc; Schnidder, Julian; Schwikowski, Benno; Van Dijl, Jan Maarten; Veiga, Patrick; Walsh, Sean; Wilkinson, Anthony J.; Stelling, Joerg; Aymerich, Stephane; Sauer, Uwe			Global Network Reorganization During Dynamic Adaptations of Bacillus subtilis Metabolism	SCIENCE			English	Article							TRANSCRIPTIONAL REGULATION; ESCHERICHIA-COLI; YEAST; RECONSTRUCTION; STARVATION; COMPLEXITY; SYSTEMS	Adaptation of cells to environmental changes requires dynamic interactions between metabolic and regulatory networks, but studies typically address only one or a few layers of regulation. For nutritional shifts between two preferred carbon sources of Bacillus subtilis, we combined statistical and model-based data analyses of dynamic transcript, protein, and metabolite abundances and promoter activities. Adaptation to malate was rapid and primarily controlled posttranscriptionally compared with the slow, mainly transcriptionally controlled adaptation to glucose that entailed nearly half of the known transcription regulation network. Interactions across multiple levels of regulation were involved in adaptive changes that could also be achieved by controlling single genes. Our analysis suggests that global trade-offs and evolutionary constraints provide incentives to favor complex control programs.	[Uhr, Markus; Stelling, Joerg] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Buescher, Joerg Martin; Kleijn, Roelco Jacobus; Schnidder, Julian; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Basel, Switzerland; [Liebermeister, Wolfram; Klipp, Edda] Humboldt Univ, D-10115 Berlin, Germany; [Jules, Matthieu; Le Chat, Ludovic; Lecointe, Francois; Noirot, Philippe; Pigeonneau, Nathalie; Aymerich, Stephane] INRA, UMR1319 Micalis, F-78350 Jouy En Josas, France; [Muntel, Jan; Hessling, Bernd; Maeder, Ulrike; Becher, Doerte] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17487 Greifswald, Germany; [Nicolas, Pierre; Bessieres, Philippe; Goelzer, Anne; Leduc, Aurelie] INRA, UR1077, F-78350 Jouy En Josas, France; [Devine, Kevin M.; Hansen, Annette; Hubner, Sebastian] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Piersma, Sjouke; Denham, Emma L.; Van Dijl, Jan Maarten] Univ Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands; [Denham, Emma L.; Van Dijl, Jan Maarten] Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Doherty, Geoff; Lewis, Peter] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Felicori, Liza] Sysdiag CNRS Bio Rad, UMR 3145, F-34184 Montpellier 4, France; [Fogg, Mark J.; Wilkinson, Anthony J.] Univ York, York Struct Biol Lab, Dept Chem, York YO10 5YW, N Yorkshire, England; [Harwood, Colin R.; Pohl, Susanne] Univ Newcastle Tyne, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Hultschig, Claus; Rinn, Bernd; Walsh, Sean] ETH, Ctr Informat Sci & Databases, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Jarmer, Hanne; Rasmussen, Simon] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Ruegheimer, Frank; Drulhe, Samuel; Schwikowski, Benno] Inst Pasteur, Syst Biol Lab, Dept Genomes & Genet, F-75015 Paris, France; [Ruegheimer, Frank; Drulhe, Samuel; Schwikowski, Benno] CNRS, URA 2171, F-75015 Paris, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Humboldt University of Berlin; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ernst Moritz Arndt Universitat Greifswald; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Trinity College Dublin; University of Groningen; University of Groningen; University of Newcastle; Centre National de la Recherche Scientifique (CNRS); University of York - UK; Newcastle University - UK; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Denmark; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Stelling, J (corresponding author), ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.	joerg.stelling@bsse.ethz.ch; stephane.aymerich@grignon.inra.fr; sauer@ethz.ch	Jules, Matthieu/GVU-5315-2022; van Dijl, Jan Maarten/G-1205-2013; Stelling, Joerg/F-7499-2010; Veiga, Patrick/A-9862-2011; Becher, Doerte/B-4454-2015; Liebermeister, Wolfram/AAC-7326-2020; Harwood, Colin/AGF-0120-2022; Sauer, Uwe/Y-3556-2019; Felicori, Liza F/I-6683-2013; Rasmussen, Simon/G-6258-2016; Rasmussen, Simon/AAA-2308-2020; Denham, Emma/P-3979-2014	Jules, Matthieu/0000-0003-0817-8949; Stelling, Joerg/0000-0002-1145-891X; Veiga, Patrick/0000-0001-6318-8547; Becher, Doerte/0000-0002-9630-5735; Liebermeister, Wolfram/0000-0002-2568-2381; Rasmussen, Simon/0000-0001-6323-9041; Rasmussen, Simon/0000-0001-6323-9041; Denham, Emma/0000-0002-5123-4099; Schwikowski, Benno/0000-0001-5127-5619; Harwood, Colin/0000-0002-3624-0001; Buescher, Joerg/0000-0002-6547-0076; Wilkinson, Anthony/0000-0003-4577-9479; Peres, Sabine/0000-0002-4467-9989; Goelzer, Anne/0000-0003-2222-6142; Lecointe, Francois/0000-0002-9596-2514; Fogg, Mark/0000-0002-6692-122X	European Commission [LSHG-CT-2006-037469]; Department of Education, Science and Training [CG110055]; National Health and Medical Research Council [455646]	European Commission(European CommissionEuropean Commission Joint Research Centre); Department of Education, Science and Training; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded through the European Commission 7th Framework project BaSysBio (LSHG-CT-2006-037469), coordinated by P. Noirot, the Department of Education, Science and Training (CG110055), and the National Health and Medical Research Council (455646). Data, algorithms, and mathematical models have been deposited in a publicly accessible relational database (www.basysbio.eu/nutrientshift/ and table S1).	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Botella E, 2010, MICROBIOL-SGM, V156, P1600, DOI 10.1099/mic.0.035758-0; Bradley PH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000270; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Canelas AB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1150; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Doan T, 2003, MOL MICROBIOL, V47, P1709, DOI 10.1046/j.1365-2958.2003.03404.x; Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Haykin S., 2004, KALMAN FILTERING NEU, V47; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kleijn RJ, 2010, J BIOL CHEM, V285, P1587, DOI 10.1074/jbc.M109.061747; Kresnowati MTAP, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100083; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Moxley JF, 2009, P NATL ACAD SCI USA, V106, P6477, DOI 10.1073/pnas.0811091106; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Ralser M, 2009, NAT BIOTECHNOL, V27, P604, DOI 10.1038/nbt0709-604; Rossell S, 2006, P NATL ACAD SCI USA, V103, P2166, DOI 10.1073/pnas.0509831103; Sauer U, 2007, SCIENCE, V316, P550, DOI 10.1126/science.1142502; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	23	192	195	4	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2012	335	6072					1099	1103		10.1126/science.1206871	http://dx.doi.org/10.1126/science.1206871			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383848				2022-12-01	WOS:000300931100047
J	Zhang, Y; McCord, RP; Ho, YJ; Lajoie, BR; Hildebrand, DG; Simon, AC; Becker, MS; Alt, FW; Dekker, J				Zhang, Yu; McCord, Rachel Patton; Ho, Yu-Jui; Lajoie, Bryan R.; Hildebrand, Dominic G.; Simon, Aline C.; Becker, Michael S.; Alt, Frederick W.; Dekker, Job			Spatial Organization of the Mouse Genome and Its Role in Recurrent Chromosomal Translocations	CELL			English	Article							DOUBLE-STRAND BREAKS; V(D)J RECOMBINATION; SEQUENCING REVEALS; B-CELLS; C-MYC; MECHANISMS; CANCER; REARRANGEMENTS; LYMPHOCYTES; STABILITY	The extent to which the three-dimensional organization of the genome contributes to chromosomal translocations is an important question in cancer genomics. We generated a high-resolution Hi-C spatial organization map of the G1-arrested mouse pro-B cell genome and used high-throughput genome-wide translocation sequencing to map translocations from target DNA double-strand breaks (DSBs) within it. RAG endonuclease-cleaved antigen-receptor loci are dominant translocation partners for target DSBs regardless of genomic position, reflecting high-frequency DSBs at these loci and their colocalization in a fraction of cells. To directly assess spatial proximity contributions, we normalized genomic DSBs via ionizing radiation. Under these conditions, translocations were highly enriched in cis along single chromosomes containing target DSBs and within other chromosomes and subchromosomal domains in a manner directly related to pre-existing spatial proximity. By combining two high-throughput genomic methods in a genetically tractable system, we provide a new lens for viewing cancer genomes.	[Zhang, Yu; Ho, Yu-Jui; Hildebrand, Dominic G.; Simon, Aline C.; Becker, Michael S.; Alt, Frederick W.] Childrens Hosp, Program Cellular & Mol Med, Immune Dis Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; [Zhang, Yu; Ho, Yu-Jui; Hildebrand, Dominic G.; Simon, Aline C.; Becker, Michael S.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yu; Ho, Yu-Jui; Hildebrand, Dominic G.; Simon, Aline C.; Becker, Michael S.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [McCord, Rachel Patton; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Programs Syst Biol, Worcester, MA 01605 USA; [McCord, Rachel Patton; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Programs Gene Funct & Express, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Alt, FW (corresponding author), Childrens Hosp, Program Cellular & Mol Med, Immune Dis Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu; job.dekker@umassmed.edu		McCord, Rachel/0000-0003-0010-5323; Becker, Michael/0000-0001-5502-7444; Ho, Yu-jui/0000-0002-7540-024X	NIH [3P01CA092625-09S1, R01 HG003143]; Leukemia and Lymphoma Society of America (LLS) SCOR; W.M. Keck Foundation; German National Merit Foundation; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100617] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America (LLS) SCOR; W.M. Keck Foundation(W.M. Keck Foundation); German National Merit Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant ARRA Supplement 3P01CA092625-09S1 and a Leukemia and Lymphoma Society of America (LLS) SCOR grant to F. W. A. and by NIH grant R01 HG003143 and a W.M. Keck Foundation Distinguished Young Scholar Award to J.D. Y.Z. was supported by CRI postdoctoral fellowship. D. G. H., A. C. S., and M. G. B. were supported by the German National Merit Foundation. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	Barreca A, 2011, J MOL ENDOCRINOL, V47, pR11, DOI 10.1530/JME-11-0004; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Gostissa M, 2009, P NATL ACAD SCI USA, V106, P2265, DOI 10.1073/pnas.0812763106; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Mahowald GK, 2009, P NATL ACAD SCI USA, V106, P18339, DOI 10.1073/pnas.0902545106; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Ohno H, 2006, J CLIN EXP HEMATOP, V46, P43, DOI 10.3960/jslrt.46.43; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Sengupta K, 2008, CHROMOSOMA, V117, P499, DOI 10.1007/s00412-008-0171-7; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Tsai AG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S1; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9	49	379	396	0	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					908	921		10.1016/j.cell.2012.02.002	http://dx.doi.org/10.1016/j.cell.2012.02.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22341456	Bronze, Green Accepted			2022-12-01	WOS:000300985000012
J	Canto, JG; Rogers, WJ; Goldberg, RJ; Peterson, ED; Wenger, NK; Vaccarino, V; Kiefe, CI; Frederick, PD; Sopko, G; Zheng, ZJ				Canto, John G.; Rogers, William J.; Goldberg, Robert J.; Peterson, Eric D.; Wenger, Nanette K.; Vaccarino, Viola; Kiefe, Catarina I.; Frederick, Paul D.; Sopko, George; Zheng, Zhi-Jie		NRMI Investigators	Association of Age and Sex With Myocardial Infarction Symptom Presentation and In-Hospital Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; NATIONAL REGISTRY; RISK-FACTORS; WOMEN; SURVIVAL; GENDER	Context Women are generally older than men at hospitalization for myocardial infarction (MI) and also present less frequently with chest pain/discomfort. However, few studies have taken age into account when examining sex differences in clinical presentation and mortality. Objective To examine the relationship between sex and symptom presentation and between sex, symptom presentation, and hospital mortality, before and after accounting for age in patients hospitalized with MI. Design, Setting, and Patients Observational study from the National Registry of Myocardial Infarction, 1994-2006, of 1 143 513 registry patients (481 581 women and 661 932 men). Main Outcome Measures We examined predictors of MI presentation without chest pain and the relationship between age, sex, and hospital mortality. Results The proportion of MI patients who presented without chest pain was significantly higher for women than men (42.0% [95% CI, 41.8%-42.1%] vs 30.7% [95% CI, 30.6%-30.8%]; P<.001). There was a significant interaction between age and sex with chest pain at presentation, with a larger sex difference in younger than older patients, which became attenuated with advancing age. Multivariable adjusted age-specific odds ratios (ORs) for lack of chest pain for women (referent, men) were younger than 45 years, 1.30 (95% CI, 1.23-1.36); 45 to 54 years, 1.26 (95% CI, 1.22-1.30); 55 to 64 years, 1.24 (95% CI, 1.21-1.27); 65 to 74 years, 1.13 (95% CI, 1.11-1.15); and 75 years or older, 1.03 (95% CI, 1.02-1.04). Two-way interaction (sex and age) on MI presentation without chest pain was significant (P<.001). The in-hospital mortality rate was 14.6% for women and 10.3% for men. Younger women presenting without chest pain had greater hospital mortality than younger men without chest pain, and these sex differences decreased or even reversed with advancing age, with adjusted OR for age younger than 45 years, 1.18 (95% CI, 1.00-1.39); 45 to 54 years, 1.13 (95% CI, 1.02-1.26); 55 to 64 years, 1.02 (95% CI, 0.96-1.09); 65 to 74 years, 0.91 (95% CI, 0.88-0.95); and 75 years or older, 0.81 (95% CI, 0.79-0.83). The 3-way interaction (sex, age, and chest pain) on mortality was significant (P<.001). Conclusion In this registry of patients hospitalized with MI, women were more likely than men to present without chest pain and had higher mortality than men within the same age group, but sex differences in clinical presentation without chest pain and in mortality were attenuated with increasing age. JAMA. 2012;307(8):813-822 www.jama.com	[Canto, John G.] Watson Clin, Lakeland, FL 33805 USA; [Canto, John G.] Lakeland Reg Med Ctr, Lakeland, FL USA; [Rogers, William J.] Univ Alabama Birmingham, Med Ctr, Birmingham, AL USA; [Goldberg, Robert J.; Kiefe, Catarina I.] Univ Massachusetts, Med Ctr, Dept Quantitat Hlth Sci, Worcester, MA USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Wenger, Nanette K.; Vaccarino, Viola] Emory Univ, Dept Med, Div Cardiol, Emory Sch Med, Atlanta, GA 30322 USA; [Vaccarino, Viola] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Frederick, Paul D.] ICON Late Phase & Outcomes Res, San Francisco, CA USA; [Sopko, George] NHLBI, NIH, Bethesda, MD 20892 USA; [Zheng, Zhi-Jie] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China	University of Alabama System; University of Alabama Birmingham; University of Massachusetts System; University of Massachusetts Worcester; Duke University; Emory University; Emory University; Rollins School Public Health; ICON plc; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Shanghai Jiao Tong University	Canto, JG (corresponding author), Watson Clin, 1600 Lakeland Hill Blvd, Lakeland, FL 33805 USA.	jcanto@watsonclinic.com	, Viola/AAW-5600-2020; Peterson, Eric David/ABF-5033-2021	Frederick, Paul/0000-0002-7936-5488	National Institutes of Health [U01HL 105268, U54 RR 026088]; Genentech; Bristol-Myers Squibb; sanofi-aventis; Eli Lilly; Schering Plough/Merck; Johnson Johnson; St Jude Inc; Bayer; Pfizer; Merck; NHLBT; Gilead Sciences; Abbott; AstraZeneca; Abbott Women's Advisory Board; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech(Roche HoldingGenentech); Bristol-Myers Squibb(Bristol-Myers Squibb); sanofi-aventis(Sanofi-Aventis); Eli Lilly(Eli Lilly); Schering Plough/Merck(Merck & CompanySchering Plough Corporation); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); St Jude Inc; Bayer(Bayer AG); Pfizer(Pfizer); Merck(Merck & Company); NHLBT; Gilead Sciences(Gilead Sciences); Abbott(Abbott Laboratories); AstraZeneca(AstraZeneca); Abbott Women's Advisory Board; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kiefe reports receiving partial funding from the National Institutes of Health (grants U01HL 105268 and U54 RR 026088). Mr Frederick reports being an employee of ICON Clinical Research, which received support from Genentech, to provide biostatistical and analytic services. Dr Peterson reported receiving research grants from Bristol-Myers Squibb, sanofi-aventis, Eli Lilly, Schering Plough/Merck, Johnson & Johnson, and St Jude Inc and consultant fees from Bayer and Pfizer. Dr Wenger reported receiving research grants and/or trial committee or data and safety monitoring board compensation from Pfizer, Merck, NHLBT, Gilead Sciences, Abbott, and Eli Lilly; she also reported receiving consultant fees from Gilead Sciences, AstraZeneca, Abbott Women's Advisory Board, Merck, and Pfizer.	Albert CM, 1996, CIRCULATION, V93, P1170, DOI 10.1161/01.CIR.93.6.1170; Benderly M, 1997, AM J EPIDEMIOL, V146, P153; Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055; Burke AP, 1998, CIRCULATION, V97, P2110, DOI 10.1161/01.CIR.97.21.2110; Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; Canto JG, 2002, ARCH INTERN MED, V162, P587, DOI 10.1001/archinte.162.5.587; Canto JG, 2007, ARCH INTERN MED, V167, P2405, DOI 10.1001/archinte.167.22.2405; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; Every NR, 1999, J AM COLL CARDIOL, V33, P1886, DOI 10.1016/S0735-1097(99)00113-8; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; Hsia J, 2004, AM J CARDIOL, V93, P673, DOI 10.1016/j.amjcard.2003.12.002; JOHANSSON S, 1984, AM J EPIDEMIOL, V119, P610, DOI 10.1093/oxfordjournals.aje.a113778; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Maynard C, 1997, ARCH INTERN MED, V157, P1379, DOI 10.1001/archinte.157.12.1379; ROBINSON K, 1988, J AM COLL CARDIOL, V11, P932, DOI 10.1016/S0735-1097(98)90048-1; Shin JY, 2010, HEART LUNG, V39, P283, DOI 10.1016/j.hrtlng.2009.10.010; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; Vaccarino V, 2009, ARCH INTERN MED, V169, P1767, DOI 10.1001/archinternmed.2009.332; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065	22	422	437	2	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2012	307	8					813	822		10.1001/jama.2012.199	http://dx.doi.org/10.1001/jama.2012.199			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896FQ	22357832	Bronze, Green Accepted			2022-12-01	WOS:000300551300024
J	MacArthur, DG; Balasubramanian, S; Frankish, A; Huang, N; Morris, J; Walter, K; Jostins, L; Habegger, L; Pickrell, JK; Montgomery, SB; Albers, CA; Zhang, ZDD; Conrad, DF; Lunter, G; Zheng, HC; Ayub, Q; DePristo, MA; Banks, E; Hu, M; Handsaker, RE; Rosenfeld, JA; Fromer, M; Jin, M; Mu, XJ; Khurana, E; Ye, K; Kay, M; Saunders, GI; Suner, MM; Hunt, T; Barnes, IHA; Amid, C; Carvalho-Silva, DR; Bignell, AH; Snow, C; Yngvadottir, B; Bumpstead, S; Cooper, DN; Xue, YL; Romero, IG; Wang, J; Li, YR; Gibbs, RA; McCarroll, SA; Dermitzakis, ET; Pritchard, JK; Barrett, JC; Harrow, J; Hurles, ME; Gerstein, MB; Tyler-Smith, C				MacArthur, Daniel G.; Balasubramanian, Suganthi; Frankish, Adam; Huang, Ni; Morris, James; Walter, Klaudia; Jostins, Luke; Habegger, Lukas; Pickrell, Joseph K.; Montgomery, Stephen B.; Albers, Cornelis A.; Zhang, Zhengdong D.; Conrad, Donald F.; Lunter, Gerton; Zheng, Hancheng; Ayub, Qasim; DePristo, Mark A.; Banks, Eric; Hu, Min; Handsaker, Robert E.; Rosenfeld, Jeffrey A.; Fromer, Menachem; Jin, Mike; Mu, Xinmeng Jasmine; Khurana, Ekta; Ye, Kai; Kay, Mike; Saunders, Gary Ian; Suner, Marie-Marthe; Hunt, Toby; Barnes, If H. A.; Amid, Clara; Carvalho-Silva, Denise R.; Bignell, Alexandra H.; Snow, Catherine; Yngvadottir, Bryndis; Bumpstead, Suzannah; Cooper, David N.; Xue, Yali; Romero, Irene Gallego; Wang, Jun; Li, Yingrui; Gibbs, Richard A.; McCarroll, Steven A.; Dermitzakis, Emmanouil T.; Pritchard, Jonathan K.; Barrett, Jeffrey C.; Harrow, Jennifer; Hurles, Matthew E.; Gerstein, Mark B.; Tyler-Smith, Chris		1000 Genomes Project Consortium	A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes	SCIENCE			English	Article							POSITIVE SELECTION; ANNOTATION; MECHANISMS; NUMBER; FORM	Genome-sequencing studies indicate that all humans carry many genetic variants predicted to cause loss of function (LoF) of protein-coding genes, suggesting unexpected redundancy in the human genome. Here we apply stringent filters to 2951 putative LoF variants obtained from 185 human genomes to determine their true prevalence and properties. We estimate that human genomes typically contain similar to 100 genuine LoF variants with similar to 20 genes completely inactivated. We identify rare and likely deleterious LoF alleles, including 26 known and 21 predicted severe disease-causing variants, as well as common LoF variants in nonessential genes. We describe functional and evolutionary differences between LoF-tolerant and recessive disease genes and a method for using these differences to prioritize candidate genes found in clinical sequencing studies.	[MacArthur, Daniel G.; Frankish, Adam; Huang, Ni; Morris, James; Walter, Klaudia; Jostins, Luke; Albers, Cornelis A.; Ayub, Qasim; Hu, Min; Kay, Mike; Saunders, Gary Ian; Suner, Marie-Marthe; Hunt, Toby; Barnes, If H. A.; Amid, Clara; Carvalho-Silva, Denise R.; Bignell, Alexandra H.; Snow, Catherine; Yngvadottir, Bryndis; Bumpstead, Suzannah; Xue, Yali; Romero, Irene Gallego; Barrett, Jeffrey C.; Harrow, Jennifer; Hurles, Matthew E.; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [MacArthur, Daniel G.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Balasubramanian, Suganthi; Habegger, Lukas; Jin, Mike; Mu, Xinmeng Jasmine; Khurana, Ekta; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Balasubramanian, Suganthi; Habegger, Lukas; Mu, Xinmeng Jasmine; Khurana, Ekta; Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pickrell, Joseph K.; Romero, Irene Gallego; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Montgomery, Stephen B.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Montgomery, Stephen B.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Albers, Cornelis A.] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Albers, Cornelis A.] NHS Blood & Transplant, Cambridge CB2 0PT, England; [Zhang, Zhengdong D.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Conrad, Donald F.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Lunter, Gerton] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Zheng, Hancheng; Wang, Jun; Li, Yingrui] BGI Shenzhen, Shenzhen 518083, Peoples R China; [DePristo, Mark A.; Banks, Eric; Handsaker, Robert E.; Fromer, Menachem; McCarroll, Steven A.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Handsaker, Robert E.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Rosenfeld, Jeffrey A.] Univ Med & Dent New Jersey, IST High Performance & Res Comp, Newark, NJ 07103 USA; [Ye, Kai] Leiden Univ, Med Ctr, Mol Epidemiol Sect, NL-2300 RC Leiden, Netherlands; [Amid, Clara] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SD, England; [Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA	Wellcome Trust Sanger Institute; University of Sydney; Yale University; Yale University; University of Chicago; Stanford University; Stanford University; University of Geneva; University of Cambridge; Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL); University of Oxford; Wellcome Centre for Human Genetics; Beijing Genomics Institute (BGI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; European Molecular Biology Laboratory (EMBL); Cardiff University; Baylor College of Medicine; Howard Hughes Medical Institute; University of Chicago; Yale University	MacArthur, DG (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	macarthur@atgu.mgh.harvard.edu	Mu, Xinmeng/P-2562-2016; Lunter, Gerton/H-4939-2016; Dermitzakis, Emmanouil/B-7687-2013; Ye, Kai/GSD-9856-2022; Khurana, Ekta/C-4933-2013; Mills, Ryan E/F-4225-2010; Fromer, Menachem/G-2116-2012; Li, Yingrui/K-1064-2015; Ye, Kai/B-3640-2012; Albers, Kees/A-4170-2015; Cooper, David N/H-4384-2011; Wang, Jun/A-7261-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Mu, Xinmeng/0000-0002-8079-0828; Ye, Kai/0000-0002-2851-6741; Mills, Ryan E/0000-0003-3425-6998; Fromer, Menachem/0000-0003-3749-4342; Albers, Kees/0000-0003-4115-3727; Cooper, David N/0000-0002-8943-8484; Balasubramanian, Suganthi/0000-0003-2243-5948; Ayub, Qasim/0000-0003-3291-0917; MacArthur, Daniel/0000-0002-5771-2290; Lunter, Gerton/0000-0002-3798-2058; Barrett, Jeffrey/0000-0002-1152-370X; Frankish, Adam/0000-0002-4333-628X; Kay, Mike/0000-0002-3282-0834; Harrow, Jennifer/0000-0003-0338-3070; Hunt, Toby/0000-0001-8377-0841; Wang, Jun/0000-0002-8540-8931; Keinan, Alon/0000-0002-9760-1122; Leinonen, Rasko/0000-0002-2639-7187; Gallego Romero, Irene/0000-0003-1613-8998; Bignell, alexandra/0000-0002-5926-7020; Snow, Catherine/0000-0002-1672-3532; Clarke, Laura/0000-0002-5989-6898; Walter, Klaudia/0000-0003-4448-0301; Amid, Clara/0000-0001-6534-7425; Saunders, Gary/0000-0002-7468-0008; Carvalho-Silva, Dr D/0000-0001-5662-1840; Montgomery, Stephen/0000-0002-5200-3903; Wang, Jun/0000-0002-2113-5874	Wellcome Trust [098051, 090532/Z/09/Z]; Australian National Health and Medical Research Council; Swiss National Science Foundation; Louis Jeantet Foundation; NIH-National Institute of Mental Health; Netherlands Organisation for Scientific Research (NWO) [639.021.125]; National Basic Research Program of China (973 program) [2011CB809200]; National Natural Science Foundation of China [30725008, 30890032, 30811130531]; Chinese 863 program [2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240080A]; Danish Natural Science Research Council; Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; BBSRC [BB/I02593X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I02593X/1] Funding Source: researchfish; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA022707] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis Jeantet Foundation; NIH-National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); Shenzhen Municipal Government; Local Government of Yantian District of Shenzhen; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	T. Shah provided the Pyvoker software used for manual assignment of genotypes based on intensity clusters; S. Edkins was involved in the Sequenom validation; and the genotyping groups at Illumina, the Wellcome Trust Sanger Institute, and The Broad Institute of Harvard and MIT provided raw intensity data for the three Illumina arrays used for genotyping validation. The work performed at the Wellcome Trust Sanger Institute was supported by Wellcome Trust grant 098051; D. G. M. was supported by a fellowship from the Australian National Health and Medical Research Council; G. L. by the Wellcome Trust (090532/Z/09/Z); E. T. D. and S. B. M. by the Swiss National Science Foundation, the Louis Jeantet Foundation, and the NIH-National Institute of Mental Health GTEx fund; K.Y. by the Netherlands Organisation for Scientific Research (NWO) VENI grant 639.021.125; and H.Z., Y.L., and J.W. by a National Basic Research Program of China (973 program no. 2011CB809200), the National Natural Science Foundation of China (30725008, 30890032, 30811130531), the Chinese 863 program (2006AA02A302, 2009AA022707), the Shenzhen Municipal Government of China (grants JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, and ZYC200903240080A), and the Ole Romer grant from the Danish Natural Science Research Council, as well as funding from the Shenzhen Municipal Government and the Local Government of Yantian District of Shenzhen. M. B. G. and C.T.-S. contributed equally to this work as senior authors. J.K.P. is on the scientific advisory board of 23andMe, and R. A. G. has a shared investment in Life Technologies. Raw sequence data for the 1000 Genomes pilot projects are available from www.1000genomes.org, and a curated list of the loss-of-function variants described in this manuscript is provided in the supporting online material.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; Balasubramanian S, 2011, GENE DEV, V25, P1, DOI 10.1101/gad.1968411; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Casola C, 2012, GENOME RES, V22, P429, DOI 10.1101/gr.127738.111; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fry AE, 2009, HUM MOL GENET, V18, P2683, DOI 10.1093/hmg/ddp192; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; McCune AR, 2002, SCIENCE, V296, P2398, DOI 10.1126/science.1071757; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Uzumcu A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.032904; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26	28	804	821	9	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					823	828		10.1126/science.1215040	http://dx.doi.org/10.1126/science.1215040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344438	Green Accepted, Green Published			2022-12-01	WOS:000300356400036
J	Degner, JF; Pai, AA; Pique-Regi, R; Veyrieras, JB; Gaffney, DJ; Pickrell, JK; De Leon, S; Michelini, K; Lewellen, N; Crawford, GE; Stephens, M; Gilad, Y; Pritchard, JK				Degner, Jacob F.; Pai, Athma A.; Pique-Regi, Roger; Veyrieras, Jean-Baptiste; Gaffney, Daniel J.; Pickrell, Joseph K.; De Leon, Sherryl; Michelini, Katelyn; Lewellen, Noah; Crawford, Gregory E.; Stephens, Matthew; Gilad, Yoav; Pritchard, Jonathan K.			DNase I sensitivity QTLs are a major determinant of human expression variation	NATURE			English	Article							HUMAN GENE-EXPRESSION; TRANSCRIPTION FACTOR-BINDING; GENOME-WIDE ASSOCIATION; OPEN CHROMATIN; MAP; YEAST	The mapping of expression quantitative trait loci (eQTLs) has emerged as an important tool for linking genetic variation to changes in gene regulation(1-5). However, it remains difficult to identify the causal variants underlying eQTLs, and little is known about the regulatory mechanisms by which they act. Here we show that genetic variants that modify chromatin accessibility and transcription factor binding are a major mechanism through which genetic variation leads to gene expression differences among humans. We used DNase I sequencing to measure chromatin accessibility in 70 Yoruba lymphoblastoid cell lines, for which genome-wide genotypes and estimates of gene expression levels are also available(6-8). We obtained a total of 2.7 billion uniquely mapped DNase I-sequencing (DNase-seq) reads, which allowed us to produce genome-widemaps of chromatin accessibility for each individual. We identified 8,902 locations at which the DNase-seq read depth correlated significantly with genotype at a nearby single nucleotide polymorphism or insertion/deletion (false discovery rate = 10%). We call such variants 'DNase I sensitivity quantitative trait loci' (dsQTLs). We found that dsQTLs are strongly enriched within inferred transcription factor binding sites and are frequently associated with allele-specific changes in transcription factor binding. A substantial fraction (16%) of dsQTLs are also associated with variation in the expression levels of nearby genes (that is, these loci are also classified as eQTLs). Conversely, we estimate that as many as 55% of eQTL single nucleotide polymorphisms are also dsQTLs. Our observations indicate that dsQTLs are highly abundant in the human genome and are likely to be important contributors to phenotypic variation.	[Degner, Jacob F.; Pai, Athma A.; Pique-Regi, Roger; Veyrieras, Jean-Baptiste; Gaffney, Daniel J.; Pickrell, Joseph K.; Stephens, Matthew; Gilad, Yoav; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Degner, Jacob F.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Veyrieras, Jean-Baptiste] BioMiningLabs, F-69001 Lyon, France; [Gaffney, Daniel J.; De Leon, Sherryl; Michelini, Katelyn; Lewellen, Noah; Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Crawford, Gregory E.] Duke Univ, Div Med Genet, Dept Pediat, Sch Med, Durham, NC 27708 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; Duke University; Duke University; University of Chicago	Pritchard, JK (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	gilad@uchicago.edu; pritch@uchicago.edu	Pique-Regi, Roger/A-4110-2009	Pique-Regi, Roger/0000-0002-1262-2275; Pai, Athma/0000-0002-7995-9948	National Institutes of Health [HG006123, MH084703, MH090951]; Howard Hughes Medical Institute; Chicago Fellows Program; American Heart Association; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084703, R01MH090951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Chicago Fellows Program; American Heart Association(American Heart Association); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Pritchard, Przeworski, Stephens and Gilad laboratories for many helpful comments or discussions, and the ENCODE Project for publicly available ChIP-seq data. This work was supported by grants from the National Institutes of Health to Y.G. (HG006123) and J.K.P. (MH084703 and MH090951), by the Howard Hughes Medical Institute, by the Chicago Fellows Program (to R. P. R.), by the American Heart Association (to A. A. P.), and by the NIH Genetics and Regulation Training grant (A.A.P. and J.F.D.).	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/nmeth.1313, 10.1038/NMETH.1313]; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Raveh-Sadka T, 2009, GENOME RES, V19, P1480, DOI 10.1101/gr.088260.108; Song Lingyun, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5384; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wasson T, 2009, GENOME RES, V19, P2101, DOI 10.1101/gr.093450.109; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	30	418	424	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					390	394		10.1038/nature10808	http://dx.doi.org/10.1038/nature10808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22307276	Green Accepted			2022-12-01	WOS:000300287100044
J	Gillison, ML; Broutian, T; Pickard, RKL; Tong, ZY; Xiao, WH; Kahle, L; Graubard, BI; Chaturvedi, AK				Gillison, Maura L.; Broutian, Tatevik; Pickard, Robert K. L.; Tong, Zhen-you; Xiao, Weihong; Kahle, Lisa; Graubard, Barry I.; Chaturvedi, Anil K.			Prevalence of Oral HPV Infection in the United States, 2009-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; NUTRITION EXAMINATION SURVEY; SQUAMOUS-CELL CARCINOMAS; NATIONAL-HEALTH; HEAD; VACCINE; RISK; PERSISTENCE; FEMALES; TOBACCO	Context Human papillomavirus (HPV) infection is the principal cause of a distinct form of oropharyngeal squamous cell carcinoma that is increasing in incidence among men in the United States. However, little is known about the epidemiology of oral HPV infection. Objective To determine the prevalence of oral HPV infection in the United States. Design, Setting, and Participants A cross-sectional study was conducted as part of the National Health and Nutrition Examination Survey (NHANES) 2009-2010, a statistically representative sample of the civilian noninstitutionalized US population. Men and women aged 14 to 69 years examined at mobile examination centers were eligible. Participants (N=5579) provided a 30-second oral rinse and gargle with mouthwash. For detection of HPV types, DNA purified from oral exfoliated cells was evaluated by polymerase chain reaction and type-specific hybridization. Demographic and behavioral data were obtained by standardized interview. Statistical analyses used NHANES sample weights to provide weighted prevalence estimates for the US population. Main Outcome Measures Prevalence of oral HPV infection. Results The prevalence of oral HPV infection among men and women aged 14 to 69 years was 6.9% (95% CI, 5.7%-8.3%) and of HPV type 16 was 1.0% (95% CI, 0.7%-1.3%). Oral HPV infection followed a bimodal pattern with respect to age, with peak prevalence among individuals aged 30 to 34 years (7.3%; 95% CI, 4.6%-11.4%) and 60 to 64 years (11.4%; 95% CI, 8.5%-15.1%). Men had a significantly higher prevalence than women for any oral HPV infection (10.1% [95% CI, 8.3%-12.3%] vs 3.6% [95% CI, 2.6%-5.0%], P < .001; unadjusted prevalence ratio [PR], 2.80 [95% CI, 2.02-3.88]). Infection was less common among those without vs those with a history of any type of sexual contact (0.9% [95% CI, 0.4%-1.8%] vs 7.5% [95% CI, 6.1%-9.1%], P < .001; PR, 8.69 [95% CI, 3.91-19.31]) and increased with number of sexual partners (P < .001 for trend) and cigarettes smoked per day (P < .001 for trend). Associations with age, sex, number of sexual partners, and current number of cigarettes smoked per day were independently associated with oral HPV infection in multivariable models. Conclusion Among men and women aged 14 to 69 years in the United States, the overall prevalence of oral HPV infection was 6.9%, and the prevalence was higher among men than among women. JAMA. 2012;307(7):693-703 Published online January 26, 2012. doi:10.1001/jama.2012.101	[Gillison, Maura L.; Broutian, Tatevik; Pickard, Robert K. L.; Tong, Zhen-you; Xiao, Weihong] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Kahle, Lisa] Informat Management Serv Inc, Silver Spring, MD USA; [Graubard, Barry I.; Chaturvedi, Anil K.] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Information Management Services, Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gillison, ML (corresponding author), Ohio State Univ, Ctr Comprehens Canc, 420 W 12th Ave, Columbus, OH 43210 USA.	maura.gillison@osumc.edu	Chaturvedi, Anil/J-2024-2015	Chaturvedi, Anil/0000-0003-2696-8899	Merck; Ohio State University Comprehensive Cancer Center; John and Nina Cassils; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023175] Funding Source: NIH RePORTER	Merck(Merck & Company); Ohio State University Comprehensive Cancer Center; John and Nina Cassils; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gillison is the principal investigator of the unrestricted grant from Merck in support of this study and has been a consultant to Merck and GlaxoSmithKline. No other disclosures were reported.; This study was supported by the Ohio State University Comprehensive Cancer Center, Merck, John and Nina Cassils, and the Intramural Research Program of the National Cancer Institute.	[Anonymous], 2008, SUDAAN LANG MAN REL; [Anonymous], 2009 2010 DAT DOC CO; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Broutian TR, 2011, J CLIN VIROL, V50, P270, DOI 10.1016/j.jcv.2010.12.005; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Finer LB, 2007, PUBLIC HEALTH REP, V122, P73, DOI 10.1177/003335490712200110; Garcia-Pineres AJ, 2006, CANCER RES, V66, P11070, DOI 10.1158/0008-5472.CAN-06-2034; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Hariri S, 2011, J INFECT DIS, V204, P566, DOI 10.1093/infdis/jir341; Hernandez BY, 2008, EMERG INFECT DIS, V14, P888, DOI 10.3201/eid1406.070616; Hong AM, 2010, VACCINE, V28, P3269, DOI 10.1016/j.vaccine.2010.02.098; Korn EL, 1998, SURV METHODOL, V24, P193; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Markowitz LE, 2009, J INFECT DIS, V200, P1059, DOI 10.1086/604729; Marks M, 2009, J VIROL METHODS, V156, P152, DOI 10.1016/j.jviromet.2008.10.013; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Safaeian M, 2010, JNCI-J NATL CANCER I, V102, P1653, DOI 10.1093/jnci/djq384; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Smith EM, 2010, CANCER CAUSE CONTROL, V21, P1369, DOI 10.1007/s10552-010-9564-z; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Wang SS, 2004, BRIT J CANCER, V91, P1269, DOI 10.1038/sj.bjc.6602088; Wiley DJ, 2006, CANCER EPIDEM BIOMAR, V15, P915, DOI 10.1158/1055-9965.EPI-05-0963	39	706	717	2	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2012	307	7					693	703		10.1001/jama.2012.101	http://dx.doi.org/10.1001/jama.2012.101			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892HY	22282321	Green Accepted, Bronze			2022-12-01	WOS:000300278500026
J	Murray, CJL; Rosenfeld, LC; Lim, SS; Andrews, KG; Foreman, KJ; Haring, D; Fullman, N; Naghavi, M; Lozano, R; Lopez, AD				Murray, Christopher J. L.; Rosenfeld, Lisa C.; Lim, Stephen S.; Andrews, Kathryn G.; Foreman, Kyle J.; Haring, Diana; Fullman, Nancy; Naghavi, Mohsen; Lozano, Rafael; Lopez, Alan D.			Global malaria mortality between 1980 and 2010: a systematic analysis	LANCET			English	Article							PLASMODIUM-FALCIPARUM MALARIA; DIAGNOSTIC GOLD STANDARDS; VERBAL AUTOPSY; CHILD-MORTALITY; NATIONAL CAUSES; 187 COUNTRIES; VALIDATION; AFRICA; HEALTH; PROGRESS	Background During the past decade, renewed global and national efforts to combat malaria have led to ambitious goals. We aimed to provide an accurate assessment of the levels and time trends in malaria mortality to aid assessment of progress towards these goals and the focusing of future efforts. Methods We systematically collected all available data for malaria mortality for the period 1980-2010, correcting for misclassification bias. We developed a range of predictive models, including ensemble models, to estimate malaria mortality with uncertainty by age, sex, country, and year. We used key predictors of malaria mortality such as Plasmodium falciparum parasite prevalence, first-line antimalarial drug resistance, and vector control. We used out-of-sample predictive validity to select the final model. Findings Global malaria deaths increased from 995 000 (95% uncertainty interval 711 000-1 412 000) in 1980 to a peak of 1 817 000 (1 430 000-2 366 000) in 2004, decreasing to 1 238 000 (929 000-1 685 000) in 2010. In Africa, malaria deaths increased from 493 000 (290 000-747 000) in 1980 to 1 613 000 (1 243 000-2 145 000) in 2004, decreasing by about 30% to 1 133 000 (848 000-1 591 000) in 2010. Outside of Africa, malaria deaths have steadily decreased from 502 000 (322 000-833 000) in 1980 to 104 000 (45 000-191 000) in 2010. We estimated more deaths in individuals aged 5 years or older than has been estimated in previous studies: 435 000 (307 000-658 000) deaths in Africa and 89 000 (33 000-177 000) deaths outside of Africa in 2010. Interpretation Our findings show that the malaria mortality burden is larger than previously estimated, especially in adults. There has been a rapid decrease in malaria mortality in Africa because of the scaling up of control activities supported by international donors. Donor support, however, needs to be increased if malaria elimination and eradication and broader health and development goals are to be met.	[Murray, Christopher J. L.; Rosenfeld, Lisa C.; Lim, Stephen S.; Andrews, Kathryn G.; Foreman, Kyle J.; Haring, Diana; Fullman, Nancy; Naghavi, Mohsen; Lozano, Rafael] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Queensland	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@u.washington.edu	Lopez, Alan/AAA-2734-2022; Lozano, Rafael/T-5352-2018; Lopez, Alan D/F-1487-2010; Lim, Stephen S/B-4055-2012	Lozano, Rafael/0000-0002-7356-8823; Lopez, Alan D/0000-0001-5818-6512; 	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill & Melinda Gates Foundation.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; [Anonymous], 2011, LANCET, V378, P1896, DOI 10.1016/S0140-6736(11)61826-6; [Anonymous], GLOB REP ANT EFF DRU; [Anonymous], FIN GLOB HLTH 2010 D; Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Flaxman AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-29; Flaxman AD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000328; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; HANDCOCK MS, 1994, J AM STAT ASSOC, V89, P368, DOI 10.2307/2290832; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2010, LANCET, V376, P1716, DOI 10.1016/S0140-6736(10)61084-7; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; James SL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-31; KNOTTERS M, 1995, GEODERMA, V67, P227, DOI 10.1016/0016-7061(95)00011-C; Korenromp E, MALARIA INCIDENCE ES; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Landagan OZ, 2007, STAT PROBABIL LETT, V77, P401, DOI 10.1016/j.spl.2006.08.006; Leach-Kemon K, 2012, HEALTH AFFAIR, V31, P228, DOI 10.1377/hlthaff.2011.1154; Lengeler C, 1999, COCHRANE DATABASE SY, P1; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-32; Lysenko AY., 1968, MEDICINSKAJA GEOGRAF, V25, P146; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-30; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Murray CJ, GLOBAL BURDEN DIS CO; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Ringwald P, 2005, SUSCEPTIBILITY PLASM; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Shah NK, 2011, LANCET, V377, P991, DOI 10.1016/S0140-6736(11)60378-4; Snow RW, 2004, AM J TROP MED HYG, V71, P16, DOI 10.4269/ajtmh.2004.71.16; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; STURCHLER D, 1989, PARASITOL TODAY, V5, P39, DOI 10.1016/0169-4758(89)90188-9; Tatem AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-4; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Trape JF, 2002, TRENDS PARASITOL, V18, P224, DOI 10.1016/S1471-4922(02)02249-3; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Trigg PI, 1998, B WORLD HEALTH ORGAN, V76, P11; United Nations News Service Section, 2011, UN ENV STRESS MAL DE; WHO, 2010, WORLD MALARIA REPORT 2010, P1; *WHO, WORLD MAL REP 2005; WHO, 2011, WORLD MAL SIT 1994; WHO, WORLD MAL REP 2011; *WHO, WORLD HLTH REP 1999; *WHO, GLOB BURD DIS GBD 20; *WHO, WORLD MAL REP 2009; World Health Organization, 2004, GLOB BURD DIS 2004 U; WORLDHEALTH ORGANIZATION (WHO), 2008, WORLD MAL REP 2008	60	1023	1057	2	260	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					413	431		10.1016/S0140-6736(12)60034-8	http://dx.doi.org/10.1016/S0140-6736(12)60034-8			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AF	22305225				2022-12-01	WOS:000300187800032
J	Iverson, V; Morris, RM; Frazar, CD; Berthiaume, CT; Morales, RL; Armbrust, EV				Iverson, Vaughn; Morris, Robert M.; Frazar, Christian D.; Berthiaume, Chris T.; Morales, Rhonda L.; Armbrust, E. Virginia			Untangling Genomes from Metagenomes: Revealing an Uncultured Class of Marine Euryarchaeota	SCIENCE			English	Article							BACTERIA; ARCHAEA; SEA; ASSEMBLAGES; METABOLISM; SEQUENCE	Ecosystems are shaped by complex communities of mostly unculturable microbes. Metagenomes provide a fragmented view of such communities, but the ecosystem functions of major groups of organisms remain mysterious. To better characterize members of these communities, we developed methods to reconstruct genomes directly from mate-paired short-read metagenomes. We closed a genome representing the as-yet uncultured marine group II Euryarchaeota, assembled de novo from 1.7% of a metagenome sequenced from surface seawater. The genome describes a motile, photo-heterotrophic cell focused on degradation of protein and lipids and clarifies the origin of proteorhodopsin. It also demonstrates that high-coverage mate-paired sequence can overcome assembly difficulties caused by interstrain variation in complex microbial communities, enabling inference of ecosystem functions for uncultured members.	[Iverson, Vaughn; Morris, Robert M.; Frazar, Christian D.; Berthiaume, Chris T.; Morales, Rhonda L.; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Box 357940, Seattle, WA 98195 USA.	armbrust@uw.edu	Morris, Robert/C-5188-2012		Gordon and Betty Moore Foundation; NSF [OCE-0723866]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF))	We thank D. Kingsbury and T. Hunkapiller for helpful conversations about experimental design; W. Martens-Habbena, D. Stahl, and J. Baross for reviewing draft protein annotations; Q. Wang for providing the RDP classifier training set data; D. Schruth for technical support; and A. Ingalls and J. Baross for valuable comments on the draft manuscript. We are grateful to Life Technologies, Incorporated, for SOLiD sequencing of the October 2008 sample. This study was supported by a Gordon and Betty Moore Foundation Marine Microbiology Investigator Award and NSF grant OCE-0723866. Sequences reported in this study have been deposited in the National Center for Biotechnology Information (NCBI) Sequence Read Archive under accession no. SRA047968 and in GenBank under accession nos. JF965490 to JF965492 and JN591771 to JN592031. The Whole Genome Shotgun project has been deposited at DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank under the accession AHCG00000000. The version described in this paper is the first version, AHCG01000000. Information regarding the custom software developed for use in this research is available at http://armbrustlab.ocean.washington.edu/software.	Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Beja O, 2004, CURR OPIN BIOTECH, V15, P187, DOI 10.1016/j.copbio.2004.03.005; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Galand PE, 2010, LIMNOL OCEANOGR, V55, P2117, DOI 10.4319/lo.2010.55.5.2117; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Herfort L, 2007, FEMS MICROBIOL ECOL, V62, P242, DOI 10.1111/j.1574-6941.2007.00397.x; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Karl DM, 2007, NAT REV MICROBIOL, V5, P759, DOI 10.1038/nrmicro1749; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Martin-Cuadrado AB, 2008, ISME J, V2, P865, DOI 10.1038/ismej.2008.40; Moreira D, 2004, ENVIRON MICROBIOL, V6, P959, DOI 10.1111/j.1462-2920.2004.00644.x; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P661, DOI 10.1128/AEM.68.2.661-667.2002; Petrovskaya LE, 2010, FEBS LETT, V584, P4193, DOI 10.1016/j.febslet.2010.09.005; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reysenbach AL, 2008, GEOBIOLOGY, V6, P331, DOI 10.1111/j.1472-4669.2008.00152.x; Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Rusch DB, 2010, P NATL ACAD SCI USA, V107, P16184, DOI 10.1073/pnas.1009513107; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	29	329	338	7	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2012	335	6068					587	590		10.1126/science.1212665	http://dx.doi.org/10.1126/science.1212665			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22301318				2022-12-01	WOS:000299769200044
J	Bowman, D				Bowman, David			Bring elephants to Australia?	NATURE			English	Editorial Material							FIRE		Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia	University of Tasmania	Bowman, D (corresponding author), Univ Tasmania, Sch Plant Sci, Private Bag 55, Hobart, Tas 7001, Australia.	david.bowman@utas.edu.au	Bowman, David M.J.S./A-2930-2011	Bowman, David M.J.S./0000-0001-8075-124X				Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Burgess CP, 2009, MED J AUSTRALIA, V190, P567, DOI 10.5694/j.1326-5377.2009.tb02566.x; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Finlayson C. M., 1997, Wetlands Ecology and Management, V5, P19, DOI 10.1023/A:1008271219441; Flannery Tim, 1994, FUTURE EATERS ECOLOG; Johnson C., 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Low T., 1999, FERAL FUTURE UNTOLD; Setterfield SA, 2010, DIVERS DISTRIB, V16, P854, DOI 10.1111/j.1472-4642.2010.00688.x; Williams RJ, 2006, AUSTRAL ECOL, V31, P925, DOI 10.1111/j.1442-9993.2006.01655.x	10	38	41	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 2	2012	482	7383					30	30		10.1038/482030a	http://dx.doi.org/10.1038/482030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22297953	Bronze			2022-12-01	WOS:000299726000015
J	Murray, J; King, D				Murray, James; King, David			Oil's tipping point has passed	NATURE			English	Editorial Material									[Murray, James] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Murray, J (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	jmurray@u.washington.edu	, James Murray/HCI-3547-2022	Murray, James/0000-0002-8577-7964				[Anonymous], 2011, REP DIAL OIL SANDS C; [Anonymous], 2011, ANN EN OUTL 2011 US; [Anonymous], 2007, FIND CRIT NUMB WHAT; Energy Watch Group, 2007, EWG SER, V3/2007; Hamilton JD, 2009, BROOKINGS PAP ECO AC, P215; Hirsch R.L., 2005, PEAKING WORLD OIL PR; Hirsch R.L., 2010, IMPENDING WORLD ENER; Hughes D, 2011, WILL NATURAL GAS FUE; International Energy Agency, 2008, WORLD EN OUTL 2008; National Research Council, 2007, COAL MIN PROC COAL R; Owen NA, 2010, ENERG POLICY, V38, P4743, DOI 10.1016/j.enpol.2010.02.026; Rutledge D, 2011, INT J COAL GEOL, V85, P23, DOI 10.1016/j.coal.2010.10.012; World Energy Council, 2010, 2010 SURV EN RES	13	257	259	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 26	2012	481	7382					433	435		10.1038/481433a	http://dx.doi.org/10.1038/481433a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	881GY	22281577	Bronze			2022-12-01	WOS:000299471800013
J	Rodriguez-Arias, D; Deballon, IO				Rodriguez-Arias, David; Ortega Deballon, Ivan			Protocols for uncontrolled donation after circulatory death	LANCET			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; HYPOTHERMIA; GUIDELINES; SUPPORT		[Rodriguez-Arias, David] CSIC, Inst Philosophy, Ctr Human & Social Sci, Madrid 28037, Spain; [Ortega Deballon, Ivan] Helicopter Emergency Med Serv, Madrid, Spain; [Ortega Deballon, Ivan] Univ Alcala de Henares, Sch Nursing, Alcala De Henares, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Ciencias Humanas y Sociales (CCHS); CSIC - Instituto de Filosofia (IFS); Universidad de Alcala	Rodriguez-Arias, D (corresponding author), CSIC, Inst Philosophy, Ctr Human & Social Sci, Madrid 28037, Spain.	david.rodriguezarias@cchs.csic.es	Rodríguez-Arias, David/K-5894-2014; ORTEGA, IVAN/C-6307-2017	Rodríguez-Arias, David/0000-0002-4555-5259; ORTEGA, IVAN/0000-0002-0819-2399				Bernat JL, 2010, CRIT CARE MED, V38, P963, DOI 10.1097/CCM.0b013e3181c58916; Bottiger BW, 2001, LANCET, V357, P1583, DOI 10.1016/S0140-6736(00)04726-7; Childress JF, 2008, J LAW MED ETHICS, V36, P766, DOI 10.1111/j.1748-720X.2008.00336.x; Conseil francais de reanimation cardiopulmonaire, 2009, Ann Fr Anesth Reanim, V28, P182, DOI 10.1016/j.annfar.2008.12.011; Lederer W, 2004, RESUSCITATION, V61, P123, DOI 10.1016/j.resuscitation.2003.12.016; Massetti M, 2005, ANN THORAC SURG, V79, P178, DOI 10.1016/j.athoracsur.2004.06.095; Nagao K, 2010, CIRC J, V74, P77, DOI 10.1253/circj.CJ-09-0502; Nielsen N, 2005, RESUSCITATION, V65, P111, DOI 10.1016/j.resuscitation.2004.11.007; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Olivecrona G, 2011, INTERV CARDIOL, V6, P12; Thiagarajan RR, 2009, ANN THORAC SURG, V87, P778, DOI 10.1016/j.athoracsur.2008.12.079; Vanden Hoek TL, 2010, CIRCULATION, V122, pS829, DOI 10.1161/CIRCULATIONAHA.110.971069; Wall SP, 2011, AM J TRANSPLANT, V11, P1417, DOI 10.1111/j.1600-6143.2011.03582.x; Zeiler K, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.021568	14	35	37	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2012	379	9823					1275	1276		10.1016/S0140-6736(11)61784-4	http://dx.doi.org/10.1016/S0140-6736(11)61784-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922FB	22483020				2022-12-01	WOS:000302531100004
J	Huang, W; Perez-Garcia, P; Pokhilko, A; Millar, AJ; Antoshechkin, I; Riechmann, JL; Mas, P				Huang, W.; Perez-Garcia, P.; Pokhilko, A.; Millar, A. J.; Antoshechkin, I.; Riechmann, J. L.; Mas, P.			Mapping the Core of the Arabidopsis Circadian Clock Defines the Network Structure of the Oscillator	SCIENCE			English	Article							PSEUDO-RESPONSE REGULATORS; TOC1; RHYTHMS; TIME; EXPRESSION; THALIANA; GIGANTEA; GENE	In many organisms, the circadian clock is composed of functionally coupled morning and evening oscillators. In Arabidopsis, oscillator coupling relies on a core loop in which the evening oscillator component TIMING OF CAB EXPRESSION 1 (TOC1) was proposed to activate a subset of morning-expressed oscillator genes. Here, we show that TOC1 does not function as an activator but rather as a general repressor of oscillator gene expression. Repression occurs through TOC1 rhythmic association to the promoters of the oscillator genes. Hormone-dependent induction of TOC1 and analysis of RNA interference plants show that TOC1 prevents the activation of morning-expressed genes at night. Our study overturns the prevailing model of the Arabidopsis circadian clock, showing that the morning and evening oscillator loops are connected through the repressing activity of TOC1.	[Huang, W.; Perez-Garcia, P.; Riechmann, J. L.; Mas, P.] Ctr Res Agr Genom, Barcelona 08193, Spain; [Pokhilko, A.; Millar, A. J.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Millar, A. J.] Ctr Syst Biol Edinburgh, Edinburgh EH9 3JD, Midlothian, Scotland; [Antoshechkin, I.; Riechmann, J. L.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Antoshechkin, I.; Riechmann, J. L.] Inst Catalana Rec & Estudis Avancats, Barcelona 08010, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Edinburgh; California Institute of Technology; ICREA	Mas, P (corresponding author), Ctr Res Agr Genom, Barcelona 08193, Spain.	paloma.mas@cragenomica.es	Perez-Garcia, Pablo/O-6860-2017; Riechmann, José Luis/M-7005-2018; Millar, Andrew J/G-2423-2012; Mas, Paloma/B-8215-2016	Perez-Garcia, Pablo/0000-0001-8595-8530; Riechmann, José Luis/0000-0003-1108-1945; Millar, Andrew J/0000-0003-1756-3654; Mas, Paloma/0000-0002-3780-8041	Ramon Areces Foundation; Spanish Ministry of Science and Innovation (MICINN); European Molecular Biology Organization (EMBO); European Heads of Research Councils; European Science Foundation; European Comission (EC); MICINN; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council [D019621]; BBSRC [BB/D019621/1] Funding Source: UKRI; ICREA Funding Source: Custom; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish	Ramon Areces Foundation; Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); European Heads of Research Councils; European Science Foundation(European Science Foundation (ESF)European Commission); European Comission (EC); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ICREA(ICREA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. Meyerowitz for comments on the manuscript, E. Centeno for help with ChIP-Seq analysis, O. Casagran for help with the microfluidic arrays, M. Perales for help with the ChIP, L. Rico for help with the inducible constructs, and L. Schaeffer and D. Trout (Jacobs Genetics and Genomics Laboratory at Caltech) for the primary sequence data processing. This work was supported by grants to P. M. from the Ramon Areces Foundation, the Spanish Ministry of Science and Innovation (MICINN), the European Molecular Biology Organization (EMBO) Young Investigators Program, and from the European Heads of Research Councils and the European Science Foundation through the European Young Investigator Award; to J.L.R. from the European Comission (EC) Marie Curie program and MICINN; and to A.J.M. and others from the EC FP7 Collaborative Project TiMet. The Centre for Systems Biology at Edinburgh is a Centre for Integrative and Systems Biology supported by the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council award D019621. W. H. is supported by a Juan de la Cierva contract (MICINN) and P. P.-G. by a Formacion de Personal Investigador fellowship (MICINN). Sequencing data have been deposited with the National Center for Biotechnology Information Gene Expression Omnibus under accession number GSE35952.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Baudry A, 2010, PLANT CELL, V22, P606, DOI 10.1105/tpc.109.072843; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Herrero E., 2012, PLANT CELL; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; McClung CR, 2010, CURR OPIN GENET DEV, V20, P588, DOI 10.1016/j.gde.2010.08.010; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Pokhilko A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.69; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Somers DE, 1998, DEVELOPMENT, V125, P485; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101	27	341	356	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					75	79		10.1126/science.1219075	http://dx.doi.org/10.1126/science.1219075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22403178	Green Submitted			2022-12-01	WOS:000302405400054
J	Abraham, T				Abraham, Thomas			Polio eradication: a complex end game	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Abraham, T (corresponding author), Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China.	thomas@hku.hk						[Anonymous], 2011, WHO WKLY EPIDEMIOL R, V46, P510; Berhane Y, 2009, LANCET INFECT DIS, V9, P655, DOI 10.1016/S1473-3099(09)70268-3; Global Polio Eradication Initiative, CIRC VACC DER POL CV	3	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 2	2012	344								e2398	10.1136/bmj.e2398	http://dx.doi.org/10.1136/bmj.e2398			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GB	22474304				2022-12-01	WOS:000302606500010
J	Collins, R				Collins, Rory			What makes UK Biobank special?	LANCET			English	Editorial Material							COHORT		UK Biobank, Stockport SK3 0SA, Lancs, England		Collins, R (corresponding author), UK Biobank, Stockport SK3 0SA, Lancs, England.	ukbiobank@ukbiobank.ac.uk			Wellcome Trust [093707] Funding Source: Medline; Medical Research Council [MC_qA137853] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Manolio TA, 2010, JAMA-J AM MED ASSOC, V304, P2290, DOI 10.1001/jama.2010.1686; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Tapia-Conyer R, 2006, INT J EPIDEMIOL, V35, P243, DOI 10.1093/ije/dyl042; UK Biobank Coordinating Centre, 2007, UKBBPROT0906; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	12	416	425	2	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1173	1174		10.1016/S0140-6736(12)60404-8	http://dx.doi.org/10.1016/S0140-6736(12)60404-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	22463865				2022-12-01	WOS:000302230400008
J	Duffy, MA; Ochs, JH; Penczykowski, RM; Civitello, DJ; Klausmeier, CA; Hall, SR				Duffy, Meghan A.; Ochs, Jessica Housley; Penczykowski, Rachel M.; Civitello, David J.; Klausmeier, Christopher A.; Hall, Spencer R.			Ecological Context Influences Epidemic Size and Parasite-Driven Evolution	SCIENCE			English	Article							RAPID EVOLUTION; SELECTIVE PREDATION; RESISTANCE; DAPHNIA; LIMITATION; PHOSPHORUS; FEEDBACKS; NITROGEN; LAKES	The occurrence and magnitude of disease outbreaks can strongly influence host evolution. In particular, when hosts face a resistance-fecundity trade-off, they might evolve increased resistance to infection during larger epidemics but increased susceptibility during smaller ones. We tested this theoretical prediction by using a zooplankton-yeast host-parasite system in which ecological factors determine epidemic size. Lakes with high productivity and low predation pressure had large yeast epidemics; during these outbreaks, hosts became more resistant to infection. However, with low productivity and high predation, epidemics remained small and hosts evolved increased susceptibility. Thus, by modulating disease outbreaks, ecological context (productivity and predation) shaped host evolution during epidemics. Consequently, anthropogenic alteration of productivity and predation might strongly influence both ecological and evolutionary outcomes of disease.	[Duffy, Meghan A.; Ochs, Jessica Housley; Penczykowski, Rachel M.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Civitello, David J.; Hall, Spencer R.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Klausmeier, Christopher A.] Michigan State Univ, WK Kellogg Biol Stn KBS, Hickory Corners, MI 49060 USA; [Klausmeier, Christopher A.] Michigan State Univ, Dept Zool, Hickory Corners, MI 49060 USA	University System of Georgia; Georgia Institute of Technology; Indiana University System; Indiana University Bloomington; Michigan State University; Michigan State University	Duffy, MA (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	duffy@gatech.edu	Penczykowski, Rachel/K-4007-2015; Duffy, Meghan A/E-6867-2016; Penczykowski, Rachel/AAH-4208-2019; Klausmeier, Christopher A/J-9339-2012; Duffy, Meghan/AFN-5376-2022; Duffy, Meghan A/A-9376-2008	Penczykowski, Rachel/0000-0003-4559-0609; Duffy, Meghan A/0000-0002-8142-0802; Penczykowski, Rachel/0000-0003-4559-0609; Duffy, Meghan/0000-0002-8142-0802; Klausmeier, Christopher/0000-0002-6987-5871	NSF [DEB-0841679, DEB-0841817, DEB-0845825, OCE-0928819]; James S. McDonnell Foundation	NSF(National Science Foundation (NSF)); James S. McDonnell Foundation	We thank S. Hernandez, K. Jansen, K. Kenline, A. Reynolds, B. Sarrell, K. van Rensburg, and C. Washington for assistance in the lab; K. Boatman, Z. Brown, A. Bowling, C. White, and P. Forys for their help with the field survey; and S. Auld and two anonymous reviewers for comments on the manuscript. This work was supported by NSF (grants DEB-0841679 to M.A.D., DEB-0841817 to S.R.H., and DEB-0845825 and OCE-0928819 to C.A.K.) and by a grant from the James S. McDonnell Foundation (to C.A.K.). We appreciate cooperation from S. Siscoe at the Indiana Department of Natural Resources's Division of Forestry and R. Ronk at the Division of Fish and Wildlife for the field survey. This is KBS contribution no. 1607. Data are available in the SOM and from the lead author (M.A.D.).	ANDERSON R M, 1991; ANTONOVICS J, 1994, P ROY SOC B-BIOL SCI, V257, P105, DOI 10.1098/rspb.1994.0101; Boots M, 1999, AM NAT, V153, P359, DOI 10.1086/303181; Boots M, 2009, PHILOS T R SOC B, V364, P27, DOI 10.1098/rstb.2008.0160; BOWERS RG, 1994, P ROY SOC B-BIOL SCI, V257, P247, DOI 10.1098/rspb.1994.0122; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Duffy MA, 2005, LIMNOL OCEANOGR, V50, P412, DOI 10.4319/lo.2005.50.2.0412; Duffy MA, 2008, AM NAT, V171, P499, DOI 10.1086/528998; Duffy MA, 2007, ECOL LETT, V10, P44, DOI 10.1111/j.1461-0248.2006.00995.x; Duffy MA, 2009, J ANIM ECOL, V78, P1106, DOI 10.1111/j.1365-2656.2009.01568.x; Duffy MA, 2009, ECOLOGY, V90, P1441, DOI 10.1890/08-1130.1; Duffy MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-80; Dybdahl MF, 1998, EVOLUTION, V52, P1057, DOI 10.1111/j.1558-5646.1998.tb01833.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Greenberg AE, 1995, STANDARD METHODS EXA; Guildford SJ, 2000, LIMNOL OCEANOGR, V45, P1213, DOI 10.4319/lo.2000.45.6.1213; Hall SR, 2011, OECOLOGIA, V166, P833, DOI 10.1007/s00442-011-1905-4; Hall SR, 2010, AM NAT, V176, P557, DOI 10.1086/656523; Hall SR, 2010, BIOSCIENCE, V60, P363, DOI 10.1525/bio.2010.60.5.6; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Keeling MJ, 2008, MODELING INFECT DIS; KITCHELL JA, 1980, LIMNOL OCEANOGR, V25, P389, DOI 10.4319/lo.1980.25.3.0389; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Overholt EP, 2012, ECOL LETT, V15, P47, DOI 10.1111/j.1461-0248.2011.01707.x; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; PARKER MA, 1991, EVOLUTION, V45, P1209, DOI 10.1111/j.1558-5646.1991.tb04387.x; Penczykowski RM, 2011, FRESHWATER BIOL, V56, P689, DOI 10.1111/j.1365-2427.2010.02499.x	27	76	76	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1636	1638		10.1126/science.1215429	http://dx.doi.org/10.1126/science.1215429			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461614				2022-12-01	WOS:000302062600048
J	Molyneux, DH				Molyneux, David H.			Tropical Lymphedemas - Control and Prevention	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Molyneux, DH (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England.							[Anonymous], 2011, Wkly Epidemiol Rec, V86, P377; [Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P17; Davey G, 2007, LANCET, V369, P888, DOI 10.1016/S0140-6736(07)60425-5; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317	4	20	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2012	366	13					1169	1171		10.1056/NEJMp1202011	http://dx.doi.org/10.1056/NEJMp1202011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	915DW	22455411	Green Accepted			2022-12-01	WOS:000302005100001
J	Nishtar, S				Nishtar, Sania			Pakistan's deadly cocktail of substandard drugs	LANCET			English	Editorial Material									Heartfile, Chak Shahzad, Islamabad, Pakistan		Nishtar, S (corresponding author), Heartfile, Chak Shahzad, Islamabad, Pakistan.	sania@heartfile.org						[Anonymous], 2016, NATL POLICY PROGRAM; McGinnis N., 2011, MEDIA REPORTS MED QU; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Nishtar S, 2010, CHOKED PIPES REFORMI; Nishtar S, 2011, LANCET, V378, P648, DOI 10.1016/S0140-6736(11)60606-5; Pak Tribune, 2006, PAK TRIBUNE     0515; Sengaloundeth S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-172; World Health Organization, 2012, DRUG SAF AL	8	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 24	2012	379	9821					1084	1085		10.1016/S0140-6736(12)60277-3	http://dx.doi.org/10.1016/S0140-6736(12)60277-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916VR	22394558				2022-12-01	WOS:000302131800012
J	Milczarek, G; Inganas, O				Milczarek, Grzegorz; Inganas, Olle			Renewable Cathode Materials from Biopolymer/Conjugated Polymer Interpenetrating Networks	SCIENCE			English	Article							ELECTROCHEMICALLY ACTIVE POLYMERS; MODIFIED ELECTRODE; POLYPYRROLE; BATTERIES; LIGNOSULFONATE; OXIDATION; CHARGE	Renewable and cheap materials in electrodes could meet the need for low-cost, intermittent electrical energy storage in a renewable energy system if sufficient charge density is obtained. Brown liquor, the waste product from paper processing, contains lignin derivatives. Polymer cathodes can be prepared by electrochemical oxidation of pyrrole to polypyrrole in solutions of lignin derivatives. The quinone group in lignin is used for electron and proton storage and exchange during redox cycling, thus combining charge storage in lignin and polypyrrole in an interpenetrating polypyrrole/lignin composite.	[Inganas, Olle] Linkoping Univ, Dept Phys Chem & Biol, S-58183 Linkoping, Sweden; [Milczarek, Grzegorz] Poznan Tech Univ, Inst Chem & Tech Electrochem, PL-60965 Poznan, Poland	Linkoping University; Poznan University of Technology	Inganas, O (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, S-58183 Linkoping, Sweden.	ois@ifm.liu.se	Milczarek, Grzegorz/N-2080-2014	Inganas, Olle/0000-0002-6243-1450	Knut and Alice Wallenberg Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Knut and Alice Wallenberg Foundation, and O.I. is a Wallenberg Scholar. We thank R. Gabrielsson, N. Solin, A. Elfving, and V. Andersson for experimental support and discussion. The kind donation of lignosulfonate samples from Borregaard LignoTech AS is gratefully acknowledged. The authors have applied for a Swedish patent on the class of materials reported here.	Agarwal U.P., 2010, LIGNIN LIGNANS ADV C, P104, DOI 10.1201/EBK1574444865; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; BJORKLUND RB, 1986, J CHEM SOC CHEM COMM, P1293, DOI 10.1039/c39860001293; Haringer D, 1999, J ELECTROCHEM SOC, V146, P2393, DOI 10.1149/1.1391947; Hashmi SA, 2004, J POWER SOURCES, V137, P145, DOI 10.1016/j.jpowsour.2004.05.007; Huang YH, 2008, CHEM MATER, V20, P7237, DOI 10.1021/cm8012304; INGANAS O, 1984, J PHYS CHEM SOLIDS, V45, P427, DOI 10.1016/0022-3697(84)90150-1; Meyer TJ, 2007, ANGEW CHEM INT EDIT, V46, P5284, DOI 10.1002/anie.200600917; Milczarek G, 2008, ELECTROANAL, V20, P211, DOI 10.1002/elan.200704071; Milczarek G, 2007, ELECTROANAL, V19, P1411, DOI 10.1002/elan.200703870; Milczarek G, 2009, LANGMUIR, V25, P10345, DOI 10.1021/la9008575; Naoi K, 2000, J ELECTROCHEM SOC, V147, P420, DOI 10.1149/1.1393212; NOVAK P, 1987, J ELECTROCHEM SOC, V134, P1341, DOI 10.1149/1.2100670; Novak P, 1997, CHEM REV, V97, P207, DOI 10.1021/cr941181o; Nyholm L, 2011, ADV MATER, V23, P3751, DOI 10.1002/adma.201004134; Nystrom G, 2009, NANO LETT, V9, P3635, DOI 10.1021/nl901852h; PEI Q, 1991, SYNTHETIC MET, V45, P35, DOI 10.1016/0379-6779(91)91845-2; Piro B, 1998, J CHIM PHYS PCB, V95, P1522, DOI 10.1051/jcp:1998320; Sasso C, 2008, BIORESOURCES, V3, P1187; Song HK, 2006, ADV MATER, V18, P1764, DOI 10.1002/adma.200600375; Yang C, 2009, IND ENG CHEM RES, V48, P9498, DOI 10.1021/ie900189j; YONEYAMA H, 1992, J ELECTROCHEM SOC, V139, P28, DOI 10.1149/1.2069187; ZINGER B, 1989, SYNTHETIC MET, V30, P209, DOI 10.1016/0379-6779(89)90791-1	23	392	403	25	680	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2012	335	6075					1468	1471		10.1126/science.1215159	http://dx.doi.org/10.1126/science.1215159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22442478				2022-12-01	WOS:000301837000040
J	Schwartz, LM; Woloshin, S				Schwartz, Lisa M.; Woloshin, Steven			NOT SO STORIES How the FDA forgot the evidence: the case of donepezil 23 mg	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Schwartz, Lisa M.; Woloshin, Steven] Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA; [Schwartz, Lisa M.; Woloshin, Steven] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Med & Media, Lebanon, NH USA	VA Outcomes Group; Dartmouth College	Schwartz, LM (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA.	Steven.Woloshin@dartmouth.edu						Eisai, 2011, 3Q FY2010 FISC YEAR; Farlow MR, 2010, CLIN THER, V32, P1234, DOI 10.1016/j.clinthera.2010.06.019; FDA Center for Drug Evaluation and Research, AR LAB; FDA Center for Drug Evauation and Research, APPL 022568 STAT REV; FDA Center for Drug Evauation and Research, APPL 022568 SUMM REV; FDA Center for Drug Evauation and Research, 2010, APPL 022568 MED REV; Memorandum of meeting minutes, 2007, M MIN MARCH 19 SUSTT; Schwartz LM, 2009, NEW ENGL J MED, V361, P1717, DOI 10.1056/NEJMp0907708	8	19	19	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 22	2012	344								e1086	10.1136/bmj.e1086	http://dx.doi.org/10.1136/bmj.e1086			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	913CP	22442352				2022-12-01	WOS:000301849300001
J	Sumino, Y; Nagai, KH; Shitaka, Y; Tanaka, D; Yoshikawa, K; Chate, H; Oiwa, K				Sumino, Yutaka; Nagai, Ken H.; Shitaka, Yuji; Tanaka, Dan; Yoshikawa, Kenichi; Chate, Hugues; Oiwa, Kazuhiro			Large-scale vortex lattice emerging from collectively moving microtubules	NATURE			English	Article							CORTICAL MICROTUBULES; SELF-ORGANIZATION; TRANSLOCATION; MOTORS; ARRAY	Spontaneous collective motion, as in some flocks of bird and schools of fish, is an example of an emergent phenomenon. Such phenomena are at present of great interest(1-5) and physicists have put forward a number of theoretical results that so far lack experimental verification(6-8). In animal behaviour studies, large-scale data collection is now technologically possible, but data are still scarce and arise from observations rather than controlled experiments. Multicellular biological systems, such as bacterial colonies or tissues(9,10), allow more control, but may have many hidden variables and interactions, hindering proper tests of theoretical ideas. However, in systems on the subcellular scale such tests may be possible, particularly in in vitro experiments with only few purified components(11-13). Motility assays, in which protein filaments are driven by molecular motors grafted to a substrate in the presence of ATP, can show collective motion for high densities of motors and attached filaments. This was demonstrated recently for the actomyosin system(14,15), but a complete understanding of the mechanisms at work is still lacking. Here we report experiments in which microtubules are propelled by surface-bound dyneins. In this system it is possible to study the local interaction: we find that colliding microtubules align with each other with high probability. At high densities, this alignment results in self-organization of the microtubules, which are on average 15 mu m long, into vortices with diameters of around 400 mu m. Inside the vortices, the microtubules circulate both clockwise and anticlockwise. On longer timescales, the vortices form a lattice structure. The emergence of these structures, as verified by a mathematical model, is the result of the smooth, reptation-like motion of single microtubules in combination with local interactions (the nematic alignment due to collisions)-there is no need for long-range interactions. Apart from its potential relevance to cortical arrays in plant cells(16,17) and other biological situations, our study provides evidence for the existence of previously unsuspected universality classes of collective motion phenomena.	[Shitaka, Yuji; Oiwa, Kazuhiro] Natl Inst Informat & Communicat Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan; [Nagai, Ken H.] Univ Tokyo, Grad Sch Sci, Dept Phys, Tokyo 1130033, Japan; [Tanaka, Dan] Nagoya Univ, Grad Sch Informat Sci, Dept Complex Syst Sci, Nagoya, Aichi 4648601, Japan; [Yoshikawa, Kenichi] Kyoto Univ, Grad Sch Sci, Dept Phys, Kyoto 6068502, Japan; [Yoshikawa, Kenichi] JST, ICORP, Kyoto 6068502, Japan; [Chate, Hugues] CEA Saclay, Serv Phys Etat Condense, F-91191 Gif Sur Yvette, France; [Oiwa, Kazuhiro] Univ Hyogo, Grad Sch Life Sci, Harima, Hyogo 6781297, Japan	National Institute of Information & Communications Technology (NICT) - Japan; University of Tokyo; Nagoya University; Kyoto University; Japan Science & Technology Agency (JST); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Hyogo	Oiwa, K (corresponding author), Natl Inst Informat & Communicat Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan.	oiwa@nict.go.jp	Chaté, Hugues/D-2156-2015; Sumino, Yutaka/W-2657-2017; Yoshikawa, Kenichi/N-1867-2019; Oiwa, Kazuhiro/D-7721-2011	Chaté, Hugues/0000-0002-6098-4094; Sumino, Yutaka/0000-0002-0724-7650; Yoshikawa, Kenichi/0000-0002-2751-7136; Oiwa, Kazuhiro/0000-0002-1281-113X; Nagai, Ken/0000-0002-8286-3111	JSPS [23-1819];  [23840019];  [21340023];  [20244067]; Grants-in-Aid for Scientific Research [21340023] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Sakakibara, Y. Uchida and R. Nakamori for the preparation of the material and observations. They as well as H. Kitahata are also thanked for discussions. Y. Sumino is supported by a Grant-in-Aid for Research Activity Start-up (no. 23840019), Grant-in-Aid for Scientific Research (B) (no. 21340023) and Grant-in-Aid for Scientific Research (A) (no. 20244067). K.H.N. would like to acknowledge the support of a fellowship from the JSPS (no. 23-1819).	Allard JF, 2010, BIOPHYS J, V99, P1082, DOI 10.1016/j.bpj.2010.05.037; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Butt T, 2010, J BIOL CHEM, V285, P4964, DOI 10.1074/jbc.M109.044792; Dixit R, 2004, PLANT CELL, V16, P3274, DOI 10.1105/tpc.104.026930; Ginelli F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.184502; Hess H, 2005, NANO LETT, V5, P629, DOI 10.1021/nl0478427; KAGAMI O, 1992, J CELL SCI, V103, P653; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Kikushima K, 2008, BIOPHYS J, V94, P4014, DOI 10.1529/biophysj.107.123083; Kudrolli A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058001; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Peruani F, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030904; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Ramaswamy S, 2010, ANNU REV CONDEN MA P, V1, P323, DOI 10.1146/annurev-conmatphys-070909-104101; Riedel IH, 2005, SCIENCE, V309, P300, DOI 10.1126/science.1110329; Sakakibara H, 1999, NATURE, V400, P586, DOI 10.1038/23066; Schaller V, 2011, P NATL ACAD SCI USA, V108, P19183, DOI 10.1073/pnas.1107540108; Schaller V, 2010, NATURE, V467, P73, DOI 10.1038/nature09312; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Tindemans SH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058103; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Wasteneys GO, 2009, TRENDS CELL BIOL, V19, P62, DOI 10.1016/j.tcb.2008.11.004; YUAN M, 1994, P NATL ACAD SCI USA, V91, P6050, DOI 10.1073/pnas.91.13.6050; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107	29	427	429	4	145	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 22	2012	483	7390					448	452		10.1038/nature10874	http://dx.doi.org/10.1038/nature10874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22437613	Green Published			2022-12-01	WOS:000301771200039
J	Gilman, RT; Nuismer, SL; Jhwueng, DC				Gilman, R. Tucker; Nuismer, Scott L.; Jhwueng, Dwueng-Chwuan			Coevolution in multidimensional trait space favours escape from parasites and pathogens	NATURE			English	Article							G-MATRIX; EVOLUTION; DIVERSITY; STABILITY; SELECTION; CONSTRAINTS; PARSNIP; HOSTS	Almost all species are subject to continuous attack by parasites and pathogens. Because parasites and pathogens tend to have shorter generation times(1,2) and often experience stronger selection due to interaction than their victims do(3,4), it is frequently argued that they should evolve more rapidly and thus maintain an advantage in the evolutionary race between defence and counter-defence(1,5). This prediction generates an apparent paradox: how do victim species survive and even thrive in the face of a continuous onslaught of more rapidly evolving enemies(5)? One potential explanation is that defence is physiologically, mechanically or behaviourally easier than attack, so that evolution is less constrained for victims than for parasites or pathogens(6). Another possible explanation is that parasites and pathogens have enemies themselves and that victim species persist because parasites and pathogens are regulated from the top down and thus generally have only modest demographic impacts on victimpopulations(7,8). Here we explore a third possibility: that victim species are not as evolutionarily impotent as conventional wisdom holds, but instead have unique evolutionary advantages that help to level the playing field. We use quantitative genetic analysis and individual-based simulations to show that victims can achieve such an advantage when coevolution involves multiple traits in both the host and the parasite.	[Gilman, R. Tucker; Jhwueng, Dwueng-Chwuan] Natl Inst Math & Biol Synth, Knoxville, TN 37916 USA; [Nuismer, Scott L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Nuismer, Scott L.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83844 USA	University of Tennessee System; University of Tennessee Knoxville; Idaho; University of Idaho; Idaho; University of Idaho	Gilman, RT (corresponding author), Natl Inst Math & Biol Synth, Knoxville, TN 37916 USA.	rtgilman@nimbios.org	Jhwueng, Dwueng-Chwuan/G-8238-2014; Gilman, R. Tucker/AAX-8512-2020	Jhwueng, Dwueng-Chwuan/0000-0001-5893-3645; 	National Science Foundation (NSF) [DMS 0540392, DEB 1118947]; US Department of Homeland Security; US Department of Agriculture through NSF [EF-0832858]; The University of Tennessee, Knoxville	National Science Foundation (NSF)(National Science Foundation (NSF)); US Department of Homeland Security(United States Department of Homeland Security (DHS)); US Department of Agriculture through NSF(National Science Foundation (NSF)); The University of Tennessee, Knoxville	We thank A. R. Ives and F. Debarre for comments. R. T. G. and D.C.J. are postdoctoral fellows at the National Institute for Mathematical and Biological Synthesis (NIMBioS). NIMBioS is sponsored by the National Science Foundation (NSF), the US Department of Homeland Security and the US Department of Agriculture through NSF award no. EF-0832858, with support from The University of Tennessee, Knoxville. Additional support for this research was provided by NSF grants DMS 0540392 and DEB 1118947 to S.L.N.	Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Agrawal AF, 2003, P ROY SOC B-BIOL SCI, V270, P323, DOI 10.1098/rspb.2002.2193; Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; BERENBAUM MR, 1986, EVOLUTION, V40, P1215, DOI 10.1111/j.1558-5646.1986.tb05746.x; Costamagna AC, 2006, ECOL APPL, V16, P1619, DOI 10.1890/1051-0761(2006)016[1619:PETCOS]2.0.CO;2; Doebeli M, 2010, SCIENCE, V328, P494, DOI 10.1126/science.1187468; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; FRANK SA, 1993, EVOLUTION, V47, P1721, DOI 10.1111/j.1558-5646.1993.tb01264.x; GOMEZ JM, 1994, ECOLOGY, V75, P1023, DOI 10.2307/1939426; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hochberg ME, 1997, OIKOS, V80, P342, DOI 10.2307/3546602; Jones AG, 2004, EVOLUTION, V58, P1639; Jones AG, 2003, EVOLUTION, V57, P1747; Jones SRM, 2001, DEV COMP IMMUNOL, V25, P841, DOI 10.1016/S0145-305X(01)00039-8; King KC, 2011, BIOL LETTERS, V7, P265, DOI 10.1098/rsbl.2010.0857; Kirkpatrick M, 2009, GENETICA, V136, P271, DOI 10.1007/s10709-008-9302-6; LANDE R, 1979, EVOLUTION, V33, P402, DOI [10.2307/2407630, 10.1111/j.1558-5646.1979.tb04694.x]; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.2307/2408842, 10.1111/j.1558-5646.1983.tb00236.x]; Nuismer SL, 2008, J EVOLUTION BIOL, V21, P958, DOI 10.1111/j.1420-9101.2008.01551.x; Nuismer SL, 2005, EVOLUTION, V59, P2073; Page RDM, 1998, MOL PHYLOGENET EVOL, V9, P276, DOI 10.1006/mpev.1997.0458; Rasmann S, 2011, J ECOL, V99, P16, DOI 10.1111/j.1365-2745.2010.01713.x; THOMPSON JN, 1986, TRENDS ECOL EVOL, V1, P105, DOI 10.1016/0169-5347(86)90036-4; Toju H, 2011, AM NAT, V177, P562, DOI 10.1086/659624; VERMEIJ GJ, 1982, AM NAT, V120, P701, DOI 10.1086/284025; Zalucki MP, 2001, ECOL ENTOMOL, V26, P212, DOI 10.1046/j.1365-2311.2001.00313.x; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x	29	58	58	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					328	330		10.1038/nature10853	http://dx.doi.org/10.1038/nature10853			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22388815				2022-12-01	WOS:000301481800048
J	Liang, ZZS; Nguyen, T; Mattila, HR; Rodriguez-Zas, SL; Seeley, TD; Robinson, GE				Liang, Zhengzheng S.; Trang Nguyen; Mattila, Heather R.; Rodriguez-Zas, Sandra L.; Seeley, Thomas D.; Robinson, Gene E.			Molecular Determinants of Scouting Behavior in Honey Bees	SCIENCE			English	Article							DOPAMINE; IMMUNOREACTIVITY; POLYMORPHISMS; DIVISION; RECRUITS; LABOR; GENE	Little is known about the molecular basis of differences in behavior among individuals. Here we report consistent novelty-seeking behavior, across different contexts, among honey bees in their tendency to scout for food sources and nest sites, and we reveal some of the molecular underpinnings of this behavior relative to foragers that do not scout. Food scouts showed extensive differences in brain gene expression relative to other foragers, including differences related to catecholamine, glutamate, and gamma-aminobutyric acid signaling. Octopamine and glutamate treatments increased the likelihood of scouting, whereas dopamine antagonist treatment decreased it. These findings demonstrate intriguing similarities in human and insect novelty seeking and suggest that this trait, which presumably evolved independently in these two lineages, may be subserved by conserved molecular components.	[Liang, Zhengzheng S.; Rodriguez-Zas, Sandra L.; Robinson, Gene E.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Trang Nguyen; Robinson, Gene E.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Mattila, Heather R.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Seeley, Thomas D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Robinson, Gene E.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Wellesley College; University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; University of Illinois System; University of Illinois Urbana-Champaign	Robinson, GE (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL 61801 USA.	generobi@illinois.edu		Liang, Zhengzheng/0000-0002-3969-4199	NSF [EF 0425852]; NIH [1DP1OD006416]; Illinois Sociogenomics Initiative; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027548] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006416] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Sociogenomics Initiative; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Special thanks to M. K. Carr-Markell and J. Recchia-Rife for extensive help in the field. We also thank the following: C. Nye and K. Pruiett (bee management); A. Brockmann, P. Date, J. Dotterer, L. Felley, M. Girard, S. Kantarovich, H. S. Pollock, and M. Wray (field assistance); T. Newman (molecular studies); S. Aref and A. Toth (statistics); E. Hadley (graphics); and A. M. Bell, D. F. Clayton, R. C. Fuller, J. S. Rhodes, C. W. Whitfield, and members of the Robinson laboratory (review of the manuscript). Supported by NSF Frontiers in Biological Research grant EF 0425852 (B. L. Schatz, PI, BeeSpace Project); NIH Director's Pioneer Award 1DP1OD006416 (G.E.R); and the Illinois Sociogenomics Initiative (G.E.R). Microarray data meet Minimum Information About Microarray Experiment (MIAME) standards and are available at ArrayExpress (www.ebi.ac.uk/arrayexpress, #E-MTAB-491). Z.S.L. and G.E.R. conceived the project, designed the experiments and wrote the paper; Z.S.L. performed sample collection, molecular and field experiments, and analyses; T.N. and S.L.R.-Z. performed microarray experiments and statistical analyses, respectively; and H.R.M. and T.D.S. contributed to protocol development and sample collection and co-wrote the paper.	Bardo MT, 1996, BEHAV BRAIN RES, V77, P23, DOI 10.1016/0166-4328(95)00203-0; Becker J. B., 2007, HDB NEUROCHEMISTRY M; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; BICKER G, 1988, J NEUROSCI, V8, P2108; Dreller C, 1998, BEHAV ECOL SOCIOBIOL, V43, P191, DOI 10.1007/s002650050480; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Fidler AE, 2007, P ROY SOC B-BIOL SCI, V274, P1685, DOI 10.1098/rspb.2007.0337; Kucharski R, 2000, GENE, V242, P399, DOI 10.1016/S0378-1119(99)00503-X; Kurshan PT, 2003, J COMP NEUROL, V466, P91, DOI 10.1002/cne.10864; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; Mustard JA, 2003, MOL BRAIN RES, V113, P67, DOI 10.1016/S0169-328X(03)00091-3; OETTINGENSPIELBERG TZ, 1949, Z VERGL PHYSIOL, V31, P454, DOI 10.1007/BF00338037; SCHURMANN FW, 1989, CELL TISSUE RES, V256, P399, DOI 10.1007/BF00218898; Seeley T.D., 2010, HONEYBEE DEMOCRACY; SEELEY TD, 1983, BEHAV ECOL SOCIOBIOL, V12, P253, DOI 10.1007/BF00290778; Viggiano D, 2002, BEHAV GENET, V32, P315, DOI 10.1023/A:1020210221156	18	93	93	5	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2012	335	6073					1225	1228		10.1126/science.1213962	http://dx.doi.org/10.1126/science.1213962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904VB	22403390				2022-12-01	WOS:000301225100045
J	Sedgwick, P				Sedgwick, Philip			Incidence rates	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175					0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 7	2012	344								e1589	10.1136/bmj.e1589	http://dx.doi.org/10.1136/bmj.e1589			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	908GV	22399704				2022-12-01	WOS:000301479800012
J	Chisholm, D; Baltussen, R; Evans, DB; Ginsberg, G; Lauer, JA; Lim, S; Ortegon, M; Salomon, J; Stanciole, A; Edejer, TTT				Chisholm, D.; Baltussen, R.; Evans, D. B.; Ginsberg, G.; Lauer, J. A.; Lim, S.; Ortegon, M.; Salomon, J.; Stanciole, A.; Edejer, T. Tan-Torres			What are the priorities for prevention and control of non-communicable diseases and injuries in sub-Saharan Africa and South East Asia?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS ANALYSIS; STRATEGIES; HEALTH		[Chisholm, D.; Evans, D. B.; Lauer, J. A.; Edejer, T. Tan-Torres] World Hlth Org, Dept Hlth Syst Financing, Geneva, Switzerland; [Baltussen, R.] Radboud Univ Nijmegen, Dept Primary & Community Care, Nijmegen, Netherlands; [Ginsberg, G.] Minist Hlth, Dept Med Technol Assessment, Jerusalem, Israel; [Lim, S.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Ortegon, M.] Univ Rosario, Sch Med, Bogota, Colombia; [Salomon, J.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Stanciole, A.] World Bank, Washington, DC 20433 USA	World Health Organization; Radboud University Nijmegen; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Universidad del Rosario; Harvard University; Harvard T.H. Chan School of Public Health; The World Bank	Chisholm, D (corresponding author), World Hlth Org, Dept Hlth Syst Financing, Geneva, Switzerland.	chisholmd@who.int	Salomon, Joshua/S-1929-2019; Baltussen, R.M.P.M./L-4181-2015	Salomon, Joshua/0000-0003-3929-5515; Ginsberg, Gary/0000-0003-1315-890X; Edejer, Tessa/0000-0003-1068-332X				Baltussen R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e615; Chisholm D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e609; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e612; Duc AH, 2011, HEALTH POLICY PLANN, V26, P210, DOI 10.1093/heapol/czq045; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Gureje O, 2007, WORLD PSYCHIATRY, V6, P42; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Lai T, 2007, HEALTH POLICY, V84, P75, DOI 10.1016/j.healthpol.2007.02.012; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Stanciole AE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e608; *UN, 2001, DECL COMM HIV AIDS; United Nations, 2011, POL DECL HIGH LEV M; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 2020, GLOBAL REPORT EPIDEM	21	23	23	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2012	344								e586	10.1136/bmj.e586	http://dx.doi.org/10.1136/bmj.e586			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XQ	22389336	Green Accepted			2022-12-01	WOS:000301232600012
J	Jeyaraj, D; Haldar, SM; Wan, XP; McCauley, MD; Ripperger, JA; Hu, K; Lu, Y; Eapen, BL; Sharma, N; Ficker, E; Cutler, MJ; Gulick, J; Sanbe, A; Robbins, J; Demolombe, S; Kondratov, RV; Shea, SA; Albrecht, U; Wehrens, XHT; Rosenbaum, DS; Jain, MK				Jeyaraj, Darwin; Haldar, Saptarsi M.; Wan, Xiaoping; McCauley, Mark D.; Ripperger, Juergen A.; Hu, Kun; Lu, Yuan; Eapen, Betty L.; Sharma, Nikunj; Ficker, Eckhard; Cutler, Michael J.; Gulick, James; Sanbe, Atsushi; Robbins, Jeffrey; Demolombe, Sophie; Kondratov, Roman V.; Shea, Steven A.; Albrecht, Urs; Wehrens, Xander H. T.; Rosenbaum, David S.; Jain, Mukesh K.			Circadian rhythms govern cardiac repolarization and arrhythmogenesis	NATURE			English	Article							QT SYNDROME; I-TO; HYPERTROPHY; EXPRESSION; INTERVAL; MAMMALS; DISEASE; DEATH	Sudden cardiac death exhibits diurnal variation in both acquired and hereditary forms of heart disease(1,2), but the molecular basis of this variation is unknown. A common mechanism that underlies susceptibility to ventricular arrhythmias is abnormalities in the duration (for example, short or long QT syndromes and heart failure)(3-5) or pattern (for example, Brugada's syndrome)(6) of myocardial repolarization. Here we provide molecular evidence that links circadian rhythms to vulnerability in ventricular arrhythmias in mice. Specifically, we show that cardiac ion-channel expression and QT-interval duration (an index of myocardial repolarization) exhibit endogenous circadian rhythmicity under the control of a clock-dependent oscillator, kruppel-like factor 15 (Klf15). Klf15 transcriptionally controls rhythmic expression of Kv channel-interacting protein 2 (KChIP2), a critical subunit required for generating the transient outward potassium current(7). Deficiency or excess of Klf15 causes loss of rhythmic QT variation, abnormal repolarization and enhanced susceptibility to ventricular arrhythmias. These findings identify circadian transcription of ion channels as a mechanism for cardiac arrhythmogenesis.	[Jeyaraj, Darwin; Haldar, Saptarsi M.; Lu, Yuan; Eapen, Betty L.; Sharma, Nikunj; Jain, Mukesh K.] Case Western Reserve Univ, Case Cardiovasc Res Inst, Harrington Heart & Vasc Inst, Dept Med,Sch Med, Cleveland, OH 44106 USA; [Jeyaraj, Darwin; Wan, Xiaoping; Ficker, Eckhard; Cutler, Michael J.; Rosenbaum, David S.] Case Western Reserve Univ, Heart & Vasc Res Ctr, Cleveland, OH 44109 USA; [McCauley, Mark D.; Wehrens, Xander H. T.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [McCauley, Mark D.; Wehrens, Xander H. T.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Ripperger, Juergen A.; Albrecht, Urs] Univ Fribourg, Div Biochem, Dept Med, CH-1700 Fribourg, Switzerland; [Hu, Kun; Shea, Steven A.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Hu, Kun; Shea, Steven A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gulick, James; Sanbe, Atsushi; Robbins, Jeffrey] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; [Demolombe, Sophie] Univ Nice Sophia Antipolis, UMR CNRS 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Kondratov, Roman V.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Kondratov, Roman V.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA	Case Western Reserve University; Case Western Reserve University; Baylor College of Medicine; Baylor College of Medicine; University of Fribourg; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Cincinnati Children's Hospital Medical Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Jeyaraj, D (corresponding author), Case Western Reserve Univ, Case Cardiovasc Res Inst, Harrington Heart & Vasc Inst, Dept Med,Sch Med, Cleveland, OH 44106 USA.	darwinjeyaraj@gmail.com; mukesh.jain2@case.edu	Wehrens, Xander/AAQ-9574-2020; Albrecht, Urs/A-9831-2011; Hu, Kun/AAJ-1897-2020; Hu, Kun/GVS-8580-2022; McCauley, Mark/AFQ-7490-2022	Wehrens, Xander/0000-0001-5044-672X; Albrecht, Urs/0000-0002-0663-8676; McCauley, Mark/0000-0003-2743-2113; Kondratov, Roman/0000-0003-3449-745X; Shea, Steven/0000-0003-1949-0954; Hu, Kun/0000-0003-0350-3132	Heart RhythmSociety Fellowship; National Institutes of Health [HL094660, HL066991, HL086614]; American Heart Association [HL089598, HL091947, HL76446, HL102241, HL054807, HL075427, HL076754, HL084154, HL086548, HL097595]; Swiss National Science Foundation [31003A/131086, M01-RR02635]; Leducq Foundation of the ENAFRA Network [07CVD03]; Centre National de la Recherche Scientifique; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL076446, K08HL086614, R01HL110630, R00HL102241, R01HL097593, R01HL086548, K08HL094660, R01HL089598, R01HL075427, K99HL102241, T32HL066991, R01HL054807, R01HL076754, R01HL084154, R01HL091947, R29HL054807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039547] Funding Source: NIH RePORTER	Heart RhythmSociety Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leducq Foundation of the ENAFRA Network(Leducq Foundation); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. F. Connors Jr for support, M. Mustar for illustrations, Y. Cui for experimental assistance, and members of the Jain laboratory for discussions. Funding sources: Heart RhythmSociety Fellowship (D.J.); National Institutes of Health grants HL094660 (D.J.), HL066991 (M.D.M.), HL086614 (S.M.H.), American Heart Association postdoctoral grant (N.S.), HL089598, HL091947 (X.H.W.), HL76446 (S.A.S.), HL102241 (K.H.), HL054807 (D.S.R.), HL075427, HL076754, HL084154, HL086548 and HL097595 (M.K.J.); Swiss National Science Foundation grants 31003A/131086 (U.A.) and M01-RR02635 (B.W.H.); Leducq Foundation grants of the ENAFRA Network 07CVD03 (S.D.); and the Centre National de la Recherche Scientifique (S.D.).	Antzelevitch C, 2007, AM J PHYSIOL-HEART C, V293, pH2024, DOI 10.1152/ajpheart.00355.2007; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; BEXTON RS, 1986, BRIT HEART J, V55, P253; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Fisch S, 2007, P NATL ACAD SCI USA, V104, P13851, DOI 10.1073/pnas.0706717104; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P2291, DOI 10.1016/j.jacc.2008.02.068; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; Hu K, 2011, CIRCULATION, V123, P961, DOI 10.1161/CIRCULATIONAHA.110.943019; KONG TQ, 1995, CIRCULATION, V92, P1507, DOI 10.1161/01.CIR.92.6.1507; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Libbus I, 2004, AM J PHYSIOL-HEART C, V286, pH1901, DOI 10.1152/ajpheart.00581.2003; Martino TA, 2009, CIRC RES, V105, P1047, DOI 10.1161/CIRCRESAHA.109.206201; Matsuo K, 1999, EUR HEART J, V20, P465, DOI 10.1053/euhj.1998.1332; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; MULLER JE, 1987, CIRCULATION, V75, P131, DOI 10.1161/01.CIR.75.1.131; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Paschos GK, 2010, CIRC RES, V106, P833, DOI 10.1161/CIRCRESAHA.109.211706; Patel U, 2009, CARDIOL REV, V17, P300, DOI 10.1097/CRD.0b013e3181c07592; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Tuteja G, 2008, NUCLEIC ACIDS RES, V36, P4149, DOI 10.1093/nar/gkn366; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Wagner S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P285, DOI 10.1161/CIRCEP.108.842799; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Yamashita T, 2003, CIRCULATION, V107, P1917, DOI 10.1161/01.CIR.0000058752.79734.F0	29	237	248	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					96	U141		10.1038/nature10852	http://dx.doi.org/10.1038/nature10852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22367544	Green Accepted, Green Submitted			2022-12-01	WOS:000300877900052
J	Sterzik, MF; Bagnulo, S; Palle, E				Sterzik, Michael F.; Bagnulo, Stefano; Palle, Enric			Biosignatures as revealed by spectropolarimetry of Earthshine	NATURE			English	Article							EXTRASOLAR PLANETS; VEGETATION SIGNATURE; POLARIZATION; SPECTRUM; SEARCH; ATMOSPHERES; SKYLIGHT; CLOUDS; LIFE	Low-resolution intensity spectra of Earth's atmosphere obtained from space reveal strong signatures of life ('biosignatures'), such as molecular oxygen and methane with abundances far from chemical equilibrium, as well as the presence of a 'red edge' (a sharp increase of albedo for wavelengths longer than 700 nm) caused by surface vegetation(1). Light passing through the atmosphere is strongly linearly polarized by scattering (from air molecules, aerosols and cloud particles) and by reflection (from oceans and land(2)). Spectropolarimetric observations of local patches of Earth's sky light from the ground contain signatures of oxygen, ozone and water, and are used to characterize the properties of clouds and aerosols(3,4). When applied to exoplanets, ground-based spectropolarimetry can better constrain properties of atmospheres and surfaces than can standard intensity spectroscopy(5-9). Here we report disk-integrated linear polarization spectra of Earthshine, which is sunlight that has been first reflected by Earth and then reflected back to Earth by the Moon(10-13). The observations allow us to determine the fractional contribution of clouds and ocean surface, and are sensitive to visible areas of vegetation as small as 10 per cent. They represent a benchmark for the diagnostics of the atmospheric composition, mean cloud height and surfaces of exoplanets.	[Sterzik, Michael F.] European So Observ, Santiago, Chile; [Bagnulo, Stefano] Armagh Observ, Armagh BT61 9DG, North Ireland; [Palle, Enric] Inst Astrofis Canarias, E-38205 Tenerife, Spain	European Southern Observatory; Instituto de Astrofisica de Canarias	Sterzik, MF (corresponding author), European So Observ, Alonso de Cordova 3107, Santiago, Chile.	msterzik@eso.org	Palle, Enric/AAE-4492-2019	Sterzik, Michael F./0000-0002-5784-4437; Palle, Enric/0000-0003-0987-1593	Spanish MICIIN [CGL2009-10641]	Spanish MICIIN(Spanish Government)	This Letter is based on data collected with the Very Large Telescope under ESO programme 87.C-0040(A) and (B). E.P. acknowledges support from the Spanish MICIIN, grant CGL2009-10641.	Aben I, 1999, GEOPHYS RES LETT, V26, P591, DOI 10.1029/1999GL900025; Appenzeller I., 1998, MESSENGER, V94, P1; Arnold L, 2002, ASTRON ASTROPHYS, V392, P231, DOI 10.1051/0004-6361:20020933; Bailey J, 2007, ASTROBIOLOGY, V7, P320, DOI 10.1089/ast.2006.0039; Boesche E, 2008, APPL OPTICS, V47, P3467, DOI 10.1364/AO.47.003467; Buenzli E, 2009, ASTRON ASTROPHYS, V504, P259, DOI 10.1051/0004-6361/200911760; COFFEEN DL, 1979, J OPT SOC AM, V69, P1051, DOI 10.1364/JOSA.69.001051; Dollfus A., 1957, ANN ASTROPHYSIQUE S, V4, P3; Fox GK, 1998, MON NOT R ASTRON SOC, V298, P303, DOI 10.1046/j.1365-8711.1998.01633.x; GOLOUB P, 1994, IEEE T GEOSCI REMOTE, V32, P78, DOI 10.1109/36.285191; Karalidi T, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116449; Keller C. U, 2010, P SOC PHOTO-OPT INS, V7735; Kokhanovsky AA, 2011, PHYS EARTH SPACE ENV, P231, DOI 10.1007/978-3-642-14791-3_5; Montanes-Rodriguez P, 2006, ASTROPHYS J, V651, P544, DOI 10.1086/507694; Palle E, 2009, NATURE, V459, P814, DOI 10.1038/nature08050; SAGAN C, 1993, NATURE, V365, P715, DOI 10.1038/365715a0; Seager S, 2005, ASTROBIOLOGY, V5, P372, DOI 10.1089/ast.2005.5.372; Shkuratov Y, 2011, PLANET SPACE SCI, V59, P1326, DOI 10.1016/j.pss.2011.06.011; Stam DM, 2008, ASTRON ASTROPHYS, V482, P989, DOI 10.1051/0004-6361:20078358; Tinetti G, 2006, ASTROBIOLOGY, V6, P881, DOI 10.1089/ast.2006.6.881; Williams DM, 2008, ICARUS, V195, P927, DOI 10.1016/j.icarus.2008.01.002; Wolstencroft RD, 2005, ASTR SOC P, V343, P211; Woolf NJ, 2002, ASTROPHYS J, V574, P430, DOI 10.1086/340929	23	74	74	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					64	66		10.1038/nature10778	http://dx.doi.org/10.1038/nature10778			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22382980				2022-12-01	WOS:000300877900044
J	Loehlin, DW; Werren, JH				Loehlin, David W.; Werren, John H.			Evolution of Shape by Multiple Regulatory Changes to a Growth Gene	SCIENCE			English	Article							WING SIZE; DROSOPHILA; NASONIA; INSIGHTS; PATHWAY; MANNER	The genetic changes responsible for morphological differences between species are largely unidentified. Such changes can involve modifications of growth that are relevant to understanding evolution, development, and disease. We identified a gene that induces male-specific wing size and shape differences between Nasonia wasp species. Fine-scale mapping and in situ hybridization reveal that changes in at least three regions (two strictly in noncoding sequence) around the gene unpaired-like (upd-like) cause changes in spatial and temporal expression of upd-like in the developing wing and corresponding changes in wing width. Upd-like shows homology to the Drosophila unpaired gene, a well-studied signaling protein that regulates cell proliferation and differentiation. Our results indicate how multiple changes in the regulation of upd-like are involved in microevolution of morphological and sex-specific differences between species.	[Loehlin, David W.; Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Loehlin, DW (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	loehlin@wisc.edu; werr@mail.rochester.edu		Werren, John/0000-0001-9353-2070	NSF [DEB-0910017]; NIH [5R01 GM070026-04, 5R24 GM084917-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070026, R24GM084917] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Gu and J. Sysol for volunteer assistance with mapping; M. Rosenberg for sharing the Nasonia wingless plasmid; and H. Jasper, J. D. Lambert, M. Welte, D. Stern, D. Presgraves, D. Wheeler, R. Edwards, A. Avery, and M. Clark for advice and technical assistance. This work was supported by NSF Doctoral Dissertation Improvement Grant DEB-0910017 to D.W.L. and NIH grants 5R01 GM070026-04 and 5R24 GM084917-04 to J.H.W. Sequences are deposited at GenBank with accessions JQ082366 to JQ082369.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Darwin C., 1859, ORIGIN SPECIES MEANS; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Galilei G., 1914, DIALOGUES 2 NEW SCI; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; Loehlin DW, 2010, HEREDITY, V104, P260, DOI 10.1038/hdy.2009.146; Loehlin DW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000821; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; McKechnie SW, 2010, MOL ECOL, V19, P775, DOI 10.1111/j.1365-294X.2009.04509.x; Mukherjee T, 2005, ONCOGENE, V24, P2503, DOI 10.1038/sj.onc.1208487; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Raychoudhury R, 2010, HEREDITY, V104, P278, DOI 10.1038/hdy.2009.147; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Robinett CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000365; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Wasik BR, 2010, EVOL DEV, V12, P353, DOI 10.1111/j.1525-142X.2010.00422.x; Werner T, 2010, NATURE, V464, P1143, DOI 10.1038/nature08896; Werren J. H., 2009, EMERGING MODEL ORGAN, V2, P267; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Weston RF, 1999, J EVOLUTION BIOL, V12, P586, DOI 10.1046/j.1420-9101.1999.00048.x	27	52	52	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					943	947		10.1126/science.1215193	http://dx.doi.org/10.1126/science.1215193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363002	Green Accepted			2022-12-01	WOS:000300931800039
J	Yoon, SI; Kurnasov, O; Natarajan, V; Hong, MS; Gudkov, AV; Osterman, AL; Wilson, IA				Yoon, Sung-il; Kurnasov, Oleg; Natarajan, Venkatesh; Hong, Minsun; Gudkov, Andrei V.; Osterman, Andrei L.; Wilson, Ian A.			Structural Basis of TLR5-Flagellin Recognition and Signaling	SCIENCE			English	Article							INNATE IMMUNE-RESPONSE; BACTERIAL FLAGELLIN; CRYSTAL-STRUCTURE; TOLL-LIKE-RECEPTOR-5; PROTOFILAMENT; SURFACE; MOUSE	Toll-like receptor 5 (TLR5) binding to bacterial flagellin activates signaling through the transcription factor NF-kappa B and triggers an innate immune response to the invading pathogen. To elucidate the structural basis and mechanistic implications of TLR5-flagellin recognition, we determined the crystal structure of zebrafish TLR5 (as a variable lymphocyte receptor hybrid protein) in complex with the D1/D2/D3 fragment of Salmonella flagellin, FliC, at 2.47 angstrom resolution. TLR5 interacts primarily with the three helices of the FliC D1 domain using its lateral side. Two TLR5-FliC 1: 1 heterodimers assemble into a 2: 2 tail-to-tail signaling complex that is stabilized by quaternary contacts of the FliC D1 domain with the convex surface of the opposing TLR5. The proposed signaling mechanism is supported by structure-guided mutagenesis and deletion analyses on CBLB502, a therapeutic protein derived from FliC.	[Kurnasov, Oleg; Osterman, Andrei L.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Yoon, Sung-il; Hong, Minsun; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Natarajan, Venkatesh; Gudkov, Andrei V.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Gudkov, Andrei V.] Cleveland BioLabs Inc, Buffalo, NY 14203 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; Roswell Park Cancer Institute; Scripps Research Institute	Osterman, AL (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	osterman@sanfordburnham.org; wilson@scripps.edu		Gudkov, Andrei/0000-0003-2548-0154	NIH [AI042266, R01 AI080446, RC2 AI087616]; Skaggs Institute for Chemical Biology; Cleveland BioLabs Inc. (CBLI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, RC2AI087616, R01AI080446, R37AI042266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; Cleveland BioLabs Inc. (CBLI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. S. Choo for critical comments on the manuscript, H. Tien and D. Marciano for automated crystal screening, X. Dai and M.-A. Elsliger for expert technical assistance, and K. Namba and K. Yonekura for generously sharing coordinates of flagellar filament. X-ray diffraction data sets were collected at SSRL beamline 11-1 and APS beamlines 23ID-B and 23ID-D. Supported by NIH grants AI042266 (I. A. W.), R01 AI080446 (A. V. G.), and RC2 AI087616 (A. V. G.); the Skaggs Institute for Chemical Biology (I. A. W.); and research grants from Cleveland BioLabs Inc. (CBLI) to Roswell Park Cancer Institute (A. V. G.) and Sanford-Burnham Medical Research Institute (A.L.O.). A.L.O. is a paid consultant for and holds stock options in CBLI which has developed the flagellin derivative CBLB502 into a radiation countermeasure. U. S. patent 8,007,812 for pharmacologically optimized FliC derivative CBLB502 is licensed to CBLI by Cleveland Clinic. Reagents are available under a materials transfer agreement. This is Scripps Research Institute manuscript 21369. The data presented in this paper are tabulated in the main paper and the supplementary material. Structure factors and coordinates for TLR5-N12<INF>VLR</INF> and TLR5-N14<INF>VLR</INF>/FliC-Delta D0 are deposited in the Protein Data Bank under accession codes 3V44 and 3V47, respectively.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Gavutis M, 2006, BIOPHYS J, V90, P3345, DOI 10.1529/biophysj.105.072546; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Iqbal M, 2005, INFECT IMMUN, V73, P2344, DOI 10.1128/IAI.73.4.2344-2350.2005; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Ohto U, 2011, J MOL BIOL, V413, P815, DOI 10.1016/j.jmb.2011.09.020; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Yoon SI, 2011, NAT STRUCT MOL BIOL, V18, P1028, DOI 10.1038/nsmb.2106	24	356	398	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					859	864		10.1126/science.1215584	http://dx.doi.org/10.1126/science.1215584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344444	Green Accepted			2022-12-01	WOS:000300356400045
J	Leung, CT; Brugge, JS				Leung, Cheuk T.; Brugge, Joan S.			Outgrowth of single oncogene-expressing cells from suppressive epithelial environments	NATURE			English	Article							IN-VIVO; BREAST-CANCER; EXTRUSION; MORPHOGENESIS; APOPTOSIS; MIGRATION; ACINI	Tumorigenesis is a clonal evolution process that is initiated from single cells within otherwise histologically normal tissue(1). It is unclear how single, sporadic mutant cells that have sustained oncogenic alterations evolve within a tightly regulated tissue environment. Here we investigated the effects of inducing oncogene expression in single cells in organotypic mammary acini as a model to elucidate the processes by which oncogenic alterations initiate clonal progression from organized epithelial environments. Sporadic cells induced to overexpress oncogenes that specifically perturb cell-cycle checkpoints (for example, E7 from human papilloma virus 16, and cyclin D1), deregulate Myc transcription or activate AKT signalling remained quiescent within growth-arrested acini. By contrast, single cells that overexpress ERBB2 initiated a cellular cascade involving cell translocation from the epithelial layer, as well as luminal outgrowth that is characteristic of neoplastic progression in early-stage epithelial tumours. In addition, ERBB2-mediated cell translocation to the lumen was found to depend on extracellular-regulated kinase and matrix metalloproteinase activities, and genetic alterations that perturb local cell-matrix adhesion drove cell translocation. We also provide evidence that luminal cell translocation may drive clonal selection by promoting either the death or the expansion of quiescent oncogene-expressing cells, depending on whether the pre-existing alterations allow anchorage-independent survival and growth. Our data show that the initial outgrowth of single oncogene-expressing cells from organized epithelial structures is a highly regulated process, and we propose that a cell translocation mechanism allows sporadic mutant cells to evade suppressive micro-environments and elicits clonal selection for survival and proliferative expansion outside the native niches of these cells.	[Leung, Cheuk T.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Joan_Brugge@hms.harvard.edu		Leung, Cheuk/0000-0002-5838-5535	National Cancer Institute [CA080111]; American Cancer Society; NATIONAL CANCER INSTITUTE [P01CA080111, R01CA105134] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Valastyan, T. Muranen and W. Lee for critical reading of the manuscript. We thank the members of the Brugge laboratory for comments and discussion, the Nikon Imaging Center at Harvard Medical School for providing imaging equipment and software, and the laboratory of G. Danuser for imaging software support. This work was supported by a grant from the National Cancer Institute (CA080111, to J.S.B.) and an American Cancer Society postdoctoral fellowship (C.T.L.).	Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DOLBERG DS, 1984, NATURE, V309, P552, DOI 10.1038/309552a0; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; Gunawardane RN, 2005, CANCER RES, V65, P11572, DOI 10.1158/0008-5472.CAN-05-1196; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Holst CR, 2003, CANCER RES, V63, P1596; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Kajita M, 2010, J CELL SCI, V123, P171, DOI 10.1242/jcs.057976; Li XH, 2010, GENE DEV, V24, P933, DOI 10.1101/gad.1901510; Lincoln DW, 2005, FRONT BIOSCI-LANDMRK, V10, P506, DOI 10.2741/1546; Marshall TW, 2011, MOL BIOL CELL, V22, P3962, DOI 10.1091/mbc.E11-05-0469; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Partanen JI, 2007, P NATL ACAD SCI USA, V104, P14694, DOI 10.1073/pnas.0704677104; Pearson GW, 2007, J CELL BIOL, V179, P1555, DOI 10.1083/jcb.200706099; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231	26	167	171	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					410	U160		10.1038/nature10826	http://dx.doi.org/10.1038/nature10826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22318515	Green Accepted			2022-12-01	WOS:000300287100048
J	Bandosz, P; O'Flaherty, M; Drygas, W; Rutkowski, M; Koziarek, J; Wyrzykowski, B; Bennett, K; Zdrojewski, T; Capewell, S				Bandosz, Piotr; O'Flaherty, Martin; Drygas, Wojciech; Rutkowski, Marcin; Koziarek, Jacek; Wyrzykowski, Bogdan; Bennett, Kathleen; Zdrojewski, Tomasz; Capewell, Simon			Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; TRENDS; RATES; SENSITIVITY; DECREASE; CARE	Objectives To examine how much of the observed rapid decrease in mortality from coronary heart disease in Poland after the political, social, and economic transformation in the early 1990s could be explained by the use of medical and surgical treatments and how much by changes in cardiovascular risk factors. Design A modelling study. Setting Sources of data included controlled trials and meta-analyses, national surveys, and official statistics. Participants Population of adults aged 25-74 in Poland in 1991-2005. Main outcome measures Number of deaths prevented or postponed in 2005 attributable to specific treatments for coronary heart disease and changes in risk factors. A previously validated epidemiological model for coronary heart disease was used to combine and analyse data on the uptake and effectiveness of specific cardiac treatments and changes in risk factors. The observed fall in deaths from coronary heart disease from 1991 to 2005 was then partitioned among specific treatments and risk factor changes. Results From 1991 to 2005, the death rate from coronary heart disease in Poland halved, resulting in 26 200 fewer coronary deaths in 2005 in people aged 25-74. About 37% (minimum estimate 13%, maximum estimate 77%) of this decrease was attributable to treatments, including treatments for heart failure (12%), initial treatments for acute coronary syndrome (9%), secondary prevention treatments after myocardial infarction or revascularisation (7%), chronic angina treatments (3%), and other treatments (6%). About 54% of the fall was attributed to changes in risk factors (minimum estimate 41%, maximum estimate 65%), mainly reductions in total cholesterol concentration (39%) and an increase in leisuretime physical activity (10%); however, these were partially offset by increases in body mass index (-4%) and prevalence of diabetes (-2%). Blood pressure fell in women, explaining about 29% of their decrease in mortality, but rose in men generating a negative influence (-8%). About 15% of the observed decrease in mortality was attributable to reduced smoking in men but was negligible in women. Conclusions Over half of the recent fall in mortality from coronary heart disease in Poland can be attributed to reductions in major risk factors and about one third to evidence based medical treatments.	[Bandosz, Piotr; Rutkowski, Marcin; Wyrzykowski, Bogdan; Zdrojewski, Tomasz] Med Univ Gdansk, Dept Hypertens & Diabetol, PL-80211 Gdansk, Poland; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England; [Drygas, Wojciech; Koziarek, Jacek] Inst Cardiol, CVD Prevent & Hlth Promot, Dept Epidemiol, PL-04635 Warsaw, Poland; [Bennett, Kathleen] St James Hosp, Trinity Ctr Hlth Sci, Dept Pharmacol & Therapeut, Dublin 8, Ireland	Fahrenheit Universities; Medical University Gdansk; University of Liverpool; Institute of Cardiology - Poland; Trinity College Dublin	Zdrojewski, T (corresponding author), Med Univ Gdansk, Dept Hypertens & Diabetol, Ul Debinki 7, PL-80211 Gdansk, Poland.	tz@gumed.edu.pl	Zdrojewski, Tomasz/AAA-8875-2020; Drygas, Wojciech/GLR-9863-2022; Bandosz, Piotr/E-4964-2017	Zdrojewski, Tomasz/0000-0001-6015-8561; O'Flaherty, Martin/0000-0001-8944-4131; Bennett, Kathleen/0000-0002-2861-7665	Polish Ministry of Health; European Commission PHEA; UK Medical Research Council [91367]; Medical Research Council [G0900847] Funding Source: researchfish; MRC [G0900847] Funding Source: UKRI	Polish Ministry of Health; European Commission PHEA; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Polish Ministry of Health, the European Commission PHEA, and the UK Medical Research Council (grant No 91367).	Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; BEAGLEHOLE R, 1986, BMJ-BRIT MED J, V292, P33, DOI 10.1136/bmj.292.6512.33; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Bots M L, 1996, J Cardiovasc Risk, V3, P271, DOI 10.1097/00043798-199606000-00002; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Broda Grazyna, 2005, Kardiol Pol, V63, pS601; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Drygas W, 2009, PUBLIC HEALTH, V123, P592, DOI 10.1016/j.puhe.2009.08.004; Drygas W., 2005, KARDIOL POL, V63, P636; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gierlotka M, 2005, KARDIOL POL, V62, P13; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Jasinski B, 2010, KARDIOL POL, V68, P520; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Men T, 2003, BRIT MED J, V327, P964, DOI 10.1136/bmj.327.7421.964; Nichol MB, 1999, ANN PHARMACOTHER, V33, P531, DOI 10.1345/aph.18233; Palmieri L, 2010, AM J PUBLIC HEALTH, V100, P684, DOI 10.2105/AJPH.2008.147173; Polonski L, 2007, KARDIOL POL, V65, P861; Rywik S, 1985, Przegl Lek, V42, P299; Stelmach Wlodzimierz, 2004, Int J Occup Med Environ Health, V17, P393; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580; Wojtyniak B., 2008, SYTUACJA ZDROWOTNA L; World Bank, 2011, OP DAT; World Health Organization Department of Health Statistics and Informatics, 2010, WHO MORT DAT; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zatonski W., 2008, CLOSING HLTH GAP EUR; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187; Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047; Zatonski W, 2008, EUR J EPIDEMIOL, V23, P3, DOI 10.1007/s10654-007-9195-1; Zdrojewski T, 2004, J HUM HYPERTENS, V18, P557, DOI 10.1038/sj.jhh.1001739; Zdrojewski Tomasz, 2004, Kardiol Pol, V61, P546; Zembala Marian, 2006, Kardiol Pol, V64, P445	40	110	111	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2012	344								d8136	10.1136/bmj.d8136	http://dx.doi.org/10.1136/bmj.d8136			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	885KV	22279114	Green Published, hybrid			2022-12-01	WOS:000299778800010
J	Mosca, TJ; Hong, WZ; Dani, VS; Favaloro, V; Luo, LQ				Mosca, Timothy J.; Hong, Weizhe; Dani, Vardhan S.; Favaloro, Vincenzo; Luo, Liqun			Trans-synaptic Teneurin signalling in neuromuscular synapse organization and target choice	NATURE			English	Article							MOSAIC ANALYSIS; BETA-SPECTRIN; PAIR-RULE; IN-VIVO; DROSOPHILA; GENE; JUNCTION; GROWTH; LOCALIZATION; SPECIFICITY	Synapse assembly requires trans-synaptic signals between the pre- and postsynapse(1), but our understanding of the essential organizational molecules involved in this process remains incomplete(2). Teneurin proteins are conserved, epidermal growth factor (EGF)-repeat-containing transmembrane proteins with large extracellular domains(3). Here we show that two Drosophila Teneurins, Ten-m and Ten-a, are required for neuromuscular synapse organization and target selection. Ten-a is presynaptic whereas Ten-m is mostly postsynaptic; neuronal Ten-a and muscle Ten-m form a complex in vivo. Pre- or postsynaptic Teneurin perturbations cause severe synapse loss and impair many facets of organization trans-synaptically and cell autonomously. These include defects in active zone apposition, release sites, membrane and vesicle organization, and synaptic transmission. Moreover, the presynaptic microtubule and postsynaptic spectrin cytoskeletons are severely disrupted, suggesting a mechanism whereby Teneurins organize the cytoskeleton, which in turn affects other aspects of synapse development. Supporting this, Ten-m physically interacts with a-Spectrin. Genetic analyses of teneurin and neuroligin reveal that they have differential roles that synergize to promote synapse assembly. Finally, at elevated endogenous levels, Ten-m regulates target selection between specific motor neurons and muscles. Our study identifies the Teneurins as a key bi-directional trans-synaptic signal involved in general synapse organization, and demonstrates that proteins such as these can also regulate target selection.	[Mosca, Timothy J.; Hong, Weizhe; Dani, Vardhan S.; Favaloro, Vincenzo; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Mosca, TJ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	tmosca@stanford.edu	Hong, Weizhe/E-3164-2010; Hong, Weizhe/AAD-7172-2020	Hong, Weizhe/0000-0003-1523-8575; Hong, Weizhe/0000-0003-1523-8575; Luo, Liqun/0000-0001-5467-9264; Mosca, Timothy/0000-0003-3485-0719	National Institutes of Health (NIH) [R01 DC-005982, 5T32 NS007280, HD007249]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank H. Aberle, V. Budnik, A. DiAntonio, R. Dubreuil, D. Featherstone, N. Reist, T. Schwarz, S. Stowers, D. Van Vactor, R. Wides, the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for fly stocks, antibodies and reagents; J. Perrino and D. Luginbuhl for technical assistance; K. Shen, K. Zinn, D. Banovic, D. Berns, Y. Chou, C. A. Frank, X. Gao, S. Hippenmeyer, K. Miyamichi, K. Sillar, B. Tasic, X. Yu and S. Zosimus for critiques. Supported by a National Institutes of Health (NIH) grant (R01 DC-005982 to L.L.), and Epilepsy, Neonatology and Developmental Biology Training Grants (NIH 5T32 NS007280 and HD007249 to T.J.M.). L.L. is an investigator of the Howard Hughes Medical Institute.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Banovic D, 2010, NEURON, V66, P724, DOI 10.1016/j.neuron.2010.05.020; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; BYERS TJ, 1989, J CELL BIOL, V109, P1633, DOI 10.1083/jcb.109.4.1633; BYERS TJ, 1987, J CELL BIOL, V105, P2103, DOI 10.1083/jcb.105.5.2103; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Higashi-Kovtun ME, 2010, J NEUROSCI, V30, P5253, DOI 10.1523/JNEUROSCI.3739-09.2010; Kenzelmann D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-30; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Laissue PP, 1999, J COMP NEUROL, V405, P543; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Liebl FLW, 2006, J NEUROBIOL, V66, P332, DOI 10.1002/neu.20229; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Lnenicka GA, 2003, J NEUROBIOL, V54, P337, DOI 10.1002/neu.10133; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; Mosca TJ, 2010, NAT NEUROSCI, V13, P935, DOI 10.1038/nn.2593; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Owald D, 2010, J CELL BIOL, V188, P565, DOI 10.1083/jcb.200908055; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Pielage J, 2011, NEURON, V69, P1114, DOI 10.1016/j.neuron.2011.02.007; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Rakovitsky N, 2007, MECH DEVELOP, V124, P911, DOI 10.1016/j.mod.2007.08.003; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Sone M, 2000, DEVELOPMENT, V127, P4157; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wichmann C, 2010, J NEUROGENET, V24, P133, DOI 10.3109/01677063.2010.489626; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Young TR, 2009, INT J BIOCHEM CELL B, V41, P990, DOI 10.1016/j.biocel.2008.06.014; Zheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022956; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	57	137	143	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					237	U122		10.1038/nature10923	http://dx.doi.org/10.1038/nature10923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22426000	Green Accepted			2022-12-01	WOS:000303149900034
J	Firestone, AJ; Weinger, JS; Maldonado, M; Barlan, K; Langston, LD; O'Donnell, M; Gelfand, VI; Kapoor, TM; Chen, JK				Firestone, Ari J.; Weinger, Joshua S.; Maldonado, Maria; Barlan, Kari; Langston, Lance D.; O'Donnell, Michael; Gelfand, Vladimir I.; Kapoor, Tarun M.; Chen, James K.			Small-molecule inhibitors of the AAA plus ATPase motor cytoplasmic dynein	NATURE			English	Article							PRIMARY CILIUM; IN-VITRO; DYNACTIN; KINETOCHORE; ORGANIZATION; CENTROSOMES; TRANSPORT; PROTEINS; MOTILITY; KINESIN	The conversion of chemical energy into mechanical force by AAA+ (ATPases associated with diverse cellular activities) ATPases is integral to cellular processes, including DNA replication, protein unfolding, cargo transport and membrane fusion(1). The AAA+ ATPase motor cytoplasmic dynein regulates ciliary trafficking(2), mitotic spindle formation(3) and organelle transport(4), and dissecting its precise functions has been challenging because of its rapid timescale of action and the lack of cell-permeable, chemical modulators. Here we describe the discovery of ciliobrevins, the first specific small-molecule antagonists of cytoplasmic dynein. Ciliobrevins perturb protein trafficking within the primary cilium, leading to their malformation and Hedgehog signalling blockade. Ciliobrevins also prevent spindle pole focusing, kinetochore-microtubule attachment, melanosome aggregation and peroxisome motility in cultured cells. We further demonstrate the ability of ciliobrevins to block dynein-dependent microtubule gliding and ATPase activity in vitro. Ciliobrevins therefore will be useful reagents for studying cellular processes that require this microtubule motor and may guide the development of additional AAA+ ATPase superfamily inhibitors.	[Firestone, Ari J.; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Weinger, Joshua S.; Maldonado, Maria; Langston, Lance D.; O'Donnell, Michael; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA; [Barlan, Kari; Gelfand, Vladimir I.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Stanford University; Rockefeller University; Northwestern University	Chen, JK (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	kapoor@rockefeller.edu; jameschen@stanford.edu	Gelfand, Vladimir/M-1974-2019; Chen, James/G-9972-2011; Gelfand, Vladimir I/D-2545-2013	Gelfand, Vladimir/0000-0002-6361-2798; Chen, James/0000-0002-9220-8436; Gelfand, Vladimir I/0000-0002-6361-2798; Firestone, Ari/0000-0001-9902-443X; O'Donnell, Michael/0000-0001-9002-4214; Maldonado, Maria/0000-0002-3428-1053; Langston, Lance/0000-0002-2736-9284	National Institutes of Health [R01 CA136574, R01 GM65933, R01 GM71772, R01 GM52111]; NATIONAL CANCER INSTITUTE [R01CA136574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R01GM052111, R01GM065933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Caspary for anti-Arl13b antibodies, W. Brinkley for human CREST anti-serum, T. Yen for anti-CENP-E antibodies, U. Peters for purified bovine dynein, S. Wacker for human kinesin-5 motor domain, R. Vallee for a pVL1393 baculovirus expression vector containing the rat dynein motor domain, and K. Bersuker and R. Kopito for TCR-alpha-GFP-expressing cells. This work was supported by funding from the National Institutes of Health (R01 CA136574 to J.K.C.; R01 GM65933 to T.M.K.; R01 GM71772 to T.M.K. and V.I.G.; R01 GM52111 to V.I.G.)	Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Arasaki K, 2007, MOL PHARMACOL, V71, P454, DOI 10.1124/mol.106.029611; BOUCHARD P, 1981, P NATL ACAD SCI-BIOL, V78, P1033, DOI 10.1073/pnas.78.2.1033; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Gaglio T, 1997, J CELL BIOL, V138, P1055, DOI 10.1083/jcb.138.5.1055; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hook P, 2005, J BIOL CHEM, V280, P33045, DOI 10.1074/jbc.M504693200; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kapoor TM, 1999, P NATL ACAD SCI USA, V96, P9106, DOI 10.1073/pnas.96.16.9106; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Park S, 1998, CANCER LETT, V127, P23, DOI 10.1016/S0304-3835(97)00543-0; SCHLIWA M, 1984, P NATL ACAD SCI-BIOL, V81, P6044, DOI 10.1073/pnas.81.19.6044; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Varma D, 2008, J CELL BIOL, V182, P1045, DOI 10.1083/jcb.200710106; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zhu GY, 2006, J MED CHEM, V49, P2063, DOI 10.1021/jm051030l	30	268	271	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					125	129		10.1038/nature10936	http://dx.doi.org/10.1038/nature10936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22425997	Green Accepted			2022-12-01	WOS:000302343400047
J	Novoa, EM; Pavon-Eternod, M; Pan, T; de Pouplana, LR				Novoa, Eva Maria; Pavon-Eternod, Mariana; Pan, Tao; de Pouplana, Lluis Ribas			A Role for tRNA Modifications in Genome Structure and Codon Usage	CELL			English	Article							ESCHERICHIA-COLI; TRANSLATION EFFICIENCY; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; PHYLOGENETIC ANALYSIS; ADENOSINE-DEAMINASE; PROTEIN EXPRESSION; BACILLUS-SUBTILIS; SELECTION	Transfer RNA (tRNA) gene content is a differentiating feature of genomes that contributes to the efficiency of the translational apparatus, but the principles shaping tRNA gene copy number and codon composition are poorly understood. Here, we report that the emergence of two specific tRNA modifications shaped the structure and composition of all extant genomes. Through the analysis of more than 500 genomes, we identify two kingdom-specific tRNA modifications as major contributors that separated archaeal, bacterial, and eukaryal genomes in terms of their tRNA gene composition. We show that, contrary to prior observations, genomic codon usage and tRNA gene frequencies correlate in all kingdoms if these two modifications are taken into account and that presence or absence of these modifications explains patterns of gene expression observed in previous studies. Finally, we experimentally demonstrate that human gene expression levels correlate well with genomic codon composition if these identified modifications are considered.	[Novoa, Eva Maria; de Pouplana, Lluis Ribas] Inst Res Biomed, Barcelona 08028, Catalonia, Spain; [Pavon-Eternod, Mariana; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [de Pouplana, Lluis Ribas] Catalan Inst Res & Adv Studies, Barcelona 08010, Catalonia, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Chicago; ICREA	de Pouplana, LR (corresponding author), Inst Res Biomed, C Baldiri Reixac 15-21, Barcelona 08028, Catalonia, Spain.	lluis.ribas@irbbarcelona.org	Novoa, Eva Maria/B-1004-2015; de Pouplana, Lluis Ribas/AAA-4738-2019; Novoa, Eva Maria/B-1004-2015	Novoa, Eva Maria/0000-0002-9367-6311; de Pouplana, Lluis Ribas/0000-0002-2087-0359; Novoa, Eva Maria/0000-0001-5567-1299	Spanish Ministry of Education and Science [BIO2009-09776]; European Union [MEPHITIS-223024]; La Caixa/IRB; NIH [1F31CA139968]; NATIONAL CANCER INSTITUTE [F31CA139968] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Spanish Ministry of Education and Science(Spanish Government); European Union(European Commission); La Caixa/IRB; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA)	We thank Dr. M. Santos and Dr. V. de Crecy-Lagard for their critical analysis of the manuscript. We also thank E. Planet and D. Rossell for their help with the statistical analysis of the data. This work has been supported by grant BIO2009-09776 from the Spanish Ministry of Education and Science, and by grant MEPHITIS-223024 from the European Union. E.M.N. is supported by a La Caixa/IRB International Ph.D. Programme Fellowship. M.P.-E. was supported by a Ruth Kirshstein Pre-doctoral Fellowship from the NIH (1F31CA139968).	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; AKASHI H, 1994, GENETICS, V136, P927; Akashi H, 2003, GENETICS, V164, P1291; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fitz-Gibbon ST, 1999, NUCLEIC ACIDS RES, V27, P4218, DOI 10.1093/nar/27.21.4218; Gerber AP, 2001, TRENDS BIOCHEM SCI, V26, P376, DOI 10.1016/S0968-0004(01)01827-8; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GONOS ES, 1990, FEBS LETT, V276, P138, DOI 10.1016/0014-5793(90)80527-P; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Iwasaki W, 2007, BIOINFORMATICS, V23, pI230, DOI 10.1093/bioinformatics/btm165; Jolliffe I., 2002, SPRINGER SERIES STAT; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Knight RD, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.0.CO;2-0; Man O, 2007, NAT GENET, V39, P415, DOI 10.1038/ng1967; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; Mian IS, 1998, J COMPUT BIOL, V5, P57, DOI 10.1089/cmb.1998.5.57; Moriyama EN, 1998, NUCLEIC ACIDS RES, V26, P3188, DOI 10.1093/nar/26.13.3188; Nasvall SJ, 2004, RNA, V10, P1662, DOI 10.1261/rna.7106404; Navon S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r12; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Ran WQ, 2010, MOL BIOL EVOL, V27, P2129, DOI 10.1093/molbev/msq102; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Stetter K.O., 1996, CIBA F SYMP, V202, P11; Stetter KO, 1996, CIBA F SYMP, V202, P1; Supek F, 2010, GENETICS, V185, P1129, DOI 10.1534/genetics.110.115477; Supek F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001004; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tekaia F, 1999, GENOME RES, V9, P550; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Tuller T, 2007, PLOS COMPUT BIOL, V3, P2510, DOI 10.1371/journal.pcbi.0030248; Withers M, 2006, RNA, V12, P933, DOI 10.1261/rna.2272306; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	71	172	184	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					202	213		10.1016/j.cell.2012.01.050	http://dx.doi.org/10.1016/j.cell.2012.01.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464330	Bronze			2022-12-01	WOS:000302235400021
J	Garnett, MJ; Edelman, EJ; Heidorn, SJ; Greenman, CD; Dastur, A; Lau, KW; Greninger, P; Thompson, IR; Luo, X; Soares, J; Liu, QS; Iorio, F; Surdez, D; Chen, L; Milano, RJ; Bignell, GR; Tam, AT; Davies, H; Stevenson, JA; Barthorpe, S; Lutz, SR; Kogera, F; Lawrence, K; McLaren-Douglas, A; Mitropoulos, X; Mironenko, T; Thi, H; Richardson, L; Zhou, WJ; Jewitt, F; Zhang, TH; O'Brien, P; Boisvert, JL; Price, S; Hur, W; Yang, WJ; Deng, XM; Butler, A; Choi, HG; Chang, J; Baselga, J; Stamenkovic, I; Engelman, JA; Sharma, SV; Delattre, O; Saez-Rodriguez, J; Gray, NS; Settleman, J; Futreal, PA; Haber, DA; Stratton, MR; Ramaswamy, S; McDermott, U; Benes, CH				Garnett, Mathew J.; Edelman, Elena J.; Heidorn, Sonja J.; Greenman, Chris D.; Dastur, Anahita; Lau, King Wai; Greninger, Patricia; Thompson, I. Richard; Luo, Xi; Soares, Jorge; Liu, Qingsong; Iorio, Francesco; Surdez, Didier; Chen, Li; Milano, Randy J.; Bignell, Graham R.; Tam, Ah T.; Davies, Helen; Stevenson, Jesse A.; Barthorpe, Syd; Lutz, Stephen R.; Kogera, Fiona; Lawrence, Karl; McLaren-Douglas, Anne; Mitropoulos, Xeni; Mironenko, Tatiana; Thi, Helen; Richardson, Laura; Zhou, Wenjun; Jewitt, Frances; Zhang, Tinghu; O'Brien, Patrick; Boisvert, Jessica L.; Price, Stacey; Hur, Wooyoung; Yang, Wanjuan; Deng, Xianming; Butler, Adam; Choi, Hwan Geun; Chang, JaeWon; Baselga, Jose; Stamenkovic, Ivan; Engelman, Jeffrey A.; Sharma, Sreenath V.; Delattre, Olivier; Saez-Rodriguez, Julio; Gray, Nathanael S.; Settleman, Jeffrey; Futreal, P. Andrew; Haber, Daniel A.; Stratton, Michael R.; Ramaswamy, Sridhar; McDermott, Ultan; Benes, Cyril H.			Systematic identification of genomic markers of drug sensitivity in cancer cells	NATURE			English	Article							MESENCHYMAL PROGENITOR CELLS; KINASE INHIBITOR; IN-VIVO; POLY(ADP-RIBOSE) POLYMERASE; EWINGS-SARCOMA; LUNG-CANCER; P53 PATHWAY; GROWTH; EXPRESSION; MELANOMA	Clinical responses to anticancer therapies are often restricted to a subset of patients. In some cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here, to uncover new biomarkers of sensitivity and resistance to cancer therapeutics, we screened a panel of several hundred cancer cell lines-which represent much of the tissue-type and genetic diversity of human cancers-with 130 drugs under clinical and preclinical investigation. In aggregate, we found that mutated cancer genes were associated with cellular response to most currently available cancer drugs. Classic oncogene addiction paradigms were modified by additional tissue-specific or expression biomarkers, and some frequently mutated genes were associated with sensitivity to a broad range of therapeutic agents. Unexpected relationships were revealed, including the marked sensitivity of Ewing's sarcoma cells harbouring the EWS (also known as EWSR1)-FLI1 gene translocation to poly(ADP-ribose) polymerase (PARP) inhibitors. By linking drug activity to the functional complexity of cancer genomes, systematic pharmacogenomic profiling in cancer cell lines provides a powerful biomarker discovery platform to guide rational cancer therapeutic strategies.	[Garnett, Mathew J.; Heidorn, Sonja J.; Greenman, Chris D.; Lau, King Wai; Thompson, I. Richard; Soares, Jorge; Iorio, Francesco; Bignell, Graham R.; Davies, Helen; Barthorpe, Syd; Kogera, Fiona; Lawrence, Karl; McLaren-Douglas, Anne; Mironenko, Tatiana; Richardson, Laura; Jewitt, Frances; O'Brien, Patrick; Price, Stacey; Yang, Wanjuan; Butler, Adam; Futreal, P. Andrew; Stratton, Michael R.; McDermott, Ultan] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Edelman, Elena J.; Dastur, Anahita; Greninger, Patricia; Luo, Xi; Chen, Li; Milano, Randy J.; Stevenson, Jesse A.; Lutz, Stephen R.; Mitropoulos, Xeni; Thi, Helen; Boisvert, Jessica L.; Baselga, Jose; Engelman, Jeffrey A.; Sharma, Sreenath V.; Settleman, Jeffrey; Haber, Daniel A.; Ramaswamy, Sridhar; Benes, Cyril H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; [Liu, Qingsong; Zhou, Wenjun; Zhang, Tinghu; Hur, Wooyoung; Deng, Xianming; Choi, Hwan Geun; Chang, JaeWon; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, Qingsong; Zhou, Wenjun; Zhang, Tinghu; Hur, Wooyoung; Deng, Xianming; Choi, Hwan Geun; Chang, JaeWon; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Iorio, Francesco; Saez-Rodriguez, Julio] EMBL EBI, Cambridge CB10 1SD, England; [Surdez, Didier; Delattre, Olivier] Inst Curie, Lab Genet & Biol Canc, F-75248 Paris 05, France; [Stamenkovic, Ivan] CHU Vaudois, Inst Pathol, Div Expt Pathol, CH-1005 Lausanne, Switzerland; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Wellcome Trust Sanger Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Howard Hughes Medical Institute	McDermott, U (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	um1@sanger.ac.uk; cbenes@partners.org	Surdez, Didier/ABG-4565-2020; Saez-Rodriguez, Julio/H-7114-2019; Thompson, I Richard/J-9900-2016; Iorio, Francesco/H-3282-2019; Liu, Qingsong/AFS-0714-2022; Iorio, Francesco/H-3284-2019; Lawrence, Karl P/I-8271-2019; 刘, 青松/AEM-1932-2022; Chang, Jae Won/AAN-4139-2020	Saez-Rodriguez, Julio/0000-0002-8552-8976; Thompson, I Richard/0000-0002-9554-550X; Liu, Qingsong/0000-0002-7829-2547; Iorio, Francesco/0000-0001-7063-8913; Lawrence, Karl P/0000-0003-0124-961X; 刘, 青松/0000-0002-7829-2547; Gill, Sonja/0000-0002-7273-9053; Deng, Xianming/0000-0002-9354-5864; Chen, Li/0000-0001-9303-4047; McDermott, Ultan/0000-0001-9032-4700; delattre, olivier/0000-0002-8730-2276	Wellcome Trust [086357]; National Institutes of Health [P41GM079575-02, 1U54HG006097-01]; Howard Hughes Medical Institute; Cancer Research UK Clinician Scientist Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM079575] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Research UK Clinician Scientist Fellowship(Cancer Research UK); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Lo Grasso of the Scripps Research Institute for providing the inhibitor JNK9L. This work was supported by a grant from the Wellcome Trust (086357; M. R. S., P. A. F., J.S., D. A. H.) and by grants from the National Institutes of Health (P41GM079575-02 to N.S.G. and 1U54HG006097-01 to N.S.G. and D. A. H.). S. R. is supported by a Physician-Scientist Early Career Award from the Howard Hughes Medical Institute. U. M. is supported by a Cancer Research UK Clinician Scientist Fellowship.	Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Boland CR, 1998, CANCER RES, V58, P5248; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Deng L, 2010, CANCER BIOL THER, V9, P875, DOI 10.4161/cbt.9.11.11634; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McCabe N, 2005, CANCER BIOL THER, V4, P934, DOI 10.4161/cbt.4.9.2141; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; McDermott U, 2009, J CLIN ONCOL, V27, P5650, DOI 10.1200/JCO.2009.22.9054; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2006, CANCER RES, V66, P7016, DOI 10.1158/0008-5472.CAN-05-3979; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoemaker R H, 1988, Prog Clin Biol Res, V276, P265; Suwaki N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002004; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	37	1601	1628	8	369	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					570	U87		10.1038/nature11005	http://dx.doi.org/10.1038/nature11005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460902	Green Accepted, Green Submitted			2022-12-01	WOS:000302006100033
J	Christie, JM; Arvai, AS; Baxter, KJ; Heilmann, M; Pratt, AJ; O'Hara, A; Kelly, SM; Hothorn, M; Smith, BO; Hitomi, K; Jenkins, GI; Getzoff, ED				Christie, John M.; Arvai, Andrew S.; Baxter, Katherine J.; Heilmann, Monika; Pratt, Ashley J.; O'Hara, Andrew; Kelly, Sharon M.; Hothorn, Michael; Smith, Brian O.; Hitomi, Kenichi; Jenkins, Gareth I.; Getzoff, Elizabeth D.			Plant UVR8 Photoreceptor Senses UV-B by Tryptophan-Mediated Disruption of Cross-Dimer Salt Bridges	SCIENCE			English	Article							SIGNALING COMPONENT UVR8; SCATTERING SAXS; ARABIDOPSIS; TRANSDUCTION; ASSEMBLIES; CHROMATIN; PROTEINS; TISSUE	The recently identified plant photoreceptor UVR8 (UV RESISTANCE LOCUS 8) triggers regulatory changes in gene expression in response to ultraviolet-B (UV-B) light through an unknown mechanism. Here, crystallographic and solution structures of the UVR8 homodimer, together with mutagenesis and far-UV circular dichroism spectroscopy, reveal its mechanisms for UV-B perception and signal transduction. beta-propeller subunits form a remarkable, tryptophan-dominated, dimer interface stitched together by a complex salt-bridge network. Salt-bridging arginines flank the excitonically coupled cross-dimer tryptophan "pyramid" responsible for UV-B sensing. Photoreception reversibly disrupts salt bridges, triggering dimer dissociation and signal initiation. Mutation of a single tryptophan to phenylalanine retunes the photoreceptor to detect UV-C wavelengths. Our analyses establish how UVR8 functions as a photoreceptor without a prosthetic chromophore to promote plant development and survival in sunlight.	[Christie, John M.; Baxter, Katherine J.; Heilmann, Monika; O'Hara, Andrew; Kelly, Sharon M.; Smith, Brian O.; Jenkins, Gareth I.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Christie, John M.; Arvai, Andrew S.; Pratt, Ashley J.; Hitomi, Kenichi; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Christie, John M.; Arvai, Andrew S.; Pratt, Ashley J.; Hitomi, Kenichi; Getzoff, Elizabeth D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Hothorn, Michael] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Hitomi, Kenichi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA; [Hitomi, Kenichi] Natl Inst Biomed Innovat, Sect Lab Equipment, Osaka 5670085, Japan	University of Glasgow; Scripps Research Institute; Scripps Research Institute; Salk Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institute of Health Sciences - Japan	Jenkins, GI (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Bower Bldg, Glasgow G12 8QQ, Lanark, Scotland.	jenkins@glasgow.ac.uk; edg@scripps.edu	Smith, Brian O/J-1899-2015; Kelly, Sharon/K-4611-2013; Hothorn, Michael/C-6807-2011; Pratt, Ashley/A-1754-2012; Smith, Brian/AAJ-9393-2020	Smith, Brian O/0000-0003-3363-4168; Pratt, Ashley/0000-0002-9702-8805; Smith, Brian/0000-0003-3363-4168; Christie, John/0000-0002-9976-0055; Hothorn, Michael/0000-0002-3597-5698; Kelly, Sharon/0000-0002-3516-1387; Baxter, Katherine/0000-0001-8237-9103	National Institutes of Health [GM37684]; Skaggs Institute for Chemical Biology; National Science Foundation; Royal Society; Leverhulme Trust [F/00179/AZ]; UK Biotechnology and Biological Sciences Research Council; Department of Energy, Office of Biological and Environmental Research; Biotechnology and Biological Sciences Research Council [BB/F014961/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684] Funding Source: NIH RePORTER; BBSRC [BB/F014961/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank C. Cloix, E. Kaiserli, N. Fraser, C. Hitomi, R. Rambo, J. Holton, J. A. Tainer, and the Structurally Integrated BiologY for Life Sciences (SIBYLS) beamline staff for discussions and assistance. This research was supported by National Institutes of Health grant GM37684 (E.D.G.); The Skaggs Institute for Chemical Biology (K.H., A.J.P.); National Science Foundation Predoctoral Fellowship (A.J.P.); Royal Society University Research Fellowship (J.M.C.); Leverhulme Trust grant F/00179/AZ (G.I.J., J.M.C., B.O.S.); and UK Biotechnology and Biological Sciences Research Council Ph.D. studentship (A.O.). J.M.C., E.D.G., K.H., and G.I.J. designed the research; A.S.A., K.B., J.M.C., K.H., M.H., S.M.K, A.O., and A.J.P. performed the research; M. Hothorn provided reagents; A.S.A., K.B., J.M.C., E.D.G., K.H., M.H., G.I.J., S.M.K., A.O., A.J.P. and B.O.S. analyzed data; and J.M.C., E.D.G., K.H., G.I.J., and A.J.P. prepared the manuscript. Crystallography and SAXS data were collected at SIBYLS through the Integrated Diffraction Analysis Technologies program supported by the Department of Energy, Office of Biological and Environmental Research. Crystallographic coordinates and structure factors are deposited in the Protein Data Bank with accession code 4D9S.	Andersson D, 2001, EUR J BIOCHEM, V268, P1118, DOI 10.1046/j.1432-1327.2001.01981.x; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Brown BA, 2008, PLANT PHYSIOL, V146, P576, DOI 10.1104/pp.107.108456; Cloix C, 2008, MOL PLANT, V1, P118, DOI 10.1093/mp/ssm012; Favory JJ, 2009, EMBO J, V28, P591, DOI 10.1038/emboj.2009.4; GRISHINA IB, 1994, FARADAY DISCUSS, V99, P245, DOI 10.1039/fd9949900245; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Ohmae E, 2001, J BIOCHEM-TOKYO, V130, P439, DOI 10.1093/oxfordjournals.jbchem.a003004; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1	18	318	349	8	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2012	335	6075					1492	1496		10.1126/science.1218091	http://dx.doi.org/10.1126/science.1218091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22323738	Green Accepted			2022-12-01	WOS:000301837000048
J	Johnson, ZL; Cheong, CG; Lee, SY				Johnson, Zachary Lee; Cheong, Cheom-Gil; Lee, Seok-Yong			Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 angstrom	NATURE			English	Article							CONSERVED GLUTAMATE RESIDUES; CNT FAMILY; DRUGS; IDENTIFICATION; COTRANSPORT; PYRIMIDINE; RESISTANCE; HOMOLOG; REVEALS; PROTEIN	Nucleosides are required for DNA and RNA synthesis, and the nucleoside adenosine has a function in a variety of signalling processes(1,2). Transport of nucleosides across cell membranes provides the major source of nucleosides in many cell types and is also responsible for the termination of adenosine signalling. As a result of their hydrophilic nature, nucleosides require a specialized class of integral membrane proteins, known as nucleoside transporters (NTs), for specific transport across cell membranes. In addition to nucleosides, NTs are important determinants for the transport of nucleoside-derived drugs across cell membranes(3-5). A wide range of nucleoside-derived drugs, including anticancer drugs (such as Ara-C and gemcitabine) and antiviral drugs (such as zidovudine and ribavirin), have been shown to depend, at least in part, on NTs for transport across cell membranes(4,6-13). Concentrative nucleoside transporters, members of the solute carrier transporter superfamily SLC28, use an ion gradient in the active transport of both nucleosides and nucleoside-derived drugs against their chemical gradients. The structural basis for selective ion-coupled nucleoside transport by concentrative nucleoside transporters is unknown. Here we present the crystal structure of a concentrative nucleoside transporter from Vibrio cholerae in complex with uridine at 2.4 angstrom. Our functional data show that, like its human orthologues, the transporter uses a sodium-ion gradient for nucleoside transport. The structure reveals the overall architecture of this class of transporter, unravels the molecular determinants for nucleoside and sodium binding, and provides a framework for understanding the mechanism of nucleoside and nucleoside drug transport across cell membranes.	[Johnson, Zachary Lee; Cheong, Cheom-Gil; Lee, Seok-Yong] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Johnson, Zachary Lee; Cheong, Cheom-Gil; Lee, Seok-Yong] Duke Univ, Med Ctr, Ion Channel Res Unit, Durham, NC 27710 USA	Duke University; Duke University	Lee, SY (corresponding author), Duke Univ, Med Ctr, Dept Biochem, 2 Genome Court, Durham, NC 27710 USA.	sylee@biochem.duke.edu			Duke University Medical Center; McKnight Endowment Fund for Neuroscience; Alfred P. Sloan Foundation; Klingenstein Fund; Mallinckrodt foundation; March of Dimes Foundation [5-FY10-473]; National Institutes of Health [1 DP2 OD008380-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100984] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008380] Funding Source: NIH RePORTER	Duke University Medical Center; McKnight Endowment Fund for Neuroscience; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Klingenstein Fund(Klingenstein Philanthropies); Mallinckrodt foundation; March of Dimes Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Data for this study were collected at beamlines SER-CAT BM22/ID22 and NE-CAT ID 24-C at the Advanced Photon Source. We thank R. MacKinnon and J. Butterwick for critical reading; R. Lefkowitz and A. Shukla for providing access and technical support for the radioactive flux assay; S. Lockless for advice on experiments; and C. Pemble for help with remote data collection. This work was supported by start-up funds from the Duke University Medical Center, the McKnight Endowment Fund for Neuroscience, the Alfred P. Sloan Foundation, the Klingenstein Fund, the Mallinckrodt foundation, the Basil O'Connor Starter Scholar Research Award 5-FY10-473 from the March of Dimes Foundation, and the National Institutes of Health Director's New Innovator Award 1 DP2 OD008380-01 (all to S.-Y.L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cano-Soldado P, 2008, BIOCHEM PHARMACOL, V75, P639, DOI 10.1016/j.bcp.2007.10.005; Cao Y, 2011, NATURE, V473, P50, DOI 10.1038/nature09939; Damaraju VL, 2003, ONCOGENE, V22, P7524, DOI 10.1038/sj.onc.1206952; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errasti-Murugarren E, 2010, PHARMACOGENOMICS, V11, P809, DOI 10.2217/PGS.10.70; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Jordheim LP, 2007, BBA-REV CANCER, V1776, P138, DOI 10.1016/j.bbcan.2007.07.004; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Koszelak-Rosenblum M, 2009, PROTEIN SCI, V18, P1828, DOI 10.1002/pro.193; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Loewen SK, 1999, J BIOL CHEM, V274, P24475, DOI 10.1074/jbc.274.35.24475; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Loewen SK, 2003, YEAST, V20, P661, DOI 10.1002/yea.1000; Mackey JR, 1998, CANCER RES, V58, P4349; Mackey JR, 1998, DRUG RESIST UPDATE, V1, P310, DOI 10.1016/S1368-7646(98)80047-2; Mackey JR, 2002, CLIN CANCER RES, V8, P110; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; Nagai K, 2005, CANCER CHEMOTH PHARM, V55, P222, DOI 10.1007/s00280-004-0861-7; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastor-Anglada M, 1998, TRENDS PHARMACOL SCI, V19, P424, DOI 10.1016/S0165-6147(98)01253-X; Pastor-Anglada M, 2004, LEUKEMIA, V18, P385, DOI 10.1038/sj.leu.2403271; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Rose JB, 2008, PHYSIOLOGY, V23, P41, DOI 10.1152/physiol.00036.2007; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Slugoski MD, 2009, J BIOL CHEM, V284, P17281, DOI 10.1074/jbc.M109.009704; Slugoski MD, 2009, J BIOL CHEM, V284, P17266, DOI 10.1074/jbc.M109.009613; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Xiao GQ, 2001, MOL PHARMACOL, V59, P339, DOI 10.1124/mol.59.2.339; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao SYM, 2007, J BIOL CHEM, V282, P30607, DOI 10.1074/jbc.M703285200; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4	39	88	90	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2012	483	7390					489	U150		10.1038/nature10882	http://dx.doi.org/10.1038/nature10882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22407322	Green Accepted			2022-12-01	WOS:000301771200048
J	Dow, LE; Lowe, SW				Dow, Lukas E.; Lowe, Scott W.			Life in the Fast Lane: Mammalian Disease Models in the Genomics Era	CELL			English	Review							PLURIPOTENT STEM-CELLS; ZINC-FINGER NUCLEASES; ENGINEERED MOUSE MODELS; IN-VIVO; HUMANIZED MICE; KNOCKOUT RATS; EMBRYO MICROINJECTION; RNA INTERFERENCE; GENE CORRECTION; LIVER-CANCER	Analyses of the human genome have proven extremely successful in identifying changes that contribute to human disease. Genetically engineered mice provide a powerful tool to analyze these changes, although they are slow and costly and do not always recapitulate human biology. Recent advances in genomic technologies, rodent-modeling approaches, and the production of patient-derived reprogrammed cell lines now provide a plethora of complementary systems to study disease states and test new therapies. Continued evolution and integration of these model systems will be the key to realizing the benefits of the genomic revolution and refining our understanding and treatment of human diseases.	[Dow, Lukas E.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	lowes@mskcc.org		Dow, Lukas/0000-0001-7048-1418	National Health & Medical Research Council of Australia; National Cancer Institute; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA008748] Funding Source: NIH RePORTER	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Amaia Lujambio for critical input and apologize to those authors whose work was not cited due to space constraints. L.E.D. was supported by an Overseas Biomedical Training fellowship from National Health & Medical Research Council of Australia, and S.W.L. is an investigator of the Howard Hughes Medical Institute. This work was supported by a consortium grant from the National Cancer Institute. S.W.L. is one of the founders of Mirimus Inc., a company that has licensed technology relating to the development of shRNA transgenic mice.	Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Amos-Landgraf JM, 2007, P NATL ACAD SCI USA, V104, P4036, DOI 10.1073/pnas.0611690104; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Billerbeck E, 2011, BLOOD, V117, P3076, DOI 10.1182/blood-2010-08-301507; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Dolgin E, 2010, NAT MED, V16, P254, DOI 10.1038/nm0310-254; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Driver JP, 2011, SEMIN IMMUNOPATHOL, V33, P67, DOI 10.1007/s00281-010-0204-1; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Heyer J, 2010, NAT REV CANCER, V10, P470, DOI 10.1038/nrc2877; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Huijbers IJ, 2011, BIOESSAYS, V33, P701, DOI 10.1002/bies.201100018; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jin ZB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017084; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kile BT, 2005, NAT REV GENET, V6, P557, DOI 10.1038/nrg1636; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Matera I, 2007, PIGM CELL RES, V20, P210, DOI 10.1111/j.1600-0749.2007.00371.x; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pinto YM, 1998, CARDIOVASC RES, V39, P77, DOI 10.1016/S0008-6363(98)00077-7; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Richmond A, 2008, DIS MODEL MECH, V1, P78, DOI 10.1242/dmm.000976; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Seibler J, 1998, BIOCHEMISTRY-US, V37, P6229, DOI 10.1021/bi980288t; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stottmann RW, 2011, GENETICS, V188, P615, DOI 10.1534/genetics.111.126862; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; Tchekneva EE, 2007, J AM SOC NEPHROL, V18, P103, DOI 10.1681/ASN.2006020164; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yu CI, 2008, BLOOD, V112, P3671, DOI 10.1182/blood-2008-05-157016; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	82	57	60	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 16	2012	148	6					1099	1109		10.1016/j.cell.2012.02.023	http://dx.doi.org/10.1016/j.cell.2012.02.023			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	913PI	22424222	Bronze, Green Accepted			2022-12-01	WOS:000301889500009
J	Mills, NL; Lee, KK; McAllister, DA; Churchhouse, AMD; MacLeod, M; Stoddart, M; Walker, S; Denvir, MA; Fox, KAA; Newby, DE				Mills, Nicholas L.; Lee, Kuan Ken; McAllister, David A.; Churchhouse, Antonia M. D.; MacLeod, Margaret; Stoddart, Mary; Walker, Simon; Denvir, Martin A.; Fox, Keith A. A.; Newby, David E.			Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE CORONARY SYNDROMES; ARTERY-DISEASE; T ASSAY; I LEVELS; RISK; POPULATION; MARKERS; PERFORMANCE; DEFINITION; MORTALITY	Objective To assess the relation between troponin concentration, assay precision, and clinical outcomes in patients with suspected acute coronary syndrome. Design Cohort study. Setting Tertiary centre in Scotland. Participants 2092 consecutive patients admitted with suspected acute coronary syndrome were stratified with a sensitive troponin I assay into three groups (<0.012, 0.012-0.049, and >= 0.050 mu g/L) based on the 99th centile for troponin concentration (0.012 mu g/L; coefficient of variation 20.8%) and the diagnostic threshold (0.050 mu g/L; 7.2%). Main outcome measure One year survival without events (recurrent myocardial infarction, death) in patients grouped by troponin concentration. Results Troponin I concentrations were <0.012 mu g/L in 988 patients (47%), 0.012-0.049 mu g/L in 352 patients (17%), and >= 0.050 mu g/L in 752 patients (36%). Adoption of the 99th centile would increase the number of people receiving a diagnosis of myocardial infarction from 752 to 1104: a relative increase of 47%. At one year, patients with troponin concentrations of 0.012-0.049 mu g/L were more likely to be dead or readmitted with recurrent myocardial infarction than those with troponin concentrations <0.012 mu g/L (13% v 3%, P<0.001; odds ratio 4.7, 95% confidence interval 2.9 to 7.9). Compared with troponin >= 0.050 mu g/L, patients with troponin 0.012-0.049 mu g/L had a higher risk profile but were less likely to have a diagnosis of, or be investigated and treated for, acute coronary syndrome. Conclusion Lowering the diagnostic threshold to the 99th centile and accepting greater assay imprecision would identify more patients with acute coronary syndrome at risk of recurrent myocardial infarction and death but would increase the diagnosis of myocardial infarction by 47%. It remains to be established whether reclassification of these patients and treatment for myocardial infarction would improve outcome.	[Mills, Nicholas L.; Lee, Kuan Ken; Churchhouse, Antonia M. D.; Denvir, Martin A.; Fox, Keith A. A.; Newby, David E.] Univ Edinburgh, BHF Univ Ctr Cardiovasc Sci, Edinburgh EH16 4SU, Midlothian, Scotland; [McAllister, David A.] Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland; [MacLeod, Margaret] Royal Infirm Edinburgh NHS Trust, Edinburgh Heart Ctr, Edinburgh EH16 4SA, Midlothian, Scotland; [Stoddart, Mary; Walker, Simon] Royal Infirm Edinburgh NHS Trust, Dept Clin Biochem, Edinburgh EH16 4SA, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Mills, NL (corresponding author), Univ Edinburgh, BHF Univ Ctr Cardiovasc Sci, Chancellors Bldg, Edinburgh EH16 4SB, Midlothian, Scotland.	nick.mills@ed.ac.uk	Fox, keith A A/I-3742-2013; Newby, David Ernest/AAB-1364-2019; Denvir, Martin A/ABA-3141-2021	Mills, Nicholas/0000-0003-0533-7991; Churchhouse, Antonia/0000-0002-2321-2140; Fox, Keith/0000-0002-0140-2752; McAllister, David/0000-0003-3550-1764	British Heart Foundation (BHF) [FS/10/024/28266, CH/92010/6773, CH/09/002/26360]; British Heart Foundation [FS/10/024/28266] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. NLM is supported by an intermediate clinical research fellowship from the British Heart Foundation (BHF) (FS/10/024/28266). KAAF and DEN are supported by BHF Chair Awards (CH/92010/6773 and CH/09/002/26360, respectively).	Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Apple FS, 2010, CLIN BIOCHEM, V43, P1034, DOI 10.1016/j.clinbiochem.2010.05.014; Apple FS, 2009, CLIN CHEM, V55, P1303, DOI 10.1373/clinchem.2009.128363; Bauer A, 2009, NEW ENGL J MED, V361, P2575, DOI 10.1056/NEJMc0909215; Body R, 2011, J AM COLL CARDIOL, V58, P1333, DOI 10.1016/j.jacc.2011.06.026; Bonaca M, 2010, J AM COLL CARDIOL, V55, P2118, DOI 10.1016/j.jacc.2010.01.044; Collinson P, 2012, HEART, V98, P312, DOI 10.1136/heartjnl-2011-300723; Eggers KM, 2008, EUR HEART J, V29, P2252, DOI 10.1093/eurheartj/ehn327; Eggers KM, 2009, CLIN CHEM, V55, P85, DOI 10.1373/clinchem.2007.101683; Jaffe AS, 2010, CLIN CHEM, V56, P941, DOI 10.1373/clinchem.2010.143958; Koerbin G, 2010, ANN CLIN BIOCHEM, V47, P524, DOI 10.1258/acb.2010.010033; Kupchak P, 2006, CLIN CHEM, V52, P752, DOI 10.1373/clinchem.2005.064477; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Lindahl B, 1996, CIRCULATION, V93, P1651, DOI 10.1161/01.CIR.93.9.1651; Lindahl B, 2010, AM HEART J, V160, P224, DOI 10.1016/j.ahj.2010.05.023; Meune C, 2011, HEART, V97, P1479, DOI 10.1136/hrt.2010.220988; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Mingels A, 2009, CLIN CHEM, V55, P101, DOI 10.1373/clinchem.2008.106427; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Morrow DA, 2007, CLIN CHEM, V53, P552, DOI 10.1373/clinchem.2006.084194; Morrow DA, 2009, NEW ENGL J MED, V361, P913, DOI 10.1056/NEJMe0905790; Myocardial Ischaemia National Audit Project (MINAP), 2011, NHS CAR PAT HEART AT, Vxx, P1; NHS National Services Scotland: Information Services Division (ISD), 2011, HOSP ACT COR HEART D, Vxx, P1; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Sabatine MS, 2009, EUR HEART J, V30, P162, DOI 10.1093/eurheartj/ehn504; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Venge P, 2009, J AM COLL CARDIOL, V54, P1165, DOI 10.1016/j.jacc.2009.05.051	27	71	81	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2012	344								e1533	10.1136/bmj.e1533	http://dx.doi.org/10.1136/bmj.e1533			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913CD	22422871	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-01	WOS:000301848100005
J	Heneghan, C; Langton, D; Thompson, M				Heneghan, Carl; Langton, David; Thompson, M.			MEDICAL DEVICES Ongoing problems with metal-on-metal hip implants	BRITISH MEDICAL JOURNAL			English	Editorial Material							FOLLOW-UP; RESURFACING ARTHROPLASTY; REPLACEMENT PATIENTS; CANCER INCIDENCE; NATIONWIDE; BEARINGS; COBALT; DEATH; IONS; ASR		[Heneghan, Carl] Univ Oxford, Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX1 2ET, England; [Langton, David] Univ Hosp N Tees, Joint Replacement Unit, Stockton On Tees, England	University of Oxford; University Hospital of North Tees	Heneghan, C (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX1 2ET, England.	carl.heneghan@phc.ox.ac.uk						Angerer J, 2012, COBALT BAT VALUE DOC; [Anonymous], 2000, BR J PERIOPER NURS, V10, P285; Bolt HM, 2012, ALKALI CHROMATES CR6; British Hip Society British Orthopaedic Association, 2011, UPD GUID LARG DIAM M; Case CP, 1996, CLIN ORTHOP RELAT R, pS269; Clarke MT, 2003, J BONE JOINT SURG BR, V85B, P913, DOI 10.1302/0301-620X.85B6.14166; Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905; COLEMAN RF, 1973, BMJ-BRIT MED J, V1, P527, DOI 10.1136/bmj.1.5852.527; Cutts S, 2006, POSTGRAD MED J, V82, P802, DOI 10.1136/pgmj.2005.044594; European Commission, 2011, EUR DAT MED DEV EUDA; FDA, 2011, INF ORTH SURG MET ON; Haddad FS, 2011, J BONE JOINT SURG BR, V93B, P572, DOI 10.1302/0301-620X.93B4.26429; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; Keegan GM, 2007, J BONE JOINT SURG BR, V89B, P567, DOI 10.1302/0301-620X.89B5.18903; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; MacDonald SJ, 2004, J ARTHROPLASTY, V19, P71, DOI 10.1016/j.arth.2004.09.008; Medicines and Healthcare products Regulatory Agency (MHRA), 2010, MED DEV AL ALL MET O; Meier B, 2011, NY TIMES        1214; MHRA, 2007, GUID COMM DIR REC TO; Mulroy WF, 1996, J BONE JOINT SURG AM, V78A, P325, DOI 10.2106/00004623-199603000-00002; NICE, 2002, CLIN EFF COST EFF ME; Paavolainen P, 1999, J ARTHROPLASTY, V14, P272, DOI 10.1016/S0883-5403(99)90051-7; SCHIRRMA.UO, 1967, BRIT MED J, V1, P544, DOI 10.1136/bmj.1.5539.544; Siebel T, 2006, P I MECH ENG H, V220, P345, DOI 10.1243/095441105X69079; Tower SS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e430; van der Weegen W, 2011, J BONE JOINT SURG BR, V93B, P298, DOI 10.1302/0301-620X.93B3.25594; Visuri TI, 2006, P I MECH ENG H, V220, P399, DOI 10.1243/095441105X63282; Visuri T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-78; Visuri T, 2010, ACTA ORTHOP, V81, P77, DOI 10.3109/17453671003667150; Walsh J, 2011, METAL METAL TOTAL HI; Witzleb WC, 2006, ACTA ORTHOP, V77, P697, DOI 10.1080/17453670610012863	31	25	25	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 28	2012	344								e1349	10.1136/bmj.e1349	http://dx.doi.org/10.1136/bmj.e1349			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XA	22374740	Bronze, Green Submitted			2022-12-01	WOS:000301231000010
J	Donohue, JM; Morden, NE; Gellad, WF; Bynum, JP; Zhou, WP; Hanlon, JT; Skinner, J				Donohue, Julie M.; Morden, Nancy E.; Gellad, Walid F.; Bynum, Julie P.; Zhou, Weiping; Hanlon, Joseph T.; Skinner, Jonathan			Sources of Regional Variation in Medicare Part D Drug Spending	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE; GEOGRAPHIC-VARIATION; POTENTIAL SAVINGS; GENERIC DRUGS; INHIBITORS; QUALITY; COST; RISK	Background Sources of regional variation in spending for prescription drugs under Medicare Part D are poorly understood, and such variation may reflect differences in health status, use of effective treatments, or selection of branded drugs over lower-cost generics. Methods We analyzed 2008 Medicare data for 4.7 million beneficiaries for prescription-drug use and expenditures overall and in three drug categories: angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs), 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins), and selective serotonin-reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Differences in per capita expenditures across hospital-referral regions (HRRs) were decomposed into annual prescription volume and cost per prescription. The ratio of prescriptions filled as branded drugs to all prescriptions filled was calculated. We adjusted all measures for demographic, socioeconomic, and health-status differences. Results Mean adjusted per capita pharmaceutical spending ranged from $2,413 in the lowest to $3,008 in the highest quintile of HRRs. Most (75.9%) of that difference was attributable to the cost per prescription ($53 vs. $63). Regional differences in cost per prescription explained 87.5% of expenditure variation for ACE inhibitors and ARBs and 56.3% for statins but only 36.1% for SSRIs and SNRIs. The ratio of branded-drug to total prescriptions, which correlated highly with cost per prescription, ranged across HRRs from 0.24 to 0.45 overall and from 0.24 to 0.55 for ACE inhibitors and ARBs, 0.29 to 0.60 for statins, and 0.15 to 0.51 for SSRIs and SNRIs. Conclusions Regional variation in Medicare Part D spending results largely from differences in the cost of drugs selected rather than prescription volume. A reduction in branded-drug use in some regions through modification of Part D plan benefits might lower costs without reducing quality of care. (Funded by the National Institute on Aging and others.)	[Donohue, Julie M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA; [Gellad, Walid F.] Univ Pittsburgh, Dept Med Gen Internal Med, Pittsburgh, PA 15261 USA; [Hanlon, Joseph T.] Univ Pittsburgh, Dept Med Geriatr Pharm & Therapeut & Biomed Infor, Pittsburgh, PA 15261 USA; [Hanlon, Joseph T.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15261 USA; [Gellad, Walid F.] Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA; [Gellad, Walid F.] RAND, Pittsburgh, PA USA; [Hanlon, Joseph T.] Vet Affairs Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Morden, Nancy E.; Bynum, Julie P.; Zhou, Weiping; Skinner, Jonathan] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA; [Morden, Nancy E.; Skinner, Jonathan] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH 03756 USA; [Skinner, Jonathan] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; RAND Corporation; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Dartmouth College; Dartmouth College; Dartmouth College	Donohue, JM (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, 130 DeSoto St,Crabtree Hall A613, Pittsburgh, PA 15261 USA.	jdonohue@pitt.edu		Donohue, Julie/0000-0003-2418-6017	National Institute on Aging [P01AG019783, AG-07-001, P30AG024827, T32 AG021885, K07AG033174, K23AG028947, R01AG034056, U01 AG012553, R56AG027017]; Agency for Healthcare Research and Quality [R01HS017695, R01HS018721, K12 HS019461]; National Institute of Nursing Research [R01 NR010135]; National Institute of Mental Health [R34 MH082682]; Robert Wood Johnson Foundation [059491]; Veterans Affairs Health Services Research and Development Service [IIR-06-062, CDA 09-207]; National Institute on Aging and others; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS017695, K12HS019461, R01HS018721] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH082682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG007001, U01AG012553, P01AG019783, R01AG034056, K07AG033174, P30AG024827, K23AG028947, T32AG021885, R56AG027017, K23AG035030] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs); National Institute on Aging and others; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institute on Aging (P01AG019783, AG-07-001, P30AG024827, T32 AG021885, K07AG033174, K23AG028947, R01AG034056, U01 AG012553, and R56AG027017), the Agency for Healthcare Research and Quality (R01HS017695, R01HS018721, and K12 HS019461), the National Institute of Nursing Research (R01 NR010135), the National Institute of Mental Health (R34 MH082682), the Robert Wood Johnson Foundation (059491), and the Veterans Affairs Health Services Research and Development Service (IIR-06-062 and CDA 09-207).; Funded by the National Institute on Aging and others.	Agency for Healthcare Research and Quality, CREAT NEW RAC ETHN C; [Anonymous], 2009, GENERIC DRUGS REVISI; [Anonymous], 2008, FACT SHEET MED PRESC; [Anonymous], LEX DAT BAS DAT LEX; [Anonymous], CENS 2000 SUMM FIL A; [Anonymous], 2007, GEN DRUG UT MED D; Anthony DL, 2009, HEALTH AFFAIR, V28, P864, DOI 10.1377/hlthaff.28.3.864; Anthony JDL, 2009, HLTH AFF MILLWOOD, V28, P1233; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Centers for Medicare and Medicaid Services, RXHCC MOD SOFTW; Dartmouth Medical School Center for the Evaluative Clinical Sciences, 1998, DARTM ATL HLTH CAR; Donohue JM, 2008, HEALTH SERV RES, V43, P1557, DOI 10.1111/j.1475-6773.2008.00858.x; Fischer MA, 2004, PHARMACOEPIDEM DR S, V13, P207, DOI 10.1002/pds.872; Fischer MA, 2004, JAMA-J AM MED ASSOC, V291, P1850, DOI 10.1001/jama.291.15.1850; Fischer MA, 2003, HEALTH SERV RES, V38, P1051, DOI 10.1111/1475-6773.00162; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Gellad WF, 2010, AM J MANAG CARE, V16, P741; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; Kaiser Family Foundation, 2007, MED PRESCR DRUG BEN; Kaiser Family Foundation, 2010, MED PRESCR DRUG PLAN; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; MaCurdy T., 2009, GEOGRAPHIC VARIATION; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189; Matchar DB., COMPARATIVE EFFECTIV; Oaxaca R., 1973, INT EC REV PHILADELP, V14, P693, DOI DOI 10.2307/2525981; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Robst J, 2007, HEALTH CARE FINANC R, V28, P15; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Shrank WH, 2007, J GEN INTERN MED, V22, P1298, DOI 10.1007/s11606-007-0284-3; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; Sutherland JM, 2009, NEW ENGL J MED, V361, P1227, DOI 10.1056/NEJMp0907172; Welch HG, 2011, JAMA-J AM MED ASSOC, V305, P1113, DOI 10.1001/jama.2011.307; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zhang YT, 2010, NEW ENGL J MED, V363, P405, DOI 10.1056/NEJMp1004872	39	58	58	3	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2012	366	6					530	538		10.1056/NEJMsa1104816	http://dx.doi.org/10.1056/NEJMsa1104816			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888GH	22316446	Green Accepted, Bronze			2022-12-01	WOS:000299991300009
J	Ghosh, R; Andersen, EC; Shapiro, JA; Gerke, JP; Kruglyak, L				Ghosh, Rajarshi; Andersen, Erik C.; Shapiro, Joshua A.; Gerke, Justin P.; Kruglyak, Leonid			Natural Variation in a Chloride Channel Subunit Confers Avermectin Resistance in C. elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; COOPERIA-ONCOPHORA; ARABIDOPSIS-THALIANA; HAEMONCHUS-CONTORTUS; IVERMECTIN; POLYMORPHISM; SENSITIVITY; ACTIVATION; NEMATODES; GENETICS	Resistance of nematodes to anthelmintics such as avermectins has emerged as a major global health and agricultural problem, but genes conferring natural resistance to avermectins are unknown. We show that a naturally occurring four-amino-acid deletion in the ligand-binding domain of GLC-1, the alpha-subunit of a glutamate-gated chloride channel, confers resistance to avermectins in the model nematode Caenorhabditis elegans. We also find that the same variant confers resistance to the avermectin-producing bacterium Streptomyces avermitilis. Population-genetic analyses identified two highly divergent haplotypes at the glc-1 locus that have been maintained at intermediate frequencies by long-term balancing selection. These results implicate variation in glutamate-gated chloride channels in avermectin resistance and provide a mechanism by which such resistance can be maintained.	[Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolut Biol, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Howard Hughes Medical Institute; Princeton University	Kruglyak, L (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu	Shapiro, Joshua/B-5948-2008	Shapiro, Joshua/0000-0002-6224-0347; Andersen, Erik/0000-0003-0229-9651	Life Science Research Foundation; NIH Ruth L. Kirschstein National Research Service; James S. McDonnell Foundation; Howard Hughes Medical Institute; NIH [R01-HG004321, R37- MH59520, P50-GM071508]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059520, R37MH059520] Funding Source: NIH RePORTER	Life Science Research Foundation; NIH Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank F. Albert, I. Ehrenreich, M. Rockman, and H. Seidel for critical reading of the manuscript and members of the Kruglyak laboratory for suggestions, K. Chattopadhyay for advice regarding protein structure analysis, and P. McGrath for sharing unpublished sequence information of the MY14 strain. Supported by a Merck fellowship of the Life Science Research Foundation (J.P.G.), NIH Ruth L. Kirschstein National Research Service Award (E. C. A.), James S. McDonnell Foundation Centennial Fellowship, Howard Hughes Medical Institute, NIH grants R01-HG004321 and R37- MH59520 (L. K.), and NIH grant P50-GM071508 to the Center for Quantitative Biology at the Lewis-Sigler Institute of Princeton University. Some of the C. elegans strains used were obtained from the Caenorhabditis Genetics Center. GenBank sequence accession numbers for the sequences are JN983734 to JN983793.	ARENA JP, 1995, J PARASITOL, V81, P286, DOI 10.2307/3283936; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; Cook A, 2006, MOL BIOCHEM PARASIT, V147, P118, DOI 10.1016/j.molbiopara.2006.02.003; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; El-Abdellati A, 2011, INT J PARASITOL, V41, P951, DOI 10.1016/j.ijpara.2011.04.003; Etter A, 1996, J BIOL CHEM, V271, P16035, DOI 10.1074/jbc.271.27.16035; Gilleard JS, 2007, PARASITOLOGY, V134, P1133, DOI 10.1017/S0031182007000066; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Kaplan RM, 2007, INT J PARASITOL, V37, P795, DOI 10.1016/j.ijpara.2007.01.001; KRUGLYAK L, 1995, GENETICS, V139, P1421; Kwon DH, 2010, INSECT MOL BIOL, V19, P583, DOI 10.1111/j.1365-2583.2010.01017.x; McCavera S, 2007, PARASITOLOGY, V134, P1111, DOI 10.1017/S0031182007000042; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; Njue AI, 2004, PARASITOL RES, V93, P419, DOI 10.1007/s00436-004-1149-x; Njue AI, 2004, J NEUROCHEM, V89, P1137, DOI 10.1111/j.1471-4159.2004.02379.x; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; TAJIMA F, 1989, GENETICS, V123, P585; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Vassilatis DK, 1997, J BIOL CHEM, V272, P33167, DOI 10.1074/jbc.272.52.33167; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010	27	106	108	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 3	2012	335	6068					574	578		10.1126/science.1214318	http://dx.doi.org/10.1126/science.1214318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22301316	Green Accepted			2022-12-01	WOS:000299769200041
J	Sethi, AJ; Wikramanayake, RM; Angerer, RC; Range, RC; Angerer, LM				Sethi, Aditya J.; Wikramanayake, Radhika M.; Angerer, Robert C.; Range, Ryan C.; Angerer, Lynne M.			Sequential Signaling Crosstalk Regulates Endomesoderm Segregation in Sea Urchin Embryos	SCIENCE			English	Article							NUCLEAR BETA-CATENIN; GENE NETWORK; VEGETAL PLATE; SPECIFICATION; ENDODERM; NOTCH; INDUCTION; CELLS; MESENDODERM; ACTIVATION	The segregation of embryonic endomesoderm into separate endoderm and mesoderm fates is not well understood in deuterostomes. Using sea urchin embryos, we showed that Notch signaling initiates segregation of the endomesoderm precursor field by inhibiting expression of a key endoderm transcription factor in presumptive mesoderm. The regulatory circuit activated by this transcription factor subsequently maintains transcription of a canonical Wnt (cWnt) ligand only in endoderm precursors. This cWnt ligand reinforces the endoderm state, amplifying the distinction between emerging endoderm and mesoderm. Before gastrulation, Notch-dependent nuclear export of an essential beta-catenin transcriptional coactivator from mesoderm renders it refractory to cWnt signals, insulating it against an endoderm fate. Thus, we report that endomesoderm segregation is a progressive process, requiring a succession of regulatory interactions between cWnt and Notch signaling.	[Sethi, Aditya J.; Angerer, Robert C.; Range, Ryan C.; Angerer, Lynne M.] NIDCR, NIH, Bethesda, MD 20892 USA; [Wikramanayake, Radhika M.] Univ Oxford, Dept Publ Hlth, Oxford, England	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Oxford	Angerer, LM (corresponding author), NIDCR, NIH, Bethesda, MD 20892 USA.	langerer@mail.nih.gov			National Institute of Dental and Craniofacial Research, NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000712] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank D. Adams and R. Benabentos for their comments. Funding was provided by the Intramural Program at the National Institute of Dental and Craniofacial Research, NIH.	Croce J, 2011, DEVELOPMENT, V138, P3297, DOI 10.1242/dev.058792; Croce JC, 2010, DEVELOPMENT, V137, P83, DOI 10.1242/dev.044149; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; De-Leon SBT, 2010, P NATL ACAD SCI USA, V107, P10103, DOI 10.1073/pnas.1004824107; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Kikuchi Y, 2004, DEV DYNAM, V229, P756, DOI 10.1002/dvdy.10483; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Logan CY, 1999, DEVELOPMENT, V126, P345; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; McClay DR, 2000, DEVELOPMENT, V127, P5113; Oliveri P, 2002, DEV BIOL, V246, P209, DOI 10.1006/dbio.2002.0627; Peter IS, 2011, NATURE, V474, P635, DOI 10.1038/nature10100; Peter IS, 2010, DEV BIOL, V340, P188, DOI 10.1016/j.ydbio.2009.10.037; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Revinski DR, 2010, DEV BIOL, V339, P477, DOI 10.1016/j.ydbio.2010.01.010; Rodaway A, 2001, CELL, V105, P169, DOI 10.1016/S0092-8674(01)00307-5; Rottinger E, 2006, DEVELOPMENT, V133, P4341, DOI 10.1242/dev.02603; Ruffins SW, 1996, DEVELOPMENT, V122, P253; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Sherwood DR, 1997, DEVELOPMENT, V124, P3363; Sherwood DR, 1999, DEVELOPMENT, V126, P1703; Sherwood DR, 2001, DEVELOPMENT, V128, P2221; Smith J, 2008, DEV BIOL, V313, P863, DOI 10.1016/j.ydbio.2007.10.042; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Sweet HC, 2002, DEVELOPMENT, V129, P1945; Sweet HC, 1999, DEVELOPMENT, V126, P5255; Wikramanayake AH, 1998, P NATL ACAD SCI USA, V95, P9343, DOI 10.1073/pnas.95.16.9343; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045	31	46	46	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 3	2012	335	6068					590	593		10.1126/science.1212867	http://dx.doi.org/10.1126/science.1212867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885HI	22301319	Green Accepted			2022-12-01	WOS:000299769200045
J	Khalili, H; Huang, ES; Jacobson, BC; Camargo, CA; Feskanich, D; Chan, AT				Khalili, Hamed; Huang, Edward S.; Jacobson, Brian C.; Camargo, Carlos A., Jr.; Feskanich, Diane; Chan, Andrew T.			Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							INTESTINAL CALCIUM-ABSORPTION; FOOD FREQUENCY QUESTIONNAIRE; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; REPRODUCIBILITY; OMEPRAZOLE; MORTALITY; VALIDITY; SMOKING; METAANALYSIS	Objective To examine the association between chronic use of proton pump inhibitors (PPIs) and risk of hip fracture. Design Prospective cohort study. Setting Nurses' Health Study, which originally recruited from the 11 most populous states in the US. Participants 79 899 postmenopausal women enrolled in the Nurses' Health Study who provided data on the use of PPIs and other risk factors biennially since 2000 and were followed up to 1 June 2008. Main outcome measure Incident hip fracture Results During 565 786 person years of follow-up, we documented 893 incident hip fractures. The absolute risk of hip fracture among regular users of PPIs was 2.02 events per 1000 person years, compared with 1.51 events per 1000 person years among non-users. Compared with non-users, the risk of hip fracture among women who regularly used PPIs for at least two years was 35% higher (age adjusted hazard ratio 1.35 (95% confidence interval 1.13 to 1.62)), with longer use associated with increasing risk (P-trend<0.01). Adjustment for risk factors, including body mass index, physical activity, and intake of calcium did not materially alter this association (hazard ratio 1.36 (1.13 to 1.63)). These associations were also not changed after accounting for reasons for PPI use. The relation between PPI use and fracture differed by smoking history (P-interaction=0.03). Among current and former smokers, PPI use was associated with greater than 50% increase in risk of fracture, with a multivariate hazard ratio for fracture of 1.51 (1.20 to 1.91). In contrast, among women who never smoked there was no association (multivariate hazard ratio 1.06 (0.77 to 1.46)). In a meta-analysis of these results with 10 prior studies, the pooled odds ratio of hip fracture associated with PPI use was 1.30 (1.25 to 1.36). Conclusion Chronic use of PPIs is associated with increased risk of hip fracture, particularly among women with a history of smoking.	[Khalili, Hamed; Huang, Edward S.; Chan, Andrew T.] Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA; [Jacobson, Brian C.] Boston Univ, Med Ctr, Sect Gastroenterol, Boston, MA 02118 USA; [Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Camargo, Carlos A., Jr.; Feskanich, Diane; Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Camargo, Carlos A., Jr.; Feskanich, Diane; Chan, Andrew T.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Chan, AT (corresponding author), Massachusetts Gen Hosp, Gastroenterol Unit, 55 Fruit St,GRJ 728A, Boston, MA 02114 USA.	achan@partners.org	Camargo, Carlos A./C-2145-2008; Chan, Andrew T/P-8293-2014	Camargo, Carlos A./0000-0002-5071-7654; Chan, Andrew T/0000-0001-7284-6767; Jacobson, Brian/0000-0001-7064-2357	US National Institutes of Health [NIH R01 CA137178, P01 CA87969]; National Institutes of Health (NIH) [R01 DK088782]; IBD Working Group; American Gastroenterological Association; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA137178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088782] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IBD Working Group; American Gastroenterological Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the US National Institutes of Health (grant No NIH R01 CA137178, P01 CA87969). ATC is a Damon Runyon Cancer Research Foundation clinical investigator. BCJ is supported by a grant from the National Institutes of Health (NIH R01 DK088782). HK is supported by a career development award from the IBD Working Group. ESH is supported by a career development award from the American Gastroenterological Association.	Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chiu HF, 2010, PHARMACOEPIDEM DR S, V19, P1131, DOI 10.1002/pds.2026; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Corley DA, 2010, GASTROENTEROLOGY, V139, P93, DOI 10.1053/j.gastro.2010.03.055; Cornuz J, 1999, AM J MED, V106, P311, DOI 10.1016/S0002-9343(99)00022-4; de Vries F, 2009, OSTEOPOROSIS INT, V20, P1989, DOI 10.1007/s00198-009-0891-4; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FDA, 2010, DRUG SAF COMM POSS I; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.2300; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Feskanich D, 1997, OSTEOPOROSIS INT, V7, P79, DOI 10.1007/BF01623465; Feskanich D, 2003, AM J CLIN NUTR, V77, P504, DOI 10.1093/ajcn/77.2.504; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; GagnemoPersson R, 1997, CALCIFIED TISSUE INT, V61, P210, DOI 10.1007/s002239900325; Gray SL, 2010, ARCH INTERN MED, V170, P765, DOI 10.1001/archinternmed.2010.94; Hansen KE, 2010, J BONE MINER RES, V25, P2510, DOI 10.1002/jbmr.166; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Jacobson BC, 2006, NEW ENGL J MED, V354, P2340, DOI 10.1056/NEJMoa054391; Kaye JA, 2008, PHARMACOTHERAPY, V28, P951, DOI 10.1592/phco.28.8.951; Krall EA, 1999, J BONE MINER RES, V14, P215, DOI 10.1359/jbmr.1999.14.2.215; Kwok CS, 2011, BONE, V48, P768, DOI 10.1016/j.bone.2010.12.015; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Liu XD, 2003, OSTEOPOROSIS INT, V14, P235, DOI 10.1007/s00198-002-1350-7; MIZUNASHI K, 1993, CALCIFIED TISSUE INT, V53, P21, DOI 10.1007/BF01352010; Ngamruengphong S, 2011, AM J GASTROENTEROL, V106, P1209, DOI 10.1038/ajg.2011.113; O'Connell MB, 2005, AM J MED, V118, P778, DOI 10.1016/j.amjmed.2005.02.007; Pouwels S, 2011, OSTEOPOROSIS INT, V22, P903, DOI 10.1007/s00198-010-1337-8; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1992, AM J EPIDEMIOL, V135, P1127, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A116211; Roux C, 2009, CALCIFIED TISSUE INT, V84, P13, DOI 10.1007/s00223-008-9188-4; Targownik LE, 2008, CAN MED ASSOC J, V179, P319, DOI 10.1503/cmaj.071330; Targownik LE, 2007, AM J GASTROENTEROL, V102, P942, DOI 10.1111/j.1572-0241.2007.01106.x; Targownik LE, 2010, GASTROENTEROLOGY, V138, P896, DOI 10.1053/j.gastro.2009.11.014; Vestergaard P, 2006, CALCIFIED TISSUE INT, V79, P76, DOI 10.1007/s00223-006-0021-7; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; WOLFE MM, 1988, NEW ENGL J MED, V319, P1707; Wright MJ, 2010, J BONE MINER RES, V25, P2205, DOI 10.1002/jbmr.108; Yang YX, 2008, CURR DRUG SAF, V3, P204, DOI 10.2174/157488608785699414; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Yu EW, 2008, CALCIFIED TISSUE INT, V83, P251, DOI 10.1007/s00223-008-9170-1	43	151	162	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 31	2012	344								e372	10.1136/bmj.e372	http://dx.doi.org/10.1136/bmj.e372			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889QI	22294756	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000300087900003
J	Dikshit, R; Gupta, PC; Ramasundarahettige, C; Gajalakshmi, V; Aleksandrowicz, L; Badwe, R; Kumar, R; Roy, S; Suraweera, W; Bray, F; Mallath, M; Singh, PK; Sinha, DN; Shet, AS; Gelband, H; Jha, P				Dikshit, Rajesh; Gupta, Prakash C.; Ramasundarahettige, Chinthanie; Gajalakshmi, Vendhan; Aleksandrowicz, Lukasz; Badwe, Rajendra; Kumar, Rajesh; Roy, Sandip; Suraweera, Wilson; Bray, Freddie; Mallath, Mohandas; Singh, Poonam K.; Sinha, Dhirendra N.; Shet, Arun S.; Gelband, Hellen; Jha, Prabhat		Million Death Study Collaborators	Cancer mortality in India: a nationally representative survey	LANCET			English	Article							CERVICAL-CANCER; DEATHS; COUNTRIES; SMOKING; BREAST	Background The age-specific mortality rates and total deaths from specific cancers have not been documented for the various regions and subpopulations of India. We therefore assessed the cause of death in 2001-03 in homes in small areas that were chosen to be representative of all the parts of India. Methods At least 130 trained physicians independently assigned causes to 122 429 deaths, which occurred in 1.1 million homes in 6671 small areas that were randomly selected to be representative of all of India, based on a structured non-medical surveyor's field report. Findings 7137 of 122 429 study deaths were due to cancer, corresponding to 556 400 national cancer deaths in India in 2010. 395 400 (71%) cancer deaths occurred in people aged 30-69 years (200 100 men and 195 300 women). At 30-69 years, the three most common fatal cancers were oral (including lip and pharynx, 45 800 [22.9%]), stomach (25 200 [12.6%]), and lung (including trachea and larynx, 22 900 [11.4%]) in men, and cervical (33 400 [17.1%]), stomach (27 500 [14.1%]), and breast (19 900 [10.2%]) in women. Tobacco-related cancers represented 42.0% (84 000) of male and 18.3% (35 700) of female cancer deaths and there were twice as many deaths from oral cancers as lung cancers. Age-standardised cancer mortality rates per 100 000 were similar in rural (men 95.6 [99% CI 89.6-101.7] and women 96.6 [90.7-102.6]) and urban areas (men 102.4 [92.7-112.1] and women 91.2 [81.9-100.5]), but varied greatly between the states, and were two times higher in the least educated than in the most educated adults (men, illiterate 106.6 [97.4-115.7] vs most educated 45.7 [37.8-53.6]; women, illiterate 106.7 [99.9-113.6] vs most educated 43.4 [30.7-56.1]). Cervical cancer was far less common in Muslim than in Hindu women (study deaths 24, age-standardised mortality ratio 0.68 [0.64-0.71] vs 340, 1.06 [1.05-1.08]). Interpretation Prevention of tobacco-related and cervical cancers and earlier detection of treatable cancers would reduce cancer deaths in India, particularly in the rural areas that are underserved by cancer services. The substantial variation in cancer rates in India suggests other risk factors or causative agents that remain to be discovered.	[Ramasundarahettige, Chinthanie; Aleksandrowicz, Lukasz; Suraweera, Wilson; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Ramasundarahettige, Chinthanie; Aleksandrowicz, Lukasz; Suraweera, Wilson; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 1W8, Canada; [Dikshit, Rajesh; Badwe, Rajendra; Mallath, Mohandas] Tata Mem Hosp, Bombay 400012, Maharashtra, India; [Gajalakshmi, Vendhan] Epidemiol Res Ctr, Madras, Tamil Nadu, India; [Gupta, Prakash C.] Healis Seskaria Inst Publ Hlth, Navi Mumbai, India; [Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Roy, Sandip] Kolkata Med Coll, Kolkata, India; [Shet, Arun S.] St Johns Natl Acad Hlth Sci, Bangalore, Karnataka, India; [Bray, Freddie] Int Agcy Res Canc, F-69372 Lyon, France; [Gelband, Hellen] Ctr Dis Dynam Econ & Policy, Washington, DC USA	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Tata Memorial Centre (TMC); Tata Memorial Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; St. John's National Academy of Health Sciences; World Health Organization; International Agency for Research on Cancer (IARC)	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.	jhap@smh.ca	Suraweera, Wilson MG/O-8962-2014	Shet, Anita/0000-0002-7204-8164; Suraweera, Wilson/0000-0001-9673-5746; Jha, Prabhat/0000-0001-7067-8341; Bray, Freddie/0000-0002-3248-7787; Shet, Arun/0000-0002-4146-0703; Aleksandrowicz, Lukasz/0000-0002-3644-1372	John E Fogarty International Center of the National Institutes of Health [R01-TW05991-01, TW07939-01]; Bill & Melinda Gates Foundation; Canada Research chair programme; University of Toronto; US National Institutes of Health; FOGARTY INTERNATIONAL CENTER [R01TW007939, R01TW005991] Funding Source: NIH RePORTER	John E Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canada Research chair programme(Canada Research Chairs); University of Toronto(University of Toronto); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Bill & Melinda Gates Foundation and US National Institutes of Health.; This study is supported by grants from the John E Fogarty International Center of the National Institutes of Health (R01-TW05991-01 and TW07939-01), Bill & Melinda Gates Foundation (Catalytic Grant for Tobacco Control in India, and Disease Control Priorities Network), Canada Research chair programme and the University of Toronto (to PJ). The opinions expressed in this report are those of the authors and do not necessarily represent those of the Government of India, Office of the RGI or study sponsors. We thank the Office of the RGI for the productive collaboration on the MDS; A Bernstein, S Rathi, and A Wong for their helpful comments on the report; and B Pezzack for graphics and J Tieulent for providing International Agency for Research Cancer mortality estimates.	[Anonymous], CAUS DEATH IND 2001; [Anonymous], 2005, SPEC FERT MORT SURV; [Anonymous], 2010, GLOB AD TOB SURV GAT; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Dhillon PK, 2011, BRIT J CANCER, V105, P723, DOI 10.1038/bjc.2011.301; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Doll R., 1966, CANC INCIDENCE 5 CON, VI; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GAJALAKSHMI CK, 1993, ACTA ONCOL, V32, P617, DOI 10.3109/02841869309092439; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gupta P C, 1996, Tob Control, V5, P114, DOI 10.1136/tc.5.2.114; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P., 2011, Economic and Political Weekly, V46, P44; Jha P, 2002, NATL MED J INDIA, V15, P32; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Jussawalla DJ, 1973, INDIAN J CANC S1; Kumar R, 2006, Indian J Public Health, V50, P90; MALHORTR.SL, 1967, GUT, V8, P361, DOI 10.1136/gut.8.4.361; Murthy NS, 2011, ASIAN PAC J CANCER P, V12, P387; National AIDS Control Organization, 2005, NAT AIDS CONTR ORG A; National Cancer Registry Programme. Indian Council of Medical Research, 2010, 3 YEAR REP POP BAS C; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Rao D. N., 1998, Indian Journal of Cancer, V35, P10; Registrar General of India, 2010, SAMPL REG SYST STAT; Registrar General of India, SPEC B MAT MORT IND; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sgaier SK, 2007, SCIENCE, V318, P1074, DOI 10.1126/science.1149157; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; SUTNICK AI, 1980, NEW ENGL J MED, V303, P945; Takiar R, 2010, ASIAN PAC J CANCER P, V11, P1045; United Nations Population Division, 2011, WORLD POP PROSP; Varmus H, 2002, NAT GENET, V32, P3, DOI 10.1038/ng963; World Health Organisation, 2002, PREV HEP B IND OV; World Health Organization, 1992, ICD 10 CLASS MENT BE; [No title captured]	40	311	314	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2012	379	9828					1807	1816		10.1016/S0140-6736(12)60358-4	http://dx.doi.org/10.1016/S0140-6736(12)60358-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941BR	22460346				2022-12-01	WOS:000303937700035
J	Han, JM; Jeong, SJ; Park, MC; Kim, G; Kwon, NH; Kim, HK; Ha, SH; Ryu, SH; Kim, S				Han, Jung Min; Jeong, Seung Jae; Park, Min Chul; Kim, Gyuyoup; Kwon, Nam Hoon; Kim, Hoi Kyoung; Ha, Sang Hoon; Ryu, Sung Ho; Kim, Sunghoon			Leucyl-tRNA Synthetase Is an Intracellular Leucine Sensor for the mTORC1-Signaling Pathway	CELL			English	Article							GTP-BINDING PROTEINS; AMINO-ACIDS; MAMMALIAN TARGET; CRYSTAL-STRUCTURE; RAG GTPASES; COMPLEX; MTOR; SEQUENCE; RAPAMYCIN; TRANSLATION	Amino acids are required for activation of the mammalian target of rapamycin (mTOR) kinase, which regulates protein translation, cell size, and autophagy. However, the amino acid sensor that directly couples intracellular amino acid-mediated signaling to mTORC1 is unknown. Here we show that leucyl-tRNA synthetase (LRS) plays a critical role in amino acid-induced mTORC1 activation by sensing intracellular leucine concentration and initiating molecular events leading to mTORC1 activation. Mutation of LRS amino acid residues important for leucine binding renders the mTORC1 pathway insensitive to intracellular levels of amino acids. We show that LRS directly binds to Rag GTPase, the mediator of amino acid signaling to mTORC1, in an amino acid-dependent manner and functions as a GTPase-activating protein (GAP) for Rag GTPase to activate mTORC1. This work demonstrates that LRS is a key mediator for amino acid signaling to mTORC1.	[Han, Jung Min; Jeong, Seung Jae; Park, Min Chul; Kim, Gyuyoup; Kwon, Nam Hoon; Kim, Hoi Kyoung; Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul 151742, South Korea; [Ha, Sang Hoon; Ryu, Sung Ho] POSTECH, Div Mol & Life Sci, Pohang 790784, South Korea; [Kim, Sunghoon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, WCU Dept Mol Med & Biopharmaceut Sci, Suwon 443270, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul 151742, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	Ryu, Sung Ho/0000-0003-0913-3048; Kim, Gyuyoup/0000-0002-4261-9958; kim, sunghoon/0000-0002-1570-3230; Han, Jung Min/0000-0003-3372-7575	Global Frontier Project [NRF-M1AXA002-2011-0028417]; WCU of the MEST [R31-2008-000-10103-0]	Global Frontier Project; WCU of the MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank D. M. Sabatini, Y. Sancak, and J. Chung for advice. This work was supported by the Global Frontier Project grant NRF-M1AXA002-2011-0028417 and by R31-2008-000-10103-0 from the WCU project of the MEST. J. M. H., conception and design, collection and analysis of data, manuscript writing, final approval of manuscript; S. J. J., M. C. P., G. K., N.H.K., H. K. K., and S. H. H., collection and analysis of data; S. H. R, conception and design; S. K., conception and design, financial support, manuscript writing, and final approval of manuscript.	Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; AUSTIN SA, 1986, EUR J BIOCHEM, V157, P39, DOI 10.1111/j.1432-1033.1986.tb09635.x; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763; Crozier SJ, 2005, J NUTR, V135, P376, DOI 10.1093/jn/135.3.376; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; CUSACK S, 1991, NUCLEIC ACIDS RES, V19, P3489, DOI 10.1093/nar/19.13.3489; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; HOUNTONDJI C, 1986, BIOCHIMIE, V68, P1071, DOI 10.1016/S0300-9084(86)80181-X; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; ROUGET P, 1968, EUR J BIOCHEM, V4, P310, DOI 10.1111/j.1432-1033.1968.tb00210.x; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Stipanuk MH, 2007, NUTR REV, V65, P122, DOI 10.1111/j.1753-4887.2007.tb00289.x; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; VAUGHAN MH, 1973, J BIOL CHEM, V248, P7087; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Xin Y, 2000, BIOCHEMISTRY-US, V39, P340, DOI 10.1021/bi991675l; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	41	540	578	2	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					410	424		10.1016/j.cell.2012.02.044	http://dx.doi.org/10.1016/j.cell.2012.02.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22424946	Bronze			2022-12-01	WOS:000302805600019
J	Lomstein, BA; Langerhuus, AT; D'Hondt, S; Jorgensen, BB; Spivack, AJ				Lomstein, Bente Aa; Langerhuus, Alice T.; D'Hondt, Steven; Jorgensen, Bo B.; Spivack, Arthur J.			Endospore abundance, microbial growth and necromass turnover in deep sub-seafloor sediment	NATURE			English	Article							AMINO-ACIDS; PERU MARGIN; SUBSEAFLOOR; BACTERIA; MAJORITY; BIOMASS	Two decades of scientific ocean drilling have demonstrated widespread microbial life in deep sub-seafloor sediment, and surprisingly high microbial-cell numbers. Despite the ubiquity of life in the deep biosphere, the large community sizes and the low energy fluxes in this vast buried ecosystemare not yet understood(1,2). It is not known whether organisms of the deep biosphere are specifically adapted to extremely low energy fluxes or whether most of the observed cells are in a dormant, spore-like state(3). Here we apply a new approach-the D:L-amino-acid model-to quantify the distributions and turnover times of living microbial biomass, endospores and microbial necromass, as well as to determine their role in the sub-seafloor carbon budget. The approach combines sensitive analyses of unique bacterial markers (muramic acid and D-amino acids) and the bacterial endospore marker, dipicolinic acid, with racemization dynamics of stereo-isomeric amino acids. Endospores are as abundant as vegetative cells and microbial activity is extremely low, leading to microbial biomass turnover times of hundreds to thousands of years. We infer from model calculations that biomass production is sustained by organic carbon deposited from the surface photosynthetic world millions of years ago and that microbial necromass is recycled over timescales of hundreds of thousands of years.	[Lomstein, Bente Aa; Langerhuus, Alice T.] Aarhus Univ, Microbiol Sect, Dept Biosci, DK-8000 Aarhus C, Denmark; [D'Hondt, Steven; Spivack, Arthur J.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Jorgensen, Bo B.] Aarhus Univ, Dept Biosci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark	Aarhus University; University of Rhode Island; Aarhus University	Lomstein, BA (corresponding author), Aarhus Univ, Microbiol Sect, Dept Biosci, Bldg 1540,Ny Munkegade 114, DK-8000 Aarhus C, Denmark.	bente.lomstein@biology.au.dk	Jorgensen, Bo B/C-2214-2013; Lomstein, Bente/I-7684-2013	Jorgensen, Bo B/0000-0001-9398-8027; 	US National Science Foundation; Max Planck Society; Danish National Research Foundation; Danish National Science Research Council; Danish Agency for Science, Technology and Innovation; Faculty of Science and Technology at the University of Aarhus	US National Science Foundation(National Science Foundation (NSF)); Max Planck Society(Max Planck Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish National Science Research Council; Danish Agency for Science, Technology and Innovation; Faculty of Science and Technology at the University of Aarhus	Bacterial cultures were provided by H. Cypionka. We thank members of the Leg 201 cruise for assistance in obtaining and processing samples. This research used samples and data provided by the Ocean Drilling Program (http://www-odp.tamu.edu/publications/201_IR/201ir.htm). The ODP was sponsored by the US National Science Foundation and participating countries under the management of Joint Oceanographic Institutions. We thank R. O. Holm and L. Poulsen for technical assistance and guidance with high-performance liquid chromatographic analyses. We thank D. L. Valentine for comments and suggestions to improve the manuscript. Financial support was provided by the Max Planck Society, the Danish National Research Foundation, the Danish National Science Research Council, the Danish Agency for Science, Technology and Innovation, the Faculty of Science and Technology at the University of Aarhus, and the US National Science Foundation.	BADA JL, 1982, INTERDISCIPL SCI REV, V7, P30, DOI 10.1179/030801882789801304; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S.L., 2003, INITIAL REPORTS, V201, P1, DOI DOI 10.2973/ODP.PROC.IR.201.111.2003; ER C, 1987, GEOMICROBIOL J, V5, P57, DOI 10.1080/01490458709385957; Fichtel J, 2007, FEMS MICROBIOL ECOL, V61, P522, DOI 10.1111/j.1574-6941.2007.00354.x; HARTGERS WA, 1994, NATURE, V369, P224, DOI 10.1038/369224a0; HEIJNEN JJ, 1992, BIOTECHNOL BIOENG, V39, P833, DOI 10.1002/bit.260390806; HSIEH LK, 1975, J BACTERIOL, V123, P463, DOI 10.1128/JB.123.2.463-470.1975; Jorgensen B. B., 2006, P OCEAN DRILLING PRO, V201, P1, DOI DOI 10.2973/0DP.PR0C.SR.201.101.2006; Jorgensen BB, 2006, SCIENCE, V314, P932, DOI 10.1126/science.1133796; Leloup J, 2009, ENVIRON MICROBIOL, V11, P1278, DOI 10.1111/j.1462-2920.2008.01855.x; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Lomstein B. A., LIMNOL OCEA IN PRESS; Lomstein BA, 2006, GEOCHIM COSMOCHIM AC, V70, P2970, DOI 10.1016/j.gca.2006.03.015; Lomstein BA, 2009, LIMNOL OCEANOGR, V54, P1139, DOI 10.4319/lo.2009.54.4.1139; Madigan M. T., 2006, BROCK BIOL MICROORG; PARKES RJ, 1993, MAR GEOL, V113, P55, DOI 10.1016/0025-3227(93)90149-P; Schichnes Denise, 2006, Microscope, V54, P91; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schrenk MO, 2010, ANNU REV MAR SCI, V2, P279, DOI 10.1146/annurev-marine-120308-081000; Takano Y, 2003, ORG GEOCHEM, V34, P1491, DOI 10.1016/S0146-6380(03)00175-X; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	24	209	212	6	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					101	104		10.1038/nature10905	http://dx.doi.org/10.1038/nature10905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22425999				2022-12-01	WOS:000302343400042
J	Cusick, RD; Kim, Y; Logan, BE				Cusick, Roland D.; Kim, Younggy; Logan, Bruce E.			Energy Capture from Thermolytic Solutions in Microbial Reverse-Electrodialysis Cells	SCIENCE			English	Article							AMMONIA-CARBON DIOXIDE; WASTE-WATER TREATMENT; FUEL-CELLS; POWER-GENERATION; OSMOSIS DESALINATION; HYDROGEN-PRODUCTION; ELECTROLYSIS CELLS; ELECTRICITY; MEMBRANE; DESIGN	Reverse electrodialysis allows for the capture of energy from salinity gradients between salt and fresh waters, but potential applications are currently limited to coastal areas and the need for a large number of membrane pairs. Using salt solutions that could be continuously regenerated with waste heat (>= 40 degrees C) and conventional technologies would allow much wider applications of salinity-gradient power production. We used reverse electrodialysis ion-exchange membrane stacks in microbial reverse-electrodialysis cells to efficiently capture salinity-gradient energy from ammonium bicarbonate salt solutions. The maximum power density using acetate reached 5.6 watts per square meter of cathode surface area, which was five times that produced without the dialysis stack, and 3.0 +/- 0.05 watts per square meter with domestic wastewater. Maximum energy recovery with acetate reached 30 +/- 0.5%.	[Cusick, Roland D.; Kim, Younggy; Logan, Bruce E.] Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Logan, BE (corresponding author), Penn State Univ, Dept Civil & Environm Engn, 212 Sackett Bldg, University Pk, PA 16802 USA.	blogan@psu.edu	Logan, Bruce E/E-7063-2012; Kim, Younggy/E-7503-2011	Logan, Bruce E/0000-0001-7478-8070; Kim, Younggy/0000-0001-7766-9990	King Abdullah University of Science and Technology (KAUST) [KUS-I1-003-13]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This research was supported by award KUS-I1-003-13 from the King Abdullah University of Science and Technology (KAUST). The data are presented in the figures and supporting online material.	Ahn Y, 2010, BIORESOURCE TECHNOL, V101, P469, DOI 10.1016/j.biortech.2009.07.039; Cheng S, 2006, ENVIRON SCI TECHNOL, V40, P2426, DOI 10.1021/es051652w; Cusick RD, 2010, INT J HYDROGEN ENERG, V35, P8855, DOI 10.1016/j.ijhydene.2010.06.077; EIA, 2010, DOEEIA0384; Fan YZ, 2007, ENVIRON SCI TECHNOL, V41, P8154, DOI 10.1021/es071739c; IPCC, 2022, CLIMATE CHANGE 2022; Kim JR, 2007, ENVIRON SCI TECHNOL, V41, P1004, DOI 10.1021/es062202m; Kim TW, 2012, DESALINATION, V284, P253, DOI 10.1016/j.desal.2011.09.008; Kim Y, 2011, P NATL ACAD SCI USA, V108, P16176, DOI 10.1073/pnas.1106335108; Kim Y, 2011, ENVIRON SCI TECHNOL, V45, P5834, DOI 10.1021/es200979b; Lalaurette E, 2009, INT J HYDROGEN ENERG, V34, P6201, DOI 10.1016/j.ijhydene.2009.05.112; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P2281, DOI 10.1021/es034923g; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344; Logan BE, 2004, ENVIRON SCI TECHNOL, V38, p160A, DOI 10.1021/es040468s; LOGAN BE, 1987, J WATER POLLUT CON F, V59, P1029; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; McCarty PL, 2011, ENVIRON SCI TECHNOL, V45, P7100, DOI 10.1021/es2014264; McCutcheon JR, 2005, DESALINATION, V174, P1, DOI 10.1016/j.desal.2004.11.002; McGinnis RL, 2007, J MEMBRANE SCI, V305, P13, DOI 10.1016/j.memsci.2007.08.027; Nam JY, 2010, J POWER SOURCES, V195, P6428, DOI 10.1016/j.jpowsour.2010.03.091; Parker DS, 2001, J ENVIRON ENG-ASCE, V127, P380, DOI 10.1061/(ASCE)0733-9372(2001)127:5(380); Ramon GZ, 2011, ENERG ENVIRON SCI, V4, P4423, DOI 10.1039/c1ee01913a; Rezaei F., 2009, APPL ENVIRON MICROB, V192, P304; Shizas I, 2004, J ENERG ENG, V130, P45, DOI 10.1061/(ASCE)0733-9402(2004)130:2(45); U.S. Department of Energy, 2005, DOEGO1020052135; Wang AJ, 2011, BIORESOURCE TECHNOL, V102, P4137, DOI 10.1016/j.biortech.2010.10.137; Wick G. L., 1978, Energy, V3, P96, DOI 10.1016/0360-5442(78)90059-2; Xie X, 2012, ENERG ENVIRON SCI, V5, P5265, DOI 10.1039/c1ee02122b	29	200	207	8	372	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2012	335	6075					1474	1477		10.1126/science.1219330	http://dx.doi.org/10.1126/science.1219330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22383807				2022-12-01	WOS:000301837000042
J	Marazzi, I; Ho, JSY; Kim, J; Manicassamy, B; Dewell, S; Albrecht, RA; Seibert, CW; Schaefer, U; Jeffrey, KL; Prinjha, RK; Lee, K; Garcia-Sastre, A; Roeder, RG; Tarakhovsky, A				Marazzi, Ivan; Ho, Jessica S. Y.; Kim, Jaehoon; Manicassamy, Balaji; Dewell, Scott; Albrecht, Randy A.; Seibert, Chris W.; Schaefer, Uwe; Jeffrey, Kate L.; Prinjha, Rab K.; Lee, Kevin; Garcia-Sastre, Adolfo; Roeder, Robert G.; Tarakhovsky, Alexander			Suppression of the antiviral response by an influenza histone mimic	NATURE			English	Article							VIRUS NS1 PROTEIN; RNA-POLYMERASE; PAF1 COMPLEX; TRANSCRIPTION ELONGATION; CHROMATIN; H3; METHYLATION; LYSINE-4; BINDING; ACETYLATION	Viral infection is commonly associated with virus-driven hijacking of host proteins. Here we describe a novel mechanism by which influenza virus affects host cells through the interaction of influenza non-structural protein 1 (NS1) with the infected cell epigenome. We show that the NS1 protein of influenza A H3N2 subtype possesses a histone-like sequence (histone mimic) that is used by the virus to target the human PAF1 transcription elongation complex (hPAF1C). We demonstrate that binding of NS1 to hPAF1C depends on the NS1 histone mimic and results in suppression of hPAF1C-mediated transcriptional elongation. Furthermore, human PAF1 has a crucial role in the antiviral response. Loss of hPAF1C binding by NS1 attenuates influenza infection, whereas hPAF1C deficiency reduces antiviral gene expression and renders cells more susceptible to viruses. We propose that the histone mimic in NS1 enables the influenza virus to affect inducible gene expression selectively, thus contributing to suppression of the antiviral response.	[Marazzi, Ivan; Ho, Jessica S. Y.; Schaefer, Uwe; Jeffrey, Kate L.; Tarakhovsky, Alexander] Rockefeller Univ, Lab Immune Cell Epigenet & Signaling, New York, NY 10065 USA; [Kim, Jaehoon; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [Manicassamy, Balaji; Albrecht, Randy A.; Seibert, Chris W.; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Manicassamy, Balaji; Albrecht, Randy A.; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Infect Pathogens Inst, New York, NY 10029 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA; [Prinjha, Rab K.; Lee, Kevin] GlaxoSmithKline, Immunoinflammat Ctr Excellence Drug Discovery, Epinova DPU, Med Res Ctr, Stevenage SG1 2NY, Herts, England; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY 10029 USA	Rockefeller University; Rockefeller University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University; GlaxoSmithKline; Icahn School of Medicine at Mount Sinai	Marazzi, I (corresponding author), Rockefeller Univ, Lab Immune Cell Epigenet & Signaling, 1230 York Ave, New York, NY 10065 USA.	imarazzi@rockefeller.edu; tarakho@rockefeller.edu	Kim, Jaehoon/G-2711-2011; Albrecht, Randy A./H-5119-2019	Kim, Jaehoon/0000-0003-4035-0438; Albrecht, Randy A./0000-0003-4008-503X; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Ho, Jessica Sook Yuin/0000-0003-2234-2602; Jeffrey, Kate/0000-0001-5746-0153; Manicassamy, Balaji/0000-0003-1964-0967; marazzi, ivan/0000-0003-3376-0922	NIH/NIAID [1K99AI095320-01]; NIAID [R01AI046954, U19AI083025, HHSN266200700010C]; CRIP (Center for Research in Influenza Pathogenesis); NIH [CA129325, R01AI068058]; Charles H. Revson Foundation; American Italian Cancer Foundation; Agency for Science, Technology and Research (A*STAR), Singapore; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [R01CA129325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI095320, R01AI068058, R01AI046954, U19AI083025] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CRIP (Center for Research in Influenza Pathogenesis); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles H. Revson Foundation; American Italian Cancer Foundation; Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. deGross and A. Rudensky for the mass spectroscopy analysis of the NS1 binding proteins. A. Rojas Soto, D. Reinberg, M. Dobenecker and T. Zhanyun provided us with recombinant CHD1 (A. R. S., D. R.), recombinant Set7/9 (M. D.) and Set1C (T.Z.). F. Casadio, P. Lewis, O. Binda, O. Gozani, N. Levenkova, A. Mele, R. Darnell, L. Core, J. Lis and P. Palese gave us valuable technical advice and help with data analysis. We acknowledge the Rockefeller University Genomics Resource Center for technical support. We thank R. Cadagan, A. Santana, W. Huang, R. Chandramouli and H. Zebronsky for technical assistance, R. Rizzo for help with manuscript preparation and C. Nathan for discussion. L. M. K. for artwork. B.M is supported by NIH/NIAID K99 Pathway to Independence award (1K99AI095320-01). A.G.-S. is partially supported by NIAID grants R01AI046954, U19AI083025 and by CRIP (Center for Research in Influenza Pathogenesis), an NIAID funded Center of Excellence for Influenza Research and Surveillance, HHSN266200700010C. R. G. R. is supported by NIH grant CA129325. J. K. is supported by Charles H. Revson Foundation. I. M. is supported by American Italian Cancer Foundation. J. H. is supported by the Agency for Science, Technology and Research (A*STAR), Singapore. A. T. is supported by the NIH grant R01AI068058 and by Starr Cancer Consortium.	Becker P. B., 2007, BMC MOL BIOL, V8; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2008, VIROLOGY, V378, P1, DOI 10.1016/j.virol.2008.05.026; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kim KY, 2011, CELL, V144, P745, DOI 10.1016/j.cell.2011.01.034; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Loucaides EM, 2009, VIROLOGY, V394, P154, DOI 10.1016/j.virol.2009.08.015; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nishiyama A, 2008, FEBS LETT, V582, P1501, DOI 10.1016/j.febslet.2008.03.044; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	50	212	218	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2012	483	7390					428	433		10.1038/nature10892	http://dx.doi.org/10.1038/nature10892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22419161	Green Accepted			2022-12-01	WOS:000301771200035
J	Clark, CE; Taylor, RS; Shore, AC; Campbell, JL				Clark, Christopher E.; Taylor, Rod S.; Shore, Angela C.; Campbell, John L.			The difference in blood pressure readings between arms and survival: primary care cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BILATERAL INDIRECT; CARDIOVASCULAR EVENTS; GENERAL-PRACTICE; WORKING PARTY; RISK-FACTORS; HYPERTENSION; PREVALENCE; MANAGEMENT; GUIDELINES; RECORDINGS	Objective To determine whether a difference in systolic blood pressure readings between arms can predict a reduced event free survival after 10 years. Design Cohort study. Setting Rural general practice in Devon, United Kingdom. Participants 230 people receiving treatment for hypertension in primary care. Intervention Bilateral blood pressure measurements recorded at three successive surgery attendances. Main outcome measures Cardiovascular events and deaths from all causes during a median follow-up of 9.8 years. Results At recruitment 24% (55/230) of participants had a mean interarm difference in systolic blood pressure of 10 mm Hg or more and 9% (21/230) of 15 mm Hg or more; these differences were associated with an increased risk of all cause mortality (adjusted hazard ratio 3.6, 95% confidence interval 2.0 to 6.5 and 3.1, 1.6 to 6.0, respectively). The risk of death was also increased in 183 participants without pre-existing cardiovascular disease with an interarm difference in systolic blood pressure of 10 mm Hg or more or 15 mm Hg or more (2.6, 1.4 to 4.8 and 2.7, 1.3 to 5.4). An interarm difference in diastolic blood pressure of 10 mm Hg or more was weakly associated with an increased risk of cardiovascular events or death. Conclusions Differences in systolic blood pressure between arms can predict an increased risk of cardiovascular events and all cause mortality over 10 years in people with hypertension. This difference could be a valuable indicator of increased cardiovascular risk. Bilateral blood pressure measurements should become a routine part of cardiovascular assessment in primary care.	[Clark, Christopher E.; Taylor, Rod S.; Campbell, John L.] Univ Exeter, Primary Care Res Grp, Inst Hlth Serv Res, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England; [Shore, Angela C.] Univ Exeter, Inst Biomed & Clin Sci, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England; [Shore, Angela C.] Univ Exeter, Peninsula NIHR Clin Res Facil, Exeter EX1 2LU, Devon, England	University of Exeter; University of Plymouth; University of Exeter; University of Plymouth; University of Exeter	Clark, CE (corresponding author), Univ Exeter, Primary Care Res Grp, Inst Hlth Serv Res, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England.	christopher.clark@pms.ac.uk	Taylor, Rod/R-9581-2019	Taylor, Rod/0000-0002-3043-6011; Shore, Angela/0000-0003-3039-308X; Campbell, John/0000-0002-6752-3493	Mid Devon Medical Practice; Scientific Foundation Board of the Royal College of General Practitioners [SFB-2009-06]; South West GP Trust; National Institute for Health Research (NIHR) Peninsula Collaboration for Leadership in Applied Health Research and Care; NIHR	Mid Devon Medical Practice; Scientific Foundation Board of the Royal College of General Practitioners; South West GP Trust; National Institute for Health Research (NIHR) Peninsula Collaboration for Leadership in Applied Health Research and Care; NIHR(National Institute for Health Research (NIHR))	We thank the staff and patients of the Mid Devon Medical Practice for their support and participation in this study.; This research was supported by the Scientific Foundation Board of the Royal College of General Practitioners (grant No SFB-2009-06), the South West GP Trust, and the National Institute for Health Research (NIHR) Peninsula Collaboration for Leadership in Applied Health Research and Care, a NIHR funded collaboration of the Peninsula College of Medicine and Dentistry, University of Exeter, University of Plymouth, and NHS South West. The project was also supported by the NIHR Peninsula Clinical Research Facility. The views and opinions expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Aboyans V, 2007, J AM COLL CARDIOL, V49, P1540, DOI 10.1016/j.jacc.2006.09.055; Aboyans V, 2010, ATHEROSCLEROSIS, V211, P266, DOI 10.1016/j.atherosclerosis.2010.01.013; Agarwal R, 2008, HYPERTENSION, V51, P657, DOI 10.1161/HYPERTENSIONAHA.107.104943; Amsterdam B., 1943, NY STATE J MED, V43, P6; Anekwe L, 2007, PULSE, V10, P17; Banks MJ, 2001, J HUM HYPERTENS, V15, P573, DOI 10.1038/sj.jhh.1001247; Baribeau Y, 2002, CIRCULATION, V106, pI11, DOI 10.1161/01.cir.0000032894.55215.32; Beevers G, 2001, BRIT MED J, V322, P981, DOI 10.1136/bmj.322.7292.981; Cassidy P, 2001, J HUM HYPERTENS, V15, P519, DOI 10.1038/sj.jhh.1001224; Clark CE, 2007, J HUM HYPERTENS, V21, P633, DOI 10.1038/sj.jhh.1002209; Clark CE, 2006, J HUM HYPERTENS, V20, P923, DOI 10.1038/sj.jhh.1002093; Clark CE, 2011, J HUM HYPERTENS, V25, P630; Clark CE, 2002, FAM PRACT, V19, P439, DOI 10.1093/fampra/19.5.439; Clark CE, 2001, BRIT MED J, V323, P399, DOI 10.1136/bmj.323.7309.399; Clark CE, 2009, DIABETIC MED S1, V26, P128; Clark CE, LANCET; Clark CE, 2007, FAM PRACT, V24, P420, DOI 10.1093/fampra/cmm035; Clark CE, 2011, AM J HYPERTENS, V24, P1189, DOI 10.1038/ajh.2011.139; Clark CE, 2009, BRIT J GEN PRACT, V59, P428, DOI 10.3399/bjgp09X420752; Collett D, 2003, MODELLING SURVIVAL D; Criqui M H, 1997, Vasc Med, V2, P221; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Department of Health, 2008, PUTT PREV 1 VASC CHE; Eguchi K, 2007, ARCH INTERN MED, V167, P388, DOI 10.1001/archinte.167.4.388; FOTHERBY MD, 1993, POSTGRAD MED J, V69, P194, DOI 10.1136/pgmj.69.809.194; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; FRANK SM, 1991, ANESTHESIOLOGY, V75, P457, DOI 10.1097/00000542-199109000-00013; Gosse P, 2002, J HYPERTENS, V20, P1045, DOI 10.1097/00004872-200206000-00004; GOULD BA, 1985, CLIN CARDIOL, V8, P423, DOI 10.1002/clc.4960080803; HARRISON EG, 1960, CIRCULATION, V22, P419, DOI 10.1161/01.CIR.22.3.419; HASHIMOTO F, 1984, WESTERN J MED, V141, P189; Heneghan C, 2007, BRIT J GEN PRACT, V57, P948, DOI 10.3399/096016407782604965; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; Igarashi Yuko, 2007, J Cardiol, V50, P281; Israel E, 1944, ACTA MED ORIENT, V3, P86; Kawamura T, 2008, ARQ BRAS CARDIOL, V90, P322, DOI 10.1590/S0066-782X2008000500003; Kay W E, 1930, Cal West Med, V33, P578; Kleefstra N, 2007, Ned Tijdschr Geneeskd, V151, P1509; Korns HM, 1933, J CLIN INVEST, V12, P143, DOI 10.1172/JCI100485; KRISTENSEN BO, 1982, ACTA MED SCAND, P69; Lane D, 2002, J HYPERTENS, V20, P1089, DOI 10.1097/00004872-200206000-00019; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Materson BJ, 2004, J HYPERTENS, V22, P2267, DOI 10.1097/00004872-200412000-00006; National Centre for Social Research, 2003, HLTH SURV ENGL 2003; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; O'Shea JC, 2000, J HUM HYPERTENS, V14, P227, DOI 10.1038/sj.jhh.1000998; Orme S, 1999, AGE AGEING, V28, P537, DOI 10.1093/ageing/28.6.537; Parker E, 2009, BRIT J GEN PRACT, V59, P206, DOI 10.3399/bjgp09X395012; Pesola GR, 2002, ACAD EMERG MED, V9, P342, DOI 10.1111/j.1553-2712.2002.tb01333.x; Pesola GR, 2001, AM J EMERG MED, V19, P43, DOI 10.1053/ajem.2001.20021; Poon LCY, 2008, BJOG-INT J OBSTET GY, V115, P1122, DOI 10.1111/j.1471-0528.2008.01756.x; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; RAY SA, 1994, BRIT J SURG, V81, P188, DOI 10.1002/bjs.1800810208; Ray W T, 2000, AANA J, V68, P525; RUEGER MJ, 1951, ANN INTERN MED, V35, P1023, DOI 10.7326/0003-4819-35-5-1023; SCHILLACI G, 1994, AM J CARDIOL, V74, P714, DOI 10.1016/0002-9149(94)90316-6; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Shadman R, 2004, J AM COLL CARDIOL, V44, P618, DOI 10.1016/j.jacc.2004.04.044; Sin Lau Y, 2005, MODERN HYPERTENSION, V5, P9; Singer AJ, 1996, ARCH INTERN MED, V156, P2005, DOI 10.1001/archinte.156.17.2005; Southby R, 1935, MED J AUSTRALIA, V2, P580, DOI DOI 10.5694/J.1326-5377.1935.TB43281.X; Verberk WJ, 2011, AM J HYPERTENS, V24, P1201, DOI 10.1038/ajh.2011.125; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	65	83	91	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2012	344								e1327	10.1136/bmj.e1327	http://dx.doi.org/10.1136/bmj.e1327			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913CJ	22433975	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000301848700002
J	Park, H; Li, YL; Tsien, RW				Park, Hyokeun; Li, Yulong; Tsien, Richard W.			Influence of Synaptic Vesicle Position on Release Probability and Exocytotic Fusion Mode	SCIENCE			English	Article							KISS-AND-RUN; LIVING CELLS; SYNAPSES; RECEPTORS; ORGANIZATION; MICROSCOPY; BOUTONS; POOLS; BRAIN; REUSE	Neurotransmission depends on movements of transmitter-laden synaptic vesicles, but accurate, nanometer-scale monitoring of vesicle dynamics in presynaptic terminals has remained elusive. Here, we report three-dimensional, real-time tracking of quantum dot-loaded single synaptic vesicles with an accuracy of 20 to 30 nanometers, less than a vesicle diameter. Determination of the time, position, and mode of fusion, aided by trypan blue quenching of Qdot fluorescence, revealed that vesicles starting close to their ultimate fusion sites tended to fuse earlier than those positioned farther away. The mode of fusion depended on the prior motion of vesicles, with long-dwelling vesicles preferring kiss-and-run rather than full-collapse fusion. Kiss-and-run fusion events were concentrated near the center of the synapse, whereas full-collapse fusion events were broadly spread.	[Park, Hyokeun; Li, Yulong; Tsien, Richard W.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Tsien, Richard W.] NYU, Inst Neurosci, New York, NY 10016 USA; [Tsien, Richard W.] NYU, Dept Physiol & Neurosci, New York, NY 10016 USA	Stanford University; New York University; New York University	Tsien, RW (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	richard.tsien@nyumc.org	Park, Hyokeun/AAY-3073-2021	Li, Yulong/0000-0002-9166-9919; Park, Hyo Keun/0000-0002-2655-4795	National Institute of Mental Health (NIH); Burnett Family Foundation; Mathers Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064070] Funding Source: NIH RePORTER	National Institute of Mental Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Burnett Family Foundation; Mathers Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Q. Zhang for discussion and for first applying Qdots to the research on vesicle release; T. Watanabe for help with building the 3D microscope; S. Syed, S.-Y. Oh, and S. Ryu for analysis programs; I. Shim for help with data analysis; A. Mitra for the construct for PSD-95-GFP; H. Martens for biotinylated antibodies against VGAT; and members of the Tsien lab for discussion. Supported by grants from National Institute of Mental Health (NIH), the Burnett Family Foundation, and Mathers Foundation.	Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Denker Annette, 2010, Front Synaptic Neurosci, V2, P135, DOI 10.3389/fnsyn.2010.00135; Diamond JS, 1997, J NEUROSCI, V17, P4672; Franks KM, 2003, J NEUROSCI, V23, P3186; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kharazia VN, 1997, NEUROSCI LETT, V238, P41, DOI 10.1016/S0304-3940(97)00846-X; Richards DA, 2009, J PHYSIOL-LONDON, V587, P5073, DOI 10.1113/jphysiol.2009.175315; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Uteshev VV, 1997, BIOPHYS J, V72, P1127, DOI 10.1016/S0006-3495(97)78761-7; Vanden Berghe P, 2006, J PHYSIOL-LONDON, V572, P707, DOI 10.1113/jphysiol.2005.100842; Watanabe TM, 2007, BIOCHEM BIOPH RES CO, V359, P1, DOI 10.1016/j.bbrc.2007.04.168; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	22	74	79	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2012	335	6074					1362	1366		10.1126/science.1216937	http://dx.doi.org/10.1126/science.1216937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22345401	Green Accepted			2022-12-01	WOS:000301531600051
J	Nicolas, P; Mader, U; Dervyn, E; Rochat, T; Leduc, A; Pigeonneau, N; Bidnenko, E; Marchadier, E; Hoebeke, M; Aymerich, S; Becher, D; Bisicchia, P; Botella, E; Delumeau, O; Doherty, G; Denham, EL; Fogg, MJ; Fromion, V; Goelzer, A; Hansen, A; Haertig, E; Harwood, CR; Homuth, G; Jarmer, H; Jules, M; Klipp, E; Le Chat, L; Lecointe, F; Lewis, P; Liebermeister, W; March, A; Mars, RAT; Nannapaneni, P; Noone, D; Pohl, S; Rinn, B; Rugheimer, F; Sappa, PK; Samson, F; Schaffer, M; Schwikowski, B; Steil, L; Stulke, J; Wiegert, T; Devine, KM; Wilkinson, AJ; van Dijl, JM; Hecker, M; Volker, U; Bessieres, P; Noirot, P				Nicolas, Pierre; Maeder, Ulrike; Dervyn, Etienne; Rochat, Tatiana; Leduc, Aurelie; Pigeonneau, Nathalie; Bidnenko, Elena; Marchadier, Elodie; Hoebeke, Mark; Aymerich, Stephane; Becher, Doerte; Bisicchia, Paola; Botella, Eric; Delumeau, Olivier; Doherty, Geoff; Denham, Emma L.; Fogg, Mark J.; Fromion, Vincent; Goelzer, Anne; Hansen, Annette; Haertig, Elisabeth; Harwood, Colin R.; Homuth, Georg; Jarmer, Hanne; Jules, Matthieu; Klipp, Edda; Le Chat, Ludovic; Lecointe, Francois; Lewis, Peter; Liebermeister, Wolfram; March, Anika; Mars, Ruben A. T.; Nannapaneni, Priyanka; Noone, David; Pohl, Susanne; Rinn, Bernd; Ruegheimer, Frank; Sappa, Praveen K.; Samson, Franck; Schaffer, Marc; Schwikowski, Benno; Steil, Leif; Stuelke, Joerg; Wiegert, Thomas; Devine, Kevin M.; Wilkinson, Anthony J.; van Dijl, Jan Maarten; Hecker, Michael; Voelker, Uwe; Bessieres, Philippe; Noirot, Philippe			Condition-Dependent Transcriptome Reveals High-Level Regulatory Architecture in Bacillus subtilis	SCIENCE			English	Article							ESCHERICHIA-COLI; RNA-POLYMERASE; IDENTIFICATION; GENOME; GENE; SEQUENCES; LANDSCAPE; DNA; RHO	Bacteria adapt to environmental stimuli by adjusting their transcriptomes in a complex manner, the full potential of which has yet to be established for any individual bacterial species. Here, we report the transcriptomes of Bacillus subtilis exposed to a wide range of environmental and nutritional conditions that the organism might encounter in nature. We comprehensively mapped transcription units (TUs) and grouped 2935 promoters into regulons controlled by various RNA polymerase sigma factors, accounting for similar to 66% of the observed variance in transcriptional activity. This global classification of promoters and detailed description of TUs revealed that a large proportion of the detected antisense RNAs arose from potentially spurious transcription initiation by alternative sigma factors and from imperfect control of transcription termination.	[Dervyn, Etienne; Rochat, Tatiana; Pigeonneau, Nathalie; Bidnenko, Elena; Marchadier, Elodie; Aymerich, Stephane; Delumeau, Olivier; Jules, Matthieu; Le Chat, Ludovic; Lecointe, Francois; Noirot, Philippe] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Nicolas, Pierre; Leduc, Aurelie; Hoebeke, Mark; Fromion, Vincent; Goelzer, Anne; Samson, Franck; Bessieres, Philippe] INRA, Math Informat & Genome UR1077, F-78350 Jouy En Josas, France; [Maeder, Ulrike; Becher, Doerte; Schaffer, Marc; Hecker, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17489 Greifswald, Germany; [Maeder, Ulrike; Homuth, Georg; Nannapaneni, Priyanka; Sappa, Praveen K.; Steil, Leif; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Bisicchia, Paola; Botella, Eric; Hansen, Annette; Noone, David] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Doherty, Geoff; Lewis, Peter] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Denham, Emma L.; van Dijl, Jan Maarten] Univ Groningen, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands; [Denham, Emma L.; van Dijl, Jan Maarten] Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Fogg, Mark J.; Wilkinson, Anthony J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Haertig, Elisabeth] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Harwood, Colin R.; Pohl, Susanne] Newcastle Univ, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Jarmer, Hanne] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst, DK-2800 Lyngby, Denmark; [Klipp, Edda] Humboldt Univ, D-10115 Berlin, Germany; [Rinn, Bernd] ETH, Ctr Informat Sci & Databases, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Ruegheimer, Frank] Inst Pasteur, Syst Biol Lab, F-75724 Paris 15, France; [Ruegheimer, Frank] CNRS, URA 2171, F-75724 Paris 15, France; [Stuelke, Joerg] Univ Gottingen, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Wiegert, Thomas] Hsch Zittau Gorlitz, FN Biotechnol, D-02763 Zittau, Germany	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Trinity College Dublin; University of Newcastle; University of Groningen; University of Groningen; University of York - UK; Braunschweig University of Technology; Newcastle University - UK; Technical University of Denmark; Humboldt University of Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Gottingen; Technische Universitat Dresden	Noirot, P (corresponding author), INRA, Micalis UMR1319, F-78350 Jouy En Josas, France.	philippe.noirot@jouy.inra.fr	Harwood, Colin/AGF-0120-2022; Stülke, Jörg/AAD-1600-2021; Steil, Leif/F-1246-2010; MARCHADIER, Elodie/AAC-8416-2019; Jules, Matthieu/GVU-5315-2022; van Dijl, Jan Maarten/G-1205-2013; Becher, Doerte/B-4454-2015; MARCHADIER, Elodie/AAX-8887-2020; Liebermeister, Wolfram/AAC-7326-2020; Denham, Emma/P-3979-2014	Steil, Leif/0000-0002-0733-8421; MARCHADIER, Elodie/0000-0001-5618-6471; Jules, Matthieu/0000-0003-0817-8949; Becher, Doerte/0000-0002-9630-5735; Liebermeister, Wolfram/0000-0002-2568-2381; Wilkinson, Anthony/0000-0003-4577-9479; Mars, Ruben A T/0000-0002-3917-9517; Lecointe, Francois/0000-0002-9596-2514; Fogg, Mark/0000-0002-6692-122X; Rochat, Tatiana/0000-0002-4533-1220; Denham, Emma/0000-0002-5123-4099; Schwikowski, Benno/0000-0001-5127-5619; HOEBEKE, Mark/0000-0001-6311-9752; Harwood, Colin/0000-0002-3624-0001; Volker, Uwe/0000-0002-5689-3448; Stulke, Jorg/0000-0001-5881-5390	European Commission [LSHG-CT-2006-037469]; German Federal Ministry of Education and Research [0313978B]; Department of Education, Science and Training [CG110055]; National Health and Medical Research Council [455646]	European Commission(European CommissionEuropean Commission Joint Research Centre); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Department of Education, Science and Training; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The data are deposited in the Gene Expression Omnibus (GEO) database (accession numbers GSE27219, GSE27303, GSE27419, and GSE27652), and are tabulated in the SOM and at www.basysbio.eu/bsubtranscriptome. This Web page provides links to the data archived in the GEO and Openbis databases. This study was supported by the European Commission-funded BaSysBio project (LSHG-CT-2006-037469), the SysMO network funded by the German Federal Ministry of Education and Research (0313978B), Department of Education, Science and Training (CG110055), and the National Health and Medical Research Council (455646). We are grateful to N. Pele, B. Giovani, C. Sautot, and B. Diep for management support. The authors declare no competing interests.	Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Fischer S.H., 2002, BACILLUS SUBTILIS IT, P181; Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; Hoebeke M, 2003, BIOINFORMATICS, V19, P859, DOI 10.1093/bioinformatics/btg101; Ibrahim M, 2007, MICROBIOL-SGM, V153, P3631, DOI 10.1099/mic.0.2007/006205-0; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Lane WJ, 2006, PLOS BIOL, V4, P1491, DOI 10.1371/journal.pbio.0040269; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Nicolas P, 2009, BIOINFORMATICS, V25, P2341, DOI 10.1093/bioinformatics/btp395; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; QUIRK PG, 1993, J BACTERIOL, V175, P647, DOI 10.1128/JB.175.3.647-654.1993; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109	25	576	580	9	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2012	335	6072					1103	1106		10.1126/science.1206848	http://dx.doi.org/10.1126/science.1206848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZL	22383849				2022-12-01	WOS:000300931100048
J	Stanciole, AE; Ortegon, M; Chisholm, D; Lauer, JA				Stanciole, Anderson E.; Ortegon, Monica; Chisholm, Dan; Lauer, Jeremy A.			Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INHALED CORTICOSTEROIDS; DOUBLE-BLIND; MORTALITY; FLUTICASONE; SALMETEROL; INTERVENTION; DEVICE; BURDEN; HEALTH	Objectives To determine the population level costs, effects, and cost effectiveness of selected, individual based interventions to combat chronic obstructive pulmonary disease (COPD) and asthma in the context of low and middle income countries. Design Sectoral cost effectiveness analysis using a lifetime population model. Setting Two World Health Organization sub-regions of the world: countries in sub-Saharan Africa with very high adult and high child mortality (AfrE); and countries in South East Asia with high adult and high child mortality (SearD). Data sources Disease rates and profiles were taken from the WHO Global Burden of Disease study; estimates of intervention effects and resource needs were drawn from clinical trials, observational studies, and treatment guidelines. Unit costs were taken from a WHO price database. Main outcome measures Cost per disability adjusted life year (DALY) averted, expressed in international dollars ($Int) for the year 2005. Results In both regions low dose inhaled corticosteroids for mild persistent asthma was considered the most cost effective intervention, with average cost per DALY averted about $Int2500. The next best value strategies were influenza vaccine for COPD in Sear-D (incremental cost $Int4950 per DALY averted) and low dose inhaled corticosteroids plus long acting beta agonists for moderate persistent asthma in Afr-E (incremental cost $Int9112 per DALY averted). Conclusions COPD is irreversible and progressive, and current treatment options produce relatively little gains relative to the cost. The treatment options available for asthma, however, generally decrease chronic respiratory disease burden at a relatively low cost.	[Stanciole, Anderson E.] World Bank, Washington, DC 20433 USA; [Ortegon, Monica] Univ Rosario, Med & Hlth Sci Sch, Bogota, Colombia; [Chisholm, Dan; Lauer, Jeremy A.] World Hlth Org, Dept Hlth Syst Financing, Geneva, Switzerland	The World Bank; Universidad del Rosario; World Health Organization	Stanciole, AE (corresponding author), World Bank, 1818 H St NW, Washington, DC 20433 USA.	astanciole@worldbank.org		Lauer, Jeremy A/0000-0003-0652-0691				Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; [Anonymous], GLOB STRAT DIAGN MAN; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; *AUSTR CTR ASTHM M, 2005, HLTH CAR EXP BURD DI; Barr RG, 2006, THORAX, V61, P854, DOI 10.1136/thx.2006.063271; Barr RG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002876.pub2; Bateman ED, 2002, EUR RESPIR J, V20, P588, DOI 10.1183/09031936.02.00294702; Bjermer L, 2003, BMJ-BRIT MED J, V327, P891, DOI 10.1136/bmj.327.7420.891; Borg S, 2004, VALUE HEALTH, V7, P153, DOI 10.1111/j.1524-4733.2004.72318.x; British Thoracic Society and Scottish Intercollegiate Guidelines Network, 2008, BRIT GUID MAN ASTHM; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Chan-Yeung M, 2004, INT J TUBERC LUNG D, V8, P159; Chan-Yeung M, 2004, INT J TUBERC LUNG D, V8, P2; Coe R, 2002, RES CAPACITY BUILDIN, V4, P6; Croxton TL, 2006, AM J RESP CRIT CARE, V174, P373, DOI 10.1164/rccm.200507-1161WS; Ducharme FM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003137.pub3; Evans, 2003, MAKING CHOICES HLTH; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; *GINA, 2007, GLOB STRAT ASTHM MAN; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Kavuru M, 2000, J ALLERGY CLIN IMMUN, V105, P1108, DOI 10.1067/mai.2000.105711; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Macie C, 2006, CHEST, V130, P640, DOI 10.1378/chest.130.3.640; Mannino D, 2005, EUR RESPIR J, V26, P189, DOI 10.1183/09031936.05.00063605; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Masoli M, 2004, GLOBAL BURDEN ASTHMA; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Mehta S., 2004, ENERGY SUSTAIN DEV, V8, P53, DOI DOI 10.1016/S0973-0826(08)60466-4; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Motala C, 2000, GUIDELINES MANAGEMEN; National Asthma Education and Prevention Program, 2007, HYPERLIPIDAEMIA DIAG; Nichol KL, 1999, ANN INTERN MED, V130, P397, DOI 10.7326/0003-4819-130-5-199903020-00003; Nonoyama ML, 2007, AM J RESP CRIT CARE, V176, P343, DOI 10.1164/rccm.200702-308OC; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Paramesh H., 2002, Indian Journal of Pediatrics, V69, P309, DOI 10.1007/BF02723216; Poole PJ, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002733.PUB2; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; RAM FS, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004403.PUB2; Rico-Mendez FG, 2005, ARCH BRONCONEUMOL, V41, P260, DOI 10.1016/S1579-2129(06)60220-6; Salomon JA, 2006, PRIORITY SETTING HLT; Sanderson K, 2004, QUAL LIFE RES, V13, P1255, DOI 10.1023/B:QURE.0000037482.92757.82; Shapiro G, 2000, AM J RESP CRIT CARE, V161, P527, DOI 10.1164/ajrccm.161.2.9905091; Shibuya K, 2001, CHRONIC OBSTRUCTIVE; Simonella L, 2006, INTERN MED J, V36, P244, DOI 10.1111/j.1445-5994.2006.01054.x; Sin DD, 2005, THORAX, V60, P992, DOI 10.1136/thx.2005.045385; Sin Don D, 2006, Proc Am Thorac Soc, V3, P624, DOI 10.1513/pats.200603-096SS; Stouthard MEA, 2000, EUR J PUBLIC HEALTH, V10, P24, DOI 10.1093/eurpub/10.1.24; The International Union against Tuberculosis and Lung Disease, 2011, GLOB ASTHM REP 2011; World Health Organization, 2020, GLOBAL REPORT EPIDEM; Yang IA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002991.pub2	53	24	25	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2012	344								e608	10.1136/bmj.e608	http://dx.doi.org/10.1136/bmj.e608			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XQ	22389338	hybrid, Green Accepted, Green Published			2022-12-01	WOS:000301232600003
J	Wong, MY; Zhou, CM; Shakiryanova, D; Lloyd, TE; Deitcher, DL; Levitan, ES				Wong, Man Yan; Zhou, Chaoming; Shakiryanova, Dinara; Lloyd, Thomas E.; Deitcher, David L.; Levitan, Edwin S.			Neuropeptide Delivery to Synapses by Long-Range Vesicle Circulation and Sporadic Capture	CELL			English	Article							AXONAL-TRANSPORT; DROSOPHILA; EXPRESSION; IDENTIFICATION; RELEASE; MOTOR; DENDRITES; PROCTOLIN	Neurotransmission requires anterograde axonal transport of dense core vesicles (DCVs) containing neuropeptides and active zone components from the soma to nerve terminals. However, it is puzzling how one-way traffic could uniformly supply sequential release sites called en passant boutons. Here, Drosophila neuropeptide-containing DCVs are tracked in vivo for minutes with a new method called simultaneous photobleaching and imaging (SPAIM). Surprisingly, anterograde DCVs typically bypass proximal boutons to accumulate initially in the most distal bouton. Then, excess distal DCVs undergo dynactin-dependent retrograde transport back through proximal boutons into the axon. Just before re-entering the soma, DCVs again reverse for another round of anterograde axonal transport. While circulating over long distances, both anterograde and retrograde DCVs are captured sporadically in en passant boutons. Therefore, vesicle circulation, which includes long-range retrograde transport and inefficient bidirectional capture, overcomes the limitations of one-way anterograde transport to uniformly supply release sites with DCVs.	[Wong, Man Yan; Zhou, Chaoming; Shakiryanova, Dinara; Levitan, Edwin S.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Lloyd, Thomas E.] Johns Hopkins Sch Med, Dept Neurol & Neurosci, Baltimore, MD 21287 USA; [Deitcher, David L.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Medicine; Cornell University	Levitan, ES (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	elevitan@pitt.edu	Deitcher, David/K-6538-2019	Lloyd, Thomas/0000-0003-4756-3700; Bulgari, Dinara/0000-0001-5352-6207; Deitcher, David/0000-0002-8512-8868	National Institutes of Health [NIH R01 NS32385]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032385, K08NS062890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Daniel Altschuler (University of Pittsburgh) for comments; Haig Keshishian (Yale University) for the Geneswitch flies; Eric Rulifson (UCSF) for the preproDilp2 clone; Dick Nassel (Stockholm University) for anti-proctolin precursor serum; and Yuh-Nung Jan (UCSF) for the UAS-ManII-EGFP flies. This work was supported by a grant from the National Institutes of Health (NIH R01 NS32385 to E. S. L.).	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Allen MJ, 1999, J NEUROSCI, V19, P9374; ALONSO G, 1983, CELL TISSUE RES, V233, P183; ANDERSON MS, 1988, J NEUROSCI, V8, P242; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Heifetz Y, 2004, P NATL ACAD SCI USA, V101, P6261, DOI 10.1073/pnas.0401337101; Husain QM, 2004, J NEUROBIOL, V59, P181, DOI 10.1002/neu.10309; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kula E, 2006, J BIOL RHYTHM, V21, P104, DOI 10.1177/0748730405285715; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; Levitan ES, 2007, NAT PROTOC, V2, P1117, DOI 10.1038/nprot.2007.142; Loveall BJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-92; Nicholson L, 2008, GENETICS, V178, P215, DOI 10.1534/genetics.107.081968; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Rolls MM, 2011, DEV NEUROBIOL, V71, P419, DOI 10.1002/dneu.20836; Shakiryanova D, 2006, NAT NEUROSCI, V9, P896, DOI 10.1038/nn1719; Strom AL, 2008, J NEUROCHEM, V106, P495, DOI 10.1111/j.1471-4159.2008.05393.x; Sturman DA, 2006, BIOPHYS J, V90, pL45, DOI 10.1529/biophysj.106.080978; Taylor CAM, 2004, J NEUROBIOL, V58, P379, DOI 10.1002/neu.10301; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zupanc GKH, 1996, MICRON, V27, P35, DOI 10.1016/0968-4328(95)00028-3	27	108	108	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					1029	1038		10.1016/j.cell.2011.12.036	http://dx.doi.org/10.1016/j.cell.2011.12.036			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385966	Green Accepted, Bronze			2022-12-01	WOS:000300985000021
J	Huber, EM; Basler, M; Schwab, R; Heinemeyer, W; Kirk, CJ; Groettrup, M; Groll, M				Huber, Eva M.; Basler, Michael; Schwab, Ricarda; Heinemeyer, Wolfgang; Kirk, Christopher J.; Groettrup, Marcus; Groll, Michael			Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity	CELL			English	Article							IMMUNOPROTEASOME SUBUNIT LMP7; YEAST 20S PROTEASOME; T-CELL REPERTOIRE; CLASS-II REGION; IRREVERSIBLE INHIBITOR; ANTIGEN PRESENTATION; SELECTIVE INHIBITOR; ANGSTROM RESOLUTION; BRANCHED-CHAIN; S PROTEASOME	Constitutive proteasomes and immunoproteasomes shape the peptide repertoire presented by major histocompatibility complex class I (MHC-I) molecules by harboring different sets of catalytically active subunits. Here, we present the crystal structures of constitutive proteasomes and immunoproteasomes from mouse in the presence and absence of the epoxyketone inhibitor PR-957 (ONX 0914) at 2.9 angstrom resolution. Based on our X-ray data, we propose a unique catalytic feature for the immunoproteasome subunit beta 5i/LMP7. Comparison of ligand-free and ligand-bound proteasomes reveals conformational changes in the S1 pocket of beta 5c/X but not beta 5i, thereby explaining the selectivity of PR-957 for beta 5i. Time-resolved structures of yeast proteasome: PR-957 complexes indicate that ligand docking to the active site occurs only via the reactive head group and the P1 side chain. Together, our results support structure-guided design of inhibitory lead structures selective for immunoproteasomes that are linked to cytokine production and diseases like cancer and autoimmune disorders.	[Basler, Michael; Schwab, Ricarda; Groettrup, Marcus] Univ Constance, Dept Biol, Div Immunol, D-78457 Constance, Germany; [Huber, Eva M.; Heinemeyer, Wolfgang; Groll, Michael] Tech Univ Munich, Lehrstuhl Biochem, Dept Chem, Ctr Integrated Prot Sci, D-85747 Garching, Germany; [Basler, Michael; Groettrup, Marcus] Univ Constance, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland; [Kirk, Christopher J.] Onyx Pharmaceut, San Francisco, CA 94080 USA	University of Konstanz; Technical University of Munich	Groettrup, M (corresponding author), Univ Constance, Dept Biol, Div Immunol, D-78457 Constance, Germany.	marcus.groettrup@uni-konstanz.de; michael.groll@ch.tum.de	Groettrup, Marcus/AAT-2623-2020; Groll, Michael/F-5572-2015; Huber, Eva/J-3130-2015	Basler, Michael/0000-0002-9428-2349	Deutsche Forschungsgemeinschaft [SFB595/TP A11, 1517/12-1]; BMBF-ProNET; Swiss National Fonds [31003A_138451]; Chemical Biology at Constance University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF-ProNET; Swiss National Fonds(Swiss National Science Foundation (SNSF)); Chemical Biology at Constance University	This work is dedicated to Professor Robert Huber on the occasion of his 75th birthday. We are grateful to B. Potts for fruitful discussions on the manuscript and to R. Huber for sharing his knowledge in the proteasome field with us. G. Werner, U. Beck, and the personnel of the animal research facility of Constance University are acknowledged for experimental support. We thank Richard Feicht for the purification of yCPs. The staff of the beamlines X06SA and X06DA at the Paul Scherrer Institute, SLS, Villigen, Switzerland, especially Takashi Tomizaki, is acknowledged for assistance during data collection. This work was supported by the Deutsche Forschungsgemeinschaft SFB595/TP A11 (M. Groll), BMBF-ProNET-T3 project To-03 (M. Groll), the Swiss National Fonds grant 31003A_138451 (M. Groettrup), and DFG grant 1517/12-1 (M. Groettrup, M.B.). R.S. is supported by the Graduate School of Chemical Biology at Constance University. M. Groll and M. Groettrup designed experiments. M.B. and R.S. purified cCPs and iCPs. E.M.H. performed activity tests and crystallographic experiments. W.H. and E.M.H. performed yeast genetics. C.J.K. provided PR-957 and edited the manuscript. E.M.H. and M. Groll collected and analyzed crystallographic data and wrote the manuscript. C.J.K. is an employee and stock holder of Onyx Pharmaceuticals.	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Badros A, 2007, CANCER-AM CANCER SOC, V110, P1042, DOI 10.1002/cncr.22921; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; Blackburn C, 2010, BIOCHEM J, V430, P461, DOI 10.1042/BJ20100383; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; Cardozo C, 1998, J BIOL CHEM, V273, P16764, DOI 10.1074/jbc.273.27.16764; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Corey EJ, 1999, CHEM PHARM BULL, V47, P1; De M, 2003, J BIOL CHEM, V278, P6153, DOI 10.1074/jbc.M209292200; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Deol P, 2007, J IMMUNOL, V178, P7557, DOI 10.4049/jimmunol.178.12.7557; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GRANT EP, 1995, J IMMUNOL, V155, P3750; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 1996, EUR J IMMUNOL, V26, P863, DOI 10.1002/eji.1830260421; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Groll M, 2006, J AM CHEM SOC, V128, P5136, DOI 10.1021/ja058320b; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Groll M, 2005, METHOD ENZYMOL, V398, P329, DOI 10.1016/S0076-6879(05)98027-0; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho YK, 2007, CHEM BIOL, V14, P419, DOI 10.1016/j.chembiol.2007.03.008; Ichikawa HT, 2012, ARTHRITIS RHEUM-US, V64, P493, DOI 10.1002/art.33333; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; Khan ML, 2011, FUTURE ONCOL, V7, P607, DOI [10.2217/FON.11.42, 10.2217/fon.11.42]; Khan S, 2001, J IMMUNOL, V167, P6859, DOI 10.4049/jimmunol.167.12.6859; Kingsbury DJ, 2000, J BIOL CHEM, V275, P24156, DOI 10.1074/jbc.M001742200; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; MICHALEK MT, 1993, NATURE, V363, P552, DOI 10.1038/363552a0; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nandi D, 1996, J IMMUNOL, V156, P2361; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; Nett M, 2009, J MED CHEM, V52, P6163, DOI 10.1021/jm901098m; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; Potts BC, 2011, CURR CANCER DRUG TAR, V11, P254; Puttaparthi K, 2005, EXP NEUROL, V196, P441, DOI 10.1016/j.expneurol.2005.08.027; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROMERO P, 1991, J EXP MED, V174, P603, DOI 10.1084/jem.174.3.603; Schmidtke G, 2000, J BIOL CHEM, V275, P22056, DOI 10.1074/jbc.M002513200; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Singh AV, 2011, BRIT J HAEMATOL, V152, P155, DOI 10.1111/j.1365-2141.2010.08491.x; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Tomaru U, 2009, BLOOD, V113, P5186, DOI 10.1182/blood-2008-11-187633; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; Tu L, 2009, EUR J IMMUNOL, V39, P3385, DOI 10.1002/eji.200839117; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Van den Eynde BJ, 2001, CURR OPIN IMMUNOL, V13, P147, DOI 10.1016/S0952-7915(00)00197-7; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1467, DOI 10.1007/s00018-011-0654-1; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; Visekruna A, 2009, INT J COLORECTAL DIS, V24, P1133, DOI 10.1007/s00384-009-0679-1; YEWDELL J, 1994, J IMMUNOL, V152, P1163	62	340	376	3	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 17	2012	148	4					727	738		10.1016/j.cell.2011.12.030	http://dx.doi.org/10.1016/j.cell.2011.12.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341445	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000300622400014
J	Oliveira, GD; Lieberman, J; Barillas-Mury, C				Oliveira, Giselle de Almeida; Lieberman, Joshua; Barillas-Mury, Carolina			Epithelial Nitration by a Peroxidase/NOX5 System Mediates Mosquito Antiplasmodial Immunity	SCIENCE			English	Article							ANOPHELES-GAMBIAE; MIDGUT CELLS; PLASMODIUM; COMPLEMENT; INVASION; DISEASE	Plasmodium ookinetes traverse midgut epithelial cells before they encounter the complement system in the mosquito hemolymph. We identified a heme peroxidase (HPX2) and NADPH oxidase 5 (NOX5) as critical mediators of midgut epithelial nitration and antiplasmodial immunity that enhance nitric oxide toxicity in Anopheles gambiae. We show that the two immune mechanisms that target ookinetes-epithelial nitration and thioester-containing protein 1 (TEP1)-mediated lysis-work sequentially, and we propose that epithelial nitration works as an opsonization-like system that promotes activation of the mosquito complement cascade.	[Oliveira, Giselle de Almeida; Lieberman, Joshua; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barillas-Mury, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Rockville, MD 20892 USA.	cbarillas@niaid.nih.gov		Oliveira, Giselle/0000-0002-5898-7843; Lieberman, Joshua/0000-0002-0376-1337	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. We thank A. Laughinghouse and K. Lee for insectary support; J. Ribeiro and J. Valenzuela for their comments and insight; and L. Garver and B. Marshall for editorial assistance.	Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Byun J, 1999, BIOCHEMISTRY-US, V38, P2590, DOI 10.1021/bi9822980; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Guzik TJ, 2008, J AM COLL CARDIOL, V52, P1803, DOI 10.1016/j.jacc.2008.07.063; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Jaramillo-Gutierrez G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011168; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Oliveira JHM, 2011, INSECT BIOCHEM MOLEC, V41, P349, DOI 10.1016/j.ibmb.2011.02.001; Pfeiffer S, 2001, FASEB J, V15, P2355, DOI 10.1096/fj.01-0295com; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Shiao SH, 2006, PLOS PATHOG, V2, P1152, DOI 10.1371/journal.ppat.0020133; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862	17	128	128	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 17	2012	335	6070					856	859		10.1126/science.1209678	http://dx.doi.org/10.1126/science.1209678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22282475	Green Accepted			2022-12-01	WOS:000300356400044
J	DuPage, M; Mazumdar, C; Schmidt, LM; Cheung, AF; Jacks, T				DuPage, Michel; Mazumdar, Claire; Schmidt, Leah M.; Cheung, Ann F.; Jacks, Tyler			Expression of tumour-specific antigens underlies cancer immunoediting	NATURE			English	Article							MOUSE MODEL; IMMUNOSURVEILLANCE; IMMUNITY; REJECTION; VARIANTS; ESCAPE; CELLS	Cancer immunoediting is a process by which immune cells, particularly lymphocytes of the adaptive immune system, protect the host from the development of cancer and alter tumour progression by driving the outgrowth of tumour cells with decreased sensitivity to immune attack(1,2). Carcinogen-induced mouse models of cancer have shown that primary tumour susceptibility is thereby enhanced in immune-compromised mice, whereas the capacity for such tumours to grow after transplantation into wild-type mice is reduced(2,3). However, many questions about the process of cancer immunoediting remain unanswered, in part because of the known antigenic complexity and heterogeneity of carcinogen-induced tumours(4). Here we adapted a genetically engineered, autochthonous mouse model of sarcomagenesis to investigate the process of cancer immunoediting. This system allows us to monitor the onset and growth of immunogenic and non-immunogenic tumours induced in situ that harbour identical genetic and histopathological characteristics. By comparing the development of such tumours in immune-competent mice with their development in mice with broad immunodeficiency or specific antigenic tolerance, we show that recognition of tumour-specific antigens by lymphocytes is critical for immunoediting against sarcomas. Furthermore, primary sarcomas were edited to become less immunogenic through the selective outgrowth of cells that were able to escape T lymphocyte attack. Loss of tumour antigen expression or presentation on major histocompatibility complex I was necessary and sufficient for this immunoediting process to occur. These results highlight the importance of tumour-specific-antigen expression in immune surveillance, and potentially, immunotherapy.	[DuPage, Michel; Mazumdar, Claire; Schmidt, Leah M.; Cheung, Ann F.; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [DuPage, Michel; Mazumdar, Claire; Schmidt, Leah M.; Cheung, Ann F.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu			NIH [1 U54 CA126515-01]; Cancer Center from National Cancer Institute [P30-CA14051]; John D. Proctor Foundation; NATIONAL CANCER INSTITUTE [U54CA126515, P30CA014051] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center from National Cancer Institute; John D. Proctor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. M. Winslow and A. G. DuPage for critical reading of this manuscript. This work was supported by grant 1 U54 CA126515-01 from the NIH, and partially by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute and the Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award (M. D.) from the John D. Proctor Foundation. T.J. is a Howard Hughes Investigator and a Daniel K. Ludwig Scholar.	Cheung AF, 2008, CANCER RES, V68, P9459, DOI 10.1158/0008-5472.CAN-08-2634; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; EMBLETON MJ, 1972, INT J CANCER, V9, P8, DOI 10.1002/ijc.2910090103; Guerra N, 2008, IMMUNITY, V28, P723, DOI 10.1016/j.immuni.2008.04.001; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Guo ZS, 2006, CANCER RES, V66, P1105, DOI 10.1158/0008-5472.CAN-05-3020; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; HEWITT HB, 1976, BRIT J CANCER, V33, P241, DOI 10.1038/bjc.1976.37; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; PREHN RT, 1957, J NATL CANCER I, V18, P769; Qin ZH, 2004, NAT IMMUNOL, V5, P3, DOI 10.1038/ni0104-3; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; SCOTT OCA, 1991, CANCER RES, V51, P757; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; STAUSS HJ, 1986, J EXP MED, V164, P1516, DOI 10.1084/jem.164.5.1516; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; UYTTENHOVE C, 1983, J EXP MED, V157, P1040, DOI 10.1084/jem.157.3.1040; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Zhou G, 2004, J EXP MED, V200, P1581, DOI 10.1084/jem.20041240; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	27	358	390	10	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					405	U1512		10.1038/nature10803	http://dx.doi.org/10.1038/nature10803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22318517	Green Accepted, Green Submitted			2022-12-01	WOS:000300287100047
J	Kuehn, BM				Kuehn, Bridget M.			Clinical Trial Network Removes Barriers Common to Studies of Neurological Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2012	307	7					655	655		10.1001/jama.2012.131	http://dx.doi.org/10.1001/jama.2012.131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	892HY	22337666				2022-12-01	WOS:000300278500004
J	Bolan, GA; Sparling, PF; Wasserheit, JN				Bolan, Gail A.; Sparling, P. Frederick; Wasserheit, Judith N.			The Emerging Threat of Untreatable Gonococcal Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NEISSERIA-GONORRHOEAE; RESISTANCE		[Bolan, Gail A.] Ctr Dis Control & Prevent, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Sparling, P. Frederick] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Wasserheit, Judith N.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Wasserheit, Judith N.] Univ Washington, Dept Med, Seattle, WA USA; [Wasserheit, Judith N.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bolan, GA (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.							[Anonymous], 2010, MMWR RECOMM REP, V59, P1; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P873; Katz AR, 2011, CLIN INFECT DIS 1219; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Workowski KA, 2008, ANN INTERN MED, V148, P888, DOI 10.7326/0003-4819-148-11-200806030-00024; Workowski KA, 2008, ANN INTERN MED, V148, P606, DOI 10.7326/0003-4819-148-8-200804150-00005	6	183	191	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2012	366	6					485	487		10.1056/NEJMp1112456	http://dx.doi.org/10.1056/NEJMp1112456			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	888GH	22316442				2022-12-01	WOS:000299991300002
J	Inagaki, HK; De-Leon, SBT; Wong, AM; Jagadish, S; Ishimoto, H; Barnea, G; Kitamoto, T; Axel, R; Anderson, DJ				Inagaki, Hidehiko K.; de-Leon, Shlomo Ben-Tabou; Wong, Allan M.; Jagadish, Smitha; Ishimoto, Hiroshi; Barnea, Gilad; Kitamoto, Toshihiro; Axel, Richard; Anderson, David J.			Visualizing Neuromodulation In Vivo: TANGO-Mapping of Dopamine Signaling Reveals Appetite Control of Sugar Sensing	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; FEEDING-BEHAVIOR; NEURAL CIRCUIT; DROSOPHILA; TASTE; RECEPTOR; MODULATION; RESPONSES; EXPRESSION; HUNGER	Behavior cannot be predicted from a "connectome'' because the brain contains a chemical "map'' of neuromodulation superimposed upon its synaptic connectivity map. Neuromodulation changes how neural circuits process information in different states, such as hunger or arousal. Here we describe a genetically based method to map, in an unbiased and brain-wide manner, sites of neuromodulation under different conditions in the Drosophila brain. This method, and genetic perturbations, reveal that the well-known effect of hunger to enhance behavioral sensitivity to sugar is mediated, at least in part, by the release of dopamine onto primary gustatory sensory neurons, which enhances sugar-evoked calcium influx. These data reinforce the concept that sensory neurons constitute an important locus for state-dependent gain control of behavior and introduce a methodology that can be extended to other neuro-modulators and model organisms.	[Inagaki, Hidehiko K.; de-Leon, Shlomo Ben-Tabou; Wong, Allan M.; Axel, Richard; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Inagaki, Hidehiko K.; de-Leon, Shlomo Ben-Tabou; Wong, Allan M.; Anderson, David J.] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; [Ishimoto, Hiroshi; Kitamoto, Toshihiro] Univ Iowa, Dept Anesthesia, Iowa City, IA 52242 USA; [Ishimoto, Hiroshi; Kitamoto, Toshihiro] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Ishimoto, Hiroshi; Kitamoto, Toshihiro] Univ Iowa, Interdisciplinary Program Neurosci, Iowa City, IA 52242 USA; [Jagadish, Smitha; Axel, Richard] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Barnea, Gilad] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of Iowa; University of Iowa; University of Iowa; Columbia University; Brown University	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Ishimoto, Hiroshi/AAV-1923-2021	Ishimoto, Hiroshi/0000-0002-8859-6931; Kitamoto, Toshihiro/0000-0003-0863-8466; Inagaki, Hidehiko/0000-0003-4580-2763; Axel, Richard/0000-0002-3141-4076	NIH [5R01MH086920, 1RO1 DA031389]; Nakajima Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086920, R01MH085081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nakajima Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. K.J. Lee for sharing Tango DNA constructs prior to publication. We also thank Drs. T. Lee, K. Deisseroth, A. Stathopoulos, and B. Pfeiffer for plasmids. Fly stocks were generously provided by the Bloomington Stock Center, the VDRC stock center, the Drosophila RNAi Screening Center, and Drs. G.M. Rubin, J. Simpson, L.L Looger, H. Keshishian, K. Scott, T. Lee, S. Birman, P. A. Garrity, C.Q. Doe, and K. Ito. We also thank Drs. H. Otsuna and Y. Wan for Fluorender and members of the Anderson lab for helpful discussion and sharing of flies. H.K.I. is supported by the Nakajima Foundation. G.B. is a Pew scholar and is supported in part by NIH grant 5R01MH086920. D.J.A. is an investigator of the Howard Hughes Medical Institute. This work was supported in part by NIH grant 1RO1 DA031389 to D.J.A.	Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BERRIDGE KC, 1991, APPETITE, V16, P103, DOI 10.1016/0195-6663(91)90036-R; Bhattacharya A, 1999, J NEUROBIOL, V39, P491, DOI 10.1002/(SICI)1097-4695(19990615)39:4<491::AID-NEU3>3.0.CO;2-6; BICKER G, 1989, NATURE, V337, P33, DOI 10.1038/337033a0; Birmingham JT, 2003, J EXP BIOL, V206, P3541, DOI 10.1242/jeb.00601; BROOKHART GL, 1987, J NEUROCHEM, V48, P1307, DOI 10.1111/j.1471-4159.1987.tb05662.x; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; DUBNER R, 1988, PROG BRAIN RES, V77, P213; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gillette R, 2000, P NATL ACAD SCI USA, V97, P3585, DOI 10.1073/pnas.97.7.3585; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; LONG TF, 1986, COMP BIOCHEM PHYS C, V83, P201, DOI 10.1016/0742-8413(86)90037-X; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Miller MR, 2009, NAT METHODS, V6, P439, DOI [10.1038/NMETH.1329, 10.1038/nmeth.1329]; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.0.CO;2-3; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; MOSKOWITZ HR, 1976, PHYSIOL BEHAV, V16, P471, DOI 10.1016/0031-9384(76)90326-7; MOSS CF, 1983, BEHAV NEUROSCI, V97, P541, DOI 10.1037/0735-7044.97.4.541; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pfaff DW, 2008, ANN NY ACAD SCI, V1129, P1, DOI 10.1196/annals.1417.031; Phillips PEM, 2003, METH MOLEC MED, V79, P443; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Scheiner R, 2004, LEARN MEMORY, V11, P303, DOI 10.1101/lm.71604; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shea SD, 2010, J CHEM NEUROANAT, V39, P132, DOI 10.1016/j.jchemneu.2009.10.002; Shiraiwa Takashi, 2007, J Vis Exp, P193, DOI 10.3791/193; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsuno Yusuke, 2009, Commun Integr Biol, V2, P362; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang W, 2007, EUR J NEUROSCI, V26, P2405, DOI 10.1111/j.1460-9568.2007.05862.x	64	199	200	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2012	148	3					583	595		10.1016/j.cell.2011.12.022	http://dx.doi.org/10.1016/j.cell.2011.12.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304923	Green Accepted, Bronze			2022-12-01	WOS:000300225000024
J	Johnson, K; Zhu, ST; Tremblay, MS; Payette, JN; Wang, JN; Bouchez, LC; Meeusen, S; Althage, A; Cho, CY; Wu, X; Schultz, PG				Johnson, Kristen; Zhu, Shoutian; Tremblay, Matthew S.; Payette, Joshua N.; Wang, Jianing; Bouchez, Laure C.; Meeusen, Shelly; Althage, Alana; Cho, Charles Y.; Wu, Xu; Schultz, Peter G.			A Stem Cell-Based Approach to Cartilage Repair	SCIENCE			English	Article							ARTICULAR-CARTILAGE; CHONDROCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; OSTEOARTHRITIS; BONE; PATHOGENESIS; FILAMIN; GENE; CHONDROGENESIS; EXPRESSION	Osteoarthritis (OA) is a degenerative joint disease that involves the destruction of articular cartilage and eventually leads to disability. Molecules that promote the selective differentiation of multipotent mesenchymal stem cells (MSCs) into chondrocytes may stimulate the repair of damaged cartilage. Using an image-based high-throughput screen, we identified the small molecule kartogenin, which promotes chondrocyte differentiation (median effective concentration = 100 nM), shows chondroprotective effects in vitro, and is efficacious in two OA animal models. Kartogenin binds filamin A, disrupts its interaction with the transcription factor core-binding factor beta subunit (CBF beta), and induces chondrogenesis by regulating the CBF beta-RUNX1 transcriptional program. This work provides new insights into the control of chondrogenesis that may ultimately lead to a stem cell-based therapy for osteoarthritis.	[Johnson, Kristen; Tremblay, Matthew S.; Meeusen, Shelly; Althage, Alana; Cho, Charles Y.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Zhu, Shoutian; Tremblay, Matthew S.; Payette, Joshua N.; Wang, Jianing; Bouchez, Laure C.; Schultz, Peter G.] Scripps Res Inst, La Jolla, CA 92037 USA; [Wu, Xu] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Novartis; Scripps Research Institute; Harvard University; Massachusetts General Hospital	Johnson, K (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.	kjohnson@gnf.org; schultz@scripps.edu	Zhu, Shoutian/M-2108-2018	Zhu, Shoutian/0000-0001-6748-225X; bouchez, laure/0000-0003-4583-6760; Johnson, Kristen/0000-0003-0788-7217	California Institute for Regenerative Medicine [TR2-01829]	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was funded by grants from the California Institute for Regenerative Medicine (TR2-01829 to P.G.S.). We are grateful to J. Walker for help in gene expression analysis. Microarray data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus with accession number GSE35546. A patent application has been submitted by the authors on the use of kartogenin for chondrogenesis.	Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Coluet J, 2009, DRUG DISCOV TODAY, V14, P913, DOI 10.1016/j.drudis.2009.07.012; Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484; Drissi H, 2002, J CELL BIOCHEM, V86, P403, DOI 10.1002/jcb.10238; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; LOHMANDER LS, 1994, ANN RHEUM DIS, V53, P8, DOI 10.1136/ard.53.1.8; Lotz MK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3046; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Read SJ, 2008, EXPERT OPIN INV DRUG, V17, P619, DOI [10.1517/13543784.17.5.619, 10.1517/13543784.17.5.619 ]; Reginster JY, 2002, RHEUMATOLOGY, V41, P1, DOI 10.1093/rheumatology/41.suppl_1.1; Reijman M, 2004, ARTHRITIS RHEUM-US, V50, P2471, DOI 10.1002/art.20332; Rutgers M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3050; Smith GN, 2006, FRONT BIOSCI-LANDMRK, V11, P3081, DOI 10.2741/2034; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; van der Kraan PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2896; VANDERKRAAN PM, 1989, AM J PATHOL, V135, P1001; Wang Y, 2007, ONCOGENE, V26, P6061, DOI 10.1038/sj.onc.1210435; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Wotton S, 2008, ONCOGENE, V27, P5856, DOI 10.1038/onc.2008.195; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Zhu ST, 2009, CELL STEM CELL, V4, P416, DOI 10.1016/j.stem.2009.04.001	35	455	505	12	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					717	721		10.1126/science.1215157	http://dx.doi.org/10.1126/science.1215157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22491093				2022-12-01	WOS:000303872300049
J	Berenson, RA; Paulus, RA; Kalman, NS				Berenson, Robert A.; Paulus, Ronald A.; Kalman, Noah S.			Medicare's Readmissions-Reduction Program - A Positive Alternative	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REHOSPITALIZATIONS		[Berenson, Robert A.] Urban Inst, Washington, DC 20037 USA; [Paulus, Ronald A.] Mission Hlth Syst, Asheville, NC USA; [Kalman, Noah S.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA	Urban Institute; Duke University	Berenson, RA (corresponding author), Urban Inst, Washington, DC 20037 USA.							Chollet D., 2011, REDUCING HOSP READMI; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Jencks SF, 2011, NEW ENGL J MED, V364, P1582; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Medicare Payment Advisory Commission, 2011, PUBL M DEC 15	6	172	173	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2012	366	15					1364	1366		10.1056/NEJMp1201268	http://dx.doi.org/10.1056/NEJMp1201268			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GV	22455754				2022-12-01	WOS:000302608600012
J	So, AD; Ruiz-Esparza, Q; Gupta, N; Cars, O				So, Anthony D.; Ruiz-Esparza, Quentin; Gupta, Neha; Cars, Otto			3Rs for innovating novel antibiotics: sharing resources, risks, and rewards	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[So, Anthony D.; Ruiz-Esparza, Quentin; Gupta, Neha] Duke Univ, Program Global Hlth & Technol Access, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Cars, Otto] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Duke University; Uppsala University	So, AD (corresponding author), Duke Univ, Program Global Hlth & Technol Access, Sanford Sch Publ Policy, Durham, NC 27708 USA.	anthony.so@duke.edu						Aronsson B., 2009, BACTERIAL CHALLENGE; Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511; BCC Research, 2010, THER DRUGS CENTR NER; BCC Research, 2010, CARD THER DRUGS TECH; BCC Research, 2010, INF DIS TREATM GLOB; Bergstrom R, 2011, DRUG RESIST UPDATE, V14, P77, DOI 10.1016/j.drup.2011.01.005; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; DiMasi JA, 2004, DRUG INF J, V38, P211, DOI 10.1177/009286150403800301; Fikes B, 2010, N COUNTY TIMES  0920; Fischer A, 2005, PLOS MED, V2, P845, DOI 10.1371/journal.pmed.0020243; Ghosh S, 2010, HINDU; Goss CH, 2008, CHILD HEALTH CARE, V37, P5, DOI 10.1080/02739610701766859; Hamad B, 2006, NAT REV DRUG DISCOV, V9, P675; Hamad B, 2010, NAT REV DRUG DISCOV, V9, P675, DOI 10.1038/nrd3267; Innovative Medicines Initiative, NEWDRUGS4BADBUGS ND4; Kesselheim AS, 2010, HEALTH AFFAIR, V29, P1689, DOI 10.1377/hlthaff.2009.0439; Laxminarayan R, 2001, ANTIBIOTIC RESISTANC; Mossialos E, POLICIES INCENTIVES; Nwaka S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000293; Nwaka S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000440; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Rai A, 2008, YALE J HLTH POLICY L, V8, P53; ReAct, 2011, REACT POL SEM 23 MAY; Schmid M, 2004, NATURE, V2, P239; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Wellcome Trust, 2010, THER	28	21	21	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e1782	10.1136/bmj.e1782	http://dx.doi.org/10.1136/bmj.e1782			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GM	22491076	Green Submitted			2022-12-01	WOS:000302607700011
J	Liu, FQ; Bakht, S; Dean, C				Liu, Fuquan; Bakht, Saleha; Dean, Caroline			Cotranscriptional Role for Arabidopsis DICER-LIKE 4 in Transcription Termination	SCIENCE			English	Article							RNA-POLYMERASE-II; SIRNA BIOGENESIS; FLC; DICER-LIKE-4; PHASE; DCL4; FCA	Transcription termination is emerging as an important component of gene regulation necessary to partition the genome and minimize transcriptional interference. We have discovered a role for the Arabidopsis RNA silencing enzyme DICER-LIKE 4 (DCL4) in transcription termination of an endogenous Arabidopsis gene, FCA. DCL4 directly associates with FCA chromatin in the 3' region and promotes cleavage of the nascent transcript in a domain downstream of the canonical polyA site. In a dcl4 mutant, the resulting transcriptional read-through triggers an RNA interference-mediated gene silencing of a transgene containing the same 3' region. We conclude that DCL4 promotes transcription termination of the Arabidopsis FCA gene, reducing the amount of aberrant RNA produced from the locus.	[Liu, Fuquan; Bakht, Saleha; Dean, Caroline] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Liu, Fuquan] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Queens University Belfast	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	caroline.dean@jic.ac.uk	Liu, Fuquan/AGD-6751-2022	Dean, Caroline/0000-0002-6555-3525	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D010799/1]; EU [LSHG-CT-2006-037900]; BBSRC [BBS/E/J/000CA447, BB/G01406X/1, BB/D010799/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA447, BB/G01406X/1, BB/D010799/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a UK Biotechnology and Biological Sciences Research Council (BBSRC) Core Strategic grant to John Innes Centre, UK BBSRC grant BB/D010799/1 (C.D.), and EU Framework VI program Integrated Project LSHG-CT-2006-037900. We thank C. Melnyk and I. Searle in D. C. Baulcombe's group at Cambridge University for dcl3-7 seeds; O. Voinnet (ETH Zurich) for seeds of dcl4-3, dcl4-4, and dcl4-6; T. Fukuhara (Tokyo University of Agriculture and Technology) for the DCL4 antibody; and G. Szittya for excellent comments on the manuscript.	Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Du QS, 2007, J VIROL, V81, P9142, DOI 10.1128/JVI.02885-06; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Ghazal G, 2009, MOL CELL, V36, P99, DOI 10.1016/j.molcel.2009.07.029; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; West S, 2008, MOL CELL, V29, P600, DOI 10.1016/j.molcel.2007.12.019; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501	21	31	38	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1621	1623		10.1126/science.1214402	http://dx.doi.org/10.1126/science.1214402			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461611				2022-12-01	WOS:000302062600044
J	Nakashiba, T; Cushman, JD; Pelkey, KA; Renaudineau, S; Buhl, DL; McHugh, TJ; Barrera, VR; Chittajallu, R; Iwamoto, KS; McBain, CJ; Fanselow, MS; Tonegawa, S				Nakashiba, Toshiaki; Cushman, Jesse D.; Pelkey, Kenneth A.; Renaudineau, Sophie; Buhl, Derek L.; McHugh, Thomas J.; Barrera, Vanessa Rodriguez; Chittajallu, Ramesh; Iwamoto, Keisuke S.; McBain, Chris J.; Fanselow, Michael S.; Tonegawa, Susumu			Young Dentate Granule Cells Mediate Pattern Separation, whereas Old Granule Cells Facilitate Pattern Completion	CELL			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; ENHANCED SYNAPTIC PLASTICITY; DOUBLE DISSOCIATION; DORSAL HIPPOCAMPUS; CRITICAL PERIOD; NMDA RECEPTORS; SPATIAL MEMORY; GYRUS; CA3; NEURONS	Adult-born granule cells (GCs), a minor population of cells in the hippocampal dentate gyrus, are highly active during the first few weeks after functional integration into the neuronal network, distinguishing them from less active, older adult-born GCs and the major population of dentate GCs generated developmentally. To ascertain whether young and old GCs perform distinct memory functions, we created a transgenic mouse in which output of old GCs was specifically inhibited while leaving a substantial portion of young GCs intact. These mice exhibited enhanced or normal pattern separation between similar contexts, which was reduced following ablation of young GCs. Furthermore, these mutant mice exhibited deficits in rapid pattern completion. Therefore, pattern separation requires adult-born young GCs but not old GCs, and older GCs contribute to the rapid recall by pattern completion. Our data suggest that as adult-born GCs age, their function switches from pattern separation to rapid pattern completion.	[Nakashiba, Toshiaki; Renaudineau, Sophie; Buhl, Derek L.; McHugh, Thomas J.; Tonegawa, Susumu] MIT, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Dept Biol, Cambridge, MA 02139 USA; [Nakashiba, Toshiaki; Renaudineau, Sophie; Buhl, Derek L.; McHugh, Thomas J.; Tonegawa, Susumu] MIT, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Cushman, Jesse D.; Barrera, Vanessa Rodriguez; Fanselow, Michael S.] Univ Calif Los Angeles, Dept Psychol, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Pelkey, Kenneth A.; Chittajallu, Ramesh; McBain, Chris J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Cellular & Synapt Neurophysiol, Natl Inst Hlth, Bethesda, MD 20892 USA; [Iwamoto, Keisuke S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tonegawa, S (corresponding author), MIT, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Dept Biol, Cambridge, MA 02139 USA.	tonegawa@mit.edu	McHugh, Thomas J/A-6693-2010; McHugh, Thomas/M-6159-2019; Buhl, Derek/AAV-3911-2021; Chittajallu, Ramesh/AAX-3749-2020	McHugh, Thomas J/0000-0002-1243-5189; McHugh, Thomas/0000-0002-1243-5189; Chittajallu, Ramesh/0000-0002-9794-0052; Buhl, Derek/0000-0003-4433-7150	Howard Hughes Medical Institute; Otsuka Maryland Research Institute; Picower Foundation; NIH [R01-MH078821, P50-MH58880, R01-MH62122]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062122, R01MH078821, P50MH058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS058280] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Otsuka Maryland Research Institute; Picower Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank F. Bushard, A. Ogawa, J. Derwin, C. Lovett, D. Rooney, C. Twiss, M. Pfau, and M. Serock for excellent technical assistance, Tonegawa lab members including J. Biedenkapp, J. Young, and G. Dragoi for comments on earlier versions of the manuscript, N. Arzoumanian for help with manuscript preparation, C. Lois for plasmids, I. Wickersham and H.S. Seung for the rabies virus, and S. Lee for help with preliminary irradiation experiments. This work was supported by the Howard Hughes Medical Institute, the Otsuka Maryland Research Institute, the Picower Foundation, and NIH grants R01-MH078821 and P50-MH58880 to S.T.; NIH grant R01-MH62122 to M.S.F.; and NICHD intramural funding to C.J.M.	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tabuchi K, 2000, J NEUROSCI RES, V59, P94, DOI 10.1002/(SICI)1097-4547(20000101)59:1<94::AID-JNR11>3.3.CO;2-H; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tronel S, 2012, HIPPOCAMPUS, V22, P292, DOI 10.1002/hipo.20895; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033	50	553	564	4	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					188	201		10.1016/j.cell.2012.01.046	http://dx.doi.org/10.1016/j.cell.2012.01.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22365813	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000302235400020
J	Lin, FR				Lin, Frank R.			Hearing Loss in Older Adults Who's Listening?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lin, Frank R.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Lin, Frank R.] Johns Hopkins Univ, Sch Med, Dept Epidemiol, Baltimore, MD 21205 USA; [Lin, Frank R.] Johns Hopkins Med Inst, Ctr Aging & Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine	Lin, FR (corresponding author), Johns Hopkins Ctr Aging & Hlth, 2024 E Monument St,Ste 2-700, Baltimore, MD 21205 USA.	flin1@jhmi.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC011279] Funding Source: NIH RePORTER; NIDCD NIH HHS [K23DC011279, K23 DC011279] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Cacioppo JT, 2011, ANN NY ACAD SCI, V1231, P17, DOI 10.1111/j.1749-6632.2011.06028.x; Chien W, 2012, ARCH INTERN MED, V172, P292, DOI 10.1001/archinternmed.2011.1408; Chou R, 2011, ANN INTERN MED, V154, P347, DOI 10.7326/0003-4819-154-5-201103010-00009; Lin FR, 2011, NEUROPSYCHOLOGY, V25, P763, DOI 10.1037/a0024238; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; MULROW CD, 1990, ANN INTERN MED, V113, P188, DOI 10.7326/0003-4819-113-3-188; Pacala JT, 2012, JAMA-J AM MED ASSOC, V307, P1185, DOI 10.1001/jama.2012.305; Peelle JE, 2011, J NEUROSCI, V31, P12638, DOI 10.1523/JNEUROSCI.2559-11.2011; US Department of Justice, 2010, 2010 ADA STAND ACC D; Wingfield A, 2005, CURR DIR PSYCHOL SCI, V14, P144, DOI 10.1111/j.0963-7214.2005.00356.x	10	69	73	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2012	307	11					1147	1148		10.1001/jama.2012.321	http://dx.doi.org/10.1001/jama.2012.321			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	911HN	22436953	Green Accepted			2022-12-01	WOS:000301708000021
J	Coste, B; Xiao, BL; Santos, JS; Syeda, R; Grandl, J; Spencer, KS; Kim, SE; Schmidt, M; Mathur, J; Dubin, AE; Montal, M; Patapoutian, A				Coste, Bertrand; Xiao, Bailong; Santos, Jose S.; Syeda, Ruhma; Grandl, Joerg; Spencer, Kathryn S.; Kim, Sung Eun; Schmidt, Manuela; Mathur, Jayanti; Dubin, Adrienne E.; Montal, Mauricio; Patapoutian, Ardem			Piezo proteins are pore-forming subunits of mechanically activated channels	NATURE			English	Article							VOLTAGE SENSOR; MECHANOTRANSDUCTION; TRANSDUCTION; NEURONS; HEARING; TOXIN	Mechanotransduction has an important role in physiology. Biological processes including sensing touch and sound waves require as-yet-unidentified cation channels that detect pressure. Mouse Piezo1 (MmPiezo1) and MmPiezo2 (also called Fam38a and Fam38b, respectively) induce mechanically activated cationic currents in cells; however, it is unknown whether Piezo proteins are pore-forming ion channels or modulate ion channels. Here we show that Drosophila melanogaster Piezo (DmPiezo, also called CG8486) also induces mechanically activated currents in cells, but through channels with remarkably distinct pore properties including sensitivity to the pore blocker ruthenium red and single channel conductances. MmPiezo1 assembles as a similar to 1.2-million-dalton homo-oligomer, with no evidence of other proteins in this complex. Purified MmPiezo1 reconstituted into asymmetric lipid bilayers and liposomes forms ruthenium-red-sensitive ion channels. These data demonstrate that Piezo proteins are an evolutionarily conserved ion channel family involved in mechanotransduction.	[Coste, Bertrand; Xiao, Bailong; Grandl, Joerg; Spencer, Kathryn S.; Kim, Sung Eun; Schmidt, Manuela; Dubin, Adrienne E.; Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Santos, Jose S.; Syeda, Ruhma; Montal, Mauricio] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Mathur, Jayanti; Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; University of California System; University of California San Diego; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	mmontal@ucsd.edu; apatapou@gnf.org	KIM, SUNG EUN/E-4918-2011	Grandl, Jorg/0000-0001-7179-7609; Schmidt, Manuela/0000-0003-1972-3519; Coste, Bertrand/0000-0002-0163-2494	National Institutes of Dental and Craniofacial Research, Neurological Disorders, General Medical Sciences; Genomics Institute of the Novartis Research Foundation; American Heart Association; NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303] Funding Source: NIH RePORTER	National Institutes of Dental and Craniofacial Research, Neurological Disorders, General Medical Sciences; Genomics Institute of the Novartis Research Foundation; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. H. Ulbrich for providing Ca<SUP>2+</SUP> channel-, NMDA receptor- and CNG channel-GFP fusion constructs used as controls for photobleaching experiments. This research was supported by grants from the National Institutes of Dental and Craniofacial Research, Neurological Disorders, General Medical Sciences, and by The Genomics Institute of the Novartis Research Foundation. B.X. and J.G. are postdoctoral fellowship recipients from the American Heart Association and the NIH, respectively.	Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; DAVIS MJ, 1992, AM J PHYSIOL, V262, pC1083, DOI 10.1152/ajpcell.1992.262.4.C1083; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Ermakov YA, 2010, BIOPHYS J, V98, P1018, DOI 10.1016/j.bpj.2009.11.044; GAMBALE F, 1990, MOL BRAIN RES, V7, P123, DOI 10.1016/0169-328X(90)90089-V; GAMBALE F, 1988, BIOPHYS J, V53, P771, DOI 10.1016/S0006-3495(88)83157-6; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; MONTAL M, 1973, BIOCHIM BIOPHYS ACTA, V298, P750, DOI 10.1016/0005-2736(73)90092-8; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Nilius B, 2010, EMBO REP, V11, P902, DOI 10.1038/embor.2010.181; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Reed-Geaghan EG, 2011, CURR OPIN GENET DEV, V21, P240, DOI 10.1016/j.gde.2010.12.009; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Tao X, 2008, J MOL BIOL, V382, P24, DOI 10.1016/j.jmb.2008.06.085; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	34	568	601	21	351	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2012	483	7388					176	U72		10.1038/nature10812	http://dx.doi.org/10.1038/nature10812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	904DT	22343900	Green Accepted			2022-12-01	WOS:000301174900030
J	Hauser, RG				Hauser, Robert G.			Here We Go Again - Another Failure of Postmarketing Device Surveillance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SAFETY		Minneapolis Heart Inst Fdn, Minneapolis, MN USA	Minneapolis Heart Institute Foundation	Hauser, RG (corresponding author), Minneapolis Heart Inst Fdn, Minneapolis, MN USA.		Hauser, Robert/AAP-1653-2020					[Anonymous], 2011, FDA CLASS VOL PHYS A; Chester K M, 2010, IMPORTANT INFORM RIA; Maisel WH, 2008, NEW ENGL J MED, V358, P985, DOI 10.1056/NEJMp0800495; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; Resnic FS, 2010, JAMA-J AM MED ASSOC, V304, P2019, DOI 10.1001/jama.2010.1633	5	58	58	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2012	366	10					873	875		10.1056/NEJMp1114695	http://dx.doi.org/10.1056/NEJMp1114695			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	904CY	22332951				2022-12-01	WOS:000301172500001
J	Zhu, C; Young-soo, S; Beaglehole, R				Zhu, Chen; Young-soo, Shin; Beaglehole, Robert			Tobacco control in China: small steps towards a giant leap	LANCET			English	Editorial Material									[Zhu, Chen] Minist Hlth, Beijing 100044, Peoples R China; [Young-soo, Shin] WHO Western Pacific Off, Manila, Philippines; [Beaglehole, Robert] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Zhu, C (corresponding author), Minist Hlth, Beijing 100044, Peoples R China.	zchen@stn.sh.cn						Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; [Anonymous], UN GEN ASS 66 SESS P; [Anonymous], 2011, XINHUA NEWS     0305; Bloomberg News, 2011, BLOOMBERG NEWS  0921; Chen Z, 2011, ANN REPORT HLTH STAT, VPublishing House of the Peking Union Medical College (Chin); Chinese Center for Disease Control and Prevention, 2011, GLOB AD TOB SURV GAT; Hu TW, 2010, TOB CONTROL, V19, P58, DOI 10.1136/tc.2009.031799; Koplan JP, 2010, LANCET, V375, P1330, DOI 10.1016/S0140-6736(10)60398-4; Liu YL, 2011, LANCET, V377, P1218, DOI 10.1016/S0140-6736(10)61391-8; The World Bank, 2011, HLTH HARM LIF CHIN S; World Bank, 1999, CURB EP GOV EC TOB C; World Health Organization, 2011, SCAL ACT NONC DIS MU	12	20	20	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2012	379	9818					779	780		10.1016/S0140-6736(11)61933-8	http://dx.doi.org/10.1016/S0140-6736(11)61933-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	901RB	22386013				2022-12-01	WOS:000300983400004
J	Han, J; Kesner, P; Metna-Laurent, M; Duan, TT; Xu, L; Georges, F; Koehl, M; Abrous, DN; Mendizabal-Zubiaga, J; Grandes, P; Liu, QS; Bai, G; Wang, W; Xiong, LZ; Ren, W; Marsicano, G; Zhang, X				Han, Jing; Kesner, Philip; Metna-Laurent, Mathilde; Duan, Tingting; Xu, Lin; Georges, Francois; Koehl, Muriel; Abrous, Djoher Nora; Mendizabal-Zubiaga, Juan; Grandes, Pedro; Liu, Qingsong; Bai, Guang; Wang, Wei; Xiong, Lize; Ren, Wei; Marsicano, Giovanni; Zhang, Xia			Acute Cannabinoids Impair Working Memory through Astroglial CB1 Receptor Modulation of Hippocampal LTD	CELL			English	Article							LONG-TERM DEPRESSION; SYNAPTIC-TRANSMISSION; SPATIAL MEMORY; ENDOCANNABINOID SYSTEM; CA1 REGION; LOCALIZATION; POTENTIATION; PERFORMANCE; EXPRESSION; PLASTICITY	Impairment of working memory is one of the most important deleterious effects of marijuana intoxication in humans, but its underlying mechanisms are presently unknown. Here, we demonstrate that the impairment of spatial working memory (SWM) and in vivo long-term depression (LTD) of synaptic strength at hippocampal CA3-CA1 synapses, induced by an acute exposure of exogenous cannabinoids, is fully abolished in conditional mutant mice lacking type-1 cannabinoid receptors (CB1R) in brain astroglial cells but is conserved in mice lacking CB1R in glutamatergic or GABAergic neurons. Blockade of neuronal glutamate N-methyl-D-aspartate receptors (NMDAR) and of synaptic trafficking of glutamate alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid receptors (AMPAR) also abolishes cannabinoid effects on SWM and LTD induction and expression. We conclude that the impairment of working memory by marijuana and cannabinoids is due to the activation of astroglial CB1R and is associated with astroglia-dependent hippocampal LTD in vivo.	[Metna-Laurent, Mathilde; Koehl, Muriel; Abrous, Djoher Nora; Marsicano, Giovanni] INSERM, F-33000 Bordeaux, France; [Metna-Laurent, Mathilde; Georges, Francois; Koehl, Muriel; Abrous, Djoher Nora; Marsicano, Giovanni] Univ Bordeaux, U862, F-33000 Bordeaux, France; [Han, Jing; Ren, Wei] Shaanxi Normal Univ, Coll Life Sci, Xian 710062, Peoples R China; [Kesner, Philip; Zhang, Xia] Univ Ottawa, Inst Mental Hlth Res Royal, Dept Psychiat, Ottawa, ON K1Z 7K4, Canada; [Kesner, Philip; Zhang, Xia] Univ Ottawa, Inst Mental Hlth Res Royal, Dept Cellular & Mol Med, Ottawa, ON K1Z 7K4, Canada; [Duan, Tingting; Xu, Lin] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China; [Duan, Tingting] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China; [Georges, Francois] CNRS, Interdisciplinary Inst Neurosci, UMR 5297, F-33000 Bordeaux, France; [Mendizabal-Zubiaga, Juan; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, Leioa 48940, Spain; [Liu, Qingsong] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Bai, Guang] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Program Neurosci, Baltimore, MD 21201 USA; [Wang, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430030, Hubai, Peoples R China; [Xiong, Lize] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Shaanxi Normal University; University of Ottawa; University of Ottawa; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; Medical College of Wisconsin; University System of Maryland; University of Maryland Baltimore; Huazhong University of Science & Technology; Air Force Military Medical University	Marsicano, G (corresponding author), INSERM, F-33000 Bordeaux, France.	giovanni.marsicano@inserm.fr; xia.zhang@rohcg.on.ca	Grandes, Pedro/AAA-1627-2019; Marsicano, Giovanni/I-9603-2016; Mendizabal, Juan Luis/H-6874-2015; Koehl, Muriel/C-3698-2011; Koehl, Muriel/ABI-2043-2020; Abrous, Nora-Djoher/N-6977-2017; Grandes, Pedro/H-7494-2015; , Ivan/D-6804-2012	Mendizabal, Juan Luis/0000-0002-4750-4797; Koehl, Muriel/0000-0002-7601-1422; Koehl, Muriel/0000-0002-7601-1422; Grandes, Pedro/0000-0003-3947-4230; abrous, nora/0000-0002-8589-305X; Zhang, Xia/0000-0002-4811-3229; GEORGES, Francois/0000-0002-2628-2638; , Ivan/0000-0002-3108-058X; Marsicano, Giovanni/0000-0003-3804-1951; Xu, Lin/0000-0002-2710-3507	NIH [DA011322, DA024741, NS38077]; Basque Country Government [GIC07/70-IT-432-07]; Ministerio de Ciencia e Innovacion [SAF2009-07065]; Red de Trastornos Adictivos, RETICS; Instituto de Salud Carlos III; MICINN [RD07/0001/2001]; National Natural Science Foundation of China (NNSFC) [30725019, 81030021]; National High Technology Research and Development Program of China (863) [2007AA02Z310]; INSERM/Avenir; INSERM; European Research Council [ERC-2010-StG-260515]; EU [HEALTH-F22008-223713]; Fondation pour la Recherche Medicale; Region Aquitaine; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Cheung Kong Scholar (Chang Jiang Scholar) Award; Canadian Foundation for Innovation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024741] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basque Country Government(Basque Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red de Trastornos Adictivos, RETICS; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); INSERM/Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Research Council(European Research Council (ERC)European Commission); EU(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Aquitaine(Region Nouvelle-Aquitaine); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cheung Kong Scholar (Chang Jiang Scholar) Award; Canadian Foundation for Innovation(Canada Foundation for Innovation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J.-C. Maillet and X. Li for technical assistance; D. Gonzales and the personnel of Animal Facility of the NeuroCentre Magendie for animal care and genotyping; Drs. D. Lagace (University of Ottawa), L. Renaud (University of Ottawa), Z. Jia (University of Toronto), P. Albert (University of Ottawa), B. Lutz (University of Mainz), and P. V. Piazza (INSERM) for discussion and comments. We also thank K. Mackie for providing the CB<INF>1</INF>R antibody, obtained with the NIH grant DA011322, as well as J. Rubenstein, M. Ekker, K. Nave, and F. Kirchhoff for providing the Cre-expressing mice used to generate conditional mutant mice. Support from China-Canada Joint Research grant (to L. Xu and X. Z.), The Basque Country Government grant (GIC07/70-IT-432-07, to P. G.), Ministerio de Ciencia e Innovacion (SAF2009-07065, to P. G.), Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III, MICINN (RD07/0001/2001, to P. G.), NIH grants (DA024741, to Q. L.; NS38077, to G. B.), grants from National Natural Science Foundation of China (NNSFC, 30725019, 81030021, to W. W.), 973 Progress (2009CB941300, to L. Xu), NNSFC for distinguished young scholars (30725039, to L. X.), Major Program of NNSFC (30930091, to L. X.), National High Technology Research and Development Program of China (863, 2007AA02Z310, to W. R.), INSERM/Avenir (to G. M.), INSERM (to D.N.A.), European Research Council (ERC-2010-StG-260515, to G. M.), EU-FP7 (REPROBESITY, HEALTH-F22008-223713, to G. M.), Fondation pour la Recherche Medicale (to G. M.), Region Aquitaine (to M. M.-L., G. M., and D.N.A.), Canadian Institutes of Health Research (to X. Z.), Natural Sciences and Engineering Research Council of Canada (to X. Z.), Cheung Kong Scholar (Chang Jiang Scholar) Award (to X. Z.), and Canadian Foundation for Innovation (to X. Z.).	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bajo M, 2009, J NEUROSCI RES, V87, P766, DOI 10.1002/jnr.21889; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Brooks J.W., 2002, CURR ANAESTH CRIT CA, V13, P215; Carlini EA, 2004, TOXICON, V44, P461, DOI 10.1016/j.toxicon.2004.05.009; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Cui SS, 2001, J NEUROSCI, V21, P9867, DOI 10.1523/JNEUROSCI.21-24-09867.2001; Domenici MR, 2006, J NEUROSCI, V26, P5794, DOI 10.1523/JNEUROSCI.0372-06.2006; Fadda P, 2004, NEUROPHARMACOLOGY, V47, P1170, DOI 10.1016/j.neuropharm.2004.08.009; Fox CJ, 2006, HIPPOCAMPUS, V16, P907, DOI 10.1002/hipo.20230; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Hajos N, 2002, NEUROPHARMACOLOGY, V43, P503, DOI 10.1016/S0028-3908(02)00157-0; Hall W, 2005, LANCET ONCOL, V6, P35, DOI 10.1016/S1470-2045(05)70024-3; Hampson RE, 2000, J NEUROSCI, V20, P8932; Han J, 2011, NEUROREPORT, V22, P181, DOI 10.1097/WNR.0b013e328343f5cb; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Higgins GA, 2005, PSYCHOPHARMACOLOGY, V179, P85, DOI 10.1007/s00213-005-2203-9; Hill MN, 2004, EUR J NEUROSCI, V20, P859, DOI 10.1111/j.1460-9568.2004.03522.x; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Hoffman AF, 2010, J NEUROSCI, V30, P545, DOI 10.1523/JNEUROSCI.4920-09.2010; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; KELSEY JE, 1993, BEHAV NEUROSCI, V107, P565, DOI 10.1037/0735-7044.107.4.565; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; LEMBERGER L, 1980, ANNU REV PHARMACOL, V20, P151, DOI 10.1146/annurev.pa.20.040180.001055; Lichtman AH, 1996, PSYCHOPHARMACOLOGY, V126, P125, DOI 10.1007/BF02246347; Liu ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015634; Lovinger David M., 2008, V184, P435; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Maalouf M, 1998, BRAIN RES, V793, P149, DOI 10.1016/S0006-8993(98)00152-8; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; Marsicano G, 2006, J Endocrinol Invest, V29, P27; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; Moldrich G, 2000, PEPTIDES, V21, P1735, DOI 10.1016/S0196-9781(00)00324-7; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; Nava F, 2001, NEUROPHARMACOLOGY, V41, P392, DOI 10.1016/S0028-3908(01)00075-2; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Ranganathan M, 2006, PSYCHOPHARMACOLOGY, V188, P425, DOI 10.1007/s00213-006-0508-y; Robinson L, 2007, BRIT J PHARMACOL, V151, P688, DOI 10.1038/sj.bjp.0707273; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Salio C, 2002, NEUROSCI LETT, V329, P13, DOI 10.1016/S0304-3940(02)00549-9; Sanderson DJ, 2008, PROG BRAIN RES, V169, P159, DOI 10.1016/S0079-6123(07)00009-X; Serpa A, 2009, EUR J PHARMACOL, V623, P41, DOI 10.1016/j.ejphar.2009.09.020; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Varvel SA, 2002, J PHARMACOL EXP THER, V301, P915, DOI 10.1124/jpet.301.3.915; Wise LE, 2009, NEUROPSYCHOPHARMACOL, V34, P2072, DOI 10.1038/npp.2009.31; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104	68	305	316	6	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 2	2012	148	5					1039	1050		10.1016/j.cell.2012.01.037	http://dx.doi.org/10.1016/j.cell.2012.01.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385967	Bronze			2022-12-01	WOS:000300985000022
J	Bonilla, WV; Frohlich, A; Senn, K; Kallert, S; Fernandez, M; Johnson, S; Kreutzfeldt, M; Hegazy, AN; Schrick, C; Fallon, PG; Klemenz, R; Nakae, S; Adler, H; Merkler, D; Lohning, M; Pinschewer, DD				Bonilla, Weldy V.; Froehlich, Anja; Senn, Karin; Kallert, Sandra; Fernandez, Marylise; Johnson, Susan; Kreutzfeldt, Mario; Hegazy, Ahmed N.; Schrick, Christina; Fallon, Padraic G.; Klemenz, Roman; Nakae, Susumu; Adler, Heiko; Merkler, Doron; Loehning, Max; Pinschewer, Daniel D.			The Alarmin Interleukin-33 Drives Protective Antiviral CD8(+) T Cell Responses	SCIENCE			English	Article							IMMUNE-RESPONSE; IL-33; MICE; INFECTION; EXPRESSION; CYTOKINE; RECEPTOR; SIGNALS; ST2; INDUCTION	Pathogen-associated molecular patterns decisively influence antiviral immune responses, whereas the contribution of endogenous signals of tissue damage, also known as damage-associated molecular patterns or alarmins, remains ill defined. We show that interleukin-33 (IL-33), an alarmin released from necrotic cells, is necessary for potent CD8(+) T cell (CTL) responses to replicating, prototypic RNA and DNA viruses in mice. IL-33 signaled through its receptor on activated CTLs, enhanced clonal expansion in a CTL-intrinsic fashion, determined plurifunctional effector cell differentiation, and was necessary for virus control. Moreover, recombinant IL-33 augmented vaccine-induced CTL responses. Radio-resistant cells of the splenic T cell zone produced IL-33, and efficient CTL responses required IL-33 from radio-resistant cells but not from hematopoietic cells. Thus, alarmin release by radio-resistant cells orchestrates protective antiviral CTL responses.	[Froehlich, Anja; Hegazy, Ahmed N.; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany; [Bonilla, Weldy V.; Kallert, Sandra; Fernandez, Marylise; Johnson, Susan; Kreutzfeldt, Mario; Schrick, Christina; Merkler, Doron; Pinschewer, Daniel D.] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; [Bonilla, Weldy V.; Kallert, Sandra; Fernandez, Marylise; Johnson, Susan; Pinschewer, Daniel D.] Univ Geneva, World Hlth Org Collaborating Ctr Vaccine Immunol, CH-1211 Geneva 4, Switzerland; [Froehlich, Anja; Hegazy, Ahmed N.; Loehning, Max] German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Senn, Karin; Klemenz, Roman] Univ Zurich Hosp, Dept Pathol, Inst Canc Res, CH-8091 Zurich, Switzerland; [Kreutzfeldt, Mario; Schrick, Christina; Merkler, Doron] Univ Hosp Geneva, Div Clin Pathol, CH-1211 Geneva 4, Switzerland; [Hegazy, Ahmed N.] Charite, Dept Gastroenterol Hepatol & Endocrinol, D-13353 Berlin, Germany; [Fallon, Padraic G.] St James Hosp, Trinity Coll Dublin, Inst Mol Med, Dublin 8, Ireland; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Adler, Heiko] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Adler, Heiko] CCG HCT, D-81377 Munich, Germany; [Merkler, Doron] Univ Gottingen, Dept Neuropathol, Univ Med Ctr, Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Geneva; University of Geneva; World Health Organization; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Zurich; University Zurich Hospital; University of Geneva; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Trinity College Dublin; University of Tokyo; Japan Science & Technology Agency (JST); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Gottingen	Lohning, M (corresponding author), Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany.	loehning@drfz.de; daniel.pinschewer@gmx.ch	Merkler, Doron/N-9157-2016; Löhning, Max/AAL-2967-2021; Fallon, Padraic/Y-2711-2019; Adler, Heiko/M-7355-2014	Merkler, Doron/0000-0002-0247-2007; Löhning, Max/0000-0001-6382-7281; Fallon, Padraic/0000-0002-8401-7293; Adler, Heiko/0000-0002-6481-6709; Pinschewer, Daniel/0000-0002-1594-3189; Kreutzfeldt, Mario/0000-0003-0335-2733; Hegazy, Ahmed N./0000-0002-2946-8251	Bundesministerium fur Bildung und Forschung (BMBF)-FORSYS; National Health and Medical Research Council; German Research Foundation [GRK1121, SFB618, SFB650]; Science Foundation Ireland; Program for Improvement of Research Environment for Young Researchers; Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency, PRESTO; BMBF (NGFNplus) [FKZ PIM-01GS0802-3]; Wilhelm Sander-Stiftung; Volkswagen Foundation; Fondation Leenaards; European Community; Swiss National Science Foundation; Grants-in-Aid for Scientific Research [23390262] Funding Source: KAKEN	Bundesministerium fur Bildung und Forschung (BMBF)-FORSYS(Federal Ministry of Education & Research (BMBF)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); German Research Foundation(German Research Foundation (DFG)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Program for Improvement of Research Environment for Young Researchers; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, PRESTO(Japan Science & Technology Agency (JST)); BMBF (NGFNplus)(Federal Ministry of Education & Research (BMBF)); Wilhelm Sander-Stiftung; Volkswagen Foundation(Volkswagen); Fondation Leenaards; European Community(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Bundesministerium fur Bildung und Forschung (BMBF)-FORSYS (A. F., M. L.), National Health and Medical Research Council (S.J.), German Research Foundation (GRK1121, A.N.H.), Science Foundation Ireland (P. G. F.), Program for Improvement of Research Environment for Young Researchers, the Special Coordination Funds for Promoting Science and Technology from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan Science and Technology Agency, PRESTO (S.N.), BMBF (NGFNplus, FKZ PIM-01GS0802-3; H. A.), Wilhelm Sander-Stiftung (H. A.), German Research Foundation (SFB618 and SFB650, M. L.), Volkswagen Foundation (Lichtenberg Program, M. L.), Fondation Leenaards (D. D. P.), European Community (D. D. P.), and Swiss National Science Foundation (D. M., D. D. P.). We thank A. Bergthaler, G. R. Burmester, C. Gabay, M. Geuking, A. Kamath, P. H. Lambert, J. Luban, B. Marsland, G. Palmer, A. Radbruch, C. A. Siegrist, and R. M. Zinkernagel for discussions and advice; H. Saito, National Research Institute for Child Health and Development, for Il33<SUP>-/-</SUP> mice obtained under a materials transfer agreement (MTA) through the RIKEN Center for Developmental Biology, Laboratory for Animal Resources and Genetic Engineering; A. McKenzie (for Il1rl1<SUP>-/-</SUP> mice obtained under MTA); the University of Zurich (for rLCMV technology obtained under MTA) and G. Jennings [Cytos Biotechnology AG, Schlieren, Switzerland, holding patent rights on VLPs provided] for reagents; and J. Weber and B. Steer for technical assistance. The data presented in this paper are tabulated in the main paper and the supporting online material. Microarray data are deposited with National Center for Biotechnology Information Gene Expression Omnibus (GEO, accession number GSE34392) and ArrayExpress (accession number E-MTAB-901). D. D. P. is or has been a shareholder, board member, and consultant to ArenaVax AG, Switzerland, and to Hookipa Biotech GmbH, Austria, commercializing rLCMV vectors (patent application EP 07 025 099.8, coauthored by D. D. P.). The authors declare that they do not have other competing financial interests.	Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Becerra A, 2008, CYTOKINE, V41, P114, DOI 10.1016/j.cyto.2007.11.001; BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dobrzanski MJ, 2004, J IMMUNOL, V172, P1380, DOI 10.4049/jimmunol.172.3.1380; EHTISHAM S, 1993, J VIROL, V67, P5247, DOI 10.1128/JVI.67.9.5247-5252.1993; Flatz L, 2010, NAT MED, V16, P339, DOI 10.1038/nm.2104; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Le Goffic R, 2011, AM J RESP CELL MOL, V45, P1125, DOI 10.1165/rcmb.2010-0516OC; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Ljutic B, 2005, J IMMUNOL, V174, P4789, DOI 10.4049/jimmunol.174.8.4789; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Rahman AH, 2008, J IMMUNOL, V181, P3804, DOI 10.4049/jimmunol.181.6.3804; Rahman AH, 2011, BLOOD, V117, P3123, DOI 10.1182/blood-2010-11-318485; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Senn KA, 2000, EUR J IMMUNOL, V30, P1929, DOI 10.1002/1521-4141(200007)30:7&lt;1929::AID-IMMU1929&gt;3.0.CO;2-1; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Yang QT, 2011, EUR J IMMUNOL, V41, P3351, DOI 10.1002/eji.201141629; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3	37	299	317	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 24	2012	335	6071					984	989		10.1126/science.1215418	http://dx.doi.org/10.1126/science.1215418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22323740				2022-12-01	WOS:000300931800051
J	Krimpenfort, P; Song, JY; Proost, N; Zevenhoven, J; Jonkers, J; Berns, A				Krimpenfort, Paul; Song, Ji-Ying; Proost, Natalie; Zevenhoven, John; Jonkers, Jos; Berns, Anton			Deleted in colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours	NATURE			English	Article							DCC GENE; BREAST-CANCER; TRANSCRIPTIONAL TARGET; NETRIN RECEPTOR; NERVOUS-SYSTEM; CELL-DEATH; APOPTOSIS; P53; MICE; EXPRESSION	Since its discovery in the early 1990s the deleted in colorectal cancer (DCC) gene, located on chromosome 18q21, has been proposed as a tumour suppressor gene as its loss is implicated in the majority of advanced colorectal and many other cancers(1). DCC belongs to the family of netrin 1 receptors, which function as dependence receptors as they control survival or apoptosis depending on ligand binding. However, the role of DCC as a tumour suppressor remains controversial because of the rarity of DCC-specific mutations and the presence of other tumour suppressor genes in the same chromosomal region. Here we show that in a mouse model of mammary carcinoma based on somatic inactivation of p53, additional loss of DCC promotes metastasis formation without affecting the primary tumour phenotype. Furthermore, we demonstrate that in cell cultures derived from p53-deficient mouse mammary tumours DCC expression controls netrin-1-dependent cell survival, providing a mechanistic basis for the enhanced metastatic capacity of tumour cells lacking DCC. Consistent with this idea, in vivo tumour-cell survival is enhanced by DCC loss. Together, our data support the function of DCC as a context-dependent tumour suppressor that limits survival of disseminated tumour cells.	[Krimpenfort, Paul; Proost, Natalie; Zevenhoven, John; Berns, Anton] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Jonkers, Jos] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Jonkers, Jos] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Song, Ji-Ying] Netherlands Canc Inst, Dept Expt Anim Pathol, NL-1066 CX Amsterdam, Netherlands; [Berns, Anton] Netherlands Canc Inst, AMC, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.berns@nki.nl	Jonkers, Jos/AAG-3246-2019	Jonkers, Jos/0000-0002-9264-9792				Alberici P, 2006, ONCOGENE, V25, P1841, DOI 10.1038/sj.onc.1209226; CHO KR, 1994, GENOMICS, V19, P525, DOI 10.1006/geno.1994.1102; Delloye-Bourgeois C, 2009, JNCI-J NATL CANCER I, V101, P237, DOI 10.1093/jnci/djn491; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Hamamoto T, 2002, CANCER RES, V62, P5955; Hibi K, 2009, ANTICANCER RES, V29, P271; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Livesey FJ, 1997, MOL CELL NEUROSCI, V8, P417, DOI 10.1006/mcne.1997.0598; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mehlen P, 2004, J CLIN ONCOL, V22, P3420, DOI 10.1200/JCO.2004.02.019; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Miyamoto Y, 2010, INT J ONCOL, V36, P1253, DOI 10.3892/ijo_00000609; PELTOMAKI P, 1991, CANCER RES, V51, P4135; Roush W, 1997, SCIENCE, V276, P534, DOI 10.1126/science.276.5312.534; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shin SK, 2007, GASTROENTEROLOGY, V133, P1849, DOI 10.1053/j.gastro.2007.08.074; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Uciechowski P, 2000, BRIT J CANCER, V83, P1664, DOI 10.1054/bjoc.2000.1501; Volenec A, 1997, NEUROREPORT, V8, P2913, DOI 10.1097/00001756-199709080-00022; Wang H, 2008, BIOCHEM BIOPH RES CO, V370, P594, DOI 10.1016/j.bbrc.2008.03.152	28	68	69	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					538	U134		10.1038/nature10790	http://dx.doi.org/10.1038/nature10790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358843				2022-12-01	WOS:000300770500053
J	Liu, N; Landreh, M; Cao, KJ; Abe, M; Hendriks, GJ; Kennerdell, JR; Zhu, YQ; Wang, LS; Bonini, NM				Liu, Nan; Landreh, Michael; Cao, Kajia; Abe, Masashi; Hendriks, Gert-Jan; Kennerdell, Jason R.; Zhu, Yongqing; Wang, Li-San; Bonini, Nancy M.			The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila	NATURE			English	Article							DOWN-REGULATION; LIFE-SPAN; DEGENERATION; BRAIN; TRANSCRIPTION; MELANOGASTER; EXPRESSION; DISEASE; TARGET; GENE	Human neurodegenerative diseases have the temporal hallmark of afflicting the elderly population. Ageing is one of the most prominent factors to influence disease onset and progression(1), yet little is known about the molecular pathways that connect these processes. To understand this connection it is necessary to identify the pathways that functionally integrate ageing, chronic maintenance of the brain and modulation of neurodegenerative disease. MicroRNAs (miRNA) are emerging as critical factors in gene regulation during development; however, their role in adult-onset, age-associated processes is only beginning to be revealed. Here we report that the conserved miRNA miR-34 regulates age-associated events and long-term brain integrity in Drosophila, providing a molecular link between ageing and neurodegeneration. Fly mir-34 expression exhibits adult-onset, brain-enriched and age-modulated characteristics. Whereas mir-34 loss triggers a gene profile of accelerated brain ageing, late-onset brain degeneration and a catastrophic decline in survival, mir-34 upregulation extends median lifespan and mitigates neurodegeneration induced by human pathogenic polyglutamine disease protein. Some of the age-associated effects of miR-34 require adult-onset translational repression of Eip74EF, an essential ETS domain transcription factor involved in steroid hormone pathways. Our studies indicate that miRNA-dependent pathways may have an impact on adult-onset, age-associated events by silencing developmental genes that later have a deleterious influence on adult life cycle and disease, and highlight fly miR-34 as a key miRNA with a role in this process.	[Liu, Nan; Landreh, Michael; Abe, Masashi; Hendriks, Gert-Jan; Kennerdell, Jason R.; Zhu, Yongqing; Bonini, Nancy M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Cao, Kajia; Wang, Li-San] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Li-San] Univ Penn, Inst Aging, Philadelphia, PA 19104 USA; [Wang, Li-San] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; [Bonini, Nancy M.] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Bonini, NM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu	Liu, Nan/D-8913-2011	Landreh, Michael/0000-0002-7958-4074; Bonini, Nancy/0000-0003-0226-5291; Hendriks, Gert-Jan/0000-0001-8798-1443	NINDS [R01-NS043578]; Ellison Foundation; Penn Genome Frontiers Institute; NIA [U01-AG-032984-02, RC2-AG036528-01]; Penn Institute on Aging [AG010124]; NIH [T32 AG00255]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124, T32AG000255, U01AG032984, RC2AG036528] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ellison Foundation(Lawrence Ellison Foundation); Penn Genome Frontiers Institute; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Penn Institute on Aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Thummel, T. Jongens and A. Bashirullah for reagents. We are grateful to A. Cashmore, A. Burguete, J. Kim, S. Cherry, B. Gregory, A. Gitler and the Bonini laboratory for discussion and critical reading of the manuscript. We thank X. Teng for assistance with fly paraffin section. This work was funded by the NINDS (R01-NS043578) and the Ellison Foundation (to N.M.B.). L.-S.W. and K. C. are supported by a pilot grant from Penn Genome Frontiers Institute. L.-S.W. is supported by NIA (U01-AG-032984-02 and RC2-AG036528-01) and a Penn Institute on Aging pilot grant (AG010124). N.M.B. is an Investigator of the Howard Hughes Medical Institute. J. R. K. received support from NIH T32 AG00255.	AMADUCCI L, 1994, CURR OPIN NEUROL, V7, P283, DOI 10.1097/00019052-199408000-00001; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Cao KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013098; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; FLETCHER JC, 1995, DEVELOPMENT, V121, P1411; Fletcher JC, 1997, P NATL ACAD SCI USA, V94, P4582, DOI 10.1073/pnas.94.9.4582; Gaughwin PM, 2011, HUM MOL GENET, V20, P2225, DOI 10.1093/hmg/ddr111; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Khanna A, 2011, AGING-US, V3, P223, DOI 10.18632/aging.100276; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Li XL, 2011, AGING-US, V3, P985, DOI 10.18632/aging.100371; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Minones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yang JR, 2013, AGE, V35, P11, DOI 10.1007/s11357-011-9324-3; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	33	282	301	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					519	U240		10.1038/nature10810	http://dx.doi.org/10.1038/nature10810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22343898	Green Accepted			2022-12-01	WOS:000300770500049
J	Di Sabatino, A; Corazza, GR				Di Sabatino, Antonio; Corazza, Gino Roberto			Nonceliac Gluten Sensitivity: Sense or Sensibility?	ANNALS OF INTERNAL MEDICINE			English	Article							IRRITABLE-BOWEL-SYNDROME; CELIAC-DISEASE; FOOD CHALLENGE; DOUBLE-BLIND; FREE DIET; EXPRESSION; SYMPTOMS; DIARRHEA	Recent studies support the existence of a new condition, nonceliac gluten sensitivity, which manifests as intestinal or extraintestinal symptoms that improve or disappear after gluten withdrawal in individuals with normal small-bowel mucosa and negative results on serum antitransglutaminase and antiendomysial antibody testing. Although the clinical value of this concept is under debate, the prevalence of nonceliac gluten sensitivity in the general population is supposed to be many times higher than that of celiac disease. The lack of an unambiguous definition of nonceliac gluten sensitivity, a major pitfall, is primarily related to the heterogeneous cause of this condition, whose symptoms are presumed to be caused by different mechanisms. If nonceliac gluten sensitivity is an etiologically heterogeneous syndrome, then management options should vary according to the predominant or concomitant underlying pathogenic pathways.	[Corazza, Gino Roberto] Univ Pavia, Fdn IRCCS Policlin San Matteo, Med Clin 1, Ctr Studio & Curia Mallatia Celiaca, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia	Corazza, GR (corresponding author), Univ Pavia, Fdn IRCCS Policlin San Matteo, Med Clin 1, Ctr Studio & Curia Mallatia Celiaca, Piazzale Golgi 5, I-27100 Pavia, Italy.	gr.corazza@smatteo.pv.it	Corazza, Gino Roberto/K-8500-2016; Di Sabatino, Antonio/K-8015-2016	Corazza, Gino Roberto/0000-0001-9532-0573; Di Sabatino, Antonio/0000-0002-0302-8645				ANDERSON IH, 1981, NEW ENGL J MED, V304, P891, DOI 10.1056/NEJM198104093041507; Asero R, 2009, CURR OPIN ALLERGY CL, V9, P379, DOI 10.1097/ACI.0b013e32832d9049; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; COOPER BT, 1981, GASTROENTEROLOGY, V81, P192; Corazza G. R., 1984, OPIOID PEPTIDES PERI, P243; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Inomata N, 2009, CURR OPIN ALLERGY CL, V9, P238, DOI 10.1097/ACI.0b013e32832aa5bc; Layton L., 2011, WASHINGTON POST 0429; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; Nowak-Wegrzyn A, 2009, J ALLERGY CLIN IMMUN, V123, pS365, DOI 10.1016/j.jaci.2009.03.042; Painter K, 2008, US TODAY        0817; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Simpson S, 2011, GASTROENTEROLOGY, V140, pS443; Springen K, 2008, NEWSWEEK        1202; SUAREZ FL, 1995, NEW ENGL J MED, V333, P1, DOI 10.1056/NEJM199507063330101; Troncone R, 2011, J INTERN MED, V269, P582, DOI 10.1111/j.1365-2796.2011.02385.x; Verdu EF, 2009, AM J GASTROENTEROL, V104, P1587, DOI 10.1038/ajg.2009.188; Wahnschaffe U, 2007, CLIN GASTROENTEROL H, V5, P844, DOI 10.1016/j.cgh.2007.03.021; Zuberbier T, 2004, ALLERGY, V59, P338, DOI 10.1046/j.1398-9995.2003.00403.x	20	87	88	0	45	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4					309	U101		10.7326/0003-4819-156-4-201202210-00010	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896YO	22351716				2022-12-01	WOS:000300607600008
J	Berns, KI; Casadevall, A; Cohen, ML; Ehrlich, SA; Enquist, LW; Fitch, JP; Franz, DR; Fraser-Liggett, CM; Grant, CM; Imperiale, MJ; Kanabrocki, J; Keim, PS; Lemon, SM; Levy, SB; Lumpkin, JR; Miller, JF; Murch, R; Nance, ME; Osterholm, MT; Relman, DA; Roth, JA; Vidaver, AK				Berns, Kenneth I.; Casadevall, Arturo; Cohen, Murray L.; Ehrlich, Susan A.; Enquist, Lynn W.; Fitch, J. Patrick; Franz, David R.; Fraser-Liggett, Claire M.; Grant, Christine M.; Imperiale, Michael J.; Kanabrocki, Joseph; Keim, Paul S.; Lemon, Stanley M.; Levy, Stuart B.; Lumpkin, John R.; Miller, Jeffery F.; Murch, Randall; Nance, Mark E.; Osterholm, Michael T.; Relman, David A.; Roth, James A.; Vidaver, Anne K.			Adaptations of Avian Flu Virus Are a Cause for Concern	SCIENCE			English	Editorial Material							RECOMBINANT DNA; GUIDELINES; MOLECULES		[Keim, Paul S.] No Arizona Univ, Flagstaff, AZ 86011 USA; [Keim, Paul S.] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Berns, Kenneth I.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Casadevall, Arturo] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Cohen, Murray L.] Frontline Healthcare Workers Safety Fdn Ltd, Atlanta, GA 30338 USA; [Ehrlich, Susan A.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Enquist, Lynn W.] Princeton Univ, Princeton, NJ 08544 USA; [Fitch, J. Patrick] Battelle Natl Biodef Inst LLC, Frederick, MD 21702 USA; [Franz, David R.] MRIGlobal, Frederick, MD 21702 USA; [Fraser-Liggett, Claire M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Grant, Christine M.] InfecDetect Rapid Diagnost Tests LLC, Princeton, NJ 08540 USA; [Imperiale, Michael J.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Kanabrocki, Joseph] Univ Chicago, Chicago, IL 60637 USA; [Lemon, Stanley M.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Levy, Stuart B.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Lumpkin, John R.] Robert Wood Johnson Fdn, Princeton, NJ 08540 USA; [Miller, Jeffery F.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Murch, Randall] Virginia Polytech Inst & State Univ, Virginia Tech Resource Ctr, Arlington, VA 22203 USA; [Nance, Mark E.] GE Healthcare, Princeton, NJ 08540 USA; [Osterholm, Michael T.] Univ Minnesota, Minneapolis, MN 55455 USA; [Relman, David A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Roth, James A.] Iowa State Univ, Ctr Food Secur & Publ Hlth, Ames, IA 50011 USA; [Vidaver, Anne K.] Univ Nebraska, Lincoln, NE 68588 USA	Northern Arizona University; Translational Genomics Research Institute; State University System of Florida; University of Florida; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; Princeton University; University System of Maryland; University of Maryland Baltimore; University of Michigan System; University of Michigan; University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Tufts University; Robert Wood Johnson Foundation (RWJF); University of California System; University of California Los Angeles; Virginia Polytechnic Institute & State University; General Electric; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Iowa State University; University of Nebraska System; University of Nebraska Lincoln	Keim, PS (corresponding author), No Arizona Univ, Flagstaff, AZ 86011 USA.	Paul.Keim@nau.edu	Roth, James A/A-7122-2009	Roth, James A/0000-0003-3562-668X; Fraser, Claire/0000-0003-1462-2428; Relman, David A./0000-0001-8331-1354				BERG P, 1975, P NATL ACAD SCI USA, V72, P1981, DOI 10.1073/pnas.72.6.1981; National Research Council, 2004, BIOT RES AG TERR; National Research Council, 2006, GLOB BIOS FUT LIF SC; National Science Advisory Board for Biosecurity (NSABB), 2008, STRAT PLAN OUTR ED D; Office of Biotechnology Activities, AB NSABB; SINGER M, 1973, SCIENCE, V181, P1114, DOI 10.1126/science.181.4105.1114; SINGER MF, 1976, SCIENCE, V193, P186, DOI 10.1126/science.11643320; World Health Organization, 2003, CONF HUM CAS H5N1 20	8	49	52	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 10	2012	335	6069					660	661		10.1126/science.1217994	http://dx.doi.org/10.1126/science.1217994			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22294736				2022-12-01	WOS:000300047100034
J	Nagata, T; Koyanagi, M; Tsukamoto, H; Saeki, S; Isono, K; Shichida, Y; Tokunaga, F; Kinoshita, M; Arikawa, K; Terakita, A				Nagata, Takashi; Koyanagi, Mitsumasa; Tsukamoto, Hisao; Saeki, Shinjiro; Isono, Kunio; Shichida, Yoshinori; Tokunaga, Fumio; Kinoshita, Michiyo; Arikawa, Kentaro; Terakita, Akihisa			Depth Perception from Image Defocus in a Jumping Spider	SCIENCE			English	Article							PRINCIPAL EYES; SPECTRAL SENSITIVITIES; USE ACCOMMODATION; SALTICIDAE; DENDRYPHANTINAE; MOVEMENTS; RECEPTORS; DISTANCE; BEHAVIOR; RETINAE	The principal eyes of jumping spiders have a unique retina with four tiered photoreceptor layers, on each of which light of different wavelengths is focused by a lens with appreciable chromatic aberration. We found that all photoreceptors in both the deepest and second-deepest layers contain a green-sensitive visual pigment, although green light is only focused on the deepest layer. This mismatch indicates that the second-deepest layer always receives defocused images, which contain depth information of the scene in optical theory. Behavioral experiments revealed that depth perception in the spider was affected by the wavelength of the illuminating light, which affects the amount of defocus in the images resulting from chromatic aberration. Therefore, we propose a depth perception mechanism based on how much the retinal image is defocused.	[Nagata, Takashi; Koyanagi, Mitsumasa; Tsukamoto, Hisao; Terakita, Akihisa] Osaka City Univ, Dept Biol & Geosci, Grad Sch Sci, Osaka 5588585, Japan; [Saeki, Shinjiro; Isono, Kunio] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan; [Shichida, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Tokunaga, Fumio] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Kinoshita, Michiyo; Arikawa, Kentaro] Grad Univ Adv Studies Sokendai, Lab Neuroethol, Hayama 2400193, Japan	Osaka Metropolitan University; Tohoku University; Kyoto University; Osaka University; Graduate University for Advanced Studies - Japan	Koyanagi, M (corresponding author), Osaka City Univ, Dept Biol & Geosci, Grad Sch Sci, Osaka 5588585, Japan.	koyanagi@sci.osaka-cu.ac.jp; terakita@sci.osaka-cu.ac.jp	Nagata, Takashi/ABB-1780-2020	Nagata, Takashi/0000-0001-5379-2951; Terakita, Akihisa/0000-0002-8379-8913; Koyanagi, Mitsumasa/0000-0002-7741-918X; Kinoshita, Michiyo/0000-0002-5818-9622; Arikawa, Kentaro/0000-0002-4365-0762	Grants-in-Aid for Scientific Research [21770078, 22687005] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		BLEST AD, 1981, J COMP PHYSIOL, V145, P227, DOI 10.1007/BF00605035; Chaudhuri S., 1999, DEPTH DEFOCUS REAL A; DEVOE RD, 1975, J GEN PHYSIOL, V66, P193, DOI 10.1085/jgp.66.2.193; EAKIN RM, 1971, J ULTRA MOL STRUCT R, V37, P618, DOI 10.1016/S0022-5320(71)80029-1; FORSTER LM, 1979, NEW ZEAL J ZOOL, V6, P79, DOI 10.1080/03014223.1979.10428351; HARKNESS L, 1977, NATURE, V267, P346, DOI 10.1038/267346a0; Harris JM, 2004, PHILOS T R SOC A, V362, P2721, DOI 10.1098/rsta.2004.1464; Kral K, 2003, BEHAV PROCESS, V64, P1, DOI 10.1016/S0376-6357(03)00054-8; LAND MF, 1969, J EXP BIOL, V51, P443; LAND MF, 1969, J EXP BIOL, V51, P471; PENTLAND AP, 1987, IEEE T PATTERN ANAL, V9, P523, DOI 10.1109/TPAMI.1987.4767940; WAGNER H, 1991, J COMP PHYSIOL A, V169, P515; YAMASHITA S, 1976, J COMP PHYSIOL, V105, P29, DOI 10.1007/BF01380051; Zurek DB, 2010, J EXP BIOL, V213, P2372, DOI 10.1242/jeb.042382	14	80	84	0	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2012	335	6067					469	471		10.1126/science.1211667	http://dx.doi.org/10.1126/science.1211667			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22282813	Green Published			2022-12-01	WOS:000299466800051
J	Shenoy, AR; Wellington, DA; Kumar, P; Kassa, H; Booth, CJ; Cresswell, P; MacMicking, JD				Shenoy, Avinash R.; Wellington, David A.; Kumar, Pradeep; Kassa, Hilina; Booth, Carmen J.; Cresswell, Peter; MacMicking, John D.			GBP5 Promotes NLRP3 Inflammasome Assembly and Immunity in Mammals	SCIENCE			English	Article							DIFFERENTIAL REQUIREMENT; CUTTING EDGE; HOST-DEFENSE; CELL-DEATH; ACTIVATION; CASPASE-1; INTERLEUKIN-1-BETA; CRYSTALS; ROLES; ASC	Inflammasomes are sensory complexes that alert the immune system to the presence of infection or tissue damage. These complexes assemble NLR (nucleotide binding and oligomerization, leucine-rich repeat) or ALR (absent in melanoma 2-like receptor) proteins to activate caspase-1 cleavage and interleukin (IL)-1 beta/IL-18 secretion. Here, we identified a non-NLR/ALR human protein that stimulates inflammasome assembly: guanylate binding protein 5 (GBP5). GBP5 promoted selective NLRP3 inflammasome responses to pathogenic bacteria and soluble but not crystalline inflammasome priming agents. Generation of Gbp5(-/-) mice revealed pronounced caspase-1 and IL-1 beta/IL-18 cleavage defects in vitro and impaired host defense and Nlrp3-dependent inflammatory responses in vivo. Thus, GBP5 serves as a unique rheostat for NLRP3 inflammasome activation and extends our understanding of the inflammasome complex beyond its core machinery.	[Shenoy, Avinash R.; Wellington, David A.; Kumar, Pradeep; Kassa, Hilina; MacMicking, John D.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, New Haven, CT 06510 USA; [Wellington, David A.; Booth, Carmen J.] Yale Univ, Sch Med, Sect Comparat Med, New Haven, CT 06510 USA; [Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	MacMicking, JD (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, 333 Cedar St, New Haven, CT 06510 USA.	john.macmicking@yale.edu		Shenoy, Avinash/0000-0001-6228-9303	Yale Brown-Coxe fellowship; Anna Fuller postdoctoral fellowship; Howard Hughes Medical Institute; NIH National Institute of Allergy and Infectious Diseases [R01 AI068041-06]; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award [1007845]; Searle Foundation [05-F-114]; Cancer Research Institute [CRI06-10]; Chrohn's and Colitis Foundation of America [R09928]; W. W. Winchester Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068041] Funding Source: NIH RePORTER	Yale Brown-Coxe fellowship; Anna Fuller postdoctoral fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Searle Foundation; Cancer Research Institute; Chrohn's and Colitis Foundation of America; W. W. Winchester Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Tschopp, M. Karin, W. Mothes, and C. Roy for plasmids. All data are tabulated in the main paper and the supplementary materials. A. R. S. was supported by Yale Brown-Coxe and Anna Fuller postdoctoral fellowships, P. C. by Howard Hughes Medical Institute, and J.D.M. by NIH National Institute of Allergy and Infectious Diseases (R01 AI068041-06), Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (1007845), Searle Foundation Scholars Program (05-F-114), Cancer Research Institute Investigator Award Program (CRI06-10), Chrohn's and Colitis Foundation of America Senior Investigator Award (R09928), and W. W. Winchester Foundation.	Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shiohara M, 2002, BIOCHEM BIOPH RES CO, V293, P1314, DOI 10.1016/S0006-291X(02)00384-4; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	26	301	312	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					481	485		10.1126/science.1217141	http://dx.doi.org/10.1126/science.1217141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22461501				2022-12-01	WOS:000303233400049
J	Xu, X; Wang, KB; Zhang, K; Ma, QY; Xing, LD; Sullivan, C; Hu, DY; Cheng, SQ; Wang, S				Xu, Xing; Wang, Kebai; Zhang, Ke; Ma, Qingyu; Xing, Lida; Sullivan, Corwin; Hu, Dongyu; Cheng, Shuqing; Wang, Shuo			A gigantic feathered dinosaur from the Lower Cretaceous of China	NATURE			English	Article							TYRANNOSAUROID DINOSAUR; NORTH-AMERICA; THEROPODA; AGE	Numerous feathered dinosaur specimens have recently been recovered from the Middle-Upper Jurassic and Lower Cretaceous deposits of northeastern China, but most of them represent small animals(1). Here we report the discovery of a gigantic new basal tyrannosauroid, Yutyrannus huali gen. et sp. nov., based on three nearly complete skeletons representing two distinct ontogenetic stages from the Lower Cretaceous Yixian Formation of Liaoning Province, China. Y. huali shares some features, particularly of the cranium, with derived tyrannosauroids(2,3), but is similar to other basal tyrannosauroids(4-12) in possessing a three-fingered manus and a typical theropod pes. Morphometric analysis suggests that Y. huali differed from tyrannosaurids in its growth strategy(13,14). Most significantly, Y. huali bears long filamentous feathers, thus providing direct evidence for the presence of extensively feathered gigantic dinosaurs and offering new insights into early feather evolution.	[Xu, Xing; Ma, Qingyu; Sullivan, Corwin; Wang, Shuo] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Xu, Xing; Hu, Dongyu] Shenyang Normal Univ, Liaoning Paleontol Museum, Shenyang 110034, Peoples R China; [Wang, Kebai; Cheng, Shuqing] Zhucheng Dinosaur Museum, Zhucheng 262200, Shandong, Peoples R China; [Zhang, Ke] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Xing, Lida] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Wang, Shuo] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Shenyang Normal University; China University of Geosciences; University of Alberta; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, 142 Xiwai St, Beijing 100044, Peoples R China.	xingxu@vip.sina.com	Wang, Shuo/AAX-8516-2020	Wang, Shuo/0000-0002-4076-0202; Xing, Lida/0000-0003-3923-9206; Sullivan, Corwin/0000-0002-5488-6797	Zhucheng Municipal Government; Erlianhaote Municipal Government; National Natural Science Foundation of China; Special Funds For Major State Basic Research Projects of China	Zhucheng Municipal Government; Erlianhaote Municipal Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds For Major State Basic Research Projects of China	We thank L. Zhang for discussions, R. Li, H. Zang and X. Ding for illustrations, and H. Wang, L. Xiang and R. Cao for preparing the specimens. We thank the Zhucheng Municipal Government and Erlianhaote Municipal Government for support. This study was supported by grants from the National Natural Science Foundation of China and Special Funds For Major State Basic Research Projects of China.	Amiot R, 2011, P NATL ACAD SCI USA, V108, P5179, DOI 10.1073/pnas.1011369108; Averianov A.O., 2010, Trudy Zoologicheskogo Instituta, V314, P42; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Brochu CA., 2003, J VERT PALEONTOL, V22, P1, DOI [DOI 10.2307/3889334, 10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947]; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Currie Philip J., 2003, Ichnos, V10, P1, DOI 10.1080/10420940390235071; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; Deng T, 2011, SCIENCE, V333, P1285, DOI 10.1126/science.1206594; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021376; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Hutt S, 2001, CRETACEOUS RES, V22, P227, DOI 10.1006/cres.2001.0252; Ji Qiang, 2009, Dizhi Tongbao, V28, P1369; Li DQ, 2010, P ROY SOC B-BIOL SCI, V277, P183, DOI 10.1098/rspb.2009.0249; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Paul G. S., 2008, TYRANNOSAURUS REX TY, P354; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; Spicer RA, 2010, PALAEOGEOGR PALAEOCL, V295, P423, DOI 10.1016/j.palaeo.2010.02.025; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311	30	89	101	1	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					92	95		10.1038/nature10906	http://dx.doi.org/10.1038/nature10906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481363				2022-12-01	WOS:000302343400040
J	Farrar, J				Farrar, Jeremy			Shift expertise to where it matters	NATURE			English	Editorial Material									Oxford Univ Clin Res Unit, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam		Farrar, J (corresponding author), Oxford Univ Clin Res Unit, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.	jfarrar@oucru.org	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust [093724] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					534	535		10.1038/483534a	http://dx.doi.org/10.1038/483534a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915EF	22460881	Green Published, Bronze			2022-12-01	WOS:000302006100014
J	Wiener, R; Zhang, XB; Wang, T; Wolberger, C				Wiener, Reuven; Zhang, Xiangbin; Wang, Tao; Wolberger, Cynthia			The mechanism of OTUB1-mediated inhibition of ubiquitination	NATURE			English	Article							CONJUGATING ENZYME COMPLEX; STRUCTURAL BASIS; POLYUBIQUITIN CHAINS; CRYSTAL-STRUCTURE; RECOGNITION; SPECIFICITY; SYSTEM; MODEL	Histones are ubiquitinated in response toDNAdouble-strand breaks (DSB), promoting recruitment of repair proteins to chromatin(1). UBC13 (also known as UBE2N) is a ubiquitin-conjugating enzyme (E2) that heterodimerizes withUEV1A(2) (also knownasUBE2V1) and synthesizes K63-linked polyubiquitin (K63Ub) chains at DSB sites in concert with the ubiquitin ligase (E3), RNF168 (ref. 3). K63Ub synthesis is regulated in a non-canonicalmanner by the deubiquitinating enzyme, OTUB1 (OTU domain-containing ubiquitin aldehydebinding protein 1), which binds preferentially to the UBC13 similar to Ub thiolester(4). Residues amino-terminal to the OTU domain, which had been implicated in ubiquitin binding(4), are required for binding to UBC13 similar to Ub and inhibition of K63Ub synthesis(5). Here we describe structural and biochemical studies elucidating how OTUB1 inhibits UBC13 and other E2 enzymes. We unexpectedly find that OTUB1 binding to UBC13 Ub is allosterically regulated by free ubiquitin, which binds to a second site in OTUB1 and increases its affinity for UBC13 similar to Ub, while at the same time disrupting interactions with UEV1A in a manner that depends on the OTUB1 N terminus. Crystal structures of an OTUB1-UBC13 complex and of OTUB1 bound to ubiquitin aldehyde and a chemical UBC13 similar to Ub conjugate show that binding of free ubiquitin to OTUB1 triggers conformational changes in the OTU domain and formation of a ubiquitinbinding helix in the N terminus, thus promoting binding of the conjugated donor ubiquitin in UBC13 similar to Ub to OTUB1. The donor ubiquitin thus cannot interact with the E2 enzyme, which has been shown to be important for ubiquitin transfer(6,7). The N-terminal helix of OTUB1 is positioned to interfere with UEV1A binding to UBC13, as well as with attack on the thiolester by an acceptor ubiquitin, thereby inhibiting K63Ub synthesis. OTUB1 binding also occludes the RING E3 binding site on UBC13, thus providing a further component of inhibition. The general features of the inhibition mechanism explain how OTUB1 inhibits other E2 enzymes4 in a non-catalytic manner.	[Wiener, Reuven; Zhang, Xiangbin; Wang, Tao; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Wiener, Reuven; Zhang, Xiangbin; Wang, Tao; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu		Wolberger, Cynthia/0000-0001-8578-2969	US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]	US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Henderson for generating the human/worm OTUB1 clone and C. Berndsen, A. DiBello, A. Datta and M. Bianchet for discussions. GM/CA-CAT has been funded in whole or in part with funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berndsen CE, 2011, ANAL BIOCHEM, V418, P102, DOI 10.1016/j.ab.2011.06.034; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capodagli GC, 2011, J VIROL, V85, P3621, DOI 10.1128/JVI.02496-10; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605	30	159	166	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					618	U143		10.1038/nature10911	http://dx.doi.org/10.1038/nature10911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22367539	Green Accepted			2022-12-01	WOS:000302006100043
J	Cramer, PE; Cirrito, JR; Wesson, DW; Lee, CYD; Karlo, JC; Zinn, AE; Casali, BT; Restivo, JL; Goebel, WD; James, MJ; Brunden, KR; Wilson, DA; Landreth, GE				Cramer, Paige E.; Cirrito, John R.; Wesson, Daniel W.; Lee, C. Y. Daniel; Karlo, J. Colleen; Zinn, Adriana E.; Casali, Brad T.; Restivo, Jessica L.; Goebel, Whitney D.; James, Michael J.; Brunden, Kurt R.; Wilson, Donald A.; Landreth, Gary E.			ApoE-Directed Therapeutics Rapidly Clear beta-Amyloid and Reverse Deficits in AD Mouse Models	SCIENCE			English	Article							ALZHEIMERS-DISEASE; COMMON VARIANTS; DYSFUNCTION; BURDEN; MICE; METABOLISM; RECEPTORS; PATHOLOGY; MEMORY; CD2AP	Alzheimer's disease (AD) is associated with impaired clearance of beta-amyloid (A beta) from the brain, a process normally facilitated by apolipoprotein E (apoE). ApoE expression is transcriptionally induced through the action of the nuclear receptors peroxisome proliferator-activated receptor gamma and liver X receptors in coordination with retinoid X receptors (RXRs). Oral administration of the RXR agonist bexarotene to a mouse model of AD resulted in enhanced clearance of soluble A beta within hours in an apoE-dependent manner. A beta plaque area was reduced more than 50% within just 72 hours. Furthermore, bexarotene stimulated the rapid reversal of cognitive, social, and olfactory deficits and improved neural circuit function. Thus, RXR activation stimulates physiological A beta clearance mechanisms, resulting in the rapid reversal of a broad range of A beta-induced deficits.	[Cramer, Paige E.; Wesson, Daniel W.; Lee, C. Y. Daniel; Karlo, J. Colleen; Zinn, Adriana E.; Casali, Brad T.; Landreth, Gary E.] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA; [Cirrito, John R.; Restivo, Jessica L.; Goebel, Whitney D.] Washington Univ, Knight Alzheimers Dis Res Ctr, Hope Ctr Neurol Disorders, Dept Neurol,Sch Med, St Louis, MO 63110 USA; [Wesson, Daniel W.; Wilson, Donald A.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA; [Wesson, Daniel W.; Wilson, Donald A.] NYU, Sch Med, Orangeburg, NY 10962 USA; [James, Michael J.; Brunden, Kurt R.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	Case Western Reserve University; Washington University (WUSTL); Nathan Kline Institute for Psychiatric Research; New York University; University of Pennsylvania; Pennsylvania Medicine	Landreth, GE (corresponding author), Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA.	gel2@case.edu	Wesson, Daniel/AAJ-6719-2020	Wesson, Daniel/0000-0002-3192-3866; Wilson, Donald/0000-0001-8918-2151	Blanchette Hooker Rockefeller Foundation; Thome Foundation; Roby and Taft Funds for Alzheimer's Research; Painstone Foundation; American Health Assistance Foundation; Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust; National Institute on Aging (NIA) [AG030482-03S1]; National Institute on Deafness and Other Communication Disorders [DC003906, RO1-AG037693]; NIA [K01 AG029524, P50-AG005681]; Shmerler family; Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University; Marian S. Ware Alzheimer Program; NATIONAL INSTITUTE ON AGING [K01AG029524, R01AG030482, P50AG005681, R01AG037693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003906] Funding Source: NIH RePORTER	Blanchette Hooker Rockefeller Foundation; Thome Foundation; Roby and Taft Funds for Alzheimer's Research; Painstone Foundation; American Health Assistance Foundation(BrightFocus Foundation); Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Shmerler family; Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University; Marian S. Ware Alzheimer Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Dr. Mangelsdorf for discussions and M. Pendergast, G. Casadesus, and I. Nagle for technical assistance. This work was supported by the Blanchette Hooker Rockefeller Foundation, Thome Foundation, Roby and Taft Funds for Alzheimer's Research, Painstone Foundation, American Health Assistance Foundation, Cure Alzheimer's Fund, Coins for Alzheimer's Research Trust, and the National Institute on Aging (NIA) (grant AG030482-03S1 to G. E. L.); National Institute on Deafness and Other Communication Disorders (grant DC003906, RO1-AG037693 to D. A. W); NIA (grants K01 AG029524 and P50-AG005681), Shmerler family, and the Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University (to J.R.C.); and Marian S. Ware Alzheimer Program (to K. R. B.). All raw data are archived on \\gel-server1 for authorized users. P. E. C. and G. E. L. hold U.S. Provisional Patent Application no. 61/224,709 regarding bexarotene as a potential therapeutic for Alzheimer's disease and are founding scientists of ReXceptor, Inc., which has licensing options from Case Western Reserve University on the use of bexarotene in the treatment of Alzheimer's disease.	Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Farol Len T, 2004, Expert Rev Anticancer Ther, V4, P180, DOI 10.1586/14737140.4.2.180; Fukumoto H, 2010, J NEUROSCI, V30, P11157, DOI 10.1523/JNEUROSCI.2884-10.2010; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Mandrekar-Colucci S, 2011, EXPERT OPIN THER TAR, V15, P1085, DOI 10.1517/14728222.2011.594043; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Murphy C, 1999, PHYSIOL BEHAV, V66, P177, DOI 10.1016/S0031-9384(98)00262-5; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Roses Allen D., 1994, Current Opinion in Biotechnology, V5, P663, DOI 10.1016/0958-1669(94)90091-4; Wesson DW, 2011, J NEUROSCI, V31, P15962, DOI 10.1523/JNEUROSCI.2085-11.2011; Wesson DW, 2011, BEHAV BRAIN RES, V216, P408, DOI 10.1016/j.bbr.2010.08.033; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010	24	792	853	8	296	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2012	335	6075					1503	1506		10.1126/science.1217697	http://dx.doi.org/10.1126/science.1217697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22323736	Green Accepted			2022-12-01	WOS:000301837000051
J	Delamothe, T				Delamothe, Tony			SPOTLIGHT: CLIMATE CHANGE The world on tilt	BRITISH MEDICAL JOURNAL			English	Article												tdelamothe@bmj.com							0	0	0	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 21	2012	344								e2207	10.1136/bmj.e2207	http://dx.doi.org/10.1136/bmj.e2207			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	913CO	22438387				2022-12-01	WOS:000301849200031
J	Wilmshurst, P				Wilmshurst, Peter			PERSONAL VIEW CLOSURE 1 seen through the MIST	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Shrewsbury Hosp, Shrewsbury, Shrops, England		Wilmshurst, P (corresponding author), Royal Shrewsbury Hosp, Shrewsbury, Shrops, England.	peter.wilmshurst@tiscali.co.uk							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 21	2012	344								e2226	10.1136/bmj.e2226	http://dx.doi.org/10.1136/bmj.e2226			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	913CO	22438388				2022-12-01	WOS:000301849200032
J	Fu, M; Yu, XZ; Lu, J; Zuo, Y				Fu, Min; Yu, Xinzhu; Lu, Ju; Zuo, Yi			Repetitive motor learning induces coordinated formation of clustered dendritic spines in vivo	NATURE			English	Article							STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; CORTEX; MEMORY; CIRCUITS; STABILITY; MICE; LTP	Many lines of evidence suggest that memory in the mammalian brain is stored with distinct spatiotemporal patterns(1,2). Despite recent progresses in identifying neuronal populations involved in memory coding(3-5), the synapse-level mechanism is still poorly understood. Computational models and electrophysiological data have shown that functional clustering of synapses along dendritic branches leads to nonlinear summation of synaptic inputs and greatly expands the computing power of a neural network(6-10). However, whether neighbouring synapses are involved in encoding similar memory and how task-specific cortical networks develop during learning remain elusive. Using transcranial two-photon microscopy(11), we followed apical dendrites of layer 5 pyramidal neurons in the motor cortex while mice practised novel forelimb skills. Here we show that a third of new dendritic spines (postsynaptic structures of most excitatory synapses) formed during the acquisition phase of learning emerge in clusters, and that most such clusters are neighbouring spine pairs. These clustered new spines are more likely to persist throughout prolonged learning sessions, and even long after training stops, than non-clustered counterparts. Moreover, formation of new spine clusters requires repetition of the same motor task, and the emergence of succedent new spine(s) accompanies the strengthening of the first new spine in the cluster. We also show that under control conditions new spines appear to avoid existing stable spines, rather than being uniformly added along dendrites. However, succedent new spines in clusters overcome such a spatial constraint and form in close vicinity to neighbouring stable spines. Our findings suggest that clustering of new synapses along dendrites is induced by repetitive activation of the cortical circuitry during learning, providing a structural basis for spatial coding of motor memory in the mammalian brain.	[Fu, Min; Yu, Xinzhu; Zuo, Yi] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Lu, Ju] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Lu, Ju] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; Stanford University; Stanford University	Zuo, Y (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	yizuo@ucsc.edu		Zuo, Yi/0000-0001-9020-0003	DANA Foundation; National Institutes of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094449, R56MH094449] Funding Source: NIH RePORTER	DANA Foundation; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. States, D. Garcia, L. Hinck, T. Jones, S. Song, W. Thompson and G. Wang for comments on this manuscript. We thank A. Perlik and T. Xu for technical support. This work was supported by grants from the DANA Foundation and the National Institutes of Mental Health to Y.Z.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Chen JL, 2010, CURR OPIN NEUROBIOL, V20, P557, DOI 10.1016/j.conb.2010.06.002; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2002, NAT NEUROSCI, V5, P297, DOI 10.1038/nn830; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Harms KJ, 2007, BRAIN RES, V1184, P65, DOI 10.1016/j.brainres.2006.02.094; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	32	283	288	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					92	U135		10.1038/nature10844	http://dx.doi.org/10.1038/nature10844			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22343892	Green Submitted, Green Accepted			2022-12-01	WOS:000300877900051
J	Garg, AX; Meirambayeva, A; Huang, AJ; Kim, J; Prasad, GVR; Knoll, G; Boudville, N; Lok, C; McFarlane, P; Karpinski, M; Storsley, L; Klarenbach, S; Lam, N; Thomas, SM; Dipchand, C; Reese, P; Doshi, M; Gibney, E; Taub, K; Young, A				Garg, Amit X.; Meirambayeva, Aizhan; Huang, Anjie; Kim, Joseph; Prasad, G. V. Ramesh; Knoll, Greg; Boudville, Neil; Lok, Charmaine; McFarlane, Philip; Karpinski, Martin; Storsley, Leroy; Klarenbach, Scott; Lam, Ngan; Thomas, Sonia M.; Dipchand, Christine; Reese, Peter; Doshi, Mona; Gibney, Eric; Taub, Ken; Young, Ann		Donor Nephrectomy Outcomes Res DON	Cardiovascular disease in kidney donors: matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLOMERULAR-FILTRATION; ELDERLY-PATIENTS; MORTALITY; OUTCOMES; METAANALYSIS; HYPERTENSION; PUBLICATION; NEPHRECTOMY; PREVALENCE; ONTARIO	Objective To determine whether people who donate a kidney have an increased risk of cardiovascular disease. Design Retrospective population based matched cohort study. Participants All people who were carefully selected to become a living kidney donor in the province of Ontario, Canada, between 1992 and 2009. The information in donor charts was manually reviewed and linked to provincial healthcare databases. Matched non-donors were selected from the healthiest segment of the general population. A total of 2028 donors and 20 280 matched non-donors were followed for a median of 6.5 years (maximum 17.7 years). Median age was 43 at the time of donation (interquartile range 34-50) and 50 at the time of follow-up (42-58). Main outcome measures The primary outcome was a composite of time to death or first major cardiovascular event. The secondary outcome was time to first major cardiovascular event censored for death. Results The risk of the primary outcome of death and major cardiovascular events was lower in donors than in non-donors (2.8 v 4.1 events per 1000 person years; hazard ratio 0.66, 95% confidence interval 0.48 to 0.90). The risk of major cardiovascular events censored for death was no different in donors than in non-donors (1.7 v 2.0 events per 1000 person years; 0.85, 0.57 to 1.27). Results were similar in all sensitivity analyses. Older age and lower income were associated with a higher risk of death and major cardiovascular events in both donors and non-donors when each group was analysed separately. Conclusions The risk of major cardiovascular events in donors is no higher in the first decade after kidney donation compared with a similarly healthy segment of the general population. While we will continue to follow people in this study, these interim results add to the evidence base supporting the safety of the practice among carefully selected donors.	[Garg, Amit X.; Meirambayeva, Aizhan; Lam, Ngan; Thomas, Sonia M.] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada; [Garg, Amit X.; Meirambayeva, Aizhan; Lam, Ngan] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Garg, Amit X.; Huang, Anjie; Kim, Joseph] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kim, Joseph; Prasad, G. V. Ramesh; Lok, Charmaine; McFarlane, Philip] Univ Toronto, Div Nephrol, Toronto, ON, Canada; [Knoll, Greg] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Boudville, Neil] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Karpinski, Martin; Storsley, Leroy] Univ Manitoba, Nephrol Sect, Winnipeg, MB, Canada; [Klarenbach, Scott] Univ Alberta, Div Nephrol, Edmonton, AB, Canada; [Dipchand, Christine] Dalhousie Univ, Div Nephrol, Halifax, NS, Canada; [Reese, Peter] Univ Penn, Div Renal, Philadelphia, PA 19104 USA; [Doshi, Mona] Wayne State Univ, Div Nephrol, Detroit, MI USA; [Gibney, Eric] Piedmont Transplant Inst, Atlanta, GA USA; [Taub, Ken] Univ Calgary, Div Nephrol, Calgary, AB, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Ottawa; University of Western Australia; University of Manitoba; University of Alberta; Dalhousie University; University of Pennsylvania; Wayne State University; University of Calgary	Garg, AX (corresponding author), London Hlth Sci Ctr, London Kidney Clin Res Unit, Room ELL-101,800 Commissioners Rd E, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Boudville, Neil/H-8864-2014; Garg, Amit X/G-3295-2011; Muirhead, Norman/G-3337-2011; Klarenbach, Scott/E-7731-2013; Lam, Ngan/AAX-3472-2020	Klarenbach, Scott/0000-0002-8611-1056; Lam, Ngan/0000-0002-0129-7091; Boudville, Neil/0000-0002-5884-640X; Lok, Charmaine/0000-0001-5365-0064; Knoll, Greg/0000-0001-5442-9310; Thomas, Sonia M./0000-0002-4930-2275	Ontario Ministry of Health and Long-Term Care (MOHLTC); Canadian Institutes of Health Research; University of Ottawa Chair in Clinical Transplantation Research; Alberta Heritage Foundation for Medical Research/Alberta Innovates Health Solutions; Alberta Health and Wellness; University of Alberta	Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Ottawa Chair in Clinical Transplantation Research; Alberta Heritage Foundation for Medical Research/Alberta Innovates Health Solutions(Alberta Heritage Foundation for Medical Research); Alberta Health and Wellness; University of Alberta(University of Alberta)	This project was conducted at the Institute for Clinical Evaluative Sciences (ICES). ICES is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). AXG was supported by a Canadian Institutes of Health Research Clinician-Scientist Award. GK was supported by a University of Ottawa Chair in Clinical Transplantation Research. SK was supported by the Alberta Heritage Foundation for Medical Research/Alberta Innovates Health Solutions, a joint initiative between Alberta Health and Wellness and the University of Alberta. The opinions, results and conclusions reported in this paper are those of the authors and are independent of the funding sources. The funding sources did not influence any aspect of this study.	Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Austin PC, 2003, JAMA-J AM MED ASSOC, V289, P3241, DOI 10.1001/jama.289.24.3241; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; Delmonico FL, 2005, TRANSPLANTATION, V79, pS53; FehrmanEkholm I, 1997, TRANSPLANTATION, V64, P976, DOI 10.1097/00007890-199710150-00007; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; Garg AX, 2008, TRANSPLANTATION, V86, P399, DOI 10.1097/TP.0b013e31817ba9e3; Haynes R, 2009, NAT CLIN PRACT NEPHR, V5, P126, DOI 10.1038/ncpneph1035; Horvat LD, 2009, KIDNEY INT, V75, P1088, DOI 10.1038/ki.2009.20; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Ibrahim HN, 2006, AM J TRANSPLANT, V6, P1479, DOI 10.1111/j.1600-6143.2006.01335.x; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Lin J, 2010, NEW ENGL J MED, V363, P797, DOI 10.1056/NEJMc1002100; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mjoen G, 2012, NEPHROL DIAL TRANSPL, V27, P443, DOI 10.1093/ndt/gfr303; Okamoto M, 2009, TRANSPLANTATION, V87, P419, DOI 10.1097/TP.0b013e318192dc95; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Statistics Canada, 2011, POP GROUPS 28 SEX 3; Statistics Canada, 2010, POP SEX AG GROUP PRO; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Tan L, 2011, J UROLOGY, V185, P1820, DOI 10.1016/j.juro.2010.12.036; Tomic A, 2010, INT SURG, V95, P343; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Young A, 2008, AM J TRANSPLANT, V8, P1878, DOI 10.1111/j.1600-6143.2008.02339.x; Young A, 2007, NEPHRON CLIN PRACT, V107, pC82, DOI 10.1159/000108648	30	135	136	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2012	344								e1203	10.1136/bmj.e1203	http://dx.doi.org/10.1136/bmj.e1203			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XJ	22381674	hybrid, Green Published			2022-12-01	WOS:000301231900002
J	Blum, ES; Abraham, MC; Yoshimura, S; Lu, Y; Shaham, S				Blum, Elyse S.; Abraham, Mary C.; Yoshimura, Satoshi; Lu, Yun; Shaham, Shai			Control of Nonapoptotic Developmental Cell Death in Caenorhabditis elegans by a Polyglutamine-Repeat Protein	SCIENCE			English	Article							C-ELEGANS; GENE; CASPASES; SURVIVAL; NEURONS	Death is a vital developmental cell fate. In Caenorhabditis elegans, programmed death of the linker cell, which leads gonadal elongation, proceeds independently of caspases and apoptotic effectors. To identify genes promoting linker-cell death, we performed a genome-wide RNA interference screen. We show that linker-cell death requires the gene pqn-41, encoding an endogenous polyglutamine-repeat protein. pqn-41 functions cell-autonomously and is expressed at the onset of linker-cell death. pqn-41 expression is controlled by the mitogen-activated protein kinase kinase SEK-1, which functions in parallel to the zinc-finger protein LIN-29 to promote cellular demise. Linker-cell death is morphologically similar to cell death associated with normal vertebrate development and polyglutamine-induced neurodegeneration. Our results may therefore provide molecular inroads to understanding nonapoptotic cell death in metazoan development and disease.	[Blum, Elyse S.; Abraham, Mary C.; Yoshimura, Satoshi; Lu, Yun; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, New York, NY 10065 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10065 USA.	shaham@rockefeller.edu			National Center for Research Resources; Rockefeller Women & Science Fellowship Program; NIH [CA09673, R01HD042680]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042680] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081490] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Rockefeller Women & Science Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Darnell and Shaham lab members for discussions; N. Tishbi for technical assistance; and D. Kim, C. Bargmann, M. Kinet, M. Kato, P. Sternberg, K. Nishiwaki, and K. Matsumoto for reagents. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, funded by the National Center for Research Resources. E.S.B. is supported in part by the Rockefeller Women & Science Fellowship Program and NIH training grant CA09673. S.S. is supported by NIH grant R01HD042680.	Abraham MC, 2007, DEV CELL, V12, P73, DOI 10.1016/j.devcel.2006.11.012; Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Borsello T, 2002, J COMP NEUROL, V453, P361, DOI 10.1002/cne.10411; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, DEVELOPMENT, V112, P591; Faber PW, 2002, P NATL ACAD SCI USA, V99, P17131, DOI 10.1073/pnas.262544899; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Johnson AD, 2001, DEVELOPMENT, V128, P2857; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; PILAR G, 1976, J CELL BIOL, V68, P339, DOI 10.1083/jcb.68.2.339; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tamai KK, 2007, DEV BIOL, V308, P562, DOI 10.1016/j.ydbio.2007.05.024	24	58	64	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					970	973		10.1126/science.1215156	http://dx.doi.org/10.1126/science.1215156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363008	Green Accepted			2022-12-01	WOS:000300931800047
J	Jin, LY; Pahuja, KB; Wickliffe, KE; Gorur, A; Baumgartel, C; Schekman, R; Rape, M				Jin, Lingyan; Pahuja, Kanika Bajaj; Wickliffe, Katherine E.; Gorur, Amita; Baumgaertel, Christine; Schekman, Randy; Rape, Michael			Ubiquitin-dependent regulation of COPII coat size and function	NATURE			English	Article							RETICULUM EXIT SITES; COLLAGEN SECRETION; MAMMALIAN-CELLS; LIGASE; CARGO; IDENTIFICATION; PROTEINS; ADAPTERS; ORGANIZATION; DEGRADATION	Packaging of proteins from the endoplasmic reticulum into COPII vesicles is essential for secretion. In cells, most COPII vesicles are approximately 60-80 nm in diameter, yet some must increase their size to accommodate 300-400 nm procollagen fibres or chylomicrons. Impaired COPII function results in collagen deposition defects, craniolenticulo-sutural dysplasia, or chylomicron retention disease, but mechanisms to enlarge COPII coats have remained elusive. Here, we identified the ubiquitin ligase CUL3-KLHL12 as a regulator of COPII coat formation. CUL3-KLHL12 catalyses the monoubiquitylation of the COPII-component SEC31 and drives the assembly of large COPII coats. As a result, ubiquitylation by CUL3-KLHL12 is essential for collagen export, yet less important for the transport of small cargo. We conclude that monoubiquitylation controls the size and function of a vesicle coat.	[Jin, Lingyan; Pahuja, Kanika Bajaj; Wickliffe, Katherine E.; Gorur, Amita; Baumgaertel, Christine; Schekman, Randy; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Pahuja, Kanika Bajaj; Gorur, Amita; Schekman, Randy] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Rape, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mrape@berkeley.edu		Rape, Michael/0000-0003-4849-6343; Bajaj Pahuja, Kanika/0000-0001-8977-9812	Pew Foundation; NIH (NIGMS); Howard Hughes Medical Institute; CIRM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083064] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003088] Funding Source: NIH RePORTER	Pew Foundation; NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); CIRM(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Schulman for advice and gifts of cDNAs and proteins. We are grateful to J. Schaletzky for critically reading the manuscript and many discussions. We thank the members of the Rape and Schekman labs for advice and suggestions, L. Lim for providing Cul3-shRNAs, C. Glazier for contributions on BTB protein cloning, and A. Fischer and M. Richner for tissue culture support. This work was funded by grants from the Pew Foundation (M. R.), the NIH (NIGMS-RO1, M. R.; NIH Director's New Innovator Award, M. R.), and the Howard Hughes Medical Institute (R. S.). L. J. was funded by a CIRM predoctoral fellowship; she is a Tang fellow. K. B. P. is an HFSP long term post-doctoral fellow.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chen SS, 2007, STEM CELLS, V25, P553, DOI 10.1634/stemcells.2006-0419; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Hughes H, 2009, J CELL SCI, V122, P2924, DOI 10.1242/jcs.044032; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Myocardial Infarction Genetics Consortium, 2009, NAT GENET, V41, P762; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Saito K, 2011, MOL BIOL CELL, V22, P2301, DOI 10.1091/mbc.E11-02-0143; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stephens DJ, 2002, J CELL SCI, V115, P1149; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Uchida K, 2005, IMMUNOLOGY, V116, P53, DOI 10.1111/j.1365-2567.2005.02197.x; Wickstrom SA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005116; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	41	224	235	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					495	U213		10.1038/nature10822	http://dx.doi.org/10.1038/nature10822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22358839	Green Accepted, Green Submitted			2022-12-01	WOS:000300770500044
J	Morice, P; Uzan, C; Uzan, S				Morice, Philippe; Uzan, Catherine; Uzan, Serge			Cancer in pregnancy: a challenging conflict of interest	LANCET			English	Editorial Material							GUIDELINES; FERTILITY; MANAGEMENT		[Morice, Philippe; Uzan, Catherine] Inst Gustave Roussy, Dept Gynaecol Surg, F-94805 Villejuif, France; [Morice, Philippe; Uzan, Catherine] Inst Gustave Roussy, Unit INSERM U 10 30, F-94805 Villejuif, France; [Morice, Philippe] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; [Uzan, Serge] Hop Tenon, Assistance Publ Hop Paris, Paris, France; [Uzan, Serge] Univ Paris 06, Paris, France; [Uzan, Serge] Int Acad Perinatal Med, Barcelona, Spain	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Morice, P (corresponding author), Inst Gustave Roussy, Dept Gynaecol Surg, Rue Camille Desmoulins, F-94805 Villejuif, France.	philippe.morice@igr.fr	Morice, Philippe/ABC-3179-2021	Morice, Philippe/0000-0003-0579-9993				Amant F, 2012, LANCET, V379, P570, DOI 10.1016/S0140-6736(11)61092-1; Amant F, 2010, EUR J CANCER, V46, P3158, DOI 10.1016/j.ejca.2010.09.010; Amant F, 2009, INT J GYNECOL CANCER, V19, pS1, DOI 10.1111/IGC.0b013e3181a1d0ec; Brenner B, 2012, LANCET, V379, P580, DOI 10.1016/S0140-6736(11)61348-2; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Letourneau JM, 2011, NAT REV CLIN ONCOL, V8, P56, DOI 10.1038/nrclinonc.2010.133; Marret H, 2010, EUR J OBSTET GYN R B, V149, P18, DOI 10.1016/j.ejogrb.2009.12.001; Morice P, 2012, LANCET, V379, P558, DOI 10.1016/S0140-6736(11)60829-5; Morice P, 2009, INT J GYNECOL CANCER, V19, P1638, DOI 10.1111/IGC.0b013e3181a83017; Pentheroudakis G, 2006, EUR J CANCER, V42, P126, DOI 10.1016/j.ejca.2005.10.014; Pentheroudakis G, 2010, ANN ONCOL, V21, pv266, DOI 10.1093/annonc/mdq198; Stensheim H, 2009, J CLIN ONCOL, V27, P45, DOI 10.1200/JCO.2008.17.4110; Van Calsteren K, 2010, J CLIN ONCOL, V28, P683, DOI 10.1200/JCO.2009.23.2801; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81	14	31	34	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2012	379	9815					495	496		10.1016/S0140-6736(11)61814-X	http://dx.doi.org/10.1016/S0140-6736(11)61814-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	891AO	22325648				2022-12-01	WOS:000300188800004
J	Bonanomi, D; Chivatakarn, O; Bai, G; Abdesselem, H; Lettieri, K; Marquardt, T; Pierchala, BA; Pfaff, SL				Bonanomi, Dario; Chivatakarn, Onanong; Bai, Ge; Abdesselem, Houari; Lettieri, Karen; Marquardt, Till; Pierchala, Brian A.; Pfaff, Samuel L.			Ret Is a Multifunctional Coreceptor that Integrates Diffusible- and Contact-Axon Guidance Signals	CELL			English	Article							LIMB MOTOR AXONS; NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; TYROSINE KINASE; LIPID RAFTS; NEURAL DEVELOPMENT; NEURONAL SURVIVAL; GDNF FAMILY; RECEPTOR; LIGANDS	Growing axons encounter multiple guidance cues, but it is unclear how separate signals are resolved and integrated into coherent instructions for growth cone navigation. We report that glycosylphosphati-dylinositol (GPI)-anchored ephrin-As function as "reverse'' signaling receptors for motor axons when contacted by transmembrane EphAs present in the dorsal limb. Ephrin-A receptors are thought to depend on transmembrane coreceptors for transmitting signals intracellularly. We show that the receptor tyrosine kinase Ret is required for motor axon attraction mediated by ephrin-A reverse signaling. Ret also mediates GPI-anchored GFR alpha 1 signaling in response to GDNF, a diffusible chemoattractant in the limb, indicating that Ret is a multifunctional coreceptor for guidance molecules. Axons respond synergistically to coactivation by GDNF and EphA ligands, and these cooperative interactions are gated by GFR alpha 1 levels. Our studies uncover a hierarchical GPI-receptor signaling network that is constructed from combinatorial components and integrated through Ret using ligand coincidence detection.	[Bonanomi, Dario; Chivatakarn, Onanong; Bai, Ge; Lettieri, Karen; Pfaff, Samuel L.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Bonanomi, Dario; Chivatakarn, Onanong; Bai, Ge; Lettieri, Karen; Pfaff, Samuel L.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Abdesselem, Houari; Pierchala, Brian A.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Marquardt, Till] European Neurosci Inst Gottingen, Dev Neurobiol Lab, D-37077 Gottingen, Germany	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of Michigan System; University of Michigan	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	pfaff@salk.edu	Bai, Ge/K-2608-2014; Bonanomi, Dario/K-3450-2016	Bonanomi, Dario/0000-0003-4517-1244	HHMI; NINDS [NS054172, NS031249]; Salk pioneer fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031249, R01NS054172] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Salk pioneer fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Laura Franco for technical assistance; Christopher Hinckley for help with two-photon imaging; Shane Andrews for help with microscopy; Shawn Driscoll for help with data analysis; Arnon Rosenthal and Buffer Fennie for Gfra1 mice; Bennett Novitch for Olig2::Cre mice; Kuo-Fen Lee for p75 mice; Martin Goulding and Andrew Boyd for EphA4 mice; Frank Costantini for Ret mice; Tsung-Chang Sung, Zhijiang Chen, Kuo-Fen Lee, Yoo-shick Lim, and Dennis O'Leary for ephrin-A2/5 and p75 plasmids and helpful discussion. D.B. was supported by HHMI, O.C. by an NINDS fellowship, G.B. by HHMI and a Salk pioneer fellowship, and S.L.P. is an investigator with HHMI. This research was supported by NINDS grants NS054172 and NS031249 and HHMI.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bai G, 2011, CELL, V144, P106, DOI 10.1016/j.cell.2010.11.053; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Damon DH, 2010, AUTON NEUROSCI-BASIC, V158, P65, DOI 10.1016/j.autneu.2010.06.004; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Dudanova I, 2011, NEURON, V71, P1, DOI 10.1016/j.neuron.2011.06.030; Dudanova I, 2010, CURR BIOL, V20, P2150, DOI 10.1016/j.cub.2010.11.021; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Gould TW, 2008, J NEUROSCI, V28, P2131, DOI 10.1523/JNEUROSCI.5185-07.2008; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kao TJ, 2011, NEURON, V71, P76, DOI 10.1016/j.neuron.2011.05.031; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; Knoll B, 2001, DEVELOPMENT, V128, P895; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Kretz A, 2006, BRAIN RES, V1090, P1, DOI 10.1016/j.brainres.2006.01.131; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Luria V, 2008, NEURON, V60, P1039, DOI 10.1016/j.neuron.2008.11.011; Marler KJM, 2008, J NEUROSCI, V28, P12700, DOI 10.1523/JNEUROSCI.1915-08.2008; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pierchala BA, 2006, J NEUROSCI, V26, P2777, DOI 10.1523/JNEUROSCI.3420-05.2006; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022	47	93	93	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 3	2012	148	3					568	582		10.1016/j.cell.2012.01.024	http://dx.doi.org/10.1016/j.cell.2012.01.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304922	Bronze, Green Accepted			2022-12-01	WOS:000300225000023
J	Dixon, JR; Selvaraj, S; Yue, F; Kim, A; Li, Y; Shen, Y; Hu, M; Liu, JS; Ren, B				Dixon, Jesse R.; Selvaraj, Siddarth; Yue, Feng; Kim, Audrey; Li, Yan; Shen, Yin; Hu, Ming; Liu, Jun S.; Ren, Bing			Topological domains in mammalian genomes identified by analysis of chromatin interactions	NATURE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR LAMINA INTERACTIONS; GENE-EXPRESSION; ORGANIZATION; ARCHITECTURE; DROSOPHILA; PLURIPOTENT; PRINCIPLES; BOUNDARY; LOCUS	The spatial organization of the genome is intimately linked to its biological function, yet our understanding of higher order genomic structure is coarse, fragmented and incomplete. In the nucleus of eukaryotic cells, interphase chromosomes occupy distinct chromosome territories, and numerous models have been proposed for how chromosomes fold within chromosome territories(1). These models, however, provide only few mechanistic details about the relationship between higher order chromatin structure and genome function. Recent advances in genomic technologies have led to rapid advances in the study of three-dimensional genome organization. In particular, Hi-C has been introduced as a method for identifying higher order chromatin interactions genome wide(2). Here we investigate the three-dimensional organization of the human and mouse genomes in embryonic stem cells and terminally differentiated cell types at unprecedented resolution. We identify large, megabase-sized local chromatin interaction domains, which we term 'topological domains', as a pervasive structural feature of the genome organization. These domains correlate with regions of the genome that constrain the spread of heterochromatin. The domains are stable across different cell types and highly conserved across species, indicating that topological domains are an inherent property of mammalian genomes. Finally, we find that the boundaries of topological domains are enriched for the insulator binding protein CTCF, housekeeping genes, transfer RNAs and short interspersed element (SINE) retrotransposons, indicating that these factors may have a role in establishing the topological domain structure of the genome.	[Dixon, Jesse R.; Selvaraj, Siddarth; Yue, Feng; Kim, Audrey; Li, Yan; Shen, Yin; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Dixon, Jesse R.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Dixon, Jesse R.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Selvaraj, Siddarth] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Hu, Ming; Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, UCSD Moores Canc Ctr, Inst Genom Med,Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Dixon, Jesse/AAT-2914-2020	Dixon, Jesse/0000-0002-6273-2181; Hu, Ming/0000-0002-6062-8794	Ludwig Institute for Cancer Research; California Institute for Regenerative Medicine (CIRM) [RN2-00905-1]; NIH [B.R. R01GH003991]; Rett Syndrome Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003991] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rett Syndrome Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful for the comments from and discussions with Z. Qin, A. Desai and members of the Ren laboratory during the course of the study. We also thank W. Bickmore and R. Eskeland for sharing the FISH data generated in mouse ES cells. This work was supported by funding from the Ludwig Institute for Cancer Research, California Institute for Regenerative Medicine (CIRM, RN2-00905-1) (to B.R.) and NIH (B.R. R01GH003991). J.R.D. is funded by a pre-doctoral training grant from CIRM. Y.S. is supported by a postdoctoral fellowship from the Rett Syndrome Research Foundation.	Amouyal M, 2010, BIOCHEM CELL BIOL, V88, P875, DOI 10.1139/O10-110; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Ebersole T, 2011, CELL CYCLE, V10, P2779, DOI 10.4161/cc.10.16.17092; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim YJ, 2011, P NATL ACAD SCI USA, V108, P7391, DOI 10.1073/pnas.1018279108; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Scott KC, 1999, GENETICS, V153, P787; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947	29	3730	3821	24	480	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					376	380		10.1038/nature11082	http://dx.doi.org/10.1038/nature11082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22495300	Green Submitted, Green Accepted			2022-12-01	WOS:000304099100044
J	Remais, JV; Eisenberg, JNS				Remais, Justin V.; Eisenberg, Joseph N. S.			Balance between clinical and environmental responses to infectious diseases	LANCET			English	Editorial Material							NEGLECTED TROPICAL DISEASES; HEALTH; CHINA		[Remais, Justin V.] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Eisenberg, Joseph N. S.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Emory University; Rollins School Public Health; University of Michigan System; University of Michigan	Remais, JV (corresponding author), Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	justin.remais@emory.edu	Remais, Justin/V-3207-2019	Remais, Justin/0000-0002-0223-4615	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI091864, R01AI050038] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI050038, R01 AI050038, K01 AI091864, K01AI091864] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boone SA, 2007, APPL ENVIRON MICROB, V73, P1687, DOI 10.1128/AEM.02051-06; Chadwick E, 1843, REPORT SANITARY CO S; Charest S, 1969, Clin Proc Child Hosp Dist Columbia, V25, P308; Feingold BJ, 2010, ENVIRON HEALTH PERSP, V118, P1165, DOI 10.1289/ehp.0901866; Gould IM, 2006, LANCET, V368, P824, DOI 10.1016/S0140-6736(06)69303-3; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; HARE R, 1961, BRIT MED J, V2, P333, DOI 10.1136/bmj.2.5248.333; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Lerer LB, 1999, LANCET, V354, P1123, DOI 10.1016/S0140-6736(05)76917-8; Li T, 2010, TRENDS PARASITOL, V26, P264, DOI 10.1016/j.pt.2010.02.007; Mahmoud A, 2009, HEALTH AFFAIR, V28, P1726, DOI 10.1377/hlthaff.28.6.1726; Platt R, 2011, NEW ENGL J MED, V364, P1464, DOI 10.1056/NEJMe1014292; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Singer BH, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000104; Snow J., 1855, MODE COMMUNICATION C; Spear RC, 2006, SCIENCE, V314, P1081, DOI 10.1126/science.314.5802.1081c; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Stiles C, 1939, J PARASITOL, V25, P296; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; WOOLLEY PV, 1957, AMER J ROENTGENOL RA, V78, P547; Worrell C, 2011, APPL ENVIRON MICROB, V77, P2192, DOI 10.1128/AEM.01561-10	22	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1457	1459		10.1016/S0140-6736(11)61227-0	http://dx.doi.org/10.1016/S0140-6736(11)61227-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	926BR	22475491	Green Accepted			2022-12-01	WOS:000302806800034
J	Szent-Gyorgyi, LE; Desai, S; Kim, D; Sax, PE; Greenberg, JO				Szent-Gyorgyi, Lara E.; Desai, Sonali; Kim, Daniel; Sax, Paul E.; Greenberg, Jeffrey O.			Removing Legal Barriers to High-Quality Care for HIV-Infected Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Szent-Gyorgyi, Lara E.; Desai, Sonali; Greenberg, Jeffrey O.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sax, Paul E.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Desai, Sonali; Kim, Daniel; Sax, Paul E.; Greenberg, Jeffrey O.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Szent-Gyorgyi, LE (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.							LIFSON AR, 1992, CLIN INFECT DIS, V14, P966, DOI 10.1093/clinids/14.4.966-a; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; 2006, MMWR MORB MORTAL WKL, V55, P1	4	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1268	1270		10.1056/NEJMp1114446	http://dx.doi.org/10.1056/NEJMp1114446			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475590				2022-12-01	WOS:000302343000003
J	Kitsios, GD; Kent, DM				Kitsios, Georgios D.; Kent, David M.			Personalised medicine: not just in our genes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENOME-WIDE ASSOCIATION; PERCUTANEOUS CORONARY INTERVENTION; CLINICAL-TRIALS; INDIVIDUAL PATIENTS; RISK; PHARMACOGENOMICS; HETEROGENEITY; PREDICTION; BENEFIT		[Kent, David M.] Tufts Univ, Sackler Sch Grad Biomed Sci, Clin & Translat Sci Program, Boston, MA 02111 USA; [Kitsios, Georgios D.; Kent, David M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Kitsios, Georgios D.] Lahey Clin Med Ctr, Dept Gen Internal Med, Burlington, MA 01803 USA	Tufts University; Tufts Medical Center; Lahey Hospital & Medical Center	Kent, DM (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Clin & Translat Sci Program, Boston, MA 02111 USA.	dkent1@tuftsmedicalcenter.org		Kitsios, Georgios/0000-0002-1018-948X	NCRR NIH HHS [UL1 RR025752] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Aradi D, 2010, AM HEART J, V160, P543, DOI 10.1016/j.ahj.2010.06.004; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Becquement L, 2011, PHARMACOGENOMICS, V12, P113, DOI [10.2217/pgs.10.147, 10.2217/PGS.10.147]; Combescure C, 2010, J THROMB HAEMOST, V8, P923, DOI 10.1111/j.1538-7836.2010.03809.x; Dahabreh IJ, 2011, ANN INTERN MED, V154, P37, DOI 10.7326/0003-4819-154-1-201101040-00006; Flockhart DA, 2008, GENET MED, V10, P139, DOI 10.1097/GIM.0b013e318163c35f; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hayward RA, 2005, HEALTH AFFAIR, V24, P1571, DOI 10.1377/hlthaff.24.6.1571; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holmes DR, 2010, J AM COLL CARDIOL, V56, P321, DOI 10.1016/j.jacc.2010.05.013; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Holmes MV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007960; Imai K, 2011, CLIN CHEM, V57, P518, DOI 10.1373/clinchem.2010.158220; Institute for Clinical Systems Improvement, 2010, DIAGN TREATM CHEST P; Institute for Clinical Systems Improvement, 2011, ANT THER SUPPL GUID; Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392; Janssens A Cecile Jw, 2010, Investig Genet, V1, P10, DOI 10.1186/2041-2223-1-10; Kangelaris KN, 2009, J GEN INTERN MED, V24, P656, DOI 10.1007/s11606-009-0949-1; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kent DM, 2002, AM J MED, V113, P104, DOI 10.1016/S0002-9343(02)01160-9; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Medical Services Commission, 2011, WARF THER MAN INV PR; Nissen SE, 2011, JAMA-J AM MED ASSOC, V306, P2727, DOI 10.1001/jama.2011.1865; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P841, DOI 10.1160/TH09-06-0418; Swen JJ, 2007, PLOS MED, V4, P1317, DOI 10.1371/journal.pmed.0040209; US FDA, 2011, TABL PHARM BIOM DRUG; Veenstra DL, 2000, AAPS PHARMSCI, V2, part. no.	34	29	30	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e2161	10.1136/bmj.e2161	http://dx.doi.org/10.1136/bmj.e2161			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GM	22491484	Green Published			2022-12-01	WOS:000302607700012
J	Gardner, C				Gardner, Caleb			Where all the ladders start	LANCET			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Gardner, C (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	cgardn12@jhmi.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1190	1191		10.1016/S0140-6736(12)60500-5	http://dx.doi.org/10.1016/S0140-6736(12)60500-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	22470930	Bronze			2022-12-01	WOS:000302230400020
J	Karaca-Mandic, P; Jena, AB; Joyce, GF; Goldman, DP				Karaca-Mandic, Pinar; Jena, Anupam B.; Joyce, Geoffrey F.; Goldman, Dana P.			Out-of-Pocket Medication Costs and Use of Medications and Health Care Services Among Children With Asthma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INHALED CORTICOSTEROIDS; PHARMACY BENEFITS; INSURANCE; DRUGS; CAPS	Context Health plans have implemented policies to restrain prescription medication spending by shifting costs toward patients. It is unknown how these policies have affected children with chronic illness. Objective To analyze the association of medication cost sharing with medication and hospital services utilization among children with asthma, the most prevalent chronic disease of childhood. Design, Setting, and Patients Retrospective study of insurance claims for 8834 US children with asthma who initiated asthma control therapy between 1997 and 2007. Using variation in out-of-pocket costs for a fixed "basket" of asthma medications across 37 employers, we estimated multivariate models of asthma medication use, asthma-related hospitalization, and emergency department (ED) visits with respect to out-of-pocket costs and child and family characteristics. Main Outcome Measures Asthma medication use, asthma-related hospitalizations, and ED visits during 1-year follow-up. Results The mean annual out-of-pocket asthma medication cost was $154 (95% CI, $152-$156) among children aged 5 to 18 years and $151 (95% CI, $148-$153) among those younger than 5 years. Among 5913 children aged 5 to 18 years, filled asthma prescriptions covered a mean of 40.9% of days (95% CI, 40.2%-41.5%). During 1-year follow-up, 121 children (2.1%) had an asthma-related hospitalization and 220 (3.7%) had an ED visit. Among 2921 children younger than 5 years, mean medication use was 46.2% of days (95% CI, 45.2%-47.1%); 136 children (4.7%) had an asthma-related hospitalization and 231 (7.9%) had an ED visit. An increase in out-of-pocket medication costs from the 25th to the 75th percentile was associated with a reduction in adjusted medication use among children aged 5 to 18 years (41.7% [95% CI, 40.7%-42.7%] vs 40.3% [95% CI, 39.4%-41.3%] of days; P=.02) but no change among younger children. Adjusted rates of asthma-related hospitalization were higher for children aged 5 to 18 years in the top quartile of out-of-pocket costs (2.4 [95% CI, 1.9-2.8] hospitalizations per 100 children vs 1.7 [95% CI, 1.3-2.1] per 100 in bottom quartile; P=.004) but not for younger children. Annual adjusted rates of ED use did not vary across out-of-pocket quartiles for either age group. Conclusion Greater cost sharing for asthma medications was associated with a slight reduction in medication use and higher rates of asthma hospitalization among children aged 5 years or older. JAMA. 2012;307(12):1284-1291 www.jama.com	[Jena, Anupam B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Wang Ambulatory Care Ctr,Dept Med, Boston, MA 02114 USA; [Karaca-Mandic, Pinar] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA; [Joyce, Geoffrey F.; Goldman, Dana P.] Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Southern California	Jena, AB (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Wang Ambulatory Care Ctr,Dept Med, 15 Parkman St, Boston, MA 02114 USA.	jena.anupam@mgh.harvard.edu	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396	National Institute of Child Health and Human Development [1R03HD058203-01A1]; National Institute on Aging [7R01AG02514]; Roybal Center for Health Policy Simulation [5P30AG024968]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024968] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Roybal Center for Health Policy Simulation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by the National Institute of Child Health and Human Development (grant 1R03HD058203-01A1), the National Institute on Aging (grant 7R01AG02514), and the Roybal Center for Health Policy Simulation (grant 5P30AG024968).	Adams RJ, 2002, J ALLERGY CLIN IMMUN, V110, P58, DOI 10.1067/mai.2002.125489; Akinbami Lara, 2006, Adv Data, P1; [Anonymous], 2010, FED REGISTER, V75, P41726; Bethell CD, 2008, MATERN CHILD HLTH J, V12, P1, DOI 10.1007/s10995-007-0220-5; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Chandra A, 2010, AM ECON REV, V100, P193, DOI 10.1257/aer.100.1.193; Duan N., 1983, J EC BUSINESS STATIS, V1, P115, DOI [DOI 10.2307/1391852, 10.2307/1391852]; Erickson SR, 2001, ANN PHARMACOTHER, V35, P997, DOI 10.1345/aph.10379; Finkelstein JA, 2002, ARCH PEDIAT ADOL MED, V156, P562, DOI 10.1001/archpedi.156.6.562; Goldman DP, 2006, HEALTH AFFAIR, V25, P1319, DOI 10.1377/hlthaff.25.5.1319; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Goldman DP, 2006, AM J MANAG CARE, V12, P21; Halterman JS, 2000, PEDIATRICS, V105, P272; HENRY RL, 1995, J PAEDIATR CHILD H, V31, P95, DOI 10.1111/j.1440-1754.1995.tb00754.x; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Huskamp HA, 2005, ARCH GEN PSYCHIAT, V62, P435, DOI 10.1001/archpsyc.62.4.435; Johnson RE, 1997, MED CARE, V35, P1119, DOI 10.1097/00005650-199711000-00004; Johnson TJ, 2006, AM J PUBLIC HEALTH, V96, P709, DOI 10.2105/AJPH.2004.059758; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; Karaca-Mandic P, 2010, HEALTH SERV RES, V45, P1227, DOI 10.1111/j.1475-6773.2010.01117.x; Kogan MD, 2010, NEW ENGL J MED, V363, P841, DOI 10.1056/NEJMsa0909994; Kozyrskyj AL, 2003, PEDIATR PULM, V36, P241, DOI 10.1002/ppul.10335; Kozyrskyj AL, 2001, ARCH PEDIAT ADOL MED, V155, P1219; LEIBOWITZ A, 1985, PEDIATRICS, V75, P942; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Newacheck PW, 1998, NEW ENGL J MED, V338, P513, DOI 10.1056/NEJM199802193380806; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tseng CW, 2004, JAMA-J AM MED ASSOC, V292, P952, DOI 10.1001/jama.292.8.952; Ungar WJ, 2008, ARCH PEDIAT ADOL MED, V162, P104, DOI 10.1001/archpediatrics.2007.21; Ungar WJ, 2011, ANN ALLERG ASTHMA IM, V106, P17, DOI 10.1016/j.anai.2010.10.006; US Census Bureau, 2010, CURR POP SURV ANN SO	32	80	80	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2012	307	12					1284	1291		10.1001/jama.2012.340	http://dx.doi.org/10.1001/jama.2012.340			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	914UP	22453569	Green Accepted, Bronze			2022-12-01	WOS:000301978400024
J	Schaller, T; Goujon, C; Malim, MH				Schaller, Torsten; Goujon, Caroline; Malim, Michael H.			HIV Interplay with SAMHD1	SCIENCE			English	Editorial Material							RESTRICTION FACTOR SAMHD1; IMMUNODEFICIENCY-VIRUS TYPE-1; DENDRITIC CELLS; VPX; PROTEIN; INFECTION		[Schaller, Torsten; Goujon, Caroline; Malim, Michael H.] Kings Coll London, Guys Hosp, Sch Med, Dept Infect Dis, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Schaller, T (corresponding author), Kings Coll London, Guys Hosp, Sch Med, Dept Infect Dis, London SE1 9RT, England.	michael.malim@kcl.ac.uk	Goujon, Caroline/AAX-8172-2021; Schaller, Torsten/ABC-9153-2020; Goujon, Caroline/B-3914-2014	Goujon, Caroline/0000-0001-8571-1108; Schaller, Torsten/0000-0001-9597-4112; Goujon, Caroline/0000-0002-7682-5725; Malim, Michael/0000-0002-7699-2064	Medical Research Council [G1001081, G0401570, G1000196] Funding Source: Medline; MRC [G0401570, G1000196, G1001081] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Genovesio A, 2011, J BIOMOL SCREEN, V16, P945, DOI 10.1177/1087057111415521; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Malim M. H., 2012, HIV BIOL PREVENTION, P119; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941	13	16	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2012	335	6074					1313	1314		10.1126/science.1221057	http://dx.doi.org/10.1126/science.1221057			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22422971				2022-12-01	WOS:000301531600035
J	Wende, H; Lechner, SG; Cheret, C; Bourane, S; Kolanczyk, ME; Pattyn, A; Reuter, K; Munier, FL; Carroll, P; Lewin, GR; Birchmeier, C				Wende, Hagen; Lechner, Stefan G.; Cheret, Cyril; Bourane, Steeve; Kolanczyk, Maria E.; Pattyn, Alexandre; Reuter, Katja; Munier, Francis L.; Carroll, Patrick; Lewin, Gary R.; Birchmeier, Carmen			The Transcription Factor c-Maf Controls Touch Receptor Development and Function	SCIENCE			English	Article							SENSORY NEURONS; MECHANORECEPTIVE AFFERENTS; CATARACT; RET; MUTATION; HAND; ORIENTATION; DEPENDENCE; SUBTYPES; DOMAIN	The sense of touch relies on detection of mechanical stimuli by specialized mechanosensory neurons. The scarcity of molecular data has made it difficult to analyze development of mechanoreceptors and to define the basis of their diversity and function. We show that the transcription factor c-Maf/c-MAF is crucial for mechanosensory function in mice and humans. The development and function of several rapidly adapting mechanoreceptor types are disrupted in c-Maf mutant mice. In particular, Pacinian corpuscles, a type of mechanoreceptor specialized to detect high-frequency vibrations, are severely atrophied. In line with this, sensitivity to high-frequency vibration is reduced in humans carrying a dominant mutation in the c-MAF gene. Thus, our work identifies a key transcription factor specifying development and function of mechanoreceptors and their end organs.	[Wende, Hagen; Lechner, Stefan G.; Cheret, Cyril; Kolanczyk, Maria E.; Reuter, Katja; Lewin, Gary R.; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bourane, Steeve] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Pattyn, Alexandre; Carroll, Patrick] INSERM, U1051, F-34091 Montpellier 05, France; [Munier, Francis L.] Jules Gonin Eye Hosp, CH-1004 Lausanne, Switzerland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Salk Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Birchmeier, C (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	cbirch@mdc-berlin.de	Alexandre, Pattyn/ABF-1346-2020; Reuter, Katja/AFM-3640-2022; Carroll, Patrick/C-2933-2012; Bourane, Steeve/AAI-6143-2020; Carroll, Patrick/AAL-7773-2021; Lewin, Gary R/B-8028-2011	Reuter, Katja/0000-0002-1559-9058; Carroll, Patrick/0000-0003-3287-8195; Bourane, Steeve/0000-0002-9805-2196; Lechner, Stefan/0000-0001-9402-9127; Wende, Hagen/0000-0002-9168-8095; Pattyn, Alexandre/0000-0003-1215-1482; Sheean, Maria Elzbieta/0000-0003-3055-0495; Cheret, Cyril/0000-0001-7382-0403; Lewin, Gary/0000-0002-2890-6352	 [SFB 665]		We are grateful to I. Schiffner, M. Terne, S. Buchert, C. Paseler, P. Stallerow, and the MDC transgenic and microarray units for technical support and animal husbandry and R. Schmidt-Ullrich, R. Hodge, A. Garratt, and W. Birchmeier (MDC, Berlin) for advice during analysis of hair types and critical reading of the manuscript. This work was funded by grants to C. B. and G. R. L. (SFB 665, NeuroCure). The authors declare no conflicts of interest.	Bensmaia SJ, 2008, J NEUROSCI, V28, P776, DOI 10.1523/JNEUROSCI.4162-07.2008; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Hansen L, 2009, INVEST OPHTH VIS SCI, V50, P3291, DOI 10.1167/iovs.08-3149; Heidenreich M, 2012, NAT NEUROSCI, V15, P138, DOI 10.1038/nn.2985; Honma Y, 2010, DEVELOPMENT, V137, P2319, DOI 10.1242/dev.046995; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V297, P405, DOI 10.1113/jphysiol.1979.sp013048; Johnson KO, 2000, J CLIN NEUROPHYSIOL, V17, P539, DOI 10.1097/00004691-200011000-00002; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Lecoin L, 2010, DEV NEUROBIOL, V70, P485, DOI 10.1002/dneu.20790; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Liu Y, 2011, CURR OPIN NEUROBIOL, V21, P52, DOI 10.1016/j.conb.2010.09.003; LOEWENSTEIN WR, 1965, J PHYSIOL-LONDON, V177, P377, DOI 10.1113/jphysiol.1965.sp007598; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Ma QF, 2009, NEURON, V64, P773, DOI 10.1016/j.neuron.2009.12.014; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; Rajaram N, 2004, MOL CELL BIOL, V24, P5694, DOI 10.1128/MCB.24.13.5694-5709.2004; Ring BZ, 2000, DEVELOPMENT, V127, P307; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Vanita V, 2006, AM J MED GENET A, V140A, P558, DOI 10.1002/ajmg.a.31126; Zelena J, 1976, Prog Brain Res, V43, P59	30	98	102	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2012	335	6074					1373	1376		10.1126/science.1214314	http://dx.doi.org/10.1126/science.1214314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908ZM	22345400				2022-12-01	WOS:000301531600054
J	Coric, I; List, B				Coric, Ilija; List, Benjamin			Asymmetric spiroacetalization catalysed by confined Bronsted acids	NATURE			English	Article							TRANSITION-METAL CATALYSIS; DACUS-OLEAE; SPIROKETALS; TRANSACETALIZATION; PHOSPHORAMIDE; DERIVATIVES; PHEROMONE; ALDEHYDES; DESIGN	Acetals are molecular substructures that contain two oxygencarbon single bonds at the same carbon atom, and are used in cells to construct carbohydrates and numerous other molecules. A distinctive subgroup are spiroacetals, acetals joining two rings, which occur in a broad range of biologically active compounds, including small insect pheromones and more complex macrocycles(1,2). Despite numerous methods for the catalytic asymmetric formation of other commonly occurring stereocentres, there are few approaches that exclusively target the chiral acetal centre and none for spiroacetals(3,4). Here we report the design and synthesis of confined Bronsted acids based on a C-2-symmetric imidodiphosphoric acid motif, enabling a catalytic enantioselective spiroacetalization reaction. These rationally constructed Bronsted acids possess an extremely sterically demanding chiral microenvironment, with a single catalytically relevant and geometrically constrained bifunctional active site. Our catalyst design is expected to be of broad utility in catalytic asymmetric reactions involving small and structurally or functionally unbiased substrates.	[Coric, Ilija; List, Benjamin] Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany	Max Planck Society	List, B (corresponding author), Max Planck Inst Kohlenforsch, Kaiser Wilhelm Pl 1, D-45470 Mulheim, Germany.	list@kofo.mpg.de	Coric, Ilija/AFP-1494-2022; List, Benjamin/A-2121-2014	Coric, Ilija/0000-0002-0435-1313; 	Max Planck Sociey; European Research Council	Max Planck Sociey(Max Planck Society); European Research Council(European Research Council (ERC)European Commission)	We thank A. Dreier and R. Goddard for crystal structure analysis of catalyst 6a. S. Vellalath and S. Muller are acknowledged for donating several previously described catalysts, and N. Wippich and S. Dehn for technical assistance. We gratefully acknowledge support from the Max Planck Sociey and the European Research Council.	Aho JE, 2005, CHEM REV, V105, P4406, DOI 10.1021/cr050559n; Akiyama T, 2004, ANGEW CHEM INT EDIT, V43, P1566, DOI 10.1002/anie.200353240; Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; Audrain H, 2000, J ORG CHEM, V65, P4487, DOI 10.1021/jo9918596; Brasholz M, 2007, EUR J ORG CHEM, V2007, P3801, DOI 10.1002/ejoc.200601054; Coric I, 2010, J AM CHEM SOC, V132, P17370, DOI 10.1021/ja108642s; Coric I, 2010, J AM CHEM SOC, V132, P8536, DOI 10.1021/ja102753d; Doyle AG, 2007, CHEM REV, V107, P5713, DOI 10.1021/cr068373r; Hamilton GL, 2007, SCIENCE, V317, P496, DOI 10.1126/science.1145229; HANIOTAKIS G, 1986, J CHEM ECOL, V12, P1559, DOI 10.1007/BF01012372; Hastings CJ, 2010, J AM CHEM SOC, V132, P6938, DOI 10.1021/ja102633e; Huang Y, 2003, NATURE, V424, P146, DOI 10.1038/424146a; Klussmann M, 2010, SYNLETT, P2189, DOI 10.1055/s-0030-1258505; Mayer S, 2006, ANGEW CHEM INT EDIT, V45, P4193, DOI 10.1002/anie.200600512; Moilanen SB, 2006, J AM CHEM SOC, V128, P1792, DOI 10.1021/ja057908f; Mukherjee S, 2007, J AM CHEM SOC, V129, P11336, DOI 10.1021/ja074678r; Nagano H, 2002, CHEM LETT, P782, DOI 10.1246/cl.2002.782; Nakashima D, 2006, J AM CHEM SOC, V128, P9626, DOI 10.1021/ja062508t; PERRON F, 1989, CHEM REV, V89, P1617, DOI 10.1021/cr00097a015; REDLICH H, 1984, ANGEW CHEM INT EDIT, V23, P519, DOI 10.1002/anie.198405191; Shapiro ND, 2011, NATURE, V470, P245, DOI 10.1038/nature09723; Shenoy SR, 2008, J AM CHEM SOC, V130, P5658, DOI 10.1021/ja801107r; Takahashi S, 2011, NAT CHEM BIOL, V7, P461, DOI [10.1038/NCHEMBIO.583, 10.1038/nchembio.583]; Takaoka LR, 2005, J AM CHEM SOC, V127, P528, DOI 10.1021/ja044642o; Uraguchi D, 2004, J AM CHEM SOC, V126, P5356, DOI 10.1021/ja0491533; Vellalath S, 2010, ANGEW CHEM INT EDIT, V49, P9749, DOI 10.1002/anie.201005347; WALL ME, 1954, J AM CHEM SOC, V76, P2849, DOI 10.1021/ja01639a086; Xu FX, 2010, J ORG CHEM, V75, P8677, DOI 10.1021/jo101640z; Zhang QW, 2009, ANGEW CHEM INT EDIT, V48, P8572, DOI 10.1002/anie.200904565; Zinzalla G, 2006, ORG BIOMOL CHEM, V4, P1977, DOI 10.1039/b603015g	30	320	323	8	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					315	319		10.1038/nature10932	http://dx.doi.org/10.1038/nature10932			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22422266				2022-12-01	WOS:000301481800045
J	Lindhardsen, J; Ahlehoff, O; Gislason, GH; Madsen, OR; Olesen, JB; Svendsen, JH; Torp-Pedersen, C; Hansen, PR				Lindhardsen, Jesper; Ahlehoff, Ole; Gislason, Gunnar Hilmar; Madsen, Ole Rintek; Olesen, Jonas Bjerring; Svendsen, Jesper Hastrup; Torp-Pedersen, Christian; Hansen, Peter Riis			Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; HEART-FAILURE; INFLAMMATION; MORTALITY; DISEASE; PERPETUATION; PREVALENCE; REGISTER; ALCOHOL	Objectives To determine if patients with rheumatoid arthritis have increased risk of atrial fibrillation and stroke. Design Longitudinal nationwide register based cohort study. Setting Inpatient and outpatient hospital care in Denmark from 1997 to 2009. Participants Entire Danish population aged over 15 years without rheumatoid arthritis, atrial fibrillation, or stroke before 1997. Participants with rheumatoid arthritis were identified by individual level linkage of diagnoses and rheumatoid arthritis treatment. Main outcome measures Rates of atrial fibrillation and stroke. Results Of 4 182 335 participants included in the cohort, 18 247 were identified as having rheumatoid arthritis during follow-up, with a mean age at disease onset of 59.2 years and a median follow-up of 4.8 years. A total of 156 484 people, including 774 with rheumatoid arthritis, were diagnosed as having atrial fibrillation (age and sex matched event rates of 8.2 per 1000 person years in rheumatoid arthritis patients and 6.0 per 1000 person years in the general population), with an adjusted incidence rate ratio of 1.41 (95% confidence interval 1.31 to 1.51). In addition, 165 343 people, including 718 with rheumatoid arthritis, had a stroke (7.6 per 1000 person years in rheumatoid arthritis and 5.7 per 1000 person years in the general population), with a resultant rate ratio of 1.32 (1.22 to 1.42). For both atrial fibrillation and stroke, relative risks were increased in all strata based on thirds of sex and age, with higher relative risks in younger patients but higher absolute risk differences in older patients. Conclusions Rheumatoid arthritis was associated with an increased incidence of atrial fibrillation and stroke. The novel finding of increased risk of atrial fibrillation in rheumatoid arthritis suggests that this arrhythmia is relevant in cardiovascular risk assessment of these patients.	[Lindhardsen, Jesper; Ahlehoff, Ole; Gislason, Gunnar Hilmar; Olesen, Jonas Bjerring; Torp-Pedersen, Christian; Hansen, Peter Riis] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Madsen, Ole Rintek] Univ Copenhagen, Gentofte Hosp, Dept Internal Med, Rheumatol Sect, DK-2900 Hellerup, Denmark; [Svendsen, Jesper Hastrup] Copenhagen Univ Hosp, Rigshosp, Ctr Heart, Dept Cardiol, DK-2100 Copenhagen O, Denmark; [Svendsen, Jesper Hastrup] Danish Natl Res Fdn Ctr Cardiac Arrhythmia DARC, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Danmarks Grundforskningsfond	Lindhardsen, J (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark.	jeslin01@geh.regionh.dk	Gislason, Gunnar/B-7561-2009; Svendsen, Jesper Hastrup/G-8573-2017; Hansen, Peter Riis/AAR-7659-2020	Gislason, Gunnar/0000-0002-0548-402X; Svendsen, Jesper Hastrup/0000-0001-8466-8515; Hansen, Peter Riis/0000-0002-9056-535X	Danish Rheumatism Association	Danish Rheumatism Association	JL has received an unrestricted grant from the Danish Rheumatism Association. The funding source had no influence on the study design, interpretation of results, or decision to submit the article. Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Andersen TF, 1999, DAN MED BULL, V46, P263; Boyer JF, 2011, JOINT BONE SPINE, V78, P179, DOI 10.1016/j.jbspin.2010.07.016; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Christiansen CF, 2009, ARCH INTERN MED, V169, P1677, DOI 10.1001/archinternmed.2009.297; De Caterina R, 2010, ARCH INTERN MED, V170, P1450, DOI 10.1001/archinternmed.2010.305; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Frost L, 2007, AM J MED, V120, P47, DOI 10.1016/j.amjmed.2005.12.027; Gaist D, 1997, DAN MED BULL, V44, P445; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Goulenok TM, 2010, JOINT BONE SPINE, V77, P146, DOI 10.1016/j.jbspin.2010.01.001; Guler H, 2007, RHEUMATOL INT, V27, P813, DOI 10.1007/s00296-007-0307-8; Hannawi S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2323; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Holmqvist ME, 2010, ANN RHEUM DIS     S3, V69, P109; Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Levy L, 2008, CLIN EXP RHEUMATOL, V26, P673; Liang KP, 2006, ARTHRITIS RHEUM-US, V54, P642, DOI 10.1002/art.21628; Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042; Mahrholdt H, 2007, HEART, V93, P122, DOI 10.1136/hrt.2005.071290; Maki-Petaja KM, 2010, ARTERY RES, V4, P99, DOI 10.1016/j.artres.2010.10.002; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252; Mitchell GF, 2007, JAMA-J AM MED ASSOC, V297, P709, DOI 10.1001/jama.297.7.709; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Nicola PJ, 2006, ARTHRITIS RHEUM-US, V54, P60, DOI 10.1002/art.21560; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Pedersen Jens K, 2007, Open Rheumatol J, V1, P18, DOI 10.2174/1874312900701010018; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Singh JA, 2004, ARTHRIT RHEUM-ARTHR, V51, P952, DOI 10.1002/art.20827; Sodergren A, 2009, CLIN EXP RHEUMATOL, V27, P641; Solomon DH, 2006, ANN RHEUM DIS, V65, P1608, DOI 10.1136/ard.2005.050377; Solomon DH, 2010, ANN RHEUM DIS, V69, P1920, DOI 10.1136/ard.2009.122226; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Tanasescu C, 2009, EUR J INTERN MED, V20, P348, DOI 10.1016/j.ejim.2008.09.005; TLUSTOCHOWICZ W, 1995, EUR HEART J, V16, P848, DOI 10.1093/oxfordjournals.eurheartj.a061005; van Eijk IC, 2011, CLIN RHEUMATOL, V30, P1113, DOI 10.1007/s10067-011-1750-1; van Sijl AM, 2011, SEMIN ARTHRITIS RHEU, V40, P389, DOI 10.1016/j.semarthrit.2010.06.006; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weber T, 2010, ARTERY RES, V4, P122, DOI 10.1016/j.artres.2010.10.033; Wislowska M, 1999, RHEUMATOL INT, V18, P163, DOI 10.1007/s002960050079; Wolfe F, 2004, AM J MED, V116, P305, DOI 10.1016/j.amjmed.2003.09.039; Wolfe F, 2003, J RHEUMATOL, V30, P36; Yavuzkir M, 2007, J INT MED RES, V35, P796, DOI 10.1177/147323000703500608	45	115	120	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2012	344								e1257	10.1136/bmj.e1257	http://dx.doi.org/10.1136/bmj.e1257			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908HL	22403267	hybrid, Green Published			2022-12-01	WOS:000301481400002
J	Chisholm, D; Naci, H; Ali, A; Tran, NT; Peden, M				Chisholm, Dan; Naci, Huseyin; Ali, Adnan; Tran, Nhan T.; Peden, Margie			Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PUBLIC-HEALTH; HELMET; INTERVENTIONS	Objective To identify and estimate the population costs and effects of a selected set of enforcement strategies for reducing the burden of road traffic injuries in developing countries. Design Cost effectiveness analysis based on an epidemiological model. Setting Two epidemiologically defined World Health Organization sub-regions of the world: countries in sub-Saharan Africa with very high adult and high child mortality (AfrE); and countries in South East Asia with high adult and high child mortality (SearD). Interventions Enforcement of speed limits via mobile speed cameras; drink-drive legislation and enforcement via breath testing campaigns; legislation and primary enforcement of seatbelt use in cars; legislation and enforcement of helmet use by motorcyclists; legislation and enforcement of helmet use by bicyclists. Main outcome measures Patterns of injury were fitted to a state transition model to determine the expected population level effects of intervention over a 10 year period, which were expressed in disability adjusted life years (DALYs) averted. Costs were expressed in international dollars ($Int) for the year 2005. Results The single most cost effective strategy varies by sub-region, but a combined intervention strategy that simultaneously enforces multiple road safety laws produces the most health gain for a given amount of investment. For example, the combined enforcement of speed limits, drink-driving laws, and motorcycle helmet use saves one DALY for a cost of $Int1000-3000 in the two sub-regions considered. Conclusions The potential impact of available road safety measures is inextricably bound by the underlying distribution of road traffic injuries across different road user groups and risk factors. Combined enforcement strategies are expected to represent the most efficient way to reduce the burden of road traffic injuries, because they benefit from considerable synergies on the cost side while generating greater overall health gains.	[Chisholm, Dan] World Hlth Org, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland; [Naci, Huseyin] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England; [Ali, Adnan; Tran, Nhan T.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Injury Res Unit, Baltimore, MD USA; [Peden, Margie] World Hlth Org, Dept Violence & Injury Prevent & Disabil, CH-1211 Geneva, Switzerland	World Health Organization; University of London; London School Economics & Political Science; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization	Chisholm, D (corresponding author), World Hlth Org, Dept Hlth Syst Financing, Ave Appia 20, CH-1211 Geneva, Switzerland.	chisholmd@who.int		Hyder, Adnan/0000-0002-7292-577X; Mary, Margaret/0000-0003-0872-9851				Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; [Anonymous], 2004, WORLD REP ROAD TRAFF; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Begg S., 2000, GLOBAL PROG EVID HLT, V2000, P1; Bishai David M, 2006, Cost Eff Resour Alloc, V4, P2, DOI 10.1186/1478-7547-4-2; Chisholm D, 2008, ROAD TRAFFIC INJURY, P4; Downing A., 2000, PRINT20000 TRL; Elvik R., 2004, HDB ROAD SAFETY MEAS; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Haileyesus T, 2007, INJURY PREV, V13, P202, DOI 10.1136/ip.2006.014019; Johns Benjamin, 2006, Cost Eff Resour Alloc, V4, P8, DOI 10.1186/1478-7547-4-8; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; KELLY P, 1991, ANN EMERG MED, V20, P852, DOI 10.1016/S0196-0644(05)81426-X; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Naci H, 2009, INJURY PREV, V15, P55, DOI 10.1136/ip.2008.018721; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Norton R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P737; ORSAY E, 1995, ANN EMERG MED, V26, P455, DOI 10.1016/S0196-0644(95)70114-1; Peek-Asa C, 1999, AM J PREV MED, V16, P57, DOI 10.1016/S0749-3797(98)00116-0; Rehm J, 2004, COMP QUANTIFICATION, P959; Ridolfo B, 2001, QUANTIFICATION DRUG; Robinson DL, 2006, BMJ-BRIT MED J, V332, P722, DOI 10.1136/bmj.332.7543.722-a; SHANKAR BS, 1992, ACCIDENT ANAL PREV, V24, P385, DOI 10.1016/0001-4575(92)90051-J; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; Tan-Torres ET, 2003, MAKING CHOICES HLTH, V1; Thompson DC, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001855, DOI 10.1002/14651858.CD001855]	27	32	33	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2012	344								e612	10.1136/bmj.e612	http://dx.doi.org/10.1136/bmj.e612			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	904XQ	22389340	hybrid, Green Published			2022-12-01	WOS:000301232600005
J	Hakim, O; Misteli, T				Hakim, Ofir; Misteli, Tom			SnapShot: Chromosome Confirmation Capture	CELL			English	Editorial Material							CONFORMATION CAPTURE; YEAST GENOME; ORGANIZATION; LOCI		[Hakim, Ofir; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hakim, O (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.			Hakim, Ofir/0000-0003-0063-2721	Intramural NIH HHS [ZIA BC010309-14] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abou El Hassan M, 2009, Nucleic Acids Res, V37, pe35, DOI 10.1093/nar/gkp028; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tiwari V.K., 2009, COLD SPRING HARB PRO, DOI pdb.prot5168; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	20	37	37	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 2	2012	148	5					1068	U245		10.1016/j.cell.2012.02.019	http://dx.doi.org/10.1016/j.cell.2012.02.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	901RR	22385969	Green Accepted, Bronze			2022-12-01	WOS:000300985000027
J	Falkowski, P				Falkowski, Paul			OCEAN SCIENCE The power of plankton	NATURE			English	Editorial Material									[Falkowski, Paul] Rutgers State Univ, Inst Marine & Coastal Sci, Piscataway, NJ 08855 USA; [Falkowski, Paul] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Falkowski, P (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Piscataway, NJ 08855 USA.	falko@marine.rutgers.edu						Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; REDFIELD AC, 1958, AM SCI, V46, P205; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857	5	188	197	4	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2012	483	7387					S17	S20		10.1038/483S17a	http://dx.doi.org/10.1038/483S17a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900HP	22378122	Bronze			2022-12-01	WOS:000300877900007
J	Long, T; Wyse, S				Long, Tammy; Wyse, Sara			A Season for Inquiry: Investigating Phenology in Local Campus Trees	SCIENCE			English	Editorial Material									[Long, Tammy] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Wyse, Sara] Bethel Univ, St Paul, MN 55112 USA	Michigan State University	Long, T (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	longta@msu.edu			Division Of Undergraduate Education [0736928] Funding Source: National Science Foundation	Division Of Undergraduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))		AAAS, 2011, VIS CHANG UND BIOL E; American Association for the Advancement of Science (AAAS), 1993, BENCHM SCI LIT; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286	4	5	5	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 24	2012	335	6071					932	933		10.1126/science.1213528	http://dx.doi.org/10.1126/science.1213528			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	900ZQ	22363000	Bronze			2022-12-01	WOS:000300931800036
J	Liu, CR; Chang, CR; Chern, Y; Wang, TH; Hsieh, WC; Shen, WC; Chang, CY; Chu, IC; Deng, N; Cohen, SN; Cheng, TH				Liu, Chia-Rung; Chang, Chuang-Rung; Chern, Yijuang; Wang, Tzu-Han; Hsieh, Wen-Chieh; Shen, Wen-Chuan; Chang, Chi-Yuan; Chu, I-Chieh; Deng, Ning; Cohen, Stanley N.; Cheng, Tzu-Hao			Spt4 Is Selectively Required for Transcription of Extended Trinucleotide Repeats	CELL			English	Article							RNA-POLYMERASE-II; NEURONAL INTRANUCLEAR INCLUSIONS; WILD-TYPE HUNTINGTIN; MUTANT HUNTINGTIN; IN-VITRO; NEUROLOGICAL PHENOTYPE; ELONGATION-FACTOR; TRIPLET REPEAT; CAG REPEATS; POLYGLUTAMINE	Lengthy trinucleotide repeats encoding polyglutamine (polyQ) stretches characterize the variant proteins of Huntington's disease and certain other inherited neurological disorders. Using a phenotypic screen to identify events that restore functionality to polyQ proteins in S. cerevisiae, we discovered that transcription elongation factor Spt4 is required to transcribe long trinucleotide repeats located either in ORFs or nonprotein-coding regions of DNA templates. Mutation of SPT4 selectively decreased synthesis of and restored enzymatic activity to expanded polyQ protein without affecting protein lacking long-polyQ stretches. RNA-seq analysis revealed limited effects of Spt4 on overall gene expression. Inhibition of Supt4h, the mammalian ortholog of Spt4, reduced mutant huntingtin protein in neuronal cells and decreased its aggregation and toxicity while not altering overall cellular mRNA synthesis. Our findings identify a cellular mechanism for transcription through repeated trinucleotides and a potential target for countermeasures against neurological disorders attributable to expanded trinucleotide regions.	[Liu, Chia-Rung; Wang, Tzu-Han; Hsieh, Wen-Chieh; Shen, Wen-Chuan; Chang, Chi-Yuan; Chu, I-Chieh; Cheng, Tzu-Hao] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Chang, Chuang-Rung] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Deng, Ning; Cohen, Stanley N.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Cheng, Tzu-Hao] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Tsing Hua University; Academia Sinica - Taiwan; Stanford University; National Yang Ming Chiao Tung University	Cheng, TH (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155,Sect 2,Linong St, Taipei 112, Taiwan.	sncohen@stanford.edu; thcheng@ym.edu.tw	chern, yijuang/S-7013-2018; Deng, Ning/H-6561-2014; Chang, Chuang-Rung/C-1815-2012	chern, yijuang/0000-0002-5842-5429; Chang, Chuang-Rung/0000-0002-6124-5429; DENG, NING/0000-0002-1321-5508	CHDI Foundation; National Science Council [NSC-96-2311-B-010-001, NSC-98-2311-B-010-001-MY3]; Ministry of Education of the Republic of China; Friends of Stanford Foundation of Taiwan	CHDI Foundation; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education of the Republic of China(Ministry of Education, Taiwan); Friends of Stanford Foundation of Taiwan	We thank Chih-Yen King, Fang-Jen Lee, Jing-Jer Lin, Michael Sherman, Michael Snyder, Elena Cattaneo, Marcy MacDonald, and the HD Community BioRepository (http://ccr.coriell.org) sponsored by CHDI Foundation for providing experimental materials. We thank Cheng-Fu Kao for technical assistance in the ChIP assay and Yong Cheng, Zhihai Ma, Mark McCreary, and Richard Lin for assistance in compilation and analysis of RNA-seq data. T.-H.C. received grants from National Science Council (NSC-96-2311-B-010-001 and NSC-98-2311-B-010-001-MY3), and the "Aim for the Top University Plan'' grant from the Ministry of Education of the Republic of China. S.N. Cohen and N. Deng received support from Kwoh-Ting Li Professorship funds endowed by the Friends of Stanford Foundation of Taiwan.	Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Belotserkovskii BP, 2011, BIOPHYS J, V100, P675, DOI 10.1016/j.bpj.2010.12.3709; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Cheng TH, 2000, GENE DEV, V14, P452; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hands S, 2008, BBA-GENE REGUL MECH, V1779, P507, DOI 10.1016/j.bbagrm.2008.05.008; Hartzog GA, 1996, MOL CELL BIOL, V16, P2848; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kiyama R, 1996, NUCLEIC ACIDS RES, V24, P4577, DOI 10.1093/nar/24.22.4577; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Lenzmeier BA, 2003, CYTOGENET GENOME RES, V100, P7, DOI 10.1159/000072836; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Lichota J, 2010, J NEUROCHEM, V113, P1, DOI [10.1111/j.1471-4159.2009.06544.x, 10.1111/j.1471-4159.2009.06544]; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MALONE EA, 1993, MOL GEN GENET, V237, P449, DOI 10.1007/BF00279450; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Parsons MA, 1998, J BIOL CHEM, V273, P26998, DOI 10.1074/jbc.273.41.26998; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Reddy K, 2011, NUCLEIC ACIDS RES, V39, P1749, DOI 10.1093/nar/gkq935; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Roy D, 2009, MOL CELL BIOL, V29, P3124, DOI 10.1128/MCB.00139-09; Salinas-Rios V, 2011, NUCLEIC ACIDS RES, V39, P7444, DOI 10.1093/nar/gkr429; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Varma H, 2007, NAT CHEM BIOL, V3, P99, DOI 10.1038/nchembio852; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wenzel S, 2010, BIOCHEM J, V425, P373, DOI 10.1042/BJ20091422; WINSTON F, 1984, GENETICS, V107, P179; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299; Xiao YY, 2005, STAT APPL GENET MOL, V4; Yu ZM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001340; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	61	73	78	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2012	148	4					690	701		10.1016/j.cell.2011.12.032	http://dx.doi.org/10.1016/j.cell.2011.12.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	897DH	22341442	Bronze			2022-12-01	WOS:000300622400011
J	Forget, AL; Kowalczykowski, SC				Forget, Anthony L.; Kowalczykowski, Stephen C.			Single-molecule imaging of DNA pairing by RecA reveals a three-dimensional homology search	NATURE			English	Article							DOUBLE-STRANDED DNA; ESCHERICHIA-COLI; PROTEIN; RECOMBINATION; MECHANISM; BINDING; EXCHANGE; TRANSLOCATION; BIOCHEMISTRY; FILAMENTS	DNA breaks can be repaired with high fidelity by homologous recombination. A ubiquitous protein that is essential for this DNA template-directed repair is RecA(1). After resection of broken DNA to produce single-stranded DNA (ssDNA), RecA assembles on this ssDNA into a filament with the unique capacity to search and find DNA sequences in double-stranded DNA (dsDNA) that are homologous to the ssDNA. This homology search is vital to recombinational DNA repair, and results in homologous pairing and exchange of DNA strands. Homologous pairing involves DNA sequence-specific target location by the RecA-ssDNA complex. Despite decades of study, the mechanism of this enigmatic search process remains unknown. RecA is a DNA-dependent ATPase, but ATP hydrolysis is not required for DNA pairing and strand exchange(2,3), eliminating active search processes. Using dual optical trapping to manipulate DNA, and single-molecule fluorescence microscopy to image DNA pairing, we demonstrate that both the three-dimensional conformational state of the dsDNA target and the length of the homologous RecA-ssDNA filament have important roles in the homology search. We discovered that as the end-to-end distance of the target dsDNA molecule is increased, constraining the available three-dimensional (3D) conformations of the molecule, the rate of homologous pairing decreases. Conversely, when the length of the ssDNA in the nucleoprotein filament is increased, homology is found faster. We propose a model for the DNA homology search process termed 'intersegmental contact sampling', in which the intrinsic multivalent nature of the RecA nucleoprotein filament is used to search DNA sequence space within 3D domains of DNA, exploiting multiple weak contacts to rapidly search for homology. Our findings highlight the importance of the 3D conformational dynamics of DNA, reveal a previously unknown facet of the homology search, and provide insight into the mechanism of DNA target location by this member of a universal family of proteins.	[Forget, Anthony L.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Forget, Anthony L.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu			American Cancer Society [PF-08-046-01-GMC]; National Institutes of Health [GM-62653, GM-64745]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062653, R01GM062653, R01GM064745] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the laboratory for their comments on this work. A.L.F. was funded by an American Cancer Society Postdoctoral Fellowship (PF-08-046-01-GMC) and S.C.K. was supported by the National Institutes of Health (GM-62653 and GM-64745).	Adzuma K, 1998, J BIOL CHEM, V273, P31565, DOI 10.1074/jbc.273.47.31565; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Berg OG, 1990, BIOL NONSPECIFIC DNA, P71; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Forget AL, 2010, TRENDS CELL BIOL, V20, P269, DOI 10.1016/j.tcb.2010.02.004; Fulconis R, 2006, EMBO J, V25, P4293, DOI 10.1038/sj.emboj.7601260; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; GONDA DK, 1983, CELL, V34, P647, DOI 10.1016/0092-8674(83)90397-5; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; HONIGBERG SM, 1985, J BIOL CHEM, V260, P1845; JULIN DA, 1986, J BIOL CHEM, V261, P1025; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.biophys.20.1.539; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5945, DOI 10.1021/bi027233i; PERKINS TT, 1994, SCIENCE, V264, P822, DOI 10.1126/science.8171336; TSANG SS, 1985, BIOCHEMISTRY-US, V24, P3226, DOI 10.1021/bi00334a023; van der Heijden T, 2008, MOL CELL, V30, P530, DOI 10.1016/j.molcel.2008.03.010; van Mameren J, 2009, NATURE, V457, P745, DOI 10.1038/nature07581	22	145	147	2	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 16	2012	482	7385					423	U178		10.1038/nature10782	http://dx.doi.org/10.1038/nature10782			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22318518	Green Accepted, Green Submitted			2022-12-01	WOS:000300287100051
J	Chen, CC; Wu, JK; Lin, HW; Pai, TP; Fu, TF; Wu, CL; Tully, T; Chiang, AS				Chen, Chun-Chao; Wu, Jie-Kai; Lin, Hsuan-Wen; Pai, Tsung-Pin; Fu, Tsai-Feng; Wu, Chia-Lin; Tully, Tim; Chiang, Ann-Shyn			Visualizing Long-Term Memory Formation in Two Neurons of the Drosophila Brain	SCIENCE			English	Article							MUSHROOM BODY NEURONS; RICIN-A-CHAIN; OLFACTORY MEMORY; EUKARYOTIC RIBOSOMES; CONSOLIDATED MEMORY; FLUORESCENT PROTEIN; NMDA RECEPTORS; TRACE; GENE; RETRIEVAL	Long-term memory (LTM) depends on the synthesis of new proteins. Using a temperature-sensitive ribosome-inactivating toxin to acutely inhibit protein synthesis, we screened individual neurons making new proteins after olfactory associative conditioning in Drosophila. Surprisingly, LTM was impaired after inhibiting protein synthesis in two dorsal-anterior-lateral (DAL) neurons but not in the mushroom body (MB), which is considered the adult learning and memory center. Using a photoconvertible fluorescent protein KAEDE to report de novo protein synthesis, we have directly visualized cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB)-dependent transcriptional activation of calcium/calmodulin-dependent protein kinase II and period genes in the DAL neurons after spaced but not massed training. Memory retention was impaired by blocking neural output in DAL during retrieval but not during acquisition or consolidation. These findings suggest an extra-MB memory circuit in Drosophila: LTM consolidation (MB to DAL), storage (DAL), and retrieval (DAL to MB).	[Chen, Chun-Chao; Wu, Jie-Kai; Lin, Hsuan-Wen; Pai, Tsung-Pin; Chiang, Ann-Shyn] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan; [Chen, Chun-Chao; Wu, Jie-Kai; Lin, Hsuan-Wen; Pai, Tsung-Pin; Chiang, Ann-Shyn] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Wu, Chia-Lin; Chiang, Ann-Shyn] Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu 30013, Taiwan; [Fu, Tsai-Feng] Natl Chi Nan Univ, Dept Appl Chem, Nantou 54561, Taiwan; [Tully, Tim] Dart Neurosci LLC, San Diego, CA 92121 USA; [Chiang, Ann-Shyn] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Chiang, Ann-Shyn] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Chi Nan University; Academia Sinica - Taiwan; University of California System; University of California San Diego	Chiang, AS (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.	aschiang@life.nthu.edu.tw		Fu, Tsai-Feng/0000-0002-0343-3018; Wu, Chia-Lin/0000-0002-7906-2364; Chiang, Ann-Shyn/0000-0001-9668-7115; Wu, Jie-Kai/0000-0002-5142-1468	Dart Neurosciences LLC; National Science Council; Ministry of Education	Dart Neurosciences LLC; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education	We thank S. Benzer, J. Blau, R. L. Davis, J. Hall, J. Hirsh, C. J. O'Kane, S. Kunes, L. Luo, T. Preat, M. Rosbash, S. Waddell, Y. Takamatsu, M. W. Young, and the Bloomington and Drosophila Genomics Resource Centers for fly stocks. We thank J. Hirsh, L. C. Griffith, and T. Preat for the antibodies. We also thank S. F. Teng for the preliminary test of UAS-kaede. This work was funded by grants from Dart Neurosciences LLC, National Science Council, and Ministry of Education to A.-S.C. C.-C. C., T. T., and A.-S.C. conceptualized the project and wrote the manuscript; C.-C. C. and A.-S.C. developed the methods and analyzed the data; C.-C. C., J.-K.W., T.-P. P., and C.-L. W carried out behavioral experiments; H.-W.L. and J.-K.W. performed imaging experiments; T.-F.F. generated the UAS-kaede transgenic flies; A.-S.C. supervised the project. The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to A.-S.C.	Akalal DBG, 2011, J NEUROSCI, V31, P5643, DOI 10.1523/JNEUROSCI.3190-10.2011; Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; Martinek S, 2000, GENETICS, V156, P1717; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; MOFFAT KG, 1992, DEVELOPMENT, V114, P681; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pascual A, 2004, NATURE, V427, P605, DOI 10.1038/427605a; Pitman JL, 2011, CURR BIOL, V21, P855, DOI 10.1016/j.cub.2011.03.069; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Wu CL, 2007, NAT NEUROSCI, V10, P1578, DOI 10.1038/nn2005; Wu CL, 2011, CURR BIOL, V21, P848, DOI 10.1016/j.cub.2011.02.041; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030	42	115	119	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2012	335	6069					678	685		10.1126/science.1212735	http://dx.doi.org/10.1126/science.1212735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	889AY	22323813				2022-12-01	WOS:000300047100043
J	Paschal, D				Paschal, Dean			Launching Complex Medical Workups From an Urgent Care Platform	ANNALS OF INTERNAL MEDICINE			English	Article								The basic parameters for medical workups have scarcely changed in the past 30 years. That is, what the internal medicine community has deemed acceptable for outpatient, inpatient, emergency department, and urgent care evaluation has remained pretty much stable or stagnant during all that time. We are failing to take advantage of the phenomenal speed and accuracy of new laboratory and imaging technologies. Due to Hurricane Katrina, which destroyed the Veterans Administration Hospital in New Orleans, those of us who work in its urgent care clinic were forced to undertake complex medical workups from an 8-to-5, walk-in platform. We have been amazed at the efficiency of this. Workups that used to take weeks can often be done in a few hours or days. What we have discovered here serendipitously may be worth deliberately duplicating elsewhere.	Tulane Univ, New Orleans, LA 70115 USA	Tulane University	Paschal, D (corresponding author), Tulane Univ, 5721 Magazine St,132, New Orleans, LA 70115 USA.	ldpaschal@bellsouth.net							0	2	2	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2012	156	3					232	U95		10.7326/0003-4819-156-3-201202070-00012	http://dx.doi.org/10.7326/0003-4819-156-3-201202070-00012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XD	22312142				2022-12-01	WOS:000299964200007
J	Cassenaer, S; Laurent, G				Cassenaer, Stijn; Laurent, Gilles			Conditional modulation of spike-timing-dependent plasticity for olfactory learning	NATURE			English	Article							DROSOPHILA MUSHROOM BODY; SYNAPTIC PLASTICITY; ODOR REPRESENTATIONS; NEURONS; MEMORY; DOPAMINE; LOCUST; BODIES; BRAIN; OSCILLATIONS	Mushroom bodies are a well-known site for associative learning in insects. Yet the precise mechanisms that underlie plasticity there and ensure their specificity remain elusive. In locusts, the synapses between the intrinsic mushroom body neurons and their postsynaptic targets obey a Hebbian spike-timing-dependent plasticity (STDP) rule. Although this property homeostatically regulates the timing of mushroom body output, its potential role in associative learning is unknown. Here we show in vivo that pre-post pairing causing STDP can, when followed by the local delivery of a reinforcement-mediating neuromodulator, specify the synapses that will undergo an associative change. At these synapses, and there only, the change is a transformation of the STDP rule itself. These results illustrate the multiple actions of STDP, including a role in associative learning, despite potential temporal dissociation between the pairings that specify synaptic modification and the delivery of reinforcement-mediating neuromodulator signals.	[Cassenaer, Stijn; Laurent, Gilles] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Cassenaer, Stijn] CALTECH, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA; [Laurent, Gilles] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany	California Institute of Technology; California Institute of Technology; Max Planck Society	Laurent, G (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	stijn@caltech.edu; gilles.laurent@brain.mpg.de	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X	Lawrence Hanson Chair at Caltech; National Institutes on Deafness and other Communication Disorders; Caltech; Office of Naval Research [N00014-07-1-0741, N00014-10-1-0735]; Max Planck Society	Lawrence Hanson Chair at Caltech; National Institutes on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Caltech; Office of Naval Research(Office of Naval Research); Max Planck Society(Max Planck Society)	This work was funded by the Lawrence Hanson Chair at Caltech, the National Institutes on Deafness and other Communication Disorders, Caltech's Broad Fellows Program, the Office of Naval Research (grants N00014-07-1-0741 and N00014-10-1-0735) and the Max Planck Society. We are grateful to L.-P. Mok for help with locust dissections and to E. Schuman, A. Siapas, E. Lubenov, M. Papadopoulou and members of the Laurent lab for comments on the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BRAUNIG P, 1991, PHILOS T ROY SOC B, V332, P221, DOI 10.1098/rstb.1991.0051; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Gutig R, 2003, J NEUROSCI, V23, P3697; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Huerta R, 2004, NEURAL COMPUT, V16, P1601, DOI 10.1162/089976604774201613; Huerta R, 2009, NEURAL COMPUT, V21, P2123, DOI 10.1162/neco.2009.03-08-733; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ito I, 2008, NAT NEUROSCI, V11, P1177, DOI 10.1038/nn.2192; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Kanerva P, 1988, SPARSE DISTRIBUTED M; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; LAURENT G, 1994, J NEUROSCI, V14, P2993; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Meeks JP, 2008, NAT NEUROSCI, V11, P1126, DOI 10.1038/nn1008-1126; Mizunami M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00172; Papadopoulou M, 2011, SCIENCE, V332, P721, DOI 10.1126/science.1201835; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Tully J. B. C. T., 1998, DROSOPHILA PRACTICAL, P265; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Waddell S, 2001, SCIENCE, V293, P1271, DOI 10.1126/science.1064604; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; WENDT B, 1992, J COMP NEUROL, V321, P387, DOI 10.1002/cne.903210307	45	149	149	5	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 2	2012	482	7383					47	U62		10.1038/nature10776	http://dx.doi.org/10.1038/nature10776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	884RN	22278062				2022-12-01	WOS:000299726000032
J	Morrison, N; Thomas, R; Smith, P				Morrison, Nicola; Thomas, Rhys; Smith, Phil			Juvenile myoclonic epilepsy	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Smith, Phil] Univ Wales Hosp, Dept Neurol, Alan Richens Epilepsy Unit, Cardiff CF14 4XW, S Glam, Wales; [Thomas, Rhys] Swansea Univ, Inst Life Sci, Swansea, W Glam, Wales	Cardiff University; Swansea University	Smith, P (corresponding author), Univ Wales Hosp, Dept Neurol, Alan Richens Epilepsy Unit, Heath Pk, Cardiff CF14 4XW, S Glam, Wales.	SmithPE@cardiff.ac.uk	Thomas, Rhys/I-3840-2019	Thomas, Rhys/0000-0003-2062-8623					0	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2012	344								e360	10.1136/bmj.e360	http://dx.doi.org/10.1136/bmj.e360			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	885LE	22282530	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000299779700005
J	Zielinski, CE; Mele, F; Aschenbrenner, D; Jarrossay, D; Ronchi, F; Gattorno, M; Monticelli, S; Lanzavecchia, A; Sallusto, F				Zielinski, Christina E.; Mele, Federico; Aschenbrenner, Dominik; Jarrossay, David; Ronchi, Francesca; Gattorno, Marco; Monticelli, Silvia; Lanzavecchia, Antonio; Sallusto, Federica			Pathogen-induced human T(H)17 cells produce IFN-gamma or IL-10 and are regulated by IL-1 beta	NATURE			English	Article							GROWTH-FACTOR-BETA; HYPER-IGE SYNDROME; CD4(+) T-CELLS; TH17 CELLS; TGF-BETA; HELPER-CELLS; DIFFERENTIATION; MEMORY; INTERLEUKIN-1-BETA; PROSTAGLANDIN-E2	IL-17-producing CD4(+) T helper cells (T(H)17) have been extensively investigated in mouse models of autoimmunity(1). However, the requirements for differentiation and the properties of pathogen-induced human T(H)17 cells remain poorly defined. Using an approach that combines the in vitro priming of naive T cells with the ex vivo analysis of memory T cells, we describe here two types of human T(H)17 cells with distinct effector function and differentiation requirements. Candida albicans-specific T(H)17 cells produced IL-17 and IFN-gamma, but no IL-10, whereas Staphylococcus aureus-specific T(H)17 cells produced IL-17 and could produce IL-10 upon restimulation. IL-6, IL-23 and IL-1 beta contributed to T(H)17 differentiation induced by both pathogens, but IL-1 beta was essential in C. albicans-induced T(H)17 differentiation to counteract the inhibitory activity of IL-12 and to prime IL-17/IFN-gamma double-producing cells. In addition, IL-1 beta inhibited IL-10 production in differentiating and in memory T(H)17 cells, whereas blockade of IL-1 beta in vivo led to increased IL-10 production by memory T(H)17 cells. We also show that, after restimulation, T(H)17 cells transiently downregulated IL-17 production through a mechanism that involved IL-2-induced activation of STAT5 and decreased expression of ROR-gamma t. Taken together these findings demonstrate that by eliciting different cytokines C. albicans and S. aureus prime T(H)17 cells that produce either IFN-gamma or IL-10, and identify IL-1 beta and IL-2 as pro-and anti-inflammatory regulators of T(H)17 cells both at priming and in the effector phase.	[Zielinski, Christina E.; Mele, Federico; Aschenbrenner, Dominik; Jarrossay, David; Ronchi, Francesca; Monticelli, Silvia; Lanzavecchia, Antonio; Sallusto, Federica] Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Gattorno, Marco] G Gaslini Sci Inst, I-16147 Genoa, Italy; [Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	Universita della Svizzera Italiana; University of Genoa; IRCCS Istituto Giannina Gaslini; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sallusto, F (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	christina.zielinski@charite.de; federica.sallusto@irb.usi.ch	Monticelli, Silvia/ABE-7054-2020; Zielinski, Christina/Y-3362-2019; Gattorno, Marco/AAL-2974-2020	Gattorno, Marco/0000-0003-0704-1916; Monticelli, Silvia/0000-0002-5909-8802; Aschenbrenner, Dominik/0000-0001-7580-2567; Zielinski, Christina/0000-0002-8184-0858; Ronchi, Francesca/0000-0002-2035-6528	German Research Foundation (DFG) [Zi 1262/1-1]; Swiss National Science Foundation [131092, 126027]; Institute of Arthritis Research (IAR); Helmut Horten Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institute of Arthritis Research (IAR); Helmut Horten Foundation	We thank O. Petrini and C. Fragoso for providing microorganisms, and M. Levings for providing the RORC lentiviral vector. We thank A. Rossetti for technical assistance, D. Baumjohann for artwork and S. Jacob and M. Uguccioni for critical reading of the manuscript. This work was supported by a fellowship of the German Research Foundation (DFG) to C.E.Z (Zi 1262/1-1) and by grants from the Swiss National Science Foundation (N. 131092 to F. S. and 126027 to A. L.) and the Institute of Arthritis Research (IAR). A. L. is supported by the Helmut Horten Foundation.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Crome SQ, 2009, EUR J IMMUNOL, V39, P1480, DOI 10.1002/eji.200838908; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mayoral RJ, 2010, METHODS MOL BIOL, V667, P205, DOI 10.1007/978-1-60761-811-9_14; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Napolitani G, 2009, EUR J IMMUNOL, V39, P1301, DOI 10.1002/eji.200838969; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Smeekens SP, 2010, INT IMMUNOL, V22, P889, DOI 10.1093/intimm/dxq442; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995	30	653	675	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					514	U139		10.1038/nature10957	http://dx.doi.org/10.1038/nature10957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22466287				2022-12-01	WOS:000303200400051
J	Joynt, KE; Jha, AK				Joynt, Karen E.; Jha, Ashish K.			Thirty-Day Readmissions - Truth and Consequences	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HOSPITAL READMISSIONS; CARE		[Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Joynt, Karen E.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Joynt, KE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; van Walraven C, 2011, CAN MED ASSOC J, V183, pE1067, DOI 10.1503/cmaj.110400; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206	5	369	371	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2012	366	15					1366	1369		10.1056/NEJMp1201598	http://dx.doi.org/10.1056/NEJMp1201598			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GV	22455752				2022-12-01	WOS:000302608600013
J	Yokoo, R; Zawadzki, KA; Nabeshima, K; Drake, M; Arur, S; Villeneuve, AM				Yokoo, Rayka; Zawadzki, Karl A.; Nabeshima, Kentaro; Drake, Melanie; Arur, Swathi; Villeneuve, Anne M.			COSA-1 Reveals Robust Homeostasis and Separable Licensing and Reinforcement Steps Governing Meiotic Crossovers	CELL			English	Article							CROSSING-OVER; CAENORHABDITIS-ELEGANS; C-ELEGANS; MUTS HOMOLOG; MAMMALIAN MEIOSIS; CHIASMA FORMATION; BUDDING YEAST; RECOMBINATION; SYNAPSIS; MECHANISM	Crossovers (COs) between homologous chromosomes ensure their faithful segregation during meiosis. We identify C. elegans COSA-1, a cyclin-related protein conserved in metazoa, as a key component required to convert meiotic double-strand breaks (DSBs) into COs. During late meiotic prophase, COSA-1 localizes to foci that correspond to the single CO site on each homolog pair and indicate sites of eventual concentration of other conserved CO proteins. Chromosomes gain and lose competence to load CO proteins during meiotic progression, with competence to load COSA-1 requiring prior licensing. Our data further suggest a self-reinforcing mechanism maintaining CO designation. Modeling of a nonlinear dose-response relationship between IR-induced DSBs and COSA-1 foci reveals efficient conversion of DSBs into COs when DSBs are limiting and a robust capacity to limit cytologically differentiated CO sites when DSBs are in excess. COSA-1 foci serve as a unique live cell readout for investigating CO formation and CO interference.	[Yokoo, Rayka; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Zawadzki, Karl A.; Nabeshima, Kentaro; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Drake, Melanie; Arur, Swathi] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	Stanford University; Stanford University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Villeneuve, AM (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	annev@stanford.edu			NIH [HG00044, R01GM67268]; Leukemia and Lymphoma Society [5381-12]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG000044, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067268] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Mitani (National Institute of Genetics, Japan) and S. Rosu (Villeneuve lab) for cosa-1(tm3298) and zhp-3(me95); N. Bhalla, A. Dernburg, A. la Volpe, B. Meyer, S. Boulton, M. Zetka, and the Caenorhabditis Genetics Center for strains and antibodies; and J. Bessler for technical support. We thank A.D. Kaiser, M. AlQuaraishi, C. Janda, C. Thomas, D. Riordan, S. Clarke, and members of the Villeneuve lab for discussions and D. Libuda and A. Fire for comments on the manuscript. This work was supported by Stanford Genome Training Program NIH HG00044 Training Grant for R.Y., Leukemia and Lymphoma Society Postdoctoral Fellowship 5381-12 to K.A.Z., and NIH grant R01GM67268 to A.M.V.	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Anderson LK, 1999, GENETICS, V151, P1569; Ashley T, 2001, J CELL SCI, V114, P685; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; CARPENTER ATC, 1975, P NATL ACAD SCI USA, V72, P3186, DOI 10.1073/pnas.72.8.3186; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; de los Santos T, 2003, GENETICS, V164, P81; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Hammarlund M, 2005, GENETICS, V171, P1047, DOI 10.1534/genetics.105.044834; Hayashi M, 2007, PLOS GENET, V3, P2068, DOI 10.1371/journal.pgen.0030191; Henzel JV, 2011, GENETICS, V187, P685, DOI 10.1534/genetics.110.124958; Higgins JD, 2008, PLANT J, V55, P28, DOI 10.1111/j.1365-313X.2008.03470.x; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; HODGKIN J, 1979, GENETICS, V91, P67; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Jantsch V, 2004, MOL CELL BIOL, V24, P7998, DOI 10.1128/MCB.24.18.7998-8006.2004; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Kelly KO, 2000, GENETICS, V156, P617; Kneitz B, 2000, GENE DEV, V14, P1085; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2009, CURR BIOL, V19, P1519, DOI 10.1016/j.cub.2009.08.048; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Martinez-Perez E, 2008, GENE DEV, V22, P2886, DOI 10.1101/gad.1694108; Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Muller HJ, 1916, AM NAT, V50, P350, DOI 10.1086/279547; Muller HJ, 1916, AM NAT, V50, P284, DOI 10.1086/279541; Muller HJ, 1916, AM NAT, V50, P421, DOI 10.1086/279553; Nabeshima K, 2004, GENETICS, V168, P1275, DOI 10.1534/genetics.104.030700; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Petri ET, 2007, CELL CYCLE, V6, P1342, DOI 10.4161/cc.6.11.4297; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Pochart P, 1997, J BIOL CHEM, V272, P30345, DOI 10.1074/jbc.272.48.30345; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; Santucci-Darmanin S, 2000, FASEB J, V14, P1539, DOI 10.1096/fj.14.11.1539; Schurko AM, 2010, INSECT MOL BIOL, V19, P165, DOI 10.1111/j.1365-2583.2009.00948.x; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Thompson L.H., 2000, ORIGIN RECOGNITION S; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; Viera A, 2009, J CELL SCI, V122, P2149, DOI 10.1242/jcs.046706; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112; Zalevsky J, 1999, GENETICS, V153, P1271; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258; ZICKLER D, 1992, GENETICS, V132, P135	55	147	149	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					75	87		10.1016/j.cell.2012.01.052	http://dx.doi.org/10.1016/j.cell.2012.01.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464324	Green Accepted, Bronze			2022-12-01	WOS:000302235400011
J	Aizen, MA; Sabatino, M; Tylianakis, JM				Aizen, Marcelo A.; Sabatino, Malena; Tylianakis, Jason M.			Specialization and Rarity Predict Nonrandom Loss of Interactions from Mutualist Networks	SCIENCE			English	Article							POLLINATION NETWORKS; PLANT; STABILITY; CONSERVATION; ARCHITECTURE; DISRUPTION; IMPACT	The loss of interactions from mutualistic networks could foreshadow both plant and animal species extinctions. Yet, the characteristics of interactions that predispose them to disruption are largely unknown. We analyzed 12 pollination webs from isolated hills ("sierras"), in Argentina, ranging from tens to thousands of hectares. We found evidence of nonrandom loss of interactions with decreasing sierra size. Low interaction frequency and high specialization between interacting partners contributed additively to increase the vulnerability of interactions to disruption. Interactions between generalists in the largest sierras were ubiquitous across sierras, but many of them lost their central structural role in the smallest sierras. Thus, particular configurations of interaction networks, along with unique ecological relations and evolutionary pathways, could be lost forever after habitat reduction.	[Aizen, Marcelo A.; Sabatino, Malena] Univ Nacl Comahue, Lab Ecotono, CRUB, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Aizen, Marcelo A.] Inst Invest Biodiversidad Medioambiente INIBIOMA, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Aizen, Marcelo A.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Dept Bot, RA-1405 Buenos Aires, DF, Argentina; [Tylianakis, Jason M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	Universidad Nacional del Comahue; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University of Canterbury	Aizen, MA (corresponding author), Univ Nacl Comahue, Lab Ecotono, CRUB, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	maizen@comahue-conicet.gob.ar	Tylianakis, Jason/B-6634-2011	Tylianakis, Jason/0000-0001-7402-5620; Aizen, Marcelo/0000-0001-9079-9749	National Institute of Agricultural Technology (INTA), Balcarce [PNECO1302]; Argentina National Research Council (CONICET) [PIP 01623]; National Fund for Research [PICT 01300]; National University of Comahue [B152/04]; Rutherford Discovery Fellowship	National Institute of Agricultural Technology (INTA), Balcarce; Argentina National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Fund for Research; National University of Comahue; Rutherford Discovery Fellowship	The authors thank J. M. Gomez, L. D. Harder, D. P. Vazquez, M. Verdu, N. M. Waser, and two anonymous referees for useful comments and suggestions; A. Saez and D. Porrini for field assistance; V. Izpizua and M. Nuciari for help in plant identification; and J. Farina and A. Roig-Alsina for help in identifying insects. Partial funding by the National Institute of Agricultural Technology (INTA), Balcarce (PNECO1302), the Argentina National Research Council (CONICET) (PIP 01623), the National Fund for Research (PICT 01300), and the National University of Comahue (B152/04) is acknowledged. M.A.A. is a career researcher and M. S. a fellow of CONICET. J.M.T. is funded by a Rutherford Discovery Fellowship administered by the Royal Society of New Zealand. Data used in the analyses are available in the Supporting Online Material.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Anderson B, 2008, EVOLUTION, V62, P220, DOI 10.1111/j.1558-5646.2007.00275.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Crisci-V. Jorge, 2001, Caldasia, V23, P21; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Muller A, 2006, BIOL CONSERV, V130, P604, DOI 10.1016/j.biocon.2006.01.023; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Padron B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006275; Pauw A, 2007, ECOLOGY, V88, P1759, DOI 10.1890/06-1383.1; Pauw A, 2011, OIKOS, V120, P344, DOI 10.1111/j.1600-0706.2010.19039.x; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Sabatino M, 2010, ECOL APPL, V20, P1491, DOI 10.1890/09-1626.1; STEINER KE, 1990, EVOLUTION, V44, P1701, DOI 10.1111/j.1558-5646.1990.tb03857.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson J.N., 1994, COEVOLUTIONARY PROCE; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vazquez DP, 2003, ECOLOGY, V84, P2493, DOI 10.1890/02-0587; Williams NM, 2007, ECOL APPL, V17, P910, DOI 10.1890/06-0269; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024	34	179	184	2	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2012	335	6075					1486	1489		10.1126/science.1215320	http://dx.doi.org/10.1126/science.1215320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912YG	22442482	Green Submitted			2022-12-01	WOS:000301837000046
J	Weiner, LM; Lotze, MT				Weiner, Louis M.; Lotze, Michael T.			Tumor-Cell Death, Autophagy, and Immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Weiner, Louis M.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Lotze, Michael T.] Univ Pittsburgh, Dept Surg, Inst Canc, Pittsburgh, PA USA; [Lotze, Michael T.] Univ Pittsburgh, Dept Immunol, Inst Canc, Pittsburgh, PA USA; [Lotze, Michael T.] Univ Pittsburgh, Dept Bioengn, Inst Canc, Pittsburgh, PA USA	Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weiner, LM (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA.				NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NCI NIH HHS [P30 CA051008] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744	5	48	51	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2012	366	12					1156	1158		10.1056/NEJMcibr1114526	http://dx.doi.org/10.1056/NEJMcibr1114526			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	912BO	22435376	Green Accepted			2022-12-01	WOS:000301769700017
J	Chen, R; Mias, GI; Li-Pook-Than, J; Jiang, LH; Lam, HYK; Chen, R; Miriami, E; Karczewski, KJ; Hariharan, M; Dewey, FE; Cheng, Y; Clark, MJ; Im, H; Habegger, L; Balasubramanian, S; O'Huallachain, M; Dudley, JT; Hillenmeyer, S; Haraksingh, R; Sharon, D; Euskirchen, G; Lacroute, P; Bettinger, K; Boyle, AP; Kasowski, M; Grubert, F; Seki, S; Garcia, M; Whirl-Carrillo, M; Gallardo, M; Blasco, MA; Greenberg, PL; Snyder, P; Klein, TE; Altman, RB; Butte, AJ; Ashley, EA; Gerstein, M; Nadeau, KC; Tang, H; Snyder, M				Chen, Rui; Mias, George I.; Li-Pook-Than, Jennifer; Jiang, Lihua; Lam, Hugo Y. K.; Chen, Rong; Miriami, Elana; Karczewski, Konrad J.; Hariharan, Manoj; Dewey, Frederick E.; Cheng, Yong; Clark, Michael J.; Im, Hogune; Habegger, Lukas; Balasubramanian, Suganthi; O'Huallachain, Maeve; Dudley, Joel T.; Hillenmeyer, Sara; Haraksingh, Rajini; Sharon, Donald; Euskirchen, Ghia; Lacroute, Phil; Bettinger, Keith; Boyle, Alan P.; Kasowski, Maya; Grubert, Fabian; Seki, Scott; Garcia, Marco; Whirl-Carrillo, Michelle; Gallardo, Mercedes; Blasco, Maria A.; Greenberg, Peter L.; Snyder, Phyllis; Klein, Teri E.; Altman, Russ B.; Butte, Atul J.; Ashley, Euan A.; Gerstein, Mark; Nadeau, Kari C.; Tang, Hua; Snyder, Michael			Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes	CELL			English	Article							TIME-SERIES ANALYSIS; PERIODICITY DETECTION; GENE ONTOLOGY; RNA; EXPRESSION; IDENTIFICATION; TRANSCRIPT; MUTATIONS; ALGORITHM; DATABASE	Personalized medicine is expected to benefit from combining genomic information with regular monitoring of physiological states by multiple high-throughput methods. Here, we present an integrative personal omics profile (iPOP), an analysis that combines genomic, transcriptomic, proteomic, metabolomic, and autoantibody profiles from a single individual over a 14 month period. Our iPOP analysis revealed various medical risks, including type 2 diabetes. It also uncovered extensive, dynamic changes in diverse molecular components and biological pathways across healthy and diseased conditions. Extremely high-coverage genomic and transcriptomic data, which provide the basis of our iPOP, revealed extensive heteroallelic changes during healthy and diseased states and an unexpected RNA editing mechanism. This study demonstrates that longitudinal iPOP can be used to interpret healthy and diseased states by connecting genomic information with additional dynamic omics activity.	[Chen, Rui; Mias, George I.; Li-Pook-Than, Jennifer; Jiang, Lihua; Lam, Hugo Y. K.; Miriami, Elana; Karczewski, Konrad J.; Hariharan, Manoj; Cheng, Yong; Clark, Michael J.; Im, Hogune; O'Huallachain, Maeve; Hillenmeyer, Sara; Haraksingh, Rajini; Sharon, Donald; Euskirchen, Ghia; Lacroute, Phil; Bettinger, Keith; Boyle, Alan P.; Kasowski, Maya; Grubert, Fabian; Whirl-Carrillo, Michelle; Snyder, Phyllis; Klein, Teri E.; Altman, Russ B.; Tang, Hua; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Chen, Rong; Dudley, Joel T.; Seki, Scott; Garcia, Marco; Butte, Atul J.; Nadeau, Kari C.] Stanford Univ, Dept Pediat, Div Syst Med, Stanford, CA 94305 USA; [Chen, Rong; Dudley, Joel T.; Seki, Scott; Butte, Atul J.; Nadeau, Kari C.] Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA; [Dewey, Frederick E.; Ashley, Euan A.] Stanford Univ, Sch Med, Div Cardiovasc Med, Ctr Inherited Cardiovasc Dis, Stanford, CA 94305 USA; [Greenberg, Peter L.] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Habegger, Lukas; Balasubramanian, Suganthi; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Habegger, Lukas; Balasubramanian, Suganthi; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Gallardo, Mercedes; Blasco, Maria A.] Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, E-28029 Madrid, Spain; [Gallardo, Mercedes] Life Length, E-28003 Madrid, Spain	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Yale University; Yale University; Yale University; Centro Nacional de Investigaciones Oncologicas (CNIO)	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Boyle, Alan/I-1848-2014; cheng, yong/I-4270-2012; Blasco, Maria A./M-1694-2014; Hariharan, Manoj/N-2855-2015; Im, Hogune/ABG-3002-2021; Mias, George/J-1138-2019; O'Huallachain, Maeve/AAO-4312-2020; Karczewski, Jakub/L-7326-2018	Boyle, Alan/0000-0002-2081-1105; Blasco, Maria A./0000-0002-4211-233X; Hariharan, Manoj/0000-0002-1006-5372; Im, Hogune/0000-0002-2812-4617; Mias, George/0000-0002-9083-1216; O'Huallachain, Maeve/0000-0002-0618-6032; Haraksingh, Rajini/0000-0002-6644-8874; Karczewski, Konrad/0000-0003-2878-4671; Whirl-Carrillo, Michelle/0000-0003-2414-9312; Karczewski, Jakub/0000-0001-9322-7842; Balasubramanian, Suganthi/0000-0003-2243-5948; Snyder, Michael/0000-0003-0784-7987	Stanford University; NIH [OD004613]; NIH/NLM [T15-LM007033]; NIH/NIGMS [R24-GM61374]; Spanish Ministry of Science and Innovation [SAF2008-05384, CSD2007-00017]; European Union [2007-A-201630, 2007-A-200950]; European Research Council [GA232854]; Korber Foundation; Fundacion Marcelino Botin; Fundacion Lilly (Espana); NIH/NHLBI [T32 HL094274, KO8 HL083914]; Breetwor Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094274, K08HL083914] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, P50HG002357, U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, R24GM061374] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Stanford University(Stanford University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Korber Foundation; Fundacion Marcelino Botin; Fundacion Lilly (Espana); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Breetwor Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	M. S. is funded by grants from Stanford University and the NIH. M.G. is funded by grants from the NIH. G.I.M. is funded by NIH training grant. K.J.K., J.T.D., and S.H. are supported by the NIH/NLM training grant T15-LM007033. T.E.K. and R.B.A are funded by NIH/NIGMS R24-GM61374. M.A.B.'s laboratory is funded by the Spanish Ministry of Science and Innovation Projects SAF2008-05384 and CSD2007-00017, European Union FP7 Projects 2007-A-201630 (GENICA) and 2007-A-200950 (TELOMARKER), European Research Council Advanced Grant GA232854, the Korber Foundation, the Fundacion Marcelino Botin, and Fundacion Lilly (Espana). F.E.D. was supported by NIH/NHLBI training grant T32 HL094274. E.A.A. was supported by NIH/NHLBI KO8 HL083914, NIH New Investigator DP2 Award OD004613, and a grant from the Breetwor Family Foundation. We dedicate this manuscript to Dr. Tara A. Gianoulis, an enthusiastic advocate for genomic science. R.B.A., E.A.A., A.B., and M.S. serve as founders and consultants for Personalis. R.B.A. is a consultant to 23andMe. M.S. is a member of the scientific advisory board of GenapSys and a consultant for Illumina. M.A.B. acts as consultant and holds stock in Life Length.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahdesmaki M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-233; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dewey FE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002280; Erlich HA, 2009, GENES IMMUN, V10, pS54, DOI 10.1038/gene.2009.92; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; Gommans WM, 2008, RNA, V14, P2074, DOI 10.1261/rna.816908; Grayson BL, 2011, GENES IMMUN, V12, P341, DOI 10.1038/gene.2011.13; Hani EH, 1998, DIABETOLOGIA, V41, P1511, DOI 10.1007/s001250051098; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hocke K, 2009, ATMOS CHEM PHYS, V9, P4197, DOI 10.5194/acp-9-4197-2009; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kusunoki Masataka, 2007, J Med Invest, V54, P243, DOI 10.2152/jmi.54.243; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lapuk A, 2010, MOL CANCER RES, V8, P961, DOI 10.1158/1541-7786.MCR-09-0528; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; SCARGLE JD, 1989, ASTROPHYS J, V343, P874, DOI 10.1086/167757; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Snyder M, 2010, GENE DEV, V24, P423, DOI 10.1101/gad.1864110; Snyder M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.32; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Sun JC, 2010, WORLD J GASTROENTERO, V16, P4611, DOI 10.3748/wjg.v16.i36.4611; Theodoridis G, 2011, MASS SPECTROM REV, V30, P884, DOI 10.1002/mas.20306; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van der Werf N, 2007, DIABETES-METAB RES, V23, P169, DOI 10.1002/dmrr.695; van Dongen HPA, 1999, BIOL RHYTHM RES, V30, P149, DOI 10.1076/brhm.30.2.149.1424; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yang RD, 2011, BIOINFORMATICS, V27, P1023, DOI 10.1093/bioinformatics/btr041; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhao W., 2008, EURASIP J BIOINFORM, V2008	60	809	837	17	301	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 16	2012	148	6					1293	1307		10.1016/j.cell.2012.02.009	http://dx.doi.org/10.1016/j.cell.2012.02.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	913PI	22424236	Green Accepted, Bronze			2022-12-01	WOS:000301889500023
J	Nitschke, M; Sayk, F; Hartel, C; Roseland, RT; Hauswaldt, S; Steinhoff, J; Fellermann, K; Derad, I; Wellhoner, P; Buning, J; Tiemer, B; Katalinic, A; Rupp, J; Lehnert, H; Solbach, W; Knobloch, JKM				Nitschke, Martin; Sayk, Friedhelm; Haertel, Christoph; Roseland, Rahel Tabea; Hauswaldt, Susanne; Steinhoff, Juergen; Fellermann, Klaus; Derad, Inge; Wellhoener, Peter; Buening, Juergen; Tiemer, Bettina; Katalinic, Alexander; Rupp, Jan; Lehnert, Hendrik; Solbach, Werner; Knobloch, Johannes K. -M.			Association Between Azithromycin Therapy and Duration of Bacterial Shedding Among Patients With Shiga Toxin-Producing Enteroaggregative Escherichia coli O104:H4	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEMOLYTIC-UREMIC SYNDROME; ANTIBIOTIC-TREATMENT; TRAVELERS DIARRHEA; EPIDEMIOLOGY; OUTBREAK; RISK	Context An outbreak of Shiga toxin-producing enteroaggregative Escherichia coli (STEC O104:H4) infection with a high incidence of hemolytic uremic syndrome (HUS) occurred in Germany in May 2011. Antibiotic treatment of STEC infection is discouraged because it might increase the risk of HUS development. However, antibiotic therapy is widely used to treat enteroaggregative E coli infection. In the German outbreak, a substantial number of patients received prophylactic azithromycin treatment as part of a therapeutic regimen with the C5 antibody eculizumab. Objective To analyze the duration of bacterial shedding in patients with STEC infection who did and did not receive oral azithromycin therapy. Design, Setting, and Patients At a single center in Lubeck, Germany, 65 patients with STEC infection, including patients with HUS as well as STEC-infected outpatients without manifestation of HUS, were investigated between May 15 and July 26, 2011, and were monitored for a mean of 39.3 days after onset of clinical symptoms. Main Outcome Measure Carriage of STEC after azithromycin therapy. Results Twenty-two patients received oral azithromycin and 43 patients did not receive antibiotic treatment. Among antibiotic-treated patients, long-term STEC carriage (>28 days) was observed in 1 of 22 patients (4.5%; 95% CI, 0%-13.3%) compared with 35 of 43 patients (81.4%; 95% CI, 69.8%-93.0%) who were not treated with antibiotics (P<.001). All 22 patients receiving azithromycin treatment had at least 3 STEC-negative stool specimens after the completion of treatment, and no recurrence of STEC was observed in these patients. As proof of principle, 15 patients who initially were not treated with antibiotics and were long-term STEC carriers were treated with oral azithromycin given for 3 days and subsequently had negative stool specimens. Conclusion Treatment with azithromycin was associated with a lower frequency of long-term STEC O104: H4 carriage. JAMA. 2012;307(10):1046-1052 www.jama.com	[Roseland, Rahel Tabea; Hauswaldt, Susanne; Rupp, Jan; Solbach, Werner; Knobloch, Johannes K. -M.] Univ Hosp Schleswig Holstein, Dept Med Microbiol & Hyg, D-23538 Lubeck, Germany; [Nitschke, Martin; Sayk, Friedhelm; Steinhoff, Juergen; Fellermann, Klaus; Derad, Inge; Wellhoener, Peter; Buening, Juergen; Lehnert, Hendrik] Univ Hosp Schleswig Holstein, Dept Internal Med 1, D-23538 Lubeck, Germany; [Haertel, Christoph] Univ Hosp Schleswig Holstein, Dept Pediat, D-23538 Lubeck, Germany; [Rupp, Jan] Univ Hosp Schleswig Holstein, Dept Internal Med Infect Dis 3, D-23538 Lubeck, Germany; [Tiemer, Bettina] Lab Gemeinschaftspraxis Lubeck, Lubeck, Germany; [Katalinic, Alexander] Med Univ Lubeck, Inst Clin Epidemiol, D-23538 Lubeck, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck	Knobloch, JKM (corresponding author), Univ Hosp Schleswig Holstein, Dept Med Microbiol & Hyg, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany.	Johannes.Knobloch@uksh.de	Knobloch, Johannes K./D-6456-2011; Rupp, Jan/C-8794-2011; Solbach, Werner/F-9217-2012; Katalinic, Alexander/D-2512-2010; Nitschke, Martin/ABA-9388-2021; Härtel, Christoph/ABD-8841-2020; Solbach, Werner/O-8582-2015	Knobloch, Johannes K./0000-0002-2591-6387; Rupp, Jan/0000-0001-8722-1233; Katalinic, Alexander/0000-0003-0490-1554; Nitschke, Martin/0000-0002-2716-7527; Solbach, Werner/0000-0002-3608-8652	Novartis; Genzyme; Roche; German Research Foundation [SFB 654]; Bayer Healthcare; Gilead; Janssen-Cilag; German Ministry of Educationand Research; bioMerieux; Bayer Vital; Alere; Alexion Pharma	Novartis(Novartis); Genzyme(Sanofi-AventisGenzyme Corporation); Roche(Roche Holding); German Research Foundation(German Research Foundation (DFG)); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Gilead(Gilead Sciences); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); German Ministry of Educationand Research(Federal Ministry of Education & Research (BMBF)); bioMerieux; Bayer Vital(Bayer AG); Alere; Alexion Pharma	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Nitschke reported receiving research and travel grants from Novartis, Genzyme, and Roche. Dr Sayk reported receiving funding from a grant of the German Research Foundation (SFB 654, Project B4). Dr Hartel reported serving on a consultant/advisory board for Drager Medical. Dr Rupp reported receiving research and travel grants from Bayer Healthcare, Gilead, and Janssen-Cilag and serving as consultant or speaker for Merck Sharpe & Dohme, Bayer Healthcare, Gilead, and Abbott. Dr Lehnert reported receiving funding from grants of the German Research Foundation and the German Ministry of Educationand Research. Dr Knobloch reported receiving research and travel grants from Novartis, bioMerieux, Bayer Vital, and Alere and serving as consultant or speaker for bioMerieux, Novartis, and Pfizer. No further disclosures were reported.; This study was not funded by any third party. Some of the patients in this are enrolled in a separate multicenter study funded by Alexion Pharma (clinicaltrials.gov identifier: NCT01410916).	Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; de la Cabada Bauche Javier, 2011, Gastroenterol Hepatol (N Y), V7, P88; Ericsson CD, 2007, J TRAVEL MED, V14, P312, DOI 10.1111/j.1708-8305.2007.00144.x; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Hill DR, 2010, CURR OPIN INFECT DIS, V23, P481, DOI 10.1097/QCO.0b013e32833dfca5; Huang DB, 2006, J MED MICROBIOL, V55, P1303, DOI 10.1099/jmm.0.46674-0; Huang David B, 2004, Semin Pediatr Infect Dis, V15, P266, DOI 10.1053/j.spid.2004.07.008; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Ohara T, 2002, ANTIMICROB AGENTS CH, V46, P3478, DOI 10.1128/AAC.46.11.3478-3483.2002; Okeke I N, 2001, Lancet Infect Dis, V1, P304, DOI 10.1016/S1473-3099(01)00144-X; Okhuysen PC, 2010, J INFECT DIS, V202, P503, DOI 10.1086/654895; Okhuysen PC, 2005, CURR OPIN INFECT DIS, V18, P522, DOI 10.1097/01.qco.0000185987.02878.6e; Parker C, 2009, LANCET, V373, P759, DOI 10.1016/S0140-6736(09)60001-5; Pedersen MG, 2008, J CLIN MICROBIOL, V46, P2987, DOI 10.1128/JCM.00871-08; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Robert Koch Institute, 2011, AUSBR FALLD EHEC HUS; Safdar N, 2002, JAMA-J AM MED ASSOC, V288, P996, DOI 10.1001/jama.288.8.996; Scheutz F, 2011, EUROSURVEILLANCE, V16, P5; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Weintraub A, 2007, J MED MICROBIOL, V56, P4, DOI 10.1099/jmm.0.46930-0; Wilson JB, 1996, J INFECT DIS, V174, P1021, DOI 10.1093/infdis/174.5.1021; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	26	106	108	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2012	307	10					1046	1052		10.1001/jama.2012.264	http://dx.doi.org/10.1001/jama.2012.264			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908GU	22416100	Bronze			2022-12-01	WOS:000301479700025
J	Little, MP; Rajaraman, P; Curtis, RE; Devesa, SS; Inskip, PD; Check, DP; Linet, MS				Little, M. P.; Rajaraman, P.; Curtis, R. E.; Devesa, S. S.; Inskip, P. D.; Check, D. P.; Linet, M. S.			Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CELLULAR-TELEPHONE USE; MALIGNANT BRAIN-TUMORS; CORDLESS PHONES; INCIDENCE RATES; TIME TRENDS; CANCER; CLONALITY; RADIATION; UPDATE; CELLS	Objective In view of mobile phone exposure being classified as a possible human carcinogen by the International Agency for Research on Cancer (IARC), we determined the compatibility of two recent reports of glioma risk (forming the basis of the IARC's classification) with observed incidence trends in the United States. Design Comparison of observed rates with projected rates of glioma incidence for 1997-2008. We estimated projected rates by combining relative risks reported in the 2010 Interphone study and a 2011 Swedish study by Hardell and colleagues with rates adjusted for age, registry, and sex; data for mobile phone use; and various latency periods. Setting US population based data for glioma incidence in 1992-2008, from 12 registries in the Surveillance, Epidemiology, and End Results (SEER) programme (Atlanta, Detroit, Los Angeles, San Francisco, San Jose-Monterey, Seattle, rural Georgia, Connecticut, Hawaii, Iowa, New Mexico, and Utah). Participants Data for 24 813 non-Hispanic white people diagnosed with glioma at age 18 years or older. Results Age specific incidence rates of glioma remained generally constant in 1992-2008 (-0.02% change per year, 95% confidence interval -0.28% to 0.25%), a period coinciding with a substantial increase in mobile phone use from close to 0% to almost 100% of the US population. If phone use was associated with glioma risk, we expected glioma incidence rates to be higher than those observed, even with a latency period of 10 years and low relative risks (1.5). Based on relative risks of glioma by tumour latency and cumulative hours of phone use in the Swedish study, predicted rates should have been at least 40% higher than observed rates in 2008. However, predicted glioma rates based on the small proportion of highly exposed people in the Interphone study could be consistent with the observed data. Results remained valid if we used either non-regular users or low users of mobile phones as the baseline category, and if we constrained relative risks to be more than 1. Conclusions Raised risks of glioma with mobile phone use, as reported by one (Swedish) study forming the basis of the IARC's re-evaluation of mobile phone exposure, are not consistent with observed incidence trends in US population data, although the US data could be consistent with the modest excess risks in the Interphone study.	[Little, M. P.; Rajaraman, P.; Curtis, R. E.; Inskip, P. D.; Linet, M. S.] NCI, Radiat Epidemiol Branch, Rockville, MD 20852 USA; [Devesa, S. S.; Check, D. P.] NCI, Biostat Branch, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Little, MP (corresponding author), NCI, Radiat Epidemiol Branch, Rockville, MD 20852 USA.	mark.little@nih.gov	Check, David P/J-7184-2015	Check, David P/0000-0003-3887-0493; Little, Mark/0000-0003-0980-7567	National Institutes of Health; National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [ZIACP010135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, and the National Cancer Institute, Division of Cancer Epidemiology and Genetics.	Advisory Group on Non-ionising Radiation, 2003, HLTH EFF RAD EL FIEL; Ahlbom A, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6605; Auvinen A, 2002, EPIDEMIOLOGY, V13, P356, DOI 10.1097/00001648-200205000-00018; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; BUSQUE L, 1994, NUCLEIC ACIDS RES, V22, P697, DOI 10.1093/nar/22.4.697; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; *CBTRUS, 2010, CBTRUS STAT REP PRIM; Cellular Telephone Industry Association (CTIA), 2011, CTIA SEM WIR IND SUR; Claus EB, 2006, CANCER-AM CANCER SOC, V106, P1358, DOI 10.1002/cncr.21733; de Vocht F, 2011, BIOELECTROMAGNETICS, V32, P675, DOI 10.1002/bem.20678; de Vocht F, 2011, BIOELECTROMAGNETICS, V32, P334, DOI 10.1002/bem.20648; Deltour I, 2009, J NATL CANCER I, V101, P1721, DOI 10.1093/jnci/djp415; Frei P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6387; Fritz A., 2000, INT CLASSIFICATION D; Hardell L, 2006, ENVIRON RES, V100, P232, DOI 10.1016/j.envres.2005.04.006; Hardell L, 2002, INT J RADIAT BIOL, V78, P931, DOI 10.1080/09553000210158038; Hardell L, 2011, INT J EPIDEMIOL, V40, P1126, DOI 10.1093/ije/dyq246; Hardell L, 2011, INT J ONCOL, V38, P1465, DOI 10.3892/ijo.2011.947; Hardell L, 2009, INT J ONCOL, V35, P5, DOI 10.3892/ijo_00000307; Howlader N. e., 2011, SEER CANC STAT REV 1; Inskip PD, 2001, NEW ENGL J MED, V344, P79, DOI 10.1056/NEJM200101113440201; Inskip PD, 2010, NEURO-ONCOLOGY, V12, P1147, DOI 10.1093/neuonc/noq077; Johansen C, 2001, JNCI-J NATL CANCER I, V93, P203, DOI 10.1093/jnci/93.3.203; La Regina M, 2003, RADIAT RES, V160, P143, DOI 10.1667/RR3028; Little MP, 2009, RADIOLOGY, V251, P6, DOI [10.1148/radiol.2511081686, 10.1148/radiol.1.2511081686]; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Muscat JE, 2000, JAMA-J AM MED ASSOC, V284, P3001, DOI 10.1001/jama.284.23.3001; National Research Council Committee, 2006, HLTH RISKS EXP LOW L; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Preston DL, 1998, EPICURE RELEASE 2 10; Ries LAG, 2007, PUBLICATION SEER; Sato Y, 2011, BIOELECTROMAGNETICS, V32, P85, DOI 10.1002/bem.20616; Schuz J, 2006, JNCI-J NATL CANCER I, V98, P1707, DOI 10.1093/jnci/djj464; SIDRANSKY D, 1992, NATURE, V355, P846, DOI 10.1038/355846a0; Surveillance Epidemiology and End Results (SEER) Program, 2011, SEER STAT DAT INC SE; Tada M, 1996, INT J CANCER, V67, P447, DOI 10.1002/(SICI)1097-0215(19960729)67:3<447::AID-IJC22>3.0.CO;2-3; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2008, UNSCEAR 2006 REP ANN; US Census Bureau, 2011, POP EST; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Zhu JJG, 1999, NEUROSURGERY, V45, P409, DOI 10.1097/00006123-199908000-00049	40	83	86	0	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2012	344								e1147	10.1136/bmj.e1147	http://dx.doi.org/10.1136/bmj.e1147			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	908HL	22403263	hybrid, Green Published			2022-12-01	WOS:000301481400001
J	Gill, JS; Tonelli, M				Gill, John S.; Tonelli, Marcello			Penny Wise, Pound Foolish? Coverage Limits on Immunosuppression after Kidney Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gill, John S.] Univ British Columbia, Div Nephrol, Vancouver, BC V5Z 1M9, Canada; [Tonelli, Marcello] Univ Alberta, Div Nephrol, Edmonton, AB, Canada; [Gill, John S.; Tonelli, Marcello] Interdisciplinary Chron Dis Collaborat, Calgary, AB, Canada	University of British Columbia; University of Alberta	Gill, JS (corresponding author), Univ British Columbia, Div Nephrol, Vancouver, BC V5Z 1M9, Canada.		Tonelli, Marcello/B-3028-2009	Tonelli, Marcello/0000-0002-0846-3187				Becker BN, 2010, CLIN J AM SOC NEPHRO, V5, P744, DOI 10.2215/CJN.02610310; Evans RW, 2010, CLIN J AM SOC NEPHRO, V5, P2323, DOI 10.2215/CJN.04220510; Kasiske BL, 2000, JAMA-J AM MED ASSOC, V283, P2445, DOI 10.1001/jama.283.18.2445; Page Timothy F, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P435, DOI 10.1586/erp.09.52; Woodward R S, 2008, Am J Transplant, V8, P2636, DOI 10.1111/j.1600-6143.2008.02422.x	5	57	58	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 16	2012	366	7					586	589		10.1056/NEJMp1114394	http://dx.doi.org/10.1056/NEJMp1114394			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	892IL	22296029				2022-12-01	WOS:000300279800003
J	Hino, T; Arakawa, T; Iwanari, H; Yurugi-Kobayashi, T; Ikeda-Suno, C; Nakada-Nakura, Y; Kusano-Arai, O; Weyand, S; Shimamura, T; Nomura, N; Cameron, AD; Kobayashi, T; Hamakubo, T; Iwata, S; Murata, T				Hino, Tomoya; Arakawa, Takatoshi; Iwanari, Hiroko; Yurugi-Kobayashi, Takami; Ikeda-Suno, Chiyo; Nakada-Nakura, Yoshiko; Kusano-Arai, Osamu; Weyand, Simone; Shimamura, Tatsuro; Nomura, Norimichi; Cameron, Alexander D.; Kobayashi, Takuya; Hamakubo, Takao; Iwata, So; Murata, Takeshi			G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody	NATURE			English	Article							ADENOSINE A(2A) RECEPTOR; CRYSTAL-STRUCTURE; COMPLEX; GPCR; VALIDATION; EXPRESSION; RHODOPSIN; MODELS	G-protein-coupled receptors are the largest class of cell-surface receptors, and these membrane proteins exist in equilibrium between inactive and active states(1-13). Conformational changes induced by extracellular ligands binding to G-protein-coupled receptors result in a cellular response through the activation of G proteins. The A(2A) adenosine receptor (A(2A)AR) is responsible for regulating blood flow to the cardiac muscle and is important in the regulation of glutamate and dopamine release in the brain(14). Here we report the raising of a mouse monoclonal antibody against human A(2A)AR that prevents agonist but not antagonist binding to the extracellular ligand-binding pocket, and describe the structure of A(2A)AR in complex with the antibody Fab fragment (Fab2838). This structure reveals that Fab2838 recognizes the intracellular surface of A(2A)AR and that its complementarity-determining region, CDR-H3, penetrates into the receptor. CDR-H3 is located in a similar position to the G-protein carboxy-terminal fragment in the active opsin structure(1) and to CDR-3 of the nanobody in the active beta(2)-adrenergic receptor structure(2), but locks A(2A)AR in an inactive conformation. These results suggest a new strategy to modulate the activity of G-protein-coupled receptors.	[Hino, Tomoya; Arakawa, Takatoshi; Yurugi-Kobayashi, Takami; Ikeda-Suno, Chiyo; Weyand, Simone; Shimamura, Tatsuro; Nomura, Norimichi; Cameron, Alexander D.; Kobayashi, Takuya; Iwata, So; Murata, Takeshi] Japan Sci & Technol Agcy, Iwata Human Receptor Crystallog Project, ERATO, Sakyo Ku, Kyoto 6068501, Japan; [Hino, Tomoya; Arakawa, Takatoshi; Yurugi-Kobayashi, Takami; Ikeda-Suno, Chiyo; Shimamura, Tatsuro; Nomura, Norimichi; Kobayashi, Takuya; Iwata, So; Murata, Takeshi] Kyoto Univ, Dept Cell Biol, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Iwanari, Hiroko; Nakada-Nakura, Yoshiko; Kusano-Arai, Osamu; Hamakubo, Takao] Univ Tokyo, Dept Mol Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Nakada-Nakura, Yoshiko] Perseus Proteom Inc, Meguro Ku, Tokyo 1530041, Japan; [Kusano-Arai, Osamu] Inst Immunol Co Ltd, Bunkyo Ku, Tokyo 1120004, Japan; [Weyand, Simone; Cameron, Alexander D.; Iwata, So] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Membrane Prot Crystallog Grp, London SW7 2AZ, England; [Weyand, Simone; Cameron, Alexander D.; Iwata, So] Diamond Light Source, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England; [Weyand, Simone; Cameron, Alexander D.; Iwata, So] Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England; [Kobayashi, Takuya] Kyoto Univ, Fac Med, Japan Sci & Technol Agcy, Kyoto 6068501, Japan; [Iwata, So; Murata, Takeshi] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan	Japan Science & Technology Agency (JST); Kyoto University; University of Tokyo; Imperial College London; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Japan Science & Technology Agency (JST); Kyoto University; RIKEN; Chiba University	Iwata, S (corresponding author), Japan Sci & Technol Agcy, Iwata Human Receptor Crystallog Project, ERATO, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	so_iwata@mac.com; t.murata@faculty.chiba-u.jp	Arakawa, Takatoshi/K-9739-2013; Murata, Takeshi/J-6181-2017; Cameron, Alexander/L-7288-2013	Arakawa, Takatoshi/0000-0001-6496-5440; Murata, Takeshi/0000-0002-5748-4670; Cameron, Alexander/0000-0001-8776-3518	Japan Science and Technology Agency; MEXT, Japan; Development of New Functional Antibody Technologies (New Energy and Industrial Technology Development Organization, Japan); Biotechnology and Biological Sciences Research Council [BB/G023425/1]; Wellcome Trust at the Diamond Light Source, UK [062164/Z/00/Z]; Grants-in-Aid for Scientific Research [22570114, 23370049, 20221010] Funding Source: KAKEN; BBSRC [BB/G023425/1] Funding Source: UKRI	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Development of New Functional Antibody Technologies (New Energy and Industrial Technology Development Organization, Japan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust at the Diamond Light Source, UK; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the ERATO Human Receptor Crystallography Project of the Japan Science and Technology Agency (S. I.), by the Targeted Proteins Research Program of MEXT, Japan (S. I.), and by Development of New Functional Antibody Technologies (New Energy and Industrial Technology Development Organization, Japan) (T. Hamakubo). It was also partly funded by the Biotechnology and Biological Sciences Research Council (BB/G023425/1) (S. I.). The work was partly performed in the Membrane Protein Laboratory funded by the Wellcome Trust (grant 062164/Z/00/Z) (S. I.) at the Diamond Light Source, UK. Data were collected at Diamond Light Source beamline I24 with the assistance of G. Evans, R. Owen, D. Axford and J. Aishima.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller CE, 2011, BBA-BIOMEMBRANES, V1808, P1290, DOI 10.1016/j.bbamem.2010.12.017; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yurugi-Kobayashi T, 2009, BIOCHEM BIOPH RES CO, V380, P271, DOI 10.1016/j.bbrc.2009.01.053	35	227	242	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2012	482	7384					237	U130		10.1038/nature10750	http://dx.doi.org/10.1038/nature10750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888HI	22286059	Green Accepted			2022-12-01	WOS:000299994100042
J	Itzkovitz, S; Blat, IC; Jacks, T; Clevers, H; van Oudenaarden, A				Itzkovitz, Shalev; Blat, Irene C.; Jacks, Tyler; Clevers, Hans; van Oudenaarden, Alexander			Optimality in the Development of Intestinal Crypts	CELL			English	Article							DUODENAL PROGENITOR POPULATION; HEMATOPOIETIC STEM-CELLS; MOUSE SMALL-INTESTINE; PANETH CELLS; CANCER; DIFFERENTIATION; EPITHELIUM; LGR5; NEURONOGENESIS; PROLIFERATION	Intestinal crypts in mammals are comprised of long-lived stem cells and shorter-lived progenies. These two populations are maintained in specific proportions during adult life. Here, we investigate the design principles governing the dynamics of these proportions during crypt morphogenesis. Using optimal control theory, we show that a proliferation strategy known as a "bang-bang" control minimizes the time to obtain a mature crypt. This strategy consists of a surge of symmetric stem cell divisions, establishing the entire stem cell pool first, followed by a sharp transition to strictly asymmetric stem cell divisions, producing nonstem cells with a delay. We validate these predictions using lineage tracing and single-molecule fluorescence in situ hybridization of intestinal crypts in infant mice, uncovering small crypts that are entirely composed of Lgr5-labeled stem cells, which become a minority as crypts continue to grow. Our approach can be used to uncover similar design principles in other developmental systems.	[Itzkovitz, Shalev; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Blat, Irene C.; Jacks, Tyler; van Oudenaarden, Alexander] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Itzkovitz, Shalev; Blat, Irene C.; Jacks, Tyler; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Clevers, Hans; van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019		NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; NIH [1DP1OD003936]; National Cancer Institute [P30-CA14051]; International Human Frontiers Science Program Organization; Machiah Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U54CA143874, DP1CA174420, P30CA014051] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); International Human Frontiers Science Program Organization(Human Frontier Science Program); Machiah Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Uri Alon for suggesting the optimality problem. We thank Johan van Es for help with the lineage tracing experiments. We also thank George Oster, Hyun Youk, Stefan Semrau and Sandy Klemm for valuable discussions. This work was supported by the NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874) and a NIH Pioneer award (1DP1OD003936) to A.v.O. and in part by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. T.J. is a Howard Hughes Investigator and a Daniel K. Ludwig Scholar. S.I. acknowledges support from the International Human Frontiers Science Program Organization and the Machiah Foundation. I.B. acknowledges support from the Howard Hughes Medical Institute Gilliam fellowship.	ALNAFUSSI AI, 1982, VIRCHOWS ARCH B, V40, P51, DOI 10.1007/BF02932850; Alon U, 2006, INTRO SYSTEMS BIOL D; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BJERKNES M, 1981, AM J ANAT, V160, P65, DOI 10.1002/aja.1001600106; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Brizova H, 2010, VIRCHOWS ARCH, V456, P671, DOI 10.1007/s00428-010-0922-8; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; CAMERON IL, 1963, J CELL BIOL, V18, P31, DOI 10.1083/jcb.18.1.31; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Frank SA, 2003, GENETICS, V163, P1527; GREY RD, 1968, DEV BIOL, V18, P501, DOI 10.1016/0012-1606(68)90054-7; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Kirk D.E., 2004, OPTIMAL CONTROL THEO; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Komarova NL, 2008, J R SOC INTERFACE, V5, P105, DOI 10.1098/rsif.2007.1054; Koo D, 1977, ELEMENTS OPTIMIZATIO; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; MACEVICZ S, 1976, BEHAV ECOL SOCIOBIOL, V1, P265, DOI 10.1007/BF00300068; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Michor F, 2003, J THEOR BIOL, V225, P377, DOI 10.1016/S0022-5193(03)00267-4; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cellbio.11.1.35; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Nowakowski Richard S, 2002, Results Probl Cell Differ, V39, P1; PERELSON AS, 1976, J MATH BIOL, V3, P325, DOI 10.1007/BF00275065; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; QUASTLER H, 1959, EXP CELL RES, V17, P420, DOI 10.1016/0014-4827(59)90063-1; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Reeves GT, 2009, PLOS BIOL, V7, P32, DOI 10.1371/journal.pbio.1000021; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; Slack JMW, 2000, SCIENCE, V287, P1431, DOI 10.1126/science.287.5457.1431; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; THRASHER JD, 1966, J EXP ZOOL, V161, P9, DOI 10.1002/jez.1401610103; THRASHER JD, 1965, J EXP ZOOL, V159, P39, DOI 10.1002/jez.1401590105; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998	45	111	112	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 3	2012	148	3					608	619		10.1016/j.cell.2011.12.025	http://dx.doi.org/10.1016/j.cell.2011.12.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304925	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000300225000026
J	Nishino, T; Takeuchi, K; Gascoigne, KE; Suzuki, A; Hori, T; Oyama, T; Morikawa, K; Cheeseman, IM; Fukagawa, T				Nishino, Tatsuya; Takeuchi, Kozo; Gascoigne, Karen E.; Suzuki, Aussie; Hori, Tetsuya; Oyama, Takuji; Morikawa, Kosuke; Cheeseman, Iain M.; Fukagawa, Tatsuo			CENP-T-W-S-X Forms a Unique Centromeric Chromatin Structure with a Histone-like Fold	CELL			English	Article							CRYSTAL-STRUCTURE; DNA; NUCLEOSOME; COMPLEX; CORE	The multiprotein kinetochore complex must assemble at a specific site on each chromosome to achieve accurate chromosome segregation. Defining the nature of the DNA-protein interactions that specify the position of the kinetochore and provide a scaffold for kinetochore formation remain key goals. Here, we demonstrate that the centromeric histone-fold-containing CENP-T-W and CENP-S-X complexes coassemble to form a stable CENP-T-W-S-X heterotetramer. High-resolution structural analysis of the individual complexes and the heterotetramer reveals similarity to other histone fold-containing complexes including canonical histones within a nucleosome. The CENP-T-W-S-X heterotetramer binds to and supercoils DNA. Mutants designed to compromise heterotetramerization or the DNA-protein contacts around the heterotetramer strongly reduce the DNA binding and supercoiling activities in vitro and compromise kinetochore assembly in vivo. These data suggest that the CENP-T-W-S-X complex forms a unique nucleosome-like structure to generate contacts with DNA, extending the "histone code'' beyond canonical nucleosome proteins.	[Nishino, Tatsuya; Takeuchi, Kozo; Suzuki, Aussie; Hori, Tetsuya; Fukagawa, Tatsuo] Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; [Nishino, Tatsuya; Takeuchi, Kozo; Suzuki, Aussie; Hori, Tetsuya; Fukagawa, Tatsuo] Grad Univ Adv Studies SOKENDAI, Mishima, Shizuoka 4118540, Japan; [Gascoigne, Karen E.; Cheeseman, Iain M.] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gascoigne, Karen E.; Cheeseman, Iain M.] Nine Cambridge Ctr, Dept Biol, MIT, Cambridge, MA 02142 USA; [Oyama, Takuji; Morikawa, Kosuke] Osaka Univ, Takara Bio Endowed Div, Dept Biomol Recognit, Inst Prot Res, Suita, Osaka 5650874, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Osaka University	Fukagawa, T (corresponding author), Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan.	tfukagaw@lab.nig.ac.jp	Fukagawa, Tatsuo/AAK-3922-2021; Suzuki, Aussie/ABF-4170-2021	Cheeseman, Iain/0000-0002-3829-5612; Oyama, Takuji/0000-0002-3411-7608; nishino, tatsuya/0000-0001-8017-8762; Takeuchi, Kozo/0000-0003-2531-9264; Suzuki, Aussie/0000-0001-7390-5116	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Cabinet Office, Government of Japan; Searle Scholars Program; NIH/National Institute of General Medical Sciences [GM088313]; The International Human Frontier Science Program Organization; MEXT; EMBO; Grants-in-Aid for Scientific Research [23121530, 22570008] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088313] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cabinet Office, Government of Japan; Searle Scholars Program; NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); The International Human Frontier Science Program Organization(Human Frontier Science Program); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EMBO(European Molecular Biology Organization (EMBO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to M. Takahashi, K. Suzuki, K. Nakaguchi, and K. Kita for technical assistance; C. Davey for the generous gift of the pUC57-601-145 plasmid; and H. Kurumizaka for the advice on histone experiments. The synchrotron radiation experiments were performed at the BL38B1 and BL44XU of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2010B1059, 2010B1060, and 2011A1211). This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers'' to TF and grants from the Searle Scholars Program and the NIH/National Institute of General Medical Sciences (GM088313) to IMC. TN is supported by The International Human Frontier Science Program Organization grant and by Grants-in-Aid for Scientific Research from MEXT. KEG is supported by an EMBO long-term fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Burley SK, 1997, CURR OPIN STRUC BIOL, V7, P94, DOI 10.1016/S0959-440X(97)80012-7; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Hartlepp KF, 2005, MOL CELL BIOL, V25, P9886, DOI 10.1128/MCB.25.22.9886-9896.2005; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Prendergast L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001082; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Suzuki A, 2011, J CELL BIOL, V193, P125, DOI 10.1083/jcb.201012050; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039	28	178	188	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2012	148	3					487	501		10.1016/j.cell.2011.11.061	http://dx.doi.org/10.1016/j.cell.2011.11.061			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304917	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000300225000017
J	Tobin, DM; Roca, FJ; Oh, SF; McFarland, R; Vickery, TW; Ray, JP; Ko, DC; Zou, YX; Bang, ND; Chau, TTH; Vary, JC; Hawn, TR; Dunstan, SJ; Farrar, JJ; Thwaites, GE; King, MC; Serhan, CN; Ramakrishnan, L				Tobin, David M.; Roca, Francisco J.; Oh, Sungwhan F.; McFarland, Ross; Vickery, Thad W.; Ray, John P.; Ko, Dennis C.; Zou, Yuxia; Bang, Nguyen D.; Chau, Tran T. H.; Vary, Jay C.; Hawn, Thomas R.; Dunstan, Sarah J.; Farrar, Jeremy J.; Thwaites, Guy E.; King, Mary-Claire; Serhan, Charles N.; Ramakrishnan, Lalita			Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections	CELL			English	Article							TUBERCULOUS MENINGITIS; MACROPHAGE DEATH; LIPID MEDIATORS; TNF-ALPHA; CELLS; NECROSIS; ASPIRIN; HIV; LEUKOTRIENE-B4; BIOSYNTHESIS	Susceptibility to tuberculosis is historically ascribed to an inadequate immune response that fails to control infecting mycobacteria. In zebrafish, we find that susceptibility to Mycobacterium marinum can result from either inadequate or excessive acute inflammation. Modulation of the leukotriene A(4) hydrolase (LTA4H) locus, which controls the balance of pro- and anti-inflammatory eicosanoids, reveals two distinct molecular routes to mycobacterial susceptibility converging on dysregulated TNF levels: inadequate inflammation causedby excess lipoxins and hyperinflammation driven by excess leukotriene B-4. We identify therapies that specifically target each of these extremes. In humans, we identify a single nucleotide polymorphism in the LTA4H promoter that regulates its transcriptional activity. In tuberculous meningitis, the polymorphism is associated with inflammatory cell recruitment, patient survival and response to adjunctive anti-inflammatory therapy. Together, our findings suggest that host-directed therapies tailored to patient LTA4H genotypes may counter detrimental effects of either extreme of inflammation.	[Tobin, David M.; Roca, Francisco J.; McFarland, Ross; Ray, John P.; Ko, Dennis C.; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Tobin, David M.; Zou, Yuxia] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Oh, Sungwhan F.; Vickery, Thad W.; Serhan, Charles N.] Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Sch Med, Boston, MA 02115 USA; [Bang, Nguyen D.] Pham Ngoc Thach Hosp TB & Lung Dis, Ho Chi Minh City, Vietnam; [Vary, Jay C.; Hawn, Thomas R.; King, Mary-Claire; Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Dunstan, Sarah J.; Farrar, Jeremy J.] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Dunstan, Sarah J.; Farrar, Jeremy J.] Univ Oxford, Ctr Trop Med, Nuffield Dept Clin Med, Oxford OX3 7LJ, England; [Thwaites, Guy E.] Kings Coll London, Ctr Clin Infect & Diagnost Res, St Thomas Hosp, London SE1 9RT, England; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Duke University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; University of Oxford; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	lalitar@uw.edu	Ray, John/F-3187-2015; Dunstan, Sarah/AAO-9597-2020; Farrar, Jeremy J./HGA-7610-2022; Thwaites, Guy E/R-4993-2019	Ray, John/0000-0001-7294-4260; Thwaites, Guy E/0000-0002-2858-2087; Farrar, Jeremy/0000-0002-2700-623X; Vary, James/0000-0001-5390-5426; Dunstan, Sarah/0000-0001-7873-933X; King, Mary-Claire/0000-0001-9426-1743; Tobin, David/0000-0003-3465-5518; Ramakrishnan, Lalita/0000-0003-0692-5533	NIH; American Cancer Society; Mallinckrodt Scholar Award; educational ministry of Spain; NWRCE for Biodefense and Emerging Infectious Diseases Research; Burroughs Wellcome Fund; Wellcome Trust; American Skin Association; Dermatology Foundation; Chinese Academy of Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054503, R01AI054503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099901] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Mallinckrodt Scholar Award; educational ministry of Spain; NWRCE for Biodefense and Emerging Infectious Diseases Research; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Wellcome Trust(Wellcome TrustEuropean Commission); American Skin Association; Dermatology Foundation; Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Rachel Brem for advice and providing the HapMap genotypes; Amy Weinmann for advice and help with macrophage transfections; Victor Mulero for recombinant zebrafish TNF; Marcel Wolbers for help with statistical analysis of the TB meningitis cohort; Glenna Peterson and Tiffany Pecor for technical support; James Cameron for fish facility management; Paul Edelstein and John Szumowski for discussion; Paul Edelstein for advice on statistics; and Paul Edelstein, Brendan Cormack and Kevin Urdahl for manuscript review. Funded by grants from the NIH (L.R., C.N.S.), an American Cancer Society postdoctoral fellowship and a Mallinckrodt Scholar Award (D.M.T.), a postdoctoral fellowship from the educational ministry of Spain (F.J.R.), the NWRCE for Biodefense and Emerging Infectious Diseases Research (L.R. and D.C.K.), the Burroughs Wellcome Fund (L.R. and T.R.H.), the Wellcome Trust, UK (G.T., J.F., S.D., T.T.H.C. and N.D.B.), the American Skin Association, the Dermatology Foundation, and an NIH postdoctoral fellowship grant (J.C.V.), and the Chinese Academy of Sciences (Y.Z.). M.C.K. is an American Cancer Society Professor. D.M.T. is a recipient of the NIH Director's New Innovator Award and L.R. is a recipient of the NIH Director's Pioneer Award.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ariel A, 2003, J IMMUNOL, V170, P6266, DOI 10.4049/jimmunol.170.12.6266; Auerbach BJ, 1996, J BIOL CHEM, V271, P1329, DOI 10.1074/jbc.271.3.1329; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Behr M, 2010, CELL, V140, P615, DOI 10.1016/j.cell.2010.02.030; CHAMBERS ST, 1984, LANCET, V2, P181; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Curtis J, 2011, TUBERCULOSIS, V91, P22, DOI 10.1016/j.tube.2010.11.001; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Donald PR, 2004, NEW ENGL J MED, V351, P1719, DOI 10.1056/NEJMp048227; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; GOLDMAN G, 1993, SURGERY, V113, P297; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Hawkey CR, 2005, CLIN INFECT DIS, V40, P1368, DOI 10.1086/429317; Kahawita IP, 2008, T ROY SOC TROP MED H, V102, P329, DOI 10.1016/j.trstmh.2008.01.004; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn S.D., 2011, TUBERCULOSIS LANCET; MARKMAN M, 1981, NEW ENGL J MED, V305, P167; Mayanja-Kizza H, 2005, J INFECT DIS, V191, P856, DOI 10.1086/427995; Mayosi B.M., 2002, COCHRANE DB SYST REV, V4), DOI [10.1002/14651858.CD000526, DOI 10.1002/14651858.CD000526]; Misra UK, 2010, J NEUROL SCI, V293, P12, DOI 10.1016/j.jns.2010.03.025; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; MUTHUSWAMY P, 1995, CHEST, V107, P1621, DOI 10.1378/chest.107.6.1621; PAYAN DG, 1984, P NATL ACAD SCI-BIOL, V81, P3501, DOI 10.1073/pnas.81.11.3501; Prasad K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub3; Roca FJ, 2008, J IMMUNOL, V181, P5071, DOI 10.4049/jimmunol.181.7.5071; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Schoeman J.F., 2011, J CHILD NEUROLOGY; Schoeman JF, 1997, PEDIATRICS, V99, P226, DOI 10.1542/peds.99.2.226; Serhan, 2010, FUNDAMENTALS INFLAMM, DOI 10.1017/CBO9781139195737; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; SERHAN CN, 1993, BIOCHEMISTRY-US, V32, P6313, DOI 10.1021/bi00076a002; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wallis RS, 2005, CLIN INFECT DIS, V41, P201, DOI 10.1086/430914	44	390	400	3	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2012	148	3					434	446		10.1016/j.cell.2011.12.023	http://dx.doi.org/10.1016/j.cell.2011.12.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304914	Green Accepted, Bronze			2022-12-01	WOS:000300225000013
J	Tenaillon, O; Rodriguez-Verdugo, A; Gaut, RL; McDonald, P; Bennett, AF; Long, AD; Gaut, BS				Tenaillon, Olivier; Rodriguez-Verdugo, Alejandra; Gaut, Rebecca L.; McDonald, Pamela; Bennett, Albert F.; Long, Anthony D.; Gaut, Brandon S.			The Molecular Diversity of Adaptive Convergence	SCIENCE			English	Article							LONG-TERM EXPERIMENT; ESCHERICHIA-COLI; EXPERIMENTAL EVOLUTION; BENEFICIAL MUTATIONS; ADAPTATION; SELECTION; TEMPERATURE; EPISTASIS	To estimate the number and diversity of beneficial mutations, we experimentally evolved 115 populations of Escherichia coli to 42.2 degrees C for 2000 generations and sequenced one genome from each population. We identified 1331 total mutations, affecting more than 600 different sites. Few mutations were shared among replicates, but a strong pattern of convergence emerged at the level of genes, operons, and functional complexes. Our experiment uncovered a set of primary functional targets of high temperature, but we estimate that many other beneficial mutations could contribute to similar adaptive outcomes. We inferred the pervasive presence of epistasis among beneficial mutations, which shaped adaptive trajectories into at least two distinct pathways involving mutations either in the RNA polymerase complex or the termination factor rho.	[Tenaillon, Olivier; Rodriguez-Verdugo, Alejandra; Gaut, Rebecca L.; McDonald, Pamela; Bennett, Albert F.; Long, Anthony D.; Gaut, Brandon S.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Tenaillon, Olivier] INSERM, UMR S 722, F-75018 Paris, France; [Tenaillon, Olivier] Univ Paris Diderot, UMR S 722, F-75018 Paris, France	University of California System; University of California Irvine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Tenaillon, O (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, 321 Steinhaus Hall, Irvine, CA 92697 USA.	olivier.tenaillon@inserm.fr; bgaut@uci.edu	Tenaillon, Olivier/L-9857-2017	Long, Tony/0000-0002-5007-8514; Tenaillon, Olivier/0000-0002-3796-1601	NSF [DEB-0748903]; Agence Nationale de la Recherche [ANR-08-GENM-023-001]	NSF(National Science Foundation (NSF)); Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank L. Chao, C. Herman, and D. Schneider for discussion. This work was supported by NSF grant DEB-0748903 to A. F. B., A. D. L., and B. S. G. and by Agence Nationale de la Recherche, Programme Genomique, grant ANR-08-GENM-023-001 to O.T. Raw sequence data are available for download at http://wfitch.bio.uci.edu/similar to tdlong/Coli_EE_RawData.tgz.	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; BENNETT AF, 1992, EVOLUTION, V46, P16, DOI 10.1111/j.1558-5646.1992.tb01981.x; BENNETT AF, 1990, NATURE, V346, P79, DOI 10.1038/346079a0; Burke MK, 2010, NATURE, V467, P587, DOI 10.1038/nature09352; CHAO L, 1983, NATURE, V303, P633, DOI 10.1038/303633a0; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Christin PA, 2010, TRENDS GENET, V26, P400, DOI 10.1016/j.tig.2010.06.005; Conrad TM, 2010, P NATL ACAD SCI USA, V107, P20500, DOI 10.1073/pnas.0911253107; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kishimoto T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001164; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LEWONTIN RC, 1964, GENETICS, V49, P49; Poon A, 2005, GENETICS, V170, P1323, DOI 10.1534/genetics.104.037259; Read KLQ, 1998, AM STAT, V52, P175, DOI 10.2307/2685477; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; Teotonio H, 2009, NAT GENET, V41, P251, DOI 10.1038/ng.289; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103	21	463	476	5	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 27	2012	335	6067					457	461		10.1126/science.1212986	http://dx.doi.org/10.1126/science.1212986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	881FG	22282810				2022-12-01	WOS:000299466800047
J	Mills, EJ; Barnighausen, T; Negin, J				Mills, Edward J.; Baernighausen, Till; Negin, Joel			HIV and Aging - Preparing for the Challenges Ahead	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AFRICA		[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Baernighausen, Till] Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Negin, Joel] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Ottawa; Harvard University; Harvard T.H. Chan School of Public Health; University of Kwazulu Natal; University of Sydney	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada.		Bärnighausen, Till/Y-2388-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD058482] Funding Source: Medline; Wellcome Trust [097410] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Hontelez JAC, 2011, AIDS, V25, P1665, DOI 10.1097/QAD.0b013e32834982ea; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, GLOB REP UNAIDS REP; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349	5	104	107	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1270	1273		10.1056/NEJMp1113643	http://dx.doi.org/10.1056/NEJMp1113643			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475591				2022-12-01	WOS:000302343000004
J	Mim, C; Cui, HS; Gawronski-Salerno, JA; Frost, A; Lyman, E; Voth, GA; Unger, VM				Mim, Carsten; Cui, Haosheng; Gawronski-Salerno, Joseph A.; Frost, Adam; Lyman, Edward; Voth, Gregory A.; Unger, Vinzenz M.			Structural Basis of Membrane Bending by the N-BAR Protein Endophilin	CELL			English	Article							CRYSTAL-STRUCTURE; DOMAIN PROTEINS; CURVATURE; DYNAMIN; INVAGINATION; SYNAPTOJANIN; AMPHIPHYSIN; HYDROLYSIS; GENERATION; MICROSCOPY	Functioning as key players in cellular regulation of membrane curvature, BAR domain proteins bend bilayers and recruit interaction partners through poorly understood mechanisms. Using electron cryo-microscopy, we present reconstructions of full-length endophilin and its N-terminal N-BAR domain in their membrane-bound state. Endophilin lattices expose large areas of membrane surface and are held together by promiscuous interactions between endophilin's amphipathic N-terminal helices. Coarse-grained molecular dynamics simulations reveal that endophilin lattices are highly dynamic and that the N-terminal helices are required for formation of a stable and regular scaffold. Furthermore, endophilin accommodates different curvatures through a quantized addition or removal of endophilin dimers, which in some cases causes dimerization of endophilin's SH3 domains, suggesting that the spatial presentation of SH3 domains, rather than affinity, governs the recruitment of downstream interaction partners.	[Mim, Carsten; Gawronski-Salerno, Joseph A.; Unger, Vinzenz M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Mim, Carsten; Gawronski-Salerno, Joseph A.; Unger, Vinzenz M.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Cui, Haosheng; Voth, Gregory A.] Univ Chicago, James Franck Inst, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA; [Cui, Haosheng; Voth, Gregory A.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Lyman, Edward] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Lyman, Edward] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Frost, Adam] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	Northwestern University; Northwestern University; University of Chicago; University of Chicago; University of Delaware; University of Delaware; Utah System of Higher Education; University of Utah	Unger, VM (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Campus Dr, Evanston, IL 60208 USA.	v-unger@northwestern.edu		Frost, Adam/0000-0003-2231-2577; Mim, Carsten/0000-0001-6402-8270	National Institutes of Health through the National Center for Research Resources' [RR017573]; Deutsche Forschungsgemeinschaft; Cancer Research Institute; PHS from the National Institutes of Health [DA24101, GM094479, GM063796]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094479, R01GM063796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024101] Funding Source: NIH RePORTER	National Institutes of Health through the National Center for Research Resources'(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Research Institute; PHS from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Pietro De Camilli and members of his lab for critical discussions and feedback. The majority of data for this work were collected at the National Resource for Automated Molecular Microscopy, which is supported by the National Institutes of Health through the National Center for Research Resources' P41 program (RR017573). We are also indebted to David Morgan for letting us use the cryoEM facility at Indiana University. This work was funded by Deutsche Forschungsgemeinschaft (C.M.) and the Cancer Research Institute (C.M.), as well as PHS grants DA24101 (V.M.U.), GM094479 (V.M.U.), and GM063796 (G.A.V.) from the National Institutes of Health.	Chang-Ileto B, 2011, DEV CELL, V20, P206, DOI 10.1016/j.devcel.2010.12.008; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Demers JP, 2009, J AM CHEM SOC, V131, P4355, DOI 10.1021/ja808255d; Egelman EH, 2007, CURR OPIN STRUC BIOL, V17, P556, DOI 10.1016/j.sbi.2007.07.006; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Llobet A, 2011, J NEUROSCI, V31, P8512, DOI 10.1523/JNEUROSCI.6223-09.2011; Lyman E, 2010, BIOPHYS J, V99, P1783, DOI 10.1016/j.bpj.2010.06.074; Mizuno N, 2010, J BIOL CHEM, V285, P23349, DOI 10.1074/jbc.M110.143776; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Solomaha E, 2005, J BIOL CHEM, V280, P23147, DOI 10.1074/jbc.M501745200; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013	36	176	176	0	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					137	145		10.1016/j.cell.2012.01.048	http://dx.doi.org/10.1016/j.cell.2012.01.048			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464326	Green Accepted, Bronze			2022-12-01	WOS:000302235400016
J	Liu, LD; Ulbrich, J; Muller, J; Wustefeld, T; Aeberhard, L; Kress, TR; Muthalagu, N; Rycak, L; Rudalska, R; Moll, R; Kempa, S; Zender, L; Eilers, M; Murphy, DJ				Liu, Lidan; Ulbrich, Jannes; Mueller, Judith; Wuestefeld, Torsten; Aeberhard, Lukas; Kress, Theresia R.; Muthalagu, Nathiya; Rycak, Lukas; Rudalska, Ramona; Moll, Roland; Kempa, Stefan; Zender, Lars; Eilers, Martin; Murphy, Daniel J.			Deregulated MYC expression induces dependence upon AMPK-related kinase 5	NATURE			English	Article							SYNTHETIC LETHAL INTERACTION; C-MYC; MITOCHONDRIAL BIOGENESIS; CANCER-CELLS; B KINASE; METABOLISM; SUPPRESSION; GLUTAMINE; ADDICTION; GROWTH	Deregulated expression of the MYC oncoprotein contributes to the genesis of many human tumours, yet strategies to exploit this for a rational tumour therapy are scarce. MYC promotes cell growth and proliferation, andalters cellularmetabolismto enhance the provision of precursors for phospholipids and cellularmacromolecules(1,2). Here we showinhuman andmurine cell lines thatoncogenic levels ofMYC establish a dependence on AMPK-related kinase 5 (ARK5; also known as NUAK1) for maintaining metabolic homeostasis and for cell survival. ARK5 is an upstream regulator of AMPK and limits protein synthesis via inhibition of the mammalian target of rapamycin 1 (mTORC1) signalling pathway. ARK5 also maintains expression of mitochondrial respiratory chain complexes and respiratory capacity, which is required for efficient glutamine metabolism. Inhibition of ARK5 leads to a collapse of cellular ATP levels in cells expressing deregulated MYC, inducing multiple pro-apoptotic responses as a secondary consequence. Depletion of ARK5 prolongs survival in MYC-driven mouse models of hepatocellular carcinoma, demonstrating that targeting cellular energy homeostasis is a valid therapeutic strategy to eliminate tumour cells that express deregulated MYC.	[Liu, Lidan; Ulbrich, Jannes; Mueller, Judith; Kress, Theresia R.; Muthalagu, Nathiya; Eilers, Martin; Murphy, Daniel J.] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Wuestefeld, Torsten; Rudalska, Ramona; Zender, Lars] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Wuestefeld, Torsten; Zender, Lars] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Aeberhard, Lukas; Kempa, Stefan] Berlin Inst Med Syst Biol, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Rycak, Lukas] Inst Mol Biol & Tumor Res, D-35037 Marburg, Germany; [Moll, Roland] Univ Marburg, Inst Pathol, D-35033 Marburg, Germany	University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Philipps University Marburg	Eilers, M (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, Hubland, D-97074 Wurzburg, Germany.	martin.eilers@biozentrum.uni-wuerzburg.de; daniel.murphy@biozentrum.uni-wuerzburg.de	kempa, stefan/C-5213-2008; Murphy, Daniel/V-1079-2019	kempa, stefan/0000-0002-0696-9299; Murphy, Daniel/0000-0002-5538-5468; Eilers, Martin/0000-0002-0376-6533	GROWTHSTOP consortium of the European Union; Deutsche Forschungsgemeinschaft [Transregio 17, Transregio 77]; Emmy Noether Programme [ZE 545/2-1]; Bundesministerium fur Bildung und Forschung; Senate of Berlin; University of Wuerzburg Graduate School of Life Sciences and the "Rebirth" Cluster of Excellence	GROWTHSTOP consortium of the European Union; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Emmy Noether Programme(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Senate of Berlin; University of Wuerzburg Graduate School of Life Sciences and the "Rebirth" Cluster of Excellence	We thank R. Baumann for immunohistochemical staining, B. Samans, A. Filmer and M. Krause for help with the siRNA screen and expression array analysis, A. Rath for help with analysis of human tumour samples, W. Kolch for siRNA targeting LATS1, S. Lowe and J. Zuber for providing the tTGMP vector, S. Martin for His-tagged annexin V expression vector, P. Schirmacher for human HCC cell lines, V. Ellenrieder for human pancreatic cancer cell lines, H. Riedesel and the staff of the Helmholtz Centre for Infection Research animal facility for technical assistance. We thank P. Gallant and all members of the Eilers laboratory for critical reading of the manuscript. Funding for this work was provided by the GROWTHSTOP consortium of the European Union, the Deutsche Forschungsgemeinschaft via the Transregio 17 (M. E.), the Transregio 77 (L.Z.) and the Emmy Noether Programme ZE 545/2-1 (L.Z.), the Bundesministerium fur Bildung und Forschung, the Senate of Berlin, the University of Wuerzburg Graduate School of Life Sciences and the "Rebirth" Cluster of Excellence.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Kempa S, 2007, PLANT J, V49, P1076, DOI 10.1111/j.1365-313X.2006.03025.x; Kempa S, 2009, J BASIC MICROB, V49, P82, DOI 10.1002/jobm.200800337; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Suzuki A, 2004, MOL CELL BIOL, V24, P3526, DOI 10.1128/MCB.24.8.3526-3535.2004; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	33	198	211	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					608	U131		10.1038/nature10927	http://dx.doi.org/10.1038/nature10927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460906	Bronze			2022-12-01	WOS:000302006100041
J	Smith, DJ; Whitehouse, I				Smith, Duncan J.; Whitehouse, Iestyn			Intrinsic coupling of lagging-strand synthesis to chromatin assembly	NATURE			English	Article							DNA-POLYMERASE-DELTA; OKAZAKI FRAGMENT MATURATION; SACCHAROMYCES-CEREVISIAE; REPLICATION FORK; SIMIAN VIRUS-40; FLAP ENDONUCLEASE-1; IN-VIVO; NUCLEOSOME; YEAST; TRANSCRIPTION	Fifty per cent of the genome is discontinuously replicated on the lagging strand as Okazaki fragments. Eukaryotic Okazaki fragments remain poorly characterized and, because nucleosomes are rapidly deposited on nascent DNA, Okazaki fragment processing and nucleosome assembly potentially affect one another. Here we show that ligation-competent Okazaki fragments in Saccharomyces cerevisiae are sized according to the nucleosome repeat. Using deep sequencing, we demonstrate that ligation junctions preferentially occur near nucleosome midpoints rather than in internucleosomal linker regions. Disrupting chromatin assembly or lagging-strand polymerase processivity affects both the size and the distribution of Okazaki fragments, suggesting a role for nascent chromatin, assembled immediately after the passage of the replication fork, in the termination of Okazaki fragment synthesis. Our studies represent the first high-resolution analysis-to our knowledge-of eukaryotic Okazaki fragments in vivo, and reveal the interconnection between lagging-strand synthesis and chromatin assembly.	[Smith, Duncan J.; Whitehouse, Iestyn] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Whitehouse, I (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	whitehoi@mskcc.org		Smith, Duncan/0000-0002-0898-8629; Whitehouse, Iestyn/0000-0003-0385-3116	Louis V. Gerstner Jr Young Investigator Award; Alfred Bressler Scholars Endowment Award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102253] Funding Source: NIH RePORTER	Louis V. Gerstner Jr Young Investigator Award; Alfred Bressler Scholars Endowment Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. McGuffee for assistance with data processing; S. Keeney, K. Marians, D. Remus, T. Tsukiyama, members of the Molecular Biology Program and Whitehouse laboratory for discussions and comments on the manuscript. This work was supported by a Louis V. Gerstner Jr Young Investigator Award and an Alfred Bressler Scholars Endowment Award to I. W. D.J.S. is an HHMI fellow of the Damon Runyon Cancer Research Foundation (DRG-#2046-10).	ANDERSON S, 1979, J BIOL CHEM, V254, P1495; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; Bielinsky AK, 1999, MOL CELL, V3, P477, DOI 10.1016/S1097-2765(00)80475-X; Bielinsky AK, 1998, SCIENCE, V279, P95, DOI 10.1126/science.279.5347.95; BLUMENTHAL AB, 1977, CELL, V12, P183, DOI 10.1016/0092-8674(77)90196-9; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Dohmen RJ, 2005, METHOD ENZYMOL, V399, P799, DOI 10.1016/S0076-6879(05)99052-6; DONG F, 1991, P NATL ACAD SCI USA, V88, P10596, DOI 10.1073/pnas.88.23.10596; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Huggins CF, 2002, MOL CELL, V10, P1201, DOI 10.1016/S1097-2765(02)00736-0; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; JOHNSTON LH, 1978, NATURE, V274, P891, DOI 10.1038/274891a0; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KAUFMANN G, 1982, NUCLEIC ACIDS RES, V10, P2309, DOI 10.1093/nar/10.7.2309; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Murakami H, 2009, METHODS MOL BIOL, V557, P117, DOI 10.1007/978-1-59745-527-5_9; NETHANEL T, 1990, J VIROL, V64, P5912, DOI 10.1128/JVI.64.12.5912-5918.1990; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nieduszynski CA, 2007, NUCLEIC ACIDS RES, V35, pD40, DOI 10.1093/nar/gkl758; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	42	189	192	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2012	483	7390					434	U80		10.1038/nature10895	http://dx.doi.org/10.1038/nature10895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912CC	22419157	Green Accepted			2022-12-01	WOS:000301771200036
J	Ichimura, A; Hirasawa, A; Poulain-Godefroy, O; Bonnefond, A; Hara, T; Yengo, L; Kimura, I; Leloire, A; Liu, N; Iida, K; Choquet, H; Besnard, P; Lecoeur, C; Vivequin, S; Ayukawa, K; Takeuchi, M; Ozawa, K; Tauber, M; Maffeis, C; Morandi, A; Buzzetti, R; Elliott, P; Pouta, A; Jarvelin, MR; Korner, A; Kiess, W; Pigeyre, M; Caiazzo, R; Van Hul, W; Van Gaal, L; Horber, F; Balkau, B; Levy-Marchal, C; Rouskas, K; Kouvatsi, A; Hebebrand, J; Hinney, A; Scherag, A; Pattou, F; Meyre, D; Koshimizu, T; Wolowczuk, I; Tsujimoto, G; Froguel, P				Ichimura, Atsuhiko; Hirasawa, Akira; Poulain-Godefroy, Odile; Bonnefond, Amelie; Hara, Takafumi; Yengo, Loic; Kimura, Ikuo; Leloire, Audrey; Liu, Ning; Iida, Keiko; Choquet, Helene; Besnard, Philippe; Lecoeur, Cecile; Vivequin, Sidonie; Ayukawa, Kumiko; Takeuchi, Masato; Ozawa, Kentaro; Tauber, Maithe; Maffeis, Claudio; Morandi, Anita; Buzzetti, Raffaella; Elliott, Paul; Pouta, Anneli; Jarvelin, Marjo-Riitta; Koerner, Antje; Kiess, Wieland; Pigeyre, Marie; Caiazzo, Roberto; Van Hul, Wim; Van Gaal, Luc; Horber, Fritz; Balkau, Beverley; Levy-Marchal, Claire; Rouskas, Konstantinos; Kouvatsi, Anastasia; Hebebrand, Johannes; Hinney, Anke; Scherag, Andre; Pattou, Francois; Meyre, David; Koshimizu, Taka-aki; Wolowczuk, Isabelle; Tsujimoto, Gozoh; Froguel, Philippe			Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human	NATURE			English	Article							PANCREATIC BETA-CELLS; CHAIN FATTY-ACIDS; INSULIN-RESISTANCE; BODY-MASS; CHILDHOOD OBESITY; PROTEIN FUNCTION; EARLY-ONSET; RECEPTOR; POPULATION; MUTATIONS	Free fatty acids provide an important energy source as nutrients, and act as signalling molecules in various cellular processes(1-4). Several G-protein-coupled receptors have been identified as free-fatty-acid receptors important in physiology as well as in several diseases(3,5-13). GPR120 (also known as O3FAR1) functions as a receptor for unsaturated long-chain free fatty acids and has a critical role in various physiological homeostasis mechanisms such as adipogenesis, regulation of appetite and food preference(5,6,14-16). Here we show that GPR120-deficient mice fed a high-fat diet develop obesity, glucose intolerance and fatty liver with decreased adipocyte differentiation and lipogenesis and enhanced hepatic lipogenesis. Insulin resistance in such mice is associated with reduced insulin signalling and enhanced inflammation in adipose tissue. In human, we show that GPR120 expression in adipose tissue is significantly higher in obese individuals than in lean controls. GPR120 exon sequencing in obese subjects reveals a deleterious non-synonymous mutation (p.R270H) that inhibits GPR120 signalling activity. Furthermore, the p.R270H variant increases the risk of obesity in European populations. Overall, this study demonstrates that the lipid sensor GPR120 has a key role in sensing dietary fat and, therefore, in the control of energy balance in both humans and rodents.	[Poulain-Godefroy, Odile; Bonnefond, Amelie; Yengo, Loic; Leloire, Audrey; Choquet, Helene; Lecoeur, Cecile; Vivequin, Sidonie; Morandi, Anita; Rouskas, Konstantinos; Meyre, David; Wolowczuk, Isabelle; Froguel, Philippe] Lille Pasteur Inst, CNRS, UMR 8199, F-59000 Lille, France; [Ichimura, Atsuhiko; Hirasawa, Akira; Hara, Takafumi; Kimura, Ikuo; Liu, Ning; Iida, Keiko; Ayukawa, Kumiko; Takeuchi, Masato; Ozawa, Kentaro; Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Sakyo Ku, Kyoto 6068501, Japan; [Pigeyre, Marie; Caiazzo, Roberto; Pattou, Francois] Lille Nord France Univ, INSERM, U859, F-59000 Lille, France; [Besnard, Philippe] Univ Bourgogne, INSERM, UMR U866, AgroSup Dijon, F-21078 Dijon, France; [Tauber, Maithe] Ctr Hosp Univ, Childrens Hosp, INSERM, U563, F-31000 Toulouse, France; [Maffeis, Claudio; Morandi, Anita] Reg Ctr Juvenile Diabet Obes & Clin Nutr, I-37134 Verona, Italy; [Maffeis, Claudio] Univ Verona, Dept Mother & Child, Paediat Sect, I-37134 Verona, Italy; [Buzzetti, Raffaella] Univ Roma La Sapienza, Dept Clin Sci, I-00161 Rome, Italy; [Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, HPA Ctr Environm & Hlth,MRC, London W2 1PG, England; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Univ Oulu, Natl Publ Hlth Inst, Bioctr Oulu, SF-90220 Oulu, Finland; [Pouta, Anneli] Univ Oulu, Inst Clin Med Obstet & Gynecol, SF-90220 Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, SF-90220 Oulu, Finland; [Koerner, Antje; Kiess, Wieland] Univ Leipzig, Ctr Pediat Res, Dept Womens & Child Hlth, D-04317 Leipzig, Germany; [Pigeyre, Marie; Caiazzo, Roberto; Pattou, Francois] Lille Univ Hosp, F-59000 Lille, France; [Van Hul, Wim] Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; [Van Gaal, Luc] Univ Antwerp Hosp, Dept Endocrinol, B-2650 Antwerp, Belgium; [Horber, Fritz] Clin Lindberg, Dept Med, Dept Surg & Internal Med, CH-8400 Winterthur, Switzerland; [Horber, Fritz] Univ Bern, CH-3011 Bern, Switzerland; [Balkau, Beverley] Ctr Res Epidemiol & Populat Hlth CRESP, INSERM, U780, F-94800 Villejuif, France; [Balkau, Beverley] Univ Paris 11, F-91405 Orsay, France; [Levy-Marchal, Claire] Hop Robert Debre, INSERM, U690, F-75935 Paris, France; [Rouskas, Konstantinos; Kouvatsi, Anastasia] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki 54124, Greece; [Hebebrand, Johannes; Hinney, Anke] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, D-45147 Essen, Germany; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, D-45122 Essen, Germany; [Meyre, David] McMaster Univ, Hamilton, ON L8S 4L8, Canada; [Koshimizu, Taka-aki] Jichi Med Univ, Div Mol Pharmacol, Dept Pharmacol, Shimotsuke, Tochigi 3290498, Japan; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London W12 0NN, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Verona; Sapienza University Rome; Imperial College London; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu; Leipzig University; Universite de Lille - ISITE; CHU Lille; University of Antwerp; University of Antwerp; University of Bern; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Aristotle University of Thessaloniki; University of Duisburg Essen; University of Duisburg Essen; McMaster University; Jichi Medical University; Imperial College London	Froguel, P (corresponding author), Lille Pasteur Inst, CNRS, UMR 8199, F-59000 Lille, France.	gtsuji@pharm.kyoto-u.ac.jp; p.froguel@imperial.ac.uk	Koshimizu, Taka-aki/G-2740-2015; Pattou, Francois/O-6151-2017; Yengo, Loic/D-2692-2017; caiazzo, robert/Y-9692-2019; Hinney, Anke/D-6953-2011; Poulain-Godefroy, Odile/AAF-5474-2021; Caiazzo, Robert/D-1958-2013; Maffeis, Claudio/AAG-5347-2020; horber, Fritz/AAL-5419-2020; Scherag, Andre/B-3805-2014; Buzzetti, Raffaella/K-3090-2016; Meyre, David/D-7315-2011; Kimura, Ikuo/B-4193-2015; Morandi, Anita/AAC-4067-2022; Körner, Antje/B-3988-2015; Bonnefond, Amélie/O-2784-2017; FROGUEL, Philippe/O-6799-2017; TAUBER, Maithe/K-7386-2014	Pattou, Francois/0000-0001-8388-3766; Yengo, Loic/0000-0002-4272-9305; caiazzo, robert/0000-0001-5383-0540; Hinney, Anke/0000-0001-5659-0706; Buzzetti, Raffaella/0000-0003-1490-6041; Meyre, David/0000-0003-4850-7444; Körner, Antje/0000-0001-6001-0356; Bonnefond, Amélie/0000-0001-9976-3005; FROGUEL, Philippe/0000-0003-2972-0784; Ichimura, Atsuhiko/0000-0003-0366-5211; Pigeyre, Marie/0000-0003-2984-8366; POULAIN-GODEFROY, Odile/0000-0001-8805-9450; Koshimizu, Taka-aki/0000-0001-5292-7535; MORANDI, Anita/0000-0002-2631-9330; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Elliott, Paul/0000-0002-7511-5684; wolowczuk, isabelle/0000-0001-6692-6904; Choquet, Helene/0000-0001-9839-8667; Van Hul, Wim/0000-0002-5065-7858; Scherag, Andre/0000-0002-9406-4704	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Conseil Regional Nord Pas de Calais/FEDER; Agence Nationale de la Recherche; Academy of Finland; University Hospital of Oulu (Finland); University of Oulu (Finland); European Commission (EURO-BLCS) [QLG1-CT-2000-01643]; Medical Research Council [G0500539, G0600705]; Medical Research Council [G1002084, G0801056B] Funding Source: researchfish; MRC [G0600705, G1002084] Funding Source: UKRI; Grants-in-Aid for Scientific Research [23890019] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Conseil Regional Nord Pas de Calais/FEDER(Region Hauts-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Academy of Finland(Academy of Finland); University Hospital of Oulu (Finland); University of Oulu (Finland); European Commission (EURO-BLCS)(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are indebted to all subjects who participated in these studies. In Japan, the study was supported in part by research grants from the Japan Society for the Promotion of Science; the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Japan Science and Technology Agency; and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy. A.I. is a fellow of the Japan Society for the Promotion of Science. A.B. is a fellow of the EU-funded EUROCHIP consortium. In France, the study was supported by le Conseil Regional Nord Pas de Calais/FEDER and the Agence Nationale de la Recherche (Programme de Recherche en Nutrition et Alimentation, SensoFAT). The Northern Finland Birth Cohort Studies 1986 received financial support from the Academy of Finland, the University Hospital of Oulu (Finland), the University of Oulu (Finland), the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), and the Medical Research Council (G0500539, G0600705, PrevMetSyn/SALVE). We thank the ABOS consortium and the CIC-CCPPRB (Lille CHRU) team for their help in sample handling and clinical data collection. We are grateful to M. Deweirder and F. Allegaert for human DNA bank management.	Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Brown JM, 2010, ARTERIOSCL THROM VAS, V30, P24, DOI 10.1161/ATVBAHA.109.198036; Buzzetti R, 2005, PEDIATR RES, V57, P138, DOI 10.1203/01.PDR.0000147728.62185.21; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Ichimura A, 2010, MOL PHARMACOL, V77, P1016, DOI 10.1124/mol.109.063321; Ichimura A, 2009, PROSTAG OTH LIPID M, V89, P82, DOI 10.1016/j.prostaglandins.2009.05.003; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jaquet D, 2004, HORM RES, V62, P92, DOI 10.1159/000079709; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Jeyakumar SM, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-27; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Miyauchi S, 2009, N-S ARCH PHARMACOL, V379, P427, DOI 10.1007/s00210-008-0390-8; Morandi A, 2009, OBESITY, V17, P202, DOI 10.1038/oby.2008.470; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Nunez EA, 1997, PROSTAG LEUKOTR ESS, V57, P107, DOI 10.1016/S0952-3278(97)90500-7; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; POSKITT EME, 1995, ACTA PAEDIATR, V84, P961, DOI 10.1111/j.1651-2227.1995.tb13806.x; Poulain-Godefroy O, 2008, AM J PHYSIOL-REG I, V295, pR1, DOI 10.1152/ajpregu.00926.2007; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Rouskas K, 2008, INT J OBESITY, V32, P1618, DOI 10.1038/ijo.2008.167; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Steffen R, 2009, OBES SURG, V19, P3, DOI 10.1007/s11695-008-9675-8; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Sun Q, 2010, MOL PHARMACOL, V78, P804, DOI 10.1124/mol.110.066324; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200	48	470	491	6	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					350	U149		10.1038/nature10798	http://dx.doi.org/10.1038/nature10798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	908HP	22343897	Green Published			2022-12-01	WOS:000301481800053
J	Schmidt, C				Schmidt, Charles			BIOELECTRONICS The bionic material	NATURE			English	Editorial Material																			0	22	22	5	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2012	483	7389					S37	S37		10.1038/483S37a	http://dx.doi.org/10.1038/483S37a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	908HP	22419210	Bronze			2022-12-01	WOS:000301481800004
J	McColl, K				McColl, Karen			HIV Mentor mothers to prevent mother-to-child transmission of HIV	BRITISH MEDICAL JOURNAL			English	Editorial Material												karenmccoll@gmail.com						Baek C., 2007, KEY FINDINGS EVALUAT; SHISANA O, 2010, S AFRICAN NATL HIV P; UNAIDS, 2011, COUNTD ZER GLOB PLAN; UNICEF, 2010, CHILDR AIDS 5 STOCKT	4	11	11	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2012	344								e1590	10.1136/bmj.e1590	http://dx.doi.org/10.1136/bmj.e1590			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	913BO	22411931				2022-12-01	WOS:000301846500005
J	Lederle, FA; Pocha, C				Lederle, Frank A.; Pocha, Christine			Screening for Liver Cancer: The Rush to Judgment	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEPATOCELLULAR-CARCINOMA; UNITED-STATES; SURVEILLANCE; CIRRHOSIS	In 2005, a professional society issued a level I recommendation to use ultrasonography to screen the 3 million Americans with cirrhosis for hepatocellular carcinoma (HCC) every 6 months. This designation was based on a large randomized trial from China that reported a reduction in HCC deaths from screening in carriers of hepatitis B surface antigen. However, besides the difference in population, this trial did not report all deaths, excluded patients after randomization, and would almost certainly have found no significant difference if the cluster randomization had been accounted for in the analysis. Misplaced confidence in the Chinese trial has led many writers to accept the effectiveness of HCC screening as proven, making it more difficult to conduct the high-quality randomized trials that are needed to ensure optimal patient care.	[Lederle, Frank A.; Pocha, Christine] Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Lederle, FA (corresponding author), Vet Affairs Med Ctr, Dept Med 111 O, 1 Vet Dr, Minneapolis, MN 55417 USA.	frank.lederle@va.gov						Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen JG, 2003, J MED SCREEN, V10, P204, DOI 10.1258/096914103771773320; Davila JA, 2011, ANN INTERN MED, V155, P275, DOI 10.7326/0003-4819-155-4-201108160-00019; Davila JA, 2011, ANN INTERN MED, V154, P85, DOI 10.7326/0003-4819-154-2-201101180-00006; Davila JA, 2010, HEPATOLOGY, V52, P132, DOI 10.1002/hep.23615; Isaakidis P, 2003, AM J EPIDEMIOL, V158, P921, DOI 10.1093/aje/kwg232; Kerry SM, 1998, BMJ-BRIT MED J, V316, P54, DOI 10.1136/bmj.316.7124.54; Lauer MS, 2011, ARCH INTERN MED, V171, P1268, DOI 10.1001/archinternmed.2011.205; Lee TH, 2002, NEW ENGL J MED, V346, P529, DOI 10.1056/NEJM200202143460715; National Cancer Institute, 2011, LIV HEP CANC SCREEN; Poustchi H, 2011, HEPATOLOGY, V54, P1998, DOI 10.1002/hep.24581; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Senn S, 2004, STAT MED, V23, P3729, DOI 10.1002/sim.2074; Sharma P, 2011, DIGEST DIS SCI, V56, P569, DOI 10.1007/s10620-010-1453-5; Stravitz RT, 2008, AM J MED, V121, P119, DOI 10.1016/j.amjmed.2007.09.020; Stroffolini T, 2004, DIGEST LIVER DIS, V36, P56, DOI 10.1016/j.dld.2003.07.007; Teefey SA, 2003, RADIOLOGY, V226, P533, DOI 10.1148/radiol.2262011980; Trevisani F, 2002, AM J GASTROENTEROL, V97, P734; Ward BW, 2010, VITAL HLTH STAT, P1; Wong CR, 2009, DIGEST DIS SCI, V54, P2712, DOI 10.1007/s10620-009-1015-x; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	22	68	69	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2012	156	5					387	U214		10.7326/0003-4819-156-5-201203060-00012	http://dx.doi.org/10.7326/0003-4819-156-5-201203060-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	902OC	22393134				2022-12-01	WOS:000301046800007
J	Huang, J; Gurung, B; Wan, BB; Matkar, S; Veniaminova, NA; Wan, K; Merchant, JL; Hua, XX; Lei, M				Huang, Jing; Gurung, Buddha; Wan, Bingbing; Matkar, Smita; Veniaminova, Natalia A.; Wan, Ke; Merchant, Juanita L.; Hua, Xianxin; Lei, Ming			The same pocket in menin binds both MLL and JUND but has opposite effects on transcription	NATURE			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; ENDOCRINE NEOPLASIA TYPE-1; PROTEIN; GENE; INTERACTS; FAMILY	Menin is a tumour suppressor protein whose loss or inactivation causes multiple endocrine neoplasia 1 (MEN1), a hereditary autosomal dominant tumour syndrome that is characterized by tumorigenesis in multiple endocrine organs(1). Menin interacts with many proteins and is involved in a variety of cellular processes(2-8). Menin binds the JUN family transcription factor JUND and inhibits its transcriptional activity(2,9). Several MEN1 missense mutations disrupt the menin-JUND interaction, suggesting a correlation between the tumour-suppressor function of menin and its suppression of JUND-activated transcription(2,10). Menin also interacts with mixed lineage leukaemia protein 1 (MLL1), a histone H3 lysine 4 methyltransferase, and functions as an oncogenic cofactor to upregulate gene transcription and promote MLL1-fusion-protein-induced leukaemogenesis(5,7,11,12). A recent report on the tethering of MLL1 to chromatin binding factor lens epithelium-derived growth factor (LEDGF) by menin indicates that menin is a molecular adaptor coordinating the functions of multiple proteins(13). Despite its importance, how menin interacts with many distinct partners and regulates their functions remains poorly understood. Here we present the crystal structures of human menin in its free form and in complexes with MLL1 or with JUND, or with an MLL1-LEDGF heterodimer. These structures show that menin contains a deep pocket that binds short peptides of MLL1 or JUND in the same manner, but that it can have opposite effects on transcription. The menin-JUND interaction blocks JUN N-terminal kinase (JNK)-mediated JUND phosphorylation and suppresses JUND-induced transcription. In contrast, menin promotes gene transcription by binding the transcription activator MLL1 through the peptide pocket while still interacting with the chromatin-anchoring protein LEDGF at a distinct surface formed by both menin and MLL1.	[Huang, Jing; Wan, Bingbing; Wan, Ke; Lei, Ming] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Huang, Jing; Wan, Bingbing; Wan, Ke; Lei, Ming] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Gurung, Buddha; Matkar, Smita; Hua, Xianxin] Univ Penn, Perelman Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Veniaminova, Natalia A.; Merchant, Juanita L.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Merchant, Juanita L.] Univ Michigan, Div Gastroenterol, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lei, M (corresponding author), Univ Michigan, Sch Med, Howard Hughes Med Inst, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	huax@mail.med.upenn.edu; leim@umich.edu	Merchant, Juanita/AAF-8277-2019	Merchant, Juanita/0000-0002-6559-8184; Wan, Bingbing/0000-0001-8629-0616	National Institutes of Health [GM 083015-01, R01-DK085121, R37-DK45729]; American Cancer Society; American Association for Cancer Research Caring for Carcinoid Foundation; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097555, R01DK085121, R37DK045729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Association for Cancer Research Caring for Carcinoid Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Wilding for the human JUND complementary DNA and P. Cherepanov for the human LEDGF cDNA. We thank Y. Chen and W. Deng for help at various stages of the project. M. L. is a Howard Hughes Medical Institute Early Career Scientist. Work was supported by National Institutes of Health grants (GM 083015-01 to M. L., R01-DK085121 to X. H. and R37-DK45729 to J.L.M.), an American Cancer Society Research Scholar grant (to M. L.) and an American Association for Cancer Research Caring for Carcinoid Foundation Grant (to X. H.). The General Medicine and Cancer Institutes Collaborative Access Team has been funded in whole or in part with federal funds from the National Cancer Institute (grant Y1-CO-1020) and the National Institute of General Medical Science (grant Y1-GM-1104). Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Busygina V, 2006, CANCER RES, V66, P8397, DOI 10.1158/0008-5472.CAN-06-0061; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen G, 2008, MOL CANCER RES, V6, P1894, DOI 10.1158/1541-7786.MCR-07-2206; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Gallo A, 2002, ONCOGENE, V21, P6434, DOI 10.1038/sj.onc.1205822; Grembecka J, 2010, J BIOL CHEM, V285, P40690, DOI 10.1074/jbc.M110.172783; Groussin L, 1999, EUR J ENDOCRINOL, V141, P15, DOI 10.1530/eje.0.1410015; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jin SH, 2003, CANCER RES, V63, P4204; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knapp JI, 2000, ONCOGENE, V19, P4706, DOI 10.1038/sj.onc.1203832; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Llano M, 2009, CURR TOP MICROBIOL, V339, P125, DOI 10.1007/978-3-642-02175-6_7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mensah-Osman EJ, 2011, AM J PHYSIOL-GASTR L, V301, pG783, DOI 10.1152/ajpgi.00160.2011; Murai MJ, 2011, J BIOL CHEM, V286, P31742, DOI 10.1074/jbc.M111.258186; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang YQ, 2007, MOL CELL ENDOCRINOL, V265, P34, DOI 10.1016/j.mce.2006.12.032; Yazgan O, 2002, J BIOL CHEM, V277, P29710, DOI 10.1074/jbc.M204552200; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	27	187	193	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 23	2012	482	7386					542	U141		10.1038/nature10806	http://dx.doi.org/10.1038/nature10806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	898VM	22327296	Green Accepted			2022-12-01	WOS:000300770500054
J	Halfmann, R; Jarosz, DF; Jones, SK; Chang, A; Lancaster, AK; Lindquist, S				Halfmann, Randal; Jarosz, Daniel F.; Jones, Sandra K.; Chang, Amelia; Lancaster, Alex K.; Lindquist, Susan			Prions are a common mechanism for phenotypic inheritance in wild yeasts	NATURE			English	Article							GENETIC-VARIATION; EVOLVABILITY PROPERTIES; EVOLUTION; STRESS; CHAPERONE; PSI+; RESISTANCE; HSP104; HSP70	The self-templating conformations of yeast prion proteins act as epigenetic elements of inheritance. Yeast prions might provide a mechanism for generating heritable phenotypic diversity that promotes survival in fluctuating environments and the evolution of new traits. However, this hypothesis is highly controversial. Prions that create new traits have not been found in wild strains, leading to the perception that they are rare 'diseases' of laboratory cultivation. Here we biochemically test approximately 700 wild strains of Saccharomyces for [PSI+] or [MOT3(+)], and find these prions in many. They conferred diverse phenotypes that were frequently beneficial under selective conditions. Simple meiotic re-assortment of the variation harboured within a strain readily fixed one such trait, making it robust and prion-independent. Finally, we genetically screened for unknown prion elements. Fully one-third of wild strains harboured them. These, too, created diverse, often beneficial phenotypes. Thus, prions broadly govern heritable traits in nature, in a manner that could profoundly expand adaptive opportunities.	[Halfmann, Randal; Jarosz, Daniel F.; Jones, Sandra K.; Chang, Amelia; Lancaster, Alex K.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Halfmann, Randal; Chang, Amelia; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	Lindquist_admin@wi.mit.edu	; Lancaster, Alexander/K-2855-2013	Jarosz, Daniel/0000-0003-3497-5888; Lancaster, Alexander/0000-0002-0002-9263; Halfmann, Randal/0000-0002-6592-1471	G. Harold and Leila Y. Mathers Foundation; HHMI; NIH [K99 GM098600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM098600] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to L. Bisson and L. Joseph, who provided the Department of Viticulture and Enology yeast collection from the University of California, Davis, USA. We also received strains from G. Fink, E. Louis, F. Dietrich and S. Dietzmann, and L. Kruglyak. We thank M. Taipale, K. Allendoerfer, K. Matlack, L. Pepper, V. Khurana, G. Fink, L. Joseph, A. Hochwagen and G. Walker for materials, discussions, and/or critical reading of the manuscript. N. Azubuine and T. Nanchung provided a constant supply of plates and media. S. L. is a Howard Hughes Medical Institute (HHMI) investigator. This work was supported by grants from the G. Harold and Leila Y. Mathers Foundation and HHMI. D.F.J. was supported as an HHMI fellow of the Damon Runyon Cancer Research Foundation (DRG-1964-08) and by an NIH Pathway to independence award (K99 GM098600). S.K.J. was supported as a summer research student by the Howard Hughes Medical Institute (HHMI) Exceptional Research Opportunities Program (EXROP).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Crow ET, 2011, SEMIN CELL DEV BIOL, V22, P452, DOI 10.1016/j.semcdb.2011.03.003; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Diezmann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005317; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIUDICI P, 1994, AM J ENOL VITICULT, V45, P107; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; Griswold CK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000517; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-42; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Lancaster AK, 2009, EVOLUTION, V63, P2350, DOI 10.1111/j.1558-5646.2009.00729.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Masel J, 2003, EVOLUTION, V57, P1498; Masel J, 2006, GENETICS, V172, P1985, DOI 10.1534/genetics.105.051649; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Resende CG, 2003, MOL MICROBIOL, V49, P1005, DOI 10.1046/j.1365-2958.2003.03608.x; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wickner RB, 2011, SEMIN CELL DEV BIOL, V22, P469, DOI 10.1016/j.semcdb.2011.02.021	46	298	301	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 16	2012	482	7385					363	U1507		10.1038/nature10875	http://dx.doi.org/10.1038/nature10875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	892LG	22337056	Green Submitted, Green Accepted			2022-12-01	WOS:000300287100038
J	Earn, DJD; He, DH; Loeb, MB; Fonseca, K; Lee, BE; Dushoff, J				Earn, David J. D.; He, Daihai; Loeb, Mark B.; Fonseca, Kevin; Lee, Bonita E.; Dushoff, Jonathan			Effects of School Closure on Incidence of Pandemic Influenza in Alberta, Canada	ANNALS OF INTERNAL MEDICINE			English	Article							ABSOLUTE-HUMIDITY; H1N1; TRANSMISSION; INFECTION; TIME; INTERVENTION; VACCINATION; STRATEGIES; EVOLUTION; INFERENCE	Background: Control of pandemic influenza by social-distancing measures, such as school closures, is a controversial aspect of pandemic planning. However, investigations of the extent to which these measures actually affect the progression of a pandemic have been limited. Objective: To examine correlations between the incidence of pandemic H1N1 (pH1N1) influenza in Alberta, Canada, in 2009 and school closures or weather changes, and to estimate the effects of school closures and weather changes on pH1N1 transmission. Design: Mathematical transmission models were fit to data that compared the pattern of confirmed pH1N1 cases with the school calendar and weather patterns. Setting: Alberta, Canada, from 19 April 2009 to 2 January 2010. Data Sources: 2009 virologic test results, 2006 census data, 2009 daily temperature and humidity data, and 2009 school calendars. Measurements: Age-specific daily counts of positive results for pH1N1 from the complete database of 35 510 specimens submitted to the Alberta Provincial Laboratory for Public Health for virologic testing from 19 April 2009 to 2 January 2010. Results: The ending and restarting of school terms had a major effect in attenuating the first wave and starting the second wave of pandemic influenza cases. Mathematical models suggested that school closure reduced transmission among school-age children by more than 50% and that this was a key factor in interrupting transmission. The models also indicated that seasonal changes in weather had a significant effect on the temporal pattern of the epidemic. Limitations: Data probably represent a small sample of all viral infections. The mathematical models make simplifying assumptions in order to make simulations and analysis feasible. Conclusion: Analysis of data from unrestricted virologic testing during an influenza pandemic provides compelling evidence that closing schools can have dramatic effects on transmission of pandemic influenza. School closure seems to be an effective strategy for slowing the spread of pandemic influenza in countries with social contact networks similar to those in Canada.	[Earn, David J. D.] McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4K1, Canada; Univ Calgary, Calgary, AB, Canada; Edmonton Clin Hlth Acad, Edmonton, AB, Canada	McMaster University; University of Calgary	Earn, DJD (corresponding author), McMaster Univ, Dept Math & Stat, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	earn@math.mcmaster.ca; daihai@math.mcmaster.ca	He, Daihai/A-9347-2008; He, Daihai/AAT-8735-2021	Earn, David/0000-0002-7562-1341; He, Daihai/0000-0003-3253-654X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Public Health Agency of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Public Health Agency of Canada	Grant Support: By the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Public Health Agency of Canada.	Aiello AE, 2010, AM J INFECT CONTROL, V38, P251, DOI 10.1016/j.ajic.2009.12.007; Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alberta Health Services, 2009, RESTR INFL RESP VIR; ANDERSON R M, 1991; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201; Burnham KP., 2002, MODEL SELECTION MULT, V2; Campbell G. S., 1998, INTRO ENV BIOPHYSICS; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Doucet A., 2001, SEQUENTIAL MONTE CAR; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Earn DJD, 2009, MATH BIOL, V14, P151; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Government of Alberta, 2006, 2006 CENS AN ALB PRO; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; He DH, 2011, THEOR ECOL-NETH, V4, P283, DOI 10.1007/s12080-011-0123-3; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Katriel G, 2011, J R SOC INTERFACE, V8, P856, DOI 10.1098/rsif.2010.0515; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Lee BE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-277; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Ma JL, 2006, MATH BIOSCI ENG, V3, P161; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Mukhi SN, 2010, ONLINE J PUBLIC HLTH, P2; Ontario Ministry of Health and Long-Term Care, 2009, GUID MAN PAT INFL LI; Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Pulinets SA, 2006, ANN GEOPHYS-GERMANY, V24, P835, DOI 10.5194/angeo-24-835-2006; Shaman Jeffrey, 2009, PLoS Curr, V2, pRRN1138, DOI 10.1371/currents.RRN1138; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shoji M, 2011, TOHOKU J EXP MED, V224, P251, DOI 10.1620/tjem.224.251; Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; World Health Organization, 2010, PAND H1N1 2010 UPD 1; World Health Organization, PAND H1N1 2009 UPD 7; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	50	130	130	4	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2012	156	3					173	U32		10.7326/0003-4819-156-3-201202070-00005	http://dx.doi.org/10.7326/0003-4819-156-3-201202070-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	887XD	22312137				2022-12-01	WOS:000299964200001
J	Dutchak, PA; Katafuchi, T; Bookout, AL; Choi, JH; Yu, RT; Mangelsdorf, DJ; Kliewer, SA				Dutchak, Paul A.; Katafuchi, Takeshi; Bookout, Angie L.; Choi, Jang Hyun; Yu, Ruth T.; Mangelsdorf, David J.; Kliewer, Steven A.			Fibroblast Growth Factor-21 Regulates PPAR gamma Activity and the Antidiabetic Actions of Thiazolidinediones	CELL			English	Article							ACTIVATED-RECEPTOR-GAMMA; INCREASES ENERGY-EXPENDITURE; BETA-KLOTHO; INSULIN SENSITIVITY; METABOLIC-ACTIVITY; 3T3 FIBROBLASTS; C/EBP-ALPHA; EXPRESSION; OBESITY; FIBROBLAST-GROWTH-FACTOR-21	Fibroblast growth factor-21 (FGF21) is a circulating hepatokine that beneficially affects carbohydrate and lipid metabolism. Here, we report that FGF21 is also an inducible, fed-state autocrine factor in adipose tissue that functions in a feed-forward loop to regulate the activity of peroxisome proliferator-activated receptor gamma (PPAR gamma), a master transcriptional regulator of adipogenesis. FGF21 knockout (KO) mice display defects in PPARg signaling including decreased body fat and attenuation of PPAR gamma-dependent gene expression. Moreover, FGF21-KO mice are refractory to both the beneficial insulin-sensitizing effects and the detrimental weight gain and edema side effects of the PPAR gamma agonist rosiglitazone. This loss of function in FGF21-KO mice is coincident with a marked increase in the sumoylation of PPAR gamma, which reduces its transcriptional activity. Adding back FGF21 prevents sumoylation and restores PPAR gamma activity. Collectively, these results reveal FGF21 as a key mediator of the physiologic and pharmacologic actions of PPAR gamma.	[Katafuchi, Takeshi; Bookout, Angie L.; Mangelsdorf, David J.; Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Dutchak, Paul A.; Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Bookout, Angie L.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Choi, Jang Hyun] Harvard Univ, Sch Med, Div Metab & Chron Dis, Dept Canc Biol,Dana Farber Canc Inst, Boston, MA 02115 USA; [Choi, Jang Hyun] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Yu, Ruth T.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Salk Institute	Mangelsdorf, DJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	davo.mango@utsouthwestern.edu; steven.kliewer@utsouthwestern.edu	Choi, Jang Hyun/B-3055-2012	Yu, Ruth/0000-0002-9527-9627; Mangelsdorf, David/0000-0002-4355-0796	Howard Hughes Medical Institute; NIH [RL1GM084436, R56DK089600, U19DK62434, GM007062]; Robert A. Welch Foundation [I-1275, I-1558]; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067158, U19DK062434, R56DK089600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062, RL1GM084436] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Regina Goetz and Moosa Mohammadi for recombinant FGF21 protein, Dr. James Richardson for histopathology expertise, and members of the D.J.M./S.A.K. laboratory for discussion. This research was supported by the Howard Hughes Medical Institute (to D.J.M.), NIH Grants RL1GM084436 and R56DK089600 (to D.J.M. and S.A.K.), U19DK62434 (to D.J.M.), and GM007062 (to A.L.B.), the Robert A. Welch Foundation (I-1275 to D.J.M. and I-1558 to S.A.K.), and the Leona M. and Harry B. Helmsley Charitable Trust (to R.T.Y.).	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Christodoulides C, 2009, J CLIN ENDOCR METAB, V94, P3594, DOI 10.1210/jc.2009-0111; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Floyd ZE, 2004, OBES RES, V12, P921, DOI 10.1038/oby.2004.112; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li K, 2009, EUR J ENDOCRINOL, V161, P391, DOI 10.1530/EJE-09-0335; Li XF, 2009, FEBS LETT, V583, P3230, DOI 10.1016/j.febslet.2009.09.012; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	56	406	429	1	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2012	148	3					556	567		10.1016/j.cell.2011.11.062	http://dx.doi.org/10.1016/j.cell.2011.11.062			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	891NX	22304921	Green Accepted, Bronze			2022-12-01	WOS:000300225000022
J	Anderson, R; Hollingsworth, TD; Truscott, J; Brooker, S				Anderson, Roy; Hollingsworth, T. Deirdre; Truscott, James; Brooker, Simon			Optimisation of mass chemotherapy to control soil-transmitted helminth infection	LANCET			English	Editorial Material									[Anderson, Roy; Hollingsworth, T. Deirdre; Truscott, James] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Brooker, Simon] London Sch Hyg & Trop Med, London WC1, England; [Brooker, Simon] Wellcome Trust Res Programme, Kenya Med Res Inst, Nairobi, Kenya	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute	Anderson, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.	roy.anderson@imperial.ac.uk	Hollingsworth, Deirdre/D-2421-2009	Hollingsworth, Deirdre/0000-0001-5962-4238; Anderson, Roy/0000-0002-9528-3175	Wellcome Trust [092654, 098045] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON R M, 1991; ANDERSON RM, 1985, PARASITOLOGY, V90, P629, DOI 10.1017/S0031182000052288; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Department for International Development, 2012, UK PROT 140 MILL NEG; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Pullan RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000958; Savioli L, 1999, MONITORING HELMINTH; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1	9	39	39	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2012	379	9813					289	290		10.1016/S0140-6736(12)60120-2	http://dx.doi.org/10.1016/S0140-6736(12)60120-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	889BA	22284644				2022-12-01	WOS:000300047300010
J	Schwartzentruber, J; Korshunov, A; Liu, XY; Jones, DTW; Pfaff, E; Jacob, K; Sturm, D; Fontebasso, AM; Quang, DAK; Tonjes, M; Hovestadt, V; Albrecht, S; Kool, M; Nantel, A; Konermann, C; Lindroth, A; Jager, N; Rausch, T; Ryzhova, M; Korbel, JO; Hielscher, T; Hauser, P; Garami, M; Klekner, A; Bognar, L; Ebinger, M; Schuhmann, MU; Scheurlen, W; Pekrun, A; Fruhwald, MC; Roggendorf, W; Kramm, C; Durken, M; Atkinson, J; Lepage, P; Montpetit, A; Zakrzewska, M; Zakrzewski, K; Liberski, PP; Dong, ZF; Siegel, P; Kulozik, AE; Zapatka, M; Guha, A; Malkin, D; Felsberg, J; Reifenberger, G; von Deimling, A; Ichimura, K; Collins, VP; Witt, H; Milde, T; Witt, O; Zhang, CD; Castelo-Branco, P; Lichter, P; Faury, D; Tabori, U; Plass, C; Majewski, J; Pfister, SM; Jabado, N				Schwartzentruber, Jeremy; Korshunov, Andrey; Liu, Xiao-Yang; Jones, David T. W.; Pfaff, Elke; Jacob, Karine; Sturm, Dominik; Fontebasso, Adam M.; Quang, Dong-Anh Khuong; Toenjes, Martje; Hovestadt, Volker; Albrecht, Steffen; Kool, Marcel; Nantel, Andre; Konermann, Carolin; Lindroth, Anders; Jaeger, Natalie; Rausch, Tobias; Ryzhova, Marina; Korbel, Jan O.; Hielscher, Thomas; Hauser, Peter; Garami, Miklos; Klekner, Almos; Bognar, Laszlo; Ebinger, Martin; Schuhmann, Martin U.; Scheurlen, Wolfram; Pekrun, Arnulf; Fruehwald, Michael C.; Roggendorf, Wolfgang; Kramm, Christoph; Duerken, Matthias; Atkinson, Jeffrey; Lepage, Pierre; Montpetit, Alexandre; Zakrzewska, Magdalena; Zakrzewski, Krzystof; Liberski, Pawel P.; Dong, Zhifeng; Siegel, Peter; Kulozik, Andreas E.; Zapatka, Marc; Guha, Abhijit; Malkin, David; Felsberg, Joerg; Reifenberger, Guido; von Deimling, Andreas; Ichimura, Koichi; Collins, V. Peter; Witt, Hendrik; Milde, Till; Witt, Olaf; Zhang, Cindy; Castelo-Branco, Pedro; Lichter, Peter; Faury, Damien; Tabori, Uri; Plass, Christoph; Majewski, Jacek; Pfister, Stefan M.; Jabado, Nada			Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma	NATURE			English	Article							INTEGRATED GENOMIC ANALYSIS; EMBRYONIC STEM-CELLS; HIGH-GRADE GLIOMAS; ATRX; TUMORS; METHYLATION; TELOMERES; ABERRATIONS; EXPRESSION; MULTIFORME	Glioblastoma multiforme (GBM) is a lethal brain tumour in adults and children. However, DNA copy number and gene expression signatures indicate differences between adult and paediatric cases(1-4). To explore the genetic events underlying this distinction, we sequenced the exomes of 48 paediatric GBM samples. Somatic mutations in the H3.3-ATRX-DAXX chromatin remodelling pathway were identified in 44% of tumours (21/48). Recurrent mutations in H3F3A, which encodes the replication-independent histone 3 variant H3.3, were observed in 31% of tumours, and led to amino acid substitutions at two critical positions within the histone tail (K27M, G34R/G34V) involved in key regulatory post-translational modifications. Mutations in ATRX (alpha-thalassaemia/mental retardation syndrome X-linked)(5) and DAXX (death-domain associated protein), encoding two subunits of a chromatin remodelling complex required for H3.3 incorporation at pericentric heterochromatin and telomeres(6,7), were identified in 31% of samples overall, and in 100% of tumours harbouring a G34R or G34V H3.3 mutation. Somatic TP53 mutations were identified in 54% of all cases, and in 86% of samples with H3F3A and/or ATRX mutations. Screening of a large cohort of gliomas of various grades and histologies (n = 784) showed H3F3A mutations to be specific to GBM and highly prevalent in children and young adults. Furthermore, the presence of H3F3A/ATRX-DAXX/TP53 mutations was strongly associated with alternative lengthening of telomeres and specific gene expression profiles. This is, to our knowledge, the first report to highlight recurrent mutations in a regulatory histone in humans, and our data suggest that defects of the chromatin architecture underlie paediatric and young adult GBM pathogenesis.	[Liu, Xiao-Yang; Jacob, Karine; Fontebasso, Adam M.; Quang, Dong-Anh Khuong; Faury, Damien; Majewski, Jacek; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; [Liu, Xiao-Yang; Jacob, Karine; Fontebasso, Adam M.; Quang, Dong-Anh Khuong; Faury, Damien; Majewski, Jacek; Jabado, Nada] McGill Univ, Dept Expt Med, Montreal, PQ H3Z 2Z3, Canada; [Schwartzentruber, Jeremy; Lepage, Pierre; Montpetit, Alexandre] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Schwartzentruber, Jeremy; Lepage, Pierre; Montpetit, Alexandre] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Korshunov, Andrey; von Deimling, Andreas] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Jones, David T. W.; Pfaff, Elke; Sturm, Dominik; Kool, Marcel; Witt, Hendrik; Pfister, Stefan M.] German Canc Res Ctr, Divis Pediat Neurooncol, D-69120 Heidelberg, Germany; [Toenjes, Martje; Hovestadt, Volker; Zapatka, Marc; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Albrecht, Steffen] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Dept Pathol, Montreal, PQ H3H 1P3, Canada; [Nantel, Andre] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Konermann, Carolin; Lindroth, Anders; Plass, Christoph] German Canc Res Ctr, Div Epigenom & Canc Risk Factors, D-69120 Heidelberg, Germany; [Jaeger, Natalie] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Rausch, Tobias; Korbel, Jan O.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Ryzhova, Marina] Burdenko Neurosurg Inst, Dept Neuropathol, Moscow 125047, Russia; [Hielscher, Thomas] German Canc Res Ctr, Div Biostat, D-69120 Heidelberg, Germany; [Hauser, Peter; Garami, Miklos] Semmelweis Univ, Dept Paediat 2, H-1094 Budapest, Hungary; [Klekner, Almos; Bognar, Laszlo] Univ Debrecen, Dept Neurosurg, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary; [Ebinger, Martin] Childrens Univ Hosp, Dept Hematol & Oncol, D-72076 Tubingen, Germany; [Schuhmann, Martin U.] Univ Hosp, Dept Neurosurg, D-72076 Tubingen, Germany; [Scheurlen, Wolfram] Nuremberg Childrens Hosp, Cnopfsche Kinderklin, D-90419 Nurnberg, Germany; [Pekrun, Arnulf] Prof Hess Childrens Hosp, D-28177 Bremen, Germany; [Fruehwald, Michael C.] Augsburg Childrens Hosp, Klinikum Augsburg, D-86156 Augsburg, Germany; [Roggendorf, Wolfgang] Univ Wurzburg, Inst Pathol, Dept Neuropathol, D-97080 Wurzburg, Germany; [Kramm, Christoph] Univ Childrens Hosp, D-06097 Halle, Germany; [Duerken, Matthias] Univ Childrens Hosp, D-68167 Mannheim, Germany; [Atkinson, Jeffrey] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Div Neurosurg,Dept Surg, Montreal, PQ H3H 1P3, Canada; [Zakrzewska, Magdalena; Liberski, Pawel P.] Med Univ Lodz, Dept Mol Pathol & Neuropathol, PL-92216 Lodz, Poland; [Zakrzewski, Krzystof] Polish Mothers Mem Hosp, Res Inst, Dept Neurosurg, PL-93338 Lodz, Poland; [Dong, Zhifeng; Siegel, Peter] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Kulozik, Andreas E.; Witt, Hendrik; Milde, Till; Witt, Olaf; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Paediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Guha, Abhijit; Zhang, Cindy; Castelo-Branco, Pedro; Tabori, Uri] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Res Inst, Toronto, ON M5G 1X8, Canada; [Malkin, David; Tabori, Uri] Univ Toronto, Hosp Sick Children, Div Hematol Oncol, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Felsberg, Joerg; Reifenberger, Guido] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [von Deimling, Andreas] Univ Heidelberg Hosp, Dept Neuropathol, D-69120 Heidelberg, Germany; [Ichimura, Koichi; Collins, V. Peter] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge CB2 0QQ, England; [Milde, Till; Witt, Olaf] German Canc Res Ctr, Clin Cooperat Unit Paediat Oncol, D-69120 Heidelberg, Germany; [Jabado, Nada] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3Z 2Z3, Canada; [Jabado, Nada] McGill Univ, Dept Paediat, Montreal, PQ H3Z 2Z3, Canada	McGill University; McGill University; McGill University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); McGill University; National Research Council Canada; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Burnazyan Federal Medical Biophysical Center; Helmholtz Association; German Cancer Research Center (DKFZ); Semmelweis University; University of Debrecen; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Klinikum Augsburg; University of Wurzburg; Martin Luther University Halle Wittenberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; McGill University; Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; McGill University; Ruprecht Karls University Heidelberg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; University of Cambridge; Helmholtz Association; German Cancer Research Center (DKFZ); McGill University; McGill University	Majewski, J (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada.	jacek.majewski@mcgill.ca; s.pfister@dkfz-heidelberg.de; nada.jabado@mcgill.ca	Garami, Miklós/AAK-5680-2021; Jones, David T. W./Z-1963-2019; Kulozik, Andreas/AAO-2432-2020; Rausch, Tobias/H-6511-2019; Zakrzewski, Krzysztof/M-5985-2014; Milde, Till/AAR-4528-2021; Khuong Quang, Dong Anh/GPT-2523-2022; Milde, Till/L-7755-2015; Plass, Christoph/H-7192-2014; Malkin, David/AAW-8715-2021; Sturm, Dominik/AAL-3689-2020; Witt, Hendrik/L-7810-2015; von Deimling, Andreas/F-7774-2013; Reifenberger, Guido/AAE-3599-2019; Lindroth, Anders M/C-7744-2015; Ebinger, Martin/O-4936-2016; Ryzhova, Marina/G-4178-2014; Zakrzewska, Magdalena/S-9308-2016; Zapatka, Marc/G-9896-2013; Kool, Marcel/H-2541-2013; Pfister, Stefan M/F-6860-2013; Jabado, Nada/AAN-4026-2020; Jones, David TW/G-9588-2013; Korbel, Jan O/G-6470-2012	Rausch, Tobias/0000-0001-5773-5620; Milde, Till/0000-0002-7267-1052; Sturm, Dominik/0000-0003-0250-1696; von Deimling, Andreas/0000-0002-5863-540X; Lindroth, Anders M/0000-0002-8291-2745; Ebinger, Martin/0000-0002-4229-8058; Ryzhova, Marina/0000-0001-7206-6365; Zakrzewska, Magdalena/0000-0001-5826-7726; Zapatka, Marc/0000-0001-8287-5967; Pfister, Stefan M/0000-0002-5447-5322; Jones, David TW/0000-0002-2036-5141; Korbel, Jan O/0000-0002-2798-3794; Zakrzewski, Krzysztof/0000-0001-5454-1783; Jaeger, Natalie/0000-0002-9589-7580; Korshunov, Andrey/0000-0002-5257-3623; Liberski, Pawel P./0000-0001-6507-4682; Castelo-Branco, Pedro/0000-0002-3453-3978; Tabori, Uri/0000-0002-5019-2683; Hovestadt, Volker/0000-0002-3480-6649; Schwartzentruber, Jeremy/0000-0002-6183-2092	Cole Foundation; Genome Canada; Canadian Institute for Health Research (CIHR); Genome BC; Genome Quebec; CIHR-ICR (Institute for Cancer Research); C17, through the Genome Canada/CIHR; Hungarian Scientific Research Fund(OTKA) [T-04639]; National Research and Development Fund (NKFP) [1A/002/2004]; German Cancer Aid [109252]; CNS tumour tissue bank [108456]; BMBF; Samantha Dickson Brain Tumour Trust; National Cancer Center Heidelberg; German Cancer Research Center; Foundation of Stars; Sybille Assmus Award for Neurooncology; Fonds de Recherche en Sante du Quebec; The Brain Tumour Charity [10/106] Funding Source: researchfish	Cole Foundation; Genome Canada(Genome Canada); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome BC; Genome Quebec; CIHR-ICR (Institute for Cancer Research)(Canadian Institutes of Health Research (CIHR)); C17, through the Genome Canada/CIHR; Hungarian Scientific Research Fund(OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research and Development Fund (NKFP); German Cancer Aid(Deutsche Krebshilfe); CNS tumour tissue bank; BMBF(Federal Ministry of Education & Research (BMBF)); Samantha Dickson Brain Tumour Trust; National Cancer Center Heidelberg; German Cancer Research Center(Helmholtz Association); Foundation of Stars; Sybille Assmus Award for Neurooncology; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); The Brain Tumour Charity	The authors are indebted to J. Rak, N. Sonenberg and C. Polychronakos for critical reading of this manuscript. D. M. Pearson, A. Wittmann, L. Sieber and L. Senf are acknowledged for technical assistance. This work was supported by the Cole Foundation, and was funded in part by Genome Canada and the Canadian Institute for Health Research (CIHR) with co-funding from Genome BC, Genome Quebec, CIHR-ICR (Institute for Cancer Research) and C17, through the Genome Canada/CIHR joint ATID Competition (project title: The Canadian Paediatric Cancer Genome Consortium: Translating next generation sequencing technologies into improved therapies for high-risk childhood cancer (NJ)), the Hungarian Scientific Research Fund(OTKA) Contract No. T-04639, the National Research and Development Fund (NKFP) Contract No. 1A/002/2004 (P. H., M. G., L. B.), the PedBrain project contributing to the International Cancer Genome Consortium funded by the German Cancer Aid (109252) and the CNS tumour tissue bank within the priority program on tumour tissue banking of the German Cancer Aid (108456), the BMBF, the Samantha Dickson Brain Tumour Trust, a grant from the National Cancer Center Heidelberg ("Paediatric Brain Tumor Preclinical Testing"), and a guest scientist stipend to M. R. from the German Cancer Research Center. X.-Y.L. and A. M. F. are the recipients of studentship awards from CIHR. K. J. is the recipient of a studentship from the Foundation of Stars. S. M. P. is the recipient of the Sybille Assmus Award for Neurooncology in 2009 and N. J. is the recipient of a Chercheur Boursier Award from Fonds de Recherche en Sante du Quebec.	Bax DA, 2010, CLIN CANCER RES, V16, P3368, DOI 10.1158/1078-0432.CCR-10-0438; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cervera AM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-89; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; De La Fuente R, 2004, DEV BIOL, V272, P1, DOI 10.1016/j.ydbio.2003.12.012; Dhayalan A, 2011, HUM MOL GENET, V20, P2195, DOI 10.1093/hmg/ddr107; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hakin-Smith V, 2003, LANCET, V361, P836, DOI 10.1016/S0140-6736(03)12681-5; Haque T, 2007, CLIN CANCER RES, V13, P6284, DOI 10.1158/1078-0432.CCR-07-0525; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Qu HQ, 2010, NEURO-ONCOLOGY, V12, P153, DOI 10.1093/neuonc/nop001; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Villard L, 1996, NAT GENET, V12, P359, DOI 10.1038/ng0496-359; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	35	1616	1645	10	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2012	482	7384					226	U119		10.1038/nature10833	http://dx.doi.org/10.1038/nature10833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	888HI	22855408				2022-12-01	WOS:000299994100040
J	Hanson, MA; Roth, CB; Jo, EJ; Griffith, MT; Scott, FL; Reinhart, G; Desale, H; Clemons, B; Cahalan, SM; Schuerer, SC; Sanna, MG; Han, GW; Kuhn, P; Rosen, H; Stevens, RC				Hanson, Michael A.; Roth, Christopher B.; Jo, Euijung; Griffith, Mark T.; Scott, Fiona L.; Reinhart, Greg; Desale, Hans; Clemons, Bryan; Cahalan, Stuart M.; Schuerer, Stephan C.; Sanna, M. Germana; Han, Gye Won; Kuhn, Peter; Rosen, Hugh; Stevens, Raymond C.			Crystal Structure of a Lipid G Protein-Coupled Receptor	SCIENCE			English	Article							LIGAND-BINDING POCKET; S1P(1); IDENTIFICATION; AGONIST; GPCR; RHODOPSIN; DISCOVERY; EDG1	The lyso-phospholipid sphingosine 1-phosphate modulates lymphocyte trafficking, endothelial development and integrity, heart rate, and vascular tone and maturation by activating G protein-coupled sphingosine 1-phosphate receptors. Here, we present the crystal structure of the sphingosine 1-phosphate receptor 1 fused to T4-lysozyme (S1P(1)-T4L) in complex with an antagonist sphingolipid mimic. Extracellular access to the binding pocket is occluded by the amino terminus and extracellular loops of the receptor. Access is gained by ligands entering laterally between helices I and VII within the transmembrane region of the receptor. This structure, along with mutagenesis, agonist structure-activity relationship data, and modeling, provides a detailed view of the molecular recognition and requirement for hydrophobic volume that activates S1P(1), resulting in the modulation of immune and stromal cell responses.	[Hanson, Michael A.; Roth, Christopher B.; Griffith, Mark T.; Scott, Fiona L.; Reinhart, Greg; Desale, Hans; Clemons, Bryan] Receptos, San Diego, CA 92121 USA; [Jo, Euijung; Cahalan, Stuart M.; Sanna, M. Germana; Rosen, Hugh] Scripps Res Inst, Dept Biol Chem, La Jolla, CA 92037 USA; [Schuerer, Stephan C.; Han, Gye Won; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Kuhn, Peter] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Rosen, Hugh] Scripps Res Inst, Mol Screening Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Hanson, MA (corresponding author), Receptos, 10835 Rd Cure,Suite 205, San Diego, CA 92121 USA.	mhanson@receptos.com; hrosen@scripps.edu; stevens@scripps.edu	Hansen, Matthew C/ABE-7226-2020; Han, Gye Won/GLQ-8724-2022; Noojipady, Praveen/B-2511-2010; Han, Gye Won/GLT-1531-2022; Stevens, Raymond/K-7272-2015; Loveland, Thomas/AAW-3332-2020; Goetz, Scott J/A-3393-2015; potapov, peter/AAE-7388-2019; Han, Gye Won/GLQ-8673-2022	Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Goetz, Scott J/0000-0002-6326-4308; Potapov, Peter/0000-0003-3977-0021; Jo, Euijung/0000-0003-1131-2723; Tyukavina, Alexandra/0000-0003-3872-9844	Protein Structure Initiative (PSI) [U54 GM094618]; NIH [P50 GM073197]; NIH Roadmap Molecular Libraries Probe Production Centers [U54 MH084512];  [AI074564];  [AI055509]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055509, U01AI074564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	Protein Structure Initiative (PSI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap Molecular Libraries Probe Production Centers; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the Protein Structure Initiative (PSI): Biology grant U54 GM094618 for structure production, NIH Roadmap grant P50 GM073197 for technology development, NIH Roadmap Molecular Libraries Probe Production Centers grant U54 MH084512 for antagonist and class II agonist identification, and AI074564 and AI055509 to H. R. and M. B. Oldstone for studying the role of S1P in infection and immunity. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences (NIGMS) or the NIH. We thank E. Chien for preliminary analysis; M. Mileni for critical evaluation of the structure; V. Cherezov, V. Katritch, and I. Wilson for careful review of the manuscript; J. Johnson, A. Leslie, W. Kabsch, and A. Perrakis for discussion and review of the experimental microdiffraction data assembly processing method; and A. Walker for assistance with manuscript preparation. We acknowledge J. Smith, R. Fischetti, and N. Sanishvili at the GM/CA-CAT beamline at the Advanced Photon Source, for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (Y1-CO-1020) and the NIGMS (Y1-GM-1104). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3V2W and 3V3Y. R. C. S. is a founder and on the Board of Directors, and H. R. is a founder and on the Scientific Advisory Board, of Receptos, a GPCR structure-based drug discovery company with an S1P<INF>1</INF> clinical compound. H. R. is an inventor on a patent application by The Scripps Research Institute (TSRI) on CYM-5442 and related S1P receptor modulators (US2010/0010001). Materials will be made available under a Material Transfer Agreement with TSRI.	[Anonymous], 2011, GLID VERS 5 7; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Fujiwara Y, 2007, J BIOL CHEM, V282, P2374, DOI 10.1074/jbc.M609648200; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schrodinger LLC, 2011, PRIM VERS 3 0; Schurer SC, 2008, ACS CHEM BIOL, V3, P486, DOI 10.1021/cb800051m; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Suite S., 2011, 2011 IND FIT DOCK PR; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	35	6038	6300	171	583	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					851	855		10.1126/science.1215904	http://dx.doi.org/10.1126/science.1215904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344443	Green Accepted			2022-12-01	WOS:000300356400043
J	Hansen, MC; Potapov, PV; Moore, R; Hancher, M; Turubanova, SA; Tyukavina, A; Thau, D; Stehman, SV; Goetz, SJ; Loveland, TR; Kommareddy, A; Egorov, A; Chini, L; Justice, CO; Townshend, JRG				Hansen, M. C.; Potapov, P. V.; Moore, R.; Hancher, M.; Turubanova, S. A.; Tyukavina, A.; Thau, D.; Stehman, S. V.; Goetz, S. J.; Loveland, T. R.; Kommareddy, A.; Egorov, A.; Chini, L.; Justice, C. O.; Townshend, J. R. G.			High-Resolution Global Maps of 21st-Century Forest Cover Change	SCIENCE			English	Article							DEFORESTATION; TRANSITION; EMISSIONS	Quantification of global forest change has been lacking despite the recognized importance of forest ecosystem services. In this study, Earth observation satellite data were used to map global forest loss (2.3 million square kilometers) and gain (0.8 million square kilometers) from 2000 to 2012 at a spatial resolution of 30 meters. The tropics were the only climate domain to exhibit a trend, with forest loss increasing by 2101 square kilometers per year. Brazil's well-documented reduction in deforestation was offset by increasing forest loss in Indonesia, Malaysia, Paraguay, Bolivia, Zambia, Angola, and elsewhere. Intensive forestry practiced within subtropical forests resulted in the highest rates of forest change globally. Boreal forest loss due largely to fire and forestry was second to that in the tropics in absolute and proportional terms. These results depict a globally consistent and locally relevant record of forest change.	[Hansen, M. C.; Potapov, P. V.; Turubanova, S. A.; Tyukavina, A.; Chini, L.; Justice, C. O.; Townshend, J. R. G.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Moore, R.; Hancher, M.; Thau, D.] Google, Mountain View, CA USA; [Stehman, S. V.] SUNY Syracuse, Dept Forest & Nat Resources Management, Syracuse, NY USA; [Goetz, S. J.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Loveland, T. R.] US Geol Survey, Sioux Falls, SD 57198 USA; [Kommareddy, A.; Egorov, A.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA	University System of Maryland; University of Maryland College Park; Google Incorporated; State University of New York (SUNY) System; Woods Hole Research Center; United States Department of the Interior; United States Geological Survey; South Dakota State University	Hansen, MC (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	mhansen@umd.edu	Hansen, Matthew C/ABE-7226-2020; Han, Gye Won/GLQ-8724-2022; Noojipady, Praveen/B-2511-2010; Han, Gye Won/GLT-1531-2022; Stevens, Raymond/K-7272-2015; Loveland, Thomas/AAW-3332-2020; Goetz, Scott J/A-3393-2015; potapov, peter/AAE-7388-2019; Han, Gye Won/GLQ-8673-2022	Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Goetz, Scott J/0000-0002-6326-4308; Potapov, Peter/0000-0003-3977-0021; Jo, Euijung/0000-0003-1131-2723; Tyukavina, Alexandra/0000-0003-3872-9844	NASA [NNH05ZDA001N, NNH07ZDA001N, NNX12AB43G, NNX12AC78G, NNX08AP33A, NNG06GD95G]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055509, U01AI074564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for Landsat data analysis and characterization was provided by the Gordon and Betty Moore Foundation, the United States Geological Survey, and Google, Inc. GLAS data analysis was supported by the David and Lucile Packard Foundation. Development of all methods was supported by NASA through its Land Cover and Land Use Change, Terrestrial Ecology, Applied Sciences, and MEaSUREs programs (grants NNH05ZDA001N, NNH07ZDA001N, NNX12AB43G, NNX12AC78G, NNX08AP33A, and NNG06GD95G) and by the U.S. Agency for International Development through its CARPE program. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U. S. government. Results are depicted and viewable online at full resolution: http://earthenginepartners.appspot.com/science-2013-global-forest.	Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/nclimate1354, 10.1038/NCLIMATE1354]; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; Edwards DP, 2011, NATURE, V477, P33, DOI 10.1038/477033a; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Food and Agricultural Organization of the United Nations, 2012, 169 FAO; Gardiner B., 2010, Destructive storms in European forests: past and forthcoming impacts; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hansen MC, 2004, ECOSYSTEMS, V7, P695, DOI 10.1007/s10021-004-0243-3; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Houghton R., 2001, CARBON MANAG, V1, P253; Instituto Nacional de Pesquisas Especias, 2013, MON BRAZ AM FOR SAT; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Potapov P, 2008, REMOTE SENS ENVIRON, V112, P3708, DOI 10.1016/j.rse.2008.05.006; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Prishchepov AV, 2013, LAND USE POLICY, V30, P873, DOI 10.1016/j.landusepol.2012.06.011; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rudel TK, 1998, RURAL SOCIOL, V63, P533, DOI 10.1111/j.1549-0831.1998.tb00691.x; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; United Nations Framework Convention on Climate Change, 2005, RED EM DEF DEV COUNT; Waterworth RM, 2007, FOREST ECOL MANAG, V238, P231, DOI 10.1016/j.foreco.2006.10.014	23	6038	6300	171	583	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					850	853		10.1126/science.1244693	http://dx.doi.org/10.1126/science.1244693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	22344443				2022-12-01	WOS:000326923000036
J	Wu, D; Hu, Q; Yan, Z; Chen, W; Yan, CY; Huang, X; Zhang, J; Yang, PY; Deng, HT; Wang, JW; Deng, XW; Shi, YG				Wu, Di; Hu, Qi; Yan, Zhen; Chen, Wen; Yan, Chuangye; Huang, Xi; Zhang, Jing; Yang, Panyu; Deng, Haiteng; Wang, Jiawei; Deng, XingWang; Shi, Yigong			Structural basis of ultraviolet-B perception by UVR8	NATURE			English	Article							CATION-PI INTERACTIONS; PLANT PHOTORECEPTOR DOMAIN; BLUE; CRYPTOCHROMES; PHYTOCHROME; REGULATOR; SOFTWARE; REVEALS	The Arabidopsis thaliana protein UVR8 is a photoreceptor for ultraviolet-B. Upon ultraviolet-B irradiation, UVR8 undergoes an immediate switch from homodimer to monomer, which triggers a signalling pathway for ultraviolet protection. The mechanism by which UVR8 senses ultraviolet-B remains largely unknown. Here we report the crystal structure of UVR8 at 1.8 angstrom resolution, revealing a symmetric homodimer of seven-bladed beta-propeller that is devoid of any external cofactor as the chromophore. Arginine residues that stabilize the homodimeric interface, principally Arg 286 and Arg 338, make elaborate intramolecular cation-pi interactions with surrounding tryptophan amino acids. Two of these tryptophans, Trp 285 and Trp 233, collectively serve as the ultraviolet-B chromophore. Our structural and biochemical analyses identify the molecular mechanism for UVR8-mediated ultraviolet-B perception, in which ultraviolet-B radiation results in destabilization of the intramolecular cation-pi interactions, causing disruption of the critical intermolecular hydrogen bonds mediated by Arg 286 and Arg 338 and subsequent dissociation of the UVR8 homodimer.	[Wu, Di; Hu, Qi; Yan, Zhen; Zhang, Jing; Deng, Haiteng; Shi, Yigong] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Wu, Di; Hu, Qi; Yan, Zhen; Yan, Chuangye; Zhang, Jing; Deng, Haiteng; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Chen, Wen; Huang, Xi; Yang, Panyu; Deng, XingWang] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Yan, Chuangye; Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Xi; Yang, Panyu; Deng, XingWang] Peking Univ, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Tsinghua University; Tsinghua University; Peking University; Tsinghua University; Peking University	Shi, YG (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021; Deng, Xing Wang/ABF-4107-2020	Wang, Jiawei/0000-0001-9893-8539; Jan, Lily/0000-0003-3938-8498; Shi, Yigong/0000-0003-2030-168X; He, Ye/0000-0002-3936-4958; Yan, Zhiqiang/0000-0003-4714-2076; Yan, Chuangye/0000-0001-9338-8048; Deng, Haiteng/0000-0001-9496-1280; Jan, Yuh Nung/0000-0003-1367-6299; Yan, Zhen/0000-0002-1999-8451	Ministry of Science and Technology [2009CB918801, 2012CB910900]; National Natural Science Foundation; Beijing Municipal Commission of Education; Beijing Municipal Commission of Science; Beijing Municipal Commission of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Beijing Municipal Commission of Science; Beijing Municipal Commission of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. He and S. Huang at SSRF, and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU, for assistance. This work was supported by funds from the Ministry of Science and Technology (grant no. 2009CB918801 to Y.S., and 2012CB910900 to X.W.D.), the National Natural Science Foundation, and the Beijing Municipal Commissions of Education and Science and Technology.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Brown BA, 2008, PLANT PHYSIOL, V146, P576, DOI 10.1104/pp.107.108456; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falciatore A, 2005, CURR TOP DEV BIOL, V68, P317, DOI 10.1016/S0070-2153(05)68011-8; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sinnokrot MO, 2002, J AM CHEM SOC, V124, P10887, DOI 10.1021/ja025896h; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van der Linden AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000503; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; YU HT, 1992, J AM CHEM SOC, V114, P8449, DOI 10.1021/ja00048a015	40	318	366	10	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					214	U96		10.1038/nature10931	http://dx.doi.org/10.1038/nature10931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22388820				2022-12-01	WOS:000303149900029
